data_2n1i_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n1i _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.8 mt . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 110.172 -0.307 . . . . 2.82 110.172 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.17 127.53 20.44 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.384 2.056 . . . . 2.04 111.589 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.422 HD13 ' H ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.97 151.62 78.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.97 -0.559 . . . . 1.53 109.917 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.66 139.72 87.21 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.567 2.178 . . . . 0.88 111.241 174.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.654 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -67.73 -7.65 28.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.637 0.606 . . . . 1.58 112.637 -172.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.482 ' OD2' ' HD3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -80.01 -9.61 59.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.724 0.297 . . . . 1.66 111.492 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.515 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 8.4 m-85 -140.18 146.76 39.16 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.501 -0.555 . . . . 1.2 109.501 -173.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 99' ' ' TRP . 13.3 pt-20 -114.2 135.21 54.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.982 0.42 . . . . 2.27 110.946 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.2 tt -101.71 129.94 47.98 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.324 -0.991 . . . . 1.37 108.324 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -162.47 150.71 14.43 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.433 -0.803 . . . . 3.75 109.792 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -82.99 111.36 18.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.0 -0.741 . . . . 2.46 109.0 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.2 p -149.07 90.7 1.77 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.773 -0.649 . . . . 2.03 109.365 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.1 m -68.43 104.12 1.82 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.248 0.547 . . . . 2.18 110.805 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.435 HG21 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -94.89 118.95 66.63 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.649 -0.705 . . . . 1.96 109.199 174.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -52.44 121.22 8.65 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.251 2.634 . . . . 1.87 112.466 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.538 ' HA3' ' SG ' ' A' ' 176' ' ' CYS . . . 108.23 -16.02 35.68 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.843 -0.694 . . . . 1.74 112.36 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.89 -71.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.724 -0.28 . . . . 1.79 111.395 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.511 ' HA3' ' NH1' ' A' ' 173' ' ' ARG . . . 133.38 -127.91 4.85 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.877 -0.678 . . . . 1.14 111.954 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.0 mt -97.66 147.6 24.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.655 0.228 . . . . 2.81 110.5 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -158.21 171.4 35.12 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.585 -0.606 . . . . 0.8 111.585 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 98' ' ' VAL . 27.7 m -99.31 111.58 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.497 0.665 . . . . 1.17 110.037 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.522 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 59.2 m95 -81.57 124.52 29.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.852 -0.613 . . . . 1.4 110.316 -172.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 202' ' ' PRO . . . -68.98 114.81 7.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.582 -0.525 . . . . 1.2 109.582 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.654 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -82.62 -9.48 59.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.37 0.605 . . . . 2.23 109.669 177.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.482 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 63.4 ttt180 -125.11 162.55 24.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.31 -0.859 . . . . 4.08 108.823 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.613 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -91.53 158.72 16.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.874 0.369 . . . . 2.86 110.952 -176.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.421 ' HE1' HG13 ' A' ' 200' ' ' ILE . 64.4 mtm -135.42 152.59 51.54 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.103 -0.703 . . . . 1.38 109.103 176.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -113.05 147.74 36.62 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.092 0.245 . . . . 2.31 110.516 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.81 123.97 2.91 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 124.474 1.109 . . . . 1.42 112.973 -170.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.75 7.7 13.01 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.451 -0.795 . . . . 1.04 111.183 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.487 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 1.0 OUTLIER -84.04 157.59 21.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.507 0.67 . . . . 2.62 110.923 -178.052 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.641 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 2.7 tmm_? -144.1 134.09 24.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.494 -0.776 . . . . 4.16 109.546 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.515 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 6.3 mt -87.76 137.36 32.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.875 -0.33 . . . . 1.11 110.119 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.38 170.99 43.76 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.917 -0.659 . . . . 1.09 111.481 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -88.62 148.38 27.1 Favored 'Cis proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.181 -1.591 . . . . 2.52 112.491 -2.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.496 ' O ' ' HA3' ' A' ' 166' ' ' GLY . 28.9 t . . . . . 0 C--N 1.328 -0.331 0 N-CA-C 108.958 -0.756 . . . . 2.5 108.958 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.448 -0.512 0 N-CA-C 112.947 -0.061 . . . . 1.69 112.947 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.66 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 23.1 t -65.56 -16.0 63.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.859 0.361 . . . . 2.0 111.349 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.557 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 24.4 p-90 -64.88 -23.82 67.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.846 0.355 . . . . 0.83 111.184 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.557 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 17.8 mt -86.3 -15.01 41.96 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.825 0.676 . . . . 1.28 112.825 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.66 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -82.17 -2.01 50.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.013 -0.675 . . . . 2.03 110.785 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -79.2 -36.88 39.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.189 -0.459 . . . . 2.19 112.077 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.839 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -64.39 133.0 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.861 0.362 . . . . 1.24 111.03 -176.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.511 ' NH1' ' HA3' ' A' ' 95' ' ' GLY . 98.8 mtt180 -118.53 -172.92 2.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 4.97 111.222 -174.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -71.31 145.0 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.177 -0.465 . . . . 1.63 110.314 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.401 ' HB2' HD12 ' A' ' 183' ' ' LEU . . . -59.61 135.88 57.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.919 -0.582 . . . . 1.34 111.563 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.538 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 41.6 t -57.1 -34.56 68.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.609 -1.178 . . . . 2.58 111.629 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.7 p -126.7 144.15 51.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.072 0.463 . . . . 2.06 110.949 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 46.0 t -72.51 -9.71 58.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.789 -0.641 . . . . 2.69 110.808 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.68 -11.77 55.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.187 0.518 . . . . 2.42 110.059 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -110.21 16.64 21.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 2.12 111.347 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -60.95 115.14 3.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 1.52 110.474 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.495 ' H ' HD11 ' A' ' 183' ' ' LEU . 18.0 t30 -154.82 38.17 0.42 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 122.084 0.945 . . . . 1.68 108.538 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.589 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.1 OUTLIER -123.18 129.93 52.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.13 -0.941 . . . . 1.43 110.711 -173.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 43.0 m -151.21 137.32 18.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.058 0.456 . . . . 1.2 111.467 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 51.2 tpp -88.18 134.91 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.952 -0.567 . . . . 1.56 110.65 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 39.9 t -113.15 131.93 55.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.939 -0.573 . . . . 2.13 110.387 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 25.2 tm0? -123.09 105.54 10.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.272 -0.64 . . . . 1.96 109.272 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.599 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 22.0 pt -136.84 142.58 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.191 -0.458 . . . . 1.62 110.426 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.9 m 57.48 27.07 13.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.403 0.439 . . . . 2.24 111.303 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.503 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 0.7 OUTLIER 64.5 14.56 9.0 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.7 -0.682 . . . . 2.83 112.475 -178.59 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 16.3 pt20 -117.75 159.66 22.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.551 -0.537 . . . . 1.86 109.551 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.4 133.47 44.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.398 -0.364 . . . . 1.59 111.965 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.641 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 43.2 m-85 -141.42 150.62 42.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.702 -0.681 . . . . 4.16 110.499 176.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.454 ' CE1' ' HB3' ' A' ' 169' ' ' LEU . 13.4 m-85 -101.17 114.21 27.95 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.437 -0.579 . . . . 1.27 109.437 175.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.429 ' HD2' ' C ' ' A' ' 195' ' ' LYS . 5.2 tmmm? -98.78 127.05 44.59 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.4 -0.593 . . . . 1.73 109.4 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.487 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 2.0 t -93.01 151.26 3.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.627 0.727 . . . . 1.33 110.015 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 197' ' ' ILE . 1.2 mm -85.68 -58.13 3.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.708 -1.133 . . . . 1.23 110.274 -168.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.429 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -137.07 179.87 6.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.335 -0.848 . . . . 1.88 110.771 176.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -48.16 136.9 11.3 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.097 0.873 . . . . 2.23 113.223 -170.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.434 HD13 ' ND2' ' A' ' 182' ' ' ASN . 33.1 mm -102.48 133.65 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.737 -0.665 . . . . 1.41 110.268 176.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -98.68 138.87 20.78 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.611 -0.722 . . . . 2.06 109.607 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 49.7 Cg_exo -55.77 115.28 2.34 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.457 2.105 . . . . 0.56 111.962 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.72 7.44 8.06 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.497 -0.859 . . . . 0.7 113.498 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.62 122.27 11.83 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.643 0.722 . . . . 1.27 111.535 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -111.78 95.36 5.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.817 -0.629 . . . . 2.92 112.03 177.243 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.489 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.4 mm? -115.65 97.68 6.27 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.33 -0.948 . . . . 1.51 109.46 173.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.839 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 0.9 OUTLIER -146.96 115.07 6.57 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.127 -0.488 . . . . 1.16 109.806 176.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.589 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.9 p -153.64 158.42 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 121.729 -0.607 . . . . 1.5 111.191 -177.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -84.89 110.92 19.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.28 -1.008 . . . . 1.77 108.28 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.223 0.535 . . . . 3.05 110.226 -178.764 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.5 mt . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 110.607 -0.145 . . . . 2.82 110.607 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.66 133.2 49.96 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.757 2.305 . . . . 2.04 112.798 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.446 ' H ' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -125.68 146.6 55.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.59 -0.732 . . . . 1.53 109.891 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.64 147.9 76.92 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.683 2.255 . . . . 0.88 111.339 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.56 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -57.59 -23.58 51.61 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.462 0.912 . . . . 1.58 113.462 -170.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -89.83 8.35 32.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.596 0.591 . . . . 1.66 112.596 -173.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.448 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 23.8 m-85 -132.54 139.47 47.89 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.8 -0.815 . . . . 1.2 108.8 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.445 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 41.8 tt0 -114.36 119.56 37.35 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.839 -0.344 . . . . 2.27 111.103 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 tt -84.19 131.67 34.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.291 -0.633 . . . . 1.37 109.291 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -140.38 124.14 17.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.264 -0.426 . . . . 3.75 110.752 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -80.84 111.82 17.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.298 -0.631 . . . . 2.46 109.298 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -177.31 127.06 0.15 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.566 -0.901 . . . . 2.03 108.566 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.2 m -90.69 105.51 17.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.887 0.375 . . . . 2.18 111.132 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.482 HG22 ' HB1' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -85.44 123.62 72.66 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 108.766 -0.827 . . . . 1.96 108.766 174.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.5 119.13 5.69 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.337 2.691 . . . . 1.87 113.233 -172.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.7 -28.74 10.87 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.645 -0.707 . . . . 1.74 112.259 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB1' HG22 ' A' ' 91' ' ' ILE . . . -117.42 -58.45 2.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.898 0.38 . . . . 1.79 110.946 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 91' ' ' ILE . . . 114.52 -138.68 15.03 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.894 -0.594 . . . . 1.14 111.722 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.32 159.74 32.91 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.503 -0.184 . . . . 2.81 110.503 175.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.57 178.17 46.46 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.576 -0.821 . . . . 0.8 112.269 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.65 148.33 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.239 -0.652 . . . . 1.17 109.239 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -119.14 120.21 36.44 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.074 -0.343 . . . . 1.4 110.074 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.477 ' H ' ' HG2' ' A' ' 205' ' ' GLU . . . -67.79 125.43 26.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.323 -0.399 . . . . 1.2 110.955 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.56 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -88.23 -1.04 57.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.881 0.372 . . . . 2.23 110.285 176.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.431 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 15.6 ttm-85 -125.7 152.62 45.03 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.392 -0.595 . . . . 4.08 109.392 174.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.554 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -76.7 159.62 30.04 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.358 -0.383 . . . . 2.86 110.728 176.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.667 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 47.3 mtm -134.25 152.11 51.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.51 -0.314 . . . . 1.38 110.262 176.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -130.66 144.52 51.49 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.691 0.62 . . . . 2.31 110.045 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -37.42 121.07 0.83 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 124.446 1.091 . . . . 1.42 113.467 -170.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.21 7.26 12.68 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.464 -0.789 . . . . 1.04 111.509 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.5 ' CD ' ' HB ' ' A' ' 196' ' ' VAL . 0.9 OUTLIER -83.68 164.42 19.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.96 0.41 . . . . 2.62 110.648 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.653 ' HG3' ' CE2' ' A' ' 193' ' ' TYR . 8.5 tmm_? -145.97 130.96 18.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.364 -0.38 . . . . 4.16 110.777 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.448 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 5.1 mt -96.45 138.24 34.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.304 -0.628 . . . . 1.11 109.304 175.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.451 ' HA3' ' C ' ' A' ' 112' ' ' PRO . . . 83.74 -117.39 4.43 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.651 -0.785 . . . . 1.09 112.608 177.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.451 ' C ' ' HA3' ' A' ' 111' ' ' GLY . 17.4 Cg_exo -66.73 167.35 56.63 Favored 'Cis proline' 0 C--N 1.347 0.498 0 CA-C-N 118.94 1.37 . . . . 2.52 113.716 5.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.42 ' O ' ' HA3' ' A' ' 166' ' ' GLY . 42.2 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 2.5 110.139 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 113.544 0.177 . . . . 1.69 113.544 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.5 t -59.54 -23.31 62.74 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.6 0.36 . . . . 2.0 111.853 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 41.4 p-90 -65.17 -17.48 64.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.007 0.432 . . . . 0.83 111.314 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 43.7 mt -80.16 -13.86 58.93 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.199 0.444 . . . . 1.28 112.199 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -70.55 -13.1 61.97 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.264 -0.574 . . . . 2.03 109.887 177.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -68.06 -36.81 80.49 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.707 -0.679 . . . . 2.19 111.406 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.655 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -69.36 124.77 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.325 -0.55 . . . . 1.24 109.942 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.493 ' HA ' ' NE ' ' A' ' 173' ' ' ARG . 3.9 mmp_? -112.29 -166.51 1.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.957 -0.565 . . . . 4.97 110.82 -176.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.0 t -73.55 151.9 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.332 . . . . 1.63 110.566 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.424 ' HB1' HD13 ' A' ' 183' ' ' LEU . . . -64.38 134.23 54.17 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.01 -0.541 . . . . 1.34 111.014 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.5 t -78.94 -12.46 60.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.381 -0.827 . . . . 2.58 110.245 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.5 m -125.74 140.99 52.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.904 -0.589 . . . . 2.06 109.641 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 61.4 m -79.38 -19.39 50.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 2.69 111.2 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -89.29 1.78 55.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.233 0.539 . . . . 2.42 110.099 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -110.78 15.81 21.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.545 -0.752 . . . . 2.12 110.412 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -60.91 116.79 4.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.85 -0.614 . . . . 1.52 110.632 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.546 ' ND2' HD11 ' A' ' 200' ' ' ILE . 23.7 t30 -153.9 33.18 0.44 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.076 0.941 . . . . 1.68 109.282 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -121.93 120.8 35.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.563 -0.744 . . . . 1.43 110.644 -172.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 30.3 m -142.92 121.91 12.81 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.265 0.555 . . . . 1.2 110.93 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.595 ' HE2' ' CZ ' ' A' ' 194' ' ' TYR . 52.2 tpp -92.19 127.74 37.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.639 -0.709 . . . . 1.56 109.981 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 38.6 t -126.11 162.43 25.36 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.402 -0.592 . . . . 2.13 109.402 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -134.43 147.06 50.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.757 0.313 . . . . 1.96 110.835 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.733 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 24.4 pt -137.42 133.48 46.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.53 -0.759 . . . . 1.62 109.479 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.7 t 55.33 28.87 12.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.954 0.407 . . . . 2.24 110.84 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 66.86 24.29 9.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.552 -0.749 . . . . 2.83 112.058 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.733 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 11.9 pt20 -118.53 155.01 31.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.09 -0.707 . . . . 1.86 109.09 172.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' A' ' 113' ' ' CYS . 38.0 mm -81.65 126.06 39.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.108 0.48 . . . . 1.59 111.806 -170.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.653 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 63.0 t80 -121.92 127.64 50.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.401 -0.818 . . . . 4.16 110.401 -174.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.595 ' CZ ' ' HE2' ' A' ' 185' ' ' MET . 7.2 m-85 -99.9 113.48 26.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.046 0.45 . . . . 1.27 110.048 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -114.97 123.32 48.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.554 -0.748 . . . . 1.73 109.952 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.5 ' HB ' ' CD ' ' A' ' 108' ' ' GLU . 2.0 t -96.45 153.35 3.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.559 0.695 . . . . 1.33 109.754 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 2.1 mm -92.61 -58.05 3.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.575 -1.193 . . . . 1.23 111.931 -166.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.522 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.7 OUTLIER -141.03 -178.18 5.45 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.616 -0.72 . . . . 1.88 111.713 -173.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.667 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.5 m-20 -45.8 116.21 1.15 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.986 0.804 . . . . 2.23 112.93 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.546 HD11 ' ND2' ' A' ' 182' ' ' ASN . 14.8 mm -88.28 135.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.563 -0.744 . . . . 1.41 109.535 170.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 46.4 mt-10 -99.94 130.43 26.35 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.236 -0.653 . . . . 2.06 109.236 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.33 117.71 2.45 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.067 2.512 . . . . 0.56 112.695 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.93 -9.99 9.63 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.872 -0.68 . . . . 0.7 112.982 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 19.9 pt-20 -138.52 121.48 16.66 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 117.569 0.685 . . . . 1.27 112.118 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.477 ' HG2' ' H ' ' A' ' 100' ' ' ALA . 7.7 mm-40 -111.2 125.0 53.33 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.061 -0.518 . . . . 2.92 110.201 170.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.529 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 2.4 mm? -122.28 99.29 6.34 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.327 -0.62 . . . . 1.51 109.327 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.655 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.3 mm? -145.62 115.59 7.38 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.497 -0.557 . . . . 1.16 109.497 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.48 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 6.3 p -153.21 157.89 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.509 -0.476 . . . . 1.5 111.169 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -98.6 111.4 23.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.84 -0.618 . . . . 1.77 109.828 173.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.434 HG23 HG13 ' A' ' 208' ' ' VAL . 52.6 t . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 109.329 -0.619 . . . . 3.05 109.329 171.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.732 -0.47 . . . . 2.82 109.732 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.41 117.64 4.17 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.0 2.467 . . . . 2.04 112.983 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.413 HD13 ' H ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -128.41 146.03 58.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.823 -0.626 . . . . 1.53 109.584 176.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -53.19 147.71 34.27 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.823 2.349 . . . . 0.88 112.11 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.557 ' O ' ' HD2' ' A' ' 101' ' ' LYS . . . -70.56 -0.39 8.46 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.551 0.574 . . . . 1.58 112.551 -173.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -106.0 4.6 29.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.881 0.372 . . . . 1.66 111.167 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -136.1 138.5 42.14 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.272 -0.64 . . . . 1.2 109.272 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.453 ' HB2' ' HE2' ' A' ' 101' ' ' LYS . 5.8 tp10 -109.81 124.27 51.01 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.299 -0.56 . . . . 2.27 111.286 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.0 tp -87.91 128.3 35.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.158 -0.473 . . . . 1.37 110.078 176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -147.87 118.87 7.66 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.635 -0.711 . . . . 3.75 109.796 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.14 112.62 10.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.989 0.424 . . . . 2.46 109.971 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.2 t -172.92 133.56 0.55 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.338 -0.986 . . . . 2.03 108.338 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.4 t -87.36 106.04 17.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.929 0.395 . . . . 2.18 110.805 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.594 HG21 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -85.79 123.12 72.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.413 -0.588 . . . . 1.96 109.413 173.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -45.59 119.32 2.64 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.515 2.81 . . . . 1.87 113.346 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.32 -29.1 10.46 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.812 -0.631 . . . . 1.74 112.415 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 173' ' ' ARG . . . -124.28 -65.88 1.02 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.048 0.451 . . . . 1.79 111.671 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.594 ' O ' HG21 ' A' ' 91' ' ' ILE . . . 123.5 -132.59 8.56 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.127 -0.789 . . . . 1.14 111.127 -175.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 pp -72.82 159.69 33.37 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.986 0.393 . . . . 2.81 110.746 175.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.91 174.73 47.09 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.844 -0.693 . . . . 0.8 111.958 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.553 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 19.4 m -106.64 130.8 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 121.266 0.555 . . . . 1.17 109.71 174.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -96.85 114.89 26.56 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.652 -0.704 . . . . 1.4 110.019 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.34 114.26 4.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.235 -0.283 . . . . 1.2 110.235 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.557 ' HD2' ' O ' ' A' ' 82' ' ' ALA . 15.8 ptpt -83.71 -8.99 59.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.244 0.545 . . . . 2.23 110.665 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 27.2 ttp180 -125.66 155.75 40.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.547 -0.751 . . . . 4.08 109.772 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.419 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -81.88 155.45 25.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.95 -0.568 . . . . 2.86 109.779 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.568 ' HB3' ' OE2' ' A' ' 108' ' ' GLU . 59.6 mtm -136.13 153.31 51.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.684 -0.234 . . . . 1.38 110.507 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -117.34 140.37 49.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.129 -0.487 . . . . 2.31 109.716 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.62 131.39 3.92 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 124.421 1.076 . . . . 1.42 113.61 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.25 7.67 11.03 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.528 -0.76 . . . . 1.04 112.368 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.568 ' OE2' ' HB3' ' A' ' 104' ' ' MET . 0.7 OUTLIER -85.74 167.9 14.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.293 0.568 . . . . 2.62 111.435 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -143.28 135.33 26.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.746 -0.661 . . . . 4.16 110.182 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 4.4 mt -104.6 132.91 50.3 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.598 -0.89 . . . . 1.11 108.598 171.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.82 166.48 39.67 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.188 -1.006 . . . . 1.09 112.724 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.18 142.03 43.75 Favored 'Cis proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.414 -1.494 . . . . 2.52 111.909 -2.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.618 ' SG ' HD11 ' A' ' 169' ' ' LEU . 56.9 m . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 121.044 0.45 . . . . 2.5 110.765 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 112.698 -0.161 . . . . 1.69 112.698 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.9 m -59.5 -39.49 83.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.001 0.371 . . . . 2.0 112.001 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.476 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 29.9 p-90 -85.55 -22.66 28.01 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.42 -0.512 . . . . 0.83 111.157 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.618 HD11 ' SG ' ' A' ' 113' ' ' CYS . 28.7 mt -86.93 -15.0 40.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.389 0.514 . . . . 1.28 112.389 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.407 ' C ' ' HD3' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -75.33 -4.09 37.24 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.661 -0.415 . . . . 2.03 110.523 176.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -76.57 -37.62 56.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.085 -0.507 . . . . 2.19 111.586 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -67.34 129.36 31.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.539 -0.464 . . . . 1.24 110.057 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.403 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . 98.9 mtt180 -125.98 -163.38 1.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.933 -0.576 . . . . 4.97 111.835 -172.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.436 ' HA ' HG12 ' A' ' 208' ' ' VAL . 20.0 t -62.62 146.83 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.261 -0.881 . . . . 1.63 111.449 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.469 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -65.35 136.13 56.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.881 -0.6 . . . . 1.34 111.343 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.74 -19.3 64.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.35 -0.841 . . . . 2.58 111.143 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 63.6 m -146.03 147.56 31.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.227 -0.442 . . . . 2.06 110.027 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 10.6 p -76.89 -13.66 59.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.877 0.37 . . . . 2.69 111.427 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -73.56 -25.34 60.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.493 0.663 . . . . 2.42 110.101 172.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.44 ' O ' ' HG ' ' A' ' 206' ' ' LEU . 17.0 m-20 -92.61 17.27 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.428 -0.805 . . . . 2.12 111.606 -176.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -55.65 114.46 1.87 Allowed 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.36 0.6 . . . . 1.52 110.068 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.674 ' ND2' HD13 ' A' ' 200' ' ' ILE . 19.5 t30 -161.59 34.51 0.13 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 122.597 1.189 . . . . 1.68 108.112 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.638 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -124.8 119.0 27.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.99 -1.005 . . . . 1.43 110.34 -172.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 61.3 m -150.62 129.37 12.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.06 0.457 . . . . 1.2 111.19 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 49.4 ttm -91.04 137.29 32.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.174 -0.466 . . . . 1.56 110.11 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 50.0 t -115.28 132.06 56.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.166 -0.47 . . . . 2.13 110.579 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 23.5 tm0? -108.87 105.21 14.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.278 -0.638 . . . . 1.96 109.278 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 13.3 pt -144.01 144.13 23.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.001 -0.545 . . . . 1.62 110.331 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.1 t 61.29 27.87 17.48 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.211 0.529 . . . . 2.24 110.371 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.408 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 6.0 mm-40 57.9 32.85 22.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.217 -0.901 . . . . 2.83 111.641 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -144.97 165.99 26.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.769 -0.65 . . . . 1.86 109.702 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.7 mm -100.23 133.11 44.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.04 0.448 . . . . 1.59 111.668 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -132.31 156.89 45.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.226 -0.897 . . . . 4.16 109.164 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.432 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 11.1 m-85 -100.31 119.3 38.2 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.43 -0.508 . . . . 1.27 109.776 173.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -98.17 118.01 33.84 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.462 -0.94 . . . . 1.73 108.462 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.516 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 1.8 t -89.32 151.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.493 0.663 . . . . 1.33 109.784 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 182' ' ' ASN . 1.3 mm -97.0 -53.66 7.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 114.656 -1.156 . . . . 1.23 111.553 -163.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.547 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -135.76 174.27 10.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.484 -0.78 . . . . 1.88 111.491 -174.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 104' ' ' MET . 3.0 m-20 -50.49 119.65 3.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.368 -0.833 . . . . 2.23 112.268 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.674 HD13 ' ND2' ' A' ' 182' ' ' ASN . 17.3 mm -86.99 135.81 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.985 -0.552 . . . . 1.41 110.627 177.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.67 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 20.1 mm-40 -101.65 134.64 20.09 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.656 -0.702 . . . . 2.06 109.481 174.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.1 113.5 1.13 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.802 2.335 . . . . 0.56 112.953 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.31 -10.21 9.34 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.68 -0.771 . . . . 0.7 113.537 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.67 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.7 pt-20 -107.55 127.37 53.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.709 0.754 . . . . 1.27 111.541 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.553 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -109.4 93.59 4.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.471 -0.786 . . . . 2.92 111.616 177.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.594 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.6 mm? -124.56 95.82 4.67 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.57 -0.852 . . . . 1.51 110.885 175.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.529 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.8 mm? -148.07 111.7 5.03 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.263 -0.643 . . . . 1.16 109.263 170.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.638 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.7 p -157.05 160.8 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 117.892 0.314 . . . . 1.5 110.437 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -109.93 110.9 22.0 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.574 -0.528 . . . . 1.77 109.574 168.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 96.5 t . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 3.05 110.216 176.249 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.459 -0.571 . . . . 2.82 109.459 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.14 119.67 6.95 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.809 2.34 . . . . 2.04 112.256 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.428 ' H ' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -126.86 144.03 48.73 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 1.53 109.723 178.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.87 144.76 87.18 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.579 2.186 . . . . 0.88 111.453 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.34 -12.27 8.77 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.798 0.666 . . . . 1.58 112.798 -173.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -80.96 -11.27 59.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.925 0.393 . . . . 1.66 110.911 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -133.92 165.1 25.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.911 -0.774 . . . . 1.2 108.911 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HA ' HG13 ' A' ' 80' ' ' ILE . 10.1 pt-20 -155.84 147.01 22.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.914 0.388 . . . . 2.27 110.671 173.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.448 HD11 ' CZ ' ' A' ' 171' ' ' TYR . 7.0 tt -92.26 132.33 36.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.864 -0.607 . . . . 1.37 110.43 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.403 ' N ' HD23 ' A' ' 86' ' ' LEU . 76.1 mtt180 -144.27 138.88 28.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.403 -0.817 . . . . 3.75 109.841 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -82.04 112.91 19.55 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.348 -0.612 . . . . 2.46 109.348 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 p -169.03 90.11 0.22 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.678 -0.692 . . . . 2.03 109.749 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 p -69.95 105.43 2.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.243 0.544 . . . . 2.18 110.744 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.537 HG22 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -85.17 123.78 72.92 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.928 -0.767 . . . . 1.96 108.928 175.265 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.08 120.27 7.68 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.287 2.658 . . . . 1.87 112.735 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.6 -11.25 53.72 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.597 -0.811 . . . . 1.74 112.181 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.537 ' HB3' HG22 ' A' ' 91' ' ' ILE . . . -134.11 -63.07 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.711 -0.288 . . . . 1.79 111.609 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.03 -145.83 17.29 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.786 -0.721 . . . . 1.14 113.106 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.56 158.68 35.23 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.4 0.28 . . . . 2.81 110.83 177.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.09 175.97 43.33 Favored Glycine 0 C--O 1.237 0.308 0 C-N-CA 120.346 -0.931 . . . . 0.8 112.421 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 98' ' ' VAL . 35.3 m -111.22 114.27 46.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.634 0.73 . . . . 1.17 109.263 174.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -80.73 100.77 8.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.476 0.655 . . . . 1.4 110.996 -169.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.08 120.95 13.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.732 -1.122 . . . . 1.2 110.751 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.558 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -101.64 13.79 33.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.513 0.673 . . . . 2.23 109.447 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -125.83 155.94 40.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.961 -1.018 . . . . 4.08 109.16 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.496 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -83.3 116.27 22.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.211 0.529 . . . . 2.86 111.244 174.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.568 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 4.8 mpp? -86.92 130.96 34.24 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.573 -0.899 . . . . 1.38 108.573 172.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.633 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 8.4 pt-20 -116.32 174.45 6.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.902 0.382 . . . . 2.31 111.914 -173.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.93 126.46 18.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.645 -0.707 . . . . 1.42 112.899 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.58 -17.19 59.71 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.779 -0.646 . . . . 1.04 114.202 168.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 7.3 pt-20 -76.28 160.09 29.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.607 0.704 . . . . 2.62 111.799 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.79 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 6.6 ttt180 -116.42 142.09 47.31 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.418 -0.81 . . . . 4.16 110.667 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.7 mt -92.47 136.21 33.4 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.952 -0.758 . . . . 1.11 108.952 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 149.88 -147.79 18.41 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.374 -0.917 . . . . 1.09 112.649 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -75.34 135.01 38.43 Favored 'Cis proline' 0 CA--C 1.532 0.376 0 C-N-CA 123.064 -1.64 . . . . 2.52 112.516 3.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.414 ' SG ' ' HA3' ' A' ' 166' ' ' GLY . 42.5 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.466 -0.788 . . . . 2.5 109.789 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.414 ' HA3' ' SG ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 111.706 -0.558 . . . . 1.69 111.706 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.3 m -54.13 -35.08 61.8 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.953 0.501 . . . . 2.0 112.226 -176.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -84.44 -17.6 38.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.886 0.374 . . . . 0.83 111.299 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 28.8 mt -86.11 -14.6 43.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.472 -0.331 . . . . 1.28 111.768 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -10.43 59.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.351 0.596 . . . . 2.03 109.541 175.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.448 ' CZ ' HD11 ' A' ' 86' ' ' LEU . 43.7 m-85 -79.52 -30.21 41.77 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.274 -0.875 . . . . 2.19 111.872 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.522 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 1.3 mm -56.03 129.64 17.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 120.858 0.361 . . . . 1.24 110.521 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 94' ' ' ALA . 13.6 mmm180 -93.94 143.59 26.21 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.501 0.667 . . . . 4.97 111.819 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.52 ' HA ' ' CD2' ' A' ' 183' ' ' LEU . 10.1 p -77.77 153.76 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.209 -0.905 . . . . 1.63 109.174 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -48.04 111.59 0.46 Allowed 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.654 0.597 . . . . 1.34 112.176 -172.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 51.6 t -66.09 -33.63 76.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.277 -0.874 . . . . 2.58 109.771 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.451 ' HB3' ' OD1' ' A' ' 180' ' ' ASP . 11.9 t -131.08 152.28 50.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.907 -0.775 . . . . 2.06 108.907 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 61.8 m -71.92 -6.09 39.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.472 -0.331 . . . . 2.69 111.545 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.89 1.38 56.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.77 0.319 . . . . 2.42 110.868 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.451 ' OD1' ' HB3' ' A' ' 177' ' ' SER . 29.3 m-20 -110.14 15.27 22.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.378 -0.374 . . . . 2.12 111.093 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 15.0 mm100 -63.63 115.51 4.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.253 0.549 . . . . 1.52 111.946 -173.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.536 ' H ' HD11 ' A' ' 183' ' ' LEU . 22.7 t30 -161.39 31.58 0.13 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.093 0.949 . . . . 1.68 108.779 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.722 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.5 OUTLIER -119.28 122.52 42.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 1.43 111.184 -171.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 60.9 m -150.13 136.01 18.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.983 0.421 . . . . 1.2 110.421 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.421 ' HB3' ' HB2' ' A' ' 209' ' ' HIS . 49.9 ttm -125.62 135.49 52.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.208 -0.451 . . . . 1.56 109.852 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 18.6 t -115.11 152.51 32.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.221 -0.445 . . . . 2.13 109.836 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.73 104.86 11.78 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.011 -0.737 . . . . 1.96 109.011 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 33.2 pt -135.49 144.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.978 -0.556 . . . . 1.62 110.541 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.8 m 57.46 30.11 18.11 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.459 0.474 . . . . 2.24 111.558 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 64.3 17.36 10.69 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.493 -0.776 . . . . 2.83 111.301 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -124.93 167.2 15.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 1.86 110.189 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.6 mm -90.73 130.07 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.069 -0.514 . . . . 1.59 110.861 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -121.76 122.95 40.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.271 -0.422 . . . . 4.16 110.535 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.79 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 13.7 m-85 -99.79 113.96 26.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.915 -0.772 . . . . 1.27 108.915 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -110.45 124.14 51.21 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.9 -0.32 . . . . 1.73 110.217 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.403 HG13 ' H ' ' A' ' 197' ' ' ILE . 1.7 t -93.42 151.85 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 122.059 0.933 . . . . 1.33 110.688 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.418 ' H ' HG12 ' A' ' 197' ' ' ILE . 0.8 OUTLIER -101.57 -56.43 5.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 113.734 -1.576 . . . . 1.23 112.009 -164.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.44 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -140.9 162.78 34.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.975 -1.012 . . . . 1.88 110.117 -176.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.568 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.4 m-20 -58.27 111.67 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.85 0.719 . . . . 2.23 112.189 -173.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.482 HG13 ' HE2' ' A' ' 104' ' ' MET . 6.1 mm -68.85 145.82 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.255 -0.884 . . . . 1.41 110.9 175.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 14.2 mt-10 -92.63 117.64 67.67 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.278 -0.873 . . . . 2.06 108.697 172.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -43.31 122.19 2.86 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.614 2.876 . . . . 0.56 113.688 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.91 -3.22 10.81 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.822 -0.704 . . . . 0.7 113.127 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 11.3 pt-20 -137.37 125.56 23.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.247 0.546 . . . . 1.27 111.031 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.522 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -109.57 108.05 18.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.017 -0.538 . . . . 2.92 111.507 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.554 ' O ' HD21 ' A' ' 207' ' ' LEU . 1.4 mm? -123.24 97.9 5.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.064 -0.655 . . . . 1.51 109.944 173.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.554 HD21 ' O ' ' A' ' 206' ' ' LEU . 1.1 mm? -149.1 102.12 3.21 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.985 -0.746 . . . . 1.16 108.985 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.722 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 6.8 t -157.28 158.25 3.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.1 -0.704 . . . . 1.5 109.1 -178.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 185' ' ' MET . 19.4 t-80 -136.25 110.57 8.45 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.453 -0.943 . . . . 1.77 108.453 162.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 3.1 p . . . . . 0 C--N 1.32 -0.7 0 CA-C-O 121.632 0.73 . . . . 3.05 109.812 179.241 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.6 mt . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 110.196 -0.298 . . . . 2.82 110.196 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.01 115.94 3.87 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.177 1.918 . . . . 2.04 112.238 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.77 146.57 62.39 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.64 -0.504 . . . . 1.53 109.64 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.38 137.81 81.58 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.801 2.334 . . . . 0.88 111.667 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.421 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -65.26 -12.17 48.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.654 0.612 . . . . 1.58 112.654 -173.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -84.9 -7.52 59.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.805 0.336 . . . . 1.66 111.473 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.49 ' CZ ' HD23 ' A' ' 110' ' ' LEU . 17.9 m-85 -120.14 161.76 20.48 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.23 -1.026 . . . . 1.2 108.23 170.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.401 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 5.9 tp10 -133.51 120.19 20.5 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.749 -0.78 . . . . 2.27 111.435 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.2 tt -84.28 126.67 33.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.999 -0.741 . . . . 1.37 108.999 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -148.61 149.26 31.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.842 -0.617 . . . . 3.75 110.726 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.32 111.99 18.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.653 -0.869 . . . . 2.46 108.653 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.2 m -149.13 81.51 1.43 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.082 -0.508 . . . . 2.03 109.809 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.4 m -65.48 104.63 1.02 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.121 -0.49 . . . . 2.18 110.875 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.503 HG22 ' HB1' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -106.02 117.63 57.08 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.128 -0.487 . . . . 1.96 109.791 177.032 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.58 122.57 11.81 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.16 2.573 . . . . 1.87 112.678 -176.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.97 -16.46 36.19 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.711 -0.677 . . . . 1.74 111.958 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.503 ' HB1' HG22 ' A' ' 91' ' ' ILE . . . -131.63 -59.78 0.95 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.931 0.396 . . . . 1.79 111.277 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.9 -127.85 7.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.954 -0.641 . . . . 1.14 112.198 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.434 HD13 ' CD1' ' A' ' 171' ' ' TYR . 0.6 OUTLIER -89.53 159.79 17.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.677 -0.12 . . . . 2.81 110.677 176.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -161.96 172.51 38.13 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.586 -0.605 . . . . 0.8 111.586 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.9 m -115.72 130.76 69.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.586 0.708 . . . . 1.17 109.79 175.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -98.11 109.17 21.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.255 -0.43 . . . . 1.4 110.498 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -64.52 116.29 6.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 1.2 109.758 176.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.462 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -79.06 -2.8 42.15 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.453 0.644 . . . . 2.23 110.439 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.442 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 41.1 ttp180 -127.41 155.78 43.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.257 -0.883 . . . . 4.08 108.823 175.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.645 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -82.8 156.59 23.59 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.829 -0.434 . . . . 2.86 109.829 176.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.615 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -127.18 152.32 47.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.323 -0.399 . . . . 1.38 110.476 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 10.4 pt-20 -105.48 173.67 6.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.394 0.616 . . . . 2.31 111.975 -170.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.93 127.29 30.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.247 -0.888 . . . . 1.42 112.656 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.23 0.77 67.46 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.101 -0.571 . . . . 1.04 113.544 170.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 1.6 pt-20 -87.14 168.41 13.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.439 0.619 . . . . 2.62 111.09 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 3.8 tmm_? -127.52 133.03 49.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.93 -0.577 . . . . 4.16 112.094 -173.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.49 HD23 ' CZ ' ' A' ' 84' ' ' PHE . 7.7 mt -86.63 142.07 28.51 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.77 -0.826 . . . . 1.11 108.77 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.64 -128.05 7.63 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.4 -0.905 . . . . 1.09 112.618 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.441 ' O ' ' HA3' ' A' ' 166' ' ' GLY . 57.2 Cg_endo -68.35 145.6 76.59 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.829 -1.321 . . . . 2.52 112.761 2.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.618 -0.719 . . . . 2.5 110.962 -176.365 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 112' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.354 -0.299 . . . . 1.69 112.354 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.8 m -69.26 -14.54 63.01 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.885 0.328 . . . . 2.0 111.885 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.426 ' O ' ' HD2' ' A' ' 171' ' ' TYR . 64.9 p-90 -56.46 -17.27 7.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.159 0.504 . . . . 0.83 111.307 176.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.496 HD11 ' CD1' ' A' ' 194' ' ' TYR . 24.8 mt -64.49 -12.79 47.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.309 -0.405 . . . . 1.28 111.876 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -11.84 26.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.76 0.314 . . . . 2.03 110.754 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.434 ' CD1' HD13 ' A' ' 96' ' ' LEU . 36.8 m-85 -77.95 -36.96 48.59 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.27 -0.423 . . . . 2.19 111.312 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.545 ' HA ' ' OE1' ' A' ' 205' ' ' GLU . 0.5 OUTLIER -59.58 137.01 22.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 120.827 -0.349 . . . . 1.24 110.483 -174.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.452 ' CB ' ' HB3' ' A' ' 94' ' ' ALA . 41.7 mmt-85 -112.18 -177.52 3.19 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.851 0.686 . . . . 4.97 112.851 -175.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 41.5 t -76.56 158.87 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 114.954 -1.021 . . . . 1.63 110.488 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.479 ' HB1' ' CD1' ' A' ' 183' ' ' LEU . . . -55.52 113.73 1.56 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.241 -0.436 . . . . 1.34 111.816 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 28.1 t -72.05 -20.64 61.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 2.58 109.622 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.3 t -126.02 139.74 53.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.686 -0.688 . . . . 2.06 109.318 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 59.7 m -75.54 -33.41 60.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.107 0.78 . . . . 2.69 113.107 -168.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -88.33 -13.29 41.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.351 0.596 . . . . 2.42 110.58 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -82.57 19.29 1.31 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.529 -0.76 . . . . 2.12 112.033 -176.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.557 ' HA ' HE21 ' A' ' 181' ' ' GLN . 0.0 OUTLIER -53.42 113.85 1.3 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.022 0.439 . . . . 1.52 110.759 -176.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.608 ' ND2' HG13 ' A' ' 200' ' ' ILE . 32.3 t30 -140.21 23.62 2.36 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 122.325 1.059 . . . . 1.68 108.94 174.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.627 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 1.0 OUTLIER -109.17 117.39 34.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.598 -0.728 . . . . 1.43 110.36 -172.244 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.1 m -149.1 135.07 18.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.056 0.455 . . . . 1.2 110.528 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.431 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 72.6 mtp -128.74 137.07 51.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.139 -0.482 . . . . 1.56 110.072 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 16.3 t -114.41 158.12 21.97 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.848 -0.614 . . . . 2.13 109.496 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.526 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 22.7 tm0? -122.88 105.19 9.79 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.134 -0.691 . . . . 1.96 109.134 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.611 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 34.9 pt -133.13 140.58 46.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.975 -0.557 . . . . 1.62 110.524 -175.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.1 m 53.78 26.24 5.84 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.394 0.434 . . . . 2.24 111.963 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.526 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 6.3 mm-40 63.4 25.41 14.56 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.595 -0.73 . . . . 2.83 112.049 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.611 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.1 pt20 -117.28 157.65 25.7 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.128 -0.693 . . . . 1.86 109.128 172.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.5 mm -89.13 121.93 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.16 0.505 . . . . 1.59 110.564 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.633 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 45.5 t80 -114.57 121.27 42.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.365 -0.834 . . . . 4.16 110.377 -172.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.685 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 11.4 m-85 -99.65 112.81 25.0 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.374 -0.602 . . . . 1.27 109.374 177.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -116.0 122.93 46.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.844 0.354 . . . . 1.73 110.906 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.563 HG13 ' SD ' ' A' ' 104' ' ' MET . 0.2 OUTLIER -90.46 149.84 3.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.438 0.637 . . . . 1.33 109.879 178.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 182' ' ' ASN . 1.3 mt -103.06 -30.11 2.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.165 -0.925 . . . . 1.23 112.009 -168.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 27.5 pttt -151.59 -179.91 7.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.137 -0.483 . . . . 1.88 111.736 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.615 ' HA ' ' O ' ' A' ' 104' ' ' MET . 17.2 t70 -82.65 131.24 35.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.32 -0.854 . . . . 2.23 110.508 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.608 HG13 ' ND2' ' A' ' 182' ' ' ASN . 43.9 mm -121.97 154.63 26.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.192 -0.458 . . . . 1.41 111.15 -173.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -78.62 120.97 82.95 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 2.06 109.85 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.3 123.7 12.56 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.025 2.483 . . . . 0.56 112.419 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.62 -1.67 10.23 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.636 -0.792 . . . . 0.7 113.097 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -136.27 123.95 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 1.27 110.649 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.545 ' OE1' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -108.83 116.09 31.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.889 -0.596 . . . . 2.92 111.415 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.498 ' C ' HD22 ' A' ' 207' ' ' LEU . 4.7 mp -126.22 99.56 5.93 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.365 -0.534 . . . . 1.51 110.297 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.529 ' HB2' HG22 ' A' ' 172' ' ' ILE . 2.4 mm? -147.76 112.59 5.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.654 0.782 . . . . 1.16 109.58 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.627 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 7.8 p -155.99 158.01 3.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.621 -0.432 . . . . 1.5 111.199 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.431 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 27.9 t-80 -114.24 110.1 19.42 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.825 -0.806 . . . . 1.77 108.825 170.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 C--N 1.321 -0.672 0 N-CA-C 109.842 -0.429 . . . . 3.05 109.842 -179.999 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 67.7 mt . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 110.102 -0.333 . . . . 2.82 110.102 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.03 122.5 11.49 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.851 2.368 . . . . 2.04 112.722 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.415 HD13 ' H ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -127.38 149.3 69.5 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.843 -0.617 . . . . 1.53 109.758 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.74 143.14 99.35 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.635 2.223 . . . . 0.88 111.857 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.568 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -68.25 -5.19 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.34 0.496 . . . . 1.58 112.34 -173.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -87.56 -4.48 58.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.896 0.379 . . . . 1.66 110.928 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.497 ' CZ ' HD23 ' A' ' 110' ' ' LEU . 11.7 m-85 -138.38 147.96 43.98 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.173 -0.677 . . . . 1.2 109.173 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.437 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 12.2 tp10 -118.36 122.72 43.54 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 121.048 -0.261 . . . . 2.27 110.642 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.9 tt -87.43 124.16 33.13 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.388 0.613 . . . . 1.37 109.578 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.501 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 90.3 mtt-85 -143.39 127.05 17.03 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.13 -0.941 . . . . 3.75 109.689 -175.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.01 110.73 4.6 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.344 -0.613 . . . . 2.46 109.344 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.8 m -157.8 115.47 3.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.266 -0.642 . . . . 2.03 109.266 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.2 m -89.84 105.35 17.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.766 0.317 . . . . 2.18 110.97 -177.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -91.62 118.59 68.43 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.818 -0.808 . . . . 1.96 108.818 173.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.99 121.36 9.75 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.098 2.532 . . . . 1.87 112.553 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.65 -23.36 24.37 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.722 -0.672 . . . . 1.74 112.369 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.465 ' HB2' HG22 ' A' ' 91' ' ' ILE . . . -122.63 -63.0 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.962 0.381 . . . . 1.79 111.082 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.76 -134.12 8.11 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.962 -0.637 . . . . 1.14 111.952 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.9 mt -89.18 159.48 17.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.398 -0.223 . . . . 2.81 110.398 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -157.68 164.96 33.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.702 -0.761 . . . . 0.8 111.944 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.531 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 33.8 m -101.25 117.18 46.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.766 0.793 . . . . 1.17 110.071 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.501 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 27.1 m95 -82.73 110.01 17.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.355 -0.839 . . . . 1.4 110.623 -171.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.22 115.2 3.94 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.882 -0.414 . . . . 1.2 109.882 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.568 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -81.8 -6.07 58.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.405 0.621 . . . . 2.23 109.849 178.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -129.61 160.75 32.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.033 -0.985 . . . . 4.08 108.688 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.596 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -92.79 158.48 15.86 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 120.87 0.367 . . . . 2.86 110.475 -178.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 55.0 mtm -131.89 153.02 50.66 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.167 -0.679 . . . . 1.38 109.167 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -105.64 137.57 43.28 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.353 0.408 . . . . 2.31 110.855 -176.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -38.25 115.18 0.42 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.679 1.237 . . . . 1.42 112.959 -173.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.67 6.96 14.07 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.379 -0.828 . . . . 1.04 111.034 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.471 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -73.6 165.68 24.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.196 0.522 . . . . 2.62 110.761 -178.275 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -145.68 134.7 22.64 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.923 -0.58 . . . . 4.16 110.959 -175.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.497 HD23 ' CZ ' ' A' ' 84' ' ' PHE . 8.1 mt -98.05 135.01 40.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.942 -0.762 . . . . 1.11 108.942 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.79 167.29 38.48 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.423 -0.894 . . . . 1.09 112.21 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.41 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 6.2 Cg_exo -79.15 155.78 91.0 Favored 'Cis proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.307 -1.539 . . . . 2.52 112.0 -2.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.9 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.501 0.667 . . . . 2.5 109.846 176.919 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.276 0 CA-C-O 120.524 -0.042 . . . . 1.69 113.199 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 17.4 t -73.4 -15.39 61.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.023 0.44 . . . . 2.0 110.732 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.441 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 10.6 p-90 -72.77 -23.46 60.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.316 -0.402 . . . . 0.83 111.521 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.441 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 29.0 mt -86.09 -15.47 41.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.482 0.549 . . . . 1.28 112.482 -174.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -78.74 -4.65 50.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.271 -0.572 . . . . 2.03 110.381 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -77.84 -37.71 47.83 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.196 -0.457 . . . . 2.19 110.996 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.737 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -70.03 120.77 18.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.818 -0.438 . . . . 1.24 109.818 177.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -113.15 -168.68 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 4.97 112.033 -173.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.49 ' HA ' HG11 ' A' ' 208' ' ' VAL . 43.8 t -62.57 142.27 16.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 115.795 -0.639 . . . . 1.63 111.436 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.46 148.03 39.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.292 -0.867 . . . . 1.34 111.883 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 48.7 t -86.21 -8.94 57.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.373 -0.83 . . . . 2.58 110.122 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.5 t -143.98 145.22 32.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.971 -0.559 . . . . 2.06 111.208 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 78.1 m -83.2 -15.82 48.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.642 -0.708 . . . . 2.69 110.298 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -81.85 -25.73 34.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.617 0.722 . . . . 2.42 110.187 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -96.42 18.28 14.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.343 -0.844 . . . . 2.12 111.815 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -59.14 114.19 2.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.183 0.516 . . . . 1.52 111.547 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.668 ' H ' HD13 ' A' ' 183' ' ' LEU . 4.7 p-10 -152.01 29.74 0.58 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.007 -0.997 . . . . 1.68 109.202 170.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.679 ' HG ' ' C ' ' A' ' 206' ' ' LEU . 1.5 mp -112.03 118.95 36.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.93 -1.032 . . . . 1.43 109.13 -175.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 86.4 m -150.08 148.23 28.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.437 0.637 . . . . 1.2 112.589 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.43 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 28.0 tpp -97.45 145.64 25.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.255 -0.884 . . . . 1.56 111.411 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 41.7 t -129.93 131.47 45.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 2.13 110.267 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -123.05 105.78 10.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.588 -0.523 . . . . 1.96 109.588 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 24.2 pt -142.67 144.01 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.847 -0.615 . . . . 1.62 110.502 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.4 m 61.85 35.43 16.53 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.463 -0.335 . . . . 2.24 111.772 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 66.61 3.91 3.13 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.88 -0.6 . . . . 2.83 111.721 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -120.61 163.74 17.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.083 0.468 . . . . 1.86 110.421 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.8 mm -107.08 136.11 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.872 -0.604 . . . . 1.59 111.196 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -138.14 156.44 47.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.029 -0.532 . . . . 4.16 110.917 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.549 ' CD2' ' HB3' ' A' ' 207' ' ' LEU . 2.4 m-30 -101.1 114.43 28.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.761 -0.654 . . . . 1.27 109.823 175.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -102.39 124.41 47.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.009 0.433 . . . . 1.73 110.178 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.471 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 0.9 OUTLIER -100.19 152.83 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.545 0.688 . . . . 1.33 110.38 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.532 HG13 ' HA ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -92.8 -41.04 12.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.813 -1.085 . . . . 1.23 112.471 -168.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.34 164.8 27.26 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.086 0.402 . . . . 1.88 112.086 -171.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 104' ' ' MET . 5.3 t70 -49.7 112.26 0.63 Allowed 'General case' 0 C--O 1.233 0.187 0 O-C-N 124.481 1.113 . . . . 2.23 110.671 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.444 HG13 ' HE2' ' A' ' 104' ' ' MET . 28.5 mm -83.13 129.2 37.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.104 -0.498 . . . . 1.41 110.868 -176.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 45.0 mt-10 -83.57 136.16 42.75 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.924 -0.58 . . . . 2.06 109.58 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.14 113.68 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.18 1.92 . . . . 0.56 111.71 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.17 -4.9 10.38 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.595 -0.812 . . . . 0.7 113.643 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.3 pt-20 -112.74 121.66 45.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.001 0.9 . . . . 1.27 111.037 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -110.6 93.79 4.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.553 -0.749 . . . . 2.92 111.658 177.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.679 ' C ' ' HG ' ' A' ' 183' ' ' LEU . 2.7 mm? -124.19 99.09 6.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.548 -0.461 . . . . 1.51 110.222 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.737 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -147.78 119.0 7.76 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.695 0.398 . . . . 1.16 110.074 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.576 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 7.4 p -154.12 157.8 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.285 -0.566 . . . . 1.5 111.473 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 16.4 t-80 -115.13 110.87 20.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.385 -0.968 . . . . 1.77 108.385 163.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 66.6 t . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.24 0.543 . . . . 3.05 110.051 -179.202 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.5 mt . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 120.659 0.266 . . . . 2.82 110.693 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.25 115.88 3.55 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.184 1.922 . . . . 2.04 111.572 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.504 ' H ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -113.63 155.93 44.25 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.039 -0.528 . . . . 1.53 110.03 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.63 154.86 66.48 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.753 2.302 . . . . 0.88 111.862 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 -10.13 30.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.604 -0.725 . . . . 1.58 112.476 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 62.9 m-20 -104.71 7.75 34.86 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.927 -0.309 . . . . 1.66 111.598 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -132.54 136.44 46.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.649 -0.5 . . . . 1.2 109.649 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.419 ' OE2' ' HD2' ' A' ' 87' ' ' ARG . 35.9 tt0 -127.34 122.91 35.0 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.382 -0.527 . . . . 2.27 110.787 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tt -87.28 125.35 34.16 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.455 -0.943 . . . . 1.37 108.455 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.419 ' HD2' ' OE2' ' A' ' 85' ' ' GLU . 13.7 ptm180 -166.15 133.83 2.81 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.336 -0.847 . . . . 3.75 109.701 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.32 111.98 2.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.92 -0.582 . . . . 2.46 110.217 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -148.17 93.25 2.14 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.67 -0.863 . . . . 2.03 108.67 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.3 t -72.23 104.63 3.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.992 -0.549 . . . . 2.18 110.867 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -105.94 114.8 62.3 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.812 -0.631 . . . . 1.96 109.365 175.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.27 120.52 7.87 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.284 2.656 . . . . 1.87 112.765 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.23 -11.42 36.89 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.009 -0.615 . . . . 1.74 112.435 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.448 ' HB3' HG21 ' A' ' 91' ' ' ILE . . . -132.97 -71.1 0.53 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.916 -0.313 . . . . 1.79 111.476 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.83 -149.6 17.32 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.742 -0.742 . . . . 1.14 112.478 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.3 mt -104.5 122.71 46.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.568 0.21 . . . . 2.81 111.568 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -138.18 -153.85 6.36 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.818 -0.706 . . . . 0.8 112.159 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 98' ' ' VAL . 35.6 m -112.17 112.27 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.934 0.873 . . . . 1.17 109.857 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -82.52 118.66 23.42 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.821 -0.627 . . . . 1.4 110.799 -171.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -66.15 117.97 9.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.426 -0.806 . . . . 1.2 110.374 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.9 -3.71 58.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.484 0.659 . . . . 2.23 110.079 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.403 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 24.6 ttm-85 -125.74 157.06 38.38 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.544 -0.91 . . . . 4.08 108.544 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.403 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -83.99 159.58 21.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.108 0.48 . . . . 2.86 110.145 177.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.626 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 44.6 mtm -128.32 153.53 46.91 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.02 -0.536 . . . . 1.38 109.912 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -120.45 139.06 53.41 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.8 -0.636 . . . . 2.31 109.925 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -39.22 122.69 1.29 Allowed 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.431 1.082 . . . . 1.42 113.395 -169.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.17 7.15 12.85 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.467 -0.788 . . . . 1.04 111.373 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.443 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -86.02 167.98 14.53 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.844 0.458 . . . . 2.62 111.019 -176.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.485 ' O ' HD23 ' A' ' 110' ' ' LEU . 3.7 ptt180 -142.77 164.15 30.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.065 -0.516 . . . . 4.16 110.514 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 109' ' ' ARG . 7.3 mt -118.48 139.25 51.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.542 -0.753 . . . . 1.11 109.055 170.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.7 -115.02 4.17 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.804 -0.712 . . . . 1.09 113.288 174.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.47 ' HD3' ' CZ ' ' A' ' 109' ' ' ARG . 70.4 Cg_endo -72.14 168.22 74.77 Favored 'Cis proline' 0 C--N 1.349 0.596 0 C-N-CA 123.858 -1.309 . . . . 2.52 112.94 4.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.472 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 52.7 t . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.412 . . . . 2.5 110.528 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.445 -0.737 0 N-CA-C 112.776 -0.13 . . . . 1.69 112.776 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.4 m -61.47 -27.38 68.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.539 0.685 . . . . 2.0 110.035 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 16.4 p-90 -85.3 -19.33 31.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.245 -0.889 . . . . 0.83 111.084 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 40.6 mt -82.08 -14.95 55.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.059 -0.518 . . . . 1.28 111.864 -173.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.409 ' C ' ' HD3' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -74.59 -8.65 57.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 2.03 110.01 175.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.536 ' O ' ' HD2' ' A' ' 173' ' ' ARG . 65.6 m-85 -85.98 -30.47 22.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.979 -0.555 . . . . 2.19 111.675 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.578 HG22 ' HB2' ' A' ' 207' ' ' LEU . 1.3 mm -51.3 138.01 8.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 O-C-N 123.393 0.433 . . . . 1.24 111.301 -173.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' A' ' 171' ' ' TYR . 14.9 mmm180 -92.14 170.88 9.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.344 0.593 . . . . 4.97 111.874 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.446 HG21 HG11 ' A' ' 208' ' ' VAL . 61.6 t -89.64 160.76 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.26 -0.882 . . . . 1.63 108.669 173.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.407 ' HB3' HD12 ' A' ' 183' ' ' LEU . . . -46.67 125.0 6.61 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.323 0.389 . . . . 1.34 111.892 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 30.8 p -75.75 -14.11 60.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.057 -0.52 . . . . 2.58 110.989 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.4 m -148.39 164.19 34.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 2.06 109.86 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 57.4 m -74.91 -22.96 58.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.973 0.416 . . . . 2.69 111.062 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.13 5.32 45.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.213 0.53 . . . . 2.42 110.402 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -110.05 15.93 22.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.42 -0.809 . . . . 2.12 110.255 -174.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.87 114.34 7.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.449 . . . . 1.52 110.427 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.579 ' ND2' HD13 ' A' ' 200' ' ' ILE . 18.7 t30 -157.43 36.74 0.28 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.001 0.905 . . . . 1.68 109.21 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.608 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.5 OUTLIER -122.9 124.57 43.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.043 -0.526 . . . . 1.43 111.169 -173.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.5 m -149.97 121.95 8.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.19 0.519 . . . . 1.2 110.735 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.422 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 48.1 ttm -97.96 133.02 43.01 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.202 -0.666 . . . . 1.56 109.202 172.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 25.0 t -112.83 132.19 55.38 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.289 -0.634 . . . . 2.13 109.289 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 24.7 tm0? -108.37 104.9 14.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.248 0.547 . . . . 1.96 109.712 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.557 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 25.3 pt -132.53 143.2 40.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.522 -0.763 . . . . 1.62 110.139 -176.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.8 m 54.1 35.93 23.49 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.324 0.39 . . . . 2.24 111.606 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 65.55 7.55 4.48 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.943 -0.571 . . . . 2.83 112.054 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 13.4 pt20 -113.79 155.26 25.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 1.86 110.529 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' A' ' 113' ' ' CYS . 51.0 mm -87.81 112.75 23.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.858 -0.61 . . . . 1.59 110.425 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -110.53 135.6 50.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.889 -0.596 . . . . 4.16 110.274 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 9.9 m-85 -102.34 114.67 29.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.59 -0.277 . . . . 1.27 110.485 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.97 117.85 31.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.866 0.365 . . . . 1.73 110.048 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.443 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 2.2 t -89.6 152.85 3.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.533 0.682 . . . . 1.33 109.869 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.5 mm -90.34 -57.2 4.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.65 -1.159 . . . . 1.23 111.486 -166.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.574 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.7 OUTLIER -141.87 -178.83 5.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.634 -0.712 . . . . 1.88 111.368 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.626 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.9 m-20 -48.45 126.66 11.84 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 124.014 0.821 . . . . 2.23 112.703 -175.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.579 HD13 ' ND2' ' A' ' 182' ' ' ASN . 18.6 mm -96.66 138.01 22.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.445 -0.798 . . . . 1.41 110.714 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -86.17 133.29 41.12 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.941 -0.572 . . . . 2.06 109.51 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 52.4 Cg_exo -54.99 113.21 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.009 1.806 . . . . 0.56 111.615 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.93 -13.08 9.19 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.742 -0.742 . . . . 0.7 113.261 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -126.52 122.56 35.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.765 0.783 . . . . 1.27 111.733 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.512 ' O ' HD11 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -111.29 115.79 29.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.807 -0.633 . . . . 2.92 111.254 175.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.512 HD11 ' O ' ' A' ' 205' ' ' GLU . 1.7 mm? -124.1 99.97 6.49 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.71 -0.478 . . . . 1.51 109.71 171.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.578 ' HB2' HG22 ' A' ' 172' ' ' ILE . 1.4 mm? -147.17 112.84 5.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.673 0.389 . . . . 1.16 110.156 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.608 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.4 p -154.92 160.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.816 -0.438 . . . . 1.5 109.816 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.422 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 53.7 t-80 -90.84 107.58 19.28 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.562 -1.273 . . . . 1.77 107.562 169.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.315 -0.905 0 CA-C-O 121.099 0.476 . . . . 3.05 110.098 178.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 110.458 -0.201 . . . . 2.82 110.458 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.64 124.57 10.37 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.702 2.268 . . . . 2.04 111.857 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.465 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -118.94 143.97 34.85 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.316 -0.402 . . . . 1.53 110.67 -178.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -54.62 147.53 48.62 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.414 2.743 . . . . 0.88 112.296 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.409 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -66.15 -12.84 58.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.92 -0.582 . . . . 1.58 112.104 -175.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.99 -24.12 59.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.19 0.519 . . . . 1.66 110.177 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 71.6 m-85 -123.72 177.39 5.73 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.836 -0.62 . . . . 1.2 110.074 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.53 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 28.2 tt0 -155.86 124.66 6.01 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.009 -0.276 . . . . 2.27 110.702 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.9 tt -84.0 125.01 31.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.474 -0.565 . . . . 1.37 109.474 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -147.79 138.9 23.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.196 -0.911 . . . . 3.75 109.538 -174.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.99 110.8 17.58 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.694 -0.484 . . . . 2.46 109.694 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m -150.0 106.61 3.52 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.749 -0.659 . . . . 2.03 109.309 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.6 m -75.91 104.17 6.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.061 0.458 . . . . 2.18 111.225 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -107.15 114.85 60.82 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.148 -0.686 . . . . 1.96 109.148 174.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 91' ' ' ILE . 37.5 Cg_exo -60.43 121.93 10.52 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.827 2.351 . . . . 1.87 112.653 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.33 -9.61 35.94 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.685 -0.769 . . . . 1.74 113.037 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.88 -70.6 0.57 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.892 0.346 . . . . 1.79 111.531 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 130.3 -161.51 23.17 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.816 -0.707 . . . . 1.14 112.047 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mt -94.68 116.78 29.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.091 -0.337 . . . . 2.81 110.091 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.443 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -119.04 -179.39 16.76 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.733 -0.746 . . . . 0.8 112.614 -176.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 19.6 m -100.78 112.7 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.698 0.761 . . . . 1.17 109.776 174.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -82.07 112.33 19.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.447 -0.797 . . . . 1.4 110.984 -169.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -66.5 114.64 5.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 1.2 109.703 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.53 ' CE ' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -95.73 2.18 53.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.427 0.632 . . . . 2.23 109.501 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -125.54 154.55 41.98 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.942 -1.027 . . . . 4.08 109.218 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.605 ' HD2' ' H ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -86.72 154.68 20.78 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.453 -0.573 . . . . 2.86 109.453 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.742 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 49.4 mtm -131.16 147.56 52.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.512 -0.313 . . . . 1.38 110.734 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -109.8 143.06 40.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.322 -0.622 . . . . 2.31 109.322 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.37 130.43 10.75 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 124.012 0.82 . . . . 1.42 112.458 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.61 7.54 13.5 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.156 -0.778 . . . . 1.04 111.156 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.96 162.87 25.68 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 122.901 0.48 . . . . 2.62 111.589 -176.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -146.93 128.26 14.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.856 -0.611 . . . . 4.16 110.881 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 3.2 mt -105.15 148.48 26.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.728 -0.841 . . . . 1.11 108.728 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.72 -151.2 19.22 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.532 -0.842 . . . . 1.09 112.181 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.561 ' HB3' ' CE2' ' A' ' 193' ' ' TYR . 86.4 Cg_endo -81.53 142.05 52.97 Favored 'Cis proline' 0 C--N 1.342 0.218 0 C-N-CA 123.823 -1.324 . . . . 2.52 112.67 0.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 121.19 0.519 . . . . 2.5 109.765 178.017 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 112.134 -0.386 . . . . 1.69 112.134 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 23.0 t -68.54 -24.79 64.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.325 0.583 . . . . 2.0 109.941 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -85.0 -18.79 33.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.794 -0.639 . . . . 0.83 109.857 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.51 ' O ' HG13 ' A' ' 172' ' ' ILE . 38.0 mt -84.1 -20.35 32.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.682 -0.69 . . . . 1.28 111.415 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.474 ' C ' ' HD3' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -76.2 -6.17 50.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.519 -0.472 . . . . 2.03 110.225 176.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.443 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 33.8 m-85 -75.83 -37.52 58.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.968 -0.56 . . . . 2.19 110.484 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -68.63 119.74 14.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.367 -0.605 . . . . 1.24 109.367 174.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -111.15 -172.29 2.0 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.539 -0.301 . . . . 4.97 110.847 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 20.6 t -68.19 149.04 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 1.63 110.771 -177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.22 126.23 25.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.894 -0.594 . . . . 1.34 111.441 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 46.2 t -72.02 -17.46 62.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 2.58 110.838 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 m -126.33 150.42 48.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.313 -0.403 . . . . 2.06 109.975 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 10.7 p -78.57 -19.02 53.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.492 0.553 . . . . 2.69 112.492 -172.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -89.17 -4.09 58.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.468 0.651 . . . . 2.42 110.051 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.15 17.48 12.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.207 -0.906 . . . . 2.12 111.642 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -69.33 113.25 6.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.327 0.584 . . . . 1.52 110.952 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.651 ' H ' HD11 ' A' ' 183' ' ' LEU . 4.1 p-10 -155.25 35.14 0.38 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.178 -0.919 . . . . 1.68 109.582 171.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.651 HD11 ' H ' ' A' ' 182' ' ' ASN . 0.5 OUTLIER -117.7 120.42 37.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.443 -0.799 . . . . 1.43 110.754 -171.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 92.7 m -148.53 139.8 23.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.099 0.476 . . . . 1.2 110.95 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 55.5 ttm -98.75 150.29 21.98 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.371 -0.603 . . . . 1.56 109.371 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 53.7 t -112.78 131.9 55.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.061 0.458 . . . . 2.13 109.97 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . 0.546 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 20.7 tm0? -120.77 104.89 10.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.769 -0.651 . . . . 1.96 109.389 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 12.9 pt -140.71 132.63 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 1.62 110.123 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 51.1 m 58.51 29.88 18.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.118 0.485 . . . . 2.24 111.059 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.546 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 0.9 OUTLIER 63.97 11.5 6.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.145 -0.934 . . . . 2.83 112.753 176.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -112.08 140.03 47.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.539 -0.541 . . . . 1.86 109.539 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.1 mm -84.77 131.68 33.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.947 -0.57 . . . . 1.59 112.02 -172.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.561 ' CE2' ' HB3' ' A' ' 112' ' ' PRO . 54.3 m-85 -128.37 165.11 21.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.045 -0.98 . . . . 4.16 109.709 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.521 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 3.9 m-85 -115.02 126.53 54.85 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.579 -0.526 . . . . 1.27 109.579 175.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -125.47 120.06 29.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.027 0.441 . . . . 1.73 110.604 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.501 HG21 HD12 ' A' ' 207' ' ' LEU . 1.5 t -85.82 152.9 3.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.126 -0.694 . . . . 1.33 109.126 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.504 HG13 ' HA ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -84.28 -48.54 16.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.891 -1.05 . . . . 1.23 111.039 -170.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.78 -178.08 6.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.635 -0.711 . . . . 1.88 111.193 -174.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.742 ' HA ' ' O ' ' A' ' 104' ' ' MET . 2.8 p-10 -43.23 124.49 3.34 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.454 1.096 . . . . 2.23 113.486 -176.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.443 HG13 ' HE3' ' A' ' 104' ' ' MET . 37.8 mm -100.98 133.11 45.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.947 -1.024 . . . . 1.41 110.122 175.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.662 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 46.5 mt-10 -90.12 128.74 48.46 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.402 -0.592 . . . . 2.06 109.402 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.76 116.75 2.03 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.952 2.435 . . . . 0.56 112.934 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 123.51 -16.11 8.0 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.953 -0.641 . . . . 0.7 113.653 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.662 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 13.9 pt-20 -111.7 122.86 48.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.827 0.814 . . . . 1.27 111.518 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.447 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -111.32 94.99 5.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.081 -0.509 . . . . 2.92 112.087 177.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.441 ' N ' HD23 ' A' ' 206' ' ' LEU . 1.2 mm? -122.77 100.17 6.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.874 -0.73 . . . . 1.51 109.859 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.569 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 0.6 OUTLIER -147.33 114.28 6.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.581 -0.281 . . . . 1.16 110.617 177.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.607 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.5 p -155.51 158.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.505 . . . . 1.5 109.635 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -85.81 110.41 19.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.245 -1.02 . . . . 1.77 108.245 166.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.32 -0.676 0 CA-C-O 121.264 0.554 . . . . 3.05 110.015 -177.669 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.795 -0.446 . . . . 2.82 109.795 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.78 116.39 3.41 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.349 2.033 . . . . 2.04 111.712 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -126.41 140.94 38.54 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.287 -0.415 . . . . 1.53 110.478 -178.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.45 138.38 83.71 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.509 2.14 . . . . 0.88 111.634 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.49 -4.12 13.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.145 0.497 . . . . 1.58 111.351 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.54 -23.01 61.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.785 -0.643 . . . . 1.66 109.457 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -128.43 177.31 7.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.295 -0.866 . . . . 1.2 108.872 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -145.54 131.43 19.14 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.18 -0.608 . . . . 2.27 110.906 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.4 tt -92.79 130.65 38.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.027 -0.533 . . . . 1.37 109.769 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -149.5 150.93 33.09 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.454 -0.794 . . . . 3.75 109.746 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -82.92 109.42 17.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.707 -0.849 . . . . 2.46 108.707 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.8 m -159.56 82.44 0.75 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.327 -0.62 . . . . 2.03 109.327 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.6 p -68.3 105.22 2.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.139 -0.482 . . . . 2.18 110.922 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.51 HG22 ' HB1' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -81.86 123.46 80.15 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.116 -0.698 . . . . 1.96 109.116 176.236 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -49.62 115.38 1.77 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.282 2.654 . . . . 1.87 113.297 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.09 -14.53 37.06 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.7 -0.762 . . . . 1.74 112.691 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.51 ' HB1' HG22 ' A' ' 91' ' ' ILE . . . -128.77 -55.77 1.21 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 1.79 111.477 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.92 -146.71 17.54 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.979 -0.629 . . . . 1.14 112.255 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 96' ' ' LEU . 1.3 pp -69.26 158.83 34.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.718 0.259 . . . . 2.81 110.914 177.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.71 172.15 43.56 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.796 -0.716 . . . . 0.8 111.995 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.1 m -108.24 120.45 59.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.678 0.751 . . . . 1.17 109.965 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -83.01 107.98 15.99 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.246 0.546 . . . . 1.4 110.859 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.42 115.56 7.99 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.551 -0.749 . . . . 1.2 110.16 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.455 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -86.57 -5.23 59.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.546 0.688 . . . . 2.23 109.359 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -128.88 159.17 36.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.008 -0.997 . . . . 4.08 109.176 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.37 137.09 33.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.244 0.545 . . . . 2.86 110.637 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.621 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 25.3 mtm -94.97 116.62 28.93 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.74 -0.837 . . . . 1.38 108.74 172.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.69 173.62 12.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.403 0.621 . . . . 2.31 111.74 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.98 118.12 7.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.276 -0.874 . . . . 1.42 111.83 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.76 1.04 63.82 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.839 -0.696 . . . . 1.04 113.198 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.58 167.95 20.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.649 -0.5 . . . . 2.62 109.649 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.63 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 5.0 tmm_? -145.82 130.6 18.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.245 0.461 . . . . 4.16 112.245 -170.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.7 mt -88.18 139.91 30.02 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.84 -0.8 . . . . 1.11 108.84 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.04 173.3 40.72 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.801 -1.19 . . . . 1.09 113.05 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -80.97 152.27 81.0 Favored 'Cis proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.954 -1.686 . . . . 2.52 112.463 -2.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.41 ' HA ' ' HA2' ' A' ' 166' ' ' GLY . 42.7 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.037 0.446 . . . . 2.5 110.715 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 112.103 -0.399 . . . . 1.69 112.103 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 20.0 t -64.25 -26.94 68.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.028 0.442 . . . . 2.0 110.126 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.497 ' O ' ' HB2' ' A' ' 171' ' ' TYR . 44.3 p-90 -86.26 -21.16 27.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.83 111.201 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 15.5 mt -82.49 -14.93 54.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.785 0.291 . . . . 1.28 111.785 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -74.63 -4.35 36.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.152 0.501 . . . . 2.03 109.911 174.292 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 168' ' ' TRP . 13.2 m-85 -76.3 -32.56 58.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.602 -0.726 . . . . 2.19 111.547 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -62.87 134.94 27.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.406 -0.518 . . . . 1.24 110.406 -175.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.483 ' CB ' ' HB3' ' A' ' 94' ' ' ALA . 13.3 mmm180 -110.2 160.1 16.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.084 0.469 . . . . 4.97 111.549 -177.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 62.6 t -67.05 147.12 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.569 -0.741 . . . . 1.63 109.31 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.5 ' HB2' HD13 ' A' ' 183' ' ' LEU . . . -54.22 141.72 28.48 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.274 0.559 . . . . 1.34 112.117 -177.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 44.9 t -91.26 -2.8 57.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.247 -0.888 . . . . 2.58 110.34 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 180' ' ' ASP . 41.5 m -141.65 145.95 35.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.199 0.523 . . . . 2.06 110.548 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 59.8 m -72.19 -31.25 65.73 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.551 -0.749 . . . . 2.69 111.584 -173.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -84.05 2.4 39.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.151 0.5 . . . . 2.42 110.428 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 177' ' ' SER . 4.2 t70 -108.91 16.65 22.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.523 -0.762 . . . . 2.12 110.507 -173.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -63.89 114.19 3.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.037 0.446 . . . . 1.52 110.555 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.492 ' H ' HD12 ' A' ' 183' ' ' LEU . 10.5 t30 -148.6 32.27 0.79 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.045 -1.094 . . . . 1.68 108.045 175.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.687 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 1.4 mp -117.15 122.16 43.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.334 -0.848 . . . . 1.43 110.746 -172.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 95.3 m -148.72 136.74 20.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.971 0.415 . . . . 1.2 110.306 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 49.7 ttm -106.07 141.92 36.63 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.54 -0.541 . . . . 1.56 109.54 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 53.4 t -111.93 131.61 55.27 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.268 -0.641 . . . . 2.13 109.268 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.1 103.86 9.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.146 -0.687 . . . . 1.96 109.146 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.506 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 22.4 pt -138.08 144.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.627 -0.715 . . . . 1.62 109.842 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.8 m 60.41 31.9 20.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.858 0.361 . . . . 2.24 111.392 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 60.11 24.09 13.36 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.785 -0.643 . . . . 2.83 112.026 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.4 pt20 -130.37 161.42 31.36 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.975 -0.38 . . . . 1.86 109.975 176.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.3 mm -103.94 131.45 52.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.21 0.529 . . . . 1.59 112.274 -174.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.63 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 30.1 m-85 -133.48 147.85 51.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.266 -0.879 . . . . 4.16 110.027 174.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 4.9 m-30 -101.57 114.44 28.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.739 -0.467 . . . . 1.27 109.739 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -99.22 121.81 41.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.392 . . . . 1.73 110.246 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 1.9 t -89.23 150.95 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 122.074 0.94 . . . . 1.33 110.173 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -95.6 -55.28 6.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 113.866 -1.515 . . . . 1.23 110.796 -165.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.39 175.22 10.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.758 -1.11 . . . . 1.88 109.733 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.621 ' HA ' ' O ' ' A' ' 104' ' ' MET . 9.2 p-10 -59.45 115.82 3.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.76 0.79 . . . . 2.23 112.2 -172.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.502 HG13 ' HE1' ' A' ' 104' ' ' MET . 4.8 mm -69.33 140.13 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.857 -1.065 . . . . 1.41 110.867 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 37.2 mt-10 -84.04 118.19 70.64 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.21 -0.663 . . . . 2.06 109.21 171.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -45.58 121.17 3.78 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.943 2.428 . . . . 0.56 112.731 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.74 -11.17 9.56 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.91 -0.662 . . . . 0.7 112.506 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 10.9 pt-20 -133.92 124.65 26.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 1.27 110.965 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.484 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -109.45 107.66 17.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.82 0.343 . . . . 2.92 111.066 177.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.573 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.2 mm? -123.41 98.93 6.08 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.186 -0.606 . . . . 1.51 110.354 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.521 ' HB2' HG23 ' A' ' 172' ' ' ILE . 1.6 mm? -148.17 105.48 3.64 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.096 -0.705 . . . . 1.16 109.096 174.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.687 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 24.5 t -154.58 158.67 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.182 -1.044 . . . . 1.5 108.182 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -85.01 108.49 17.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.895 -1.15 . . . . 1.77 107.895 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--N 1.315 -0.926 0 CA-C-O 121.674 0.749 . . . . 3.05 110.68 -176.535 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 78.6 mt . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.581 0.229 . . . . 2.82 110.45 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.39 121.45 8.88 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.9 2.4 . . . . 2.04 112.522 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.457 ' H ' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -120.83 152.96 56.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.901 -0.59 . . . . 1.53 109.934 178.386 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.85 150.58 85.74 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.391 2.061 . . . . 0.88 110.995 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.23 8.36 1.35 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.876 -0.602 . . . . 1.58 112.377 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -112.88 1.23 15.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.143 0.497 . . . . 1.66 111.243 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -137.38 136.11 37.58 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.396 -0.964 . . . . 1.2 108.396 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -123.12 130.02 52.21 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.077 -0.649 . . . . 2.27 111.127 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tt -83.7 130.55 34.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 1.37 109.505 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.481 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 97.0 mtt180 -143.71 126.85 16.53 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.507 -0.77 . . . . 3.75 109.468 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.76 111.78 17.52 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.479 -0.488 . . . . 2.46 109.891 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.0 p -162.69 97.47 0.96 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.657 -0.701 . . . . 2.03 109.463 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.5 m -68.21 104.08 1.73 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.966 0.412 . . . . 2.18 110.777 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -87.04 122.19 71.24 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.233 -0.654 . . . . 1.96 109.233 175.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.54 119.09 4.68 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.187 2.591 . . . . 1.87 112.821 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.01 -20.43 28.8 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 121.003 -0.618 . . . . 1.74 112.685 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.74 -72.45 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.032 0.416 . . . . 1.79 111.3 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.519 ' HA3' ' NH1' ' A' ' 173' ' ' ARG . . . 131.85 -130.58 5.99 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.932 -0.651 . . . . 1.14 112.557 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt -99.68 158.17 15.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.681 0.24 . . . . 2.81 110.485 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.24 -179.85 39.33 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.269 -0.732 . . . . 0.8 111.269 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.407 ' O ' HG21 ' A' ' 98' ' ' VAL . 33.8 m -102.9 119.69 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.543 0.687 . . . . 1.17 109.504 174.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.481 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 49.4 m95 -83.83 114.62 21.76 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.562 -0.744 . . . . 1.4 111.023 -170.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.23 115.29 12.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.067 -0.716 . . . . 1.2 109.067 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -92.55 2.27 56.79 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.648 0.737 . . . . 2.23 109.641 -176.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -125.75 161.24 27.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.979 -1.01 . . . . 4.08 108.355 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 155.99 39.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.0 0.428 . . . . 2.86 111.169 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.655 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 34.8 mtm -120.15 149.31 42.44 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.393 -0.966 . . . . 1.38 108.393 171.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 47.1 mt-10 -119.39 173.88 6.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.523 0.678 . . . . 2.31 112.399 -172.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.12 115.58 6.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.884 -1.053 . . . . 1.42 111.976 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.32 1.88 57.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.685 -0.769 . . . . 1.04 113.522 171.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 6.8 pt-20 -86.07 166.27 15.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.483 0.641 . . . . 2.62 110.647 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.48 ' HG2' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -127.96 143.41 51.09 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.109 -0.496 . . . . 4.16 110.233 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.48 ' N ' ' HG2' ' A' ' 109' ' ' ARG . 7.5 mt -87.35 125.8 34.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.128 -1.064 . . . . 1.11 108.128 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -140.73 157.14 25.7 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 119.885 -1.15 . . . . 1.09 113.17 -172.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.92 154.33 96.94 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.585 -1.839 . . . . 2.52 112.175 -1.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.5 ' HA ' HD13 ' A' ' 169' ' ' LEU . 59.5 m . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.913 -0.585 . . . . 2.5 111.061 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 111.424 -0.671 . . . . 1.69 111.424 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 8.7 t -64.56 -17.66 64.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.267 0.556 . . . . 2.0 110.628 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.497 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 26.9 p-90 -74.31 -21.76 59.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.297 0.57 . . . . 0.83 110.274 177.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 40.6 mt -86.43 -20.22 28.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.738 -0.665 . . . . 1.28 112.1 -175.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -71.88 -5.04 31.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.623 -0.431 . . . . 2.03 110.577 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -79.9 -37.27 35.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.913 -0.585 . . . . 2.19 111.798 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.696 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -62.83 131.64 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.751 -0.38 . . . . 1.24 110.273 -178.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.519 ' NH1' ' HA3' ' A' ' 95' ' ' GLY . 99.2 mtt180 -115.07 -171.41 1.94 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.296 -0.411 . . . . 4.97 111.429 -174.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.4 t -76.47 141.0 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-N 116.298 -0.41 . . . . 1.63 110.229 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.492 ' HB1' ' NE2' ' A' ' 181' ' ' GLN . . . -61.07 138.44 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.821 -0.627 . . . . 1.34 111.944 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 37.6 t -72.85 -6.87 47.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.169 -0.923 . . . . 2.58 110.69 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.3 t -126.07 139.77 53.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 2.06 110.383 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 61.6 m -88.15 -18.81 27.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.052 -0.522 . . . . 2.69 110.59 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -83.97 -14.95 49.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.102 0.477 . . . . 2.42 110.522 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -110.04 17.57 20.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.828 -0.624 . . . . 2.12 111.185 -176.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.492 ' NE2' ' HB1' ' A' ' 175' ' ' ALA . 30.1 mm-40 -54.94 115.49 2.23 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.179 0.514 . . . . 1.52 110.86 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.545 ' H ' HD11 ' A' ' 183' ' ' LEU . 5.5 p-10 -144.05 32.36 1.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.667 0.746 . . . . 1.68 109.384 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.601 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.2 OUTLIER -116.0 124.51 50.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.038 -0.983 . . . . 1.43 110.606 -173.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 97.7 m -146.49 121.59 10.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.287 0.565 . . . . 1.2 111.387 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.588 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 39.0 ttm -113.24 129.49 56.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 1.56 109.431 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 35.2 t -115.86 165.05 13.52 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.407 -0.59 . . . . 2.13 109.407 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -129.88 105.23 7.86 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.166 -0.679 . . . . 1.96 109.166 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.62 143.93 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.748 -0.66 . . . . 1.62 110.518 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.4 t 62.56 34.06 15.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.254 0.549 . . . . 2.24 110.312 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 58.32 30.0 18.93 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.377 -0.829 . . . . 2.83 111.979 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -140.54 167.28 22.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.996 0.427 . . . . 1.86 110.212 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.3 mm -82.29 152.33 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.982 -0.748 . . . . 1.59 108.982 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -143.75 120.1 10.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.754 0.311 . . . . 4.16 110.542 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 15.0 m-85 -100.9 113.49 26.49 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.734 -0.469 . . . . 1.27 109.734 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -118.79 129.45 55.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.654 0.264 . . . . 1.73 110.31 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 1.2 t -95.3 150.99 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.951 0.882 . . . . 1.33 110.645 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -98.68 -45.47 12.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.176 -1.375 . . . . 1.23 112.004 -163.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 199' ' ' ASP . 0.1 OUTLIER -154.84 -177.66 6.67 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.155 -0.929 . . . . 1.88 109.886 -173.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.655 ' HA ' ' O ' ' A' ' 104' ' ' MET . 15.4 t70 -59.22 123.32 16.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.374 0.607 . . . . 2.23 111.515 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.465 HG13 ' HE3' ' A' ' 104' ' ' MET . 14.8 mm -106.94 136.58 41.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.805 -0.634 . . . . 1.41 110.323 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.54 122.6 80.89 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.714 -0.676 . . . . 2.06 110.331 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -51.46 119.97 6.26 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.51 2.14 . . . . 0.56 111.745 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.72 -8.5 9.35 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.456 -0.878 . . . . 0.7 112.374 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -132.5 123.24 26.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.295 0.569 . . . . 1.27 110.146 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.3 96.2 6.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.729 -0.668 . . . . 2.92 111.436 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.455 ' C ' HD22 ' A' ' 207' ' ' LEU . 0.8 OUTLIER -115.58 99.89 7.67 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.836 -0.745 . . . . 1.51 110.114 177.195 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.696 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.87 112.99 6.14 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.069 -0.715 . . . . 1.16 109.069 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.601 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 3.9 p -155.28 160.08 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 O-C-N 121.984 -0.447 . . . . 1.5 110.96 -176.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.588 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 54.9 t-80 -80.27 128.6 33.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.564 -0.902 . . . . 1.77 108.564 166.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 42.4 t . . . . . 0 C--N 1.325 -0.499 0 N-CA-C 109.386 -0.598 . . . . 3.05 109.386 174.183 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 74.0 mt . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 109.95 -0.389 . . . . 2.82 109.95 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.91 116.96 4.12 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.347 2.031 . . . . 2.04 111.442 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.415 HG22 ' HB3' ' A' ' 168' ' ' TRP . 0.2 OUTLIER -131.59 147.28 65.41 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.399 -0.364 . . . . 1.53 110.365 -178.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.93 133.05 14.82 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.346 2.031 . . . . 0.88 110.761 171.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.03 -8.88 33.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.317 . . . . 1.58 111.6 -176.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -70.74 -19.7 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.049 -0.523 . . . . 1.66 110.606 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.52 ' CZ ' HD21 ' A' ' 110' ' ' LEU . 19.0 m-85 -123.78 148.27 46.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.346 -0.612 . . . . 1.2 109.346 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.4 ' HB2' ' HE2' ' A' ' 101' ' ' LYS . 7.2 tp10 -109.9 117.38 33.67 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.786 -0.366 . . . . 2.27 110.495 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.408 HD11 ' CE2' ' A' ' 171' ' ' TYR . 8.3 tt -83.67 130.09 34.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.409 -0.589 . . . . 1.37 109.409 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -143.89 124.4 13.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.06 -0.518 . . . . 3.75 111.443 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -83.03 112.48 19.81 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.432 -0.581 . . . . 2.46 109.432 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 33.0 t -170.09 149.58 3.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.118 -0.697 . . . . 2.03 109.118 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.3 m -100.61 104.91 16.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.746 0.308 . . . . 2.18 110.871 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -97.56 123.77 50.99 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.229 -0.656 . . . . 1.96 109.229 175.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.16 121.1 9.36 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.023 2.482 . . . . 1.87 112.738 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.48 -15.66 35.16 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.724 -0.671 . . . . 1.74 112.07 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.433 ' HB2' HG21 ' A' ' 91' ' ' ILE . . . -132.99 -60.14 0.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.839 0.352 . . . . 1.79 111.7 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.525 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 121.74 -125.87 6.28 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.307 -0.717 . . . . 1.14 111.307 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 89' ' ' SER . 0.7 OUTLIER -89.0 160.67 17.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.803 -0.443 . . . . 2.81 109.803 173.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.2 169.49 41.27 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.19 -1.005 . . . . 0.8 112.779 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 205' ' ' GLU . 11.3 m -104.2 148.81 8.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.1 -0.704 . . . . 1.17 109.1 174.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -118.53 120.17 36.71 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.647 0.26 . . . . 1.4 110.753 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.477 ' H ' ' HG2' ' A' ' 205' ' ' GLU . . . -71.61 122.36 20.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.235 -0.283 . . . . 1.2 110.235 176.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.613 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -90.36 11.91 19.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.657 0.741 . . . . 2.23 110.141 -178.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.2 ttp85 -137.35 159.11 42.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.155 -0.929 . . . . 4.08 108.565 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.655 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -85.34 155.93 21.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.956 0.408 . . . . 2.86 110.744 -178.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 63.0 mtm -132.05 153.01 50.84 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.171 -0.677 . . . . 1.38 109.171 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -120.07 143.68 47.99 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.13 0.269 . . . . 2.31 110.842 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -34.89 117.33 0.38 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.76 1.287 . . . . 1.42 113.544 -172.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.44 7.89 11.77 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.688 -0.687 . . . . 1.04 111.76 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.489 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -80.39 161.71 24.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.114 0.483 . . . . 2.62 110.71 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.549 ' HG3' ' CE2' ' A' ' 193' ' ' TYR . 0.0 OUTLIER -141.17 145.45 35.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.139 -0.482 . . . . 4.16 110.513 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.52 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 6.3 mt -107.51 150.74 26.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.36 -0.607 . . . . 1.11 109.36 173.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.13 -143.24 17.14 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.318 -0.944 . . . . 1.09 113.319 173.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.23 165.94 47.59 Favored 'Cis proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.822 -1.324 . . . . 2.52 113.316 2.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 31.7 t . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 2.5 110.655 -177.082 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 N-CA-C 112.333 -0.307 . . . . 1.69 112.333 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.509 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 1.2 m -57.27 -29.9 64.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.668 0.387 . . . . 2.0 111.499 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.415 ' HB3' HG22 ' A' ' 80' ' ' ILE . 45.5 p-90 -85.59 -23.46 27.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.83 111.13 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 17.7 mt -86.4 -15.55 40.01 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.805 0.298 . . . . 1.28 111.805 -177.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -76.13 -1.71 27.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.806 -0.358 . . . . 2.03 110.413 177.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.408 ' CE2' HD11 ' A' ' 86' ' ' LEU . 37.9 m-85 -81.67 -37.13 27.92 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.112 -0.495 . . . . 2.19 112.058 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -65.07 140.99 18.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 120.151 -0.62 . . . . 1.24 110.913 -173.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 -123.7 -168.27 1.75 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.839 -0.619 . . . . 4.97 111.467 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.0 t -69.63 156.64 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.58 -0.737 . . . . 1.63 110.626 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.441 ' HA ' HD12 ' A' ' 206' ' ' LEU . . . -55.88 132.99 51.04 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.141 -0.481 . . . . 1.34 110.508 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.1 m -71.77 -20.87 61.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.604 -0.725 . . . . 2.58 111.033 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 24.7 m -130.63 157.11 43.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.466 -0.334 . . . . 2.06 111.181 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . 0.468 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 3.3 p -59.01 -56.71 18.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.219 0.451 . . . . 2.69 112.219 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.76 -1.4 21.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 2.42 111.758 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -95.06 17.32 14.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.264 -0.426 . . . . 2.12 111.623 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 30.2 mm-40 -56.57 113.77 1.75 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.976 0.417 . . . . 1.52 109.889 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.547 ' OD1' ' HG3' ' A' ' 198' ' ' LYS . 17.8 t30 -159.25 43.82 0.24 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.121 -1.066 . . . . 1.68 108.121 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.593 ' HB3' ' O ' ' A' ' 206' ' ' LEU . 0.7 OUTLIER -142.42 128.86 20.11 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.003 -0.998 . . . . 1.43 111.578 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 29.8 m -150.38 120.81 7.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.088 -0.96 . . . . 1.2 110.184 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.567 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 44.9 ttm -109.19 118.44 36.72 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.654 -0.498 . . . . 1.56 109.654 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 36.7 t -113.86 166.42 11.59 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.169 -0.469 . . . . 2.13 109.774 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -124.09 134.39 53.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.829 0.347 . . . . 1.96 110.653 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 23.5 pt -148.05 140.94 18.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.722 -0.672 . . . . 1.62 109.946 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 190' ' ' GLU . 8.3 t 54.4 38.99 30.6 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.113 0.482 . . . . 2.24 110.62 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 190' ' ' GLU . 37.0 tt0 72.79 -1.47 3.0 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.186 -0.916 . . . . 2.83 112.163 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -117.8 154.2 32.18 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.443 -0.785 . . . . 1.86 111.367 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.8 mm -81.66 129.12 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.348 -0.842 . . . . 1.59 111.157 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.549 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 72.8 t80 -114.97 131.19 56.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.763 -1.108 . . . . 4.16 109.737 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 3.9 m-85 -98.98 112.3 24.46 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.157 -0.683 . . . . 1.27 109.157 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.424 ' HD2' ' C ' ' A' ' 195' ' ' LYS . 5.0 tmmm? -112.1 120.07 40.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.7 -0.682 . . . . 1.73 109.454 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.489 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 1.8 t -94.33 150.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-O 121.591 0.71 . . . . 1.33 109.326 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.8 mm -87.71 -55.58 6.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.696 -1.138 . . . . 1.23 110.65 -166.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.547 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -144.71 -178.84 6.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.722 -0.672 . . . . 1.88 111.973 177.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.486 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.0 OUTLIER -47.25 128.71 12.15 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.767 1.025 . . . . 2.23 113.767 -171.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.48 HG13 ' HE1' ' A' ' 104' ' ' MET . 38.7 mm -95.25 136.79 25.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.348 -0.842 . . . . 1.41 110.545 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -89.55 123.3 67.01 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.457 -0.572 . . . . 2.06 109.457 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' A' ' 103' ' ' LYS . 77.2 Cg_exo -47.22 123.18 7.36 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.258 2.639 . . . . 0.56 112.602 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.2 -18.77 8.32 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.914 -0.66 . . . . 0.7 112.84 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -132.55 121.25 22.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.523 0.661 . . . . 1.27 111.898 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.477 ' HG2' ' H ' ' A' ' 100' ' ' ALA . 13.2 mm-40 -110.32 118.02 35.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 2.92 109.982 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.593 ' O ' ' HB3' ' A' ' 183' ' ' LEU . 1.9 mm? -112.28 100.8 9.09 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.376 -0.972 . . . . 1.51 108.376 171.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.686 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.3 mm? -143.44 113.49 7.23 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.492 0.495 . . . . 1.16 109.891 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.434 ' H ' ' HB2' ' A' ' 183' ' ' LEU . 1.4 p -152.21 159.53 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.837 0.351 . . . . 1.5 110.289 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.567 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 44.8 t-80 -98.52 111.22 23.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.689 -1.226 . . . . 1.77 107.689 171.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 109.241 -0.652 . . . . 3.05 109.241 175.32 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.5 mt . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.519 -0.178 . . . . 2.82 110.519 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.45 125.14 10.97 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.532 2.155 . . . . 2.04 112.218 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.528 ' H ' HD12 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -111.9 159.03 35.03 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.142 -0.481 . . . . 1.53 110.973 -175.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -64.52 162.47 30.83 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.33 2.686 . . . . 0.88 112.648 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.19 -4.38 17.37 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.438 0.903 . . . . 1.58 113.438 -170.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 59.8 m-20 -111.64 1.78 16.95 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.529 -0.468 . . . . 1.66 111.839 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -128.2 140.67 51.78 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.783 -0.821 . . . . 1.2 108.783 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 101' ' ' LYS . 37.0 tt0 -122.48 126.21 47.39 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.569 -0.452 . . . . 2.27 110.183 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.572 HD12 ' CE2' ' A' ' 171' ' ' TYR . 6.2 tt -83.98 127.2 33.71 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.85 -0.614 . . . . 1.37 109.533 -178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.409 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 45.4 mtp180 -152.86 128.44 10.05 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.231 -0.895 . . . . 3.75 109.792 -174.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.3 112.55 19.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.099 -0.704 . . . . 2.46 109.099 174.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -163.96 92.14 0.66 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.529 -0.915 . . . . 2.03 108.529 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 m -54.35 105.4 0.15 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.678 -0.692 . . . . 2.18 112.083 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -92.19 123.38 62.76 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.627 -0.715 . . . . 1.96 109.181 173.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -46.58 116.9 1.78 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.449 2.766 . . . . 1.87 113.366 -175.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.87 -27.18 13.54 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.005 -0.617 . . . . 1.74 112.491 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.05 -62.32 1.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.81 0.338 . . . . 1.79 111.133 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 115.09 -113.6 2.99 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.009 -0.615 . . . . 1.14 111.922 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.38 159.29 24.39 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 122.122 0.169 . . . . 2.81 110.683 176.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.04 -179.19 46.38 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.618 -0.801 . . . . 0.8 112.109 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 29.4 m -115.77 114.66 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.6 0.714 . . . . 1.17 109.88 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.409 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 28.2 m95 -83.22 120.14 25.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.513 -0.767 . . . . 1.4 110.98 -170.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -66.51 121.76 16.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.236 -0.438 . . . . 1.2 110.39 177.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.434 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 1.1 mppt? -90.73 -9.02 48.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.153 0.502 . . . . 2.23 110.286 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -135.47 157.44 46.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.308 -0.86 . . . . 4.08 108.681 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.616 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -79.27 159.83 27.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 120.913 0.387 . . . . 2.86 110.38 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.795 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 52.8 mtm -129.13 142.05 51.0 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.395 -0.594 . . . . 1.38 109.395 177.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.35 140.81 37.91 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.852 -0.425 . . . . 2.31 109.852 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.07 128.26 3.56 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 124.175 0.922 . . . . 1.42 112.488 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.85 7.8 11.38 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.55 -0.75 . . . . 1.04 111.681 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.08 163.89 17.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.096 0.474 . . . . 2.62 111.297 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -145.98 135.34 22.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.585 -0.524 . . . . 4.16 109.585 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 5.0 mt -101.47 143.37 31.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.848 -0.427 . . . . 1.11 109.848 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.77 -136.13 9.81 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.693 -0.765 . . . . 1.09 112.34 176.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.22 149.54 93.62 Favored 'Cis proline' 0 C--N 1.343 0.267 0 C-N-CA 123.309 -1.538 . . . . 2.52 112.645 2.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.441 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 31.0 t . . . . . 0 N--CA 1.443 -0.783 0 N-CA-C 108.662 -0.866 . . . . 2.5 108.662 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 112.768 -0.133 . . . . 1.69 112.768 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 17.3 m -79.3 -28.62 42.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.107 0.48 . . . . 2.0 110.447 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.482 ' CB ' HG21 ' A' ' 80' ' ' ILE . 40.5 p-90 -65.03 -17.46 64.46 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.693 -0.685 . . . . 0.83 111.33 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 65.3 mt -68.78 -14.18 62.86 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.229 -0.896 . . . . 1.28 112.002 -175.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.453 ' C ' ' HD3' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -69.69 -13.19 62.18 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.671 0.272 . . . . 2.03 111.189 178.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.572 ' CE2' HD12 ' A' ' 86' ' ' LEU . 46.1 m-85 -78.47 -37.83 42.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 2.19 111.924 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -70.51 125.68 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.638 -0.425 . . . . 1.24 110.141 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.8 mtp85 -117.85 -161.76 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.282 -0.417 . . . . 4.97 111.657 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.8 t -72.37 157.62 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.116 -0.493 . . . . 1.63 111.213 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.479 ' HB2' ' CD1' ' A' ' 183' ' ' LEU . . . -57.15 153.34 11.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.802 -0.635 . . . . 1.34 112.167 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 28.8 p -85.98 -10.72 54.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.333 -0.849 . . . . 2.58 110.678 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 34.0 m -153.63 170.87 19.79 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.193 -0.458 . . . . 2.06 110.82 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 10.5 p -71.95 -43.09 65.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.154 0.502 . . . . 2.69 110.87 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -78.26 4.02 13.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.404 0.621 . . . . 2.42 110.439 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -101.94 16.46 25.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.371 -0.832 . . . . 2.12 110.468 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 31.5 mm-40 -67.53 113.89 5.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 1.52 111.015 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.627 ' ND2' HD13 ' A' ' 200' ' ' ILE . 16.6 t30 -150.94 33.64 0.6 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.253 1.025 . . . . 1.68 108.354 173.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.627 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.2 OUTLIER -124.24 123.2 39.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.41 -0.813 . . . . 1.43 110.701 -171.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 96.0 m -150.8 127.4 10.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.111 0.482 . . . . 1.2 110.738 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 63.6 mtp -114.4 136.05 53.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.951 0.405 . . . . 1.56 110.218 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 1.4 p -113.51 137.56 51.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.654 -0.703 . . . . 2.13 110.775 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -109.08 104.01 13.12 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.796 -0.816 . . . . 1.96 108.796 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 27.5 pt -141.56 145.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 1.62 110.371 -176.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.2 m 65.13 26.4 12.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 2.24 110.897 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 62.76 19.47 11.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.407 -0.815 . . . . 2.83 111.28 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -131.7 168.03 18.46 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.481 -0.563 . . . . 1.86 109.481 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 113' ' ' CYS . 48.3 mm -99.89 132.41 45.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.179 0.514 . . . . 1.59 111.903 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -125.02 137.4 54.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.995 -0.548 . . . . 4.16 110.747 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 7.3 m-85 -100.94 117.08 34.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.966 -0.561 . . . . 1.27 109.725 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -113.01 120.28 40.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.926 0.394 . . . . 1.73 110.405 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.01 152.74 3.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.321 -0.622 . . . . 1.33 109.321 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.55 -56.18 5.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.09 -0.959 . . . . 1.23 112.105 -166.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.62 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -135.02 175.79 9.25 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.953 -0.567 . . . . 1.88 111.379 -173.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.795 ' HA ' ' O ' ' A' ' 104' ' ' MET . 17.0 t70 -50.18 112.54 0.69 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.762 0.791 . . . . 2.23 112.061 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.627 HD13 ' ND2' ' A' ' 182' ' ' ASN . 8.9 mm -79.94 136.22 23.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.633 -1.167 . . . . 1.41 111.117 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.608 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 42.3 mt-10 -88.5 126.96 58.44 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 109.261 -0.644 . . . . 2.06 109.261 173.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.51 111.8 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 121.86 1.706 . . . . 0.56 111.019 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.04 -6.4 10.23 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.63 -0.795 . . . . 0.7 113.175 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 22.2 pt-20 -115.24 121.26 42.39 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.687 0.744 . . . . 1.27 110.636 174.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -111.72 95.38 5.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.045 -0.525 . . . . 2.92 111.549 174.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.488 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.8 mm? -122.35 99.72 6.57 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.121 -0.632 . . . . 1.51 109.569 174.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.575 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -146.47 113.37 6.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.973 0.509 . . . . 1.16 109.83 177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.627 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.1 p -154.87 160.4 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 110.098 -0.334 . . . . 1.5 110.098 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.536 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 59.3 t-80 -93.69 109.87 21.51 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.902 -1.147 . . . . 1.77 107.902 171.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 C--N 1.316 -0.868 0 N-CA-C 109.603 -0.517 . . . . 3.05 109.603 177.345 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 81.9 mt . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 110.445 -0.205 . . . . 2.82 110.445 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -72.12 116.56 4.76 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.322 2.014 . . . . 2.04 111.013 175.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.45 ' H ' HD11 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -125.73 146.31 54.62 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.275 -0.42 . . . . 1.53 110.3 -177.127 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.03 124.45 16.3 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.27 1.98 . . . . 0.88 110.406 170.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.21 -8.37 12.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.415 0.524 . . . . 1.58 112.415 -173.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.61 -9.03 31.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.197 0.522 . . . . 1.66 111.542 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -134.52 156.75 48.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.164 -1.05 . . . . 1.2 108.164 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -121.46 116.15 24.18 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.135 -0.626 . . . . 2.27 111.246 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.3 tt -86.41 128.2 34.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.782 -0.451 . . . . 1.37 109.782 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -151.12 130.66 13.0 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.48 -0.782 . . . . 3.75 109.682 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -68.21 112.03 4.89 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.367 -0.605 . . . . 2.46 109.367 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.7 t -169.52 110.7 0.46 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.423 -0.584 . . . . 2.03 109.423 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 t -90.85 107.77 19.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.21 -0.45 . . . . 2.18 110.739 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.486 HG22 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -79.11 121.95 83.8 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.35 -0.611 . . . . 1.96 109.35 175.024 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.42 114.93 1.77 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.371 2.714 . . . . 1.87 112.988 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.09 -9.83 36.74 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.95 -0.643 . . . . 1.74 112.727 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.486 ' HB3' HG22 ' A' ' 91' ' ' ILE . . . -135.76 -60.26 0.74 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.971 0.385 . . . . 1.79 111.665 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 122.76 -146.09 16.5 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.647 -0.787 . . . . 1.14 112.716 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 mt -80.4 159.03 25.82 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.254 -0.276 . . . . 2.81 110.254 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.03 169.09 39.51 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.802 -0.713 . . . . 0.8 111.774 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 27.5 m -98.41 114.21 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.773 0.796 . . . . 1.17 109.262 172.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -81.76 101.76 10.34 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.234 -0.893 . . . . 1.4 110.663 -167.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.37 115.22 5.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.733 -0.667 . . . . 1.2 109.701 175.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.447 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -94.0 15.76 16.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.607 0.717 . . . . 2.23 109.515 -177.347 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -148.43 160.83 42.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.562 -1.199 . . . . 4.08 108.144 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.76 158.79 34.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.435 0.636 . . . . 2.86 111.453 -174.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.532 ' HE2' HG13 ' A' ' 200' ' ' ILE . 54.0 mtm -134.5 143.71 47.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.98 -1.119 . . . . 1.38 107.98 170.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 52.3 mt-10 -130.28 174.45 9.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.43 . . . . 2.31 112.157 -172.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.64 122.48 11.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.495 -0.775 . . . . 1.42 113.054 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.18 -25.53 11.28 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 1.04 113.927 169.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 10.1 pt-20 -73.98 160.92 30.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.375 0.607 . . . . 2.62 112.007 -174.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.704 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 0.7 OUTLIER -124.9 134.64 52.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.029 -0.987 . . . . 4.16 110.474 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mt -87.84 133.52 33.88 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.973 -0.751 . . . . 1.11 108.973 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.87 -132.87 5.43 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.487 -0.863 . . . . 1.09 112.433 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.06 134.4 17.97 Favored 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 123.947 -1.272 . . . . 2.52 112.881 1.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.486 -0.779 . . . . 2.5 111.642 -175.394 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 120.395 -0.114 . . . . 1.69 112.821 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.52 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 3.5 p -65.99 -24.74 66.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.138 0.494 . . . . 2.0 110.774 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -84.22 -17.68 39.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.019 -0.537 . . . . 0.83 110.544 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.7 -14.13 58.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.993 -0.549 . . . . 1.28 111.442 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 167' ' ' SER . 21.2 ptmt -64.66 -18.98 65.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.927 0.394 . . . . 2.03 110.5 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -72.53 -37.57 68.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.92 -0.582 . . . . 2.19 111.621 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -73.97 117.73 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.513 0.673 . . . . 1.24 110.855 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 -172.05 2.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.891 -1.05 . . . . 4.97 110.3 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.485 ' HA ' HD22 ' A' ' 183' ' ' LEU . 2.3 p -65.2 147.03 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.345 0.593 . . . . 1.63 111.781 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.15 149.45 28.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.611 -1.177 . . . . 1.34 112.599 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 53.7 t -60.32 -44.43 95.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.117 -0.947 . . . . 2.58 110.828 175.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 87.1 p -137.75 164.64 28.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.72 -0.474 . . . . 2.06 109.72 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . 0.473 ' HA ' ' OE1' ' A' ' 181' ' ' GLN . 75.8 m -78.4 4.36 13.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 2.69 111.849 -176.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -89.06 -7.34 56.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.2 0.524 . . . . 2.42 109.647 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.445 ' O ' ' HG ' ' A' ' 206' ' ' LEU . 23.6 m-20 -109.04 15.59 23.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.566 -0.743 . . . . 2.12 110.813 -176.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.473 ' OE1' ' HA ' ' A' ' 178' ' ' CYS . 15.0 mm100 -66.52 115.7 6.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.572 0.701 . . . . 1.52 111.746 -172.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.515 ' H ' HD12 ' A' ' 183' ' ' LEU . 14.1 t30 -165.03 39.74 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.682 -1.229 . . . . 1.68 107.682 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.665 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.7 OUTLIER -122.05 119.87 32.67 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.522 -0.763 . . . . 1.43 111.301 -170.422 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.5 m -150.93 121.82 7.6 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.241 0.543 . . . . 1.2 111.884 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.541 ' HB3' ' CB ' ' A' ' 209' ' ' HIS . 10.8 ttm -111.51 129.3 56.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.273 -0.64 . . . . 1.56 109.273 172.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 49.9 t -115.31 155.79 26.66 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.733 0.301 . . . . 2.13 110.266 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -116.01 112.39 21.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.291 -0.633 . . . . 1.96 109.291 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.498 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 41.5 pt -138.54 143.17 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.46 -0.336 . . . . 1.62 110.675 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.9 t 55.86 37.86 29.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 2.24 111.639 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 60.47 28.43 18.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.824 -0.625 . . . . 2.83 111.712 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 12.9 pt20 -145.11 156.22 43.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.859 0.361 . . . . 1.86 110.49 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.6 mm -82.25 134.79 26.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.191 0.52 . . . . 1.59 111.264 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -124.64 122.3 37.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.669 -0.696 . . . . 4.16 109.665 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.704 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 26.4 m-85 -99.37 113.69 26.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.095 -0.705 . . . . 1.27 109.095 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -111.25 127.1 55.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.351 -0.386 . . . . 1.73 110.375 -172.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.404 ' CG2' ' HG3' ' A' ' 108' ' ' GLU . 1.5 t -95.19 150.73 4.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.91 0.862 . . . . 1.33 110.248 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.6 mm -100.22 -53.67 7.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.841 -1.527 . . . . 1.23 111.618 -163.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.41 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -153.3 -178.89 7.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.065 -0.97 . . . . 1.88 110.799 -179.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 104' ' ' MET . 9.6 p-10 -52.85 110.96 0.58 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.992 0.808 . . . . 2.23 112.673 -172.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.532 HG13 ' HE2' ' A' ' 104' ' ' MET . 2.6 mm -80.89 134.47 27.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.693 -0.685 . . . . 1.41 110.349 171.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 12.5 mm-40 -81.67 120.56 78.16 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.548 -0.751 . . . . 2.06 109.559 173.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.51 115.43 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.145 2.564 . . . . 0.56 112.358 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.27 -11.49 9.18 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.71 -0.757 . . . . 0.7 113.076 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 13.0 pt-20 -123.46 125.59 45.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.78 0.79 . . . . 1.27 111.613 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.447 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -108.96 99.88 9.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.529 -1.214 . . . . 2.92 112.069 -175.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.546 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.1 mm? -122.55 100.38 6.9 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.492 -0.483 . . . . 1.51 110.473 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.527 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.0 mm? -145.61 113.67 6.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.816 0.446 . . . . 1.16 110.303 174.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.665 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.9 p -155.83 161.79 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 O-C-N 122.164 -0.335 . . . . 1.5 110.41 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.541 ' CB ' ' HB3' ' A' ' 185' ' ' MET . 33.0 t-80 -131.44 109.89 10.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.189 -0.671 . . . . 1.77 109.189 161.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 121.186 0.517 . . . . 3.05 109.746 174.519 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.492 0.186 . . . . 2.82 110.745 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.95 116.57 4.44 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.323 2.015 . . . . 2.04 111.867 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.453 ' H ' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -118.43 134.81 23.42 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.199 -0.455 . . . . 1.53 109.933 178.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.52 146.9 50.54 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.584 2.189 . . . . 0.88 111.936 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.25 6.89 3.89 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.268 0.84 . . . . 1.58 113.268 -168.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -116.97 5.91 12.93 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.798 -0.564 . . . . 1.66 112.102 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.573 ' CZ ' HD23 ' A' ' 110' ' ' LEU . 10.6 m-85 -130.47 138.35 50.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.66 -0.867 . . . . 1.2 108.66 176.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 101' ' ' LYS . 1.2 tp10 -108.52 117.42 34.13 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.759 -0.376 . . . . 2.27 110.37 -174.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.415 HD21 ' N ' ' A' ' 87' ' ' ARG . 6.6 tt -84.13 126.85 33.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.955 -0.758 . . . . 1.37 108.955 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.415 ' N ' HD21 ' A' ' 86' ' ' LEU . 78.5 mtp180 -149.52 119.02 6.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.622 -0.717 . . . . 3.75 110.74 -173.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -73.47 112.24 9.37 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.997 -0.742 . . . . 2.46 108.997 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.4 p -155.16 158.7 39.36 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.674 -0.694 . . . . 2.03 109.355 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.1 m -99.47 103.14 14.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.837 -0.431 . . . . 2.18 109.837 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -108.04 111.38 62.09 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.194 -0.457 . . . . 1.96 109.94 177.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -58.42 125.2 17.7 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.034 2.49 . . . . 1.87 112.92 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.76 -13.3 38.54 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.889 -0.672 . . . . 1.74 112.136 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -136.27 -54.83 0.75 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.125 0.488 . . . . 1.79 110.631 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.78 -94.65 0.5 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.319 -0.855 . . . . 1.14 111.213 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 171' ' ' TYR . 0.5 OUTLIER -108.99 160.52 15.95 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.805 -0.698 . . . . 2.81 109.626 172.196 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -170.39 165.63 38.89 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.079 -1.057 . . . . 0.8 112.997 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 15.9 m -106.7 147.17 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.825 -0.435 . . . . 1.17 109.825 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -109.2 117.21 33.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.533 -0.303 . . . . 1.4 110.617 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 202' ' ' PRO . . . -67.46 128.65 37.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.525 -0.307 . . . . 1.2 110.173 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -99.54 -9.07 23.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 2.23 111.249 -176.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.497 ' HG3' ' N ' ' A' ' 103' ' ' LYS . 20.9 tpt180 -125.85 150.3 47.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.208 0.528 . . . . 4.08 111.448 -176.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.497 ' N ' ' HG3' ' A' ' 102' ' ' ARG . 1.5 tptm -61.32 138.45 58.24 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.866 -1.061 . . . . 2.86 111.061 173.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.515 ' HE1' HG13 ' A' ' 200' ' ' ILE . 77.5 mtm -127.86 152.61 47.61 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.607 -0.886 . . . . 1.38 108.607 173.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.7 135.16 54.46 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 123.232 0.332 . . . . 2.31 110.563 -174.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -37.79 112.7 0.23 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 124.872 1.357 . . . . 1.42 112.803 -174.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.95 7.26 11.75 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.581 -0.736 . . . . 1.04 111.341 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.444 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -75.37 165.91 24.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.907 0.384 . . . . 2.62 110.398 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.456 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 2.4 tmm_? -145.61 131.65 19.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.37 -0.377 . . . . 4.16 111.063 -176.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.573 HD23 ' CZ ' ' A' ' 84' ' ' PHE . 4.8 mt -99.48 137.11 38.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.058 -0.719 . . . . 1.11 109.058 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.85 -168.21 31.15 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.314 -0.946 . . . . 1.09 112.438 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.414 ' HA ' ' CE2' ' A' ' 193' ' ' TYR . 7.6 Cg_exo -73.45 146.11 86.0 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.736 -1.36 . . . . 2.52 112.395 1.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 2.5 110.691 -178.902 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.282 0 N-CA-C 112.913 -0.075 . . . . 1.69 112.913 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 5.7 m -66.22 -23.83 66.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.965 0.412 . . . . 2.0 110.352 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.45 ' O ' ' HB2' ' A' ' 171' ' ' TYR . 48.5 p-90 -86.0 -24.82 26.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.929 -0.578 . . . . 0.83 110.548 176.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 26.5 mt -76.89 -25.83 53.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 1.28 111.189 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.482 ' HE2' ' CE2' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -72.25 -1.57 15.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.049 0.452 . . . . 2.03 110.447 176.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.482 ' CE2' ' HE2' ' A' ' 170' ' ' LYS . 17.8 m-85 -82.2 -38.19 24.95 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.178 -0.464 . . . . 2.19 111.128 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -73.27 111.77 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.421 -0.511 . . . . 1.24 109.654 177.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.448 ' O ' ' HB ' ' A' ' 208' ' ' VAL . 3.3 mmp_? -114.22 -155.02 0.56 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.936 -0.574 . . . . 4.97 110.975 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 39.4 t -61.83 148.67 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 1.63 111.552 -173.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.84 121.91 6.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.026 -0.988 . . . . 1.34 112.405 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 2.4 p -73.82 -9.74 58.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.573 -0.739 . . . . 2.58 110.686 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.3 t -148.19 138.28 22.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.637 -0.71 . . . . 2.06 109.562 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . 0.619 ' HA ' ' OE1' ' A' ' 181' ' ' GLN . 8.5 p -86.22 -13.99 45.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.211 0.529 . . . . 2.69 111.027 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.67 -8.69 51.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.018 -0.537 . . . . 2.42 110.319 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -110.81 19.61 18.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.557 -0.747 . . . . 2.12 111.859 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.619 ' OE1' ' HA ' ' A' ' 178' ' ' CYS . 15.1 mm100 -52.89 116.07 2.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.508 0.671 . . . . 1.52 111.958 -173.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.709 ' ND2' HD13 ' A' ' 200' ' ' ILE . 28.7 t30 -152.94 37.05 0.49 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.097 -0.956 . . . . 1.68 108.787 177.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.637 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.9 OUTLIER -117.85 121.08 39.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.545 -0.752 . . . . 1.43 111.027 -173.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 84.1 m -150.08 146.71 27.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.89 0.376 . . . . 1.2 110.938 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.469 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 51.7 tpp -109.88 145.85 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 1.56 110.093 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 8.4 m -132.05 140.05 48.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.198 0.523 . . . . 2.13 111.187 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -116.44 104.47 11.48 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.953 -0.758 . . . . 1.96 108.953 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 21.7 pt -141.04 145.45 25.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.019 -0.537 . . . . 1.62 110.457 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.5 m 67.73 30.67 6.3 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.193 0.521 . . . . 2.24 110.916 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 62.13 22.24 12.99 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.089 -0.959 . . . . 2.83 111.926 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.412 ' HG3' ' CE1' ' A' ' 193' ' ' TYR . 4.2 pt20 -141.05 167.28 22.56 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.16 -0.473 . . . . 1.86 109.8 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.5 mm -92.73 137.03 23.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.279 -0.418 . . . . 1.59 110.72 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.456 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 27.8 m-85 -135.85 150.54 49.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.317 0.579 . . . . 4.16 111.508 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.453 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 6.6 m-85 -100.71 113.72 26.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.364 -0.835 . . . . 1.27 109.588 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.09 122.74 47.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.947 0.403 . . . . 1.73 110.195 -176.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.463 ' CG1' HD22 ' A' ' 182' ' ' ASN . 1.9 t -94.41 152.5 3.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.775 0.798 . . . . 1.33 109.96 -177.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.2 -54.5 7.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.606 -1.179 . . . . 1.23 111.395 -166.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.583 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -135.05 168.17 19.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.847 -0.615 . . . . 1.88 111.336 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 104' ' ' MET . 2.0 m-20 -46.36 125.87 7.3 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.143 0.902 . . . . 2.23 112.531 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.709 HD13 ' ND2' ' A' ' 182' ' ' ASN . 27.6 mm -94.4 134.95 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.72 -0.673 . . . . 1.41 111.319 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 50.6 mt-10 -105.35 125.79 32.58 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.481 -0.781 . . . . 2.06 109.518 174.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 87.8 Cg_exo -41.52 113.47 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.816 3.011 . . . . 0.56 113.551 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 120.43 6.37 9.72 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.815 -0.707 . . . . 0.7 113.054 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.7 pt-20 -118.26 123.8 46.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.193 0.497 . . . . 1.27 110.694 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.491 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -109.51 91.17 3.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.919 -0.582 . . . . 2.92 111.278 176.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.576 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 2.3 mm? -125.98 95.0 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.388 -0.525 . . . . 1.51 110.076 172.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 206' ' ' LEU . 1.7 mm? -148.63 113.9 5.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.857 0.463 . . . . 1.16 109.883 172.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.637 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.7 p -156.65 159.41 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.676 0.671 . . . . 1.5 111.421 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 46.7 t-80 -106.56 111.98 24.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.313 -0.625 . . . . 1.77 109.313 164.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 C--N 1.321 -0.668 0 N-CA-C 109.869 -0.419 . . . . 3.05 109.869 173.964 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.7 mt . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 109.008 -0.738 . . . . 2.82 109.008 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.11 122.05 11.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.606 2.204 . . . . 2.04 112.323 -176.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.406 ' H ' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.46 142.65 45.99 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.875 -0.602 . . . . 1.53 109.979 178.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.95 142.69 19.21 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.388 2.725 . . . . 0.88 112.686 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.67 -16.32 47.75 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.581 -0.736 . . . . 1.58 112.251 -175.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -68.43 -23.09 64.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.958 -0.565 . . . . 1.66 110.557 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -120.9 161.86 20.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.91 -0.586 . . . . 1.2 110.223 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.573 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 33.5 tt0 -139.15 130.53 26.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.814 -0.354 . . . . 2.27 110.922 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.447 HD11 ' CZ ' ' A' ' 171' ' ' TYR . 5.2 tt -85.68 127.74 34.58 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.351 0.596 . . . . 1.37 110.484 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -148.76 140.59 23.71 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.127 -0.942 . . . . 3.75 110.031 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -82.79 112.25 19.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.04 0.447 . . . . 2.46 109.88 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.5 m -156.23 94.99 1.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.982 -0.748 . . . . 2.03 108.982 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.9 t -62.05 105.85 0.64 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.128 0.489 . . . . 2.18 111.474 -174.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.412 HG23 ' HD3' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -99.56 117.25 64.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.018 -0.734 . . . . 1.96 109.018 172.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.77 121.71 9.7 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.152 2.568 . . . . 1.87 112.741 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.11 -15.39 36.55 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.804 -0.712 . . . . 1.74 112.338 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -133.91 -59.78 0.83 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.966 0.412 . . . . 1.79 111.299 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.73 -116.09 3.0 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.773 -0.727 . . . . 1.14 112.216 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.29 158.43 16.12 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 122.455 0.302 . . . . 2.81 110.766 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 171' ' ' TYR . . . -151.26 172.25 30.83 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.313 -0.946 . . . . 0.8 113.465 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.425 ' O ' ' HG2' ' A' ' 205' ' ' GLU . 14.3 m -117.64 111.19 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.399 0.619 . . . . 1.17 109.718 175.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -82.69 126.74 32.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.749 -0.66 . . . . 1.4 111.383 -170.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.31 114.74 9.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.394 -0.595 . . . . 1.2 109.394 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.573 ' CE ' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -94.58 0.46 55.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.002 -0.74 . . . . 2.23 109.002 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -124.66 157.53 35.33 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.675 -1.148 . . . . 4.08 108.831 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.561 ' HD2' ' H ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -90.28 155.1 19.23 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.671 -0.492 . . . . 2.86 109.671 -177.16 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.471 ' HE3' HG13 ' A' ' 200' ' ' ILE . 60.3 mtm -135.43 148.44 49.3 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.549 -0.908 . . . . 1.38 108.549 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.87 146.99 39.22 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.995 -0.282 . . . . 2.31 110.623 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.26 121.81 2.0 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 124.301 1.001 . . . . 1.42 113.024 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.59 7.49 11.99 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.367 -0.833 . . . . 1.04 111.318 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.573 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.9 OUTLIER -79.78 156.2 27.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.264 0.554 . . . . 2.62 110.799 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.52 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 7.3 tmm_? -145.49 135.89 24.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.685 -0.689 . . . . 4.16 110.355 -176.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 6.2 mt -101.1 151.38 21.89 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.82 -0.437 . . . . 1.11 109.82 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.14 -174.01 44.8 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.609 -0.597 . . . . 1.09 111.609 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -83.02 141.37 42.75 Favored 'Cis proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.982 -1.674 . . . . 2.52 112.44 -2.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 121.604 0.716 . . . . 2.5 109.513 175.648 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.37 0 N-CA-C 113.302 0.081 . . . . 1.69 113.302 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.4 t -71.39 -14.42 62.17 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.547 0.203 . . . . 2.0 111.547 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 48.5 p-90 -56.94 -23.46 45.59 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.027 0.441 . . . . 0.83 111.734 -176.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 32.1 mt -73.45 -12.83 60.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.241 0.46 . . . . 1.28 112.241 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.428 ' HD2' ' C ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -66.12 -14.37 61.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.012 0.434 . . . . 2.03 110.155 177.289 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.507 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 41.5 m-85 -72.61 -31.43 65.16 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 115.782 -0.644 . . . . 2.19 111.887 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -66.28 116.37 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.317 -0.553 . . . . 1.24 110.175 -177.268 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.412 ' HD3' HG23 ' A' ' 91' ' ' ILE . 18.0 ptt180 -75.83 155.79 35.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.573 -0.74 . . . . 4.97 111.83 -174.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.538 ' HB ' HG11 ' A' ' 208' ' ' VAL . 2.7 p -83.82 147.01 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.371 -0.831 . . . . 1.63 109.352 172.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.449 ' HB1' HD12 ' A' ' 183' ' ' LEU . . . -45.88 123.72 4.71 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 123.933 0.771 . . . . 1.34 112.391 -174.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 51.8 t -80.42 -9.43 59.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 2.58 109.504 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 13.0 t -126.27 138.43 53.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.166 -0.924 . . . . 2.06 109.21 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 61.3 m -77.48 -15.88 59.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.876 0.37 . . . . 2.69 111.093 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -89.68 0.62 56.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.016 0.436 . . . . 2.42 110.578 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.18 17.88 21.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.865 -0.607 . . . . 2.12 111.619 -172.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -59.16 113.5 2.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.126 0.489 . . . . 1.52 111.04 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.5 ' H ' HD11 ' A' ' 183' ' ' LEU . 62.4 t30 -146.64 29.28 1.03 Allowed 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.845 -0.798 . . . . 1.68 108.845 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.666 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -118.76 121.59 40.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.687 -0.688 . . . . 1.43 111.113 -170.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.6 m -150.2 133.46 16.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.282 0.563 . . . . 1.2 111.518 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 46.6 ttm -100.14 135.09 42.11 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.146 -0.687 . . . . 1.56 109.146 174.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 15.2 m -117.84 131.69 56.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.181 0.515 . . . . 2.13 111.575 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.46 103.63 14.03 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.28 -1.007 . . . . 1.96 108.28 174.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 22.8 pt -138.4 144.18 30.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.734 -0.666 . . . . 1.62 109.839 -177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 m 61.27 28.75 18.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.213 0.53 . . . . 2.24 110.318 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 56.2 34.86 24.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.121 -0.945 . . . . 2.83 111.789 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -142.06 157.64 44.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.626 -0.716 . . . . 1.86 109.619 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.6 mm -94.56 131.32 41.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.301 -0.409 . . . . 1.59 111.264 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.52 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 27.0 m-85 -131.98 157.47 43.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.935 -0.575 . . . . 4.16 111.148 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 3.3 m-85 -101.3 113.68 26.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.956 -0.757 . . . . 1.27 108.956 173.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -110.22 125.62 53.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.936 0.398 . . . . 1.73 110.012 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.573 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 1.9 t -96.57 151.44 4.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.747 0.784 . . . . 1.33 110.202 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.403 HD11 ' N ' ' A' ' 197' ' ' ILE . 0.9 OUTLIER -92.64 -53.8 8.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.543 -1.208 . . . . 1.23 110.591 -167.288 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.494 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -132.0 171.12 13.99 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.085 -0.961 . . . . 1.88 110.678 175.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -53.9 143.84 20.37 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.87 0.693 . . . . 2.23 112.87 -171.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.471 HG13 ' HE3' ' A' ' 104' ' ' MET . 31.4 mm -99.85 133.46 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.594 -0.73 . . . . 1.41 110.387 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -95.13 131.36 30.2 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 109.372 -0.603 . . . . 2.06 109.372 173.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -50.95 116.2 2.49 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.605 2.203 . . . . 0.56 112.042 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 123.26 -12.86 8.44 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.666 -0.778 . . . . 0.7 112.948 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.68 119.17 21.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.607 0.703 . . . . 1.27 111.032 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -113.05 96.72 6.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.283 -0.871 . . . . 2.92 111.484 177.177 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.474 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.1 mm? -114.14 99.07 7.35 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.52 -0.872 . . . . 1.51 110.524 177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.546 ' HB2' HG22 ' A' ' 172' ' ' ILE . 1.5 mm? -147.19 112.39 5.51 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.327 0.651 . . . . 1.16 109.502 174.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.666 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 2.6 p -156.64 161.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.392 -0.595 . . . . 1.5 109.392 -177.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -123.31 105.71 10.08 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.002 -0.74 . . . . 1.77 109.002 162.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 109.277 -0.638 . . . . 3.05 109.277 173.448 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 110.335 -0.246 . . . . 2.82 110.335 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.17 116.47 4.19 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.287 1.992 . . . . 2.04 111.695 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.435 ' H ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -122.03 151.56 58.48 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.051 -0.522 . . . . 1.53 110.292 -178.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.409 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 82.7 Cg_exo -48.31 134.37 25.41 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.195 2.596 . . . . 0.88 112.441 175.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.69 -20.94 66.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.51 -0.768 . . . . 1.58 112.225 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -68.62 -8.26 40.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.442 0.534 . . . . 1.66 112.442 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -139.93 152.39 46.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.199 -0.667 . . . . 1.2 109.199 -176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -113.63 126.68 55.53 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.782 -0.367 . . . . 2.27 111.544 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.02 127.68 34.7 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.774 -0.824 . . . . 1.37 108.774 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -144.22 147.14 33.22 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.651 -0.704 . . . . 3.75 109.848 -174.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -82.3 112.3 19.16 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.862 -0.792 . . . . 2.46 108.862 172.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 23.3 t -164.9 140.78 5.62 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.366 -0.605 . . . . 2.03 109.366 -176.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 m -99.34 107.32 19.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.8 0.333 . . . . 2.18 110.692 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -105.9 120.46 48.99 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.427 -0.583 . . . . 1.96 109.427 175.245 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 91' ' ' ILE . 50.7 Cg_exo -56.02 123.31 13.53 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.031 2.487 . . . . 1.87 113.312 -176.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.75 -26.82 14.68 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.95 -0.643 . . . . 1.74 112.394 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.55 -57.96 2.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.212 0.53 . . . . 1.79 110.604 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.06 -120.13 4.13 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 111.199 -0.761 . . . . 1.14 111.199 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -87.17 127.81 35.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.387 -0.598 . . . . 2.81 109.387 173.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.504 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -129.2 157.47 21.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.295 -0.955 . . . . 0.8 113.053 -172.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 98' ' ' VAL . 35.6 m -97.52 114.61 35.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.597 0.713 . . . . 1.17 109.259 173.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -82.19 115.4 21.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.738 -0.665 . . . . 1.4 110.812 -170.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.57 114.78 12.2 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.331 -0.849 . . . . 1.2 109.981 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.09 8.58 42.54 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.975 0.893 . . . . 2.23 109.052 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.464 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 50.5 ttp85 -125.66 153.42 43.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.168 -1.378 . . . . 4.08 108.111 172.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.7 ' HB2' ' O ' ' A' ' 200' ' ' ILE . 0.0 OUTLIER -87.32 126.52 34.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.589 0.709 . . . . 2.86 109.475 -179.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.698 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 25.8 mtm -94.57 138.92 31.86 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.483 -0.562 . . . . 1.38 109.483 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 10.9 pt-20 -120.34 175.14 6.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.976 0.417 . . . . 2.31 111.945 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.57 125.65 17.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 1.42 112.955 -175.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.27 -14.74 62.12 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.91 -0.662 . . . . 1.04 114.274 168.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 6.7 pt-20 -78.3 158.62 28.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.79 0.795 . . . . 2.62 111.109 -176.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 8.5 ttm180 -119.59 143.86 47.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.471 -0.786 . . . . 4.16 110.654 -176.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 mt -101.34 146.99 26.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.247 -0.649 . . . . 1.11 109.247 172.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.83 -127.82 7.74 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.45 -0.881 . . . . 1.09 112.892 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.01 158.63 69.17 Favored 'Cis proline' 0 N--CA 1.477 0.55 0 C-N-CA 123.622 -1.408 . . . . 2.52 112.854 1.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.059 -0.519 . . . . 2.5 110.838 -177.01 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.575 0 N-CA-C 112.063 -0.415 . . . . 1.69 112.063 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 16.0 m -56.19 -41.35 75.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.383 0.273 . . . . 2.0 111.442 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.409 ' CZ2' ' HG2' ' A' ' 81' ' ' PRO . 27.4 p-90 -87.45 -22.04 25.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.846 0.355 . . . . 0.83 111.382 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 38.9 mt -85.61 -14.87 44.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.746 0.276 . . . . 1.28 111.746 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.1 OUTLIER -75.29 -4.67 40.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 2.03 110.224 174.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.504 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 29.4 m-85 -77.43 -38.44 49.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.528 -0.76 . . . . 2.19 110.64 177.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -81.45 117.48 27.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.145 0.497 . . . . 1.24 110.552 178.765 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 43.1 mmt-85 -131.09 -161.8 1.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.627 -0.715 . . . . 4.97 110.825 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.451 ' HA ' HG13 ' A' ' 208' ' ' VAL . 6.2 t -62.49 139.65 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.286 0.565 . . . . 1.63 111.97 -168.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.512 ' HB1' ' NE2' ' A' ' 181' ' ' GLN . . . -71.7 164.82 25.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.154 -0.93 . . . . 1.34 111.276 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 47.4 t -92.45 -21.28 20.27 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.298 -0.864 . . . . 2.58 112.054 -169.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.3 m -143.16 -179.74 6.56 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.422 0.527 . . . . 2.06 112.422 -174.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 6.3 p -74.49 -53.03 10.28 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.117 0.414 . . . . 2.69 112.117 -175.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.15 -12.9 61.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.817 0.817 . . . . 2.42 109.468 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 206' ' ' LEU . 28.5 t0 -80.54 -1.58 42.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.326 -1.307 . . . . 2.12 110.192 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.512 ' NE2' ' HB1' ' A' ' 175' ' ' ALA . 33.9 mm-40 -73.22 116.52 13.85 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.164 0.507 . . . . 1.52 111.572 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.505 ' OD1' ' HG3' ' A' ' 198' ' ' LYS . 16.8 t30 -156.1 38.8 0.35 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.02 -1.104 . . . . 1.68 108.02 173.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.637 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.1 OUTLIER -124.55 124.76 42.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.442 -0.799 . . . . 1.43 111.233 -172.348 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 99.8 m -150.9 133.86 15.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 1.2 110.86 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.447 ' HE1' ' CZ ' ' A' ' 194' ' ' TYR . 37.3 ttm -127.53 136.29 51.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.009 -0.541 . . . . 1.56 109.548 176.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 9.0 p -130.21 165.64 21.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.799 0.333 . . . . 2.13 110.41 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.79 104.98 11.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.189 -0.671 . . . . 1.96 109.189 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.517 HD12 ' CD2' ' A' ' 193' ' ' TYR . 43.9 pt -135.53 145.16 32.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 1.62 110.712 -175.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.8 m 62.06 28.76 17.39 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.36 0.413 . . . . 2.24 111.449 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 66.94 21.75 10.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.579 -0.737 . . . . 2.83 111.791 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -133.48 166.43 22.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.379 . . . . 1.86 110.421 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.6 mm -88.2 130.06 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.922 -0.581 . . . . 1.59 109.752 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.517 ' CD2' HD12 ' A' ' 188' ' ' ILE . 35.2 t80 -120.56 124.44 45.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 4.16 110.881 -173.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.658 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 7.4 m-85 -99.94 113.69 26.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.562 -0.903 . . . . 1.27 108.562 174.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -110.81 124.91 52.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.234 -0.284 . . . . 1.73 110.234 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.413 HG11 ' H ' ' A' ' 197' ' ' ILE . 1.6 t -91.86 150.57 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.924 0.869 . . . . 1.33 110.53 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.413 ' H ' HG11 ' A' ' 196' ' ' VAL . 1.0 OUTLIER -100.66 -54.57 6.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 113.964 -1.471 . . . . 1.23 111.565 -163.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.505 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -146.21 169.77 18.1 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.849 -1.069 . . . . 1.88 109.576 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.698 ' HA ' ' O ' ' A' ' 104' ' ' MET . 4.0 m-20 -61.83 110.9 1.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.355 0.597 . . . . 2.23 111.973 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.7 ' O ' ' HB2' ' A' ' 103' ' ' LYS . 3.8 mm -69.05 148.0 11.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.032 -0.985 . . . . 1.41 110.545 175.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 52.6 mt-10 -89.0 117.57 68.39 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 108.646 -0.872 . . . . 2.06 108.646 170.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.12 117.79 2.43 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.87 2.38 . . . . 0.56 112.323 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.98 2.68 10.17 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.762 -0.732 . . . . 0.7 112.805 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 11.7 pt-20 -140.48 126.42 19.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.32 0.581 . . . . 1.27 110.505 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.418 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -108.7 105.27 14.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.657 -0.702 . . . . 2.92 111.839 -177.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.579 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.9 mm? -122.87 99.81 6.58 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.576 -0.45 . . . . 1.51 110.206 175.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.569 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.94 113.39 6.29 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.89 0.476 . . . . 1.16 109.763 175.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.637 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.6 p -155.93 160.87 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 122.07 -0.394 . . . . 1.5 110.58 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 185' ' ' MET . 43.5 t-80 -81.87 112.4 18.96 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.793 -1.558 . . . . 1.77 106.793 165.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.6 m . . . . . 0 C--N 1.315 -0.926 0 CA-C-O 122.064 0.935 . . . . 3.05 110.469 -178.737 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 88.7 mt . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 110.559 -0.163 . . . . 2.82 110.559 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.98 116.88 3.61 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.756 2.304 . . . . 2.04 112.067 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.477 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -118.3 147.05 40.87 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.042 -0.526 . . . . 1.53 109.781 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.52 133.97 61.19 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.15 1.9 . . . . 0.88 110.527 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.5 -16.5 15.65 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.569 0.543 . . . . 1.58 112.44 -174.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.9 -24.53 66.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.194 0.521 . . . . 1.66 110.309 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -121.76 177.38 5.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.69 -0.687 . . . . 1.2 109.395 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.484 ' OE2' ' HD3' ' A' ' 87' ' ' ARG . 33.1 tt0 -154.93 131.72 10.73 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.723 -0.391 . . . . 2.27 110.732 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tt -84.5 131.14 34.68 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.726 -0.842 . . . . 1.37 108.726 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.484 ' HD3' ' OE2' ' A' ' 85' ' ' GLU . 14.4 mmm-85 -138.35 142.9 39.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.084 -0.507 . . . . 3.75 110.94 -173.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.72 110.21 12.37 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.364 -0.976 . . . . 2.46 108.364 171.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 p -168.99 94.58 0.32 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.874 -0.603 . . . . 2.03 110.01 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -81.64 104.68 12.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.203 -0.453 . . . . 2.18 111.016 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.544 HD11 ' SG ' ' A' ' 176' ' ' CYS . 0.0 OUTLIER -104.51 119.44 53.77 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.985 -0.552 . . . . 1.96 109.586 176.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -52.16 124.61 15.24 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.464 2.776 . . . . 1.87 113.12 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.7 -29.46 9.86 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.709 -0.678 . . . . 1.74 112.046 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.523 ' O ' ' HD2' ' A' ' 173' ' ' ARG . . . -118.4 -66.89 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.816 0.341 . . . . 1.79 111.242 177.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.94 -145.93 17.83 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.523 -0.631 . . . . 1.14 111.523 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mt -91.67 118.27 30.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.877 0.338 . . . . 2.81 110.254 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -129.6 -179.36 15.94 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.881 -0.676 . . . . 0.8 111.485 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.7 m -92.44 147.47 5.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.911 -0.774 . . . . 1.17 108.911 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -116.17 118.42 32.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.756 0.312 . . . . 1.4 110.544 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.08 120.27 14.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.174 -0.466 . . . . 1.2 110.033 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.506 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -89.15 15.5 8.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.587 0.708 . . . . 2.23 110.063 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.428 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 32.7 ttp85 -141.66 158.49 43.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.092 -0.958 . . . . 4.08 108.423 176.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.627 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -82.61 158.98 22.82 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.953 0.406 . . . . 2.86 110.633 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.662 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 58.4 mtm -133.27 151.1 51.89 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.381 -0.6 . . . . 1.38 109.381 176.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -114.74 138.42 50.75 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 123.338 0.399 . . . . 2.31 110.745 -176.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -37.24 122.05 0.86 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.783 1.302 . . . . 1.42 113.742 -171.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.66 7.16 12.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.928 -0.653 . . . . 1.04 112.141 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.458 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.6 OUTLIER -84.26 159.46 20.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.058 0.456 . . . . 2.62 110.744 -178.123 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.614 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 7.0 tmm_? -146.1 136.09 23.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 4.16 110.715 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.6 mt -93.22 142.25 27.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.555 -0.535 . . . . 1.11 109.555 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.17 171.59 44.43 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.675 -0.774 . . . . 1.09 111.904 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.2 137.94 46.25 Favored 'Cis proline' 0 C--N 1.345 0.382 0 C-N-CA 123.722 -1.366 . . . . 2.52 112.151 -0.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.783 ' SG ' ' HA ' ' A' ' 193' ' ' TYR . 13.3 m . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 2.5 111.429 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.448 0 N-CA-C 111.69 -0.564 . . . . 1.69 111.69 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.648 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 31.4 t -76.54 -20.24 57.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.16 0.505 . . . . 2.0 111.053 -175.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 42.4 p-90 -69.33 -18.65 63.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.066 0.46 . . . . 0.83 110.832 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 113' ' ' CYS . 33.3 mt -80.31 -17.91 50.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.001 -0.545 . . . . 1.28 112.269 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.648 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -82.66 -3.91 56.99 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.106 -0.638 . . . . 2.03 110.575 178.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.414 ' O ' ' HG3' ' A' ' 173' ' ' ARG . 54.1 m-85 -77.88 -36.08 50.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 2.19 110.726 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -68.08 129.72 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.131 -0.692 . . . . 1.24 109.131 174.412 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.523 ' HD2' ' O ' ' A' ' 94' ' ' ALA . 45.7 mtt180 -129.7 -160.72 1.06 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.553 -0.294 . . . . 4.97 110.814 -174.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.424 ' HA ' HG11 ' A' ' 208' ' ' VAL . 16.1 t -62.96 148.95 10.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.355 0.409 . . . . 1.63 111.292 -173.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.48 132.12 39.43 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.692 -0.685 . . . . 1.34 111.431 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.544 ' SG ' HD11 ' A' ' 91' ' ' ILE . 23.2 m -55.2 -25.01 30.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.949 -1.023 . . . . 2.58 112.237 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 92.8 p -149.29 -179.0 6.71 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.012 -0.366 . . . . 2.06 110.012 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 47.4 t -80.95 -23.69 38.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.902 0.382 . . . . 2.69 110.531 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -88.54 -10.27 49.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.699 0.285 . . . . 2.42 110.97 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -91.15 15.94 10.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.377 -0.374 . . . . 2.12 111.246 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 17.0 mm100 -63.33 114.04 3.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.129 0.49 . . . . 1.52 110.385 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.536 ' OD1' ' HG3' ' A' ' 198' ' ' LYS . 21.8 t30 -165.68 43.21 0.07 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.101 -1.074 . . . . 1.68 108.101 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.603 ' HB3' ' O ' ' A' ' 206' ' ' LEU . 0.8 OUTLIER -142.57 128.88 19.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.583 -0.735 . . . . 1.43 111.888 -175.426 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 29.3 m -151.34 141.51 22.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.803 -1.089 . . . . 1.2 110.335 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 54.0 tpp -90.11 139.77 30.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.947 -0.39 . . . . 1.56 109.947 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 52.8 t -113.67 132.11 55.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.173 0.511 . . . . 2.13 110.471 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -122.01 105.56 10.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.707 -0.849 . . . . 1.96 108.707 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.456 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 16.3 pt -139.64 142.99 31.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.987 -0.551 . . . . 1.62 110.689 -176.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.7 m 57.18 38.1 28.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.153 -0.476 . . . . 2.24 110.968 177.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 67.86 6.24 4.99 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.48 -0.782 . . . . 2.83 112.119 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.5 pt20 -124.94 161.13 27.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 1.86 110.842 -176.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.84 137.12 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.813 -0.63 . . . . 1.59 111.645 -176.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.783 ' HA ' ' SG ' ' A' ' 113' ' ' CYS . 25.4 m-85 -140.9 155.02 46.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.623 -0.717 . . . . 4.16 110.294 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 2.2 m-85 -100.15 113.2 25.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.735 -0.469 . . . . 1.27 109.735 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -102.78 123.51 46.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.076 0.465 . . . . 1.73 110.231 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.458 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 1.6 t -94.68 151.96 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.714 0.769 . . . . 1.33 109.632 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.8 mm -90.67 -56.4 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.361 -1.291 . . . . 1.23 111.201 -166.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.536 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -145.29 -178.16 5.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.373 -0.83 . . . . 1.88 111.891 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.662 ' HA ' ' O ' ' A' ' 104' ' ' MET . 18.6 t70 -46.07 132.44 9.53 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.689 0.996 . . . . 2.23 113.689 -172.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.488 HG13 ' HE2' ' A' ' 104' ' ' MET . 26.4 mm -101.49 132.79 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.231 -0.895 . . . . 1.41 110.349 174.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 35.8 mt-10 -89.35 126.59 57.99 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.337 -0.616 . . . . 2.06 109.337 173.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.03 116.95 2.19 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.962 2.441 . . . . 0.56 112.86 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.05 -4.94 10.47 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.78 -0.724 . . . . 0.7 113.299 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 9.5 pt-20 -142.29 120.35 12.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.476 0.638 . . . . 1.27 112.022 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -111.96 125.35 53.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.73 -0.668 . . . . 2.92 110.225 171.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.603 ' O ' ' HB3' ' A' ' 183' ' ' LEU . 2.5 mm? -120.01 102.06 8.28 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.671 -0.862 . . . . 1.51 108.671 172.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.529 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.9 mm? -143.76 113.45 7.09 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.138 0.274 . . . . 1.16 110.925 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.442 ' H ' ' HB2' ' A' ' 183' ' ' LEU . 1.9 p -153.61 159.8 3.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 O-C-N 122.105 -0.372 . . . . 1.5 111.259 176.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -94.47 111.88 23.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.659 -0.867 . . . . 1.77 108.659 167.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 210' ' ' VAL . 6.2 p . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 121.313 0.578 . . . . 3.05 111.589 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 83.5 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.651 0.263 . . . . 2.82 110.987 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.88 121.12 8.53 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.838 2.358 . . . . 2.04 112.292 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.485 ' H ' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -127.78 153.28 77.94 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.746 -0.661 . . . . 1.53 109.281 177.693 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.32 141.7 88.71 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.388 2.059 . . . . 0.88 111.746 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.504 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -65.68 -12.33 52.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.987 0.736 . . . . 1.58 112.987 -171.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -82.68 -19.71 37.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.037 0.384 . . . . 1.66 112.037 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.515 ' HE2' ' SD ' ' A' ' 104' ' ' MET . 5.1 m-85 -116.83 144.88 43.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.838 -0.43 . . . . 1.2 109.838 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -116.46 117.07 28.9 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.886 -0.326 . . . . 2.27 110.725 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.49 HD13 ' CE2' ' A' ' 171' ' ' TYR . 8.2 tt -86.09 124.3 32.36 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.962 -0.755 . . . . 1.37 108.962 176.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -140.37 128.4 22.13 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.791 -0.641 . . . . 3.75 110.692 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -81.83 112.95 19.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.899 -0.778 . . . . 2.46 108.899 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -166.9 162.73 15.99 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.881 -0.785 . . . . 2.03 108.881 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.0 t -99.83 105.55 17.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.905 0.383 . . . . 2.18 110.627 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.422 HG23 ' HB1' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -101.59 117.34 62.06 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.25 -0.648 . . . . 1.96 109.25 174.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -55.98 123.29 13.48 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.029 2.486 . . . . 1.87 113.116 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.65 -18.39 40.99 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.7 -0.762 . . . . 1.74 112.665 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HB1' HG23 ' A' ' 91' ' ' ILE . . . -129.34 -55.91 1.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.215 0.531 . . . . 1.79 111.517 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.414 ' O ' HG21 ' A' ' 91' ' ' ILE . . . 121.24 -103.35 0.88 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 111.267 -0.733 . . . . 1.14 111.267 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.4 160.78 14.24 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.95 -0.389 . . . . 2.81 109.95 172.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.96 171.79 44.66 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.512 -0.852 . . . . 0.8 112.464 177.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 86' ' ' LEU . 17.0 m -107.29 147.36 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.182 -0.673 . . . . 1.17 109.182 173.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -125.79 110.59 13.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.755 0.312 . . . . 1.4 111.07 -174.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -59.83 125.77 24.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.85 -0.614 . . . . 1.2 111.115 177.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.504 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -93.18 -3.88 53.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.331 0.586 . . . . 2.23 110.203 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.5 ttp85 -133.16 155.3 49.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.934 -1.135 . . . . 4.08 107.934 171.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.661 ' C ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -84.16 158.56 21.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.277 0.56 . . . . 2.86 110.685 -175.437 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.597 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 54.9 mtm -117.36 154.33 31.49 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.784 . . . . 1.38 109.068 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -107.83 136.12 48.09 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.41 0.444 . . . . 2.31 110.376 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -39.11 117.29 0.67 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.624 1.202 . . . . 1.42 112.991 -174.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.33 7.46 12.33 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.544 -0.753 . . . . 1.04 111.547 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.424 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -75.64 165.22 25.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.054 0.454 . . . . 2.62 110.742 -178.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.537 ' HD3' ' CD1' ' A' ' 193' ' ' TYR . 7.1 tmm_? -141.38 132.66 26.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.386 -0.37 . . . . 4.16 110.297 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.486 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 5.9 mt -100.75 138.49 37.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.616 -0.513 . . . . 1.11 109.616 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.49 173.75 46.43 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.976 -0.63 . . . . 1.09 111.696 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -83.9 146.86 53.15 Favored 'Cis proline' 0 C--O 1.236 0.4 0 C-N-CA 123.316 -1.535 . . . . 2.52 112.77 -0.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.1 t . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.661 -0.7 . . . . 2.5 109.634 175.681 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.096 0 N-CA-C 113.665 0.226 . . . . 1.69 113.665 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.689 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 20.5 t -63.41 -16.05 59.41 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.809 0.444 . . . . 2.0 111.726 -174.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.501 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 25.5 p-90 -71.7 -23.58 61.67 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.019 -0.426 . . . . 0.83 110.293 178.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.501 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 29.2 mt -86.75 -17.65 33.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 1.28 112.283 -176.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -75.77 -10.73 59.68 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.382 -0.527 . . . . 2.03 110.248 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.49 ' CE2' HD13 ' A' ' 86' ' ' LEU . 52.1 m-85 -69.79 -36.98 76.16 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.824 -0.625 . . . . 2.19 111.06 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.69 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -69.83 127.01 31.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.482 -0.487 . . . . 1.24 109.729 177.539 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -115.07 179.15 4.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.022 -0.536 . . . . 4.97 110.401 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.497 ' HA ' HD22 ' A' ' 183' ' ' LEU . 1.7 p -71.4 142.37 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.458 . . . . 1.63 111.165 -177.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.28 142.47 21.05 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.16 -0.927 . . . . 1.34 112.572 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 47.5 t -82.87 -2.93 56.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.208 -0.906 . . . . 2.58 110.531 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 27.2 t -142.84 139.88 31.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.993 -0.549 . . . . 2.06 109.589 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 33.6 t -73.31 -13.99 61.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.309 0.576 . . . . 2.69 110.485 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -88.44 -4.42 58.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.346 0.593 . . . . 2.42 109.93 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -110.84 15.49 21.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.49 -0.777 . . . . 2.12 111.107 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 15.9 mm100 -60.11 115.67 3.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.528 -0.545 . . . . 1.52 109.528 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.598 ' OD1' ' HG3' ' A' ' 198' ' ' LYS . 19.2 t30 -153.63 32.97 0.45 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.165 0.983 . . . . 1.68 108.799 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.54 HD21 ' N ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -122.52 129.51 52.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.368 -0.833 . . . . 1.43 110.315 -174.013 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.5 m -150.42 138.66 20.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.074 0.464 . . . . 1.2 110.933 177.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 21.1 tpp -102.05 129.02 48.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.941 -0.572 . . . . 1.56 109.962 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 43.5 t -111.95 140.93 46.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.051 0.453 . . . . 2.13 110.585 -175.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.81 104.26 10.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.904 -0.589 . . . . 1.96 109.621 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.443 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 17.8 pt -142.73 145.33 23.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.679 -0.691 . . . . 1.62 110.229 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.4 m 63.15 27.61 15.72 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.114 0.483 . . . . 2.24 111.047 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 64.56 10.5 5.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.125 -0.943 . . . . 2.83 111.62 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.9 pt20 -120.6 167.95 11.88 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.974 -0.38 . . . . 1.86 109.974 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.2 mm -93.59 137.09 23.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.058 -0.519 . . . . 1.59 110.305 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.537 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 2.4 m-85 -138.52 151.4 47.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.221 0.534 . . . . 4.16 111.244 177.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.448 ' CD1' HD13 ' A' ' 169' ' ' LEU . 4.8 m-85 -99.54 113.6 26.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.568 -0.742 . . . . 1.27 109.627 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.28 118.83 37.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.992 -0.549 . . . . 1.73 110.176 -177.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.424 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 2.0 t -91.08 152.95 3.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.515 0.674 . . . . 1.33 110.057 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.2 mm -91.44 -58.07 3.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.64 -1.164 . . . . 1.23 111.301 -167.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.598 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -139.78 173.13 11.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.69 -0.686 . . . . 1.88 111.51 -176.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.597 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.1 m-20 -47.05 120.18 2.95 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.231 -0.895 . . . . 2.23 112.871 -176.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.458 HG13 ' HE2' ' A' ' 104' ' ' MET . 21.0 mm -82.15 140.11 16.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.185 -0.916 . . . . 1.41 110.984 176.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.97 130.71 47.31 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.534 -0.543 . . . . 2.06 109.534 171.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.11 117.53 4.13 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.493 2.128 . . . . 0.56 112.289 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.52 -11.11 9.71 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.798 -0.715 . . . . 0.7 112.576 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -143.04 119.69 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 1.27 111.791 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 100' ' ' ALA . 40.6 mt-10 -111.7 127.21 55.7 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.196 -0.315 . . . . 2.92 110.518 169.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.481 ' C ' HD21 ' A' ' 207' ' ' LEU . 2.6 mm? -115.72 100.35 7.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.146 -0.686 . . . . 1.51 109.146 175.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.69 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.33 125.37 13.63 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.495 -0.928 . . . . 1.16 108.495 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' A' ' 174' ' ' VAL . 9.8 p -152.87 157.1 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.234 -0.586 . . . . 1.5 111.439 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -109.72 106.47 16.12 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.815 -0.809 . . . . 1.77 108.815 163.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.319 -0.736 0 N-CA-C 109.226 -0.657 . . . . 3.05 109.226 170.333 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.8 mt . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.688 -0.486 . . . . 2.82 109.688 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.97 135.06 33.86 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.603 2.202 . . . . 2.04 112.231 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.429 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.48 136.94 29.89 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.819 -0.628 . . . . 1.53 109.903 -178.732 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.55 151.58 7.2 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.358 2.706 . . . . 0.88 112.574 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.13 -6.44 3.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.671 0.989 . . . . 1.58 113.671 -169.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 52.1 m-20 -110.34 2.02 18.84 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.886 -0.509 . . . . 1.66 111.994 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -130.92 138.44 49.77 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.16 -0.681 . . . . 1.2 109.16 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.57 136.67 53.54 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.72 -0.392 . . . . 2.27 110.061 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.8 tt -85.37 126.44 33.76 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.454 0.645 . . . . 1.37 109.29 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.434 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 51.1 mtp180 -143.34 118.75 10.28 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.863 -1.062 . . . . 3.75 109.507 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -80.73 110.16 15.97 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.283 -0.636 . . . . 2.46 109.283 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.9 p -164.32 109.26 0.98 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.474 -0.785 . . . . 2.03 108.959 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.9 m -71.13 105.67 3.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.054 0.454 . . . . 2.18 110.953 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -92.99 117.99 67.71 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.049 -0.723 . . . . 1.96 109.049 173.082 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -51.93 121.27 8.44 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.016 2.477 . . . . 1.87 112.554 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.44 ' HA3' ' SG ' ' A' ' 176' ' ' CYS . . . 108.5 -16.34 34.61 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.015 -0.612 . . . . 1.74 112.45 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.21 -61.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.97 0.414 . . . . 1.79 111.244 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 91' ' ' ILE . . . 121.09 -123.22 5.47 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 121.055 -0.593 . . . . 1.14 111.925 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mt -102.23 158.43 16.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.931 -0.396 . . . . 2.81 109.931 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -167.17 177.52 41.73 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.616 -0.802 . . . . 0.8 112.013 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 98' ' ' VAL . 27.7 m -104.87 114.95 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.494 0.664 . . . . 1.17 109.689 175.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 51.3 m95 -82.76 127.55 33.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.583 -0.735 . . . . 1.4 111.405 -169.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -74.87 116.19 15.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.686 -0.688 . . . . 1.2 110.465 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.45 1.0 57.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 2.23 110.096 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -140.46 156.18 46.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.552 -0.749 . . . . 4.08 109.13 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.553 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -80.4 159.0 25.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.112 0.482 . . . . 2.86 110.738 -178.621 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.682 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 55.3 mtm -129.46 152.11 49.36 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.064 -0.516 . . . . 1.38 110.026 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -121.5 139.81 53.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.117 -0.492 . . . . 2.31 110.273 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -39.19 125.04 1.57 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 124.708 1.255 . . . . 1.42 113.264 -170.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.26 7.03 12.87 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.319 -0.855 . . . . 1.04 111.094 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.62 162.18 18.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.116 0.484 . . . . 2.62 110.929 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.577 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 6.3 tmm_? -146.96 132.29 18.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.982 -0.554 . . . . 4.16 110.301 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 4.7 mt -95.26 130.78 41.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.027 -0.731 . . . . 1.11 109.027 173.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.13 166.6 38.28 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.308 -0.949 . . . . 1.09 112.426 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.459 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 94.5 Cg_endo -87.17 158.12 48.58 Favored 'Cis proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.917 -1.701 . . . . 2.52 112.553 -2.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.3 t . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 121.367 0.603 . . . . 2.5 109.557 174.579 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.444 0 N-CA-C 111.071 -0.812 . . . . 1.69 111.071 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.641 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 13.5 m -64.59 -15.04 60.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.362 -0.419 . . . . 2.0 111.47 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.587 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 17.5 p-90 -70.6 -25.99 63.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 0.83 111.197 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.587 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 18.2 mt -86.3 -15.15 41.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.643 0.609 . . . . 1.28 112.643 -173.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.641 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -77.8 -1.93 33.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.564 -0.454 . . . . 2.03 110.963 -179.296 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -84.38 -37.94 20.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.221 0.452 . . . . 2.19 112.221 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.734 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -65.07 128.64 28.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.975 0.417 . . . . 1.24 110.616 -176.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -119.67 -164.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 4.97 110.854 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.3 t -71.61 143.87 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.956 0.408 . . . . 1.63 110.523 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.53 ' HB1' ' NE2' ' A' ' 181' ' ' GLN . . . -65.59 143.49 57.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.759 -0.655 . . . . 1.34 111.111 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.44 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 42.0 t -63.52 -19.49 64.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.024 -0.989 . . . . 2.58 111.354 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 180' ' ' ASP . 17.8 t -125.62 138.78 53.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.218 0.532 . . . . 2.06 110.558 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 8.6 p -77.49 -26.39 51.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.552 -0.749 . . . . 2.69 111.337 -176.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.47 -3.8 58.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.336 0.589 . . . . 2.42 110.224 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 177' ' ' SER . 1.2 m-20 -107.81 16.26 23.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.434 -0.803 . . . . 2.12 110.461 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.53 ' NE2' ' HB1' ' A' ' 175' ' ' ALA . 31.7 mm-40 -58.36 120.17 8.26 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.374 0.607 . . . . 1.52 110.961 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.524 ' ND2' HD12 ' A' ' 200' ' ' ILE . 13.5 t30 -142.86 35.54 1.4 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.394 -1.336 . . . . 1.68 107.394 175.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.639 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.2 OUTLIER -120.44 125.0 46.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.526 -1.215 . . . . 1.43 110.906 -173.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.5 m -150.5 133.08 15.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.923 0.392 . . . . 1.2 110.703 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 48.7 ttm -100.27 140.19 34.87 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.654 -0.498 . . . . 1.56 109.654 174.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 32.5 m -124.95 131.55 53.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.137 0.494 . . . . 2.13 111.138 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.74 104.96 14.79 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.656 -0.868 . . . . 1.96 108.656 176.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 22.3 pt -139.19 144.4 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.921 -0.582 . . . . 1.62 110.054 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.0 t 64.71 30.18 12.56 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.217 0.532 . . . . 2.24 110.235 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 58.48 34.11 23.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.387 -0.824 . . . . 2.83 111.355 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -145.3 154.44 42.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 1.86 110.711 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.99 128.45 45.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.167 -0.47 . . . . 1.59 111.749 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.577 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 40.9 m-85 -131.31 155.79 46.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.525 -0.761 . . . . 4.16 110.565 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.471 ' CE1' ' HB3' ' A' ' 169' ' ' LEU . 11.3 m-85 -103.5 114.52 28.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.96 -0.755 . . . . 1.27 108.96 173.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -100.1 118.83 37.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.175 -0.466 . . . . 1.73 109.887 -175.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.41 HG11 HD22 ' A' ' 182' ' ' ASN . 1.9 t -83.38 152.16 3.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.408 0.623 . . . . 1.33 109.649 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.1 mm -94.01 -55.15 6.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.912 -1.04 . . . . 1.23 111.202 -167.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.478 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -143.85 -179.71 6.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 1.88 111.963 -179.443 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.682 ' HA ' ' O ' ' A' ' 104' ' ' MET . 23.7 t70 -45.89 121.98 3.51 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.3 1.0 . . . . 2.23 113.009 -175.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.524 HD12 ' ND2' ' A' ' 182' ' ' ASN . 21.1 mm -92.23 130.77 40.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.999 -1.0 . . . . 1.41 111.38 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -76.93 121.59 85.01 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.38 -0.827 . . . . 2.06 108.933 171.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.88 114.1 1.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.001 1.801 . . . . 0.56 111.181 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.15 -0.53 10.65 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.57 -0.824 . . . . 0.7 113.428 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -133.45 123.38 25.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.492 0.646 . . . . 1.27 111.145 175.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.05 96.44 6.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.75 -0.659 . . . . 2.92 111.754 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.503 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.3 mm? -113.03 99.03 7.54 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.835 -0.746 . . . . 1.51 109.773 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.734 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -145.57 114.1 6.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.554 0.341 . . . . 1.16 110.452 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.639 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.8 p -155.83 160.48 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.137 -0.32 . . . . 1.5 110.137 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -93.22 110.2 21.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.006 -1.109 . . . . 1.77 108.006 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.317 -0.828 0 CA-C-O 121.257 0.551 . . . . 3.05 110.213 179.905 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.1 mt . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 110.496 -0.187 . . . . 2.82 110.496 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.33 120.41 7.55 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.607 2.205 . . . . 2.04 112.114 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -113.11 141.67 26.04 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.308 -0.405 . . . . 1.53 109.921 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.32 144.67 70.73 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.773 2.315 . . . . 0.88 112.14 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.655 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -62.82 -13.08 29.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.526 -0.761 . . . . 1.58 112.332 -173.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.95 -9.84 59.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.107 -0.497 . . . . 1.66 111.062 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.538 ' CZ ' HD21 ' A' ' 110' ' ' LEU . 9.3 m-85 -138.13 149.97 46.4 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.384 -0.599 . . . . 1.2 109.384 -173.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.554 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 9.5 tp10 -125.27 133.84 52.51 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.428 -0.509 . . . . 2.27 111.316 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.88 122.79 33.26 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.214 -0.661 . . . . 1.37 109.214 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.425 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 39.8 mmt180 -147.28 124.58 11.55 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.913 -1.04 . . . . 3.75 109.452 -174.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.1 110.56 8.49 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.106 -0.702 . . . . 2.46 109.106 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.8 m -143.99 94.18 2.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.603 -0.726 . . . . 2.03 109.133 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -64.64 101.86 0.51 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.472 0.654 . . . . 2.18 111.357 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.488 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -108.91 117.03 54.77 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 108.501 -0.926 . . . . 1.96 108.501 172.211 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.86 123.48 13.61 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.907 2.404 . . . . 1.87 112.542 -173.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.51 -23.69 23.91 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.132 -0.556 . . . . 1.74 112.5 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.488 ' HB3' HG21 ' A' ' 91' ' ' ILE . . . -114.95 -68.33 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.95 -0.3 . . . . 1.79 111.513 -178.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.84 -158.09 15.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.665 -0.779 . . . . 1.14 112.339 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.453 ' C ' ' HD3' ' A' ' 173' ' ' ARG . 8.3 mt -101.17 122.55 43.82 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.684 0.242 . . . . 2.81 110.908 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -133.97 -159.35 8.9 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.711 -0.757 . . . . 0.8 112.388 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 98' ' ' VAL . 17.3 m -112.29 105.02 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 122.094 0.95 . . . . 1.17 109.812 177.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.425 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 6.4 m95 -83.3 123.28 29.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.173 -0.921 . . . . 1.4 110.194 -171.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.89 117.79 6.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.134 -0.485 . . . . 1.2 110.367 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.655 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -78.83 -0.15 29.45 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.063 0.459 . . . . 2.23 110.676 178.18 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.413 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 34.5 ttp180 -141.48 162.86 34.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.666 -0.864 . . . . 4.08 108.666 178.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.413 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -79.09 160.02 27.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.273 0.558 . . . . 2.86 111.182 178.316 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.484 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 44.9 mtm -130.77 153.04 49.47 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.063 -1.088 . . . . 1.38 108.063 172.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -126.66 146.97 49.99 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.091 0.244 . . . . 2.31 110.764 -177.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -36.34 121.13 0.69 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.716 1.26 . . . . 1.42 113.77 -168.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.2 6.83 13.18 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.268 -0.878 . . . . 1.04 111.349 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.472 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -85.03 157.01 20.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.05 0.453 . . . . 2.62 110.253 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.689 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 5.9 tmm_? -146.47 133.79 20.66 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.096 -0.502 . . . . 4.16 110.189 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.538 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 3.9 mt -96.92 135.68 38.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.429 -0.952 . . . . 1.11 108.429 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.67 169.63 38.25 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.878 -1.153 . . . . 1.09 112.732 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.586 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 74.0 Cg_endo -77.8 167.14 79.48 Favored 'Cis proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.977 -1.676 . . . . 2.52 112.297 -1.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.8 t . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 121.071 0.462 . . . . 2.5 110.539 177.924 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.392 0 N-CA-C 112.63 -0.188 . . . . 1.69 112.63 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.634 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 2.9 m -63.79 -14.86 56.37 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.669 0.388 . . . . 2.0 111.989 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' TRP . . . . . 0.431 ' CB ' HG22 ' A' ' 80' ' ' ILE . 19.7 p-90 -69.39 -21.42 63.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.988 0.366 . . . . 0.83 111.988 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 18.3 mt -80.73 -14.56 58.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.942 0.719 . . . . 1.28 112.942 -173.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.634 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -68.04 -10.44 53.75 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.286 -0.566 . . . . 2.03 110.205 176.334 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.541 ' O ' ' HD2' ' A' ' 173' ' ' ARG . 50.9 m-85 -78.89 -27.89 43.95 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.749 -0.66 . . . . 2.19 112.4 -175.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.634 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 1.6 mm -57.87 139.05 18.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 117.895 0.316 . . . . 1.24 111.289 -175.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.541 ' HD2' ' O ' ' A' ' 171' ' ' TYR . 18.2 mmm180 -95.24 147.67 23.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.103 0.478 . . . . 4.97 112.034 -174.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 81.6 t -66.56 148.61 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.374 -0.83 . . . . 1.63 108.773 168.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.457 ' HB3' ' CD1' ' A' ' 183' ' ' LEU . . . -57.32 122.94 13.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.026 0.441 . . . . 1.34 112.108 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.56 -28.7 68.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.573 -0.74 . . . . 2.58 109.967 175.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.0 p -126.73 139.51 53.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.879 -0.6 . . . . 2.06 110.614 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 54.0 t -76.97 -8.41 57.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.992 -0.549 . . . . 2.69 111.093 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.02 -3.87 58.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.204 0.526 . . . . 2.42 110.238 177.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -111.81 17.91 19.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.638 -0.71 . . . . 2.12 111.816 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.52 ' HA ' HE21 ' A' ' 181' ' ' GLN . 0.1 OUTLIER -55.43 114.84 1.99 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.289 0.566 . . . . 1.52 110.897 -176.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.533 ' H ' HD13 ' A' ' 183' ' ' LEU . 18.3 t30 -155.03 32.49 0.39 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 122.062 0.934 . . . . 1.68 108.7 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.722 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 2.0 mp -115.36 120.36 39.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.381 -0.827 . . . . 1.43 110.975 -173.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 95.4 m -148.66 138.96 22.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.324 0.583 . . . . 1.2 111.366 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' MET . . . . . 0.465 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 65.5 mtp -120.71 135.51 55.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.93 -0.577 . . . . 1.56 109.758 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 44.2 t -114.52 141.9 47.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.93 0.395 . . . . 2.13 110.736 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.71 103.93 13.49 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.026 -0.731 . . . . 1.96 109.026 177.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 11.6 pt -146.34 145.08 20.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.967 -0.56 . . . . 1.62 110.218 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.4 t 67.3 33.91 5.14 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.509 0.506 . . . . 2.24 110.242 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 66.33 8.38 5.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.419 -0.809 . . . . 2.83 111.701 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.35 167.72 19.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.062 0.458 . . . . 1.86 110.935 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.2 mm -98.35 128.45 49.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.674 -0.694 . . . . 1.59 110.469 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.689 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 2.2 m-85 -118.44 146.95 44.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.161 0.505 . . . . 4.16 110.708 175.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.438 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 3.2 m-85 -100.95 113.2 25.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.934 -0.765 . . . . 1.27 108.934 175.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -111.57 123.8 50.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.925 0.393 . . . . 1.73 110.184 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.472 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 2.1 t -93.67 152.3 3.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.777 0.799 . . . . 1.33 110.386 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.2 mm -92.98 -54.83 6.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.433 -1.258 . . . . 1.23 110.801 -166.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.487 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -138.78 -179.25 5.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.437 -0.801 . . . . 1.88 110.1 178.312 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 104' ' ' MET . 4.8 p-10 -56.09 135.8 52.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.68 0.752 . . . . 2.23 112.389 -173.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.502 HD13 ' ND2' ' A' ' 182' ' ' ASN . 28.4 mm -96.48 138.11 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.238 -0.892 . . . . 1.41 110.817 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -83.34 127.51 68.29 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.949 -0.569 . . . . 2.06 109.534 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.2 115.57 2.26 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.835 2.357 . . . . 0.56 112.367 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.0 -12.94 9.17 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.471 -0.871 . . . . 0.7 113.543 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.76 123.0 34.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.563 0.681 . . . . 1.27 111.504 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.634 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -110.47 112.1 23.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.766 -0.652 . . . . 2.92 111.142 177.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.497 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 0.9 OUTLIER -122.51 98.96 6.16 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.317 -0.553 . . . . 1.51 109.606 173.551 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.557 ' HB2' HG23 ' A' ' 172' ' ' ILE . 1.7 mm? -147.74 106.55 3.83 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.722 -0.473 . . . . 1.16 109.722 175.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.722 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 19.5 t -154.91 157.45 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.014 -1.106 . . . . 1.5 108.014 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' HIS . . . . . 0.465 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 3.6 t-80 -89.23 109.86 20.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.731 -0.84 . . . . 1.77 108.731 173.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 C--N 1.32 -0.694 0 CA-C-O 121.624 0.726 . . . . 3.05 110.665 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.814 0 N-CA-C 111.79 -0.524 . . . . 33.41 111.79 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.416 ' OG ' ' HB3' ' A' ' 67' ' ' PRO . 19.5 m -71.92 132.37 44.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.045 0.45 . . . . 34.1 110.907 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.02 -22.95 9.54 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.965 -0.636 . . . . 32.51 111.907 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -145.72 141.02 16.32 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.287 -0.264 . . . . 31.98 110.287 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.12 95.45 0.14 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.657 2.238 . . . . 30.45 111.427 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.2 m -71.74 -56.37 5.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.865 -0.607 . . . . 29.01 111.261 -174.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.1 t 56.2 59.98 3.42 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.057 0.456 . . . . 27.14 110.647 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -135.02 113.5 11.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.042 -0.527 . . . . 25.83 109.669 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 t70 64.74 -171.75 0.18 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.98 0.8 . . . . 23.8 109.947 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -97.5 49.71 1.05 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.227 0.537 . . . . 22.03 110.545 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.8 m -83.69 114.27 52.63 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.253 -0.885 . . . . 19.63 110.548 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.01 125.62 13.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.662 2.241 . . . . 17.86 112.035 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -75.64 74.46 2.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.959 -0.564 . . . . 17.61 110.336 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -93.57 162.03 14.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.597 -0.728 . . . . 15.63 111.706 -175.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.54 12.28 78.4 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.739 -0.664 . . . . 12.12 113.216 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.2 t 58.14 75.15 0.56 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.826 0.346 . . . . 10.78 111.122 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.416 ' HB3' ' OG ' ' A' ' 52' ' ' SER . 2.8 Cg_exo -75.91 78.33 3.17 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.577 2.185 . . . . 10.17 111.422 177.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -114.84 143.71 44.67 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.234 -0.894 . . . . 7.8 110.626 -176.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -132.22 142.94 49.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.628 -0.508 . . . . 8.14 109.628 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.75 121.1 73.28 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.223 -0.444 . . . . 6.11 111.137 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.4 -160.95 0.14 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.784 2.323 . . . . 6.51 112.103 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.5 m -60.86 -42.07 91.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.815 0.34 . . . . 6.76 110.787 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -94.62 108.41 20.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.201 -0.666 . . . . 5.18 109.201 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.529 ' O ' HD11 ' A' ' 74' ' ' ILE . 1.9 pp -77.0 139.9 66.07 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.017 -0.538 . . . . 4.5 111.622 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.65 -4.88 16.17 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.049 2.499 . . . . 4.4 112.449 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.419 ' HB2' HD13 ' A' ' 74' ' ' ILE . 35.2 mt-10 -62.75 -57.73 9.93 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.504 -0.554 . . . . 3.91 109.504 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.6 t70 54.21 71.42 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.54 -1.209 . . . . 3.16 110.261 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.8 mt -68.69 128.27 92.97 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.13 -0.941 . . . . 2.82 110.172 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.454 ' O ' ' HA2' ' A' ' 164' ' ' GLY . 23.4 Cg_endo -63.17 127.53 20.44 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.384 2.056 . . . . 2.04 111.589 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.422 HD13 ' H ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.97 151.62 78.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.97 -0.559 . . . . 1.53 109.917 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.66 139.72 87.21 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.567 2.178 . . . . 0.88 111.241 174.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.654 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -67.73 -7.65 28.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.637 0.606 . . . . 1.58 112.637 -172.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.482 ' OD2' ' HD3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -80.01 -9.61 59.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.724 0.297 . . . . 1.66 111.492 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.515 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 8.4 m-85 -140.18 146.76 39.16 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.501 -0.555 . . . . 1.2 109.501 -173.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 99' ' ' TRP . 13.3 pt-20 -114.2 135.21 54.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.982 0.42 . . . . 2.27 110.946 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.2 tt -101.71 129.94 47.98 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.324 -0.991 . . . . 1.37 108.324 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -162.47 150.71 14.43 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.433 -0.803 . . . . 3.75 109.792 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -82.99 111.36 18.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.0 -0.741 . . . . 2.46 109.0 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.2 p -149.07 90.7 1.77 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.773 -0.649 . . . . 2.03 109.365 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.1 m -68.43 104.12 1.82 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.248 0.547 . . . . 2.18 110.805 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.435 HG21 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -94.89 118.95 66.63 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.649 -0.705 . . . . 1.96 109.199 174.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -52.44 121.22 8.65 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.251 2.634 . . . . 1.87 112.466 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.538 ' HA3' ' SG ' ' A' ' 176' ' ' CYS . . . 108.23 -16.02 35.68 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.843 -0.694 . . . . 1.74 112.36 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.89 -71.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.724 -0.28 . . . . 1.79 111.395 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.511 ' HA3' ' NH1' ' A' ' 173' ' ' ARG . . . 133.38 -127.91 4.85 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.877 -0.678 . . . . 1.14 111.954 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.0 mt -97.66 147.6 24.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.655 0.228 . . . . 2.81 110.5 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -158.21 171.4 35.12 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.585 -0.606 . . . . 0.8 111.585 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 98' ' ' VAL . 27.7 m -99.31 111.58 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.497 0.665 . . . . 1.17 110.037 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.522 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 59.2 m95 -81.57 124.52 29.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.852 -0.613 . . . . 1.4 110.316 -172.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 202' ' ' PRO . . . -68.98 114.81 7.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.582 -0.525 . . . . 1.2 109.582 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.654 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -82.62 -9.48 59.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.37 0.605 . . . . 2.23 109.669 177.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.482 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 63.4 ttt180 -125.11 162.55 24.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.31 -0.859 . . . . 4.08 108.823 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.613 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -91.53 158.72 16.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.874 0.369 . . . . 2.86 110.952 -176.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.421 ' HE1' HG13 ' A' ' 200' ' ' ILE . 64.4 mtm -135.42 152.59 51.54 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.103 -0.703 . . . . 1.38 109.103 176.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -113.05 147.74 36.62 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.092 0.245 . . . . 2.31 110.516 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.81 123.97 2.91 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 124.474 1.109 . . . . 1.42 112.973 -170.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.75 7.7 13.01 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.451 -0.795 . . . . 1.04 111.183 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.487 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 1.0 OUTLIER -84.04 157.59 21.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.507 0.67 . . . . 2.62 110.923 -178.052 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.641 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 2.7 tmm_? -144.1 134.09 24.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.494 -0.776 . . . . 4.16 109.546 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.515 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 6.3 mt -87.76 137.36 32.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.875 -0.33 . . . . 1.11 110.119 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.38 170.99 43.76 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.917 -0.659 . . . . 1.09 111.481 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -88.62 148.38 27.1 Favored 'Cis proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.181 -1.591 . . . . 2.52 112.491 -2.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.496 ' O ' ' HA3' ' A' ' 166' ' ' GLY . 28.9 t -100.57 -67.67 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.958 -0.756 . . . . 2.5 108.958 172.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.558 ' O ' ' HB2' ' A' ' 191' ' ' GLN . 16.7 m -139.31 140.9 36.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.842 -0.617 . . . . 2.46 109.66 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 115' ' ' VAL . 13.6 p -111.62 31.08 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 122.575 1.178 . . . . 4.37 109.095 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 12.2 m -75.96 120.09 80.13 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 114.479 -1.237 . . . . 5.65 111.289 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.579 ' HB2' ' OE1' ' A' ' 136' ' ' GLU . 48.7 Cg_endo -68.57 -165.56 0.13 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.126 2.551 . . . . 5.38 113.07 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.512 ' HD2' ' N ' ' A' ' 118' ' ' ARG . 5.1 mpt_? -63.62 -63.26 1.22 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.756 -0.656 . . . . 8.57 110.471 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.88 45.85 1.2 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.401 -0.818 . . . . 7.27 111.741 -175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -104.02 20.46 18.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.788 0.327 . . . . 6.4 111.575 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 63.2 83.79 0.16 Allowed 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.817 0.818 . . . . 5.88 111.682 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -94.11 150.63 20.16 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.133 -0.94 . . . . 7.76 109.517 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 123' ' ' GLU . 7.1 mp0 -57.36 -71.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.895 0.379 . . . . 9.01 110.376 -175.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.7 m -160.09 -60.52 0.06 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.378 -0.601 . . . . 9.14 109.378 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.47 ' HA ' ' CZ3' ' A' ' 128' ' ' TRP . 16.4 t0 -145.29 139.85 27.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.458 -0.792 . . . . 7.6 110.787 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -130.93 3.79 4.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.616 0.722 . . . . 8.0 109.441 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.434 ' O ' HG11 ' A' ' 220' ' ' VAL . . . 141.4 35.17 0.1 Allowed Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.507 -0.77 . . . . 4.59 112.502 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . 0.47 ' CZ3' ' HA ' ' A' ' 125' ' ' ASP . 0.0 OUTLIER -152.52 -87.16 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.416 0.627 . . . . 4.93 109.761 177.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 175.85 -47.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.401 -1.272 . . . . 7.65 108.398 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 22.8 pt20 -178.66 94.42 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.952 -1.022 . . . . 9.61 109.871 177.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.468 HG21 ' NE2' ' A' ' 187' ' ' GLN . 1.4 pp -70.31 -11.57 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 112.186 0.439 . . . . 6.05 112.186 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.17 57.74 4.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.273 1.035 . . . . 8.5 110.108 177.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.3 t -111.4 26.98 10.11 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.118 -1.401 . . . . 9.82 110.05 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -151.09 126.63 10.13 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.044 -0.98 . . . . 11.21 109.783 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.58 114.23 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.479 0.657 . . . . 10.92 110.822 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.579 ' OE1' ' HB2' ' A' ' 117' ' ' PRO . 40.4 tt0 -80.86 74.63 7.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.771 -0.649 . . . . 13.25 110.116 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.78 -35.64 37.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.693 -0.685 . . . . 14.01 110.217 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.9 m 51.38 80.4 0.3 Allowed Pre-proline 0 C--O 1.235 0.338 0 CA-C-N 116.081 -0.509 . . . . 14.1 111.745 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.85 127.27 24.5 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.776 2.318 . . . . 14.7 111.85 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -84.18 32.94 0.49 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.101 0.477 . . . . 14.44 111.125 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -114.22 -2.89 13.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.933 -0.576 . . . . 15.9 110.099 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -152.49 -68.71 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.845 -0.693 . . . . 16.0 112.021 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 9.6 p -79.51 93.08 5.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.06 0.457 . . . . 15.6 111.209 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.4 mt -125.04 -61.82 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.081 -0.509 . . . . 14.1 110.369 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 29.2 p 46.62 75.43 0.12 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.599 -0.728 . . . . 13.19 112.046 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -86.63 -15.74 38.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.549 0.69 . . . . 15.92 109.197 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.4 pp -104.85 168.57 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.846 -1.07 . . . . 14.07 110.618 177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 37.2 p -134.35 120.93 20.49 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.299 -0.41 . . . . 13.67 110.216 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.26 116.0 8.35 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.05 -0.352 . . . . 13.02 110.05 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -91.85 140.12 29.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.218 -0.446 . . . . 14.68 110.419 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.9 64.92 4.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.757 -0.656 . . . . 13.55 109.636 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -100.49 -149.08 23.13 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.729 -0.669 . . . . 15.8 113.218 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.9 m -93.21 28.32 2.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.251 0.463 . . . . 17.08 112.251 -171.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -86.52 -81.33 0.22 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.162 0.505 . . . . 18.43 110.247 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -145.69 47.38 1.27 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.515 -0.766 . . . . 18.74 109.308 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -132.97 83.61 2.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.696 -0.684 . . . . 14.81 111.179 -173.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 18.6 t -86.09 37.44 0.72 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.652 0.739 . . . . 14.64 109.53 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.61 130.38 74.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.597 -0.729 . . . . 13.38 109.385 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -96.94 82.05 3.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.227 0.537 . . . . 10.61 109.831 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.45 ' O ' ' HG2' ' A' ' 162' ' ' GLN . . . -148.2 158.56 44.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.716 -0.675 . . . . 10.22 109.918 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 55.86 33.13 20.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.563 0.697 . . . . 10.69 110.449 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 160' ' ' ALA . 29.8 mm-40 -118.32 -72.5 0.68 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.646 -0.706 . . . . 9.45 109.932 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -117.06 132.39 56.7 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.919 -0.582 . . . . 6.56 110.292 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 79' ' ' PRO . . . 151.1 91.7 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.782 -0.723 . . . . 4.17 111.862 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.35 -45.21 92.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.009 0.433 . . . . 3.14 110.561 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 113' ' ' CYS . . . 131.97 -31.76 3.0 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.739 -0.743 . . . . 1.69 112.947 176.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.66 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 23.1 t -65.56 -16.0 63.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.859 0.361 . . . . 2.0 111.349 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.557 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 24.4 p-90 -64.88 -23.82 67.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.846 0.355 . . . . 0.83 111.184 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.557 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 17.8 mt -86.3 -15.01 41.96 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.825 0.676 . . . . 1.28 112.825 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.66 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -82.17 -2.01 50.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.013 -0.675 . . . . 2.03 110.785 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -79.2 -36.88 39.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.189 -0.459 . . . . 2.19 112.077 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.839 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -64.39 133.0 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.861 0.362 . . . . 1.24 111.03 -176.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.511 ' NH1' ' HA3' ' A' ' 95' ' ' GLY . 98.8 mtt180 -118.53 -172.92 2.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 4.97 111.222 -174.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -71.31 145.0 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.177 -0.465 . . . . 1.63 110.314 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.401 ' HB2' HD12 ' A' ' 183' ' ' LEU . . . -59.61 135.88 57.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.919 -0.582 . . . . 1.34 111.563 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.538 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 41.6 t -57.1 -34.56 68.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.609 -1.178 . . . . 2.58 111.629 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.7 p -126.7 144.15 51.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.072 0.463 . . . . 2.06 110.949 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 46.0 t -72.51 -9.71 58.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.789 -0.641 . . . . 2.69 110.808 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.68 -11.77 55.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.187 0.518 . . . . 2.42 110.059 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -110.21 16.64 21.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 2.12 111.347 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -60.95 115.14 3.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 1.52 110.474 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.495 ' H ' HD11 ' A' ' 183' ' ' LEU . 18.0 t30 -154.82 38.17 0.42 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 122.084 0.945 . . . . 1.68 108.538 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.589 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.1 OUTLIER -123.18 129.93 52.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.13 -0.941 . . . . 1.43 110.711 -173.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 43.0 m -151.21 137.32 18.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.058 0.456 . . . . 1.2 111.467 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 51.2 tpp -88.18 134.91 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.952 -0.567 . . . . 1.56 110.65 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 39.9 t -113.15 131.93 55.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.939 -0.573 . . . . 2.13 110.387 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 25.2 tm0? -123.09 105.54 10.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.272 -0.64 . . . . 1.96 109.272 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.599 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 22.0 pt -136.84 142.58 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.191 -0.458 . . . . 1.62 110.426 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.9 m 57.48 27.07 13.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.403 0.439 . . . . 2.24 111.303 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.503 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 0.7 OUTLIER 64.5 14.56 9.0 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.7 -0.682 . . . . 2.83 112.475 -178.59 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 16.3 pt20 -117.75 159.66 22.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.551 -0.537 . . . . 1.86 109.551 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.4 133.47 44.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.398 -0.364 . . . . 1.59 111.965 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.641 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 43.2 m-85 -141.42 150.62 42.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.702 -0.681 . . . . 4.16 110.499 176.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.454 ' CE1' ' HB3' ' A' ' 169' ' ' LEU . 13.4 m-85 -101.17 114.21 27.95 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.437 -0.579 . . . . 1.27 109.437 175.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.429 ' HD2' ' C ' ' A' ' 195' ' ' LYS . 5.2 tmmm? -98.78 127.05 44.59 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.4 -0.593 . . . . 1.73 109.4 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.487 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 2.0 t -93.01 151.26 3.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.627 0.727 . . . . 1.33 110.015 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 197' ' ' ILE . 1.2 mm -85.68 -58.13 3.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.708 -1.133 . . . . 1.23 110.274 -168.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.429 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -137.07 179.87 6.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.335 -0.848 . . . . 1.88 110.771 176.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -48.16 136.9 11.3 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.097 0.873 . . . . 2.23 113.223 -170.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.434 HD13 ' ND2' ' A' ' 182' ' ' ASN . 33.1 mm -102.48 133.65 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.737 -0.665 . . . . 1.41 110.268 176.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -98.68 138.87 20.78 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.611 -0.722 . . . . 2.06 109.607 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 49.7 Cg_exo -55.77 115.28 2.34 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.457 2.105 . . . . 0.56 111.962 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.72 7.44 8.06 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.497 -0.859 . . . . 0.7 113.498 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.62 122.27 11.83 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.643 0.722 . . . . 1.27 111.535 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -111.78 95.36 5.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.817 -0.629 . . . . 2.92 112.03 177.243 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.489 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.4 mm? -115.65 97.68 6.27 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.33 -0.948 . . . . 1.51 109.46 173.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.839 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 0.9 OUTLIER -146.96 115.07 6.57 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.127 -0.488 . . . . 1.16 109.806 176.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.589 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.9 p -153.64 158.42 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 121.729 -0.607 . . . . 1.5 111.191 -177.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -84.89 110.92 19.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.28 -1.008 . . . . 1.77 108.28 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 61.7 t -60.24 119.97 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.223 0.535 . . . . 3.05 110.226 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.455 ' HA ' ' HA3' ' A' ' 218' ' ' GLY . 0.3 OUTLIER -137.28 138.93 40.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.598 -0.728 . . . . 5.7 110.637 -175.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -133.34 30.17 3.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.615 0.721 . . . . 5.8 109.921 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -168.82 -74.31 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 108.585 -1.806 . . . . 5.61 108.585 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.458 HG13 ' CD1' ' A' ' 215' ' ' TYR . 7.9 t -139.7 -66.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.459 0.647 . . . . 6.31 109.451 170.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.618 ' H ' ' HD2' ' A' ' 216' ' ' PRO . 70.8 m-85 -138.86 -56.77 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 115.213 -0.903 . . . . 9.04 112.814 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.618 ' HD2' ' H ' ' A' ' 215' ' ' TYR . 37.0 Cg_endo -64.16 -67.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.102 1.868 . . . . 7.78 113.97 -161.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -61.19 -9.19 4.42 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.238 0.459 . . . . 8.02 112.238 -172.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 211' ' ' LYS . . . -59.9 -44.06 97.47 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.926 -0.579 . . . . 8.64 113.085 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.2 t -145.63 -21.0 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.141 0.422 . . . . 9.96 112.141 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 216' ' ' PRO . 3.7 m -104.55 155.58 37.17 Favored Pre-proline 0 C--N 1.326 -0.446 0 C-N-CA 120.881 -0.328 . . . . 9.62 110.192 177.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -72.04 131.1 17.55 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.144 1.896 . . . . 12.02 111.486 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.3 -1.87 10.32 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.596 2.197 . . . . 13.11 112.214 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -125.76 49.86 0.9 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.425 -0.807 . . . . 14.03 111.288 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 51.9 tp -64.85 134.18 53.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.562 0.22 . . . . 16.32 110.791 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 32.0 t70 68.33 13.56 9.04 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.689 -0.687 . . . . 17.7 111.108 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 116.005 -0.543 . . . . 18.9 111.296 -179.619 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.153 -0.379 . . . . 33.41 112.153 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.7 t -113.13 68.76 0.68 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.376 0.608 . . . . 34.1 110.647 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.39 -47.99 3.89 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.598 -1.001 . . . . 32.51 110.598 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -88.97 121.72 69.47 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.541 -0.54 . . . . 31.98 109.541 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -59.62 109.64 0.61 Allowed 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.488 2.125 . . . . 30.45 112.091 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 3.3 p -95.42 11.33 33.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.015 0.436 . . . . 29.01 111.296 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.5 m -71.93 93.36 1.35 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.111 -0.495 . . . . 27.14 109.978 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 61.71 47.93 5.94 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.858 -0.61 . . . . 25.83 110.555 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 56' ' ' THR . 7.1 p-10 -76.29 145.76 39.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.644 -0.707 . . . . 23.8 110.509 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.475 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 21.1 t80 -104.7 80.08 1.61 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.31 -0.626 . . . . 22.03 109.31 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 49.4 m -106.91 98.19 20.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.104 -0.498 . . . . 19.63 110.923 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 60' ' ' PHE . 3.5 Cg_exo -81.34 135.82 9.67 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.945 2.43 . . . . 17.86 111.825 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -82.55 -17.58 44.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.127 -0.488 . . . . 17.61 110.095 175.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -63.0 129.86 42.22 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.316 0.579 . . . . 15.63 110.561 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.34 -20.04 9.09 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.701 -0.761 . . . . 12.12 111.856 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.414 ' N ' ' HD3' ' A' ' 67' ' ' PRO . 9.2 t -133.89 64.4 66.67 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.914 0.388 . . . . 10.78 110.198 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 66' ' ' SER . 2.2 Cg_endo -84.17 79.12 2.7 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.648 2.232 . . . . 10.17 111.48 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.821 ' HH ' ' HG3' ' A' ' 75' ' ' PRO . 63.3 t80 -94.76 90.19 5.98 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.357 -0.838 . . . . 7.8 110.304 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -87.93 124.47 33.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.772 -0.649 . . . . 8.14 110.444 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.55 117.88 68.06 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 115.962 -0.563 . . . . 6.11 109.788 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.69 -159.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.985 2.457 . . . . 6.51 112.303 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.0 m -53.71 -32.02 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 111.923 0.342 . . . . 6.76 111.923 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -101.22 114.69 28.9 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.595 -0.52 . . . . 5.18 109.595 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.536 ' O ' HD11 ' A' ' 74' ' ' ILE . 2.3 pp -83.54 138.92 41.09 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.135 0.493 . . . . 4.5 111.192 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.821 ' HG3' ' HH ' ' A' ' 68' ' ' TYR . 96.5 Cg_endo -78.08 -4.22 14.16 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.91 2.407 . . . . 4.4 112.725 -176.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.49 -67.59 0.57 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.073 -0.512 . . . . 3.91 109.663 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.46 ' H ' HD13 ' A' ' 74' ' ' ILE . 31.3 t70 49.92 75.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.131 -0.941 . . . . 3.16 110.914 177.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.463 HG22 ' HB2' ' A' ' 165' ' ' ALA . 41.5 mt -75.07 117.84 65.94 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.228 -0.896 . . . . 2.82 110.607 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.66 133.2 49.96 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.757 2.305 . . . . 2.04 112.798 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.446 ' H ' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -125.68 146.6 55.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.59 -0.732 . . . . 1.53 109.891 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.64 147.9 76.92 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.683 2.255 . . . . 0.88 111.339 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.56 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -57.59 -23.58 51.61 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.462 0.912 . . . . 1.58 113.462 -170.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -89.83 8.35 32.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.596 0.591 . . . . 1.66 112.596 -173.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.448 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 23.8 m-85 -132.54 139.47 47.89 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.8 -0.815 . . . . 1.2 108.8 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.445 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 41.8 tt0 -114.36 119.56 37.35 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.839 -0.344 . . . . 2.27 111.103 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 tt -84.19 131.67 34.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.291 -0.633 . . . . 1.37 109.291 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -140.38 124.14 17.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.264 -0.426 . . . . 3.75 110.752 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -80.84 111.82 17.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.298 -0.631 . . . . 2.46 109.298 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -177.31 127.06 0.15 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.566 -0.901 . . . . 2.03 108.566 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.2 m -90.69 105.51 17.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.887 0.375 . . . . 2.18 111.132 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.482 HG22 ' HB1' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -85.44 123.62 72.66 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 108.766 -0.827 . . . . 1.96 108.766 174.249 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.5 119.13 5.69 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.337 2.691 . . . . 1.87 113.233 -172.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.7 -28.74 10.87 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.645 -0.707 . . . . 1.74 112.259 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB1' HG22 ' A' ' 91' ' ' ILE . . . -117.42 -58.45 2.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.898 0.38 . . . . 1.79 110.946 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 91' ' ' ILE . . . 114.52 -138.68 15.03 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.894 -0.594 . . . . 1.14 111.722 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.32 159.74 32.91 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.503 -0.184 . . . . 2.81 110.503 175.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.57 178.17 46.46 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.576 -0.821 . . . . 0.8 112.269 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.65 148.33 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.239 -0.652 . . . . 1.17 109.239 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -119.14 120.21 36.44 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.074 -0.343 . . . . 1.4 110.074 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.477 ' H ' ' HG2' ' A' ' 205' ' ' GLU . . . -67.79 125.43 26.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.323 -0.399 . . . . 1.2 110.955 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.56 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -88.23 -1.04 57.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.881 0.372 . . . . 2.23 110.285 176.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.431 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 15.6 ttm-85 -125.7 152.62 45.03 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.392 -0.595 . . . . 4.08 109.392 174.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.554 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -76.7 159.62 30.04 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.358 -0.383 . . . . 2.86 110.728 176.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.667 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 47.3 mtm -134.25 152.11 51.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.51 -0.314 . . . . 1.38 110.262 176.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -130.66 144.52 51.49 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.691 0.62 . . . . 2.31 110.045 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -37.42 121.07 0.83 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 124.446 1.091 . . . . 1.42 113.467 -170.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.21 7.26 12.68 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.464 -0.789 . . . . 1.04 111.509 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.5 ' CD ' ' HB ' ' A' ' 196' ' ' VAL . 0.9 OUTLIER -83.68 164.42 19.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.96 0.41 . . . . 2.62 110.648 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.653 ' HG3' ' CE2' ' A' ' 193' ' ' TYR . 8.5 tmm_? -145.97 130.96 18.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.364 -0.38 . . . . 4.16 110.777 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.448 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 5.1 mt -96.45 138.24 34.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.304 -0.628 . . . . 1.11 109.304 175.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.451 ' HA3' ' C ' ' A' ' 112' ' ' PRO . . . 83.74 -117.39 4.43 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.651 -0.785 . . . . 1.09 112.608 177.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.451 ' C ' ' HA3' ' A' ' 111' ' ' GLY . 17.4 Cg_exo -66.73 167.35 56.63 Favored 'Cis proline' 0 C--N 1.347 0.498 0 CA-C-N 118.94 1.37 . . . . 2.52 113.716 5.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.42 ' O ' ' HA3' ' A' ' 166' ' ' GLY . 42.2 t -68.6 -39.85 80.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 2.5 110.139 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.552 ' HB ' ' H ' ' A' ' 192' ' ' ILE . 48.9 t -122.54 128.88 75.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.008 -0.738 . . . . 2.46 109.008 175.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.9 m -111.19 -174.73 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.078 -0.51 . . . . 4.37 110.154 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.448 ' HB ' ' HD3' ' A' ' 117' ' ' PRO . 16.2 t -57.4 -54.96 49.46 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 111.735 0.272 . . . . 5.65 111.735 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.448 ' HD3' ' HB ' ' A' ' 116' ' ' VAL . 55.2 Cg_endo -70.47 135.35 28.57 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.731 1.62 . . . . 5.38 112.254 176.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 67.3 178.99 0.23 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.773 -0.648 . . . . 8.57 111.378 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -159.95 146.99 16.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.266 -0.425 . . . . 7.27 110.56 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.19 73.43 8.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.395 0.617 . . . . 6.4 110.477 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.33 158.11 36.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.258 -0.883 . . . . 5.88 110.691 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -74.92 58.54 0.85 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.13 -0.941 . . . . 7.76 111.311 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -61.12 -45.71 93.56 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.375 -1.284 . . . . 9.01 109.978 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.3 m -143.59 -62.18 0.4 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.578 -0.737 . . . . 9.14 110.433 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -124.72 -176.35 3.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.008 0.432 . . . . 7.6 110.574 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -152.08 140.08 20.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.562 -0.745 . . . . 8.0 109.789 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.02 11.1 60.48 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.766 -0.731 . . . . 4.59 113.088 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . 0.48 ' CG ' ' N ' ' A' ' 129' ' ' GLU . 1.4 p90 -141.72 -78.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.059 0.43 . . . . 4.93 111.017 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.48 ' N ' ' CG ' ' A' ' 128' ' ' TRP . 3.4 pt-20 -167.91 -65.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.058 0.392 . . . . 7.65 112.058 -175.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.479 ' H ' ' HG3' ' A' ' 129' ' ' GLU . 29.2 pt20 -176.1 164.55 2.79 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.219 -0.289 . . . . 9.61 110.219 -169.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.453 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -122.21 4.42 5.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.357 0.599 . . . . 6.05 109.831 171.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.9 mp -95.53 155.37 16.77 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.419 -0.809 . . . . 8.5 109.316 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.7 t 41.67 43.34 2.36 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.234 0.959 . . . . 9.82 112.114 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -112.3 120.46 41.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.172 0.51 . . . . 11.21 110.665 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.8 p -85.11 133.12 30.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.454 -0.794 . . . . 10.92 111.368 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -64.06 131.58 47.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.82 -0.627 . . . . 13.25 110.299 176.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.1 p -88.17 -26.3 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.997 -0.547 . . . . 14.01 110.326 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.8 t -117.85 86.81 25.63 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.619 -0.512 . . . . 14.1 109.619 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.13 119.21 5.43 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.945 2.43 . . . . 14.7 112.428 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -82.33 83.47 7.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.992 -0.549 . . . . 14.44 110.644 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -99.59 -36.49 9.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.419 0.628 . . . . 15.9 110.02 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -146.34 166.94 28.05 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.787 -0.925 . . . . 16.0 110.787 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 24.7 t 58.51 40.96 23.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.697 0.76 . . . . 15.6 109.936 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.6 mt -83.74 -24.93 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.307 -0.86 . . . . 14.1 110.326 -176.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.6 t -70.03 115.22 8.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.421 0.629 . . . . 13.19 110.706 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -108.7 -62.33 1.48 Allowed 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.292 -1.003 . . . . 15.92 108.292 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.455 HD13 HG21 ' A' ' 147' ' ' ILE . 3.7 mt 61.95 177.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 114.333 -1.303 . . . . 14.07 110.427 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.7 p -134.08 58.54 1.77 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.238 0.542 . . . . 13.67 111.072 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -138.03 151.42 47.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.803 -0.635 . . . . 13.02 110.945 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 60.77 60.64 1.85 Allowed 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 122.139 0.971 . . . . 14.68 111.524 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.6 pp -133.47 22.07 4.0 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.212 -1.358 . . . . 13.55 109.716 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 134.83 94.02 0.46 Allowed Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.73 -1.123 . . . . 15.8 110.919 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.6 p -66.19 -29.04 69.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.18 0.514 . . . . 17.08 110.546 -177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -111.71 -69.22 0.88 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.61 -0.723 . . . . 18.43 109.974 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.497 ' H ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -117.07 146.21 43.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.332 -0.849 . . . . 18.74 111.158 -174.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.19 151.7 23.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.021 -0.536 . . . . 14.81 110.431 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 10.2 p -108.97 -25.92 10.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.084 -0.507 . . . . 14.64 111.019 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.9 p -69.61 144.04 14.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.852 -0.425 . . . . 13.38 109.852 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -85.76 137.92 32.46 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.45 -0.5 . . . . 10.61 110.724 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -172.91 -59.13 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.214 -0.903 . . . . 10.22 109.727 -176.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -87.66 -28.63 21.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.673 -0.694 . . . . 10.69 110.896 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -68.1 -48.8 64.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.127 -0.694 . . . . 9.45 109.127 175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 67.59 84.79 0.15 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.348 -0.842 . . . . 6.56 111.695 170.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -67.79 146.37 46.65 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.487 -1.045 . . . . 4.17 110.487 171.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.463 ' HB2' HG22 ' A' ' 78' ' ' ILE . . . -75.43 7.13 3.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.196 0.498 . . . . 3.14 111.949 -175.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 113' ' ' CYS . . . 80.54 -48.59 3.69 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.251 -0.431 . . . . 1.69 113.544 174.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.5 t -59.54 -23.31 62.74 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.6 0.36 . . . . 2.0 111.853 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 41.4 p-90 -65.17 -17.48 64.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.007 0.432 . . . . 0.83 111.314 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 43.7 mt -80.16 -13.86 58.93 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.199 0.444 . . . . 1.28 112.199 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -70.55 -13.1 61.97 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.264 -0.574 . . . . 2.03 109.887 177.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -68.06 -36.81 80.49 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.707 -0.679 . . . . 2.19 111.406 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.655 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -69.36 124.77 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.325 -0.55 . . . . 1.24 109.942 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.493 ' HA ' ' NE ' ' A' ' 173' ' ' ARG . 3.9 mmp_? -112.29 -166.51 1.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.957 -0.565 . . . . 4.97 110.82 -176.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.0 t -73.55 151.9 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.332 . . . . 1.63 110.566 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.424 ' HB1' HD13 ' A' ' 183' ' ' LEU . . . -64.38 134.23 54.17 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.01 -0.541 . . . . 1.34 111.014 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.5 t -78.94 -12.46 60.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.381 -0.827 . . . . 2.58 110.245 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.5 m -125.74 140.99 52.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.904 -0.589 . . . . 2.06 109.641 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 61.4 m -79.38 -19.39 50.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 2.69 111.2 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -89.29 1.78 55.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.233 0.539 . . . . 2.42 110.099 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -110.78 15.81 21.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.545 -0.752 . . . . 2.12 110.412 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -60.91 116.79 4.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.85 -0.614 . . . . 1.52 110.632 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.546 ' ND2' HD11 ' A' ' 200' ' ' ILE . 23.7 t30 -153.9 33.18 0.44 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.076 0.941 . . . . 1.68 109.282 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -121.93 120.8 35.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.563 -0.744 . . . . 1.43 110.644 -172.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 30.3 m -142.92 121.91 12.81 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.265 0.555 . . . . 1.2 110.93 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.595 ' HE2' ' CZ ' ' A' ' 194' ' ' TYR . 52.2 tpp -92.19 127.74 37.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.639 -0.709 . . . . 1.56 109.981 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 38.6 t -126.11 162.43 25.36 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.402 -0.592 . . . . 2.13 109.402 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -134.43 147.06 50.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.757 0.313 . . . . 1.96 110.835 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.733 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 24.4 pt -137.42 133.48 46.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.53 -0.759 . . . . 1.62 109.479 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.7 t 55.33 28.87 12.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.954 0.407 . . . . 2.24 110.84 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 66.86 24.29 9.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.552 -0.749 . . . . 2.83 112.058 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.733 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 11.9 pt20 -118.53 155.01 31.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.09 -0.707 . . . . 1.86 109.09 172.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.552 ' H ' ' HB ' ' A' ' 114' ' ' VAL . 38.0 mm -81.65 126.06 39.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.108 0.48 . . . . 1.59 111.806 -170.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.653 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 63.0 t80 -121.92 127.64 50.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.401 -0.818 . . . . 4.16 110.401 -174.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.595 ' CZ ' ' HE2' ' A' ' 185' ' ' MET . 7.2 m-85 -99.9 113.48 26.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.046 0.45 . . . . 1.27 110.048 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -114.97 123.32 48.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.554 -0.748 . . . . 1.73 109.952 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.5 ' HB ' ' CD ' ' A' ' 108' ' ' GLU . 2.0 t -96.45 153.35 3.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.559 0.695 . . . . 1.33 109.754 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 2.1 mm -92.61 -58.05 3.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.575 -1.193 . . . . 1.23 111.931 -166.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.522 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.7 OUTLIER -141.03 -178.18 5.45 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.616 -0.72 . . . . 1.88 111.713 -173.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.667 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.5 m-20 -45.8 116.21 1.15 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.986 0.804 . . . . 2.23 112.93 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.546 HD11 ' ND2' ' A' ' 182' ' ' ASN . 14.8 mm -88.28 135.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.563 -0.744 . . . . 1.41 109.535 170.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 46.4 mt-10 -99.94 130.43 26.35 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.236 -0.653 . . . . 2.06 109.236 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.33 117.71 2.45 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.067 2.512 . . . . 0.56 112.695 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.93 -9.99 9.63 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.872 -0.68 . . . . 0.7 112.982 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 19.9 pt-20 -138.52 121.48 16.66 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 117.569 0.685 . . . . 1.27 112.118 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.477 ' HG2' ' H ' ' A' ' 100' ' ' ALA . 7.7 mm-40 -111.2 125.0 53.33 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.061 -0.518 . . . . 2.92 110.201 170.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.529 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 2.4 mm? -122.28 99.29 6.34 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.327 -0.62 . . . . 1.51 109.327 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.655 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.3 mm? -145.62 115.59 7.38 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.497 -0.557 . . . . 1.16 109.497 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.48 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 6.3 p -153.21 157.89 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.509 -0.476 . . . . 1.5 111.169 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -98.6 111.4 23.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.84 -0.618 . . . . 1.77 109.828 173.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.434 HG23 HG13 ' A' ' 208' ' ' VAL . 52.6 t -122.04 94.92 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.329 -0.619 . . . . 3.05 109.329 171.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.419 ' HE3' ' HG2' ' A' ' 212' ' ' GLU . 26.3 ttpt -153.99 154.59 34.03 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.837 -0.801 . . . . 5.7 108.837 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.419 ' HG2' ' HE3' ' A' ' 211' ' ' LYS . 24.1 mm-40 36.25 89.45 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 O-C-N 124.804 1.315 . . . . 5.8 112.496 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.24 41.37 1.11 Allowed Glycine 0 C--O 1.227 -0.291 0 CA-C-N 116.234 -0.439 . . . . 5.61 113.006 -175.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.419 ' H ' ' C ' ' A' ' 212' ' ' GLU . 18.6 t -108.77 -65.79 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.136 0.493 . . . . 6.31 110.183 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.451 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 42.1 m-85 -61.88 -56.21 34.22 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.245 -0.889 . . . . 9.04 112.285 -175.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 17.9 Cg_endo -57.64 -44.15 44.08 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.193 1.929 . . . . 7.78 112.769 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.31 -33.45 63.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.01 0.433 . . . . 8.02 110.977 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 88.47 21.86 42.67 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.072 -0.585 . . . . 8.64 111.813 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 12.4 p -85.23 49.72 1.8 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.069 0.461 . . . . 9.96 111.464 -175.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 14.9 m -79.56 114.75 48.18 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.927 -0.578 . . . . 9.62 110.749 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.29 130.62 25.9 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.761 2.307 . . . . 12.02 112.223 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.83 55.58 5.3 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.95 2.433 . . . . 13.11 112.794 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -163.79 172.26 39.63 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.804 -0.712 . . . . 14.03 112.25 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 8.0 tt -144.75 129.53 18.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.547 -0.538 . . . . 16.32 109.547 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -112.3 -46.53 3.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.07 0.462 . . . . 17.7 110.649 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.288 -0.863 . . . . 18.9 110.232 -178.081 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 111.903 -0.479 . . . . 33.41 111.903 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.7 m -86.01 -39.16 17.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.838 0.351 . . . . 34.1 110.644 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.63 142.12 15.02 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.108 -0.568 . . . . 32.51 111.782 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -90.75 126.55 55.48 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.911 0.386 . . . . 31.98 110.975 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.84 117.9 5.22 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.421 2.081 . . . . 30.45 112.007 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -143.89 144.29 31.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.062 -0.517 . . . . 29.01 109.795 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 p -153.91 65.35 0.72 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.017 0.437 . . . . 27.14 110.984 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.6 136.96 56.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.013 -0.54 . . . . 25.83 110.423 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.34 88.44 6.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.999 0.428 . . . . 23.8 110.436 175.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -107.25 145.48 32.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.157 -0.474 . . . . 22.03 109.937 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 35.5 p 46.97 77.02 0.49 Allowed Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.38 0.672 . . . . 19.63 112.183 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.94 87.15 0.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.574 2.183 . . . . 17.86 111.267 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -96.42 44.65 1.06 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.956 -1.02 . . . . 17.61 110.945 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -78.29 97.93 5.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.851 -0.613 . . . . 15.63 110.094 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.33 74.79 1.43 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.884 -0.674 . . . . 12.12 112.016 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 48.8 m -147.98 137.76 12.38 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.891 -0.411 . . . . 10.78 109.891 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 66' ' ' SER . 25.6 Cg_exo -62.82 102.18 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.755 2.304 . . . . 10.17 111.909 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -96.15 120.37 36.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.124 -0.489 . . . . 7.8 110.94 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.492 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 42.4 tt0 -94.56 141.44 28.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.071 -0.513 . . . . 8.14 109.895 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.71 110.49 17.42 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.505 -0.316 . . . . 6.11 110.413 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 69' ' ' GLU . 32.1 Cg_exo -61.33 -74.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.865 2.377 . . . . 6.51 112.165 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.446 ' H ' ' HB2' ' A' ' 71' ' ' PRO . 11.9 p -121.59 -32.92 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.167 -0.47 . . . . 6.76 110.631 175.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -98.27 124.79 43.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.157 -0.474 . . . . 5.18 110.323 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.408 HD11 ' O ' ' A' ' 74' ' ' ILE . 1.9 pp -77.48 152.31 81.01 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.201 -0.454 . . . . 4.5 111.675 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -90.96 26.42 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.052 2.501 . . . . 4.4 112.685 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.405 ' HB2' HD13 ' A' ' 74' ' ' ILE . 10.8 mm-40 -74.02 -61.91 1.69 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.888 -0.596 . . . . 3.91 110.054 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 62.96 67.91 0.66 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.536 -0.757 . . . . 3.16 110.56 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.0 mt -69.45 123.59 88.74 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.337 -0.847 . . . . 2.82 109.732 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.41 117.64 4.17 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.0 2.467 . . . . 2.04 112.983 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.413 HD13 ' H ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -128.41 146.03 58.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.823 -0.626 . . . . 1.53 109.584 176.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -53.19 147.71 34.27 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.823 2.349 . . . . 0.88 112.11 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.557 ' O ' ' HD2' ' A' ' 101' ' ' LYS . . . -70.56 -0.39 8.46 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.551 0.574 . . . . 1.58 112.551 -173.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -106.0 4.6 29.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.881 0.372 . . . . 1.66 111.167 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -136.1 138.5 42.14 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.272 -0.64 . . . . 1.2 109.272 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.453 ' HB2' ' HE2' ' A' ' 101' ' ' LYS . 5.8 tp10 -109.81 124.27 51.01 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.299 -0.56 . . . . 2.27 111.286 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.0 tp -87.91 128.3 35.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.158 -0.473 . . . . 1.37 110.078 176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -147.87 118.87 7.66 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.635 -0.711 . . . . 3.75 109.796 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.14 112.62 10.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.989 0.424 . . . . 2.46 109.971 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.2 t -172.92 133.56 0.55 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.338 -0.986 . . . . 2.03 108.338 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.4 t -87.36 106.04 17.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.929 0.395 . . . . 2.18 110.805 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.594 HG21 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -85.79 123.12 72.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.413 -0.588 . . . . 1.96 109.413 173.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -45.59 119.32 2.64 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.515 2.81 . . . . 1.87 113.346 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.32 -29.1 10.46 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.812 -0.631 . . . . 1.74 112.415 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 173' ' ' ARG . . . -124.28 -65.88 1.02 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.048 0.451 . . . . 1.79 111.671 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.594 ' O ' HG21 ' A' ' 91' ' ' ILE . . . 123.5 -132.59 8.56 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.127 -0.789 . . . . 1.14 111.127 -175.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 pp -72.82 159.69 33.37 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.986 0.393 . . . . 2.81 110.746 175.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.91 174.73 47.09 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.844 -0.693 . . . . 0.8 111.958 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.553 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 19.4 m -106.64 130.8 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 121.266 0.555 . . . . 1.17 109.71 174.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -96.85 114.89 26.56 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.652 -0.704 . . . . 1.4 110.019 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.34 114.26 4.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.235 -0.283 . . . . 1.2 110.235 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.557 ' HD2' ' O ' ' A' ' 82' ' ' ALA . 15.8 ptpt -83.71 -8.99 59.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.244 0.545 . . . . 2.23 110.665 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 27.2 ttp180 -125.66 155.75 40.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.547 -0.751 . . . . 4.08 109.772 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.419 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -81.88 155.45 25.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.95 -0.568 . . . . 2.86 109.779 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.568 ' HB3' ' OE2' ' A' ' 108' ' ' GLU . 59.6 mtm -136.13 153.31 51.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.684 -0.234 . . . . 1.38 110.507 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -117.34 140.37 49.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.129 -0.487 . . . . 2.31 109.716 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.62 131.39 3.92 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 124.421 1.076 . . . . 1.42 113.61 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.25 7.67 11.03 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.528 -0.76 . . . . 1.04 112.368 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.568 ' OE2' ' HB3' ' A' ' 104' ' ' MET . 0.7 OUTLIER -85.74 167.9 14.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.293 0.568 . . . . 2.62 111.435 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -143.28 135.33 26.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.746 -0.661 . . . . 4.16 110.182 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 4.4 mt -104.6 132.91 50.3 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.598 -0.89 . . . . 1.11 108.598 171.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.82 166.48 39.67 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.188 -1.006 . . . . 1.09 112.724 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.18 142.03 43.75 Favored 'Cis proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.414 -1.494 . . . . 2.52 111.909 -2.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.618 ' SG ' HD11 ' A' ' 169' ' ' LEU . 56.9 m -88.32 -2.9 58.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.044 0.45 . . . . 2.5 110.765 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 192' ' ' ILE . 15.6 m -94.37 126.55 46.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.047 -0.524 . . . . 2.46 110.802 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 165' ' ' ALA . 45.7 t -74.0 140.27 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.702 -0.681 . . . . 4.37 109.359 176.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 32.6 m -43.95 113.35 1.54 Allowed Pre-proline 0 CA--C 1.536 0.435 0 O-C-N 124.012 0.82 . . . . 5.65 112.056 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 116' ' ' VAL . 23.4 Cg_exo -64.5 166.73 16.69 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.128 2.552 . . . . 5.38 113.407 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 74.17 148.7 0.1 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.009 -0.996 . . . . 8.57 110.788 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 71.32 -50.6 0.69 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.418 0.687 . . . . 7.27 112.328 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.19 -73.06 0.16 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.236 0.214 . . . . 6.4 111.383 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 55.87 94.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.691 0.619 . . . . 5.88 111.394 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -62.89 143.94 57.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.63 -0.714 . . . . 7.76 111.442 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 124' ' ' THR . 0.6 OUTLIER -141.42 -49.91 0.41 Allowed 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.209 -0.905 . . . . 9.01 108.717 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.44 ' N ' ' HG3' ' A' ' 123' ' ' GLU . 25.2 m -78.66 -58.57 3.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.672 -0.695 . . . . 9.14 110.304 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -91.59 124.55 35.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.35 -0.841 . . . . 7.6 111.169 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -125.14 -170.77 2.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.022 -0.535 . . . . 8.0 110.647 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 179.72 -39.52 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.013 -0.835 . . . . 4.59 111.013 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -126.45 -56.59 1.4 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.518 -0.549 . . . . 4.93 109.518 175.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.575 ' HG3' ' H ' ' A' ' 130' ' ' GLN . 6.7 pt-20 -179.64 -69.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.839 -0.619 . . . . 7.65 110.777 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.575 ' H ' ' HG3' ' A' ' 129' ' ' GLU . 6.1 tp-100 -174.29 161.26 3.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.107 -0.701 . . . . 9.61 109.107 -175.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.44 40.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.018 0.437 . . . . 6.05 111.512 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.95 57.34 4.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.026 0.917 . . . . 8.5 110.546 176.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.6 t -150.22 27.86 0.75 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.444 -1.253 . . . . 9.82 109.571 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -96.78 89.27 4.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.171 -0.922 . . . . 11.21 110.516 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.1 p -56.61 136.59 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.613 -0.721 . . . . 10.92 110.756 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.431 ' OE2' ' HB3' ' A' ' 140' ' ' GLN . 5.0 tp10 -80.23 82.89 6.19 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.988 -0.551 . . . . 13.25 110.038 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.72 -30.78 39.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.699 -0.682 . . . . 14.01 110.462 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.1 m -105.4 104.71 49.21 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.592 -0.521 . . . . 14.1 109.592 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -42.59 118.53 1.15 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.427 2.752 . . . . 14.7 112.89 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.431 ' HB3' ' OE2' ' A' ' 136' ' ' GLU . 3.7 pt20 -80.09 47.17 0.87 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.629 0.728 . . . . 14.44 111.158 -174.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -111.02 74.34 0.86 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.609 -0.723 . . . . 15.9 110.602 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 144.65 -168.7 26.75 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.818 -0.706 . . . . 16.0 112.149 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 50.7 t -79.4 103.82 9.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.03 0.443 . . . . 15.6 110.178 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 61.6 mt -127.47 129.8 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.724 -0.843 . . . . 14.1 108.724 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.6 t -61.44 114.76 3.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.804 0.811 . . . . 13.19 111.126 -177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -126.46 -6.13 6.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.159 -0.928 . . . . 15.92 109.164 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.8 pp -106.85 158.78 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 115.127 -0.942 . . . . 14.07 111.273 -174.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 48.5 t -123.39 139.79 53.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.271 -0.877 . . . . 13.67 108.642 173.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -94.22 145.46 24.7 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.039 0.447 . . . . 13.02 110.942 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -82.52 83.93 7.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.72 -0.673 . . . . 14.68 109.6 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' A' ' 160' ' ' ALA . 0.7 OUTLIER -89.88 49.04 1.66 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.585 -0.734 . . . . 13.55 111.941 -175.082 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -60.76 -24.79 62.79 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 121.216 -0.516 . . . . 15.8 112.686 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.5 m -148.33 25.66 0.98 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.104 0.478 . . . . 17.08 110.474 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.441 ' CG ' ' HA ' ' A' ' 151' ' ' LEU . 18.9 mm-40 -95.41 -77.05 0.48 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.843 -0.617 . . . . 18.43 110.075 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.08 157.44 44.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.647 -0.871 . . . . 18.74 108.647 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -133.19 36.31 3.44 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.645 -0.422 . . . . 14.81 111.849 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 85.0 m -135.89 -60.2 0.74 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.654 -0.248 . . . . 14.64 111.174 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.8 t -82.02 124.48 39.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.77 0.319 . . . . 13.38 111.627 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 48.47 67.91 0.77 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.15 -0.932 . . . . 10.61 112.403 176.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.451 ' HA ' HD21 ' A' ' 151' ' ' LEU . . . -86.68 162.73 17.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.037 -0.529 . . . . 10.22 110.493 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -104.87 46.77 0.9 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.305 0.574 . . . . 10.69 110.551 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -74.55 -21.64 59.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.804 -0.635 . . . . 9.45 110.766 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 68.81 -174.44 0.19 Allowed 'General case' 0 N--CA 1.462 0.158 0 O-C-N 124.233 0.958 . . . . 6.56 110.084 -174.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.544 ' O ' ' HD1' ' A' ' 168' ' ' TRP . . . 170.17 -80.91 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.162 -1.018 . . . . 4.17 112.334 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 115' ' ' VAL . . . -50.6 119.06 3.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 3.14 111.242 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.65 -42.98 3.0 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.845 -0.616 . . . . 1.69 112.698 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.9 m -59.5 -39.49 83.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.001 0.371 . . . . 2.0 112.001 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.544 ' HD1' ' O ' ' A' ' 164' ' ' GLY . 29.9 p-90 -85.55 -22.66 28.01 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.42 -0.512 . . . . 0.83 111.157 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.618 HD11 ' SG ' ' A' ' 113' ' ' CYS . 28.7 mt -86.93 -15.0 40.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.389 0.514 . . . . 1.28 112.389 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.407 ' C ' ' HD3' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -75.33 -4.09 37.24 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.661 -0.415 . . . . 2.03 110.523 176.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -76.57 -37.62 56.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.085 -0.507 . . . . 2.19 111.586 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -67.34 129.36 31.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.539 -0.464 . . . . 1.24 110.057 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.403 ' HB2' ' HB2' ' A' ' 94' ' ' ALA . 98.9 mtt180 -125.98 -163.38 1.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.933 -0.576 . . . . 4.97 111.835 -172.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.436 ' HA ' HG12 ' A' ' 208' ' ' VAL . 20.0 t -62.62 146.83 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.261 -0.881 . . . . 1.63 111.449 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.469 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -65.35 136.13 56.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.881 -0.6 . . . . 1.34 111.343 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.74 -19.3 64.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.35 -0.841 . . . . 2.58 111.143 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 63.6 m -146.03 147.56 31.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.227 -0.442 . . . . 2.06 110.027 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 10.6 p -76.89 -13.66 59.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.877 0.37 . . . . 2.69 111.427 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -73.56 -25.34 60.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.493 0.663 . . . . 2.42 110.101 172.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.44 ' O ' ' HG ' ' A' ' 206' ' ' LEU . 17.0 m-20 -92.61 17.27 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.428 -0.805 . . . . 2.12 111.606 -176.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -55.65 114.46 1.87 Allowed 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.36 0.6 . . . . 1.52 110.068 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.674 ' ND2' HD13 ' A' ' 200' ' ' ILE . 19.5 t30 -161.59 34.51 0.13 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 122.597 1.189 . . . . 1.68 108.112 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.638 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -124.8 119.0 27.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.99 -1.005 . . . . 1.43 110.34 -172.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 61.3 m -150.62 129.37 12.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.06 0.457 . . . . 1.2 111.19 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 49.4 ttm -91.04 137.29 32.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.174 -0.466 . . . . 1.56 110.11 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 50.0 t -115.28 132.06 56.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.166 -0.47 . . . . 2.13 110.579 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 23.5 tm0? -108.87 105.21 14.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.278 -0.638 . . . . 1.96 109.278 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 13.3 pt -144.01 144.13 23.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.001 -0.545 . . . . 1.62 110.331 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.1 t 61.29 27.87 17.48 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.211 0.529 . . . . 2.24 110.371 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.408 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 6.0 mm-40 57.9 32.85 22.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.217 -0.901 . . . . 2.83 111.641 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -144.97 165.99 26.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.769 -0.65 . . . . 1.86 109.702 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.404 ' H ' HG12 ' A' ' 114' ' ' VAL . 48.7 mm -100.23 133.11 44.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.04 0.448 . . . . 1.59 111.668 -173.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -132.31 156.89 45.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.226 -0.897 . . . . 4.16 109.164 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.432 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 11.1 m-85 -100.31 119.3 38.2 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.43 -0.508 . . . . 1.27 109.776 173.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -98.17 118.01 33.84 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.462 -0.94 . . . . 1.73 108.462 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.516 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 1.8 t -89.32 151.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.493 0.663 . . . . 1.33 109.784 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 182' ' ' ASN . 1.3 mm -97.0 -53.66 7.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 114.656 -1.156 . . . . 1.23 111.553 -163.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.547 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -135.76 174.27 10.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.484 -0.78 . . . . 1.88 111.491 -174.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 104' ' ' MET . 3.0 m-20 -50.49 119.65 3.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.368 -0.833 . . . . 2.23 112.268 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.674 HD13 ' ND2' ' A' ' 182' ' ' ASN . 17.3 mm -86.99 135.81 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.985 -0.552 . . . . 1.41 110.627 177.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.67 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 20.1 mm-40 -101.65 134.64 20.09 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.656 -0.702 . . . . 2.06 109.481 174.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.1 113.5 1.13 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.802 2.335 . . . . 0.56 112.953 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.31 -10.21 9.34 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.68 -0.771 . . . . 0.7 113.537 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.67 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.7 pt-20 -107.55 127.37 53.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.709 0.754 . . . . 1.27 111.541 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.553 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -109.4 93.59 4.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.471 -0.786 . . . . 2.92 111.616 177.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.594 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.6 mm? -124.56 95.82 4.67 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.57 -0.852 . . . . 1.51 110.885 175.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.529 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.8 mm? -148.07 111.7 5.03 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.263 -0.643 . . . . 1.16 109.263 170.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.638 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.7 p -157.05 160.8 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 117.892 0.314 . . . . 1.5 110.437 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -109.93 110.9 22.0 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.574 -0.528 . . . . 1.77 109.574 168.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 96.5 t -120.18 99.59 7.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 3.05 110.216 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -140.41 131.12 25.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.952 -0.567 . . . . 5.7 109.569 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -81.04 74.4 8.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.424 0.63 . . . . 5.8 110.475 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 151.31 63.08 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.533 -0.758 . . . . 5.61 111.882 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.05 -71.55 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.604 0.24 . . . . 6.31 110.524 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.508 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 88.4 t80 -73.65 -50.97 5.58 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.454 -0.339 . . . . 9.04 111.75 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 18.6 Cg_endo -59.67 -41.88 51.85 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.073 1.849 . . . . 7.78 112.517 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 220' ' ' VAL . 7.7 mp -101.75 -94.17 0.29 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.295 -0.411 . . . . 8.02 110.62 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 53.11 -115.29 4.43 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.379 -0.439 . . . . 8.64 112.442 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.5 32.36 2.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.947 0.403 . . . . 9.96 110.76 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 221' ' ' PRO . 27.7 m -73.66 138.47 77.2 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 116.161 -0.472 . . . . 9.62 110.766 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 20.8 Cg_exo -65.38 130.79 26.19 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.751 2.3 . . . . 12.02 112.3 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.47 58.9 6.5 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.948 2.432 . . . . 13.11 112.384 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -152.56 151.14 23.02 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 111.382 -0.687 . . . . 14.03 111.382 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 45.1 tp -141.03 126.21 18.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.331 -0.248 . . . . 16.32 110.331 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -119.69 -53.93 2.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.16 0.505 . . . . 17.7 110.363 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.597 -0.729 . . . . 18.9 109.716 -176.784 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.673 -0.571 . . . . 33.41 111.673 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.5 t -71.44 -30.54 66.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.301 0.572 . . . . 34.1 110.03 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.455 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . -92.55 162.76 26.95 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.689 -0.767 . . . . 32.51 111.269 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -107.8 99.86 32.25 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 110.118 -0.327 . . . . 31.98 110.118 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 23.5 Cg_exo -64.64 112.63 2.02 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.883 2.389 . . . . 30.45 112.245 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 p -91.57 141.49 28.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.988 -0.551 . . . . 29.01 110.442 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.0 m 58.62 54.66 5.23 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.248 0.547 . . . . 27.14 110.298 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -53.39 101.25 0.04 OUTLIER 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.822 -1.081 . . . . 25.83 111.494 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 52.11 47.29 25.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.826 -0.625 . . . . 23.8 111.146 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.3 t80 62.02 62.59 1.2 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.825 -0.625 . . . . 22.03 110.118 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.592 ' OG1' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -61.43 -52.14 72.42 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.933 -0.576 . . . . 19.63 112.048 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.592 ' HD3' ' OG1' ' A' ' 61' ' ' THR . 11.5 Cg_exo -71.23 103.42 1.39 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.903 1.736 . . . . 17.86 110.696 174.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -76.71 75.55 3.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.71 -0.677 . . . . 17.61 110.676 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -61.35 134.45 56.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.639 -0.71 . . . . 15.63 110.077 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.74 146.39 16.28 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.798 -0.715 . . . . 12.12 111.621 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.9 t -120.43 130.57 24.79 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 110.328 -0.249 . . . . 10.78 110.328 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.47 149.39 74.61 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.877 2.385 . . . . 10.17 112.402 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -68.23 129.03 38.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.906 -0.588 . . . . 7.8 110.396 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.19 145.6 29.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.07 0.462 . . . . 8.14 110.338 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.9 136.2 82.68 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.579 -0.737 . . . . 6.11 110.85 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.23 -159.42 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.964 2.442 . . . . 6.51 111.81 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.76 -36.75 50.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.718 0.294 . . . . 6.76 111.013 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -102.9 131.41 49.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.826 -0.435 . . . . 5.18 109.826 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.52 ' O ' HD13 ' A' ' 74' ' ' ILE . 2.6 pp -78.57 141.07 60.14 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.051 -0.522 . . . . 4.5 111.904 -177.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -88.58 13.23 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.097 2.531 . . . . 4.4 113.067 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -85.32 -67.85 0.77 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.833 -0.432 . . . . 3.91 109.833 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.4 t70 57.25 67.14 1.02 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.93 0.871 . . . . 3.16 110.602 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.7 mt -105.91 108.65 62.05 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 114.88 -1.054 . . . . 2.82 109.459 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.14 119.67 6.95 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.809 2.34 . . . . 2.04 112.256 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.428 ' H ' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -126.86 144.03 48.73 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 1.53 109.723 178.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.87 144.76 87.18 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.579 2.186 . . . . 0.88 111.453 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.34 -12.27 8.77 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.798 0.666 . . . . 1.58 112.798 -173.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -80.96 -11.27 59.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.925 0.393 . . . . 1.66 110.911 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -133.92 165.1 25.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.911 -0.774 . . . . 1.2 108.911 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HA ' HG13 ' A' ' 80' ' ' ILE . 10.1 pt-20 -155.84 147.01 22.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.914 0.388 . . . . 2.27 110.671 173.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.448 HD11 ' CZ ' ' A' ' 171' ' ' TYR . 7.0 tt -92.26 132.33 36.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.864 -0.607 . . . . 1.37 110.43 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.403 ' N ' HD23 ' A' ' 86' ' ' LEU . 76.1 mtt180 -144.27 138.88 28.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.403 -0.817 . . . . 3.75 109.841 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -82.04 112.91 19.55 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.348 -0.612 . . . . 2.46 109.348 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 p -169.03 90.11 0.22 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.678 -0.692 . . . . 2.03 109.749 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 p -69.95 105.43 2.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.243 0.544 . . . . 2.18 110.744 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.537 HG22 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -85.17 123.78 72.92 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.928 -0.767 . . . . 1.96 108.928 175.265 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.08 120.27 7.68 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.287 2.658 . . . . 1.87 112.735 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.6 -11.25 53.72 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.597 -0.811 . . . . 1.74 112.181 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.537 ' HB3' HG22 ' A' ' 91' ' ' ILE . . . -134.11 -63.07 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.711 -0.288 . . . . 1.79 111.609 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.03 -145.83 17.29 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.786 -0.721 . . . . 1.14 113.106 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.56 158.68 35.23 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.4 0.28 . . . . 2.81 110.83 177.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.09 175.97 43.33 Favored Glycine 0 C--O 1.237 0.308 0 C-N-CA 120.346 -0.931 . . . . 0.8 112.421 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 98' ' ' VAL . 35.3 m -111.22 114.27 46.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.634 0.73 . . . . 1.17 109.263 174.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -80.73 100.77 8.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.476 0.655 . . . . 1.4 110.996 -169.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.08 120.95 13.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.732 -1.122 . . . . 1.2 110.751 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.558 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -101.64 13.79 33.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.513 0.673 . . . . 2.23 109.447 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -125.83 155.94 40.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.961 -1.018 . . . . 4.08 109.16 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.496 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -83.3 116.27 22.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.211 0.529 . . . . 2.86 111.244 174.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.568 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 4.8 mpp? -86.92 130.96 34.24 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.573 -0.899 . . . . 1.38 108.573 172.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.633 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 8.4 pt-20 -116.32 174.45 6.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.902 0.382 . . . . 2.31 111.914 -173.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.93 126.46 18.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.645 -0.707 . . . . 1.42 112.899 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.58 -17.19 59.71 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.779 -0.646 . . . . 1.04 114.202 168.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.633 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 7.3 pt-20 -76.28 160.09 29.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.607 0.704 . . . . 2.62 111.799 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.79 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 6.6 ttt180 -116.42 142.09 47.31 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.418 -0.81 . . . . 4.16 110.667 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.7 mt -92.47 136.21 33.4 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.952 -0.758 . . . . 1.11 108.952 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 149.88 -147.79 18.41 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.374 -0.917 . . . . 1.09 112.649 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -75.34 135.01 38.43 Favored 'Cis proline' 0 CA--C 1.532 0.376 0 C-N-CA 123.064 -1.64 . . . . 2.52 112.516 3.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.414 ' SG ' ' HA3' ' A' ' 166' ' ' GLY . 42.5 t -74.7 -67.46 0.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.466 -0.788 . . . . 2.5 109.789 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.5 m -130.36 144.11 38.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.753 -0.658 . . . . 2.46 109.344 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.3 m -92.62 -161.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.076 -0.511 . . . . 4.37 110.325 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.4 m -39.96 129.84 1.57 Allowed Pre-proline 0 C--O 1.236 0.394 0 O-C-N 123.776 0.672 . . . . 5.65 111.936 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.22 92.47 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.411 2.741 . . . . 5.38 113.245 -173.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.84 -40.18 2.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.773 -0.649 . . . . 8.57 110.316 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.42 76.37 1.09 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.15 -0.477 . . . . 7.27 110.915 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.02 142.32 27.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.137 -0.483 . . . . 6.4 109.795 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -129.84 134.5 47.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.013 0.435 . . . . 5.88 111.526 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.913 ' HZ1' ' HH ' ' A' ' 215' ' ' TYR . 22.8 ptmt -94.11 146.61 23.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.584 -0.735 . . . . 7.76 109.791 175.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -126.81 -82.99 0.62 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.234 -0.439 . . . . 9.01 110.031 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.8 m -126.46 -57.18 1.38 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.552 -0.536 . . . . 9.14 109.552 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.66 137.01 49.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.605 -0.725 . . . . 7.6 109.419 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -132.71 134.05 44.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.078 0.466 . . . . 8.0 111.283 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -98.7 9.11 62.08 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.677 -0.692 . . . . 4.59 111.817 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . 0.414 ' HA ' ' HE3' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -158.82 -99.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.538 -0.331 . . . . 4.93 111.391 177.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -152.62 -53.2 0.11 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.004 0.43 . . . . 7.65 110.523 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -166.97 174.1 8.71 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.632 -0.507 . . . . 9.61 109.632 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -131.19 51.64 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.128 0.489 . . . . 6.05 111.32 -176.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.6 mp -87.66 58.25 4.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.95 0.881 . . . . 8.5 109.816 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.8 p -136.34 35.49 2.74 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.469 -1.242 . . . . 9.82 110.452 -175.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -59.4 127.63 33.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.799 -0.637 . . . . 11.21 110.209 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.31 134.63 21.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.524 -0.762 . . . . 10.92 111.293 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -125.9 -5.74 6.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.746 -0.661 . . . . 13.25 110.663 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.2 m -94.08 8.93 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.19 -0.459 . . . . 14.01 112.182 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.8 p -151.83 74.04 7.86 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 120.676 0.274 . . . . 14.1 110.975 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.76 72.82 3.71 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.79 2.326 . . . . 14.7 111.798 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -127.63 21.72 6.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.105 -0.952 . . . . 14.44 110.285 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -66.42 121.15 14.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 15.9 109.882 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 117.06 -17.42 12.79 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.795 -0.922 . . . . 16.0 110.795 -171.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 64.6 m -131.07 35.28 3.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.602 0.715 . . . . 15.6 110.168 176.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.9 mt -101.88 -52.13 8.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.309 -0.859 . . . . 14.1 109.281 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.9 p -83.31 39.54 0.66 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.564 -0.744 . . . . 13.19 110.51 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -83.43 -16.97 43.77 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.597 -0.729 . . . . 15.92 109.733 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.9 pp -89.07 166.21 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.025 -0.989 . . . . 14.07 110.928 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.2 t -133.11 89.07 2.57 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.007 -0.542 . . . . 13.67 109.765 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -82.85 148.74 27.56 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.004 -0.544 . . . . 13.02 109.737 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -88.69 99.86 12.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.118 0.485 . . . . 14.68 110.489 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 76.3 mt -103.2 42.29 1.18 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.844 -0.616 . . . . 13.55 110.072 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -85.45 18.45 29.0 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.118 -0.563 . . . . 15.8 112.47 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.457 ' CB ' ' HA ' ' A' ' 158' ' ' VAL . 70.4 m 65.65 28.08 11.26 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.344 0.498 . . . . 17.08 112.344 175.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.37 -79.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 18.43 110.057 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -128.49 23.16 5.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.435 0.636 . . . . 18.74 110.638 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 157' ' ' CYS . 54.1 m-85 -115.43 29.28 8.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.305 -0.861 . . . . 14.81 109.83 176.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 156' ' ' PHE . 75.7 m 72.81 136.08 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 O-C-N 124.115 0.884 . . . . 14.64 111.399 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.457 ' HA ' ' CB ' ' A' ' 153' ' ' SER . 23.5 t -74.78 126.78 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.551 -0.75 . . . . 13.38 109.214 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 59.88 65.85 1.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.229 0.538 . . . . 10.61 109.651 -173.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.46 ' C ' HD21 ' A' ' 161' ' ' ASN . . . -72.7 -56.01 5.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.467 -0.788 . . . . 10.22 111.941 -175.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . 0.46 HD21 ' C ' ' A' ' 160' ' ' ALA . 0.9 OUTLIER -118.53 52.39 1.04 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.966 0.412 . . . . 10.69 110.439 -177.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -112.64 -18.08 12.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.125 -0.489 . . . . 9.45 110.978 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -124.04 33.2 5.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.101 -0.499 . . . . 6.56 110.714 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -77.41 68.36 2.7 Favored Glycine 0 C--N 1.329 0.151 0 CA-C-N 115.711 -0.677 . . . . 4.17 112.355 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -160.49 -38.81 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.017 0.437 . . . . 3.14 110.893 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.414 ' HA3' ' SG ' ' A' ' 113' ' ' CYS . . . 101.26 20.34 13.99 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.845 -0.693 . . . . 1.69 111.706 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.3 m -54.13 -35.08 61.8 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.953 0.501 . . . . 2.0 112.226 -176.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -84.44 -17.6 38.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.886 0.374 . . . . 0.83 111.299 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 28.8 mt -86.11 -14.6 43.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.472 -0.331 . . . . 1.28 111.768 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -10.43 59.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.351 0.596 . . . . 2.03 109.541 175.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.448 ' CZ ' HD11 ' A' ' 86' ' ' LEU . 43.7 m-85 -79.52 -30.21 41.77 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.274 -0.875 . . . . 2.19 111.872 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.522 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 1.3 mm -56.03 129.64 17.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 120.858 0.361 . . . . 1.24 110.521 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.413 ' HB3' ' HB2' ' A' ' 94' ' ' ALA . 13.6 mmm180 -93.94 143.59 26.21 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.501 0.667 . . . . 4.97 111.819 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.52 ' HA ' ' CD2' ' A' ' 183' ' ' LEU . 10.1 p -77.77 153.76 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.209 -0.905 . . . . 1.63 109.174 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -48.04 111.59 0.46 Allowed 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.654 0.597 . . . . 1.34 112.176 -172.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 51.6 t -66.09 -33.63 76.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.277 -0.874 . . . . 2.58 109.771 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.451 ' HB3' ' OD1' ' A' ' 180' ' ' ASP . 11.9 t -131.08 152.28 50.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.907 -0.775 . . . . 2.06 108.907 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 61.8 m -71.92 -6.09 39.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.472 -0.331 . . . . 2.69 111.545 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.89 1.38 56.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.77 0.319 . . . . 2.42 110.868 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.451 ' OD1' ' HB3' ' A' ' 177' ' ' SER . 29.3 m-20 -110.14 15.27 22.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.378 -0.374 . . . . 2.12 111.093 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 15.0 mm100 -63.63 115.51 4.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.253 0.549 . . . . 1.52 111.946 -173.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.536 ' H ' HD11 ' A' ' 183' ' ' LEU . 22.7 t30 -161.39 31.58 0.13 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.093 0.949 . . . . 1.68 108.779 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.722 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.5 OUTLIER -119.28 122.52 42.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 1.43 111.184 -171.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 60.9 m -150.13 136.01 18.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.983 0.421 . . . . 1.2 110.421 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.421 ' HB3' ' HB2' ' A' ' 209' ' ' HIS . 49.9 ttm -125.62 135.49 52.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.208 -0.451 . . . . 1.56 109.852 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 18.6 t -115.11 152.51 32.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.221 -0.445 . . . . 2.13 109.836 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.73 104.86 11.78 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.011 -0.737 . . . . 1.96 109.011 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 33.2 pt -135.49 144.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.978 -0.556 . . . . 1.62 110.541 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.8 m 57.46 30.11 18.11 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.459 0.474 . . . . 2.24 111.558 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 64.3 17.36 10.69 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.493 -0.776 . . . . 2.83 111.301 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -124.93 167.2 15.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 1.86 110.189 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.6 mm -90.73 130.07 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.069 -0.514 . . . . 1.59 110.861 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -121.76 122.95 40.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.271 -0.422 . . . . 4.16 110.535 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.79 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 13.7 m-85 -99.79 113.96 26.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.915 -0.772 . . . . 1.27 108.915 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -110.45 124.14 51.21 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.9 -0.32 . . . . 1.73 110.217 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.403 HG13 ' H ' ' A' ' 197' ' ' ILE . 1.7 t -93.42 151.85 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 122.059 0.933 . . . . 1.33 110.688 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.418 ' H ' HG12 ' A' ' 197' ' ' ILE . 0.8 OUTLIER -101.57 -56.43 5.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 113.734 -1.576 . . . . 1.23 112.009 -164.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.44 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -140.9 162.78 34.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.975 -1.012 . . . . 1.88 110.117 -176.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.568 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.4 m-20 -58.27 111.67 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.85 0.719 . . . . 2.23 112.189 -173.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.482 HG13 ' HE2' ' A' ' 104' ' ' MET . 6.1 mm -68.85 145.82 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.255 -0.884 . . . . 1.41 110.9 175.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 14.2 mt-10 -92.63 117.64 67.67 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.278 -0.873 . . . . 2.06 108.697 172.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -43.31 122.19 2.86 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.614 2.876 . . . . 0.56 113.688 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.91 -3.22 10.81 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.822 -0.704 . . . . 0.7 113.127 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 11.3 pt-20 -137.37 125.56 23.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.247 0.546 . . . . 1.27 111.031 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.522 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -109.57 108.05 18.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.017 -0.538 . . . . 2.92 111.507 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.554 ' O ' HD21 ' A' ' 207' ' ' LEU . 1.4 mm? -123.24 97.9 5.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.064 -0.655 . . . . 1.51 109.944 173.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.554 HD21 ' O ' ' A' ' 206' ' ' LEU . 1.1 mm? -149.1 102.12 3.21 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.985 -0.746 . . . . 1.16 108.985 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.722 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 6.8 t -157.28 158.25 3.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.1 -0.704 . . . . 1.5 109.1 -178.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 185' ' ' MET . 19.4 t-80 -136.25 110.57 8.45 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.453 -0.943 . . . . 1.77 108.453 162.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 3.1 p -88.16 100.75 10.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.632 0.73 . . . . 3.05 109.812 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 128' ' ' TRP . 67.5 mttm -84.02 121.18 27.05 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.515 -0.766 . . . . 5.7 110.448 -177.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.56 -58.37 1.91 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.419 -0.809 . . . . 5.8 110.133 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -81.57 40.42 2.6 Favored Glycine 0 C--N 1.31 -0.9 0 CA-C-N 115.322 -0.854 . . . . 5.61 111.889 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.511 ' O ' ' HA3' ' A' ' 218' ' ' GLY . 34.9 t -132.96 -70.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.258 0.551 . . . . 6.31 110.145 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.913 ' HH ' ' HZ1' ' A' ' 122' ' ' LYS . 88.2 t80 -97.14 -58.56 0.17 Allowed Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 115.555 -0.748 . . . . 9.04 112.144 -176.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' A' ' 215' ' ' TYR . 43.4 Cg_endo -69.51 -47.81 0.92 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.56 1.507 . . . . 7.78 112.608 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.6 mp -92.63 16.26 12.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.333 0.587 . . . . 8.02 109.815 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 214' ' ' VAL . . . -112.7 154.87 16.64 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.646 -0.706 . . . . 8.64 111.776 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.9 p -93.17 47.21 1.25 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.187 0.518 . . . . 9.96 110.692 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.438 ' O ' ' HD3' ' A' ' 222' ' ' PRO . 29.2 m -61.63 140.86 95.1 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.582 -0.735 . . . . 9.62 110.723 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.79 110.48 2.91 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.854 2.369 . . . . 12.02 112.261 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 220' ' ' VAL . 91.1 Cg_endo -92.65 1.11 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.021 2.481 . . . . 13.11 112.123 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 139.55 -160.13 25.96 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.213 -0.903 . . . . 14.03 111.126 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 24.2 tp 68.83 120.69 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.503 0.668 . . . . 16.32 112.282 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -103.66 -44.33 5.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.803 -0.635 . . . . 17.7 109.866 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 . . . . . 0 C--O 1.249 1.067 0 CA-C-N 115.364 -0.835 . . . . 18.9 109.298 179.115 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.785 -0.526 . . . . 33.41 111.785 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.5 m -67.43 158.41 31.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.808 0.337 . . . . 34.1 111.004 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.67 76.52 1.29 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.706 -0.759 . . . . 32.51 111.545 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -98.22 108.84 49.39 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.716 0.294 . . . . 31.98 110.763 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.39 102.77 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.716 2.278 . . . . 30.45 111.7 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.9 m -76.0 87.67 2.94 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.908 -0.404 . . . . 29.01 109.908 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.2 t -78.21 77.09 4.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.286 0.565 . . . . 27.14 109.841 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.29 66.39 1.54 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.843 -0.799 . . . . 25.83 108.843 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -143.09 133.53 24.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.162 -0.926 . . . . 23.8 110.119 -176.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -96.9 152.43 18.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.381 -0.372 . . . . 22.03 110.828 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.2 p -98.18 108.27 46.04 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.265 -0.425 . . . . 19.63 110.356 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.04 96.45 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.668 2.245 . . . . 17.86 112.937 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -86.06 51.27 2.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.135 -0.938 . . . . 17.61 110.192 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -124.06 36.72 4.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.653 -0.703 . . . . 15.63 110.578 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.06 34.25 75.86 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.629 -0.796 . . . . 12.12 111.327 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.1 t -105.61 134.76 19.55 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.887 -0.412 . . . . 10.78 109.887 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.59 87.77 1.23 Allowed 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.643 2.229 . . . . 10.17 112.144 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -104.49 107.25 18.09 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.41 -0.814 . . . . 7.8 110.46 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -92.89 104.79 16.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.453 -0.34 . . . . 8.14 110.128 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.77 144.19 87.96 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 116.211 -0.45 . . . . 6.11 109.9 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -40.52 -70.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.697 2.931 . . . . 6.51 113.94 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.1 p -110.76 -31.17 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.068 -0.515 . . . . 6.76 111.608 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -73.2 106.91 5.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.215 0.531 . . . . 5.18 111.293 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.519 ' O ' HD13 ' A' ' 74' ' ' ILE . 1.9 pp -79.6 141.96 56.9 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.72 -0.673 . . . . 4.5 110.981 174.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.86 4.65 6.29 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 122.953 2.435 . . . . 4.4 113.009 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.414 ' HB2' HD12 ' A' ' 74' ' ' ILE . 10.0 mm-40 -64.45 -61.25 2.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.201 -0.454 . . . . 3.91 110.02 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.1 t70 62.91 78.99 0.27 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.025 -0.989 . . . . 3.16 110.773 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.6 mt -85.5 125.55 69.2 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.289 -0.868 . . . . 2.82 110.196 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.01 115.94 3.87 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.177 1.918 . . . . 2.04 112.238 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.77 146.57 62.39 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.64 -0.504 . . . . 1.53 109.64 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.38 137.81 81.58 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.801 2.334 . . . . 0.88 111.667 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.421 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -65.26 -12.17 48.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.654 0.612 . . . . 1.58 112.654 -173.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -84.9 -7.52 59.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.805 0.336 . . . . 1.66 111.473 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.49 ' CZ ' HD23 ' A' ' 110' ' ' LEU . 17.9 m-85 -120.14 161.76 20.48 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.23 -1.026 . . . . 1.2 108.23 170.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.401 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 5.9 tp10 -133.51 120.19 20.5 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.749 -0.78 . . . . 2.27 111.435 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.2 tt -84.28 126.67 33.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.999 -0.741 . . . . 1.37 108.999 177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -148.61 149.26 31.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.842 -0.617 . . . . 3.75 110.726 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.32 111.99 18.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.653 -0.869 . . . . 2.46 108.653 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.2 m -149.13 81.51 1.43 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.082 -0.508 . . . . 2.03 109.809 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.4 m -65.48 104.63 1.02 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.121 -0.49 . . . . 2.18 110.875 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.503 HG22 ' HB1' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -106.02 117.63 57.08 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.128 -0.487 . . . . 1.96 109.791 177.032 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.58 122.57 11.81 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.16 2.573 . . . . 1.87 112.678 -176.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.97 -16.46 36.19 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.711 -0.677 . . . . 1.74 111.958 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.503 ' HB1' HG22 ' A' ' 91' ' ' ILE . . . -131.63 -59.78 0.95 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.931 0.396 . . . . 1.79 111.277 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.9 -127.85 7.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.954 -0.641 . . . . 1.14 112.198 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.434 HD13 ' CD1' ' A' ' 171' ' ' TYR . 0.6 OUTLIER -89.53 159.79 17.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.677 -0.12 . . . . 2.81 110.677 176.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -161.96 172.51 38.13 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.586 -0.605 . . . . 0.8 111.586 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.9 m -115.72 130.76 69.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.586 0.708 . . . . 1.17 109.79 175.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -98.11 109.17 21.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.255 -0.43 . . . . 1.4 110.498 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -64.52 116.29 6.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 1.2 109.758 176.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.462 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -79.06 -2.8 42.15 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.453 0.644 . . . . 2.23 110.439 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.442 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 41.1 ttp180 -127.41 155.78 43.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.257 -0.883 . . . . 4.08 108.823 175.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.645 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -82.8 156.59 23.59 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.829 -0.434 . . . . 2.86 109.829 176.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.615 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -127.18 152.32 47.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.323 -0.399 . . . . 1.38 110.476 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 10.4 pt-20 -105.48 173.67 6.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.394 0.616 . . . . 2.31 111.975 -170.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.93 127.29 30.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.247 -0.888 . . . . 1.42 112.656 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.23 0.77 67.46 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.101 -0.571 . . . . 1.04 113.544 170.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 1.6 pt-20 -87.14 168.41 13.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.439 0.619 . . . . 2.62 111.09 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 3.8 tmm_? -127.52 133.03 49.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.93 -0.577 . . . . 4.16 112.094 -173.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.49 HD23 ' CZ ' ' A' ' 84' ' ' PHE . 7.7 mt -86.63 142.07 28.51 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.77 -0.826 . . . . 1.11 108.77 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.64 -128.05 7.63 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.4 -0.905 . . . . 1.09 112.618 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.441 ' O ' ' HA3' ' A' ' 166' ' ' GLY . 57.2 Cg_endo -68.35 145.6 76.59 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.829 -1.321 . . . . 2.52 112.761 2.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t -73.5 -26.46 60.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.618 -0.719 . . . . 2.5 110.962 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.474 ' HB ' ' H ' ' A' ' 192' ' ' ILE . 70.9 t -138.15 131.01 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.113 -0.494 . . . . 2.46 110.336 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.5 t -65.78 133.96 30.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 4.37 109.616 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.1 t -56.71 113.64 6.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 O-C-N 123.503 0.502 . . . . 5.65 111.675 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.47 145.57 59.24 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.732 2.288 . . . . 5.38 111.237 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.404 ' HB2' ' OD1' ' A' ' 134' ' ' ASP . 6.1 mpt_? -71.69 -34.96 70.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.086 -0.506 . . . . 8.57 111.143 -174.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -162.02 75.66 0.47 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.195 -0.457 . . . . 7.27 110.649 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -99.43 159.43 15.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.356 -0.384 . . . . 6.4 111.561 -177.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.84 95.46 2.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.69 -0.686 . . . . 5.88 110.021 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -53.71 131.42 39.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.841 0.829 . . . . 7.76 111.899 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -72.83 -66.94 0.6 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.455 -1.248 . . . . 9.01 110.68 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.4 m -83.71 -76.96 0.27 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.731 -0.668 . . . . 9.14 110.53 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.5 t70 179.74 -56.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.681 -0.859 . . . . 7.6 108.681 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -153.23 159.47 42.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.26 -1.336 . . . . 8.0 107.775 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.45 40.02 94.28 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.461 -0.876 . . . . 4.59 112.094 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . 0.533 ' HE3' ' N ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -89.13 -95.41 0.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.63 0.252 . . . . 4.93 111.334 -178.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.533 ' N ' ' HE3' ' A' ' 128' ' ' TRP . 12.0 pt-20 -161.9 -45.75 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.955 -0.758 . . . . 7.65 108.955 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.442 ' HA ' ' OE1' ' A' ' 130' ' ' GLN . 6.4 tp60 176.34 131.79 0.05 OUTLIER 'General case' 0 CA--C 1.523 -0.074 0 CA-C-N 115.36 -0.836 . . . . 9.61 109.022 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.557 ' H ' HD11 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -109.67 -1.84 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.622 -0.431 . . . . 6.05 110.955 176.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.6 mp -81.78 62.58 5.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.744 0.783 . . . . 8.5 110.134 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 19.4 p -128.05 30.24 5.27 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.649 -1.159 . . . . 9.82 110.484 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.404 ' OD1' ' HB2' ' A' ' 118' ' ' ARG . 3.3 p30 -73.27 127.76 33.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.817 -0.629 . . . . 11.21 111.231 -177.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.8 p -68.35 138.15 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.356 -0.838 . . . . 10.92 110.677 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -71.18 119.1 14.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.44 -0.8 . . . . 13.25 111.179 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.2 p -79.12 -22.78 12.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.854 0.835 . . . . 14.01 108.857 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.8 m -144.99 94.61 5.32 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.892 -1.049 . . . . 14.1 108.887 173.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -35.21 124.1 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.811 3.674 . . . . 14.7 114.738 -173.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -104.66 -6.29 20.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.139 -0.937 . . . . 14.44 109.095 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -46.22 121.58 3.42 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.1 -0.955 . . . . 15.9 111.162 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 135.89 -41.04 1.47 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.18 -0.768 . . . . 16.0 111.18 -174.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 23.7 p -101.12 31.06 3.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.461 0.648 . . . . 15.6 110.938 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 61.4 mt -112.26 -65.82 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.516 -0.766 . . . . 14.1 109.595 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.2 p -88.14 43.18 1.11 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.543 0.687 . . . . 13.19 110.318 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -77.73 -13.04 60.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.215 -0.902 . . . . 15.92 110.097 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.7 pp -110.13 161.81 8.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.981 -1.008 . . . . 14.07 110.64 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.8 t -104.91 55.3 0.7 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.685 0.755 . . . . 13.67 110.459 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -93.4 59.18 2.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.592 -0.892 . . . . 13.02 108.592 172.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -88.39 80.95 7.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.516 -1.22 . . . . 14.68 110.578 -172.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -91.9 10.1 30.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.465 -0.789 . . . . 13.55 111.714 -178.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.484 ' HA2' ' CD1' ' A' ' 156' ' ' PHE . . . -97.58 12.79 64.58 Favored Glycine 0 C--N 1.317 -0.483 0 C-N-CA 120.78 -0.724 . . . . 15.8 112.771 -175.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.7 m -88.46 -39.09 14.49 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.901 0.381 . . . . 17.08 110.703 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -110.58 -78.79 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 18.43 111.372 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -137.95 133.84 34.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.895 0.379 . . . . 18.74 110.252 -177.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.485 ' HB3' ' O ' ' A' ' 151' ' ' LEU . 38.8 p90 -151.06 167.6 27.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.144 0.497 . . . . 14.81 111.302 -176.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 34.5 m -133.47 122.32 23.49 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.621 -0.881 . . . . 14.64 108.621 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.9 t -69.85 129.37 34.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.274 -0.269 . . . . 13.38 110.274 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 60.55 54.05 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.563 0.697 . . . . 10.61 110.997 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -119.56 -60.96 1.67 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.146 -0.933 . . . . 10.22 109.995 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -81.44 -27.96 34.42 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.221 0.534 . . . . 10.69 109.655 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -71.86 -21.4 61.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.402 -0.817 . . . . 9.45 109.616 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.448 ' C ' ' HB2' ' A' ' 167' ' ' SER . . . -90.53 61.45 4.92 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.439 -0.801 . . . . 6.56 110.269 176.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -126.67 -61.8 0.15 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.812 -0.709 . . . . 4.17 111.75 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.28 101.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.12 0.486 . . . . 3.14 110.716 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 112' ' ' PRO . . . 90.69 -37.55 3.36 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.756 -0.656 . . . . 1.69 112.354 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.448 ' HB2' ' C ' ' A' ' 163' ' ' ALA . 15.8 m -69.26 -14.54 63.01 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.885 0.328 . . . . 2.0 111.885 -177.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.426 ' O ' ' HD2' ' A' ' 171' ' ' TYR . 64.9 p-90 -56.46 -17.27 7.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.159 0.504 . . . . 0.83 111.307 176.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.496 HD11 ' CD1' ' A' ' 194' ' ' TYR . 24.8 mt -64.49 -12.79 47.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.309 -0.405 . . . . 1.28 111.876 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -11.84 26.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.76 0.314 . . . . 2.03 110.754 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.434 ' CD1' HD13 ' A' ' 96' ' ' LEU . 36.8 m-85 -77.95 -36.96 48.59 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.27 -0.423 . . . . 2.19 111.312 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.545 ' HA ' ' OE1' ' A' ' 205' ' ' GLU . 0.5 OUTLIER -59.58 137.01 22.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 120.827 -0.349 . . . . 1.24 110.483 -174.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.452 ' CB ' ' HB3' ' A' ' 94' ' ' ALA . 41.7 mmt-85 -112.18 -177.52 3.19 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.851 0.686 . . . . 4.97 112.851 -175.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 41.5 t -76.56 158.87 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 114.954 -1.021 . . . . 1.63 110.488 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.479 ' HB1' ' CD1' ' A' ' 183' ' ' LEU . . . -55.52 113.73 1.56 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.241 -0.436 . . . . 1.34 111.816 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 28.1 t -72.05 -20.64 61.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 2.58 109.622 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.3 t -126.02 139.74 53.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.686 -0.688 . . . . 2.06 109.318 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 59.7 m -75.54 -33.41 60.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.107 0.78 . . . . 2.69 113.107 -168.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -88.33 -13.29 41.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.351 0.596 . . . . 2.42 110.58 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -82.57 19.29 1.31 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.529 -0.76 . . . . 2.12 112.033 -176.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.557 ' HA ' HE21 ' A' ' 181' ' ' GLN . 0.0 OUTLIER -53.42 113.85 1.3 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.022 0.439 . . . . 1.52 110.759 -176.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.608 ' ND2' HG13 ' A' ' 200' ' ' ILE . 32.3 t30 -140.21 23.62 2.36 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 122.325 1.059 . . . . 1.68 108.94 174.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.627 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 1.0 OUTLIER -109.17 117.39 34.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.598 -0.728 . . . . 1.43 110.36 -172.244 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.1 m -149.1 135.07 18.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.056 0.455 . . . . 1.2 110.528 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.431 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 72.6 mtp -128.74 137.07 51.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.139 -0.482 . . . . 1.56 110.072 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 16.3 t -114.41 158.12 21.97 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.848 -0.614 . . . . 2.13 109.496 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.526 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 22.7 tm0? -122.88 105.19 9.79 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.134 -0.691 . . . . 1.96 109.134 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.611 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 34.9 pt -133.13 140.58 46.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.975 -0.557 . . . . 1.62 110.524 -175.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.1 m 53.78 26.24 5.84 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.394 0.434 . . . . 2.24 111.963 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.526 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 6.3 mm-40 63.4 25.41 14.56 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.595 -0.73 . . . . 2.83 112.049 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.611 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.1 pt20 -117.28 157.65 25.7 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.128 -0.693 . . . . 1.86 109.128 172.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.474 ' H ' ' HB ' ' A' ' 114' ' ' VAL . 49.5 mm -89.13 121.93 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.16 0.505 . . . . 1.59 110.564 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.633 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 45.5 t80 -114.57 121.27 42.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.365 -0.834 . . . . 4.16 110.377 -172.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.685 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 11.4 m-85 -99.65 112.81 25.0 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.374 -0.602 . . . . 1.27 109.374 177.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -116.0 122.93 46.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.844 0.354 . . . . 1.73 110.906 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.563 HG13 ' SD ' ' A' ' 104' ' ' MET . 0.2 OUTLIER -90.46 149.84 3.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.438 0.637 . . . . 1.33 109.879 178.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 182' ' ' ASN . 1.3 mt -103.06 -30.11 2.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.165 -0.925 . . . . 1.23 112.009 -168.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 27.5 pttt -151.59 -179.91 7.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.137 -0.483 . . . . 1.88 111.736 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.615 ' HA ' ' O ' ' A' ' 104' ' ' MET . 17.2 t70 -82.65 131.24 35.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.32 -0.854 . . . . 2.23 110.508 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.608 HG13 ' ND2' ' A' ' 182' ' ' ASN . 43.9 mm -121.97 154.63 26.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.192 -0.458 . . . . 1.41 111.15 -173.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -78.62 120.97 82.95 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 2.06 109.85 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.3 123.7 12.56 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.025 2.483 . . . . 0.56 112.419 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.62 -1.67 10.23 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.636 -0.792 . . . . 0.7 113.097 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -136.27 123.95 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 1.27 110.649 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.545 ' OE1' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -108.83 116.09 31.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.889 -0.596 . . . . 2.92 111.415 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.498 ' C ' HD22 ' A' ' 207' ' ' LEU . 4.7 mp -126.22 99.56 5.93 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.365 -0.534 . . . . 1.51 110.297 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.529 ' HB2' HG22 ' A' ' 172' ' ' ILE . 2.4 mm? -147.76 112.59 5.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.654 0.782 . . . . 1.16 109.58 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.627 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 7.8 p -155.99 158.01 3.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.621 -0.432 . . . . 1.5 111.199 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.431 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 27.9 t-80 -114.24 110.1 19.42 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.825 -0.806 . . . . 1.77 108.825 170.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 45.0 t -104.22 96.65 4.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.842 -0.429 . . . . 3.05 109.842 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -65.95 150.06 49.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.32 -0.4 . . . . 5.7 109.986 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -61.22 82.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 O-C-N 124.063 0.852 . . . . 5.8 112.49 -172.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.83 33.28 86.52 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 114.984 -1.007 . . . . 5.61 113.128 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 53.6 t -93.75 -83.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.949 -0.3 . . . . 6.31 110.899 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.551 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 71.5 m-85 -83.59 -50.12 0.68 Allowed Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 112.266 0.469 . . . . 9.04 112.266 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 18.2 Cg_endo -59.01 -44.6 33.82 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.062 1.841 . . . . 7.78 112.893 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.0 mp -92.16 -30.36 15.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.838 0.351 . . . . 8.02 111.357 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 74.48 24.95 71.55 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.174 -0.536 . . . . 8.64 112.878 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 8.6 p -97.02 55.0 1.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.057 0.456 . . . . 9.96 111.158 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.45 107.76 38.54 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.892 -0.594 . . . . 9.62 111.374 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.03 116.59 4.77 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.4 2.067 . . . . 12.02 112.047 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.06 66.84 7.81 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.981 2.454 . . . . 13.11 112.422 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.26 46.49 5.83 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.628 -0.796 . . . . 14.03 111.622 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 32.9 tp -145.12 120.83 10.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.962 0.41 . . . . 16.32 110.242 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -136.83 -38.08 0.65 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.997 -0.547 . . . . 17.7 110.045 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.25 1.102 0 CA-C-N 115.627 -0.715 . . . . 18.9 110.491 -178.689 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 111.658 -0.577 . . . . 33.41 111.658 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.3 p -94.87 -38.71 10.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.92 0.39 . . . . 34.1 110.541 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.66 141.02 15.35 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.023 -0.608 . . . . 32.51 112.066 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 52.49 67.86 3.59 Favored Pre-proline 0 C--O 1.233 0.231 0 C-N-CA 122.672 0.389 . . . . 31.98 110.91 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.61 -151.05 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.07 2.513 . . . . 30.45 112.406 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -60.98 -40.63 94.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.056 0.455 . . . . 29.01 111.255 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.7 m -126.09 104.34 8.2 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.149 -0.478 . . . . 27.14 110.411 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -127.65 152.38 47.75 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.804 -0.443 . . . . 25.83 109.804 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -160.9 175.09 12.91 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.078 -0.342 . . . . 23.8 110.078 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -144.51 49.08 1.33 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.957 0.884 . . . . 22.03 108.633 172.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.9 p -64.73 134.02 95.9 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.641 -1.163 . . . . 19.63 110.5 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -60.84 101.82 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.719 2.279 . . . . 17.86 112.664 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -88.66 -13.46 39.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.547 -0.751 . . . . 17.61 109.703 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.05 129.73 40.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.282 -0.872 . . . . 15.63 109.747 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 68' ' ' TYR . . . 89.33 -12.4 66.72 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.498 -0.858 . . . . 12.12 112.087 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.454 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 48.0 t -66.97 -53.29 26.87 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 110.071 -0.344 . . . . 10.78 110.071 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 66' ' ' SER . 96.3 Cg_endo -80.66 68.18 8.4 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.419 1.413 . . . . 10.17 110.036 167.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 72.6 t80 -73.86 130.56 40.15 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.312 -1.313 . . . . 7.8 110.502 -173.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.15 84.19 1.02 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.224 0.535 . . . . 8.14 109.746 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.18 140.17 39.48 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.407 -0.815 . . . . 6.11 110.51 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.425 ' HB2' ' H ' ' A' ' 72' ' ' VAL . 88.9 Cg_exo -46.63 -75.55 0.03 OUTLIER 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.399 2.732 . . . . 6.51 113.708 -177.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.425 ' H ' ' HB2' ' A' ' 71' ' ' PRO . 9.3 p -83.9 -31.91 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.294 -0.412 . . . . 6.76 111.568 -176.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -72.73 119.66 17.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.071 0.462 . . . . 5.18 110.66 -177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.488 ' O ' HD13 ' A' ' 74' ' ' ILE . 2.2 pp -81.11 147.34 60.89 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.808 -0.633 . . . . 4.5 111.166 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -86.75 27.64 0.57 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.088 2.525 . . . . 4.4 112.975 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -96.84 -71.9 0.66 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.558 -0.534 . . . . 3.91 109.558 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.2 t70 49.36 70.63 0.46 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.154 -0.93 . . . . 3.16 111.444 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 67.7 mt -76.04 129.01 81.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.574 -0.739 . . . . 2.82 110.102 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.03 122.5 11.49 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.851 2.368 . . . . 2.04 112.722 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.415 HD13 ' H ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -127.38 149.3 69.5 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.843 -0.617 . . . . 1.53 109.758 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.74 143.14 99.35 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.635 2.223 . . . . 0.88 111.857 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.568 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -68.25 -5.19 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.34 0.496 . . . . 1.58 112.34 -173.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -87.56 -4.48 58.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.896 0.379 . . . . 1.66 110.928 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.497 ' CZ ' HD23 ' A' ' 110' ' ' LEU . 11.7 m-85 -138.38 147.96 43.98 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.173 -0.677 . . . . 1.2 109.173 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.437 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 12.2 tp10 -118.36 122.72 43.54 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 121.048 -0.261 . . . . 2.27 110.642 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.9 tt -87.43 124.16 33.13 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.388 0.613 . . . . 1.37 109.578 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.501 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 90.3 mtt-85 -143.39 127.05 17.03 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.13 -0.941 . . . . 3.75 109.689 -175.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.01 110.73 4.6 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.344 -0.613 . . . . 2.46 109.344 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.8 m -157.8 115.47 3.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.266 -0.642 . . . . 2.03 109.266 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.2 m -89.84 105.35 17.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.766 0.317 . . . . 2.18 110.97 -177.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.465 HG22 ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -91.62 118.59 68.43 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.818 -0.808 . . . . 1.96 108.818 173.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.99 121.36 9.75 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.098 2.532 . . . . 1.87 112.553 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.65 -23.36 24.37 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.722 -0.672 . . . . 1.74 112.369 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.465 ' HB2' HG22 ' A' ' 91' ' ' ILE . . . -122.63 -63.0 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.962 0.381 . . . . 1.79 111.082 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.76 -134.12 8.11 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.962 -0.637 . . . . 1.14 111.952 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.9 mt -89.18 159.48 17.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.398 -0.223 . . . . 2.81 110.398 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -157.68 164.96 33.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.702 -0.761 . . . . 0.8 111.944 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.531 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 33.8 m -101.25 117.18 46.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.766 0.793 . . . . 1.17 110.071 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.501 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 27.1 m95 -82.73 110.01 17.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.355 -0.839 . . . . 1.4 110.623 -171.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.22 115.2 3.94 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.882 -0.414 . . . . 1.2 109.882 176.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.568 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -81.8 -6.07 58.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.405 0.621 . . . . 2.23 109.849 178.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -129.61 160.75 32.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.033 -0.985 . . . . 4.08 108.688 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.596 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -92.79 158.48 15.86 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 120.87 0.367 . . . . 2.86 110.475 -178.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 55.0 mtm -131.89 153.02 50.66 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.167 -0.679 . . . . 1.38 109.167 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -105.64 137.57 43.28 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.353 0.408 . . . . 2.31 110.855 -176.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -38.25 115.18 0.42 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.679 1.237 . . . . 1.42 112.959 -173.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.67 6.96 14.07 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.379 -0.828 . . . . 1.04 111.034 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.471 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -73.6 165.68 24.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.196 0.522 . . . . 2.62 110.761 -178.275 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -145.68 134.7 22.64 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.923 -0.58 . . . . 4.16 110.959 -175.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.497 HD23 ' CZ ' ' A' ' 84' ' ' PHE . 8.1 mt -98.05 135.01 40.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.942 -0.762 . . . . 1.11 108.942 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.79 167.29 38.48 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.423 -0.894 . . . . 1.09 112.21 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.41 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 6.2 Cg_exo -79.15 155.78 91.0 Favored 'Cis proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.307 -1.539 . . . . 2.52 112.0 -2.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.9 t -110.43 4.47 20.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.501 0.667 . . . . 2.5 109.846 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.5 m -83.18 157.24 3.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.471 -0.786 . . . . 2.46 110.695 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.2 87.91 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.478 0.656 . . . . 4.37 110.72 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.444 ' HB ' ' HD3' ' A' ' 117' ' ' PRO . 20.9 t -60.59 -51.61 78.59 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.701 -0.681 . . . . 5.65 111.752 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.444 ' HD3' ' HB ' ' A' ' 116' ' ' VAL . 66.0 Cg_endo -73.52 75.18 3.05 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.837 1.691 . . . . 5.38 111.66 174.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.462 ' NH2' ' HG2' ' A' ' 136' ' ' GLU . 76.5 mtm-85 -66.06 -36.48 83.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.83 -0.623 . . . . 8.57 110.294 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 48.75 76.66 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.12 0.887 . . . . 7.27 111.438 175.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 67.0 104.38 0.04 OUTLIER 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.628 -0.714 . . . . 6.4 110.637 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -52.11 126.08 17.54 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.528 -0.76 . . . . 5.88 111.148 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.535 ' HZ1' ' HB3' ' A' ' 122' ' ' LYS . 0.3 OUTLIER -70.06 167.14 18.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.675 -0.693 . . . . 7.76 111.107 -177.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -50.4 -55.31 16.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.527 -0.76 . . . . 9.01 111.752 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.2 m -128.93 -89.2 0.51 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.229 -0.286 . . . . 9.14 110.229 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.441 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 39.0 t0 -177.29 157.81 1.38 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.066 0.46 . . . . 7.6 110.561 176.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -123.81 -7.95 7.87 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.419 -0.809 . . . . 8.0 109.125 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -87.99 -68.63 1.29 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.208 -0.905 . . . . 4.59 112.876 -174.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . 0.611 ' CE3' ' HG2' ' A' ' 129' ' ' GLU . 6.5 p-90 -140.55 -35.27 0.5 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.386 0.884 . . . . 4.93 113.386 -171.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.611 ' HG2' ' CE3' ' A' ' 128' ' ' TRP . 9.3 pt-20 -177.3 -35.01 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.182 0.446 . . . . 7.65 111.342 174.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.46 ' CG ' ' HG ' ' A' ' 132' ' ' LEU . 28.0 tt0 -179.27 97.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.187 -0.671 . . . . 9.61 109.187 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.449 HD11 ' HG2' ' A' ' 122' ' ' LYS . 1.8 pp -76.51 -8.33 11.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.055 0.455 . . . . 6.05 111.315 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.46 ' HG ' ' CG ' ' A' ' 130' ' ' GLN . 0.3 OUTLIER -88.72 66.85 8.21 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.138 0.97 . . . . 8.5 109.812 176.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.0 t -113.23 23.4 13.33 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.506 -1.224 . . . . 9.82 109.465 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -155.84 125.7 6.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.063 -0.971 . . . . 11.21 110.139 -174.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.422 HG11 HG13 ' A' ' 137' ' ' VAL . 12.6 p -81.02 136.57 22.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.022 0.439 . . . . 10.92 110.302 176.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.462 ' HG2' ' NH2' ' A' ' 118' ' ' ARG . 4.2 mm-40 -77.14 85.7 3.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.025 0.441 . . . . 13.25 111.164 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.422 HG13 HG11 ' A' ' 135' ' ' VAL . 26.5 m -77.23 -23.01 14.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.869 -0.605 . . . . 14.01 109.393 173.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.7 m 53.58 89.08 0.11 Allowed Pre-proline 0 C--O 1.235 0.322 0 O-C-N 124.119 0.887 . . . . 14.1 111.581 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.35 77.9 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.136 2.557 . . . . 14.7 111.763 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -151.0 50.08 0.85 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.708 -0.678 . . . . 14.44 110.186 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -64.93 118.71 9.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.556 -0.747 . . . . 15.9 110.505 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.65 -61.34 4.5 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.853 -0.689 . . . . 16.0 111.836 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 3.9 p -88.44 87.68 7.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.036 0.446 . . . . 15.6 110.568 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 50.4 mm -65.66 -37.24 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.519 . . . . 14.1 110.382 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.2 t -123.42 113.31 18.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.481 0.658 . . . . 13.19 110.45 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -99.54 -11.02 21.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.514 0.673 . . . . 15.92 109.657 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.41 ' H ' HG13 ' A' ' 147' ' ' ILE . 2.8 pp -86.56 157.67 3.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.013 -0.994 . . . . 14.07 111.581 -174.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.9 m -132.24 70.91 1.46 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.038 -0.727 . . . . 13.67 109.038 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.55 156.28 46.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.873 -0.603 . . . . 13.02 111.313 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -136.94 135.97 38.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.379 -0.828 . . . . 14.68 109.267 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.15 38.93 0.9 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.328 0.585 . . . . 13.55 111.131 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -166.76 -139.56 2.69 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.738 -0.744 . . . . 15.8 112.01 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.7 m -145.46 -47.57 0.22 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.24 0.543 . . . . 17.08 109.903 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.54 -66.49 0.93 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.674 -0.693 . . . . 18.43 109.874 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.52 ' H ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -116.4 138.0 51.71 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.166 -0.925 . . . . 18.74 109.89 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -153.32 26.67 0.52 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.8 0.81 . . . . 14.81 110.491 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 6.4 p -90.17 -13.8 34.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.114 -0.948 . . . . 14.64 110.837 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 37.4 t -99.62 139.4 21.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.034 -0.53 . . . . 13.38 109.64 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.64 57.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.172 0.511 . . . . 10.61 110.986 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.94 -58.84 3.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.596 -0.729 . . . . 10.22 110.445 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -89.22 34.74 0.8 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.44 0.638 . . . . 10.69 110.567 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -138.99 -62.11 0.55 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.647 -0.706 . . . . 9.45 110.116 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 58.48 40.13 24.3 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.205 0.526 . . . . 6.56 111.551 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.0 -141.68 42.0 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.827 -0.624 . . . . 4.17 112.538 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -136.66 12.88 3.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.832 0.349 . . . . 3.14 110.583 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . -124.3 0.01 8.8 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.71 -0.757 . . . . 1.69 113.199 -177.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 17.4 t -73.4 -15.39 61.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.023 0.44 . . . . 2.0 110.732 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.441 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 10.6 p-90 -72.77 -23.46 60.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.316 -0.402 . . . . 0.83 111.521 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.441 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 29.0 mt -86.09 -15.47 41.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.482 0.549 . . . . 1.28 112.482 -174.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -78.74 -4.65 50.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.271 -0.572 . . . . 2.03 110.381 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -77.84 -37.71 47.83 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.196 -0.457 . . . . 2.19 110.996 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.737 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -70.03 120.77 18.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.818 -0.438 . . . . 1.24 109.818 177.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -113.15 -168.68 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 4.97 112.033 -173.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.49 ' HA ' HG11 ' A' ' 208' ' ' VAL . 43.8 t -62.57 142.27 16.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 115.795 -0.639 . . . . 1.63 111.436 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.46 148.03 39.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.292 -0.867 . . . . 1.34 111.883 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 48.7 t -86.21 -8.94 57.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.373 -0.83 . . . . 2.58 110.122 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.5 t -143.98 145.22 32.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.971 -0.559 . . . . 2.06 111.208 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 78.1 m -83.2 -15.82 48.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.642 -0.708 . . . . 2.69 110.298 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -81.85 -25.73 34.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.617 0.722 . . . . 2.42 110.187 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -96.42 18.28 14.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.343 -0.844 . . . . 2.12 111.815 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -59.14 114.19 2.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.183 0.516 . . . . 1.52 111.547 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.668 ' H ' HD13 ' A' ' 183' ' ' LEU . 4.7 p-10 -152.01 29.74 0.58 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.007 -0.997 . . . . 1.68 109.202 170.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.679 ' HG ' ' C ' ' A' ' 206' ' ' LEU . 1.5 mp -112.03 118.95 36.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.93 -1.032 . . . . 1.43 109.13 -175.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 86.4 m -150.08 148.23 28.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.437 0.637 . . . . 1.2 112.589 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.43 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 28.0 tpp -97.45 145.64 25.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.255 -0.884 . . . . 1.56 111.411 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 41.7 t -129.93 131.47 45.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 2.13 110.267 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -123.05 105.78 10.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.588 -0.523 . . . . 1.96 109.588 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 24.2 pt -142.67 144.01 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.847 -0.615 . . . . 1.62 110.502 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.4 m 61.85 35.43 16.53 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.463 -0.335 . . . . 2.24 111.772 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 66.61 3.91 3.13 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.88 -0.6 . . . . 2.83 111.721 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -120.61 163.74 17.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.083 0.468 . . . . 1.86 110.421 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.8 mm -107.08 136.11 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.872 -0.604 . . . . 1.59 111.196 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -138.14 156.44 47.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.029 -0.532 . . . . 4.16 110.917 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.549 ' CD2' ' HB3' ' A' ' 207' ' ' LEU . 2.4 m-30 -101.1 114.43 28.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.761 -0.654 . . . . 1.27 109.823 175.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -102.39 124.41 47.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.009 0.433 . . . . 1.73 110.178 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.471 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 0.9 OUTLIER -100.19 152.83 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.545 0.688 . . . . 1.33 110.38 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.532 HG13 ' HA ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -92.8 -41.04 12.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.813 -1.085 . . . . 1.23 112.471 -168.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.34 164.8 27.26 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.086 0.402 . . . . 1.88 112.086 -171.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 104' ' ' MET . 5.3 t70 -49.7 112.26 0.63 Allowed 'General case' 0 C--O 1.233 0.187 0 O-C-N 124.481 1.113 . . . . 2.23 110.671 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.444 HG13 ' HE2' ' A' ' 104' ' ' MET . 28.5 mm -83.13 129.2 37.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.104 -0.498 . . . . 1.41 110.868 -176.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 45.0 mt-10 -83.57 136.16 42.75 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.924 -0.58 . . . . 2.06 109.58 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.14 113.68 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.18 1.92 . . . . 0.56 111.71 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.17 -4.9 10.38 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.595 -0.812 . . . . 0.7 113.643 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.3 pt-20 -112.74 121.66 45.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.001 0.9 . . . . 1.27 111.037 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -110.6 93.79 4.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.553 -0.749 . . . . 2.92 111.658 177.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.679 ' C ' ' HG ' ' A' ' 183' ' ' LEU . 2.7 mm? -124.19 99.09 6.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.548 -0.461 . . . . 1.51 110.222 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.737 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -147.78 119.0 7.76 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.695 0.398 . . . . 1.16 110.074 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.576 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 7.4 p -154.12 157.8 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.285 -0.566 . . . . 1.5 111.473 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 16.4 t-80 -115.13 110.87 20.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.385 -0.968 . . . . 1.77 108.385 163.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 66.6 t -75.44 99.12 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.24 0.543 . . . . 3.05 110.051 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm -79.33 121.24 24.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.517 -0.765 . . . . 5.7 110.709 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -98.74 3.69 47.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.427 -0.806 . . . . 5.8 111.696 -170.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -174.66 56.09 0.13 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.335 -0.936 . . . . 5.61 112.647 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.611 ' O ' ' HA3' ' A' ' 218' ' ' GLY . 39.3 t -124.7 -78.18 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.827 0.346 . . . . 6.31 110.292 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.459 ' H ' ' HD2' ' A' ' 216' ' ' PRO . 18.1 t80 -102.31 -57.41 0.1 Allowed Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.357 -0.383 . . . . 9.04 110.584 173.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' A' ' 215' ' ' TYR . 35.2 Cg_endo -64.08 -46.82 7.44 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 121.574 1.516 . . . . 7.78 112.404 -172.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -108.68 16.82 22.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.532 -0.544 . . . . 8.02 109.532 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.611 ' HA3' ' O ' ' A' ' 214' ' ' VAL . . . -94.31 -141.5 11.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.585 -0.817 . . . . 8.64 113.292 -172.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.4 t -101.12 62.52 0.97 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.76 0.79 . . . . 9.96 110.414 -175.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.54 ' O ' ' HD3' ' A' ' 222' ' ' PRO . 33.0 m -117.07 153.05 49.56 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.384 -0.826 . . . . 9.62 110.164 176.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -94.73 98.04 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.274 2.649 . . . . 12.02 112.202 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 220' ' ' VAL . 93.8 Cg_endo -87.43 9.49 3.86 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.798 2.332 . . . . 13.11 112.642 -177.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -139.59 40.33 1.43 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.279 -0.729 . . . . 14.03 111.279 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.7 tt -88.54 127.95 35.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.978 0.418 . . . . 16.32 110.298 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -123.94 -50.11 1.83 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.979 -0.555 . . . . 17.7 109.528 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.641 -0.695 . . . . 18.9 109.327 175.645 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.713 0 N-CA-C 111.713 -0.555 . . . . 33.41 111.713 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.0 p -75.78 121.52 22.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.721 0.296 . . . . 34.1 110.744 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.05 110.9 3.32 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.603 -0.808 . . . . 32.51 112.535 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -118.18 100.71 51.78 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 110.094 -0.335 . . . . 31.98 110.094 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.03 -8.31 17.65 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.4 2.067 . . . . 30.45 111.835 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.441 HG23 ' OD2' ' A' ' 59' ' ' ASP . 61.9 m -148.36 129.49 14.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.675 -0.693 . . . . 29.01 109.986 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.0 p -141.48 63.36 1.44 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.1 0.476 . . . . 27.14 110.951 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 60.57 73.9 0.47 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.281 -0.872 . . . . 25.83 110.823 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.441 ' OD2' HG23 ' A' ' 56' ' ' THR . 19.7 m-20 -65.83 129.67 40.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.663 -0.699 . . . . 23.8 110.865 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -99.11 123.3 43.31 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.409 -0.589 . . . . 22.03 109.409 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.7 p -94.31 113.42 60.79 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.739 0.304 . . . . 19.63 110.998 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.96 135.78 38.99 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.653 2.235 . . . . 17.86 112.359 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -78.81 160.58 27.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.482 -0.781 . . . . 17.61 111.183 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -123.49 45.07 2.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.081 -0.508 . . . . 15.63 109.801 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.09 67.46 0.48 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.847 -0.692 . . . . 12.12 112.572 -176.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.7 t -121.51 118.42 29.77 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.467 -0.568 . . . . 10.78 109.467 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -62.8 110.88 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.748 2.298 . . . . 10.17 112.222 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -115.81 102.6 9.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.585 -0.524 . . . . 7.8 109.585 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -70.02 145.46 51.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.978 -0.555 . . . . 8.14 110.162 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.04 115.61 30.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.067 -0.515 . . . . 6.11 110.853 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.63 -157.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.967 2.444 . . . . 6.51 112.835 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.06 -41.54 93.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 6.76 110.977 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -98.07 107.13 19.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.928 0.394 . . . . 5.18 110.123 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 74' ' ' ILE . 2.4 pp -86.19 139.88 34.46 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.696 -0.483 . . . . 4.5 109.696 173.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -76.93 21.97 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.924 2.416 . . . . 4.4 113.582 -173.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -99.38 -68.95 0.78 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.812 -0.44 . . . . 3.91 109.812 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t70 59.68 89.54 0.06 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.395 -0.821 . . . . 3.16 110.561 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.5 mt -80.12 122.64 83.22 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.594 -0.73 . . . . 2.82 110.693 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.25 115.88 3.55 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.184 1.922 . . . . 2.04 111.572 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.504 ' H ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -113.63 155.93 44.25 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.039 -0.528 . . . . 1.53 110.03 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.63 154.86 66.48 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.753 2.302 . . . . 0.88 111.862 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 -10.13 30.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.604 -0.725 . . . . 1.58 112.476 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 62.9 m-20 -104.71 7.75 34.86 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.927 -0.309 . . . . 1.66 111.598 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -132.54 136.44 46.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.649 -0.5 . . . . 1.2 109.649 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.419 ' OE2' ' HD2' ' A' ' 87' ' ' ARG . 35.9 tt0 -127.34 122.91 35.0 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.382 -0.527 . . . . 2.27 110.787 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tt -87.28 125.35 34.16 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.455 -0.943 . . . . 1.37 108.455 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.419 ' HD2' ' OE2' ' A' ' 85' ' ' GLU . 13.7 ptm180 -166.15 133.83 2.81 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.336 -0.847 . . . . 3.75 109.701 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.32 111.98 2.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.92 -0.582 . . . . 2.46 110.217 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -148.17 93.25 2.14 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.67 -0.863 . . . . 2.03 108.67 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.3 t -72.23 104.63 3.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.992 -0.549 . . . . 2.18 110.867 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -105.94 114.8 62.3 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.812 -0.631 . . . . 1.96 109.365 175.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.27 120.52 7.87 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.284 2.656 . . . . 1.87 112.765 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.23 -11.42 36.89 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.009 -0.615 . . . . 1.74 112.435 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.448 ' HB3' HG21 ' A' ' 91' ' ' ILE . . . -132.97 -71.1 0.53 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.916 -0.313 . . . . 1.79 111.476 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.83 -149.6 17.32 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.742 -0.742 . . . . 1.14 112.478 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.3 mt -104.5 122.71 46.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.568 0.21 . . . . 2.81 111.568 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -138.18 -153.85 6.36 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.818 -0.706 . . . . 0.8 112.159 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 98' ' ' VAL . 35.6 m -112.17 112.27 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.934 0.873 . . . . 1.17 109.857 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -82.52 118.66 23.42 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.821 -0.627 . . . . 1.4 110.799 -171.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -66.15 117.97 9.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.426 -0.806 . . . . 1.2 110.374 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.9 -3.71 58.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.484 0.659 . . . . 2.23 110.079 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.403 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 24.6 ttm-85 -125.74 157.06 38.38 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.544 -0.91 . . . . 4.08 108.544 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.403 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -83.99 159.58 21.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.108 0.48 . . . . 2.86 110.145 177.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.626 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 44.6 mtm -128.32 153.53 46.91 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.02 -0.536 . . . . 1.38 109.912 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -120.45 139.06 53.41 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.8 -0.636 . . . . 2.31 109.925 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -39.22 122.69 1.29 Allowed 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.431 1.082 . . . . 1.42 113.395 -169.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.17 7.15 12.85 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.467 -0.788 . . . . 1.04 111.373 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.443 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -86.02 167.98 14.53 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.844 0.458 . . . . 2.62 111.019 -176.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.485 ' O ' HD23 ' A' ' 110' ' ' LEU . 3.7 ptt180 -142.77 164.15 30.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.065 -0.516 . . . . 4.16 110.514 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 109' ' ' ARG . 7.3 mt -118.48 139.25 51.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.542 -0.753 . . . . 1.11 109.055 170.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.7 -115.02 4.17 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.804 -0.712 . . . . 1.09 113.288 174.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.47 ' HD3' ' CZ ' ' A' ' 109' ' ' ARG . 70.4 Cg_endo -72.14 168.22 74.77 Favored 'Cis proline' 0 C--N 1.349 0.596 0 C-N-CA 123.858 -1.309 . . . . 2.52 112.94 4.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.472 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 52.7 t -66.76 -36.48 82.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.412 . . . . 2.5 110.528 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.457 ' HB ' ' H ' ' A' ' 192' ' ' ILE . 47.7 t -120.38 122.16 67.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.224 -0.658 . . . . 2.46 109.224 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.5 m -98.78 -163.07 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.268 -0.424 . . . . 4.37 110.546 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.4 m -57.1 140.28 78.2 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.431 -0.349 . . . . 5.65 110.716 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.06 100.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.267 2.645 . . . . 5.38 113.103 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -95.02 -34.48 12.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.965 -0.562 . . . . 8.57 109.8 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -159.34 160.07 34.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.151 -0.931 . . . . 7.27 109.866 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -77.78 80.24 4.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.955 0.407 . . . . 6.4 111.006 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.22 130.57 16.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.957 -0.565 . . . . 5.88 110.236 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -94.79 154.98 17.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.951 -0.568 . . . . 7.76 110.886 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -84.15 -71.4 0.51 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.959 -0.564 . . . . 9.01 110.598 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.7 m -135.14 -94.51 0.27 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.053 -0.259 . . . . 9.14 110.875 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.421 ' HA ' ' CZ3' ' A' ' 128' ' ' TRP . 8.9 t70 -171.92 -140.89 0.02 OUTLIER 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.385 -0.968 . . . . 7.6 108.385 -176.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 76.57 -43.83 0.46 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.014 0.926 . . . . 8.0 112.549 171.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -73.33 -34.77 57.29 Favored Glycine 0 C--N 1.31 -0.875 0 CA-C-N 115.53 -0.759 . . . . 4.59 113.109 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . 0.537 ' HE3' ' N ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -150.24 -103.24 0.07 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.036 0.384 . . . . 4.93 112.036 -179.118 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.537 ' N ' ' HE3' ' A' ' 128' ' ' TRP . 12.1 pt-20 -163.37 -37.23 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.309 -0.405 . . . . 7.65 110.034 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 178.36 141.74 0.1 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.941 -0.572 . . . . 9.61 109.768 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.509 ' H ' HD11 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -118.63 -13.34 10.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.911 0.386 . . . . 6.05 110.343 173.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.9 mp -83.69 75.89 10.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.28 0.562 . . . . 8.5 110.132 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 44.2 p -128.72 59.58 1.54 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.299 -0.864 . . . . 9.82 109.131 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 67.17 70.7 0.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.293 -0.867 . . . . 11.21 109.645 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.4 t -71.14 111.0 4.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.296 -0.865 . . . . 10.92 110.624 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -68.42 142.01 55.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.795 -0.639 . . . . 13.25 109.475 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.5 t -43.73 -52.73 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 123.52 0.513 . . . . 14.01 111.381 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.3 m 55.21 83.35 0.23 Allowed Pre-proline 0 C--O 1.235 0.301 0 O-C-N 123.838 0.711 . . . . 14.1 110.689 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -47.03 121.71 5.44 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.282 2.655 . . . . 14.7 112.636 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.496 ' HB3' ' SG ' ' A' ' 143' ' ' CYS . 77.2 mt-30 -59.99 122.37 14.14 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.441 -0.799 . . . . 14.44 110.367 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -100.12 140.8 33.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.756 -0.656 . . . . 15.9 110.211 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.76 -59.94 3.59 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.671 -0.776 . . . . 16.0 112.122 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 140' ' ' GLN . 6.8 p -81.4 66.52 6.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.441 0.638 . . . . 15.6 111.154 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 49.7 mm -89.7 -57.07 4.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.721 -0.672 . . . . 14.1 110.05 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 26.9 m -78.08 92.64 4.41 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.828 -0.624 . . . . 13.19 110.4 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -116.2 -42.42 3.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.126 -0.488 . . . . 15.92 109.867 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.453 HG23 HD13 ' A' ' 147' ' ' ILE . 3.9 mt 59.08 -179.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.634 0.731 . . . . 14.07 111.106 173.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.0 m -95.97 68.54 2.76 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.523 -0.547 . . . . 13.67 109.523 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -59.73 108.54 0.76 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.781 -0.645 . . . . 13.02 111.201 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -81.74 132.93 35.3 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.243 -0.651 . . . . 14.68 109.243 174.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.8 pp -111.03 23.72 13.79 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.359 0.599 . . . . 13.55 110.892 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 154' ' ' GLU . . . 98.5 74.58 1.16 Allowed Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.623 -0.717 . . . . 15.8 111.48 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 t -76.66 37.19 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.471 0.653 . . . . 17.08 110.8 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 152' ' ' GLY . 37.0 mt-10 -75.6 -60.81 2.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.485 -0.78 . . . . 18.43 108.914 175.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.55 20.12 3.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.781 -1.099 . . . . 18.74 110.026 177.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -128.14 87.64 2.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.643 -0.708 . . . . 14.81 110.794 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 37.3 t -120.55 36.75 4.47 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.551 -0.907 . . . . 14.64 108.551 176.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.7 136.75 56.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.143 -0.935 . . . . 13.38 110.475 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.471 ' OD1' ' HB2' ' A' ' 162' ' ' GLN . 34.6 t70 -75.42 99.5 4.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 10.61 110.675 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -126.65 -49.94 1.5 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.795 -0.639 . . . . 10.22 111.341 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -101.97 14.8 30.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.388 -0.369 . . . . 10.69 111.331 -175.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.471 ' HB2' ' OD1' ' A' ' 159' ' ' ASP . 54.2 mt-30 -109.75 -81.2 0.58 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.469 -0.332 . . . . 9.45 110.521 177.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.418 ' HB2' ' OD2' ' A' ' 159' ' ' ASP . . . -88.81 72.8 8.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.187 0.517 . . . . 6.56 110.833 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -75.46 85.14 0.84 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.704 -0.68 . . . . 4.17 112.382 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.74 160.62 30.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.891 0.377 . . . . 3.14 110.562 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 113' ' ' CYS . . . -86.88 37.43 3.19 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.15 -0.548 . . . . 1.69 112.776 -176.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 3.4 m -61.47 -27.38 68.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.539 0.685 . . . . 2.0 110.035 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 16.4 p-90 -85.3 -19.33 31.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.245 -0.889 . . . . 0.83 111.084 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 40.6 mt -82.08 -14.95 55.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.059 -0.518 . . . . 1.28 111.864 -173.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.409 ' C ' ' HD3' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -74.59 -8.65 57.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 2.03 110.01 175.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.536 ' O ' ' HD2' ' A' ' 173' ' ' ARG . 65.6 m-85 -85.98 -30.47 22.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.979 -0.555 . . . . 2.19 111.675 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.578 HG22 ' HB2' ' A' ' 207' ' ' LEU . 1.3 mm -51.3 138.01 8.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 O-C-N 123.393 0.433 . . . . 1.24 111.301 -173.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' A' ' 171' ' ' TYR . 14.9 mmm180 -92.14 170.88 9.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.344 0.593 . . . . 4.97 111.874 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.446 HG21 HG11 ' A' ' 208' ' ' VAL . 61.6 t -89.64 160.76 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.26 -0.882 . . . . 1.63 108.669 173.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.407 ' HB3' HD12 ' A' ' 183' ' ' LEU . . . -46.67 125.0 6.61 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.323 0.389 . . . . 1.34 111.892 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 30.8 p -75.75 -14.11 60.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.057 -0.52 . . . . 2.58 110.989 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.4 m -148.39 164.19 34.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 2.06 109.86 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 57.4 m -74.91 -22.96 58.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.973 0.416 . . . . 2.69 111.062 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.13 5.32 45.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.213 0.53 . . . . 2.42 110.402 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -110.05 15.93 22.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.42 -0.809 . . . . 2.12 110.255 -174.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.87 114.34 7.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.449 . . . . 1.52 110.427 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.579 ' ND2' HD13 ' A' ' 200' ' ' ILE . 18.7 t30 -157.43 36.74 0.28 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.001 0.905 . . . . 1.68 109.21 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.608 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.5 OUTLIER -122.9 124.57 43.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.043 -0.526 . . . . 1.43 111.169 -173.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.5 m -149.97 121.95 8.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.19 0.519 . . . . 1.2 110.735 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.422 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 48.1 ttm -97.96 133.02 43.01 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.202 -0.666 . . . . 1.56 109.202 172.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 25.0 t -112.83 132.19 55.38 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.289 -0.634 . . . . 2.13 109.289 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 24.7 tm0? -108.37 104.9 14.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.248 0.547 . . . . 1.96 109.712 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.557 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 25.3 pt -132.53 143.2 40.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.522 -0.763 . . . . 1.62 110.139 -176.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.8 m 54.1 35.93 23.49 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.324 0.39 . . . . 2.24 111.606 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 65.55 7.55 4.48 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.943 -0.571 . . . . 2.83 112.054 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 13.4 pt20 -113.79 155.26 25.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 1.86 110.529 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.457 ' H ' ' HB ' ' A' ' 114' ' ' VAL . 51.0 mm -87.81 112.75 23.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.858 -0.61 . . . . 1.59 110.425 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -110.53 135.6 50.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.889 -0.596 . . . . 4.16 110.274 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 9.9 m-85 -102.34 114.67 29.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.59 -0.277 . . . . 1.27 110.485 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.97 117.85 31.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.866 0.365 . . . . 1.73 110.048 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.443 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 2.2 t -89.6 152.85 3.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.533 0.682 . . . . 1.33 109.869 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.5 mm -90.34 -57.2 4.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.65 -1.159 . . . . 1.23 111.486 -166.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.574 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.7 OUTLIER -141.87 -178.83 5.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.634 -0.712 . . . . 1.88 111.368 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.626 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.9 m-20 -48.45 126.66 11.84 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 124.014 0.821 . . . . 2.23 112.703 -175.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.579 HD13 ' ND2' ' A' ' 182' ' ' ASN . 18.6 mm -96.66 138.01 22.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.445 -0.798 . . . . 1.41 110.714 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -86.17 133.29 41.12 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.941 -0.572 . . . . 2.06 109.51 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 52.4 Cg_exo -54.99 113.21 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.009 1.806 . . . . 0.56 111.615 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.93 -13.08 9.19 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.742 -0.742 . . . . 0.7 113.261 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -126.52 122.56 35.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.765 0.783 . . . . 1.27 111.733 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.512 ' O ' HD11 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -111.29 115.79 29.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.807 -0.633 . . . . 2.92 111.254 175.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.512 HD11 ' O ' ' A' ' 205' ' ' GLU . 1.7 mm? -124.1 99.97 6.49 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.71 -0.478 . . . . 1.51 109.71 171.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.578 ' HB2' HG22 ' A' ' 172' ' ' ILE . 1.4 mm? -147.17 112.84 5.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.673 0.389 . . . . 1.16 110.156 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.608 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.4 p -154.92 160.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.816 -0.438 . . . . 1.5 109.816 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.422 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 53.7 t-80 -90.84 107.58 19.28 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.562 -1.273 . . . . 1.77 107.562 169.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.7 m -73.89 126.0 33.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.099 0.476 . . . . 3.05 110.098 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -78.76 126.53 30.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.316 0.579 . . . . 5.7 110.581 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -115.54 14.84 16.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.407 -0.815 . . . . 5.8 110.267 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.16 27.39 72.97 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.514 -0.766 . . . . 5.61 112.624 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . 0.5 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 43.7 t -99.95 -71.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.946 0.403 . . . . 6.31 110.646 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.516 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 86.6 m-85 -60.52 -53.99 59.16 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.724 -0.671 . . . . 9.04 112.259 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 13.9 Cg_endo -54.5 -42.44 68.04 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.532 2.154 . . . . 7.78 112.98 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.33 -10.15 56.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.442 -0.345 . . . . 8.02 111.826 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 67.75 42.54 86.81 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 116.012 -0.54 . . . . 8.64 112.744 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.5 ' OG1' ' HA ' ' A' ' 214' ' ' VAL . 24.4 p -81.63 -0.57 43.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.128 0.49 . . . . 9.96 111.414 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 221' ' ' PRO . 20.4 m -80.77 139.85 50.61 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.991 -0.55 . . . . 9.62 110.436 177.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 15.6 Cg_exo -69.02 114.86 3.73 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.581 2.187 . . . . 12.02 111.756 177.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.71 96.38 0.43 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.844 2.363 . . . . 13.11 111.673 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.18 -118.23 4.65 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.726 -0.749 . . . . 14.03 111.623 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 37.2 tp -160.1 122.77 3.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.822 0.344 . . . . 16.32 110.636 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -128.18 -6.06 5.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.959 -0.564 . . . . 17.7 110.459 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.376 -0.821 . . . . 18.9 109.795 179.715 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 112.104 -0.398 . . . . 33.41 112.104 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.7 t -139.2 126.84 21.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.371 -0.603 . . . . 34.1 109.371 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.69 -47.88 3.03 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.407 -0.677 . . . . 32.51 111.407 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 60.23 85.76 0.17 Allowed Pre-proline 0 C--O 1.231 0.128 0 C-N-CA 123.045 0.538 . . . . 31.98 111.123 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -55.78 97.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.976 2.45 . . . . 30.45 112.394 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.6 m -113.65 136.6 52.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.642 -0.708 . . . . 29.01 110.199 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.0 m 64.91 61.65 0.77 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.401 0.619 . . . . 27.14 109.953 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -89.45 20.15 4.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.618 -0.719 . . . . 25.83 110.942 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -98.99 98.17 9.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.171 -0.468 . . . . 23.8 110.266 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -104.53 137.94 41.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.93 -0.577 . . . . 22.03 110.443 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.3 m -96.07 115.3 65.48 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.96 -0.564 . . . . 19.63 110.518 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.9 92.9 0.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.393 2.062 . . . . 17.86 111.339 176.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -82.64 -37.38 25.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.249 -0.887 . . . . 17.61 110.352 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -90.58 165.18 13.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.686 -0.688 . . . . 15.63 110.346 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.15 -124.79 8.52 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.778 -0.725 . . . . 12.12 111.918 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.8 m -153.08 97.1 2.84 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 120.481 0.181 . . . . 10.78 110.598 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.28 97.88 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.5 2.134 . . . . 10.17 111.64 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -86.9 130.99 34.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.849 -0.614 . . . . 7.8 110.866 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -132.06 147.39 52.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.794 -0.639 . . . . 8.14 109.547 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.74 112.05 26.27 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.366 -0.379 . . . . 6.11 110.485 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.07 -157.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.637 2.225 . . . . 6.51 112.234 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.6 m -60.58 -31.2 48.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.881 0.372 . . . . 6.76 110.984 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -112.63 120.33 41.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.35 -0.387 . . . . 5.18 110.066 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.456 ' O ' HD11 ' A' ' 74' ' ' ILE . 1.9 pp -77.01 149.56 80.08 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.361 -0.381 . . . . 4.5 110.225 175.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.32 12.54 1.53 Allowed 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.628 2.218 . . . . 4.4 114.333 -167.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -124.2 -83.49 0.65 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 121.139 -0.224 . . . . 3.91 110.978 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.5 t70 65.07 80.11 0.24 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.923 0.764 . . . . 3.16 110.176 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.0 mt -72.97 124.39 90.66 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.356 -0.838 . . . . 2.82 110.458 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.64 124.57 10.37 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.702 2.268 . . . . 2.04 111.857 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.465 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -118.94 143.97 34.85 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.316 -0.402 . . . . 1.53 110.67 -178.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -54.62 147.53 48.62 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.414 2.743 . . . . 0.88 112.296 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.409 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -66.15 -12.84 58.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.92 -0.582 . . . . 1.58 112.104 -175.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.99 -24.12 59.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.19 0.519 . . . . 1.66 110.177 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 71.6 m-85 -123.72 177.39 5.73 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.836 -0.62 . . . . 1.2 110.074 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.53 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 28.2 tt0 -155.86 124.66 6.01 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.009 -0.276 . . . . 2.27 110.702 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.9 tt -84.0 125.01 31.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.474 -0.565 . . . . 1.37 109.474 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -147.79 138.9 23.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.196 -0.911 . . . . 3.75 109.538 -174.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.99 110.8 17.58 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.694 -0.484 . . . . 2.46 109.694 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m -150.0 106.61 3.52 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.749 -0.659 . . . . 2.03 109.309 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.6 m -75.91 104.17 6.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.061 0.458 . . . . 2.18 111.225 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -107.15 114.85 60.82 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.148 -0.686 . . . . 1.96 109.148 174.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 91' ' ' ILE . 37.5 Cg_exo -60.43 121.93 10.52 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.827 2.351 . . . . 1.87 112.653 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.33 -9.61 35.94 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.685 -0.769 . . . . 1.74 113.037 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.88 -70.6 0.57 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.892 0.346 . . . . 1.79 111.531 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 130.3 -161.51 23.17 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.816 -0.707 . . . . 1.14 112.047 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mt -94.68 116.78 29.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.091 -0.337 . . . . 2.81 110.091 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.443 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -119.04 -179.39 16.76 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.733 -0.746 . . . . 0.8 112.614 -176.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 19.6 m -100.78 112.7 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.698 0.761 . . . . 1.17 109.776 174.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -82.07 112.33 19.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.447 -0.797 . . . . 1.4 110.984 -169.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -66.5 114.64 5.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 1.2 109.703 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.53 ' CE ' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -95.73 2.18 53.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.427 0.632 . . . . 2.23 109.501 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -125.54 154.55 41.98 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.942 -1.027 . . . . 4.08 109.218 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.605 ' HD2' ' H ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -86.72 154.68 20.78 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.453 -0.573 . . . . 2.86 109.453 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.742 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 49.4 mtm -131.16 147.56 52.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.512 -0.313 . . . . 1.38 110.734 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -109.8 143.06 40.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.322 -0.622 . . . . 2.31 109.322 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.37 130.43 10.75 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 124.012 0.82 . . . . 1.42 112.458 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.61 7.54 13.5 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.156 -0.778 . . . . 1.04 111.156 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -78.96 162.87 25.68 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 122.901 0.48 . . . . 2.62 111.589 -176.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -146.93 128.26 14.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.856 -0.611 . . . . 4.16 110.881 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 3.2 mt -105.15 148.48 26.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.728 -0.841 . . . . 1.11 108.728 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.72 -151.2 19.22 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.532 -0.842 . . . . 1.09 112.181 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.561 ' HB3' ' CE2' ' A' ' 193' ' ' TYR . 86.4 Cg_endo -81.53 142.05 52.97 Favored 'Cis proline' 0 C--N 1.342 0.218 0 C-N-CA 123.823 -1.324 . . . . 2.52 112.67 0.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 14.2 m -72.48 -27.94 62.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.19 0.519 . . . . 2.5 109.765 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.5 t -121.44 116.64 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.342 -0.845 . . . . 2.46 109.131 175.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 m -91.25 -169.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.248 -0.433 . . . . 4.37 111.37 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.572 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 2.4 p -63.04 -38.1 39.1 Favored Pre-proline 0 CA--C 1.553 1.088 0 N-CA-C 114.491 1.293 . . . . 5.65 114.491 -173.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 116' ' ' VAL . 9.4 Cg_endo -53.22 140.53 61.41 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 121.687 1.592 . . . . 5.38 112.543 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -68.04 -28.55 67.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.308 -0.86 . . . . 8.57 111.792 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.12 74.41 0.22 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.928 -0.578 . . . . 7.27 110.683 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.8 -79.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.582 -0.736 . . . . 6.4 111.232 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 65.15 138.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.74 0.781 . . . . 5.88 111.575 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -66.8 138.8 57.62 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.41 -0.814 . . . . 7.76 110.256 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -69.15 -49.39 57.34 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.001 -0.74 . . . . 9.01 109.001 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 78.7 m -162.68 -58.79 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.197 -0.911 . . . . 9.14 108.722 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.88 177.59 6.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.182 -0.917 . . . . 7.6 111.055 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -132.4 156.61 46.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.359 -0.837 . . . . 8.0 109.465 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.727 ' HA3' ' SD ' ' A' ' 185' ' ' MET . . . -146.77 25.96 1.64 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.961 -1.114 . . . . 4.59 113.564 -177.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.45 -111.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.533 0.568 . . . . 4.93 112.533 176.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -141.17 -57.94 0.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.927 0.343 . . . . 7.65 111.927 -171.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.524 ' HG2' ' H ' ' A' ' 132' ' ' LEU . 8.4 tt0 -172.05 142.46 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.502 0.191 . . . . 9.61 110.688 -172.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.508 ' H ' HD11 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -127.11 13.81 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.324 0.583 . . . . 6.05 110.265 174.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.524 ' H ' ' HG2' ' A' ' 130' ' ' GLN . 9.5 mp -81.15 70.63 8.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.536 -0.756 . . . . 8.5 110.487 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.1 p -101.78 41.7 1.19 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.317 -0.856 . . . . 9.82 110.524 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 60.67 67.19 0.85 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.649 -0.705 . . . . 11.21 110.166 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -58.5 130.94 22.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.931 -1.031 . . . . 10.92 111.287 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -85.9 148.26 25.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.735 -0.666 . . . . 13.25 110.326 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 138' ' ' SER . 27.5 m -96.1 9.77 5.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.457 -0.338 . . . . 14.01 110.452 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 137' ' ' VAL . 73.5 m 72.96 143.58 0.1 OUTLIER Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 114.934 -1.03 . . . . 14.1 111.276 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.41 87.75 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.532 2.155 . . . . 14.7 112.007 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -83.04 36.89 0.52 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.242 0.544 . . . . 14.44 110.077 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -85.46 -6.58 59.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.369 -0.832 . . . . 15.9 110.639 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -160.42 -179.21 35.05 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.865 -0.607 . . . . 16.0 111.69 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 38.4 t -72.56 130.77 41.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.986 0.422 . . . . 15.6 110.444 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.4 mt -101.24 62.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 122.172 0.987 . . . . 14.1 108.405 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.57 44.2 0.27 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.311 -1.313 . . . . 13.19 113.127 -172.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -101.79 -17.46 16.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.807 -0.812 . . . . 15.92 108.807 171.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.3 pp -124.31 163.66 23.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.953 -1.021 . . . . 14.07 109.766 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.2 t -149.13 68.48 1.05 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.672 0.749 . . . . 13.67 109.766 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -131.28 75.72 1.67 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.401 -0.818 . . . . 13.02 110.162 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.41 97.74 7.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.066 -0.97 . . . . 14.68 110.234 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.7 mt -82.74 57.09 3.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.873 0.368 . . . . 13.55 110.734 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.54 31.98 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.627 -0.797 . . . . 15.8 112.666 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.9 m -114.92 -58.34 2.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.822 0.344 . . . . 17.08 110.532 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -101.75 -103.79 0.26 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.852 0.358 . . . . 18.43 111.427 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -119.37 23.13 11.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.273 0.559 . . . . 18.74 111.391 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -107.84 19.49 20.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.866 -0.607 . . . . 14.81 109.969 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 3.4 p -69.8 -29.54 66.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.387 -0.824 . . . . 14.64 110.503 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.0 t -70.74 125.16 28.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.311 -0.626 . . . . 13.38 109.311 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -81.4 82.11 7.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.476 0.655 . . . . 10.61 110.835 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -118.27 -23.73 7.18 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.539 -1.209 . . . . 10.22 109.068 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -71.54 -38.26 71.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.306 -1.315 . . . . 10.69 111.718 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.36 -41.31 7.89 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.897 -0.408 . . . . 9.45 109.897 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -66.67 101.11 0.75 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.854 -0.612 . . . . 6.56 110.866 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -166.74 -94.35 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.734 -0.946 . . . . 4.17 110.734 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 41.33 -92.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.667 0.988 . . . . 3.14 113.667 172.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -131.17 14.07 5.43 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.069 -0.586 . . . . 1.69 112.134 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 23.0 t -68.54 -24.79 64.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.325 0.583 . . . . 2.0 109.941 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -85.0 -18.79 33.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.794 -0.639 . . . . 0.83 109.857 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.51 ' O ' HG13 ' A' ' 172' ' ' ILE . 38.0 mt -84.1 -20.35 32.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.682 -0.69 . . . . 1.28 111.415 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.474 ' C ' ' HD3' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -76.2 -6.17 50.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.519 -0.472 . . . . 2.03 110.225 176.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.443 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 33.8 m-85 -75.83 -37.52 58.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.968 -0.56 . . . . 2.19 110.484 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -68.63 119.74 14.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.367 -0.605 . . . . 1.24 109.367 174.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -111.15 -172.29 2.0 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.539 -0.301 . . . . 4.97 110.847 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 20.6 t -68.19 149.04 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 1.63 110.771 -177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.22 126.23 25.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.894 -0.594 . . . . 1.34 111.441 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 46.2 t -72.02 -17.46 62.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 2.58 110.838 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 m -126.33 150.42 48.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.313 -0.403 . . . . 2.06 109.975 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 10.7 p -78.57 -19.02 53.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.492 0.553 . . . . 2.69 112.492 -172.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -89.17 -4.09 58.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.468 0.651 . . . . 2.42 110.051 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.15 17.48 12.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.207 -0.906 . . . . 2.12 111.642 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -69.33 113.25 6.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.327 0.584 . . . . 1.52 110.952 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.651 ' H ' HD11 ' A' ' 183' ' ' LEU . 4.1 p-10 -155.25 35.14 0.38 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.178 -0.919 . . . . 1.68 109.582 171.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.651 HD11 ' H ' ' A' ' 182' ' ' ASN . 0.5 OUTLIER -117.7 120.42 37.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.443 -0.799 . . . . 1.43 110.754 -171.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 92.7 m -148.53 139.8 23.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.099 0.476 . . . . 1.2 110.95 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.727 ' SD ' ' HA3' ' A' ' 127' ' ' GLY . 55.5 ttm -98.75 150.29 21.98 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.371 -0.603 . . . . 1.56 109.371 174.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 53.7 t -112.78 131.9 55.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.061 0.458 . . . . 2.13 109.97 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . 0.546 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 20.7 tm0? -120.77 104.89 10.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.769 -0.651 . . . . 1.96 109.389 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 12.9 pt -140.71 132.63 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 1.62 110.123 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 51.1 m 58.51 29.88 18.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.118 0.485 . . . . 2.24 111.059 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.546 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 0.9 OUTLIER 63.97 11.5 6.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.145 -0.934 . . . . 2.83 112.753 176.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -112.08 140.03 47.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.539 -0.541 . . . . 1.86 109.539 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.1 mm -84.77 131.68 33.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.947 -0.57 . . . . 1.59 112.02 -172.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.561 ' CE2' ' HB3' ' A' ' 112' ' ' PRO . 54.3 m-85 -128.37 165.11 21.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.045 -0.98 . . . . 4.16 109.709 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.521 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 3.9 m-85 -115.02 126.53 54.85 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.579 -0.526 . . . . 1.27 109.579 175.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -125.47 120.06 29.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.027 0.441 . . . . 1.73 110.604 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.501 HG21 HD12 ' A' ' 207' ' ' LEU . 1.5 t -85.82 152.9 3.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.126 -0.694 . . . . 1.33 109.126 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.504 HG13 ' HA ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -84.28 -48.54 16.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.891 -1.05 . . . . 1.23 111.039 -170.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.78 -178.08 6.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.635 -0.711 . . . . 1.88 111.193 -174.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.742 ' HA ' ' O ' ' A' ' 104' ' ' MET . 2.8 p-10 -43.23 124.49 3.34 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.454 1.096 . . . . 2.23 113.486 -176.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.443 HG13 ' HE3' ' A' ' 104' ' ' MET . 37.8 mm -100.98 133.11 45.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.947 -1.024 . . . . 1.41 110.122 175.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.662 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 46.5 mt-10 -90.12 128.74 48.46 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.402 -0.592 . . . . 2.06 109.402 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.76 116.75 2.03 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.952 2.435 . . . . 0.56 112.934 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 123.51 -16.11 8.0 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.953 -0.641 . . . . 0.7 113.653 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.662 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 13.9 pt-20 -111.7 122.86 48.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.827 0.814 . . . . 1.27 111.518 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.447 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -111.32 94.99 5.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.081 -0.509 . . . . 2.92 112.087 177.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.441 ' N ' HD23 ' A' ' 206' ' ' LEU . 1.2 mm? -122.77 100.17 6.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.874 -0.73 . . . . 1.51 109.859 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.569 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 0.6 OUTLIER -147.33 114.28 6.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.581 -0.281 . . . . 1.16 110.617 177.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.607 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.5 p -155.51 158.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.505 . . . . 1.5 109.635 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -85.81 110.41 19.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.245 -1.02 . . . . 1.77 108.245 166.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 p -71.78 123.66 26.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.264 0.554 . . . . 3.05 110.015 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -144.02 131.86 21.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.0 -0.545 . . . . 5.7 110.801 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.455 ' O ' HD23 ' A' ' 217' ' ' LEU . 10.7 pt-20 -130.07 -2.95 4.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 5.8 110.366 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' A' ' 217' ' ' LEU . . . -163.59 60.82 0.26 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.561 -0.828 . . . . 5.61 112.724 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 52.4 t -113.47 -75.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.846 0.355 . . . . 6.31 110.155 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.418 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 52.3 t80 -87.48 -58.57 0.28 Allowed Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.119 -0.491 . . . . 9.04 110.971 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.419 ' HB2' HD21 ' A' ' 217' ' ' LEU . 18.0 Cg_endo -57.87 -51.27 8.3 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 121.979 1.786 . . . . 7.78 112.628 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.513 ' HB2' ' HA2' ' A' ' 213' ' ' GLY . 2.4 mm? -102.7 41.96 1.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.396 0.617 . . . . 8.02 109.993 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -114.18 -165.56 15.48 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.398 -0.819 . . . . 8.64 111.741 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.9 p -89.41 54.05 2.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.322 0.582 . . . . 9.96 110.874 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.96 157.09 34.51 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.59 -0.732 . . . . 9.62 110.379 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.07 138.95 88.42 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.523 2.149 . . . . 12.02 112.27 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.93 99.39 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.734 2.289 . . . . 13.11 111.771 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 132.09 -119.92 2.64 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.882 -0.887 . . . . 14.03 110.882 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 40.1 tp -150.98 123.54 8.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.819 0.342 . . . . 16.32 110.184 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -88.01 -38.39 15.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.934 -0.575 . . . . 17.7 110.481 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.288 -0.863 . . . . 18.9 110.421 178.831 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 111.952 -0.459 . . . . 33.41 111.952 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.2 t -160.01 152.06 20.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.713 0.292 . . . . 34.1 110.476 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.22 -133.03 19.64 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.248 -0.501 . . . . 32.51 112.032 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -135.24 113.11 11.25 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.661 -0.496 . . . . 31.98 109.661 177.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.73 56.9 4.23 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.882 2.388 . . . . 30.45 112.723 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 p -67.31 -42.39 83.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.078 0.466 . . . . 29.01 110.462 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.9 t -99.6 67.47 1.5 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.095 -0.706 . . . . 27.14 109.095 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -94.36 82.01 4.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.942 -0.572 . . . . 25.83 110.323 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -96.08 112.52 24.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.472 -0.785 . . . . 23.8 110.097 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.554 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 66.5 m-85 -72.27 94.37 1.58 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.938 -0.393 . . . . 22.03 109.938 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.5 p -106.72 92.5 7.4 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.788 -0.642 . . . . 19.63 111.112 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 60' ' ' PHE . 7.7 Cg_exo -72.59 125.68 10.83 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.981 2.454 . . . . 17.86 111.922 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -86.16 49.05 1.71 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.276 0.56 . . . . 17.61 109.824 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -126.2 131.33 52.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.329 -0.851 . . . . 15.63 109.799 -176.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.448 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . -109.75 -114.69 3.65 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.671 -0.776 . . . . 12.12 111.669 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.3 m -110.25 91.62 11.86 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.608 -0.515 . . . . 10.78 109.608 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 65' ' ' GLY . 4.5 Cg_exo -73.5 98.69 1.06 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.906 2.404 . . . . 10.17 112.057 -176.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -83.45 89.23 7.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.093 -0.503 . . . . 7.8 109.747 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -113.64 152.01 30.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.017 -0.538 . . . . 8.14 110.438 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.11 122.41 77.6 Favored Pre-proline 0 C--N 1.319 -0.717 0 CA-C-N 115.739 -0.664 . . . . 6.11 111.239 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.97 -70.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.558 2.838 . . . . 6.51 113.064 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.1 p -124.33 -43.51 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.117 -0.492 . . . . 6.76 111.432 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -92.1 108.5 19.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.402 -0.363 . . . . 5.18 110.08 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.552 ' O ' HD11 ' A' ' 74' ' ' ILE . 2.1 pp -80.0 134.61 56.09 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 121.22 0.533 . . . . 4.5 111.482 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.27 0.5 9.68 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.953 2.435 . . . . 4.4 112.396 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.37 -59.5 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.092 -0.707 . . . . 3.91 109.092 175.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.2 t70 65.44 100.34 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.736 -1.12 . . . . 3.16 111.756 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.0 118.01 67.22 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.331 -0.849 . . . . 2.82 109.795 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.78 116.39 3.41 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.349 2.033 . . . . 2.04 111.712 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -126.41 140.94 38.54 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.287 -0.415 . . . . 1.53 110.478 -178.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.45 138.38 83.71 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.509 2.14 . . . . 0.88 111.634 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.49 -4.12 13.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.145 0.497 . . . . 1.58 111.351 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.54 -23.01 61.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.785 -0.643 . . . . 1.66 109.457 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -128.43 177.31 7.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.295 -0.866 . . . . 1.2 108.872 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -145.54 131.43 19.14 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.18 -0.608 . . . . 2.27 110.906 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.4 tt -92.79 130.65 38.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.027 -0.533 . . . . 1.37 109.769 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -149.5 150.93 33.09 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.454 -0.794 . . . . 3.75 109.746 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -82.92 109.42 17.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.707 -0.849 . . . . 2.46 108.707 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.8 m -159.56 82.44 0.75 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.327 -0.62 . . . . 2.03 109.327 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.6 p -68.3 105.22 2.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.139 -0.482 . . . . 2.18 110.922 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.51 HG22 ' HB1' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -81.86 123.46 80.15 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.116 -0.698 . . . . 1.96 109.116 176.236 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -49.62 115.38 1.77 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.282 2.654 . . . . 1.87 113.297 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.09 -14.53 37.06 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.7 -0.762 . . . . 1.74 112.691 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.51 ' HB1' HG22 ' A' ' 91' ' ' ILE . . . -128.77 -55.77 1.21 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 1.79 111.477 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.92 -146.71 17.54 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.979 -0.629 . . . . 1.14 112.255 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 96' ' ' LEU . 1.3 pp -69.26 158.83 34.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.718 0.259 . . . . 2.81 110.914 177.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.71 172.15 43.56 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.796 -0.716 . . . . 0.8 111.995 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.1 m -108.24 120.45 59.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.678 0.751 . . . . 1.17 109.965 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -83.01 107.98 15.99 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.246 0.546 . . . . 1.4 110.859 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.42 115.56 7.99 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.551 -0.749 . . . . 1.2 110.16 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.455 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -86.57 -5.23 59.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.546 0.688 . . . . 2.23 109.359 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -128.88 159.17 36.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.008 -0.997 . . . . 4.08 109.176 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.37 137.09 33.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.244 0.545 . . . . 2.86 110.637 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.621 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 25.3 mtm -94.97 116.62 28.93 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.74 -0.837 . . . . 1.38 108.74 172.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.69 173.62 12.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.403 0.621 . . . . 2.31 111.74 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.98 118.12 7.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.276 -0.874 . . . . 1.42 111.83 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.76 1.04 63.82 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.839 -0.696 . . . . 1.04 113.198 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.58 167.95 20.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.649 -0.5 . . . . 2.62 109.649 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.63 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 5.0 tmm_? -145.82 130.6 18.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.245 0.461 . . . . 4.16 112.245 -170.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.7 mt -88.18 139.91 30.02 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.84 -0.8 . . . . 1.11 108.84 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.04 173.3 40.72 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.801 -1.19 . . . . 1.09 113.05 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -80.97 152.27 81.0 Favored 'Cis proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.954 -1.686 . . . . 2.52 112.463 -2.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.41 ' HA ' ' HA2' ' A' ' 166' ' ' GLY . 42.7 t -96.57 -0.58 48.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.037 0.446 . . . . 2.5 110.715 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.8 m -120.18 133.46 66.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.231 -0.44 . . . . 2.46 111.074 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.518 HG11 ' H ' ' A' ' 116' ' ' VAL . 2.0 t -89.91 179.23 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.638 -0.875 . . . . 4.37 108.638 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.518 ' H ' HG11 ' A' ' 115' ' ' VAL . 21.6 t -51.99 -51.57 69.9 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 117.739 0.245 . . . . 5.65 111.616 177.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 116' ' ' VAL . 36.2 Cg_endo -66.0 89.96 0.25 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.96 1.774 . . . . 5.38 111.479 171.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 -84.3 -39.63 18.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.001 -0.545 . . . . 8.57 110.081 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 49.87 47.51 23.03 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.671 0.607 . . . . 7.27 111.314 175.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -98.71 137.54 37.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.804 -0.634 . . . . 6.4 111.192 -175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.09 89.21 0.92 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.808 -0.633 . . . . 5.88 110.284 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.535 ' HD3' ' O ' ' A' ' 124' ' ' THR . 7.3 ptpp? -95.84 157.22 15.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.261 -0.882 . . . . 7.76 110.882 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -98.16 -28.86 13.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.165 -0.679 . . . . 9.01 109.165 172.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.535 ' O ' ' HD3' ' A' ' 122' ' ' LYS . 87.1 m -154.02 -74.53 0.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.996 -1.002 . . . . 9.14 109.847 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -178.59 -74.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.76 -0.654 . . . . 7.6 109.807 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 63.42 17.99 10.71 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.629 0.728 . . . . 8.0 111.266 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 90.34 50.8 2.9 Favored Glycine 0 C--N 1.309 -0.947 0 CA-C-N 115.075 -0.966 . . . . 4.59 110.846 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . 0.499 ' CE2' HD11 ' A' ' 192' ' ' ILE . 28.8 t-105 71.97 131.88 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 123.266 1.508 . . . . 4.93 112.025 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.476 ' OE1' HD12 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -59.89 -25.61 65.24 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 111.993 -2.367 . . . . 7.65 112.365 177.421 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 128' ' ' TRP . 26.2 mt-30 64.49 35.61 9.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.277 -0.874 . . . . 9.61 112.848 173.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.476 HD12 ' OE1' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -64.57 -27.49 42.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.689 0.28 . . . . 6.05 111.385 178.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.92 80.75 2.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.253 0.549 . . . . 8.5 110.177 176.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.3 p -131.66 45.1 2.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.04 -0.527 . . . . 9.82 110.757 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.8 t70 68.36 105.55 0.05 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.255 -0.884 . . . . 11.21 111.324 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -53.75 131.71 16.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.261 -0.881 . . . . 10.92 111.38 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -87.95 -166.05 1.48 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.531 -0.759 . . . . 13.25 110.244 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.8 t -60.97 -39.34 81.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.104 0.478 . . . . 14.01 110.197 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.7 t -103.95 108.47 59.98 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.86 -0.609 . . . . 14.1 110.133 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.74 162.95 21.26 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.9 2.4 . . . . 14.7 112.121 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -104.26 35.38 2.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.492 0.663 . . . . 14.44 110.081 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -80.81 108.8 14.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.622 -0.717 . . . . 15.9 111.286 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -135.17 -92.59 0.4 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.514 -0.851 . . . . 16.0 111.932 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 3.6 p -89.13 45.31 1.28 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.338 0.59 . . . . 15.6 111.105 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.8 mt -87.66 -11.0 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.812 0.815 . . . . 14.1 109.626 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.8 t -147.79 147.2 29.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.666 -0.697 . . . . 13.19 109.989 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -113.99 -3.23 13.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.362 0.601 . . . . 15.92 109.672 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 39.0 pt -114.85 165.05 10.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.329 -0.851 . . . . 14.07 110.206 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.0 m -92.73 59.86 3.33 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.069 0.462 . . . . 13.67 110.174 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.44 146.27 53.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.566 -0.743 . . . . 13.02 109.826 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -128.36 121.44 29.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.976 0.417 . . . . 14.68 110.974 -176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.02 31.63 1.07 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.012 -0.54 . . . . 13.55 110.936 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -113.38 43.57 1.68 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.93 -0.652 . . . . 15.8 111.937 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.6 t 66.21 15.37 10.06 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.086 0.554 . . . . 17.08 111.461 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -94.61 -92.74 0.19 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.847 0.356 . . . . 18.43 110.782 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -120.94 101.42 7.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.116 -0.493 . . . . 18.74 110.805 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -133.79 171.51 14.05 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.604 -0.725 . . . . 14.81 109.895 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.403 ' O ' HG23 ' A' ' 158' ' ' VAL . 52.8 m -124.77 102.54 7.63 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.445 -0.343 . . . . 14.64 110.461 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 157' ' ' CYS . 9.4 m 49.69 -172.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 124.29 0.994 . . . . 13.38 112.863 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -71.47 69.71 0.6 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.051 -0.977 . . . . 10.61 110.081 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -102.38 -83.13 0.47 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.228 -0.442 . . . . 10.22 111.014 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -90.27 39.49 0.97 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.094 0.473 . . . . 10.69 110.842 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -120.82 -80.89 0.63 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.913 -0.585 . . . . 9.45 110.156 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -163.86 170.62 16.56 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.932 -0.576 . . . . 6.56 109.975 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 155.48 -160.14 29.68 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.374 -0.917 . . . . 4.17 112.627 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.59 146.72 34.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.891 0.377 . . . . 3.14 111.203 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 113' ' ' CYS . . . 100.77 -41.42 2.15 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.587 -0.816 . . . . 1.69 112.103 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 20.0 t -64.25 -26.94 68.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.028 0.442 . . . . 2.0 110.126 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.497 ' O ' ' HB2' ' A' ' 171' ' ' TYR . 44.3 p-90 -86.26 -21.16 27.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.83 111.201 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 15.5 mt -82.49 -14.93 54.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.785 0.291 . . . . 1.28 111.785 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -74.63 -4.35 36.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.152 0.501 . . . . 2.03 109.911 174.292 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 168' ' ' TRP . 13.2 m-85 -76.3 -32.56 58.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.602 -0.726 . . . . 2.19 111.547 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -62.87 134.94 27.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.406 -0.518 . . . . 1.24 110.406 -175.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.483 ' CB ' ' HB3' ' A' ' 94' ' ' ALA . 13.3 mmm180 -110.2 160.1 16.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.084 0.469 . . . . 4.97 111.549 -177.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 62.6 t -67.05 147.12 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.569 -0.741 . . . . 1.63 109.31 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.5 ' HB2' HD13 ' A' ' 183' ' ' LEU . . . -54.22 141.72 28.48 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.274 0.559 . . . . 1.34 112.117 -177.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 44.9 t -91.26 -2.8 57.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.247 -0.888 . . . . 2.58 110.34 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 180' ' ' ASP . 41.5 m -141.65 145.95 35.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.199 0.523 . . . . 2.06 110.548 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 59.8 m -72.19 -31.25 65.73 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.551 -0.749 . . . . 2.69 111.584 -173.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -84.05 2.4 39.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.151 0.5 . . . . 2.42 110.428 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 177' ' ' SER . 4.2 t70 -108.91 16.65 22.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.523 -0.762 . . . . 2.12 110.507 -173.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -63.89 114.19 3.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.037 0.446 . . . . 1.52 110.555 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.492 ' H ' HD12 ' A' ' 183' ' ' LEU . 10.5 t30 -148.6 32.27 0.79 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.045 -1.094 . . . . 1.68 108.045 175.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.687 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 1.4 mp -117.15 122.16 43.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.334 -0.848 . . . . 1.43 110.746 -172.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 95.3 m -148.72 136.74 20.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.971 0.415 . . . . 1.2 110.306 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 49.7 ttm -106.07 141.92 36.63 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.54 -0.541 . . . . 1.56 109.54 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 53.4 t -111.93 131.61 55.27 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.268 -0.641 . . . . 2.13 109.268 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.1 103.86 9.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.146 -0.687 . . . . 1.96 109.146 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.506 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 22.4 pt -138.08 144.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.627 -0.715 . . . . 1.62 109.842 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.8 m 60.41 31.9 20.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.858 0.361 . . . . 2.24 111.392 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 60.11 24.09 13.36 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.785 -0.643 . . . . 2.83 112.026 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.4 pt20 -130.37 161.42 31.36 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.975 -0.38 . . . . 1.86 109.975 176.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.499 HD11 ' CE2' ' A' ' 128' ' ' TRP . 49.3 mm -103.94 131.45 52.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.21 0.529 . . . . 1.59 112.274 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.63 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 30.1 m-85 -133.48 147.85 51.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.266 -0.879 . . . . 4.16 110.027 174.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.412 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 4.9 m-30 -101.57 114.44 28.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.739 -0.467 . . . . 1.27 109.739 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -99.22 121.81 41.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.392 . . . . 1.73 110.246 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 1.9 t -89.23 150.95 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 122.074 0.94 . . . . 1.33 110.173 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -95.6 -55.28 6.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 113.866 -1.515 . . . . 1.23 110.796 -165.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.39 175.22 10.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.758 -1.11 . . . . 1.88 109.733 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.621 ' HA ' ' O ' ' A' ' 104' ' ' MET . 9.2 p-10 -59.45 115.82 3.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.76 0.79 . . . . 2.23 112.2 -172.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.502 HG13 ' HE1' ' A' ' 104' ' ' MET . 4.8 mm -69.33 140.13 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.857 -1.065 . . . . 1.41 110.867 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 37.2 mt-10 -84.04 118.19 70.64 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.21 -0.663 . . . . 2.06 109.21 171.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -45.58 121.17 3.78 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.943 2.428 . . . . 0.56 112.731 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.74 -11.17 9.56 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.91 -0.662 . . . . 0.7 112.506 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 10.9 pt-20 -133.92 124.65 26.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 1.27 110.965 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.484 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -109.45 107.66 17.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.82 0.343 . . . . 2.92 111.066 177.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.573 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.2 mm? -123.41 98.93 6.08 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.186 -0.606 . . . . 1.51 110.354 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.521 ' HB2' HG23 ' A' ' 172' ' ' ILE . 1.6 mm? -148.17 105.48 3.64 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.096 -0.705 . . . . 1.16 109.096 174.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.687 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 24.5 t -154.58 158.67 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.182 -1.044 . . . . 1.5 108.182 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -85.01 108.49 17.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.895 -1.15 . . . . 1.77 107.895 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.3 m -85.06 94.55 3.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.674 0.749 . . . . 3.05 110.68 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -93.19 125.64 37.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.424 -0.807 . . . . 5.7 111.05 -175.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -132.98 26.25 4.27 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.042 -0.981 . . . . 5.8 109.4 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.522 ' HA3' HD12 ' A' ' 217' ' ' LEU . . . 105.29 97.43 2.49 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.17 -0.923 . . . . 5.61 111.34 -174.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 28.2 t -98.01 -62.39 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.177 0.513 . . . . 6.31 110.276 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.601 ' HH ' ' HB3' ' A' ' 222' ' ' PRO . 59.5 t80 -59.31 -52.0 77.51 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.003 -0.999 . . . . 9.04 111.766 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 19.3 Cg_endo -61.63 -42.99 29.09 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.275 1.983 . . . . 7.78 112.946 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.522 HD12 ' HA3' ' A' ' 213' ' ' GLY . 7.6 mp -89.64 28.76 1.25 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.071 0.462 . . . . 8.02 110.917 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -149.38 170.21 29.64 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.961 -0.856 . . . . 8.64 110.961 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.1 m -104.56 17.07 24.82 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.179 0.514 . . . . 9.96 110.447 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 221' ' ' PRO . 6.6 m -61.63 125.81 85.44 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.713 -0.676 . . . . 9.62 111.266 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 10.6 Cg_exo -71.37 155.27 60.42 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.69 2.26 . . . . 12.02 111.975 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.601 ' HB3' ' HH ' ' A' ' 215' ' ' TYR . 69.5 Cg_endo -75.11 48.41 2.02 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.081 2.521 . . . . 13.11 111.689 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 122.21 -99.85 0.68 Allowed Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.715 -0.954 . . . . 14.03 110.715 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 33.9 tp -151.04 122.42 7.85 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.646 -0.501 . . . . 16.32 109.646 176.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -112.16 -66.38 1.09 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.368 -0.378 . . . . 17.7 110.756 -176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 . . . . . 0 C--O 1.249 1.064 0 O-C-N 123.71 0.632 . . . . 18.9 111.274 -179.55 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.945 -0.462 . . . . 33.41 111.945 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.5 m -135.41 46.9 2.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.199 0.523 . . . . 34.1 110.551 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.78 8.03 17.08 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.575 -0.821 . . . . 32.51 112.274 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -102.15 139.71 20.52 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.325 -0.25 . . . . 31.98 110.325 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.42 98.47 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.427 2.085 . . . . 30.45 111.497 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 p -64.91 113.42 3.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.284 0.564 . . . . 29.01 110.967 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.3 m -153.12 44.11 0.63 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.59 -0.732 . . . . 27.14 109.286 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.2 67.0 9.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.355 -0.839 . . . . 25.83 111.129 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -106.46 140.12 39.85 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.01 -0.541 . . . . 23.8 109.653 176.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -62.92 109.25 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.0 0.429 . . . . 22.03 110.381 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.7 m -108.97 117.99 52.49 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.864 -0.607 . . . . 19.63 110.821 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.85 144.74 97.06 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.604 2.203 . . . . 17.86 111.402 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.471 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 62.9 mttp -86.21 40.43 0.87 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.161 0.505 . . . . 17.61 111.889 -175.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -96.77 116.72 29.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.435 -0.58 . . . . 15.63 109.435 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.47 -4.75 84.1 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.798 -0.715 . . . . 12.12 111.89 -176.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 63' ' ' LYS . 14.9 m -65.42 -46.11 69.78 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.436 0.532 . . . . 10.78 112.436 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.449 ' HD3' ' HB2' ' A' ' 66' ' ' SER . 52.5 Cg_exo -57.26 98.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 121.975 1.783 . . . . 10.17 112.12 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -98.75 125.97 44.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.595 -0.73 . . . . 7.8 111.47 -175.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -95.96 135.95 37.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.714 -0.675 . . . . 8.14 109.432 174.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.69 112.92 46.05 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.46 -0.337 . . . . 6.11 110.689 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -62.14 -76.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.269 2.646 . . . . 6.51 112.564 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.3 p -120.96 -32.31 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.399 . . . . 6.76 110.801 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -105.69 119.86 40.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.055 -0.521 . . . . 5.18 109.763 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.551 ' O ' HD11 ' A' ' 74' ' ' ILE . 2.3 pp -79.06 138.37 56.79 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.978 0.418 . . . . 4.5 110.994 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.12 -2.34 12.56 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.752 2.302 . . . . 4.4 113.003 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -72.82 -62.72 1.35 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.688 -0.486 . . . . 3.91 109.688 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 t70 57.2 83.34 0.11 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.766 -1.106 . . . . 3.16 111.02 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.43 132.94 91.17 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.446 -0.797 . . . . 2.82 110.45 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.39 121.45 8.88 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.9 2.4 . . . . 2.04 112.522 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.457 ' H ' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -120.83 152.96 56.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.901 -0.59 . . . . 1.53 109.934 178.386 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.85 150.58 85.74 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.391 2.061 . . . . 0.88 110.995 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.23 8.36 1.35 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.876 -0.602 . . . . 1.58 112.377 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -112.88 1.23 15.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.143 0.497 . . . . 1.66 111.243 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -137.38 136.11 37.58 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.396 -0.964 . . . . 1.2 108.396 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -123.12 130.02 52.21 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.077 -0.649 . . . . 2.27 111.127 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tt -83.7 130.55 34.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 1.37 109.505 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.481 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 97.0 mtt180 -143.71 126.85 16.53 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.507 -0.77 . . . . 3.75 109.468 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.76 111.78 17.52 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.479 -0.488 . . . . 2.46 109.891 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.0 p -162.69 97.47 0.96 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.657 -0.701 . . . . 2.03 109.463 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.5 m -68.21 104.08 1.73 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.966 0.412 . . . . 2.18 110.777 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -87.04 122.19 71.24 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.233 -0.654 . . . . 1.96 109.233 175.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.54 119.09 4.68 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.187 2.591 . . . . 1.87 112.821 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.01 -20.43 28.8 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 121.003 -0.618 . . . . 1.74 112.685 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.74 -72.45 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.032 0.416 . . . . 1.79 111.3 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.519 ' HA3' ' NH1' ' A' ' 173' ' ' ARG . . . 131.85 -130.58 5.99 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.932 -0.651 . . . . 1.14 112.557 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt -99.68 158.17 15.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.681 0.24 . . . . 2.81 110.485 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.24 -179.85 39.33 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.269 -0.732 . . . . 0.8 111.269 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.407 ' O ' HG21 ' A' ' 98' ' ' VAL . 33.8 m -102.9 119.69 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.543 0.687 . . . . 1.17 109.504 174.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.481 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 49.4 m95 -83.83 114.62 21.76 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.562 -0.744 . . . . 1.4 111.023 -170.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.23 115.29 12.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.067 -0.716 . . . . 1.2 109.067 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -92.55 2.27 56.79 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.648 0.737 . . . . 2.23 109.641 -176.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -125.75 161.24 27.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.979 -1.01 . . . . 4.08 108.355 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 155.99 39.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.0 0.428 . . . . 2.86 111.169 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.655 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 34.8 mtm -120.15 149.31 42.44 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.393 -0.966 . . . . 1.38 108.393 171.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 47.1 mt-10 -119.39 173.88 6.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.523 0.678 . . . . 2.31 112.399 -172.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.12 115.58 6.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.884 -1.053 . . . . 1.42 111.976 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.32 1.88 57.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.685 -0.769 . . . . 1.04 113.522 171.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 6.8 pt-20 -86.07 166.27 15.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.483 0.641 . . . . 2.62 110.647 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.48 ' HG2' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -127.96 143.41 51.09 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.109 -0.496 . . . . 4.16 110.233 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.48 ' N ' ' HG2' ' A' ' 109' ' ' ARG . 7.5 mt -87.35 125.8 34.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.128 -1.064 . . . . 1.11 108.128 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -140.73 157.14 25.7 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 119.885 -1.15 . . . . 1.09 113.17 -172.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.92 154.33 96.94 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.585 -1.839 . . . . 2.52 112.175 -1.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.5 ' HA ' HD13 ' A' ' 169' ' ' LEU . 59.5 m -92.31 -21.47 20.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.913 -0.585 . . . . 2.5 111.061 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.6 m -140.05 176.37 5.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.991 -0.55 . . . . 2.46 110.056 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 164' ' ' GLY . 29.9 m -65.01 -178.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.513 0.673 . . . . 4.37 111.354 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.0 m -73.52 156.79 88.51 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.707 -0.678 . . . . 5.65 110.15 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.72 167.83 4.85 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.503 2.135 . . . . 5.38 112.138 176.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 70.52 -171.7 0.17 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.878 -0.601 . . . . 8.57 109.725 -173.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 58.2 -161.28 0.24 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.783 0.325 . . . . 7.27 111.211 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.28 92.6 1.43 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.092 -0.504 . . . . 6.4 110.383 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.65 116.98 9.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.377 -0.374 . . . . 5.88 111.006 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -88.28 143.18 27.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.044 -0.525 . . . . 7.76 110.655 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -64.77 -39.3 93.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.747 -0.66 . . . . 9.01 109.798 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.4 m -149.06 -102.02 0.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.625 -0.716 . . . . 9.14 109.497 171.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -159.5 25.18 0.19 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.99 0.424 . . . . 7.6 110.116 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -141.45 155.9 45.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.956 -0.566 . . . . 8.0 111.194 -172.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 119.61 -38.76 2.69 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.901 -0.879 . . . . 4.59 110.901 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.72 -111.91 0.06 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.987 -0.607 . . . . 4.93 111.034 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 130' ' ' GLN . 6.2 pt-20 -149.42 -60.39 0.21 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.522 0.201 . . . . 7.65 110.959 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.414 ' H ' ' HG3' ' A' ' 129' ' ' GLU . 78.9 mt-30 -150.65 141.78 23.11 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 110.223 -0.288 . . . . 9.61 110.223 -176.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 pp -124.26 19.93 4.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.858 0.361 . . . . 6.05 111.917 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -90.41 50.82 1.9 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.484 1.135 . . . . 8.5 109.509 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.2 t -94.67 25.29 4.09 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.721 -1.581 . . . . 9.82 111.03 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -73.58 132.66 43.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.611 -0.885 . . . . 11.21 108.611 172.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 40.2 t -74.21 85.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.526 0.679 . . . . 10.92 110.57 -174.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -103.9 1.57 31.5 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.34 -0.846 . . . . 13.25 109.922 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.5 m -80.84 -7.18 10.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.654 -0.703 . . . . 14.01 111.076 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.438 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 44.0 m -85.59 144.26 39.79 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.079 -0.51 . . . . 14.1 110.065 177.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.26 107.6 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.859 2.372 . . . . 14.7 112.261 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 138' ' ' SER . 12.3 mm100 -102.62 38.26 1.75 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.992 -0.549 . . . . 14.44 109.614 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -78.09 -36.47 48.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.492 -0.776 . . . . 15.9 110.841 -173.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -94.19 169.64 29.47 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.762 -0.733 . . . . 16.0 112.171 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 5.4 p -77.69 57.61 1.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.252 0.549 . . . . 15.6 111.142 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 53.7 mt -82.21 -46.54 19.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.742 -0.663 . . . . 14.1 109.841 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.4 p -82.95 134.67 35.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.639 -0.71 . . . . 13.19 111.34 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.517 ' HB2' ' HZ2' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -105.09 -3.41 23.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.209 0.528 . . . . 15.92 109.882 178.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.485 ' O ' HD13 ' A' ' 147' ' ' ILE . 2.2 pp -80.68 142.23 14.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.457 -0.792 . . . . 14.07 111.458 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.0 p -173.04 48.18 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.301 -0.863 . . . . 13.67 108.81 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -74.59 106.23 6.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.992 -1.003 . . . . 13.02 110.813 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -72.36 127.15 31.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.903 -0.589 . . . . 14.68 111.015 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 pp -130.06 31.95 4.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.791 -0.641 . . . . 13.55 109.49 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 132.05 96.57 0.67 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.14 -0.936 . . . . 15.8 111.179 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.8 m -65.79 -35.23 80.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.83 0.347 . . . . 17.08 111.246 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -106.19 -72.09 0.73 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.391 0.615 . . . . 18.43 110.743 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -129.77 142.11 50.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.245 -0.888 . . . . 18.74 111.171 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -148.37 126.18 11.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.951 -0.568 . . . . 14.81 110.472 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 84.8 m -83.96 61.04 6.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.843 0.354 . . . . 14.64 110.505 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 42.6 t 62.91 108.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.248 -0.887 . . . . 13.38 111.05 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.581 ' OD2' ' HB2' ' A' ' 162' ' ' GLN . 5.2 t70 60.57 169.49 0.09 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.08 -0.964 . . . . 10.61 111.07 -172.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -177.32 -43.54 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.824 -0.625 . . . . 10.22 110.438 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -114.87 19.34 15.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.988 -0.551 . . . . 10.69 111.453 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.581 ' HB2' ' OD2' ' A' ' 159' ' ' ASP . 21.7 mt-30 -127.59 -48.87 1.4 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.036 -0.266 . . . . 9.45 110.702 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 62.01 53.24 3.07 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.365 0.603 . . . . 6.56 110.602 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 115' ' ' VAL . . . -146.12 87.73 0.16 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.381 -0.827 . . . . 4.17 111.557 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 115' ' ' VAL . . . -143.65 170.22 16.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.62 0.248 . . . . 3.14 110.84 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -115.95 14.02 16.86 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.424 -0.671 . . . . 1.69 111.424 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 8.7 t -64.56 -17.66 64.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.267 0.556 . . . . 2.0 110.628 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.497 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 26.9 p-90 -74.31 -21.76 59.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.297 0.57 . . . . 0.83 110.274 177.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 40.6 mt -86.43 -20.22 28.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.738 -0.665 . . . . 1.28 112.1 -175.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -71.88 -5.04 31.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.623 -0.431 . . . . 2.03 110.577 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -79.9 -37.27 35.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.913 -0.585 . . . . 2.19 111.798 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.696 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -62.83 131.64 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.751 -0.38 . . . . 1.24 110.273 -178.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.519 ' NH1' ' HA3' ' A' ' 95' ' ' GLY . 99.2 mtt180 -115.07 -171.41 1.94 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.296 -0.411 . . . . 4.97 111.429 -174.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.4 t -76.47 141.0 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-N 116.298 -0.41 . . . . 1.63 110.229 -177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.492 ' HB1' ' NE2' ' A' ' 181' ' ' GLN . . . -61.07 138.44 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.821 -0.627 . . . . 1.34 111.944 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 37.6 t -72.85 -6.87 47.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.169 -0.923 . . . . 2.58 110.69 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.3 t -126.07 139.77 53.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 2.06 110.383 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 61.6 m -88.15 -18.81 27.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.052 -0.522 . . . . 2.69 110.59 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -83.97 -14.95 49.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.102 0.477 . . . . 2.42 110.522 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -110.04 17.57 20.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.828 -0.624 . . . . 2.12 111.185 -176.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.492 ' NE2' ' HB1' ' A' ' 175' ' ' ALA . 30.1 mm-40 -54.94 115.49 2.23 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.179 0.514 . . . . 1.52 110.86 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.545 ' H ' HD11 ' A' ' 183' ' ' LEU . 5.5 p-10 -144.05 32.36 1.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.667 0.746 . . . . 1.68 109.384 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.601 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.2 OUTLIER -116.0 124.51 50.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.038 -0.983 . . . . 1.43 110.606 -173.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 97.7 m -146.49 121.59 10.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.287 0.565 . . . . 1.2 111.387 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.588 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 39.0 ttm -113.24 129.49 56.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 1.56 109.431 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 35.2 t -115.86 165.05 13.52 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.407 -0.59 . . . . 2.13 109.407 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -129.88 105.23 7.86 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.166 -0.679 . . . . 1.96 109.166 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.62 143.93 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.748 -0.66 . . . . 1.62 110.518 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.4 t 62.56 34.06 15.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.254 0.549 . . . . 2.24 110.312 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 58.32 30.0 18.93 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.377 -0.829 . . . . 2.83 111.979 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -140.54 167.28 22.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.996 0.427 . . . . 1.86 110.212 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.3 mm -82.29 152.33 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.982 -0.748 . . . . 1.59 108.982 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -143.75 120.1 10.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.754 0.311 . . . . 4.16 110.542 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 15.0 m-85 -100.9 113.49 26.49 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.734 -0.469 . . . . 1.27 109.734 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -118.79 129.45 55.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.654 0.264 . . . . 1.73 110.31 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 1.2 t -95.3 150.99 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.951 0.882 . . . . 1.33 110.645 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -98.68 -45.47 12.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.176 -1.375 . . . . 1.23 112.004 -163.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 199' ' ' ASP . 0.1 OUTLIER -154.84 -177.66 6.67 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.155 -0.929 . . . . 1.88 109.886 -173.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.655 ' HA ' ' O ' ' A' ' 104' ' ' MET . 15.4 t70 -59.22 123.32 16.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.374 0.607 . . . . 2.23 111.515 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.465 HG13 ' HE3' ' A' ' 104' ' ' MET . 14.8 mm -106.94 136.58 41.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.805 -0.634 . . . . 1.41 110.323 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.54 122.6 80.89 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.714 -0.676 . . . . 2.06 110.331 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -51.46 119.97 6.26 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.51 2.14 . . . . 0.56 111.745 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.72 -8.5 9.35 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.456 -0.878 . . . . 0.7 112.374 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -132.5 123.24 26.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.295 0.569 . . . . 1.27 110.146 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.3 96.2 6.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.729 -0.668 . . . . 2.92 111.436 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.455 ' C ' HD22 ' A' ' 207' ' ' LEU . 0.8 OUTLIER -115.58 99.89 7.67 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.836 -0.745 . . . . 1.51 110.114 177.195 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.696 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.87 112.99 6.14 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.069 -0.715 . . . . 1.16 109.069 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.601 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 3.9 p -155.28 160.08 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 O-C-N 121.984 -0.447 . . . . 1.5 110.96 -176.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.588 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 54.9 t-80 -80.27 128.6 33.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.564 -0.902 . . . . 1.77 108.564 166.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.48 94.58 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.386 -0.598 . . . . 3.05 109.386 174.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 209' ' ' HIS . 49.8 mtpt -86.78 126.67 34.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.615 -0.721 . . . . 5.7 111.017 -173.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 216' ' ' PRO . 12.3 pt-20 -154.1 -147.69 0.22 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.469 -0.787 . . . . 5.8 108.9 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -81.63 42.66 2.82 Favored Glycine 0 C--N 1.32 -0.324 0 C-N-CA 121.098 -0.573 . . . . 5.61 113.401 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 29.9 t -109.35 -80.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.946 0.403 . . . . 6.31 110.698 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.481 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 64.0 m-85 -94.95 -50.03 0.25 Allowed Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 113.022 0.749 . . . . 9.04 113.022 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 17.8 Cg_endo -60.79 -44.87 23.23 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.741 1.627 . . . . 7.78 112.709 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.8 mp -86.72 -25.26 24.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.218 0.532 . . . . 8.02 110.707 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 69.81 17.11 72.96 Favored Glycine 0 C--N 1.33 0.247 0 CA-C-N 115.582 -0.735 . . . . 8.64 112.891 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.9 p -88.1 48.8 1.69 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.241 0.543 . . . . 9.96 111.542 -176.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 221' ' ' PRO . 3.9 m -85.63 116.49 65.85 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.8 -0.636 . . . . 9.62 111.251 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 2.3 Cg_endo -80.34 129.35 7.56 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.637 2.225 . . . . 12.02 111.509 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.52 95.41 0.39 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.637 2.225 . . . . 13.11 112.267 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 88.92 165.24 41.09 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.788 -0.642 . . . . 14.03 112.215 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 50.0 tp -115.38 123.98 50.06 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.734 -0.469 . . . . 16.32 109.734 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.62 -22.61 14.42 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.984 0.421 . . . . 17.7 110.983 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.321 -0.847 . . . . 18.9 109.759 177.111 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 111.737 -0.545 . . . . 33.41 111.737 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.1 p -65.4 110.33 2.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.11 0.481 . . . . 34.1 111.342 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.73 -41.84 0.69 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.302 -0.719 . . . . 32.51 111.302 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -120.15 108.38 38.37 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.785 -0.45 . . . . 31.98 109.785 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.76 125.92 16.39 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.498 2.132 . . . . 30.45 111.717 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.7 p 46.81 68.72 0.58 Allowed 'General case' 0 C--O 1.233 0.227 0 O-C-N 123.759 0.662 . . . . 29.01 111.465 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.4 m -62.66 141.93 58.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.907 -0.588 . . . . 27.14 109.969 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -103.01 18.81 20.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.217 0.532 . . . . 25.83 110.498 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -90.65 51.6 2.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.756 -0.656 . . . . 23.8 110.662 -177.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -70.9 109.5 5.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 22.03 110.736 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.4 p -113.06 108.74 52.85 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.551 -0.75 . . . . 19.63 110.371 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.24 117.43 4.28 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.576 2.184 . . . . 17.86 112.235 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -114.31 55.55 0.74 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.585 -0.734 . . . . 17.61 109.061 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -108.48 103.91 13.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.361 -0.836 . . . . 15.63 110.913 -172.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.21 64.61 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.528 -0.844 . . . . 12.12 112.517 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -128.0 86.38 58.27 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.722 0.296 . . . . 10.78 110.78 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -86.48 156.07 9.25 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.865 2.377 . . . . 10.17 112.671 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.416 ' CE1' ' HG2' ' A' ' 75' ' ' PRO . 71.7 t80 -76.2 85.44 3.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.737 -0.665 . . . . 7.8 109.644 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.48 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 8.9 tp10 -81.72 121.17 26.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.25 -0.432 . . . . 8.14 110.088 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.4 93.45 13.67 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 116.132 -0.485 . . . . 6.11 110.808 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 69' ' ' GLU . 28.6 Cg_endo -91.53 -156.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.983 2.455 . . . . 6.51 111.74 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.21 -31.8 46.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.08 0.466 . . . . 6.76 110.793 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -111.03 107.01 16.27 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.528 -0.545 . . . . 5.18 109.528 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.405 HD13 ' CG ' ' A' ' 76' ' ' GLU . 27.9 pt -80.11 154.43 74.92 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.202 -0.453 . . . . 4.5 111.232 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.416 ' HG2' ' CE1' ' A' ' 68' ' ' TYR . 87.1 Cg_endo -87.8 14.67 2.31 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.972 2.448 . . . . 4.4 113.163 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.405 ' CG ' HD13 ' A' ' 74' ' ' ILE . 24.5 mm-40 -68.82 -58.86 3.59 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.283 -0.636 . . . . 3.91 109.283 173.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 66.21 84.73 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.597 -1.183 . . . . 3.16 111.503 175.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 74.0 mt -86.71 120.04 71.6 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.152 -0.931 . . . . 2.82 109.95 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.91 116.96 4.12 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.347 2.031 . . . . 2.04 111.442 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.415 HG22 ' HB3' ' A' ' 168' ' ' TRP . 0.2 OUTLIER -131.59 147.28 65.41 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.399 -0.364 . . . . 1.53 110.365 -178.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.93 133.05 14.82 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.346 2.031 . . . . 0.88 110.761 171.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.03 -8.88 33.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.317 . . . . 1.58 111.6 -176.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -70.74 -19.7 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.049 -0.523 . . . . 1.66 110.606 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.52 ' CZ ' HD21 ' A' ' 110' ' ' LEU . 19.0 m-85 -123.78 148.27 46.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.346 -0.612 . . . . 1.2 109.346 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.4 ' HB2' ' HE2' ' A' ' 101' ' ' LYS . 7.2 tp10 -109.9 117.38 33.67 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.786 -0.366 . . . . 2.27 110.495 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.408 HD11 ' CE2' ' A' ' 171' ' ' TYR . 8.3 tt -83.67 130.09 34.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.409 -0.589 . . . . 1.37 109.409 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -143.89 124.4 13.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.06 -0.518 . . . . 3.75 111.443 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -83.03 112.48 19.81 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.432 -0.581 . . . . 2.46 109.432 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 33.0 t -170.09 149.58 3.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.118 -0.697 . . . . 2.03 109.118 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.3 m -100.61 104.91 16.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.746 0.308 . . . . 2.18 110.871 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.525 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -97.56 123.77 50.99 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.229 -0.656 . . . . 1.96 109.229 175.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.16 121.1 9.36 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.023 2.482 . . . . 1.87 112.738 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.48 -15.66 35.16 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.724 -0.671 . . . . 1.74 112.07 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.433 ' HB2' HG21 ' A' ' 91' ' ' ILE . . . -132.99 -60.14 0.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.839 0.352 . . . . 1.79 111.7 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.525 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 121.74 -125.87 6.28 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.307 -0.717 . . . . 1.14 111.307 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 89' ' ' SER . 0.7 OUTLIER -89.0 160.67 17.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.803 -0.443 . . . . 2.81 109.803 173.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.2 169.49 41.27 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.19 -1.005 . . . . 0.8 112.779 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 205' ' ' GLU . 11.3 m -104.2 148.81 8.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.1 -0.704 . . . . 1.17 109.1 174.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -118.53 120.17 36.71 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.647 0.26 . . . . 1.4 110.753 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.477 ' H ' ' HG2' ' A' ' 205' ' ' GLU . . . -71.61 122.36 20.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.235 -0.283 . . . . 1.2 110.235 176.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.613 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -90.36 11.91 19.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.657 0.741 . . . . 2.23 110.141 -178.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.2 ttp85 -137.35 159.11 42.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.155 -0.929 . . . . 4.08 108.565 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.655 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -85.34 155.93 21.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.956 0.408 . . . . 2.86 110.744 -178.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.486 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 63.0 mtm -132.05 153.01 50.84 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.171 -0.677 . . . . 1.38 109.171 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -120.07 143.68 47.99 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.13 0.269 . . . . 2.31 110.842 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -34.89 117.33 0.38 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.76 1.287 . . . . 1.42 113.544 -172.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.44 7.89 11.77 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.688 -0.687 . . . . 1.04 111.76 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.489 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -80.39 161.71 24.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.114 0.483 . . . . 2.62 110.71 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.549 ' HG3' ' CE2' ' A' ' 193' ' ' TYR . 0.0 OUTLIER -141.17 145.45 35.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.139 -0.482 . . . . 4.16 110.513 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.52 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 6.3 mt -107.51 150.74 26.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.36 -0.607 . . . . 1.11 109.36 173.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.13 -143.24 17.14 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.318 -0.944 . . . . 1.09 113.319 173.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.23 165.94 47.59 Favored 'Cis proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.822 -1.324 . . . . 2.52 113.316 2.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 31.7 t -87.51 -57.96 2.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 2.5 110.655 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.7 m -115.48 132.29 65.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.905 0.383 . . . . 2.46 110.35 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.29 35.99 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.899 0.857 . . . . 4.37 109.285 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.9 p -89.63 116.91 67.55 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.1 -0.955 . . . . 5.65 110.783 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.43 ' O ' ' HB2' ' A' ' 118' ' ' ARG . 60.7 Cg_endo -88.15 104.5 0.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.733 2.289 . . . . 5.38 112.1 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.601 ' NE ' ' HA ' ' A' ' 118' ' ' ARG . 1.4 mmp_? 73.76 144.93 0.08 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.727 -0.669 . . . . 8.57 111.42 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 54.49 62.81 2.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.226 -0.897 . . . . 7.27 110.349 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.75 114.52 2.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.687 -0.688 . . . . 6.4 111.527 -178.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.46 122.56 21.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.761 -0.654 . . . . 5.88 110.304 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -76.51 167.27 22.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.887 -0.597 . . . . 7.76 110.278 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.424 ' C ' ' HG1' ' A' ' 124' ' ' THR . 40.0 mt-10 -59.68 -74.4 0.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.94 0.4 . . . . 9.01 110.338 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.424 ' HG1' ' C ' ' A' ' 123' ' ' GLU . 42.8 m -159.15 -56.36 0.06 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.38 -0.6 . . . . 9.14 109.38 175.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -73.46 160.13 32.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.54 -0.755 . . . . 7.6 110.569 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -141.32 139.76 33.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.012 0.434 . . . . 8.0 110.631 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -89.15 -9.21 67.76 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.96 -0.638 . . . . 4.59 111.865 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . 0.49 ' HB3' ' HB3' ' A' ' 209' ' ' HIS . 0.8 OUTLIER -130.76 -78.41 0.53 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 110.553 -0.166 . . . . 4.93 110.553 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.627 ' OE1' ' HD2' ' A' ' 216' ' ' PRO . 1.8 pt-20 -168.42 -72.94 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.624 0.231 . . . . 7.65 111.624 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -171.76 160.68 5.72 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.247 -0.279 . . . . 9.61 110.247 -174.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.66 47.75 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 6.05 111.503 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.14 53.45 2.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 122.327 1.06 . . . . 8.5 111.065 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.3 p -95.31 27.32 3.35 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.143 -1.389 . . . . 9.82 109.282 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -133.56 98.51 4.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.609 -1.178 . . . . 11.21 109.992 -175.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 49.7 t -77.48 109.81 12.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.953 -0.567 . . . . 10.92 109.97 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -76.12 78.62 2.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.308 0.575 . . . . 13.25 110.282 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p -128.71 4.42 2.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.529 0.681 . . . . 14.01 110.294 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.0 m -127.67 97.58 30.13 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.074 -0.512 . . . . 14.1 111.111 -175.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.87 77.69 3.98 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.657 2.238 . . . . 14.7 111.683 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.24 30.66 2.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.713 -0.676 . . . . 14.44 110.983 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -95.39 171.62 8.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.83 -0.623 . . . . 15.9 110.546 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.77 -80.04 0.2 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.939 -0.573 . . . . 16.0 111.669 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 7.0 p -111.66 46.13 1.15 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.124 0.488 . . . . 15.6 110.78 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 61.5 mt -76.37 -38.13 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.112 0.482 . . . . 14.1 110.272 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.7 t -82.11 55.92 2.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.2 1.0 . . . . 13.19 110.332 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -90.8 -16.25 28.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.413 -0.812 . . . . 15.92 110.229 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.1 pp -96.85 155.24 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.562 -0.744 . . . . 14.07 110.661 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.4 m -136.09 152.72 51.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.687 0.279 . . . . 13.67 110.838 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.38 85.1 4.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.233 -0.439 . . . . 13.02 110.374 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.68 79.49 9.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.0 -0.546 . . . . 14.68 110.501 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.3 54.05 2.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.6 0.714 . . . . 13.55 110.741 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.85 137.28 2.96 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.32 -0.854 . . . . 15.8 111.035 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.3 m -76.26 -16.83 59.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.202 0.525 . . . . 17.08 110.805 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -113.35 -66.08 1.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.402 0.62 . . . . 18.43 109.787 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.03 170.88 15.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.19 -0.914 . . . . 18.74 109.128 177.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -132.48 27.89 4.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.272 0.558 . . . . 14.81 110.925 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 50.4 t -75.8 90.02 2.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.355 -0.839 . . . . 14.64 110.33 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.1 p -161.91 135.94 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.788 -0.642 . . . . 13.38 109.994 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -75.76 63.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.457 0.646 . . . . 10.61 110.84 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -116.41 -69.29 0.86 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.136 -0.938 . . . . 10.22 109.562 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -93.23 -13.92 27.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.311 0.576 . . . . 10.69 109.783 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.436 ' C ' ' H ' ' A' ' 164' ' ' GLY . 97.8 mt-30 -84.47 -18.93 34.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.481 -0.781 . . . . 9.45 110.398 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.48 35.18 0.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.78 -0.645 . . . . 6.56 111.148 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 162' ' ' GLN . . . -87.14 55.78 4.57 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.831 -0.622 . . . . 4.17 111.567 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.35 -30.78 68.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.964 0.411 . . . . 3.14 110.835 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.85 -34.62 3.16 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.005 -0.617 . . . . 1.69 112.333 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.509 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 1.2 m -57.27 -29.9 64.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.668 0.387 . . . . 2.0 111.499 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.415 ' HB3' HG22 ' A' ' 80' ' ' ILE . 45.5 p-90 -85.59 -23.46 27.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.83 111.13 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 17.7 mt -86.4 -15.55 40.01 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.805 0.298 . . . . 1.28 111.805 -177.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -76.13 -1.71 27.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.806 -0.358 . . . . 2.03 110.413 177.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.408 ' CE2' HD11 ' A' ' 86' ' ' LEU . 37.9 m-85 -81.67 -37.13 27.92 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.112 -0.495 . . . . 2.19 112.058 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.686 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -65.07 140.99 18.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 120.151 -0.62 . . . . 1.24 110.913 -173.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 -123.7 -168.27 1.75 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.839 -0.619 . . . . 4.97 111.467 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.0 t -69.63 156.64 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.58 -0.737 . . . . 1.63 110.626 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.441 ' HA ' HD12 ' A' ' 206' ' ' LEU . . . -55.88 132.99 51.04 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.141 -0.481 . . . . 1.34 110.508 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.1 m -71.77 -20.87 61.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.604 -0.725 . . . . 2.58 111.033 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 24.7 m -130.63 157.11 43.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.466 -0.334 . . . . 2.06 111.181 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . 0.468 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 3.3 p -59.01 -56.71 18.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.219 0.451 . . . . 2.69 112.219 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.76 -1.4 21.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 2.42 111.758 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -95.06 17.32 14.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.264 -0.426 . . . . 2.12 111.623 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 30.2 mm-40 -56.57 113.77 1.75 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.976 0.417 . . . . 1.52 109.889 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.547 ' OD1' ' HG3' ' A' ' 198' ' ' LYS . 17.8 t30 -159.25 43.82 0.24 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.121 -1.066 . . . . 1.68 108.121 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.593 ' HB3' ' O ' ' A' ' 206' ' ' LEU . 0.7 OUTLIER -142.42 128.86 20.11 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.003 -0.998 . . . . 1.43 111.578 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 29.8 m -150.38 120.81 7.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.088 -0.96 . . . . 1.2 110.184 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.567 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 44.9 ttm -109.19 118.44 36.72 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.654 -0.498 . . . . 1.56 109.654 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 36.7 t -113.86 166.42 11.59 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.169 -0.469 . . . . 2.13 109.774 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -124.09 134.39 53.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.829 0.347 . . . . 1.96 110.653 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 23.5 pt -148.05 140.94 18.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.722 -0.672 . . . . 1.62 109.946 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 190' ' ' GLU . 8.3 t 54.4 38.99 30.6 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.113 0.482 . . . . 2.24 110.62 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 190' ' ' GLU . 37.0 tt0 72.79 -1.47 3.0 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.186 -0.916 . . . . 2.83 112.163 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -117.8 154.2 32.18 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.443 -0.785 . . . . 1.86 111.367 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.8 mm -81.66 129.12 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.348 -0.842 . . . . 1.59 111.157 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.549 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 72.8 t80 -114.97 131.19 56.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.763 -1.108 . . . . 4.16 109.737 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 3.9 m-85 -98.98 112.3 24.46 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.157 -0.683 . . . . 1.27 109.157 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.424 ' HD2' ' C ' ' A' ' 195' ' ' LYS . 5.0 tmmm? -112.1 120.07 40.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.7 -0.682 . . . . 1.73 109.454 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.489 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 1.8 t -94.33 150.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-O 121.591 0.71 . . . . 1.33 109.326 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.8 mm -87.71 -55.58 6.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.696 -1.138 . . . . 1.23 110.65 -166.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.547 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -144.71 -178.84 6.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.722 -0.672 . . . . 1.88 111.973 177.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.486 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.0 OUTLIER -47.25 128.71 12.15 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.767 1.025 . . . . 2.23 113.767 -171.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.48 HG13 ' HE1' ' A' ' 104' ' ' MET . 38.7 mm -95.25 136.79 25.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.348 -0.842 . . . . 1.41 110.545 176.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -89.55 123.3 67.01 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.457 -0.572 . . . . 2.06 109.457 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' A' ' 103' ' ' LYS . 77.2 Cg_exo -47.22 123.18 7.36 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.258 2.639 . . . . 0.56 112.602 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.2 -18.77 8.32 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.914 -0.66 . . . . 0.7 112.84 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -132.55 121.25 22.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.523 0.661 . . . . 1.27 111.898 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.477 ' HG2' ' H ' ' A' ' 100' ' ' ALA . 13.2 mm-40 -110.32 118.02 35.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 2.92 109.982 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.593 ' O ' ' HB3' ' A' ' 183' ' ' LEU . 1.9 mm? -112.28 100.8 9.09 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.376 -0.972 . . . . 1.51 108.376 171.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.686 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.3 mm? -143.44 113.49 7.23 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.492 0.495 . . . . 1.16 109.891 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.434 ' H ' ' HB2' ' A' ' 183' ' ' LEU . 1.4 p -152.21 159.53 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.837 0.351 . . . . 1.5 110.289 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.567 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 44.8 t-80 -98.52 111.22 23.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.689 -1.226 . . . . 1.77 107.689 171.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.5 m -66.91 110.36 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 109.241 -0.652 . . . . 3.05 109.241 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -51.05 124.59 11.75 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.565 -0.743 . . . . 5.7 111.279 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -111.37 -1.87 15.82 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.179 -0.918 . . . . 5.8 110.611 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 217' ' ' LEU . . . 101.22 67.05 0.8 Allowed Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.381 -0.827 . . . . 5.61 112.599 176.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 44.1 t -109.88 -62.09 2.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.59 0.71 . . . . 6.31 109.398 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.421 ' HB3' ' HD3' ' A' ' 216' ' ' PRO . 90.9 t80 -92.38 -63.07 0.18 Allowed Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.339 -0.846 . . . . 9.04 112.239 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.627 ' HD2' ' OE1' ' A' ' 129' ' ' GLU . 32.1 Cg_endo -63.56 -50.42 3.38 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.033 1.822 . . . . 7.78 113.355 -173.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.446 ' HB2' ' HA2' ' A' ' 213' ' ' GLY . 7.7 mp -73.64 -42.53 61.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 8.02 110.978 -177.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.41 -134.41 12.18 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.97 -0.634 . . . . 8.64 111.689 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 41.2 p 51.68 44.46 29.19 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.385 0.674 . . . . 9.96 111.191 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 27.2 m -67.7 153.25 95.38 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.675 -0.693 . . . . 9.62 111.616 -173.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.463 ' HB2' ' HD3' ' A' ' 222' ' ' PRO . 53.5 Cg_exo -50.5 -51.65 10.6 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.422 2.081 . . . . 12.02 113.404 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 221' ' ' PRO . 90.0 Cg_endo -77.72 27.27 0.47 Allowed 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 121.771 1.647 . . . . 13.11 112.57 176.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -101.57 153.44 18.85 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.501 -0.639 . . . . 14.03 111.501 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 40.6 tp -150.57 127.57 11.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.666 0.27 . . . . 16.32 110.829 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.08 6.77 4.6 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.832 -0.433 . . . . 17.7 109.832 174.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 . . . . . 0 C--O 1.252 1.203 0 CA-C-N 115.554 -0.748 . . . . 18.9 110.416 -177.213 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 112.27 -0.332 . . . . 33.41 112.27 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 p -132.21 36.37 3.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.278 0.561 . . . . 34.1 110.169 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.16 62.79 4.21 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.622 -0.717 . . . . 32.51 112.413 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 88.9 m-85 -102.36 133.41 20.58 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 109.817 -0.438 . . . . 31.98 109.817 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 54' ' ' PHE . 21.2 Cg_exo -65.36 83.28 0.21 Allowed 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.741 2.294 . . . . 30.45 111.679 176.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.2 p -73.31 -18.23 61.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.149 -0.478 . . . . 29.01 111.283 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.6 p -77.55 57.03 1.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.798 -0.637 . . . . 27.14 110.98 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.58 79.65 8.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.039 -0.528 . . . . 25.83 110.705 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.82 134.36 53.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.959 0.409 . . . . 23.8 110.402 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -117.13 98.43 6.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.591 . . . . 22.03 110.012 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.6 m -83.91 117.4 68.57 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.126 -0.488 . . . . 19.63 109.875 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.62 120.53 8.1 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.092 1.862 . . . . 17.86 110.978 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -81.25 66.19 6.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.499 0.666 . . . . 17.61 111.123 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -77.05 109.51 10.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.079 -0.964 . . . . 15.63 109.551 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.14 154.13 33.67 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 121.03 -0.605 . . . . 12.12 111.921 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.4 t -71.36 113.84 22.85 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 110.034 -0.358 . . . . 10.78 110.034 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -84.7 142.75 9.3 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.7 2.266 . . . . 10.17 112.344 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -83.49 129.16 34.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.637 -0.505 . . . . 7.8 109.637 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -96.08 136.43 36.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.849 -0.614 . . . . 8.14 110.219 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -63.36 118.55 44.84 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 116.175 -0.466 . . . . 6.11 110.116 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.404 ' HB2' ' H ' ' A' ' 72' ' ' VAL . 22.7 Cg_exo -65.43 -81.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.899 2.399 . . . . 6.51 112.725 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.404 ' H ' ' HB2' ' A' ' 71' ' ' PRO . 10.2 p -107.79 -39.87 4.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.281 -0.418 . . . . 6.76 110.476 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.497 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 33.2 p90 -87.75 119.13 27.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.068 -0.515 . . . . 5.18 109.966 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.436 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.4 pp -87.25 151.25 51.0 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 116.273 -0.422 . . . . 4.5 110.945 177.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -87.27 19.24 1.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.856 2.371 . . . . 4.4 112.963 -175.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.41 ' HB2' HD11 ' A' ' 74' ' ' ILE . 33.8 mt-10 -89.58 -68.61 0.77 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.656 -0.498 . . . . 3.91 109.656 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.9 t70 53.88 78.29 0.16 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.73 0.643 . . . . 3.16 111.244 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.5 mt -107.64 133.53 20.38 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.106 -0.497 . . . . 2.82 110.519 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.45 125.14 10.97 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.532 2.155 . . . . 2.04 112.218 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.528 ' H ' HD12 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -111.9 159.03 35.03 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.142 -0.481 . . . . 1.53 110.973 -175.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -64.52 162.47 30.83 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.33 2.686 . . . . 0.88 112.648 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.19 -4.38 17.37 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.438 0.903 . . . . 1.58 113.438 -170.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.465 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 59.8 m-20 -111.64 1.78 16.95 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.529 -0.468 . . . . 1.66 111.839 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -128.2 140.67 51.78 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.783 -0.821 . . . . 1.2 108.783 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HB2' ' HD2' ' A' ' 101' ' ' LYS . 37.0 tt0 -122.48 126.21 47.39 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.569 -0.452 . . . . 2.27 110.183 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.572 HD12 ' CE2' ' A' ' 171' ' ' TYR . 6.2 tt -83.98 127.2 33.71 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.85 -0.614 . . . . 1.37 109.533 -178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.409 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 45.4 mtp180 -152.86 128.44 10.05 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.231 -0.895 . . . . 3.75 109.792 -174.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.3 112.55 19.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.099 -0.704 . . . . 2.46 109.099 174.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -163.96 92.14 0.66 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.529 -0.915 . . . . 2.03 108.529 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 m -54.35 105.4 0.15 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.678 -0.692 . . . . 2.18 112.083 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -92.19 123.38 62.76 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.627 -0.715 . . . . 1.96 109.181 173.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -46.58 116.9 1.78 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.449 2.766 . . . . 1.87 113.366 -175.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.87 -27.18 13.54 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.005 -0.617 . . . . 1.74 112.491 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.05 -62.32 1.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.81 0.338 . . . . 1.79 111.133 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 115.09 -113.6 2.99 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.009 -0.615 . . . . 1.14 111.922 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.38 159.29 24.39 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 122.122 0.169 . . . . 2.81 110.683 176.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.04 -179.19 46.38 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.618 -0.801 . . . . 0.8 112.109 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 29.4 m -115.77 114.66 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.6 0.714 . . . . 1.17 109.88 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.409 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 28.2 m95 -83.22 120.14 25.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.513 -0.767 . . . . 1.4 110.98 -170.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -66.51 121.76 16.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.236 -0.438 . . . . 1.2 110.39 177.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.434 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 1.1 mppt? -90.73 -9.02 48.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.153 0.502 . . . . 2.23 110.286 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -135.47 157.44 46.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.308 -0.86 . . . . 4.08 108.681 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.616 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -79.27 159.83 27.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 120.913 0.387 . . . . 2.86 110.38 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.795 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 52.8 mtm -129.13 142.05 51.0 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.395 -0.594 . . . . 1.38 109.395 177.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.35 140.81 37.91 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.852 -0.425 . . . . 2.31 109.852 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.07 128.26 3.56 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 124.175 0.922 . . . . 1.42 112.488 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.85 7.8 11.38 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.55 -0.75 . . . . 1.04 111.681 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.08 163.89 17.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.096 0.474 . . . . 2.62 111.297 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -145.98 135.34 22.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.585 -0.524 . . . . 4.16 109.585 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 5.0 mt -101.47 143.37 31.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.848 -0.427 . . . . 1.11 109.848 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.77 -136.13 9.81 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.693 -0.765 . . . . 1.09 112.34 176.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.22 149.54 93.62 Favored 'Cis proline' 0 C--N 1.343 0.267 0 C-N-CA 123.309 -1.538 . . . . 2.52 112.645 2.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.441 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 31.0 t -95.67 151.39 19.39 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.662 -0.866 . . . . 2.5 108.662 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t 59.47 84.97 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.776 -0.824 . . . . 2.46 108.776 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' A' ' 163' ' ' ALA . 28.3 m -71.54 -166.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.12 -0.945 . . . . 4.37 111.88 -174.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.1 p -47.33 115.24 3.47 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 116.029 -0.532 . . . . 5.65 111.28 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.45 88.63 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.145 2.563 . . . . 5.38 112.877 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -100.51 -32.06 10.97 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.044 -0.724 . . . . 8.57 109.044 172.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.6 -53.51 0.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.895 -1.048 . . . . 7.27 109.56 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 49.53 55.99 8.52 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.804 0.69 . . . . 6.4 111.984 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.01 89.66 3.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.49 -0.777 . . . . 5.88 110.835 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -90.99 172.58 8.48 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.172 -0.922 . . . . 7.76 110.289 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -60.07 -70.84 0.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.279 -0.419 . . . . 9.01 110.812 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 47.1 m -149.16 -69.3 0.21 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.597 -0.52 . . . . 9.14 109.597 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.2 t70 65.06 163.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.644 0.735 . . . . 7.6 111.647 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -113.84 121.6 44.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.968 -0.56 . . . . 8.0 110.676 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.41 -48.88 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.377 -0.689 . . . . 4.59 111.377 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . 0.523 ' CD1' HD11 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -136.95 -109.56 0.19 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.517 -0.341 . . . . 4.93 111.117 176.102 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -165.0 -43.03 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.002 0.429 . . . . 7.65 109.937 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -144.55 150.73 38.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.125 -0.489 . . . . 9.61 110.28 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.43 -20.06 6.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.953 0.406 . . . . 6.05 110.772 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.76 65.5 9.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.865 0.84 . . . . 8.5 111.37 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 56.1 p -93.04 37.34 1.03 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.118 -0.946 . . . . 9.82 110.22 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.4 t70 58.66 66.92 0.99 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.379 -0.828 . . . . 11.21 109.755 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.01 108.14 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.365 -0.834 . . . . 10.92 111.418 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -143.37 78.78 1.61 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.593 -0.731 . . . . 13.25 109.74 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.8 p -86.83 -16.55 9.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.813 0.816 . . . . 14.01 108.865 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 27.3 t -173.53 136.56 0.7 Allowed Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 114.499 -1.228 . . . . 14.1 108.211 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.9 78.07 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.518 2.145 . . . . 14.7 112.013 177.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -92.08 54.02 2.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.72 -0.673 . . . . 14.44 110.718 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.22 83.43 3.69 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.752 -0.658 . . . . 15.9 110.511 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.93 -42.74 1.23 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.956 -0.64 . . . . 16.0 111.812 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 34.3 t -135.24 83.84 2.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.993 0.425 . . . . 15.6 110.624 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.57 -35.74 75.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.232 0.539 . . . . 14.1 109.75 176.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -156.93 132.23 9.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.652 -0.704 . . . . 13.19 110.219 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -94.46 -13.2 26.42 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.529 0.681 . . . . 15.92 109.599 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.9 pt -109.79 168.07 4.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.13 -0.941 . . . . 14.07 110.366 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 33.3 t -129.31 120.5 25.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.037 0.446 . . . . 13.67 110.579 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -78.33 86.54 4.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.055 -0.72 . . . . 13.02 109.055 172.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -139.24 140.93 37.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.539 -0.755 . . . . 14.68 109.975 -174.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 pp -109.73 14.69 23.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.286 0.565 . . . . 13.55 111.539 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 140.58 143.45 4.32 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.738 -0.744 . . . . 15.8 112.224 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.0 m -84.52 -1.1 55.29 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.889 0.376 . . . . 17.08 111.121 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.07 -82.7 0.35 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.201 -0.454 . . . . 18.43 111.705 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -115.77 168.07 10.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.821 -0.627 . . . . 18.74 111.4 -172.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 62.1 35.65 15.67 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.442 -0.799 . . . . 14.81 111.225 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 42.4 t -83.65 -24.95 31.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.126 0.488 . . . . 14.64 110.674 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 55.4 t -125.96 129.86 72.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.046 -0.524 . . . . 13.38 110.025 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.46 70.67 0.56 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.674 0.609 . . . . 10.61 111.309 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -148.6 -96.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.113 -0.494 . . . . 10.22 110.996 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -122.53 -32.25 3.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.709 0.29 . . . . 10.69 111.611 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.576 ' HG2' ' N ' ' A' ' 163' ' ' ALA . 1.0 OUTLIER -79.89 -45.43 18.63 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 122.02 0.914 . . . . 9.45 108.952 -179.062 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.576 ' N ' ' HG2' ' A' ' 162' ' ' GLN . . . -122.47 142.31 50.7 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.705 -1.588 . . . . 6.56 110.219 175.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.74 11.15 74.7 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.576 -0.821 . . . . 4.17 112.174 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.78 -8.07 55.96 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.893 0.331 . . . . 3.14 111.893 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 113' ' ' CYS . . . -140.21 19.45 2.86 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.31 -0.948 . . . . 1.69 112.768 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 17.3 m -79.3 -28.62 42.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.107 0.48 . . . . 2.0 110.447 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.482 ' CB ' HG21 ' A' ' 80' ' ' ILE . 40.5 p-90 -65.03 -17.46 64.46 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.693 -0.685 . . . . 0.83 111.33 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 65.3 mt -68.78 -14.18 62.86 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.229 -0.896 . . . . 1.28 112.002 -175.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.453 ' C ' ' HD3' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -69.69 -13.19 62.18 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.671 0.272 . . . . 2.03 111.189 178.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.572 ' CE2' HD12 ' A' ' 86' ' ' LEU . 46.1 m-85 -78.47 -37.83 42.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 2.19 111.924 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -70.51 125.68 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.638 -0.425 . . . . 1.24 110.141 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 48.8 mtp85 -117.85 -161.76 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.282 -0.417 . . . . 4.97 111.657 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.8 t -72.37 157.62 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.116 -0.493 . . . . 1.63 111.213 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.479 ' HB2' ' CD1' ' A' ' 183' ' ' LEU . . . -57.15 153.34 11.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.802 -0.635 . . . . 1.34 112.167 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 28.8 p -85.98 -10.72 54.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.333 -0.849 . . . . 2.58 110.678 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 34.0 m -153.63 170.87 19.79 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.193 -0.458 . . . . 2.06 110.82 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 10.5 p -71.95 -43.09 65.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.154 0.502 . . . . 2.69 110.87 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -78.26 4.02 13.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.404 0.621 . . . . 2.42 110.439 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -101.94 16.46 25.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.371 -0.832 . . . . 2.12 110.468 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 31.5 mm-40 -67.53 113.89 5.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 1.52 111.015 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.627 ' ND2' HD13 ' A' ' 200' ' ' ILE . 16.6 t30 -150.94 33.64 0.6 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.253 1.025 . . . . 1.68 108.354 173.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.627 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.2 OUTLIER -124.24 123.2 39.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.41 -0.813 . . . . 1.43 110.701 -171.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 96.0 m -150.8 127.4 10.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.111 0.482 . . . . 1.2 110.738 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 63.6 mtp -114.4 136.05 53.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.951 0.405 . . . . 1.56 110.218 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 1.4 p -113.51 137.56 51.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.654 -0.703 . . . . 2.13 110.775 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -109.08 104.01 13.12 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.796 -0.816 . . . . 1.96 108.796 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 27.5 pt -141.56 145.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 1.62 110.371 -176.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.2 m 65.13 26.4 12.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 2.24 110.897 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 62.76 19.47 11.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.407 -0.815 . . . . 2.83 111.28 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -131.7 168.03 18.46 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.481 -0.563 . . . . 1.86 109.481 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.523 HD11 ' CD1' ' A' ' 128' ' ' TRP . 48.3 mm -99.89 132.41 45.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.179 0.514 . . . . 1.59 111.903 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -125.02 137.4 54.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.995 -0.548 . . . . 4.16 110.747 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 7.3 m-85 -100.94 117.08 34.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.966 -0.561 . . . . 1.27 109.725 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -113.01 120.28 40.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.926 0.394 . . . . 1.73 110.405 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.01 152.74 3.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.321 -0.622 . . . . 1.33 109.321 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.55 -56.18 5.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.09 -0.959 . . . . 1.23 112.105 -166.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.62 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -135.02 175.79 9.25 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.953 -0.567 . . . . 1.88 111.379 -173.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.795 ' HA ' ' O ' ' A' ' 104' ' ' MET . 17.0 t70 -50.18 112.54 0.69 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.762 0.791 . . . . 2.23 112.061 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.627 HD13 ' ND2' ' A' ' 182' ' ' ASN . 8.9 mm -79.94 136.22 23.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.633 -1.167 . . . . 1.41 111.117 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.608 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 42.3 mt-10 -88.5 126.96 58.44 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 109.261 -0.644 . . . . 2.06 109.261 173.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.51 111.8 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 121.86 1.706 . . . . 0.56 111.019 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.04 -6.4 10.23 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.63 -0.795 . . . . 0.7 113.175 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 22.2 pt-20 -115.24 121.26 42.39 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.687 0.744 . . . . 1.27 110.636 174.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -111.72 95.38 5.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.045 -0.525 . . . . 2.92 111.549 174.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.488 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.8 mm? -122.35 99.72 6.57 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.121 -0.632 . . . . 1.51 109.569 174.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.575 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -146.47 113.37 6.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.973 0.509 . . . . 1.16 109.83 177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.627 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.1 p -154.87 160.4 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 110.098 -0.334 . . . . 1.5 110.098 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.536 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 59.3 t-80 -93.69 109.87 21.51 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.902 -1.147 . . . . 1.77 107.902 171.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.5 m -73.75 128.99 36.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.603 -0.517 . . . . 3.05 109.603 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -123.9 164.32 19.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.094 -0.503 . . . . 5.7 111.437 -169.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -91.23 14.44 14.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.336 -0.847 . . . . 5.8 109.927 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.406 ' CA ' HD12 ' A' ' 217' ' ' LEU . . . 92.42 78.9 1.41 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.74 -0.664 . . . . 5.61 111.917 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.83 -73.08 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.935 0.398 . . . . 6.31 110.819 -175.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.464 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 99.6 m-85 -72.45 -52.75 6.48 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.754 -0.657 . . . . 9.04 111.913 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 34.9 Cg_endo -65.42 -56.97 0.29 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.108 1.872 . . . . 7.78 113.489 -176.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.406 HD12 ' CA ' ' A' ' 213' ' ' GLY . 7.8 mp -75.33 -71.12 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.528 0.204 . . . . 8.02 110.869 -175.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 157.02 159.35 9.43 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.483 -0.865 . . . . 8.64 112.689 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 14.6 t 175.67 -23.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 122.791 0.436 . . . . 9.96 109.851 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.56 150.82 47.14 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.952 -0.567 . . . . 9.62 110.098 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.4 111.38 0.85 Allowed 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.891 2.394 . . . . 12.02 112.336 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.65 47.55 2.6 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.003 2.469 . . . . 13.11 112.451 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -119.57 154.29 16.51 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.703 -0.68 . . . . 14.03 111.56 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.3 tp -69.0 125.83 27.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.924 0.392 . . . . 16.32 110.434 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.74 -49.51 0.89 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.192 -0.458 . . . . 17.7 110.725 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 119.002 -0.523 . . . . 18.9 110.685 -179.719 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.845 -0.502 . . . . 33.41 111.845 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.5 m -74.55 104.17 5.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.184 0.516 . . . . 34.1 110.964 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.32 -150.62 22.37 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.066 -0.814 . . . . 32.51 111.066 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -122.97 77.02 50.38 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.941 0.371 . . . . 31.98 110.824 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.22 120.97 7.37 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.664 2.242 . . . . 30.45 111.425 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.5 m -61.3 113.66 2.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.042 0.449 . . . . 29.01 110.524 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.5 m -100.18 61.64 1.08 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.153 -0.476 . . . . 27.14 110.223 -175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 60.46 28.89 18.56 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.277 -0.874 . . . . 25.83 111.044 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -113.55 137.96 50.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.027 -0.533 . . . . 23.8 110.613 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -102.59 139.2 38.5 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.885 -0.598 . . . . 22.03 110.175 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.426 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 9.9 t -106.57 127.0 29.0 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.398 -0.365 . . . . 19.63 110.032 176.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 36.7 Cg_exo -61.02 138.27 77.37 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.785 2.323 . . . . 17.86 112.516 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -72.2 -16.86 61.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.615 -0.721 . . . . 17.61 110.235 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.83 106.54 1.91 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.582 -0.735 . . . . 15.63 110.104 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.92 12.43 74.35 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.765 -0.731 . . . . 12.12 111.963 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.8 t -84.99 113.6 50.94 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.981 -0.377 . . . . 10.78 109.981 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.25 100.02 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.828 2.352 . . . . 10.17 111.999 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -147.5 117.56 7.26 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.765 -0.652 . . . . 7.8 109.63 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -100.64 153.79 19.13 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.839 -0.619 . . . . 8.14 110.07 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.51 110.08 10.47 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.961 -0.563 . . . . 6.11 111.563 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.34 -164.67 0.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.963 2.442 . . . . 6.51 111.326 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 p -62.84 -34.34 65.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.929 0.395 . . . . 6.76 110.146 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -116.61 113.31 22.53 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.731 -0.47 . . . . 5.18 109.731 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.428 ' CD1' ' H ' ' A' ' 77' ' ' ASP . 2.4 pp -88.46 137.58 30.54 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.245 -0.434 . . . . 4.5 110.497 176.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -85.88 10.74 3.56 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.932 2.421 . . . . 4.4 112.586 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -82.7 -64.65 1.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.812 -0.631 . . . . 3.91 110.858 -177.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.428 ' H ' ' CD1' ' A' ' 74' ' ' ILE . 1.7 m-20 68.46 95.3 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.578 -0.737 . . . . 3.16 110.963 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 81.9 mt -69.26 124.45 90.46 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.429 -0.805 . . . . 2.82 110.445 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -72.12 116.56 4.76 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.322 2.014 . . . . 2.04 111.013 175.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.45 ' H ' HD11 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -125.73 146.31 54.62 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.275 -0.42 . . . . 1.53 110.3 -177.127 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.03 124.45 16.3 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.27 1.98 . . . . 0.88 110.406 170.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.21 -8.37 12.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.415 0.524 . . . . 1.58 112.415 -173.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.61 -9.03 31.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.197 0.522 . . . . 1.66 111.542 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -134.52 156.75 48.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.164 -1.05 . . . . 1.2 108.164 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -121.46 116.15 24.18 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.135 -0.626 . . . . 2.27 111.246 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.3 tt -86.41 128.2 34.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.782 -0.451 . . . . 1.37 109.782 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -151.12 130.66 13.0 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.48 -0.782 . . . . 3.75 109.682 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -68.21 112.03 4.89 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.367 -0.605 . . . . 2.46 109.367 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.7 t -169.52 110.7 0.46 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.423 -0.584 . . . . 2.03 109.423 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 t -90.85 107.77 19.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.21 -0.45 . . . . 2.18 110.739 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.486 HG22 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -79.11 121.95 83.8 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.35 -0.611 . . . . 1.96 109.35 175.024 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.42 114.93 1.77 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.371 2.714 . . . . 1.87 112.988 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.09 -9.83 36.74 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.95 -0.643 . . . . 1.74 112.727 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.486 ' HB3' HG22 ' A' ' 91' ' ' ILE . . . -135.76 -60.26 0.74 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.971 0.385 . . . . 1.79 111.665 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 122.76 -146.09 16.5 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.647 -0.787 . . . . 1.14 112.716 177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 mt -80.4 159.03 25.82 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.254 -0.276 . . . . 2.81 110.254 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.03 169.09 39.51 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.802 -0.713 . . . . 0.8 111.774 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 27.5 m -98.41 114.21 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.773 0.796 . . . . 1.17 109.262 172.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -81.76 101.76 10.34 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.234 -0.893 . . . . 1.4 110.663 -167.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.37 115.22 5.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.733 -0.667 . . . . 1.2 109.701 175.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.447 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -94.0 15.76 16.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.607 0.717 . . . . 2.23 109.515 -177.347 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -148.43 160.83 42.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.562 -1.199 . . . . 4.08 108.144 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.76 158.79 34.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.435 0.636 . . . . 2.86 111.453 -174.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.532 ' HE2' HG13 ' A' ' 200' ' ' ILE . 54.0 mtm -134.5 143.71 47.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.98 -1.119 . . . . 1.38 107.98 170.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.606 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 52.3 mt-10 -130.28 174.45 9.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.43 . . . . 2.31 112.157 -172.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.64 122.48 11.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.495 -0.775 . . . . 1.42 113.054 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.18 -25.53 11.28 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 1.04 113.927 169.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 10.1 pt-20 -73.98 160.92 30.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.375 0.607 . . . . 2.62 112.007 -174.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.704 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 0.7 OUTLIER -124.9 134.64 52.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.029 -0.987 . . . . 4.16 110.474 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mt -87.84 133.52 33.88 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.973 -0.751 . . . . 1.11 108.973 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.87 -132.87 5.43 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.487 -0.863 . . . . 1.09 112.433 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.06 134.4 17.97 Favored 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 123.947 -1.272 . . . . 2.52 112.881 1.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.4 t -70.06 -28.23 65.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.486 -0.779 . . . . 2.5 111.642 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.0 p 178.72 151.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 109.862 -0.421 . . . . 2.46 109.862 -177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.3 -159.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.926 -0.768 . . . . 4.37 108.926 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.3 p -54.99 117.28 13.59 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.965 0.412 . . . . 5.65 110.195 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.506 ' HB2' ' O ' ' A' ' 121' ' ' ALA . 81.9 Cg_endo -77.3 62.92 7.72 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.978 2.452 . . . . 5.38 113.132 -174.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 69.19 -58.59 0.5 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.895 0.878 . . . . 8.57 111.103 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.71 -66.5 0.23 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.672 -0.694 . . . . 7.27 109.268 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -163.16 56.37 0.19 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.682 -0.69 . . . . 6.4 109.96 175.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 117' ' ' PRO . . . -145.55 121.1 10.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.106 -0.952 . . . . 5.88 110.245 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -57.63 140.76 50.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.702 -0.681 . . . . 7.76 111.52 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -115.36 -33.34 5.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.297 0.57 . . . . 9.01 110.989 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 36.1 m -155.7 -40.98 0.08 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.067 0.937 . . . . 9.14 109.21 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -51.62 158.62 0.9 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.219 -1.81 . . . . 7.6 111.931 176.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -167.04 149.37 6.17 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.24 -0.891 . . . . 8.0 109.427 175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.454 ' HA3' ' HE3' ' A' ' 211' ' ' LYS . . . 106.78 59.28 0.59 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.226 -0.988 . . . . 4.59 113.487 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . 0.419 ' HZ3' ' CE1' ' A' ' 215' ' ' TYR . 0.0 OUTLIER -138.91 -162.63 1.34 Allowed 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.515 -1.291 . . . . 4.93 107.515 176.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 130' ' ' GLN . 10.0 pt-20 -83.15 -46.82 12.29 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.131 -0.692 . . . . 7.65 109.131 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 47.4 tt0 165.63 103.91 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.092 0 O-C-N 124.29 0.994 . . . . 9.61 109.44 176.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.9 pp -92.17 3.81 7.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.405 -0.518 . . . . 6.05 110.51 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.8 mp -80.62 69.97 7.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.839 -0.619 . . . . 8.5 109.722 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.1 p -120.17 29.21 7.62 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.338 -0.847 . . . . 9.82 110.253 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -64.34 110.4 2.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.321 -0.854 . . . . 11.21 110.415 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 56.5 t -74.41 137.27 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.856 -0.611 . . . . 10.92 109.888 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.94 71.59 1.56 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.8 0.81 . . . . 13.25 110.584 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.7 p -93.35 -20.73 6.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.303 -0.862 . . . . 14.01 109.534 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.6 m -124.04 95.13 44.5 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.598 -0.728 . . . . 14.1 110.365 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.02 89.25 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.857 2.372 . . . . 14.7 111.554 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -101.69 -16.04 16.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.993 -0.548 . . . . 14.44 111.636 -175.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.58 130.5 46.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.223 0.535 . . . . 15.9 111.342 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.77 -11.47 49.66 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.741 -0.742 . . . . 16.0 111.57 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 13.4 p -159.24 40.25 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.249 0.547 . . . . 15.6 110.294 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 63.6 mt -78.8 116.44 22.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.725 -0.671 . . . . 14.1 109.98 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.2 t -84.28 124.36 31.15 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.491 -0.559 . . . . 13.19 109.491 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -122.06 -7.84 8.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.846 -0.616 . . . . 15.92 111.497 -172.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.3 pp -104.72 134.25 46.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.217 0.532 . . . . 14.07 111.052 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.6 t 174.41 53.56 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.81 -1.086 . . . . 13.67 108.574 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -128.01 44.48 2.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.399 -0.819 . . . . 13.02 112.141 -170.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -86.25 80.6 8.69 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.487 0.661 . . . . 14.68 109.457 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.458 ' HB2' ' CG ' ' A' ' 156' ' ' PHE . 2.7 pp -113.2 25.6 11.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.678 -0.692 . . . . 13.55 111.035 -177.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -117.72 66.04 0.35 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.694 -0.685 . . . . 15.8 111.993 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.3 t -145.78 -77.29 0.19 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.1 -0.333 . . . . 17.08 110.1 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -107.77 -76.45 0.61 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.038 0.446 . . . . 18.43 111.012 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -152.42 153.18 33.06 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.808 -0.633 . . . . 18.74 110.215 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.458 ' CG ' ' HB2' ' A' ' 151' ' ' LEU . 39.2 p90 -144.03 149.94 37.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.039 0.447 . . . . 14.81 111.099 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 43.0 t -138.5 34.77 2.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.576 0.703 . . . . 14.64 109.13 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.06 134.69 59.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.525 -0.761 . . . . 13.38 110.961 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -93.28 90.09 6.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.272 -0.422 . . . . 10.61 109.881 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -100.59 -45.63 5.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.09 -0.504 . . . . 10.22 110.594 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -126.66 25.64 6.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.215 -0.448 . . . . 10.69 111.712 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -97.3 -49.77 4.81 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.151 -0.22 . . . . 9.45 110.758 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 57.66 57.85 4.04 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.548 0.689 . . . . 6.56 110.814 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -105.04 -116.49 4.22 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.478 -0.783 . . . . 4.17 111.696 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 59.86 -79.7 0.02 OUTLIER 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.45 0.7 . . . . 3.14 112.778 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -134.33 18.47 4.17 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.714 -0.755 . . . . 1.69 112.821 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.52 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 3.5 p -65.99 -24.74 66.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.138 0.494 . . . . 2.0 110.774 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -84.22 -17.68 39.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.019 -0.537 . . . . 0.83 110.544 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.7 -14.13 58.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.993 -0.549 . . . . 1.28 111.442 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 167' ' ' SER . 21.2 ptmt -64.66 -18.98 65.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.927 0.394 . . . . 2.03 110.5 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -72.53 -37.57 68.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.92 -0.582 . . . . 2.19 111.621 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -73.97 117.73 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.513 0.673 . . . . 1.24 110.855 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 -172.05 2.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.891 -1.05 . . . . 4.97 110.3 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.485 ' HA ' HD22 ' A' ' 183' ' ' LEU . 2.3 p -65.2 147.03 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.345 0.593 . . . . 1.63 111.781 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.15 149.45 28.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.611 -1.177 . . . . 1.34 112.599 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 53.7 t -60.32 -44.43 95.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.117 -0.947 . . . . 2.58 110.828 175.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 87.1 p -137.75 164.64 28.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.72 -0.474 . . . . 2.06 109.72 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . 0.473 ' HA ' ' OE1' ' A' ' 181' ' ' GLN . 75.8 m -78.4 4.36 13.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 2.69 111.849 -176.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -89.06 -7.34 56.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.2 0.524 . . . . 2.42 109.647 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.445 ' O ' ' HG ' ' A' ' 206' ' ' LEU . 23.6 m-20 -109.04 15.59 23.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.566 -0.743 . . . . 2.12 110.813 -176.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.473 ' OE1' ' HA ' ' A' ' 178' ' ' CYS . 15.0 mm100 -66.52 115.7 6.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.572 0.701 . . . . 1.52 111.746 -172.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.515 ' H ' HD12 ' A' ' 183' ' ' LEU . 14.1 t30 -165.03 39.74 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.682 -1.229 . . . . 1.68 107.682 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.665 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.7 OUTLIER -122.05 119.87 32.67 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.522 -0.763 . . . . 1.43 111.301 -170.422 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.5 m -150.93 121.82 7.6 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.241 0.543 . . . . 1.2 111.884 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.541 ' HB3' ' CB ' ' A' ' 209' ' ' HIS . 10.8 ttm -111.51 129.3 56.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.273 -0.64 . . . . 1.56 109.273 172.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 49.9 t -115.31 155.79 26.66 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.733 0.301 . . . . 2.13 110.266 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -116.01 112.39 21.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.291 -0.633 . . . . 1.96 109.291 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.498 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 41.5 pt -138.54 143.17 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.46 -0.336 . . . . 1.62 110.675 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.9 t 55.86 37.86 29.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 2.24 111.639 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 60.47 28.43 18.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.824 -0.625 . . . . 2.83 111.712 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 12.9 pt20 -145.11 156.22 43.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.859 0.361 . . . . 1.86 110.49 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.415 HD12 ' CD1' ' A' ' 128' ' ' TRP . 47.6 mm -82.25 134.79 26.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.191 0.52 . . . . 1.59 111.264 -175.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -124.64 122.3 37.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.669 -0.696 . . . . 4.16 109.665 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.704 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 26.4 m-85 -99.37 113.69 26.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.095 -0.705 . . . . 1.27 109.095 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -111.25 127.1 55.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.351 -0.386 . . . . 1.73 110.375 -172.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.404 ' CG2' ' HG3' ' A' ' 108' ' ' GLU . 1.5 t -95.19 150.73 4.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.91 0.862 . . . . 1.33 110.248 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.6 mm -100.22 -53.67 7.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.841 -1.527 . . . . 1.23 111.618 -163.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.41 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -153.3 -178.89 7.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.065 -0.97 . . . . 1.88 110.799 -179.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 104' ' ' MET . 9.6 p-10 -52.85 110.96 0.58 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.992 0.808 . . . . 2.23 112.673 -172.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.532 HG13 ' HE2' ' A' ' 104' ' ' MET . 2.6 mm -80.89 134.47 27.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.693 -0.685 . . . . 1.41 110.349 171.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 12.5 mm-40 -81.67 120.56 78.16 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.548 -0.751 . . . . 2.06 109.559 173.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.51 115.43 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.145 2.564 . . . . 0.56 112.358 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.27 -11.49 9.18 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.71 -0.757 . . . . 0.7 113.076 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 13.0 pt-20 -123.46 125.59 45.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.78 0.79 . . . . 1.27 111.613 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.447 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -108.96 99.88 9.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.529 -1.214 . . . . 2.92 112.069 -175.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.546 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.1 mm? -122.55 100.38 6.9 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.492 -0.483 . . . . 1.51 110.473 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.527 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.0 mm? -145.61 113.67 6.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.816 0.446 . . . . 1.16 110.303 174.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.665 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.9 p -155.83 161.79 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 O-C-N 122.164 -0.335 . . . . 1.5 110.41 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.541 ' CB ' ' HB3' ' A' ' 185' ' ' MET . 33.0 t-80 -131.44 109.89 10.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.189 -0.671 . . . . 1.77 109.189 161.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 86.1 t -68.93 121.79 18.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.186 0.517 . . . . 3.05 109.746 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.454 ' HE3' ' HA3' ' A' ' 127' ' ' GLY . 53.9 mttm -112.0 164.35 13.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.618 -0.719 . . . . 5.7 110.083 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -77.75 50.88 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.283 -0.417 . . . . 5.8 112.122 -173.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.459 ' CA ' ' HB2' ' A' ' 217' ' ' LEU . . . 52.16 49.44 50.02 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.882 -0.599 . . . . 5.61 113.674 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.1 -74.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.044 0.449 . . . . 6.31 110.018 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.573 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 66.7 m-85 -94.82 -46.81 0.27 Allowed Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.928 -0.578 . . . . 9.04 112.367 175.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 14.8 Cg_endo -56.54 -46.26 31.34 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 121.901 1.734 . . . . 7.78 112.805 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.459 ' HB2' ' CA ' ' A' ' 213' ' ' GLY . 7.2 mp -94.46 -57.27 2.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.943 0.402 . . . . 8.02 110.425 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 94.27 47.55 2.8 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.623 -0.799 . . . . 8.64 112.001 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 23.1 p -105.04 4.18 31.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.02 0.438 . . . . 9.96 110.984 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 19.8 m -85.47 150.34 53.91 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.155 -0.475 . . . . 9.62 111.135 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.461 ' HB2' ' HD3' ' A' ' 222' ' ' PRO . 50.7 Cg_exo -50.95 -51.82 10.39 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.714 2.276 . . . . 12.02 113.687 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' A' ' 221' ' ' PRO . 92.7 Cg_endo -81.1 26.86 0.59 Allowed 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 121.643 1.562 . . . . 13.11 112.212 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -111.99 73.0 0.21 Allowed Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.905 -0.589 . . . . 14.03 111.632 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.4 tt -59.27 127.2 30.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.922 0.392 . . . . 16.32 110.355 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -115.89 9.0 14.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.077 0.465 . . . . 17.7 110.705 -177.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.873 -0.584 . . . . 18.9 110.63 -177.036 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.953 -0.459 . . . . 33.41 111.953 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.9 m 63.83 23.81 13.53 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.174 0.512 . . . . 34.1 111.211 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.14 137.73 4.35 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.006 -0.616 . . . . 32.51 111.699 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.463 ' CD2' ' HD2' ' A' ' 55' ' ' PRO . 64.0 t80 -167.34 141.08 2.97 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.978 -0.749 . . . . 31.98 108.978 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.463 ' HD2' ' CD2' ' A' ' 54' ' ' PHE . 30.3 Cg_endo -64.74 70.1 0.24 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.78 2.32 . . . . 30.45 112.438 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -101.13 30.04 4.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.732 0.777 . . . . 29.01 109.307 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 p -87.16 110.59 20.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.206 -0.907 . . . . 27.14 111.275 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.16 84.39 1.94 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.246 0.546 . . . . 25.83 109.65 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -127.22 126.55 42.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.588 -0.733 . . . . 23.8 109.671 174.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.7 t80 54.86 78.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.381 -0.827 . . . . 22.03 111.407 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.4 137.72 97.21 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.067 -0.515 . . . . 19.63 110.299 174.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.8 99.73 0.15 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.557 2.171 . . . . 17.86 111.482 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -80.87 -31.1 35.46 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.265 -0.879 . . . . 17.61 110.697 -176.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -122.59 147.1 46.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.866 -0.607 . . . . 15.63 110.37 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.23 66.74 3.14 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.067 -0.587 . . . . 12.12 111.707 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 p -55.99 120.21 32.13 Favored Pre-proline 0 C--N 1.328 -0.362 0 C-N-CA 122.885 0.474 . . . . 10.78 111.645 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.12 96.35 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.842 2.362 . . . . 10.17 112.132 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -101.39 118.91 37.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.613 -0.721 . . . . 7.8 109.954 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -81.13 96.37 7.17 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.1 0.476 . . . . 8.14 110.601 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 140.06 95.95 Favored Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-N 115.483 -0.781 . . . . 6.11 110.419 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.68 -158.59 0.07 OUTLIER 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.809 2.339 . . . . 6.51 112.312 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.43 -38.55 70.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.27 -0.423 . . . . 6.76 111.028 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -87.77 121.05 29.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.362 -0.381 . . . . 5.18 109.99 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.519 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.0 pp -77.23 140.83 65.93 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.058 -0.519 . . . . 4.5 111.929 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.6 1.51 9.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.266 2.644 . . . . 4.4 112.453 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.32 -53.08 62.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.696 -0.683 . . . . 3.91 109.758 176.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.2 t70 74.16 94.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.54 -1.209 . . . . 3.16 110.551 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.3 mt -80.87 123.46 82.25 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.238 -0.892 . . . . 2.82 110.745 -174.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.95 116.57 4.44 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.323 2.015 . . . . 2.04 111.867 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.453 ' H ' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -118.43 134.81 23.42 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.199 -0.455 . . . . 1.53 109.933 178.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.52 146.9 50.54 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.584 2.189 . . . . 0.88 111.936 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.25 6.89 3.89 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.268 0.84 . . . . 1.58 113.268 -168.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -116.97 5.91 12.93 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.798 -0.564 . . . . 1.66 112.102 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.573 ' CZ ' HD23 ' A' ' 110' ' ' LEU . 10.6 m-85 -130.47 138.35 50.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.66 -0.867 . . . . 1.2 108.66 176.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.461 ' HB2' ' HD2' ' A' ' 101' ' ' LYS . 1.2 tp10 -108.52 117.42 34.13 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.759 -0.376 . . . . 2.27 110.37 -174.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.415 HD21 ' N ' ' A' ' 87' ' ' ARG . 6.6 tt -84.13 126.85 33.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.955 -0.758 . . . . 1.37 108.955 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.415 ' N ' HD21 ' A' ' 86' ' ' LEU . 78.5 mtp180 -149.52 119.02 6.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.622 -0.717 . . . . 3.75 110.74 -173.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -73.47 112.24 9.37 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.997 -0.742 . . . . 2.46 108.997 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.4 p -155.16 158.7 39.36 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.674 -0.694 . . . . 2.03 109.355 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.1 m -99.47 103.14 14.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.837 -0.431 . . . . 2.18 109.837 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 91' ' ' ILE . 0.0 OUTLIER -108.04 111.38 62.09 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.194 -0.457 . . . . 1.96 109.94 177.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -58.42 125.2 17.7 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.034 2.49 . . . . 1.87 112.92 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.76 -13.3 38.54 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.889 -0.672 . . . . 1.74 112.136 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -136.27 -54.83 0.75 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.125 0.488 . . . . 1.79 110.631 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.78 -94.65 0.5 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.319 -0.855 . . . . 1.14 111.213 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 171' ' ' TYR . 0.5 OUTLIER -108.99 160.52 15.95 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.805 -0.698 . . . . 2.81 109.626 172.196 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -170.39 165.63 38.89 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.079 -1.057 . . . . 0.8 112.997 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 15.9 m -106.7 147.17 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.825 -0.435 . . . . 1.17 109.825 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -109.2 117.21 33.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.533 -0.303 . . . . 1.4 110.617 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 202' ' ' PRO . . . -67.46 128.65 37.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.525 -0.307 . . . . 1.2 110.173 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -99.54 -9.07 23.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 2.23 111.249 -176.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.497 ' HG3' ' N ' ' A' ' 103' ' ' LYS . 20.9 tpt180 -125.85 150.3 47.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.208 0.528 . . . . 4.08 111.448 -176.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.497 ' N ' ' HG3' ' A' ' 102' ' ' ARG . 1.5 tptm -61.32 138.45 58.24 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.866 -1.061 . . . . 2.86 111.061 173.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.515 ' HE1' HG13 ' A' ' 200' ' ' ILE . 77.5 mtm -127.86 152.61 47.61 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.607 -0.886 . . . . 1.38 108.607 173.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.7 135.16 54.46 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 123.232 0.332 . . . . 2.31 110.563 -174.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -37.79 112.7 0.23 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 124.872 1.357 . . . . 1.42 112.803 -174.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.95 7.26 11.75 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.581 -0.736 . . . . 1.04 111.341 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.444 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -75.37 165.91 24.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.907 0.384 . . . . 2.62 110.398 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.456 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 2.4 tmm_? -145.61 131.65 19.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.37 -0.377 . . . . 4.16 111.063 -176.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.573 HD23 ' CZ ' ' A' ' 84' ' ' PHE . 4.8 mt -99.48 137.11 38.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.058 -0.719 . . . . 1.11 109.058 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.85 -168.21 31.15 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.314 -0.946 . . . . 1.09 112.438 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.414 ' HA ' ' CE2' ' A' ' 193' ' ' TYR . 7.6 Cg_exo -73.45 146.11 86.0 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.736 -1.36 . . . . 2.52 112.395 1.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 t -76.49 -18.14 58.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 2.5 110.691 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.4 p -171.79 132.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.213 -0.449 . . . . 2.46 110.527 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.87 72.44 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.645 -0.872 . . . . 4.37 108.645 175.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.9 p -105.25 110.0 63.88 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.688 -0.687 . . . . 5.65 111.604 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.14 52.29 2.48 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.822 2.348 . . . . 5.38 111.32 174.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -142.8 -76.41 0.26 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.07 -0.968 . . . . 8.57 109.977 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -176.97 161.16 1.9 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.175 -0.92 . . . . 7.27 108.938 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -97.2 119.7 36.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.887 -0.412 . . . . 6.4 109.887 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.48 128.51 56.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.924 0.392 . . . . 5.88 110.985 -177.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.423 ' HD3' ' HG2' ' A' ' 130' ' ' GLN . 24.5 pttm -67.41 136.24 54.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.625 -0.716 . . . . 7.76 111.608 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -84.75 -57.46 3.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.967 -1.015 . . . . 9.01 110.902 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 17.3 m -145.15 -64.03 0.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.85 0.315 . . . . 9.14 111.85 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -99.35 -170.67 1.94 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.269 0.557 . . . . 7.6 112.125 -170.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.449 ' HA ' ' CD1' ' A' ' 132' ' ' LEU . 36.3 p90 -146.13 145.48 30.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.052 -0.976 . . . . 8.0 110.121 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -139.82 -76.26 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.7 -0.762 . . . . 4.59 112.065 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . 0.644 ' CD1' ' HG2' ' A' ' 129' ' ' GLU . 16.5 p90 -77.38 -36.99 53.0 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.305 -0.998 . . . . 4.93 108.305 176.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.644 ' HG2' ' CD1' ' A' ' 128' ' ' TRP . 13.7 pt-20 -160.11 -159.08 0.68 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.845 -1.525 . . . . 7.65 107.03 170.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.446 ' HG3' ' HB3' ' A' ' 126' ' ' PHE . 31.8 tt0 -120.83 53.04 1.14 Allowed 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.409 -0.516 . . . . 9.61 111.408 -167.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.492 HG13 ' HG3' ' A' ' 129' ' ' GLU . 1.9 pp -139.78 40.67 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.204 0.526 . . . . 6.05 111.073 175.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.449 ' CD1' ' HA ' ' A' ' 126' ' ' PHE . 10.0 mp -59.41 100.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.547 -0.751 . . . . 8.5 110.504 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.6 t -106.26 47.55 0.87 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.529 0.681 . . . . 9.82 110.897 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -73.92 83.64 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.735 -0.666 . . . . 11.21 110.033 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.8 p -46.96 112.21 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.642 0.734 . . . . 10.92 111.836 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -106.37 -74.8 0.65 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.451 -0.795 . . . . 13.25 110.525 -176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.3 p -94.45 -26.44 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.171 -0.468 . . . . 14.01 110.178 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.7 t 57.6 80.11 0.3 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.095 -0.502 . . . . 14.1 111.313 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -86.18 163.14 10.0 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.408 2.072 . . . . 14.7 111.832 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 61.1 33.81 19.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.987 -0.551 . . . . 14.44 111.342 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.49 -178.97 4.06 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.703 -0.48 . . . . 15.9 109.703 176.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.97 -45.45 3.2 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.656 -0.783 . . . . 16.0 111.592 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 6.0 p -95.52 32.06 1.88 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.454 0.645 . . . . 15.6 110.509 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.7 mt -108.92 -44.21 6.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.32 -0.854 . . . . 14.1 109.319 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.9 p -77.71 54.05 1.18 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.395 -0.82 . . . . 13.19 111.08 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -85.93 -19.14 30.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.988 0.899 . . . . 15.92 108.752 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 19.3 pt -97.08 168.05 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.02 -1.445 . . . . 14.07 109.337 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 28.8 m -117.72 114.13 22.87 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.817 0.341 . . . . 13.67 110.332 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -81.3 85.22 6.44 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.239 -0.437 . . . . 13.02 110.306 178.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -65.78 121.56 15.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.925 -0.58 . . . . 14.68 109.997 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.7 mt -109.16 35.04 3.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.209 -0.451 . . . . 13.55 110.521 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.96 -89.84 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.255 -0.974 . . . . 15.8 112.675 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.8 t -168.43 -36.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.226 0.536 . . . . 17.08 109.985 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -107.06 -83.02 0.54 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.775 -0.648 . . . . 18.43 110.232 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -135.87 -178.33 5.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.544 -0.753 . . . . 18.74 109.925 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -145.68 120.56 9.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.109 0.481 . . . . 14.81 110.985 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 63.3 m -100.33 46.7 0.95 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.338 0.59 . . . . 14.64 109.737 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.87 147.33 13.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.783 -0.644 . . . . 13.38 110.366 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -92.79 139.99 29.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.008 -0.542 . . . . 10.61 110.24 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -124.17 -76.96 0.59 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.81 0.338 . . . . 10.22 110.863 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -80.75 -8.44 59.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.995 0.426 . . . . 10.69 110.931 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -77.08 -20.36 55.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.792 -0.64 . . . . 9.45 110.609 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.74 90.47 4.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.012 -0.54 . . . . 6.56 111.09 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.65 -105.66 0.19 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.098 -0.801 . . . . 4.17 111.098 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.459 ' C ' ' H ' ' A' ' 167' ' ' SER . . . 47.95 79.89 0.06 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.184 0.593 . . . . 3.14 112.221 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.03 26.88 1.16 Allowed Glycine 0 CA--C 1.519 0.282 0 CA-C-N 116.015 -0.539 . . . . 1.69 112.913 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 165' ' ' ALA . 5.7 m -66.22 -23.83 66.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.965 0.412 . . . . 2.0 110.352 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.45 ' O ' ' HB2' ' A' ' 171' ' ' TYR . 48.5 p-90 -86.0 -24.82 26.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.929 -0.578 . . . . 0.83 110.548 176.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 26.5 mt -76.89 -25.83 53.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 1.28 111.189 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.482 ' HE2' ' CE2' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -72.25 -1.57 15.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.049 0.452 . . . . 2.03 110.447 176.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.482 ' CE2' ' HE2' ' A' ' 170' ' ' LYS . 17.8 m-85 -82.2 -38.19 24.95 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.178 -0.464 . . . . 2.19 111.128 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -73.27 111.77 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.421 -0.511 . . . . 1.24 109.654 177.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.448 ' O ' ' HB ' ' A' ' 208' ' ' VAL . 3.3 mmp_? -114.22 -155.02 0.56 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.936 -0.574 . . . . 4.97 110.975 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 39.4 t -61.83 148.67 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 1.63 111.552 -173.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.84 121.91 6.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.026 -0.988 . . . . 1.34 112.405 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 2.4 p -73.82 -9.74 58.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.573 -0.739 . . . . 2.58 110.686 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.3 t -148.19 138.28 22.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.637 -0.71 . . . . 2.06 109.562 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . 0.619 ' HA ' ' OE1' ' A' ' 181' ' ' GLN . 8.5 p -86.22 -13.99 45.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.211 0.529 . . . . 2.69 111.027 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.67 -8.69 51.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.018 -0.537 . . . . 2.42 110.319 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -110.81 19.61 18.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.557 -0.747 . . . . 2.12 111.859 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.619 ' OE1' ' HA ' ' A' ' 178' ' ' CYS . 15.1 mm100 -52.89 116.07 2.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.508 0.671 . . . . 1.52 111.958 -173.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.709 ' ND2' HD13 ' A' ' 200' ' ' ILE . 28.7 t30 -152.94 37.05 0.49 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.097 -0.956 . . . . 1.68 108.787 177.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.637 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.9 OUTLIER -117.85 121.08 39.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.545 -0.752 . . . . 1.43 111.027 -173.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 84.1 m -150.08 146.71 27.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.89 0.376 . . . . 1.2 110.938 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.469 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 51.7 tpp -109.88 145.85 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 1.56 110.093 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 8.4 m -132.05 140.05 48.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.198 0.523 . . . . 2.13 111.187 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -116.44 104.47 11.48 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.953 -0.758 . . . . 1.96 108.953 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 21.7 pt -141.04 145.45 25.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.019 -0.537 . . . . 1.62 110.457 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.5 m 67.73 30.67 6.3 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.193 0.521 . . . . 2.24 110.916 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 62.13 22.24 12.99 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.089 -0.959 . . . . 2.83 111.926 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.412 ' HG3' ' CE1' ' A' ' 193' ' ' TYR . 4.2 pt20 -141.05 167.28 22.56 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.16 -0.473 . . . . 1.86 109.8 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.5 mm -92.73 137.03 23.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.279 -0.418 . . . . 1.59 110.72 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.456 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 27.8 m-85 -135.85 150.54 49.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.317 0.579 . . . . 4.16 111.508 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.453 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 6.6 m-85 -100.71 113.72 26.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.364 -0.835 . . . . 1.27 109.588 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.09 122.74 47.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.947 0.403 . . . . 1.73 110.195 -176.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.463 ' CG1' HD22 ' A' ' 182' ' ' ASN . 1.9 t -94.41 152.5 3.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.775 0.798 . . . . 1.33 109.96 -177.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.2 -54.5 7.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.606 -1.179 . . . . 1.23 111.395 -166.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.583 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -135.05 168.17 19.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.847 -0.615 . . . . 1.88 111.336 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 104' ' ' MET . 2.0 m-20 -46.36 125.87 7.3 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.143 0.902 . . . . 2.23 112.531 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.709 HD13 ' ND2' ' A' ' 182' ' ' ASN . 27.6 mm -94.4 134.95 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.72 -0.673 . . . . 1.41 111.319 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 50.6 mt-10 -105.35 125.79 32.58 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.481 -0.781 . . . . 2.06 109.518 174.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 87.8 Cg_exo -41.52 113.47 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.816 3.011 . . . . 0.56 113.551 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 120.43 6.37 9.72 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.815 -0.707 . . . . 0.7 113.054 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.7 pt-20 -118.26 123.8 46.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.193 0.497 . . . . 1.27 110.694 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.491 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -109.51 91.17 3.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.919 -0.582 . . . . 2.92 111.278 176.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.576 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 2.3 mm? -125.98 95.0 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.388 -0.525 . . . . 1.51 110.076 172.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 206' ' ' LEU . 1.7 mm? -148.63 113.9 5.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.857 0.463 . . . . 1.16 109.883 172.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.637 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.7 p -156.65 159.41 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.676 0.671 . . . . 1.5 111.421 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 46.7 t-80 -106.56 111.98 24.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.313 -0.625 . . . . 1.77 109.313 164.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 16.9 m -98.12 136.76 27.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.869 -0.419 . . . . 3.05 109.869 173.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 27.0 pttt -98.39 113.99 26.17 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.422 0.629 . . . . 5.7 110.488 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -105.2 12.77 31.55 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.551 -0.749 . . . . 5.8 111.401 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -171.75 51.71 0.18 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.201 -0.999 . . . . 5.61 112.539 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 31.3 t -132.43 -75.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.019 0.437 . . . . 6.31 110.268 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.419 ' H ' ' HD2' ' A' ' 216' ' ' PRO . 86.1 t80 -98.98 -56.5 0.17 Allowed Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.14 -0.482 . . . . 9.04 111.687 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.419 ' HD2' ' H ' ' A' ' 215' ' ' TYR . 33.0 Cg_endo -65.73 -43.74 9.34 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.529 1.486 . . . . 7.78 112.185 -176.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.6 mp -107.71 77.16 1.11 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.326 0.584 . . . . 8.02 109.559 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -169.71 173.67 43.93 Favored Glycine 0 C--N 1.312 -0.779 0 CA-C-N 115.301 -0.863 . . . . 8.64 111.742 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 16.8 p -95.89 57.74 1.85 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.46 0.647 . . . . 9.96 110.252 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 29.3 m -85.12 146.37 45.2 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.378 -0.828 . . . . 9.62 111.149 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.474 ' HB2' ' HD3' ' A' ' 222' ' ' PRO . 85.8 Cg_exo -43.85 -50.59 7.16 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.253 2.635 . . . . 12.02 114.52 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 221' ' ' PRO . 6.6 Cg_exo -74.79 9.17 2.04 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.152 1.901 . . . . 13.11 113.098 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -74.81 -35.46 50.56 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.918 -0.873 . . . . 14.03 110.918 175.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 49.3 tp -153.99 124.86 7.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.733 -0.469 . . . . 16.32 109.733 175.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -137.98 16.32 2.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.109 0.481 . . . . 17.7 110.459 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.679 -0.676 . . . . 18.9 110.467 179.794 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.223 -0.351 . . . . 33.41 112.223 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 26.7 t -83.38 165.22 19.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.694 0.283 . . . . 34.1 110.243 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.59 81.82 1.39 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.917 -0.659 . . . . 32.51 111.95 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 55.37 76.37 0.51 Allowed Pre-proline 0 N--CA 1.464 0.269 0 C-N-CA 122.485 0.314 . . . . 31.98 110.915 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.78 143.53 80.36 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.925 2.416 . . . . 30.45 112.854 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.2 m -113.11 134.13 54.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 29.01 110.269 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 m -82.89 136.45 34.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.094 0.473 . . . . 27.14 110.755 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -93.59 20.18 7.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.821 -0.627 . . . . 25.83 109.826 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -84.1 62.0 6.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.443 -0.799 . . . . 23.8 111.638 -172.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -115.48 44.13 1.92 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.32 -0.622 . . . . 22.03 109.32 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.6 p -123.11 93.33 48.31 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.243 -0.889 . . . . 19.63 110.925 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.2 107.82 0.87 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.69 2.26 . . . . 17.86 112.49 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -95.36 5.45 51.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.738 -0.665 . . . . 17.61 110.248 177.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.7 24.74 11.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.806 -0.634 . . . . 15.63 110.975 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.27 -177.78 18.71 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.749 . . . . 12.12 112.093 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.6 p -121.31 88.94 46.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.922 0.391 . . . . 10.78 111.296 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.97 135.03 12.16 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.69 2.26 . . . . 10.17 112.214 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -87.28 149.88 24.26 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.799 -0.445 . . . . 7.8 109.799 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.86 98.71 4.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.017 0.437 . . . . 8.14 111.03 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.07 128.6 64.54 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.751 -0.659 . . . . 6.11 109.905 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.57 -168.48 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.642 2.228 . . . . 6.51 112.742 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.06 -38.34 73.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.285 -0.416 . . . . 6.76 110.732 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -90.43 109.88 20.99 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.725 -0.472 . . . . 5.18 109.725 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.49 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.1 pp -78.12 141.57 62.83 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 121.026 0.441 . . . . 4.5 110.564 176.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.43 -5.27 13.6 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.18 2.587 . . . . 4.4 113.821 -172.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -79.1 -65.79 0.95 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.914 0.387 . . . . 3.91 110.123 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.1 t70 54.23 71.3 0.53 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.126 -0.943 . . . . 3.16 110.326 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.7 mt -89.82 120.0 69.41 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.304 -0.862 . . . . 2.82 109.008 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.645 ' O ' ' HA2' ' A' ' 164' ' ' GLY . 18.2 Cg_endo -58.11 122.05 11.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.606 2.204 . . . . 2.04 112.323 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.406 ' H ' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.46 142.65 45.99 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.875 -0.602 . . . . 1.53 109.979 178.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.95 142.69 19.21 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.388 2.725 . . . . 0.88 112.686 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.67 -16.32 47.75 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.581 -0.736 . . . . 1.58 112.251 -175.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -68.43 -23.09 64.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.958 -0.565 . . . . 1.66 110.557 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -120.9 161.86 20.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.91 -0.586 . . . . 1.2 110.223 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.573 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 33.5 tt0 -139.15 130.53 26.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.814 -0.354 . . . . 2.27 110.922 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.447 HD11 ' CZ ' ' A' ' 171' ' ' TYR . 5.2 tt -85.68 127.74 34.58 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.351 0.596 . . . . 1.37 110.484 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -148.76 140.59 23.71 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.127 -0.942 . . . . 3.75 110.031 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -82.79 112.25 19.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.04 0.447 . . . . 2.46 109.88 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.5 m -156.23 94.99 1.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.982 -0.748 . . . . 2.03 108.982 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.9 t -62.05 105.85 0.64 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.128 0.489 . . . . 2.18 111.474 -174.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.412 HG23 ' HD3' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -99.56 117.25 64.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.018 -0.734 . . . . 1.96 109.018 172.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.77 121.71 9.7 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.152 2.568 . . . . 1.87 112.741 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.11 -15.39 36.55 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.804 -0.712 . . . . 1.74 112.338 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -133.91 -59.78 0.83 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.966 0.412 . . . . 1.79 111.299 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.73 -116.09 3.0 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.773 -0.727 . . . . 1.14 112.216 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.29 158.43 16.12 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 122.455 0.302 . . . . 2.81 110.766 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 171' ' ' TYR . . . -151.26 172.25 30.83 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.313 -0.946 . . . . 0.8 113.465 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.425 ' O ' ' HG2' ' A' ' 205' ' ' GLU . 14.3 m -117.64 111.19 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.399 0.619 . . . . 1.17 109.718 175.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -82.69 126.74 32.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.749 -0.66 . . . . 1.4 111.383 -170.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.31 114.74 9.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.394 -0.595 . . . . 1.2 109.394 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.573 ' CE ' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -94.58 0.46 55.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.002 -0.74 . . . . 2.23 109.002 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -124.66 157.53 35.33 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.675 -1.148 . . . . 4.08 108.831 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.561 ' HD2' ' H ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -90.28 155.1 19.23 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.671 -0.492 . . . . 2.86 109.671 -177.16 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.471 ' HE3' HG13 ' A' ' 200' ' ' ILE . 60.3 mtm -135.43 148.44 49.3 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.549 -0.908 . . . . 1.38 108.549 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.87 146.99 39.22 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.995 -0.282 . . . . 2.31 110.623 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.26 121.81 2.0 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 124.301 1.001 . . . . 1.42 113.024 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.59 7.49 11.99 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.367 -0.833 . . . . 1.04 111.318 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.573 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.9 OUTLIER -79.78 156.2 27.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.264 0.554 . . . . 2.62 110.799 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.52 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 7.3 tmm_? -145.49 135.89 24.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.685 -0.689 . . . . 4.16 110.355 -176.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 6.2 mt -101.1 151.38 21.89 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.82 -0.437 . . . . 1.11 109.82 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.14 -174.01 44.8 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.609 -0.597 . . . . 1.09 111.609 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -83.02 141.37 42.75 Favored 'Cis proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.982 -1.674 . . . . 2.52 112.44 -2.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -88.43 -8.37 55.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.604 0.716 . . . . 2.5 109.513 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.2 m -121.34 132.05 71.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.367 -0.833 . . . . 2.46 109.489 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.5 m -133.52 -164.77 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.338 -0.392 . . . . 4.37 110.772 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 21.4 m -52.45 152.69 6.05 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.753 -0.658 . . . . 5.65 111.974 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 116' ' ' VAL . 6.0 Cg_exo -78.36 59.82 7.25 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.91 2.407 . . . . 5.38 112.507 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 118' ' ' ARG . 16.0 ptt-85 -169.23 165.71 10.86 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.82 -0.807 . . . . 8.57 108.82 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 53.4 -147.06 0.5 Allowed 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.45 0.469 . . . . 7.27 111.042 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 64.49 -83.41 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.182 0.593 . . . . 6.4 111.961 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 56.32 93.44 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.162 0.585 . . . . 5.88 111.188 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -59.19 130.82 48.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.54 -0.755 . . . . 7.76 111.447 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -95.44 -56.85 2.57 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.397 -1.274 . . . . 9.01 110.372 -175.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.429 ' HB ' ' H ' ' A' ' 125' ' ' ASP . 7.0 m -101.47 -83.83 0.45 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.177 -0.465 . . . . 9.14 109.784 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 126' ' ' PHE . 10.5 t70 60.2 -170.61 0.14 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.127 -0.488 . . . . 7.6 111.654 172.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.448 ' H ' ' CG ' ' A' ' 125' ' ' ASP . 64.3 t80 -90.61 -30.55 17.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 122.105 0.955 . . . . 8.0 109.213 173.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.92 33.42 26.95 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 113.918 -1.492 . . . . 4.59 113.292 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . . . . . . . . . 2.1 p90 -60.12 -46.34 89.96 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.358 -0.608 . . . . 4.93 109.358 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 173.88 -171.03 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.347 -1.353 . . . . 7.65 107.347 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -121.47 108.36 13.55 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.129 0.49 . . . . 9.61 110.678 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.486 ' H ' HD11 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -59.38 -20.63 18.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.357 -0.838 . . . . 6.05 111.378 176.492 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.414 ' H ' HD22 ' A' ' 132' ' ' LEU . 0.3 OUTLIER -81.16 68.26 7.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.812 0.815 . . . . 8.5 109.599 174.023 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.8 t -122.15 28.33 7.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.672 -1.149 . . . . 9.82 109.274 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -141.73 89.43 2.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.827 -1.078 . . . . 11.21 109.461 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.57 141.83 15.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.021 -0.536 . . . . 10.92 110.592 -177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -73.64 93.55 2.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.002 -0.544 . . . . 13.25 110.628 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.4 -39.92 82.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.558 -0.746 . . . . 14.01 109.62 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t 48.32 74.99 0.71 Allowed Pre-proline 0 C--O 1.236 0.365 0 CA-C-N 115.578 -0.737 . . . . 14.1 110.781 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -70.99 85.91 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.925 2.417 . . . . 14.7 111.553 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -85.61 59.24 5.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.753 -0.658 . . . . 14.44 111.408 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -70.96 -38.52 72.81 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.204 -0.665 . . . . 15.9 109.204 174.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -109.0 -172.59 21.07 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.724 -0.95 . . . . 16.0 110.724 172.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 58.7 m -83.4 60.39 5.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.182 0.515 . . . . 15.6 110.839 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 10.5 mt -87.42 54.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.638 0.732 . . . . 14.1 110.317 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.4 t -121.92 12.4 10.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.709 0.766 . . . . 13.19 109.801 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -83.76 -10.38 58.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.274 -0.876 . . . . 15.92 109.813 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.9 pp -81.91 172.98 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.88 -1.055 . . . . 14.07 111.6 -177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 50.5 m -144.47 64.12 1.31 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.185 -0.461 . . . . 13.67 110.252 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 69.11 143.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.447 -0.797 . . . . 13.02 111.868 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -88.64 68.01 8.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.64 0.733 . . . . 14.68 109.83 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.59 105.32 4.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.757 -1.11 . . . . 13.55 109.809 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 118.74 74.35 0.45 Allowed Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.607 -0.997 . . . . 15.8 110.607 -174.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.0 t -151.65 -60.56 0.17 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.684 0.278 . . . . 17.08 110.713 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -123.65 -83.03 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 18.43 111.614 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.0 23.62 6.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.022 0.439 . . . . 18.74 110.853 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -143.15 112.57 6.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.919 -0.582 . . . . 14.81 110.753 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 42.0 t -151.53 -70.17 0.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.11 -0.495 . . . . 14.64 110.755 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -96.78 120.9 46.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.837 0.351 . . . . 13.38 110.919 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 49.94 48.26 22.08 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.134 -0.939 . . . . 10.61 111.561 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.76 -39.71 76.52 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.0 -1.0 . . . . 10.22 111.076 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -111.15 16.47 21.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.846 -0.615 . . . . 10.69 109.744 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -121.73 -39.73 2.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.991 -0.55 . . . . 9.45 112.239 -171.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.4 21.0 3.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.363 0.601 . . . . 6.56 111.247 -178.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 79' ' ' PRO . . . 136.63 166.37 10.82 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.359 -0.837 . . . . 4.17 112.173 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -117.36 23.08 12.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.415 0.626 . . . . 3.14 110.334 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 77.85 -59.49 3.84 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.6 -0.727 . . . . 1.69 113.302 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.4 t -71.39 -14.42 62.17 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.547 0.203 . . . . 2.0 111.547 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 48.5 p-90 -56.94 -23.46 45.59 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.027 0.441 . . . . 0.83 111.734 -176.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 32.1 mt -73.45 -12.83 60.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.241 0.46 . . . . 1.28 112.241 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.428 ' HD2' ' C ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -66.12 -14.37 61.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.012 0.434 . . . . 2.03 110.155 177.289 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.507 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 41.5 m-85 -72.61 -31.43 65.16 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 115.782 -0.644 . . . . 2.19 111.887 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -66.28 116.37 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.317 -0.553 . . . . 1.24 110.175 -177.268 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.412 ' HD3' HG23 ' A' ' 91' ' ' ILE . 18.0 ptt180 -75.83 155.79 35.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.573 -0.74 . . . . 4.97 111.83 -174.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.538 ' HB ' HG11 ' A' ' 208' ' ' VAL . 2.7 p -83.82 147.01 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.371 -0.831 . . . . 1.63 109.352 172.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.449 ' HB1' HD12 ' A' ' 183' ' ' LEU . . . -45.88 123.72 4.71 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 123.933 0.771 . . . . 1.34 112.391 -174.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 51.8 t -80.42 -9.43 59.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 2.58 109.504 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 13.0 t -126.27 138.43 53.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.166 -0.924 . . . . 2.06 109.21 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 61.3 m -77.48 -15.88 59.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.876 0.37 . . . . 2.69 111.093 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -89.68 0.62 56.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.016 0.436 . . . . 2.42 110.578 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.18 17.88 21.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.865 -0.607 . . . . 2.12 111.619 -172.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -59.16 113.5 2.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.126 0.489 . . . . 1.52 111.04 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.5 ' H ' HD11 ' A' ' 183' ' ' LEU . 62.4 t30 -146.64 29.28 1.03 Allowed 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.845 -0.798 . . . . 1.68 108.845 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.666 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -118.76 121.59 40.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.687 -0.688 . . . . 1.43 111.113 -170.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.6 m -150.2 133.46 16.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.282 0.563 . . . . 1.2 111.518 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 46.6 ttm -100.14 135.09 42.11 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.146 -0.687 . . . . 1.56 109.146 174.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 15.2 m -117.84 131.69 56.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.181 0.515 . . . . 2.13 111.575 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.46 103.63 14.03 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.28 -1.007 . . . . 1.96 108.28 174.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 22.8 pt -138.4 144.18 30.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.734 -0.666 . . . . 1.62 109.839 -177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 m 61.27 28.75 18.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.213 0.53 . . . . 2.24 110.318 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 56.2 34.86 24.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.121 -0.945 . . . . 2.83 111.789 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -142.06 157.64 44.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.626 -0.716 . . . . 1.86 109.619 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.6 mm -94.56 131.32 41.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.301 -0.409 . . . . 1.59 111.264 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.52 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 27.0 m-85 -131.98 157.47 43.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.935 -0.575 . . . . 4.16 111.148 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 3.3 m-85 -101.3 113.68 26.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.956 -0.757 . . . . 1.27 108.956 173.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -110.22 125.62 53.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.936 0.398 . . . . 1.73 110.012 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.573 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 1.9 t -96.57 151.44 4.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.747 0.784 . . . . 1.33 110.202 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.403 HD11 ' N ' ' A' ' 197' ' ' ILE . 0.9 OUTLIER -92.64 -53.8 8.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.543 -1.208 . . . . 1.23 110.591 -167.288 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.494 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -132.0 171.12 13.99 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.085 -0.961 . . . . 1.88 110.678 175.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -53.9 143.84 20.37 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.87 0.693 . . . . 2.23 112.87 -171.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.471 HG13 ' HE3' ' A' ' 104' ' ' MET . 31.4 mm -99.85 133.46 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.594 -0.73 . . . . 1.41 110.387 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -95.13 131.36 30.2 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 109.372 -0.603 . . . . 2.06 109.372 173.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -50.95 116.2 2.49 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.605 2.203 . . . . 0.56 112.042 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 123.26 -12.86 8.44 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.666 -0.778 . . . . 0.7 112.948 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.68 119.17 21.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.607 0.703 . . . . 1.27 111.032 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -113.05 96.72 6.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.283 -0.871 . . . . 2.92 111.484 177.177 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.474 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.1 mm? -114.14 99.07 7.35 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.52 -0.872 . . . . 1.51 110.524 177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.546 ' HB2' HG22 ' A' ' 172' ' ' ILE . 1.5 mm? -147.19 112.39 5.51 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.327 0.651 . . . . 1.16 109.502 174.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.666 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 2.6 p -156.64 161.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.392 -0.595 . . . . 1.5 109.392 -177.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -123.31 105.71 10.08 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.002 -0.74 . . . . 1.77 109.002 162.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 53.5 t -132.82 95.22 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.277 -0.638 . . . . 3.05 109.277 173.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -123.11 139.44 54.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.986 -0.552 . . . . 5.7 109.66 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -96.87 2.21 51.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.778 0.323 . . . . 5.8 111.074 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -132.8 33.98 2.54 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.44 -0.886 . . . . 5.61 113.035 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 65.3 t -128.54 -77.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.788 0.327 . . . . 6.31 111.014 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.539 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 56.3 t80 -65.19 -53.76 38.02 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 112.387 0.514 . . . . 9.04 112.387 -176.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 11.4 Cg_endo -52.21 -37.85 70.71 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.921 2.414 . . . . 7.78 112.731 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 mp -77.81 20.24 0.36 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.611 -0.722 . . . . 8.02 112.242 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 93.78 20.98 29.77 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.873 -0.68 . . . . 8.64 112.644 176.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.1 m 60.92 67.82 0.79 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.549 0.69 . . . . 9.96 110.006 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.85 154.18 72.98 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.255 -0.884 . . . . 9.62 110.374 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 222' ' ' PRO . 28.5 Cg_endo -64.06 141.95 78.93 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.404 2.07 . . . . 12.02 111.616 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 221' ' ' PRO . 11.7 Cg_exo -71.52 42.31 0.47 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.185 2.59 . . . . 13.11 112.974 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -143.91 18.71 2.17 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.939 -0.865 . . . . 14.03 110.939 176.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 42.5 tp -94.07 129.65 40.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.631 -0.285 . . . . 16.32 110.395 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -103.24 -16.2 15.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.96 0.409 . . . . 17.7 110.848 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.592 -0.718 . . . . 18.9 110.259 179.503 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 112.003 -0.439 . . . . 33.41 112.003 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.6 m -73.22 -21.8 60.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.835 0.35 . . . . 34.1 110.925 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.88 49.77 3.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.044 -0.598 . . . . 32.51 112.291 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.415 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 83.8 t80 -69.73 -44.96 24.57 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 111.731 0.271 . . . . 31.98 111.731 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 54' ' ' PHE . 21.6 Cg_exo -65.76 -15.37 48.87 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.012 1.808 . . . . 30.45 111.783 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 m -74.87 78.2 2.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.504 0.669 . . . . 29.01 110.246 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.6 t -135.77 96.28 3.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.242 -0.89 . . . . 27.14 109.208 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -86.17 28.14 0.85 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.288 0.566 . . . . 25.83 110.741 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -87.76 59.57 5.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.922 -0.581 . . . . 23.8 110.6 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -91.17 58.57 3.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.979 -0.555 . . . . 22.03 109.681 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.463 ' HB ' ' CG ' ' A' ' 64' ' ' GLU . 11.7 p -118.7 83.48 22.35 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.762 -0.653 . . . . 19.63 110.879 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.94 118.74 5.83 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 123.075 2.517 . . . . 17.86 112.832 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt 50.17 67.27 0.94 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.483 -0.781 . . . . 17.61 112.825 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' CG ' ' HB ' ' A' ' 61' ' ' THR . 71.7 mm-40 -69.42 118.15 11.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.174 -0.466 . . . . 15.63 109.749 173.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.03 -28.83 6.46 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.01 -0.836 . . . . 12.12 111.01 -174.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.7 m -88.99 124.61 64.72 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 109.773 -0.455 . . . . 10.78 109.773 176.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.37 102.14 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.59 2.193 . . . . 10.17 112.042 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -92.52 126.86 37.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.996 -0.547 . . . . 7.8 110.1 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.6 120.82 15.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.348 -0.387 . . . . 8.14 110.167 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.47 118.7 39.82 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.234 -0.439 . . . . 6.11 111.249 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -84.91 -157.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.098 2.532 . . . . 6.51 112.411 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.1 p -58.45 -40.55 78.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.095 -0.502 . . . . 6.76 110.496 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -81.86 110.78 17.47 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.033 0.444 . . . . 5.18 110.11 174.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.491 ' O ' HD13 ' A' ' 74' ' ' ILE . 1.8 pp -77.85 142.89 65.77 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.988 -0.551 . . . . 4.5 110.847 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.73 39.56 0.77 Allowed 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.755 2.304 . . . . 4.4 113.167 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -83.6 -68.85 0.68 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.318 -0.401 . . . . 3.91 110.668 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 52.67 69.99 0.63 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.631 -0.713 . . . . 3.16 110.191 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.0 mt -80.36 120.76 80.4 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.475 -0.784 . . . . 2.82 110.335 -175.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.17 116.47 4.19 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.287 1.992 . . . . 2.04 111.695 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.435 ' H ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -122.03 151.56 58.48 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.051 -0.522 . . . . 1.53 110.292 -178.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.409 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 82.7 Cg_exo -48.31 134.37 25.41 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.195 2.596 . . . . 0.88 112.441 175.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.69 -20.94 66.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.51 -0.768 . . . . 1.58 112.225 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -68.62 -8.26 40.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.442 0.534 . . . . 1.66 112.442 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -139.93 152.39 46.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.199 -0.667 . . . . 1.2 109.199 -176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -113.63 126.68 55.53 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.782 -0.367 . . . . 2.27 111.544 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.02 127.68 34.7 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.774 -0.824 . . . . 1.37 108.774 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -144.22 147.14 33.22 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.651 -0.704 . . . . 3.75 109.848 -174.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -82.3 112.3 19.16 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.862 -0.792 . . . . 2.46 108.862 172.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 23.3 t -164.9 140.78 5.62 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.366 -0.605 . . . . 2.03 109.366 -176.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 m -99.34 107.32 19.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.8 0.333 . . . . 2.18 110.692 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -105.9 120.46 48.99 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.427 -0.583 . . . . 1.96 109.427 175.245 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 91' ' ' ILE . 50.7 Cg_exo -56.02 123.31 13.53 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.031 2.487 . . . . 1.87 113.312 -176.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.75 -26.82 14.68 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.95 -0.643 . . . . 1.74 112.394 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.55 -57.96 2.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.212 0.53 . . . . 1.79 110.604 178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.06 -120.13 4.13 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 111.199 -0.761 . . . . 1.14 111.199 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -87.17 127.81 35.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.387 -0.598 . . . . 2.81 109.387 173.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.504 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -129.2 157.47 21.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.295 -0.955 . . . . 0.8 113.053 -172.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 98' ' ' VAL . 35.6 m -97.52 114.61 35.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.597 0.713 . . . . 1.17 109.259 173.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -82.19 115.4 21.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.738 -0.665 . . . . 1.4 110.812 -170.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.57 114.78 12.2 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.331 -0.849 . . . . 1.2 109.981 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.09 8.58 42.54 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.975 0.893 . . . . 2.23 109.052 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.464 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 50.5 ttp85 -125.66 153.42 43.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.168 -1.378 . . . . 4.08 108.111 172.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.7 ' HB2' ' O ' ' A' ' 200' ' ' ILE . 0.0 OUTLIER -87.32 126.52 34.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.589 0.709 . . . . 2.86 109.475 -179.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.698 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 25.8 mtm -94.57 138.92 31.86 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.483 -0.562 . . . . 1.38 109.483 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.578 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 10.9 pt-20 -120.34 175.14 6.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.976 0.417 . . . . 2.31 111.945 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.57 125.65 17.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 1.42 112.955 -175.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.27 -14.74 62.12 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.91 -0.662 . . . . 1.04 114.274 168.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 6.7 pt-20 -78.3 158.62 28.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.79 0.795 . . . . 2.62 111.109 -176.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 8.5 ttm180 -119.59 143.86 47.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.471 -0.786 . . . . 4.16 110.654 -176.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 mt -101.34 146.99 26.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.247 -0.649 . . . . 1.11 109.247 172.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.83 -127.82 7.74 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.45 -0.881 . . . . 1.09 112.892 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.01 158.63 69.17 Favored 'Cis proline' 0 N--CA 1.477 0.55 0 C-N-CA 123.622 -1.408 . . . . 2.52 112.854 1.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t -81.78 -19.57 41.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.059 -0.519 . . . . 2.5 110.838 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.1 m -142.66 152.78 17.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.018 -0.537 . . . . 2.46 109.91 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.8 p -134.53 29.56 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 122.376 1.084 . . . . 4.37 109.575 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.0 p -103.32 110.11 63.07 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 114.864 -1.062 . . . . 5.65 111.06 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -81.3 80.84 2.84 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.715 2.276 . . . . 5.38 112.816 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -124.77 -82.96 0.64 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.1 -0.5 . . . . 8.57 110.882 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -172.07 -43.18 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.337 0.589 . . . . 7.27 110.192 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.18 153.55 49.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.594 -0.73 . . . . 6.4 109.713 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.26 90.38 2.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.396 0.617 . . . . 5.88 110.19 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.478 ' HE2' ' O ' ' A' ' 124' ' ' THR . 19.8 ptmt -112.04 153.38 26.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.238 -0.892 . . . . 7.76 111.491 -177.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.414 ' HB2' ' H ' ' A' ' 124' ' ' THR . 6.6 mt-10 -85.53 -76.64 0.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.816 -0.809 . . . . 9.01 108.816 175.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.478 ' O ' ' HE2' ' A' ' 122' ' ' LYS . 32.5 m -113.7 -72.18 0.72 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.309 -0.859 . . . . 9.14 109.138 174.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -179.1 -53.94 0.01 OUTLIER 'General case' 0 C--N 1.338 0.069 0 CA-C-O 121.214 0.531 . . . . 7.6 111.218 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -84.82 10.65 10.95 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.213 0.82 . . . . 8.0 113.213 -170.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.99 -28.14 73.42 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 116.187 -0.461 . . . . 4.59 113.256 -177.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . 0.501 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 0.3 OUTLIER -150.03 -51.51 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.188 0.518 . . . . 4.93 110.36 -179.441 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -175.37 -179.25 1.26 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.363 -0.835 . . . . 7.65 108.949 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -106.38 90.3 3.31 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.076 -0.712 . . . . 9.61 109.076 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.74 130.48 33.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.78 -0.645 . . . . 6.05 110.552 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.95 55.05 0.88 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.169 0.985 . . . . 8.5 110.234 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.9 t -119.98 21.84 11.71 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.2 -1.364 . . . . 9.82 109.511 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.12 61.31 6.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.653 -1.158 . . . . 11.21 110.221 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.64 121.63 18.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.11 -0.95 . . . . 10.92 111.053 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -89.99 78.67 6.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.275 0.56 . . . . 13.25 110.018 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.89 -24.0 19.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.744 0.783 . . . . 14.01 109.356 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.3 t -131.73 116.83 16.11 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-N 115.093 -0.958 . . . . 14.1 108.828 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -43.58 109.3 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.401 2.734 . . . . 14.7 112.074 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -119.18 6.42 11.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.872 -0.604 . . . . 14.44 111.602 -172.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -76.58 115.07 15.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.974 0.416 . . . . 15.9 110.286 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.61 -150.12 22.31 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.411 -0.676 . . . . 16.0 111.411 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 46.2 t -85.83 93.54 8.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.997 0.427 . . . . 15.6 110.532 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.7 mt -73.02 -39.36 57.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.084 -0.71 . . . . 14.1 109.084 174.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -157.78 138.78 13.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.364 -0.834 . . . . 13.19 109.818 175.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -116.52 -10.33 11.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.292 0.568 . . . . 15.92 110.0 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 28.3 pt -86.5 165.37 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.553 -0.749 . . . . 14.07 110.385 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.5 p -134.21 119.36 18.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.153 -0.476 . . . . 13.67 110.191 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -77.32 132.04 38.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.053 -0.522 . . . . 13.02 110.453 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -123.17 125.15 44.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.159 -0.473 . . . . 14.68 110.169 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.42 35.41 0.71 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.042 -0.526 . . . . 13.55 110.715 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 156' ' ' PHE . . . -147.21 69.71 0.36 Allowed Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.778 -0.929 . . . . 15.8 110.778 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.5 p -145.49 -65.29 0.32 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.668 0.27 . . . . 17.08 111.64 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -78.32 -83.29 0.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.416 -0.356 . . . . 18.43 111.423 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.54 -0.43 6.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.916 0.389 . . . . 18.74 111.045 -178.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.576 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 95.0 m-85 -98.76 147.66 24.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.321 -0.399 . . . . 14.81 110.055 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 15.2 t -149.88 32.0 0.7 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.426 0.631 . . . . 14.64 109.822 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 66.7 t -130.95 138.98 52.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.655 -0.702 . . . . 13.38 109.77 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -79.88 53.97 1.77 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.073 0.463 . . . . 10.61 110.719 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.01 -57.51 6.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.687 -0.688 . . . . 10.22 111.14 -176.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -86.85 -2.48 58.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.148 -0.478 . . . . 10.69 110.781 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.462 ' C ' ' H ' ' A' ' 164' ' ' GLY . 22.5 mt-30 -97.83 -15.68 20.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.12 -0.491 . . . . 9.45 110.646 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.13 33.02 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.908 -0.587 . . . . 6.56 110.861 174.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 162' ' ' GLN . . . -88.68 58.45 4.08 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.308 -0.717 . . . . 4.17 111.308 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -118.48 147.45 43.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.884 0.373 . . . . 3.14 110.62 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -88.33 1.06 84.07 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.905 -0.664 . . . . 1.69 112.063 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 16.0 m -56.19 -41.35 75.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.383 0.273 . . . . 2.0 111.442 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.409 ' CZ2' ' HG2' ' A' ' 81' ' ' PRO . 27.4 p-90 -87.45 -22.04 25.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.846 0.355 . . . . 0.83 111.382 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 38.9 mt -85.61 -14.87 44.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.746 0.276 . . . . 1.28 111.746 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.1 OUTLIER -75.29 -4.67 40.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 2.03 110.224 174.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.504 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 29.4 m-85 -77.43 -38.44 49.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.528 -0.76 . . . . 2.19 110.64 177.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -81.45 117.48 27.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.145 0.497 . . . . 1.24 110.552 178.765 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 43.1 mmt-85 -131.09 -161.8 1.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.627 -0.715 . . . . 4.97 110.825 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.451 ' HA ' HG13 ' A' ' 208' ' ' VAL . 6.2 t -62.49 139.65 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.286 0.565 . . . . 1.63 111.97 -168.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.512 ' HB1' ' NE2' ' A' ' 181' ' ' GLN . . . -71.7 164.82 25.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.154 -0.93 . . . . 1.34 111.276 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 47.4 t -92.45 -21.28 20.27 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.298 -0.864 . . . . 2.58 112.054 -169.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.3 m -143.16 -179.74 6.56 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.422 0.527 . . . . 2.06 112.422 -174.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 6.3 p -74.49 -53.03 10.28 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.117 0.414 . . . . 2.69 112.117 -175.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.15 -12.9 61.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.817 0.817 . . . . 2.42 109.468 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 206' ' ' LEU . 28.5 t0 -80.54 -1.58 42.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.326 -1.307 . . . . 2.12 110.192 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.512 ' NE2' ' HB1' ' A' ' 175' ' ' ALA . 33.9 mm-40 -73.22 116.52 13.85 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.164 0.507 . . . . 1.52 111.572 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.505 ' OD1' ' HG3' ' A' ' 198' ' ' LYS . 16.8 t30 -156.1 38.8 0.35 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.02 -1.104 . . . . 1.68 108.02 173.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.637 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.1 OUTLIER -124.55 124.76 42.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.442 -0.799 . . . . 1.43 111.233 -172.348 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 99.8 m -150.9 133.86 15.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 1.2 110.86 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.447 ' HE1' ' CZ ' ' A' ' 194' ' ' TYR . 37.3 ttm -127.53 136.29 51.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.009 -0.541 . . . . 1.56 109.548 176.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 9.0 p -130.21 165.64 21.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.799 0.333 . . . . 2.13 110.41 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.79 104.98 11.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.189 -0.671 . . . . 1.96 109.189 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.517 HD12 ' CD2' ' A' ' 193' ' ' TYR . 43.9 pt -135.53 145.16 32.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 1.62 110.712 -175.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.8 m 62.06 28.76 17.39 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.36 0.413 . . . . 2.24 111.449 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 66.94 21.75 10.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.579 -0.737 . . . . 2.83 111.791 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -133.48 166.43 22.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.379 . . . . 1.86 110.421 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.6 mm -88.2 130.06 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.922 -0.581 . . . . 1.59 109.752 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.517 ' CD2' HD12 ' A' ' 188' ' ' ILE . 35.2 t80 -120.56 124.44 45.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 4.16 110.881 -173.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.658 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 7.4 m-85 -99.94 113.69 26.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.562 -0.903 . . . . 1.27 108.562 174.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -110.81 124.91 52.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.234 -0.284 . . . . 1.73 110.234 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.413 HG11 ' H ' ' A' ' 197' ' ' ILE . 1.6 t -91.86 150.57 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.924 0.869 . . . . 1.33 110.53 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.413 ' H ' HG11 ' A' ' 196' ' ' VAL . 1.0 OUTLIER -100.66 -54.57 6.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 113.964 -1.471 . . . . 1.23 111.565 -163.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.505 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -146.21 169.77 18.1 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.849 -1.069 . . . . 1.88 109.576 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.698 ' HA ' ' O ' ' A' ' 104' ' ' MET . 4.0 m-20 -61.83 110.9 1.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.355 0.597 . . . . 2.23 111.973 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.7 ' O ' ' HB2' ' A' ' 103' ' ' LYS . 3.8 mm -69.05 148.0 11.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.032 -0.985 . . . . 1.41 110.545 175.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 52.6 mt-10 -89.0 117.57 68.39 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 108.646 -0.872 . . . . 2.06 108.646 170.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.12 117.79 2.43 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.87 2.38 . . . . 0.56 112.323 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.98 2.68 10.17 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.762 -0.732 . . . . 0.7 112.805 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 11.7 pt-20 -140.48 126.42 19.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.32 0.581 . . . . 1.27 110.505 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.418 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -108.7 105.27 14.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.657 -0.702 . . . . 2.92 111.839 -177.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.579 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.9 mm? -122.87 99.81 6.58 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.576 -0.45 . . . . 1.51 110.206 175.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.569 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.94 113.39 6.29 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.89 0.476 . . . . 1.16 109.763 175.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.637 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.6 p -155.93 160.87 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 122.07 -0.394 . . . . 1.5 110.58 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.501 ' CG ' ' HB2' ' A' ' 128' ' ' TRP . 43.5 t-80 -81.87 112.4 18.96 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.793 -1.558 . . . . 1.77 106.793 165.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.6 m -73.67 94.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 122.064 0.935 . . . . 3.05 110.469 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -87.67 142.64 27.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.742 -1.117 . . . . 5.7 110.289 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -136.72 15.49 3.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.887 0.375 . . . . 5.8 110.941 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 154.13 89.99 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.106 -1.045 . . . . 5.61 112.854 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 14.5 t -94.29 -71.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.786 0.326 . . . . 6.31 110.367 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.455 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 72.1 t80 -76.83 -56.56 1.32 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.299 -0.409 . . . . 9.04 111.576 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 19.3 Cg_endo -59.81 -42.03 49.37 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.168 1.912 . . . . 7.78 112.744 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.4 mp -94.45 17.27 13.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.101 -0.5 . . . . 8.02 110.898 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -101.74 166.56 18.18 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.855 -0.688 . . . . 8.64 111.626 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.2 p -84.14 49.32 1.62 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.186 0.517 . . . . 9.96 110.725 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 27.0 m -95.57 133.53 25.58 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.909 -0.587 . . . . 9.62 111.288 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -84.41 119.98 2.42 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.427 2.085 . . . . 12.02 111.813 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -68.59 -13.05 36.38 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.33 2.02 . . . . 13.11 111.966 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -121.0 57.63 0.59 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.346 -1.102 . . . . 14.03 110.346 174.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 10.0 tt -62.02 119.79 9.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.301 0.572 . . . . 16.32 111.474 -172.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -129.61 -21.58 3.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.278 -0.874 . . . . 17.7 110.242 177.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.437 -0.792 . . . . 18.9 110.443 -177.235 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 112.004 -0.438 . . . . 33.41 112.004 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.4 m -82.25 -22.85 35.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.936 0.398 . . . . 34.1 110.548 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -140.39 -147.59 5.01 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.95 -0.643 . . . . 32.51 111.908 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -74.63 141.42 76.06 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.311 0.1 . . . . 31.98 110.806 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -74.77 68.04 5.62 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.93 2.42 . . . . 30.45 112.392 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.6 p -81.05 61.25 4.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.308 -0.406 . . . . 29.01 111.013 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.0 m 60.79 62.44 1.48 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.579 0.704 . . . . 27.14 109.83 -174.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -90.34 11.88 20.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.365 -0.834 . . . . 25.83 110.856 -174.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -75.02 114.0 13.0 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.442 -0.799 . . . . 23.8 110.466 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -120.21 136.03 54.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.29 -0.414 . . . . 22.03 109.935 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.2 m -74.44 116.9 57.53 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 19.63 110.872 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.03 112.19 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.195 2.597 . . . . 17.86 112.532 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -126.43 40.93 3.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.593 -0.731 . . . . 17.61 109.342 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -82.96 149.17 27.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.314 -0.857 . . . . 15.63 110.337 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.9 -130.06 1.53 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.804 -0.712 . . . . 12.12 112.112 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.1 m 57.28 72.43 0.93 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.013 0.435 . . . . 10.78 111.115 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -73.82 139.04 27.07 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.965 2.443 . . . . 10.17 111.823 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -85.62 93.2 8.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.052 0.453 . . . . 7.8 110.475 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -96.28 129.77 43.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.913 -0.585 . . . . 8.14 109.944 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.67 128.08 75.8 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.139 -0.482 . . . . 6.11 111.08 -176.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -45.4 -74.82 0.04 OUTLIER 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 123.784 2.989 . . . . 6.51 114.453 -175.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.9 p -115.22 -48.88 4.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.151 -0.477 . . . . 6.76 111.761 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -85.17 140.81 30.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.712 0.292 . . . . 5.18 110.242 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.543 ' O ' HD13 ' A' ' 74' ' ' ILE . 2.2 pp -76.38 139.22 67.74 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.222 0.534 . . . . 4.5 111.625 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.68 8.7 4.48 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.849 2.366 . . . . 4.4 112.533 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.47 -61.21 2.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.874 -0.603 . . . . 3.91 109.713 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.4 t70 56.16 76.59 0.28 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.038 -0.983 . . . . 3.16 110.668 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 88.7 mt -73.65 133.17 80.06 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.178 -0.919 . . . . 2.82 110.559 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.98 116.88 3.61 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.756 2.304 . . . . 2.04 112.067 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.477 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -118.3 147.05 40.87 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.042 -0.526 . . . . 1.53 109.781 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.52 133.97 61.19 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.15 1.9 . . . . 0.88 110.527 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.5 -16.5 15.65 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.569 0.543 . . . . 1.58 112.44 -174.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.9 -24.53 66.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.194 0.521 . . . . 1.66 110.309 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -121.76 177.38 5.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.69 -0.687 . . . . 1.2 109.395 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.484 ' OE2' ' HD3' ' A' ' 87' ' ' ARG . 33.1 tt0 -154.93 131.72 10.73 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.723 -0.391 . . . . 2.27 110.732 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tt -84.5 131.14 34.68 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.726 -0.842 . . . . 1.37 108.726 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.484 ' HD3' ' OE2' ' A' ' 85' ' ' GLU . 14.4 mmm-85 -138.35 142.9 39.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.084 -0.507 . . . . 3.75 110.94 -173.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.72 110.21 12.37 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.364 -0.976 . . . . 2.46 108.364 171.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 p -168.99 94.58 0.32 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.874 -0.603 . . . . 2.03 110.01 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -81.64 104.68 12.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.203 -0.453 . . . . 2.18 111.016 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.544 HD11 ' SG ' ' A' ' 176' ' ' CYS . 0.0 OUTLIER -104.51 119.44 53.77 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.985 -0.552 . . . . 1.96 109.586 176.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -52.16 124.61 15.24 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.464 2.776 . . . . 1.87 113.12 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.7 -29.46 9.86 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.709 -0.678 . . . . 1.74 112.046 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.523 ' O ' ' HD2' ' A' ' 173' ' ' ARG . . . -118.4 -66.89 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.816 0.341 . . . . 1.79 111.242 177.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.94 -145.93 17.83 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.523 -0.631 . . . . 1.14 111.523 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mt -91.67 118.27 30.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.877 0.338 . . . . 2.81 110.254 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -129.6 -179.36 15.94 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.881 -0.676 . . . . 0.8 111.485 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.7 m -92.44 147.47 5.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.911 -0.774 . . . . 1.17 108.911 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -116.17 118.42 32.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.756 0.312 . . . . 1.4 110.544 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.08 120.27 14.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.174 -0.466 . . . . 1.2 110.033 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.506 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -89.15 15.5 8.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.587 0.708 . . . . 2.23 110.063 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.428 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 32.7 ttp85 -141.66 158.49 43.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.092 -0.958 . . . . 4.08 108.423 176.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.627 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -82.61 158.98 22.82 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.953 0.406 . . . . 2.86 110.633 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.662 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 58.4 mtm -133.27 151.1 51.89 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.381 -0.6 . . . . 1.38 109.381 176.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -114.74 138.42 50.75 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 123.338 0.399 . . . . 2.31 110.745 -176.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -37.24 122.05 0.86 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.783 1.302 . . . . 1.42 113.742 -171.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.66 7.16 12.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.928 -0.653 . . . . 1.04 112.141 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.458 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.6 OUTLIER -84.26 159.46 20.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.058 0.456 . . . . 2.62 110.744 -178.123 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.614 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 7.0 tmm_? -146.1 136.09 23.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 4.16 110.715 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.6 mt -93.22 142.25 27.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.555 -0.535 . . . . 1.11 109.555 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.17 171.59 44.43 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.675 -0.774 . . . . 1.09 111.904 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.2 137.94 46.25 Favored 'Cis proline' 0 C--N 1.345 0.382 0 C-N-CA 123.722 -1.366 . . . . 2.52 112.151 -0.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.783 ' SG ' ' HA ' ' A' ' 193' ' ' TYR . 13.3 m -87.18 -32.3 19.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 2.5 111.429 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 p -123.96 98.78 5.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.434 0.635 . . . . 2.46 110.166 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.9 m -106.37 25.16 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.473 0.654 . . . . 4.37 111.147 -177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.55 128.1 70.77 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.379 -0.828 . . . . 5.65 110.145 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.56 161.99 42.79 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.807 2.338 . . . . 5.38 112.488 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 66.57 -81.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.702 0.626 . . . . 8.57 110.887 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -178.65 -38.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.779 -0.646 . . . . 7.27 109.365 -177.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 62.56 84.98 0.13 Allowed 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.963 0.79 . . . . 6.4 112.115 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.94 83.34 3.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.614 -0.721 . . . . 5.88 109.967 174.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.467 ' HE3' ' HB3' ' A' ' 125' ' ' ASP . 55.9 pttt -74.49 176.83 6.46 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.797 -1.092 . . . . 7.76 111.432 -177.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 123' ' ' GLU . 5.1 mp0 -46.15 -71.71 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.585 -1.189 . . . . 9.01 111.781 -174.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 p -146.79 -100.24 0.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.461 -0.336 . . . . 9.14 110.916 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.467 ' HB3' ' HE3' ' A' ' 122' ' ' LYS . 36.2 t70 63.08 116.86 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.9 0.857 . . . . 7.6 111.705 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -86.9 157.67 19.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.495 -0.775 . . . . 8.0 110.585 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 147.12 -47.26 0.69 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.66 -0.781 . . . . 4.59 111.662 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -158.87 -40.19 0.06 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.844 -0.428 . . . . 4.93 109.844 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.546 ' O ' HD11 ' A' ' 131' ' ' ILE . 16.0 mt-10 67.93 -77.33 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.325 0 O-C-N 124.303 1.002 . . . . 7.65 110.944 173.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 41.42 -88.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.012 1.115 . . . . 9.61 114.012 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.546 HD11 ' O ' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -58.81 -24.94 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 113.283 0.846 . . . . 6.05 113.283 -169.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 129' ' ' GLU . 0.4 OUTLIER -82.25 60.96 5.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.901 0.858 . . . . 8.5 111.772 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.432 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 24.6 p -144.7 42.16 1.34 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.259 -1.337 . . . . 9.82 108.794 173.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 133' ' ' THR . 31.8 t70 73.92 105.39 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.984 -1.007 . . . . 11.21 109.548 -168.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 63.7 t -70.23 94.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 10.92 111.156 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -119.55 -6.3 10.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.506 -0.77 . . . . 13.25 109.386 175.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.25 -3.96 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.324 -0.853 . . . . 14.01 111.47 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.1 m -153.11 75.19 6.72 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.427 -0.351 . . . . 14.1 110.947 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.4 106.19 1.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.973 2.449 . . . . 14.7 111.515 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 61.25 73.52 0.48 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.087 -0.506 . . . . 14.44 110.598 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -11.99 58.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.107 -0.497 . . . . 15.9 111.876 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 164.25 -38.02 0.3 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.742 -0.742 . . . . 16.0 112.181 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 25.1 p -100.95 144.16 30.22 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.023 -0.362 . . . . 15.6 110.023 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 27.8 mm -108.71 50.89 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 122.061 0.934 . . . . 14.1 109.101 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.63 95.24 3.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.789 -1.096 . . . . 13.19 110.312 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -105.55 -20.63 13.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.829 -0.623 . . . . 15.92 110.301 -175.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.9 pt -128.7 168.12 22.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.448 -0.796 . . . . 14.07 110.837 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.5 p -123.28 113.19 18.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.923 -0.58 . . . . 13.67 110.872 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -88.29 148.86 24.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.905 -0.589 . . . . 13.02 109.753 175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -91.07 124.56 35.39 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.912 0.387 . . . . 14.68 110.759 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 pp -99.98 14.34 30.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.19 0.519 . . . . 13.55 111.042 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 126.61 106.83 1.48 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.321 -0.854 . . . . 15.8 111.6 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 18.0 m -80.15 -29.04 38.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.766 0.317 . . . . 17.08 110.803 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -95.08 -68.04 0.82 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.032 0.444 . . . . 18.43 110.046 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -124.66 149.19 47.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.762 -0.654 . . . . 18.74 110.02 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.18 142.41 15.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.18 -0.463 . . . . 14.81 110.44 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 60.0 m -130.31 7.1 4.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.219 -0.446 . . . . 14.64 110.34 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.14 135.46 44.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.108 -0.497 . . . . 13.38 110.772 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -97.35 125.98 42.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.005 -0.543 . . . . 10.61 111.138 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -120.23 -53.07 2.15 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.623 -0.717 . . . . 10.22 109.756 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -136.48 42.18 2.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.892 -0.595 . . . . 10.69 110.41 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -94.7 -15.77 23.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.082 0.468 . . . . 9.45 110.438 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 66.33 39.43 4.06 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.84 -1.073 . . . . 6.56 110.819 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -59.62 -31.13 70.22 Favored Glycine 0 C--N 1.33 0.247 0 CA-C-N 115.558 -0.746 . . . . 4.17 113.417 -176.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -64.97 -14.88 61.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.928 0.344 . . . . 3.14 111.928 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -125.42 4.59 8.19 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.784 -0.722 . . . . 1.69 111.69 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.648 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 31.4 t -76.54 -20.24 57.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.16 0.505 . . . . 2.0 111.053 -175.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 42.4 p-90 -69.33 -18.65 63.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.066 0.46 . . . . 0.83 110.832 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 113' ' ' CYS . 33.3 mt -80.31 -17.91 50.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.001 -0.545 . . . . 1.28 112.269 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.648 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -82.66 -3.91 56.99 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.106 -0.638 . . . . 2.03 110.575 178.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.414 ' O ' ' HG3' ' A' ' 173' ' ' ARG . 54.1 m-85 -77.88 -36.08 50.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 2.19 110.726 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -68.08 129.72 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.131 -0.692 . . . . 1.24 109.131 174.412 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.523 ' HD2' ' O ' ' A' ' 94' ' ' ALA . 45.7 mtt180 -129.7 -160.72 1.06 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.553 -0.294 . . . . 4.97 110.814 -174.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.424 ' HA ' HG11 ' A' ' 208' ' ' VAL . 16.1 t -62.96 148.95 10.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.355 0.409 . . . . 1.63 111.292 -173.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.48 132.12 39.43 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.692 -0.685 . . . . 1.34 111.431 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.544 ' SG ' HD11 ' A' ' 91' ' ' ILE . 23.2 m -55.2 -25.01 30.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.949 -1.023 . . . . 2.58 112.237 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 92.8 p -149.29 -179.0 6.71 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.012 -0.366 . . . . 2.06 110.012 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 47.4 t -80.95 -23.69 38.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.902 0.382 . . . . 2.69 110.531 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -88.54 -10.27 49.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.699 0.285 . . . . 2.42 110.97 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -91.15 15.94 10.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.377 -0.374 . . . . 2.12 111.246 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 17.0 mm100 -63.33 114.04 3.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.129 0.49 . . . . 1.52 110.385 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.536 ' OD1' ' HG3' ' A' ' 198' ' ' LYS . 21.8 t30 -165.68 43.21 0.07 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.101 -1.074 . . . . 1.68 108.101 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.603 ' HB3' ' O ' ' A' ' 206' ' ' LEU . 0.8 OUTLIER -142.57 128.88 19.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.583 -0.735 . . . . 1.43 111.888 -175.426 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 29.3 m -151.34 141.51 22.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.803 -1.089 . . . . 1.2 110.335 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 54.0 tpp -90.11 139.77 30.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.947 -0.39 . . . . 1.56 109.947 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 52.8 t -113.67 132.11 55.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.173 0.511 . . . . 2.13 110.471 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -122.01 105.56 10.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.707 -0.849 . . . . 1.96 108.707 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.456 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 16.3 pt -139.64 142.99 31.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.987 -0.551 . . . . 1.62 110.689 -176.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.7 m 57.18 38.1 28.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.153 -0.476 . . . . 2.24 110.968 177.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 67.86 6.24 4.99 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.48 -0.782 . . . . 2.83 112.119 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.5 pt20 -124.94 161.13 27.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 1.86 110.842 -176.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.84 137.12 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.813 -0.63 . . . . 1.59 111.645 -176.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.783 ' HA ' ' SG ' ' A' ' 113' ' ' CYS . 25.4 m-85 -140.9 155.02 46.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.623 -0.717 . . . . 4.16 110.294 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 2.2 m-85 -100.15 113.2 25.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.735 -0.469 . . . . 1.27 109.735 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -102.78 123.51 46.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.076 0.465 . . . . 1.73 110.231 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.458 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 1.6 t -94.68 151.96 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.714 0.769 . . . . 1.33 109.632 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.8 mm -90.67 -56.4 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.361 -1.291 . . . . 1.23 111.201 -166.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.536 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -145.29 -178.16 5.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.373 -0.83 . . . . 1.88 111.891 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.662 ' HA ' ' O ' ' A' ' 104' ' ' MET . 18.6 t70 -46.07 132.44 9.53 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.689 0.996 . . . . 2.23 113.689 -172.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.488 HG13 ' HE2' ' A' ' 104' ' ' MET . 26.4 mm -101.49 132.79 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.231 -0.895 . . . . 1.41 110.349 174.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 35.8 mt-10 -89.35 126.59 57.99 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.337 -0.616 . . . . 2.06 109.337 173.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.03 116.95 2.19 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.962 2.441 . . . . 0.56 112.86 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.05 -4.94 10.47 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.78 -0.724 . . . . 0.7 113.299 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 9.5 pt-20 -142.29 120.35 12.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.476 0.638 . . . . 1.27 112.022 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -111.96 125.35 53.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.73 -0.668 . . . . 2.92 110.225 171.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.603 ' O ' ' HB3' ' A' ' 183' ' ' LEU . 2.5 mm? -120.01 102.06 8.28 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.671 -0.862 . . . . 1.51 108.671 172.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.529 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.9 mm? -143.76 113.45 7.09 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.138 0.274 . . . . 1.16 110.925 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.442 ' H ' ' HB2' ' A' ' 183' ' ' LEU . 1.9 p -153.61 159.8 3.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 O-C-N 122.105 -0.372 . . . . 1.5 111.259 176.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -94.47 111.88 23.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.659 -0.867 . . . . 1.77 108.659 167.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 210' ' ' VAL . 6.2 p -137.88 94.72 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.313 0.578 . . . . 3.05 111.589 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 66.5 129.8 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.024 -0.989 . . . . 5.7 112.843 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.2 173.95 11.0 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.311 -0.996 . . . . 5.8 108.311 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.526 ' HA2' HD23 ' A' ' 217' ' ' LEU . . . -89.37 45.71 3.15 Favored Glycine 0 C--N 1.304 -1.222 0 CA-C-N 115.376 -0.829 . . . . 5.61 112.263 -175.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.1 t -98.34 -72.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.916 0.389 . . . . 6.31 110.773 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.464 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 77.2 t80 -76.92 -53.79 1.72 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.326 -0.397 . . . . 9.04 111.593 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 19.8 Cg_endo -61.11 -45.67 18.51 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.987 1.791 . . . . 7.78 112.692 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.526 HD23 ' HA2' ' A' ' 213' ' ' GLY . 4.2 mm? -86.97 -66.58 0.89 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.514 -0.312 . . . . 8.02 110.881 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 138.7 -135.93 7.71 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.327 -0.94 . . . . 8.64 112.219 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 74.8 p 54.02 35.97 23.4 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.665 0.786 . . . . 9.96 110.73 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.505 ' O ' ' HD3' ' A' ' 222' ' ' PRO . 29.9 m -69.64 142.22 91.23 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 115.419 -0.81 . . . . 9.62 110.781 -175.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.04 106.19 1.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.71 2.273 . . . . 12.02 111.725 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 220' ' ' VAL . 89.5 Cg_endo -84.81 70.1 5.66 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.734 2.29 . . . . 13.11 111.982 -177.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 86.67 -32.46 3.95 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.849 -0.614 . . . . 14.03 112.003 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 36.8 tp -124.7 127.67 47.63 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.058 -0.349 . . . . 16.32 110.058 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -121.08 2.46 10.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.234 0.54 . . . . 17.7 110.158 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.464 -0.779 . . . . 18.9 110.238 178.945 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 111.769 -0.532 . . . . 33.41 111.769 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.5 m -114.89 29.99 7.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.012 0.434 . . . . 34.1 111.171 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.96 -56.39 3.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.81 -0.709 . . . . 32.51 112.14 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -130.33 139.86 36.92 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 110.037 -0.357 . . . . 31.98 110.037 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.74 -12.59 31.27 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.959 2.439 . . . . 30.45 112.723 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 p -80.71 122.44 27.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.077 -0.511 . . . . 29.01 110.745 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.8 p -80.31 59.43 3.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.409 0.623 . . . . 27.14 111.9 -176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -90.63 56.66 3.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.012 -0.736 . . . . 25.83 109.012 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.79 57.63 0.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.579 -0.737 . . . . 23.8 110.61 -177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -74.59 102.37 4.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.358 -0.608 . . . . 22.03 109.358 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.8 t -137.95 137.3 21.02 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.603 -0.726 . . . . 19.63 109.931 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.84 79.27 0.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.44 2.094 . . . . 17.86 112.413 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -106.02 -28.32 10.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.365 -1.288 . . . . 17.61 109.667 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -91.73 3.99 53.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.588 -0.733 . . . . 15.63 109.963 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.24 123.17 2.35 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.119 -0.946 . . . . 12.12 111.38 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -120.49 102.16 45.53 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 110.343 -0.243 . . . . 10.78 110.343 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.94 135.11 36.68 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.197 1.931 . . . . 10.17 111.231 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -68.94 121.27 16.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.208 -0.451 . . . . 7.8 110.715 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -111.1 125.62 53.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.718 -0.674 . . . . 8.14 110.479 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.19 170.63 11.58 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.859 -0.61 . . . . 6.11 110.079 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.66 -154.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.379 2.053 . . . . 6.51 112.458 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.0 p -55.95 -41.98 69.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 6.76 111.17 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -97.46 112.62 24.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.897 0.38 . . . . 5.18 110.531 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.548 ' O ' HD13 ' A' ' 74' ' ' ILE . 2.1 pp -78.49 141.97 61.69 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.916 -0.584 . . . . 4.5 110.52 174.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.44 26.03 0.65 Allowed 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.779 2.319 . . . . 4.4 112.832 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -101.35 -72.22 0.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.265 -0.425 . . . . 3.91 111.124 -176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.9 t70 63.7 94.44 0.05 Allowed 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.946 0.779 . . . . 3.16 109.712 -172.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 83.5 mt -67.83 123.33 86.76 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.556 -0.747 . . . . 2.82 110.987 -175.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.88 121.12 8.53 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.838 2.358 . . . . 2.04 112.292 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.485 ' H ' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -127.78 153.28 77.94 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.746 -0.661 . . . . 1.53 109.281 177.693 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.32 141.7 88.71 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.388 2.059 . . . . 0.88 111.746 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.504 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -65.68 -12.33 52.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.987 0.736 . . . . 1.58 112.987 -171.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -82.68 -19.71 37.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.037 0.384 . . . . 1.66 112.037 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.515 ' HE2' ' SD ' ' A' ' 104' ' ' MET . 5.1 m-85 -116.83 144.88 43.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.838 -0.43 . . . . 1.2 109.838 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -116.46 117.07 28.9 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.886 -0.326 . . . . 2.27 110.725 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.49 HD13 ' CE2' ' A' ' 171' ' ' TYR . 8.2 tt -86.09 124.3 32.36 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.962 -0.755 . . . . 1.37 108.962 176.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -140.37 128.4 22.13 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.791 -0.641 . . . . 3.75 110.692 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -81.83 112.95 19.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.899 -0.778 . . . . 2.46 108.899 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -166.9 162.73 15.99 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.881 -0.785 . . . . 2.03 108.881 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.0 t -99.83 105.55 17.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.905 0.383 . . . . 2.18 110.627 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.422 HG23 ' HB1' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -101.59 117.34 62.06 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.25 -0.648 . . . . 1.96 109.25 174.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -55.98 123.29 13.48 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.029 2.486 . . . . 1.87 113.116 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.65 -18.39 40.99 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.7 -0.762 . . . . 1.74 112.665 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HB1' HG23 ' A' ' 91' ' ' ILE . . . -129.34 -55.91 1.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.215 0.531 . . . . 1.79 111.517 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.414 ' O ' HG21 ' A' ' 91' ' ' ILE . . . 121.24 -103.35 0.88 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 111.267 -0.733 . . . . 1.14 111.267 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.4 160.78 14.24 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.95 -0.389 . . . . 2.81 109.95 172.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.96 171.79 44.66 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.512 -0.852 . . . . 0.8 112.464 177.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 86' ' ' LEU . 17.0 m -107.29 147.36 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.182 -0.673 . . . . 1.17 109.182 173.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -125.79 110.59 13.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.755 0.312 . . . . 1.4 111.07 -174.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -59.83 125.77 24.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.85 -0.614 . . . . 1.2 111.115 177.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.504 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -93.18 -3.88 53.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.331 0.586 . . . . 2.23 110.203 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.5 ttp85 -133.16 155.3 49.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.934 -1.135 . . . . 4.08 107.934 171.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.661 ' C ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -84.16 158.56 21.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.277 0.56 . . . . 2.86 110.685 -175.437 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.597 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 54.9 mtm -117.36 154.33 31.49 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.784 . . . . 1.38 109.068 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -107.83 136.12 48.09 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.41 0.444 . . . . 2.31 110.376 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -39.11 117.29 0.67 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.624 1.202 . . . . 1.42 112.991 -174.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.33 7.46 12.33 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.544 -0.753 . . . . 1.04 111.547 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.424 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -75.64 165.22 25.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.054 0.454 . . . . 2.62 110.742 -178.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.537 ' HD3' ' CD1' ' A' ' 193' ' ' TYR . 7.1 tmm_? -141.38 132.66 26.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.386 -0.37 . . . . 4.16 110.297 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.486 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 5.9 mt -100.75 138.49 37.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.616 -0.513 . . . . 1.11 109.616 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.49 173.75 46.43 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.976 -0.63 . . . . 1.09 111.696 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -83.9 146.86 53.15 Favored 'Cis proline' 0 C--O 1.236 0.4 0 C-N-CA 123.316 -1.535 . . . . 2.52 112.77 -0.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.1 t -94.16 -39.46 10.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.661 -0.7 . . . . 2.5 109.634 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.3 p -171.11 132.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.619 -0.719 . . . . 2.46 109.922 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.9 t -65.34 150.53 10.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.051 -0.722 . . . . 4.37 109.051 176.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.2 t -44.54 114.09 1.89 Allowed Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 123.663 0.602 . . . . 5.65 111.003 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 77.6 Cg_exo -50.68 97.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.778 2.986 . . . . 5.38 113.524 -175.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -137.02 -65.69 0.54 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.15 -0.932 . . . . 8.57 109.274 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.23 -39.6 39.9 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.312 0.577 . . . . 7.27 109.724 174.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -125.5 143.65 50.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.336 -0.847 . . . . 6.4 109.619 176.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.68 107.65 3.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.772 0.32 . . . . 5.88 111.033 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -68.66 112.35 5.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.565 0.697 . . . . 7.76 111.156 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -117.91 -41.06 2.93 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.015 -0.993 . . . . 9.01 109.639 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 28.9 m -60.17 -52.82 63.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.458 -0.792 . . . . 9.14 109.949 173.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.85 126.93 31.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.35 -0.841 . . . . 7.6 109.192 173.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -69.43 143.07 53.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.055 0.455 . . . . 8.0 111.615 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -153.37 -69.57 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.033 -0.827 . . . . 4.59 111.033 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.51 -118.18 0.29 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 110.04 -0.355 . . . . 4.93 110.04 172.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.525 ' HG3' ' N ' ' A' ' 130' ' ' GLN . 7.7 pt-20 -142.75 -54.09 0.41 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.58 0.229 . . . . 7.65 110.771 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.525 ' N ' ' HG3' ' A' ' 129' ' ' GLU . 45.2 mt-30 -151.07 153.31 34.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.545 -0.298 . . . . 9.61 110.531 -173.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.3 -16.65 4.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.917 0.389 . . . . 6.05 110.249 168.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.36 58.14 4.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.86 0.838 . . . . 8.5 111.198 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.2 t -178.96 28.51 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 114.337 -1.301 . . . . 9.82 109.298 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -68.18 115.12 7.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.19 -0.914 . . . . 11.21 110.701 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.86 131.26 26.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.578 -0.737 . . . . 10.92 110.914 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.38 97.88 7.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.152 0.501 . . . . 13.25 110.373 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.77 -23.79 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.798 -0.637 . . . . 14.01 110.01 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.1 t -107.26 126.29 30.42 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.674 -0.694 . . . . 14.1 110.062 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.28 80.79 2.14 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.532 2.155 . . . . 14.7 111.632 177.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -95.87 100.86 12.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.673 -0.694 . . . . 14.44 111.077 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -127.66 173.51 9.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.3 -0.863 . . . . 15.9 110.325 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.63 -97.36 0.4 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.08 -0.581 . . . . 16.0 112.389 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 7.4 p -80.79 69.22 7.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.405 0.621 . . . . 15.6 110.626 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 39.8 mt -89.04 102.9 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.836 -0.62 . . . . 14.1 110.178 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 t -118.66 142.82 47.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.011 0.434 . . . . 13.19 110.485 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -121.79 -4.18 9.18 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.28 0.562 . . . . 15.92 109.971 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.7 pp -107.49 168.56 3.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.731 -0.668 . . . . 14.07 111.266 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 49.7 m -154.0 57.43 0.72 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.706 -0.849 . . . . 13.67 108.706 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -87.28 46.24 1.36 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.181 -0.918 . . . . 13.02 110.958 -170.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -159.67 142.47 13.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.337 -0.847 . . . . 14.68 109.387 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.6 pp -130.27 159.29 37.35 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 120.958 0.409 . . . . 13.55 110.083 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 154' ' ' GLU . . . -89.44 100.31 2.65 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.543 -0.753 . . . . 15.8 111.253 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.7 m -68.11 14.11 0.07 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.556 0.576 . . . . 17.08 112.556 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.458 ' H ' ' C ' ' A' ' 152' ' ' GLY . 36.1 mt-10 -63.35 -61.92 2.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.732 0.777 . . . . 18.43 109.746 174.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.506 ' H ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -117.42 -0.75 11.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.877 -1.056 . . . . 18.74 110.814 -179.24 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -100.39 87.63 3.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.172 0.511 . . . . 14.81 111.054 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 53.8 t -82.96 -46.61 12.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.773 -0.825 . . . . 14.64 108.773 172.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 67.1 t -101.34 128.34 53.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.534 -0.757 . . . . 13.38 109.788 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' A' ' 162' ' ' GLN . 23.9 t70 -88.31 117.03 26.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.348 0.594 . . . . 10.61 111.543 -177.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -108.26 -28.56 9.38 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.195 -0.911 . . . . 10.22 109.611 172.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -52.73 -57.57 9.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.353 -1.294 . . . . 10.69 111.442 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.449 ' HB2' ' OD1' ' A' ' 159' ' ' ASP . 35.5 mt-30 -85.55 -55.26 4.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.827 -0.624 . . . . 9.45 110.012 -177.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.0 71.46 6.71 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.666 -0.697 . . . . 6.56 110.705 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -66.21 109.42 2.89 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.859 -0.686 . . . . 4.17 111.714 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.88 -58.04 10.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.574 0.226 . . . . 3.14 110.779 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 74.97 -57.06 2.69 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.079 -0.51 . . . . 1.69 113.665 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.689 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 20.5 t -63.41 -16.05 59.41 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.809 0.444 . . . . 2.0 111.726 -174.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.501 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 25.5 p-90 -71.7 -23.58 61.67 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.019 -0.426 . . . . 0.83 110.293 178.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.501 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 29.2 mt -86.75 -17.65 33.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 1.28 112.283 -176.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -75.77 -10.73 59.68 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.382 -0.527 . . . . 2.03 110.248 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.49 ' CE2' HD13 ' A' ' 86' ' ' LEU . 52.1 m-85 -69.79 -36.98 76.16 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.824 -0.625 . . . . 2.19 111.06 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.69 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -69.83 127.01 31.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.482 -0.487 . . . . 1.24 109.729 177.539 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -115.07 179.15 4.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.022 -0.536 . . . . 4.97 110.401 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.497 ' HA ' HD22 ' A' ' 183' ' ' LEU . 1.7 p -71.4 142.37 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.458 . . . . 1.63 111.165 -177.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.28 142.47 21.05 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.16 -0.927 . . . . 1.34 112.572 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 47.5 t -82.87 -2.93 56.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.208 -0.906 . . . . 2.58 110.531 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 27.2 t -142.84 139.88 31.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.993 -0.549 . . . . 2.06 109.589 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 33.6 t -73.31 -13.99 61.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.309 0.576 . . . . 2.69 110.485 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -88.44 -4.42 58.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.346 0.593 . . . . 2.42 109.93 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -110.84 15.49 21.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.49 -0.777 . . . . 2.12 111.107 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 15.9 mm100 -60.11 115.67 3.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.528 -0.545 . . . . 1.52 109.528 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.598 ' OD1' ' HG3' ' A' ' 198' ' ' LYS . 19.2 t30 -153.63 32.97 0.45 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.165 0.983 . . . . 1.68 108.799 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.54 HD21 ' N ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -122.52 129.51 52.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.368 -0.833 . . . . 1.43 110.315 -174.013 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.5 m -150.42 138.66 20.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.074 0.464 . . . . 1.2 110.933 177.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 21.1 tpp -102.05 129.02 48.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.941 -0.572 . . . . 1.56 109.962 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 43.5 t -111.95 140.93 46.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.051 0.453 . . . . 2.13 110.585 -175.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.81 104.26 10.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.904 -0.589 . . . . 1.96 109.621 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.443 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 17.8 pt -142.73 145.33 23.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.679 -0.691 . . . . 1.62 110.229 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.4 m 63.15 27.61 15.72 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.114 0.483 . . . . 2.24 111.047 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 64.56 10.5 5.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.125 -0.943 . . . . 2.83 111.62 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.9 pt20 -120.6 167.95 11.88 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.974 -0.38 . . . . 1.86 109.974 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.2 mm -93.59 137.09 23.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.058 -0.519 . . . . 1.59 110.305 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.537 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 2.4 m-85 -138.52 151.4 47.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.221 0.534 . . . . 4.16 111.244 177.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.448 ' CD1' HD13 ' A' ' 169' ' ' LEU . 4.8 m-85 -99.54 113.6 26.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.568 -0.742 . . . . 1.27 109.627 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.28 118.83 37.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.992 -0.549 . . . . 1.73 110.176 -177.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.424 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 2.0 t -91.08 152.95 3.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.515 0.674 . . . . 1.33 110.057 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.2 mm -91.44 -58.07 3.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.64 -1.164 . . . . 1.23 111.301 -167.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.598 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -139.78 173.13 11.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.69 -0.686 . . . . 1.88 111.51 -176.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.597 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.1 m-20 -47.05 120.18 2.95 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.231 -0.895 . . . . 2.23 112.871 -176.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.458 HG13 ' HE2' ' A' ' 104' ' ' MET . 21.0 mm -82.15 140.11 16.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.185 -0.916 . . . . 1.41 110.984 176.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.97 130.71 47.31 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.534 -0.543 . . . . 2.06 109.534 171.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.11 117.53 4.13 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.493 2.128 . . . . 0.56 112.289 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.52 -11.11 9.71 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.798 -0.715 . . . . 0.7 112.576 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -143.04 119.69 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 1.27 111.791 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 100' ' ' ALA . 40.6 mt-10 -111.7 127.21 55.7 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.196 -0.315 . . . . 2.92 110.518 169.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.481 ' C ' HD21 ' A' ' 207' ' ' LEU . 2.6 mm? -115.72 100.35 7.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.146 -0.686 . . . . 1.51 109.146 175.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.69 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.33 125.37 13.63 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.495 -0.928 . . . . 1.16 108.495 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' A' ' 174' ' ' VAL . 9.8 p -152.87 157.1 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.234 -0.586 . . . . 1.5 111.439 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -109.72 106.47 16.12 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.815 -0.809 . . . . 1.77 108.815 163.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.4 m -107.4 143.07 18.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.226 -0.657 . . . . 3.05 109.226 170.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -111.42 127.35 55.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.434 0.635 . . . . 5.7 111.282 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -130.88 47.13 2.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.226 -0.897 . . . . 5.8 109.722 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 71.08 49.53 27.02 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.578 -0.737 . . . . 5.61 112.401 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.0 -83.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 O-C-N 122.765 -0.256 . . . . 6.31 111.133 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -68.71 -61.37 3.72 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 112.761 0.652 . . . . 9.04 112.761 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.44 -41.05 80.31 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.348 2.032 . . . . 7.78 113.228 -172.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.46 -8.12 54.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.764 -0.653 . . . . 8.02 111.67 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 63.66 27.13 70.53 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.326 -0.464 . . . . 8.64 112.874 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 10.1 t -110.24 41.62 1.71 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.547 0.689 . . . . 9.96 110.436 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 21.5 m -75.42 126.91 87.09 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.794 -0.639 . . . . 9.62 110.08 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.78 116.95 4.91 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.357 2.038 . . . . 12.02 111.933 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.41 53.87 4.47 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.686 2.257 . . . . 13.11 112.318 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 155.58 -160.11 29.69 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.332 -0.707 . . . . 14.03 111.332 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 54.4 tp -140.47 124.12 17.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.941 0.37 . . . . 16.32 110.451 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -123.9 -52.47 1.78 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.1 -0.5 . . . . 17.7 110.674 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.674 -0.679 . . . . 18.9 110.056 -176.517 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 112.259 -0.337 . . . . 33.41 112.259 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.4 m 64.37 38.1 7.97 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.859 0.464 . . . . 34.1 111.054 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.82 55.66 5.02 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 121.012 -0.613 . . . . 32.51 112.243 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -116.42 121.54 33.21 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 110.274 -0.269 . . . . 31.98 110.274 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.19 122.93 12.14 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.824 2.35 . . . . 30.45 112.444 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 t -138.26 95.52 3.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.199 0.523 . . . . 29.01 110.066 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m -63.01 109.1 1.37 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.894 -0.593 . . . . 27.14 109.846 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 63.03 -160.74 0.3 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.447 -0.797 . . . . 25.83 109.932 -175.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t70 69.26 27.21 5.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.804 0.811 . . . . 23.8 110.146 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -84.52 69.68 10.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.494 0.664 . . . . 22.03 110.117 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 p -87.62 117.29 68.33 Favored Pre-proline 0 N--CA 1.448 -0.569 0 CA-C-N 115.652 -0.704 . . . . 19.63 110.021 175.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.94 103.72 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.968 2.446 . . . . 17.86 112.747 -176.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -92.28 -11.29 35.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.625 -0.716 . . . . 17.61 109.746 177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.27 148.08 32.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.501 -0.772 . . . . 15.63 110.215 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.9 110.97 2.94 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.821 -0.627 . . . . 12.12 112.03 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.2 m -98.4 113.34 64.02 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.882 -0.414 . . . . 10.78 109.882 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -61.53 100.39 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.863 2.375 . . . . 10.17 112.296 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -105.28 107.85 19.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.263 -0.426 . . . . 7.8 110.143 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -72.37 142.8 48.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.963 -0.562 . . . . 8.14 109.771 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.51 116.07 63.45 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 116.151 -0.477 . . . . 6.11 110.678 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.53 -151.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.649 2.232 . . . . 6.51 111.369 174.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.08 -34.87 71.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.167 0.508 . . . . 6.76 109.787 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -88.46 107.73 19.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.531 . . . . 5.18 109.592 172.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.532 ' O ' HD13 ' A' ' 74' ' ' ILE . 2.3 pp -79.72 137.84 54.5 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 120.943 0.401 . . . . 4.5 110.705 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.84 4.07 6.79 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.75 2.3 . . . . 4.4 113.02 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -79.79 -66.27 0.9 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.226 -0.443 . . . . 3.91 109.857 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.4 t70 62.04 98.26 0.03 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.914 -1.039 . . . . 3.16 111.777 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.8 mt -84.73 111.45 35.19 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.735 -0.666 . . . . 2.82 109.688 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.97 135.06 33.86 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.603 2.202 . . . . 2.04 112.231 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.429 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.48 136.94 29.89 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.819 -0.628 . . . . 1.53 109.903 -178.732 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.55 151.58 7.2 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.358 2.706 . . . . 0.88 112.574 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.13 -6.44 3.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.671 0.989 . . . . 1.58 113.671 -169.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 52.1 m-20 -110.34 2.02 18.84 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.886 -0.509 . . . . 1.66 111.994 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -130.92 138.44 49.77 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.16 -0.681 . . . . 1.2 109.16 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.57 136.67 53.54 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.72 -0.392 . . . . 2.27 110.061 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.8 tt -85.37 126.44 33.76 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.454 0.645 . . . . 1.37 109.29 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.434 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 51.1 mtp180 -143.34 118.75 10.28 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.863 -1.062 . . . . 3.75 109.507 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -80.73 110.16 15.97 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.283 -0.636 . . . . 2.46 109.283 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.9 p -164.32 109.26 0.98 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.474 -0.785 . . . . 2.03 108.959 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.9 m -71.13 105.67 3.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.054 0.454 . . . . 2.18 110.953 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -92.99 117.99 67.71 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.049 -0.723 . . . . 1.96 109.049 173.082 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -51.93 121.27 8.44 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.016 2.477 . . . . 1.87 112.554 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.44 ' HA3' ' SG ' ' A' ' 176' ' ' CYS . . . 108.5 -16.34 34.61 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.015 -0.612 . . . . 1.74 112.45 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.21 -61.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.97 0.414 . . . . 1.79 111.244 178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 91' ' ' ILE . . . 121.09 -123.22 5.47 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 121.055 -0.593 . . . . 1.14 111.925 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mt -102.23 158.43 16.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.931 -0.396 . . . . 2.81 109.931 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -167.17 177.52 41.73 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.616 -0.802 . . . . 0.8 112.013 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 98' ' ' VAL . 27.7 m -104.87 114.95 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.494 0.664 . . . . 1.17 109.689 175.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 51.3 m95 -82.76 127.55 33.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.583 -0.735 . . . . 1.4 111.405 -169.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -74.87 116.19 15.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.686 -0.688 . . . . 1.2 110.465 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.45 1.0 57.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 2.23 110.096 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -140.46 156.18 46.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.552 -0.749 . . . . 4.08 109.13 175.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.553 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -80.4 159.0 25.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.112 0.482 . . . . 2.86 110.738 -178.621 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.682 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 55.3 mtm -129.46 152.11 49.36 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.064 -0.516 . . . . 1.38 110.026 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -121.5 139.81 53.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.117 -0.492 . . . . 2.31 110.273 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -39.19 125.04 1.57 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 124.708 1.255 . . . . 1.42 113.264 -170.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.26 7.03 12.87 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.319 -0.855 . . . . 1.04 111.094 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.62 162.18 18.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.116 0.484 . . . . 2.62 110.929 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.577 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 6.3 tmm_? -146.96 132.29 18.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.982 -0.554 . . . . 4.16 110.301 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 4.7 mt -95.26 130.78 41.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.027 -0.731 . . . . 1.11 109.027 173.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.13 166.6 38.28 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.308 -0.949 . . . . 1.09 112.426 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.459 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 94.5 Cg_endo -87.17 158.12 48.58 Favored 'Cis proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.917 -1.701 . . . . 2.52 112.553 -2.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.3 t -102.74 -52.46 3.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.367 0.603 . . . . 2.5 109.557 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -158.11 133.76 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.581 -0.736 . . . . 2.46 109.435 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.415 ' O ' ' HB3' ' A' ' 119' ' ' ALA . 34.0 m -133.64 163.45 37.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.911 -0.586 . . . . 4.37 109.867 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.466 ' HB ' ' HD3' ' A' ' 117' ' ' PRO . 17.8 t -65.21 -54.71 30.87 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 112.178 0.436 . . . . 5.65 112.178 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.466 ' HD3' ' HB ' ' A' ' 116' ' ' VAL . 71.6 Cg_endo -73.77 135.95 22.4 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.828 1.686 . . . . 5.38 112.956 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 71.01 -52.31 0.68 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.14 0.793 . . . . 8.57 113.14 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 115' ' ' VAL . . . -72.74 161.34 30.87 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.222 -0.288 . . . . 7.27 110.222 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.414 ' HB2' ' HE2' ' A' ' 122' ' ' LYS . . . -114.75 102.25 9.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.892 0.377 . . . . 6.4 110.799 -177.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.21 97.3 7.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.988 -0.551 . . . . 5.88 110.891 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 120' ' ' ALA . 74.5 mmtt -93.79 135.77 34.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.513 -0.767 . . . . 7.76 110.674 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -77.02 -25.23 52.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.744 -0.662 . . . . 9.01 109.546 174.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.6 m -47.25 -51.91 17.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.847 -1.07 . . . . 9.14 111.07 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -85.53 79.73 9.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.861 -0.609 . . . . 7.6 110.501 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -90.06 104.06 16.67 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.888 0.852 . . . . 8.0 110.895 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -138.86 5.75 3.11 Favored Glycine 0 C--N 1.316 -0.565 0 CA-C-N 114.805 -1.089 . . . . 4.59 111.529 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . 0.491 ' HE3' ' N ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -114.1 -113.7 0.34 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.276 -0.462 . . . . 4.93 110.923 -177.225 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.491 ' N ' ' HE3' ' A' ' 128' ' ' TRP . 5.9 pt-20 -142.26 -49.15 0.36 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.276 -0.268 . . . . 7.65 110.276 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -175.57 125.23 0.23 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.54 -0.3 . . . . 9.61 110.216 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 pp -119.33 18.17 6.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.824 0.345 . . . . 6.05 111.345 175.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.2 mp -74.65 88.57 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.967 -0.561 . . . . 8.5 110.071 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.2 t -170.39 82.0 0.1 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.057 0.932 . . . . 9.82 110.209 -174.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.25 67.52 7.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.624 -0.716 . . . . 11.21 110.19 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 15.0 p -60.89 136.08 24.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.515 -0.766 . . . . 10.92 110.883 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -65.59 118.14 9.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.783 -0.644 . . . . 13.25 110.624 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.37 -10.73 12.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.021 -0.536 . . . . 14.01 110.419 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.0 m 58.84 77.69 0.39 Allowed Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 115.174 -0.921 . . . . 14.1 111.227 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.62 130.13 25.58 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.759 2.306 . . . . 14.7 111.783 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -84.96 65.32 9.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.247 0.546 . . . . 14.44 110.846 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -100.2 148.08 25.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.86 -0.609 . . . . 15.9 110.177 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.47 52.39 0.55 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.719 -0.753 . . . . 16.0 112.016 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 64.3 m 61.56 43.74 9.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.344 0.592 . . . . 15.6 110.743 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 57.2 mt -127.48 83.76 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.586 -0.734 . . . . 14.1 109.869 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.9 p -126.76 88.0 2.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.97 0.414 . . . . 13.19 111.099 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -104.32 -13.14 16.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.965 -0.561 . . . . 15.92 110.247 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.4 HD12 ' O ' ' A' ' 147' ' ' ILE . 2.4 pp -72.46 155.84 7.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.61 -0.723 . . . . 14.07 111.374 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.5 p -164.24 54.3 0.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.26 0.552 . . . . 13.67 110.787 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.63 139.19 44.95 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.777 -0.647 . . . . 13.02 109.981 178.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -160.83 131.21 5.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.426 -0.352 . . . . 14.68 110.551 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 66.5 mt -72.72 93.56 1.66 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.964 -0.562 . . . . 13.55 110.13 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 136.79 35.38 0.2 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.657 -0.701 . . . . 15.8 112.037 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.1 p -117.0 -63.58 1.43 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.106 0.479 . . . . 17.08 109.923 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -99.31 -71.67 0.69 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.509 0.671 . . . . 18.43 109.368 175.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.41 160.7 29.76 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.075 -0.966 . . . . 18.74 108.667 174.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -149.86 143.11 25.1 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.79 -0.448 . . . . 14.81 109.79 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 48.5 t -160.91 -39.48 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.038 0.446 . . . . 14.64 110.403 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.2 t -87.03 127.11 40.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 13.38 110.391 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 162' ' ' GLN . 18.1 t70 -65.18 106.67 1.36 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.914 -0.585 . . . . 10.61 110.191 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -107.62 -76.99 0.6 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.061 0.457 . . . . 10.22 111.348 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -91.73 -1.34 57.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.97 -0.559 . . . . 10.69 111.981 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.459 ' HB2' ' OD1' ' A' ' 159' ' ' ASP . 15.9 mm100 -79.1 -25.47 43.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.973 0.416 . . . . 9.45 110.752 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 63.17 32.98 14.75 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.245 -0.889 . . . . 6.56 111.996 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -92.9 -29.56 10.43 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.332 -0.707 . . . . 4.17 111.332 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.8 77.7 3.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.265 0.555 . . . . 3.14 109.979 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . -158.21 -40.26 0.02 OUTLIER Glycine 0 C--N 1.316 -0.571 0 CA-C-N 114.933 -1.03 . . . . 1.69 111.071 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.641 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 13.5 m -64.59 -15.04 60.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.362 -0.419 . . . . 2.0 111.47 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.587 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 17.5 p-90 -70.6 -25.99 63.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 0.83 111.197 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.587 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 18.2 mt -86.3 -15.15 41.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.643 0.609 . . . . 1.28 112.643 -173.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.641 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -77.8 -1.93 33.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.564 -0.454 . . . . 2.03 110.963 -179.296 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -84.38 -37.94 20.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.221 0.452 . . . . 2.19 112.221 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.734 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -65.07 128.64 28.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.975 0.417 . . . . 1.24 110.616 -176.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -119.67 -164.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 4.97 110.854 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.3 t -71.61 143.87 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.956 0.408 . . . . 1.63 110.523 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.53 ' HB1' ' NE2' ' A' ' 181' ' ' GLN . . . -65.59 143.49 57.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.759 -0.655 . . . . 1.34 111.111 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.44 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 42.0 t -63.52 -19.49 64.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.024 -0.989 . . . . 2.58 111.354 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 180' ' ' ASP . 17.8 t -125.62 138.78 53.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.218 0.532 . . . . 2.06 110.558 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 8.6 p -77.49 -26.39 51.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.552 -0.749 . . . . 2.69 111.337 -176.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.47 -3.8 58.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.336 0.589 . . . . 2.42 110.224 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.41 ' HB2' ' HB3' ' A' ' 177' ' ' SER . 1.2 m-20 -107.81 16.26 23.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.434 -0.803 . . . . 2.12 110.461 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.53 ' NE2' ' HB1' ' A' ' 175' ' ' ALA . 31.7 mm-40 -58.36 120.17 8.26 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.374 0.607 . . . . 1.52 110.961 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.524 ' ND2' HD12 ' A' ' 200' ' ' ILE . 13.5 t30 -142.86 35.54 1.4 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.394 -1.336 . . . . 1.68 107.394 175.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.639 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.2 OUTLIER -120.44 125.0 46.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.526 -1.215 . . . . 1.43 110.906 -173.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.5 m -150.5 133.08 15.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.923 0.392 . . . . 1.2 110.703 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 48.7 ttm -100.27 140.19 34.87 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.654 -0.498 . . . . 1.56 109.654 174.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 32.5 m -124.95 131.55 53.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.137 0.494 . . . . 2.13 111.138 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.74 104.96 14.79 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.656 -0.868 . . . . 1.96 108.656 176.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 22.3 pt -139.19 144.4 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.921 -0.582 . . . . 1.62 110.054 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.0 t 64.71 30.18 12.56 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.217 0.532 . . . . 2.24 110.235 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 58.48 34.11 23.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.387 -0.824 . . . . 2.83 111.355 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -145.3 154.44 42.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 1.86 110.711 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.99 128.45 45.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.167 -0.47 . . . . 1.59 111.749 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.577 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 40.9 m-85 -131.31 155.79 46.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.525 -0.761 . . . . 4.16 110.565 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.471 ' CE1' ' HB3' ' A' ' 169' ' ' LEU . 11.3 m-85 -103.5 114.52 28.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.96 -0.755 . . . . 1.27 108.96 173.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -100.1 118.83 37.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.175 -0.466 . . . . 1.73 109.887 -175.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.41 HG11 HD22 ' A' ' 182' ' ' ASN . 1.9 t -83.38 152.16 3.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.408 0.623 . . . . 1.33 109.649 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.1 mm -94.01 -55.15 6.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.912 -1.04 . . . . 1.23 111.202 -167.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.478 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -143.85 -179.71 6.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 1.88 111.963 -179.443 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.682 ' HA ' ' O ' ' A' ' 104' ' ' MET . 23.7 t70 -45.89 121.98 3.51 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.3 1.0 . . . . 2.23 113.009 -175.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.524 HD12 ' ND2' ' A' ' 182' ' ' ASN . 21.1 mm -92.23 130.77 40.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.999 -1.0 . . . . 1.41 111.38 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -76.93 121.59 85.01 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.38 -0.827 . . . . 2.06 108.933 171.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.88 114.1 1.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.001 1.801 . . . . 0.56 111.181 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.15 -0.53 10.65 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.57 -0.824 . . . . 0.7 113.428 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -133.45 123.38 25.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.492 0.646 . . . . 1.27 111.145 175.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.05 96.44 6.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.75 -0.659 . . . . 2.92 111.754 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.503 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.3 mm? -113.03 99.03 7.54 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.835 -0.746 . . . . 1.51 109.773 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.734 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -145.57 114.1 6.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.554 0.341 . . . . 1.16 110.452 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.639 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.8 p -155.83 160.48 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.137 -0.32 . . . . 1.5 110.137 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -93.22 110.2 21.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.006 -1.109 . . . . 1.77 108.006 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 14.8 m -72.48 117.31 15.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.257 0.551 . . . . 3.05 110.213 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 211' ' ' LYS . 39.4 mmtm -74.21 129.8 38.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.676 0.75 . . . . 5.7 112.708 -170.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.95 -14.28 13.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.514 -1.221 . . . . 5.8 109.405 174.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 94.44 79.35 1.45 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 114.656 -1.156 . . . . 5.61 112.668 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 45.6 t -111.95 -78.57 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.773 0.32 . . . . 6.31 110.931 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.559 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 75.9 t80 -66.32 -52.63 36.23 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 111.85 0.315 . . . . 9.04 111.85 -177.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 12.5 Cg_endo -54.08 -39.68 84.66 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.613 2.209 . . . . 7.78 112.867 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 mp -84.55 -4.86 59.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.251 -0.431 . . . . 8.02 111.913 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 61.97 46.9 93.13 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.941 -0.572 . . . . 8.64 112.918 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.9 p -83.54 -36.12 24.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.911 0.386 . . . . 9.96 111.211 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 221' ' ' PRO . 24.3 m -67.25 138.84 94.58 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.021 -0.536 . . . . 9.62 111.085 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 5.1 Cg_exo -79.26 120.24 4.45 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.688 2.259 . . . . 12.02 111.97 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.69 50.68 3.51 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.879 2.386 . . . . 13.11 111.96 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -179.9 153.12 11.59 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.064 -0.814 . . . . 14.03 111.064 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 48.1 tp -120.12 125.69 48.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.138 0.494 . . . . 16.32 110.881 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -139.93 17.19 2.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.47 -0.787 . . . . 17.7 109.371 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 C--O 1.249 1.032 0 CA-C-N 115.098 -0.955 . . . . 18.9 110.068 -177.041 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 112.529 -0.228 . . . . 33.41 112.529 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.0 m -91.05 22.83 3.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.836 0.35 . . . . 34.1 111.547 -176.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.03 -156.89 53.41 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.891 -0.671 . . . . 32.51 112.138 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -148.69 95.48 3.96 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.926 -0.398 . . . . 31.98 109.926 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.9 107.41 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.859 2.373 . . . . 30.45 111.599 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.5 m -106.98 81.62 1.58 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.238 0.542 . . . . 29.01 110.231 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.6 t -92.56 151.04 20.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.963 -0.562 . . . . 27.14 110.141 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -152.19 145.26 24.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.245 -0.434 . . . . 25.83 109.995 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -85.04 109.33 18.13 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.085 -0.709 . . . . 23.8 109.085 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -79.28 65.06 4.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.029 -0.532 . . . . 22.03 110.925 -175.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.9 p -59.22 127.81 84.59 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.555 -0.748 . . . . 19.63 110.878 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.42 95.54 0.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.811 2.341 . . . . 17.86 112.283 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -113.26 87.6 2.64 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.299 -0.864 . . . . 17.61 109.747 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -108.94 155.47 20.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.307 -0.406 . . . . 15.63 110.116 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.78 -156.97 24.14 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.802 -0.713 . . . . 12.12 111.812 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.3 p -112.17 98.15 41.66 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 110.224 -0.287 . . . . 10.78 110.224 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.19 106.98 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.673 2.248 . . . . 10.17 112.344 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -119.97 139.27 52.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.084 -0.507 . . . . 7.8 109.874 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -128.51 145.49 51.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.864 0.364 . . . . 8.14 110.368 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.87 124.18 55.33 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.825 -0.625 . . . . 6.11 110.021 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.78 -165.55 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.596 2.198 . . . . 6.51 112.089 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.2 m -60.01 -37.77 73.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.734 0.302 . . . . 6.76 111.262 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -105.45 127.7 53.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.884 -0.413 . . . . 5.18 109.884 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.558 ' O ' HD11 ' A' ' 74' ' ' ILE . 2.2 pp -77.77 141.11 63.81 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.138 -0.483 . . . . 4.5 111.573 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.3 28.25 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.887 2.391 . . . . 4.4 112.515 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -92.55 -68.69 0.78 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.332 -0.394 . . . . 3.91 111.032 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.95 68.52 0.57 Allowed 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.716 0.635 . . . . 3.16 110.183 -175.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.1 mt -76.68 119.1 75.98 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.481 -0.781 . . . . 2.82 110.496 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.33 120.41 7.55 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.607 2.205 . . . . 2.04 112.114 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -113.11 141.67 26.04 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.308 -0.405 . . . . 1.53 109.921 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.32 144.67 70.73 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.773 2.315 . . . . 0.88 112.14 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.655 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -62.82 -13.08 29.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.526 -0.761 . . . . 1.58 112.332 -173.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.95 -9.84 59.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.107 -0.497 . . . . 1.66 111.062 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.538 ' CZ ' HD21 ' A' ' 110' ' ' LEU . 9.3 m-85 -138.13 149.97 46.4 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.384 -0.599 . . . . 1.2 109.384 -173.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.554 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 9.5 tp10 -125.27 133.84 52.51 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.428 -0.509 . . . . 2.27 111.316 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.88 122.79 33.26 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.214 -0.661 . . . . 1.37 109.214 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.425 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 39.8 mmt180 -147.28 124.58 11.55 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.913 -1.04 . . . . 3.75 109.452 -174.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.1 110.56 8.49 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.106 -0.702 . . . . 2.46 109.106 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.8 m -143.99 94.18 2.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.603 -0.726 . . . . 2.03 109.133 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -64.64 101.86 0.51 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.472 0.654 . . . . 2.18 111.357 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.488 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -108.91 117.03 54.77 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 108.501 -0.926 . . . . 1.96 108.501 172.211 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.86 123.48 13.61 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.907 2.404 . . . . 1.87 112.542 -173.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.51 -23.69 23.91 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.132 -0.556 . . . . 1.74 112.5 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.488 ' HB3' HG21 ' A' ' 91' ' ' ILE . . . -114.95 -68.33 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.95 -0.3 . . . . 1.79 111.513 -178.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.84 -158.09 15.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.665 -0.779 . . . . 1.14 112.339 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.453 ' C ' ' HD3' ' A' ' 173' ' ' ARG . 8.3 mt -101.17 122.55 43.82 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.684 0.242 . . . . 2.81 110.908 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -133.97 -159.35 8.9 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.711 -0.757 . . . . 0.8 112.388 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 98' ' ' VAL . 17.3 m -112.29 105.02 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 122.094 0.95 . . . . 1.17 109.812 177.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.425 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 6.4 m95 -83.3 123.28 29.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.173 -0.921 . . . . 1.4 110.194 -171.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.89 117.79 6.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.134 -0.485 . . . . 1.2 110.367 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.655 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -78.83 -0.15 29.45 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.063 0.459 . . . . 2.23 110.676 178.18 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.413 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 34.5 ttp180 -141.48 162.86 34.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.666 -0.864 . . . . 4.08 108.666 178.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.413 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -79.09 160.02 27.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.273 0.558 . . . . 2.86 111.182 178.316 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.484 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 44.9 mtm -130.77 153.04 49.47 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.063 -1.088 . . . . 1.38 108.063 172.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -126.66 146.97 49.99 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.091 0.244 . . . . 2.31 110.764 -177.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -36.34 121.13 0.69 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.716 1.26 . . . . 1.42 113.77 -168.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.2 6.83 13.18 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.268 -0.878 . . . . 1.04 111.349 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.472 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -85.03 157.01 20.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.05 0.453 . . . . 2.62 110.253 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.689 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 5.9 tmm_? -146.47 133.79 20.66 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.096 -0.502 . . . . 4.16 110.189 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.538 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 3.9 mt -96.92 135.68 38.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.429 -0.952 . . . . 1.11 108.429 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.67 169.63 38.25 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.878 -1.153 . . . . 1.09 112.732 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.586 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 74.0 Cg_endo -77.8 167.14 79.48 Favored 'Cis proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.977 -1.676 . . . . 2.52 112.297 -1.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.8 t -109.52 -1.6 18.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.071 0.462 . . . . 2.5 110.539 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.38 149.37 20.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.01 0.433 . . . . 2.46 111.236 -176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.5 p -140.57 97.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.395 -0.82 . . . . 4.37 109.397 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.524 ' CG1' ' HD3' ' A' ' 117' ' ' PRO . 3.2 p -75.29 -34.11 1.56 Allowed Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 113.265 0.839 . . . . 5.65 113.265 -176.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.524 ' HD3' ' CG1' ' A' ' 116' ' ' VAL . 15.7 Cg_exo -69.46 101.61 0.89 Allowed 'Trans proline' 0 C--N 1.363 1.306 0 CA-C-N 120.891 1.354 . . . . 5.38 111.662 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.8 mtp-105 70.08 153.63 0.12 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.918 0.761 . . . . 8.57 111.124 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 63.65 -91.06 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.998 -0.546 . . . . 7.27 111.272 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 53.39 59.97 4.03 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.253 0.549 . . . . 6.4 111.662 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.99 122.0 36.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.782 -0.645 . . . . 5.88 111.356 -177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -75.91 144.19 41.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.689 -0.687 . . . . 7.76 109.971 176.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -133.63 -39.86 0.89 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.811 0.3 . . . . 9.01 111.811 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 41.0 m -83.36 -69.0 0.66 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.749 0.309 . . . . 9.14 111.162 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.92 172.67 13.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.601 -0.518 . . . . 7.6 109.601 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -133.96 126.56 30.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.381 0.61 . . . . 8.0 111.012 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.08 -13.64 53.95 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.635 -0.793 . . . . 4.59 111.421 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TRP . . . . . 0.418 ' CZ2' HG22 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -138.76 -101.43 0.17 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.495 -0.353 . . . . 4.93 111.392 179.154 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -146.92 -59.95 0.29 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.495 -0.321 . . . . 7.65 110.74 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -166.47 159.94 14.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.047 -0.353 . . . . 9.61 110.047 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.53 ' H ' HD12 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -113.12 -5.39 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.606 -0.27 . . . . 6.05 111.522 178.681 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.77 51.92 1.61 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.25 1.024 . . . . 8.5 111.179 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 12.8 t -122.86 17.33 10.18 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.073 -1.421 . . . . 9.82 109.034 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.415 ' HB3' HG23 ' A' ' 116' ' ' VAL . 31.1 t70 -122.41 126.04 47.14 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.324 -1.307 . . . . 11.21 108.984 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.8 t -75.7 115.56 17.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.041 -0.527 . . . . 10.92 111.267 -173.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.21 150.15 47.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.516 -0.766 . . . . 13.25 109.769 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.3 m -92.02 43.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.394 0.616 . . . . 14.01 110.877 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.7 m -124.94 72.8 64.11 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.643 -0.708 . . . . 14.1 110.706 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.42 122.95 9.43 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.724 2.283 . . . . 14.7 111.465 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 60.96 81.17 0.19 Allowed 'General case' 0 C--O 1.232 0.145 0 O-C-N 123.669 0.606 . . . . 14.44 111.077 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.84 124.57 19.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.315 -0.402 . . . . 15.9 110.387 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.24 84.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.439 -0.665 . . . . 16.0 111.439 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 49.6 t 59.37 73.35 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.445 0.64 . . . . 15.6 110.594 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 73.2 mt -106.1 -44.29 7.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.608 -0.724 . . . . 14.1 110.069 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 38.6 p 48.95 69.89 0.53 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.766 -0.652 . . . . 13.19 111.916 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -95.3 -13.13 25.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.691 -0.686 . . . . 15.92 110.154 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.1 pp -86.61 166.58 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.576 -0.738 . . . . 14.07 111.566 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.5 t -164.59 134.5 3.88 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.195 -1.039 . . . . 13.67 108.195 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 66.57 75.62 0.32 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.854 0.721 . . . . 13.02 110.99 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -76.33 149.03 37.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.531 -0.759 . . . . 14.68 109.944 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.524 ' HB3' ' O ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -90.79 87.27 6.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.626 0.727 . . . . 13.55 112.181 -174.405 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -112.86 64.45 0.27 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.012 -0.835 . . . . 15.8 111.012 171.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.9 t 69.38 21.15 7.05 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.219 0.608 . . . . 17.08 110.559 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -98.52 -77.34 0.51 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.862 -0.608 . . . . 18.43 110.619 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 151' ' ' LEU . 15.9 ptpt -143.65 153.52 42.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.214 -0.903 . . . . 18.74 109.94 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -110.86 79.27 1.19 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.174 0.511 . . . . 14.81 110.19 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 47.2 t -69.34 122.42 18.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.688 -0.687 . . . . 14.64 110.766 -178.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.31 147.11 7.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.82 -0.627 . . . . 13.38 110.336 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 55.05 52.51 11.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.412 0.625 . . . . 10.61 110.453 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.14 -65.57 0.07 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.987 -1.006 . . . . 10.22 110.463 -176.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -129.98 23.18 5.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.52 . . . . 10.69 111.623 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -86.85 -40.07 15.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.86 0.362 . . . . 9.45 110.98 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.26 136.32 51.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.097 -0.501 . . . . 6.56 110.628 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 140.23 -40.23 1.41 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.775 -0.726 . . . . 4.17 111.668 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.97 66.8 6.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.247 0.546 . . . . 3.14 110.698 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . -130.9 -33.11 0.48 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.339 -0.846 . . . . 1.69 112.63 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.634 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 2.9 m -63.79 -14.86 56.37 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.669 0.388 . . . . 2.0 111.989 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' TRP . . . . . 0.431 ' CB ' HG22 ' A' ' 80' ' ' ILE . 19.7 p-90 -69.39 -21.42 63.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.988 0.366 . . . . 0.83 111.988 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 18.3 mt -80.73 -14.56 58.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.942 0.719 . . . . 1.28 112.942 -173.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.634 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -68.04 -10.44 53.75 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.286 -0.566 . . . . 2.03 110.205 176.334 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.541 ' O ' ' HD2' ' A' ' 173' ' ' ARG . 50.9 m-85 -78.89 -27.89 43.95 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.749 -0.66 . . . . 2.19 112.4 -175.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.634 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 1.6 mm -57.87 139.05 18.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 117.895 0.316 . . . . 1.24 111.289 -175.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.541 ' HD2' ' O ' ' A' ' 171' ' ' TYR . 18.2 mmm180 -95.24 147.67 23.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.103 0.478 . . . . 4.97 112.034 -174.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 81.6 t -66.56 148.61 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.374 -0.83 . . . . 1.63 108.773 168.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.457 ' HB3' ' CD1' ' A' ' 183' ' ' LEU . . . -57.32 122.94 13.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.026 0.441 . . . . 1.34 112.108 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.56 -28.7 68.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.573 -0.74 . . . . 2.58 109.967 175.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.0 p -126.73 139.51 53.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.879 -0.6 . . . . 2.06 110.614 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 54.0 t -76.97 -8.41 57.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.992 -0.549 . . . . 2.69 111.093 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.02 -3.87 58.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.204 0.526 . . . . 2.42 110.238 177.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -111.81 17.91 19.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.638 -0.71 . . . . 2.12 111.816 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.52 ' HA ' HE21 ' A' ' 181' ' ' GLN . 0.1 OUTLIER -55.43 114.84 1.99 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.289 0.566 . . . . 1.52 110.897 -176.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.533 ' H ' HD13 ' A' ' 183' ' ' LEU . 18.3 t30 -155.03 32.49 0.39 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 122.062 0.934 . . . . 1.68 108.7 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.722 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 2.0 mp -115.36 120.36 39.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.381 -0.827 . . . . 1.43 110.975 -173.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 95.4 m -148.66 138.96 22.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.324 0.583 . . . . 1.2 111.366 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' MET . . . . . 0.465 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 65.5 mtp -120.71 135.51 55.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.93 -0.577 . . . . 1.56 109.758 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 44.2 t -114.52 141.9 47.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.93 0.395 . . . . 2.13 110.736 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.71 103.93 13.49 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.026 -0.731 . . . . 1.96 109.026 177.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 11.6 pt -146.34 145.08 20.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.967 -0.56 . . . . 1.62 110.218 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.4 t 67.3 33.91 5.14 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.509 0.506 . . . . 2.24 110.242 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 66.33 8.38 5.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.419 -0.809 . . . . 2.83 111.701 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.35 167.72 19.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.062 0.458 . . . . 1.86 110.935 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.2 mm -98.35 128.45 49.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.674 -0.694 . . . . 1.59 110.469 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.689 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 2.2 m-85 -118.44 146.95 44.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.161 0.505 . . . . 4.16 110.708 175.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.438 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 3.2 m-85 -100.95 113.2 25.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.934 -0.765 . . . . 1.27 108.934 175.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -111.57 123.8 50.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.925 0.393 . . . . 1.73 110.184 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.472 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 2.1 t -93.67 152.3 3.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.777 0.799 . . . . 1.33 110.386 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.2 mm -92.98 -54.83 6.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.433 -1.258 . . . . 1.23 110.801 -166.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.487 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -138.78 -179.25 5.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.437 -0.801 . . . . 1.88 110.1 178.312 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 104' ' ' MET . 4.8 p-10 -56.09 135.8 52.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.68 0.752 . . . . 2.23 112.389 -173.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.502 HD13 ' ND2' ' A' ' 182' ' ' ASN . 28.4 mm -96.48 138.11 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.238 -0.892 . . . . 1.41 110.817 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -83.34 127.51 68.29 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.949 -0.569 . . . . 2.06 109.534 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.2 115.57 2.26 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.835 2.357 . . . . 0.56 112.367 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.0 -12.94 9.17 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.471 -0.871 . . . . 0.7 113.543 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.76 123.0 34.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.563 0.681 . . . . 1.27 111.504 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.634 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -110.47 112.1 23.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.766 -0.652 . . . . 2.92 111.142 177.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.497 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 0.9 OUTLIER -122.51 98.96 6.16 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.317 -0.553 . . . . 1.51 109.606 173.551 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.557 ' HB2' HG23 ' A' ' 172' ' ' ILE . 1.7 mm? -147.74 106.55 3.83 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.722 -0.473 . . . . 1.16 109.722 175.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.722 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 19.5 t -154.91 157.45 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.014 -1.106 . . . . 1.5 108.014 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.465 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 3.6 t-80 -89.23 109.86 20.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.731 -0.84 . . . . 1.77 108.731 173.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.8 93.89 2.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.624 0.726 . . . . 3.05 110.665 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -142.01 139.69 32.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.369 -0.832 . . . . 5.7 109.893 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -89.75 1.13 56.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.214 -0.448 . . . . 5.8 111.184 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.429 ' CA ' ' HB2' ' A' ' 217' ' ' LEU . . . -139.09 65.89 0.53 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.616 -0.802 . . . . 5.61 112.647 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 41.3 t -103.49 -72.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.831 0.348 . . . . 6.31 110.611 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' TYR . . . . . 0.431 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 66.8 t80 -82.33 -57.17 0.49 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.218 -0.446 . . . . 9.04 111.214 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 18.9 Cg_endo -60.43 -43.1 35.89 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.252 1.968 . . . . 7.78 112.828 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.429 ' HB2' ' CA ' ' A' ' 213' ' ' GLY . 7.2 mp -99.73 25.82 6.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.95 0.405 . . . . 8.02 110.782 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -104.9 169.73 17.11 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.781 -0.724 . . . . 8.64 112.077 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 17.3 p -85.28 -2.31 57.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.982 0.42 . . . . 9.96 110.852 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.414 ' O ' ' HD3' ' A' ' 222' ' ' PRO . 23.5 m -63.31 129.21 93.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.774 -0.648 . . . . 9.62 110.218 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.07 112.17 3.03 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.48 2.12 . . . . 12.02 112.941 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 220' ' ' VAL . 92.2 Cg_endo -85.28 3.38 7.32 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.715 2.277 . . . . 13.11 111.438 176.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 224' ' ' LEU . . . 166.23 169.57 30.01 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.195 -1.162 . . . . 14.03 110.195 -177.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.432 ' HB3' ' O ' ' A' ' 223' ' ' GLY . 59.1 tp 70.79 136.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.335 0.588 . . . . 16.32 111.366 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -140.6 -51.89 0.47 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.823 -0.626 . . . . 17.7 110.314 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--O 1.249 1.064 0 CA-C-N 116.044 -0.525 . . . . 18.9 110.564 179.79 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.8 mt . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 110.172 -0.307 . . . . 2.4500000000000002 110.172 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.17 127.53 20.44 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.384 2.056 . . . . 1.75 111.589 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.526 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.97 151.62 78.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.97 -0.559 . . . . 1.01 109.917 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.66 139.72 87.21 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.567 2.178 . . . . 0.72999999999999998 111.241 174.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.661 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -67.73 -7.65 28.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.637 0.606 . . . . 1.04 112.637 -172.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.487 ' OD2' ' HD3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -80.01 -9.61 59.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.724 0.297 . . . . 1.6599999999999999 111.492 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.524 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 8.4 m-85 -140.18 146.76 39.16 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 -173.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 99' ' ' TRP . 13.3 pt-20 -114.2 135.21 54.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.982 0.42 . . . . 2.27 110.946 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.2 tt -101.71 129.94 47.98 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.324 -0.991 . . . . 0.79000000000000004 108.324 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -162.47 150.71 14.43 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.433 -0.803 . . . . 3.21 109.792 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -82.99 111.36 18.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.0 -0.741 . . . . 2.46 109.0 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.2 p -149.07 90.7 1.77 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.773 -0.649 . . . . 1.5800000000000001 109.365 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.1 m -68.43 104.12 1.82 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.248 0.547 . . . . 1.8600000000000001 110.805 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -94.89 118.95 66.63 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.649 -0.705 . . . . 1.45 109.199 174.683 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -52.44 121.22 8.65 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.251 2.634 . . . . 1.6100000000000001 112.466 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.545 ' HA3' ' SG ' ' A' ' 176' ' ' CYS . . . 108.23 -16.02 35.68 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.843 -0.694 . . . . 1.74 112.36 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.436 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -135.89 -71.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.724 -0.28 . . . . 1.4099999999999999 111.395 177.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.528 ' HA3' ' NH1' ' A' ' 173' ' ' ARG . . . 133.38 -127.91 4.85 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.877 -0.678 . . . . 1.0900000000000001 111.954 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.0 mt -97.66 147.6 24.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.655 0.228 . . . . 2.3100000000000001 110.5 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -158.21 171.4 35.12 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.585 -0.606 . . . . 0.58999999999999997 111.585 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 27.7 m -99.31 111.58 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.497 0.665 . . . . 0.67000000000000004 110.037 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.538 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 59.2 m95 -81.57 124.52 29.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.852 -0.613 . . . . 1.1299999999999999 110.316 -172.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 202' ' ' PRO . . . -68.98 114.81 7.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.582 -0.525 . . . . 0.54000000000000004 109.582 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.661 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -82.62 -9.48 59.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.37 0.605 . . . . 1.6799999999999999 109.669 177.428 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.487 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 63.4 ttt180 -125.11 162.55 24.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.31 -0.859 . . . . 3.5 108.823 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.602 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -91.53 158.72 16.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.874 0.369 . . . . 2.3999999999999999 110.952 -176.097 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.491 ' HE3' HG13 ' A' ' 200' ' ' ILE . 64.4 mtm -135.42 152.59 51.54 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.103 -0.703 . . . . 1.22 109.103 176.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -113.05 147.74 36.62 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.092 0.245 . . . . 2.3100000000000001 110.516 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.81 123.97 2.91 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 124.474 1.109 . . . . 0.83999999999999997 112.973 -170.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.75 7.7 13.01 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.451 -0.795 . . . . 1.04 111.183 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.508 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 1.0 OUTLIER -84.04 157.59 21.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.507 0.67 . . . . 2.6200000000000001 110.923 -178.052 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.657 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 2.7 tmm_? -144.1 134.09 24.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.494 -0.776 . . . . 3.6200000000000001 109.546 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.524 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 6.3 mt -87.76 137.36 32.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.875 -0.33 . . . . 0.53000000000000003 110.119 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.38 170.99 43.76 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.917 -0.659 . . . . 1.02 111.481 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -88.62 148.38 27.1 Favored 'Cis proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.181 -1.591 . . . . 2.1000000000000001 112.491 -2.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.514 ' HB2' HD12 ' A' ' 169' ' ' LEU . 28.9 t . . . . . 0 C--N 1.328 -0.331 0 N-CA-C 108.958 -0.756 . . . . 2.0 108.958 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.448 -0.512 0 N-CA-C 112.947 -0.061 . . . . 1.3 112.947 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.676 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 23.1 t -65.56 -16.0 63.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.859 0.361 . . . . 1.8200000000000001 111.349 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.558 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 24.4 p-90 -64.88 -23.82 67.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.846 0.355 . . . . 0.69999999999999996 111.184 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.558 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 17.8 mt -86.3 -15.01 41.96 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.825 0.676 . . . . 0.66000000000000003 112.825 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.676 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -82.17 -2.01 50.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.013 -0.675 . . . . 1.48 110.785 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -79.2 -36.88 39.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.189 -0.459 . . . . 1.97 112.077 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.847 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -64.39 133.0 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.861 0.362 . . . . 0.67000000000000004 111.03 -176.447 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.528 ' NH1' ' HA3' ' A' ' 95' ' ' GLY . 98.8 mtt180 -118.53 -172.92 2.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 4.3399999999999999 111.222 -174.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -71.31 145.0 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.177 -0.465 . . . . 1.0700000000000001 110.314 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.496 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -59.61 135.88 57.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.919 -0.582 . . . . 0.70999999999999996 111.563 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.545 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 41.6 t -57.1 -34.56 68.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.609 -1.178 . . . . 1.8799999999999999 111.629 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.7 p -126.7 144.15 51.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.072 0.463 . . . . 1.6299999999999999 110.949 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 46.0 t -72.51 -9.71 58.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.789 -0.641 . . . . 1.96 110.808 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.68 -11.77 55.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.187 0.518 . . . . 2.4199999999999999 110.059 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -110.21 16.64 21.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 2.1200000000000001 111.347 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -60.95 115.14 3.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 1.3500000000000001 110.474 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.631 ' H ' HD12 ' A' ' 183' ' ' LEU . 18.0 t30 -154.82 38.17 0.42 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 122.084 0.945 . . . . 1.6799999999999999 108.538 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.631 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.1 OUTLIER -123.18 129.93 52.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.13 -0.941 . . . . 0.81000000000000005 110.711 -173.497 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 43.0 m -151.21 137.32 18.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.058 0.456 . . . . 0.51000000000000001 111.467 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 51.2 tpp -88.18 134.91 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.952 -0.567 . . . . 1.3500000000000001 110.65 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' CYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 195' ' ' LYS . 39.9 t -113.15 131.93 55.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.939 -0.573 . . . . 1.73 110.387 176.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.519 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 25.2 tm0? -123.09 105.54 10.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.272 -0.64 . . . . 1.9299999999999999 109.272 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.614 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 22.0 pt -136.84 142.58 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.191 -0.458 . . . . 1.1100000000000001 110.426 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.9 m 57.48 27.07 13.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.403 0.439 . . . . 1.8600000000000001 111.303 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.519 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 0.7 OUTLIER 64.5 14.56 9.0 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.7 -0.682 . . . . 2.8300000000000001 112.475 -178.59 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 16.3 pt20 -117.75 159.66 22.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.551 -0.537 . . . . 1.75 109.551 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.4 133.47 44.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.398 -0.364 . . . . 1.01 111.965 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.657 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 43.2 m-85 -141.42 150.62 42.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.702 -0.681 . . . . 3.9399999999999999 110.499 176.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.464 ' CE1' ' HB3' ' A' ' 169' ' ' LEU . 13.4 m-85 -101.17 114.21 27.95 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.437 -0.579 . . . . 0.92000000000000004 109.437 175.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.421 ' C ' ' HD2' ' A' ' 195' ' ' LYS . 5.2 tmmm? -98.78 127.05 44.59 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.4 -0.593 . . . . 1.1100000000000001 109.4 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.508 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 2.0 t -93.01 151.26 3.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.627 0.727 . . . . 0.69999999999999996 110.015 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 197' ' ' ILE . 1.2 mm -85.68 -58.13 3.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.708 -1.133 . . . . 0.62 110.274 -168.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.44 ' C ' ' HE3' ' A' ' 198' ' ' LYS . 0.0 OUTLIER -137.07 179.87 6.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.335 -0.848 . . . . 1.3799999999999999 110.771 176.551 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -48.16 136.9 11.3 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.097 0.873 . . . . 2.23 113.223 -170.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.491 HG13 ' HE3' ' A' ' 104' ' ' MET . 33.1 mm -102.48 133.65 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.737 -0.665 . . . . 0.88 110.268 176.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 202' ' ' PRO . 49.1 mt-10 -98.68 138.87 20.78 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.611 -0.722 . . . . 2.0600000000000001 109.607 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 49.7 Cg_exo -55.77 115.28 2.34 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.457 2.105 . . . . 0.51000000000000001 111.962 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.72 7.44 8.06 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.497 -0.859 . . . . 0.69999999999999996 113.498 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.62 122.27 11.83 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.643 0.722 . . . . 1.27 111.535 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -111.78 95.36 5.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.817 -0.629 . . . . 2.9199999999999999 112.03 177.243 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.484 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.4 mm? -115.65 97.68 6.27 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.33 -0.948 . . . . 0.90000000000000002 109.46 173.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.847 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 0.9 OUTLIER -146.96 115.07 6.57 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.53000000000000003 109.806 176.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.612 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.9 p -153.64 158.42 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 121.729 -0.607 . . . . 0.91000000000000003 111.191 -177.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -84.89 110.92 19.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.28 -1.008 . . . . 1.55 108.28 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.223 0.535 . . . . 2.5600000000000001 110.226 -178.764 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.5 mt . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 110.607 -0.145 . . . . 2.4500000000000002 110.607 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.66 133.2 49.96 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.757 2.305 . . . . 1.75 112.798 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.581 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -125.68 146.6 55.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.59 -0.732 . . . . 1.01 109.891 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.64 147.9 76.92 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.683 2.255 . . . . 0.72999999999999998 111.339 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.56 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -57.59 -23.58 51.61 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.462 0.912 . . . . 1.04 113.462 -170.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -89.83 8.35 32.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.596 0.591 . . . . 1.6599999999999999 112.596 -173.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.457 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 23.8 m-85 -132.54 139.47 47.89 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.8 -0.815 . . . . 1.0 108.8 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.457 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 41.8 tt0 -114.36 119.56 37.35 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.839 -0.344 . . . . 2.27 111.103 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 tt -84.19 131.67 34.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.291 -0.633 . . . . 0.79000000000000004 109.291 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -140.38 124.14 17.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.264 -0.426 . . . . 3.21 110.752 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -80.84 111.82 17.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.298 -0.631 . . . . 2.46 109.298 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -177.31 127.06 0.15 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.566 -0.901 . . . . 1.5800000000000001 108.566 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.2 m -90.69 105.51 17.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.887 0.375 . . . . 1.8600000000000001 111.132 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.538 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -85.44 123.62 72.66 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 108.766 -0.827 . . . . 1.45 108.766 174.249 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.5 119.13 5.69 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.337 2.691 . . . . 1.6100000000000001 113.233 -172.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.7 -28.74 10.87 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.645 -0.707 . . . . 1.74 112.259 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -117.42 -58.45 2.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.898 0.38 . . . . 1.4099999999999999 110.946 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 114.52 -138.68 15.03 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.894 -0.594 . . . . 1.0900000000000001 111.722 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -73.32 159.74 32.91 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.503 -0.184 . . . . 2.3100000000000001 110.503 175.433 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.57 178.17 46.46 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.576 -0.821 . . . . 0.58999999999999997 112.269 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.65 148.33 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.239 -0.652 . . . . 0.67000000000000004 109.239 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -119.14 120.21 36.44 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.074 -0.343 . . . . 1.1299999999999999 110.074 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.508 ' H ' ' HG2' ' A' ' 205' ' ' GLU . . . -67.79 125.43 26.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.323 -0.399 . . . . 0.54000000000000004 110.955 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.56 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -88.23 -1.04 57.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.881 0.372 . . . . 1.6799999999999999 110.285 176.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 15.6 ttm-85 -125.7 152.62 45.03 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.392 -0.595 . . . . 3.5 109.392 174.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.54 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -76.7 159.62 30.04 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.358 -0.383 . . . . 2.3999999999999999 110.728 176.429 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.672 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 47.3 mtm -134.25 152.11 51.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.51 -0.314 . . . . 1.22 110.262 176.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -130.66 144.52 51.49 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.691 0.62 . . . . 2.3100000000000001 110.045 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -37.42 121.07 0.83 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 124.446 1.091 . . . . 0.83999999999999997 113.467 -170.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.21 7.26 12.68 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.464 -0.789 . . . . 1.04 111.509 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.52 ' CD ' ' HB ' ' A' ' 196' ' ' VAL . 0.9 OUTLIER -83.68 164.42 19.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.96 0.41 . . . . 2.6200000000000001 110.648 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.665 ' HG3' ' CE2' ' A' ' 193' ' ' TYR . 8.5 tmm_? -145.97 130.96 18.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.364 -0.38 . . . . 3.6200000000000001 110.777 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.457 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 5.1 mt -96.45 138.24 34.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.304 -0.628 . . . . 0.53000000000000003 109.304 175.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.453 ' HA3' ' C ' ' A' ' 112' ' ' PRO . . . 83.74 -117.39 4.43 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.651 -0.785 . . . . 1.02 112.608 177.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.453 ' C ' ' HA3' ' A' ' 111' ' ' GLY . 17.4 Cg_exo -66.73 167.35 56.63 Favored 'Cis proline' 0 C--N 1.347 0.498 0 CA-C-N 118.94 1.37 . . . . 2.1000000000000001 113.716 5.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.436 ' O ' ' HA3' ' A' ' 166' ' ' GLY . 42.2 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 2.0 110.139 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 113.544 0.177 . . . . 1.3 113.544 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.5 t -59.54 -23.31 62.74 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.6 0.36 . . . . 1.8200000000000001 111.853 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 41.4 p-90 -65.17 -17.48 64.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.007 0.432 . . . . 0.69999999999999996 111.314 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 43.7 mt -80.16 -13.86 58.93 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.199 0.444 . . . . 0.66000000000000003 112.199 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -70.55 -13.1 61.97 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.264 -0.574 . . . . 1.48 109.887 177.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -68.06 -36.81 80.49 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.707 -0.679 . . . . 1.97 111.406 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.655 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -69.36 124.77 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.325 -0.55 . . . . 0.67000000000000004 109.942 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.493 ' NE ' ' HA ' ' A' ' 173' ' ' ARG . 3.9 mmp_? -112.29 -166.51 1.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.957 -0.565 . . . . 4.3399999999999999 110.82 -176.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.0 t -73.55 151.9 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.332 . . . . 1.0700000000000001 110.566 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -64.38 134.23 54.17 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.01 -0.541 . . . . 0.70999999999999996 111.014 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.5 t -78.94 -12.46 60.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.381 -0.827 . . . . 1.8799999999999999 110.245 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 180' ' ' ASP . 46.5 m -125.74 140.99 52.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.904 -0.589 . . . . 1.6299999999999999 109.641 176.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' CYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 61.4 m -79.38 -19.39 50.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 1.96 111.2 -176.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -89.29 1.78 55.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.233 0.539 . . . . 2.4199999999999999 110.099 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 177' ' ' SER . 27.6 t70 -110.78 15.81 21.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.545 -0.752 . . . . 2.1200000000000001 110.412 -176.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 16.8 mm100 -60.91 116.79 4.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.85 -0.614 . . . . 1.3500000000000001 110.632 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.611 ' ND2' HD11 ' A' ' 200' ' ' ILE . 23.7 t30 -153.9 33.18 0.44 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.076 0.941 . . . . 1.6799999999999999 109.282 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -121.93 120.8 35.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.563 -0.744 . . . . 0.81000000000000005 110.644 -172.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 30.3 m -142.92 121.91 12.81 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.265 0.555 . . . . 0.51000000000000001 110.93 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.415 ' HB2' ' HE2' ' A' ' 185' ' ' MET . 52.2 tpp -92.19 127.74 37.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.639 -0.709 . . . . 1.3500000000000001 109.981 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 38.6 t -126.11 162.43 25.36 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.402 -0.592 . . . . 1.73 109.402 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -134.43 147.06 50.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.757 0.313 . . . . 1.9299999999999999 110.835 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.742 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 24.4 pt -137.42 133.48 46.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.53 -0.759 . . . . 1.1100000000000001 109.479 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.7 t 55.33 28.87 12.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.954 0.407 . . . . 1.8600000000000001 110.84 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 66.86 24.29 9.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.552 -0.749 . . . . 2.8300000000000001 112.058 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.742 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 11.9 pt20 -118.53 155.01 31.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.09 -0.707 . . . . 1.75 109.09 172.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' A' ' 113' ' ' CYS . 38.0 mm -81.65 126.06 39.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.108 0.48 . . . . 1.01 111.806 -170.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.665 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 63.0 t80 -121.92 127.64 50.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.401 -0.818 . . . . 3.9399999999999999 110.401 -174.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 7.2 m-85 -99.9 113.48 26.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.046 0.45 . . . . 0.92000000000000004 110.048 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -114.97 123.32 48.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.554 -0.748 . . . . 1.1100000000000001 109.952 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.52 ' HB ' ' CD ' ' A' ' 108' ' ' GLU . 2.0 t -96.45 153.35 3.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.559 0.695 . . . . 0.69999999999999996 109.754 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 2.1 mm -92.61 -58.05 3.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.575 -1.193 . . . . 0.62 111.931 -166.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.522 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.7 OUTLIER -141.03 -178.18 5.45 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.616 -0.72 . . . . 1.3799999999999999 111.713 -173.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.672 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.5 m-20 -45.8 116.21 1.15 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.986 0.804 . . . . 2.23 112.93 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.611 HD11 ' ND2' ' A' ' 182' ' ' ASN . 14.8 mm -88.28 135.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.563 -0.744 . . . . 0.88 109.535 170.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 46.4 mt-10 -99.94 130.43 26.35 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.236 -0.653 . . . . 2.0600000000000001 109.236 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.33 117.71 2.45 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.067 2.512 . . . . 0.51000000000000001 112.695 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.93 -9.99 9.63 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.872 -0.68 . . . . 0.69999999999999996 112.982 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 19.9 pt-20 -138.52 121.48 16.66 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 117.569 0.685 . . . . 1.27 112.118 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.508 ' HG2' ' H ' ' A' ' 100' ' ' ALA . 7.7 mm-40 -111.2 125.0 53.33 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.061 -0.518 . . . . 2.9199999999999999 110.201 170.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.538 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 2.4 mm? -122.28 99.29 6.34 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.327 -0.62 . . . . 0.90000000000000002 109.327 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.655 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.3 mm? -145.62 115.59 7.38 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.497 -0.557 . . . . 0.53000000000000003 109.497 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.495 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 6.3 p -153.21 157.89 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.509 -0.476 . . . . 0.91000000000000003 111.169 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -98.6 111.4 23.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.84 -0.618 . . . . 1.55 109.828 173.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.45 HG23 HG13 ' A' ' 208' ' ' VAL . 52.6 t . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 109.329 -0.619 . . . . 2.5600000000000001 109.329 171.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.732 -0.47 . . . . 2.4500000000000002 109.732 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.41 117.64 4.17 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.0 2.467 . . . . 1.75 112.983 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.504 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -128.41 146.03 58.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.823 -0.626 . . . . 1.01 109.584 176.165 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -53.19 147.71 34.27 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.823 2.349 . . . . 0.72999999999999998 112.11 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.576 ' O ' ' HD2' ' A' ' 101' ' ' LYS . . . -70.56 -0.39 8.46 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.551 0.574 . . . . 1.04 112.551 -173.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -106.0 4.6 29.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.881 0.372 . . . . 1.6599999999999999 111.167 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -136.1 138.5 42.14 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.502 ' HB2' ' HE2' ' A' ' 101' ' ' LYS . 5.8 tp10 -109.81 124.27 51.01 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.299 -0.56 . . . . 2.27 111.286 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.429 ' HB2' HG21 ' A' ' 80' ' ' ILE . 58.0 tp -87.91 128.3 35.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.158 -0.473 . . . . 0.79000000000000004 110.078 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -147.87 118.87 7.66 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.635 -0.711 . . . . 3.21 109.796 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.14 112.62 10.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.989 0.424 . . . . 2.46 109.971 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.2 t -172.92 133.56 0.55 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.338 -0.986 . . . . 1.5800000000000001 108.338 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.4 t -87.36 106.04 17.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.929 0.395 . . . . 1.8600000000000001 110.805 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -85.79 123.12 72.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.413 -0.588 . . . . 1.45 109.413 173.222 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -45.59 119.32 2.64 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.515 2.81 . . . . 1.6100000000000001 113.346 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.32 -29.1 10.46 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.812 -0.631 . . . . 1.74 112.415 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 173' ' ' ARG . . . -124.28 -65.88 1.02 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.048 0.451 . . . . 1.4099999999999999 111.671 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.604 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 123.5 -132.59 8.56 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.127 -0.789 . . . . 1.0900000000000001 111.127 -175.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 1.2 pp -72.82 159.69 33.37 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.986 0.393 . . . . 2.3100000000000001 110.746 175.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.91 174.73 47.09 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.844 -0.693 . . . . 0.58999999999999997 111.958 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 19.4 m -106.64 130.8 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 121.266 0.555 . . . . 0.67000000000000004 109.71 174.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -96.85 114.89 26.56 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.652 -0.704 . . . . 1.1299999999999999 110.019 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 202' ' ' PRO . . . -64.34 114.26 4.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.235 -0.283 . . . . 0.54000000000000004 110.235 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 82' ' ' ALA . 15.8 ptpt -83.71 -8.99 59.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.244 0.545 . . . . 1.6799999999999999 110.665 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 27.2 ttp180 -125.66 155.75 40.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.547 -0.751 . . . . 3.5 109.772 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.432 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -81.88 155.45 25.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.95 -0.568 . . . . 2.3999999999999999 109.779 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.584 ' HB3' ' OE2' ' A' ' 108' ' ' GLU . 59.6 mtm -136.13 153.31 51.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.684 -0.234 . . . . 1.22 110.507 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -117.34 140.37 49.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.129 -0.487 . . . . 2.3100000000000001 109.716 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.62 131.39 3.92 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 124.421 1.076 . . . . 0.83999999999999997 113.61 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.25 7.67 11.03 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.528 -0.76 . . . . 1.04 112.368 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.584 ' OE2' ' HB3' ' A' ' 104' ' ' MET . 0.7 OUTLIER -85.74 167.9 14.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.293 0.568 . . . . 2.6200000000000001 111.435 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -143.28 135.33 26.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.746 -0.661 . . . . 3.6200000000000001 110.182 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 4.4 mt -104.6 132.91 50.3 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.598 -0.89 . . . . 0.53000000000000003 108.598 171.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.82 166.48 39.67 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.188 -1.006 . . . . 1.02 112.724 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.18 142.03 43.75 Favored 'Cis proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.414 -1.494 . . . . 2.1000000000000001 111.909 -2.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.614 ' SG ' HD13 ' A' ' 169' ' ' LEU . 56.9 m . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 121.044 0.45 . . . . 2.0 110.765 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 112.698 -0.161 . . . . 1.3 112.698 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.9 m -59.5 -39.49 83.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.001 0.371 . . . . 1.8200000000000001 112.001 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.474 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 29.9 p-90 -85.55 -22.66 28.01 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.42 -0.512 . . . . 0.69999999999999996 111.157 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.614 HD13 ' SG ' ' A' ' 113' ' ' CYS . 28.7 mt -86.93 -15.0 40.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.389 0.514 . . . . 0.66000000000000003 112.389 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.401 ' C ' ' HD3' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -75.33 -4.09 37.24 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.661 -0.415 . . . . 1.48 110.523 176.686 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -76.57 -37.62 56.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.085 -0.507 . . . . 1.97 111.586 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -67.34 129.36 31.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.539 -0.464 . . . . 0.67000000000000004 110.057 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.427 ' HB3' ' H ' ' A' ' 174' ' ' VAL . 98.9 mtt180 -125.98 -163.38 1.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.933 -0.576 . . . . 4.3399999999999999 111.835 -172.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.451 ' HA ' HG11 ' A' ' 208' ' ' VAL . 20.0 t -62.62 146.83 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.261 -0.881 . . . . 1.0700000000000001 111.449 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.613 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -65.35 136.13 56.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.881 -0.6 . . . . 0.70999999999999996 111.343 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.74 -19.3 64.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.35 -0.841 . . . . 1.8799999999999999 111.143 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 63.6 m -146.03 147.56 31.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.227 -0.442 . . . . 1.6299999999999999 110.027 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' CYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 10.6 p -76.89 -13.66 59.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.877 0.37 . . . . 1.96 111.427 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -73.56 -25.34 60.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.493 0.663 . . . . 2.4199999999999999 110.101 172.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.451 ' O ' ' HG ' ' A' ' 206' ' ' LEU . 17.0 m-20 -92.61 17.27 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.428 -0.805 . . . . 2.1200000000000001 111.606 -176.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 29.6 mm-40 -55.65 114.46 1.87 Allowed 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.36 0.6 . . . . 1.3500000000000001 110.068 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.744 ' ND2' HD11 ' A' ' 200' ' ' ILE . 19.5 t30 -161.59 34.51 0.13 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 122.597 1.189 . . . . 1.6799999999999999 108.112 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.654 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -124.8 119.0 27.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.99 -1.005 . . . . 0.81000000000000005 110.34 -172.399 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 61.3 m -150.62 129.37 12.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.06 0.457 . . . . 0.51000000000000001 111.19 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 49.4 ttm -91.04 137.29 32.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.174 -0.466 . . . . 1.3500000000000001 110.11 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 50.0 t -115.28 132.06 56.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.166 -0.47 . . . . 1.73 110.579 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 23.5 tm0? -108.87 105.21 14.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.278 -0.638 . . . . 1.9299999999999999 109.278 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 13.3 pt -144.01 144.13 23.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.001 -0.545 . . . . 1.1100000000000001 110.331 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.1 t 61.29 27.87 17.48 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.211 0.529 . . . . 1.8600000000000001 110.371 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.416 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 6.0 mm-40 57.9 32.85 22.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.217 -0.901 . . . . 2.8300000000000001 111.641 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -144.97 165.99 26.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.769 -0.65 . . . . 1.75 109.702 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.7 mm -100.23 133.11 44.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.04 0.448 . . . . 1.01 111.668 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -132.31 156.89 45.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.226 -0.897 . . . . 3.9399999999999999 109.164 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 11.1 m-85 -100.31 119.3 38.2 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.43 -0.508 . . . . 0.92000000000000004 109.776 173.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -98.17 118.01 33.84 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.462 -0.94 . . . . 1.1100000000000001 108.462 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.533 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 1.8 t -89.32 151.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.493 0.663 . . . . 0.69999999999999996 109.784 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.449 HG13 ' HA ' ' A' ' 182' ' ' ASN . 1.3 mm -97.0 -53.66 7.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 114.656 -1.156 . . . . 0.62 111.553 -163.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.551 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -135.76 174.27 10.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.484 -0.78 . . . . 1.3799999999999999 111.491 -174.676 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 104' ' ' MET . 3.0 m-20 -50.49 119.65 3.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.368 -0.833 . . . . 2.23 112.268 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.744 HD11 ' ND2' ' A' ' 182' ' ' ASN . 17.3 mm -86.99 135.81 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.985 -0.552 . . . . 0.88 110.627 177.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 20.1 mm-40 -101.65 134.64 20.09 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.656 -0.702 . . . . 2.0600000000000001 109.481 174.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 73.5 Cg_exo -51.1 113.5 1.13 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.802 2.335 . . . . 0.51000000000000001 112.953 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.31 -10.21 9.34 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.68 -0.771 . . . . 0.69999999999999996 113.537 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.7 pt-20 -107.55 127.37 53.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.709 0.754 . . . . 1.27 111.541 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.564 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -109.4 93.59 4.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.471 -0.786 . . . . 2.9199999999999999 111.616 177.657 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.616 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.6 mm? -124.56 95.82 4.67 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.57 -0.852 . . . . 0.90000000000000002 110.885 175.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.532 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.8 mm? -148.07 111.7 5.03 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.263 -0.643 . . . . 0.53000000000000003 109.263 170.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.654 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.7 p -157.05 160.8 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 117.892 0.314 . . . . 0.91000000000000003 110.437 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -109.93 110.9 22.0 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.574 -0.528 . . . . 1.55 109.574 168.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 96.5 t . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 2.5600000000000001 110.216 176.249 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.459 -0.571 . . . . 2.4500000000000002 109.459 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.14 119.67 6.95 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.809 2.34 . . . . 1.75 112.256 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.545 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -126.86 144.03 48.73 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 1.01 109.723 178.428 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.87 144.76 87.18 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.579 2.186 . . . . 0.72999999999999998 111.453 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.34 -12.27 8.77 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.798 0.666 . . . . 1.04 112.798 -173.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -80.96 -11.27 59.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.925 0.393 . . . . 1.6599999999999999 110.911 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -133.92 165.1 25.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.444 ' HA ' HG13 ' A' ' 80' ' ' ILE . 10.1 pt-20 -155.84 147.01 22.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.914 0.388 . . . . 2.27 110.671 173.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.456 HD11 ' CZ ' ' A' ' 171' ' ' TYR . 7.0 tt -92.26 132.33 36.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.864 -0.607 . . . . 0.79000000000000004 110.43 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.405 ' N ' HD23 ' A' ' 86' ' ' LEU . 76.1 mtt180 -144.27 138.88 28.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.403 -0.817 . . . . 3.21 109.841 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -82.04 112.91 19.55 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.348 -0.612 . . . . 2.46 109.348 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 p -169.03 90.11 0.22 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.678 -0.692 . . . . 1.5800000000000001 109.749 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 p -69.95 105.43 2.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.243 0.544 . . . . 1.8600000000000001 110.744 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.633 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -85.17 123.78 72.92 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.928 -0.767 . . . . 1.45 108.928 175.265 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.08 120.27 7.68 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.287 2.658 . . . . 1.6100000000000001 112.735 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.6 -11.25 53.72 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.597 -0.811 . . . . 1.74 112.181 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.633 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -134.11 -63.07 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.711 -0.288 . . . . 1.4099999999999999 111.609 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.03 -145.83 17.29 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.786 -0.721 . . . . 1.0900000000000001 113.106 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -72.56 158.68 35.23 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.4 0.28 . . . . 2.3100000000000001 110.83 177.113 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.09 175.97 43.33 Favored Glycine 0 C--O 1.237 0.308 0 C-N-CA 120.346 -0.931 . . . . 0.58999999999999997 112.421 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 98' ' ' VAL . 35.3 m -111.22 114.27 46.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.634 0.73 . . . . 0.67000000000000004 109.263 174.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -80.73 100.77 8.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.476 0.655 . . . . 1.1299999999999999 110.996 -169.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.08 120.95 13.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.732 -1.122 . . . . 0.54000000000000004 110.751 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.634 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -101.64 13.79 33.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.513 0.673 . . . . 1.6799999999999999 109.447 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -125.83 155.94 40.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.961 -1.018 . . . . 3.5 109.16 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -83.3 116.27 22.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.211 0.529 . . . . 2.3999999999999999 111.244 174.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.595 ' HE1' HG21 ' A' ' 200' ' ' ILE . 4.8 mpp? -86.92 130.96 34.24 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.573 -0.899 . . . . 1.22 108.573 172.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 8.4 pt-20 -116.32 174.45 6.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.902 0.382 . . . . 2.3100000000000001 111.914 -173.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.93 126.46 18.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.645 -0.707 . . . . 0.83999999999999997 112.899 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.58 -17.19 59.71 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.779 -0.646 . . . . 1.04 114.202 168.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 7.3 pt-20 -76.28 160.09 29.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.607 0.704 . . . . 2.6200000000000001 111.799 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.794 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 6.6 ttt180 -116.42 142.09 47.31 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.418 -0.81 . . . . 3.6200000000000001 110.667 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.7 mt -92.47 136.21 33.4 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.952 -0.758 . . . . 0.53000000000000003 108.952 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 149.88 -147.79 18.41 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.374 -0.917 . . . . 1.02 112.649 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 75.4 Cg_endo -75.34 135.01 38.43 Favored 'Cis proline' 0 CA--C 1.532 0.376 0 C-N-CA 123.064 -1.64 . . . . 2.1000000000000001 112.516 3.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.434 ' SG ' ' HA3' ' A' ' 166' ' ' GLY . 42.5 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.466 -0.788 . . . . 2.0 109.789 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.434 ' HA3' ' SG ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 111.706 -0.558 . . . . 1.3 111.706 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.3 m -54.13 -35.08 61.8 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.953 0.501 . . . . 1.8200000000000001 112.226 -176.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -84.44 -17.6 38.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.886 0.374 . . . . 0.69999999999999996 111.299 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 28.8 mt -86.11 -14.6 43.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.472 -0.331 . . . . 0.66000000000000003 111.768 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -10.43 59.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.351 0.596 . . . . 1.48 109.541 175.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.456 ' CZ ' HD11 ' A' ' 86' ' ' LEU . 43.7 m-85 -79.52 -30.21 41.77 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.274 -0.875 . . . . 1.97 111.872 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.539 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 1.3 mm -56.03 129.64 17.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 120.858 0.361 . . . . 0.67000000000000004 110.521 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -93.94 143.59 26.21 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.501 0.667 . . . . 4.3399999999999999 111.819 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.53 ' HA ' ' CD2' ' A' ' 183' ' ' LEU . 10.1 p -77.77 153.76 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.209 -0.905 . . . . 1.0700000000000001 109.174 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -48.04 111.59 0.46 Allowed 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.654 0.597 . . . . 0.70999999999999996 112.176 -172.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 51.6 t -66.09 -33.63 76.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.277 -0.874 . . . . 1.8799999999999999 109.771 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.467 ' HB3' ' OD1' ' A' ' 180' ' ' ASP . 11.9 t -131.08 152.28 50.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.907 -0.775 . . . . 1.6299999999999999 108.907 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' CYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 61.8 m -71.92 -6.09 39.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.472 -0.331 . . . . 1.96 111.545 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.89 1.38 56.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.77 0.319 . . . . 2.4199999999999999 110.868 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 177' ' ' SER . 29.3 m-20 -110.14 15.27 22.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.378 -0.374 . . . . 2.1200000000000001 111.093 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 15.0 mm100 -63.63 115.51 4.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.253 0.549 . . . . 1.3500000000000001 111.946 -173.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.816 ' H ' HD12 ' A' ' 183' ' ' LEU . 22.7 t30 -161.39 31.58 0.13 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.093 0.949 . . . . 1.6799999999999999 108.779 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.816 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.5 OUTLIER -119.28 122.52 42.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 0.81000000000000005 111.184 -171.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 60.9 m -150.13 136.01 18.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.983 0.421 . . . . 0.51000000000000001 110.421 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.471 ' HB3' ' HB2' ' A' ' 209' ' ' HIS . 49.9 ttm -125.62 135.49 52.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.208 -0.451 . . . . 1.3500000000000001 109.852 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 18.6 t -115.11 152.51 32.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.221 -0.445 . . . . 1.73 109.836 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.73 104.86 11.78 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.011 -0.737 . . . . 1.9299999999999999 109.011 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 33.2 pt -135.49 144.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.978 -0.556 . . . . 1.1100000000000001 110.541 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.8 m 57.46 30.11 18.11 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.459 0.474 . . . . 1.8600000000000001 111.558 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 64.3 17.36 10.69 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.493 -0.776 . . . . 2.8300000000000001 111.301 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -124.93 167.2 15.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 1.75 110.189 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.6 mm -90.73 130.07 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.069 -0.514 . . . . 1.01 110.861 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -121.76 122.95 40.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.271 -0.422 . . . . 3.9399999999999999 110.535 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.794 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 13.7 m-85 -99.79 113.96 26.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.915 -0.772 . . . . 0.92000000000000004 108.915 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -110.45 124.14 51.21 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.9 -0.32 . . . . 1.1100000000000001 110.217 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 104' ' ' MET . 1.7 t -93.42 151.85 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 122.059 0.933 . . . . 0.69999999999999996 110.688 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.57 -56.43 5.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 113.734 -1.576 . . . . 0.62 112.009 -164.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.445 ' HE3' ' HB2' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -140.9 162.78 34.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.975 -1.012 . . . . 1.3799999999999999 110.117 -176.069 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.4 m-20 -58.27 111.67 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.85 0.719 . . . . 2.23 112.189 -173.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.595 HG21 ' HE1' ' A' ' 104' ' ' MET . 6.1 mm -68.85 145.82 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.255 -0.884 . . . . 0.88 110.9 175.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 14.2 mt-10 -92.63 117.64 67.67 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.278 -0.873 . . . . 2.0600000000000001 108.697 172.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -43.31 122.19 2.86 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.614 2.876 . . . . 0.51000000000000001 113.688 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.91 -3.22 10.81 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.822 -0.704 . . . . 0.69999999999999996 113.127 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 11.3 pt-20 -137.37 125.56 23.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.247 0.546 . . . . 1.27 111.031 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.539 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -109.57 108.05 18.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.017 -0.538 . . . . 2.9199999999999999 111.507 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.561 ' O ' HD22 ' A' ' 207' ' ' LEU . 1.4 mm? -123.24 97.9 5.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.064 -0.655 . . . . 0.90000000000000002 109.944 173.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 206' ' ' LEU . 1.1 mm? -149.1 102.12 3.21 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.985 -0.746 . . . . 0.53000000000000003 108.985 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.793 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 6.8 t -157.28 158.25 3.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.1 -0.704 . . . . 0.91000000000000003 109.1 -178.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 185' ' ' MET . 19.4 t-80 -136.25 110.57 8.45 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.453 -0.943 . . . . 1.55 108.453 162.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 3.1 p . . . . . 0 C--N 1.32 -0.7 0 CA-C-O 121.632 0.73 . . . . 2.5600000000000001 109.812 179.241 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.6 mt . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 110.196 -0.298 . . . . 2.4500000000000002 110.196 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.01 115.94 3.87 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.177 1.918 . . . . 1.75 112.238 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -131.77 146.57 62.39 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.64 -0.504 . . . . 1.01 109.64 178.378 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.38 137.81 81.58 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.801 2.334 . . . . 0.72999999999999998 111.667 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.426 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -65.26 -12.17 48.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.654 0.612 . . . . 1.04 112.654 -173.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -84.9 -7.52 59.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.805 0.336 . . . . 1.6599999999999999 111.473 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.507 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 17.9 m-85 -120.14 161.76 20.48 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.23 -1.026 . . . . 1.0 108.23 170.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.405 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 5.9 tp10 -133.51 120.19 20.5 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.749 -0.78 . . . . 2.27 111.435 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HA ' HG12 ' A' ' 98' ' ' VAL . 7.2 tt -84.28 126.67 33.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.999 -0.741 . . . . 0.79000000000000004 108.999 177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -148.61 149.26 31.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.842 -0.617 . . . . 3.21 110.726 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.32 111.99 18.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.653 -0.869 . . . . 2.46 108.653 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.2 m -149.13 81.51 1.43 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.082 -0.508 . . . . 1.5800000000000001 109.809 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.4 m -65.48 104.63 1.02 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.121 -0.49 . . . . 1.8600000000000001 110.875 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.583 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -106.02 117.63 57.08 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.128 -0.487 . . . . 1.45 109.791 177.032 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 91' ' ' ILE . 52.5 Cg_exo -54.58 122.57 11.81 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.16 2.573 . . . . 1.6100000000000001 112.678 -176.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.97 -16.46 36.19 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.711 -0.677 . . . . 1.74 111.958 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.583 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -131.63 -59.78 0.95 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.931 0.396 . . . . 1.4099999999999999 111.277 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.9 -127.85 7.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.954 -0.641 . . . . 1.0900000000000001 112.198 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.446 HD13 ' CD1' ' A' ' 171' ' ' TYR . 0.6 OUTLIER -89.53 159.79 17.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.677 -0.12 . . . . 2.3100000000000001 110.677 176.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -161.96 172.51 38.13 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.586 -0.605 . . . . 0.58999999999999997 111.586 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 86' ' ' LEU . 5.9 m -115.72 130.76 69.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.586 0.708 . . . . 0.67000000000000004 109.79 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -98.11 109.17 21.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.255 -0.43 . . . . 1.1299999999999999 110.498 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -64.52 116.29 6.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.54000000000000004 109.758 176.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.545 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -79.06 -2.8 42.15 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.453 0.644 . . . . 1.6799999999999999 110.439 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 41.1 ttp180 -127.41 155.78 43.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.257 -0.883 . . . . 3.5 108.823 175.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.64 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -82.8 156.59 23.59 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.829 -0.434 . . . . 2.3999999999999999 109.829 176.713 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.625 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -127.18 152.32 47.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.323 -0.399 . . . . 1.22 110.476 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 10.4 pt-20 -105.48 173.67 6.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.394 0.616 . . . . 2.3100000000000001 111.975 -170.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.93 127.29 30.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.247 -0.888 . . . . 0.83999999999999997 112.656 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.23 0.77 67.46 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.101 -0.571 . . . . 1.04 113.544 170.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 1.6 pt-20 -87.14 168.41 13.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.439 0.619 . . . . 2.6200000000000001 111.09 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 3.8 tmm_? -127.52 133.03 49.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.93 -0.577 . . . . 3.6200000000000001 112.094 -173.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.507 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 7.7 mt -86.63 142.07 28.51 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.77 -0.826 . . . . 0.53000000000000003 108.77 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.64 -128.05 7.63 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.4 -0.905 . . . . 1.02 112.618 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.461 ' O ' ' HA3' ' A' ' 166' ' ' GLY . 57.2 Cg_endo -68.35 145.6 76.59 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.829 -1.321 . . . . 2.1000000000000001 112.761 2.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.618 -0.719 . . . . 2.0 110.962 -176.365 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 112' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.354 -0.299 . . . . 1.3 112.354 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.8 m -69.26 -14.54 63.01 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.885 0.328 . . . . 1.8200000000000001 111.885 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.423 ' O ' ' HD2' ' A' ' 171' ' ' TYR . 64.9 p-90 -56.46 -17.27 7.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.159 0.504 . . . . 0.69999999999999996 111.307 176.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.502 HD13 ' CD1' ' A' ' 194' ' ' TYR . 24.8 mt -64.49 -12.79 47.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.309 -0.405 . . . . 0.66000000000000003 111.876 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -11.84 26.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.76 0.314 . . . . 1.48 110.754 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.446 ' CD1' HD13 ' A' ' 96' ' ' LEU . 36.8 m-85 -77.95 -36.96 48.59 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.27 -0.423 . . . . 1.97 111.312 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.811 HG21 ' HB2' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -59.58 137.01 22.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 120.827 -0.349 . . . . 0.67000000000000004 110.483 -174.207 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.484 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 41.7 mmt-85 -112.18 -177.52 3.19 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.851 0.686 . . . . 4.3399999999999999 112.851 -175.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.464 HG22 HG21 ' A' ' 208' ' ' VAL . 41.5 t -76.56 158.87 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 114.954 -1.021 . . . . 1.0700000000000001 110.488 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.533 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -55.52 113.73 1.56 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.241 -0.436 . . . . 0.70999999999999996 111.816 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 28.1 t -72.05 -20.64 61.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 1.8799999999999999 109.622 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.3 t -126.02 139.74 53.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.686 -0.688 . . . . 1.6299999999999999 109.318 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' CYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 59.7 m -75.54 -33.41 60.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.107 0.78 . . . . 1.96 113.107 -168.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -88.33 -13.29 41.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.351 0.596 . . . . 2.4199999999999999 110.58 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -82.57 19.29 1.31 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.529 -0.76 . . . . 2.1200000000000001 112.033 -176.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 21.4 mm-40 -53.42 113.85 1.3 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.022 0.439 . . . . 1.3500000000000001 110.759 -176.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.691 ' H ' HD12 ' A' ' 183' ' ' LEU . 32.3 t30 -140.21 23.62 2.36 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 122.325 1.059 . . . . 1.6799999999999999 108.94 174.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.691 HD12 ' H ' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -109.17 117.39 34.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.598 -0.728 . . . . 0.81000000000000005 110.36 -172.244 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.1 m -149.1 135.07 18.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.056 0.455 . . . . 0.51000000000000001 110.528 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.454 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 72.6 mtp -128.74 137.07 51.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.139 -0.482 . . . . 1.3500000000000001 110.072 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 16.3 t -114.41 158.12 21.97 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.848 -0.614 . . . . 1.73 109.496 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.537 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 22.7 tm0? -122.88 105.19 9.79 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.134 -0.691 . . . . 1.9299999999999999 109.134 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.632 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 34.9 pt -133.13 140.58 46.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.975 -0.557 . . . . 1.1100000000000001 110.524 -175.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.1 m 53.78 26.24 5.84 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.394 0.434 . . . . 1.8600000000000001 111.963 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.537 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 6.3 mm-40 63.4 25.41 14.56 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.595 -0.73 . . . . 2.8300000000000001 112.049 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 29.8 pt20 -117.28 157.65 25.7 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.128 -0.693 . . . . 1.75 109.128 172.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.5 mm -89.13 121.93 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.16 0.505 . . . . 1.01 110.564 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.63 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 45.5 t80 -114.57 121.27 42.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.365 -0.834 . . . . 3.9399999999999999 110.377 -172.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 11.4 m-85 -99.65 112.81 25.0 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.374 -0.602 . . . . 0.92000000000000004 109.374 177.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -116.0 122.93 46.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.844 0.354 . . . . 1.1100000000000001 110.906 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.574 HG11 ' SD ' ' A' ' 104' ' ' MET . 0.2 OUTLIER -90.46 149.84 3.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.438 0.637 . . . . 0.69999999999999996 109.879 178.157 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 182' ' ' ASN . 1.3 mt -103.06 -30.11 2.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.165 -0.925 . . . . 0.62 112.009 -168.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 27.5 pttt -151.59 -179.91 7.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.137 -0.483 . . . . 1.3799999999999999 111.736 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.625 ' HA ' ' O ' ' A' ' 104' ' ' MET . 17.2 t70 -82.65 131.24 35.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.32 -0.854 . . . . 2.23 110.508 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.614 HG13 ' ND2' ' A' ' 182' ' ' ASN . 43.9 mm -121.97 154.63 26.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.192 -0.458 . . . . 0.88 111.15 -173.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 48.9 mt-10 -78.62 120.97 82.95 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 2.0600000000000001 109.85 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.3 123.7 12.56 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.025 2.483 . . . . 0.51000000000000001 112.419 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.62 -1.67 10.23 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.636 -0.792 . . . . 0.69999999999999996 113.097 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 10.5 pt-20 -136.27 123.95 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 1.27 110.649 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.535 ' OE1' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -108.83 116.09 31.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.889 -0.596 . . . . 2.9199999999999999 111.415 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.504 ' C ' HD22 ' A' ' 207' ' ' LEU . 4.7 mp -126.22 99.56 5.93 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.365 -0.534 . . . . 0.90000000000000002 110.297 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.811 ' HB2' HG21 ' A' ' 172' ' ' ILE . 2.4 mm? -147.76 112.59 5.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.654 0.782 . . . . 0.53000000000000003 109.58 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.664 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 7.8 p -155.99 158.01 3.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.621 -0.432 . . . . 0.91000000000000003 111.199 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.454 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 27.9 t-80 -114.24 110.1 19.42 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.825 -0.806 . . . . 1.55 108.825 170.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 C--N 1.321 -0.672 0 N-CA-C 109.842 -0.429 . . . . 2.5600000000000001 109.842 -179.999 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 67.7 mt . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 110.102 -0.333 . . . . 2.4500000000000002 110.102 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.03 122.5 11.49 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.851 2.368 . . . . 1.75 112.722 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.537 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -127.38 149.3 69.5 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.843 -0.617 . . . . 1.01 109.758 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.74 143.14 99.35 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.635 2.223 . . . . 0.72999999999999998 111.857 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.57 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -68.25 -5.19 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.34 0.496 . . . . 1.04 112.34 -173.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -87.56 -4.48 58.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.896 0.379 . . . . 1.6599999999999999 110.928 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.509 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 11.7 m-85 -138.38 147.96 43.98 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.45 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 12.2 tp10 -118.36 122.72 43.54 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 121.048 -0.261 . . . . 2.27 110.642 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.9 tt -87.43 124.16 33.13 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.388 0.613 . . . . 0.79000000000000004 109.578 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.508 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 90.3 mtt-85 -143.39 127.05 17.03 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.13 -0.941 . . . . 3.21 109.689 -175.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.01 110.73 4.6 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.344 -0.613 . . . . 2.46 109.344 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.8 m -157.8 115.47 3.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.266 -0.642 . . . . 1.5800000000000001 109.266 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.2 m -89.84 105.35 17.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.766 0.317 . . . . 1.8600000000000001 110.97 -177.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -91.62 118.59 68.43 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.818 -0.808 . . . . 1.45 108.818 173.097 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.99 121.36 9.75 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.098 2.532 . . . . 1.6100000000000001 112.553 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.65 -23.36 24.37 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.722 -0.672 . . . . 1.74 112.369 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.539 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -122.63 -63.0 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.962 0.381 . . . . 1.4099999999999999 111.082 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 127.76 -134.12 8.11 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.962 -0.637 . . . . 1.0900000000000001 111.952 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.9 mt -89.18 159.48 17.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.398 -0.223 . . . . 2.3100000000000001 110.398 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -157.68 164.96 33.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.702 -0.761 . . . . 0.58999999999999997 111.944 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 33.8 m -101.25 117.18 46.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.766 0.793 . . . . 0.67000000000000004 110.071 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.508 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 27.1 m95 -82.73 110.01 17.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.355 -0.839 . . . . 1.1299999999999999 110.623 -171.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -62.22 115.2 3.94 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.882 -0.414 . . . . 0.54000000000000004 109.882 176.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -81.8 -6.07 58.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.405 0.621 . . . . 1.6799999999999999 109.849 178.378 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -129.61 160.75 32.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.033 -0.985 . . . . 3.5 108.688 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.578 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -92.79 158.48 15.86 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 120.87 0.367 . . . . 2.3999999999999999 110.475 -178.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.594 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 55.0 mtm -131.89 153.02 50.66 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.167 -0.679 . . . . 1.22 109.167 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -105.64 137.57 43.28 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.353 0.408 . . . . 2.3100000000000001 110.855 -176.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -38.25 115.18 0.42 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.679 1.237 . . . . 0.83999999999999997 112.959 -173.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.67 6.96 14.07 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.379 -0.828 . . . . 1.04 111.034 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.493 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -73.6 165.68 24.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.196 0.522 . . . . 2.6200000000000001 110.761 -178.275 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 3.9 tmm_? -145.68 134.7 22.64 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.923 -0.58 . . . . 3.6200000000000001 110.959 -175.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.509 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 8.1 mt -98.05 135.01 40.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.942 -0.762 . . . . 0.53000000000000003 108.942 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.79 167.29 38.48 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.423 -0.894 . . . . 1.02 112.21 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.43 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 6.2 Cg_exo -79.15 155.78 91.0 Favored 'Cis proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.307 -1.539 . . . . 2.1000000000000001 112.0 -2.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.9 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.501 0.667 . . . . 2.0 109.846 176.919 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.276 0 CA-C-O 120.524 -0.042 . . . . 1.3 113.199 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 17.4 t -73.4 -15.39 61.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.023 0.44 . . . . 1.8200000000000001 110.732 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.439 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 10.6 p-90 -72.77 -23.46 60.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.316 -0.402 . . . . 0.69999999999999996 111.521 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.439 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 29.0 mt -86.09 -15.47 41.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.482 0.549 . . . . 0.66000000000000003 112.482 -174.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -78.74 -4.65 50.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.271 -0.572 . . . . 1.48 110.381 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -77.84 -37.71 47.83 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.196 -0.457 . . . . 1.97 110.996 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.746 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -70.03 120.77 18.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.818 -0.438 . . . . 0.67000000000000004 109.818 177.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -113.15 -168.68 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 4.3399999999999999 112.033 -173.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.479 ' HA ' HG11 ' A' ' 208' ' ' VAL . 43.8 t -62.57 142.27 16.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 115.795 -0.639 . . . . 1.0700000000000001 111.436 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.46 148.03 39.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.292 -0.867 . . . . 0.70999999999999996 111.883 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 48.7 t -86.21 -8.94 57.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.373 -0.83 . . . . 1.8799999999999999 110.122 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.5 t -143.98 145.22 32.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.971 -0.559 . . . . 1.6299999999999999 111.208 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 78.1 m -83.2 -15.82 48.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.642 -0.708 . . . . 1.96 110.298 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -81.85 -25.73 34.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.617 0.722 . . . . 2.4199999999999999 110.187 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -96.42 18.28 14.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.343 -0.844 . . . . 2.1200000000000001 111.815 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -59.14 114.19 2.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.183 0.516 . . . . 1.3500000000000001 111.547 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.868 ' H ' HD12 ' A' ' 183' ' ' LEU . 4.7 p-10 -152.01 29.74 0.58 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.007 -0.997 . . . . 1.6799999999999999 109.202 170.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.868 HD12 ' H ' ' A' ' 182' ' ' ASN . 1.5 mp -112.03 118.95 36.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.93 -1.032 . . . . 0.81000000000000005 109.13 -175.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 86.4 m -150.08 148.23 28.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.437 0.637 . . . . 0.51000000000000001 112.589 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.437 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 28.0 tpp -97.45 145.64 25.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.255 -0.884 . . . . 1.3500000000000001 111.411 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 41.7 t -129.93 131.47 45.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 1.73 110.267 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -123.05 105.78 10.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.588 -0.523 . . . . 1.9299999999999999 109.588 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 24.2 pt -142.67 144.01 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.847 -0.615 . . . . 1.1100000000000001 110.502 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.4 m 61.85 35.43 16.53 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.463 -0.335 . . . . 1.8600000000000001 111.772 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 66.61 3.91 3.13 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.88 -0.6 . . . . 2.8300000000000001 111.721 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.4 pt20 -120.61 163.74 17.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.083 0.468 . . . . 1.75 110.421 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.8 mm -107.08 136.11 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.872 -0.604 . . . . 1.01 111.196 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -138.14 156.44 47.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.029 -0.532 . . . . 3.9399999999999999 110.917 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.556 ' CD2' ' HB3' ' A' ' 207' ' ' LEU . 2.4 m-30 -101.1 114.43 28.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.761 -0.654 . . . . 0.92000000000000004 109.823 175.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -102.39 124.41 47.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.009 0.433 . . . . 1.1100000000000001 110.178 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.53 HG22 HD11 ' A' ' 207' ' ' LEU . 0.9 OUTLIER -100.19 152.83 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.545 0.688 . . . . 0.69999999999999996 110.38 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.575 HG13 ' HA ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -92.8 -41.04 12.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.813 -1.085 . . . . 0.62 112.471 -168.586 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.34 164.8 27.26 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.086 0.402 . . . . 1.3799999999999999 112.086 -171.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.594 ' HA ' ' O ' ' A' ' 104' ' ' MET . 5.3 t70 -49.7 112.26 0.63 Allowed 'General case' 0 C--O 1.233 0.187 0 O-C-N 124.481 1.113 . . . . 2.23 110.671 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.512 HG13 ' HE3' ' A' ' 104' ' ' MET . 28.5 mm -83.13 129.2 37.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.104 -0.498 . . . . 0.88 110.868 -176.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 45.0 mt-10 -83.57 136.16 42.75 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.924 -0.58 . . . . 2.0600000000000001 109.58 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 103' ' ' LYS . 31.3 Cg_exo -58.14 113.68 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.18 1.92 . . . . 0.51000000000000001 111.71 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.17 -4.9 10.38 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.595 -0.812 . . . . 0.69999999999999996 113.643 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.3 pt-20 -112.74 121.66 45.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.001 0.9 . . . . 1.27 111.037 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.539 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -110.6 93.79 4.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.553 -0.749 . . . . 2.9199999999999999 111.658 177.1 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.681 ' C ' ' HG ' ' A' ' 183' ' ' LEU . 2.7 mm? -124.19 99.09 6.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.548 -0.461 . . . . 0.90000000000000002 110.222 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.746 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -147.78 119.0 7.76 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.695 0.398 . . . . 0.53000000000000003 110.074 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.593 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 7.4 p -154.12 157.8 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.285 -0.566 . . . . 0.91000000000000003 111.473 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 16.4 t-80 -115.13 110.87 20.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.385 -0.968 . . . . 1.55 108.385 163.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 66.6 t . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.24 0.543 . . . . 2.5600000000000001 110.051 -179.202 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 168' ' ' TRP . 66.5 mt . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 120.659 0.266 . . . . 2.4500000000000002 110.693 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.25 115.88 3.55 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.184 1.922 . . . . 1.75 111.572 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.637 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -113.63 155.93 44.25 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.039 -0.528 . . . . 1.01 110.03 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.63 154.86 66.48 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.753 2.302 . . . . 0.72999999999999998 111.862 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 -10.13 30.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.604 -0.725 . . . . 1.04 112.476 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 62.9 m-20 -104.71 7.75 34.86 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.927 -0.309 . . . . 1.6599999999999999 111.598 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -132.54 136.44 46.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.649 -0.5 . . . . 1.0 109.649 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.437 ' OE2' ' HD2' ' A' ' 87' ' ' ARG . 35.9 tt0 -127.34 122.91 35.0 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.382 -0.527 . . . . 2.27 110.787 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tt -87.28 125.35 34.16 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.455 -0.943 . . . . 0.79000000000000004 108.455 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.437 ' HD2' ' OE2' ' A' ' 85' ' ' GLU . 13.7 ptm180 -166.15 133.83 2.81 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.336 -0.847 . . . . 3.21 109.701 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.32 111.98 2.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.92 -0.582 . . . . 2.46 110.217 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -148.17 93.25 2.14 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.67 -0.863 . . . . 1.5800000000000001 108.67 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.3 t -72.23 104.63 3.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.992 -0.549 . . . . 1.8600000000000001 110.867 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.509 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -105.94 114.8 62.3 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.812 -0.631 . . . . 1.45 109.365 175.28 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.27 120.52 7.87 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.284 2.656 . . . . 1.6100000000000001 112.765 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.23 -11.42 36.89 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.009 -0.615 . . . . 1.74 112.435 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.509 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -132.97 -71.1 0.53 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.916 -0.313 . . . . 1.4099999999999999 111.476 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.83 -149.6 17.32 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.742 -0.742 . . . . 1.0900000000000001 112.478 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.3 mt -104.5 122.71 46.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.568 0.21 . . . . 2.3100000000000001 111.568 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -138.18 -153.85 6.36 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.818 -0.706 . . . . 0.58999999999999997 112.159 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.52 HG21 ' CE3' ' A' ' 168' ' ' TRP . 35.6 m -112.17 112.27 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.934 0.873 . . . . 0.67000000000000004 109.857 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -82.52 118.66 23.42 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.821 -0.627 . . . . 1.1299999999999999 110.799 -171.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -66.15 117.97 9.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.426 -0.806 . . . . 0.54000000000000004 110.374 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.9 -3.71 58.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.484 0.659 . . . . 1.6799999999999999 110.079 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.412 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 24.6 ttm-85 -125.74 157.06 38.38 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.544 -0.91 . . . . 3.5 108.544 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.412 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -83.99 159.58 21.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.108 0.48 . . . . 2.3999999999999999 110.145 177.713 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.625 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 44.6 mtm -128.32 153.53 46.91 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.02 -0.536 . . . . 1.22 109.912 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -120.45 139.06 53.41 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.8 -0.636 . . . . 2.3100000000000001 109.925 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -39.22 122.69 1.29 Allowed 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.431 1.082 . . . . 0.83999999999999997 113.395 -169.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.17 7.15 12.85 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.467 -0.788 . . . . 1.04 111.373 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.462 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -86.02 167.98 14.53 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.844 0.458 . . . . 2.6200000000000001 111.019 -176.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.49 ' CZ ' ' HD3' ' A' ' 112' ' ' PRO . 3.7 ptt180 -142.77 164.15 30.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.065 -0.516 . . . . 3.6200000000000001 110.514 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 109' ' ' ARG . 7.3 mt -118.48 139.25 51.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.542 -0.753 . . . . 0.53000000000000003 109.055 170.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.7 -115.02 4.17 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.804 -0.712 . . . . 1.02 113.288 174.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.49 ' HD3' ' CZ ' ' A' ' 109' ' ' ARG . 70.4 Cg_endo -72.14 168.22 74.77 Favored 'Cis proline' 0 C--N 1.349 0.596 0 C-N-CA 123.858 -1.309 . . . . 2.1000000000000001 112.94 4.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.507 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 52.7 t . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.412 . . . . 2.0 110.528 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.445 -0.737 0 N-CA-C 112.776 -0.13 . . . . 1.3 112.776 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.404 ' HB2' HG23 ' A' ' 78' ' ' ILE . 3.4 m -61.47 -27.38 68.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.539 0.685 . . . . 1.8200000000000001 110.035 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.52 ' CE3' HG21 ' A' ' 98' ' ' VAL . 16.4 p-90 -85.3 -19.33 31.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.245 -0.889 . . . . 0.69999999999999996 111.084 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 40.6 mt -82.08 -14.95 55.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.059 -0.518 . . . . 0.66000000000000003 111.864 -173.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -74.59 -8.65 57.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 1.48 110.01 175.028 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.557 ' O ' ' HD2' ' A' ' 173' ' ' ARG . 65.6 m-85 -85.98 -30.47 22.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.979 -0.555 . . . . 1.97 111.675 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.783 HG21 ' HB2' ' A' ' 207' ' ' LEU . 1.3 mm -51.3 138.01 8.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 O-C-N 123.393 0.433 . . . . 0.67000000000000004 111.301 -173.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.557 ' HD2' ' O ' ' A' ' 171' ' ' TYR . 14.9 mmm180 -92.14 170.88 9.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.344 0.593 . . . . 4.3399999999999999 111.874 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.478 HG22 HG11 ' A' ' 208' ' ' VAL . 61.6 t -89.64 160.76 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.26 -0.882 . . . . 1.0700000000000001 108.669 173.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.538 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -46.67 125.0 6.61 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.323 0.389 . . . . 0.70999999999999996 111.892 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 30.8 p -75.75 -14.11 60.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.057 -0.52 . . . . 1.8799999999999999 110.989 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.4 m -148.39 164.19 34.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 1.6299999999999999 109.86 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 57.4 m -74.91 -22.96 58.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.973 0.416 . . . . 1.96 111.062 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.13 5.32 45.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.213 0.53 . . . . 2.4199999999999999 110.402 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -110.05 15.93 22.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.42 -0.809 . . . . 2.1200000000000001 110.255 -174.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.87 114.34 7.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.449 . . . . 1.3500000000000001 110.427 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.784 ' H ' HD12 ' A' ' 183' ' ' LEU . 18.7 t30 -157.43 36.74 0.28 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.001 0.905 . . . . 1.6799999999999999 109.21 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.784 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.5 OUTLIER -122.9 124.57 43.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.043 -0.526 . . . . 0.81000000000000005 111.169 -173.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.5 m -149.97 121.95 8.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.19 0.519 . . . . 0.51000000000000001 110.735 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.432 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 48.1 ttm -97.96 133.02 43.01 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.202 -0.666 . . . . 1.3500000000000001 109.202 172.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 25.0 t -112.83 132.19 55.38 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.289 -0.634 . . . . 1.73 109.289 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 24.7 tm0? -108.37 104.9 14.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.248 0.547 . . . . 1.9299999999999999 109.712 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.578 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 25.3 pt -132.53 143.2 40.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.522 -0.763 . . . . 1.1100000000000001 110.139 -176.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.8 m 54.1 35.93 23.49 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.324 0.39 . . . . 1.8600000000000001 111.606 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 65.55 7.55 4.48 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.943 -0.571 . . . . 2.8300000000000001 112.054 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 13.4 pt20 -113.79 155.26 25.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 1.75 110.529 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 113' ' ' CYS . 51.0 mm -87.81 112.75 23.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.858 -0.61 . . . . 1.01 110.425 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -110.53 135.6 50.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.889 -0.596 . . . . 3.9399999999999999 110.274 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 9.9 m-85 -102.34 114.67 29.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.59 -0.277 . . . . 0.92000000000000004 110.485 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.97 117.85 31.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.866 0.365 . . . . 1.1100000000000001 110.048 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.462 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 2.2 t -89.6 152.85 3.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.533 0.682 . . . . 0.69999999999999996 109.869 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.5 mm -90.34 -57.2 4.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.65 -1.159 . . . . 0.62 111.486 -166.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.582 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.7 OUTLIER -141.87 -178.83 5.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.634 -0.712 . . . . 1.3799999999999999 111.368 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.625 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.9 m-20 -48.45 126.66 11.84 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 124.014 0.821 . . . . 2.23 112.703 -175.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.623 HD11 ' ND2' ' A' ' 182' ' ' ASN . 18.6 mm -96.66 138.01 22.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.445 -0.798 . . . . 0.88 110.714 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -86.17 133.29 41.12 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.941 -0.572 . . . . 2.0600000000000001 109.51 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 52.4 Cg_exo -54.99 113.21 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.009 1.806 . . . . 0.51000000000000001 111.615 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.93 -13.08 9.19 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.742 -0.742 . . . . 0.69999999999999996 113.261 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -126.52 122.56 35.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.765 0.783 . . . . 1.27 111.733 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.533 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -111.29 115.79 29.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.807 -0.633 . . . . 2.9199999999999999 111.254 175.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 205' ' ' GLU . 1.7 mm? -124.1 99.97 6.49 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.71 -0.478 . . . . 0.90000000000000002 109.71 171.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.783 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.4 mm? -147.17 112.84 5.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.673 0.389 . . . . 0.53000000000000003 110.156 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.646 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.4 p -154.92 160.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.816 -0.438 . . . . 0.91000000000000003 109.816 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.432 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 52.5 t60 -90.84 107.58 19.28 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.562 -1.273 . . . . 1.55 107.562 169.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.315 -0.905 0 CA-C-O 121.099 0.476 . . . . 2.5600000000000001 110.098 178.99 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 110.458 -0.201 . . . . 2.4500000000000002 110.458 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.64 124.57 10.37 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.702 2.268 . . . . 1.75 111.857 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.615 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -118.94 143.97 34.85 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.316 -0.402 . . . . 1.01 110.67 -178.846 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -54.62 147.53 48.62 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.414 2.743 . . . . 0.72999999999999998 112.296 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.422 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -66.15 -12.84 58.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.92 -0.582 . . . . 1.04 112.104 -175.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.99 -24.12 59.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.19 0.519 . . . . 1.6599999999999999 110.177 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 71.6 m-85 -123.72 177.39 5.73 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.074 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.545 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 28.2 tt0 -155.86 124.66 6.01 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.009 -0.276 . . . . 2.27 110.702 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.9 tt -84.0 125.01 31.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.474 -0.565 . . . . 0.79000000000000004 109.474 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -147.79 138.9 23.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.196 -0.911 . . . . 3.21 109.538 -174.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.99 110.8 17.58 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.694 -0.484 . . . . 2.46 109.694 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m -150.0 106.61 3.52 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.749 -0.659 . . . . 1.5800000000000001 109.309 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.6 m -75.91 104.17 6.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.061 0.458 . . . . 1.8600000000000001 111.225 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.425 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -107.15 114.85 60.82 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.148 -0.686 . . . . 1.45 109.148 174.103 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 91' ' ' ILE . 37.5 Cg_exo -60.43 121.93 10.52 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.827 2.351 . . . . 1.6100000000000001 112.653 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.33 -9.61 35.94 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.685 -0.769 . . . . 1.74 113.037 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -131.88 -70.6 0.57 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.892 0.346 . . . . 1.4099999999999999 111.531 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 130.3 -161.51 23.17 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.816 -0.707 . . . . 1.0900000000000001 112.047 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mt -94.68 116.78 29.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.091 -0.337 . . . . 2.3100000000000001 110.091 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.464 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -119.04 -179.39 16.76 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.733 -0.746 . . . . 0.58999999999999997 112.614 -176.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 19.6 m -100.78 112.7 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.698 0.761 . . . . 0.67000000000000004 109.776 174.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -82.07 112.33 19.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.447 -0.797 . . . . 1.1299999999999999 110.984 -169.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -66.5 114.64 5.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.54000000000000004 109.703 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.554 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -95.73 2.18 53.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.427 0.632 . . . . 1.6799999999999999 109.501 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -125.54 154.55 41.98 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.942 -1.027 . . . . 3.5 109.218 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.625 ' H ' ' HD2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -86.72 154.68 20.78 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.453 -0.573 . . . . 2.3999999999999999 109.453 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.744 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 49.4 mtm -131.16 147.56 52.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.512 -0.313 . . . . 1.22 110.734 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -109.8 143.06 40.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.322 -0.622 . . . . 2.3100000000000001 109.322 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.37 130.43 10.75 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 124.012 0.82 . . . . 0.83999999999999997 112.458 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.61 7.54 13.5 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.156 -0.778 . . . . 1.04 111.156 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 0.8 OUTLIER -78.96 162.87 25.68 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 122.901 0.48 . . . . 2.6200000000000001 111.589 -176.468 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 109' ' ' ARG . 2.8 tmm_? -146.93 128.26 14.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.856 -0.611 . . . . 3.6200000000000001 110.881 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 3.2 mt -105.15 148.48 26.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.728 -0.841 . . . . 0.53000000000000003 108.728 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 129.72 -151.2 19.22 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.532 -0.842 . . . . 1.02 112.181 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.557 ' HB3' ' CE2' ' A' ' 193' ' ' TYR . 86.4 Cg_endo -81.53 142.05 52.97 Favored 'Cis proline' 0 C--N 1.342 0.218 0 C-N-CA 123.823 -1.324 . . . . 2.1000000000000001 112.67 0.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 121.19 0.519 . . . . 2.0 109.765 178.017 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 112.134 -0.386 . . . . 1.3 112.134 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 23.0 t -68.54 -24.79 64.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.325 0.583 . . . . 1.8200000000000001 109.941 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -85.0 -18.79 33.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.794 -0.639 . . . . 0.69999999999999996 109.857 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.538 ' O ' HG13 ' A' ' 172' ' ' ILE . 38.0 mt -84.1 -20.35 32.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.682 -0.69 . . . . 0.66000000000000003 111.415 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.463 ' HD3' ' C ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -76.2 -6.17 50.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.519 -0.472 . . . . 1.48 110.225 176.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.464 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 33.8 m-85 -75.83 -37.52 58.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.968 -0.56 . . . . 1.97 110.484 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.646 HD12 ' HB2' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -68.63 119.74 14.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.367 -0.605 . . . . 0.67000000000000004 109.367 174.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -111.15 -172.29 2.0 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.539 -0.301 . . . . 4.3399999999999999 110.847 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.412 HG22 HG11 ' A' ' 208' ' ' VAL . 20.6 t -68.19 149.04 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 1.0700000000000001 110.771 -177.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.577 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -56.22 126.23 25.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.894 -0.594 . . . . 0.70999999999999996 111.441 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 46.2 t -72.02 -17.46 62.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 1.8799999999999999 110.838 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 m -126.33 150.42 48.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.313 -0.403 . . . . 1.6299999999999999 109.975 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 10.7 p -78.57 -19.02 53.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.492 0.553 . . . . 1.96 112.492 -172.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -89.17 -4.09 58.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.468 0.651 . . . . 2.4199999999999999 110.051 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.15 17.48 12.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.207 -0.906 . . . . 2.1200000000000001 111.642 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -69.33 113.25 6.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.327 0.584 . . . . 1.3500000000000001 110.952 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 1.033 ' H ' HD12 ' A' ' 183' ' ' LEU . 4.1 p-10 -155.25 35.14 0.38 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.178 -0.919 . . . . 1.6799999999999999 109.582 171.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 1.033 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.5 OUTLIER -117.7 120.42 37.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.443 -0.799 . . . . 0.81000000000000005 110.754 -171.363 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 92.7 m -148.53 139.8 23.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.099 0.476 . . . . 0.51000000000000001 110.95 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 55.5 ttm -98.75 150.29 21.98 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.371 -0.603 . . . . 1.3500000000000001 109.371 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 53.7 t -112.78 131.9 55.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.061 0.458 . . . . 1.73 109.97 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.557 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 20.7 tm0? -120.77 104.89 10.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.769 -0.651 . . . . 1.9299999999999999 109.389 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 12.9 pt -140.71 132.63 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 1.1100000000000001 110.123 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 51.1 m 58.51 29.88 18.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.118 0.485 . . . . 1.8600000000000001 111.059 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.557 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 0.9 OUTLIER 63.97 11.5 6.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.145 -0.934 . . . . 2.8300000000000001 112.753 176.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -112.08 140.03 47.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.539 -0.541 . . . . 1.75 109.539 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.1 mm -84.77 131.68 33.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.947 -0.57 . . . . 1.01 112.02 -172.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 112' ' ' PRO . 54.3 m-85 -128.37 165.11 21.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.045 -0.98 . . . . 3.9399999999999999 109.709 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.557 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 3.9 m-85 -115.02 126.53 54.85 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.579 -0.526 . . . . 0.92000000000000004 109.579 175.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -125.47 120.06 29.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.027 0.441 . . . . 1.1100000000000001 110.604 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.503 HG22 HD11 ' A' ' 207' ' ' LEU . 1.5 t -85.82 152.9 3.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.126 -0.694 . . . . 0.69999999999999996 109.126 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.538 HG13 ' HA ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -84.28 -48.54 16.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.891 -1.05 . . . . 0.62 111.039 -170.035 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.78 -178.08 6.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.635 -0.711 . . . . 1.3799999999999999 111.193 -174.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.744 ' HA ' ' O ' ' A' ' 104' ' ' MET . 2.8 p-10 -43.23 124.49 3.34 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.454 1.096 . . . . 2.23 113.486 -176.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.482 HG13 ' HE3' ' A' ' 104' ' ' MET . 37.8 mm -100.98 133.11 45.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.947 -1.024 . . . . 0.88 110.122 175.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.676 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 46.5 mt-10 -90.12 128.74 48.46 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.402 -0.592 . . . . 2.0600000000000001 109.402 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.76 116.75 2.03 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.952 2.435 . . . . 0.51000000000000001 112.934 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 123.51 -16.11 8.0 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.953 -0.641 . . . . 0.69999999999999996 113.653 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.676 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 13.9 pt-20 -111.7 122.86 48.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.827 0.814 . . . . 1.27 111.518 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -111.32 94.99 5.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.081 -0.509 . . . . 2.9199999999999999 112.087 177.674 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.455 HD22 ' N ' ' A' ' 206' ' ' LEU . 1.2 mm? -122.77 100.17 6.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.874 -0.73 . . . . 0.90000000000000002 109.859 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.646 ' HB2' HD12 ' A' ' 172' ' ' ILE . 0.6 OUTLIER -147.33 114.28 6.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.581 -0.281 . . . . 0.53000000000000003 110.617 177.472 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.646 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.5 p -155.51 158.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.505 . . . . 0.91000000000000003 109.635 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -85.81 110.41 19.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.245 -1.02 . . . . 1.55 108.245 166.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.32 -0.676 0 CA-C-O 121.264 0.554 . . . . 2.5600000000000001 110.015 -177.669 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.795 -0.446 . . . . 2.4500000000000002 109.795 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.78 116.39 3.41 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.349 2.033 . . . . 1.75 111.712 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.579 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -126.41 140.94 38.54 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.287 -0.415 . . . . 1.01 110.478 -178.153 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.45 138.38 83.71 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.509 2.14 . . . . 0.72999999999999998 111.634 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.49 -4.12 13.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.145 0.497 . . . . 1.04 111.351 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.54 -23.01 61.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.785 -0.643 . . . . 1.6599999999999999 109.457 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -128.43 177.31 7.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.295 -0.866 . . . . 1.0 108.872 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -145.54 131.43 19.14 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.18 -0.608 . . . . 2.27 110.906 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.4 tt -92.79 130.65 38.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.027 -0.533 . . . . 0.79000000000000004 109.769 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -149.5 150.93 33.09 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.454 -0.794 . . . . 3.21 109.746 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -82.92 109.42 17.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.707 -0.849 . . . . 2.46 108.707 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.8 m -159.56 82.44 0.75 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.327 -0.62 . . . . 1.5800000000000001 109.327 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.6 p -68.3 105.22 2.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.139 -0.482 . . . . 1.8600000000000001 110.922 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.6 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -81.86 123.46 80.15 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.116 -0.698 . . . . 1.45 109.116 176.236 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -49.62 115.38 1.77 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.282 2.654 . . . . 1.6100000000000001 113.297 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.09 -14.53 37.06 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.7 -0.762 . . . . 1.74 112.691 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.6 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -128.77 -55.77 1.21 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 1.4099999999999999 111.477 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.92 -146.71 17.54 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.979 -0.629 . . . . 1.0900000000000001 112.255 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.414 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 1.3 pp -69.26 158.83 34.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.718 0.259 . . . . 2.3100000000000001 110.914 177.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.71 172.15 43.56 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.796 -0.716 . . . . 0.58999999999999997 111.995 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.1 m -108.24 120.45 59.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.678 0.751 . . . . 0.67000000000000004 109.965 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -83.01 107.98 15.99 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.246 0.546 . . . . 1.1299999999999999 110.859 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.42 115.56 7.99 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.551 -0.749 . . . . 0.54000000000000004 110.16 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.537 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -86.57 -5.23 59.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.546 0.688 . . . . 1.6799999999999999 109.359 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -128.88 159.17 36.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.008 -0.997 . . . . 3.5 109.176 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.432 ' HD3' ' H ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -85.37 137.09 33.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.244 0.545 . . . . 2.3999999999999999 110.637 -177.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.634 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 25.3 mtm -94.97 116.62 28.93 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.74 -0.837 . . . . 1.22 108.74 172.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.69 173.62 12.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.403 0.621 . . . . 2.3100000000000001 111.74 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.98 118.12 7.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.276 -0.874 . . . . 0.83999999999999997 111.83 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.76 1.04 63.82 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.839 -0.696 . . . . 1.04 113.198 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.58 167.95 20.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.649 -0.5 . . . . 2.6200000000000001 109.649 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.636 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 5.0 tmm_? -145.82 130.6 18.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.245 0.461 . . . . 3.6200000000000001 112.245 -170.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.7 mt -88.18 139.91 30.02 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.84 -0.8 . . . . 0.53000000000000003 108.84 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.04 173.3 40.72 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.801 -1.19 . . . . 1.02 113.05 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -80.97 152.27 81.0 Favored 'Cis proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.954 -1.686 . . . . 2.1000000000000001 112.463 -2.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.442 ' HA ' ' HA2' ' A' ' 166' ' ' GLY . 42.7 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.037 0.446 . . . . 2.0 110.715 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 112.103 -0.399 . . . . 1.3 112.103 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 20.0 t -64.25 -26.94 68.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.028 0.442 . . . . 1.8200000000000001 110.126 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.499 ' O ' ' HB2' ' A' ' 171' ' ' TYR . 44.3 p-90 -86.26 -21.16 27.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.69999999999999996 111.201 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 15.5 mt -82.49 -14.93 54.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.785 0.291 . . . . 0.66000000000000003 111.785 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -74.63 -4.35 36.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.152 0.501 . . . . 1.48 109.911 174.292 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' A' ' 168' ' ' TRP . 13.2 m-85 -76.3 -32.56 58.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.602 -0.726 . . . . 1.97 111.547 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.568 HG21 ' HB2' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -62.87 134.94 27.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.406 -0.518 . . . . 0.67000000000000004 110.406 -175.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.495 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 13.3 mmm180 -110.2 160.1 16.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.084 0.469 . . . . 4.3399999999999999 111.549 -177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.422 HG22 HG11 ' A' ' 208' ' ' VAL . 62.6 t -67.05 147.12 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.569 -0.741 . . . . 1.0700000000000001 109.31 175.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.702 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -54.22 141.72 28.48 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.274 0.559 . . . . 0.70999999999999996 112.117 -177.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 44.9 t -91.26 -2.8 57.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.247 -0.888 . . . . 1.8799999999999999 110.34 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 180' ' ' ASP . 41.5 m -141.65 145.95 35.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.199 0.523 . . . . 1.6299999999999999 110.548 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 59.8 m -72.19 -31.25 65.73 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.551 -0.749 . . . . 1.96 111.584 -173.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -84.05 2.4 39.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.151 0.5 . . . . 2.4199999999999999 110.428 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 177' ' ' SER . 4.2 t70 -108.91 16.65 22.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.523 -0.762 . . . . 2.1200000000000001 110.507 -173.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -63.89 114.19 3.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.037 0.446 . . . . 1.3500000000000001 110.555 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.861 ' H ' HD12 ' A' ' 183' ' ' LEU . 10.5 t30 -148.6 32.27 0.79 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.045 -1.094 . . . . 1.6799999999999999 108.045 175.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.861 HD12 ' H ' ' A' ' 182' ' ' ASN . 1.4 mp -117.15 122.16 43.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.334 -0.848 . . . . 0.81000000000000005 110.746 -172.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 95.3 m -148.72 136.74 20.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.971 0.415 . . . . 0.51000000000000001 110.306 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 49.7 ttm -106.07 141.92 36.63 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.54 -0.541 . . . . 1.3500000000000001 109.54 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 53.4 t -111.93 131.61 55.27 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.268 -0.641 . . . . 1.73 109.268 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.1 103.86 9.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.146 -0.687 . . . . 1.9299999999999999 109.146 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.529 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 22.4 pt -138.08 144.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.627 -0.715 . . . . 1.1100000000000001 109.842 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.8 m 60.41 31.9 20.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.858 0.361 . . . . 1.8600000000000001 111.392 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 60.11 24.09 13.36 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.785 -0.643 . . . . 2.8300000000000001 112.026 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 29.3 pt20 -130.37 161.42 31.36 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.975 -0.38 . . . . 1.75 109.975 176.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.3 mm -103.94 131.45 52.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.21 0.529 . . . . 1.01 112.274 -174.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.636 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 30.1 m-85 -133.48 147.85 51.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.266 -0.879 . . . . 3.9399999999999999 110.027 174.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 4.9 m-30 -101.57 114.44 28.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.739 -0.467 . . . . 0.92000000000000004 109.739 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -99.22 121.81 41.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.392 . . . . 1.1100000000000001 110.246 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 1.9 t -89.23 150.95 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 122.074 0.94 . . . . 0.69999999999999996 110.173 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.413 HG13 ' HA ' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -95.6 -55.28 6.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 113.866 -1.515 . . . . 0.62 110.796 -165.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.39 175.22 10.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.758 -1.11 . . . . 1.3799999999999999 109.733 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.634 ' HA ' ' O ' ' A' ' 104' ' ' MET . 9.2 p-10 -59.45 115.82 3.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.76 0.79 . . . . 2.23 112.2 -172.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.451 HD11 ' ND2' ' A' ' 182' ' ' ASN . 4.8 mm -69.33 140.13 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.857 -1.065 . . . . 0.88 110.867 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 37.2 mt-10 -84.04 118.19 70.64 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.21 -0.663 . . . . 2.0600000000000001 109.21 171.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -45.58 121.17 3.78 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.943 2.428 . . . . 0.51000000000000001 112.731 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.74 -11.17 9.56 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.91 -0.662 . . . . 0.69999999999999996 112.506 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 10.9 pt-20 -133.92 124.65 26.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 1.27 110.965 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.504 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -109.45 107.66 17.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.82 0.343 . . . . 2.9199999999999999 111.066 177.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.585 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.2 mm? -123.41 98.93 6.08 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.186 -0.606 . . . . 0.90000000000000002 110.354 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.568 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.6 mm? -148.17 105.48 3.64 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.096 -0.705 . . . . 0.53000000000000003 109.096 174.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.737 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 24.5 t -154.58 158.67 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.182 -1.044 . . . . 0.91000000000000003 108.182 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 26.2 t60 -85.01 108.49 17.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.895 -1.15 . . . . 1.55 107.895 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--N 1.315 -0.926 0 CA-C-O 121.674 0.749 . . . . 2.5600000000000001 110.68 -176.535 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 78.6 mt . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.581 0.229 . . . . 2.4500000000000002 110.45 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.39 121.45 8.88 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.9 2.4 . . . . 1.75 112.522 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.577 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -120.83 152.96 56.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.901 -0.59 . . . . 1.01 109.934 178.386 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.85 150.58 85.74 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.391 2.061 . . . . 0.72999999999999998 110.995 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.23 8.36 1.35 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.876 -0.602 . . . . 1.04 112.377 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -112.88 1.23 15.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.143 0.497 . . . . 1.6599999999999999 111.243 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -137.38 136.11 37.58 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -123.12 130.02 52.21 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.077 -0.649 . . . . 2.27 111.127 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tt -83.7 130.55 34.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 0.79000000000000004 109.505 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 97.0 mtt180 -143.71 126.85 16.53 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.507 -0.77 . . . . 3.21 109.468 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.76 111.78 17.52 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.479 -0.488 . . . . 2.46 109.891 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.0 p -162.69 97.47 0.96 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.657 -0.701 . . . . 1.5800000000000001 109.463 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.5 m -68.21 104.08 1.73 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.966 0.412 . . . . 1.8600000000000001 110.777 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -87.04 122.19 71.24 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.233 -0.654 . . . . 1.45 109.233 175.455 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.54 119.09 4.68 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.187 2.591 . . . . 1.6100000000000001 112.821 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.01 -20.43 28.8 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 121.003 -0.618 . . . . 1.74 112.685 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.417 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -131.74 -72.45 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.032 0.416 . . . . 1.4099999999999999 111.3 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.533 ' HA3' ' NH1' ' A' ' 173' ' ' ARG . . . 131.85 -130.58 5.99 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.932 -0.651 . . . . 1.0900000000000001 112.557 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt -99.68 158.17 15.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.681 0.24 . . . . 2.3100000000000001 110.485 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.24 -179.85 39.33 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.269 -0.732 . . . . 0.58999999999999997 111.269 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.8 m -102.9 119.69 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.543 0.687 . . . . 0.67000000000000004 109.504 174.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.482 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 49.4 m95 -83.83 114.62 21.76 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.562 -0.744 . . . . 1.1299999999999999 111.023 -170.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.23 115.29 12.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.067 -0.716 . . . . 0.54000000000000004 109.067 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.532 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -92.55 2.27 56.79 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.648 0.737 . . . . 1.6799999999999999 109.641 -176.348 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -125.75 161.24 27.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.979 -1.01 . . . . 3.5 108.355 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 155.99 39.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.0 0.428 . . . . 2.3999999999999999 111.169 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.668 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 34.8 mtm -120.15 149.31 42.44 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.393 -0.966 . . . . 1.22 108.393 171.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 47.1 mt-10 -119.39 173.88 6.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.523 0.678 . . . . 2.3100000000000001 112.399 -172.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.12 115.58 6.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.884 -1.053 . . . . 0.83999999999999997 111.976 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.32 1.88 57.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.685 -0.769 . . . . 1.04 113.522 171.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 6.8 pt-20 -86.07 166.27 15.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.483 0.641 . . . . 2.6200000000000001 110.647 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.478 ' HG2' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -127.96 143.41 51.09 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.109 -0.496 . . . . 3.6200000000000001 110.233 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.478 ' N ' ' HG2' ' A' ' 109' ' ' ARG . 7.5 mt -87.35 125.8 34.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.128 -1.064 . . . . 0.53000000000000003 108.128 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -140.73 157.14 25.7 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 119.885 -1.15 . . . . 1.02 113.17 -172.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.92 154.33 96.94 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.585 -1.839 . . . . 2.1000000000000001 112.175 -1.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.524 ' HA ' HD12 ' A' ' 169' ' ' LEU . 59.5 m . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.913 -0.585 . . . . 2.0 111.061 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.401 ' HA3' ' C ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 111.424 -0.671 . . . . 1.3 111.424 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 8.7 t -64.56 -17.66 64.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.267 0.556 . . . . 1.8200000000000001 110.628 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.498 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 26.9 p-90 -74.31 -21.76 59.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.297 0.57 . . . . 0.69999999999999996 110.274 177.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 40.6 mt -86.43 -20.22 28.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.738 -0.665 . . . . 0.66000000000000003 112.1 -175.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -71.88 -5.04 31.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.623 -0.431 . . . . 1.48 110.577 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -79.9 -37.27 35.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.913 -0.585 . . . . 1.97 111.798 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.696 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -62.83 131.64 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.751 -0.38 . . . . 0.67000000000000004 110.273 -178.723 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.533 ' NH1' ' HA3' ' A' ' 95' ' ' GLY . 99.2 mtt180 -115.07 -171.41 1.94 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.296 -0.411 . . . . 4.3399999999999999 111.429 -174.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.509 HG22 HG11 ' A' ' 208' ' ' VAL . 4.4 t -76.47 141.0 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-N 116.298 -0.41 . . . . 1.0700000000000001 110.229 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -61.07 138.44 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.821 -0.627 . . . . 0.70999999999999996 111.944 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 37.6 t -72.85 -6.87 47.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.169 -0.923 . . . . 1.8799999999999999 110.69 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.3 t -126.07 139.77 53.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 1.6299999999999999 110.383 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 61.6 m -88.15 -18.81 27.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.052 -0.522 . . . . 1.96 110.59 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -83.97 -14.95 49.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.102 0.477 . . . . 2.4199999999999999 110.522 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -110.04 17.57 20.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.828 -0.624 . . . . 2.1200000000000001 111.185 -176.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -54.94 115.49 2.23 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.179 0.514 . . . . 1.3500000000000001 110.86 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.722 ' H ' HD12 ' A' ' 183' ' ' LEU . 5.5 p-10 -144.05 32.36 1.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.667 0.746 . . . . 1.6799999999999999 109.384 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.722 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.2 OUTLIER -116.0 124.51 50.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.038 -0.983 . . . . 0.81000000000000005 110.606 -173.144 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 97.7 m -146.49 121.59 10.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.287 0.565 . . . . 0.51000000000000001 111.387 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.596 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 39.0 ttm -113.24 129.49 56.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 1.3500000000000001 109.431 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 35.2 t -115.86 165.05 13.52 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.407 -0.59 . . . . 1.73 109.407 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.435 HE22 ' HA ' ' A' ' 190' ' ' GLU . 25.3 tm0? -129.88 105.23 7.86 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.166 -0.679 . . . . 1.9299999999999999 109.166 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.62 143.93 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.748 -0.66 . . . . 1.1100000000000001 110.518 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.4 t 62.56 34.06 15.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.254 0.549 . . . . 1.8600000000000001 110.312 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.435 ' HA ' HE22 ' A' ' 187' ' ' GLN . 17.3 mm-40 58.32 30.0 18.93 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.377 -0.829 . . . . 2.8300000000000001 111.979 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -140.54 167.28 22.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.996 0.427 . . . . 1.75 110.212 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.3 mm -82.29 152.33 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.982 -0.748 . . . . 1.01 108.982 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -143.75 120.1 10.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.754 0.311 . . . . 3.9399999999999999 110.542 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.545 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 15.0 m-85 -100.9 113.49 26.49 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.734 -0.469 . . . . 0.92000000000000004 109.734 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -118.79 129.45 55.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.654 0.264 . . . . 1.1100000000000001 110.31 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 1.2 t -95.3 150.99 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.951 0.882 . . . . 0.69999999999999996 110.645 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -98.68 -45.47 12.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.176 -1.375 . . . . 0.62 112.004 -163.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 199' ' ' ASP . 0.1 OUTLIER -154.84 -177.66 6.67 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.155 -0.929 . . . . 1.3799999999999999 109.886 -173.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.668 ' HA ' ' O ' ' A' ' 104' ' ' MET . 15.4 t70 -59.22 123.32 16.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.374 0.607 . . . . 2.23 111.515 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.413 HG13 ' HE3' ' A' ' 104' ' ' MET . 14.8 mm -106.94 136.58 41.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.805 -0.634 . . . . 0.88 110.323 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.54 122.6 80.89 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.714 -0.676 . . . . 2.0600000000000001 110.331 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -51.46 119.97 6.26 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.51 2.14 . . . . 0.51000000000000001 111.745 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.72 -8.5 9.35 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.456 -0.878 . . . . 0.69999999999999996 112.374 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -132.5 123.24 26.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.295 0.569 . . . . 1.27 110.146 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.3 96.2 6.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.729 -0.668 . . . . 2.9199999999999999 111.436 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.466 ' C ' HD22 ' A' ' 207' ' ' LEU . 0.8 OUTLIER -115.58 99.89 7.67 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.836 -0.745 . . . . 0.90000000000000002 110.114 177.195 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.696 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.87 112.99 6.14 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.069 -0.715 . . . . 0.53000000000000003 109.069 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.631 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 3.9 p -155.28 160.08 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 O-C-N 121.984 -0.447 . . . . 0.91000000000000003 110.96 -176.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.596 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 54.9 t-80 -80.27 128.6 33.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.564 -0.902 . . . . 1.55 108.564 166.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 42.4 t . . . . . 0 C--N 1.325 -0.499 0 N-CA-C 109.386 -0.598 . . . . 2.5600000000000001 109.386 174.183 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 74.0 mt . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 109.95 -0.389 . . . . 2.4500000000000002 109.95 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.91 116.96 4.12 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.347 2.031 . . . . 1.75 111.442 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 168' ' ' TRP . 0.2 OUTLIER -131.59 147.28 65.41 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.399 -0.364 . . . . 1.01 110.365 -178.387 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 80' ' ' ILE . 2.8 Cg_exo -75.93 133.05 14.82 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.346 2.031 . . . . 0.72999999999999998 110.761 171.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.03 -8.88 33.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.317 . . . . 1.04 111.6 -176.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -70.74 -19.7 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.049 -0.523 . . . . 1.6599999999999999 110.606 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.53 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 19.0 m-85 -123.78 148.27 46.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.346 -0.612 . . . . 1.0 109.346 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.438 ' HB2' ' HE2' ' A' ' 101' ' ' LYS . 7.2 tp10 -109.9 117.38 33.67 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.786 -0.366 . . . . 2.27 110.495 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.443 ' HA ' HG12 ' A' ' 98' ' ' VAL . 8.3 tt -83.67 130.09 34.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.409 -0.589 . . . . 0.79000000000000004 109.409 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -143.89 124.4 13.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.06 -0.518 . . . . 3.21 111.443 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -83.03 112.48 19.81 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.432 -0.581 . . . . 2.46 109.432 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 33.0 t -170.09 149.58 3.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.118 -0.697 . . . . 1.5800000000000001 109.118 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.3 m -100.61 104.91 16.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.746 0.308 . . . . 1.8600000000000001 110.871 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -97.56 123.77 50.99 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.229 -0.656 . . . . 1.45 109.229 175.296 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.16 121.1 9.36 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.023 2.482 . . . . 1.6100000000000001 112.738 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.48 -15.66 35.16 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.724 -0.671 . . . . 1.74 112.07 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.502 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -132.99 -60.14 0.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.839 0.352 . . . . 1.4099999999999999 111.7 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.561 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 121.74 -125.87 6.28 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.307 -0.717 . . . . 1.0900000000000001 111.307 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 89' ' ' SER . 0.7 OUTLIER -89.0 160.67 17.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.803 -0.443 . . . . 2.3100000000000001 109.803 173.523 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.2 169.49 41.27 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.19 -1.005 . . . . 0.58999999999999997 112.779 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 86' ' ' LEU . 11.3 m -104.2 148.81 8.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.1 -0.704 . . . . 0.67000000000000004 109.1 174.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -118.53 120.17 36.71 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.647 0.26 . . . . 1.1299999999999999 110.753 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.517 ' H ' ' HG2' ' A' ' 205' ' ' GLU . . . -71.61 122.36 20.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.235 -0.283 . . . . 0.54000000000000004 110.235 176.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.685 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -90.36 11.91 19.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.657 0.741 . . . . 1.6799999999999999 110.141 -178.464 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.2 ttp85 -137.35 159.11 42.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.155 -0.929 . . . . 3.5 108.565 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.657 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -85.34 155.93 21.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.956 0.408 . . . . 2.3999999999999999 110.744 -178.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 63.0 mtm -132.05 153.01 50.84 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.171 -0.677 . . . . 1.22 109.171 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -120.07 143.68 47.99 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.13 0.269 . . . . 2.3100000000000001 110.842 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . . . -34.89 117.33 0.38 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.76 1.287 . . . . 0.83999999999999997 113.544 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.44 7.89 11.77 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.688 -0.687 . . . . 1.04 111.76 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.507 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -80.39 161.71 24.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.114 0.483 . . . . 2.6200000000000001 110.71 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.546 ' HG3' ' CE2' ' A' ' 193' ' ' TYR . 0.0 OUTLIER -141.17 145.45 35.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.139 -0.482 . . . . 3.6200000000000001 110.513 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.53 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 6.3 mt -107.51 150.74 26.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.36 -0.607 . . . . 0.53000000000000003 109.36 173.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.13 -143.24 17.14 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.318 -0.944 . . . . 1.02 113.319 173.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.23 165.94 47.59 Favored 'Cis proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.822 -1.324 . . . . 2.1000000000000001 113.316 2.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 31.7 t . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 2.0 110.655 -177.082 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 N-CA-C 112.333 -0.307 . . . . 1.3 112.333 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.524 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 1.2 m -57.27 -29.9 64.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.668 0.387 . . . . 1.8200000000000001 111.499 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.493 ' HB3' HG22 ' A' ' 80' ' ' ILE . 45.5 p-90 -85.59 -23.46 27.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.69999999999999996 111.13 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 17.7 mt -86.4 -15.55 40.01 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.805 0.298 . . . . 0.66000000000000003 111.805 -177.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -76.13 -1.71 27.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.806 -0.358 . . . . 1.48 110.413 177.448 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.426 ' CE2' HD11 ' A' ' 86' ' ' LEU . 37.9 m-85 -81.67 -37.13 27.92 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.112 -0.495 . . . . 1.97 112.058 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -65.07 140.99 18.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 120.151 -0.62 . . . . 0.67000000000000004 110.913 -173.562 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 -123.7 -168.27 1.75 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.839 -0.619 . . . . 4.3399999999999999 111.467 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.401 HG22 HG11 ' A' ' 208' ' ' VAL . 7.0 t -69.63 156.64 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.58 -0.737 . . . . 1.0700000000000001 110.626 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.576 ' HA ' HD12 ' A' ' 206' ' ' LEU . . . -55.88 132.99 51.04 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.141 -0.481 . . . . 0.70999999999999996 110.508 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.1 m -71.77 -20.87 61.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.604 -0.725 . . . . 1.8799999999999999 111.033 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.403 ' HB2' ' OD1' ' A' ' 180' ' ' ASP . 24.7 m -130.63 157.11 43.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.466 -0.334 . . . . 1.6299999999999999 111.181 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' CYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 3.3 p -59.01 -56.71 18.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.219 0.451 . . . . 1.96 112.219 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.76 -1.4 21.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 2.4199999999999999 111.758 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.403 ' OD1' ' HB2' ' A' ' 177' ' ' SER . 4.5 m-20 -95.06 17.32 14.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.264 -0.426 . . . . 2.1200000000000001 111.623 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 16.3 mm100 -56.57 113.77 1.75 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.976 0.417 . . . . 1.3500000000000001 109.889 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.554 ' OD1' ' HE2' ' A' ' 198' ' ' LYS . 17.8 t30 -159.25 43.82 0.24 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.121 -1.066 . . . . 1.6799999999999999 108.121 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.599 ' HB3' ' O ' ' A' ' 206' ' ' LEU . 0.7 OUTLIER -142.42 128.86 20.11 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.003 -0.998 . . . . 0.81000000000000005 111.578 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 29.8 m -150.38 120.81 7.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.088 -0.96 . . . . 0.51000000000000001 110.184 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.585 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 44.9 ttm -109.19 118.44 36.72 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.654 -0.498 . . . . 1.3500000000000001 109.654 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 36.7 t -113.86 166.42 11.59 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.169 -0.469 . . . . 1.73 109.774 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -124.09 134.39 53.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.829 0.347 . . . . 1.9299999999999999 110.653 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 23.5 pt -148.05 140.94 18.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.722 -0.672 . . . . 1.1100000000000001 109.946 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 190' ' ' GLU . 8.3 t 54.4 38.99 30.6 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.113 0.482 . . . . 1.8600000000000001 110.62 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 37.0 tt0 72.79 -1.47 3.0 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.186 -0.916 . . . . 2.8300000000000001 112.163 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -117.8 154.2 32.18 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.443 -0.785 . . . . 1.75 111.367 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 192' ' ' ILE . 26.8 mm -81.66 129.12 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.348 -0.842 . . . . 1.01 111.157 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.546 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 72.8 t80 -114.97 131.19 56.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.763 -1.108 . . . . 3.9399999999999999 109.737 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 3.9 m-85 -98.98 112.3 24.46 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.157 -0.683 . . . . 0.92000000000000004 109.157 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 195' ' ' LYS . 5.0 tmmm? -112.1 120.07 40.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.7 -0.682 . . . . 1.1100000000000001 109.454 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.56 HG22 HD11 ' A' ' 207' ' ' LEU . 1.8 t -94.33 150.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-O 121.591 0.71 . . . . 0.69999999999999996 109.326 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.8 mm -87.71 -55.58 6.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.696 -1.138 . . . . 0.62 110.65 -166.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.554 ' HE2' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -144.71 -178.84 6.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.722 -0.672 . . . . 1.3799999999999999 111.973 177.66 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.0 OUTLIER -47.25 128.71 12.15 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.767 1.025 . . . . 2.23 113.767 -171.42 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 38.7 mm -95.25 136.79 25.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.348 -0.842 . . . . 0.88 110.545 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 42.5 mt-10 -89.55 123.3 67.01 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.457 -0.572 . . . . 2.0600000000000001 109.457 171.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' A' ' 103' ' ' LYS . 77.2 Cg_exo -47.22 123.18 7.36 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.258 2.639 . . . . 0.51000000000000001 112.602 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.2 -18.77 8.32 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.914 -0.66 . . . . 0.69999999999999996 112.84 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 11.0 pt-20 -132.55 121.25 22.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.523 0.661 . . . . 1.27 111.898 -178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.517 ' HG2' ' H ' ' A' ' 100' ' ' ALA . 13.2 mm-40 -110.32 118.02 35.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 2.9199999999999999 109.982 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.599 ' O ' ' HB3' ' A' ' 183' ' ' LEU . 1.9 mm? -112.28 100.8 9.09 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.376 -0.972 . . . . 0.90000000000000002 108.376 171.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.692 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.3 mm? -143.44 113.49 7.23 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.492 0.495 . . . . 0.53000000000000003 109.891 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.549 HG12 HD12 ' A' ' 183' ' ' LEU . 1.4 p -152.21 159.53 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.837 0.351 . . . . 0.91000000000000003 110.289 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.585 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 44.8 t-80 -98.52 111.22 23.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.689 -1.226 . . . . 1.55 107.689 171.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 109.241 -0.652 . . . . 2.5600000000000001 109.241 175.32 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.5 mt . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.519 -0.178 . . . . 2.4500000000000002 110.519 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.45 125.14 10.97 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.532 2.155 . . . . 1.75 112.218 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.694 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -111.9 159.03 35.03 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.142 -0.481 . . . . 1.01 110.973 -175.65 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -64.52 162.47 30.83 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.33 2.686 . . . . 0.72999999999999998 112.648 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.19 -4.38 17.37 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.438 0.903 . . . . 1.04 113.438 -170.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 59.8 m-20 -111.64 1.78 16.95 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.529 -0.468 . . . . 1.6599999999999999 111.839 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -128.2 140.67 51.78 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.456 ' HB2' ' HD2' ' A' ' 101' ' ' LYS . 37.0 tt0 -122.48 126.21 47.39 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.569 -0.452 . . . . 2.27 110.183 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.591 HD11 ' CE2' ' A' ' 171' ' ' TYR . 6.2 tt -83.98 127.2 33.71 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.85 -0.614 . . . . 0.79000000000000004 109.533 -178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.42 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 45.4 mtp180 -152.86 128.44 10.05 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.231 -0.895 . . . . 3.21 109.792 -174.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.3 112.55 19.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.099 -0.704 . . . . 2.46 109.099 174.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -163.96 92.14 0.66 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.529 -0.915 . . . . 1.5800000000000001 108.529 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 m -54.35 105.4 0.15 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.678 -0.692 . . . . 1.8600000000000001 112.083 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -92.19 123.38 62.76 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.627 -0.715 . . . . 1.45 109.181 173.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -46.58 116.9 1.78 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.449 2.766 . . . . 1.6100000000000001 113.366 -175.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.87 -27.18 13.54 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.005 -0.617 . . . . 1.74 112.491 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.05 -62.32 1.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.81 0.338 . . . . 1.4099999999999999 111.133 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 115.09 -113.6 2.99 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.009 -0.615 . . . . 1.0900000000000001 111.922 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.38 159.29 24.39 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 122.122 0.169 . . . . 2.3100000000000001 110.683 176.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.04 -179.19 46.38 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.618 -0.801 . . . . 0.58999999999999997 112.109 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.435 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 29.4 m -115.77 114.66 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.6 0.714 . . . . 0.67000000000000004 109.88 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 28.2 m95 -83.22 120.14 25.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.513 -0.767 . . . . 1.1299999999999999 110.98 -170.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -66.51 121.76 16.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.236 -0.438 . . . . 0.54000000000000004 110.39 177.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.456 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 1.1 mppt? -90.73 -9.02 48.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.153 0.502 . . . . 1.6799999999999999 110.286 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -135.47 157.44 46.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.308 -0.86 . . . . 3.5 108.681 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.6 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -79.27 159.83 27.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 120.913 0.387 . . . . 2.3999999999999999 110.38 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.808 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 52.8 mtm -129.13 142.05 51.0 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.395 -0.594 . . . . 1.22 109.395 177.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.35 140.81 37.91 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.852 -0.425 . . . . 2.3100000000000001 109.852 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.07 128.26 3.56 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 124.175 0.922 . . . . 0.83999999999999997 112.488 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.85 7.8 11.38 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.55 -0.75 . . . . 1.04 111.681 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 0.6 OUTLIER -86.08 163.89 17.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.096 0.474 . . . . 2.6200000000000001 111.297 -179.285 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -145.98 135.34 22.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.585 -0.524 . . . . 3.6200000000000001 109.585 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 5.0 mt -101.47 143.37 31.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.848 -0.427 . . . . 0.53000000000000003 109.848 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 124.77 -136.13 9.81 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.693 -0.765 . . . . 1.02 112.34 176.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.441 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 71.6 Cg_endo -75.22 149.54 93.62 Favored 'Cis proline' 0 C--N 1.343 0.267 0 C-N-CA 123.309 -1.538 . . . . 2.1000000000000001 112.645 2.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.461 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 31.0 t . . . . . 0 N--CA 1.443 -0.783 0 N-CA-C 108.662 -0.866 . . . . 2.0 108.662 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 112.768 -0.133 . . . . 1.3 112.768 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 17.3 m -79.3 -28.62 42.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.107 0.48 . . . . 1.8200000000000001 110.447 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.518 ' CB ' HG22 ' A' ' 80' ' ' ILE . 40.5 p-90 -65.03 -17.46 64.46 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.693 -0.685 . . . . 0.69999999999999996 111.33 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 65.3 mt -68.78 -14.18 62.86 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.229 -0.896 . . . . 0.66000000000000003 112.002 -175.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.452 ' HD3' ' C ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -69.69 -13.19 62.18 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.671 0.272 . . . . 1.48 111.189 178.724 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.591 ' CE2' HD11 ' A' ' 86' ' ' LEU . 46.1 m-85 -78.47 -37.83 42.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 1.97 111.924 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.579 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -70.51 125.68 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.638 -0.425 . . . . 0.67000000000000004 110.141 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 173' ' ' ARG . 48.8 mtp85 -117.85 -161.76 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.282 -0.417 . . . . 4.3399999999999999 111.657 -176.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.8 t -72.37 157.62 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.116 -0.493 . . . . 1.0700000000000001 111.213 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.781 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -57.15 153.34 11.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.802 -0.635 . . . . 0.70999999999999996 112.167 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 28.8 p -85.98 -10.72 54.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.333 -0.849 . . . . 1.8799999999999999 110.678 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 34.0 m -153.63 170.87 19.79 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.193 -0.458 . . . . 1.6299999999999999 110.82 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' CYS . . . . . 0.549 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 10.5 p -71.95 -43.09 65.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.154 0.502 . . . . 1.96 110.87 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -78.26 4.02 13.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.404 0.621 . . . . 2.4199999999999999 110.439 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -101.94 16.46 25.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.371 -0.832 . . . . 2.1200000000000001 110.468 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 31.5 mm-40 -67.53 113.89 5.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 1.3500000000000001 111.015 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.785 ' H ' HD12 ' A' ' 183' ' ' LEU . 16.6 t30 -150.94 33.64 0.6 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.253 1.025 . . . . 1.6799999999999999 108.354 173.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.785 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.2 OUTLIER -124.24 123.2 39.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.41 -0.813 . . . . 0.81000000000000005 110.701 -171.646 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 96.0 m -150.8 127.4 10.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.111 0.482 . . . . 0.51000000000000001 110.738 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.555 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 63.6 mtp -114.4 136.05 53.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.951 0.405 . . . . 1.3500000000000001 110.218 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 1.4 p -113.51 137.56 51.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.654 -0.703 . . . . 1.73 110.775 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.08 104.01 13.12 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.796 -0.816 . . . . 1.9299999999999999 108.796 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 27.5 pt -141.56 145.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 1.1100000000000001 110.371 -176.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.2 m 65.13 26.4 12.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 1.8600000000000001 110.897 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 62.76 19.47 11.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.407 -0.815 . . . . 2.8300000000000001 111.28 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -131.7 168.03 18.46 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.481 -0.563 . . . . 1.75 109.481 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.44 ' HB ' ' HB3' ' A' ' 113' ' ' CYS . 48.3 mm -99.89 132.41 45.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.179 0.514 . . . . 1.01 111.903 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -125.02 137.4 54.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.995 -0.548 . . . . 3.9399999999999999 110.747 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 7.3 m-85 -100.94 117.08 34.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.966 -0.561 . . . . 0.92000000000000004 109.725 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -113.01 120.28 40.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.926 0.394 . . . . 1.1100000000000001 110.405 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.43 HG22 HD11 ' A' ' 207' ' ' LEU . 2.0 t -88.01 152.74 3.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.321 -0.622 . . . . 0.69999999999999996 109.321 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.55 -56.18 5.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.09 -0.959 . . . . 0.62 112.105 -166.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.632 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -135.02 175.79 9.25 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.953 -0.567 . . . . 1.3799999999999999 111.379 -173.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.808 ' HA ' ' O ' ' A' ' 104' ' ' MET . 17.0 t70 -50.18 112.54 0.69 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.762 0.791 . . . . 2.23 112.061 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.69 HD11 ' ND2' ' A' ' 182' ' ' ASN . 8.9 mm -79.94 136.22 23.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.633 -1.167 . . . . 0.88 111.117 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.622 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 42.3 mt-10 -88.5 126.96 58.44 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 109.261 -0.644 . . . . 2.0600000000000001 109.261 173.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.51 111.8 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 121.86 1.706 . . . . 0.51000000000000001 111.019 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.04 -6.4 10.23 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.63 -0.795 . . . . 0.69999999999999996 113.175 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 22.2 pt-20 -115.24 121.26 42.39 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.687 0.744 . . . . 1.27 110.636 174.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.456 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -111.72 95.38 5.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.045 -0.525 . . . . 2.9199999999999999 111.549 174.473 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.49 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.8 mm? -122.35 99.72 6.57 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.121 -0.632 . . . . 0.90000000000000002 109.569 174.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.579 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -146.47 113.37 6.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.973 0.509 . . . . 0.53000000000000003 109.83 177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.659 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.1 p -154.87 160.4 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 110.098 -0.334 . . . . 0.91000000000000003 110.098 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.555 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 59.3 t-80 -93.69 109.87 21.51 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.902 -1.147 . . . . 1.55 107.902 171.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 C--N 1.316 -0.868 0 N-CA-C 109.603 -0.517 . . . . 2.5600000000000001 109.603 177.345 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 81.9 mt . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 110.445 -0.205 . . . . 2.4500000000000002 110.445 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -72.12 116.56 4.76 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.322 2.014 . . . . 1.75 111.013 175.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.561 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -125.73 146.31 54.62 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.275 -0.42 . . . . 1.01 110.3 -177.127 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.03 124.45 16.3 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.27 1.98 . . . . 0.72999999999999998 110.406 170.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.21 -8.37 12.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.415 0.524 . . . . 1.04 112.415 -173.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.61 -9.03 31.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.197 0.522 . . . . 1.6599999999999999 111.542 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -134.52 156.75 48.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -121.46 116.15 24.18 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.135 -0.626 . . . . 2.27 111.246 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.406 HD11 ' CE2' ' A' ' 171' ' ' TYR . 8.3 tt -86.41 128.2 34.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.782 -0.451 . . . . 0.79000000000000004 109.782 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -151.12 130.66 13.0 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.48 -0.782 . . . . 3.21 109.682 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -68.21 112.03 4.89 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.367 -0.605 . . . . 2.46 109.367 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.7 t -169.52 110.7 0.46 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.423 -0.584 . . . . 1.5800000000000001 109.423 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 t -90.85 107.77 19.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.21 -0.45 . . . . 1.8600000000000001 110.739 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.58 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -79.11 121.95 83.8 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.35 -0.611 . . . . 1.45 109.35 175.024 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.42 114.93 1.77 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.371 2.714 . . . . 1.6100000000000001 112.988 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.09 -9.83 36.74 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.95 -0.643 . . . . 1.74 112.727 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.58 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -135.76 -60.26 0.74 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.971 0.385 . . . . 1.4099999999999999 111.665 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.431 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 122.76 -146.09 16.5 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.647 -0.787 . . . . 1.0900000000000001 112.716 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 mt -80.4 159.03 25.82 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.254 -0.276 . . . . 2.3100000000000001 110.254 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.414 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -165.03 169.09 39.51 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.802 -0.713 . . . . 0.58999999999999997 111.774 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 27.5 m -98.41 114.21 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.773 0.796 . . . . 0.67000000000000004 109.262 172.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -81.76 101.76 10.34 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.234 -0.893 . . . . 1.1299999999999999 110.663 -167.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.37 115.22 5.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.733 -0.667 . . . . 0.54000000000000004 109.701 175.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.539 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -94.0 15.76 16.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.607 0.717 . . . . 1.6799999999999999 109.515 -177.347 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -148.43 160.83 42.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.562 -1.199 . . . . 3.5 108.144 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.76 158.79 34.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.435 0.636 . . . . 2.3999999999999999 111.453 -174.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 54.0 mtm -134.5 143.71 47.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.98 -1.119 . . . . 1.22 107.98 170.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 52.3 mt-10 -130.28 174.45 9.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.43 . . . . 2.3100000000000001 112.157 -172.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.64 122.48 11.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.495 -0.775 . . . . 0.83999999999999997 113.054 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.18 -25.53 11.28 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 1.04 113.927 169.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 10.1 pt-20 -73.98 160.92 30.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.375 0.607 . . . . 2.6200000000000001 112.007 -174.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.71 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 0.7 OUTLIER -124.9 134.64 52.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.029 -0.987 . . . . 3.6200000000000001 110.474 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mt -87.84 133.52 33.88 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.973 -0.751 . . . . 0.53000000000000003 108.973 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.87 -132.87 5.43 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.487 -0.863 . . . . 1.02 112.433 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.06 134.4 17.97 Favored 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 123.947 -1.272 . . . . 2.1000000000000001 112.881 1.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.486 -0.779 . . . . 2.0 111.642 -175.394 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 120.395 -0.114 . . . . 1.3 112.821 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.52 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 3.5 p -65.99 -24.74 66.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.138 0.494 . . . . 1.8200000000000001 110.774 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -84.22 -17.68 39.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.019 -0.537 . . . . 0.69999999999999996 110.544 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.7 -14.13 58.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.993 -0.549 . . . . 0.66000000000000003 111.442 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 167' ' ' SER . 21.2 ptmt -64.66 -18.98 65.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.927 0.394 . . . . 1.48 110.5 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.414 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 53.6 m-85 -72.53 -37.57 68.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.92 -0.582 . . . . 1.97 111.621 -175.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -73.97 117.73 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.513 0.673 . . . . 0.67000000000000004 110.855 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 -172.05 2.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.891 -1.05 . . . . 4.3399999999999999 110.3 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.517 ' HA ' HD22 ' A' ' 183' ' ' LEU . 2.3 p -65.2 147.03 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.345 0.593 . . . . 1.0700000000000001 111.781 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.593 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -59.15 149.45 28.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.611 -1.177 . . . . 0.70999999999999996 112.599 -174.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 53.7 t -60.32 -44.43 95.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.117 -0.947 . . . . 1.8799999999999999 110.828 175.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 87.1 p -137.75 164.64 28.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.72 -0.474 . . . . 1.6299999999999999 109.72 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' CYS . . . . . 0.478 ' HA ' ' OE1' ' A' ' 181' ' ' GLN . 75.8 m -78.4 4.36 13.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 1.96 111.849 -176.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -89.06 -7.34 56.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.2 0.524 . . . . 2.4199999999999999 109.647 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.529 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . 23.6 m-20 -109.04 15.59 23.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.566 -0.743 . . . . 2.1200000000000001 110.813 -176.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.478 ' OE1' ' HA ' ' A' ' 178' ' ' CYS . 15.0 mm100 -66.52 115.7 6.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.572 0.701 . . . . 1.3500000000000001 111.746 -172.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.748 ' H ' HD12 ' A' ' 183' ' ' LEU . 14.1 t30 -165.03 39.74 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.682 -1.229 . . . . 1.6799999999999999 107.682 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.748 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.7 OUTLIER -122.05 119.87 32.67 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.522 -0.763 . . . . 0.81000000000000005 111.301 -170.422 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.5 m -150.93 121.82 7.6 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.241 0.543 . . . . 0.51000000000000001 111.884 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.575 ' HB3' ' HB2' ' A' ' 209' ' ' HIS . 10.8 ttm -111.51 129.3 56.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.273 -0.64 . . . . 1.3500000000000001 109.273 172.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 49.9 t -115.31 155.79 26.66 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.733 0.301 . . . . 1.73 110.266 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -116.01 112.39 21.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.291 -0.633 . . . . 1.9299999999999999 109.291 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.517 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 41.5 pt -138.54 143.17 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.46 -0.336 . . . . 1.1100000000000001 110.675 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.9 t 55.86 37.86 29.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 1.8600000000000001 111.639 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 60.47 28.43 18.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.824 -0.625 . . . . 2.8300000000000001 111.712 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 12.9 pt20 -145.11 156.22 43.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.859 0.361 . . . . 1.75 110.49 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.6 mm -82.25 134.79 26.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.191 0.52 . . . . 1.01 111.264 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -124.64 122.3 37.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.669 -0.696 . . . . 3.9399999999999999 109.665 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.71 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 26.4 m-85 -99.37 113.69 26.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.095 -0.705 . . . . 0.92000000000000004 109.095 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -111.25 127.1 55.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.351 -0.386 . . . . 1.1100000000000001 110.375 -172.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.466 HG23 ' HG3' ' A' ' 108' ' ' GLU . 1.5 t -95.19 150.73 4.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.91 0.862 . . . . 0.69999999999999996 110.248 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.6 mm -100.22 -53.67 7.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.841 -1.527 . . . . 0.62 111.618 -163.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.422 ' C ' ' HE3' ' A' ' 198' ' ' LYS . 0.0 OUTLIER -153.3 -178.89 7.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.065 -0.97 . . . . 1.3799999999999999 110.799 -179.409 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 104' ' ' MET . 9.6 p-10 -52.85 110.96 0.58 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.992 0.808 . . . . 2.23 112.673 -172.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 200' ' ' ILE . 2.6 mm -80.89 134.47 27.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.693 -0.685 . . . . 0.88 110.349 171.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 12.5 mm-40 -81.67 120.56 78.16 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.548 -0.751 . . . . 2.0600000000000001 109.559 173.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.51 115.43 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.145 2.564 . . . . 0.51000000000000001 112.358 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.27 -11.49 9.18 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.71 -0.757 . . . . 0.69999999999999996 113.076 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 13.0 pt-20 -123.46 125.59 45.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.78 0.79 . . . . 1.27 111.613 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -108.96 99.88 9.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.529 -1.214 . . . . 2.9199999999999999 112.069 -175.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.552 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.1 mm? -122.55 100.38 6.9 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.492 -0.483 . . . . 0.90000000000000002 110.473 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.53 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.0 mm? -145.61 113.67 6.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.816 0.446 . . . . 0.53000000000000003 110.303 174.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.691 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.9 p -155.83 161.79 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 O-C-N 122.164 -0.335 . . . . 0.91000000000000003 110.41 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.575 ' HB2' ' HB3' ' A' ' 185' ' ' MET . 33.0 t-80 -131.44 109.89 10.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.189 -0.671 . . . . 1.55 109.189 161.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 121.186 0.517 . . . . 2.5600000000000001 109.746 174.519 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.492 0.186 . . . . 2.4500000000000002 110.745 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.95 116.57 4.44 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.323 2.015 . . . . 1.75 111.867 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.545 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -118.43 134.81 23.42 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.199 -0.455 . . . . 1.01 109.933 178.682 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.52 146.9 50.54 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.584 2.189 . . . . 0.72999999999999998 111.936 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.25 6.89 3.89 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.268 0.84 . . . . 1.04 113.268 -168.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -116.97 5.91 12.93 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.798 -0.564 . . . . 1.6599999999999999 112.102 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.581 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 10.6 m-85 -130.47 138.35 50.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.66 -0.867 . . . . 1.0 108.66 176.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.481 ' HB2' ' HD2' ' A' ' 101' ' ' LYS . 1.2 tp10 -108.52 117.42 34.13 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.759 -0.376 . . . . 2.27 110.37 -174.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.439 ' HA ' HG12 ' A' ' 98' ' ' VAL . 6.6 tt -84.13 126.85 33.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.955 -0.758 . . . . 0.79000000000000004 108.955 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.425 ' N ' HD23 ' A' ' 86' ' ' LEU . 78.5 mtp180 -149.52 119.02 6.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.622 -0.717 . . . . 3.21 110.74 -173.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -73.47 112.24 9.37 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.997 -0.742 . . . . 2.46 108.997 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.4 p -155.16 158.7 39.36 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.674 -0.694 . . . . 1.5800000000000001 109.355 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.1 m -99.47 103.14 14.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.837 -0.431 . . . . 1.8600000000000001 109.837 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.04 111.38 62.09 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.194 -0.457 . . . . 1.45 109.94 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -58.42 125.2 17.7 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.034 2.49 . . . . 1.6100000000000001 112.92 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.76 -13.3 38.54 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.889 -0.672 . . . . 1.74 112.136 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -136.27 -54.83 0.75 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.125 0.488 . . . . 1.4099999999999999 110.631 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.78 -94.65 0.5 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.319 -0.855 . . . . 1.0900000000000001 111.213 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 171' ' ' TYR . 0.5 OUTLIER -108.99 160.52 15.95 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.805 -0.698 . . . . 2.3100000000000001 109.626 172.196 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -170.39 165.63 38.89 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.079 -1.057 . . . . 0.58999999999999997 112.997 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 15.9 m -106.7 147.17 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.825 -0.435 . . . . 0.67000000000000004 109.825 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -109.2 117.21 33.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.533 -0.303 . . . . 1.1299999999999999 110.617 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 202' ' ' PRO . . . -67.46 128.65 37.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.525 -0.307 . . . . 0.54000000000000004 110.173 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.481 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -99.54 -9.07 23.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 1.6799999999999999 111.249 -176.858 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 103' ' ' LYS . 20.9 tpt180 -125.85 150.3 47.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.208 0.528 . . . . 3.5 111.448 -176.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.471 ' N ' ' HG3' ' A' ' 102' ' ' ARG . 1.5 tptm -61.32 138.45 58.24 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.866 -1.061 . . . . 2.3999999999999999 111.061 173.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.513 ' HE3' HG13 ' A' ' 200' ' ' ILE . 77.5 mtm -127.86 152.61 47.61 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.607 -0.886 . . . . 1.22 108.607 173.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.7 135.16 54.46 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 123.232 0.332 . . . . 2.3100000000000001 110.563 -174.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.415 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . . . -37.79 112.7 0.23 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 124.872 1.357 . . . . 0.83999999999999997 112.803 -174.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.95 7.26 11.75 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.581 -0.736 . . . . 1.04 111.341 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.464 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -75.37 165.91 24.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.907 0.384 . . . . 2.6200000000000001 110.398 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.461 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 2.4 tmm_? -145.61 131.65 19.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.37 -0.377 . . . . 3.6200000000000001 111.063 -176.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.581 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 4.8 mt -99.48 137.11 38.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.058 -0.719 . . . . 0.53000000000000003 109.058 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.85 -168.21 31.15 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.314 -0.946 . . . . 1.02 112.438 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.45 146.11 86.0 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.736 -1.36 . . . . 2.1000000000000001 112.395 1.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 2.0 110.691 -178.902 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.282 0 N-CA-C 112.913 -0.075 . . . . 1.3 112.913 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 5.7 m -66.22 -23.83 66.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.965 0.412 . . . . 1.8200000000000001 110.352 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.449 ' O ' ' HB2' ' A' ' 171' ' ' TYR . 48.5 p-90 -86.0 -24.82 26.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.929 -0.578 . . . . 0.69999999999999996 110.548 176.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 26.5 mt -76.89 -25.83 53.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.66000000000000003 111.189 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.502 ' HE2' ' CE2' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -72.25 -1.57 15.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.049 0.452 . . . . 1.48 110.447 176.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.502 ' CE2' ' HE2' ' A' ' 170' ' ' LYS . 17.8 m-85 -82.2 -38.19 24.95 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.178 -0.464 . . . . 1.97 111.128 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -73.27 111.77 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.421 -0.511 . . . . 0.67000000000000004 109.654 177.382 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.459 ' O ' ' HB ' ' A' ' 208' ' ' VAL . 3.3 mmp_? -114.22 -155.02 0.56 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.936 -0.574 . . . . 4.3399999999999999 110.975 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 39.4 t -61.83 148.67 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 1.0700000000000001 111.552 -173.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.408 ' HB2' ' CD1' ' A' ' 183' ' ' LEU . . . -50.84 121.91 6.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.026 -0.988 . . . . 0.70999999999999996 112.405 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 2.4 p -73.82 -9.74 58.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.573 -0.739 . . . . 1.8799999999999999 110.686 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.3 t -148.19 138.28 22.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.637 -0.71 . . . . 1.6299999999999999 109.562 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' CYS . . . . . 0.632 ' HA ' ' OE1' ' A' ' 181' ' ' GLN . 8.5 p -86.22 -13.99 45.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.211 0.529 . . . . 1.96 111.027 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.67 -8.69 51.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.018 -0.537 . . . . 2.4199999999999999 110.319 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -110.81 19.61 18.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.557 -0.747 . . . . 2.1200000000000001 111.859 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.632 ' OE1' ' HA ' ' A' ' 178' ' ' CYS . 15.1 mm100 -52.89 116.07 2.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.508 0.671 . . . . 1.3500000000000001 111.958 -173.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.767 ' ND2' HD11 ' A' ' 200' ' ' ILE . 28.7 t30 -152.94 37.05 0.49 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.097 -0.956 . . . . 1.6799999999999999 108.787 177.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.725 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -117.85 121.08 39.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.545 -0.752 . . . . 0.81000000000000005 111.027 -173.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 84.1 m -150.08 146.71 27.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.89 0.376 . . . . 0.51000000000000001 110.938 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.485 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 51.7 tpp -109.88 145.85 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 1.3500000000000001 110.093 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 8.4 m -132.05 140.05 48.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.198 0.523 . . . . 1.73 111.187 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.418 ' HG2' HD13 ' A' ' 192' ' ' ILE . 0.5 OUTLIER -116.44 104.47 11.48 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.953 -0.758 . . . . 1.9299999999999999 108.953 177.765 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 21.7 pt -141.04 145.45 25.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.019 -0.537 . . . . 1.1100000000000001 110.457 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.5 m 67.73 30.67 6.3 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.193 0.521 . . . . 1.8600000000000001 110.916 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 62.13 22.24 12.99 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.089 -0.959 . . . . 2.8300000000000001 111.926 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 193' ' ' TYR . 4.2 pt20 -141.05 167.28 22.56 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.16 -0.473 . . . . 1.75 109.8 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.418 HD13 ' HG2' ' A' ' 187' ' ' GLN . 43.5 mm -92.73 137.03 23.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.279 -0.418 . . . . 1.01 110.72 -175.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.461 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 27.8 m-85 -135.85 150.54 49.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.317 0.579 . . . . 3.9399999999999999 111.508 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 6.6 m-85 -100.71 113.72 26.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.364 -0.835 . . . . 0.92000000000000004 109.588 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.09 122.74 47.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.947 0.403 . . . . 1.1100000000000001 110.195 -176.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.47 ' CG1' HD21 ' A' ' 182' ' ' ASN . 1.9 t -94.41 152.5 3.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.775 0.798 . . . . 0.69999999999999996 109.96 -177.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.2 -54.5 7.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.606 -1.179 . . . . 0.62 111.395 -166.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.588 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -135.05 168.17 19.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.847 -0.615 . . . . 1.3799999999999999 111.336 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 104' ' ' MET . 2.0 m-20 -46.36 125.87 7.3 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.143 0.902 . . . . 2.23 112.531 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.767 HD11 ' ND2' ' A' ' 182' ' ' ASN . 27.6 mm -94.4 134.95 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.72 -0.673 . . . . 0.88 111.319 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 50.6 mt-10 -105.35 125.79 32.58 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.481 -0.781 . . . . 2.0600000000000001 109.518 174.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 87.8 Cg_exo -41.52 113.47 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.816 3.011 . . . . 0.51000000000000001 113.551 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 120.43 6.37 9.72 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.815 -0.707 . . . . 0.69999999999999996 113.054 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.7 pt-20 -118.26 123.8 46.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.193 0.497 . . . . 1.27 110.694 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.5 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -109.51 91.17 3.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.919 -0.582 . . . . 2.9199999999999999 111.278 176.63 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.579 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 2.3 mm? -125.98 95.0 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.388 -0.525 . . . . 0.90000000000000002 110.076 172.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.514 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.7 mm? -148.63 113.9 5.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.857 0.463 . . . . 0.53000000000000003 109.883 172.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.656 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.7 p -156.65 159.41 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.676 0.671 . . . . 0.91000000000000003 111.421 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 86.6 t60 -106.56 111.98 24.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.313 -0.625 . . . . 1.55 109.313 164.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 C--N 1.321 -0.668 0 N-CA-C 109.869 -0.419 . . . . 2.5600000000000001 109.869 173.964 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.7 mt . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 109.008 -0.738 . . . . 2.4500000000000002 109.008 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.11 122.05 11.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.606 2.204 . . . . 1.75 112.323 -176.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.499 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.46 142.65 45.99 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.875 -0.602 . . . . 1.01 109.979 178.624 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.95 142.69 19.21 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.388 2.725 . . . . 0.72999999999999998 112.686 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.67 -16.32 47.75 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.581 -0.736 . . . . 1.04 112.251 -175.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -68.43 -23.09 64.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.958 -0.565 . . . . 1.6599999999999999 110.557 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -120.9 161.86 20.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.223 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.59 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 33.5 tt0 -139.15 130.53 26.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.814 -0.354 . . . . 2.27 110.922 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 171' ' ' TYR . 5.2 tt -85.68 127.74 34.58 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.351 0.596 . . . . 0.79000000000000004 110.484 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -148.76 140.59 23.71 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.127 -0.942 . . . . 3.21 110.031 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -82.79 112.25 19.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.04 0.447 . . . . 2.46 109.88 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.5 m -156.23 94.99 1.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.982 -0.748 . . . . 1.5800000000000001 108.982 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.9 t -62.05 105.85 0.64 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.128 0.489 . . . . 1.8600000000000001 111.474 -174.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.452 HG21 ' HD3' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -99.56 117.25 64.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.018 -0.734 . . . . 1.45 109.018 172.772 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.77 121.71 9.7 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.152 2.568 . . . . 1.6100000000000001 112.741 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.11 -15.39 36.55 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.804 -0.712 . . . . 1.74 112.338 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.446 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -133.91 -59.78 0.83 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.966 0.412 . . . . 1.4099999999999999 111.299 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.73 -116.09 3.0 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.773 -0.727 . . . . 1.0900000000000001 112.216 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.29 158.43 16.12 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 122.455 0.302 . . . . 2.3100000000000001 110.766 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 171' ' ' TYR . . . -151.26 172.25 30.83 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.313 -0.946 . . . . 0.58999999999999997 113.465 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 205' ' ' GLU . 14.3 m -117.64 111.19 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.399 0.619 . . . . 0.67000000000000004 109.718 175.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -82.69 126.74 32.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.749 -0.66 . . . . 1.1299999999999999 111.383 -170.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.31 114.74 9.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.394 -0.595 . . . . 0.54000000000000004 109.394 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.59 ' CE ' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -94.58 0.46 55.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.002 -0.74 . . . . 1.6799999999999999 109.002 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -124.66 157.53 35.33 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.675 -1.148 . . . . 3.5 108.831 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.613 ' H ' ' HD2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -90.28 155.1 19.23 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.671 -0.492 . . . . 2.3999999999999999 109.671 -177.16 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.439 ' HE3' HG13 ' A' ' 200' ' ' ILE . 60.3 mtm -135.43 148.44 49.3 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.549 -0.908 . . . . 1.22 108.549 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.87 146.99 39.22 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.995 -0.282 . . . . 2.3100000000000001 110.623 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.26 121.81 2.0 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 124.301 1.001 . . . . 0.83999999999999997 113.024 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.59 7.49 11.99 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.367 -0.833 . . . . 1.04 111.318 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.599 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.9 OUTLIER -79.78 156.2 27.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.264 0.554 . . . . 2.6200000000000001 110.799 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.525 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 7.3 tmm_? -145.49 135.89 24.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.685 -0.689 . . . . 3.6200000000000001 110.355 -176.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 6.2 mt -101.1 151.38 21.89 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.82 -0.437 . . . . 0.53000000000000003 109.82 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.14 -174.01 44.8 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.609 -0.597 . . . . 1.02 111.609 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -83.02 141.37 42.75 Favored 'Cis proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.982 -1.674 . . . . 2.1000000000000001 112.44 -2.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 121.604 0.716 . . . . 2.0 109.513 175.648 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.37 0 N-CA-C 113.302 0.081 . . . . 1.3 113.302 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.4 t -71.39 -14.42 62.17 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.547 0.203 . . . . 1.8200000000000001 111.547 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.416 ' HB2' HG22 ' A' ' 80' ' ' ILE . 48.5 p-90 -56.94 -23.46 45.59 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.027 0.441 . . . . 0.69999999999999996 111.734 -176.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 32.1 mt -73.45 -12.83 60.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.241 0.46 . . . . 0.66000000000000003 112.241 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.431 ' C ' ' HD2' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -66.12 -14.37 61.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.012 0.434 . . . . 1.48 110.155 177.289 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.524 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 41.5 m-85 -72.61 -31.43 65.16 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 115.782 -0.644 . . . . 1.97 111.887 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.775 HG21 ' HB2' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -66.28 116.37 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.317 -0.553 . . . . 0.67000000000000004 110.175 -177.268 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.452 ' HD3' HG21 ' A' ' 91' ' ' ILE . 18.0 ptt180 -75.83 155.79 35.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.573 -0.74 . . . . 4.3399999999999999 111.83 -174.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.607 ' HB ' HG11 ' A' ' 208' ' ' VAL . 2.7 p -83.82 147.01 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.371 -0.831 . . . . 1.0700000000000001 109.352 172.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -45.88 123.72 4.71 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 123.933 0.771 . . . . 0.70999999999999996 112.391 -174.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 51.8 t -80.42 -9.43 59.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 1.8799999999999999 109.504 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 13.0 t -126.27 138.43 53.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.166 -0.924 . . . . 1.6299999999999999 109.21 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 61.3 m -77.48 -15.88 59.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.876 0.37 . . . . 1.96 111.093 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -89.68 0.62 56.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.016 0.436 . . . . 2.4199999999999999 110.578 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.18 17.88 21.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.865 -0.607 . . . . 2.1200000000000001 111.619 -172.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -59.16 113.5 2.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.126 0.489 . . . . 1.3500000000000001 111.04 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.815 ' H ' HD12 ' A' ' 183' ' ' LEU . 62.4 t30 -146.64 29.28 1.03 Allowed 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.845 -0.798 . . . . 1.6799999999999999 108.845 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.815 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.4 OUTLIER -118.76 121.59 40.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.687 -0.688 . . . . 0.81000000000000005 111.113 -170.659 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.6 m -150.2 133.46 16.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.282 0.563 . . . . 0.51000000000000001 111.518 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 46.6 ttm -100.14 135.09 42.11 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.146 -0.687 . . . . 1.3500000000000001 109.146 174.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 15.2 m -117.84 131.69 56.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.181 0.515 . . . . 1.73 111.575 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.46 103.63 14.03 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.28 -1.007 . . . . 1.9299999999999999 108.28 174.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 22.8 pt -138.4 144.18 30.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.734 -0.666 . . . . 1.1100000000000001 109.839 -177.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 m 61.27 28.75 18.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.213 0.53 . . . . 1.8600000000000001 110.318 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 56.2 34.86 24.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.121 -0.945 . . . . 2.8300000000000001 111.789 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -142.06 157.64 44.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.626 -0.716 . . . . 1.75 109.619 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.6 mm -94.56 131.32 41.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.301 -0.409 . . . . 1.01 111.264 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.525 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 27.0 m-85 -131.98 157.47 43.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.935 -0.575 . . . . 3.9399999999999999 111.148 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 3.3 m-85 -101.3 113.68 26.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.956 -0.757 . . . . 0.92000000000000004 108.956 173.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -110.22 125.62 53.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.936 0.398 . . . . 1.1100000000000001 110.012 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.599 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 1.9 t -96.57 151.44 4.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.747 0.784 . . . . 0.69999999999999996 110.202 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 197' ' ' ILE . 0.9 OUTLIER -92.64 -53.8 8.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.543 -1.208 . . . . 0.62 110.591 -167.288 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.504 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -132.0 171.12 13.99 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.085 -0.961 . . . . 1.3799999999999999 110.678 175.638 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -53.9 143.84 20.37 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.87 0.693 . . . . 2.23 112.87 -171.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.439 HG13 ' HE3' ' A' ' 104' ' ' MET . 31.4 mm -99.85 133.46 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.594 -0.73 . . . . 0.88 110.387 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -95.13 131.36 30.2 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 109.372 -0.603 . . . . 2.0600000000000001 109.372 173.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -50.95 116.2 2.49 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.605 2.203 . . . . 0.51000000000000001 112.042 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 123.26 -12.86 8.44 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.666 -0.778 . . . . 0.69999999999999996 112.948 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.68 119.17 21.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.607 0.703 . . . . 1.27 111.032 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -113.05 96.72 6.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.283 -0.871 . . . . 2.9199999999999999 111.484 177.177 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.474 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.1 mm? -114.14 99.07 7.35 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.52 -0.872 . . . . 0.90000000000000002 110.524 177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.775 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.5 mm? -147.19 112.39 5.51 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.327 0.651 . . . . 0.53000000000000003 109.502 174.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.695 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 2.6 p -156.64 161.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.392 -0.595 . . . . 0.91000000000000003 109.392 -177.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -123.31 105.71 10.08 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.002 -0.74 . . . . 1.55 109.002 162.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 109.277 -0.638 . . . . 2.5600000000000001 109.277 173.448 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 110.335 -0.246 . . . . 2.4500000000000002 110.335 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.17 116.47 4.19 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.287 1.992 . . . . 1.75 111.695 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.531 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -122.03 151.56 58.48 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.051 -0.522 . . . . 1.01 110.292 -178.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 82.7 Cg_exo -48.31 134.37 25.41 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.195 2.596 . . . . 0.72999999999999998 112.441 175.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.69 -20.94 66.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.51 -0.768 . . . . 1.04 112.225 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -68.62 -8.26 40.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.442 0.534 . . . . 1.6599999999999999 112.442 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.438 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 7.4 m-85 -139.93 152.39 46.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' A' ' 87' ' ' ARG . 35.0 mt-10 -113.63 126.68 55.53 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.782 -0.367 . . . . 2.27 111.544 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.02 127.68 34.7 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.774 -0.824 . . . . 0.79000000000000004 108.774 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' A' ' 85' ' ' GLU . 99.7 mtt180 -144.22 147.14 33.22 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.651 -0.704 . . . . 3.21 109.848 -174.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -82.3 112.3 19.16 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.862 -0.792 . . . . 2.46 108.862 172.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 23.3 t -164.9 140.78 5.62 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.366 -0.605 . . . . 1.5800000000000001 109.366 -176.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 m -99.34 107.32 19.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.8 0.333 . . . . 1.8600000000000001 110.692 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -105.9 120.46 48.99 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.427 -0.583 . . . . 1.45 109.427 175.245 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 91' ' ' ILE . 50.7 Cg_exo -56.02 123.31 13.53 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.031 2.487 . . . . 1.6100000000000001 113.312 -176.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.75 -26.82 14.68 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.95 -0.643 . . . . 1.74 112.394 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.441 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -117.55 -57.96 2.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.212 0.53 . . . . 1.4099999999999999 110.604 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.06 -120.13 4.13 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 111.199 -0.761 . . . . 1.0900000000000001 111.199 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -87.17 127.81 35.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.387 -0.598 . . . . 2.3100000000000001 109.387 173.048 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -129.2 157.47 21.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.295 -0.955 . . . . 0.58999999999999997 113.053 -172.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 98' ' ' VAL . 35.6 m -97.52 114.61 35.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.597 0.713 . . . . 0.67000000000000004 109.259 173.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -82.19 115.4 21.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.738 -0.665 . . . . 1.1299999999999999 110.812 -170.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.57 114.78 12.2 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.331 -0.849 . . . . 0.54000000000000004 109.981 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.424 ' CD ' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -95.09 8.58 42.54 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.975 0.893 . . . . 1.6799999999999999 109.052 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 50.5 ttp85 -125.66 153.42 43.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.168 -1.378 . . . . 3.5 108.111 172.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.715 ' HB2' ' O ' ' A' ' 200' ' ' ILE . 0.0 OUTLIER -87.32 126.52 34.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.589 0.709 . . . . 2.3999999999999999 109.475 -179.513 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.708 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 25.8 mtm -94.57 138.92 31.86 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.483 -0.562 . . . . 1.22 109.483 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 10.9 pt-20 -120.34 175.14 6.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.976 0.417 . . . . 2.3100000000000001 111.945 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.57 125.65 17.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 0.83999999999999997 112.955 -175.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.27 -14.74 62.12 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.91 -0.662 . . . . 1.04 114.274 168.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 6.7 pt-20 -78.3 158.62 28.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.79 0.795 . . . . 2.6200000000000001 111.109 -176.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.664 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 8.5 ttm180 -119.59 143.86 47.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.471 -0.786 . . . . 3.6200000000000001 110.654 -176.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.438 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 3.9 mt -101.34 146.99 26.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.247 -0.649 . . . . 0.53000000000000003 109.247 172.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.83 -127.82 7.74 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.45 -0.881 . . . . 1.02 112.892 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.01 158.63 69.17 Favored 'Cis proline' 0 N--CA 1.477 0.55 0 C-N-CA 123.622 -1.408 . . . . 2.1000000000000001 112.854 1.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.059 -0.519 . . . . 2.0 110.838 -177.01 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.575 0 N-CA-C 112.063 -0.415 . . . . 1.3 112.063 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 16.0 m -56.19 -41.35 75.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.383 0.273 . . . . 1.8200000000000001 111.442 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.408 ' CZ2' ' HG2' ' A' ' 81' ' ' PRO . 27.4 p-90 -87.45 -22.04 25.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.846 0.355 . . . . 0.69999999999999996 111.382 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.488 HD23 HD11 ' A' ' 172' ' ' ILE . 38.9 mt -85.61 -14.87 44.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.746 0.276 . . . . 0.66000000000000003 111.746 -176.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.1 OUTLIER -75.29 -4.67 40.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 1.48 110.224 174.896 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.522 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 29.4 m-85 -77.43 -38.44 49.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.528 -0.76 . . . . 1.97 110.64 177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -81.45 117.48 27.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.145 0.497 . . . . 0.67000000000000004 110.552 178.765 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 173' ' ' ARG . 43.1 mmt-85 -131.09 -161.8 1.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.627 -0.715 . . . . 4.3399999999999999 110.825 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.47 ' HA ' HG11 ' A' ' 208' ' ' VAL . 6.2 t -62.49 139.65 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.286 0.565 . . . . 1.0700000000000001 111.97 -168.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.563 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -71.7 164.82 25.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.154 -0.93 . . . . 0.70999999999999996 111.276 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 47.4 t -92.45 -21.28 20.27 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.298 -0.864 . . . . 1.8799999999999999 112.054 -169.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.3 m -143.16 -179.74 6.56 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.422 0.527 . . . . 1.6299999999999999 112.422 -174.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 6.3 p -74.49 -53.03 10.28 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.117 0.414 . . . . 1.96 112.117 -175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.15 -12.9 61.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.817 0.817 . . . . 2.4199999999999999 109.468 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.476 ' O ' ' HG ' ' A' ' 206' ' ' LEU . 28.5 t0 -80.54 -1.58 42.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.326 -1.307 . . . . 2.1200000000000001 110.192 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -73.22 116.52 13.85 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.164 0.507 . . . . 1.3500000000000001 111.572 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.543 ' H ' HD12 ' A' ' 183' ' ' LEU . 16.8 t30 -156.1 38.8 0.35 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.02 -1.104 . . . . 1.6799999999999999 108.02 173.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.666 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.1 OUTLIER -124.55 124.76 42.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.442 -0.799 . . . . 0.81000000000000005 111.233 -172.348 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 99.8 m -150.9 133.86 15.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.51000000000000001 110.86 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.453 ' HB3' ' HB2' ' A' ' 209' ' ' HIS . 37.3 ttm -127.53 136.29 51.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.009 -0.541 . . . . 1.3500000000000001 109.548 176.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 9.0 p -130.21 165.64 21.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.799 0.333 . . . . 1.73 110.41 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.79 104.98 11.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.189 -0.671 . . . . 1.9299999999999999 109.189 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.519 HD11 ' CD2' ' A' ' 193' ' ' TYR . 43.9 pt -135.53 145.16 32.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 1.1100000000000001 110.712 -175.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.8 m 62.06 28.76 17.39 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.36 0.413 . . . . 1.8600000000000001 111.449 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 66.94 21.75 10.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.579 -0.737 . . . . 2.8300000000000001 111.791 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -133.48 166.43 22.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.379 . . . . 1.75 110.421 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.6 mm -88.2 130.06 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.922 -0.581 . . . . 1.01 109.752 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.519 ' CD2' HD11 ' A' ' 188' ' ' ILE . 35.2 t80 -120.56 124.44 45.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 3.9399999999999999 110.881 -173.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 7.4 m-85 -99.94 113.69 26.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.562 -0.903 . . . . 0.92000000000000004 108.562 174.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -110.81 124.91 52.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.234 -0.284 . . . . 1.1100000000000001 110.234 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 104' ' ' MET . 1.6 t -91.86 150.57 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.924 0.869 . . . . 0.69999999999999996 110.53 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.66 -54.57 6.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 113.964 -1.471 . . . . 0.62 111.565 -163.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.508 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -146.21 169.77 18.1 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.849 -1.069 . . . . 1.3799999999999999 109.576 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.708 ' HA ' ' O ' ' A' ' 104' ' ' MET . 4.0 m-20 -61.83 110.9 1.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.355 0.597 . . . . 2.23 111.973 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.715 ' O ' ' HB2' ' A' ' 103' ' ' LYS . 3.8 mm -69.05 148.0 11.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.032 -0.985 . . . . 0.88 110.545 175.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 52.6 mt-10 -89.0 117.57 68.39 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 108.646 -0.872 . . . . 2.0600000000000001 108.646 170.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.12 117.79 2.43 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.87 2.38 . . . . 0.51000000000000001 112.323 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.98 2.68 10.17 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.762 -0.732 . . . . 0.69999999999999996 112.805 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 11.7 pt-20 -140.48 126.42 19.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.32 0.581 . . . . 1.27 110.505 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.44 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -108.7 105.27 14.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.657 -0.702 . . . . 2.9199999999999999 111.839 -177.507 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.594 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.9 mm? -122.87 99.81 6.58 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.576 -0.45 . . . . 0.90000000000000002 110.206 175.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.94 113.39 6.29 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.89 0.476 . . . . 0.53000000000000003 109.763 175.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.666 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.6 p -155.93 160.87 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 122.07 -0.394 . . . . 0.91000000000000003 110.58 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 185' ' ' MET . 43.5 t-80 -81.87 112.4 18.96 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.793 -1.558 . . . . 1.55 106.793 165.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.6 m . . . . . 0 C--N 1.315 -0.926 0 CA-C-O 122.064 0.935 . . . . 2.5600000000000001 110.469 -178.737 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 88.7 mt . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 110.559 -0.163 . . . . 2.4500000000000002 110.559 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.98 116.88 3.61 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.756 2.304 . . . . 1.75 112.067 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.634 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -118.3 147.05 40.87 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.042 -0.526 . . . . 1.01 109.781 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.52 133.97 61.19 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.15 1.9 . . . . 0.72999999999999998 110.527 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.5 -16.5 15.65 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.569 0.543 . . . . 1.04 112.44 -174.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.9 -24.53 66.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.194 0.521 . . . . 1.6599999999999999 110.309 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 59.7 m-85 -121.76 177.38 5.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.69 -0.687 . . . . 1.0 109.395 178.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.495 ' OE2' ' HD3' ' A' ' 87' ' ' ARG . 33.1 tt0 -154.93 131.72 10.73 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.723 -0.391 . . . . 2.27 110.732 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tt -84.5 131.14 34.68 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.726 -0.842 . . . . 0.79000000000000004 108.726 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.495 ' HD3' ' OE2' ' A' ' 85' ' ' GLU . 14.4 mmm-85 -138.35 142.9 39.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.084 -0.507 . . . . 3.21 110.94 -173.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.72 110.21 12.37 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.364 -0.976 . . . . 2.46 108.364 171.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 p -168.99 94.58 0.32 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.874 -0.603 . . . . 1.5800000000000001 110.01 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -81.64 104.68 12.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.203 -0.453 . . . . 1.8600000000000001 111.016 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.503 HD12 ' SG ' ' A' ' 176' ' ' CYS . 0.0 OUTLIER -104.51 119.44 53.77 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.985 -0.552 . . . . 1.45 109.586 176.887 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -52.16 124.61 15.24 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.464 2.776 . . . . 1.6100000000000001 113.12 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.7 -29.46 9.86 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.709 -0.678 . . . . 1.74 112.046 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.533 ' O ' ' HD2' ' A' ' 173' ' ' ARG . . . -118.4 -66.89 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.816 0.341 . . . . 1.4099999999999999 111.242 177.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.94 -145.93 17.83 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.523 -0.631 . . . . 1.0900000000000001 111.523 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mt -91.67 118.27 30.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.877 0.338 . . . . 2.3100000000000001 110.254 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -129.6 -179.36 15.94 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.881 -0.676 . . . . 0.58999999999999997 111.485 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.7 m -92.44 147.47 5.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.911 -0.774 . . . . 0.67000000000000004 108.911 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -116.17 118.42 32.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.756 0.312 . . . . 1.1299999999999999 110.544 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.45 ' H ' ' HG2' ' A' ' 205' ' ' GLU . . . -69.08 120.27 14.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.174 -0.466 . . . . 0.54000000000000004 110.033 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.579 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -89.15 15.5 8.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.587 0.708 . . . . 1.6799999999999999 110.063 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 32.7 ttp85 -141.66 158.49 43.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.092 -0.958 . . . . 3.5 108.423 176.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.622 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -82.61 158.98 22.82 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.953 0.406 . . . . 2.3999999999999999 110.633 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.664 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 58.4 mtm -133.27 151.1 51.89 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.381 -0.6 . . . . 1.22 109.381 176.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -114.74 138.42 50.75 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 123.338 0.399 . . . . 2.3100000000000001 110.745 -176.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . . . -37.24 122.05 0.86 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.783 1.302 . . . . 0.83999999999999997 113.742 -171.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.66 7.16 12.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.928 -0.653 . . . . 1.04 112.141 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.473 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.6 OUTLIER -84.26 159.46 20.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.058 0.456 . . . . 2.6200000000000001 110.744 -178.123 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.62 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 7.0 tmm_? -146.1 136.09 23.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 3.6200000000000001 110.715 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.408 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 6.6 mt -93.22 142.25 27.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.555 -0.535 . . . . 0.53000000000000003 109.555 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.17 171.59 44.43 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.675 -0.774 . . . . 1.02 111.904 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.2 137.94 46.25 Favored 'Cis proline' 0 C--N 1.345 0.382 0 C-N-CA 123.722 -1.366 . . . . 2.1000000000000001 112.151 -0.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.786 ' SG ' ' HA ' ' A' ' 193' ' ' TYR . 13.3 m . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 2.0 111.429 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.448 0 N-CA-C 111.69 -0.564 . . . . 1.3 111.69 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.659 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 31.4 t -76.54 -20.24 57.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.16 0.505 . . . . 1.8200000000000001 111.053 -175.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.416 ' CB ' HG22 ' A' ' 80' ' ' ILE . 42.4 p-90 -69.33 -18.65 63.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.066 0.46 . . . . 0.69999999999999996 110.832 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 113' ' ' CYS . 33.3 mt -80.31 -17.91 50.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.001 -0.545 . . . . 0.66000000000000003 112.269 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.659 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -82.66 -3.91 56.99 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.106 -0.638 . . . . 1.48 110.575 178.761 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.434 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 54.1 m-85 -77.88 -36.08 50.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 1.97 110.726 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.539 HD12 ' HB2' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -68.08 129.72 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.131 -0.692 . . . . 0.67000000000000004 109.131 174.412 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.533 ' HD2' ' O ' ' A' ' 94' ' ' ALA . 45.7 mtt180 -129.7 -160.72 1.06 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.553 -0.294 . . . . 4.3399999999999999 110.814 -174.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 16.1 t -62.96 148.95 10.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.355 0.409 . . . . 1.0700000000000001 111.292 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.41 ' HA ' HD12 ' A' ' 206' ' ' LEU . . . -53.48 132.12 39.43 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.692 -0.685 . . . . 0.70999999999999996 111.431 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.503 ' SG ' HD12 ' A' ' 91' ' ' ILE . 23.2 m -55.2 -25.01 30.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.949 -1.023 . . . . 1.8799999999999999 112.237 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 92.8 p -149.29 -179.0 6.71 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.012 -0.366 . . . . 1.6299999999999999 110.012 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' CYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 47.4 t -80.95 -23.69 38.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.902 0.382 . . . . 1.96 110.531 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -88.54 -10.27 49.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.699 0.285 . . . . 2.4199999999999999 110.97 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -91.15 15.94 10.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.377 -0.374 . . . . 2.1200000000000001 111.246 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 89.5 mm-40 -63.33 114.04 3.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.129 0.49 . . . . 1.3500000000000001 110.385 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.54 ' OD1' ' HE2' ' A' ' 198' ' ' LYS . 21.8 t30 -165.68 43.21 0.07 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.101 -1.074 . . . . 1.6799999999999999 108.101 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.608 ' HB3' ' O ' ' A' ' 206' ' ' LEU . 0.8 OUTLIER -142.57 128.88 19.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.583 -0.735 . . . . 0.81000000000000005 111.888 -175.426 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 29.3 m -151.34 141.51 22.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.803 -1.089 . . . . 0.51000000000000001 110.335 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 54.0 tpp -90.11 139.77 30.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.947 -0.39 . . . . 1.3500000000000001 109.947 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 52.8 t -113.67 132.11 55.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.173 0.511 . . . . 1.73 110.471 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -122.01 105.56 10.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.707 -0.849 . . . . 1.9299999999999999 108.707 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.479 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 16.3 pt -139.64 142.99 31.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.987 -0.551 . . . . 1.1100000000000001 110.689 -176.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.7 m 57.18 38.1 28.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.153 -0.476 . . . . 1.8600000000000001 110.968 177.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 67.86 6.24 4.99 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.48 -0.782 . . . . 2.8300000000000001 112.119 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 29.2 pt20 -124.94 161.13 27.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 1.75 110.842 -176.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.84 137.12 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.813 -0.63 . . . . 1.01 111.645 -176.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.786 ' HA ' ' SG ' ' A' ' 113' ' ' CYS . 25.4 m-85 -140.9 155.02 46.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.623 -0.717 . . . . 3.9399999999999999 110.294 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 2.2 m-85 -100.15 113.2 25.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.735 -0.469 . . . . 0.92000000000000004 109.735 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -102.78 123.51 46.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.076 0.465 . . . . 1.1100000000000001 110.231 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.526 HG22 HD11 ' A' ' 207' ' ' LEU . 1.6 t -94.68 151.96 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.714 0.769 . . . . 0.69999999999999996 109.632 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.8 mm -90.67 -56.4 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.361 -1.291 . . . . 0.62 111.201 -166.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.54 ' HE2' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -145.29 -178.16 5.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.373 -0.83 . . . . 1.3799999999999999 111.891 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.664 ' HA ' ' O ' ' A' ' 104' ' ' MET . 18.6 t70 -46.07 132.44 9.53 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.689 0.996 . . . . 2.23 113.689 -172.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.492 HD11 ' ND2' ' A' ' 182' ' ' ASN . 26.4 mm -101.49 132.79 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.231 -0.895 . . . . 0.88 110.349 174.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 35.8 mt-10 -89.35 126.59 57.99 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.337 -0.616 . . . . 2.0600000000000001 109.337 173.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.03 116.95 2.19 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.962 2.441 . . . . 0.51000000000000001 112.86 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.05 -4.94 10.47 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.78 -0.724 . . . . 0.69999999999999996 113.299 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 9.5 pt-20 -142.29 120.35 12.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.476 0.638 . . . . 1.27 112.022 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' A' ' 100' ' ' ALA . 17.7 mm-40 -111.96 125.35 53.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.73 -0.668 . . . . 2.9199999999999999 110.225 171.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.608 ' O ' ' HB3' ' A' ' 183' ' ' LEU . 2.5 mm? -120.01 102.06 8.28 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.671 -0.862 . . . . 0.90000000000000002 108.671 172.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.539 ' HB2' HD12 ' A' ' 172' ' ' ILE . 1.9 mm? -143.76 113.45 7.09 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.138 0.274 . . . . 0.53000000000000003 110.925 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.541 HG12 HD12 ' A' ' 183' ' ' LEU . 1.9 p -153.61 159.8 3.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 O-C-N 122.105 -0.372 . . . . 0.91000000000000003 111.259 176.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -94.47 111.88 23.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.659 -0.867 . . . . 1.55 108.659 167.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 210' ' ' VAL . 6.2 p . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 121.313 0.578 . . . . 2.5600000000000001 111.589 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 83.5 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.651 0.263 . . . . 2.4500000000000002 110.987 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.88 121.12 8.53 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.838 2.358 . . . . 1.75 112.292 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.592 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -127.78 153.28 77.94 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.746 -0.661 . . . . 1.01 109.281 177.693 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.32 141.7 88.71 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.388 2.059 . . . . 0.72999999999999998 111.746 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.516 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -65.68 -12.33 52.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.987 0.736 . . . . 1.04 112.987 -171.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -82.68 -19.71 37.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.037 0.384 . . . . 1.6599999999999999 112.037 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.521 ' HE2' ' SD ' ' A' ' 104' ' ' MET . 5.1 m-85 -116.83 144.88 43.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -116.46 117.07 28.9 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.886 -0.326 . . . . 2.27 110.725 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.494 HD11 ' CE2' ' A' ' 171' ' ' TYR . 8.2 tt -86.09 124.3 32.36 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.962 -0.755 . . . . 0.79000000000000004 108.962 176.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -140.37 128.4 22.13 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.791 -0.641 . . . . 3.21 110.692 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -81.83 112.95 19.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.899 -0.778 . . . . 2.46 108.899 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -166.9 162.73 15.99 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.881 -0.785 . . . . 1.5800000000000001 108.881 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.0 t -99.83 105.55 17.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.905 0.383 . . . . 1.8600000000000001 110.627 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -101.59 117.34 62.06 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.25 -0.648 . . . . 1.45 109.25 174.584 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -55.98 123.29 13.48 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.029 2.486 . . . . 1.6100000000000001 113.116 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.412 ' HA3' ' SG ' ' A' ' 176' ' ' CYS . . . 105.65 -18.39 40.99 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.7 -0.762 . . . . 1.74 112.665 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.494 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -129.34 -55.91 1.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.215 0.531 . . . . 1.4099999999999999 111.517 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.471 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 121.24 -103.35 0.88 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 111.267 -0.733 . . . . 1.0900000000000001 111.267 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.4 160.78 14.24 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.95 -0.389 . . . . 2.3100000000000001 109.95 172.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.96 171.79 44.66 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.512 -0.852 . . . . 0.58999999999999997 112.464 177.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 86' ' ' LEU . 17.0 m -107.29 147.36 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.182 -0.673 . . . . 0.67000000000000004 109.182 173.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -125.79 110.59 13.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.755 0.312 . . . . 1.1299999999999999 111.07 -174.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.517 ' H ' ' HG3' ' A' ' 205' ' ' GLU . . . -59.83 125.77 24.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.85 -0.614 . . . . 0.54000000000000004 111.115 177.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -93.18 -3.88 53.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.331 0.586 . . . . 1.6799999999999999 110.203 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.5 ttp85 -133.16 155.3 49.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.934 -1.135 . . . . 3.5 107.934 171.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.658 ' HD3' ' C ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -84.16 158.56 21.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.277 0.56 . . . . 2.3999999999999999 110.685 -175.437 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 54.9 mtm -117.36 154.33 31.49 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.784 . . . . 1.22 109.068 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -107.83 136.12 48.09 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.41 0.444 . . . . 2.3100000000000001 110.376 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.422 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . . . -39.11 117.29 0.67 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.624 1.202 . . . . 0.83999999999999997 112.991 -174.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.33 7.46 12.33 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.544 -0.753 . . . . 1.04 111.547 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.446 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -75.64 165.22 25.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.054 0.454 . . . . 2.6200000000000001 110.742 -178.371 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.545 ' HD3' ' CD1' ' A' ' 193' ' ' TYR . 7.1 tmm_? -141.38 132.66 26.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.386 -0.37 . . . . 3.6200000000000001 110.297 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.497 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 5.9 mt -100.75 138.49 37.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.616 -0.513 . . . . 0.53000000000000003 109.616 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.49 173.75 46.43 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.976 -0.63 . . . . 1.02 111.696 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -83.9 146.86 53.15 Favored 'Cis proline' 0 C--O 1.236 0.4 0 C-N-CA 123.316 -1.535 . . . . 2.1000000000000001 112.77 -0.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.1 t . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.661 -0.7 . . . . 2.0 109.634 175.681 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.096 0 N-CA-C 113.665 0.226 . . . . 1.3 113.665 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.706 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 20.5 t -63.41 -16.05 59.41 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.809 0.444 . . . . 1.8200000000000001 111.726 -174.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.503 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 25.5 p-90 -71.7 -23.58 61.67 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.019 -0.426 . . . . 0.69999999999999996 110.293 178.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.503 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 29.2 mt -86.75 -17.65 33.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 0.66000000000000003 112.283 -176.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.706 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -75.77 -10.73 59.68 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.382 -0.527 . . . . 1.48 110.248 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.494 ' CE2' HD11 ' A' ' 86' ' ' LEU . 52.1 m-85 -69.79 -36.98 76.16 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.824 -0.625 . . . . 1.97 111.06 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.693 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -69.83 127.01 31.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.482 -0.487 . . . . 0.67000000000000004 109.729 177.539 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -115.07 179.15 4.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.022 -0.536 . . . . 4.3399999999999999 110.401 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.627 ' HA ' HD22 ' A' ' 183' ' ' LEU . 1.7 p -71.4 142.37 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.458 . . . . 1.0700000000000001 111.165 -177.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.28 142.47 21.05 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.16 -0.927 . . . . 0.70999999999999996 112.572 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.412 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 47.5 t -82.87 -2.93 56.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.208 -0.906 . . . . 1.8799999999999999 110.531 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 27.2 t -142.84 139.88 31.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.993 -0.549 . . . . 1.6299999999999999 109.589 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 33.6 t -73.31 -13.99 61.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.309 0.576 . . . . 1.96 110.485 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -88.44 -4.42 58.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.346 0.593 . . . . 2.4199999999999999 109.93 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -110.84 15.49 21.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.49 -0.777 . . . . 2.1200000000000001 111.107 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 15.9 mm100 -60.11 115.67 3.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.528 -0.545 . . . . 1.3500000000000001 109.528 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.6 ' OD1' ' HG3' ' A' ' 198' ' ' LYS . 19.2 t30 -153.63 32.97 0.45 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.165 0.983 . . . . 1.6799999999999999 108.799 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.627 HD22 ' HA ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -122.52 129.51 52.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.368 -0.833 . . . . 0.81000000000000005 110.315 -174.013 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.5 m -150.42 138.66 20.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.074 0.464 . . . . 0.51000000000000001 110.933 177.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.485 ' HB2' ' HE2' ' A' ' 185' ' ' MET . 21.1 tpp -102.05 129.02 48.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.941 -0.572 . . . . 1.3500000000000001 109.962 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 43.5 t -111.95 140.93 46.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.051 0.453 . . . . 1.73 110.585 -175.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.81 104.26 10.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.904 -0.589 . . . . 1.9299999999999999 109.621 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.465 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 17.8 pt -142.73 145.33 23.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.679 -0.691 . . . . 1.1100000000000001 110.229 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.4 m 63.15 27.61 15.72 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.114 0.483 . . . . 1.8600000000000001 111.047 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 64.56 10.5 5.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.125 -0.943 . . . . 2.8300000000000001 111.62 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.9 pt20 -120.6 167.95 11.88 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.974 -0.38 . . . . 1.75 109.974 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.2 mm -93.59 137.09 23.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.058 -0.519 . . . . 1.01 110.305 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.545 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 2.4 m-85 -138.52 151.4 47.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.221 0.534 . . . . 3.9399999999999999 111.244 177.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.475 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 4.8 m-85 -99.54 113.6 26.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.568 -0.742 . . . . 0.92000000000000004 109.627 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.28 118.83 37.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.992 -0.549 . . . . 1.1100000000000001 110.176 -177.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.448 HG22 HD11 ' A' ' 207' ' ' LEU . 2.0 t -91.08 152.95 3.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.515 0.674 . . . . 0.69999999999999996 110.057 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.405 HG13 ' HA ' ' A' ' 182' ' ' ASN . 1.2 mm -91.44 -58.07 3.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.64 -1.164 . . . . 0.62 111.301 -167.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.6 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -139.78 173.13 11.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.69 -0.686 . . . . 1.3799999999999999 111.51 -176.928 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.592 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.1 m-20 -47.05 120.18 2.95 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.231 -0.895 . . . . 2.23 112.871 -176.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.485 HD11 ' ND2' ' A' ' 182' ' ' ASN . 21.0 mm -82.15 140.11 16.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.185 -0.916 . . . . 0.88 110.984 176.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 202' ' ' PRO . 44.6 mt-10 -86.97 130.71 47.31 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.534 -0.543 . . . . 2.0600000000000001 109.534 171.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 201' ' ' GLU . 53.2 Cg_exo -55.11 117.53 4.13 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.493 2.128 . . . . 0.51000000000000001 112.289 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.52 -11.11 9.71 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.798 -0.715 . . . . 0.69999999999999996 112.576 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 200' ' ' ILE . 11.3 pt-20 -143.04 119.69 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 1.27 111.791 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.517 ' HG3' ' H ' ' A' ' 100' ' ' ALA . 40.6 mt-10 -111.7 127.21 55.7 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.196 -0.315 . . . . 2.9199999999999999 110.518 169.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.487 ' C ' HD22 ' A' ' 207' ' ' LEU . 2.6 mm? -115.72 100.35 7.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.146 -0.686 . . . . 0.90000000000000002 109.146 175.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.693 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.33 125.37 13.63 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.495 -0.928 . . . . 0.53000000000000003 108.495 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.602 HG11 ' HB ' ' A' ' 174' ' ' VAL . 9.8 p -152.87 157.1 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.234 -0.586 . . . . 0.91000000000000003 111.439 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -109.72 106.47 16.12 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.815 -0.809 . . . . 1.55 108.815 163.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.319 -0.736 0 N-CA-C 109.226 -0.657 . . . . 2.5600000000000001 109.226 170.333 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.8 mt . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.688 -0.486 . . . . 2.4500000000000002 109.688 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.97 135.06 33.86 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.603 2.202 . . . . 1.75 112.231 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.52 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.48 136.94 29.89 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.819 -0.628 . . . . 1.01 109.903 -178.732 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.55 151.58 7.2 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.358 2.706 . . . . 0.72999999999999998 112.574 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.13 -6.44 3.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.671 0.989 . . . . 1.04 113.671 -169.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 52.1 m-20 -110.34 2.02 18.84 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.886 -0.509 . . . . 1.6599999999999999 111.994 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -130.92 138.44 49.77 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.16 -0.681 . . . . 1.0 109.16 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.57 136.67 53.54 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.72 -0.392 . . . . 2.27 110.061 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.8 tt -85.37 126.44 33.76 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.454 0.645 . . . . 0.79000000000000004 109.29 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.444 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 51.1 mtp180 -143.34 118.75 10.28 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.863 -1.062 . . . . 3.21 109.507 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -80.73 110.16 15.97 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.283 -0.636 . . . . 2.46 109.283 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.9 p -164.32 109.26 0.98 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.474 -0.785 . . . . 1.5800000000000001 108.959 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.9 m -71.13 105.67 3.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.054 0.454 . . . . 1.8600000000000001 110.953 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -92.99 117.99 67.71 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.049 -0.723 . . . . 1.45 109.049 173.082 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -51.93 121.27 8.44 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.016 2.477 . . . . 1.6100000000000001 112.554 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.449 ' HA3' ' SG ' ' A' ' 176' ' ' CYS . . . 108.5 -16.34 34.61 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.015 -0.612 . . . . 1.74 112.45 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -135.21 -61.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.97 0.414 . . . . 1.4099999999999999 111.244 178.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.483 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 121.09 -123.22 5.47 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 121.055 -0.593 . . . . 1.0900000000000001 111.925 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mt -102.23 158.43 16.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.931 -0.396 . . . . 2.3100000000000001 109.931 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -167.17 177.52 41.73 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.616 -0.802 . . . . 0.58999999999999997 112.013 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.87 114.95 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.494 0.664 . . . . 0.67000000000000004 109.689 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.444 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 51.3 m95 -82.76 127.55 33.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.583 -0.735 . . . . 1.1299999999999999 111.405 -169.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -74.87 116.19 15.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.686 -0.688 . . . . 0.54000000000000004 110.465 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.5 OUTLIER -90.45 1.0 57.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 1.6799999999999999 110.096 -178.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 102' ' ' ARG . 17.4 ttp180 -140.46 156.18 46.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.552 -0.749 . . . . 3.5 109.13 175.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -80.4 159.0 25.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.112 0.482 . . . . 2.3999999999999999 110.738 -178.621 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.689 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 55.3 mtm -129.46 152.11 49.36 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.064 -0.516 . . . . 1.22 110.026 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -121.5 139.81 53.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.117 -0.492 . . . . 2.3100000000000001 110.273 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -39.19 125.04 1.57 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 124.708 1.255 . . . . 0.83999999999999997 113.264 -170.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.26 7.03 12.87 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.319 -0.855 . . . . 1.04 111.094 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.62 162.18 18.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.116 0.484 . . . . 2.6200000000000001 110.929 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.586 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 6.3 tmm_? -146.96 132.29 18.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.982 -0.554 . . . . 3.6200000000000001 110.301 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 4.7 mt -95.26 130.78 41.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.027 -0.731 . . . . 0.53000000000000003 109.027 173.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.13 166.6 38.28 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.308 -0.949 . . . . 1.02 112.426 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.469 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 94.5 Cg_endo -87.17 158.12 48.58 Favored 'Cis proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.917 -1.701 . . . . 2.1000000000000001 112.553 -2.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.3 t . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 121.367 0.603 . . . . 2.0 109.557 174.579 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.444 0 N-CA-C 111.071 -0.812 . . . . 1.3 111.071 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.655 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 13.5 m -64.59 -15.04 60.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.362 -0.419 . . . . 1.8200000000000001 111.47 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.59 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 17.5 p-90 -70.6 -25.99 63.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 0.69999999999999996 111.197 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.59 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 18.2 mt -86.3 -15.15 41.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.643 0.609 . . . . 0.66000000000000003 112.643 -173.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.655 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -77.8 -1.93 33.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.564 -0.454 . . . . 1.48 110.963 -179.296 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -84.38 -37.94 20.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.221 0.452 . . . . 1.97 112.221 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.747 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -65.07 128.64 28.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.975 0.417 . . . . 0.67000000000000004 110.616 -176.441 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -119.67 -164.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 4.3399999999999999 110.854 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.3 t -71.61 143.87 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.956 0.408 . . . . 1.0700000000000001 110.523 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -65.59 143.49 57.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.759 -0.655 . . . . 0.70999999999999996 111.111 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.449 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 42.0 t -63.52 -19.49 64.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.024 -0.989 . . . . 1.8799999999999999 111.354 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 180' ' ' ASP . 17.8 t -125.62 138.78 53.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.218 0.532 . . . . 1.6299999999999999 110.558 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' CYS . . . . . 0.554 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 8.6 p -77.49 -26.39 51.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.552 -0.749 . . . . 1.96 111.337 -176.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.47 -3.8 58.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.336 0.589 . . . . 2.4199999999999999 110.224 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 177' ' ' SER . 1.2 m-20 -107.81 16.26 23.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.434 -0.803 . . . . 2.1200000000000001 110.461 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.554 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 16.4 mm100 -58.36 120.17 8.26 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.374 0.607 . . . . 1.3500000000000001 110.961 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.584 ' ND2' HD11 ' A' ' 200' ' ' ILE . 13.5 t30 -142.86 35.54 1.4 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.394 -1.336 . . . . 1.6799999999999999 107.394 175.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.678 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.2 OUTLIER -120.44 125.0 46.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.526 -1.215 . . . . 0.81000000000000005 110.906 -173.114 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.5 m -150.5 133.08 15.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.923 0.392 . . . . 0.51000000000000001 110.703 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 48.7 ttm -100.27 140.19 34.87 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.654 -0.498 . . . . 1.3500000000000001 109.654 174.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 32.5 m -124.95 131.55 53.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.137 0.494 . . . . 1.73 111.138 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.74 104.96 14.79 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.656 -0.868 . . . . 1.9299999999999999 108.656 176.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 22.3 pt -139.19 144.4 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.921 -0.582 . . . . 1.1100000000000001 110.054 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.0 t 64.71 30.18 12.56 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.217 0.532 . . . . 1.8600000000000001 110.235 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 58.48 34.11 23.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.387 -0.824 . . . . 2.8300000000000001 111.355 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -145.3 154.44 42.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 1.75 110.711 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.99 128.45 45.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.167 -0.47 . . . . 1.01 111.749 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.586 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 40.9 m-85 -131.31 155.79 46.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.525 -0.761 . . . . 3.9399999999999999 110.565 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.483 ' CE1' ' HB3' ' A' ' 169' ' ' LEU . 11.3 m-85 -103.5 114.52 28.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.96 -0.755 . . . . 0.92000000000000004 108.96 173.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -100.1 118.83 37.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.175 -0.466 . . . . 1.1100000000000001 109.887 -175.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.455 HG12 HD21 ' A' ' 182' ' ' ASN . 1.9 t -83.38 152.16 3.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.408 0.623 . . . . 0.69999999999999996 109.649 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.1 mm -94.01 -55.15 6.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.912 -1.04 . . . . 0.62 111.202 -167.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.481 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -143.85 -179.71 6.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 1.3799999999999999 111.963 -179.443 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.689 ' HA ' ' O ' ' A' ' 104' ' ' MET . 23.7 t70 -45.89 121.98 3.51 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.3 1.0 . . . . 2.23 113.009 -175.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.584 HD11 ' ND2' ' A' ' 182' ' ' ASN . 21.1 mm -92.23 130.77 40.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.999 -1.0 . . . . 0.88 111.38 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 11.8 mm-40 -76.93 121.59 85.01 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.38 -0.827 . . . . 2.0600000000000001 108.933 171.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.88 114.1 1.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.001 1.801 . . . . 0.51000000000000001 111.181 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.15 -0.53 10.65 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.57 -0.824 . . . . 0.69999999999999996 113.428 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 10.2 pt-20 -133.45 123.38 25.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.492 0.646 . . . . 1.27 111.145 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.05 96.44 6.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.75 -0.659 . . . . 2.9199999999999999 111.754 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.505 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.3 mm? -113.03 99.03 7.54 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.835 -0.746 . . . . 0.90000000000000002 109.773 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.747 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -145.57 114.1 6.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.554 0.341 . . . . 0.53000000000000003 110.452 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.678 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.8 p -155.83 160.48 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.137 -0.32 . . . . 0.91000000000000003 110.137 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -93.22 110.2 21.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.006 -1.109 . . . . 1.55 108.006 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.317 -0.828 0 CA-C-O 121.257 0.551 . . . . 2.5600000000000001 110.213 179.905 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.1 mt . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 110.496 -0.187 . . . . 2.4500000000000002 110.496 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.33 120.41 7.55 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.607 2.205 . . . . 1.75 112.114 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.64 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -113.11 141.67 26.04 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.308 -0.405 . . . . 1.01 109.921 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.32 144.67 70.73 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.773 2.315 . . . . 0.72999999999999998 112.14 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.662 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -62.82 -13.08 29.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.526 -0.761 . . . . 1.04 112.332 -173.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.95 -9.84 59.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.107 -0.497 . . . . 1.6599999999999999 111.062 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.551 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 9.3 m-85 -138.13 149.97 46.4 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 -173.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.567 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 9.5 tp10 -125.27 133.84 52.51 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.428 -0.509 . . . . 2.27 111.316 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.88 122.79 33.26 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.214 -0.661 . . . . 0.79000000000000004 109.214 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.445 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 39.8 mmt180 -147.28 124.58 11.55 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.913 -1.04 . . . . 3.21 109.452 -174.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.1 110.56 8.49 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.106 -0.702 . . . . 2.46 109.106 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.8 m -143.99 94.18 2.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.603 -0.726 . . . . 1.5800000000000001 109.133 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -64.64 101.86 0.51 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.472 0.654 . . . . 1.8600000000000001 111.357 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.581 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -108.91 117.03 54.77 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 108.501 -0.926 . . . . 1.45 108.501 172.211 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.86 123.48 13.61 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.907 2.404 . . . . 1.6100000000000001 112.542 -173.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.51 -23.69 23.91 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.132 -0.556 . . . . 1.74 112.5 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -114.95 -68.33 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.95 -0.3 . . . . 1.4099999999999999 111.513 -178.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.84 -158.09 15.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.665 -0.779 . . . . 1.0900000000000001 112.339 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.466 ' C ' ' HD3' ' A' ' 173' ' ' ARG . 8.3 mt -101.17 122.55 43.82 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.684 0.242 . . . . 2.3100000000000001 110.908 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -133.97 -159.35 8.9 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.711 -0.757 . . . . 0.58999999999999997 112.388 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 98' ' ' VAL . 17.3 m -112.29 105.02 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 122.094 0.95 . . . . 0.67000000000000004 109.812 177.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.445 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 6.4 m95 -83.3 123.28 29.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.173 -0.921 . . . . 1.1299999999999999 110.194 -171.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.89 117.79 6.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.134 -0.485 . . . . 0.54000000000000004 110.367 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.662 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -78.83 -0.15 29.45 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.063 0.459 . . . . 1.6799999999999999 110.676 178.18 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 34.5 ttp180 -141.48 162.86 34.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.666 -0.864 . . . . 3.5 108.666 178.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.419 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -79.09 160.02 27.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.273 0.558 . . . . 2.3999999999999999 111.182 178.316 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.567 ' HE3' HG13 ' A' ' 200' ' ' ILE . 44.9 mtm -130.77 153.04 49.47 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.063 -1.088 . . . . 1.22 108.063 172.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -126.66 146.97 49.99 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.091 0.244 . . . . 2.3100000000000001 110.764 -177.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -36.34 121.13 0.69 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.716 1.26 . . . . 0.83999999999999997 113.77 -168.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.2 6.83 13.18 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.268 -0.878 . . . . 1.04 111.349 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.491 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -85.03 157.01 20.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.05 0.453 . . . . 2.6200000000000001 110.253 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.697 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 5.9 tmm_? -146.47 133.79 20.66 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.096 -0.502 . . . . 3.6200000000000001 110.189 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.551 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 3.9 mt -96.92 135.68 38.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.429 -0.952 . . . . 0.53000000000000003 108.429 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.67 169.63 38.25 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.878 -1.153 . . . . 1.02 112.732 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.599 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 74.0 Cg_endo -77.8 167.14 79.48 Favored 'Cis proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.977 -1.676 . . . . 2.1000000000000001 112.297 -1.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.8 t . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 121.071 0.462 . . . . 2.0 110.539 177.924 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.392 0 N-CA-C 112.63 -0.188 . . . . 1.3 112.63 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.648 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 2.9 m -63.79 -14.86 56.37 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.669 0.388 . . . . 1.8200000000000001 111.989 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' TRP . . . . . 0.498 ' HB2' HG22 ' A' ' 80' ' ' ILE . 19.7 p-90 -69.39 -21.42 63.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.988 0.366 . . . . 0.69999999999999996 111.988 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 169' ' ' LEU . 18.3 mt -80.73 -14.56 58.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.942 0.719 . . . . 0.66000000000000003 112.942 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.648 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -68.04 -10.44 53.75 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.286 -0.566 . . . . 1.48 110.205 176.334 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.565 ' O ' ' HD2' ' A' ' 173' ' ' ARG . 50.9 m-85 -78.89 -27.89 43.95 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.749 -0.66 . . . . 1.97 112.4 -175.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.647 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 1.6 mm -57.87 139.05 18.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 117.895 0.316 . . . . 0.67000000000000004 111.289 -175.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.565 ' HD2' ' O ' ' A' ' 171' ' ' TYR . 18.2 mmm180 -95.24 147.67 23.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.103 0.478 . . . . 4.3399999999999999 112.034 -174.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.434 HG22 HG11 ' A' ' 208' ' ' VAL . 81.6 t -66.56 148.61 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.374 -0.83 . . . . 1.0700000000000001 108.773 168.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.738 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -57.32 122.94 13.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.026 0.441 . . . . 0.70999999999999996 112.108 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.56 -28.7 68.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.573 -0.74 . . . . 1.8799999999999999 109.967 175.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.0 p -126.73 139.51 53.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.879 -0.6 . . . . 1.6299999999999999 110.614 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 54.0 t -76.97 -8.41 57.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.992 -0.549 . . . . 1.96 111.093 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.02 -3.87 58.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.204 0.526 . . . . 2.4199999999999999 110.238 177.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -111.81 17.91 19.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.638 -0.71 . . . . 2.1200000000000001 111.816 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -55.43 114.84 1.99 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.289 0.566 . . . . 1.3500000000000001 110.897 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.862 ' H ' HD12 ' A' ' 183' ' ' LEU . 18.3 t30 -155.03 32.49 0.39 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 122.062 0.934 . . . . 1.6799999999999999 108.7 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.862 HD12 ' H ' ' A' ' 182' ' ' ASN . 2.0 mp -115.36 120.36 39.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.381 -0.827 . . . . 0.81000000000000005 110.975 -173.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 95.4 m -148.66 138.96 22.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.324 0.583 . . . . 0.51000000000000001 111.366 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' MET . . . . . 0.466 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 65.5 mtp -120.71 135.51 55.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.93 -0.577 . . . . 1.3500000000000001 109.758 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 44.2 t -114.52 141.9 47.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.93 0.395 . . . . 1.73 110.736 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLN . . . . . 0.416 ' HG2' HD13 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -106.71 103.93 13.49 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.026 -0.731 . . . . 1.9299999999999999 109.026 177.275 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 11.6 pt -146.34 145.08 20.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.967 -0.56 . . . . 1.1100000000000001 110.218 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.4 t 67.3 33.91 5.14 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.509 0.506 . . . . 1.8600000000000001 110.242 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 66.33 8.38 5.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.419 -0.809 . . . . 2.8300000000000001 111.701 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.35 167.72 19.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.062 0.458 . . . . 1.75 110.935 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.416 HD13 ' HG2' ' A' ' 187' ' ' GLN . 50.2 mm -98.35 128.45 49.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.674 -0.694 . . . . 1.01 110.469 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.697 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 2.2 m-85 -118.44 146.95 44.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.161 0.505 . . . . 3.9399999999999999 110.708 175.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 3.2 m-85 -100.95 113.2 25.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.934 -0.765 . . . . 0.92000000000000004 108.934 175.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -111.57 123.8 50.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.925 0.393 . . . . 1.1100000000000001 110.184 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.494 ' CG1' HD21 ' A' ' 182' ' ' ASN . 2.1 t -93.67 152.3 3.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.777 0.799 . . . . 0.69999999999999996 110.386 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.2 mm -92.98 -54.83 6.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.433 -1.258 . . . . 0.62 110.801 -166.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.49 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -138.78 -179.25 5.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.437 -0.801 . . . . 1.3799999999999999 110.1 178.312 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 104' ' ' MET . 4.8 p-10 -56.09 135.8 52.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.68 0.752 . . . . 2.23 112.389 -173.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.567 HG13 ' HE3' ' A' ' 104' ' ' MET . 28.4 mm -96.48 138.11 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.238 -0.892 . . . . 0.88 110.817 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -83.34 127.51 68.29 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.949 -0.569 . . . . 2.0600000000000001 109.534 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.2 115.57 2.26 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.835 2.357 . . . . 0.51000000000000001 112.367 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.0 -12.94 9.17 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.471 -0.871 . . . . 0.69999999999999996 113.543 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.76 123.0 34.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.563 0.681 . . . . 1.27 111.504 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.647 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -110.47 112.1 23.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.766 -0.652 . . . . 2.9199999999999999 111.142 177.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.502 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 0.9 OUTLIER -122.51 98.96 6.16 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.317 -0.553 . . . . 0.90000000000000002 109.606 173.551 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.621 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.7 mm? -147.74 106.55 3.83 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.722 -0.473 . . . . 0.53000000000000003 109.722 175.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.753 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 19.5 t -154.91 157.45 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.014 -1.106 . . . . 0.91000000000000003 108.014 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' HIS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 3.6 t-80 -89.23 109.86 20.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.731 -0.84 . . . . 1.55 108.731 173.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 C--N 1.32 -0.694 0 CA-C-O 121.624 0.726 . . . . 2.5600000000000001 110.665 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.651 ' N ' ' HG1' ' A' ' 56' ' ' THR . . . . . . . . 0 N--CA 1.483 1.814 0 N-CA-C 111.79 -0.524 . . . . 33.259999999999998 111.79 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.423 ' OG ' ' HB3' ' A' ' 67' ' ' PRO . 19.5 m -71.92 132.37 44.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.045 0.45 . . . . 33.920000000000002 110.907 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.02 -22.95 9.54 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.965 -0.636 . . . . 32.350000000000001 111.907 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -145.72 141.02 16.32 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.287 -0.264 . . . . 31.649999999999999 110.287 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.12 95.45 0.14 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.657 2.238 . . . . 29.989999999999998 111.427 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.651 ' HG1' ' N ' ' A' ' 51' ' ' GLY . 21.2 m -71.74 -56.37 5.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.865 -0.607 . . . . 28.920000000000002 111.261 -174.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.1 t 56.2 59.98 3.42 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.057 0.456 . . . . 26.940000000000001 110.647 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -135.02 113.5 11.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.042 -0.527 . . . . 25.829999999999998 109.669 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 t70 64.74 -171.75 0.18 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.98 0.8 . . . . 23.530000000000001 109.947 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -97.5 49.71 1.05 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.227 0.537 . . . . 21.640000000000001 110.545 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.8 m -83.69 114.27 52.63 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.253 -0.885 . . . . 19.420000000000002 110.548 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.01 125.62 13.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.662 2.241 . . . . 17.170000000000002 112.035 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -75.64 74.46 2.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.959 -0.564 . . . . 17.469999999999999 110.336 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -93.57 162.03 14.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.597 -0.728 . . . . 15.630000000000001 111.706 -175.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.54 12.28 78.4 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.739 -0.664 . . . . 12.039999999999999 113.216 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.2 t 58.14 75.15 0.56 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.826 0.346 . . . . 10.67 111.122 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.423 ' HB3' ' OG ' ' A' ' 52' ' ' SER . 2.8 Cg_exo -75.91 78.33 3.17 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.577 2.185 . . . . 9.6899999999999995 111.422 177.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -114.84 143.71 44.67 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.234 -0.894 . . . . 7.7000000000000002 110.626 -176.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -132.22 142.94 49.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.628 -0.508 . . . . 8.1400000000000006 109.628 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.75 121.1 73.28 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.223 -0.444 . . . . 5.96 111.137 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.4 -160.95 0.14 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.784 2.323 . . . . 6.1299999999999999 112.103 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.5 m -60.86 -42.07 91.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.815 0.34 . . . . 6.5300000000000002 110.787 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -94.62 108.41 20.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.201 -0.666 . . . . 5.0099999999999998 109.201 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.519 ' O ' HD12 ' A' ' 74' ' ' ILE . 1.9 pp -77.0 139.9 66.07 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.017 -0.538 . . . . 4.2300000000000004 111.622 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.65 -4.88 16.17 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.049 2.499 . . . . 4.1200000000000001 112.449 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' HB2' HD13 ' A' ' 74' ' ' ILE . 35.2 mt-10 -62.75 -57.73 9.93 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.504 -0.554 . . . . 3.8199999999999998 109.504 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.6 t70 54.21 71.42 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.54 -1.209 . . . . 3.1600000000000001 110.261 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.8 mt -68.69 128.27 92.97 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.13 -0.941 . . . . 2.4500000000000002 110.172 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.448 ' O ' ' HA2' ' A' ' 164' ' ' GLY . 23.4 Cg_endo -63.17 127.53 20.44 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.384 2.056 . . . . 1.75 111.589 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.526 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.97 151.62 78.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.97 -0.559 . . . . 1.01 109.917 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.66 139.72 87.21 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.567 2.178 . . . . 0.72999999999999998 111.241 174.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.661 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -67.73 -7.65 28.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.637 0.606 . . . . 1.04 112.637 -172.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.487 ' OD2' ' HD3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -80.01 -9.61 59.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.724 0.297 . . . . 1.6599999999999999 111.492 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.524 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 8.4 m-85 -140.18 146.76 39.16 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 -173.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 99' ' ' TRP . 13.3 pt-20 -114.2 135.21 54.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.982 0.42 . . . . 2.27 110.946 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.2 tt -101.71 129.94 47.98 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.324 -0.991 . . . . 0.79000000000000004 108.324 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -162.47 150.71 14.43 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.433 -0.803 . . . . 3.21 109.792 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -82.99 111.36 18.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.0 -0.741 . . . . 2.46 109.0 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.2 p -149.07 90.7 1.77 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.773 -0.649 . . . . 1.5800000000000001 109.365 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.1 m -68.43 104.12 1.82 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.248 0.547 . . . . 1.8600000000000001 110.805 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -94.89 118.95 66.63 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.649 -0.705 . . . . 1.45 109.199 174.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -52.44 121.22 8.65 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.251 2.634 . . . . 1.6100000000000001 112.466 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.545 ' HA3' ' SG ' ' A' ' 176' ' ' CYS . . . 108.23 -16.02 35.68 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.843 -0.694 . . . . 1.74 112.36 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.436 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -135.89 -71.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.724 -0.28 . . . . 1.4099999999999999 111.395 177.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.528 ' HA3' ' NH1' ' A' ' 173' ' ' ARG . . . 133.38 -127.91 4.85 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.877 -0.678 . . . . 1.0900000000000001 111.954 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.0 mt -97.66 147.6 24.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.655 0.228 . . . . 2.3100000000000001 110.5 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -158.21 171.4 35.12 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.585 -0.606 . . . . 0.58999999999999997 111.585 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 27.7 m -99.31 111.58 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.497 0.665 . . . . 0.67000000000000004 110.037 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.538 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 59.2 m95 -81.57 124.52 29.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.852 -0.613 . . . . 1.1299999999999999 110.316 -172.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 202' ' ' PRO . . . -68.98 114.81 7.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.582 -0.525 . . . . 0.54000000000000004 109.582 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.661 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -82.62 -9.48 59.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.37 0.605 . . . . 1.6799999999999999 109.669 177.428 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.487 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 63.4 ttt180 -125.11 162.55 24.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.31 -0.859 . . . . 3.5 108.823 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.602 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -91.53 158.72 16.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.874 0.369 . . . . 2.3999999999999999 110.952 -176.097 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.491 ' HE3' HG13 ' A' ' 200' ' ' ILE . 64.4 mtm -135.42 152.59 51.54 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.103 -0.703 . . . . 1.22 109.103 176.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -113.05 147.74 36.62 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.092 0.245 . . . . 2.3100000000000001 110.516 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.81 123.97 2.91 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 124.474 1.109 . . . . 0.83999999999999997 112.973 -170.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.75 7.7 13.01 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.451 -0.795 . . . . 1.04 111.183 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.508 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 1.0 OUTLIER -84.04 157.59 21.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.507 0.67 . . . . 2.6200000000000001 110.923 -178.052 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.657 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 2.7 tmm_? -144.1 134.09 24.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.494 -0.776 . . . . 3.6200000000000001 109.546 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.524 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 6.3 mt -87.76 137.36 32.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.875 -0.33 . . . . 0.53000000000000003 110.119 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.38 170.99 43.76 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.917 -0.659 . . . . 1.02 111.481 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -88.62 148.38 27.1 Favored 'Cis proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.181 -1.591 . . . . 2.1000000000000001 112.491 -2.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.514 ' HB2' HD12 ' A' ' 169' ' ' LEU . 28.9 t -100.57 -67.67 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.958 -0.756 . . . . 2.0 108.958 172.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.571 ' O ' ' HB2' ' A' ' 191' ' ' GLN . 16.7 m -139.31 140.9 36.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.842 -0.617 . . . . 2.0299999999999998 109.66 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 115' ' ' VAL . 13.6 p -111.62 31.08 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 122.575 1.178 . . . . 3.9500000000000002 109.095 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.437 HG22 ' HB ' ' A' ' 114' ' ' VAL . 12.2 m -75.96 120.09 80.13 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 114.479 -1.237 . . . . 5.21 111.289 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.589 ' HB2' ' OE1' ' A' ' 136' ' ' GLU . 48.7 Cg_endo -68.57 -165.56 0.13 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.126 2.551 . . . . 5.0700000000000003 113.07 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.521 ' HD2' ' N ' ' A' ' 118' ' ' ARG . 5.1 mpt_? -63.62 -63.26 1.22 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.756 -0.656 . . . . 7.9900000000000002 110.471 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.88 45.85 1.2 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.401 -0.818 . . . . 6.9500000000000002 111.741 -175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -104.02 20.46 18.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.788 0.327 . . . . 6.0899999999999999 111.575 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 63.2 83.79 0.16 Allowed 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.817 0.818 . . . . 5.5599999999999996 111.682 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -94.11 150.63 20.16 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.133 -0.94 . . . . 7.4199999999999999 109.517 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.482 ' H ' ' CD ' ' A' ' 123' ' ' GLU . 7.1 mp0 -57.36 -71.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.895 0.379 . . . . 9.0099999999999998 110.376 -175.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.7 m -160.09 -60.52 0.06 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.378 -0.601 . . . . 8.8800000000000008 109.378 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.48 ' HA ' ' CZ3' ' A' ' 128' ' ' TRP . 16.4 t0 -145.29 139.85 27.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.458 -0.792 . . . . 7.5999999999999996 110.787 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -130.93 3.79 4.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.616 0.722 . . . . 7.2300000000000004 109.441 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.415 ' O ' HG11 ' A' ' 220' ' ' VAL . . . 141.4 35.17 0.1 Allowed Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.507 -0.77 . . . . 4.5899999999999999 112.502 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TRP . . . . . 0.487 ' HE3' ' H ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -152.52 -87.16 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.416 0.627 . . . . 4.9299999999999997 109.761 177.487 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.487 ' H ' ' HE3' ' A' ' 128' ' ' TRP . 7.3 pt-20 175.85 -47.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.401 -1.272 . . . . 7.6500000000000004 108.398 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.418 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 22.8 pt20 -178.66 94.42 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.952 -1.022 . . . . 8.8399999999999999 109.871 177.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.443 ' HB ' ' HG3' ' A' ' 190' ' ' GLU . 1.4 pp -70.31 -11.57 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 112.186 0.439 . . . . 6.0499999999999998 112.186 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.17 57.74 4.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.273 1.035 . . . . 8.5 110.108 177.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.3 t -111.4 26.98 10.11 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.118 -1.401 . . . . 9.8200000000000003 110.05 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -151.09 126.63 10.13 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.044 -0.98 . . . . 11.210000000000001 109.783 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.58 114.23 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.479 0.657 . . . . 10.84 110.822 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.589 ' OE1' ' HB2' ' A' ' 117' ' ' PRO . 40.4 tt0 -80.86 74.63 7.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.771 -0.649 . . . . 13.25 110.116 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.78 -35.64 37.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.693 -0.685 . . . . 13.890000000000001 110.217 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.9 m 51.38 80.4 0.3 Allowed Pre-proline 0 C--O 1.235 0.338 0 CA-C-N 116.081 -0.509 . . . . 14.050000000000001 111.745 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.85 127.27 24.5 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.776 2.318 . . . . 14.41 111.85 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -84.18 32.94 0.49 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.101 0.477 . . . . 14.44 111.125 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -114.22 -2.89 13.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.933 -0.576 . . . . 15.9 110.099 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -152.49 -68.71 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.845 -0.693 . . . . 15.6 112.021 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 9.6 p -79.51 93.08 5.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.06 0.457 . . . . 15.6 111.209 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.4 mt -125.04 -61.82 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.081 -0.509 . . . . 13.85 110.369 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 29.2 p 46.62 75.43 0.12 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.599 -0.728 . . . . 13.19 112.046 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -86.63 -15.74 38.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.549 0.69 . . . . 15.67 109.197 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 147' ' ' ILE . 2.4 pp -104.85 168.57 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.846 -1.07 . . . . 13.77 110.618 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 37.2 p -134.35 120.93 20.49 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.299 -0.41 . . . . 13.619999999999999 110.216 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.26 116.0 8.35 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.05 -0.352 . . . . 13.02 110.05 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -91.85 140.12 29.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.218 -0.446 . . . . 14.68 110.419 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.9 64.92 4.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.757 -0.656 . . . . 13.550000000000001 109.636 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -100.49 -149.08 23.13 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.729 -0.669 . . . . 15.800000000000001 113.218 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.9 m -93.21 28.32 2.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.251 0.463 . . . . 17.079999999999998 112.251 -171.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -86.52 -81.33 0.22 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.162 0.505 . . . . 18.43 110.247 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -145.69 47.38 1.27 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.515 -0.766 . . . . 18.530000000000001 109.308 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -132.97 83.61 2.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.696 -0.684 . . . . 14.32 111.179 -173.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 18.6 t -86.09 37.44 0.72 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.652 0.739 . . . . 14.51 109.53 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.61 130.38 74.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.597 -0.729 . . . . 13.06 109.385 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -96.94 82.05 3.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.227 0.537 . . . . 10.33 109.831 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 162' ' ' GLN . . . -148.2 158.56 44.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.716 -0.675 . . . . 9.8800000000000008 109.918 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 55.86 33.13 20.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.563 0.697 . . . . 10.23 110.449 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 160' ' ' ALA . 29.8 mm-40 -118.32 -72.5 0.68 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.646 -0.706 . . . . 9.0600000000000005 109.932 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -117.06 132.39 56.7 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.919 -0.582 . . . . 6.1900000000000004 110.292 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 79' ' ' PRO . . . 151.1 91.7 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.782 -0.723 . . . . 3.9700000000000002 111.862 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.35 -45.21 92.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.009 0.433 . . . . 2.6299999999999999 110.561 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 113' ' ' CYS . . . 131.97 -31.76 3.0 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.739 -0.743 . . . . 1.3 112.947 176.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.676 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 23.1 t -65.56 -16.0 63.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.859 0.361 . . . . 1.8200000000000001 111.349 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.558 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 24.4 p-90 -64.88 -23.82 67.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.846 0.355 . . . . 0.69999999999999996 111.184 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.558 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 17.8 mt -86.3 -15.01 41.96 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.825 0.676 . . . . 0.66000000000000003 112.825 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.676 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -82.17 -2.01 50.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.013 -0.675 . . . . 1.48 110.785 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -79.2 -36.88 39.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.189 -0.459 . . . . 1.97 112.077 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.847 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -64.39 133.0 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.861 0.362 . . . . 0.67000000000000004 111.03 -176.447 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.528 ' NH1' ' HA3' ' A' ' 95' ' ' GLY . 98.8 mtt180 -118.53 -172.92 2.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 4.3399999999999999 111.222 -174.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -71.31 145.0 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.177 -0.465 . . . . 1.0700000000000001 110.314 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.496 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -59.61 135.88 57.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.919 -0.582 . . . . 0.70999999999999996 111.563 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.545 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 41.6 t -57.1 -34.56 68.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.609 -1.178 . . . . 1.8799999999999999 111.629 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.7 p -126.7 144.15 51.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.072 0.463 . . . . 1.6299999999999999 110.949 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 46.0 t -72.51 -9.71 58.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.789 -0.641 . . . . 1.96 110.808 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.68 -11.77 55.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.187 0.518 . . . . 2.4199999999999999 110.059 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -110.21 16.64 21.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 2.1200000000000001 111.347 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -60.95 115.14 3.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 1.3500000000000001 110.474 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.631 ' H ' HD12 ' A' ' 183' ' ' LEU . 18.0 t30 -154.82 38.17 0.42 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 122.084 0.945 . . . . 1.6799999999999999 108.538 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.631 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.1 OUTLIER -123.18 129.93 52.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.13 -0.941 . . . . 0.81000000000000005 110.711 -173.497 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 43.0 m -151.21 137.32 18.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.058 0.456 . . . . 0.51000000000000001 111.467 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 51.2 tpp -88.18 134.91 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.952 -0.567 . . . . 1.3500000000000001 110.65 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' CYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 195' ' ' LYS . 39.9 t -113.15 131.93 55.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.939 -0.573 . . . . 1.73 110.387 176.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.09 105.54 10.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.272 -0.64 . . . . 1.9299999999999999 109.272 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.614 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 22.0 pt -136.84 142.58 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.191 -0.458 . . . . 1.1100000000000001 110.426 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.9 m 57.48 27.07 13.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.403 0.439 . . . . 1.8600000000000001 111.303 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.498 ' HG2' ' HG3' ' A' ' 118' ' ' ARG . 0.7 OUTLIER 64.5 14.56 9.0 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.7 -0.682 . . . . 2.8300000000000001 112.475 -178.59 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 16.3 pt20 -117.75 159.66 22.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.551 -0.537 . . . . 1.75 109.551 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.4 133.47 44.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.398 -0.364 . . . . 1.01 111.965 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.657 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 43.2 m-85 -141.42 150.62 42.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.702 -0.681 . . . . 3.9399999999999999 110.499 176.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.464 ' CE1' ' HB3' ' A' ' 169' ' ' LEU . 13.4 m-85 -101.17 114.21 27.95 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.437 -0.579 . . . . 0.92000000000000004 109.437 175.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.421 ' C ' ' HD2' ' A' ' 195' ' ' LYS . 5.2 tmmm? -98.78 127.05 44.59 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.4 -0.593 . . . . 1.1100000000000001 109.4 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.508 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 2.0 t -93.01 151.26 3.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.627 0.727 . . . . 0.69999999999999996 110.015 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 197' ' ' ILE . 1.2 mm -85.68 -58.13 3.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.708 -1.133 . . . . 0.62 110.274 -168.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.44 ' C ' ' HE3' ' A' ' 198' ' ' LYS . 0.0 OUTLIER -137.07 179.87 6.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.335 -0.848 . . . . 1.3799999999999999 110.771 176.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -48.16 136.9 11.3 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.097 0.873 . . . . 2.23 113.223 -170.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.491 HG13 ' HE3' ' A' ' 104' ' ' MET . 33.1 mm -102.48 133.65 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.737 -0.665 . . . . 0.88 110.268 176.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 202' ' ' PRO . 49.1 mt-10 -98.68 138.87 20.78 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.611 -0.722 . . . . 2.0600000000000001 109.607 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 49.7 Cg_exo -55.77 115.28 2.34 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.457 2.105 . . . . 0.51000000000000001 111.962 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.72 7.44 8.06 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.497 -0.859 . . . . 0.69999999999999996 113.498 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.62 122.27 11.83 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.643 0.722 . . . . 1.27 111.535 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -111.78 95.36 5.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.817 -0.629 . . . . 2.9199999999999999 112.03 177.243 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.484 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.4 mm? -115.65 97.68 6.27 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.33 -0.948 . . . . 0.90000000000000002 109.46 173.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.847 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 0.9 OUTLIER -146.96 115.07 6.57 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.53000000000000003 109.806 176.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.612 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.9 p -153.64 158.42 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 121.729 -0.607 . . . . 0.91000000000000003 111.191 -177.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -84.89 110.92 19.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.28 -1.008 . . . . 1.55 108.28 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 61.7 t -60.24 119.97 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.223 0.535 . . . . 2.5600000000000001 110.226 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.485 ' HA ' ' HA3' ' A' ' 218' ' ' GLY . 0.3 OUTLIER -137.28 138.93 40.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.598 -0.728 . . . . 5.3600000000000003 110.637 -175.355 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -133.34 30.17 3.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.615 0.721 . . . . 5.7999999999999998 109.921 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -168.82 -74.31 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 108.585 -1.806 . . . . 5.6100000000000003 108.585 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.467 HG12 ' CD1' ' A' ' 215' ' ' TYR . 7.9 t -139.7 -66.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.459 0.647 . . . . 6.3099999999999996 109.451 170.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.714 ' H ' ' HD2' ' A' ' 216' ' ' PRO . 70.8 m-85 -138.86 -56.77 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 115.213 -0.903 . . . . 8.8300000000000001 112.814 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.714 ' HD2' ' H ' ' A' ' 215' ' ' TYR . 37.0 Cg_endo -64.16 -67.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.102 1.868 . . . . 7.7800000000000002 113.97 -161.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -61.19 -9.19 4.42 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.238 0.459 . . . . 8.0199999999999996 112.238 -172.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 211' ' ' LYS . . . -59.9 -44.06 97.47 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.926 -0.579 . . . . 8.6400000000000006 113.085 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.2 t -145.63 -21.0 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.141 0.422 . . . . 9.7200000000000006 112.141 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 216' ' ' PRO . 3.7 m -104.55 155.58 37.17 Favored Pre-proline 0 C--N 1.326 -0.446 0 C-N-CA 120.881 -0.328 . . . . 9.6199999999999992 110.192 177.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -72.04 131.1 17.55 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.144 1.896 . . . . 11.65 111.486 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.3 -1.87 10.32 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.596 2.197 . . . . 13.109999999999999 112.214 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -125.76 49.86 0.9 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.425 -0.807 . . . . 14.029999999999999 111.288 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 51.9 tp -64.85 134.18 53.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.562 0.22 . . . . 16.100000000000001 110.791 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 32.0 t70 68.33 13.56 9.04 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.689 -0.687 . . . . 17.699999999999999 111.108 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 116.005 -0.543 . . . . 18.899999999999999 111.296 -179.619 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.153 -0.379 . . . . 33.259999999999998 112.153 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.7 t -113.13 68.76 0.68 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.376 0.608 . . . . 33.920000000000002 110.647 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.39 -47.99 3.89 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.598 -1.001 . . . . 32.350000000000001 110.598 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -88.97 121.72 69.47 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.541 -0.54 . . . . 31.649999999999999 109.541 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -59.62 109.64 0.61 Allowed 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.488 2.125 . . . . 29.989999999999998 112.091 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 3.3 p -95.42 11.33 33.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.015 0.436 . . . . 28.920000000000002 111.296 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.5 m -71.93 93.36 1.35 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.111 -0.495 . . . . 26.940000000000001 109.978 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 61.71 47.93 5.94 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.858 -0.61 . . . . 25.829999999999998 110.555 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.431 ' HB3' ' HA ' ' A' ' 56' ' ' THR . 7.1 p-10 -76.29 145.76 39.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.644 -0.707 . . . . 23.530000000000001 110.509 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.486 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 21.1 t80 -104.7 80.08 1.61 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.31 -0.626 . . . . 21.640000000000001 109.31 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 49.4 m -106.91 98.19 20.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.104 -0.498 . . . . 19.420000000000002 110.923 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 60' ' ' PHE . 3.5 Cg_exo -81.34 135.82 9.67 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.945 2.43 . . . . 17.170000000000002 111.825 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -82.55 -17.58 44.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.127 -0.488 . . . . 17.469999999999999 110.095 175.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -63.0 129.86 42.22 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.316 0.579 . . . . 15.630000000000001 110.561 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.34 -20.04 9.09 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.701 -0.761 . . . . 12.039999999999999 111.856 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.404 ' N ' ' HD3' ' A' ' 67' ' ' PRO . 9.2 t -133.89 64.4 66.67 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.914 0.388 . . . . 10.67 110.198 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 66' ' ' SER . 2.2 Cg_endo -84.17 79.12 2.7 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.648 2.232 . . . . 9.6899999999999995 111.48 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -94.76 90.19 5.98 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.357 -0.838 . . . . 7.7000000000000002 110.304 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -87.93 124.47 33.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.772 -0.649 . . . . 8.1400000000000006 110.444 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -91.55 117.88 68.06 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 115.962 -0.563 . . . . 5.96 109.788 177.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 12.2 Cg_exo -70.69 -159.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.985 2.457 . . . . 6.1299999999999999 112.303 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.0 m -53.71 -32.02 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 111.923 0.342 . . . . 6.5300000000000002 111.923 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -101.22 114.69 28.9 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.595 -0.52 . . . . 5.0099999999999998 109.595 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.531 HD13 ' H ' ' A' ' 77' ' ' ASP . 2.3 pp -83.54 138.92 41.09 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.135 0.493 . . . . 4.2300000000000004 111.192 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.08 -4.22 14.16 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.91 2.407 . . . . 4.1200000000000001 112.725 -176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.49 -67.59 0.57 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.073 -0.512 . . . . 3.8199999999999998 109.663 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.531 ' H ' HD13 ' A' ' 74' ' ' ILE . 31.3 t70 49.92 75.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.131 -0.941 . . . . 3.1600000000000001 110.914 177.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.549 HG23 ' HB3' ' A' ' 165' ' ' ALA . 41.5 mt -75.07 117.84 65.94 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.228 -0.896 . . . . 2.4500000000000002 110.607 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.66 133.2 49.96 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.757 2.305 . . . . 1.75 112.798 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.581 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -125.68 146.6 55.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.59 -0.732 . . . . 1.01 109.891 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.64 147.9 76.92 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.683 2.255 . . . . 0.72999999999999998 111.339 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.56 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -57.59 -23.58 51.61 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.462 0.912 . . . . 1.04 113.462 -170.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -89.83 8.35 32.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.596 0.591 . . . . 1.6599999999999999 112.596 -173.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.457 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 23.8 m-85 -132.54 139.47 47.89 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.8 -0.815 . . . . 1.0 108.8 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.457 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 41.8 tt0 -114.36 119.56 37.35 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.839 -0.344 . . . . 2.27 111.103 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 tt -84.19 131.67 34.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.291 -0.633 . . . . 0.79000000000000004 109.291 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -140.38 124.14 17.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.264 -0.426 . . . . 3.21 110.752 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -80.84 111.82 17.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.298 -0.631 . . . . 2.46 109.298 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -177.31 127.06 0.15 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.566 -0.901 . . . . 1.5800000000000001 108.566 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.2 m -90.69 105.51 17.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.887 0.375 . . . . 1.8600000000000001 111.132 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.538 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -85.44 123.62 72.66 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 108.766 -0.827 . . . . 1.45 108.766 174.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.5 119.13 5.69 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.337 2.691 . . . . 1.6100000000000001 113.233 -172.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.7 -28.74 10.87 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.645 -0.707 . . . . 1.74 112.259 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -117.42 -58.45 2.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.898 0.38 . . . . 1.4099999999999999 110.946 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 114.52 -138.68 15.03 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.894 -0.594 . . . . 1.0900000000000001 111.722 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -73.32 159.74 32.91 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.503 -0.184 . . . . 2.3100000000000001 110.503 175.433 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.57 178.17 46.46 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.576 -0.821 . . . . 0.58999999999999997 112.269 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.65 148.33 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.239 -0.652 . . . . 0.67000000000000004 109.239 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -119.14 120.21 36.44 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.074 -0.343 . . . . 1.1299999999999999 110.074 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.508 ' H ' ' HG2' ' A' ' 205' ' ' GLU . . . -67.79 125.43 26.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.323 -0.399 . . . . 0.54000000000000004 110.955 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.56 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -88.23 -1.04 57.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.881 0.372 . . . . 1.6799999999999999 110.285 176.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 15.6 ttm-85 -125.7 152.62 45.03 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.392 -0.595 . . . . 3.5 109.392 174.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.54 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -76.7 159.62 30.04 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.358 -0.383 . . . . 2.3999999999999999 110.728 176.429 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.672 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 47.3 mtm -134.25 152.11 51.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.51 -0.314 . . . . 1.22 110.262 176.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -130.66 144.52 51.49 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.691 0.62 . . . . 2.3100000000000001 110.045 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -37.42 121.07 0.83 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 124.446 1.091 . . . . 0.83999999999999997 113.467 -170.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.21 7.26 12.68 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.464 -0.789 . . . . 1.04 111.509 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.52 ' CD ' ' HB ' ' A' ' 196' ' ' VAL . 0.9 OUTLIER -83.68 164.42 19.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.96 0.41 . . . . 2.6200000000000001 110.648 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.665 ' HG3' ' CE2' ' A' ' 193' ' ' TYR . 8.5 tmm_? -145.97 130.96 18.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.364 -0.38 . . . . 3.6200000000000001 110.777 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.457 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 5.1 mt -96.45 138.24 34.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.304 -0.628 . . . . 0.53000000000000003 109.304 175.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.453 ' HA3' ' C ' ' A' ' 112' ' ' PRO . . . 83.74 -117.39 4.43 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.651 -0.785 . . . . 1.02 112.608 177.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.453 ' C ' ' HA3' ' A' ' 111' ' ' GLY . 17.4 Cg_exo -66.73 167.35 56.63 Favored 'Cis proline' 0 C--N 1.347 0.498 0 CA-C-N 118.94 1.37 . . . . 2.1000000000000001 113.716 5.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.436 ' O ' ' HA3' ' A' ' 166' ' ' GLY . 42.2 t -68.6 -39.85 80.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 2.0 110.139 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.582 ' HB ' ' H ' ' A' ' 192' ' ' ILE . 48.9 t -122.54 128.88 75.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.008 -0.738 . . . . 2.0299999999999998 109.008 175.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.9 m -111.19 -174.73 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.078 -0.51 . . . . 3.9500000000000002 110.154 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.479 ' HB ' ' HD3' ' A' ' 117' ' ' PRO . 16.2 t -57.4 -54.96 49.46 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 111.735 0.272 . . . . 5.21 111.735 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.479 ' HD3' ' HB ' ' A' ' 116' ' ' VAL . 55.2 Cg_endo -70.47 135.35 28.57 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.731 1.62 . . . . 5.0700000000000003 112.254 176.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 67.3 178.99 0.23 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.773 -0.648 . . . . 7.9900000000000002 111.378 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -159.95 146.99 16.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.266 -0.425 . . . . 6.9500000000000002 110.56 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.19 73.43 8.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.395 0.617 . . . . 6.0899999999999999 110.477 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.33 158.11 36.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.258 -0.883 . . . . 5.5599999999999996 110.691 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -74.92 58.54 0.85 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.13 -0.941 . . . . 7.4199999999999999 111.311 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -61.12 -45.71 93.56 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.375 -1.284 . . . . 9.0099999999999998 109.978 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.3 m -143.59 -62.18 0.4 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.578 -0.737 . . . . 8.8800000000000008 110.433 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -124.72 -176.35 3.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.008 0.432 . . . . 7.5999999999999996 110.574 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -152.08 140.08 20.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.562 -0.745 . . . . 7.2300000000000004 109.789 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.02 11.1 60.48 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.766 -0.731 . . . . 4.5899999999999999 113.088 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TRP . . . . . 0.48 ' CG ' ' N ' ' A' ' 129' ' ' GLU . 1.4 p90 -141.72 -78.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.059 0.43 . . . . 4.9299999999999997 111.017 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.48 ' N ' ' CG ' ' A' ' 128' ' ' TRP . 3.4 pt-20 -167.91 -65.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.058 0.392 . . . . 7.6500000000000004 112.058 -175.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.471 ' H ' ' HG3' ' A' ' 129' ' ' GLU . 29.2 pt20 -176.1 164.55 2.79 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.219 -0.289 . . . . 8.8399999999999999 110.219 -169.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.49 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -122.21 4.42 5.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.357 0.599 . . . . 6.0499999999999998 109.831 171.242 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.9 mp -95.53 155.37 16.77 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.419 -0.809 . . . . 8.5 109.316 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.7 t 41.67 43.34 2.36 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.234 0.959 . . . . 9.8200000000000003 112.114 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -112.3 120.46 41.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.172 0.51 . . . . 11.210000000000001 110.665 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.8 p -85.11 133.12 30.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.454 -0.794 . . . . 10.84 111.368 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -64.06 131.58 47.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.82 -0.627 . . . . 13.25 110.299 176.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.1 p -88.17 -26.3 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.997 -0.547 . . . . 13.890000000000001 110.326 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.8 t -117.85 86.81 25.63 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.619 -0.512 . . . . 14.050000000000001 109.619 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.13 119.21 5.43 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.945 2.43 . . . . 14.41 112.428 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -82.33 83.47 7.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.992 -0.549 . . . . 14.44 110.644 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -99.59 -36.49 9.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.419 0.628 . . . . 15.9 110.02 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -146.34 166.94 28.05 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.787 -0.925 . . . . 15.6 110.787 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 24.7 t 58.51 40.96 23.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.697 0.76 . . . . 15.6 109.936 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.6 mt -83.74 -24.93 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.307 -0.86 . . . . 13.85 110.326 -176.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.6 t -70.03 115.22 8.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.421 0.629 . . . . 13.19 110.706 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -108.7 -62.33 1.48 Allowed 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.292 -1.003 . . . . 15.67 108.292 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.714 HG22 ' H ' ' A' ' 148' ' ' SER . 3.7 mt 61.95 177.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 114.333 -1.303 . . . . 13.77 110.427 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.714 ' H ' HG22 ' A' ' 147' ' ' ILE . 2.7 p -134.08 58.54 1.77 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.238 0.542 . . . . 13.619999999999999 111.072 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -138.03 151.42 47.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.803 -0.635 . . . . 13.02 110.945 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 60.77 60.64 1.85 Allowed 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 122.139 0.971 . . . . 14.68 111.524 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.6 pp -133.47 22.07 4.0 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.212 -1.358 . . . . 13.550000000000001 109.716 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 134.83 94.02 0.46 Allowed Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.73 -1.123 . . . . 15.800000000000001 110.919 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.6 p -66.19 -29.04 69.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.18 0.514 . . . . 17.079999999999998 110.546 -177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -111.71 -69.22 0.88 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.61 -0.723 . . . . 18.43 109.974 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.579 ' HD2' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -117.07 146.21 43.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.332 -0.849 . . . . 18.530000000000001 111.158 -174.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.19 151.7 23.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.021 -0.536 . . . . 14.32 110.431 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 10.2 p -108.97 -25.92 10.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.084 -0.507 . . . . 14.51 111.019 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.9 p -69.61 144.04 14.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.852 -0.425 . . . . 13.06 109.852 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 162' ' ' GLN . 43.5 t0 -85.76 137.92 32.46 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.45 -0.5 . . . . 10.33 110.724 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.441 ' HB1' ' HB2' ' A' ' 148' ' ' SER . . . -172.91 -59.13 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.214 -0.903 . . . . 9.8800000000000008 109.727 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -87.66 -28.63 21.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.673 -0.694 . . . . 10.23 110.896 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HB2' ' OD1' ' A' ' 159' ' ' ASP . 47.4 mt-30 -68.1 -48.8 64.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.127 -0.694 . . . . 9.0600000000000005 109.127 175.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 67.59 84.79 0.15 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.348 -0.842 . . . . 6.1900000000000004 111.695 170.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -67.79 146.37 46.65 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.487 -1.045 . . . . 3.9700000000000002 110.487 171.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.549 ' HB3' HG23 ' A' ' 78' ' ' ILE . . . -75.43 7.13 3.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.196 0.498 . . . . 2.6299999999999999 111.949 -175.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 113' ' ' CYS . . . 80.54 -48.59 3.69 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.251 -0.431 . . . . 1.3 113.544 174.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.5 t -59.54 -23.31 62.74 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.6 0.36 . . . . 1.8200000000000001 111.853 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 41.4 p-90 -65.17 -17.48 64.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.007 0.432 . . . . 0.69999999999999996 111.314 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 43.7 mt -80.16 -13.86 58.93 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.199 0.444 . . . . 0.66000000000000003 112.199 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -70.55 -13.1 61.97 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.264 -0.574 . . . . 1.48 109.887 177.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -68.06 -36.81 80.49 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.707 -0.679 . . . . 1.97 111.406 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.655 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -69.36 124.77 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.325 -0.55 . . . . 0.67000000000000004 109.942 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.493 ' NE ' ' HA ' ' A' ' 173' ' ' ARG . 3.9 mmp_? -112.29 -166.51 1.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.957 -0.565 . . . . 4.3399999999999999 110.82 -176.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.0 t -73.55 151.9 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.332 . . . . 1.0700000000000001 110.566 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -64.38 134.23 54.17 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.01 -0.541 . . . . 0.70999999999999996 111.014 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.5 t -78.94 -12.46 60.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.381 -0.827 . . . . 1.8799999999999999 110.245 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 180' ' ' ASP . 46.5 m -125.74 140.99 52.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.904 -0.589 . . . . 1.6299999999999999 109.641 176.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' CYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 61.4 m -79.38 -19.39 50.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 1.96 111.2 -176.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -89.29 1.78 55.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.233 0.539 . . . . 2.4199999999999999 110.099 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 177' ' ' SER . 27.6 t70 -110.78 15.81 21.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.545 -0.752 . . . . 2.1200000000000001 110.412 -176.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 16.8 mm100 -60.91 116.79 4.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.85 -0.614 . . . . 1.3500000000000001 110.632 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.611 ' ND2' HD11 ' A' ' 200' ' ' ILE . 23.7 t30 -153.9 33.18 0.44 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.076 0.941 . . . . 1.6799999999999999 109.282 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -121.93 120.8 35.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.563 -0.744 . . . . 0.81000000000000005 110.644 -172.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 30.3 m -142.92 121.91 12.81 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.265 0.555 . . . . 0.51000000000000001 110.93 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.415 ' HB2' ' HE2' ' A' ' 185' ' ' MET . 52.2 tpp -92.19 127.74 37.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.639 -0.709 . . . . 1.3500000000000001 109.981 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 38.6 t -126.11 162.43 25.36 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.402 -0.592 . . . . 1.73 109.402 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -134.43 147.06 50.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.757 0.313 . . . . 1.9299999999999999 110.835 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.742 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 24.4 pt -137.42 133.48 46.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.53 -0.759 . . . . 1.1100000000000001 109.479 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.7 t 55.33 28.87 12.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.954 0.407 . . . . 1.8600000000000001 110.84 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 66.86 24.29 9.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.552 -0.749 . . . . 2.8300000000000001 112.058 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.742 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 11.9 pt20 -118.53 155.01 31.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.09 -0.707 . . . . 1.75 109.09 172.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.582 ' H ' ' HB ' ' A' ' 114' ' ' VAL . 38.0 mm -81.65 126.06 39.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.108 0.48 . . . . 1.01 111.806 -170.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.665 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 63.0 t80 -121.92 127.64 50.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.401 -0.818 . . . . 3.9399999999999999 110.401 -174.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 7.2 m-85 -99.9 113.48 26.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.046 0.45 . . . . 0.92000000000000004 110.048 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -114.97 123.32 48.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.554 -0.748 . . . . 1.1100000000000001 109.952 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.52 ' HB ' ' CD ' ' A' ' 108' ' ' GLU . 2.0 t -96.45 153.35 3.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.559 0.695 . . . . 0.69999999999999996 109.754 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 2.1 mm -92.61 -58.05 3.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.575 -1.193 . . . . 0.62 111.931 -166.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.522 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.7 OUTLIER -141.03 -178.18 5.45 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.616 -0.72 . . . . 1.3799999999999999 111.713 -173.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.672 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.5 m-20 -45.8 116.21 1.15 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.986 0.804 . . . . 2.23 112.93 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.611 HD11 ' ND2' ' A' ' 182' ' ' ASN . 14.8 mm -88.28 135.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.563 -0.744 . . . . 0.88 109.535 170.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 46.4 mt-10 -99.94 130.43 26.35 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.236 -0.653 . . . . 2.0600000000000001 109.236 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.33 117.71 2.45 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.067 2.512 . . . . 0.51000000000000001 112.695 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.93 -9.99 9.63 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.872 -0.68 . . . . 0.69999999999999996 112.982 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 19.9 pt-20 -138.52 121.48 16.66 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 117.569 0.685 . . . . 1.27 112.118 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.508 ' HG2' ' H ' ' A' ' 100' ' ' ALA . 7.7 mm-40 -111.2 125.0 53.33 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.061 -0.518 . . . . 2.9199999999999999 110.201 170.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.538 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 2.4 mm? -122.28 99.29 6.34 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.327 -0.62 . . . . 0.90000000000000002 109.327 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.655 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.3 mm? -145.62 115.59 7.38 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.497 -0.557 . . . . 0.53000000000000003 109.497 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.495 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 6.3 p -153.21 157.89 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.509 -0.476 . . . . 0.91000000000000003 111.169 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -98.6 111.4 23.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.84 -0.618 . . . . 1.55 109.828 173.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.45 HG23 HG13 ' A' ' 208' ' ' VAL . 52.6 t -122.04 94.92 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.329 -0.619 . . . . 2.5600000000000001 109.329 171.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.459 ' HE3' ' HG2' ' A' ' 212' ' ' GLU . 26.3 ttpt -153.99 154.59 34.03 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.837 -0.801 . . . . 5.3600000000000003 108.837 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.459 ' HG2' ' HE3' ' A' ' 211' ' ' LYS . 24.1 mm-40 36.25 89.45 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 O-C-N 124.804 1.315 . . . . 5.7999999999999998 112.496 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.24 41.37 1.11 Allowed Glycine 0 C--O 1.227 -0.291 0 CA-C-N 116.234 -0.439 . . . . 5.6100000000000003 113.006 -175.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 18.6 t -108.77 -65.79 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.136 0.493 . . . . 6.3099999999999996 110.183 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.46 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 42.1 m-85 -61.88 -56.21 34.22 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.245 -0.889 . . . . 8.8300000000000001 112.285 -175.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 17.9 Cg_endo -57.64 -44.15 44.08 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.193 1.929 . . . . 7.7800000000000002 112.769 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.31 -33.45 63.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.01 0.433 . . . . 8.0199999999999996 110.977 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 88.47 21.86 42.67 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.072 -0.585 . . . . 8.6400000000000006 111.813 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 12.4 p -85.23 49.72 1.8 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.069 0.461 . . . . 9.7200000000000006 111.464 -175.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 14.9 m -79.56 114.75 48.18 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.927 -0.578 . . . . 9.6199999999999992 110.749 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.29 130.62 25.9 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.761 2.307 . . . . 11.65 112.223 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.83 55.58 5.3 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.95 2.433 . . . . 13.109999999999999 112.794 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -163.79 172.26 39.63 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.804 -0.712 . . . . 14.029999999999999 112.25 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 8.0 tt -144.75 129.53 18.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.547 -0.538 . . . . 16.100000000000001 109.547 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -112.3 -46.53 3.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.07 0.462 . . . . 17.699999999999999 110.649 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.288 -0.863 . . . . 18.899999999999999 110.232 -178.081 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 111.903 -0.479 . . . . 33.259999999999998 111.903 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.7 m -86.01 -39.16 17.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.838 0.351 . . . . 33.920000000000002 110.644 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.63 142.12 15.02 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.108 -0.568 . . . . 32.350000000000001 111.782 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -90.75 126.55 55.48 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.911 0.386 . . . . 31.649999999999999 110.975 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.84 117.9 5.22 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.421 2.081 . . . . 29.989999999999998 112.007 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -143.89 144.29 31.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.062 -0.517 . . . . 28.920000000000002 109.795 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 p -153.91 65.35 0.72 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.017 0.437 . . . . 26.940000000000001 110.984 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.6 136.96 56.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.013 -0.54 . . . . 25.829999999999998 110.423 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.34 88.44 6.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.999 0.428 . . . . 23.530000000000001 110.436 175.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -107.25 145.48 32.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.157 -0.474 . . . . 21.640000000000001 109.937 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 35.5 p 46.97 77.02 0.49 Allowed Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.38 0.672 . . . . 19.420000000000002 112.183 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.94 87.15 0.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.574 2.183 . . . . 17.170000000000002 111.267 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -96.42 44.65 1.06 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.956 -1.02 . . . . 17.469999999999999 110.945 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -78.29 97.93 5.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.851 -0.613 . . . . 15.630000000000001 110.094 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.33 74.79 1.43 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.884 -0.674 . . . . 12.039999999999999 112.016 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 48.8 m -147.98 137.76 12.38 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.891 -0.411 . . . . 10.67 109.891 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 66' ' ' SER . 25.6 Cg_exo -62.82 102.18 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.755 2.304 . . . . 9.6899999999999995 111.909 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -96.15 120.37 36.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.124 -0.489 . . . . 7.7000000000000002 110.94 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.488 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 42.4 tt0 -94.56 141.44 28.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.071 -0.513 . . . . 8.1400000000000006 109.895 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.71 110.49 17.42 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.505 -0.316 . . . . 5.96 110.413 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 69' ' ' GLU . 32.1 Cg_exo -61.33 -74.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.865 2.377 . . . . 6.1299999999999999 112.165 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 p -121.59 -32.92 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.167 -0.47 . . . . 6.5300000000000002 110.631 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -98.27 124.79 43.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.157 -0.474 . . . . 5.0099999999999998 110.323 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.438 HG13 ' H ' ' A' ' 74' ' ' ILE . 1.9 pp -77.48 152.31 81.01 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.201 -0.454 . . . . 4.2300000000000004 111.675 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -90.96 26.42 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.052 2.501 . . . . 4.1200000000000001 112.685 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' HB2' HD13 ' A' ' 74' ' ' ILE . 10.8 mm-40 -74.02 -61.91 1.69 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.888 -0.596 . . . . 3.8199999999999998 110.054 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 62.96 67.91 0.66 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.536 -0.757 . . . . 3.1600000000000001 110.56 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.0 mt -69.45 123.59 88.74 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.337 -0.847 . . . . 2.4500000000000002 109.732 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.41 117.64 4.17 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.0 2.467 . . . . 1.75 112.983 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.504 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -128.41 146.03 58.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.823 -0.626 . . . . 1.01 109.584 176.165 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -53.19 147.71 34.27 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.823 2.349 . . . . 0.72999999999999998 112.11 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.576 ' O ' ' HD2' ' A' ' 101' ' ' LYS . . . -70.56 -0.39 8.46 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.551 0.574 . . . . 1.04 112.551 -173.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -106.0 4.6 29.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.881 0.372 . . . . 1.6599999999999999 111.167 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -136.1 138.5 42.14 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.502 ' HB2' ' HE2' ' A' ' 101' ' ' LYS . 5.8 tp10 -109.81 124.27 51.01 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.299 -0.56 . . . . 2.27 111.286 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.429 ' HB2' HG21 ' A' ' 80' ' ' ILE . 58.0 tp -87.91 128.3 35.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.158 -0.473 . . . . 0.79000000000000004 110.078 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -147.87 118.87 7.66 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.635 -0.711 . . . . 3.21 109.796 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.14 112.62 10.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.989 0.424 . . . . 2.46 109.971 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.2 t -172.92 133.56 0.55 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.338 -0.986 . . . . 1.5800000000000001 108.338 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.4 t -87.36 106.04 17.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.929 0.395 . . . . 1.8600000000000001 110.805 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -85.79 123.12 72.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.413 -0.588 . . . . 1.45 109.413 173.222 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -45.59 119.32 2.64 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.515 2.81 . . . . 1.6100000000000001 113.346 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.32 -29.1 10.46 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.812 -0.631 . . . . 1.74 112.415 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 173' ' ' ARG . . . -124.28 -65.88 1.02 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.048 0.451 . . . . 1.4099999999999999 111.671 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.604 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 123.5 -132.59 8.56 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.127 -0.789 . . . . 1.0900000000000001 111.127 -175.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 1.2 pp -72.82 159.69 33.37 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.986 0.393 . . . . 2.3100000000000001 110.746 175.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.91 174.73 47.09 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.844 -0.693 . . . . 0.58999999999999997 111.958 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 19.4 m -106.64 130.8 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 121.266 0.555 . . . . 0.67000000000000004 109.71 174.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -96.85 114.89 26.56 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.652 -0.704 . . . . 1.1299999999999999 110.019 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 202' ' ' PRO . . . -64.34 114.26 4.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.235 -0.283 . . . . 0.54000000000000004 110.235 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 82' ' ' ALA . 15.8 ptpt -83.71 -8.99 59.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.244 0.545 . . . . 1.6799999999999999 110.665 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 27.2 ttp180 -125.66 155.75 40.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.547 -0.751 . . . . 3.5 109.772 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.432 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -81.88 155.45 25.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.95 -0.568 . . . . 2.3999999999999999 109.779 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.584 ' HB3' ' OE2' ' A' ' 108' ' ' GLU . 59.6 mtm -136.13 153.31 51.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.684 -0.234 . . . . 1.22 110.507 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -117.34 140.37 49.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.129 -0.487 . . . . 2.3100000000000001 109.716 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.62 131.39 3.92 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 124.421 1.076 . . . . 0.83999999999999997 113.61 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.25 7.67 11.03 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.528 -0.76 . . . . 1.04 112.368 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.584 ' OE2' ' HB3' ' A' ' 104' ' ' MET . 0.7 OUTLIER -85.74 167.9 14.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.293 0.568 . . . . 2.6200000000000001 111.435 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -143.28 135.33 26.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.746 -0.661 . . . . 3.6200000000000001 110.182 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 4.4 mt -104.6 132.91 50.3 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.598 -0.89 . . . . 0.53000000000000003 108.598 171.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.82 166.48 39.67 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.188 -1.006 . . . . 1.02 112.724 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.18 142.03 43.75 Favored 'Cis proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.414 -1.494 . . . . 2.1000000000000001 111.909 -2.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.614 ' SG ' HD13 ' A' ' 169' ' ' LEU . 56.9 m -88.32 -2.9 58.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.044 0.45 . . . . 2.0 110.765 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.493 HG13 ' H ' ' A' ' 192' ' ' ILE . 15.6 m -94.37 126.55 46.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.047 -0.524 . . . . 2.0299999999999998 110.802 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 165' ' ' ALA . 45.7 t -74.0 140.27 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.702 -0.681 . . . . 3.9500000000000002 109.359 176.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 32.6 m -43.95 113.35 1.54 Allowed Pre-proline 0 CA--C 1.536 0.435 0 O-C-N 124.012 0.82 . . . . 5.21 112.056 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 116' ' ' VAL . 23.4 Cg_exo -64.5 166.73 16.69 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.128 2.552 . . . . 5.0700000000000003 113.407 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 74.17 148.7 0.1 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.009 -0.996 . . . . 7.9900000000000002 110.788 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 71.32 -50.6 0.69 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.418 0.687 . . . . 6.9500000000000002 112.328 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.19 -73.06 0.16 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.236 0.214 . . . . 6.0899999999999999 111.383 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 55.87 94.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.691 0.619 . . . . 5.5599999999999996 111.394 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -62.89 143.94 57.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.63 -0.714 . . . . 7.4199999999999999 111.442 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 124' ' ' THR . 0.6 OUTLIER -141.42 -49.91 0.41 Allowed 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.209 -0.905 . . . . 9.0099999999999998 108.717 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.41 ' N ' ' HG3' ' A' ' 123' ' ' GLU . 25.2 m -78.66 -58.57 3.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.672 -0.695 . . . . 8.8800000000000008 110.304 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -91.59 124.55 35.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.35 -0.841 . . . . 7.5999999999999996 111.169 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -125.14 -170.77 2.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.022 -0.535 . . . . 7.2300000000000004 110.647 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 179.72 -39.52 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.013 -0.835 . . . . 4.5899999999999999 111.013 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -126.45 -56.59 1.4 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.518 -0.549 . . . . 4.9299999999999997 109.518 175.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.595 ' HG3' ' H ' ' A' ' 130' ' ' GLN . 6.7 pt-20 -179.64 -69.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.839 -0.619 . . . . 7.6500000000000004 110.777 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.595 ' H ' ' HG3' ' A' ' 129' ' ' GLU . 6.1 tp-100 -174.29 161.26 3.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.107 -0.701 . . . . 8.8399999999999999 109.107 -175.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.44 40.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.018 0.437 . . . . 6.0499999999999998 111.512 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.95 57.34 4.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.026 0.917 . . . . 8.5 110.546 176.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.6 t -150.22 27.86 0.75 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.444 -1.253 . . . . 9.8200000000000003 109.571 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -96.78 89.27 4.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.171 -0.922 . . . . 11.210000000000001 110.516 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.1 p -56.61 136.59 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.613 -0.721 . . . . 10.84 110.756 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 136' ' ' GLU . 5.0 tp10 -80.23 82.89 6.19 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.988 -0.551 . . . . 13.25 110.038 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.72 -30.78 39.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.699 -0.682 . . . . 13.890000000000001 110.462 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.1 m -105.4 104.71 49.21 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.592 -0.521 . . . . 14.050000000000001 109.592 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -42.59 118.53 1.15 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.427 2.752 . . . . 14.41 112.89 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.436 ' HB3' ' OE2' ' A' ' 136' ' ' GLU . 3.7 pt20 -80.09 47.17 0.87 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.629 0.728 . . . . 14.44 111.158 -174.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -111.02 74.34 0.86 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.609 -0.723 . . . . 15.9 110.602 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 144.65 -168.7 26.75 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.818 -0.706 . . . . 15.6 112.149 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 50.7 t -79.4 103.82 9.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.03 0.443 . . . . 15.6 110.178 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 61.6 mt -127.47 129.8 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.724 -0.843 . . . . 13.85 108.724 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.6 t -61.44 114.76 3.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.804 0.811 . . . . 13.19 111.126 -177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -126.46 -6.13 6.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.159 -0.928 . . . . 15.67 109.164 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.41 ' H ' HG13 ' A' ' 147' ' ' ILE . 2.8 pp -106.85 158.78 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 115.127 -0.942 . . . . 13.77 111.273 -174.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 48.5 t -123.39 139.79 53.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.271 -0.877 . . . . 13.619999999999999 108.642 173.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -94.22 145.46 24.7 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.039 0.447 . . . . 13.02 110.942 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -82.52 83.93 7.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.72 -0.673 . . . . 14.68 109.6 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.535 HD21 ' HA ' ' A' ' 160' ' ' ALA . 0.7 OUTLIER -89.88 49.04 1.66 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.585 -0.734 . . . . 13.550000000000001 111.941 -175.082 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -60.76 -24.79 62.79 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 121.216 -0.516 . . . . 15.800000000000001 112.686 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.5 m -148.33 25.66 0.98 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.104 0.478 . . . . 17.079999999999998 110.474 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 151' ' ' LEU . 18.9 mm-40 -95.41 -77.05 0.48 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.843 -0.617 . . . . 18.43 110.075 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.08 157.44 44.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.647 -0.871 . . . . 18.530000000000001 108.647 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -133.19 36.31 3.44 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.645 -0.422 . . . . 14.32 111.849 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 85.0 m -135.89 -60.2 0.74 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.654 -0.248 . . . . 14.51 111.174 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.8 t -82.02 124.48 39.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.77 0.319 . . . . 13.06 111.627 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 48.47 67.91 0.77 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.15 -0.932 . . . . 10.33 112.403 176.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.535 ' HA ' HD21 ' A' ' 151' ' ' LEU . . . -86.68 162.73 17.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.037 -0.529 . . . . 9.8800000000000008 110.493 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -104.87 46.77 0.9 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.305 0.574 . . . . 10.23 110.551 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -74.55 -21.64 59.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.804 -0.635 . . . . 9.0600000000000005 110.766 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 68.81 -174.44 0.19 Allowed 'General case' 0 N--CA 1.462 0.158 0 O-C-N 124.233 0.958 . . . . 6.1900000000000004 110.084 -174.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.54 ' O ' ' HD1' ' A' ' 168' ' ' TRP . . . 170.17 -80.91 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.162 -1.018 . . . . 3.9700000000000002 112.334 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 115' ' ' VAL . . . -50.6 119.06 3.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 2.6299999999999999 111.242 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.65 -42.98 3.0 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.845 -0.616 . . . . 1.3 112.698 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.9 m -59.5 -39.49 83.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.001 0.371 . . . . 1.8200000000000001 112.001 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.54 ' HD1' ' O ' ' A' ' 164' ' ' GLY . 29.9 p-90 -85.55 -22.66 28.01 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.42 -0.512 . . . . 0.69999999999999996 111.157 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.614 HD13 ' SG ' ' A' ' 113' ' ' CYS . 28.7 mt -86.93 -15.0 40.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.389 0.514 . . . . 0.66000000000000003 112.389 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.401 ' C ' ' HD3' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -75.33 -4.09 37.24 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.661 -0.415 . . . . 1.48 110.523 176.686 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -76.57 -37.62 56.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.085 -0.507 . . . . 1.97 111.586 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -67.34 129.36 31.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.539 -0.464 . . . . 0.67000000000000004 110.057 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.427 ' HB3' ' H ' ' A' ' 174' ' ' VAL . 98.9 mtt180 -125.98 -163.38 1.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.933 -0.576 . . . . 4.3399999999999999 111.835 -172.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.451 ' HA ' HG11 ' A' ' 208' ' ' VAL . 20.0 t -62.62 146.83 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.261 -0.881 . . . . 1.0700000000000001 111.449 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.613 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -65.35 136.13 56.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.881 -0.6 . . . . 0.70999999999999996 111.343 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.74 -19.3 64.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.35 -0.841 . . . . 1.8799999999999999 111.143 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 63.6 m -146.03 147.56 31.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.227 -0.442 . . . . 1.6299999999999999 110.027 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' CYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 10.6 p -76.89 -13.66 59.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.877 0.37 . . . . 1.96 111.427 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -73.56 -25.34 60.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.493 0.663 . . . . 2.4199999999999999 110.101 172.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.451 ' O ' ' HG ' ' A' ' 206' ' ' LEU . 17.0 m-20 -92.61 17.27 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.428 -0.805 . . . . 2.1200000000000001 111.606 -176.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 29.6 mm-40 -55.65 114.46 1.87 Allowed 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.36 0.6 . . . . 1.3500000000000001 110.068 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.744 ' ND2' HD11 ' A' ' 200' ' ' ILE . 19.5 t30 -161.59 34.51 0.13 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 122.597 1.189 . . . . 1.6799999999999999 108.112 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.654 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -124.8 119.0 27.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.99 -1.005 . . . . 0.81000000000000005 110.34 -172.399 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 61.3 m -150.62 129.37 12.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.06 0.457 . . . . 0.51000000000000001 111.19 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 49.4 ttm -91.04 137.29 32.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.174 -0.466 . . . . 1.3500000000000001 110.11 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 50.0 t -115.28 132.06 56.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.166 -0.47 . . . . 1.73 110.579 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 23.5 tm0? -108.87 105.21 14.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.278 -0.638 . . . . 1.9299999999999999 109.278 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 13.3 pt -144.01 144.13 23.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.001 -0.545 . . . . 1.1100000000000001 110.331 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.1 t 61.29 27.87 17.48 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.211 0.529 . . . . 1.8600000000000001 110.371 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.416 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 6.0 mm-40 57.9 32.85 22.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.217 -0.901 . . . . 2.8300000000000001 111.641 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -144.97 165.99 26.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.769 -0.65 . . . . 1.75 109.702 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.493 ' H ' HG13 ' A' ' 114' ' ' VAL . 48.7 mm -100.23 133.11 44.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.04 0.448 . . . . 1.01 111.668 -173.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -132.31 156.89 45.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.226 -0.897 . . . . 3.9399999999999999 109.164 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 11.1 m-85 -100.31 119.3 38.2 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.43 -0.508 . . . . 0.92000000000000004 109.776 173.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -98.17 118.01 33.84 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.462 -0.94 . . . . 1.1100000000000001 108.462 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.533 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 1.8 t -89.32 151.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.493 0.663 . . . . 0.69999999999999996 109.784 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.449 HG13 ' HA ' ' A' ' 182' ' ' ASN . 1.3 mm -97.0 -53.66 7.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 114.656 -1.156 . . . . 0.62 111.553 -163.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.551 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -135.76 174.27 10.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.484 -0.78 . . . . 1.3799999999999999 111.491 -174.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 104' ' ' MET . 3.0 m-20 -50.49 119.65 3.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.368 -0.833 . . . . 2.23 112.268 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.744 HD11 ' ND2' ' A' ' 182' ' ' ASN . 17.3 mm -86.99 135.81 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.985 -0.552 . . . . 0.88 110.627 177.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 20.1 mm-40 -101.65 134.64 20.09 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.656 -0.702 . . . . 2.0600000000000001 109.481 174.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 73.5 Cg_exo -51.1 113.5 1.13 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.802 2.335 . . . . 0.51000000000000001 112.953 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.31 -10.21 9.34 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.68 -0.771 . . . . 0.69999999999999996 113.537 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.7 pt-20 -107.55 127.37 53.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.709 0.754 . . . . 1.27 111.541 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.564 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -109.4 93.59 4.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.471 -0.786 . . . . 2.9199999999999999 111.616 177.657 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.616 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.6 mm? -124.56 95.82 4.67 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.57 -0.852 . . . . 0.90000000000000002 110.885 175.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.532 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.8 mm? -148.07 111.7 5.03 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.263 -0.643 . . . . 0.53000000000000003 109.263 170.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.654 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.7 p -157.05 160.8 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 117.892 0.314 . . . . 0.91000000000000003 110.437 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -109.93 110.9 22.0 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.574 -0.528 . . . . 1.55 109.574 168.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 96.5 t -120.18 99.59 7.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 2.5600000000000001 110.216 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -140.41 131.12 25.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.952 -0.567 . . . . 5.3600000000000003 109.569 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -81.04 74.4 8.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.424 0.63 . . . . 5.7999999999999998 110.475 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 217' ' ' LEU . . . 151.31 63.08 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.533 -0.758 . . . . 5.6100000000000003 111.882 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.05 -71.55 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.604 0.24 . . . . 6.3099999999999996 110.524 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.513 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 88.4 t80 -73.65 -50.97 5.58 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.454 -0.339 . . . . 8.8300000000000001 111.75 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 18.6 Cg_endo -59.67 -41.88 51.85 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.073 1.849 . . . . 7.7800000000000002 112.517 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.434 ' O ' HG22 ' A' ' 220' ' ' VAL . 7.7 mp -101.75 -94.17 0.29 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.295 -0.411 . . . . 8.0199999999999996 110.62 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 53.11 -115.29 4.43 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.379 -0.439 . . . . 8.6400000000000006 112.442 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.5 32.36 2.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.947 0.403 . . . . 9.7200000000000006 110.76 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 221' ' ' PRO . 27.7 m -73.66 138.47 77.2 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 116.161 -0.472 . . . . 9.6199999999999992 110.766 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 20.8 Cg_exo -65.38 130.79 26.19 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.751 2.3 . . . . 11.65 112.3 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.47 58.9 6.5 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.948 2.432 . . . . 13.109999999999999 112.384 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -152.56 151.14 23.02 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 111.382 -0.687 . . . . 14.029999999999999 111.382 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 45.1 tp -141.03 126.21 18.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.331 -0.248 . . . . 16.100000000000001 110.331 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -119.69 -53.93 2.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.16 0.505 . . . . 17.699999999999999 110.363 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.597 -0.729 . . . . 18.899999999999999 109.716 -176.784 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.673 -0.571 . . . . 33.259999999999998 111.673 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.5 t -71.44 -30.54 66.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.301 0.572 . . . . 33.920000000000002 110.03 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . -92.55 162.76 26.95 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.689 -0.767 . . . . 32.350000000000001 111.269 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -107.8 99.86 32.25 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 110.118 -0.327 . . . . 31.649999999999999 110.118 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 23.5 Cg_exo -64.64 112.63 2.02 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.883 2.389 . . . . 29.989999999999998 112.245 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 p -91.57 141.49 28.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.988 -0.551 . . . . 28.920000000000002 110.442 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.407 ' HA ' ' OG1' ' A' ' 61' ' ' THR . 34.0 m 58.62 54.66 5.23 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.248 0.547 . . . . 26.940000000000001 110.298 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 58' ' ' GLU . 1.5 mp0 -53.39 101.25 0.04 OUTLIER 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.822 -1.081 . . . . 25.829999999999998 111.494 -176.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 52.11 47.29 25.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.826 -0.625 . . . . 23.530000000000001 111.146 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.3 t80 62.02 62.59 1.2 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.825 -0.625 . . . . 21.640000000000001 110.118 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.61 ' OG1' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -61.43 -52.14 72.42 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.933 -0.576 . . . . 19.420000000000002 112.048 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.61 ' HD3' ' OG1' ' A' ' 61' ' ' THR . 11.5 Cg_exo -71.23 103.42 1.39 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.903 1.736 . . . . 17.170000000000002 110.696 174.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -76.71 75.55 3.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.71 -0.677 . . . . 17.469999999999999 110.676 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -61.35 134.45 56.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.639 -0.71 . . . . 15.630000000000001 110.077 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.74 146.39 16.28 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.798 -0.715 . . . . 12.039999999999999 111.621 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.9 t -120.43 130.57 24.79 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 110.328 -0.249 . . . . 10.67 110.328 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.47 149.39 74.61 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.877 2.385 . . . . 9.6899999999999995 112.402 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -68.23 129.03 38.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.906 -0.588 . . . . 7.7000000000000002 110.396 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -103.19 145.6 29.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.07 0.462 . . . . 8.1400000000000006 110.338 178.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.9 136.2 82.68 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.579 -0.737 . . . . 5.96 110.85 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.23 -159.42 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.964 2.442 . . . . 6.1299999999999999 111.81 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.76 -36.75 50.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.718 0.294 . . . . 6.5300000000000002 111.013 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -102.9 131.41 49.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.826 -0.435 . . . . 5.0099999999999998 109.826 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.525 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.6 pp -78.57 141.07 60.14 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.051 -0.522 . . . . 4.2300000000000004 111.904 -177.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -88.58 13.23 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.097 2.531 . . . . 4.1200000000000001 113.067 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -85.32 -67.85 0.77 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.833 -0.432 . . . . 3.8199999999999998 109.833 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.4 t70 57.25 67.14 1.02 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.93 0.871 . . . . 3.1600000000000001 110.602 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.7 mt -105.91 108.65 62.05 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 114.88 -1.054 . . . . 2.4500000000000002 109.459 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.14 119.67 6.95 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.809 2.34 . . . . 1.75 112.256 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.545 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -126.86 144.03 48.73 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 1.01 109.723 178.428 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.87 144.76 87.18 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.579 2.186 . . . . 0.72999999999999998 111.453 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.34 -12.27 8.77 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.798 0.666 . . . . 1.04 112.798 -173.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -80.96 -11.27 59.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.925 0.393 . . . . 1.6599999999999999 110.911 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -133.92 165.1 25.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.444 ' HA ' HG13 ' A' ' 80' ' ' ILE . 10.1 pt-20 -155.84 147.01 22.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.914 0.388 . . . . 2.27 110.671 173.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.456 HD11 ' CZ ' ' A' ' 171' ' ' TYR . 7.0 tt -92.26 132.33 36.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.864 -0.607 . . . . 0.79000000000000004 110.43 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.405 ' N ' HD23 ' A' ' 86' ' ' LEU . 76.1 mtt180 -144.27 138.88 28.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.403 -0.817 . . . . 3.21 109.841 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -82.04 112.91 19.55 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.348 -0.612 . . . . 2.46 109.348 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 p -169.03 90.11 0.22 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.678 -0.692 . . . . 1.5800000000000001 109.749 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 p -69.95 105.43 2.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.243 0.544 . . . . 1.8600000000000001 110.744 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.633 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -85.17 123.78 72.92 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.928 -0.767 . . . . 1.45 108.928 175.265 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.08 120.27 7.68 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.287 2.658 . . . . 1.6100000000000001 112.735 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.6 -11.25 53.72 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.597 -0.811 . . . . 1.74 112.181 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.633 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -134.11 -63.07 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.711 -0.288 . . . . 1.4099999999999999 111.609 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.03 -145.83 17.29 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.786 -0.721 . . . . 1.0900000000000001 113.106 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -72.56 158.68 35.23 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.4 0.28 . . . . 2.3100000000000001 110.83 177.113 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.09 175.97 43.33 Favored Glycine 0 C--O 1.237 0.308 0 C-N-CA 120.346 -0.931 . . . . 0.58999999999999997 112.421 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 98' ' ' VAL . 35.3 m -111.22 114.27 46.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.634 0.73 . . . . 0.67000000000000004 109.263 174.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -80.73 100.77 8.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.476 0.655 . . . . 1.1299999999999999 110.996 -169.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.08 120.95 13.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.732 -1.122 . . . . 0.54000000000000004 110.751 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.634 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -101.64 13.79 33.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.513 0.673 . . . . 1.6799999999999999 109.447 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -125.83 155.94 40.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.961 -1.018 . . . . 3.5 109.16 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -83.3 116.27 22.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.211 0.529 . . . . 2.3999999999999999 111.244 174.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.595 ' HE1' HG21 ' A' ' 200' ' ' ILE . 4.8 mpp? -86.92 130.96 34.24 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.573 -0.899 . . . . 1.22 108.573 172.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 8.4 pt-20 -116.32 174.45 6.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.902 0.382 . . . . 2.3100000000000001 111.914 -173.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.93 126.46 18.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.645 -0.707 . . . . 0.83999999999999997 112.899 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.58 -17.19 59.71 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.779 -0.646 . . . . 1.04 114.202 168.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 7.3 pt-20 -76.28 160.09 29.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.607 0.704 . . . . 2.6200000000000001 111.799 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.794 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 6.6 ttt180 -116.42 142.09 47.31 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.418 -0.81 . . . . 3.6200000000000001 110.667 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.7 mt -92.47 136.21 33.4 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.952 -0.758 . . . . 0.53000000000000003 108.952 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 149.88 -147.79 18.41 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.374 -0.917 . . . . 1.02 112.649 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 75.4 Cg_endo -75.34 135.01 38.43 Favored 'Cis proline' 0 CA--C 1.532 0.376 0 C-N-CA 123.064 -1.64 . . . . 2.1000000000000001 112.516 3.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.434 ' SG ' ' HA3' ' A' ' 166' ' ' GLY . 42.5 t -74.7 -67.46 0.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.466 -0.788 . . . . 2.0 109.789 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 191' ' ' GLN . 16.5 m -130.36 144.11 38.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.753 -0.658 . . . . 2.0299999999999998 109.344 176.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.3 m -92.62 -161.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.076 -0.511 . . . . 3.9500000000000002 110.325 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.4 m -39.96 129.84 1.57 Allowed Pre-proline 0 C--O 1.236 0.394 0 O-C-N 123.776 0.672 . . . . 5.21 111.936 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.22 92.47 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.411 2.741 . . . . 5.0700000000000003 113.245 -173.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.84 -40.18 2.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.773 -0.649 . . . . 7.9900000000000002 110.316 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.42 76.37 1.09 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.15 -0.477 . . . . 6.9500000000000002 110.915 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.02 142.32 27.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.137 -0.483 . . . . 6.0899999999999999 109.795 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -129.84 134.5 47.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.013 0.435 . . . . 5.5599999999999996 111.526 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -94.11 146.61 23.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.584 -0.735 . . . . 7.4199999999999999 109.791 175.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -126.81 -82.99 0.62 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.234 -0.439 . . . . 9.0099999999999998 110.031 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.8 m -126.46 -57.18 1.38 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.552 -0.536 . . . . 8.8800000000000008 109.552 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.66 137.01 49.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.605 -0.725 . . . . 7.5999999999999996 109.419 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -132.71 134.05 44.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.078 0.466 . . . . 7.2300000000000004 111.283 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -98.7 9.11 62.08 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.677 -0.692 . . . . 4.5899999999999999 111.817 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TRP . . . . . 0.437 ' HA ' ' HE3' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -158.82 -99.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.538 -0.331 . . . . 4.9299999999999997 111.391 177.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -152.62 -53.2 0.11 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.004 0.43 . . . . 7.6500000000000004 110.523 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -166.97 174.1 8.71 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.632 -0.507 . . . . 8.8399999999999999 109.632 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.446 HD13 ' N ' ' A' ' 131' ' ' ILE . 0.1 OUTLIER -131.19 51.64 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.128 0.489 . . . . 6.0499999999999998 111.32 -176.33 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.6 mp -87.66 58.25 4.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.95 0.881 . . . . 8.5 109.816 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.8 p -136.34 35.49 2.74 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.469 -1.242 . . . . 9.8200000000000003 110.452 -175.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -59.4 127.63 33.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.799 -0.637 . . . . 11.210000000000001 110.209 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.31 134.63 21.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.524 -0.762 . . . . 10.84 111.293 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -125.9 -5.74 6.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.746 -0.661 . . . . 13.25 110.663 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.2 m -94.08 8.93 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.19 -0.459 . . . . 13.890000000000001 112.182 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.8 p -151.83 74.04 7.86 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 120.676 0.274 . . . . 14.050000000000001 110.975 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.76 72.82 3.71 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.79 2.326 . . . . 14.41 111.798 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -127.63 21.72 6.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.105 -0.952 . . . . 14.44 110.285 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -66.42 121.15 14.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 15.9 109.882 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 117.06 -17.42 12.79 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.795 -0.922 . . . . 15.6 110.795 -171.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 64.6 m -131.07 35.28 3.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.602 0.715 . . . . 15.6 110.168 176.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.9 mt -101.88 -52.13 8.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.309 -0.859 . . . . 13.85 109.281 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.9 p -83.31 39.54 0.66 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.564 -0.744 . . . . 13.19 110.51 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -83.43 -16.97 43.77 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.597 -0.729 . . . . 15.67 109.733 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 147' ' ' ILE . 1.9 pp -89.07 166.21 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.025 -0.989 . . . . 13.77 110.928 -178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.2 t -133.11 89.07 2.57 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.007 -0.542 . . . . 13.619999999999999 109.765 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -82.85 148.74 27.56 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.004 -0.544 . . . . 13.02 109.737 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -88.69 99.86 12.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.118 0.485 . . . . 14.68 110.489 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 76.3 mt -103.2 42.29 1.18 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.844 -0.616 . . . . 13.550000000000001 110.072 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -85.45 18.45 29.0 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.118 -0.563 . . . . 15.800000000000001 112.47 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.471 ' CB ' ' HA ' ' A' ' 158' ' ' VAL . 70.4 m 65.65 28.08 11.26 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.344 0.498 . . . . 17.079999999999998 112.344 175.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.37 -79.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 18.43 110.057 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -128.49 23.16 5.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.435 0.636 . . . . 18.530000000000001 110.638 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 157' ' ' CYS . 54.1 m-85 -115.43 29.28 8.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.305 -0.861 . . . . 14.32 109.83 176.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 156' ' ' PHE . 75.7 m 72.81 136.08 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 O-C-N 124.115 0.884 . . . . 14.51 111.399 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.471 ' HA ' ' CB ' ' A' ' 153' ' ' SER . 23.5 t -74.78 126.78 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.551 -0.75 . . . . 13.06 109.214 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 59.88 65.85 1.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.229 0.538 . . . . 10.33 109.651 -173.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.7 -56.01 5.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.467 -0.788 . . . . 9.8800000000000008 111.941 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -118.53 52.39 1.04 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.966 0.412 . . . . 10.23 110.439 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -112.64 -18.08 12.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.125 -0.489 . . . . 9.0600000000000005 110.978 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -124.04 33.2 5.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.101 -0.499 . . . . 6.1900000000000004 110.714 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -77.41 68.36 2.7 Favored Glycine 0 C--N 1.329 0.151 0 CA-C-N 115.711 -0.677 . . . . 3.9700000000000002 112.355 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -160.49 -38.81 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.017 0.437 . . . . 2.6299999999999999 110.893 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.434 ' HA3' ' SG ' ' A' ' 113' ' ' CYS . . . 101.26 20.34 13.99 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.845 -0.693 . . . . 1.3 111.706 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.3 m -54.13 -35.08 61.8 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.953 0.501 . . . . 1.8200000000000001 112.226 -176.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -84.44 -17.6 38.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.886 0.374 . . . . 0.69999999999999996 111.299 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 28.8 mt -86.11 -14.6 43.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.472 -0.331 . . . . 0.66000000000000003 111.768 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -10.43 59.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.351 0.596 . . . . 1.48 109.541 175.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.456 ' CZ ' HD11 ' A' ' 86' ' ' LEU . 43.7 m-85 -79.52 -30.21 41.77 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.274 -0.875 . . . . 1.97 111.872 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.539 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 1.3 mm -56.03 129.64 17.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 120.858 0.361 . . . . 0.67000000000000004 110.521 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -93.94 143.59 26.21 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.501 0.667 . . . . 4.3399999999999999 111.819 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.53 ' HA ' ' CD2' ' A' ' 183' ' ' LEU . 10.1 p -77.77 153.76 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.209 -0.905 . . . . 1.0700000000000001 109.174 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -48.04 111.59 0.46 Allowed 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.654 0.597 . . . . 0.70999999999999996 112.176 -172.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 51.6 t -66.09 -33.63 76.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.277 -0.874 . . . . 1.8799999999999999 109.771 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.467 ' HB3' ' OD1' ' A' ' 180' ' ' ASP . 11.9 t -131.08 152.28 50.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.907 -0.775 . . . . 1.6299999999999999 108.907 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' CYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 61.8 m -71.92 -6.09 39.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.472 -0.331 . . . . 1.96 111.545 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.89 1.38 56.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.77 0.319 . . . . 2.4199999999999999 110.868 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 177' ' ' SER . 29.3 m-20 -110.14 15.27 22.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.378 -0.374 . . . . 2.1200000000000001 111.093 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 15.0 mm100 -63.63 115.51 4.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.253 0.549 . . . . 1.3500000000000001 111.946 -173.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.816 ' H ' HD12 ' A' ' 183' ' ' LEU . 22.7 t30 -161.39 31.58 0.13 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.093 0.949 . . . . 1.6799999999999999 108.779 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.816 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.5 OUTLIER -119.28 122.52 42.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 0.81000000000000005 111.184 -171.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 60.9 m -150.13 136.01 18.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.983 0.421 . . . . 0.51000000000000001 110.421 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.471 ' HB3' ' HB2' ' A' ' 209' ' ' HIS . 49.9 ttm -125.62 135.49 52.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.208 -0.451 . . . . 1.3500000000000001 109.852 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 18.6 t -115.11 152.51 32.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.221 -0.445 . . . . 1.73 109.836 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.73 104.86 11.78 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.011 -0.737 . . . . 1.9299999999999999 109.011 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 33.2 pt -135.49 144.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.978 -0.556 . . . . 1.1100000000000001 110.541 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.8 m 57.46 30.11 18.11 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.459 0.474 . . . . 1.8600000000000001 111.558 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 64.3 17.36 10.69 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.493 -0.776 . . . . 2.8300000000000001 111.301 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.417 ' HB2' HG23 ' A' ' 114' ' ' VAL . 4.0 pt20 -124.93 167.2 15.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 1.75 110.189 177.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.6 mm -90.73 130.07 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.069 -0.514 . . . . 1.01 110.861 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -121.76 122.95 40.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.271 -0.422 . . . . 3.9399999999999999 110.535 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.794 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 13.7 m-85 -99.79 113.96 26.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.915 -0.772 . . . . 0.92000000000000004 108.915 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -110.45 124.14 51.21 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.9 -0.32 . . . . 1.1100000000000001 110.217 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 104' ' ' MET . 1.7 t -93.42 151.85 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 122.059 0.933 . . . . 0.69999999999999996 110.688 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.57 -56.43 5.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 113.734 -1.576 . . . . 0.62 112.009 -164.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.445 ' HE3' ' HB2' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -140.9 162.78 34.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.975 -1.012 . . . . 1.3799999999999999 110.117 -176.069 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.4 m-20 -58.27 111.67 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.85 0.719 . . . . 2.23 112.189 -173.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.595 HG21 ' HE1' ' A' ' 104' ' ' MET . 6.1 mm -68.85 145.82 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.255 -0.884 . . . . 0.88 110.9 175.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 14.2 mt-10 -92.63 117.64 67.67 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.278 -0.873 . . . . 2.0600000000000001 108.697 172.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -43.31 122.19 2.86 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.614 2.876 . . . . 0.51000000000000001 113.688 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.91 -3.22 10.81 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.822 -0.704 . . . . 0.69999999999999996 113.127 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 11.3 pt-20 -137.37 125.56 23.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.247 0.546 . . . . 1.27 111.031 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.539 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -109.57 108.05 18.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.017 -0.538 . . . . 2.9199999999999999 111.507 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.561 ' O ' HD22 ' A' ' 207' ' ' LEU . 1.4 mm? -123.24 97.9 5.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.064 -0.655 . . . . 0.90000000000000002 109.944 173.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 206' ' ' LEU . 1.1 mm? -149.1 102.12 3.21 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.985 -0.746 . . . . 0.53000000000000003 108.985 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.793 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 6.8 t -157.28 158.25 3.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.1 -0.704 . . . . 0.91000000000000003 109.1 -178.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 185' ' ' MET . 19.4 t-80 -136.25 110.57 8.45 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.453 -0.943 . . . . 1.55 108.453 162.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 3.1 p -88.16 100.75 10.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.632 0.73 . . . . 2.5600000000000001 109.812 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 128' ' ' TRP . 67.5 mttm -84.02 121.18 27.05 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.515 -0.766 . . . . 5.3600000000000003 110.448 -177.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.56 -58.37 1.91 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.419 -0.809 . . . . 5.7999999999999998 110.133 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -81.57 40.42 2.6 Favored Glycine 0 C--N 1.31 -0.9 0 CA-C-N 115.322 -0.854 . . . . 5.6100000000000003 111.889 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.518 ' O ' ' HA3' ' A' ' 218' ' ' GLY . 34.9 t -132.96 -70.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.258 0.551 . . . . 6.3099999999999996 110.145 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.457 ' HB3' ' HD3' ' A' ' 216' ' ' PRO . 88.2 t80 -97.14 -58.56 0.17 Allowed Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 115.555 -0.748 . . . . 8.8300000000000001 112.144 -176.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 215' ' ' TYR . 43.4 Cg_endo -69.51 -47.81 0.92 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.56 1.507 . . . . 7.7800000000000002 112.608 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 217' ' ' LEU . 6.6 mp -92.63 16.26 12.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.333 0.587 . . . . 8.0199999999999996 109.815 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 214' ' ' VAL . . . -112.7 154.87 16.64 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.646 -0.706 . . . . 8.6400000000000006 111.776 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.9 p -93.17 47.21 1.25 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.187 0.518 . . . . 9.7200000000000006 110.692 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.433 ' O ' ' HD3' ' A' ' 222' ' ' PRO . 29.2 m -61.63 140.86 95.1 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.582 -0.735 . . . . 9.6199999999999992 110.723 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 8.1 Cg_exo -71.79 110.48 2.91 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.854 2.369 . . . . 11.65 112.261 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 220' ' ' VAL . 91.1 Cg_endo -92.65 1.11 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.021 2.481 . . . . 13.109999999999999 112.123 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 139.55 -160.13 25.96 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.213 -0.903 . . . . 14.029999999999999 111.126 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 24.2 tp 68.83 120.69 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.503 0.668 . . . . 16.100000000000001 112.282 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -103.66 -44.33 5.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.803 -0.635 . . . . 17.699999999999999 109.866 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 . . . . . 0 C--O 1.249 1.067 0 CA-C-N 115.364 -0.835 . . . . 18.899999999999999 109.298 179.115 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.785 -0.526 . . . . 33.259999999999998 111.785 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.5 m -67.43 158.41 31.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.808 0.337 . . . . 33.920000000000002 111.004 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.67 76.52 1.29 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.706 -0.759 . . . . 32.350000000000001 111.545 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -98.22 108.84 49.39 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.716 0.294 . . . . 31.649999999999999 110.763 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.39 102.77 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.716 2.278 . . . . 29.989999999999998 111.7 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.9 m -76.0 87.67 2.94 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.908 -0.404 . . . . 28.920000000000002 109.908 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.2 t -78.21 77.09 4.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.286 0.565 . . . . 26.940000000000001 109.841 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.29 66.39 1.54 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.843 -0.799 . . . . 25.829999999999998 108.843 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -143.09 133.53 24.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.162 -0.926 . . . . 23.530000000000001 110.119 -176.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -96.9 152.43 18.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.381 -0.372 . . . . 21.640000000000001 110.828 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.2 p -98.18 108.27 46.04 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.265 -0.425 . . . . 19.420000000000002 110.356 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.04 96.45 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.668 2.245 . . . . 17.170000000000002 112.937 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -86.06 51.27 2.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.135 -0.938 . . . . 17.469999999999999 110.192 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -124.06 36.72 4.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.653 -0.703 . . . . 15.630000000000001 110.578 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.06 34.25 75.86 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.629 -0.796 . . . . 12.039999999999999 111.327 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.1 t -105.61 134.76 19.55 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.887 -0.412 . . . . 10.67 109.887 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.59 87.77 1.23 Allowed 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.643 2.229 . . . . 9.6899999999999995 112.144 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -104.49 107.25 18.09 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.41 -0.814 . . . . 7.7000000000000002 110.46 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -92.89 104.79 16.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.453 -0.34 . . . . 8.1400000000000006 110.128 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.77 144.19 87.96 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 116.211 -0.45 . . . . 5.96 109.9 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -40.52 -70.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.697 2.931 . . . . 6.1299999999999999 113.94 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.1 p -110.76 -31.17 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.068 -0.515 . . . . 6.5300000000000002 111.608 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -73.2 106.91 5.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.215 0.531 . . . . 5.0099999999999998 111.293 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.51 ' O ' HD12 ' A' ' 74' ' ' ILE . 1.9 pp -79.6 141.96 56.9 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.72 -0.673 . . . . 4.2300000000000004 110.981 174.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.86 4.65 6.29 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 122.953 2.435 . . . . 4.1200000000000001 113.009 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.429 ' HB2' HD13 ' A' ' 74' ' ' ILE . 10.0 mm-40 -64.45 -61.25 2.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.201 -0.454 . . . . 3.8199999999999998 110.02 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.1 t70 62.91 78.99 0.27 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.025 -0.989 . . . . 3.1600000000000001 110.773 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.6 mt -85.5 125.55 69.2 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.289 -0.868 . . . . 2.4500000000000002 110.196 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.01 115.94 3.87 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.177 1.918 . . . . 1.75 112.238 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -131.77 146.57 62.39 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.64 -0.504 . . . . 1.01 109.64 178.378 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.38 137.81 81.58 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.801 2.334 . . . . 0.72999999999999998 111.667 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.426 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -65.26 -12.17 48.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.654 0.612 . . . . 1.04 112.654 -173.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -84.9 -7.52 59.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.805 0.336 . . . . 1.6599999999999999 111.473 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.507 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 17.9 m-85 -120.14 161.76 20.48 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.23 -1.026 . . . . 1.0 108.23 170.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.405 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 5.9 tp10 -133.51 120.19 20.5 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.749 -0.78 . . . . 2.27 111.435 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HA ' HG12 ' A' ' 98' ' ' VAL . 7.2 tt -84.28 126.67 33.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.999 -0.741 . . . . 0.79000000000000004 108.999 177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -148.61 149.26 31.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.842 -0.617 . . . . 3.21 110.726 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.32 111.99 18.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.653 -0.869 . . . . 2.46 108.653 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.2 m -149.13 81.51 1.43 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.082 -0.508 . . . . 1.5800000000000001 109.809 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.4 m -65.48 104.63 1.02 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.121 -0.49 . . . . 1.8600000000000001 110.875 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.583 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -106.02 117.63 57.08 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.128 -0.487 . . . . 1.45 109.791 177.032 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 91' ' ' ILE . 52.5 Cg_exo -54.58 122.57 11.81 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.16 2.573 . . . . 1.6100000000000001 112.678 -176.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.97 -16.46 36.19 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.711 -0.677 . . . . 1.74 111.958 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.583 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -131.63 -59.78 0.95 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.931 0.396 . . . . 1.4099999999999999 111.277 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.9 -127.85 7.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.954 -0.641 . . . . 1.0900000000000001 112.198 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.446 HD13 ' CD1' ' A' ' 171' ' ' TYR . 0.6 OUTLIER -89.53 159.79 17.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.677 -0.12 . . . . 2.3100000000000001 110.677 176.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -161.96 172.51 38.13 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.586 -0.605 . . . . 0.58999999999999997 111.586 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 86' ' ' LEU . 5.9 m -115.72 130.76 69.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.586 0.708 . . . . 0.67000000000000004 109.79 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -98.11 109.17 21.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.255 -0.43 . . . . 1.1299999999999999 110.498 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -64.52 116.29 6.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.54000000000000004 109.758 176.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.545 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -79.06 -2.8 42.15 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.453 0.644 . . . . 1.6799999999999999 110.439 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 41.1 ttp180 -127.41 155.78 43.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.257 -0.883 . . . . 3.5 108.823 175.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.64 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -82.8 156.59 23.59 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.829 -0.434 . . . . 2.3999999999999999 109.829 176.713 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.625 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -127.18 152.32 47.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.323 -0.399 . . . . 1.22 110.476 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 10.4 pt-20 -105.48 173.67 6.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.394 0.616 . . . . 2.3100000000000001 111.975 -170.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.93 127.29 30.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.247 -0.888 . . . . 0.83999999999999997 112.656 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.23 0.77 67.46 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.101 -0.571 . . . . 1.04 113.544 170.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 1.6 pt-20 -87.14 168.41 13.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.439 0.619 . . . . 2.6200000000000001 111.09 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 3.8 tmm_? -127.52 133.03 49.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.93 -0.577 . . . . 3.6200000000000001 112.094 -173.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.507 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 7.7 mt -86.63 142.07 28.51 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.77 -0.826 . . . . 0.53000000000000003 108.77 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.64 -128.05 7.63 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.4 -0.905 . . . . 1.02 112.618 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.461 ' O ' ' HA3' ' A' ' 166' ' ' GLY . 57.2 Cg_endo -68.35 145.6 76.59 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.829 -1.321 . . . . 2.1000000000000001 112.761 2.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t -73.5 -26.46 60.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.618 -0.719 . . . . 2.0 110.962 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.488 ' HB ' ' H ' ' A' ' 192' ' ' ILE . 70.9 t -138.15 131.01 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.113 -0.494 . . . . 2.0299999999999998 110.336 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.5 t -65.78 133.96 30.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 3.9500000000000002 109.616 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.1 t -56.71 113.64 6.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 O-C-N 123.503 0.502 . . . . 5.21 111.675 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.47 145.57 59.24 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.732 2.288 . . . . 5.0700000000000003 111.237 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.41 ' HB2' ' OD1' ' A' ' 134' ' ' ASP . 6.1 mpt_? -71.69 -34.96 70.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.086 -0.506 . . . . 7.9900000000000002 111.143 -174.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -162.02 75.66 0.47 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.195 -0.457 . . . . 6.9500000000000002 110.649 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -99.43 159.43 15.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.356 -0.384 . . . . 6.0899999999999999 111.561 -177.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.84 95.46 2.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.69 -0.686 . . . . 5.5599999999999996 110.021 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -53.71 131.42 39.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.841 0.829 . . . . 7.4199999999999999 111.899 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -72.83 -66.94 0.6 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.455 -1.248 . . . . 9.0099999999999998 110.68 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.4 m -83.71 -76.96 0.27 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.731 -0.668 . . . . 8.8800000000000008 110.53 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.5 t70 179.74 -56.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.681 -0.859 . . . . 7.5999999999999996 108.681 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -153.23 159.47 42.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.26 -1.336 . . . . 7.2300000000000004 107.775 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.45 40.02 94.28 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.461 -0.876 . . . . 4.5899999999999999 112.094 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TRP . . . . . 0.539 ' HE3' ' N ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -89.13 -95.41 0.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.63 0.252 . . . . 4.9299999999999997 111.334 -178.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.539 ' N ' ' HE3' ' A' ' 128' ' ' TRP . 12.0 pt-20 -161.9 -45.75 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.955 -0.758 . . . . 7.6500000000000004 108.955 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.465 ' OE1' ' HA ' ' A' ' 130' ' ' GLN . 6.4 tp60 176.34 131.79 0.05 OUTLIER 'General case' 0 CA--C 1.523 -0.074 0 CA-C-N 115.36 -0.836 . . . . 8.8399999999999999 109.022 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.701 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -109.67 -1.84 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.622 -0.431 . . . . 6.0499999999999998 110.955 176.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.6 mp -81.78 62.58 5.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.744 0.783 . . . . 8.5 110.134 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 19.4 p -128.05 30.24 5.27 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.649 -1.159 . . . . 9.8200000000000003 110.484 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 118' ' ' ARG . 3.3 p30 -73.27 127.76 33.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.817 -0.629 . . . . 11.210000000000001 111.231 -177.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.8 p -68.35 138.15 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.356 -0.838 . . . . 10.84 110.677 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -71.18 119.1 14.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.44 -0.8 . . . . 13.25 111.179 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.2 p -79.12 -22.78 12.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.854 0.835 . . . . 13.890000000000001 108.857 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.8 m -144.99 94.61 5.32 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.892 -1.049 . . . . 14.050000000000001 108.887 173.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -35.21 124.1 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.811 3.674 . . . . 14.41 114.738 -173.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -104.66 -6.29 20.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.139 -0.937 . . . . 14.44 109.095 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -46.22 121.58 3.42 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.1 -0.955 . . . . 15.9 111.162 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 135.89 -41.04 1.47 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.18 -0.768 . . . . 15.6 111.18 -174.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 23.7 p -101.12 31.06 3.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.461 0.648 . . . . 15.6 110.938 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 61.4 mt -112.26 -65.82 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.516 -0.766 . . . . 13.85 109.595 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.2 p -88.14 43.18 1.11 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.543 0.687 . . . . 13.19 110.318 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -77.73 -13.04 60.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.215 -0.902 . . . . 15.67 110.097 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.7 pp -110.13 161.81 8.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.981 -1.008 . . . . 13.77 110.64 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.8 t -104.91 55.3 0.7 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.685 0.755 . . . . 13.619999999999999 110.459 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -93.4 59.18 2.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.592 -0.892 . . . . 13.02 108.592 172.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -88.39 80.95 7.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.516 -1.22 . . . . 14.68 110.578 -172.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -91.9 10.1 30.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.465 -0.789 . . . . 13.550000000000001 111.714 -178.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.501 ' HA2' ' CD1' ' A' ' 156' ' ' PHE . . . -97.58 12.79 64.58 Favored Glycine 0 C--N 1.317 -0.483 0 C-N-CA 120.78 -0.724 . . . . 15.800000000000001 112.771 -175.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.7 m -88.46 -39.09 14.49 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.901 0.381 . . . . 17.079999999999998 110.703 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -110.58 -78.79 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 18.43 111.372 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.508 ' N ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -137.95 133.84 34.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.895 0.379 . . . . 18.530000000000001 110.252 -177.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.501 ' CD1' ' HA2' ' A' ' 152' ' ' GLY . 38.8 p90 -151.06 167.6 27.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.144 0.497 . . . . 14.32 111.302 -176.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 34.5 m -133.47 122.32 23.49 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.621 -0.881 . . . . 14.51 108.621 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.9 t -69.85 129.37 34.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.274 -0.269 . . . . 13.06 110.274 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 60.55 54.05 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.563 0.697 . . . . 10.33 110.997 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -119.56 -60.96 1.67 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.146 -0.933 . . . . 9.8800000000000008 109.995 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -81.44 -27.96 34.42 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.221 0.534 . . . . 10.23 109.655 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -71.86 -21.4 61.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.402 -0.817 . . . . 9.0600000000000005 109.616 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.459 ' C ' ' HB2' ' A' ' 167' ' ' SER . . . -90.53 61.45 4.92 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.439 -0.801 . . . . 6.1900000000000004 110.269 176.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -126.67 -61.8 0.15 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.812 -0.709 . . . . 3.9700000000000002 111.75 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.28 101.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.12 0.486 . . . . 2.6299999999999999 110.716 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 112' ' ' PRO . . . 90.69 -37.55 3.36 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.756 -0.656 . . . . 1.3 112.354 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.459 ' HB2' ' C ' ' A' ' 163' ' ' ALA . 15.8 m -69.26 -14.54 63.01 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.885 0.328 . . . . 1.8200000000000001 111.885 -177.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.423 ' O ' ' HD2' ' A' ' 171' ' ' TYR . 64.9 p-90 -56.46 -17.27 7.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.159 0.504 . . . . 0.69999999999999996 111.307 176.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.502 HD13 ' CD1' ' A' ' 194' ' ' TYR . 24.8 mt -64.49 -12.79 47.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.309 -0.405 . . . . 0.66000000000000003 111.876 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -11.84 26.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.76 0.314 . . . . 1.48 110.754 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.446 ' CD1' HD13 ' A' ' 96' ' ' LEU . 36.8 m-85 -77.95 -36.96 48.59 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.27 -0.423 . . . . 1.97 111.312 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.811 HG21 ' HB2' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -59.58 137.01 22.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 120.827 -0.349 . . . . 0.67000000000000004 110.483 -174.207 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.484 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 41.7 mmt-85 -112.18 -177.52 3.19 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.851 0.686 . . . . 4.3399999999999999 112.851 -175.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.464 HG22 HG21 ' A' ' 208' ' ' VAL . 41.5 t -76.56 158.87 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 114.954 -1.021 . . . . 1.0700000000000001 110.488 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.533 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -55.52 113.73 1.56 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.241 -0.436 . . . . 0.70999999999999996 111.816 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 28.1 t -72.05 -20.64 61.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 1.8799999999999999 109.622 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.3 t -126.02 139.74 53.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.686 -0.688 . . . . 1.6299999999999999 109.318 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' CYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 59.7 m -75.54 -33.41 60.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.107 0.78 . . . . 1.96 113.107 -168.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -88.33 -13.29 41.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.351 0.596 . . . . 2.4199999999999999 110.58 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -82.57 19.29 1.31 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.529 -0.76 . . . . 2.1200000000000001 112.033 -176.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 21.4 mm-40 -53.42 113.85 1.3 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.022 0.439 . . . . 1.3500000000000001 110.759 -176.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.691 ' H ' HD12 ' A' ' 183' ' ' LEU . 32.3 t30 -140.21 23.62 2.36 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 122.325 1.059 . . . . 1.6799999999999999 108.94 174.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.691 HD12 ' H ' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -109.17 117.39 34.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.598 -0.728 . . . . 0.81000000000000005 110.36 -172.244 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.1 m -149.1 135.07 18.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.056 0.455 . . . . 0.51000000000000001 110.528 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.454 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 72.6 mtp -128.74 137.07 51.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.139 -0.482 . . . . 1.3500000000000001 110.072 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 16.3 t -114.41 158.12 21.97 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.848 -0.614 . . . . 1.73 109.496 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.537 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 22.7 tm0? -122.88 105.19 9.79 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.134 -0.691 . . . . 1.9299999999999999 109.134 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.632 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 34.9 pt -133.13 140.58 46.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.975 -0.557 . . . . 1.1100000000000001 110.524 -175.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.1 m 53.78 26.24 5.84 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.394 0.434 . . . . 1.8600000000000001 111.963 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.537 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 6.3 mm-40 63.4 25.41 14.56 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.595 -0.73 . . . . 2.8300000000000001 112.049 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 29.8 pt20 -117.28 157.65 25.7 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.128 -0.693 . . . . 1.75 109.128 172.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.488 ' H ' ' HB ' ' A' ' 114' ' ' VAL . 49.5 mm -89.13 121.93 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.16 0.505 . . . . 1.01 110.564 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.63 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 45.5 t80 -114.57 121.27 42.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.365 -0.834 . . . . 3.9399999999999999 110.377 -172.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 11.4 m-85 -99.65 112.81 25.0 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.374 -0.602 . . . . 0.92000000000000004 109.374 177.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -116.0 122.93 46.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.844 0.354 . . . . 1.1100000000000001 110.906 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.574 HG11 ' SD ' ' A' ' 104' ' ' MET . 0.2 OUTLIER -90.46 149.84 3.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.438 0.637 . . . . 0.69999999999999996 109.879 178.157 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 182' ' ' ASN . 1.3 mt -103.06 -30.11 2.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.165 -0.925 . . . . 0.62 112.009 -168.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 27.5 pttt -151.59 -179.91 7.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.137 -0.483 . . . . 1.3799999999999999 111.736 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.625 ' HA ' ' O ' ' A' ' 104' ' ' MET . 17.2 t70 -82.65 131.24 35.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.32 -0.854 . . . . 2.23 110.508 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.614 HG13 ' ND2' ' A' ' 182' ' ' ASN . 43.9 mm -121.97 154.63 26.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.192 -0.458 . . . . 0.88 111.15 -173.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 48.9 mt-10 -78.62 120.97 82.95 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 2.0600000000000001 109.85 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.3 123.7 12.56 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.025 2.483 . . . . 0.51000000000000001 112.419 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.62 -1.67 10.23 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.636 -0.792 . . . . 0.69999999999999996 113.097 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 10.5 pt-20 -136.27 123.95 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 1.27 110.649 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.535 ' OE1' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -108.83 116.09 31.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.889 -0.596 . . . . 2.9199999999999999 111.415 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.504 ' C ' HD22 ' A' ' 207' ' ' LEU . 4.7 mp -126.22 99.56 5.93 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.365 -0.534 . . . . 0.90000000000000002 110.297 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.811 ' HB2' HG21 ' A' ' 172' ' ' ILE . 2.4 mm? -147.76 112.59 5.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.654 0.782 . . . . 0.53000000000000003 109.58 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.664 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 7.8 p -155.99 158.01 3.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.621 -0.432 . . . . 0.91000000000000003 111.199 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.454 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 27.9 t-80 -114.24 110.1 19.42 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.825 -0.806 . . . . 1.55 108.825 170.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 45.0 t -104.22 96.65 4.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.842 -0.429 . . . . 2.5600000000000001 109.842 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -65.95 150.06 49.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.32 -0.4 . . . . 5.3600000000000003 109.986 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -61.22 82.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 O-C-N 124.063 0.852 . . . . 5.7999999999999998 112.49 -172.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.83 33.28 86.52 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 114.984 -1.007 . . . . 5.6100000000000003 113.128 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 53.6 t -93.75 -83.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.949 -0.3 . . . . 6.3099999999999996 110.899 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.563 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 71.5 m-85 -83.59 -50.12 0.68 Allowed Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 112.266 0.469 . . . . 8.8300000000000001 112.266 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 18.2 Cg_endo -59.01 -44.6 33.82 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.062 1.841 . . . . 7.7800000000000002 112.893 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.0 mp -92.16 -30.36 15.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.838 0.351 . . . . 8.0199999999999996 111.357 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 74.48 24.95 71.55 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.174 -0.536 . . . . 8.6400000000000006 112.878 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 8.6 p -97.02 55.0 1.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.057 0.456 . . . . 9.7200000000000006 111.158 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 220' ' ' VAL . 22.4 m -120.45 107.76 38.54 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.892 -0.594 . . . . 9.6199999999999992 111.374 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.03 116.59 4.77 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.4 2.067 . . . . 11.65 112.047 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.06 66.84 7.81 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.981 2.454 . . . . 13.109999999999999 112.422 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.26 46.49 5.83 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.628 -0.796 . . . . 14.029999999999999 111.622 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 32.9 tp -145.12 120.83 10.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.962 0.41 . . . . 16.100000000000001 110.242 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -136.83 -38.08 0.65 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.997 -0.547 . . . . 17.699999999999999 110.045 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.25 1.102 0 CA-C-N 115.627 -0.715 . . . . 18.899999999999999 110.491 -178.689 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 111.658 -0.577 . . . . 33.259999999999998 111.658 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.3 p -94.87 -38.71 10.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.92 0.39 . . . . 33.920000000000002 110.541 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.66 141.02 15.35 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.023 -0.608 . . . . 32.350000000000001 112.066 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 52.49 67.86 3.59 Favored Pre-proline 0 C--O 1.233 0.231 0 C-N-CA 122.672 0.389 . . . . 31.649999999999999 110.91 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.61 -151.05 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.07 2.513 . . . . 29.989999999999998 112.406 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -60.98 -40.63 94.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.056 0.455 . . . . 28.920000000000002 111.255 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.7 m -126.09 104.34 8.2 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.149 -0.478 . . . . 26.940000000000001 110.411 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -127.65 152.38 47.75 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.804 -0.443 . . . . 25.829999999999998 109.804 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -160.9 175.09 12.91 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.078 -0.342 . . . . 23.530000000000001 110.078 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -144.51 49.08 1.33 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.957 0.884 . . . . 21.640000000000001 108.633 172.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.9 p -64.73 134.02 95.9 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.641 -1.163 . . . . 19.420000000000002 110.5 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -60.84 101.82 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.719 2.279 . . . . 17.170000000000002 112.664 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -88.66 -13.46 39.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.547 -0.751 . . . . 17.469999999999999 109.703 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.05 129.73 40.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.282 -0.872 . . . . 15.630000000000001 109.747 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 68' ' ' TYR . . . 89.33 -12.4 66.72 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.498 -0.858 . . . . 12.039999999999999 112.087 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.481 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 48.0 t -66.97 -53.29 26.87 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 110.071 -0.344 . . . . 10.67 110.071 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 66' ' ' SER . 96.3 Cg_endo -80.66 68.18 8.4 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.419 1.413 . . . . 9.6899999999999995 110.036 167.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 72.6 t80 -73.86 130.56 40.15 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.312 -1.313 . . . . 7.7000000000000002 110.502 -173.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.15 84.19 1.02 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.224 0.535 . . . . 8.1400000000000006 109.746 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 73' ' ' TYR . . . -84.18 140.17 39.48 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.407 -0.815 . . . . 5.96 110.51 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -46.63 -75.55 0.03 OUTLIER 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.399 2.732 . . . . 6.1299999999999999 113.708 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.3 p -83.9 -31.91 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.294 -0.412 . . . . 6.5300000000000002 111.568 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.479 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 81.7 t80 -72.73 119.66 17.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.071 0.462 . . . . 5.0099999999999998 110.66 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.493 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.2 pp -81.11 147.34 60.89 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.808 -0.633 . . . . 4.2300000000000004 111.166 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -86.75 27.64 0.57 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.088 2.525 . . . . 4.1200000000000001 112.975 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -96.84 -71.9 0.66 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.558 -0.534 . . . . 3.8199999999999998 109.558 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.2 t70 49.36 70.63 0.46 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.154 -0.93 . . . . 3.1600000000000001 111.444 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 67.7 mt -76.04 129.01 81.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.574 -0.739 . . . . 2.4500000000000002 110.102 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.03 122.5 11.49 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.851 2.368 . . . . 1.75 112.722 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.537 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -127.38 149.3 69.5 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.843 -0.617 . . . . 1.01 109.758 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.74 143.14 99.35 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.635 2.223 . . . . 0.72999999999999998 111.857 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.57 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -68.25 -5.19 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.34 0.496 . . . . 1.04 112.34 -173.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -87.56 -4.48 58.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.896 0.379 . . . . 1.6599999999999999 110.928 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.509 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 11.7 m-85 -138.38 147.96 43.98 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.45 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 12.2 tp10 -118.36 122.72 43.54 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 121.048 -0.261 . . . . 2.27 110.642 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.9 tt -87.43 124.16 33.13 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.388 0.613 . . . . 0.79000000000000004 109.578 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 90.3 mtt-85 -143.39 127.05 17.03 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.13 -0.941 . . . . 3.21 109.689 -175.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.01 110.73 4.6 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.344 -0.613 . . . . 2.46 109.344 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.8 m -157.8 115.47 3.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.266 -0.642 . . . . 1.5800000000000001 109.266 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.2 m -89.84 105.35 17.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.766 0.317 . . . . 1.8600000000000001 110.97 -177.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -91.62 118.59 68.43 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.818 -0.808 . . . . 1.45 108.818 173.097 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.99 121.36 9.75 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.098 2.532 . . . . 1.6100000000000001 112.553 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.65 -23.36 24.37 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.722 -0.672 . . . . 1.74 112.369 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.539 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -122.63 -63.0 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.962 0.381 . . . . 1.4099999999999999 111.082 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 127.76 -134.12 8.11 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.962 -0.637 . . . . 1.0900000000000001 111.952 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.9 mt -89.18 159.48 17.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.398 -0.223 . . . . 2.3100000000000001 110.398 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -157.68 164.96 33.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.702 -0.761 . . . . 0.58999999999999997 111.944 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 33.8 m -101.25 117.18 46.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.766 0.793 . . . . 0.67000000000000004 110.071 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.508 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 27.1 m95 -82.73 110.01 17.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.355 -0.839 . . . . 1.1299999999999999 110.623 -171.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -62.22 115.2 3.94 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.882 -0.414 . . . . 0.54000000000000004 109.882 176.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -81.8 -6.07 58.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.405 0.621 . . . . 1.6799999999999999 109.849 178.378 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -129.61 160.75 32.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.033 -0.985 . . . . 3.5 108.688 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.578 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -92.79 158.48 15.86 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 120.87 0.367 . . . . 2.3999999999999999 110.475 -178.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.594 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 55.0 mtm -131.89 153.02 50.66 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.167 -0.679 . . . . 1.22 109.167 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -105.64 137.57 43.28 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.353 0.408 . . . . 2.3100000000000001 110.855 -176.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -38.25 115.18 0.42 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.679 1.237 . . . . 0.83999999999999997 112.959 -173.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.67 6.96 14.07 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.379 -0.828 . . . . 1.04 111.034 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.493 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -73.6 165.68 24.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.196 0.522 . . . . 2.6200000000000001 110.761 -178.275 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 3.9 tmm_? -145.68 134.7 22.64 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.923 -0.58 . . . . 3.6200000000000001 110.959 -175.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.509 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 8.1 mt -98.05 135.01 40.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.942 -0.762 . . . . 0.53000000000000003 108.942 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.79 167.29 38.48 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.423 -0.894 . . . . 1.02 112.21 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.43 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 6.2 Cg_exo -79.15 155.78 91.0 Favored 'Cis proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.307 -1.539 . . . . 2.1000000000000001 112.0 -2.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.9 t -110.43 4.47 20.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.501 0.667 . . . . 2.0 109.846 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.5 m -83.18 157.24 3.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.471 -0.786 . . . . 2.0299999999999998 110.695 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.2 87.91 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.478 0.656 . . . . 3.9500000000000002 110.72 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.468 ' HB ' ' HD3' ' A' ' 117' ' ' PRO . 20.9 t -60.59 -51.61 78.59 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.701 -0.681 . . . . 5.21 111.752 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.468 ' HD3' ' HB ' ' A' ' 116' ' ' VAL . 66.0 Cg_endo -73.52 75.18 3.05 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.837 1.691 . . . . 5.0700000000000003 111.66 174.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.468 HH21 ' HG2' ' A' ' 136' ' ' GLU . 76.5 mtm-85 -66.06 -36.48 83.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.83 -0.623 . . . . 7.9900000000000002 110.294 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 48.75 76.66 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.12 0.887 . . . . 6.9500000000000002 111.438 175.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 67.0 104.38 0.04 OUTLIER 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.628 -0.714 . . . . 6.0899999999999999 110.637 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -52.11 126.08 17.54 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.528 -0.76 . . . . 5.5599999999999996 111.148 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.485 ' HG2' HD11 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -70.06 167.14 18.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.675 -0.693 . . . . 7.4199999999999999 111.107 -177.661 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -50.4 -55.31 16.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.527 -0.76 . . . . 9.0099999999999998 111.752 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.2 m -128.93 -89.2 0.51 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.229 -0.286 . . . . 8.8800000000000008 110.229 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 39.0 t0 -177.29 157.81 1.38 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.066 0.46 . . . . 7.5999999999999996 110.561 176.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -123.81 -7.95 7.87 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.419 -0.809 . . . . 7.2300000000000004 109.125 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -87.99 -68.63 1.29 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.208 -0.905 . . . . 4.5899999999999999 112.876 -174.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TRP . . . . . 0.621 ' CE3' ' HG2' ' A' ' 129' ' ' GLU . 6.5 p-90 -140.55 -35.27 0.5 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.386 0.884 . . . . 4.9299999999999997 113.386 -171.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.621 ' HG2' ' CE3' ' A' ' 128' ' ' TRP . 9.3 pt-20 -177.3 -35.01 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.182 0.446 . . . . 7.6500000000000004 111.342 174.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.461 ' CG ' ' HG ' ' A' ' 132' ' ' LEU . 28.0 tt0 -179.27 97.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.187 -0.671 . . . . 8.8399999999999999 109.187 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.485 HD11 ' HG2' ' A' ' 122' ' ' LYS . 1.8 pp -76.51 -8.33 11.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.055 0.455 . . . . 6.0499999999999998 111.315 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.461 ' HG ' ' CG ' ' A' ' 130' ' ' GLN . 0.3 OUTLIER -88.72 66.85 8.21 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.138 0.97 . . . . 8.5 109.812 176.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.0 t -113.23 23.4 13.33 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.506 -1.224 . . . . 9.8200000000000003 109.465 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -155.84 125.7 6.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.063 -0.971 . . . . 11.210000000000001 110.139 -174.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.46 HG13 HG13 ' A' ' 137' ' ' VAL . 12.6 p -81.02 136.57 22.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.022 0.439 . . . . 10.84 110.302 176.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.468 ' HG2' HH21 ' A' ' 118' ' ' ARG . 4.2 mm-40 -77.14 85.7 3.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.025 0.441 . . . . 13.25 111.164 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.46 HG13 HG13 ' A' ' 135' ' ' VAL . 26.5 m -77.23 -23.01 14.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.869 -0.605 . . . . 13.890000000000001 109.393 173.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.7 m 53.58 89.08 0.11 Allowed Pre-proline 0 C--O 1.235 0.322 0 O-C-N 124.119 0.887 . . . . 14.050000000000001 111.581 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.35 77.9 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.136 2.557 . . . . 14.41 111.763 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -151.0 50.08 0.85 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.708 -0.678 . . . . 14.44 110.186 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -64.93 118.71 9.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.556 -0.747 . . . . 15.9 110.505 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.65 -61.34 4.5 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.853 -0.689 . . . . 15.6 111.836 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 3.9 p -88.44 87.68 7.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.036 0.446 . . . . 15.6 110.568 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 50.4 mm -65.66 -37.24 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.519 . . . . 13.85 110.382 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.2 t -123.42 113.31 18.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.481 0.658 . . . . 13.19 110.45 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -99.54 -11.02 21.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.514 0.673 . . . . 15.67 109.657 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.421 ' H ' HG13 ' A' ' 147' ' ' ILE . 2.8 pp -86.56 157.67 3.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.013 -0.994 . . . . 13.77 111.581 -174.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.9 m -132.24 70.91 1.46 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.038 -0.727 . . . . 13.619999999999999 109.038 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.55 156.28 46.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.873 -0.603 . . . . 13.02 111.313 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -136.94 135.97 38.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.379 -0.828 . . . . 14.68 109.267 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.15 38.93 0.9 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.328 0.585 . . . . 13.550000000000001 111.131 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -166.76 -139.56 2.69 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.738 -0.744 . . . . 15.800000000000001 112.01 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.7 m -145.46 -47.57 0.22 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.24 0.543 . . . . 17.079999999999998 109.903 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.54 -66.49 0.93 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.674 -0.693 . . . . 18.43 109.874 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.607 ' HD2' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -116.4 138.0 51.71 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.166 -0.925 . . . . 18.530000000000001 109.89 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -153.32 26.67 0.52 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.8 0.81 . . . . 14.32 110.491 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 6.4 p -90.17 -13.8 34.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.114 -0.948 . . . . 14.51 110.837 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 37.4 t -99.62 139.4 21.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.034 -0.53 . . . . 13.06 109.64 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.64 57.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.172 0.511 . . . . 10.33 110.986 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.94 -58.84 3.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.596 -0.729 . . . . 9.8800000000000008 110.445 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -89.22 34.74 0.8 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.44 0.638 . . . . 10.23 110.567 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -138.99 -62.11 0.55 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.647 -0.706 . . . . 9.0600000000000005 110.116 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 58.48 40.13 24.3 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.205 0.526 . . . . 6.1900000000000004 111.551 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.0 -141.68 42.0 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.827 -0.624 . . . . 3.9700000000000002 112.538 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -136.66 12.88 3.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.832 0.349 . . . . 2.6299999999999999 110.583 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . -124.3 0.01 8.8 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.71 -0.757 . . . . 1.3 113.199 -177.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 17.4 t -73.4 -15.39 61.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.023 0.44 . . . . 1.8200000000000001 110.732 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.439 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 10.6 p-90 -72.77 -23.46 60.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.316 -0.402 . . . . 0.69999999999999996 111.521 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.439 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 29.0 mt -86.09 -15.47 41.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.482 0.549 . . . . 0.66000000000000003 112.482 -174.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -78.74 -4.65 50.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.271 -0.572 . . . . 1.48 110.381 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -77.84 -37.71 47.83 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.196 -0.457 . . . . 1.97 110.996 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.746 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -70.03 120.77 18.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.818 -0.438 . . . . 0.67000000000000004 109.818 177.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -113.15 -168.68 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 4.3399999999999999 112.033 -173.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.479 ' HA ' HG11 ' A' ' 208' ' ' VAL . 43.8 t -62.57 142.27 16.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 115.795 -0.639 . . . . 1.0700000000000001 111.436 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.46 148.03 39.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.292 -0.867 . . . . 0.70999999999999996 111.883 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 48.7 t -86.21 -8.94 57.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.373 -0.83 . . . . 1.8799999999999999 110.122 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.5 t -143.98 145.22 32.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.971 -0.559 . . . . 1.6299999999999999 111.208 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 78.1 m -83.2 -15.82 48.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.642 -0.708 . . . . 1.96 110.298 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -81.85 -25.73 34.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.617 0.722 . . . . 2.4199999999999999 110.187 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -96.42 18.28 14.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.343 -0.844 . . . . 2.1200000000000001 111.815 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -59.14 114.19 2.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.183 0.516 . . . . 1.3500000000000001 111.547 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.868 ' H ' HD12 ' A' ' 183' ' ' LEU . 4.7 p-10 -152.01 29.74 0.58 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.007 -0.997 . . . . 1.6799999999999999 109.202 170.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.868 HD12 ' H ' ' A' ' 182' ' ' ASN . 1.5 mp -112.03 118.95 36.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.93 -1.032 . . . . 0.81000000000000005 109.13 -175.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 86.4 m -150.08 148.23 28.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.437 0.637 . . . . 0.51000000000000001 112.589 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.437 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 28.0 tpp -97.45 145.64 25.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.255 -0.884 . . . . 1.3500000000000001 111.411 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 41.7 t -129.93 131.47 45.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 1.73 110.267 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -123.05 105.78 10.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.588 -0.523 . . . . 1.9299999999999999 109.588 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 24.2 pt -142.67 144.01 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.847 -0.615 . . . . 1.1100000000000001 110.502 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.4 m 61.85 35.43 16.53 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.463 -0.335 . . . . 1.8600000000000001 111.772 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 66.61 3.91 3.13 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.88 -0.6 . . . . 2.8300000000000001 111.721 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.4 pt20 -120.61 163.74 17.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.083 0.468 . . . . 1.75 110.421 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.8 mm -107.08 136.11 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.872 -0.604 . . . . 1.01 111.196 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -138.14 156.44 47.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.029 -0.532 . . . . 3.9399999999999999 110.917 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.556 ' CD2' ' HB3' ' A' ' 207' ' ' LEU . 2.4 m-30 -101.1 114.43 28.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.761 -0.654 . . . . 0.92000000000000004 109.823 175.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -102.39 124.41 47.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.009 0.433 . . . . 1.1100000000000001 110.178 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.53 HG22 HD11 ' A' ' 207' ' ' LEU . 0.9 OUTLIER -100.19 152.83 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.545 0.688 . . . . 0.69999999999999996 110.38 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.575 HG13 ' HA ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -92.8 -41.04 12.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.813 -1.085 . . . . 0.62 112.471 -168.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.34 164.8 27.26 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.086 0.402 . . . . 1.3799999999999999 112.086 -171.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.594 ' HA ' ' O ' ' A' ' 104' ' ' MET . 5.3 t70 -49.7 112.26 0.63 Allowed 'General case' 0 C--O 1.233 0.187 0 O-C-N 124.481 1.113 . . . . 2.23 110.671 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.512 HG13 ' HE3' ' A' ' 104' ' ' MET . 28.5 mm -83.13 129.2 37.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.104 -0.498 . . . . 0.88 110.868 -176.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 45.0 mt-10 -83.57 136.16 42.75 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.924 -0.58 . . . . 2.0600000000000001 109.58 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 103' ' ' LYS . 31.3 Cg_exo -58.14 113.68 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.18 1.92 . . . . 0.51000000000000001 111.71 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.17 -4.9 10.38 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.595 -0.812 . . . . 0.69999999999999996 113.643 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.3 pt-20 -112.74 121.66 45.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.001 0.9 . . . . 1.27 111.037 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.539 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -110.6 93.79 4.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.553 -0.749 . . . . 2.9199999999999999 111.658 177.1 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.681 ' C ' ' HG ' ' A' ' 183' ' ' LEU . 2.7 mm? -124.19 99.09 6.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.548 -0.461 . . . . 0.90000000000000002 110.222 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.746 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -147.78 119.0 7.76 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.695 0.398 . . . . 0.53000000000000003 110.074 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.593 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 7.4 p -154.12 157.8 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.285 -0.566 . . . . 0.91000000000000003 111.473 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 16.4 t-80 -115.13 110.87 20.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.385 -0.968 . . . . 1.55 108.385 163.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 66.6 t -75.44 99.12 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.24 0.543 . . . . 2.5600000000000001 110.051 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm -79.33 121.24 24.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.517 -0.765 . . . . 5.3600000000000003 110.709 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -98.74 3.69 47.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.427 -0.806 . . . . 5.7999999999999998 111.696 -170.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -174.66 56.09 0.13 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.335 -0.936 . . . . 5.6100000000000003 112.647 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.618 ' O ' ' HA3' ' A' ' 218' ' ' GLY . 39.3 t -124.7 -78.18 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.827 0.346 . . . . 6.3099999999999996 110.292 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.566 ' H ' ' HD2' ' A' ' 216' ' ' PRO . 18.1 t80 -102.31 -57.41 0.1 Allowed Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.357 -0.383 . . . . 8.8300000000000001 110.584 173.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.566 ' HD2' ' H ' ' A' ' 215' ' ' TYR . 35.2 Cg_endo -64.08 -46.82 7.44 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 121.574 1.516 . . . . 7.7800000000000002 112.404 -172.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -108.68 16.82 22.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.532 -0.544 . . . . 8.0199999999999996 109.532 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 214' ' ' VAL . . . -94.31 -141.5 11.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.585 -0.817 . . . . 8.6400000000000006 113.292 -172.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.4 t -101.12 62.52 0.97 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.76 0.79 . . . . 9.7200000000000006 110.414 -175.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.558 ' O ' ' HD3' ' A' ' 222' ' ' PRO . 33.0 m -117.07 153.05 49.56 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.384 -0.826 . . . . 9.6199999999999992 110.164 176.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -94.73 98.04 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.274 2.649 . . . . 11.65 112.202 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 220' ' ' VAL . 93.8 Cg_endo -87.43 9.49 3.86 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.798 2.332 . . . . 13.109999999999999 112.642 -177.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -139.59 40.33 1.43 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.279 -0.729 . . . . 14.029999999999999 111.279 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.7 tt -88.54 127.95 35.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.978 0.418 . . . . 16.100000000000001 110.298 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -123.94 -50.11 1.83 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.979 -0.555 . . . . 17.699999999999999 109.528 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.641 -0.695 . . . . 18.899999999999999 109.327 175.645 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.713 0 N-CA-C 111.713 -0.555 . . . . 33.259999999999998 111.713 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.0 p -75.78 121.52 22.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.721 0.296 . . . . 33.920000000000002 110.744 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.05 110.9 3.32 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.603 -0.808 . . . . 32.350000000000001 112.535 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -118.18 100.71 51.78 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 110.094 -0.335 . . . . 31.649999999999999 110.094 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.03 -8.31 17.65 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.4 2.067 . . . . 29.989999999999998 111.835 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.45 HG23 ' OD2' ' A' ' 59' ' ' ASP . 61.9 m -148.36 129.49 14.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.675 -0.693 . . . . 28.920000000000002 109.986 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.0 p -141.48 63.36 1.44 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.1 0.476 . . . . 26.940000000000001 110.951 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 60.57 73.9 0.47 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.281 -0.872 . . . . 25.829999999999998 110.823 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.45 ' OD2' HG23 ' A' ' 56' ' ' THR . 19.7 m-20 -65.83 129.67 40.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.663 -0.699 . . . . 23.530000000000001 110.865 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -99.11 123.3 43.31 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.409 -0.589 . . . . 21.640000000000001 109.409 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.7 p -94.31 113.42 60.79 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.739 0.304 . . . . 19.420000000000002 110.998 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.96 135.78 38.99 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.653 2.235 . . . . 17.170000000000002 112.359 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -78.81 160.58 27.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.482 -0.781 . . . . 17.469999999999999 111.183 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -123.49 45.07 2.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.081 -0.508 . . . . 15.630000000000001 109.801 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.09 67.46 0.48 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.847 -0.692 . . . . 12.039999999999999 112.572 -176.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.7 t -121.51 118.42 29.77 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.467 -0.568 . . . . 10.67 109.467 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -62.8 110.88 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.748 2.298 . . . . 9.6899999999999995 112.222 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -115.81 102.6 9.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.585 -0.524 . . . . 7.7000000000000002 109.585 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -70.02 145.46 51.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.978 -0.555 . . . . 8.1400000000000006 110.162 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.04 115.61 30.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.067 -0.515 . . . . 5.96 110.853 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.63 -157.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.967 2.444 . . . . 6.1299999999999999 112.835 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.06 -41.54 93.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 6.5300000000000002 110.977 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -98.07 107.13 19.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.928 0.394 . . . . 5.0099999999999998 110.123 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.431 ' H ' HG13 ' A' ' 74' ' ' ILE . 2.4 pp -86.19 139.88 34.46 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.696 -0.483 . . . . 4.2300000000000004 109.696 173.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -76.93 21.97 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.924 2.416 . . . . 4.1200000000000001 113.582 -173.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -99.38 -68.95 0.78 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.812 -0.44 . . . . 3.8199999999999998 109.812 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t70 59.68 89.54 0.06 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.395 -0.821 . . . . 3.1600000000000001 110.561 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 168' ' ' TRP . 66.5 mt -80.12 122.64 83.22 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.594 -0.73 . . . . 2.4500000000000002 110.693 -178.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.25 115.88 3.55 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.184 1.922 . . . . 1.75 111.572 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.637 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -113.63 155.93 44.25 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.039 -0.528 . . . . 1.01 110.03 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.63 154.86 66.48 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.753 2.302 . . . . 0.72999999999999998 111.862 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 -10.13 30.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.604 -0.725 . . . . 1.04 112.476 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 62.9 m-20 -104.71 7.75 34.86 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.927 -0.309 . . . . 1.6599999999999999 111.598 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -132.54 136.44 46.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.649 -0.5 . . . . 1.0 109.649 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.437 ' OE2' ' HD2' ' A' ' 87' ' ' ARG . 35.9 tt0 -127.34 122.91 35.0 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.382 -0.527 . . . . 2.27 110.787 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tt -87.28 125.35 34.16 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.455 -0.943 . . . . 0.79000000000000004 108.455 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.437 ' HD2' ' OE2' ' A' ' 85' ' ' GLU . 13.7 ptm180 -166.15 133.83 2.81 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.336 -0.847 . . . . 3.21 109.701 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.32 111.98 2.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.92 -0.582 . . . . 2.46 110.217 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -148.17 93.25 2.14 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.67 -0.863 . . . . 1.5800000000000001 108.67 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.3 t -72.23 104.63 3.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.992 -0.549 . . . . 1.8600000000000001 110.867 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.509 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -105.94 114.8 62.3 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.812 -0.631 . . . . 1.45 109.365 175.28 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.27 120.52 7.87 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.284 2.656 . . . . 1.6100000000000001 112.765 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.23 -11.42 36.89 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.009 -0.615 . . . . 1.74 112.435 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.509 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -132.97 -71.1 0.53 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.916 -0.313 . . . . 1.4099999999999999 111.476 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.83 -149.6 17.32 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.742 -0.742 . . . . 1.0900000000000001 112.478 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.3 mt -104.5 122.71 46.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.568 0.21 . . . . 2.3100000000000001 111.568 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -138.18 -153.85 6.36 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.818 -0.706 . . . . 0.58999999999999997 112.159 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.52 HG21 ' CE3' ' A' ' 168' ' ' TRP . 35.6 m -112.17 112.27 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.934 0.873 . . . . 0.67000000000000004 109.857 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -82.52 118.66 23.42 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.821 -0.627 . . . . 1.1299999999999999 110.799 -171.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -66.15 117.97 9.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.426 -0.806 . . . . 0.54000000000000004 110.374 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.9 -3.71 58.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.484 0.659 . . . . 1.6799999999999999 110.079 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.412 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 24.6 ttm-85 -125.74 157.06 38.38 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.544 -0.91 . . . . 3.5 108.544 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.412 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -83.99 159.58 21.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.108 0.48 . . . . 2.3999999999999999 110.145 177.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.625 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 44.6 mtm -128.32 153.53 46.91 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.02 -0.536 . . . . 1.22 109.912 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -120.45 139.06 53.41 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.8 -0.636 . . . . 2.3100000000000001 109.925 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -39.22 122.69 1.29 Allowed 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.431 1.082 . . . . 0.83999999999999997 113.395 -169.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.17 7.15 12.85 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.467 -0.788 . . . . 1.04 111.373 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.462 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -86.02 167.98 14.53 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.844 0.458 . . . . 2.6200000000000001 111.019 -176.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.49 ' CZ ' ' HD3' ' A' ' 112' ' ' PRO . 3.7 ptt180 -142.77 164.15 30.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.065 -0.516 . . . . 3.6200000000000001 110.514 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 109' ' ' ARG . 7.3 mt -118.48 139.25 51.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.542 -0.753 . . . . 0.53000000000000003 109.055 170.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.7 -115.02 4.17 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.804 -0.712 . . . . 1.02 113.288 174.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.49 ' HD3' ' CZ ' ' A' ' 109' ' ' ARG . 70.4 Cg_endo -72.14 168.22 74.77 Favored 'Cis proline' 0 C--N 1.349 0.596 0 C-N-CA 123.858 -1.309 . . . . 2.1000000000000001 112.94 4.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.507 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 52.7 t -66.76 -36.48 82.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.412 . . . . 2.0 110.528 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.454 ' HB ' ' H ' ' A' ' 192' ' ' ILE . 47.7 t -120.38 122.16 67.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.224 -0.658 . . . . 2.0299999999999998 109.224 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.5 m -98.78 -163.07 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.268 -0.424 . . . . 3.9500000000000002 110.546 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.4 m -57.1 140.28 78.2 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.431 -0.349 . . . . 5.21 110.716 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.06 100.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.267 2.645 . . . . 5.0700000000000003 113.103 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -95.02 -34.48 12.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.965 -0.562 . . . . 7.9900000000000002 109.8 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -159.34 160.07 34.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.151 -0.931 . . . . 6.9500000000000002 109.866 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -77.78 80.24 4.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.955 0.407 . . . . 6.0899999999999999 111.006 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.22 130.57 16.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.957 -0.565 . . . . 5.5599999999999996 110.236 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -94.79 154.98 17.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.951 -0.568 . . . . 7.4199999999999999 110.886 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -84.15 -71.4 0.51 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.959 -0.564 . . . . 9.0099999999999998 110.598 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 125' ' ' ASP . 5.7 m -135.14 -94.51 0.27 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.053 -0.259 . . . . 8.8800000000000008 110.875 176.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.433 ' H ' ' HB ' ' A' ' 124' ' ' THR . 8.9 t70 -171.92 -140.89 0.02 OUTLIER 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.385 -0.968 . . . . 7.5999999999999996 108.385 -176.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 76.57 -43.83 0.46 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.014 0.926 . . . . 7.2300000000000004 112.549 171.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -73.33 -34.77 57.29 Favored Glycine 0 C--N 1.31 -0.875 0 CA-C-N 115.53 -0.759 . . . . 4.5899999999999999 113.109 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TRP . . . . . 0.541 ' HE3' ' N ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -150.24 -103.24 0.07 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.036 0.384 . . . . 4.9299999999999997 112.036 -179.118 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.541 ' N ' ' HE3' ' A' ' 128' ' ' TRP . 12.1 pt-20 -163.37 -37.23 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.309 -0.405 . . . . 7.6500000000000004 110.034 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 178.36 141.74 0.1 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.941 -0.572 . . . . 8.8399999999999999 109.768 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.571 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -118.63 -13.34 10.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.911 0.386 . . . . 6.0499999999999998 110.343 173.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.9 mp -83.69 75.89 10.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.28 0.562 . . . . 8.5 110.132 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 44.2 p -128.72 59.58 1.54 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.299 -0.864 . . . . 9.8200000000000003 109.131 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 67.17 70.7 0.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.293 -0.867 . . . . 11.210000000000001 109.645 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.4 t -71.14 111.0 4.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.296 -0.865 . . . . 10.84 110.624 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -68.42 142.01 55.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.795 -0.639 . . . . 13.25 109.475 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.5 t -43.73 -52.73 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 123.52 0.513 . . . . 13.890000000000001 111.381 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.3 m 55.21 83.35 0.23 Allowed Pre-proline 0 C--O 1.235 0.301 0 O-C-N 123.838 0.711 . . . . 14.050000000000001 110.689 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -47.03 121.71 5.44 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.282 2.655 . . . . 14.41 112.636 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.512 ' HB3' ' SG ' ' A' ' 143' ' ' CYS . 77.2 mt-30 -59.99 122.37 14.14 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.441 -0.799 . . . . 14.44 110.367 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -100.12 140.8 33.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.756 -0.656 . . . . 15.9 110.211 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.76 -59.94 3.59 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.671 -0.776 . . . . 15.6 112.122 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 140' ' ' GLN . 6.8 p -81.4 66.52 6.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.441 0.638 . . . . 15.6 111.154 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 49.7 mm -89.7 -57.07 4.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.721 -0.672 . . . . 13.85 110.05 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 26.9 m -78.08 92.64 4.41 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.828 -0.624 . . . . 13.19 110.4 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -116.2 -42.42 3.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.126 -0.488 . . . . 15.67 109.867 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.678 HG22 ' H ' ' A' ' 148' ' ' SER . 3.9 mt 59.08 -179.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.634 0.731 . . . . 13.77 111.106 173.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.678 ' H ' HG22 ' A' ' 147' ' ' ILE . 20.0 m -95.97 68.54 2.76 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.523 -0.547 . . . . 13.619999999999999 109.523 175.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -59.73 108.54 0.76 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.781 -0.645 . . . . 13.02 111.201 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -81.74 132.93 35.3 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.243 -0.651 . . . . 14.68 109.243 174.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.8 pp -111.03 23.72 13.79 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.359 0.599 . . . . 13.550000000000001 110.892 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 154' ' ' GLU . . . 98.5 74.58 1.16 Allowed Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.623 -0.717 . . . . 15.800000000000001 111.48 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 t -76.66 37.19 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.471 0.653 . . . . 17.079999999999998 110.8 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' A' ' 152' ' ' GLY . 37.0 mt-10 -75.6 -60.81 2.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.485 -0.78 . . . . 18.43 108.914 175.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.432 ' HD2' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -134.55 20.12 3.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.781 -1.099 . . . . 18.530000000000001 110.026 177.063 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -128.14 87.64 2.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.643 -0.708 . . . . 14.32 110.794 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 37.3 t -120.55 36.75 4.47 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.551 -0.907 . . . . 14.51 108.551 176.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.7 136.75 56.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.143 -0.935 . . . . 13.06 110.475 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.488 ' OD1' ' HB2' ' A' ' 162' ' ' GLN . 34.6 t70 -75.42 99.5 4.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 10.33 110.675 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -126.65 -49.94 1.5 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.795 -0.639 . . . . 9.8800000000000008 111.341 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -101.97 14.8 30.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.388 -0.369 . . . . 10.23 111.331 -175.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.488 ' HB2' ' OD1' ' A' ' 159' ' ' ASP . 54.2 mt-30 -109.75 -81.2 0.58 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.469 -0.332 . . . . 9.0600000000000005 110.521 177.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.432 ' HB3' ' OD2' ' A' ' 159' ' ' ASP . . . -88.81 72.8 8.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.187 0.517 . . . . 6.1900000000000004 110.833 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -75.46 85.14 0.84 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.704 -0.68 . . . . 3.9700000000000002 112.382 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.74 160.62 30.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.891 0.377 . . . . 2.6299999999999999 110.562 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 113' ' ' CYS . . . -86.88 37.43 3.19 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.15 -0.548 . . . . 1.3 112.776 -176.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.404 ' HB2' HG23 ' A' ' 78' ' ' ILE . 3.4 m -61.47 -27.38 68.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.539 0.685 . . . . 1.8200000000000001 110.035 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.52 ' CE3' HG21 ' A' ' 98' ' ' VAL . 16.4 p-90 -85.3 -19.33 31.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.245 -0.889 . . . . 0.69999999999999996 111.084 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 40.6 mt -82.08 -14.95 55.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.059 -0.518 . . . . 0.66000000000000003 111.864 -173.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -74.59 -8.65 57.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 1.48 110.01 175.028 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.557 ' O ' ' HD2' ' A' ' 173' ' ' ARG . 65.6 m-85 -85.98 -30.47 22.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.979 -0.555 . . . . 1.97 111.675 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.783 HG21 ' HB2' ' A' ' 207' ' ' LEU . 1.3 mm -51.3 138.01 8.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 O-C-N 123.393 0.433 . . . . 0.67000000000000004 111.301 -173.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.557 ' HD2' ' O ' ' A' ' 171' ' ' TYR . 14.9 mmm180 -92.14 170.88 9.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.344 0.593 . . . . 4.3399999999999999 111.874 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.478 HG22 HG11 ' A' ' 208' ' ' VAL . 61.6 t -89.64 160.76 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.26 -0.882 . . . . 1.0700000000000001 108.669 173.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.538 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -46.67 125.0 6.61 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.323 0.389 . . . . 0.70999999999999996 111.892 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 30.8 p -75.75 -14.11 60.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.057 -0.52 . . . . 1.8799999999999999 110.989 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.4 m -148.39 164.19 34.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 1.6299999999999999 109.86 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 57.4 m -74.91 -22.96 58.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.973 0.416 . . . . 1.96 111.062 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.13 5.32 45.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.213 0.53 . . . . 2.4199999999999999 110.402 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -110.05 15.93 22.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.42 -0.809 . . . . 2.1200000000000001 110.255 -174.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.87 114.34 7.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.449 . . . . 1.3500000000000001 110.427 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.784 ' H ' HD12 ' A' ' 183' ' ' LEU . 18.7 t30 -157.43 36.74 0.28 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.001 0.905 . . . . 1.6799999999999999 109.21 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.784 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.5 OUTLIER -122.9 124.57 43.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.043 -0.526 . . . . 0.81000000000000005 111.169 -173.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.5 m -149.97 121.95 8.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.19 0.519 . . . . 0.51000000000000001 110.735 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.432 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 48.1 ttm -97.96 133.02 43.01 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.202 -0.666 . . . . 1.3500000000000001 109.202 172.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 25.0 t -112.83 132.19 55.38 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.289 -0.634 . . . . 1.73 109.289 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 24.7 tm0? -108.37 104.9 14.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.248 0.547 . . . . 1.9299999999999999 109.712 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.578 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 25.3 pt -132.53 143.2 40.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.522 -0.763 . . . . 1.1100000000000001 110.139 -176.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.8 m 54.1 35.93 23.49 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.324 0.39 . . . . 1.8600000000000001 111.606 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 65.55 7.55 4.48 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.943 -0.571 . . . . 2.8300000000000001 112.054 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 13.4 pt20 -113.79 155.26 25.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 1.75 110.529 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.454 ' H ' ' HB ' ' A' ' 114' ' ' VAL . 51.0 mm -87.81 112.75 23.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.858 -0.61 . . . . 1.01 110.425 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -110.53 135.6 50.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.889 -0.596 . . . . 3.9399999999999999 110.274 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 9.9 m-85 -102.34 114.67 29.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.59 -0.277 . . . . 0.92000000000000004 110.485 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.97 117.85 31.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.866 0.365 . . . . 1.1100000000000001 110.048 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.462 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 2.2 t -89.6 152.85 3.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.533 0.682 . . . . 0.69999999999999996 109.869 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.5 mm -90.34 -57.2 4.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.65 -1.159 . . . . 0.62 111.486 -166.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.582 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.7 OUTLIER -141.87 -178.83 5.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.634 -0.712 . . . . 1.3799999999999999 111.368 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.625 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.9 m-20 -48.45 126.66 11.84 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 124.014 0.821 . . . . 2.23 112.703 -175.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.623 HD11 ' ND2' ' A' ' 182' ' ' ASN . 18.6 mm -96.66 138.01 22.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.445 -0.798 . . . . 0.88 110.714 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -86.17 133.29 41.12 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.941 -0.572 . . . . 2.0600000000000001 109.51 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 52.4 Cg_exo -54.99 113.21 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.009 1.806 . . . . 0.51000000000000001 111.615 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.93 -13.08 9.19 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.742 -0.742 . . . . 0.69999999999999996 113.261 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -126.52 122.56 35.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.765 0.783 . . . . 1.27 111.733 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.533 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -111.29 115.79 29.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.807 -0.633 . . . . 2.9199999999999999 111.254 175.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 205' ' ' GLU . 1.7 mm? -124.1 99.97 6.49 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.71 -0.478 . . . . 0.90000000000000002 109.71 171.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.783 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.4 mm? -147.17 112.84 5.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.673 0.389 . . . . 0.53000000000000003 110.156 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.646 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.4 p -154.92 160.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.816 -0.438 . . . . 0.91000000000000003 109.816 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.432 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 52.5 t60 -90.84 107.58 19.28 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.562 -1.273 . . . . 1.55 107.562 169.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.7 m -73.89 126.0 33.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.099 0.476 . . . . 2.5600000000000001 110.098 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -78.76 126.53 30.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.316 0.579 . . . . 5.3600000000000003 110.581 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -115.54 14.84 16.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.407 -0.815 . . . . 5.7999999999999998 110.267 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.402 ' HA2' HD23 ' A' ' 217' ' ' LEU . . . 70.16 27.39 72.97 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.514 -0.766 . . . . 5.6100000000000003 112.624 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.499 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 43.7 t -99.95 -71.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.946 0.403 . . . . 6.3099999999999996 110.646 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.524 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 86.6 m-85 -60.52 -53.99 59.16 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.724 -0.671 . . . . 8.8300000000000001 112.259 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 13.9 Cg_endo -54.5 -42.44 68.04 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.532 2.154 . . . . 7.7800000000000002 112.98 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.402 HD23 ' HA2' ' A' ' 213' ' ' GLY . 3.8 mm? -85.33 -10.15 56.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.442 -0.345 . . . . 8.0199999999999996 111.826 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 67.75 42.54 86.81 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 116.012 -0.54 . . . . 8.6400000000000006 112.744 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 214' ' ' VAL . 24.4 p -81.63 -0.57 43.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.128 0.49 . . . . 9.7200000000000006 111.414 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.441 ' HA ' ' HD3' ' A' ' 221' ' ' PRO . 20.4 m -80.77 139.85 50.61 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.991 -0.55 . . . . 9.6199999999999992 110.436 177.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 15.6 Cg_exo -69.02 114.86 3.73 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.581 2.187 . . . . 11.65 111.756 177.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 221' ' ' PRO . 15.3 Cg_exo -67.71 96.38 0.43 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.844 2.363 . . . . 13.109999999999999 111.673 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.18 -118.23 4.65 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.726 -0.749 . . . . 14.029999999999999 111.623 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 37.2 tp -160.1 122.77 3.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.822 0.344 . . . . 16.100000000000001 110.636 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -128.18 -6.06 5.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.959 -0.564 . . . . 17.699999999999999 110.459 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.376 -0.821 . . . . 18.899999999999999 109.795 179.715 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 112.104 -0.398 . . . . 33.259999999999998 112.104 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.7 t -139.2 126.84 21.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.371 -0.603 . . . . 33.920000000000002 109.371 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.69 -47.88 3.03 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.407 -0.677 . . . . 32.350000000000001 111.407 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 60.23 85.76 0.17 Allowed Pre-proline 0 C--O 1.231 0.128 0 C-N-CA 123.045 0.538 . . . . 31.649999999999999 111.123 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -55.78 97.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.976 2.45 . . . . 29.989999999999998 112.394 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.6 m -113.65 136.6 52.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.642 -0.708 . . . . 28.920000000000002 110.199 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.0 m 64.91 61.65 0.77 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.401 0.619 . . . . 26.940000000000001 109.953 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -89.45 20.15 4.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.618 -0.719 . . . . 25.829999999999998 110.942 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -98.99 98.17 9.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.171 -0.468 . . . . 23.530000000000001 110.266 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -104.53 137.94 41.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.93 -0.577 . . . . 21.640000000000001 110.443 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.3 m -96.07 115.3 65.48 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.96 -0.564 . . . . 19.420000000000002 110.518 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.9 92.9 0.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.393 2.062 . . . . 17.170000000000002 111.339 176.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -82.64 -37.38 25.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.249 -0.887 . . . . 17.469999999999999 110.352 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -90.58 165.18 13.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.686 -0.688 . . . . 15.630000000000001 110.346 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.15 -124.79 8.52 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.778 -0.725 . . . . 12.039999999999999 111.918 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.419 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 51.8 m -153.08 97.1 2.84 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 120.481 0.181 . . . . 10.67 110.598 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 66' ' ' SER . 30.1 Cg_endo -64.28 97.88 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.5 2.134 . . . . 9.6899999999999995 111.64 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -86.9 130.99 34.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.849 -0.614 . . . . 7.7000000000000002 110.866 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -132.06 147.39 52.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.794 -0.639 . . . . 8.1400000000000006 109.547 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.74 112.05 26.27 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.366 -0.379 . . . . 5.96 110.485 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.07 -157.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.637 2.225 . . . . 6.1299999999999999 112.234 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.6 m -60.58 -31.2 48.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.881 0.372 . . . . 6.5300000000000002 110.984 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -112.63 120.33 41.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.35 -0.387 . . . . 5.0099999999999998 110.066 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.463 ' O ' HD12 ' A' ' 74' ' ' ILE . 1.9 pp -77.01 149.56 80.08 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.361 -0.381 . . . . 4.2300000000000004 110.225 175.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.32 12.54 1.53 Allowed 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.628 2.218 . . . . 4.1200000000000001 114.333 -167.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -124.2 -83.49 0.65 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 121.139 -0.224 . . . . 3.8199999999999998 110.978 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.5 t70 65.07 80.11 0.24 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.923 0.764 . . . . 3.1600000000000001 110.176 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.0 mt -72.97 124.39 90.66 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.356 -0.838 . . . . 2.4500000000000002 110.458 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.64 124.57 10.37 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.702 2.268 . . . . 1.75 111.857 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.615 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -118.94 143.97 34.85 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.316 -0.402 . . . . 1.01 110.67 -178.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -54.62 147.53 48.62 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.414 2.743 . . . . 0.72999999999999998 112.296 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.422 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -66.15 -12.84 58.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.92 -0.582 . . . . 1.04 112.104 -175.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.99 -24.12 59.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.19 0.519 . . . . 1.6599999999999999 110.177 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 71.6 m-85 -123.72 177.39 5.73 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.074 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.545 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 28.2 tt0 -155.86 124.66 6.01 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.009 -0.276 . . . . 2.27 110.702 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.9 tt -84.0 125.01 31.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.474 -0.565 . . . . 0.79000000000000004 109.474 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -147.79 138.9 23.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.196 -0.911 . . . . 3.21 109.538 -174.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.99 110.8 17.58 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.694 -0.484 . . . . 2.46 109.694 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m -150.0 106.61 3.52 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.749 -0.659 . . . . 1.5800000000000001 109.309 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.6 m -75.91 104.17 6.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.061 0.458 . . . . 1.8600000000000001 111.225 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.425 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -107.15 114.85 60.82 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.148 -0.686 . . . . 1.45 109.148 174.103 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 91' ' ' ILE . 37.5 Cg_exo -60.43 121.93 10.52 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.827 2.351 . . . . 1.6100000000000001 112.653 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.33 -9.61 35.94 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.685 -0.769 . . . . 1.74 113.037 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -131.88 -70.6 0.57 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.892 0.346 . . . . 1.4099999999999999 111.531 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 130.3 -161.51 23.17 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.816 -0.707 . . . . 1.0900000000000001 112.047 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mt -94.68 116.78 29.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.091 -0.337 . . . . 2.3100000000000001 110.091 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.464 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -119.04 -179.39 16.76 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.733 -0.746 . . . . 0.58999999999999997 112.614 -176.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 19.6 m -100.78 112.7 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.698 0.761 . . . . 0.67000000000000004 109.776 174.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -82.07 112.33 19.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.447 -0.797 . . . . 1.1299999999999999 110.984 -169.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -66.5 114.64 5.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.54000000000000004 109.703 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.554 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -95.73 2.18 53.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.427 0.632 . . . . 1.6799999999999999 109.501 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -125.54 154.55 41.98 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.942 -1.027 . . . . 3.5 109.218 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.625 ' H ' ' HD2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -86.72 154.68 20.78 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.453 -0.573 . . . . 2.3999999999999999 109.453 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.744 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 49.4 mtm -131.16 147.56 52.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.512 -0.313 . . . . 1.22 110.734 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -109.8 143.06 40.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.322 -0.622 . . . . 2.3100000000000001 109.322 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.37 130.43 10.75 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 124.012 0.82 . . . . 0.83999999999999997 112.458 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.61 7.54 13.5 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.156 -0.778 . . . . 1.04 111.156 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 0.8 OUTLIER -78.96 162.87 25.68 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 122.901 0.48 . . . . 2.6200000000000001 111.589 -176.468 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 109' ' ' ARG . 2.8 tmm_? -146.93 128.26 14.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.856 -0.611 . . . . 3.6200000000000001 110.881 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 3.2 mt -105.15 148.48 26.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.728 -0.841 . . . . 0.53000000000000003 108.728 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 129.72 -151.2 19.22 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.532 -0.842 . . . . 1.02 112.181 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.557 ' HB3' ' CE2' ' A' ' 193' ' ' TYR . 86.4 Cg_endo -81.53 142.05 52.97 Favored 'Cis proline' 0 C--N 1.342 0.218 0 C-N-CA 123.823 -1.324 . . . . 2.1000000000000001 112.67 0.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 14.2 m -72.48 -27.94 62.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.19 0.519 . . . . 2.0 109.765 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.5 t -121.44 116.64 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.342 -0.845 . . . . 2.0299999999999998 109.131 175.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.421 HG23 ' HG2' ' A' ' 117' ' ' PRO . 1.4 m -91.25 -169.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.248 -0.433 . . . . 3.9500000000000002 111.37 -177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.581 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 2.4 p -63.04 -38.1 39.1 Favored Pre-proline 0 CA--C 1.553 1.088 0 N-CA-C 114.491 1.293 . . . . 5.21 114.491 -173.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 116' ' ' VAL . 9.4 Cg_endo -53.22 140.53 61.41 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 121.687 1.592 . . . . 5.0700000000000003 112.543 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -68.04 -28.55 67.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.308 -0.86 . . . . 7.9900000000000002 111.792 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.12 74.41 0.22 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.928 -0.578 . . . . 6.9500000000000002 110.683 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.8 -79.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.582 -0.736 . . . . 6.0899999999999999 111.232 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 65.15 138.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.74 0.781 . . . . 5.5599999999999996 111.575 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -66.8 138.8 57.62 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.41 -0.814 . . . . 7.4199999999999999 110.256 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -69.15 -49.39 57.34 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.001 -0.74 . . . . 9.0099999999999998 109.001 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 78.7 m -162.68 -58.79 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.197 -0.911 . . . . 8.8800000000000008 108.722 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.88 177.59 6.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.182 -0.917 . . . . 7.5999999999999996 111.055 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -132.4 156.61 46.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.359 -0.837 . . . . 7.2300000000000004 109.465 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.739 ' HA3' ' SD ' ' A' ' 185' ' ' MET . . . -146.77 25.96 1.64 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.961 -1.114 . . . . 4.5899999999999999 113.564 -177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TRP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 187' ' ' GLN . 0.0 OUTLIER -155.45 -111.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.533 0.568 . . . . 4.9299999999999997 112.533 176.146 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -141.17 -57.94 0.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.927 0.343 . . . . 7.6500000000000004 111.927 -171.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.601 ' HG2' ' H ' ' A' ' 132' ' ' LEU . 8.4 tt0 -172.05 142.46 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.502 0.191 . . . . 8.8399999999999999 110.688 -172.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.575 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -127.11 13.81 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.324 0.583 . . . . 6.0499999999999998 110.265 174.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.601 ' H ' ' HG2' ' A' ' 130' ' ' GLN . 9.5 mp -81.15 70.63 8.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.536 -0.756 . . . . 8.5 110.487 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.1 p -101.78 41.7 1.19 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.317 -0.856 . . . . 9.8200000000000003 110.524 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 60.67 67.19 0.85 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.649 -0.705 . . . . 11.210000000000001 110.166 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -58.5 130.94 22.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.931 -1.031 . . . . 10.84 111.287 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -85.9 148.26 25.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.735 -0.666 . . . . 13.25 110.326 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 138' ' ' SER . 27.5 m -96.1 9.77 5.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.457 -0.338 . . . . 13.890000000000001 110.452 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 137' ' ' VAL . 73.5 m 72.96 143.58 0.1 OUTLIER Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 114.934 -1.03 . . . . 14.050000000000001 111.276 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.41 87.75 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.532 2.155 . . . . 14.41 112.007 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -83.04 36.89 0.52 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.242 0.544 . . . . 14.44 110.077 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -85.46 -6.58 59.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.369 -0.832 . . . . 15.9 110.639 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -160.42 -179.21 35.05 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.865 -0.607 . . . . 15.6 111.69 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 38.4 t -72.56 130.77 41.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.986 0.422 . . . . 15.6 110.444 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.4 mt -101.24 62.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 122.172 0.987 . . . . 13.85 108.405 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.57 44.2 0.27 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.311 -1.313 . . . . 13.19 113.127 -172.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -101.79 -17.46 16.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.807 -0.812 . . . . 15.67 108.807 171.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.402 ' H ' HG13 ' A' ' 147' ' ' ILE . 2.3 pp -124.31 163.66 23.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.953 -1.021 . . . . 13.77 109.766 176.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.2 t -149.13 68.48 1.05 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.672 0.749 . . . . 13.619999999999999 109.766 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -131.28 75.72 1.67 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.401 -0.818 . . . . 13.02 110.162 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.41 97.74 7.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.066 -0.97 . . . . 14.68 110.234 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.7 mt -82.74 57.09 3.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.873 0.368 . . . . 13.550000000000001 110.734 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.54 31.98 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.627 -0.797 . . . . 15.800000000000001 112.666 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.9 m -114.92 -58.34 2.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.822 0.344 . . . . 17.079999999999998 110.532 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -101.75 -103.79 0.26 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.852 0.358 . . . . 18.43 111.427 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -119.37 23.13 11.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.273 0.559 . . . . 18.530000000000001 111.391 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -107.84 19.49 20.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.866 -0.607 . . . . 14.32 109.969 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 3.4 p -69.8 -29.54 66.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.387 -0.824 . . . . 14.51 110.503 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.0 t -70.74 125.16 28.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.311 -0.626 . . . . 13.06 109.311 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -81.4 82.11 7.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.476 0.655 . . . . 10.33 110.835 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -118.27 -23.73 7.18 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.539 -1.209 . . . . 9.8800000000000008 109.068 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -71.54 -38.26 71.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.306 -1.315 . . . . 10.23 111.718 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.36 -41.31 7.89 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.897 -0.408 . . . . 9.0600000000000005 109.897 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -66.67 101.11 0.75 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.854 -0.612 . . . . 6.1900000000000004 110.866 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -166.74 -94.35 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.734 -0.946 . . . . 3.9700000000000002 110.734 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 41.33 -92.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.667 0.988 . . . . 2.6299999999999999 113.667 172.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -131.17 14.07 5.43 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.069 -0.586 . . . . 1.3 112.134 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 23.0 t -68.54 -24.79 64.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.325 0.583 . . . . 1.8200000000000001 109.941 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -85.0 -18.79 33.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.794 -0.639 . . . . 0.69999999999999996 109.857 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.538 ' O ' HG13 ' A' ' 172' ' ' ILE . 38.0 mt -84.1 -20.35 32.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.682 -0.69 . . . . 0.66000000000000003 111.415 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.463 ' HD3' ' C ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -76.2 -6.17 50.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.519 -0.472 . . . . 1.48 110.225 176.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.464 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 33.8 m-85 -75.83 -37.52 58.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.968 -0.56 . . . . 1.97 110.484 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.646 HD12 ' HB2' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -68.63 119.74 14.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.367 -0.605 . . . . 0.67000000000000004 109.367 174.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -111.15 -172.29 2.0 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.539 -0.301 . . . . 4.3399999999999999 110.847 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.412 HG22 HG11 ' A' ' 208' ' ' VAL . 20.6 t -68.19 149.04 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 1.0700000000000001 110.771 -177.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.577 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -56.22 126.23 25.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.894 -0.594 . . . . 0.70999999999999996 111.441 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 46.2 t -72.02 -17.46 62.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 1.8799999999999999 110.838 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 m -126.33 150.42 48.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.313 -0.403 . . . . 1.6299999999999999 109.975 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 10.7 p -78.57 -19.02 53.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.492 0.553 . . . . 1.96 112.492 -172.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -89.17 -4.09 58.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.468 0.651 . . . . 2.4199999999999999 110.051 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.15 17.48 12.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.207 -0.906 . . . . 2.1200000000000001 111.642 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -69.33 113.25 6.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.327 0.584 . . . . 1.3500000000000001 110.952 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 1.033 ' H ' HD12 ' A' ' 183' ' ' LEU . 4.1 p-10 -155.25 35.14 0.38 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.178 -0.919 . . . . 1.6799999999999999 109.582 171.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 1.033 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.5 OUTLIER -117.7 120.42 37.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.443 -0.799 . . . . 0.81000000000000005 110.754 -171.363 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 92.7 m -148.53 139.8 23.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.099 0.476 . . . . 0.51000000000000001 110.95 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.739 ' SD ' ' HA3' ' A' ' 127' ' ' GLY . 55.5 ttm -98.75 150.29 21.98 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.371 -0.603 . . . . 1.3500000000000001 109.371 174.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 53.7 t -112.78 131.9 55.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.061 0.458 . . . . 1.73 109.97 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.557 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 20.7 tm0? -120.77 104.89 10.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.769 -0.651 . . . . 1.9299999999999999 109.389 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 12.9 pt -140.71 132.63 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 1.1100000000000001 110.123 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 51.1 m 58.51 29.88 18.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.118 0.485 . . . . 1.8600000000000001 111.059 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.557 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 0.9 OUTLIER 63.97 11.5 6.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.145 -0.934 . . . . 2.8300000000000001 112.753 176.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -112.08 140.03 47.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.539 -0.541 . . . . 1.75 109.539 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.1 mm -84.77 131.68 33.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.947 -0.57 . . . . 1.01 112.02 -172.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 112' ' ' PRO . 54.3 m-85 -128.37 165.11 21.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.045 -0.98 . . . . 3.9399999999999999 109.709 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.557 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 3.9 m-85 -115.02 126.53 54.85 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.579 -0.526 . . . . 0.92000000000000004 109.579 175.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -125.47 120.06 29.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.027 0.441 . . . . 1.1100000000000001 110.604 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.503 HG22 HD11 ' A' ' 207' ' ' LEU . 1.5 t -85.82 152.9 3.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.126 -0.694 . . . . 0.69999999999999996 109.126 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.538 HG13 ' HA ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -84.28 -48.54 16.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.891 -1.05 . . . . 0.62 111.039 -170.035 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.78 -178.08 6.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.635 -0.711 . . . . 1.3799999999999999 111.193 -174.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.744 ' HA ' ' O ' ' A' ' 104' ' ' MET . 2.8 p-10 -43.23 124.49 3.34 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.454 1.096 . . . . 2.23 113.486 -176.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.482 HG13 ' HE3' ' A' ' 104' ' ' MET . 37.8 mm -100.98 133.11 45.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.947 -1.024 . . . . 0.88 110.122 175.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.676 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 46.5 mt-10 -90.12 128.74 48.46 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.402 -0.592 . . . . 2.0600000000000001 109.402 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.76 116.75 2.03 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.952 2.435 . . . . 0.51000000000000001 112.934 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 123.51 -16.11 8.0 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.953 -0.641 . . . . 0.69999999999999996 113.653 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.676 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 13.9 pt-20 -111.7 122.86 48.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.827 0.814 . . . . 1.27 111.518 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -111.32 94.99 5.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.081 -0.509 . . . . 2.9199999999999999 112.087 177.674 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.455 HD22 ' N ' ' A' ' 206' ' ' LEU . 1.2 mm? -122.77 100.17 6.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.874 -0.73 . . . . 0.90000000000000002 109.859 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.646 ' HB2' HD12 ' A' ' 172' ' ' ILE . 0.6 OUTLIER -147.33 114.28 6.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.581 -0.281 . . . . 0.53000000000000003 110.617 177.472 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.646 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.5 p -155.51 158.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.505 . . . . 0.91000000000000003 109.635 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -85.81 110.41 19.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.245 -1.02 . . . . 1.55 108.245 166.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 p -71.78 123.66 26.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.264 0.554 . . . . 2.5600000000000001 110.015 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -144.02 131.86 21.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.0 -0.545 . . . . 5.3600000000000003 110.801 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.456 ' O ' HD23 ' A' ' 217' ' ' LEU . 10.7 pt-20 -130.07 -2.95 4.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 5.7999999999999998 110.366 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.55 ' HA2' ' HB2' ' A' ' 217' ' ' LEU . . . -163.59 60.82 0.26 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.561 -0.828 . . . . 5.6100000000000003 112.724 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 52.4 t -113.47 -75.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.846 0.355 . . . . 6.3099999999999996 110.155 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.443 ' H ' ' HD2' ' A' ' 216' ' ' PRO . 52.3 t80 -87.48 -58.57 0.28 Allowed Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.119 -0.491 . . . . 8.8300000000000001 110.971 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.443 ' HD2' ' H ' ' A' ' 215' ' ' TYR . 18.0 Cg_endo -57.87 -51.27 8.3 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 121.979 1.786 . . . . 7.7800000000000002 112.628 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.55 ' HB2' ' HA2' ' A' ' 213' ' ' GLY . 2.4 mm? -102.7 41.96 1.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.396 0.617 . . . . 8.0199999999999996 109.993 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -114.18 -165.56 15.48 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.398 -0.819 . . . . 8.6400000000000006 111.741 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.9 p -89.41 54.05 2.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.322 0.582 . . . . 9.7200000000000006 110.874 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.96 157.09 34.51 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.59 -0.732 . . . . 9.6199999999999992 110.379 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.07 138.95 88.42 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.523 2.149 . . . . 11.65 112.27 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.93 99.39 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.734 2.289 . . . . 13.109999999999999 111.771 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 132.09 -119.92 2.64 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.882 -0.887 . . . . 14.029999999999999 110.882 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 40.1 tp -150.98 123.54 8.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.819 0.342 . . . . 16.100000000000001 110.184 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -88.01 -38.39 15.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.934 -0.575 . . . . 17.699999999999999 110.481 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.288 -0.863 . . . . 18.899999999999999 110.421 178.831 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 111.952 -0.459 . . . . 33.259999999999998 111.952 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.2 t -160.01 152.06 20.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.713 0.292 . . . . 33.920000000000002 110.476 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.22 -133.03 19.64 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.248 -0.501 . . . . 32.350000000000001 112.032 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -135.24 113.11 11.25 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.661 -0.496 . . . . 31.649999999999999 109.661 177.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.73 56.9 4.23 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.882 2.388 . . . . 29.989999999999998 112.723 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 p -67.31 -42.39 83.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.078 0.466 . . . . 28.920000000000002 110.462 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.9 t -99.6 67.47 1.5 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.095 -0.706 . . . . 26.940000000000001 109.095 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -94.36 82.01 4.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.942 -0.572 . . . . 25.829999999999998 110.323 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -96.08 112.52 24.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.472 -0.785 . . . . 23.530000000000001 110.097 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.567 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 66.5 m-85 -72.27 94.37 1.58 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.938 -0.393 . . . . 21.640000000000001 109.938 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.5 p -106.72 92.5 7.4 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.788 -0.642 . . . . 19.420000000000002 111.112 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.567 ' HD3' ' O ' ' A' ' 60' ' ' PHE . 7.7 Cg_exo -72.59 125.68 10.83 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.981 2.454 . . . . 17.170000000000002 111.922 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -86.16 49.05 1.71 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.276 0.56 . . . . 17.469999999999999 109.824 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -126.2 131.33 52.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.329 -0.851 . . . . 15.630000000000001 109.799 -176.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . -109.75 -114.69 3.65 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.671 -0.776 . . . . 12.039999999999999 111.669 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.3 m -110.25 91.62 11.86 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.608 -0.515 . . . . 10.67 109.608 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 65' ' ' GLY . 4.5 Cg_exo -73.5 98.69 1.06 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.906 2.404 . . . . 9.6899999999999995 112.057 -176.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -83.45 89.23 7.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.093 -0.503 . . . . 7.7000000000000002 109.747 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -113.64 152.01 30.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.017 -0.538 . . . . 8.1400000000000006 110.438 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.439 ' HB2' ' HD3' ' A' ' 75' ' ' PRO . . . -83.11 122.41 77.6 Favored Pre-proline 0 C--N 1.319 -0.717 0 CA-C-N 115.739 -0.664 . . . . 5.96 111.239 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.97 -70.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.558 2.838 . . . . 6.1299999999999999 113.064 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.1 p -124.33 -43.51 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.117 -0.492 . . . . 6.5300000000000002 111.432 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -92.1 108.5 19.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.402 -0.363 . . . . 5.0099999999999998 110.08 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.531 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.1 pp -80.0 134.61 56.09 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 121.22 0.533 . . . . 4.2300000000000004 111.482 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.439 ' HD3' ' HB2' ' A' ' 70' ' ' ALA . 71.8 Cg_endo -77.27 0.5 9.68 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.953 2.435 . . . . 4.1200000000000001 112.396 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.37 -59.5 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.092 -0.707 . . . . 3.8199999999999998 109.092 175.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.447 ' H ' HD13 ' A' ' 74' ' ' ILE . 24.2 t70 65.44 100.34 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.736 -1.12 . . . . 3.1600000000000001 111.756 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.0 118.01 67.22 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.331 -0.849 . . . . 2.4500000000000002 109.795 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.78 116.39 3.41 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.349 2.033 . . . . 1.75 111.712 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.579 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -126.41 140.94 38.54 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.287 -0.415 . . . . 1.01 110.478 -178.153 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.45 138.38 83.71 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.509 2.14 . . . . 0.72999999999999998 111.634 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.49 -4.12 13.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.145 0.497 . . . . 1.04 111.351 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.54 -23.01 61.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.785 -0.643 . . . . 1.6599999999999999 109.457 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -128.43 177.31 7.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.295 -0.866 . . . . 1.0 108.872 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -145.54 131.43 19.14 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.18 -0.608 . . . . 2.27 110.906 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.4 tt -92.79 130.65 38.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.027 -0.533 . . . . 0.79000000000000004 109.769 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -149.5 150.93 33.09 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.454 -0.794 . . . . 3.21 109.746 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -82.92 109.42 17.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.707 -0.849 . . . . 2.46 108.707 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.8 m -159.56 82.44 0.75 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.327 -0.62 . . . . 1.5800000000000001 109.327 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.6 p -68.3 105.22 2.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.139 -0.482 . . . . 1.8600000000000001 110.922 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.6 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -81.86 123.46 80.15 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.116 -0.698 . . . . 1.45 109.116 176.236 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -49.62 115.38 1.77 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.282 2.654 . . . . 1.6100000000000001 113.297 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.09 -14.53 37.06 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.7 -0.762 . . . . 1.74 112.691 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.6 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -128.77 -55.77 1.21 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 1.4099999999999999 111.477 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.92 -146.71 17.54 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.979 -0.629 . . . . 1.0900000000000001 112.255 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.414 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 1.3 pp -69.26 158.83 34.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.718 0.259 . . . . 2.3100000000000001 110.914 177.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.71 172.15 43.56 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.796 -0.716 . . . . 0.58999999999999997 111.995 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.1 m -108.24 120.45 59.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.678 0.751 . . . . 0.67000000000000004 109.965 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -83.01 107.98 15.99 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.246 0.546 . . . . 1.1299999999999999 110.859 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.42 115.56 7.99 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.551 -0.749 . . . . 0.54000000000000004 110.16 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.537 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -86.57 -5.23 59.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.546 0.688 . . . . 1.6799999999999999 109.359 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -128.88 159.17 36.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.008 -0.997 . . . . 3.5 109.176 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.432 ' HD3' ' H ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -85.37 137.09 33.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.244 0.545 . . . . 2.3999999999999999 110.637 -177.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.634 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 25.3 mtm -94.97 116.62 28.93 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.74 -0.837 . . . . 1.22 108.74 172.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.69 173.62 12.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.403 0.621 . . . . 2.3100000000000001 111.74 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.98 118.12 7.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.276 -0.874 . . . . 0.83999999999999997 111.83 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.76 1.04 63.82 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.839 -0.696 . . . . 1.04 113.198 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.58 167.95 20.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.649 -0.5 . . . . 2.6200000000000001 109.649 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.636 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 5.0 tmm_? -145.82 130.6 18.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.245 0.461 . . . . 3.6200000000000001 112.245 -170.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.7 mt -88.18 139.91 30.02 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.84 -0.8 . . . . 0.53000000000000003 108.84 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.04 173.3 40.72 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.801 -1.19 . . . . 1.02 113.05 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -80.97 152.27 81.0 Favored 'Cis proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.954 -1.686 . . . . 2.1000000000000001 112.463 -2.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.442 ' HA ' ' HA2' ' A' ' 166' ' ' GLY . 42.7 t -96.57 -0.58 48.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.037 0.446 . . . . 2.0 110.715 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.8 m -120.18 133.46 66.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.231 -0.44 . . . . 2.0299999999999998 111.074 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 116' ' ' VAL . 2.0 t -89.91 179.23 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.638 -0.875 . . . . 3.9500000000000002 108.638 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.577 ' H ' HG12 ' A' ' 115' ' ' VAL . 21.6 t -51.99 -51.57 69.9 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 117.739 0.245 . . . . 5.21 111.616 177.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 116' ' ' VAL . 36.2 Cg_endo -66.0 89.96 0.25 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.96 1.774 . . . . 5.0700000000000003 111.479 171.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 -84.3 -39.63 18.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.001 -0.545 . . . . 7.9900000000000002 110.081 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 49.87 47.51 23.03 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.671 0.607 . . . . 6.9500000000000002 111.314 175.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -98.71 137.54 37.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.804 -0.634 . . . . 6.0899999999999999 111.192 -175.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.09 89.21 0.92 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.808 -0.633 . . . . 5.5599999999999996 110.284 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.545 ' HD3' ' O ' ' A' ' 124' ' ' THR . 7.3 ptpp? -95.84 157.22 15.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.261 -0.882 . . . . 7.4199999999999999 110.882 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -98.16 -28.86 13.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.165 -0.679 . . . . 9.0099999999999998 109.165 172.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.545 ' O ' ' HD3' ' A' ' 122' ' ' LYS . 87.1 m -154.02 -74.53 0.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.996 -1.002 . . . . 8.8800000000000008 109.847 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -178.59 -74.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.76 -0.654 . . . . 7.5999999999999996 109.807 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 63.42 17.99 10.71 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.629 0.728 . . . . 7.2300000000000004 111.266 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 90.34 50.8 2.9 Favored Glycine 0 C--N 1.309 -0.947 0 CA-C-N 115.075 -0.966 . . . . 4.5899999999999999 110.846 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TRP . . . . . 0.511 ' CE2' HD11 ' A' ' 192' ' ' ILE . 28.8 t-105 71.97 131.88 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 123.266 1.508 . . . . 4.9299999999999997 112.025 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.479 ' OE1' HD12 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -59.89 -25.61 65.24 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 111.993 -2.367 . . . . 7.6500000000000004 112.365 177.421 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 128' ' ' TRP . 26.2 mt-30 64.49 35.61 9.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.277 -0.874 . . . . 8.8399999999999999 112.848 173.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.615 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -64.57 -27.49 42.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.689 0.28 . . . . 6.0499999999999998 111.385 178.48 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.92 80.75 2.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.253 0.549 . . . . 8.5 110.177 176.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.3 p -131.66 45.1 2.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.04 -0.527 . . . . 9.8200000000000003 110.757 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.8 t70 68.36 105.55 0.05 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.255 -0.884 . . . . 11.210000000000001 111.324 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -53.75 131.71 16.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.261 -0.881 . . . . 10.84 111.38 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -87.95 -166.05 1.48 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.531 -0.759 . . . . 13.25 110.244 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.8 t -60.97 -39.34 81.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.104 0.478 . . . . 13.890000000000001 110.197 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.7 t -103.95 108.47 59.98 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.86 -0.609 . . . . 14.050000000000001 110.133 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.74 162.95 21.26 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.9 2.4 . . . . 14.41 112.121 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -104.26 35.38 2.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.492 0.663 . . . . 14.44 110.081 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -80.81 108.8 14.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.622 -0.717 . . . . 15.9 111.286 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -135.17 -92.59 0.4 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.514 -0.851 . . . . 15.6 111.932 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 3.6 p -89.13 45.31 1.28 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.338 0.59 . . . . 15.6 111.105 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.8 mt -87.66 -11.0 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.812 0.815 . . . . 13.85 109.626 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.8 t -147.79 147.2 29.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.666 -0.697 . . . . 13.19 109.989 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -113.99 -3.23 13.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.362 0.601 . . . . 15.67 109.672 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 39.0 pt -114.85 165.05 10.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.329 -0.851 . . . . 13.77 110.206 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.0 m -92.73 59.86 3.33 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.069 0.462 . . . . 13.619999999999999 110.174 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.44 146.27 53.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.566 -0.743 . . . . 13.02 109.826 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -128.36 121.44 29.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.976 0.417 . . . . 14.68 110.974 -176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.02 31.63 1.07 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.012 -0.54 . . . . 13.550000000000001 110.936 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -113.38 43.57 1.68 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.93 -0.652 . . . . 15.800000000000001 111.937 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.6 t 66.21 15.37 10.06 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.086 0.554 . . . . 17.079999999999998 111.461 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -94.61 -92.74 0.19 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.847 0.356 . . . . 18.43 110.782 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -120.94 101.42 7.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.116 -0.493 . . . . 18.530000000000001 110.805 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -133.79 171.51 14.05 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.604 -0.725 . . . . 14.32 109.895 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 52.8 m -124.77 102.54 7.63 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.445 -0.343 . . . . 14.51 110.461 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.4 m 49.69 -172.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 124.29 0.994 . . . . 13.06 112.863 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -71.47 69.71 0.6 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.051 -0.977 . . . . 10.33 110.081 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -102.38 -83.13 0.47 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.228 -0.442 . . . . 9.8800000000000008 111.014 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -90.27 39.49 0.97 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.094 0.473 . . . . 10.23 110.842 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -120.82 -80.89 0.63 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.913 -0.585 . . . . 9.0600000000000005 110.156 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -163.86 170.62 16.56 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.932 -0.576 . . . . 6.1900000000000004 109.975 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 155.48 -160.14 29.68 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.374 -0.917 . . . . 3.9700000000000002 112.627 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.59 146.72 34.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.891 0.377 . . . . 2.6299999999999999 111.203 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 113' ' ' CYS . . . 100.77 -41.42 2.15 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.587 -0.816 . . . . 1.3 112.103 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 20.0 t -64.25 -26.94 68.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.028 0.442 . . . . 1.8200000000000001 110.126 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.499 ' O ' ' HB2' ' A' ' 171' ' ' TYR . 44.3 p-90 -86.26 -21.16 27.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.69999999999999996 111.201 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 15.5 mt -82.49 -14.93 54.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.785 0.291 . . . . 0.66000000000000003 111.785 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -74.63 -4.35 36.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.152 0.501 . . . . 1.48 109.911 174.292 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' A' ' 168' ' ' TRP . 13.2 m-85 -76.3 -32.56 58.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.602 -0.726 . . . . 1.97 111.547 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.568 HG21 ' HB2' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -62.87 134.94 27.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.406 -0.518 . . . . 0.67000000000000004 110.406 -175.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.495 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 13.3 mmm180 -110.2 160.1 16.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.084 0.469 . . . . 4.3399999999999999 111.549 -177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.422 HG22 HG11 ' A' ' 208' ' ' VAL . 62.6 t -67.05 147.12 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.569 -0.741 . . . . 1.0700000000000001 109.31 175.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.702 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -54.22 141.72 28.48 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.274 0.559 . . . . 0.70999999999999996 112.117 -177.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 44.9 t -91.26 -2.8 57.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.247 -0.888 . . . . 1.8799999999999999 110.34 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 180' ' ' ASP . 41.5 m -141.65 145.95 35.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.199 0.523 . . . . 1.6299999999999999 110.548 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 59.8 m -72.19 -31.25 65.73 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.551 -0.749 . . . . 1.96 111.584 -173.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -84.05 2.4 39.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.151 0.5 . . . . 2.4199999999999999 110.428 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 177' ' ' SER . 4.2 t70 -108.91 16.65 22.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.523 -0.762 . . . . 2.1200000000000001 110.507 -173.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -63.89 114.19 3.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.037 0.446 . . . . 1.3500000000000001 110.555 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.861 ' H ' HD12 ' A' ' 183' ' ' LEU . 10.5 t30 -148.6 32.27 0.79 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.045 -1.094 . . . . 1.6799999999999999 108.045 175.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.861 HD12 ' H ' ' A' ' 182' ' ' ASN . 1.4 mp -117.15 122.16 43.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.334 -0.848 . . . . 0.81000000000000005 110.746 -172.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 95.3 m -148.72 136.74 20.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.971 0.415 . . . . 0.51000000000000001 110.306 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 49.7 ttm -106.07 141.92 36.63 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.54 -0.541 . . . . 1.3500000000000001 109.54 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 53.4 t -111.93 131.61 55.27 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.268 -0.641 . . . . 1.73 109.268 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.1 103.86 9.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.146 -0.687 . . . . 1.9299999999999999 109.146 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.529 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 22.4 pt -138.08 144.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.627 -0.715 . . . . 1.1100000000000001 109.842 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.8 m 60.41 31.9 20.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.858 0.361 . . . . 1.8600000000000001 111.392 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 60.11 24.09 13.36 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.785 -0.643 . . . . 2.8300000000000001 112.026 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 29.3 pt20 -130.37 161.42 31.36 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.975 -0.38 . . . . 1.75 109.975 176.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.511 HD11 ' CE2' ' A' ' 128' ' ' TRP . 49.3 mm -103.94 131.45 52.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.21 0.529 . . . . 1.01 112.274 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.636 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 30.1 m-85 -133.48 147.85 51.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.266 -0.879 . . . . 3.9399999999999999 110.027 174.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 4.9 m-30 -101.57 114.44 28.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.739 -0.467 . . . . 0.92000000000000004 109.739 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -99.22 121.81 41.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.392 . . . . 1.1100000000000001 110.246 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 1.9 t -89.23 150.95 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 122.074 0.94 . . . . 0.69999999999999996 110.173 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.413 HG13 ' HA ' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -95.6 -55.28 6.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 113.866 -1.515 . . . . 0.62 110.796 -165.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.39 175.22 10.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.758 -1.11 . . . . 1.3799999999999999 109.733 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.634 ' HA ' ' O ' ' A' ' 104' ' ' MET . 9.2 p-10 -59.45 115.82 3.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.76 0.79 . . . . 2.23 112.2 -172.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.451 HD11 ' ND2' ' A' ' 182' ' ' ASN . 4.8 mm -69.33 140.13 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.857 -1.065 . . . . 0.88 110.867 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 37.2 mt-10 -84.04 118.19 70.64 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.21 -0.663 . . . . 2.0600000000000001 109.21 171.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -45.58 121.17 3.78 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.943 2.428 . . . . 0.51000000000000001 112.731 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.74 -11.17 9.56 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.91 -0.662 . . . . 0.69999999999999996 112.506 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 10.9 pt-20 -133.92 124.65 26.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 1.27 110.965 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.504 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -109.45 107.66 17.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.82 0.343 . . . . 2.9199999999999999 111.066 177.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.585 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.2 mm? -123.41 98.93 6.08 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.186 -0.606 . . . . 0.90000000000000002 110.354 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.568 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.6 mm? -148.17 105.48 3.64 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.096 -0.705 . . . . 0.53000000000000003 109.096 174.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.737 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 24.5 t -154.58 158.67 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.182 -1.044 . . . . 0.91000000000000003 108.182 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -85.01 108.49 17.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.895 -1.15 . . . . 1.55 107.895 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.3 m -85.06 94.55 3.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.674 0.749 . . . . 2.5600000000000001 110.68 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -93.19 125.64 37.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.424 -0.807 . . . . 5.3600000000000003 111.05 -175.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -132.98 26.25 4.27 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.042 -0.981 . . . . 5.7999999999999998 109.4 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.643 ' HA3' HD13 ' A' ' 217' ' ' LEU . . . 105.29 97.43 2.49 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.17 -0.923 . . . . 5.6100000000000003 111.34 -174.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 28.2 t -98.01 -62.39 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.177 0.513 . . . . 6.3099999999999996 110.276 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.498 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 59.5 t80 -59.31 -52.0 77.51 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.003 -0.999 . . . . 8.8300000000000001 111.766 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 19.3 Cg_endo -61.63 -42.99 29.09 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.275 1.983 . . . . 7.7800000000000002 112.946 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.643 HD13 ' HA3' ' A' ' 213' ' ' GLY . 7.6 mp -89.64 28.76 1.25 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.071 0.462 . . . . 8.0199999999999996 110.917 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -149.38 170.21 29.64 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.961 -0.856 . . . . 8.6400000000000006 110.961 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.1 m -104.56 17.07 24.82 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.179 0.514 . . . . 9.7200000000000006 110.447 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.484 ' HA ' ' HD3' ' A' ' 221' ' ' PRO . 6.6 m -61.63 125.81 85.44 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.713 -0.676 . . . . 9.6199999999999992 111.266 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 10.6 Cg_exo -71.37 155.27 60.42 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.69 2.26 . . . . 11.65 111.975 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.11 48.41 2.02 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.081 2.521 . . . . 13.109999999999999 111.689 176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 122.21 -99.85 0.68 Allowed Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.715 -0.954 . . . . 14.029999999999999 110.715 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 33.9 tp -151.04 122.42 7.85 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.646 -0.501 . . . . 16.100000000000001 109.646 176.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -112.16 -66.38 1.09 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.368 -0.378 . . . . 17.699999999999999 110.756 -176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 . . . . . 0 C--O 1.249 1.064 0 O-C-N 123.71 0.632 . . . . 18.899999999999999 111.274 -179.55 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.945 -0.462 . . . . 33.259999999999998 111.945 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.5 m -135.41 46.9 2.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.199 0.523 . . . . 33.920000000000002 110.551 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.78 8.03 17.08 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.575 -0.821 . . . . 32.350000000000001 112.274 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -102.15 139.71 20.52 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.325 -0.25 . . . . 31.649999999999999 110.325 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.42 98.47 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.427 2.085 . . . . 29.989999999999998 111.497 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 p -64.91 113.42 3.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.284 0.564 . . . . 28.920000000000002 110.967 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.3 m -153.12 44.11 0.63 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.59 -0.732 . . . . 26.940000000000001 109.286 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.2 67.0 9.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.355 -0.839 . . . . 25.829999999999998 111.129 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -106.46 140.12 39.85 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.01 -0.541 . . . . 23.530000000000001 109.653 176.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -62.92 109.25 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.0 0.429 . . . . 21.640000000000001 110.381 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.7 m -108.97 117.99 52.49 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.864 -0.607 . . . . 19.420000000000002 110.821 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.85 144.74 97.06 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.604 2.203 . . . . 17.170000000000002 111.402 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 62.9 mttp -86.21 40.43 0.87 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.161 0.505 . . . . 17.469999999999999 111.889 -175.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -96.77 116.72 29.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.435 -0.58 . . . . 15.630000000000001 109.435 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.47 -4.75 84.1 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.798 -0.715 . . . . 12.039999999999999 111.89 -176.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 63' ' ' LYS . 14.9 m -65.42 -46.11 69.78 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.436 0.532 . . . . 10.67 112.436 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 66' ' ' SER . 52.5 Cg_exo -57.26 98.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 121.975 1.783 . . . . 9.6899999999999995 112.12 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -98.75 125.97 44.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.595 -0.73 . . . . 7.7000000000000002 111.47 -175.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -95.96 135.95 37.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.714 -0.675 . . . . 8.1400000000000006 109.432 174.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.69 112.92 46.05 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.46 -0.337 . . . . 5.96 110.689 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -62.14 -76.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.269 2.646 . . . . 6.1299999999999999 112.564 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.3 p -120.96 -32.31 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.399 . . . . 6.5300000000000002 110.801 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -105.69 119.86 40.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.055 -0.521 . . . . 5.0099999999999998 109.763 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.55 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.3 pp -79.06 138.37 56.79 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.978 0.418 . . . . 4.2300000000000004 110.994 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.12 -2.34 12.56 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.752 2.302 . . . . 4.1200000000000001 113.003 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -72.82 -62.72 1.35 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.688 -0.486 . . . . 3.8199999999999998 109.688 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.406 ' H ' HD13 ' A' ' 74' ' ' ILE . 16.1 t70 57.2 83.34 0.11 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.766 -1.106 . . . . 3.1600000000000001 111.02 176.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.43 132.94 91.17 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.446 -0.797 . . . . 2.4500000000000002 110.45 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.39 121.45 8.88 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.9 2.4 . . . . 1.75 112.522 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.577 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -120.83 152.96 56.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.901 -0.59 . . . . 1.01 109.934 178.386 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.85 150.58 85.74 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.391 2.061 . . . . 0.72999999999999998 110.995 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.23 8.36 1.35 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.876 -0.602 . . . . 1.04 112.377 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -112.88 1.23 15.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.143 0.497 . . . . 1.6599999999999999 111.243 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -137.38 136.11 37.58 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -123.12 130.02 52.21 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.077 -0.649 . . . . 2.27 111.127 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tt -83.7 130.55 34.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 0.79000000000000004 109.505 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 97.0 mtt180 -143.71 126.85 16.53 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.507 -0.77 . . . . 3.21 109.468 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.76 111.78 17.52 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.479 -0.488 . . . . 2.46 109.891 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.0 p -162.69 97.47 0.96 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.657 -0.701 . . . . 1.5800000000000001 109.463 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.5 m -68.21 104.08 1.73 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.966 0.412 . . . . 1.8600000000000001 110.777 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -87.04 122.19 71.24 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.233 -0.654 . . . . 1.45 109.233 175.455 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.54 119.09 4.68 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.187 2.591 . . . . 1.6100000000000001 112.821 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.01 -20.43 28.8 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 121.003 -0.618 . . . . 1.74 112.685 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.417 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -131.74 -72.45 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.032 0.416 . . . . 1.4099999999999999 111.3 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.533 ' HA3' ' NH1' ' A' ' 173' ' ' ARG . . . 131.85 -130.58 5.99 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.932 -0.651 . . . . 1.0900000000000001 112.557 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt -99.68 158.17 15.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.681 0.24 . . . . 2.3100000000000001 110.485 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.24 -179.85 39.33 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.269 -0.732 . . . . 0.58999999999999997 111.269 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.8 m -102.9 119.69 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.543 0.687 . . . . 0.67000000000000004 109.504 174.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.482 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 49.4 m95 -83.83 114.62 21.76 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.562 -0.744 . . . . 1.1299999999999999 111.023 -170.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.23 115.29 12.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.067 -0.716 . . . . 0.54000000000000004 109.067 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.532 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -92.55 2.27 56.79 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.648 0.737 . . . . 1.6799999999999999 109.641 -176.348 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -125.75 161.24 27.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.979 -1.01 . . . . 3.5 108.355 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 155.99 39.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.0 0.428 . . . . 2.3999999999999999 111.169 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.668 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 34.8 mtm -120.15 149.31 42.44 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.393 -0.966 . . . . 1.22 108.393 171.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 47.1 mt-10 -119.39 173.88 6.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.523 0.678 . . . . 2.3100000000000001 112.399 -172.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.12 115.58 6.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.884 -1.053 . . . . 0.83999999999999997 111.976 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.32 1.88 57.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.685 -0.769 . . . . 1.04 113.522 171.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 6.8 pt-20 -86.07 166.27 15.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.483 0.641 . . . . 2.6200000000000001 110.647 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.478 ' HG2' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -127.96 143.41 51.09 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.109 -0.496 . . . . 3.6200000000000001 110.233 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.478 ' N ' ' HG2' ' A' ' 109' ' ' ARG . 7.5 mt -87.35 125.8 34.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.128 -1.064 . . . . 0.53000000000000003 108.128 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -140.73 157.14 25.7 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 119.885 -1.15 . . . . 1.02 113.17 -172.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.92 154.33 96.94 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.585 -1.839 . . . . 2.1000000000000001 112.175 -1.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.524 ' HA ' HD12 ' A' ' 169' ' ' LEU . 59.5 m -92.31 -21.47 20.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.913 -0.585 . . . . 2.0 111.061 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.6 m -140.05 176.37 5.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.991 -0.55 . . . . 2.0299999999999998 110.056 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 165' ' ' ALA . 29.9 m -65.01 -178.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.513 0.673 . . . . 3.9500000000000002 111.354 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.0 m -73.52 156.79 88.51 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.707 -0.678 . . . . 5.21 110.15 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.72 167.83 4.85 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.503 2.135 . . . . 5.0700000000000003 112.138 176.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 70.52 -171.7 0.17 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.878 -0.601 . . . . 7.9900000000000002 109.725 -173.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 58.2 -161.28 0.24 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.783 0.325 . . . . 6.9500000000000002 111.211 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.28 92.6 1.43 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.092 -0.504 . . . . 6.0899999999999999 110.383 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.65 116.98 9.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.377 -0.374 . . . . 5.5599999999999996 111.006 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -88.28 143.18 27.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.044 -0.525 . . . . 7.4199999999999999 110.655 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -64.77 -39.3 93.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.747 -0.66 . . . . 9.0099999999999998 109.798 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.4 m -149.06 -102.02 0.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.625 -0.716 . . . . 8.8800000000000008 109.497 171.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -159.5 25.18 0.19 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.99 0.424 . . . . 7.5999999999999996 110.116 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -141.45 155.9 45.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.956 -0.566 . . . . 7.2300000000000004 111.194 -172.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 119.61 -38.76 2.69 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.901 -0.879 . . . . 4.5899999999999999 110.901 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.72 -111.91 0.06 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.987 -0.607 . . . . 4.9299999999999997 111.034 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 130' ' ' GLN . 6.2 pt-20 -149.42 -60.39 0.21 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.522 0.201 . . . . 7.6500000000000004 110.959 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.441 ' H ' ' HG3' ' A' ' 129' ' ' GLU . 78.9 mt-30 -150.65 141.78 23.11 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 110.223 -0.288 . . . . 8.8399999999999999 110.223 -176.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 pp -124.26 19.93 4.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.858 0.361 . . . . 6.0499999999999998 111.917 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -90.41 50.82 1.9 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.484 1.135 . . . . 8.5 109.509 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.2 t -94.67 25.29 4.09 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.721 -1.581 . . . . 9.8200000000000003 111.03 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -73.58 132.66 43.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.611 -0.885 . . . . 11.210000000000001 108.611 172.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 40.2 t -74.21 85.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.526 0.679 . . . . 10.84 110.57 -174.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -103.9 1.57 31.5 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.34 -0.846 . . . . 13.25 109.922 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.5 m -80.84 -7.18 10.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.654 -0.703 . . . . 13.890000000000001 111.076 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 44.0 m -85.59 144.26 39.79 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.079 -0.51 . . . . 14.050000000000001 110.065 177.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.26 107.6 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.859 2.372 . . . . 14.41 112.261 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 138' ' ' SER . 12.3 mm100 -102.62 38.26 1.75 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.992 -0.549 . . . . 14.44 109.614 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -78.09 -36.47 48.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.492 -0.776 . . . . 15.9 110.841 -173.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -94.19 169.64 29.47 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.762 -0.733 . . . . 15.6 112.171 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 5.4 p -77.69 57.61 1.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.252 0.549 . . . . 15.6 111.142 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 53.7 mt -82.21 -46.54 19.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.742 -0.663 . . . . 13.85 109.841 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.4 p -82.95 134.67 35.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.639 -0.71 . . . . 13.19 111.34 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 -3.41 23.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.209 0.528 . . . . 15.67 109.882 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.488 ' O ' HD12 ' A' ' 147' ' ' ILE . 2.2 pp -80.68 142.23 14.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.457 -0.792 . . . . 13.77 111.458 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.0 p -173.04 48.18 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.301 -0.863 . . . . 13.619999999999999 108.81 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -74.59 106.23 6.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.992 -1.003 . . . . 13.02 110.813 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -72.36 127.15 31.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.903 -0.589 . . . . 14.68 111.015 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 pp -130.06 31.95 4.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.791 -0.641 . . . . 13.550000000000001 109.49 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 132.05 96.57 0.67 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.14 -0.936 . . . . 15.800000000000001 111.179 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.8 m -65.79 -35.23 80.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.83 0.347 . . . . 17.079999999999998 111.246 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -106.19 -72.09 0.73 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.391 0.615 . . . . 18.43 110.743 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -129.77 142.11 50.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.245 -0.888 . . . . 18.530000000000001 111.171 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -148.37 126.18 11.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.951 -0.568 . . . . 14.32 110.472 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 84.8 m -83.96 61.04 6.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.843 0.354 . . . . 14.51 110.505 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 42.6 t 62.91 108.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.248 -0.887 . . . . 13.06 111.05 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.594 ' OD2' ' HB2' ' A' ' 162' ' ' GLN . 5.2 t70 60.57 169.49 0.09 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.08 -0.964 . . . . 10.33 111.07 -172.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -177.32 -43.54 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.824 -0.625 . . . . 9.8800000000000008 110.438 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -114.87 19.34 15.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.988 -0.551 . . . . 10.23 111.453 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.594 ' HB2' ' OD2' ' A' ' 159' ' ' ASP . 21.7 mt-30 -127.59 -48.87 1.4 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.036 -0.266 . . . . 9.0600000000000005 110.702 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 62.01 53.24 3.07 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.365 0.603 . . . . 6.1900000000000004 110.602 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 115' ' ' VAL . . . -146.12 87.73 0.16 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.381 -0.827 . . . . 3.9700000000000002 111.557 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 115' ' ' VAL . . . -143.65 170.22 16.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.62 0.248 . . . . 2.6299999999999999 110.84 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.401 ' HA3' ' C ' ' A' ' 113' ' ' CYS . . . -115.95 14.02 16.86 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.424 -0.671 . . . . 1.3 111.424 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 8.7 t -64.56 -17.66 64.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.267 0.556 . . . . 1.8200000000000001 110.628 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.498 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 26.9 p-90 -74.31 -21.76 59.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.297 0.57 . . . . 0.69999999999999996 110.274 177.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 40.6 mt -86.43 -20.22 28.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.738 -0.665 . . . . 0.66000000000000003 112.1 -175.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -71.88 -5.04 31.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.623 -0.431 . . . . 1.48 110.577 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -79.9 -37.27 35.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.913 -0.585 . . . . 1.97 111.798 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.696 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -62.83 131.64 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.751 -0.38 . . . . 0.67000000000000004 110.273 -178.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.533 ' NH1' ' HA3' ' A' ' 95' ' ' GLY . 99.2 mtt180 -115.07 -171.41 1.94 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.296 -0.411 . . . . 4.3399999999999999 111.429 -174.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.509 HG22 HG11 ' A' ' 208' ' ' VAL . 4.4 t -76.47 141.0 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-N 116.298 -0.41 . . . . 1.0700000000000001 110.229 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -61.07 138.44 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.821 -0.627 . . . . 0.70999999999999996 111.944 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 37.6 t -72.85 -6.87 47.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.169 -0.923 . . . . 1.8799999999999999 110.69 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.3 t -126.07 139.77 53.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 1.6299999999999999 110.383 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 61.6 m -88.15 -18.81 27.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.052 -0.522 . . . . 1.96 110.59 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -83.97 -14.95 49.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.102 0.477 . . . . 2.4199999999999999 110.522 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -110.04 17.57 20.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.828 -0.624 . . . . 2.1200000000000001 111.185 -176.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -54.94 115.49 2.23 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.179 0.514 . . . . 1.3500000000000001 110.86 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.722 ' H ' HD12 ' A' ' 183' ' ' LEU . 5.5 p-10 -144.05 32.36 1.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.667 0.746 . . . . 1.6799999999999999 109.384 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.722 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.2 OUTLIER -116.0 124.51 50.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.038 -0.983 . . . . 0.81000000000000005 110.606 -173.144 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 97.7 m -146.49 121.59 10.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.287 0.565 . . . . 0.51000000000000001 111.387 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.596 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 39.0 ttm -113.24 129.49 56.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 1.3500000000000001 109.431 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 35.2 t -115.86 165.05 13.52 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.407 -0.59 . . . . 1.73 109.407 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.88 105.23 7.86 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.166 -0.679 . . . . 1.9299999999999999 109.166 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.62 143.93 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.748 -0.66 . . . . 1.1100000000000001 110.518 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.4 t 62.56 34.06 15.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.254 0.549 . . . . 1.8600000000000001 110.312 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 58.32 30.0 18.93 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.377 -0.829 . . . . 2.8300000000000001 111.979 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -140.54 167.28 22.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.996 0.427 . . . . 1.75 110.212 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.3 mm -82.29 152.33 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.982 -0.748 . . . . 1.01 108.982 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -143.75 120.1 10.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.754 0.311 . . . . 3.9399999999999999 110.542 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.545 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 15.0 m-85 -100.9 113.49 26.49 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.734 -0.469 . . . . 0.92000000000000004 109.734 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -118.79 129.45 55.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.654 0.264 . . . . 1.1100000000000001 110.31 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 1.2 t -95.3 150.99 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.951 0.882 . . . . 0.69999999999999996 110.645 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -98.68 -45.47 12.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.176 -1.375 . . . . 0.62 112.004 -163.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 199' ' ' ASP . 0.1 OUTLIER -154.84 -177.66 6.67 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.155 -0.929 . . . . 1.3799999999999999 109.886 -173.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.668 ' HA ' ' O ' ' A' ' 104' ' ' MET . 15.4 t70 -59.22 123.32 16.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.374 0.607 . . . . 2.23 111.515 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.413 HG13 ' HE3' ' A' ' 104' ' ' MET . 14.8 mm -106.94 136.58 41.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.805 -0.634 . . . . 0.88 110.323 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.54 122.6 80.89 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.714 -0.676 . . . . 2.0600000000000001 110.331 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -51.46 119.97 6.26 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.51 2.14 . . . . 0.51000000000000001 111.745 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.72 -8.5 9.35 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.456 -0.878 . . . . 0.69999999999999996 112.374 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -132.5 123.24 26.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.295 0.569 . . . . 1.27 110.146 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.3 96.2 6.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.729 -0.668 . . . . 2.9199999999999999 111.436 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.466 ' C ' HD22 ' A' ' 207' ' ' LEU . 0.8 OUTLIER -115.58 99.89 7.67 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.836 -0.745 . . . . 0.90000000000000002 110.114 177.195 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.696 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.87 112.99 6.14 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.069 -0.715 . . . . 0.53000000000000003 109.069 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.631 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 3.9 p -155.28 160.08 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 O-C-N 121.984 -0.447 . . . . 0.91000000000000003 110.96 -176.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.596 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 54.9 t-80 -80.27 128.6 33.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.564 -0.902 . . . . 1.55 108.564 166.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.48 94.58 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.386 -0.598 . . . . 2.5600000000000001 109.386 174.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 209' ' ' HIS . 49.8 mtpt -86.78 126.67 34.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.615 -0.721 . . . . 5.3600000000000003 111.017 -173.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 216' ' ' PRO . 12.3 pt-20 -154.1 -147.69 0.22 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.469 -0.787 . . . . 5.7999999999999998 108.9 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -81.63 42.66 2.82 Favored Glycine 0 C--N 1.32 -0.324 0 C-N-CA 121.098 -0.573 . . . . 5.6100000000000003 113.401 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 29.9 t -109.35 -80.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.946 0.403 . . . . 6.3099999999999996 110.698 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.512 ' H ' ' HD2' ' A' ' 216' ' ' PRO . 64.0 m-85 -94.95 -50.03 0.25 Allowed Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 113.022 0.749 . . . . 8.8300000000000001 113.022 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.512 ' HD2' ' H ' ' A' ' 215' ' ' TYR . 17.8 Cg_endo -60.79 -44.87 23.23 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.741 1.627 . . . . 7.7800000000000002 112.709 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.8 mp -86.72 -25.26 24.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.218 0.532 . . . . 8.0199999999999996 110.707 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 69.81 17.11 72.96 Favored Glycine 0 C--N 1.33 0.247 0 CA-C-N 115.582 -0.735 . . . . 8.6400000000000006 112.891 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.9 p -88.1 48.8 1.69 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.241 0.543 . . . . 9.7200000000000006 111.542 -176.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 221' ' ' PRO . 3.9 m -85.63 116.49 65.85 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.8 -0.636 . . . . 9.6199999999999992 111.251 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 2.3 Cg_endo -80.34 129.35 7.56 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.637 2.225 . . . . 11.65 111.509 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.52 95.41 0.39 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.637 2.225 . . . . 13.109999999999999 112.267 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 88.92 165.24 41.09 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.788 -0.642 . . . . 14.029999999999999 112.215 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 50.0 tp -115.38 123.98 50.06 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.734 -0.469 . . . . 16.100000000000001 109.734 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.62 -22.61 14.42 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.984 0.421 . . . . 17.699999999999999 110.983 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.321 -0.847 . . . . 18.899999999999999 109.759 177.111 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 111.737 -0.545 . . . . 33.259999999999998 111.737 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.1 p -65.4 110.33 2.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.11 0.481 . . . . 33.920000000000002 111.342 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.73 -41.84 0.69 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.302 -0.719 . . . . 32.350000000000001 111.302 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -120.15 108.38 38.37 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.785 -0.45 . . . . 31.649999999999999 109.785 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.76 125.92 16.39 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.498 2.132 . . . . 29.989999999999998 111.717 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.7 p 46.81 68.72 0.58 Allowed 'General case' 0 C--O 1.233 0.227 0 O-C-N 123.759 0.662 . . . . 28.920000000000002 111.465 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.4 m -62.66 141.93 58.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.907 -0.588 . . . . 26.940000000000001 109.969 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -103.01 18.81 20.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.217 0.532 . . . . 25.829999999999998 110.498 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -90.65 51.6 2.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.756 -0.656 . . . . 23.530000000000001 110.662 -177.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -70.9 109.5 5.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 21.640000000000001 110.736 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.4 p -113.06 108.74 52.85 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.551 -0.75 . . . . 19.420000000000002 110.371 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.24 117.43 4.28 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.576 2.184 . . . . 17.170000000000002 112.235 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -114.31 55.55 0.74 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.585 -0.734 . . . . 17.469999999999999 109.061 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -108.48 103.91 13.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.361 -0.836 . . . . 15.630000000000001 110.913 -172.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.21 64.61 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.528 -0.844 . . . . 12.039999999999999 112.517 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -128.0 86.38 58.27 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.722 0.296 . . . . 10.67 110.78 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -86.48 156.07 9.25 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.865 2.377 . . . . 9.6899999999999995 112.671 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.444 ' CE1' ' HG2' ' A' ' 75' ' ' PRO . 71.7 t80 -76.2 85.44 3.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.737 -0.665 . . . . 7.7000000000000002 109.644 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.494 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 8.9 tp10 -81.72 121.17 26.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.25 -0.432 . . . . 8.1400000000000006 110.088 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.4 93.45 13.67 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 116.132 -0.485 . . . . 5.96 110.808 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 69' ' ' GLU . 28.6 Cg_endo -91.53 -156.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.983 2.455 . . . . 6.1299999999999999 111.74 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.21 -31.8 46.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.08 0.466 . . . . 6.5300000000000002 110.793 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -111.03 107.01 16.27 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.528 -0.545 . . . . 5.0099999999999998 109.528 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.413 HD12 ' CG ' ' A' ' 76' ' ' GLU . 27.9 pt -80.11 154.43 74.92 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.202 -0.453 . . . . 4.2300000000000004 111.232 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.444 ' HG2' ' CE1' ' A' ' 68' ' ' TYR . 87.1 Cg_endo -87.8 14.67 2.31 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.972 2.448 . . . . 4.1200000000000001 113.163 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.413 ' CG ' HD12 ' A' ' 74' ' ' ILE . 24.5 mm-40 -68.82 -58.86 3.59 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.283 -0.636 . . . . 3.8199999999999998 109.283 173.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 66.21 84.73 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.597 -1.183 . . . . 3.1600000000000001 111.503 175.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 74.0 mt -86.71 120.04 71.6 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.152 -0.931 . . . . 2.4500000000000002 109.95 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.91 116.96 4.12 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.347 2.031 . . . . 1.75 111.442 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 168' ' ' TRP . 0.2 OUTLIER -131.59 147.28 65.41 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.399 -0.364 . . . . 1.01 110.365 -178.387 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 80' ' ' ILE . 2.8 Cg_exo -75.93 133.05 14.82 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.346 2.031 . . . . 0.72999999999999998 110.761 171.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.03 -8.88 33.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.317 . . . . 1.04 111.6 -176.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -70.74 -19.7 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.049 -0.523 . . . . 1.6599999999999999 110.606 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.53 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 19.0 m-85 -123.78 148.27 46.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.346 -0.612 . . . . 1.0 109.346 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.438 ' HB2' ' HE2' ' A' ' 101' ' ' LYS . 7.2 tp10 -109.9 117.38 33.67 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.786 -0.366 . . . . 2.27 110.495 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.443 ' HA ' HG12 ' A' ' 98' ' ' VAL . 8.3 tt -83.67 130.09 34.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.409 -0.589 . . . . 0.79000000000000004 109.409 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -143.89 124.4 13.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.06 -0.518 . . . . 3.21 111.443 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -83.03 112.48 19.81 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.432 -0.581 . . . . 2.46 109.432 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 33.0 t -170.09 149.58 3.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.118 -0.697 . . . . 1.5800000000000001 109.118 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.3 m -100.61 104.91 16.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.746 0.308 . . . . 1.8600000000000001 110.871 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -97.56 123.77 50.99 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.229 -0.656 . . . . 1.45 109.229 175.296 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.16 121.1 9.36 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.023 2.482 . . . . 1.6100000000000001 112.738 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.48 -15.66 35.16 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.724 -0.671 . . . . 1.74 112.07 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.502 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -132.99 -60.14 0.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.839 0.352 . . . . 1.4099999999999999 111.7 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.561 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 121.74 -125.87 6.28 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.307 -0.717 . . . . 1.0900000000000001 111.307 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 89' ' ' SER . 0.7 OUTLIER -89.0 160.67 17.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.803 -0.443 . . . . 2.3100000000000001 109.803 173.523 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.2 169.49 41.27 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.19 -1.005 . . . . 0.58999999999999997 112.779 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 86' ' ' LEU . 11.3 m -104.2 148.81 8.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.1 -0.704 . . . . 0.67000000000000004 109.1 174.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -118.53 120.17 36.71 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.647 0.26 . . . . 1.1299999999999999 110.753 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.517 ' H ' ' HG2' ' A' ' 205' ' ' GLU . . . -71.61 122.36 20.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.235 -0.283 . . . . 0.54000000000000004 110.235 176.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.685 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -90.36 11.91 19.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.657 0.741 . . . . 1.6799999999999999 110.141 -178.464 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.2 ttp85 -137.35 159.11 42.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.155 -0.929 . . . . 3.5 108.565 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.657 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -85.34 155.93 21.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.956 0.408 . . . . 2.3999999999999999 110.744 -178.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 63.0 mtm -132.05 153.01 50.84 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.171 -0.677 . . . . 1.22 109.171 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -120.07 143.68 47.99 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.13 0.269 . . . . 2.3100000000000001 110.842 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . . . -34.89 117.33 0.38 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.76 1.287 . . . . 0.83999999999999997 113.544 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.44 7.89 11.77 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.688 -0.687 . . . . 1.04 111.76 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.507 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -80.39 161.71 24.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.114 0.483 . . . . 2.6200000000000001 110.71 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.546 ' HG3' ' CE2' ' A' ' 193' ' ' TYR . 0.0 OUTLIER -141.17 145.45 35.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.139 -0.482 . . . . 3.6200000000000001 110.513 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.53 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 6.3 mt -107.51 150.74 26.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.36 -0.607 . . . . 0.53000000000000003 109.36 173.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.13 -143.24 17.14 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.318 -0.944 . . . . 1.02 113.319 173.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.23 165.94 47.59 Favored 'Cis proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.822 -1.324 . . . . 2.1000000000000001 113.316 2.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 31.7 t -87.51 -57.96 2.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 2.0 110.655 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.7 m -115.48 132.29 65.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.905 0.383 . . . . 2.0299999999999998 110.35 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.29 35.99 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.899 0.857 . . . . 3.9500000000000002 109.285 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.9 p -89.63 116.91 67.55 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.1 -0.955 . . . . 5.21 110.783 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 118' ' ' ARG . 60.7 Cg_endo -88.15 104.5 0.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.733 2.289 . . . . 5.0700000000000003 112.1 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.622 ' HA ' ' NE ' ' A' ' 118' ' ' ARG . 1.4 mmp_? 73.76 144.93 0.08 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.727 -0.669 . . . . 7.9900000000000002 111.42 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 54.49 62.81 2.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.226 -0.897 . . . . 6.9500000000000002 110.349 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.75 114.52 2.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.687 -0.688 . . . . 6.0899999999999999 111.527 -178.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.46 122.56 21.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.761 -0.654 . . . . 5.5599999999999996 110.304 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -76.51 167.27 22.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.887 -0.597 . . . . 7.4199999999999999 110.278 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.68 -74.4 0.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.94 0.4 . . . . 9.0099999999999998 110.338 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 42.8 m -159.15 -56.36 0.06 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.38 -0.6 . . . . 8.8800000000000008 109.38 175.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -73.46 160.13 32.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.54 -0.755 . . . . 7.5999999999999996 110.569 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -141.32 139.76 33.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.012 0.434 . . . . 7.2300000000000004 110.631 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -89.15 -9.21 67.76 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.96 -0.638 . . . . 4.5899999999999999 111.865 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TRP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 209' ' ' HIS . 0.8 OUTLIER -130.76 -78.41 0.53 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 110.553 -0.166 . . . . 4.9299999999999997 110.553 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.641 ' OE1' ' HD2' ' A' ' 216' ' ' PRO . 1.8 pt-20 -168.42 -72.94 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.624 0.231 . . . . 7.6500000000000004 111.624 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.431 ' HG3' ' HG ' ' A' ' 132' ' ' LEU . 6.4 tp-100 -171.76 160.68 5.72 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.247 -0.279 . . . . 8.8399999999999999 110.247 -174.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.443 ' CG2' HD11 ' A' ' 192' ' ' ILE . 0.2 OUTLIER -126.66 47.75 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 6.0499999999999998 111.503 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.431 ' HG ' ' HG3' ' A' ' 130' ' ' GLN . 0.9 OUTLIER -81.14 53.45 2.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 122.327 1.06 . . . . 8.5 111.065 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.3 p -95.31 27.32 3.35 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.143 -1.389 . . . . 9.8200000000000003 109.282 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.403 ' CG ' HH22 ' A' ' 118' ' ' ARG . 27.5 t70 -133.56 98.51 4.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.609 -1.178 . . . . 11.210000000000001 109.992 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 49.7 t -77.48 109.81 12.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.953 -0.567 . . . . 10.84 109.97 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -76.12 78.62 2.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.308 0.575 . . . . 13.25 110.282 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p -128.71 4.42 2.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.529 0.681 . . . . 13.890000000000001 110.294 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.0 m -127.67 97.58 30.13 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.074 -0.512 . . . . 14.050000000000001 111.111 -175.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.87 77.69 3.98 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.657 2.238 . . . . 14.41 111.683 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.24 30.66 2.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.713 -0.676 . . . . 14.44 110.983 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -95.39 171.62 8.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.83 -0.623 . . . . 15.9 110.546 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.77 -80.04 0.2 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.939 -0.573 . . . . 15.6 111.669 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 7.0 p -111.66 46.13 1.15 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.124 0.488 . . . . 15.6 110.78 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 61.5 mt -76.37 -38.13 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.112 0.482 . . . . 13.85 110.272 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.7 t -82.11 55.92 2.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.2 1.0 . . . . 13.19 110.332 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -90.8 -16.25 28.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.413 -0.812 . . . . 15.67 110.229 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.426 ' H ' HG13 ' A' ' 147' ' ' ILE . 2.1 pp -96.85 155.24 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.562 -0.744 . . . . 13.77 110.661 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.4 m -136.09 152.72 51.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.687 0.279 . . . . 13.619999999999999 110.838 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.38 85.1 4.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.233 -0.439 . . . . 13.02 110.374 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.68 79.49 9.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.0 -0.546 . . . . 14.68 110.501 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.3 54.05 2.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.6 0.714 . . . . 13.550000000000001 110.741 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.85 137.28 2.96 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.32 -0.854 . . . . 15.800000000000001 111.035 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.3 m -76.26 -16.83 59.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.202 0.525 . . . . 17.079999999999998 110.805 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -113.35 -66.08 1.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.402 0.62 . . . . 18.43 109.787 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.03 170.88 15.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.19 -0.914 . . . . 18.530000000000001 109.128 177.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -132.48 27.89 4.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.272 0.558 . . . . 14.32 110.925 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 50.4 t -75.8 90.02 2.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.355 -0.839 . . . . 14.51 110.33 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.1 p -161.91 135.94 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.788 -0.642 . . . . 13.06 109.994 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -75.76 63.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.457 0.646 . . . . 10.33 110.84 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -116.41 -69.29 0.86 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.136 -0.938 . . . . 9.8800000000000008 109.562 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -93.23 -13.92 27.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.311 0.576 . . . . 10.23 109.783 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -84.47 -18.93 34.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.481 -0.781 . . . . 9.0600000000000005 110.398 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.48 35.18 0.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.78 -0.645 . . . . 6.1900000000000004 111.148 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -87.14 55.78 4.57 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.831 -0.622 . . . . 3.9700000000000002 111.567 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.35 -30.78 68.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.964 0.411 . . . . 2.6299999999999999 110.835 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.85 -34.62 3.16 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.005 -0.617 . . . . 1.3 112.333 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.524 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 1.2 m -57.27 -29.9 64.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.668 0.387 . . . . 1.8200000000000001 111.499 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.493 ' HB3' HG22 ' A' ' 80' ' ' ILE . 45.5 p-90 -85.59 -23.46 27.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.69999999999999996 111.13 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 17.7 mt -86.4 -15.55 40.01 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.805 0.298 . . . . 0.66000000000000003 111.805 -177.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -76.13 -1.71 27.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.806 -0.358 . . . . 1.48 110.413 177.448 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.426 ' CE2' HD11 ' A' ' 86' ' ' LEU . 37.9 m-85 -81.67 -37.13 27.92 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.112 -0.495 . . . . 1.97 112.058 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -65.07 140.99 18.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 120.151 -0.62 . . . . 0.67000000000000004 110.913 -173.562 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 -123.7 -168.27 1.75 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.839 -0.619 . . . . 4.3399999999999999 111.467 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.401 HG22 HG11 ' A' ' 208' ' ' VAL . 7.0 t -69.63 156.64 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.58 -0.737 . . . . 1.0700000000000001 110.626 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.576 ' HA ' HD12 ' A' ' 206' ' ' LEU . . . -55.88 132.99 51.04 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.141 -0.481 . . . . 0.70999999999999996 110.508 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.1 m -71.77 -20.87 61.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.604 -0.725 . . . . 1.8799999999999999 111.033 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.403 ' HB2' ' OD1' ' A' ' 180' ' ' ASP . 24.7 m -130.63 157.11 43.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.466 -0.334 . . . . 1.6299999999999999 111.181 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' CYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 3.3 p -59.01 -56.71 18.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.219 0.451 . . . . 1.96 112.219 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.76 -1.4 21.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 2.4199999999999999 111.758 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.403 ' OD1' ' HB2' ' A' ' 177' ' ' SER . 4.5 m-20 -95.06 17.32 14.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.264 -0.426 . . . . 2.1200000000000001 111.623 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 16.3 mm100 -56.57 113.77 1.75 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.976 0.417 . . . . 1.3500000000000001 109.889 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.554 ' OD1' ' HE2' ' A' ' 198' ' ' LYS . 17.8 t30 -159.25 43.82 0.24 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.121 -1.066 . . . . 1.6799999999999999 108.121 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.599 ' HB3' ' O ' ' A' ' 206' ' ' LEU . 0.7 OUTLIER -142.42 128.86 20.11 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.003 -0.998 . . . . 0.81000000000000005 111.578 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 29.8 m -150.38 120.81 7.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.088 -0.96 . . . . 0.51000000000000001 110.184 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.585 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 44.9 ttm -109.19 118.44 36.72 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.654 -0.498 . . . . 1.3500000000000001 109.654 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 36.7 t -113.86 166.42 11.59 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.169 -0.469 . . . . 1.73 109.774 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -124.09 134.39 53.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.829 0.347 . . . . 1.9299999999999999 110.653 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 23.5 pt -148.05 140.94 18.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.722 -0.672 . . . . 1.1100000000000001 109.946 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 190' ' ' GLU . 8.3 t 54.4 38.99 30.6 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.113 0.482 . . . . 1.8600000000000001 110.62 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 37.0 tt0 72.79 -1.47 3.0 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.186 -0.916 . . . . 2.8300000000000001 112.163 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -117.8 154.2 32.18 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.443 -0.785 . . . . 1.75 111.367 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.443 HD11 ' CG2' ' A' ' 131' ' ' ILE . 26.8 mm -81.66 129.12 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.348 -0.842 . . . . 1.01 111.157 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.546 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 72.8 t80 -114.97 131.19 56.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.763 -1.108 . . . . 3.9399999999999999 109.737 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 3.9 m-85 -98.98 112.3 24.46 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.157 -0.683 . . . . 0.92000000000000004 109.157 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 195' ' ' LYS . 5.0 tmmm? -112.1 120.07 40.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.7 -0.682 . . . . 1.1100000000000001 109.454 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.56 HG22 HD11 ' A' ' 207' ' ' LEU . 1.8 t -94.33 150.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-O 121.591 0.71 . . . . 0.69999999999999996 109.326 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.8 mm -87.71 -55.58 6.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.696 -1.138 . . . . 0.62 110.65 -166.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.554 ' HE2' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -144.71 -178.84 6.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.722 -0.672 . . . . 1.3799999999999999 111.973 177.66 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.0 OUTLIER -47.25 128.71 12.15 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.767 1.025 . . . . 2.23 113.767 -171.42 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 38.7 mm -95.25 136.79 25.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.348 -0.842 . . . . 0.88 110.545 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 42.5 mt-10 -89.55 123.3 67.01 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.457 -0.572 . . . . 2.0600000000000001 109.457 171.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' A' ' 103' ' ' LYS . 77.2 Cg_exo -47.22 123.18 7.36 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.258 2.639 . . . . 0.51000000000000001 112.602 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.2 -18.77 8.32 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.914 -0.66 . . . . 0.69999999999999996 112.84 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 11.0 pt-20 -132.55 121.25 22.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.523 0.661 . . . . 1.27 111.898 -178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.517 ' HG2' ' H ' ' A' ' 100' ' ' ALA . 13.2 mm-40 -110.32 118.02 35.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 2.9199999999999999 109.982 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.599 ' O ' ' HB3' ' A' ' 183' ' ' LEU . 1.9 mm? -112.28 100.8 9.09 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.376 -0.972 . . . . 0.90000000000000002 108.376 171.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.692 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.3 mm? -143.44 113.49 7.23 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.492 0.495 . . . . 0.53000000000000003 109.891 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.549 HG12 HD12 ' A' ' 183' ' ' LEU . 1.4 p -152.21 159.53 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.837 0.351 . . . . 0.91000000000000003 110.289 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.585 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 44.8 t-80 -98.52 111.22 23.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.689 -1.226 . . . . 1.55 107.689 171.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.5 m -66.91 110.36 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 109.241 -0.652 . . . . 2.5600000000000001 109.241 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -51.05 124.59 11.75 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.565 -0.743 . . . . 5.3600000000000003 111.279 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -111.37 -1.87 15.82 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.179 -0.918 . . . . 5.7999999999999998 110.611 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' A' ' 217' ' ' LEU . . . 101.22 67.05 0.8 Allowed Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.381 -0.827 . . . . 5.6100000000000003 112.599 176.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 44.1 t -109.88 -62.09 2.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.59 0.71 . . . . 6.3099999999999996 109.398 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.447 ' HB3' ' HD3' ' A' ' 216' ' ' PRO . 90.9 t80 -92.38 -63.07 0.18 Allowed Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.339 -0.846 . . . . 8.8300000000000001 112.239 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.641 ' HD2' ' OE1' ' A' ' 129' ' ' GLU . 32.1 Cg_endo -63.56 -50.42 3.38 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.033 1.822 . . . . 7.7800000000000002 113.355 -173.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.478 ' HB2' ' HA2' ' A' ' 213' ' ' GLY . 7.7 mp -73.64 -42.53 61.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 8.0199999999999996 110.978 -177.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.41 -134.41 12.18 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.97 -0.634 . . . . 8.6400000000000006 111.689 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 41.2 p 51.68 44.46 29.19 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.385 0.674 . . . . 9.7200000000000006 111.191 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 27.2 m -67.7 153.25 95.38 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.675 -0.693 . . . . 9.6199999999999992 111.616 -173.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.462 ' HB2' ' HD3' ' A' ' 222' ' ' PRO . 53.5 Cg_exo -50.5 -51.65 10.6 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.422 2.081 . . . . 11.65 113.404 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.462 ' HD3' ' HB2' ' A' ' 221' ' ' PRO . 90.0 Cg_endo -77.72 27.27 0.47 Allowed 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 121.771 1.647 . . . . 13.109999999999999 112.57 176.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -101.57 153.44 18.85 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.501 -0.639 . . . . 14.029999999999999 111.501 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 40.6 tp -150.57 127.57 11.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.666 0.27 . . . . 16.100000000000001 110.829 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.08 6.77 4.6 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.832 -0.433 . . . . 17.699999999999999 109.832 174.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 . . . . . 0 C--O 1.252 1.203 0 CA-C-N 115.554 -0.748 . . . . 18.899999999999999 110.416 -177.213 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 112.27 -0.332 . . . . 33.259999999999998 112.27 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 p -132.21 36.37 3.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.278 0.561 . . . . 33.920000000000002 110.169 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.16 62.79 4.21 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.622 -0.717 . . . . 32.350000000000001 112.413 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 88.9 m-85 -102.36 133.41 20.58 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 109.817 -0.438 . . . . 31.649999999999999 109.817 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 54' ' ' PHE . 21.2 Cg_exo -65.36 83.28 0.21 Allowed 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.741 2.294 . . . . 29.989999999999998 111.679 176.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.2 p -73.31 -18.23 61.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.149 -0.478 . . . . 28.920000000000002 111.283 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.6 p -77.55 57.03 1.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.798 -0.637 . . . . 26.940000000000001 110.98 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.58 79.65 8.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.039 -0.528 . . . . 25.829999999999998 110.705 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.82 134.36 53.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.959 0.409 . . . . 23.530000000000001 110.402 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -117.13 98.43 6.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.591 . . . . 21.640000000000001 110.012 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.6 m -83.91 117.4 68.57 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.126 -0.488 . . . . 19.420000000000002 109.875 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.62 120.53 8.1 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.092 1.862 . . . . 17.170000000000002 110.978 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -81.25 66.19 6.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.499 0.666 . . . . 17.469999999999999 111.123 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -77.05 109.51 10.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.079 -0.964 . . . . 15.630000000000001 109.551 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.14 154.13 33.67 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 121.03 -0.605 . . . . 12.039999999999999 111.921 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.4 t -71.36 113.84 22.85 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 110.034 -0.358 . . . . 10.67 110.034 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -84.7 142.75 9.3 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.7 2.266 . . . . 9.6899999999999995 112.344 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -83.49 129.16 34.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.637 -0.505 . . . . 7.7000000000000002 109.637 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -96.08 136.43 36.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.849 -0.614 . . . . 8.1400000000000006 110.219 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.503 ' HB1' ' O ' ' A' ' 73' ' ' TYR . . . -63.36 118.55 44.84 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 116.175 -0.466 . . . . 5.96 110.116 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 22.7 Cg_exo -65.43 -81.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.899 2.399 . . . . 6.1299999999999999 112.725 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.411 ' H ' ' HB2' ' A' ' 71' ' ' PRO . 10.2 p -107.79 -39.87 4.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.281 -0.418 . . . . 6.5300000000000002 110.476 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.503 ' O ' ' HB1' ' A' ' 70' ' ' ALA . 33.2 p90 -87.75 119.13 27.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.068 -0.515 . . . . 5.0099999999999998 109.966 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.4 pp -87.25 151.25 51.0 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 116.273 -0.422 . . . . 4.2300000000000004 110.945 177.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -87.27 19.24 1.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.856 2.371 . . . . 4.1200000000000001 112.963 -175.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' HB2' HD13 ' A' ' 74' ' ' ILE . 33.8 mt-10 -89.58 -68.61 0.77 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.656 -0.498 . . . . 3.8199999999999998 109.656 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.9 t70 53.88 78.29 0.16 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.73 0.643 . . . . 3.1600000000000001 111.244 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.5 mt -107.64 133.53 20.38 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.106 -0.497 . . . . 2.4500000000000002 110.519 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.45 125.14 10.97 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.532 2.155 . . . . 1.75 112.218 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.694 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -111.9 159.03 35.03 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.142 -0.481 . . . . 1.01 110.973 -175.65 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -64.52 162.47 30.83 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.33 2.686 . . . . 0.72999999999999998 112.648 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.19 -4.38 17.37 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.438 0.903 . . . . 1.04 113.438 -170.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 59.8 m-20 -111.64 1.78 16.95 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.529 -0.468 . . . . 1.6599999999999999 111.839 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -128.2 140.67 51.78 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.456 ' HB2' ' HD2' ' A' ' 101' ' ' LYS . 37.0 tt0 -122.48 126.21 47.39 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.569 -0.452 . . . . 2.27 110.183 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.591 HD11 ' CE2' ' A' ' 171' ' ' TYR . 6.2 tt -83.98 127.2 33.71 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.85 -0.614 . . . . 0.79000000000000004 109.533 -178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.42 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 45.4 mtp180 -152.86 128.44 10.05 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.231 -0.895 . . . . 3.21 109.792 -174.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.3 112.55 19.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.099 -0.704 . . . . 2.46 109.099 174.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -163.96 92.14 0.66 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.529 -0.915 . . . . 1.5800000000000001 108.529 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 m -54.35 105.4 0.15 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.678 -0.692 . . . . 1.8600000000000001 112.083 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -92.19 123.38 62.76 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.627 -0.715 . . . . 1.45 109.181 173.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -46.58 116.9 1.78 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.449 2.766 . . . . 1.6100000000000001 113.366 -175.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.87 -27.18 13.54 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.005 -0.617 . . . . 1.74 112.491 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.05 -62.32 1.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.81 0.338 . . . . 1.4099999999999999 111.133 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 115.09 -113.6 2.99 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.009 -0.615 . . . . 1.0900000000000001 111.922 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.38 159.29 24.39 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 122.122 0.169 . . . . 2.3100000000000001 110.683 176.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.04 -179.19 46.38 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.618 -0.801 . . . . 0.58999999999999997 112.109 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.435 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 29.4 m -115.77 114.66 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.6 0.714 . . . . 0.67000000000000004 109.88 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 28.2 m95 -83.22 120.14 25.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.513 -0.767 . . . . 1.1299999999999999 110.98 -170.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -66.51 121.76 16.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.236 -0.438 . . . . 0.54000000000000004 110.39 177.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.456 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 1.1 mppt? -90.73 -9.02 48.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.153 0.502 . . . . 1.6799999999999999 110.286 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -135.47 157.44 46.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.308 -0.86 . . . . 3.5 108.681 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.6 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -79.27 159.83 27.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 120.913 0.387 . . . . 2.3999999999999999 110.38 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.808 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 52.8 mtm -129.13 142.05 51.0 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.395 -0.594 . . . . 1.22 109.395 177.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.35 140.81 37.91 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.852 -0.425 . . . . 2.3100000000000001 109.852 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.07 128.26 3.56 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 124.175 0.922 . . . . 0.83999999999999997 112.488 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.85 7.8 11.38 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.55 -0.75 . . . . 1.04 111.681 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 0.6 OUTLIER -86.08 163.89 17.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.096 0.474 . . . . 2.6200000000000001 111.297 -179.285 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -145.98 135.34 22.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.585 -0.524 . . . . 3.6200000000000001 109.585 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 5.0 mt -101.47 143.37 31.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.848 -0.427 . . . . 0.53000000000000003 109.848 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 124.77 -136.13 9.81 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.693 -0.765 . . . . 1.02 112.34 176.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.441 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 71.6 Cg_endo -75.22 149.54 93.62 Favored 'Cis proline' 0 C--N 1.343 0.267 0 C-N-CA 123.309 -1.538 . . . . 2.1000000000000001 112.645 2.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.461 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 31.0 t -95.67 151.39 19.39 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.662 -0.866 . . . . 2.0 108.662 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t 59.47 84.97 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.776 -0.824 . . . . 2.0299999999999998 108.776 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 163' ' ' ALA . 28.3 m -71.54 -166.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.12 -0.945 . . . . 3.9500000000000002 111.88 -174.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 2.1 p -47.33 115.24 3.47 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 116.029 -0.532 . . . . 5.21 111.28 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 116' ' ' VAL . 27.7 Cg_exo -62.45 88.63 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.145 2.563 . . . . 5.0700000000000003 112.877 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -100.51 -32.06 10.97 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.044 -0.724 . . . . 7.9900000000000002 109.044 172.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.6 -53.51 0.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.895 -1.048 . . . . 6.9500000000000002 109.56 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 49.53 55.99 8.52 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.804 0.69 . . . . 6.0899999999999999 111.984 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.01 89.66 3.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.49 -0.777 . . . . 5.5599999999999996 110.835 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -90.99 172.58 8.48 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.172 -0.922 . . . . 7.4199999999999999 110.289 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -60.07 -70.84 0.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.279 -0.419 . . . . 9.0099999999999998 110.812 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 47.1 m -149.16 -69.3 0.21 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.597 -0.52 . . . . 8.8800000000000008 109.597 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.2 t70 65.06 163.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.644 0.735 . . . . 7.5999999999999996 111.647 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -113.84 121.6 44.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.968 -0.56 . . . . 7.2300000000000004 110.676 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.41 -48.88 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.377 -0.689 . . . . 4.5899999999999999 111.377 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TRP . . . . . 0.539 ' CD1' HD11 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -136.95 -109.56 0.19 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.517 -0.341 . . . . 4.9299999999999997 111.117 176.102 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' A' ' 130' ' ' GLN . 10.7 pt-20 -165.0 -43.03 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.002 0.429 . . . . 7.6500000000000004 109.937 176.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.402 ' N ' ' HG3' ' A' ' 129' ' ' GLU . 48.4 mt-30 -144.55 150.73 38.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.125 -0.489 . . . . 8.8399999999999999 110.28 -177.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.43 -20.06 6.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.953 0.406 . . . . 6.0499999999999998 110.772 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.76 65.5 9.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.865 0.84 . . . . 8.5 111.37 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 56.1 p -93.04 37.34 1.03 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.118 -0.946 . . . . 9.8200000000000003 110.22 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.4 t70 58.66 66.92 0.99 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.379 -0.828 . . . . 11.210000000000001 109.755 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.01 108.14 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.365 -0.834 . . . . 10.84 111.418 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -143.37 78.78 1.61 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.593 -0.731 . . . . 13.25 109.74 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.8 p -86.83 -16.55 9.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.813 0.816 . . . . 13.890000000000001 108.865 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 27.3 t -173.53 136.56 0.7 Allowed Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 114.499 -1.228 . . . . 14.050000000000001 108.211 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.9 78.07 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.518 2.145 . . . . 14.41 112.013 177.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -92.08 54.02 2.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.72 -0.673 . . . . 14.44 110.718 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.22 83.43 3.69 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.752 -0.658 . . . . 15.9 110.511 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.93 -42.74 1.23 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.956 -0.64 . . . . 15.6 111.812 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 34.3 t -135.24 83.84 2.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.993 0.425 . . . . 15.6 110.624 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.57 -35.74 75.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.232 0.539 . . . . 13.85 109.75 176.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -156.93 132.23 9.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.652 -0.704 . . . . 13.19 110.219 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -94.46 -13.2 26.42 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.529 0.681 . . . . 15.67 109.599 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.9 pt -109.79 168.07 4.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.13 -0.941 . . . . 13.77 110.366 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 33.3 t -129.31 120.5 25.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.037 0.446 . . . . 13.619999999999999 110.579 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -78.33 86.54 4.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.055 -0.72 . . . . 13.02 109.055 172.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -139.24 140.93 37.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.539 -0.755 . . . . 14.68 109.975 -174.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 pp -109.73 14.69 23.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.286 0.565 . . . . 13.550000000000001 111.539 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 140.58 143.45 4.32 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.738 -0.744 . . . . 15.800000000000001 112.224 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.0 m -84.52 -1.1 55.29 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.889 0.376 . . . . 17.079999999999998 111.121 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.07 -82.7 0.35 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.201 -0.454 . . . . 18.43 111.705 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -115.77 168.07 10.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.821 -0.627 . . . . 18.530000000000001 111.4 -172.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 62.1 35.65 15.67 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.442 -0.799 . . . . 14.32 111.225 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 42.4 t -83.65 -24.95 31.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.126 0.488 . . . . 14.51 110.674 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 55.4 t -125.96 129.86 72.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.046 -0.524 . . . . 13.06 110.025 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.46 70.67 0.56 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.674 0.609 . . . . 10.33 111.309 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -148.6 -96.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.113 -0.494 . . . . 9.8800000000000008 110.996 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -122.53 -32.25 3.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.709 0.29 . . . . 10.23 111.611 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.554 ' HG2' ' N ' ' A' ' 163' ' ' ALA . 1.0 OUTLIER -79.89 -45.43 18.63 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 122.02 0.914 . . . . 9.0600000000000005 108.952 -179.062 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.554 ' N ' ' HG2' ' A' ' 162' ' ' GLN . . . -122.47 142.31 50.7 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.705 -1.588 . . . . 6.1900000000000004 110.219 175.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.74 11.15 74.7 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.576 -0.821 . . . . 3.9700000000000002 112.174 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.78 -8.07 55.96 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.893 0.331 . . . . 2.6299999999999999 111.893 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 113' ' ' CYS . . . -140.21 19.45 2.86 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.31 -0.948 . . . . 1.3 112.768 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 17.3 m -79.3 -28.62 42.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.107 0.48 . . . . 1.8200000000000001 110.447 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.518 ' CB ' HG22 ' A' ' 80' ' ' ILE . 40.5 p-90 -65.03 -17.46 64.46 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.693 -0.685 . . . . 0.69999999999999996 111.33 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 65.3 mt -68.78 -14.18 62.86 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.229 -0.896 . . . . 0.66000000000000003 112.002 -175.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.452 ' HD3' ' C ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -69.69 -13.19 62.18 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.671 0.272 . . . . 1.48 111.189 178.724 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.591 ' CE2' HD11 ' A' ' 86' ' ' LEU . 46.1 m-85 -78.47 -37.83 42.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 1.97 111.924 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.579 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -70.51 125.68 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.638 -0.425 . . . . 0.67000000000000004 110.141 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 173' ' ' ARG . 48.8 mtp85 -117.85 -161.76 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.282 -0.417 . . . . 4.3399999999999999 111.657 -176.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.8 t -72.37 157.62 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.116 -0.493 . . . . 1.0700000000000001 111.213 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.781 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -57.15 153.34 11.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.802 -0.635 . . . . 0.70999999999999996 112.167 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 28.8 p -85.98 -10.72 54.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.333 -0.849 . . . . 1.8799999999999999 110.678 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 34.0 m -153.63 170.87 19.79 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.193 -0.458 . . . . 1.6299999999999999 110.82 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' CYS . . . . . 0.549 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 10.5 p -71.95 -43.09 65.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.154 0.502 . . . . 1.96 110.87 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -78.26 4.02 13.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.404 0.621 . . . . 2.4199999999999999 110.439 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -101.94 16.46 25.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.371 -0.832 . . . . 2.1200000000000001 110.468 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 31.5 mm-40 -67.53 113.89 5.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 1.3500000000000001 111.015 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.785 ' H ' HD12 ' A' ' 183' ' ' LEU . 16.6 t30 -150.94 33.64 0.6 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.253 1.025 . . . . 1.6799999999999999 108.354 173.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.785 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.2 OUTLIER -124.24 123.2 39.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.41 -0.813 . . . . 0.81000000000000005 110.701 -171.646 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 96.0 m -150.8 127.4 10.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.111 0.482 . . . . 0.51000000000000001 110.738 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.555 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 63.6 mtp -114.4 136.05 53.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.951 0.405 . . . . 1.3500000000000001 110.218 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 1.4 p -113.51 137.56 51.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.654 -0.703 . . . . 1.73 110.775 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.08 104.01 13.12 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.796 -0.816 . . . . 1.9299999999999999 108.796 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 27.5 pt -141.56 145.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 1.1100000000000001 110.371 -176.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.2 m 65.13 26.4 12.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 1.8600000000000001 110.897 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 62.76 19.47 11.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.407 -0.815 . . . . 2.8300000000000001 111.28 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -131.7 168.03 18.46 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.481 -0.563 . . . . 1.75 109.481 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.539 HD11 ' CD1' ' A' ' 128' ' ' TRP . 48.3 mm -99.89 132.41 45.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.179 0.514 . . . . 1.01 111.903 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -125.02 137.4 54.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.995 -0.548 . . . . 3.9399999999999999 110.747 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 7.3 m-85 -100.94 117.08 34.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.966 -0.561 . . . . 0.92000000000000004 109.725 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -113.01 120.28 40.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.926 0.394 . . . . 1.1100000000000001 110.405 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.43 HG22 HD11 ' A' ' 207' ' ' LEU . 2.0 t -88.01 152.74 3.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.321 -0.622 . . . . 0.69999999999999996 109.321 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.55 -56.18 5.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.09 -0.959 . . . . 0.62 112.105 -166.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.632 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -135.02 175.79 9.25 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.953 -0.567 . . . . 1.3799999999999999 111.379 -173.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.808 ' HA ' ' O ' ' A' ' 104' ' ' MET . 17.0 t70 -50.18 112.54 0.69 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.762 0.791 . . . . 2.23 112.061 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.69 HD11 ' ND2' ' A' ' 182' ' ' ASN . 8.9 mm -79.94 136.22 23.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.633 -1.167 . . . . 0.88 111.117 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.622 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 42.3 mt-10 -88.5 126.96 58.44 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 109.261 -0.644 . . . . 2.0600000000000001 109.261 173.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.51 111.8 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 121.86 1.706 . . . . 0.51000000000000001 111.019 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.04 -6.4 10.23 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.63 -0.795 . . . . 0.69999999999999996 113.175 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 22.2 pt-20 -115.24 121.26 42.39 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.687 0.744 . . . . 1.27 110.636 174.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.456 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -111.72 95.38 5.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.045 -0.525 . . . . 2.9199999999999999 111.549 174.473 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.49 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.8 mm? -122.35 99.72 6.57 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.121 -0.632 . . . . 0.90000000000000002 109.569 174.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.579 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -146.47 113.37 6.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.973 0.509 . . . . 0.53000000000000003 109.83 177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.659 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.1 p -154.87 160.4 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 110.098 -0.334 . . . . 0.91000000000000003 110.098 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.555 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 59.3 t-80 -93.69 109.87 21.51 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.902 -1.147 . . . . 1.55 107.902 171.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.5 m -73.75 128.99 36.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.603 -0.517 . . . . 2.5600000000000001 109.603 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -123.9 164.32 19.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.094 -0.503 . . . . 5.3600000000000003 111.437 -169.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -91.23 14.44 14.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.336 -0.847 . . . . 5.7999999999999998 109.927 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.418 ' HA3' HD13 ' A' ' 217' ' ' LEU . . . 92.42 78.9 1.41 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.74 -0.664 . . . . 5.6100000000000003 111.917 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.83 -73.08 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.935 0.398 . . . . 6.3099999999999996 110.819 -175.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.472 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 99.6 m-85 -72.45 -52.75 6.48 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.754 -0.657 . . . . 8.8300000000000001 111.913 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 34.9 Cg_endo -65.42 -56.97 0.29 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.108 1.872 . . . . 7.7800000000000002 113.489 -176.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.418 HD13 ' HA3' ' A' ' 213' ' ' GLY . 7.8 mp -75.33 -71.12 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.528 0.204 . . . . 8.0199999999999996 110.869 -175.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 219' ' ' THR . . . 157.02 159.35 9.43 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.483 -0.865 . . . . 8.6400000000000006 112.689 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 218' ' ' GLY . 14.6 t 175.67 -23.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 122.791 0.436 . . . . 9.7200000000000006 109.851 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.56 150.82 47.14 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.952 -0.567 . . . . 9.6199999999999992 110.098 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.4 111.38 0.85 Allowed 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.891 2.394 . . . . 11.65 112.336 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.65 47.55 2.6 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.003 2.469 . . . . 13.109999999999999 112.451 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -119.57 154.29 16.51 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.703 -0.68 . . . . 14.029999999999999 111.56 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.3 tp -69.0 125.83 27.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.924 0.392 . . . . 16.100000000000001 110.434 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.74 -49.51 0.89 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.192 -0.458 . . . . 17.699999999999999 110.725 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 119.002 -0.523 . . . . 18.899999999999999 110.685 -179.719 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.845 -0.502 . . . . 33.259999999999998 111.845 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.5 m -74.55 104.17 5.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.184 0.516 . . . . 33.920000000000002 110.964 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.32 -150.62 22.37 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.066 -0.814 . . . . 32.350000000000001 111.066 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -122.97 77.02 50.38 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.941 0.371 . . . . 31.649999999999999 110.824 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.22 120.97 7.37 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.664 2.242 . . . . 29.989999999999998 111.425 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.5 m -61.3 113.66 2.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.042 0.449 . . . . 28.920000000000002 110.524 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.5 m -100.18 61.64 1.08 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.153 -0.476 . . . . 26.940000000000001 110.223 -175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 60.46 28.89 18.56 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.277 -0.874 . . . . 25.829999999999998 111.044 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -113.55 137.96 50.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.027 -0.533 . . . . 23.530000000000001 110.613 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -102.59 139.2 38.5 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.885 -0.598 . . . . 21.640000000000001 110.175 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 9.9 t -106.57 127.0 29.0 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.398 -0.365 . . . . 19.420000000000002 110.032 176.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 36.7 Cg_exo -61.02 138.27 77.37 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.785 2.323 . . . . 17.170000000000002 112.516 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -72.2 -16.86 61.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.615 -0.721 . . . . 17.469999999999999 110.235 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.83 106.54 1.91 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.582 -0.735 . . . . 15.630000000000001 110.104 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.92 12.43 74.35 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.765 -0.731 . . . . 12.039999999999999 111.963 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.8 t -84.99 113.6 50.94 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.981 -0.377 . . . . 10.67 109.981 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.25 100.02 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.828 2.352 . . . . 9.6899999999999995 111.999 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -147.5 117.56 7.26 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.765 -0.652 . . . . 7.7000000000000002 109.63 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -100.64 153.79 19.13 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.839 -0.619 . . . . 8.1400000000000006 110.07 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.51 110.08 10.47 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.961 -0.563 . . . . 5.96 111.563 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.34 -164.67 0.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.963 2.442 . . . . 6.1299999999999999 111.326 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 p -62.84 -34.34 65.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.929 0.395 . . . . 6.5300000000000002 110.146 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -116.61 113.31 22.53 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.731 -0.47 . . . . 5.0099999999999998 109.731 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.487 ' CD1' ' H ' ' A' ' 77' ' ' ASP . 2.4 pp -88.46 137.58 30.54 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.245 -0.434 . . . . 4.2300000000000004 110.497 176.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -85.88 10.74 3.56 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.932 2.421 . . . . 4.1200000000000001 112.586 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -82.7 -64.65 1.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.812 -0.631 . . . . 3.8199999999999998 110.858 -177.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.487 ' H ' ' CD1' ' A' ' 74' ' ' ILE . 1.7 m-20 68.46 95.3 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.578 -0.737 . . . . 3.1600000000000001 110.963 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 81.9 mt -69.26 124.45 90.46 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.429 -0.805 . . . . 2.4500000000000002 110.445 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -72.12 116.56 4.76 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.322 2.014 . . . . 1.75 111.013 175.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.561 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -125.73 146.31 54.62 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.275 -0.42 . . . . 1.01 110.3 -177.127 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.03 124.45 16.3 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.27 1.98 . . . . 0.72999999999999998 110.406 170.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.21 -8.37 12.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.415 0.524 . . . . 1.04 112.415 -173.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.61 -9.03 31.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.197 0.522 . . . . 1.6599999999999999 111.542 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -134.52 156.75 48.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -121.46 116.15 24.18 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.135 -0.626 . . . . 2.27 111.246 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.406 HD11 ' CE2' ' A' ' 171' ' ' TYR . 8.3 tt -86.41 128.2 34.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.782 -0.451 . . . . 0.79000000000000004 109.782 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -151.12 130.66 13.0 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.48 -0.782 . . . . 3.21 109.682 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -68.21 112.03 4.89 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.367 -0.605 . . . . 2.46 109.367 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.7 t -169.52 110.7 0.46 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.423 -0.584 . . . . 1.5800000000000001 109.423 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 t -90.85 107.77 19.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.21 -0.45 . . . . 1.8600000000000001 110.739 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.58 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -79.11 121.95 83.8 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.35 -0.611 . . . . 1.45 109.35 175.024 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.42 114.93 1.77 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.371 2.714 . . . . 1.6100000000000001 112.988 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.09 -9.83 36.74 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.95 -0.643 . . . . 1.74 112.727 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.58 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -135.76 -60.26 0.74 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.971 0.385 . . . . 1.4099999999999999 111.665 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.431 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 122.76 -146.09 16.5 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.647 -0.787 . . . . 1.0900000000000001 112.716 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 mt -80.4 159.03 25.82 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.254 -0.276 . . . . 2.3100000000000001 110.254 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.414 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -165.03 169.09 39.51 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.802 -0.713 . . . . 0.58999999999999997 111.774 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 27.5 m -98.41 114.21 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.773 0.796 . . . . 0.67000000000000004 109.262 172.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -81.76 101.76 10.34 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.234 -0.893 . . . . 1.1299999999999999 110.663 -167.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.37 115.22 5.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.733 -0.667 . . . . 0.54000000000000004 109.701 175.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.539 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -94.0 15.76 16.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.607 0.717 . . . . 1.6799999999999999 109.515 -177.347 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -148.43 160.83 42.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.562 -1.199 . . . . 3.5 108.144 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.76 158.79 34.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.435 0.636 . . . . 2.3999999999999999 111.453 -174.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 54.0 mtm -134.5 143.71 47.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.98 -1.119 . . . . 1.22 107.98 170.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 52.3 mt-10 -130.28 174.45 9.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.43 . . . . 2.3100000000000001 112.157 -172.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.64 122.48 11.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.495 -0.775 . . . . 0.83999999999999997 113.054 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.18 -25.53 11.28 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 1.04 113.927 169.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 10.1 pt-20 -73.98 160.92 30.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.375 0.607 . . . . 2.6200000000000001 112.007 -174.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.71 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 0.7 OUTLIER -124.9 134.64 52.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.029 -0.987 . . . . 3.6200000000000001 110.474 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mt -87.84 133.52 33.88 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.973 -0.751 . . . . 0.53000000000000003 108.973 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.87 -132.87 5.43 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.487 -0.863 . . . . 1.02 112.433 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.06 134.4 17.97 Favored 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 123.947 -1.272 . . . . 2.1000000000000001 112.881 1.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.401 ' O ' ' HB ' ' A' ' 114' ' ' VAL . 53.4 t -70.06 -28.23 65.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.486 -0.779 . . . . 2.0 111.642 -175.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 113' ' ' CYS . 8.0 p 178.72 151.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 109.862 -0.421 . . . . 2.0299999999999998 109.862 -177.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.3 -159.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.926 -0.768 . . . . 3.9500000000000002 108.926 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.3 p -54.99 117.28 13.59 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.965 0.412 . . . . 5.21 110.195 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.523 ' HB2' ' O ' ' A' ' 121' ' ' ALA . 81.9 Cg_endo -77.3 62.92 7.72 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.978 2.452 . . . . 5.0700000000000003 113.132 -174.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 69.19 -58.59 0.5 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.895 0.878 . . . . 7.9900000000000002 111.103 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.71 -66.5 0.23 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.672 -0.694 . . . . 6.9500000000000002 109.268 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -163.16 56.37 0.19 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.682 -0.69 . . . . 6.0899999999999999 109.96 175.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 117' ' ' PRO . . . -145.55 121.1 10.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.106 -0.952 . . . . 5.5599999999999996 110.245 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -57.63 140.76 50.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.702 -0.681 . . . . 7.4199999999999999 111.52 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -115.36 -33.34 5.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.297 0.57 . . . . 9.0099999999999998 110.989 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 36.1 m -155.7 -40.98 0.08 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.067 0.937 . . . . 8.8800000000000008 109.21 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -51.62 158.62 0.9 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.219 -1.81 . . . . 7.5999999999999996 111.931 176.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -167.04 149.37 6.17 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.24 -0.891 . . . . 7.2300000000000004 109.427 175.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.483 ' HA3' ' HE3' ' A' ' 211' ' ' LYS . . . 106.78 59.28 0.59 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.226 -0.988 . . . . 4.5899999999999999 113.487 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TRP . . . . . 0.465 ' CD1' HD11 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -138.91 -162.63 1.34 Allowed 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.515 -1.291 . . . . 4.9299999999999997 107.515 176.685 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 130' ' ' GLN . 10.0 pt-20 -83.15 -46.82 12.29 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.131 -0.692 . . . . 7.6500000000000004 109.131 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 47.4 tt0 165.63 103.91 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.092 0 O-C-N 124.29 0.994 . . . . 8.8399999999999999 109.44 176.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.404 HD12 HD12 ' A' ' 132' ' ' LEU . 1.9 pp -92.17 3.81 7.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.405 -0.518 . . . . 6.0499999999999998 110.51 175.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.404 HD12 HD12 ' A' ' 131' ' ' ILE . 5.8 mp -80.62 69.97 7.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.839 -0.619 . . . . 8.5 109.722 177.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.1 p -120.17 29.21 7.62 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.338 -0.847 . . . . 9.8200000000000003 110.253 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -64.34 110.4 2.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.321 -0.854 . . . . 11.210000000000001 110.415 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 56.5 t -74.41 137.27 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.856 -0.611 . . . . 10.84 109.888 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.94 71.59 1.56 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.8 0.81 . . . . 13.25 110.584 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.7 p -93.35 -20.73 6.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.303 -0.862 . . . . 13.890000000000001 109.534 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.6 m -124.04 95.13 44.5 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.598 -0.728 . . . . 14.050000000000001 110.365 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.02 89.25 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.857 2.372 . . . . 14.41 111.554 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -101.69 -16.04 16.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.993 -0.548 . . . . 14.44 111.636 -175.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.58 130.5 46.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.223 0.535 . . . . 15.9 111.342 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.77 -11.47 49.66 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.741 -0.742 . . . . 15.6 111.57 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 13.4 p -159.24 40.25 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.249 0.547 . . . . 15.6 110.294 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 63.6 mt -78.8 116.44 22.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.725 -0.671 . . . . 13.85 109.98 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.2 t -84.28 124.36 31.15 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.491 -0.559 . . . . 13.19 109.491 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -122.06 -7.84 8.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.846 -0.616 . . . . 15.67 111.497 -172.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.3 pp -104.72 134.25 46.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.217 0.532 . . . . 13.77 111.052 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.6 t 174.41 53.56 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.81 -1.086 . . . . 13.619999999999999 108.574 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -128.01 44.48 2.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.399 -0.819 . . . . 13.02 112.141 -170.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -86.25 80.6 8.69 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.487 0.661 . . . . 14.68 109.457 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.474 ' HB2' ' CG ' ' A' ' 156' ' ' PHE . 2.7 pp -113.2 25.6 11.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.678 -0.692 . . . . 13.550000000000001 111.035 -177.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -117.72 66.04 0.35 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.694 -0.685 . . . . 15.800000000000001 111.993 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.3 t -145.78 -77.29 0.19 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.1 -0.333 . . . . 17.079999999999998 110.1 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -107.77 -76.45 0.61 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.038 0.446 . . . . 18.43 111.012 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -152.42 153.18 33.06 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.808 -0.633 . . . . 18.530000000000001 110.215 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.474 ' CG ' ' HB2' ' A' ' 151' ' ' LEU . 39.2 p90 -144.03 149.94 37.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.039 0.447 . . . . 14.32 111.099 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 43.0 t -138.5 34.77 2.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.576 0.703 . . . . 14.51 109.13 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.06 134.69 59.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.525 -0.761 . . . . 13.06 110.961 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -93.28 90.09 6.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.272 -0.422 . . . . 10.33 109.881 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -100.59 -45.63 5.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.09 -0.504 . . . . 9.8800000000000008 110.594 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -126.66 25.64 6.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.215 -0.448 . . . . 10.23 111.712 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -97.3 -49.77 4.81 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.151 -0.22 . . . . 9.0600000000000005 110.758 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 57.66 57.85 4.04 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.548 0.689 . . . . 6.1900000000000004 110.814 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -105.04 -116.49 4.22 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.478 -0.783 . . . . 3.9700000000000002 111.696 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 59.86 -79.7 0.02 OUTLIER 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.45 0.7 . . . . 2.6299999999999999 112.778 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -134.33 18.47 4.17 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.714 -0.755 . . . . 1.3 112.821 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.52 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 3.5 p -65.99 -24.74 66.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.138 0.494 . . . . 1.8200000000000001 110.774 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -84.22 -17.68 39.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.019 -0.537 . . . . 0.69999999999999996 110.544 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.7 -14.13 58.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.993 -0.549 . . . . 0.66000000000000003 111.442 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 167' ' ' SER . 21.2 ptmt -64.66 -18.98 65.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.927 0.394 . . . . 1.48 110.5 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.414 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 53.6 m-85 -72.53 -37.57 68.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.92 -0.582 . . . . 1.97 111.621 -175.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -73.97 117.73 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.513 0.673 . . . . 0.67000000000000004 110.855 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 -172.05 2.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.891 -1.05 . . . . 4.3399999999999999 110.3 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.517 ' HA ' HD22 ' A' ' 183' ' ' LEU . 2.3 p -65.2 147.03 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.345 0.593 . . . . 1.0700000000000001 111.781 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.593 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -59.15 149.45 28.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.611 -1.177 . . . . 0.70999999999999996 112.599 -174.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 53.7 t -60.32 -44.43 95.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.117 -0.947 . . . . 1.8799999999999999 110.828 175.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 87.1 p -137.75 164.64 28.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.72 -0.474 . . . . 1.6299999999999999 109.72 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' CYS . . . . . 0.478 ' HA ' ' OE1' ' A' ' 181' ' ' GLN . 75.8 m -78.4 4.36 13.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 1.96 111.849 -176.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -89.06 -7.34 56.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.2 0.524 . . . . 2.4199999999999999 109.647 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.529 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . 23.6 m-20 -109.04 15.59 23.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.566 -0.743 . . . . 2.1200000000000001 110.813 -176.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.478 ' OE1' ' HA ' ' A' ' 178' ' ' CYS . 15.0 mm100 -66.52 115.7 6.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.572 0.701 . . . . 1.3500000000000001 111.746 -172.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.748 ' H ' HD12 ' A' ' 183' ' ' LEU . 14.1 t30 -165.03 39.74 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.682 -1.229 . . . . 1.6799999999999999 107.682 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.748 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.7 OUTLIER -122.05 119.87 32.67 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.522 -0.763 . . . . 0.81000000000000005 111.301 -170.422 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.5 m -150.93 121.82 7.6 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.241 0.543 . . . . 0.51000000000000001 111.884 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.575 ' HB3' ' HB2' ' A' ' 209' ' ' HIS . 10.8 ttm -111.51 129.3 56.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.273 -0.64 . . . . 1.3500000000000001 109.273 172.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 49.9 t -115.31 155.79 26.66 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.733 0.301 . . . . 1.73 110.266 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.44 ' HG3' ' HB3' ' A' ' 128' ' ' TRP . 25.4 tm0? -116.01 112.39 21.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.291 -0.633 . . . . 1.9299999999999999 109.291 178.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.517 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 41.5 pt -138.54 143.17 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.46 -0.336 . . . . 1.1100000000000001 110.675 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.9 t 55.86 37.86 29.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 1.8600000000000001 111.639 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 60.47 28.43 18.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.824 -0.625 . . . . 2.8300000000000001 111.712 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 12.9 pt20 -145.11 156.22 43.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.859 0.361 . . . . 1.75 110.49 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.465 HD11 ' CD1' ' A' ' 128' ' ' TRP . 47.6 mm -82.25 134.79 26.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.191 0.52 . . . . 1.01 111.264 -175.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -124.64 122.3 37.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.669 -0.696 . . . . 3.9399999999999999 109.665 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.71 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 26.4 m-85 -99.37 113.69 26.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.095 -0.705 . . . . 0.92000000000000004 109.095 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -111.25 127.1 55.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.351 -0.386 . . . . 1.1100000000000001 110.375 -172.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.466 HG23 ' HG3' ' A' ' 108' ' ' GLU . 1.5 t -95.19 150.73 4.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.91 0.862 . . . . 0.69999999999999996 110.248 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.6 mm -100.22 -53.67 7.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.841 -1.527 . . . . 0.62 111.618 -163.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.422 ' C ' ' HE3' ' A' ' 198' ' ' LYS . 0.0 OUTLIER -153.3 -178.89 7.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.065 -0.97 . . . . 1.3799999999999999 110.799 -179.409 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 104' ' ' MET . 9.6 p-10 -52.85 110.96 0.58 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.992 0.808 . . . . 2.23 112.673 -172.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 200' ' ' ILE . 2.6 mm -80.89 134.47 27.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.693 -0.685 . . . . 0.88 110.349 171.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 12.5 mm-40 -81.67 120.56 78.16 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.548 -0.751 . . . . 2.0600000000000001 109.559 173.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.51 115.43 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.145 2.564 . . . . 0.51000000000000001 112.358 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.27 -11.49 9.18 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.71 -0.757 . . . . 0.69999999999999996 113.076 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 13.0 pt-20 -123.46 125.59 45.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.78 0.79 . . . . 1.27 111.613 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -108.96 99.88 9.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.529 -1.214 . . . . 2.9199999999999999 112.069 -175.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.552 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.1 mm? -122.55 100.38 6.9 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.492 -0.483 . . . . 0.90000000000000002 110.473 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.53 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.0 mm? -145.61 113.67 6.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.816 0.446 . . . . 0.53000000000000003 110.303 174.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.691 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.9 p -155.83 161.79 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 O-C-N 122.164 -0.335 . . . . 0.91000000000000003 110.41 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.575 ' HB2' ' HB3' ' A' ' 185' ' ' MET . 33.0 t-80 -131.44 109.89 10.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.189 -0.671 . . . . 1.55 109.189 161.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 86.1 t -68.93 121.79 18.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.186 0.517 . . . . 2.5600000000000001 109.746 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.483 ' HE3' ' HA3' ' A' ' 127' ' ' GLY . 53.9 mttm -112.0 164.35 13.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.618 -0.719 . . . . 5.3600000000000003 110.083 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -77.75 50.88 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.283 -0.417 . . . . 5.7999999999999998 112.122 -173.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.553 ' HA2' HD13 ' A' ' 217' ' ' LEU . . . 52.16 49.44 50.02 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.882 -0.599 . . . . 5.6100000000000003 113.674 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.1 -74.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.044 0.449 . . . . 6.3099999999999996 110.018 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.582 ' H ' ' HD2' ' A' ' 216' ' ' PRO . 66.7 m-85 -94.82 -46.81 0.27 Allowed Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.928 -0.578 . . . . 8.8300000000000001 112.367 175.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.582 ' HD2' ' H ' ' A' ' 215' ' ' TYR . 14.8 Cg_endo -56.54 -46.26 31.34 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 121.901 1.734 . . . . 7.7800000000000002 112.805 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.553 HD13 ' HA2' ' A' ' 213' ' ' GLY . 7.2 mp -94.46 -57.27 2.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.943 0.402 . . . . 8.0199999999999996 110.425 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 94.27 47.55 2.8 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.623 -0.799 . . . . 8.6400000000000006 112.001 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 23.1 p -105.04 4.18 31.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.02 0.438 . . . . 9.7200000000000006 110.984 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 19.8 m -85.47 150.34 53.91 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.155 -0.475 . . . . 9.6199999999999992 111.135 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.459 ' HB2' ' HD3' ' A' ' 222' ' ' PRO . 50.7 Cg_exo -50.95 -51.82 10.39 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.714 2.276 . . . . 11.65 113.687 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 221' ' ' PRO . 92.7 Cg_endo -81.1 26.86 0.59 Allowed 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 121.643 1.562 . . . . 13.109999999999999 112.212 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -111.99 73.0 0.21 Allowed Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.905 -0.589 . . . . 14.029999999999999 111.632 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.4 tt -59.27 127.2 30.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.922 0.392 . . . . 16.100000000000001 110.355 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -115.89 9.0 14.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.077 0.465 . . . . 17.699999999999999 110.705 -177.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.873 -0.584 . . . . 18.899999999999999 110.63 -177.036 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.953 -0.459 . . . . 33.259999999999998 111.953 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.9 m 63.83 23.81 13.53 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.174 0.512 . . . . 33.920000000000002 111.211 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.14 137.73 4.35 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.006 -0.616 . . . . 32.350000000000001 111.699 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.469 ' CD2' ' HD2' ' A' ' 55' ' ' PRO . 64.0 t80 -167.34 141.08 2.97 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.978 -0.749 . . . . 31.649999999999999 108.978 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.469 ' HD2' ' CD2' ' A' ' 54' ' ' PHE . 30.3 Cg_endo -64.74 70.1 0.24 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.78 2.32 . . . . 29.989999999999998 112.438 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -101.13 30.04 4.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.732 0.777 . . . . 28.920000000000002 109.307 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 p -87.16 110.59 20.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.206 -0.907 . . . . 26.940000000000001 111.275 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.16 84.39 1.94 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.246 0.546 . . . . 25.829999999999998 109.65 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -127.22 126.55 42.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.588 -0.733 . . . . 23.530000000000001 109.671 174.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.7 t80 54.86 78.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.381 -0.827 . . . . 21.640000000000001 111.407 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.4 137.72 97.21 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.067 -0.515 . . . . 19.420000000000002 110.299 174.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.8 99.73 0.15 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.557 2.171 . . . . 17.170000000000002 111.482 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -80.87 -31.1 35.46 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.265 -0.879 . . . . 17.469999999999999 110.697 -176.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -122.59 147.1 46.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.866 -0.607 . . . . 15.630000000000001 110.37 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.23 66.74 3.14 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.067 -0.587 . . . . 12.039999999999999 111.707 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 p -55.99 120.21 32.13 Favored Pre-proline 0 C--N 1.328 -0.362 0 C-N-CA 122.885 0.474 . . . . 10.67 111.645 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.12 96.35 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.842 2.362 . . . . 9.6899999999999995 112.132 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -101.39 118.91 37.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.613 -0.721 . . . . 7.7000000000000002 109.954 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -81.13 96.37 7.17 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.1 0.476 . . . . 8.1400000000000006 110.601 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 140.06 95.95 Favored Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-N 115.483 -0.781 . . . . 5.96 110.419 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.68 -158.59 0.07 OUTLIER 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.809 2.339 . . . . 6.1299999999999999 112.312 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.43 -38.55 70.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.27 -0.423 . . . . 6.5300000000000002 111.028 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -87.77 121.05 29.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.362 -0.381 . . . . 5.0099999999999998 109.99 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.0 pp -77.23 140.83 65.93 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.058 -0.519 . . . . 4.2300000000000004 111.929 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.6 1.51 9.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.266 2.644 . . . . 4.1200000000000001 112.453 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.32 -53.08 62.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.696 -0.683 . . . . 3.8199999999999998 109.758 176.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.2 t70 74.16 94.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.54 -1.209 . . . . 3.1600000000000001 110.551 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.3 mt -80.87 123.46 82.25 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.238 -0.892 . . . . 2.4500000000000002 110.745 -174.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.95 116.57 4.44 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.323 2.015 . . . . 1.75 111.867 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.545 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -118.43 134.81 23.42 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.199 -0.455 . . . . 1.01 109.933 178.682 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.52 146.9 50.54 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.584 2.189 . . . . 0.72999999999999998 111.936 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.25 6.89 3.89 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.268 0.84 . . . . 1.04 113.268 -168.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -116.97 5.91 12.93 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.798 -0.564 . . . . 1.6599999999999999 112.102 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.581 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 10.6 m-85 -130.47 138.35 50.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.66 -0.867 . . . . 1.0 108.66 176.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.481 ' HB2' ' HD2' ' A' ' 101' ' ' LYS . 1.2 tp10 -108.52 117.42 34.13 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.759 -0.376 . . . . 2.27 110.37 -174.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.439 ' HA ' HG12 ' A' ' 98' ' ' VAL . 6.6 tt -84.13 126.85 33.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.955 -0.758 . . . . 0.79000000000000004 108.955 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.425 ' N ' HD23 ' A' ' 86' ' ' LEU . 78.5 mtp180 -149.52 119.02 6.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.622 -0.717 . . . . 3.21 110.74 -173.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -73.47 112.24 9.37 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.997 -0.742 . . . . 2.46 108.997 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.4 p -155.16 158.7 39.36 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.674 -0.694 . . . . 1.5800000000000001 109.355 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.1 m -99.47 103.14 14.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.837 -0.431 . . . . 1.8600000000000001 109.837 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.04 111.38 62.09 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.194 -0.457 . . . . 1.45 109.94 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -58.42 125.2 17.7 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.034 2.49 . . . . 1.6100000000000001 112.92 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.76 -13.3 38.54 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.889 -0.672 . . . . 1.74 112.136 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -136.27 -54.83 0.75 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.125 0.488 . . . . 1.4099999999999999 110.631 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.78 -94.65 0.5 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.319 -0.855 . . . . 1.0900000000000001 111.213 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 171' ' ' TYR . 0.5 OUTLIER -108.99 160.52 15.95 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.805 -0.698 . . . . 2.3100000000000001 109.626 172.196 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -170.39 165.63 38.89 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.079 -1.057 . . . . 0.58999999999999997 112.997 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 15.9 m -106.7 147.17 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.825 -0.435 . . . . 0.67000000000000004 109.825 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -109.2 117.21 33.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.533 -0.303 . . . . 1.1299999999999999 110.617 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 202' ' ' PRO . . . -67.46 128.65 37.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.525 -0.307 . . . . 0.54000000000000004 110.173 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.481 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -99.54 -9.07 23.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 1.6799999999999999 111.249 -176.858 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 103' ' ' LYS . 20.9 tpt180 -125.85 150.3 47.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.208 0.528 . . . . 3.5 111.448 -176.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.471 ' N ' ' HG3' ' A' ' 102' ' ' ARG . 1.5 tptm -61.32 138.45 58.24 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.866 -1.061 . . . . 2.3999999999999999 111.061 173.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.513 ' HE3' HG13 ' A' ' 200' ' ' ILE . 77.5 mtm -127.86 152.61 47.61 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.607 -0.886 . . . . 1.22 108.607 173.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.7 135.16 54.46 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 123.232 0.332 . . . . 2.3100000000000001 110.563 -174.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.415 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . . . -37.79 112.7 0.23 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 124.872 1.357 . . . . 0.83999999999999997 112.803 -174.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.95 7.26 11.75 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.581 -0.736 . . . . 1.04 111.341 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.464 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -75.37 165.91 24.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.907 0.384 . . . . 2.6200000000000001 110.398 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.461 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 2.4 tmm_? -145.61 131.65 19.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.37 -0.377 . . . . 3.6200000000000001 111.063 -176.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.581 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 4.8 mt -99.48 137.11 38.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.058 -0.719 . . . . 0.53000000000000003 109.058 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.85 -168.21 31.15 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.314 -0.946 . . . . 1.02 112.438 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.45 146.11 86.0 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.736 -1.36 . . . . 2.1000000000000001 112.395 1.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 t -76.49 -18.14 58.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 2.0 110.691 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.4 p -171.79 132.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.213 -0.449 . . . . 2.0299999999999998 110.527 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.87 72.44 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.645 -0.872 . . . . 3.9500000000000002 108.645 175.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.9 p -105.25 110.0 63.88 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.688 -0.687 . . . . 5.21 111.604 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.14 52.29 2.48 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.822 2.348 . . . . 5.0700000000000003 111.32 174.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -142.8 -76.41 0.26 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.07 -0.968 . . . . 7.9900000000000002 109.977 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -176.97 161.16 1.9 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.175 -0.92 . . . . 6.9500000000000002 108.938 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -97.2 119.7 36.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.887 -0.412 . . . . 6.0899999999999999 109.887 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.48 128.51 56.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.924 0.392 . . . . 5.5599999999999996 110.985 -177.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.459 ' HD3' ' HG2' ' A' ' 130' ' ' GLN . 24.5 pttm -67.41 136.24 54.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.625 -0.716 . . . . 7.4199999999999999 111.608 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -84.75 -57.46 3.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.967 -1.015 . . . . 9.0099999999999998 110.902 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 17.3 m -145.15 -64.03 0.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.85 0.315 . . . . 8.8800000000000008 111.85 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -99.35 -170.67 1.94 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.269 0.557 . . . . 7.5999999999999996 112.125 -170.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.467 ' HB3' ' HG3' ' A' ' 130' ' ' GLN . 36.3 p90 -146.13 145.48 30.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.052 -0.976 . . . . 7.2300000000000004 110.121 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 211' ' ' LYS . . . -139.82 -76.26 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.7 -0.762 . . . . 4.5899999999999999 112.065 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TRP . . . . . 0.648 ' CD1' ' HG2' ' A' ' 129' ' ' GLU . 16.5 p90 -77.38 -36.99 53.0 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.305 -0.998 . . . . 4.9299999999999997 108.305 176.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.648 ' HG2' ' CD1' ' A' ' 128' ' ' TRP . 13.7 pt-20 -160.11 -159.08 0.68 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.845 -1.525 . . . . 7.6500000000000004 107.03 170.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.467 ' HG3' ' HB3' ' A' ' 126' ' ' PHE . 31.8 tt0 -120.83 53.04 1.14 Allowed 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.409 -0.516 . . . . 8.8399999999999999 111.408 -167.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.499 HG13 ' HG3' ' A' ' 129' ' ' GLU . 1.9 pp -139.78 40.67 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.204 0.526 . . . . 6.0499999999999998 111.073 175.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.459 ' HG ' ' CH2' ' A' ' 128' ' ' TRP . 10.0 mp -59.41 100.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.547 -0.751 . . . . 8.5 110.504 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.6 t -106.26 47.55 0.87 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.529 0.681 . . . . 9.8200000000000003 110.897 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -73.92 83.64 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.735 -0.666 . . . . 11.210000000000001 110.033 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.8 p -46.96 112.21 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.642 0.734 . . . . 10.84 111.836 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -106.37 -74.8 0.65 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.451 -0.795 . . . . 13.25 110.525 -176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.3 p -94.45 -26.44 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.171 -0.468 . . . . 13.890000000000001 110.178 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.7 t 57.6 80.11 0.3 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.095 -0.502 . . . . 14.050000000000001 111.313 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -86.18 163.14 10.0 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.408 2.072 . . . . 14.41 111.832 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 61.1 33.81 19.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.987 -0.551 . . . . 14.44 111.342 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.49 -178.97 4.06 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.703 -0.48 . . . . 15.9 109.703 176.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.97 -45.45 3.2 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.656 -0.783 . . . . 15.6 111.592 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 6.0 p -95.52 32.06 1.88 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.454 0.645 . . . . 15.6 110.509 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.7 mt -108.92 -44.21 6.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.32 -0.854 . . . . 13.85 109.319 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.9 p -77.71 54.05 1.18 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.395 -0.82 . . . . 13.19 111.08 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -85.93 -19.14 30.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.988 0.899 . . . . 15.67 108.752 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 147' ' ' ILE . 19.3 pt -97.08 168.05 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.02 -1.445 . . . . 13.77 109.337 175.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 28.8 m -117.72 114.13 22.87 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.817 0.341 . . . . 13.619999999999999 110.332 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -81.3 85.22 6.44 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.239 -0.437 . . . . 13.02 110.306 178.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -65.78 121.56 15.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.925 -0.58 . . . . 14.68 109.997 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.7 mt -109.16 35.04 3.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.209 -0.451 . . . . 13.550000000000001 110.521 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.96 -89.84 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.255 -0.974 . . . . 15.800000000000001 112.675 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.8 t -168.43 -36.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.226 0.536 . . . . 17.079999999999998 109.985 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -107.06 -83.02 0.54 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.775 -0.648 . . . . 18.43 110.232 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -135.87 -178.33 5.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.544 -0.753 . . . . 18.530000000000001 109.925 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -145.68 120.56 9.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.109 0.481 . . . . 14.32 110.985 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 63.3 m -100.33 46.7 0.95 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.338 0.59 . . . . 14.51 109.737 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.87 147.33 13.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.783 -0.644 . . . . 13.06 110.366 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -92.79 139.99 29.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.008 -0.542 . . . . 10.33 110.24 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -124.17 -76.96 0.59 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.81 0.338 . . . . 9.8800000000000008 110.863 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -80.75 -8.44 59.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.995 0.426 . . . . 10.23 110.931 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -77.08 -20.36 55.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.792 -0.64 . . . . 9.0600000000000005 110.609 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.74 90.47 4.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.012 -0.54 . . . . 6.1900000000000004 111.09 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.65 -105.66 0.19 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.098 -0.801 . . . . 3.9700000000000002 111.098 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.418 ' C ' ' H ' ' A' ' 167' ' ' SER . . . 47.95 79.89 0.06 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.184 0.593 . . . . 2.6299999999999999 112.221 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.03 26.88 1.16 Allowed Glycine 0 CA--C 1.519 0.282 0 CA-C-N 116.015 -0.539 . . . . 1.3 112.913 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 5.7 m -66.22 -23.83 66.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.965 0.412 . . . . 1.8200000000000001 110.352 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.449 ' O ' ' HB2' ' A' ' 171' ' ' TYR . 48.5 p-90 -86.0 -24.82 26.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.929 -0.578 . . . . 0.69999999999999996 110.548 176.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 26.5 mt -76.89 -25.83 53.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.66000000000000003 111.189 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.502 ' HE2' ' CE2' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -72.25 -1.57 15.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.049 0.452 . . . . 1.48 110.447 176.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.502 ' CE2' ' HE2' ' A' ' 170' ' ' LYS . 17.8 m-85 -82.2 -38.19 24.95 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.178 -0.464 . . . . 1.97 111.128 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -73.27 111.77 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.421 -0.511 . . . . 0.67000000000000004 109.654 177.382 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.459 ' O ' ' HB ' ' A' ' 208' ' ' VAL . 3.3 mmp_? -114.22 -155.02 0.56 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.936 -0.574 . . . . 4.3399999999999999 110.975 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 39.4 t -61.83 148.67 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 1.0700000000000001 111.552 -173.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.408 ' HB2' ' CD1' ' A' ' 183' ' ' LEU . . . -50.84 121.91 6.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.026 -0.988 . . . . 0.70999999999999996 112.405 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 2.4 p -73.82 -9.74 58.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.573 -0.739 . . . . 1.8799999999999999 110.686 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.3 t -148.19 138.28 22.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.637 -0.71 . . . . 1.6299999999999999 109.562 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' CYS . . . . . 0.632 ' HA ' ' OE1' ' A' ' 181' ' ' GLN . 8.5 p -86.22 -13.99 45.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.211 0.529 . . . . 1.96 111.027 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.67 -8.69 51.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.018 -0.537 . . . . 2.4199999999999999 110.319 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -110.81 19.61 18.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.557 -0.747 . . . . 2.1200000000000001 111.859 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.632 ' OE1' ' HA ' ' A' ' 178' ' ' CYS . 15.1 mm100 -52.89 116.07 2.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.508 0.671 . . . . 1.3500000000000001 111.958 -173.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.767 ' ND2' HD11 ' A' ' 200' ' ' ILE . 28.7 t30 -152.94 37.05 0.49 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.097 -0.956 . . . . 1.6799999999999999 108.787 177.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.725 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -117.85 121.08 39.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.545 -0.752 . . . . 0.81000000000000005 111.027 -173.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 84.1 m -150.08 146.71 27.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.89 0.376 . . . . 0.51000000000000001 110.938 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.485 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 51.7 tpp -109.88 145.85 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 1.3500000000000001 110.093 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 8.4 m -132.05 140.05 48.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.198 0.523 . . . . 1.73 111.187 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.418 ' HG2' HD13 ' A' ' 192' ' ' ILE . 0.5 OUTLIER -116.44 104.47 11.48 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.953 -0.758 . . . . 1.9299999999999999 108.953 177.765 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 21.7 pt -141.04 145.45 25.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.019 -0.537 . . . . 1.1100000000000001 110.457 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.5 m 67.73 30.67 6.3 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.193 0.521 . . . . 1.8600000000000001 110.916 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 62.13 22.24 12.99 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.089 -0.959 . . . . 2.8300000000000001 111.926 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 193' ' ' TYR . 4.2 pt20 -141.05 167.28 22.56 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.16 -0.473 . . . . 1.75 109.8 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.418 HD13 ' HG2' ' A' ' 187' ' ' GLN . 43.5 mm -92.73 137.03 23.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.279 -0.418 . . . . 1.01 110.72 -175.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.461 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 27.8 m-85 -135.85 150.54 49.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.317 0.579 . . . . 3.9399999999999999 111.508 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 6.6 m-85 -100.71 113.72 26.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.364 -0.835 . . . . 0.92000000000000004 109.588 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.09 122.74 47.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.947 0.403 . . . . 1.1100000000000001 110.195 -176.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.47 ' CG1' HD21 ' A' ' 182' ' ' ASN . 1.9 t -94.41 152.5 3.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.775 0.798 . . . . 0.69999999999999996 109.96 -177.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.2 -54.5 7.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.606 -1.179 . . . . 0.62 111.395 -166.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.588 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -135.05 168.17 19.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.847 -0.615 . . . . 1.3799999999999999 111.336 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 104' ' ' MET . 2.0 m-20 -46.36 125.87 7.3 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.143 0.902 . . . . 2.23 112.531 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.767 HD11 ' ND2' ' A' ' 182' ' ' ASN . 27.6 mm -94.4 134.95 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.72 -0.673 . . . . 0.88 111.319 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 50.6 mt-10 -105.35 125.79 32.58 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.481 -0.781 . . . . 2.0600000000000001 109.518 174.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 87.8 Cg_exo -41.52 113.47 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.816 3.011 . . . . 0.51000000000000001 113.551 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 120.43 6.37 9.72 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.815 -0.707 . . . . 0.69999999999999996 113.054 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.7 pt-20 -118.26 123.8 46.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.193 0.497 . . . . 1.27 110.694 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.5 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -109.51 91.17 3.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.919 -0.582 . . . . 2.9199999999999999 111.278 176.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.579 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 2.3 mm? -125.98 95.0 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.388 -0.525 . . . . 0.90000000000000002 110.076 172.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.514 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.7 mm? -148.63 113.9 5.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.857 0.463 . . . . 0.53000000000000003 109.883 172.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.656 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.7 p -156.65 159.41 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.676 0.671 . . . . 0.91000000000000003 111.421 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 86.6 t60 -106.56 111.98 24.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.313 -0.625 . . . . 1.55 109.313 164.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 16.9 m -98.12 136.76 27.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.869 -0.419 . . . . 2.5600000000000001 109.869 173.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.415 ' HD3' ' HA2' ' A' ' 127' ' ' GLY . 27.0 pttt -98.39 113.99 26.17 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.422 0.629 . . . . 5.3600000000000003 110.488 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -105.2 12.77 31.55 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.551 -0.749 . . . . 5.7999999999999998 111.401 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -171.75 51.71 0.18 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.201 -0.999 . . . . 5.6100000000000003 112.539 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 31.3 t -132.43 -75.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.019 0.437 . . . . 6.3099999999999996 110.268 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.509 ' H ' ' HD2' ' A' ' 216' ' ' PRO . 86.1 t80 -98.98 -56.5 0.17 Allowed Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.14 -0.482 . . . . 8.8300000000000001 111.687 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.509 ' HD2' ' H ' ' A' ' 215' ' ' TYR . 33.0 Cg_endo -65.73 -43.74 9.34 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.529 1.486 . . . . 7.7800000000000002 112.185 -176.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.6 mp -107.71 77.16 1.11 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.326 0.584 . . . . 8.0199999999999996 109.559 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -169.71 173.67 43.93 Favored Glycine 0 C--N 1.312 -0.779 0 CA-C-N 115.301 -0.863 . . . . 8.6400000000000006 111.742 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 16.8 p -95.89 57.74 1.85 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.46 0.647 . . . . 9.7200000000000006 110.252 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 29.3 m -85.12 146.37 45.2 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.378 -0.828 . . . . 9.6199999999999992 111.149 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.448 ' HB2' ' HD3' ' A' ' 222' ' ' PRO . 85.8 Cg_exo -43.85 -50.59 7.16 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.253 2.635 . . . . 11.65 114.52 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' A' ' 221' ' ' PRO . 6.6 Cg_exo -74.79 9.17 2.04 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.152 1.901 . . . . 13.109999999999999 113.098 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -74.81 -35.46 50.56 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.918 -0.873 . . . . 14.029999999999999 110.918 175.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 49.3 tp -153.99 124.86 7.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.733 -0.469 . . . . 16.100000000000001 109.733 175.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -137.98 16.32 2.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.109 0.481 . . . . 17.699999999999999 110.459 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.679 -0.676 . . . . 18.899999999999999 110.467 179.794 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.223 -0.351 . . . . 33.259999999999998 112.223 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 26.7 t -83.38 165.22 19.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.694 0.283 . . . . 33.920000000000002 110.243 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.59 81.82 1.39 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.917 -0.659 . . . . 32.350000000000001 111.95 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 55.37 76.37 0.51 Allowed Pre-proline 0 N--CA 1.464 0.269 0 C-N-CA 122.485 0.314 . . . . 31.649999999999999 110.915 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.78 143.53 80.36 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.925 2.416 . . . . 29.989999999999998 112.854 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.2 m -113.11 134.13 54.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 28.920000000000002 110.269 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 m -82.89 136.45 34.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.094 0.473 . . . . 26.940000000000001 110.755 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -93.59 20.18 7.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.821 -0.627 . . . . 25.829999999999998 109.826 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -84.1 62.0 6.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.443 -0.799 . . . . 23.530000000000001 111.638 -172.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -115.48 44.13 1.92 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.32 -0.622 . . . . 21.640000000000001 109.32 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.6 p -123.11 93.33 48.31 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.243 -0.889 . . . . 19.420000000000002 110.925 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.2 107.82 0.87 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.69 2.26 . . . . 17.170000000000002 112.49 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -95.36 5.45 51.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.738 -0.665 . . . . 17.469999999999999 110.248 177.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.7 24.74 11.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.806 -0.634 . . . . 15.630000000000001 110.975 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.27 -177.78 18.71 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.749 . . . . 12.039999999999999 112.093 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.6 p -121.31 88.94 46.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.922 0.391 . . . . 10.67 111.296 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.97 135.03 12.16 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.69 2.26 . . . . 9.6899999999999995 112.214 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -87.28 149.88 24.26 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.799 -0.445 . . . . 7.7000000000000002 109.799 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.86 98.71 4.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.017 0.437 . . . . 8.1400000000000006 111.03 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.07 128.6 64.54 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.751 -0.659 . . . . 5.96 109.905 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.57 -168.48 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.642 2.228 . . . . 6.1299999999999999 112.742 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.06 -38.34 73.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.285 -0.416 . . . . 6.5300000000000002 110.732 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -90.43 109.88 20.99 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.725 -0.472 . . . . 5.0099999999999998 109.725 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.1 pp -78.12 141.57 62.83 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 121.026 0.441 . . . . 4.2300000000000004 110.564 176.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.43 -5.27 13.6 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.18 2.587 . . . . 4.1200000000000001 113.821 -172.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -79.1 -65.79 0.95 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.914 0.387 . . . . 3.8199999999999998 110.123 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.455 ' H ' ' CD1' ' A' ' 74' ' ' ILE . 37.1 t70 54.23 71.3 0.53 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.126 -0.943 . . . . 3.1600000000000001 110.326 -177.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.7 mt -89.82 120.0 69.41 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.304 -0.862 . . . . 2.4500000000000002 109.008 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.658 ' O ' ' HA2' ' A' ' 164' ' ' GLY . 18.2 Cg_endo -58.11 122.05 11.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.606 2.204 . . . . 1.75 112.323 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.499 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.46 142.65 45.99 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.875 -0.602 . . . . 1.01 109.979 178.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.95 142.69 19.21 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.388 2.725 . . . . 0.72999999999999998 112.686 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.67 -16.32 47.75 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.581 -0.736 . . . . 1.04 112.251 -175.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -68.43 -23.09 64.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.958 -0.565 . . . . 1.6599999999999999 110.557 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -120.9 161.86 20.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.223 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.59 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 33.5 tt0 -139.15 130.53 26.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.814 -0.354 . . . . 2.27 110.922 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 171' ' ' TYR . 5.2 tt -85.68 127.74 34.58 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.351 0.596 . . . . 0.79000000000000004 110.484 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -148.76 140.59 23.71 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.127 -0.942 . . . . 3.21 110.031 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -82.79 112.25 19.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.04 0.447 . . . . 2.46 109.88 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.5 m -156.23 94.99 1.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.982 -0.748 . . . . 1.5800000000000001 108.982 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.9 t -62.05 105.85 0.64 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.128 0.489 . . . . 1.8600000000000001 111.474 -174.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.452 HG21 ' HD3' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -99.56 117.25 64.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.018 -0.734 . . . . 1.45 109.018 172.772 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.77 121.71 9.7 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.152 2.568 . . . . 1.6100000000000001 112.741 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.11 -15.39 36.55 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.804 -0.712 . . . . 1.74 112.338 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.446 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -133.91 -59.78 0.83 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.966 0.412 . . . . 1.4099999999999999 111.299 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.73 -116.09 3.0 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.773 -0.727 . . . . 1.0900000000000001 112.216 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.29 158.43 16.12 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 122.455 0.302 . . . . 2.3100000000000001 110.766 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 171' ' ' TYR . . . -151.26 172.25 30.83 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.313 -0.946 . . . . 0.58999999999999997 113.465 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 205' ' ' GLU . 14.3 m -117.64 111.19 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.399 0.619 . . . . 0.67000000000000004 109.718 175.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -82.69 126.74 32.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.749 -0.66 . . . . 1.1299999999999999 111.383 -170.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.31 114.74 9.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.394 -0.595 . . . . 0.54000000000000004 109.394 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.59 ' CE ' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -94.58 0.46 55.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.002 -0.74 . . . . 1.6799999999999999 109.002 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -124.66 157.53 35.33 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.675 -1.148 . . . . 3.5 108.831 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.613 ' H ' ' HD2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -90.28 155.1 19.23 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.671 -0.492 . . . . 2.3999999999999999 109.671 -177.16 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.439 ' HE3' HG13 ' A' ' 200' ' ' ILE . 60.3 mtm -135.43 148.44 49.3 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.549 -0.908 . . . . 1.22 108.549 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.87 146.99 39.22 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.995 -0.282 . . . . 2.3100000000000001 110.623 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.26 121.81 2.0 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 124.301 1.001 . . . . 0.83999999999999997 113.024 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.59 7.49 11.99 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.367 -0.833 . . . . 1.04 111.318 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.599 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.9 OUTLIER -79.78 156.2 27.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.264 0.554 . . . . 2.6200000000000001 110.799 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.525 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 7.3 tmm_? -145.49 135.89 24.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.685 -0.689 . . . . 3.6200000000000001 110.355 -176.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 6.2 mt -101.1 151.38 21.89 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.82 -0.437 . . . . 0.53000000000000003 109.82 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.14 -174.01 44.8 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.609 -0.597 . . . . 1.02 111.609 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -83.02 141.37 42.75 Favored 'Cis proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.982 -1.674 . . . . 2.1000000000000001 112.44 -2.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -88.43 -8.37 55.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.604 0.716 . . . . 2.0 109.513 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.2 m -121.34 132.05 71.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.367 -0.833 . . . . 2.0299999999999998 109.489 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.5 m -133.52 -164.77 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.338 -0.392 . . . . 3.9500000000000002 110.772 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.469 HG23 ' HG2' ' A' ' 118' ' ' ARG . 21.4 m -52.45 152.69 6.05 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.753 -0.658 . . . . 5.21 111.974 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 116' ' ' VAL . 6.0 Cg_exo -78.36 59.82 7.25 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.91 2.407 . . . . 5.0700000000000003 112.507 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.469 ' HG2' HG23 ' A' ' 116' ' ' VAL . 16.0 ptt-85 -169.23 165.71 10.86 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.82 -0.807 . . . . 7.9900000000000002 108.82 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 53.4 -147.06 0.5 Allowed 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.45 0.469 . . . . 6.9500000000000002 111.042 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 64.49 -83.41 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.182 0.593 . . . . 6.0899999999999999 111.961 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 56.32 93.44 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.162 0.585 . . . . 5.5599999999999996 111.188 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -59.19 130.82 48.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.54 -0.755 . . . . 7.4199999999999999 111.447 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -95.44 -56.85 2.57 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.397 -1.274 . . . . 9.0099999999999998 110.372 -175.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 m -101.47 -83.83 0.45 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.177 -0.465 . . . . 8.8800000000000008 109.784 176.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.5 t70 60.2 -170.61 0.14 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.127 -0.488 . . . . 7.5999999999999996 111.654 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -90.61 -30.55 17.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 122.105 0.955 . . . . 7.2300000000000004 109.213 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.92 33.42 26.95 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 113.918 -1.492 . . . . 4.5899999999999999 113.292 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TRP . . . . . 0.443 ' HZ2' HG23 ' A' ' 131' ' ' ILE . 2.1 p90 -60.12 -46.34 89.96 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.358 -0.608 . . . . 4.9299999999999997 109.358 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 173.88 -171.03 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.347 -1.353 . . . . 7.6500000000000004 107.347 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -121.47 108.36 13.55 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.129 0.49 . . . . 8.8399999999999999 110.678 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.613 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -59.38 -20.63 18.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.357 -0.838 . . . . 6.0499999999999998 111.378 176.492 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 132' ' ' LEU . 0.3 OUTLIER -81.16 68.26 7.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.812 0.815 . . . . 8.5 109.599 174.023 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.8 t -122.15 28.33 7.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.672 -1.149 . . . . 9.8200000000000003 109.274 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -141.73 89.43 2.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.827 -1.078 . . . . 11.210000000000001 109.461 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.57 141.83 15.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.021 -0.536 . . . . 10.84 110.592 -177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -73.64 93.55 2.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.002 -0.544 . . . . 13.25 110.628 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.4 -39.92 82.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.558 -0.746 . . . . 13.890000000000001 109.62 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t 48.32 74.99 0.71 Allowed Pre-proline 0 C--O 1.236 0.365 0 CA-C-N 115.578 -0.737 . . . . 14.050000000000001 110.781 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -70.99 85.91 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.925 2.417 . . . . 14.41 111.553 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -85.61 59.24 5.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.753 -0.658 . . . . 14.44 111.408 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -70.96 -38.52 72.81 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.204 -0.665 . . . . 15.9 109.204 174.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -109.0 -172.59 21.07 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.724 -0.95 . . . . 15.6 110.724 172.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 58.7 m -83.4 60.39 5.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.182 0.515 . . . . 15.6 110.839 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 10.5 mt -87.42 54.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.638 0.732 . . . . 13.85 110.317 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.4 t -121.92 12.4 10.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.709 0.766 . . . . 13.19 109.801 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -83.76 -10.38 58.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.274 -0.876 . . . . 15.67 109.813 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.41 HG13 ' H ' ' A' ' 147' ' ' ILE . 1.9 pp -81.91 172.98 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.88 -1.055 . . . . 13.77 111.6 -177.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 50.5 m -144.47 64.12 1.31 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.185 -0.461 . . . . 13.619999999999999 110.252 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 69.11 143.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.447 -0.797 . . . . 13.02 111.868 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -88.64 68.01 8.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.64 0.733 . . . . 14.68 109.83 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.59 105.32 4.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.757 -1.11 . . . . 13.550000000000001 109.809 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 118.74 74.35 0.45 Allowed Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.607 -0.997 . . . . 15.800000000000001 110.607 -174.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.0 t -151.65 -60.56 0.17 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.684 0.278 . . . . 17.079999999999998 110.713 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -123.65 -83.03 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 18.43 111.614 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.0 23.62 6.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.022 0.439 . . . . 18.530000000000001 110.853 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -143.15 112.57 6.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.919 -0.582 . . . . 14.32 110.753 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 42.0 t -151.53 -70.17 0.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.11 -0.495 . . . . 14.51 110.755 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -96.78 120.9 46.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.837 0.351 . . . . 13.06 110.919 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 49.94 48.26 22.08 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.134 -0.939 . . . . 10.33 111.561 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.76 -39.71 76.52 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.0 -1.0 . . . . 9.8800000000000008 111.076 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -111.15 16.47 21.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.846 -0.615 . . . . 10.23 109.744 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -121.73 -39.73 2.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.991 -0.55 . . . . 9.0600000000000005 112.239 -171.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.4 21.0 3.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.363 0.601 . . . . 6.1900000000000004 111.247 -178.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.658 ' HA2' ' O ' ' A' ' 79' ' ' PRO . . . 136.63 166.37 10.82 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.359 -0.837 . . . . 3.9700000000000002 112.173 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -117.36 23.08 12.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.415 0.626 . . . . 2.6299999999999999 110.334 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 77.85 -59.49 3.84 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.6 -0.727 . . . . 1.3 113.302 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.4 t -71.39 -14.42 62.17 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.547 0.203 . . . . 1.8200000000000001 111.547 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.416 ' HB2' HG22 ' A' ' 80' ' ' ILE . 48.5 p-90 -56.94 -23.46 45.59 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.027 0.441 . . . . 0.69999999999999996 111.734 -176.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 32.1 mt -73.45 -12.83 60.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.241 0.46 . . . . 0.66000000000000003 112.241 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.431 ' C ' ' HD2' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -66.12 -14.37 61.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.012 0.434 . . . . 1.48 110.155 177.289 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.524 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 41.5 m-85 -72.61 -31.43 65.16 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 115.782 -0.644 . . . . 1.97 111.887 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.775 HG21 ' HB2' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -66.28 116.37 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.317 -0.553 . . . . 0.67000000000000004 110.175 -177.268 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.452 ' HD3' HG21 ' A' ' 91' ' ' ILE . 18.0 ptt180 -75.83 155.79 35.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.573 -0.74 . . . . 4.3399999999999999 111.83 -174.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.607 ' HB ' HG11 ' A' ' 208' ' ' VAL . 2.7 p -83.82 147.01 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.371 -0.831 . . . . 1.0700000000000001 109.352 172.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -45.88 123.72 4.71 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 123.933 0.771 . . . . 0.70999999999999996 112.391 -174.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 51.8 t -80.42 -9.43 59.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 1.8799999999999999 109.504 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 13.0 t -126.27 138.43 53.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.166 -0.924 . . . . 1.6299999999999999 109.21 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 61.3 m -77.48 -15.88 59.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.876 0.37 . . . . 1.96 111.093 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -89.68 0.62 56.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.016 0.436 . . . . 2.4199999999999999 110.578 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.18 17.88 21.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.865 -0.607 . . . . 2.1200000000000001 111.619 -172.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -59.16 113.5 2.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.126 0.489 . . . . 1.3500000000000001 111.04 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.815 ' H ' HD12 ' A' ' 183' ' ' LEU . 62.4 t30 -146.64 29.28 1.03 Allowed 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.845 -0.798 . . . . 1.6799999999999999 108.845 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.815 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.4 OUTLIER -118.76 121.59 40.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.687 -0.688 . . . . 0.81000000000000005 111.113 -170.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.6 m -150.2 133.46 16.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.282 0.563 . . . . 0.51000000000000001 111.518 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 46.6 ttm -100.14 135.09 42.11 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.146 -0.687 . . . . 1.3500000000000001 109.146 174.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 15.2 m -117.84 131.69 56.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.181 0.515 . . . . 1.73 111.575 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.46 103.63 14.03 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.28 -1.007 . . . . 1.9299999999999999 108.28 174.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 22.8 pt -138.4 144.18 30.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.734 -0.666 . . . . 1.1100000000000001 109.839 -177.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 m 61.27 28.75 18.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.213 0.53 . . . . 1.8600000000000001 110.318 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 56.2 34.86 24.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.121 -0.945 . . . . 2.8300000000000001 111.789 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -142.06 157.64 44.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.626 -0.716 . . . . 1.75 109.619 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.6 mm -94.56 131.32 41.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.301 -0.409 . . . . 1.01 111.264 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.525 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 27.0 m-85 -131.98 157.47 43.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.935 -0.575 . . . . 3.9399999999999999 111.148 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 3.3 m-85 -101.3 113.68 26.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.956 -0.757 . . . . 0.92000000000000004 108.956 173.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -110.22 125.62 53.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.936 0.398 . . . . 1.1100000000000001 110.012 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.599 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 1.9 t -96.57 151.44 4.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.747 0.784 . . . . 0.69999999999999996 110.202 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 197' ' ' ILE . 0.9 OUTLIER -92.64 -53.8 8.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.543 -1.208 . . . . 0.62 110.591 -167.288 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.504 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -132.0 171.12 13.99 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.085 -0.961 . . . . 1.3799999999999999 110.678 175.638 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -53.9 143.84 20.37 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.87 0.693 . . . . 2.23 112.87 -171.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.439 HG13 ' HE3' ' A' ' 104' ' ' MET . 31.4 mm -99.85 133.46 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.594 -0.73 . . . . 0.88 110.387 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -95.13 131.36 30.2 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 109.372 -0.603 . . . . 2.0600000000000001 109.372 173.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -50.95 116.2 2.49 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.605 2.203 . . . . 0.51000000000000001 112.042 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 123.26 -12.86 8.44 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.666 -0.778 . . . . 0.69999999999999996 112.948 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.68 119.17 21.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.607 0.703 . . . . 1.27 111.032 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -113.05 96.72 6.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.283 -0.871 . . . . 2.9199999999999999 111.484 177.177 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.474 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.1 mm? -114.14 99.07 7.35 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.52 -0.872 . . . . 0.90000000000000002 110.524 177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.775 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.5 mm? -147.19 112.39 5.51 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.327 0.651 . . . . 0.53000000000000003 109.502 174.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.695 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 2.6 p -156.64 161.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.392 -0.595 . . . . 0.91000000000000003 109.392 -177.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -123.31 105.71 10.08 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.002 -0.74 . . . . 1.55 109.002 162.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 53.5 t -132.82 95.22 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.277 -0.638 . . . . 2.5600000000000001 109.277 173.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -123.11 139.44 54.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.986 -0.552 . . . . 5.3600000000000003 109.66 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -96.87 2.21 51.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.778 0.323 . . . . 5.7999999999999998 111.074 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -132.8 33.98 2.54 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.44 -0.886 . . . . 5.6100000000000003 113.035 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 65.3 t -128.54 -77.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.788 0.327 . . . . 6.3099999999999996 111.014 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.541 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 56.3 t80 -65.19 -53.76 38.02 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 112.387 0.514 . . . . 8.8300000000000001 112.387 -176.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 11.4 Cg_endo -52.21 -37.85 70.71 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.921 2.414 . . . . 7.7800000000000002 112.731 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 mp -77.81 20.24 0.36 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.611 -0.722 . . . . 8.0199999999999996 112.242 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 93.78 20.98 29.77 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.873 -0.68 . . . . 8.6400000000000006 112.644 176.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.1 m 60.92 67.82 0.79 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.549 0.69 . . . . 9.7200000000000006 110.006 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.85 154.18 72.98 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.255 -0.884 . . . . 9.6199999999999992 110.374 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' A' ' 222' ' ' PRO . 28.5 Cg_endo -64.06 141.95 78.93 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.404 2.07 . . . . 11.65 111.616 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 221' ' ' PRO . 11.7 Cg_exo -71.52 42.31 0.47 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.185 2.59 . . . . 13.109999999999999 112.974 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -143.91 18.71 2.17 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.939 -0.865 . . . . 14.029999999999999 110.939 176.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 42.5 tp -94.07 129.65 40.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.631 -0.285 . . . . 16.100000000000001 110.395 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -103.24 -16.2 15.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.96 0.409 . . . . 17.699999999999999 110.848 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.592 -0.718 . . . . 18.899999999999999 110.259 179.503 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 112.003 -0.439 . . . . 33.259999999999998 112.003 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.6 m -73.22 -21.8 60.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.835 0.35 . . . . 33.920000000000002 110.925 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.88 49.77 3.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.044 -0.598 . . . . 32.350000000000001 112.291 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.431 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 83.8 t80 -69.73 -44.96 24.57 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 111.731 0.271 . . . . 31.649999999999999 111.731 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 54' ' ' PHE . 21.6 Cg_exo -65.76 -15.37 48.87 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.012 1.808 . . . . 29.989999999999998 111.783 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 m -74.87 78.2 2.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.504 0.669 . . . . 28.920000000000002 110.246 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.6 t -135.77 96.28 3.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.242 -0.89 . . . . 26.940000000000001 109.208 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -86.17 28.14 0.85 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.288 0.566 . . . . 25.829999999999998 110.741 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -87.76 59.57 5.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.922 -0.581 . . . . 23.530000000000001 110.6 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -91.17 58.57 3.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.979 -0.555 . . . . 21.640000000000001 109.681 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.467 ' HB ' ' CG ' ' A' ' 64' ' ' GLU . 11.7 p -118.7 83.48 22.35 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.762 -0.653 . . . . 19.420000000000002 110.879 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.94 118.74 5.83 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 123.075 2.517 . . . . 17.170000000000002 112.832 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt 50.17 67.27 0.94 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.483 -0.781 . . . . 17.469999999999999 112.825 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.467 ' CG ' ' HB ' ' A' ' 61' ' ' THR . 71.7 mm-40 -69.42 118.15 11.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.174 -0.466 . . . . 15.630000000000001 109.749 173.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.03 -28.83 6.46 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.01 -0.836 . . . . 12.039999999999999 111.01 -174.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 42.7 m -88.99 124.61 64.72 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 109.773 -0.455 . . . . 10.67 109.773 176.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 66' ' ' SER . 23.1 Cg_exo -64.37 102.14 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.59 2.193 . . . . 9.6899999999999995 112.042 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -92.52 126.86 37.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.996 -0.547 . . . . 7.7000000000000002 110.1 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.6 120.82 15.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.348 -0.387 . . . . 8.1400000000000006 110.167 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.47 118.7 39.82 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.234 -0.439 . . . . 5.96 111.249 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -84.91 -157.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.098 2.532 . . . . 6.1299999999999999 112.411 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.1 p -58.45 -40.55 78.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.095 -0.502 . . . . 6.5300000000000002 110.496 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -81.86 110.78 17.47 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.033 0.444 . . . . 5.0099999999999998 110.11 174.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.477 ' O ' HD12 ' A' ' 74' ' ' ILE . 1.8 pp -77.85 142.89 65.77 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.988 -0.551 . . . . 4.2300000000000004 110.847 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.73 39.56 0.77 Allowed 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.755 2.304 . . . . 4.1200000000000001 113.167 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.4 ' CG ' HD13 ' A' ' 74' ' ' ILE . 8.6 mm-40 -83.6 -68.85 0.68 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.318 -0.401 . . . . 3.8199999999999998 110.668 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 52.67 69.99 0.63 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.631 -0.713 . . . . 3.1600000000000001 110.191 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.0 mt -80.36 120.76 80.4 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.475 -0.784 . . . . 2.4500000000000002 110.335 -175.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.17 116.47 4.19 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.287 1.992 . . . . 1.75 111.695 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.531 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -122.03 151.56 58.48 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.051 -0.522 . . . . 1.01 110.292 -178.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 82.7 Cg_exo -48.31 134.37 25.41 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.195 2.596 . . . . 0.72999999999999998 112.441 175.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.69 -20.94 66.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.51 -0.768 . . . . 1.04 112.225 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -68.62 -8.26 40.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.442 0.534 . . . . 1.6599999999999999 112.442 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.438 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 7.4 m-85 -139.93 152.39 46.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' A' ' 87' ' ' ARG . 35.0 mt-10 -113.63 126.68 55.53 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.782 -0.367 . . . . 2.27 111.544 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.02 127.68 34.7 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.774 -0.824 . . . . 0.79000000000000004 108.774 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' A' ' 85' ' ' GLU . 99.7 mtt180 -144.22 147.14 33.22 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.651 -0.704 . . . . 3.21 109.848 -174.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -82.3 112.3 19.16 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.862 -0.792 . . . . 2.46 108.862 172.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 23.3 t -164.9 140.78 5.62 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.366 -0.605 . . . . 1.5800000000000001 109.366 -176.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 m -99.34 107.32 19.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.8 0.333 . . . . 1.8600000000000001 110.692 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -105.9 120.46 48.99 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.427 -0.583 . . . . 1.45 109.427 175.245 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 91' ' ' ILE . 50.7 Cg_exo -56.02 123.31 13.53 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.031 2.487 . . . . 1.6100000000000001 113.312 -176.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.75 -26.82 14.68 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.95 -0.643 . . . . 1.74 112.394 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.441 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -117.55 -57.96 2.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.212 0.53 . . . . 1.4099999999999999 110.604 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.06 -120.13 4.13 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 111.199 -0.761 . . . . 1.0900000000000001 111.199 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -87.17 127.81 35.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.387 -0.598 . . . . 2.3100000000000001 109.387 173.048 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -129.2 157.47 21.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.295 -0.955 . . . . 0.58999999999999997 113.053 -172.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 98' ' ' VAL . 35.6 m -97.52 114.61 35.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.597 0.713 . . . . 0.67000000000000004 109.259 173.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -82.19 115.4 21.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.738 -0.665 . . . . 1.1299999999999999 110.812 -170.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.57 114.78 12.2 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.331 -0.849 . . . . 0.54000000000000004 109.981 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.424 ' CD ' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -95.09 8.58 42.54 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.975 0.893 . . . . 1.6799999999999999 109.052 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 50.5 ttp85 -125.66 153.42 43.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.168 -1.378 . . . . 3.5 108.111 172.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.715 ' HB2' ' O ' ' A' ' 200' ' ' ILE . 0.0 OUTLIER -87.32 126.52 34.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.589 0.709 . . . . 2.3999999999999999 109.475 -179.513 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.708 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 25.8 mtm -94.57 138.92 31.86 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.483 -0.562 . . . . 1.22 109.483 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 10.9 pt-20 -120.34 175.14 6.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.976 0.417 . . . . 2.3100000000000001 111.945 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.57 125.65 17.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 0.83999999999999997 112.955 -175.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.27 -14.74 62.12 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.91 -0.662 . . . . 1.04 114.274 168.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 6.7 pt-20 -78.3 158.62 28.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.79 0.795 . . . . 2.6200000000000001 111.109 -176.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.664 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 8.5 ttm180 -119.59 143.86 47.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.471 -0.786 . . . . 3.6200000000000001 110.654 -176.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.438 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 3.9 mt -101.34 146.99 26.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.247 -0.649 . . . . 0.53000000000000003 109.247 172.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.83 -127.82 7.74 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.45 -0.881 . . . . 1.02 112.892 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.01 158.63 69.17 Favored 'Cis proline' 0 N--CA 1.477 0.55 0 C-N-CA 123.622 -1.408 . . . . 2.1000000000000001 112.854 1.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t -81.78 -19.57 41.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.059 -0.519 . . . . 2.0 110.838 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.1 m -142.66 152.78 17.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.018 -0.537 . . . . 2.0299999999999998 109.91 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.8 p -134.53 29.56 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 122.376 1.084 . . . . 3.9500000000000002 109.575 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.0 p -103.32 110.11 63.07 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 114.864 -1.062 . . . . 5.21 111.06 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -81.3 80.84 2.84 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.715 2.276 . . . . 5.0700000000000003 112.816 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -124.77 -82.96 0.64 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.1 -0.5 . . . . 7.9900000000000002 110.882 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -172.07 -43.18 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.337 0.589 . . . . 6.9500000000000002 110.192 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.18 153.55 49.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.594 -0.73 . . . . 6.0899999999999999 109.713 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.26 90.38 2.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.396 0.617 . . . . 5.5599999999999996 110.19 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 124' ' ' THR . 19.8 ptmt -112.04 153.38 26.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.238 -0.892 . . . . 7.4199999999999999 111.491 -177.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.448 ' HB2' ' H ' ' A' ' 124' ' ' THR . 6.6 mt-10 -85.53 -76.64 0.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.816 -0.809 . . . . 9.0099999999999998 108.816 175.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.497 ' O ' ' HE2' ' A' ' 122' ' ' LYS . 32.5 m -113.7 -72.18 0.72 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.309 -0.859 . . . . 8.8800000000000008 109.138 174.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -179.1 -53.94 0.01 OUTLIER 'General case' 0 C--N 1.338 0.069 0 CA-C-O 121.214 0.531 . . . . 7.5999999999999996 111.218 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.443 ' HA ' HG11 ' A' ' 214' ' ' VAL . 67.9 m-85 -84.82 10.65 10.95 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.213 0.82 . . . . 7.2300000000000004 113.213 -170.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.99 -28.14 73.42 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 116.187 -0.461 . . . . 4.5899999999999999 113.256 -177.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TRP . . . . . 0.512 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 0.3 OUTLIER -150.03 -51.51 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.188 0.518 . . . . 4.9299999999999997 110.36 -179.441 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -175.37 -179.25 1.26 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.363 -0.835 . . . . 7.6500000000000004 108.949 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -106.38 90.3 3.31 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.076 -0.712 . . . . 8.8399999999999999 109.076 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.427 HD12 ' CZ2' ' A' ' 128' ' ' TRP . 0.2 OUTLIER -67.74 130.48 33.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.78 -0.645 . . . . 6.0499999999999998 110.552 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.95 55.05 0.88 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.169 0.985 . . . . 8.5 110.234 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.9 t -119.98 21.84 11.71 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.2 -1.364 . . . . 9.8200000000000003 109.511 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.12 61.31 6.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.653 -1.158 . . . . 11.210000000000001 110.221 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.64 121.63 18.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.11 -0.95 . . . . 10.84 111.053 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -89.99 78.67 6.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.275 0.56 . . . . 13.25 110.018 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.89 -24.0 19.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.744 0.783 . . . . 13.890000000000001 109.356 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.3 t -131.73 116.83 16.11 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-N 115.093 -0.958 . . . . 14.050000000000001 108.828 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -43.58 109.3 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.401 2.734 . . . . 14.41 112.074 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -119.18 6.42 11.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.872 -0.604 . . . . 14.44 111.602 -172.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -76.58 115.07 15.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.974 0.416 . . . . 15.9 110.286 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.61 -150.12 22.31 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.411 -0.676 . . . . 15.6 111.411 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 46.2 t -85.83 93.54 8.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.997 0.427 . . . . 15.6 110.532 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.7 mt -73.02 -39.36 57.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.084 -0.71 . . . . 13.85 109.084 174.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -157.78 138.78 13.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.364 -0.834 . . . . 13.19 109.818 175.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -116.52 -10.33 11.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.292 0.568 . . . . 15.67 110.0 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 28.3 pt -86.5 165.37 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.553 -0.749 . . . . 13.77 110.385 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.5 p -134.21 119.36 18.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.153 -0.476 . . . . 13.619999999999999 110.191 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -77.32 132.04 38.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.053 -0.522 . . . . 13.02 110.453 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -123.17 125.15 44.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.159 -0.473 . . . . 14.68 110.169 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.42 35.41 0.71 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.042 -0.526 . . . . 13.550000000000001 110.715 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.58 ' HA2' ' O ' ' A' ' 156' ' ' PHE . . . -147.21 69.71 0.36 Allowed Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.778 -0.929 . . . . 15.800000000000001 110.778 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.5 p -145.49 -65.29 0.32 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.668 0.27 . . . . 17.079999999999998 111.64 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -78.32 -83.29 0.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.416 -0.356 . . . . 18.43 111.423 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.413 ' HD2' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -127.54 -0.43 6.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.916 0.389 . . . . 18.530000000000001 111.045 -178.648 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.58 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 95.0 m-85 -98.76 147.66 24.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.321 -0.399 . . . . 14.32 110.055 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 15.2 t -149.88 32.0 0.7 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.426 0.631 . . . . 14.51 109.822 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 66.7 t -130.95 138.98 52.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.655 -0.702 . . . . 13.06 109.77 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -79.88 53.97 1.77 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.073 0.463 . . . . 10.33 110.719 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.01 -57.51 6.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.687 -0.688 . . . . 9.8800000000000008 111.14 -176.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -86.85 -2.48 58.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.148 -0.478 . . . . 10.23 110.781 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.418 ' C ' ' H ' ' A' ' 164' ' ' GLY . 22.5 mt-30 -97.83 -15.68 20.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.12 -0.491 . . . . 9.0600000000000005 110.646 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.13 33.02 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.908 -0.587 . . . . 6.1900000000000004 110.861 174.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 162' ' ' GLN . . . -88.68 58.45 4.08 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.308 -0.717 . . . . 3.9700000000000002 111.308 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -118.48 147.45 43.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.884 0.373 . . . . 2.6299999999999999 110.62 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -88.33 1.06 84.07 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.905 -0.664 . . . . 1.3 112.063 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 16.0 m -56.19 -41.35 75.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.383 0.273 . . . . 1.8200000000000001 111.442 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.408 ' CZ2' ' HG2' ' A' ' 81' ' ' PRO . 27.4 p-90 -87.45 -22.04 25.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.846 0.355 . . . . 0.69999999999999996 111.382 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.488 HD23 HD11 ' A' ' 172' ' ' ILE . 38.9 mt -85.61 -14.87 44.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.746 0.276 . . . . 0.66000000000000003 111.746 -176.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.1 OUTLIER -75.29 -4.67 40.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 1.48 110.224 174.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.522 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 29.4 m-85 -77.43 -38.44 49.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.528 -0.76 . . . . 1.97 110.64 177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -81.45 117.48 27.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.145 0.497 . . . . 0.67000000000000004 110.552 178.765 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 173' ' ' ARG . 43.1 mmt-85 -131.09 -161.8 1.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.627 -0.715 . . . . 4.3399999999999999 110.825 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.47 ' HA ' HG11 ' A' ' 208' ' ' VAL . 6.2 t -62.49 139.65 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.286 0.565 . . . . 1.0700000000000001 111.97 -168.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.563 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -71.7 164.82 25.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.154 -0.93 . . . . 0.70999999999999996 111.276 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 47.4 t -92.45 -21.28 20.27 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.298 -0.864 . . . . 1.8799999999999999 112.054 -169.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.3 m -143.16 -179.74 6.56 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.422 0.527 . . . . 1.6299999999999999 112.422 -174.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 6.3 p -74.49 -53.03 10.28 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.117 0.414 . . . . 1.96 112.117 -175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.15 -12.9 61.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.817 0.817 . . . . 2.4199999999999999 109.468 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.476 ' O ' ' HG ' ' A' ' 206' ' ' LEU . 28.5 t0 -80.54 -1.58 42.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.326 -1.307 . . . . 2.1200000000000001 110.192 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -73.22 116.52 13.85 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.164 0.507 . . . . 1.3500000000000001 111.572 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.543 ' H ' HD12 ' A' ' 183' ' ' LEU . 16.8 t30 -156.1 38.8 0.35 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.02 -1.104 . . . . 1.6799999999999999 108.02 173.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.666 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.1 OUTLIER -124.55 124.76 42.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.442 -0.799 . . . . 0.81000000000000005 111.233 -172.348 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 99.8 m -150.9 133.86 15.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.51000000000000001 110.86 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.453 ' HB3' ' HB2' ' A' ' 209' ' ' HIS . 37.3 ttm -127.53 136.29 51.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.009 -0.541 . . . . 1.3500000000000001 109.548 176.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 9.0 p -130.21 165.64 21.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.799 0.333 . . . . 1.73 110.41 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.79 104.98 11.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.189 -0.671 . . . . 1.9299999999999999 109.189 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.519 HD11 ' CD2' ' A' ' 193' ' ' TYR . 43.9 pt -135.53 145.16 32.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 1.1100000000000001 110.712 -175.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.8 m 62.06 28.76 17.39 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.36 0.413 . . . . 1.8600000000000001 111.449 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 66.94 21.75 10.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.579 -0.737 . . . . 2.8300000000000001 111.791 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -133.48 166.43 22.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.379 . . . . 1.75 110.421 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.6 mm -88.2 130.06 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.922 -0.581 . . . . 1.01 109.752 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.519 ' CD2' HD11 ' A' ' 188' ' ' ILE . 35.2 t80 -120.56 124.44 45.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 3.9399999999999999 110.881 -173.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 7.4 m-85 -99.94 113.69 26.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.562 -0.903 . . . . 0.92000000000000004 108.562 174.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -110.81 124.91 52.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.234 -0.284 . . . . 1.1100000000000001 110.234 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 104' ' ' MET . 1.6 t -91.86 150.57 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.924 0.869 . . . . 0.69999999999999996 110.53 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.66 -54.57 6.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 113.964 -1.471 . . . . 0.62 111.565 -163.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.508 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -146.21 169.77 18.1 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.849 -1.069 . . . . 1.3799999999999999 109.576 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.708 ' HA ' ' O ' ' A' ' 104' ' ' MET . 4.0 m-20 -61.83 110.9 1.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.355 0.597 . . . . 2.23 111.973 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.715 ' O ' ' HB2' ' A' ' 103' ' ' LYS . 3.8 mm -69.05 148.0 11.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.032 -0.985 . . . . 0.88 110.545 175.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 52.6 mt-10 -89.0 117.57 68.39 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 108.646 -0.872 . . . . 2.0600000000000001 108.646 170.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.12 117.79 2.43 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.87 2.38 . . . . 0.51000000000000001 112.323 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.98 2.68 10.17 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.762 -0.732 . . . . 0.69999999999999996 112.805 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 11.7 pt-20 -140.48 126.42 19.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.32 0.581 . . . . 1.27 110.505 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.44 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -108.7 105.27 14.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.657 -0.702 . . . . 2.9199999999999999 111.839 -177.507 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.594 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.9 mm? -122.87 99.81 6.58 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.576 -0.45 . . . . 0.90000000000000002 110.206 175.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.94 113.39 6.29 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.89 0.476 . . . . 0.53000000000000003 109.763 175.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.666 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.6 p -155.93 160.87 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 122.07 -0.394 . . . . 0.91000000000000003 110.58 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.512 ' CG ' ' HB2' ' A' ' 128' ' ' TRP . 43.5 t-80 -81.87 112.4 18.96 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.793 -1.558 . . . . 1.55 106.793 165.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.6 m -73.67 94.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 122.064 0.935 . . . . 2.5600000000000001 110.469 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -87.67 142.64 27.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.742 -1.117 . . . . 5.3600000000000003 110.289 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -136.72 15.49 3.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.887 0.375 . . . . 5.7999999999999998 110.941 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 154.13 89.99 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.106 -1.045 . . . . 5.6100000000000003 112.854 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 126' ' ' PHE . 14.5 t -94.29 -71.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.786 0.326 . . . . 6.3099999999999996 110.367 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.469 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 72.1 t80 -76.83 -56.56 1.32 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.299 -0.409 . . . . 8.8300000000000001 111.576 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 19.3 Cg_endo -59.81 -42.03 49.37 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.168 1.912 . . . . 7.7800000000000002 112.744 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.4 mp -94.45 17.27 13.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.101 -0.5 . . . . 8.0199999999999996 110.898 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -101.74 166.56 18.18 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.855 -0.688 . . . . 8.6400000000000006 111.626 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.2 p -84.14 49.32 1.62 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.186 0.517 . . . . 9.7200000000000006 110.725 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 27.0 m -95.57 133.53 25.58 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.909 -0.587 . . . . 9.6199999999999992 111.288 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -84.41 119.98 2.42 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.427 2.085 . . . . 11.65 111.813 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -68.59 -13.05 36.38 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.33 2.02 . . . . 13.109999999999999 111.966 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -121.0 57.63 0.59 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.346 -1.102 . . . . 14.029999999999999 110.346 174.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 10.0 tt -62.02 119.79 9.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.301 0.572 . . . . 16.100000000000001 111.474 -172.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -129.61 -21.58 3.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.278 -0.874 . . . . 17.699999999999999 110.242 177.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.437 -0.792 . . . . 18.899999999999999 110.443 -177.235 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 112.004 -0.438 . . . . 33.259999999999998 112.004 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.4 m -82.25 -22.85 35.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.936 0.398 . . . . 33.920000000000002 110.548 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -140.39 -147.59 5.01 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.95 -0.643 . . . . 32.350000000000001 111.908 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 68.2 m-85 -74.63 141.42 76.06 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.311 0.1 . . . . 31.649999999999999 110.806 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 54' ' ' PHE . 3.1 Cg_exo -74.77 68.04 5.62 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.93 2.42 . . . . 29.989999999999998 112.392 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.6 p -81.05 61.25 4.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.308 -0.406 . . . . 28.920000000000002 111.013 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.0 m 60.79 62.44 1.48 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.579 0.704 . . . . 26.940000000000001 109.83 -174.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' CG ' ' HA ' ' A' ' 55' ' ' PRO . 11.8 mm-40 -90.34 11.88 20.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.365 -0.834 . . . . 25.829999999999998 110.856 -174.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -75.02 114.0 13.0 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.442 -0.799 . . . . 23.530000000000001 110.466 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -120.21 136.03 54.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.29 -0.414 . . . . 21.640000000000001 109.935 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.2 m -74.44 116.9 57.53 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 19.420000000000002 110.872 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.03 112.19 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.195 2.597 . . . . 17.170000000000002 112.532 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -126.43 40.93 3.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.593 -0.731 . . . . 17.469999999999999 109.342 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -82.96 149.17 27.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.314 -0.857 . . . . 15.630000000000001 110.337 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.9 -130.06 1.53 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.804 -0.712 . . . . 12.039999999999999 112.112 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.1 m 57.28 72.43 0.93 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.013 0.435 . . . . 10.67 111.115 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -73.82 139.04 27.07 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.965 2.443 . . . . 9.6899999999999995 111.823 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -85.62 93.2 8.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.052 0.453 . . . . 7.7000000000000002 110.475 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -96.28 129.77 43.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.913 -0.585 . . . . 8.1400000000000006 109.944 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.67 128.08 75.8 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.139 -0.482 . . . . 5.96 111.08 -176.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -45.4 -74.82 0.04 OUTLIER 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 123.784 2.989 . . . . 6.1299999999999999 114.453 -175.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.9 p -115.22 -48.88 4.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.151 -0.477 . . . . 6.5300000000000002 111.761 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -85.17 140.81 30.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.712 0.292 . . . . 5.0099999999999998 110.242 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.535 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.2 pp -76.38 139.22 67.74 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.222 0.534 . . . . 4.2300000000000004 111.625 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.68 8.7 4.48 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.849 2.366 . . . . 4.1200000000000001 112.533 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.47 -61.21 2.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.874 -0.603 . . . . 3.8199999999999998 109.713 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.4 t70 56.16 76.59 0.28 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.038 -0.983 . . . . 3.1600000000000001 110.668 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 88.7 mt -73.65 133.17 80.06 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.178 -0.919 . . . . 2.4500000000000002 110.559 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.98 116.88 3.61 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.756 2.304 . . . . 1.75 112.067 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.634 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -118.3 147.05 40.87 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.042 -0.526 . . . . 1.01 109.781 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.52 133.97 61.19 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.15 1.9 . . . . 0.72999999999999998 110.527 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.5 -16.5 15.65 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.569 0.543 . . . . 1.04 112.44 -174.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.9 -24.53 66.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.194 0.521 . . . . 1.6599999999999999 110.309 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 59.7 m-85 -121.76 177.38 5.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.69 -0.687 . . . . 1.0 109.395 178.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.495 ' OE2' ' HD3' ' A' ' 87' ' ' ARG . 33.1 tt0 -154.93 131.72 10.73 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.723 -0.391 . . . . 2.27 110.732 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tt -84.5 131.14 34.68 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.726 -0.842 . . . . 0.79000000000000004 108.726 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.495 ' HD3' ' OE2' ' A' ' 85' ' ' GLU . 14.4 mmm-85 -138.35 142.9 39.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.084 -0.507 . . . . 3.21 110.94 -173.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.72 110.21 12.37 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.364 -0.976 . . . . 2.46 108.364 171.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 p -168.99 94.58 0.32 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.874 -0.603 . . . . 1.5800000000000001 110.01 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -81.64 104.68 12.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.203 -0.453 . . . . 1.8600000000000001 111.016 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.503 HD12 ' SG ' ' A' ' 176' ' ' CYS . 0.0 OUTLIER -104.51 119.44 53.77 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.985 -0.552 . . . . 1.45 109.586 176.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -52.16 124.61 15.24 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.464 2.776 . . . . 1.6100000000000001 113.12 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.7 -29.46 9.86 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.709 -0.678 . . . . 1.74 112.046 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.533 ' O ' ' HD2' ' A' ' 173' ' ' ARG . . . -118.4 -66.89 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.816 0.341 . . . . 1.4099999999999999 111.242 177.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.94 -145.93 17.83 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.523 -0.631 . . . . 1.0900000000000001 111.523 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mt -91.67 118.27 30.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.877 0.338 . . . . 2.3100000000000001 110.254 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -129.6 -179.36 15.94 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.881 -0.676 . . . . 0.58999999999999997 111.485 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.7 m -92.44 147.47 5.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.911 -0.774 . . . . 0.67000000000000004 108.911 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -116.17 118.42 32.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.756 0.312 . . . . 1.1299999999999999 110.544 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.45 ' H ' ' HG2' ' A' ' 205' ' ' GLU . . . -69.08 120.27 14.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.174 -0.466 . . . . 0.54000000000000004 110.033 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.579 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -89.15 15.5 8.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.587 0.708 . . . . 1.6799999999999999 110.063 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 32.7 ttp85 -141.66 158.49 43.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.092 -0.958 . . . . 3.5 108.423 176.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.622 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -82.61 158.98 22.82 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.953 0.406 . . . . 2.3999999999999999 110.633 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.664 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 58.4 mtm -133.27 151.1 51.89 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.381 -0.6 . . . . 1.22 109.381 176.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -114.74 138.42 50.75 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 123.338 0.399 . . . . 2.3100000000000001 110.745 -176.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . . . -37.24 122.05 0.86 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.783 1.302 . . . . 0.83999999999999997 113.742 -171.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.66 7.16 12.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.928 -0.653 . . . . 1.04 112.141 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.473 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.6 OUTLIER -84.26 159.46 20.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.058 0.456 . . . . 2.6200000000000001 110.744 -178.123 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.62 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 7.0 tmm_? -146.1 136.09 23.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 3.6200000000000001 110.715 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.408 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 6.6 mt -93.22 142.25 27.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.555 -0.535 . . . . 0.53000000000000003 109.555 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.17 171.59 44.43 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.675 -0.774 . . . . 1.02 111.904 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.2 137.94 46.25 Favored 'Cis proline' 0 C--N 1.345 0.382 0 C-N-CA 123.722 -1.366 . . . . 2.1000000000000001 112.151 -0.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.786 ' SG ' ' HA ' ' A' ' 193' ' ' TYR . 13.3 m -87.18 -32.3 19.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 2.0 111.429 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 p -123.96 98.78 5.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.434 0.635 . . . . 2.0299999999999998 110.166 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.465 HG21 ' HB3' ' A' ' 165' ' ' ALA . 32.9 m -106.37 25.16 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.473 0.654 . . . . 3.9500000000000002 111.147 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.55 128.1 70.77 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.379 -0.828 . . . . 5.21 110.145 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.56 161.99 42.79 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.807 2.338 . . . . 5.0700000000000003 112.488 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 66.57 -81.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.702 0.626 . . . . 7.9900000000000002 110.887 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -178.65 -38.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.779 -0.646 . . . . 6.9500000000000002 109.365 -177.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 62.56 84.98 0.13 Allowed 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.963 0.79 . . . . 6.0899999999999999 112.115 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.407 ' CB ' ' HA ' ' A' ' 132' ' ' LEU . . . -76.94 83.34 3.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.614 -0.721 . . . . 5.5599999999999996 109.967 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.479 ' HE3' ' HB3' ' A' ' 125' ' ' ASP . 55.9 pttt -74.49 176.83 6.46 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.797 -1.092 . . . . 7.4199999999999999 111.432 -177.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.585 ' H ' ' CD ' ' A' ' 123' ' ' GLU . 5.1 mp0 -46.15 -71.71 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.585 -1.189 . . . . 9.0099999999999998 111.781 -174.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 p -146.79 -100.24 0.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.461 -0.336 . . . . 8.8800000000000008 110.916 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.479 ' HB3' ' HE3' ' A' ' 122' ' ' LYS . 36.2 t70 63.08 116.86 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.9 0.857 . . . . 7.5999999999999996 111.705 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -86.9 157.67 19.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.495 -0.775 . . . . 7.2300000000000004 110.585 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 147.12 -47.26 0.69 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.66 -0.781 . . . . 4.5899999999999999 111.662 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -158.87 -40.19 0.06 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.844 -0.428 . . . . 4.9299999999999997 109.844 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.543 ' O ' HD13 ' A' ' 131' ' ' ILE . 16.0 mt-10 67.93 -77.33 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.325 0 O-C-N 124.303 1.002 . . . . 7.6500000000000004 110.944 173.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 41.42 -88.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.012 1.115 . . . . 8.8399999999999999 114.012 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.543 HD13 ' O ' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -58.81 -24.94 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 113.283 0.846 . . . . 6.0499999999999998 113.283 -169.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' A' ' 129' ' ' GLU . 0.4 OUTLIER -82.25 60.96 5.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.901 0.858 . . . . 8.5 111.772 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.445 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 24.6 p -144.7 42.16 1.34 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.259 -1.337 . . . . 9.8200000000000003 108.794 173.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 133' ' ' THR . 31.8 t70 73.92 105.39 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.984 -1.007 . . . . 11.210000000000001 109.548 -168.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 63.7 t -70.23 94.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 10.84 111.156 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -119.55 -6.3 10.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.506 -0.77 . . . . 13.25 109.386 175.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.25 -3.96 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.324 -0.853 . . . . 13.890000000000001 111.47 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.1 m -153.11 75.19 6.72 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.427 -0.351 . . . . 14.050000000000001 110.947 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.4 106.19 1.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.973 2.449 . . . . 14.41 111.515 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 61.25 73.52 0.48 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.087 -0.506 . . . . 14.44 110.598 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -11.99 58.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.107 -0.497 . . . . 15.9 111.876 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 164.25 -38.02 0.3 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.742 -0.742 . . . . 15.6 112.181 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 25.1 p -100.95 144.16 30.22 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.023 -0.362 . . . . 15.6 110.023 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 27.8 mm -108.71 50.89 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 122.061 0.934 . . . . 13.85 109.101 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.63 95.24 3.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.789 -1.096 . . . . 13.19 110.312 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -105.55 -20.63 13.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.829 -0.623 . . . . 15.67 110.301 -175.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.9 pt -128.7 168.12 22.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.448 -0.796 . . . . 13.77 110.837 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.5 p -123.28 113.19 18.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.923 -0.58 . . . . 13.619999999999999 110.872 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -88.29 148.86 24.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.905 -0.589 . . . . 13.02 109.753 175.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -91.07 124.56 35.39 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.912 0.387 . . . . 14.68 110.759 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 pp -99.98 14.34 30.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.19 0.519 . . . . 13.550000000000001 111.042 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 126.61 106.83 1.48 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.321 -0.854 . . . . 15.800000000000001 111.6 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 18.0 m -80.15 -29.04 38.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.766 0.317 . . . . 17.079999999999998 110.803 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -95.08 -68.04 0.82 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.032 0.444 . . . . 18.43 110.046 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -124.66 149.19 47.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.762 -0.654 . . . . 18.530000000000001 110.02 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.18 142.41 15.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.18 -0.463 . . . . 14.32 110.44 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 60.0 m -130.31 7.1 4.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.219 -0.446 . . . . 14.51 110.34 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.14 135.46 44.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.108 -0.497 . . . . 13.06 110.772 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -97.35 125.98 42.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.005 -0.543 . . . . 10.33 111.138 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -120.23 -53.07 2.15 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.623 -0.717 . . . . 9.8800000000000008 109.756 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -136.48 42.18 2.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.892 -0.595 . . . . 10.23 110.41 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -94.7 -15.77 23.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.082 0.468 . . . . 9.0600000000000005 110.438 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 66.33 39.43 4.06 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.84 -1.073 . . . . 6.1900000000000004 110.819 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -59.62 -31.13 70.22 Favored Glycine 0 C--N 1.33 0.247 0 CA-C-N 115.558 -0.746 . . . . 3.9700000000000002 113.417 -176.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.465 ' HB3' HG21 ' A' ' 115' ' ' VAL . . . -64.97 -14.88 61.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.928 0.344 . . . . 2.6299999999999999 111.928 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -125.42 4.59 8.19 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.784 -0.722 . . . . 1.3 111.69 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.659 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 31.4 t -76.54 -20.24 57.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.16 0.505 . . . . 1.8200000000000001 111.053 -175.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.416 ' CB ' HG22 ' A' ' 80' ' ' ILE . 42.4 p-90 -69.33 -18.65 63.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.066 0.46 . . . . 0.69999999999999996 110.832 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 113' ' ' CYS . 33.3 mt -80.31 -17.91 50.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.001 -0.545 . . . . 0.66000000000000003 112.269 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.659 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -82.66 -3.91 56.99 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.106 -0.638 . . . . 1.48 110.575 178.761 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.434 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 54.1 m-85 -77.88 -36.08 50.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 1.97 110.726 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.539 HD12 ' HB2' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -68.08 129.72 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.131 -0.692 . . . . 0.67000000000000004 109.131 174.412 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.533 ' HD2' ' O ' ' A' ' 94' ' ' ALA . 45.7 mtt180 -129.7 -160.72 1.06 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.553 -0.294 . . . . 4.3399999999999999 110.814 -174.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 16.1 t -62.96 148.95 10.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.355 0.409 . . . . 1.0700000000000001 111.292 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.41 ' HA ' HD12 ' A' ' 206' ' ' LEU . . . -53.48 132.12 39.43 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.692 -0.685 . . . . 0.70999999999999996 111.431 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.503 ' SG ' HD12 ' A' ' 91' ' ' ILE . 23.2 m -55.2 -25.01 30.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.949 -1.023 . . . . 1.8799999999999999 112.237 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 92.8 p -149.29 -179.0 6.71 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.012 -0.366 . . . . 1.6299999999999999 110.012 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' CYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 47.4 t -80.95 -23.69 38.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.902 0.382 . . . . 1.96 110.531 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -88.54 -10.27 49.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.699 0.285 . . . . 2.4199999999999999 110.97 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -91.15 15.94 10.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.377 -0.374 . . . . 2.1200000000000001 111.246 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 89.5 mm-40 -63.33 114.04 3.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.129 0.49 . . . . 1.3500000000000001 110.385 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.54 ' OD1' ' HE2' ' A' ' 198' ' ' LYS . 21.8 t30 -165.68 43.21 0.07 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.101 -1.074 . . . . 1.6799999999999999 108.101 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.608 ' HB3' ' O ' ' A' ' 206' ' ' LEU . 0.8 OUTLIER -142.57 128.88 19.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.583 -0.735 . . . . 0.81000000000000005 111.888 -175.426 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 29.3 m -151.34 141.51 22.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.803 -1.089 . . . . 0.51000000000000001 110.335 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 54.0 tpp -90.11 139.77 30.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.947 -0.39 . . . . 1.3500000000000001 109.947 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 52.8 t -113.67 132.11 55.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.173 0.511 . . . . 1.73 110.471 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -122.01 105.56 10.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.707 -0.849 . . . . 1.9299999999999999 108.707 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.479 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 16.3 pt -139.64 142.99 31.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.987 -0.551 . . . . 1.1100000000000001 110.689 -176.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.7 m 57.18 38.1 28.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.153 -0.476 . . . . 1.8600000000000001 110.968 177.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 67.86 6.24 4.99 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.48 -0.782 . . . . 2.8300000000000001 112.119 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 29.2 pt20 -124.94 161.13 27.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 1.75 110.842 -176.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.84 137.12 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.813 -0.63 . . . . 1.01 111.645 -176.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.786 ' HA ' ' SG ' ' A' ' 113' ' ' CYS . 25.4 m-85 -140.9 155.02 46.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.623 -0.717 . . . . 3.9399999999999999 110.294 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 2.2 m-85 -100.15 113.2 25.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.735 -0.469 . . . . 0.92000000000000004 109.735 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -102.78 123.51 46.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.076 0.465 . . . . 1.1100000000000001 110.231 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.526 HG22 HD11 ' A' ' 207' ' ' LEU . 1.6 t -94.68 151.96 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.714 0.769 . . . . 0.69999999999999996 109.632 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.8 mm -90.67 -56.4 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.361 -1.291 . . . . 0.62 111.201 -166.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.54 ' HE2' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -145.29 -178.16 5.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.373 -0.83 . . . . 1.3799999999999999 111.891 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.664 ' HA ' ' O ' ' A' ' 104' ' ' MET . 18.6 t70 -46.07 132.44 9.53 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.689 0.996 . . . . 2.23 113.689 -172.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.492 HD11 ' ND2' ' A' ' 182' ' ' ASN . 26.4 mm -101.49 132.79 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.231 -0.895 . . . . 0.88 110.349 174.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 35.8 mt-10 -89.35 126.59 57.99 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.337 -0.616 . . . . 2.0600000000000001 109.337 173.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.03 116.95 2.19 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.962 2.441 . . . . 0.51000000000000001 112.86 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.05 -4.94 10.47 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.78 -0.724 . . . . 0.69999999999999996 113.299 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 9.5 pt-20 -142.29 120.35 12.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.476 0.638 . . . . 1.27 112.022 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' A' ' 100' ' ' ALA . 17.7 mm-40 -111.96 125.35 53.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.73 -0.668 . . . . 2.9199999999999999 110.225 171.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.608 ' O ' ' HB3' ' A' ' 183' ' ' LEU . 2.5 mm? -120.01 102.06 8.28 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.671 -0.862 . . . . 0.90000000000000002 108.671 172.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.539 ' HB2' HD12 ' A' ' 172' ' ' ILE . 1.9 mm? -143.76 113.45 7.09 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.138 0.274 . . . . 0.53000000000000003 110.925 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.541 HG12 HD12 ' A' ' 183' ' ' LEU . 1.9 p -153.61 159.8 3.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 O-C-N 122.105 -0.372 . . . . 0.91000000000000003 111.259 176.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -94.47 111.88 23.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.659 -0.867 . . . . 1.55 108.659 167.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 210' ' ' VAL . 6.2 p -137.88 94.72 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.313 0.578 . . . . 2.5600000000000001 111.589 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 66.5 129.8 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.024 -0.989 . . . . 5.3600000000000003 112.843 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.2 173.95 11.0 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.311 -0.996 . . . . 5.7999999999999998 108.311 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.561 ' HA2' HD23 ' A' ' 217' ' ' LEU . . . -89.37 45.71 3.15 Favored Glycine 0 C--N 1.304 -1.222 0 CA-C-N 115.376 -0.829 . . . . 5.6100000000000003 112.263 -175.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.1 t -98.34 -72.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.916 0.389 . . . . 6.3099999999999996 110.773 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.472 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 77.2 t80 -76.92 -53.79 1.72 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.326 -0.397 . . . . 8.8300000000000001 111.593 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 19.8 Cg_endo -61.11 -45.67 18.51 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.987 1.791 . . . . 7.7800000000000002 112.692 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.561 HD23 ' HA2' ' A' ' 213' ' ' GLY . 4.2 mm? -86.97 -66.58 0.89 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.514 -0.312 . . . . 8.0199999999999996 110.881 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 138.7 -135.93 7.71 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.327 -0.94 . . . . 8.6400000000000006 112.219 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 74.8 p 54.02 35.97 23.4 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.665 0.786 . . . . 9.7200000000000006 110.73 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.505 ' O ' ' HD3' ' A' ' 222' ' ' PRO . 29.9 m -69.64 142.22 91.23 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 115.419 -0.81 . . . . 9.6199999999999992 110.781 -175.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 2.3 Cg_endo -81.04 106.19 1.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.71 2.273 . . . . 11.65 111.725 177.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 220' ' ' VAL . 89.5 Cg_endo -84.81 70.1 5.66 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.734 2.29 . . . . 13.109999999999999 111.982 -177.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 86.67 -32.46 3.95 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.849 -0.614 . . . . 14.029999999999999 112.003 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 36.8 tp -124.7 127.67 47.63 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.058 -0.349 . . . . 16.100000000000001 110.058 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -121.08 2.46 10.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.234 0.54 . . . . 17.699999999999999 110.158 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.464 -0.779 . . . . 18.899999999999999 110.238 178.945 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 111.769 -0.532 . . . . 33.259999999999998 111.769 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.5 m -114.89 29.99 7.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.012 0.434 . . . . 33.920000000000002 111.171 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.96 -56.39 3.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.81 -0.709 . . . . 32.350000000000001 112.14 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -130.33 139.86 36.92 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 110.037 -0.357 . . . . 31.649999999999999 110.037 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.74 -12.59 31.27 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.959 2.439 . . . . 29.989999999999998 112.723 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 p -80.71 122.44 27.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.077 -0.511 . . . . 28.920000000000002 110.745 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.8 p -80.31 59.43 3.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.409 0.623 . . . . 26.940000000000001 111.9 -176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -90.63 56.66 3.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.012 -0.736 . . . . 25.829999999999998 109.012 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.79 57.63 0.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.579 -0.737 . . . . 23.530000000000001 110.61 -177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -74.59 102.37 4.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.358 -0.608 . . . . 21.640000000000001 109.358 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.8 t -137.95 137.3 21.02 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.603 -0.726 . . . . 19.420000000000002 109.931 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.84 79.27 0.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.44 2.094 . . . . 17.170000000000002 112.413 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -106.02 -28.32 10.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.365 -1.288 . . . . 17.469999999999999 109.667 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -91.73 3.99 53.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.588 -0.733 . . . . 15.630000000000001 109.963 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.24 123.17 2.35 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.119 -0.946 . . . . 12.039999999999999 111.38 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -120.49 102.16 45.53 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 110.343 -0.243 . . . . 10.67 110.343 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.94 135.11 36.68 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.197 1.931 . . . . 9.6899999999999995 111.231 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -68.94 121.27 16.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.208 -0.451 . . . . 7.7000000000000002 110.715 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -111.1 125.62 53.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.718 -0.674 . . . . 8.1400000000000006 110.479 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.19 170.63 11.58 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.859 -0.61 . . . . 5.96 110.079 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.66 -154.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.379 2.053 . . . . 6.1299999999999999 112.458 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.0 p -55.95 -41.98 69.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 6.5300000000000002 111.17 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -97.46 112.62 24.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.897 0.38 . . . . 5.0099999999999998 110.531 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.535 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.1 pp -78.49 141.97 61.69 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.916 -0.584 . . . . 4.2300000000000004 110.52 174.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.44 26.03 0.65 Allowed 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.779 2.319 . . . . 4.1200000000000001 112.832 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -101.35 -72.22 0.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.265 -0.425 . . . . 3.8199999999999998 111.124 -176.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.9 t70 63.7 94.44 0.05 Allowed 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.946 0.779 . . . . 3.1600000000000001 109.712 -172.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 83.5 mt -67.83 123.33 86.76 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.556 -0.747 . . . . 2.4500000000000002 110.987 -175.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.88 121.12 8.53 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.838 2.358 . . . . 1.75 112.292 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.592 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -127.78 153.28 77.94 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.746 -0.661 . . . . 1.01 109.281 177.693 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.32 141.7 88.71 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.388 2.059 . . . . 0.72999999999999998 111.746 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.516 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -65.68 -12.33 52.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.987 0.736 . . . . 1.04 112.987 -171.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -82.68 -19.71 37.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.037 0.384 . . . . 1.6599999999999999 112.037 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.521 ' HE2' ' SD ' ' A' ' 104' ' ' MET . 5.1 m-85 -116.83 144.88 43.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -116.46 117.07 28.9 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.886 -0.326 . . . . 2.27 110.725 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.494 HD11 ' CE2' ' A' ' 171' ' ' TYR . 8.2 tt -86.09 124.3 32.36 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.962 -0.755 . . . . 0.79000000000000004 108.962 176.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -140.37 128.4 22.13 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.791 -0.641 . . . . 3.21 110.692 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -81.83 112.95 19.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.899 -0.778 . . . . 2.46 108.899 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -166.9 162.73 15.99 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.881 -0.785 . . . . 1.5800000000000001 108.881 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.0 t -99.83 105.55 17.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.905 0.383 . . . . 1.8600000000000001 110.627 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -101.59 117.34 62.06 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.25 -0.648 . . . . 1.45 109.25 174.584 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -55.98 123.29 13.48 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.029 2.486 . . . . 1.6100000000000001 113.116 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.412 ' HA3' ' SG ' ' A' ' 176' ' ' CYS . . . 105.65 -18.39 40.99 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.7 -0.762 . . . . 1.74 112.665 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.494 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -129.34 -55.91 1.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.215 0.531 . . . . 1.4099999999999999 111.517 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.471 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 121.24 -103.35 0.88 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 111.267 -0.733 . . . . 1.0900000000000001 111.267 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.4 160.78 14.24 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.95 -0.389 . . . . 2.3100000000000001 109.95 172.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.96 171.79 44.66 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.512 -0.852 . . . . 0.58999999999999997 112.464 177.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 86' ' ' LEU . 17.0 m -107.29 147.36 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.182 -0.673 . . . . 0.67000000000000004 109.182 173.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -125.79 110.59 13.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.755 0.312 . . . . 1.1299999999999999 111.07 -174.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.517 ' H ' ' HG3' ' A' ' 205' ' ' GLU . . . -59.83 125.77 24.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.85 -0.614 . . . . 0.54000000000000004 111.115 177.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -93.18 -3.88 53.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.331 0.586 . . . . 1.6799999999999999 110.203 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.5 ttp85 -133.16 155.3 49.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.934 -1.135 . . . . 3.5 107.934 171.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.658 ' HD3' ' C ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -84.16 158.56 21.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.277 0.56 . . . . 2.3999999999999999 110.685 -175.437 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 54.9 mtm -117.36 154.33 31.49 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.784 . . . . 1.22 109.068 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -107.83 136.12 48.09 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.41 0.444 . . . . 2.3100000000000001 110.376 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.422 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . . . -39.11 117.29 0.67 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.624 1.202 . . . . 0.83999999999999997 112.991 -174.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.33 7.46 12.33 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.544 -0.753 . . . . 1.04 111.547 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.446 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -75.64 165.22 25.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.054 0.454 . . . . 2.6200000000000001 110.742 -178.371 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.545 ' HD3' ' CD1' ' A' ' 193' ' ' TYR . 7.1 tmm_? -141.38 132.66 26.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.386 -0.37 . . . . 3.6200000000000001 110.297 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.497 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 5.9 mt -100.75 138.49 37.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.616 -0.513 . . . . 0.53000000000000003 109.616 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.49 173.75 46.43 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.976 -0.63 . . . . 1.02 111.696 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -83.9 146.86 53.15 Favored 'Cis proline' 0 C--O 1.236 0.4 0 C-N-CA 123.316 -1.535 . . . . 2.1000000000000001 112.77 -0.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.1 t -94.16 -39.46 10.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.661 -0.7 . . . . 2.0 109.634 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.3 p -171.11 132.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.619 -0.719 . . . . 2.0299999999999998 109.922 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.9 t -65.34 150.53 10.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.051 -0.722 . . . . 3.9500000000000002 109.051 176.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.2 t -44.54 114.09 1.89 Allowed Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 123.663 0.602 . . . . 5.21 111.003 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 77.6 Cg_exo -50.68 97.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.778 2.986 . . . . 5.0700000000000003 113.524 -175.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -137.02 -65.69 0.54 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.15 -0.932 . . . . 7.9900000000000002 109.274 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.23 -39.6 39.9 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.312 0.577 . . . . 6.9500000000000002 109.724 174.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -125.5 143.65 50.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.336 -0.847 . . . . 6.0899999999999999 109.619 176.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.68 107.65 3.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.772 0.32 . . . . 5.5599999999999996 111.033 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -68.66 112.35 5.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.565 0.697 . . . . 7.4199999999999999 111.156 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -117.91 -41.06 2.93 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.015 -0.993 . . . . 9.0099999999999998 109.639 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 28.9 m -60.17 -52.82 63.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.458 -0.792 . . . . 8.8800000000000008 109.949 173.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.85 126.93 31.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.35 -0.841 . . . . 7.5999999999999996 109.192 173.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -69.43 143.07 53.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.055 0.455 . . . . 7.2300000000000004 111.615 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -153.37 -69.57 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.033 -0.827 . . . . 4.5899999999999999 111.033 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.51 -118.18 0.29 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 110.04 -0.355 . . . . 4.9299999999999997 110.04 172.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.532 ' HG3' ' N ' ' A' ' 130' ' ' GLN . 7.7 pt-20 -142.75 -54.09 0.41 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.58 0.229 . . . . 7.6500000000000004 110.771 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.532 ' N ' ' HG3' ' A' ' 129' ' ' GLU . 45.2 mt-30 -151.07 153.31 34.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.545 -0.298 . . . . 8.8399999999999999 110.531 -173.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.406 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -124.3 -16.65 4.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.917 0.389 . . . . 6.0499999999999998 110.249 168.876 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.36 58.14 4.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.86 0.838 . . . . 8.5 111.198 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.2 t -178.96 28.51 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 114.337 -1.301 . . . . 9.8200000000000003 109.298 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -68.18 115.12 7.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.19 -0.914 . . . . 11.210000000000001 110.701 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.86 131.26 26.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.578 -0.737 . . . . 10.84 110.914 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.38 97.88 7.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.152 0.501 . . . . 13.25 110.373 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.77 -23.79 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.798 -0.637 . . . . 13.890000000000001 110.01 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.1 t -107.26 126.29 30.42 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.674 -0.694 . . . . 14.050000000000001 110.062 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.28 80.79 2.14 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.532 2.155 . . . . 14.41 111.632 177.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -95.87 100.86 12.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.673 -0.694 . . . . 14.44 111.077 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -127.66 173.51 9.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.3 -0.863 . . . . 15.9 110.325 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.63 -97.36 0.4 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.08 -0.581 . . . . 15.6 112.389 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 7.4 p -80.79 69.22 7.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.405 0.621 . . . . 15.6 110.626 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 39.8 mt -89.04 102.9 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.836 -0.62 . . . . 13.85 110.178 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 t -118.66 142.82 47.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.011 0.434 . . . . 13.19 110.485 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -121.79 -4.18 9.18 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.28 0.562 . . . . 15.67 109.971 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.45 ' H ' HG13 ' A' ' 147' ' ' ILE . 2.7 pp -107.49 168.56 3.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.731 -0.668 . . . . 13.77 111.266 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 49.7 m -154.0 57.43 0.72 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.706 -0.849 . . . . 13.619999999999999 108.706 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -87.28 46.24 1.36 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.181 -0.918 . . . . 13.02 110.958 -170.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -159.67 142.47 13.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.337 -0.847 . . . . 14.68 109.387 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.407 HD23 ' NE2' ' A' ' 162' ' ' GLN . 4.6 pp -130.27 159.29 37.35 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 120.958 0.409 . . . . 13.550000000000001 110.083 -177.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 154' ' ' GLU . . . -89.44 100.31 2.65 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.543 -0.753 . . . . 15.800000000000001 111.253 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.7 m -68.11 14.11 0.07 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.556 0.576 . . . . 17.079999999999998 112.556 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 152' ' ' GLY . 36.1 mt-10 -63.35 -61.92 2.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.732 0.777 . . . . 18.43 109.746 174.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.549 ' HD2' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -117.42 -0.75 11.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.877 -1.056 . . . . 18.530000000000001 110.814 -179.24 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -100.39 87.63 3.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.172 0.511 . . . . 14.32 111.054 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 53.8 t -82.96 -46.61 12.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.773 -0.825 . . . . 14.51 108.773 172.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 67.1 t -101.34 128.34 53.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.534 -0.757 . . . . 13.06 109.788 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' A' ' 162' ' ' GLN . 23.9 t70 -88.31 117.03 26.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.348 0.594 . . . . 10.33 111.543 -177.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -108.26 -28.56 9.38 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.195 -0.911 . . . . 9.8800000000000008 109.611 172.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -52.73 -57.57 9.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.353 -1.294 . . . . 10.23 111.442 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.449 ' HB2' ' OD1' ' A' ' 159' ' ' ASP . 35.5 mt-30 -85.55 -55.26 4.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.827 -0.624 . . . . 9.0600000000000005 110.012 -177.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.0 71.46 6.71 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.666 -0.697 . . . . 6.1900000000000004 110.705 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -66.21 109.42 2.89 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.859 -0.686 . . . . 3.9700000000000002 111.714 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.88 -58.04 10.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.574 0.226 . . . . 2.6299999999999999 110.779 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 74.97 -57.06 2.69 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.079 -0.51 . . . . 1.3 113.665 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.706 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 20.5 t -63.41 -16.05 59.41 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.809 0.444 . . . . 1.8200000000000001 111.726 -174.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.503 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 25.5 p-90 -71.7 -23.58 61.67 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.019 -0.426 . . . . 0.69999999999999996 110.293 178.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.503 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 29.2 mt -86.75 -17.65 33.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 0.66000000000000003 112.283 -176.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.706 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -75.77 -10.73 59.68 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.382 -0.527 . . . . 1.48 110.248 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.494 ' CE2' HD11 ' A' ' 86' ' ' LEU . 52.1 m-85 -69.79 -36.98 76.16 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.824 -0.625 . . . . 1.97 111.06 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.693 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -69.83 127.01 31.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.482 -0.487 . . . . 0.67000000000000004 109.729 177.539 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -115.07 179.15 4.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.022 -0.536 . . . . 4.3399999999999999 110.401 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.627 ' HA ' HD22 ' A' ' 183' ' ' LEU . 1.7 p -71.4 142.37 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.458 . . . . 1.0700000000000001 111.165 -177.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.28 142.47 21.05 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.16 -0.927 . . . . 0.70999999999999996 112.572 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.412 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 47.5 t -82.87 -2.93 56.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.208 -0.906 . . . . 1.8799999999999999 110.531 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 27.2 t -142.84 139.88 31.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.993 -0.549 . . . . 1.6299999999999999 109.589 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 33.6 t -73.31 -13.99 61.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.309 0.576 . . . . 1.96 110.485 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -88.44 -4.42 58.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.346 0.593 . . . . 2.4199999999999999 109.93 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -110.84 15.49 21.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.49 -0.777 . . . . 2.1200000000000001 111.107 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 15.9 mm100 -60.11 115.67 3.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.528 -0.545 . . . . 1.3500000000000001 109.528 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.6 ' OD1' ' HG3' ' A' ' 198' ' ' LYS . 19.2 t30 -153.63 32.97 0.45 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.165 0.983 . . . . 1.6799999999999999 108.799 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.627 HD22 ' HA ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -122.52 129.51 52.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.368 -0.833 . . . . 0.81000000000000005 110.315 -174.013 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.5 m -150.42 138.66 20.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.074 0.464 . . . . 0.51000000000000001 110.933 177.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.485 ' HB2' ' HE2' ' A' ' 185' ' ' MET . 21.1 tpp -102.05 129.02 48.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.941 -0.572 . . . . 1.3500000000000001 109.962 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 43.5 t -111.95 140.93 46.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.051 0.453 . . . . 1.73 110.585 -175.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.81 104.26 10.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.904 -0.589 . . . . 1.9299999999999999 109.621 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.465 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 17.8 pt -142.73 145.33 23.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.679 -0.691 . . . . 1.1100000000000001 110.229 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.4 m 63.15 27.61 15.72 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.114 0.483 . . . . 1.8600000000000001 111.047 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 64.56 10.5 5.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.125 -0.943 . . . . 2.8300000000000001 111.62 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.9 pt20 -120.6 167.95 11.88 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.974 -0.38 . . . . 1.75 109.974 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.2 mm -93.59 137.09 23.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.058 -0.519 . . . . 1.01 110.305 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.545 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 2.4 m-85 -138.52 151.4 47.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.221 0.534 . . . . 3.9399999999999999 111.244 177.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.475 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 4.8 m-85 -99.54 113.6 26.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.568 -0.742 . . . . 0.92000000000000004 109.627 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.28 118.83 37.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.992 -0.549 . . . . 1.1100000000000001 110.176 -177.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.448 HG22 HD11 ' A' ' 207' ' ' LEU . 2.0 t -91.08 152.95 3.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.515 0.674 . . . . 0.69999999999999996 110.057 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.405 HG13 ' HA ' ' A' ' 182' ' ' ASN . 1.2 mm -91.44 -58.07 3.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.64 -1.164 . . . . 0.62 111.301 -167.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.6 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -139.78 173.13 11.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.69 -0.686 . . . . 1.3799999999999999 111.51 -176.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.592 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.1 m-20 -47.05 120.18 2.95 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.231 -0.895 . . . . 2.23 112.871 -176.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.485 HD11 ' ND2' ' A' ' 182' ' ' ASN . 21.0 mm -82.15 140.11 16.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.185 -0.916 . . . . 0.88 110.984 176.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 202' ' ' PRO . 44.6 mt-10 -86.97 130.71 47.31 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.534 -0.543 . . . . 2.0600000000000001 109.534 171.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 201' ' ' GLU . 53.2 Cg_exo -55.11 117.53 4.13 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.493 2.128 . . . . 0.51000000000000001 112.289 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.52 -11.11 9.71 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.798 -0.715 . . . . 0.69999999999999996 112.576 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 200' ' ' ILE . 11.3 pt-20 -143.04 119.69 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 1.27 111.791 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.517 ' HG3' ' H ' ' A' ' 100' ' ' ALA . 40.6 mt-10 -111.7 127.21 55.7 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.196 -0.315 . . . . 2.9199999999999999 110.518 169.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.487 ' C ' HD22 ' A' ' 207' ' ' LEU . 2.6 mm? -115.72 100.35 7.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.146 -0.686 . . . . 0.90000000000000002 109.146 175.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.693 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.33 125.37 13.63 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.495 -0.928 . . . . 0.53000000000000003 108.495 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.602 HG11 ' HB ' ' A' ' 174' ' ' VAL . 9.8 p -152.87 157.1 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.234 -0.586 . . . . 0.91000000000000003 111.439 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -109.72 106.47 16.12 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.815 -0.809 . . . . 1.55 108.815 163.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.4 m -107.4 143.07 18.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.226 -0.657 . . . . 2.5600000000000001 109.226 170.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -111.42 127.35 55.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.434 0.635 . . . . 5.3600000000000003 111.282 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -130.88 47.13 2.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.226 -0.897 . . . . 5.7999999999999998 109.722 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 71.08 49.53 27.02 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.578 -0.737 . . . . 5.6100000000000003 112.401 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.0 -83.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 O-C-N 122.765 -0.256 . . . . 6.3099999999999996 111.133 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.405 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 69.2 m-85 -68.71 -61.37 3.72 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 112.761 0.652 . . . . 8.8300000000000001 112.761 -175.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 19.7 Cg_endo -56.44 -41.05 80.31 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.348 2.032 . . . . 7.7800000000000002 113.228 -172.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.46 -8.12 54.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.764 -0.653 . . . . 8.0199999999999996 111.67 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 63.66 27.13 70.53 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.326 -0.464 . . . . 8.6400000000000006 112.874 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 10.1 t -110.24 41.62 1.71 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.547 0.689 . . . . 9.7200000000000006 110.436 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 21.5 m -75.42 126.91 87.09 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.794 -0.639 . . . . 9.6199999999999992 110.08 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.78 116.95 4.91 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.357 2.038 . . . . 11.65 111.933 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.41 53.87 4.47 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.686 2.257 . . . . 13.109999999999999 112.318 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 155.58 -160.11 29.69 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.332 -0.707 . . . . 14.029999999999999 111.332 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 54.4 tp -140.47 124.12 17.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.941 0.37 . . . . 16.100000000000001 110.451 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -123.9 -52.47 1.78 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.1 -0.5 . . . . 17.699999999999999 110.674 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.674 -0.679 . . . . 18.899999999999999 110.056 -176.517 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 112.259 -0.337 . . . . 33.259999999999998 112.259 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.4 m 64.37 38.1 7.97 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.859 0.464 . . . . 33.920000000000002 111.054 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.82 55.66 5.02 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 121.012 -0.613 . . . . 32.350000000000001 112.243 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -116.42 121.54 33.21 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 110.274 -0.269 . . . . 31.649999999999999 110.274 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.19 122.93 12.14 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.824 2.35 . . . . 29.989999999999998 112.444 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 t -138.26 95.52 3.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.199 0.523 . . . . 28.920000000000002 110.066 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m -63.01 109.1 1.37 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.894 -0.593 . . . . 26.940000000000001 109.846 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 63.03 -160.74 0.3 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.447 -0.797 . . . . 25.829999999999998 109.932 -175.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t70 69.26 27.21 5.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.804 0.811 . . . . 23.530000000000001 110.146 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -84.52 69.68 10.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.494 0.664 . . . . 21.640000000000001 110.117 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 7.4 p -87.62 117.29 68.33 Favored Pre-proline 0 N--CA 1.448 -0.569 0 CA-C-N 115.652 -0.704 . . . . 19.420000000000002 110.021 175.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 34.9 Cg_exo -58.94 103.72 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.968 2.446 . . . . 17.170000000000002 112.747 -176.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -92.28 -11.29 35.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.625 -0.716 . . . . 17.469999999999999 109.746 177.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.27 148.08 32.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.501 -0.772 . . . . 15.630000000000001 110.215 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.9 110.97 2.94 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.821 -0.627 . . . . 12.039999999999999 112.03 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.2 m -98.4 113.34 64.02 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.882 -0.414 . . . . 10.67 109.882 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -61.53 100.39 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.863 2.375 . . . . 9.6899999999999995 112.296 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -105.28 107.85 19.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.263 -0.426 . . . . 7.7000000000000002 110.143 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -72.37 142.8 48.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.963 -0.562 . . . . 8.1400000000000006 109.771 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.51 116.07 63.45 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 116.151 -0.477 . . . . 5.96 110.678 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.53 -151.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.649 2.232 . . . . 6.1299999999999999 111.369 174.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.08 -34.87 71.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.167 0.508 . . . . 6.5300000000000002 109.787 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -88.46 107.73 19.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.531 . . . . 5.0099999999999998 109.592 172.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.532 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.3 pp -79.72 137.84 54.5 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 120.943 0.401 . . . . 4.2300000000000004 110.705 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.84 4.07 6.79 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.75 2.3 . . . . 4.1200000000000001 113.02 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -79.79 -66.27 0.9 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.226 -0.443 . . . . 3.8199999999999998 109.857 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.419 ' H ' ' CD1' ' A' ' 74' ' ' ILE . 21.4 t70 62.04 98.26 0.03 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.914 -1.039 . . . . 3.1600000000000001 111.777 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.8 mt -84.73 111.45 35.19 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.735 -0.666 . . . . 2.4500000000000002 109.688 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.97 135.06 33.86 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.603 2.202 . . . . 1.75 112.231 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.52 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.48 136.94 29.89 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.819 -0.628 . . . . 1.01 109.903 -178.732 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.55 151.58 7.2 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.358 2.706 . . . . 0.72999999999999998 112.574 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.13 -6.44 3.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.671 0.989 . . . . 1.04 113.671 -169.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 52.1 m-20 -110.34 2.02 18.84 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.886 -0.509 . . . . 1.6599999999999999 111.994 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -130.92 138.44 49.77 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.16 -0.681 . . . . 1.0 109.16 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.57 136.67 53.54 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.72 -0.392 . . . . 2.27 110.061 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.8 tt -85.37 126.44 33.76 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.454 0.645 . . . . 0.79000000000000004 109.29 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.444 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 51.1 mtp180 -143.34 118.75 10.28 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.863 -1.062 . . . . 3.21 109.507 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -80.73 110.16 15.97 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.283 -0.636 . . . . 2.46 109.283 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.9 p -164.32 109.26 0.98 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.474 -0.785 . . . . 1.5800000000000001 108.959 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.9 m -71.13 105.67 3.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.054 0.454 . . . . 1.8600000000000001 110.953 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -92.99 117.99 67.71 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.049 -0.723 . . . . 1.45 109.049 173.082 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -51.93 121.27 8.44 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.016 2.477 . . . . 1.6100000000000001 112.554 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.449 ' HA3' ' SG ' ' A' ' 176' ' ' CYS . . . 108.5 -16.34 34.61 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.015 -0.612 . . . . 1.74 112.45 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -135.21 -61.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.97 0.414 . . . . 1.4099999999999999 111.244 178.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.483 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 121.09 -123.22 5.47 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 121.055 -0.593 . . . . 1.0900000000000001 111.925 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mt -102.23 158.43 16.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.931 -0.396 . . . . 2.3100000000000001 109.931 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -167.17 177.52 41.73 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.616 -0.802 . . . . 0.58999999999999997 112.013 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.87 114.95 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.494 0.664 . . . . 0.67000000000000004 109.689 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.444 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 51.3 m95 -82.76 127.55 33.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.583 -0.735 . . . . 1.1299999999999999 111.405 -169.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -74.87 116.19 15.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.686 -0.688 . . . . 0.54000000000000004 110.465 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.5 OUTLIER -90.45 1.0 57.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 1.6799999999999999 110.096 -178.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 102' ' ' ARG . 17.4 ttp180 -140.46 156.18 46.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.552 -0.749 . . . . 3.5 109.13 175.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -80.4 159.0 25.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.112 0.482 . . . . 2.3999999999999999 110.738 -178.621 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.689 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 55.3 mtm -129.46 152.11 49.36 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.064 -0.516 . . . . 1.22 110.026 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -121.5 139.81 53.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.117 -0.492 . . . . 2.3100000000000001 110.273 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -39.19 125.04 1.57 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 124.708 1.255 . . . . 0.83999999999999997 113.264 -170.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.26 7.03 12.87 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.319 -0.855 . . . . 1.04 111.094 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.62 162.18 18.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.116 0.484 . . . . 2.6200000000000001 110.929 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.586 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 6.3 tmm_? -146.96 132.29 18.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.982 -0.554 . . . . 3.6200000000000001 110.301 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 4.7 mt -95.26 130.78 41.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.027 -0.731 . . . . 0.53000000000000003 109.027 173.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.13 166.6 38.28 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.308 -0.949 . . . . 1.02 112.426 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.469 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 94.5 Cg_endo -87.17 158.12 48.58 Favored 'Cis proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.917 -1.701 . . . . 2.1000000000000001 112.553 -2.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.3 t -102.74 -52.46 3.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.367 0.603 . . . . 2.0 109.557 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -158.11 133.76 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.581 -0.736 . . . . 2.0299999999999998 109.435 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 119' ' ' ALA . 34.0 m -133.64 163.45 37.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.911 -0.586 . . . . 3.9500000000000002 109.867 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.493 ' HB ' ' HD3' ' A' ' 117' ' ' PRO . 17.8 t -65.21 -54.71 30.87 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 112.178 0.436 . . . . 5.21 112.178 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.493 ' HD3' ' HB ' ' A' ' 116' ' ' VAL . 71.6 Cg_endo -73.77 135.95 22.4 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.828 1.686 . . . . 5.0700000000000003 112.956 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 71.01 -52.31 0.68 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.14 0.793 . . . . 7.9900000000000002 113.14 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 115' ' ' VAL . . . -72.74 161.34 30.87 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.222 -0.288 . . . . 6.9500000000000002 110.222 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.514 ' HB1' ' HE2' ' A' ' 122' ' ' LYS . . . -114.75 102.25 9.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.892 0.377 . . . . 6.0899999999999999 110.799 -177.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.21 97.3 7.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.988 -0.551 . . . . 5.5599999999999996 110.891 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.514 ' HE2' ' HB1' ' A' ' 120' ' ' ALA . 74.5 mmtt -93.79 135.77 34.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.513 -0.767 . . . . 7.4199999999999999 110.674 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -77.02 -25.23 52.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.744 -0.662 . . . . 9.0099999999999998 109.546 174.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.6 m -47.25 -51.91 17.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.847 -1.07 . . . . 8.8800000000000008 111.07 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -85.53 79.73 9.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.861 -0.609 . . . . 7.5999999999999996 110.501 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -90.06 104.06 16.67 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.888 0.852 . . . . 7.2300000000000004 110.895 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -138.86 5.75 3.11 Favored Glycine 0 C--N 1.316 -0.565 0 CA-C-N 114.805 -1.089 . . . . 4.5899999999999999 111.529 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TRP . . . . . 0.496 ' HE3' ' N ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -114.1 -113.7 0.34 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.276 -0.462 . . . . 4.9299999999999997 110.923 -177.225 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.496 ' N ' ' HE3' ' A' ' 128' ' ' TRP . 5.9 pt-20 -142.26 -49.15 0.36 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.276 -0.268 . . . . 7.6500000000000004 110.276 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -175.57 125.23 0.23 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.54 -0.3 . . . . 8.8399999999999999 110.216 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 pp -119.33 18.17 6.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.824 0.345 . . . . 6.0499999999999998 111.345 175.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.2 mp -74.65 88.57 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.967 -0.561 . . . . 8.5 110.071 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.2 t -170.39 82.0 0.1 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.057 0.932 . . . . 9.8200000000000003 110.209 -174.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.25 67.52 7.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.624 -0.716 . . . . 11.210000000000001 110.19 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.452 HG12 HG21 ' A' ' 116' ' ' VAL . 15.0 p -60.89 136.08 24.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.515 -0.766 . . . . 10.84 110.883 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -65.59 118.14 9.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.783 -0.644 . . . . 13.25 110.624 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.37 -10.73 12.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.021 -0.536 . . . . 13.890000000000001 110.419 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.0 m 58.84 77.69 0.39 Allowed Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 115.174 -0.921 . . . . 14.050000000000001 111.227 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.62 130.13 25.58 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.759 2.306 . . . . 14.41 111.783 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -84.96 65.32 9.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.247 0.546 . . . . 14.44 110.846 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -100.2 148.08 25.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.86 -0.609 . . . . 15.9 110.177 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.47 52.39 0.55 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.719 -0.753 . . . . 15.6 112.016 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 64.3 m 61.56 43.74 9.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.344 0.592 . . . . 15.6 110.743 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 57.2 mt -127.48 83.76 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.586 -0.734 . . . . 13.85 109.869 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.9 p -126.76 88.0 2.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.97 0.414 . . . . 13.19 111.099 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -104.32 -13.14 16.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.965 -0.561 . . . . 15.67 110.247 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.459 ' H ' HG13 ' A' ' 147' ' ' ILE . 2.4 pp -72.46 155.84 7.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.61 -0.723 . . . . 13.77 111.374 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.5 p -164.24 54.3 0.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.26 0.552 . . . . 13.619999999999999 110.787 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.63 139.19 44.95 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.777 -0.647 . . . . 13.02 109.981 178.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -160.83 131.21 5.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.426 -0.352 . . . . 14.68 110.551 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 66.5 mt -72.72 93.56 1.66 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.964 -0.562 . . . . 13.550000000000001 110.13 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 136.79 35.38 0.2 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.657 -0.701 . . . . 15.800000000000001 112.037 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.1 p -117.0 -63.58 1.43 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.106 0.479 . . . . 17.079999999999998 109.923 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -99.31 -71.67 0.69 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.509 0.671 . . . . 18.43 109.368 175.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.41 160.7 29.76 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.075 -0.966 . . . . 18.530000000000001 108.667 174.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -149.86 143.11 25.1 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.79 -0.448 . . . . 14.32 109.79 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 48.5 t -160.91 -39.48 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.038 0.446 . . . . 14.51 110.403 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.2 t -87.03 127.11 40.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 13.06 110.391 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.477 ' OD1' ' HB2' ' A' ' 162' ' ' GLN . 18.1 t70 -65.18 106.67 1.36 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.914 -0.585 . . . . 10.33 110.191 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -107.62 -76.99 0.6 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.061 0.457 . . . . 9.8800000000000008 111.348 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -91.73 -1.34 57.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.97 -0.559 . . . . 10.23 111.981 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.477 ' HB2' ' OD1' ' A' ' 159' ' ' ASP . 15.9 mm100 -79.1 -25.47 43.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.973 0.416 . . . . 9.0600000000000005 110.752 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 63.17 32.98 14.75 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.245 -0.889 . . . . 6.1900000000000004 111.996 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -92.9 -29.56 10.43 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.332 -0.707 . . . . 3.9700000000000002 111.332 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.8 77.7 3.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.265 0.555 . . . . 2.6299999999999999 109.979 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . -158.21 -40.26 0.02 OUTLIER Glycine 0 C--N 1.316 -0.571 0 CA-C-N 114.933 -1.03 . . . . 1.3 111.071 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.655 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 13.5 m -64.59 -15.04 60.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.362 -0.419 . . . . 1.8200000000000001 111.47 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.59 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 17.5 p-90 -70.6 -25.99 63.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 0.69999999999999996 111.197 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.59 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 18.2 mt -86.3 -15.15 41.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.643 0.609 . . . . 0.66000000000000003 112.643 -173.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.655 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -77.8 -1.93 33.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.564 -0.454 . . . . 1.48 110.963 -179.296 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -84.38 -37.94 20.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.221 0.452 . . . . 1.97 112.221 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.747 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -65.07 128.64 28.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.975 0.417 . . . . 0.67000000000000004 110.616 -176.441 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -119.67 -164.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 4.3399999999999999 110.854 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.3 t -71.61 143.87 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.956 0.408 . . . . 1.0700000000000001 110.523 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -65.59 143.49 57.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.759 -0.655 . . . . 0.70999999999999996 111.111 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.449 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 42.0 t -63.52 -19.49 64.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.024 -0.989 . . . . 1.8799999999999999 111.354 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 180' ' ' ASP . 17.8 t -125.62 138.78 53.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.218 0.532 . . . . 1.6299999999999999 110.558 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' CYS . . . . . 0.554 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 8.6 p -77.49 -26.39 51.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.552 -0.749 . . . . 1.96 111.337 -176.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.47 -3.8 58.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.336 0.589 . . . . 2.4199999999999999 110.224 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 177' ' ' SER . 1.2 m-20 -107.81 16.26 23.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.434 -0.803 . . . . 2.1200000000000001 110.461 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.554 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 16.4 mm100 -58.36 120.17 8.26 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.374 0.607 . . . . 1.3500000000000001 110.961 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.584 ' ND2' HD11 ' A' ' 200' ' ' ILE . 13.5 t30 -142.86 35.54 1.4 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.394 -1.336 . . . . 1.6799999999999999 107.394 175.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.678 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.2 OUTLIER -120.44 125.0 46.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.526 -1.215 . . . . 0.81000000000000005 110.906 -173.114 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.5 m -150.5 133.08 15.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.923 0.392 . . . . 0.51000000000000001 110.703 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 48.7 ttm -100.27 140.19 34.87 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.654 -0.498 . . . . 1.3500000000000001 109.654 174.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 32.5 m -124.95 131.55 53.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.137 0.494 . . . . 1.73 111.138 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.74 104.96 14.79 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.656 -0.868 . . . . 1.9299999999999999 108.656 176.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 22.3 pt -139.19 144.4 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.921 -0.582 . . . . 1.1100000000000001 110.054 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.0 t 64.71 30.18 12.56 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.217 0.532 . . . . 1.8600000000000001 110.235 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 58.48 34.11 23.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.387 -0.824 . . . . 2.8300000000000001 111.355 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -145.3 154.44 42.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 1.75 110.711 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.99 128.45 45.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.167 -0.47 . . . . 1.01 111.749 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.586 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 40.9 m-85 -131.31 155.79 46.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.525 -0.761 . . . . 3.9399999999999999 110.565 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.483 ' CE1' ' HB3' ' A' ' 169' ' ' LEU . 11.3 m-85 -103.5 114.52 28.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.96 -0.755 . . . . 0.92000000000000004 108.96 173.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -100.1 118.83 37.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.175 -0.466 . . . . 1.1100000000000001 109.887 -175.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.455 HG12 HD21 ' A' ' 182' ' ' ASN . 1.9 t -83.38 152.16 3.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.408 0.623 . . . . 0.69999999999999996 109.649 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.1 mm -94.01 -55.15 6.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.912 -1.04 . . . . 0.62 111.202 -167.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.481 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -143.85 -179.71 6.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 1.3799999999999999 111.963 -179.443 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.689 ' HA ' ' O ' ' A' ' 104' ' ' MET . 23.7 t70 -45.89 121.98 3.51 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.3 1.0 . . . . 2.23 113.009 -175.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.584 HD11 ' ND2' ' A' ' 182' ' ' ASN . 21.1 mm -92.23 130.77 40.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.999 -1.0 . . . . 0.88 111.38 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 11.8 mm-40 -76.93 121.59 85.01 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.38 -0.827 . . . . 2.0600000000000001 108.933 171.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.88 114.1 1.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.001 1.801 . . . . 0.51000000000000001 111.181 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.15 -0.53 10.65 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.57 -0.824 . . . . 0.69999999999999996 113.428 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 10.2 pt-20 -133.45 123.38 25.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.492 0.646 . . . . 1.27 111.145 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.05 96.44 6.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.75 -0.659 . . . . 2.9199999999999999 111.754 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.505 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.3 mm? -113.03 99.03 7.54 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.835 -0.746 . . . . 0.90000000000000002 109.773 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.747 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -145.57 114.1 6.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.554 0.341 . . . . 0.53000000000000003 110.452 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.678 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.8 p -155.83 160.48 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.137 -0.32 . . . . 0.91000000000000003 110.137 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -93.22 110.2 21.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.006 -1.109 . . . . 1.55 108.006 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 14.8 m -72.48 117.31 15.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.257 0.551 . . . . 2.5600000000000001 110.213 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -74.21 129.8 38.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.676 0.75 . . . . 5.3600000000000003 112.708 -170.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 0.0 OUTLIER -111.95 -14.28 13.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.514 -1.221 . . . . 5.7999999999999998 109.405 174.144 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 94.44 79.35 1.45 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 114.656 -1.156 . . . . 5.6100000000000003 112.668 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 45.6 t -111.95 -78.57 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.773 0.32 . . . . 6.3099999999999996 110.931 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.562 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 75.9 t80 -66.32 -52.63 36.23 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 111.85 0.315 . . . . 8.8300000000000001 111.85 -177.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 12.5 Cg_endo -54.08 -39.68 84.66 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.613 2.209 . . . . 7.7800000000000002 112.867 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 mp -84.55 -4.86 59.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.251 -0.431 . . . . 8.0199999999999996 111.913 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 61.97 46.9 93.13 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.941 -0.572 . . . . 8.6400000000000006 112.918 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.9 p -83.54 -36.12 24.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.911 0.386 . . . . 9.7200000000000006 111.211 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 221' ' ' PRO . 24.3 m -67.25 138.84 94.58 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.021 -0.536 . . . . 9.6199999999999992 111.085 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 5.1 Cg_exo -79.26 120.24 4.45 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.688 2.259 . . . . 11.65 111.97 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.69 50.68 3.51 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.879 2.386 . . . . 13.109999999999999 111.96 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -179.9 153.12 11.59 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.064 -0.814 . . . . 14.029999999999999 111.064 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 48.1 tp -120.12 125.69 48.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.138 0.494 . . . . 16.100000000000001 110.881 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -139.93 17.19 2.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.47 -0.787 . . . . 17.699999999999999 109.371 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 C--O 1.249 1.032 0 CA-C-N 115.098 -0.955 . . . . 18.899999999999999 110.068 -177.041 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 112.529 -0.228 . . . . 33.259999999999998 112.529 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.0 m -91.05 22.83 3.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.836 0.35 . . . . 33.920000000000002 111.547 -176.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.03 -156.89 53.41 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.891 -0.671 . . . . 32.350000000000001 112.138 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -148.69 95.48 3.96 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.926 -0.398 . . . . 31.649999999999999 109.926 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.9 107.41 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.859 2.373 . . . . 29.989999999999998 111.599 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.5 m -106.98 81.62 1.58 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.238 0.542 . . . . 28.920000000000002 110.231 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.6 t -92.56 151.04 20.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.963 -0.562 . . . . 26.940000000000001 110.141 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -152.19 145.26 24.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.245 -0.434 . . . . 25.829999999999998 109.995 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -85.04 109.33 18.13 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.085 -0.709 . . . . 23.530000000000001 109.085 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -79.28 65.06 4.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.029 -0.532 . . . . 21.640000000000001 110.925 -175.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.9 p -59.22 127.81 84.59 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.555 -0.748 . . . . 19.420000000000002 110.878 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.42 95.54 0.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.811 2.341 . . . . 17.170000000000002 112.283 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -113.26 87.6 2.64 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.299 -0.864 . . . . 17.469999999999999 109.747 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -108.94 155.47 20.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.307 -0.406 . . . . 15.630000000000001 110.116 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.78 -156.97 24.14 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.802 -0.713 . . . . 12.039999999999999 111.812 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.3 p -112.17 98.15 41.66 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 110.224 -0.287 . . . . 10.67 110.224 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.19 106.98 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.673 2.248 . . . . 9.6899999999999995 112.344 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -119.97 139.27 52.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.084 -0.507 . . . . 7.7000000000000002 109.874 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -128.51 145.49 51.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.864 0.364 . . . . 8.1400000000000006 110.368 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.87 124.18 55.33 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.825 -0.625 . . . . 5.96 110.021 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.78 -165.55 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.596 2.198 . . . . 6.1299999999999999 112.089 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.2 m -60.01 -37.77 73.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.734 0.302 . . . . 6.5300000000000002 111.262 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -105.45 127.7 53.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.884 -0.413 . . . . 5.0099999999999998 109.884 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.562 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.2 pp -77.77 141.11 63.81 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.138 -0.483 . . . . 4.2300000000000004 111.573 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.3 28.25 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.887 2.391 . . . . 4.1200000000000001 112.515 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -92.55 -68.69 0.78 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.332 -0.394 . . . . 3.8199999999999998 111.032 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.95 68.52 0.57 Allowed 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.716 0.635 . . . . 3.1600000000000001 110.183 -175.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.1 mt -76.68 119.1 75.98 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.481 -0.781 . . . . 2.4500000000000002 110.496 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.33 120.41 7.55 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.607 2.205 . . . . 1.75 112.114 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.64 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -113.11 141.67 26.04 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.308 -0.405 . . . . 1.01 109.921 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.32 144.67 70.73 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.773 2.315 . . . . 0.72999999999999998 112.14 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.662 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -62.82 -13.08 29.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.526 -0.761 . . . . 1.04 112.332 -173.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.95 -9.84 59.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.107 -0.497 . . . . 1.6599999999999999 111.062 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.551 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 9.3 m-85 -138.13 149.97 46.4 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 -173.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.567 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 9.5 tp10 -125.27 133.84 52.51 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.428 -0.509 . . . . 2.27 111.316 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.88 122.79 33.26 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.214 -0.661 . . . . 0.79000000000000004 109.214 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.445 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 39.8 mmt180 -147.28 124.58 11.55 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.913 -1.04 . . . . 3.21 109.452 -174.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.1 110.56 8.49 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.106 -0.702 . . . . 2.46 109.106 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.8 m -143.99 94.18 2.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.603 -0.726 . . . . 1.5800000000000001 109.133 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -64.64 101.86 0.51 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.472 0.654 . . . . 1.8600000000000001 111.357 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.581 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -108.91 117.03 54.77 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 108.501 -0.926 . . . . 1.45 108.501 172.211 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.86 123.48 13.61 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.907 2.404 . . . . 1.6100000000000001 112.542 -173.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.51 -23.69 23.91 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.132 -0.556 . . . . 1.74 112.5 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -114.95 -68.33 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.95 -0.3 . . . . 1.4099999999999999 111.513 -178.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.84 -158.09 15.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.665 -0.779 . . . . 1.0900000000000001 112.339 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.466 ' C ' ' HD3' ' A' ' 173' ' ' ARG . 8.3 mt -101.17 122.55 43.82 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.684 0.242 . . . . 2.3100000000000001 110.908 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -133.97 -159.35 8.9 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.711 -0.757 . . . . 0.58999999999999997 112.388 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 98' ' ' VAL . 17.3 m -112.29 105.02 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 122.094 0.95 . . . . 0.67000000000000004 109.812 177.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.445 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 6.4 m95 -83.3 123.28 29.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.173 -0.921 . . . . 1.1299999999999999 110.194 -171.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.89 117.79 6.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.134 -0.485 . . . . 0.54000000000000004 110.367 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.662 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -78.83 -0.15 29.45 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.063 0.459 . . . . 1.6799999999999999 110.676 178.18 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 34.5 ttp180 -141.48 162.86 34.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.666 -0.864 . . . . 3.5 108.666 178.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.419 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -79.09 160.02 27.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.273 0.558 . . . . 2.3999999999999999 111.182 178.316 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.567 ' HE3' HG13 ' A' ' 200' ' ' ILE . 44.9 mtm -130.77 153.04 49.47 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.063 -1.088 . . . . 1.22 108.063 172.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -126.66 146.97 49.99 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.091 0.244 . . . . 2.3100000000000001 110.764 -177.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -36.34 121.13 0.69 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.716 1.26 . . . . 0.83999999999999997 113.77 -168.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.2 6.83 13.18 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.268 -0.878 . . . . 1.04 111.349 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.491 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -85.03 157.01 20.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.05 0.453 . . . . 2.6200000000000001 110.253 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.697 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 5.9 tmm_? -146.47 133.79 20.66 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.096 -0.502 . . . . 3.6200000000000001 110.189 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.551 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 3.9 mt -96.92 135.68 38.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.429 -0.952 . . . . 0.53000000000000003 108.429 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.67 169.63 38.25 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.878 -1.153 . . . . 1.02 112.732 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.599 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 74.0 Cg_endo -77.8 167.14 79.48 Favored 'Cis proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.977 -1.676 . . . . 2.1000000000000001 112.297 -1.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.8 t -109.52 -1.6 18.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.071 0.462 . . . . 2.0 110.539 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.38 149.37 20.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.01 0.433 . . . . 2.0299999999999998 111.236 -176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.5 p -140.57 97.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.395 -0.82 . . . . 3.9500000000000002 109.397 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.522 ' CG1' ' HD3' ' A' ' 117' ' ' PRO . 3.2 p -75.29 -34.11 1.56 Allowed Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 113.265 0.839 . . . . 5.21 113.265 -176.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.522 ' HD3' ' CG1' ' A' ' 116' ' ' VAL . 15.7 Cg_exo -69.46 101.61 0.89 Allowed 'Trans proline' 0 C--N 1.363 1.306 0 CA-C-N 120.891 1.354 . . . . 5.0700000000000003 111.662 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.8 mtp-105 70.08 153.63 0.12 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.918 0.761 . . . . 7.9900000000000002 111.124 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 63.65 -91.06 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.998 -0.546 . . . . 6.9500000000000002 111.272 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 53.39 59.97 4.03 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.253 0.549 . . . . 6.0899999999999999 111.662 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.99 122.0 36.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.782 -0.645 . . . . 5.5599999999999996 111.356 -177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.406 ' HD2' ' HB3' ' A' ' 126' ' ' PHE . 23.8 pttm -75.91 144.19 41.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.689 -0.687 . . . . 7.4199999999999999 109.971 176.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -133.63 -39.86 0.89 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.811 0.3 . . . . 9.0099999999999998 111.811 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 41.0 m -83.36 -69.0 0.66 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.749 0.309 . . . . 8.8800000000000008 111.162 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.92 172.67 13.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.601 -0.518 . . . . 7.5999999999999996 109.601 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.406 ' HB3' ' HD2' ' A' ' 122' ' ' LYS . 23.7 p90 -133.96 126.56 30.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.381 0.61 . . . . 7.2300000000000004 111.012 -177.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.08 -13.64 53.95 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.635 -0.793 . . . . 4.5899999999999999 111.421 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TRP . . . . . 0.427 ' CZ2' HG23 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -138.76 -101.43 0.17 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.495 -0.353 . . . . 4.9299999999999997 111.392 179.154 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -146.92 -59.95 0.29 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.495 -0.321 . . . . 7.6500000000000004 110.74 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -166.47 159.94 14.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.047 -0.353 . . . . 8.8399999999999999 110.047 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.591 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -113.12 -5.39 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.606 -0.27 . . . . 6.0499999999999998 111.522 178.681 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.77 51.92 1.61 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.25 1.024 . . . . 8.5 111.179 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 12.8 t -122.86 17.33 10.18 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.073 -1.421 . . . . 9.8200000000000003 109.034 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.443 ' HB3' HG21 ' A' ' 116' ' ' VAL . 31.1 t70 -122.41 126.04 47.14 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.324 -1.307 . . . . 11.210000000000001 108.984 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.8 t -75.7 115.56 17.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.041 -0.527 . . . . 10.84 111.267 -173.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.21 150.15 47.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.516 -0.766 . . . . 13.25 109.769 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.3 m -92.02 43.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.394 0.616 . . . . 13.890000000000001 110.877 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.7 m -124.94 72.8 64.11 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.643 -0.708 . . . . 14.050000000000001 110.706 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.42 122.95 9.43 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.724 2.283 . . . . 14.41 111.465 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 60.96 81.17 0.19 Allowed 'General case' 0 C--O 1.232 0.145 0 O-C-N 123.669 0.606 . . . . 14.44 111.077 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.84 124.57 19.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.315 -0.402 . . . . 15.9 110.387 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.24 84.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.439 -0.665 . . . . 15.6 111.439 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 49.6 t 59.37 73.35 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.445 0.64 . . . . 15.6 110.594 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 73.2 mt -106.1 -44.29 7.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.608 -0.724 . . . . 13.85 110.069 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 38.6 p 48.95 69.89 0.53 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.766 -0.652 . . . . 13.19 111.916 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -95.3 -13.13 25.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.691 -0.686 . . . . 15.67 110.154 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 147' ' ' ILE . 2.1 pp -86.61 166.58 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.576 -0.738 . . . . 13.77 111.566 -177.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.5 t -164.59 134.5 3.88 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.195 -1.039 . . . . 13.619999999999999 108.195 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 66.57 75.62 0.32 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.854 0.721 . . . . 13.02 110.99 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -76.33 149.03 37.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.531 -0.759 . . . . 14.68 109.944 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.534 ' HB3' ' O ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -90.79 87.27 6.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.626 0.727 . . . . 13.550000000000001 112.181 -174.405 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -112.86 64.45 0.27 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.012 -0.835 . . . . 15.800000000000001 111.012 171.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.9 t 69.38 21.15 7.05 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.219 0.608 . . . . 17.079999999999998 110.559 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -98.52 -77.34 0.51 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.862 -0.608 . . . . 18.43 110.619 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 151' ' ' LEU . 15.9 ptpt -143.65 153.52 42.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.214 -0.903 . . . . 18.530000000000001 109.94 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -110.86 79.27 1.19 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.174 0.511 . . . . 14.32 110.19 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 47.2 t -69.34 122.42 18.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.688 -0.687 . . . . 14.51 110.766 -178.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.31 147.11 7.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.82 -0.627 . . . . 13.06 110.336 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 55.05 52.51 11.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.412 0.625 . . . . 10.33 110.453 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.14 -65.57 0.07 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.987 -1.006 . . . . 9.8800000000000008 110.463 -176.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -129.98 23.18 5.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.52 . . . . 10.23 111.623 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -86.85 -40.07 15.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.86 0.362 . . . . 9.0600000000000005 110.98 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.26 136.32 51.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.097 -0.501 . . . . 6.1900000000000004 110.628 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 140.23 -40.23 1.41 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.775 -0.726 . . . . 3.9700000000000002 111.668 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.97 66.8 6.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.247 0.546 . . . . 2.6299999999999999 110.698 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . -130.9 -33.11 0.48 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.339 -0.846 . . . . 1.3 112.63 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.648 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 2.9 m -63.79 -14.86 56.37 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.669 0.388 . . . . 1.8200000000000001 111.989 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' TRP . . . . . 0.498 ' HB2' HG22 ' A' ' 80' ' ' ILE . 19.7 p-90 -69.39 -21.42 63.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.988 0.366 . . . . 0.69999999999999996 111.988 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 169' ' ' LEU . 18.3 mt -80.73 -14.56 58.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.942 0.719 . . . . 0.66000000000000003 112.942 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.648 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -68.04 -10.44 53.75 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.286 -0.566 . . . . 1.48 110.205 176.334 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.565 ' O ' ' HD2' ' A' ' 173' ' ' ARG . 50.9 m-85 -78.89 -27.89 43.95 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.749 -0.66 . . . . 1.97 112.4 -175.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.647 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 1.6 mm -57.87 139.05 18.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 117.895 0.316 . . . . 0.67000000000000004 111.289 -175.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.565 ' HD2' ' O ' ' A' ' 171' ' ' TYR . 18.2 mmm180 -95.24 147.67 23.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.103 0.478 . . . . 4.3399999999999999 112.034 -174.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.434 HG22 HG11 ' A' ' 208' ' ' VAL . 81.6 t -66.56 148.61 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.374 -0.83 . . . . 1.0700000000000001 108.773 168.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.738 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -57.32 122.94 13.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.026 0.441 . . . . 0.70999999999999996 112.108 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.56 -28.7 68.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.573 -0.74 . . . . 1.8799999999999999 109.967 175.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.0 p -126.73 139.51 53.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.879 -0.6 . . . . 1.6299999999999999 110.614 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 54.0 t -76.97 -8.41 57.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.992 -0.549 . . . . 1.96 111.093 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.02 -3.87 58.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.204 0.526 . . . . 2.4199999999999999 110.238 177.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -111.81 17.91 19.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.638 -0.71 . . . . 2.1200000000000001 111.816 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -55.43 114.84 1.99 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.289 0.566 . . . . 1.3500000000000001 110.897 -176.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.862 ' H ' HD12 ' A' ' 183' ' ' LEU . 18.3 t30 -155.03 32.49 0.39 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 122.062 0.934 . . . . 1.6799999999999999 108.7 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.862 HD12 ' H ' ' A' ' 182' ' ' ASN . 2.0 mp -115.36 120.36 39.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.381 -0.827 . . . . 0.81000000000000005 110.975 -173.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 95.4 m -148.66 138.96 22.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.324 0.583 . . . . 0.51000000000000001 111.366 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' MET . . . . . 0.466 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 65.5 mtp -120.71 135.51 55.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.93 -0.577 . . . . 1.3500000000000001 109.758 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 44.2 t -114.52 141.9 47.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.93 0.395 . . . . 1.73 110.736 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLN . . . . . 0.416 ' HG2' HD13 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -106.71 103.93 13.49 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.026 -0.731 . . . . 1.9299999999999999 109.026 177.275 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 11.6 pt -146.34 145.08 20.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.967 -0.56 . . . . 1.1100000000000001 110.218 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.4 t 67.3 33.91 5.14 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.509 0.506 . . . . 1.8600000000000001 110.242 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 66.33 8.38 5.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.419 -0.809 . . . . 2.8300000000000001 111.701 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.35 167.72 19.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.062 0.458 . . . . 1.75 110.935 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.416 HD13 ' HG2' ' A' ' 187' ' ' GLN . 50.2 mm -98.35 128.45 49.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.674 -0.694 . . . . 1.01 110.469 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.697 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 2.2 m-85 -118.44 146.95 44.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.161 0.505 . . . . 3.9399999999999999 110.708 175.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 3.2 m-85 -100.95 113.2 25.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.934 -0.765 . . . . 0.92000000000000004 108.934 175.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -111.57 123.8 50.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.925 0.393 . . . . 1.1100000000000001 110.184 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.494 ' CG1' HD21 ' A' ' 182' ' ' ASN . 2.1 t -93.67 152.3 3.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.777 0.799 . . . . 0.69999999999999996 110.386 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.2 mm -92.98 -54.83 6.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.433 -1.258 . . . . 0.62 110.801 -166.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.49 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -138.78 -179.25 5.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.437 -0.801 . . . . 1.3799999999999999 110.1 178.312 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 104' ' ' MET . 4.8 p-10 -56.09 135.8 52.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.68 0.752 . . . . 2.23 112.389 -173.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.567 HG13 ' HE3' ' A' ' 104' ' ' MET . 28.4 mm -96.48 138.11 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.238 -0.892 . . . . 0.88 110.817 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -83.34 127.51 68.29 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.949 -0.569 . . . . 2.0600000000000001 109.534 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.2 115.57 2.26 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.835 2.357 . . . . 0.51000000000000001 112.367 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.0 -12.94 9.17 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.471 -0.871 . . . . 0.69999999999999996 113.543 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.76 123.0 34.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.563 0.681 . . . . 1.27 111.504 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.647 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -110.47 112.1 23.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.766 -0.652 . . . . 2.9199999999999999 111.142 177.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.502 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 0.9 OUTLIER -122.51 98.96 6.16 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.317 -0.553 . . . . 0.90000000000000002 109.606 173.551 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.621 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.7 mm? -147.74 106.55 3.83 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.722 -0.473 . . . . 0.53000000000000003 109.722 175.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.753 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 19.5 t -154.91 157.45 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.014 -1.106 . . . . 0.91000000000000003 108.014 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 3.6 t-80 -89.23 109.86 20.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.731 -0.84 . . . . 1.55 108.731 173.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.8 93.89 2.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.624 0.726 . . . . 2.5600000000000001 110.665 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -142.01 139.69 32.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.369 -0.832 . . . . 5.3600000000000003 109.893 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -89.75 1.13 56.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.214 -0.448 . . . . 5.7999999999999998 111.184 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.443 ' CA ' ' HB2' ' A' ' 217' ' ' LEU . . . -139.09 65.89 0.53 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.616 -0.802 . . . . 5.6100000000000003 112.647 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 41.3 t -103.49 -72.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.831 0.348 . . . . 6.3099999999999996 110.611 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' TYR . . . . . 0.44 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 66.8 t80 -82.33 -57.17 0.49 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.218 -0.446 . . . . 8.8300000000000001 111.214 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 18.9 Cg_endo -60.43 -43.1 35.89 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.252 1.968 . . . . 7.7800000000000002 112.828 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.443 ' HB2' ' CA ' ' A' ' 213' ' ' GLY . 7.2 mp -99.73 25.82 6.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.95 0.405 . . . . 8.0199999999999996 110.782 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -104.9 169.73 17.11 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.781 -0.724 . . . . 8.6400000000000006 112.077 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 17.3 p -85.28 -2.31 57.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.982 0.42 . . . . 9.7200000000000006 110.852 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' VAL . . . . . 0.425 ' O ' ' HD3' ' A' ' 222' ' ' PRO . 23.5 m -63.31 129.21 93.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.774 -0.648 . . . . 9.6199999999999992 110.218 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.07 112.17 3.03 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.48 2.12 . . . . 11.65 112.941 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 220' ' ' VAL . 92.2 Cg_endo -85.28 3.38 7.32 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.715 2.277 . . . . 13.109999999999999 111.438 176.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 224' ' ' LEU . . . 166.23 169.57 30.01 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.195 -1.162 . . . . 14.029999999999999 110.195 -177.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' A' ' 223' ' ' GLY . 59.1 tp 70.79 136.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.335 0.588 . . . . 16.100000000000001 111.366 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -140.6 -51.89 0.47 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.823 -0.626 . . . . 17.699999999999999 110.314 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--O 1.249 1.064 0 CA-C-N 116.044 -0.525 . . . . 18.899999999999999 110.564 179.79 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.8 mt . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 110.172 -0.307 . . . . 2.45 110.172 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.17 127.53 20.44 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.384 2.056 . . . . 1.75 111.589 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.526 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.97 151.62 78.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.97 -0.559 . . . . 1.01 109.917 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.66 139.72 87.21 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.567 2.178 . . . . 0.73 111.241 174.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.661 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -67.73 -7.65 28.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.637 0.606 . . . . 1.04 112.637 -172.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.487 ' OD2' ' HD3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -80.01 -9.61 59.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.724 0.297 . . . . 1.66 111.492 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.524 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 8.4 m-85 -140.18 146.76 39.16 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 -173.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 99' ' ' TRP . 13.3 pt-20 -114.2 135.21 54.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.982 0.42 . . . . 2.27 110.946 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.2 tt -101.71 129.94 47.98 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.324 -0.991 . . . . 0.79 108.324 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -162.47 150.71 14.43 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.433 -0.803 . . . . 3.21 109.792 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -82.99 111.36 18.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.0 -0.741 . . . . 2.46 109.0 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.2 p -149.07 90.7 1.77 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.773 -0.649 . . . . 1.58 109.365 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.1 m -68.43 104.12 1.82 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.248 0.547 . . . . 1.86 110.805 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -94.89 118.95 66.63 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.649 -0.705 . . . . 1.45 109.199 174.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -52.44 121.22 8.65 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.251 2.634 . . . . 1.61 112.466 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.545 ' HA3' ' SG ' ' A' ' 176' ' ' CYS . . . 108.23 -16.02 35.68 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.843 -0.694 . . . . 1.74 112.36 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.436 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -135.89 -71.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.724 -0.28 . . . . 1.41 111.395 177.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.528 ' HA3' ' NH1' ' A' ' 173' ' ' ARG . . . 133.38 -127.91 4.85 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.877 -0.678 . . . . 1.09 111.954 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.0 mt -97.66 147.6 24.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.655 0.228 . . . . 2.31 110.5 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -158.21 171.4 35.12 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.585 -0.606 . . . . 0.59 111.585 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 27.7 m -99.31 111.58 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.497 0.665 . . . . 0.67 110.037 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.538 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 59.2 m95 -81.57 124.52 29.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.852 -0.613 . . . . 1.13 110.316 -172.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 202' ' ' PRO . . . -68.98 114.81 7.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.582 -0.525 . . . . 0.54 109.582 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.661 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -82.62 -9.48 59.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.37 0.605 . . . . 1.68 109.669 177.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.487 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 63.4 ttt180 -125.11 162.55 24.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.31 -0.859 . . . . 3.5 108.823 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.602 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -91.53 158.72 16.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.874 0.369 . . . . 2.4 110.952 -176.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.491 ' HE3' HG13 ' A' ' 200' ' ' ILE . 64.4 mtm -135.42 152.59 51.54 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.103 -0.703 . . . . 1.22 109.103 176.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -113.05 147.74 36.62 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.092 0.245 . . . . 2.31 110.516 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.81 123.97 2.91 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 124.474 1.109 . . . . 0.84 112.973 -170.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.75 7.7 13.01 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.451 -0.795 . . . . 1.04 111.183 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.508 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 1.0 OUTLIER -84.04 157.59 21.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.507 0.67 . . . . 2.62 110.923 -178.052 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.657 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 2.7 tmm_? -144.1 134.09 24.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.494 -0.776 . . . . 3.62 109.546 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.524 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 6.3 mt -87.76 137.36 32.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.875 -0.33 . . . . 0.53 110.119 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.38 170.99 43.76 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.917 -0.659 . . . . 1.02 111.481 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -88.62 148.38 27.1 Favored 'Cis proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.181 -1.591 . . . . 2.1 112.491 -2.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.514 ' HB2' HD12 ' A' ' 169' ' ' LEU . 28.9 t . . . . . 0 C--N 1.328 -0.331 0 N-CA-C 108.958 -0.756 . . . . 2.0 108.958 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.448 -0.512 0 N-CA-C 112.947 -0.061 . . . . 1.3 112.947 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.676 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 23.1 t -65.56 -16.0 63.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.859 0.361 . . . . 1.82 111.349 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.558 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 24.4 p-90 -64.88 -23.82 67.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.846 0.355 . . . . 0.7 111.184 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.558 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 17.8 mt -86.3 -15.01 41.96 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.825 0.676 . . . . 0.66 112.825 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.676 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -82.17 -2.01 50.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.013 -0.675 . . . . 1.48 110.785 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -79.2 -36.88 39.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.189 -0.459 . . . . 1.97 112.077 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.847 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -64.39 133.0 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.861 0.362 . . . . 0.67 111.03 -176.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.528 ' NH1' ' HA3' ' A' ' 95' ' ' GLY . 98.8 mtt180 -118.53 -172.92 2.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 4.34 111.222 -174.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -71.31 145.0 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.177 -0.465 . . . . 1.07 110.314 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.496 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -59.61 135.88 57.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.919 -0.582 . . . . 0.71 111.563 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.545 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 41.6 t -57.1 -34.56 68.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.609 -1.178 . . . . 1.88 111.629 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.7 p -126.7 144.15 51.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.072 0.463 . . . . 1.63 110.949 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 46.0 t -72.51 -9.71 58.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.789 -0.641 . . . . 1.96 110.808 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.68 -11.77 55.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.187 0.518 . . . . 2.42 110.059 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -110.21 16.64 21.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 2.12 111.347 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -60.95 115.14 3.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 1.35 110.474 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.631 ' H ' HD12 ' A' ' 183' ' ' LEU . 18.0 t30 -154.82 38.17 0.42 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 122.084 0.945 . . . . 1.68 108.538 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.631 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.1 OUTLIER -123.18 129.93 52.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.13 -0.941 . . . . 0.81 110.711 -173.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 43.0 m -151.21 137.32 18.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.058 0.456 . . . . 0.51 111.467 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 51.2 tpp -88.18 134.91 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.952 -0.567 . . . . 1.35 110.65 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 195' ' ' LYS . 39.9 t -113.15 131.93 55.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.939 -0.573 . . . . 1.73 110.387 176.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.519 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 25.2 tm0? -123.09 105.54 10.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.272 -0.64 . . . . 1.93 109.272 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.614 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 22.0 pt -136.84 142.58 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.191 -0.458 . . . . 1.11 110.426 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.9 m 57.48 27.07 13.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.403 0.439 . . . . 1.86 111.303 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.519 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 0.7 OUTLIER 64.5 14.56 9.0 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.7 -0.682 . . . . 2.83 112.475 -178.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 16.3 pt20 -117.75 159.66 22.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.551 -0.537 . . . . 1.75 109.551 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.4 133.47 44.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.398 -0.364 . . . . 1.01 111.965 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.657 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 43.2 m-85 -141.42 150.62 42.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.702 -0.681 . . . . 3.94 110.499 176.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.464 ' CE1' ' HB3' ' A' ' 169' ' ' LEU . 13.4 m-85 -101.17 114.21 27.95 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.437 -0.579 . . . . 0.92 109.437 175.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.421 ' HD2' ' C ' ' A' ' 195' ' ' LYS . 5.2 tmmm? -98.78 127.05 44.59 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.4 -0.593 . . . . 1.11 109.4 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.508 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 2.0 t -93.01 151.26 3.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.627 0.727 . . . . 0.7 110.015 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 197' ' ' ILE . 1.2 mm -85.68 -58.13 3.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.708 -1.133 . . . . 0.62 110.274 -168.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.44 ' HE3' ' C ' ' A' ' 198' ' ' LYS . 0.0 OUTLIER -137.07 179.87 6.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.335 -0.848 . . . . 1.38 110.771 176.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -48.16 136.9 11.3 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.097 0.873 . . . . 2.23 113.223 -170.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.491 HG13 ' HE3' ' A' ' 104' ' ' MET . 33.1 mm -102.48 133.65 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.737 -0.665 . . . . 0.88 110.268 176.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 202' ' ' PRO . 49.1 mt-10 -98.68 138.87 20.78 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.611 -0.722 . . . . 2.06 109.607 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 49.7 Cg_exo -55.77 115.28 2.34 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.457 2.105 . . . . 0.51 111.962 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.72 7.44 8.06 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.497 -0.859 . . . . 0.7 113.498 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.62 122.27 11.83 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.643 0.722 . . . . 1.27 111.535 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -111.78 95.36 5.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.817 -0.629 . . . . 2.92 112.03 177.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.484 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.4 mm? -115.65 97.68 6.27 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.33 -0.948 . . . . 0.9 109.46 173.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.847 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 0.9 OUTLIER -146.96 115.07 6.57 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.53 109.806 176.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.612 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.9 p -153.64 158.42 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 121.729 -0.607 . . . . 0.91 111.191 -177.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -84.89 110.92 19.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.28 -1.008 . . . . 1.55 108.28 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.223 0.535 . . . . 2.56 110.226 -178.764 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 41.5 mt . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 110.607 -0.145 . . . . 2.45 110.607 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.66 133.2 49.96 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.757 2.305 . . . . 1.75 112.798 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.581 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -125.68 146.6 55.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.59 -0.732 . . . . 1.01 109.891 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.64 147.9 76.92 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.683 2.255 . . . . 0.73 111.339 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.56 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -57.59 -23.58 51.61 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.462 0.912 . . . . 1.04 113.462 -170.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -89.83 8.35 32.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.596 0.591 . . . . 1.66 112.596 -173.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.457 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 23.8 m-85 -132.54 139.47 47.89 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.8 -0.815 . . . . 1.0 108.8 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.457 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 41.8 tt0 -114.36 119.56 37.35 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.839 -0.344 . . . . 2.27 111.103 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 tt -84.19 131.67 34.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.291 -0.633 . . . . 0.79 109.291 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -140.38 124.14 17.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.264 -0.426 . . . . 3.21 110.752 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -80.84 111.82 17.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.298 -0.631 . . . . 2.46 109.298 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -177.31 127.06 0.15 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.566 -0.901 . . . . 1.58 108.566 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.2 m -90.69 105.51 17.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.887 0.375 . . . . 1.86 111.132 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.538 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -85.44 123.62 72.66 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 108.766 -0.827 . . . . 1.45 108.766 174.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.5 119.13 5.69 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.337 2.691 . . . . 1.61 113.233 -172.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.7 -28.74 10.87 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.645 -0.707 . . . . 1.74 112.259 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -117.42 -58.45 2.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.898 0.38 . . . . 1.41 110.946 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 114.52 -138.68 15.03 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.894 -0.594 . . . . 1.09 111.722 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -73.32 159.74 32.91 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.503 -0.184 . . . . 2.31 110.503 175.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.57 178.17 46.46 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.576 -0.821 . . . . 0.59 112.269 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.65 148.33 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.239 -0.652 . . . . 0.67 109.239 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -119.14 120.21 36.44 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.074 -0.343 . . . . 1.13 110.074 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.508 ' H ' ' HG2' ' A' ' 205' ' ' GLU . . . -67.79 125.43 26.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.323 -0.399 . . . . 0.54 110.955 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.56 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -88.23 -1.04 57.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.881 0.372 . . . . 1.68 110.285 176.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 15.6 ttm-85 -125.7 152.62 45.03 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.392 -0.595 . . . . 3.5 109.392 174.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.54 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -76.7 159.62 30.04 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.358 -0.383 . . . . 2.4 110.728 176.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.672 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 47.3 mtm -134.25 152.11 51.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.51 -0.314 . . . . 1.22 110.262 176.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -130.66 144.52 51.49 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.691 0.62 . . . . 2.31 110.045 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -37.42 121.07 0.83 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 124.446 1.091 . . . . 0.84 113.467 -170.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.21 7.26 12.68 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.464 -0.789 . . . . 1.04 111.509 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.52 ' CD ' ' HB ' ' A' ' 196' ' ' VAL . 0.9 OUTLIER -83.68 164.42 19.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.96 0.41 . . . . 2.62 110.648 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.665 ' HG3' ' CE2' ' A' ' 193' ' ' TYR . 8.5 tmm_? -145.97 130.96 18.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.364 -0.38 . . . . 3.62 110.777 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.457 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 5.1 mt -96.45 138.24 34.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.304 -0.628 . . . . 0.53 109.304 175.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.453 ' HA3' ' C ' ' A' ' 112' ' ' PRO . . . 83.74 -117.39 4.43 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.651 -0.785 . . . . 1.02 112.608 177.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.453 ' C ' ' HA3' ' A' ' 111' ' ' GLY . 17.4 Cg_exo -66.73 167.35 56.63 Favored 'Cis proline' 0 C--N 1.347 0.498 0 CA-C-N 118.94 1.37 . . . . 2.1 113.716 5.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.436 ' O ' ' HA3' ' A' ' 166' ' ' GLY . 42.2 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 2.0 110.139 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 113.544 0.177 . . . . 1.3 113.544 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.5 t -59.54 -23.31 62.74 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.6 0.36 . . . . 1.82 111.853 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 41.4 p-90 -65.17 -17.48 64.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.007 0.432 . . . . 0.7 111.314 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 43.7 mt -80.16 -13.86 58.93 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.199 0.444 . . . . 0.66 112.199 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -70.55 -13.1 61.97 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.264 -0.574 . . . . 1.48 109.887 177.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -68.06 -36.81 80.49 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.707 -0.679 . . . . 1.97 111.406 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.655 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -69.36 124.77 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.325 -0.55 . . . . 0.67 109.942 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.493 ' HA ' ' NE ' ' A' ' 173' ' ' ARG . 3.9 mmp_? -112.29 -166.51 1.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.957 -0.565 . . . . 4.34 110.82 -176.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.0 t -73.55 151.9 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.332 . . . . 1.07 110.566 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -64.38 134.23 54.17 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.01 -0.541 . . . . 0.71 111.014 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.5 t -78.94 -12.46 60.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.381 -0.827 . . . . 1.88 110.245 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 180' ' ' ASP . 46.5 m -125.74 140.99 52.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.904 -0.589 . . . . 1.63 109.641 176.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 61.4 m -79.38 -19.39 50.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 1.96 111.2 -176.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -89.29 1.78 55.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.233 0.539 . . . . 2.42 110.099 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 177' ' ' SER . 27.6 t70 -110.78 15.81 21.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.545 -0.752 . . . . 2.12 110.412 -176.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 16.8 mm100 -60.91 116.79 4.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.85 -0.614 . . . . 1.35 110.632 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.611 ' ND2' HD11 ' A' ' 200' ' ' ILE . 23.7 t30 -153.9 33.18 0.44 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.076 0.941 . . . . 1.68 109.282 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -121.93 120.8 35.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.563 -0.744 . . . . 0.81 110.644 -172.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 30.3 m -142.92 121.91 12.81 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.265 0.555 . . . . 0.51 110.93 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.415 ' HB2' ' HE2' ' A' ' 185' ' ' MET . 52.2 tpp -92.19 127.74 37.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.639 -0.709 . . . . 1.35 109.981 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 38.6 t -126.11 162.43 25.36 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.402 -0.592 . . . . 1.73 109.402 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -134.43 147.06 50.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.757 0.313 . . . . 1.93 110.835 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.742 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 24.4 pt -137.42 133.48 46.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.53 -0.759 . . . . 1.11 109.479 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.7 t 55.33 28.87 12.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.954 0.407 . . . . 1.86 110.84 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 66.86 24.29 9.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.552 -0.749 . . . . 2.83 112.058 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.742 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 11.9 pt20 -118.53 155.01 31.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.09 -0.707 . . . . 1.75 109.09 172.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' A' ' 113' ' ' CYS . 38.0 mm -81.65 126.06 39.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.108 0.48 . . . . 1.01 111.806 -170.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.665 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 63.0 t80 -121.92 127.64 50.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.401 -0.818 . . . . 3.94 110.401 -174.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 7.2 m-85 -99.9 113.48 26.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.046 0.45 . . . . 0.92 110.048 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -114.97 123.32 48.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.554 -0.748 . . . . 1.11 109.952 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.52 ' HB ' ' CD ' ' A' ' 108' ' ' GLU . 2.0 t -96.45 153.35 3.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.559 0.695 . . . . 0.7 109.754 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 2.1 mm -92.61 -58.05 3.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.575 -1.193 . . . . 0.62 111.931 -166.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.522 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.7 OUTLIER -141.03 -178.18 5.45 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.616 -0.72 . . . . 1.38 111.713 -173.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.672 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.5 m-20 -45.8 116.21 1.15 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.986 0.804 . . . . 2.23 112.93 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.611 HD11 ' ND2' ' A' ' 182' ' ' ASN . 14.8 mm -88.28 135.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.563 -0.744 . . . . 0.88 109.535 170.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 46.4 mt-10 -99.94 130.43 26.35 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.236 -0.653 . . . . 2.06 109.236 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.33 117.71 2.45 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.067 2.512 . . . . 0.51 112.695 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.93 -9.99 9.63 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.872 -0.68 . . . . 0.7 112.982 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 19.9 pt-20 -138.52 121.48 16.66 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 117.569 0.685 . . . . 1.27 112.118 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.508 ' HG2' ' H ' ' A' ' 100' ' ' ALA . 7.7 mm-40 -111.2 125.0 53.33 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.061 -0.518 . . . . 2.92 110.201 170.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.538 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 2.4 mm? -122.28 99.29 6.34 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.327 -0.62 . . . . 0.9 109.327 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.655 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.3 mm? -145.62 115.59 7.38 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.497 -0.557 . . . . 0.53 109.497 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.495 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 6.3 p -153.21 157.89 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.509 -0.476 . . . . 0.91 111.169 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -98.6 111.4 23.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.84 -0.618 . . . . 1.55 109.828 173.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.45 HG23 HG13 ' A' ' 208' ' ' VAL . 52.6 t . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 109.329 -0.619 . . . . 2.56 109.329 171.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.732 -0.47 . . . . 2.45 109.732 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.41 117.64 4.17 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.0 2.467 . . . . 1.75 112.983 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.504 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -128.41 146.03 58.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.823 -0.626 . . . . 1.01 109.584 176.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -53.19 147.71 34.27 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.823 2.349 . . . . 0.73 112.11 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.576 ' O ' ' HD2' ' A' ' 101' ' ' LYS . . . -70.56 -0.39 8.46 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.551 0.574 . . . . 1.04 112.551 -173.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -106.0 4.6 29.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.881 0.372 . . . . 1.66 111.167 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -136.1 138.5 42.14 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.502 ' HB2' ' HE2' ' A' ' 101' ' ' LYS . 5.8 tp10 -109.81 124.27 51.01 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.299 -0.56 . . . . 2.27 111.286 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.429 ' HB2' HG21 ' A' ' 80' ' ' ILE . 58.0 tp -87.91 128.3 35.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.158 -0.473 . . . . 0.79 110.078 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -147.87 118.87 7.66 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.635 -0.711 . . . . 3.21 109.796 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.14 112.62 10.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.989 0.424 . . . . 2.46 109.971 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.2 t -172.92 133.56 0.55 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.338 -0.986 . . . . 1.58 108.338 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.4 t -87.36 106.04 17.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.929 0.395 . . . . 1.86 110.805 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -85.79 123.12 72.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.413 -0.588 . . . . 1.45 109.413 173.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -45.59 119.32 2.64 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.515 2.81 . . . . 1.61 113.346 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.32 -29.1 10.46 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.812 -0.631 . . . . 1.74 112.415 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 173' ' ' ARG . . . -124.28 -65.88 1.02 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.048 0.451 . . . . 1.41 111.671 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.604 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 123.5 -132.59 8.56 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.127 -0.789 . . . . 1.09 111.127 -175.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 1.2 pp -72.82 159.69 33.37 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.986 0.393 . . . . 2.31 110.746 175.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.91 174.73 47.09 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.844 -0.693 . . . . 0.59 111.958 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 19.4 m -106.64 130.8 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 121.266 0.555 . . . . 0.67 109.71 174.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -96.85 114.89 26.56 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.652 -0.704 . . . . 1.13 110.019 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 202' ' ' PRO . . . -64.34 114.26 4.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.235 -0.283 . . . . 0.54 110.235 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 82' ' ' ALA . 15.8 ptpt -83.71 -8.99 59.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.244 0.545 . . . . 1.68 110.665 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 27.2 ttp180 -125.66 155.75 40.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.547 -0.751 . . . . 3.5 109.772 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.432 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -81.88 155.45 25.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.95 -0.568 . . . . 2.4 109.779 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.584 ' HB3' ' OE2' ' A' ' 108' ' ' GLU . 59.6 mtm -136.13 153.31 51.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.684 -0.234 . . . . 1.22 110.507 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -117.34 140.37 49.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.129 -0.487 . . . . 2.31 109.716 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.62 131.39 3.92 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 124.421 1.076 . . . . 0.84 113.61 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.25 7.67 11.03 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.528 -0.76 . . . . 1.04 112.368 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.584 ' OE2' ' HB3' ' A' ' 104' ' ' MET . 0.7 OUTLIER -85.74 167.9 14.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.293 0.568 . . . . 2.62 111.435 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -143.28 135.33 26.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.746 -0.661 . . . . 3.62 110.182 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 4.4 mt -104.6 132.91 50.3 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.598 -0.89 . . . . 0.53 108.598 171.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.82 166.48 39.67 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.188 -1.006 . . . . 1.02 112.724 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.18 142.03 43.75 Favored 'Cis proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.414 -1.494 . . . . 2.1 111.909 -2.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.614 ' SG ' HD13 ' A' ' 169' ' ' LEU . 56.9 m . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 121.044 0.45 . . . . 2.0 110.765 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 112.698 -0.161 . . . . 1.3 112.698 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.9 m -59.5 -39.49 83.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.001 0.371 . . . . 1.82 112.001 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.474 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 29.9 p-90 -85.55 -22.66 28.01 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.42 -0.512 . . . . 0.7 111.157 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.614 HD13 ' SG ' ' A' ' 113' ' ' CYS . 28.7 mt -86.93 -15.0 40.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.389 0.514 . . . . 0.66 112.389 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.401 ' C ' ' HD3' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -75.33 -4.09 37.24 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.661 -0.415 . . . . 1.48 110.523 176.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -76.57 -37.62 56.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.085 -0.507 . . . . 1.97 111.586 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -67.34 129.36 31.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.539 -0.464 . . . . 0.67 110.057 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.427 ' HB3' ' H ' ' A' ' 174' ' ' VAL . 98.9 mtt180 -125.98 -163.38 1.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.933 -0.576 . . . . 4.34 111.835 -172.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.451 ' HA ' HG11 ' A' ' 208' ' ' VAL . 20.0 t -62.62 146.83 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.261 -0.881 . . . . 1.07 111.449 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.613 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -65.35 136.13 56.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.881 -0.6 . . . . 0.71 111.343 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.74 -19.3 64.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.35 -0.841 . . . . 1.88 111.143 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 63.6 m -146.03 147.56 31.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.227 -0.442 . . . . 1.63 110.027 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 10.6 p -76.89 -13.66 59.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.877 0.37 . . . . 1.96 111.427 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -73.56 -25.34 60.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.493 0.663 . . . . 2.42 110.101 172.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.451 ' O ' ' HG ' ' A' ' 206' ' ' LEU . 17.0 m-20 -92.61 17.27 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.428 -0.805 . . . . 2.12 111.606 -176.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 29.6 mm-40 -55.65 114.46 1.87 Allowed 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.36 0.6 . . . . 1.35 110.068 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.744 ' ND2' HD11 ' A' ' 200' ' ' ILE . 19.5 t30 -161.59 34.51 0.13 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 122.597 1.189 . . . . 1.68 108.112 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.654 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -124.8 119.0 27.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.99 -1.005 . . . . 0.81 110.34 -172.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 61.3 m -150.62 129.37 12.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.06 0.457 . . . . 0.51 111.19 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 49.4 ttm -91.04 137.29 32.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.174 -0.466 . . . . 1.35 110.11 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 50.0 t -115.28 132.06 56.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.166 -0.47 . . . . 1.73 110.579 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 23.5 tm0? -108.87 105.21 14.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.278 -0.638 . . . . 1.93 109.278 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 13.3 pt -144.01 144.13 23.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.001 -0.545 . . . . 1.11 110.331 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.1 t 61.29 27.87 17.48 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.211 0.529 . . . . 1.86 110.371 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.416 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 6.0 mm-40 57.9 32.85 22.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.217 -0.901 . . . . 2.83 111.641 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -144.97 165.99 26.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.769 -0.65 . . . . 1.75 109.702 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.7 mm -100.23 133.11 44.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.04 0.448 . . . . 1.01 111.668 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -132.31 156.89 45.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.226 -0.897 . . . . 3.94 109.164 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 11.1 m-85 -100.31 119.3 38.2 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.43 -0.508 . . . . 0.92 109.776 173.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -98.17 118.01 33.84 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.462 -0.94 . . . . 1.11 108.462 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.533 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 1.8 t -89.32 151.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.493 0.663 . . . . 0.7 109.784 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.449 HG13 ' HA ' ' A' ' 182' ' ' ASN . 1.3 mm -97.0 -53.66 7.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 114.656 -1.156 . . . . 0.62 111.553 -163.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.551 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -135.76 174.27 10.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.484 -0.78 . . . . 1.38 111.491 -174.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 104' ' ' MET . 3.0 m-20 -50.49 119.65 3.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.368 -0.833 . . . . 2.23 112.268 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.744 HD11 ' ND2' ' A' ' 182' ' ' ASN . 17.3 mm -86.99 135.81 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.985 -0.552 . . . . 0.88 110.627 177.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 20.1 mm-40 -101.65 134.64 20.09 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.656 -0.702 . . . . 2.06 109.481 174.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 73.5 Cg_exo -51.1 113.5 1.13 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.802 2.335 . . . . 0.51 112.953 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.31 -10.21 9.34 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.68 -0.771 . . . . 0.7 113.537 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.7 pt-20 -107.55 127.37 53.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.709 0.754 . . . . 1.27 111.541 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.564 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -109.4 93.59 4.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.471 -0.786 . . . . 2.92 111.616 177.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.616 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.6 mm? -124.56 95.82 4.67 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.57 -0.852 . . . . 0.9 110.885 175.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.532 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.8 mm? -148.07 111.7 5.03 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.263 -0.643 . . . . 0.53 109.263 170.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.654 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.7 p -157.05 160.8 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 117.892 0.314 . . . . 0.91 110.437 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -109.93 110.9 22.0 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.574 -0.528 . . . . 1.55 109.574 168.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 96.5 t . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 2.56 110.216 176.249 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.459 -0.571 . . . . 2.45 109.459 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.14 119.67 6.95 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.809 2.34 . . . . 1.75 112.256 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.545 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -126.86 144.03 48.73 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 1.01 109.723 178.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.87 144.76 87.18 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.579 2.186 . . . . 0.73 111.453 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.34 -12.27 8.77 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.798 0.666 . . . . 1.04 112.798 -173.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -80.96 -11.27 59.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.925 0.393 . . . . 1.66 110.911 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -133.92 165.1 25.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.444 ' HA ' HG13 ' A' ' 80' ' ' ILE . 10.1 pt-20 -155.84 147.01 22.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.914 0.388 . . . . 2.27 110.671 173.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.456 HD11 ' CZ ' ' A' ' 171' ' ' TYR . 7.0 tt -92.26 132.33 36.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.864 -0.607 . . . . 0.79 110.43 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.405 ' N ' HD23 ' A' ' 86' ' ' LEU . 76.1 mtt180 -144.27 138.88 28.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.403 -0.817 . . . . 3.21 109.841 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -82.04 112.91 19.55 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.348 -0.612 . . . . 2.46 109.348 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 p -169.03 90.11 0.22 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.678 -0.692 . . . . 1.58 109.749 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 p -69.95 105.43 2.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.243 0.544 . . . . 1.86 110.744 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.633 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -85.17 123.78 72.92 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.928 -0.767 . . . . 1.45 108.928 175.265 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.08 120.27 7.68 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.287 2.658 . . . . 1.61 112.735 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.6 -11.25 53.72 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.597 -0.811 . . . . 1.74 112.181 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.633 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -134.11 -63.07 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.711 -0.288 . . . . 1.41 111.609 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.03 -145.83 17.29 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.786 -0.721 . . . . 1.09 113.106 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -72.56 158.68 35.23 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.4 0.28 . . . . 2.31 110.83 177.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.09 175.97 43.33 Favored Glycine 0 C--O 1.237 0.308 0 C-N-CA 120.346 -0.931 . . . . 0.59 112.421 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 98' ' ' VAL . 35.3 m -111.22 114.27 46.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.634 0.73 . . . . 0.67 109.263 174.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -80.73 100.77 8.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.476 0.655 . . . . 1.13 110.996 -169.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.08 120.95 13.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.732 -1.122 . . . . 0.54 110.751 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.634 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -101.64 13.79 33.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.513 0.673 . . . . 1.68 109.447 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -125.83 155.94 40.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.961 -1.018 . . . . 3.5 109.16 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.483 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -83.3 116.27 22.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.211 0.529 . . . . 2.4 111.244 174.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.595 ' HE1' HG21 ' A' ' 200' ' ' ILE . 4.8 mpp? -86.92 130.96 34.24 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.573 -0.899 . . . . 1.22 108.573 172.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 8.4 pt-20 -116.32 174.45 6.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.902 0.382 . . . . 2.31 111.914 -173.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.93 126.46 18.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.645 -0.707 . . . . 0.84 112.899 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.58 -17.19 59.71 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.779 -0.646 . . . . 1.04 114.202 168.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 7.3 pt-20 -76.28 160.09 29.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.607 0.704 . . . . 2.62 111.799 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.794 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 6.6 ttt180 -116.42 142.09 47.31 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.418 -0.81 . . . . 3.62 110.667 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.7 mt -92.47 136.21 33.4 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.952 -0.758 . . . . 0.53 108.952 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 149.88 -147.79 18.41 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.374 -0.917 . . . . 1.02 112.649 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 75.4 Cg_endo -75.34 135.01 38.43 Favored 'Cis proline' 0 CA--C 1.532 0.376 0 C-N-CA 123.064 -1.64 . . . . 2.1 112.516 3.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.434 ' SG ' ' HA3' ' A' ' 166' ' ' GLY . 42.5 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.466 -0.788 . . . . 2.0 109.789 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.434 ' HA3' ' SG ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 111.706 -0.558 . . . . 1.3 111.706 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.3 m -54.13 -35.08 61.8 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.953 0.501 . . . . 1.82 112.226 -176.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -84.44 -17.6 38.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.886 0.374 . . . . 0.7 111.299 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 28.8 mt -86.11 -14.6 43.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.472 -0.331 . . . . 0.66 111.768 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -10.43 59.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.351 0.596 . . . . 1.48 109.541 175.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.456 ' CZ ' HD11 ' A' ' 86' ' ' LEU . 43.7 m-85 -79.52 -30.21 41.77 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.274 -0.875 . . . . 1.97 111.872 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.539 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 1.3 mm -56.03 129.64 17.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 120.858 0.361 . . . . 0.67 110.521 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -93.94 143.59 26.21 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.501 0.667 . . . . 4.34 111.819 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.53 ' HA ' ' CD2' ' A' ' 183' ' ' LEU . 10.1 p -77.77 153.76 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.209 -0.905 . . . . 1.07 109.174 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -48.04 111.59 0.46 Allowed 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.654 0.597 . . . . 0.71 112.176 -172.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 51.6 t -66.09 -33.63 76.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.277 -0.874 . . . . 1.88 109.771 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.467 ' HB3' ' OD1' ' A' ' 180' ' ' ASP . 11.9 t -131.08 152.28 50.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.907 -0.775 . . . . 1.63 108.907 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 61.8 m -71.92 -6.09 39.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.472 -0.331 . . . . 1.96 111.545 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.89 1.38 56.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.77 0.319 . . . . 2.42 110.868 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 177' ' ' SER . 29.3 m-20 -110.14 15.27 22.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.378 -0.374 . . . . 2.12 111.093 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 15.0 mm100 -63.63 115.51 4.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.253 0.549 . . . . 1.35 111.946 -173.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.816 ' H ' HD12 ' A' ' 183' ' ' LEU . 22.7 t30 -161.39 31.58 0.13 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.093 0.949 . . . . 1.68 108.779 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.816 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.5 OUTLIER -119.28 122.52 42.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 0.81 111.184 -171.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 60.9 m -150.13 136.01 18.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.983 0.421 . . . . 0.51 110.421 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.471 ' HB3' ' HB2' ' A' ' 209' ' ' HIS . 49.9 ttm -125.62 135.49 52.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.208 -0.451 . . . . 1.35 109.852 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 18.6 t -115.11 152.51 32.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.221 -0.445 . . . . 1.73 109.836 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.73 104.86 11.78 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.011 -0.737 . . . . 1.93 109.011 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 33.2 pt -135.49 144.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.978 -0.556 . . . . 1.11 110.541 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.8 m 57.46 30.11 18.11 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.459 0.474 . . . . 1.86 111.558 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 64.3 17.36 10.69 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.493 -0.776 . . . . 2.83 111.301 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -124.93 167.2 15.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 1.75 110.189 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.6 mm -90.73 130.07 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.069 -0.514 . . . . 1.01 110.861 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -121.76 122.95 40.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.271 -0.422 . . . . 3.94 110.535 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.794 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 13.7 m-85 -99.79 113.96 26.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.915 -0.772 . . . . 0.92 108.915 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -110.45 124.14 51.21 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.9 -0.32 . . . . 1.11 110.217 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 104' ' ' MET . 1.7 t -93.42 151.85 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 122.059 0.933 . . . . 0.7 110.688 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.57 -56.43 5.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 113.734 -1.576 . . . . 0.62 112.009 -164.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.445 ' HE3' ' HB2' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -140.9 162.78 34.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.975 -1.012 . . . . 1.38 110.117 -176.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.4 m-20 -58.27 111.67 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.85 0.719 . . . . 2.23 112.189 -173.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.595 HG21 ' HE1' ' A' ' 104' ' ' MET . 6.1 mm -68.85 145.82 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.255 -0.884 . . . . 0.88 110.9 175.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 14.2 mt-10 -92.63 117.64 67.67 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.278 -0.873 . . . . 2.06 108.697 172.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -43.31 122.19 2.86 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.614 2.876 . . . . 0.51 113.688 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.91 -3.22 10.81 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.822 -0.704 . . . . 0.7 113.127 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 11.3 pt-20 -137.37 125.56 23.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.247 0.546 . . . . 1.27 111.031 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.539 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -109.57 108.05 18.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.017 -0.538 . . . . 2.92 111.507 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.561 ' O ' HD22 ' A' ' 207' ' ' LEU . 1.4 mm? -123.24 97.9 5.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.064 -0.655 . . . . 0.9 109.944 173.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 206' ' ' LEU . 1.1 mm? -149.1 102.12 3.21 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.985 -0.746 . . . . 0.53 108.985 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.793 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 6.8 t -157.28 158.25 3.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.1 -0.704 . . . . 0.91 109.1 -178.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 185' ' ' MET . 19.4 t-80 -136.25 110.57 8.45 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.453 -0.943 . . . . 1.55 108.453 162.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 3.1 p . . . . . 0 C--N 1.32 -0.7 0 CA-C-O 121.632 0.73 . . . . 2.56 109.812 179.241 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.6 mt . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 110.196 -0.298 . . . . 2.45 110.196 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.01 115.94 3.87 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.177 1.918 . . . . 1.75 112.238 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -131.77 146.57 62.39 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.64 -0.504 . . . . 1.01 109.64 178.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.38 137.81 81.58 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.801 2.334 . . . . 0.73 111.667 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.426 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -65.26 -12.17 48.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.654 0.612 . . . . 1.04 112.654 -173.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -84.9 -7.52 59.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.805 0.336 . . . . 1.66 111.473 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.507 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 17.9 m-85 -120.14 161.76 20.48 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.23 -1.026 . . . . 1.0 108.23 170.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.405 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 5.9 tp10 -133.51 120.19 20.5 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.749 -0.78 . . . . 2.27 111.435 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HA ' HG12 ' A' ' 98' ' ' VAL . 7.2 tt -84.28 126.67 33.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.999 -0.741 . . . . 0.79 108.999 177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -148.61 149.26 31.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.842 -0.617 . . . . 3.21 110.726 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.32 111.99 18.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.653 -0.869 . . . . 2.46 108.653 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.2 m -149.13 81.51 1.43 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.082 -0.508 . . . . 1.58 109.809 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.4 m -65.48 104.63 1.02 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.121 -0.49 . . . . 1.86 110.875 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.583 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -106.02 117.63 57.08 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.128 -0.487 . . . . 1.45 109.791 177.032 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 91' ' ' ILE . 52.5 Cg_exo -54.58 122.57 11.81 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.16 2.573 . . . . 1.61 112.678 -176.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.97 -16.46 36.19 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.711 -0.677 . . . . 1.74 111.958 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.583 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -131.63 -59.78 0.95 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.931 0.396 . . . . 1.41 111.277 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.9 -127.85 7.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.954 -0.641 . . . . 1.09 112.198 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.446 HD13 ' CD1' ' A' ' 171' ' ' TYR . 0.6 OUTLIER -89.53 159.79 17.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.677 -0.12 . . . . 2.31 110.677 176.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -161.96 172.51 38.13 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.586 -0.605 . . . . 0.59 111.586 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 86' ' ' LEU . 5.9 m -115.72 130.76 69.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.586 0.708 . . . . 0.67 109.79 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -98.11 109.17 21.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.255 -0.43 . . . . 1.13 110.498 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -64.52 116.29 6.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.54 109.758 176.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.545 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -79.06 -2.8 42.15 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.453 0.644 . . . . 1.68 110.439 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 41.1 ttp180 -127.41 155.78 43.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.257 -0.883 . . . . 3.5 108.823 175.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.64 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -82.8 156.59 23.59 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.829 -0.434 . . . . 2.4 109.829 176.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.625 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -127.18 152.32 47.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.323 -0.399 . . . . 1.22 110.476 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 10.4 pt-20 -105.48 173.67 6.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.394 0.616 . . . . 2.31 111.975 -170.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.93 127.29 30.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.247 -0.888 . . . . 0.84 112.656 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.23 0.77 67.46 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.101 -0.571 . . . . 1.04 113.544 170.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 1.6 pt-20 -87.14 168.41 13.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.439 0.619 . . . . 2.62 111.09 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 3.8 tmm_? -127.52 133.03 49.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.93 -0.577 . . . . 3.62 112.094 -173.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.507 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 7.7 mt -86.63 142.07 28.51 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.77 -0.826 . . . . 0.53 108.77 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.64 -128.05 7.63 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.4 -0.905 . . . . 1.02 112.618 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.461 ' O ' ' HA3' ' A' ' 166' ' ' GLY . 57.2 Cg_endo -68.35 145.6 76.59 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.829 -1.321 . . . . 2.1 112.761 2.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.618 -0.719 . . . . 2.0 110.962 -176.365 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 112' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.386 0 N-CA-C 112.354 -0.299 . . . . 1.3 112.354 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.8 m -69.26 -14.54 63.01 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.885 0.328 . . . . 1.82 111.885 -177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.423 ' O ' ' HD2' ' A' ' 171' ' ' TYR . 64.9 p-90 -56.46 -17.27 7.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.159 0.504 . . . . 0.7 111.307 176.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.502 HD13 ' CD1' ' A' ' 194' ' ' TYR . 24.8 mt -64.49 -12.79 47.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.309 -0.405 . . . . 0.66 111.876 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -11.84 26.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.76 0.314 . . . . 1.48 110.754 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.446 ' CD1' HD13 ' A' ' 96' ' ' LEU . 36.8 m-85 -77.95 -36.96 48.59 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.27 -0.423 . . . . 1.97 111.312 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.811 HG21 ' HB2' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -59.58 137.01 22.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 120.827 -0.349 . . . . 0.67 110.483 -174.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.484 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 41.7 mmt-85 -112.18 -177.52 3.19 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.851 0.686 . . . . 4.34 112.851 -175.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.464 HG22 HG21 ' A' ' 208' ' ' VAL . 41.5 t -76.56 158.87 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 114.954 -1.021 . . . . 1.07 110.488 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.533 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -55.52 113.73 1.56 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.241 -0.436 . . . . 0.71 111.816 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 28.1 t -72.05 -20.64 61.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 1.88 109.622 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.3 t -126.02 139.74 53.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.686 -0.688 . . . . 1.63 109.318 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 59.7 m -75.54 -33.41 60.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.107 0.78 . . . . 1.96 113.107 -168.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -88.33 -13.29 41.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.351 0.596 . . . . 2.42 110.58 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -82.57 19.29 1.31 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.529 -0.76 . . . . 2.12 112.033 -176.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.59 ' HA ' HE21 ' A' ' 181' ' ' GLN . 0.0 OUTLIER -53.42 113.85 1.3 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.022 0.439 . . . . 1.35 110.759 -176.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.691 ' H ' HD12 ' A' ' 183' ' ' LEU . 32.3 t30 -140.21 23.62 2.36 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 122.325 1.059 . . . . 1.68 108.94 174.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.691 HD12 ' H ' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -109.17 117.39 34.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.598 -0.728 . . . . 0.81 110.36 -172.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.1 m -149.1 135.07 18.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.056 0.455 . . . . 0.51 110.528 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.454 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 72.6 mtp -128.74 137.07 51.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.139 -0.482 . . . . 1.35 110.072 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 16.3 t -114.41 158.12 21.97 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.848 -0.614 . . . . 1.73 109.496 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.537 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 22.7 tm0? -122.88 105.19 9.79 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.134 -0.691 . . . . 1.93 109.134 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.632 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 34.9 pt -133.13 140.58 46.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.975 -0.557 . . . . 1.11 110.524 -175.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.1 m 53.78 26.24 5.84 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.394 0.434 . . . . 1.86 111.963 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.537 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 6.3 mm-40 63.4 25.41 14.56 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.595 -0.73 . . . . 2.83 112.049 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.1 pt20 -117.28 157.65 25.7 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.128 -0.693 . . . . 1.75 109.128 172.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.5 mm -89.13 121.93 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.16 0.505 . . . . 1.01 110.564 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.63 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 45.5 t80 -114.57 121.27 42.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.365 -0.834 . . . . 3.94 110.377 -172.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 11.4 m-85 -99.65 112.81 25.0 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.374 -0.602 . . . . 0.92 109.374 177.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -116.0 122.93 46.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.844 0.354 . . . . 1.11 110.906 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.574 HG11 ' SD ' ' A' ' 104' ' ' MET . 0.2 OUTLIER -90.46 149.84 3.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.438 0.637 . . . . 0.7 109.879 178.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 182' ' ' ASN . 1.3 mt -103.06 -30.11 2.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.165 -0.925 . . . . 0.62 112.009 -168.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 27.5 pttt -151.59 -179.91 7.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.137 -0.483 . . . . 1.38 111.736 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.625 ' HA ' ' O ' ' A' ' 104' ' ' MET . 17.2 t70 -82.65 131.24 35.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.32 -0.854 . . . . 2.23 110.508 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.614 HG13 ' ND2' ' A' ' 182' ' ' ASN . 43.9 mm -121.97 154.63 26.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.192 -0.458 . . . . 0.88 111.15 -173.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 48.9 mt-10 -78.62 120.97 82.95 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 2.06 109.85 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.3 123.7 12.56 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.025 2.483 . . . . 0.51 112.419 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.62 -1.67 10.23 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.636 -0.792 . . . . 0.7 113.097 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 10.5 pt-20 -136.27 123.95 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 1.27 110.649 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.535 ' OE1' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -108.83 116.09 31.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.889 -0.596 . . . . 2.92 111.415 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.504 ' C ' HD22 ' A' ' 207' ' ' LEU . 4.7 mp -126.22 99.56 5.93 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.365 -0.534 . . . . 0.9 110.297 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.811 ' HB2' HG21 ' A' ' 172' ' ' ILE . 2.4 mm? -147.76 112.59 5.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.654 0.782 . . . . 0.53 109.58 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.664 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 7.8 p -155.99 158.01 3.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.621 -0.432 . . . . 0.91 111.199 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.454 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 27.9 t-80 -114.24 110.1 19.42 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.825 -0.806 . . . . 1.55 108.825 170.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 C--N 1.321 -0.672 0 N-CA-C 109.842 -0.429 . . . . 2.56 109.842 -179.999 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 67.7 mt . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 110.102 -0.333 . . . . 2.45 110.102 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.03 122.5 11.49 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.851 2.368 . . . . 1.75 112.722 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.537 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -127.38 149.3 69.5 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.843 -0.617 . . . . 1.01 109.758 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.74 143.14 99.35 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.635 2.223 . . . . 0.73 111.857 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.57 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -68.25 -5.19 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.34 0.496 . . . . 1.04 112.34 -173.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -87.56 -4.48 58.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.896 0.379 . . . . 1.66 110.928 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.509 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 11.7 m-85 -138.38 147.96 43.98 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.45 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 12.2 tp10 -118.36 122.72 43.54 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 121.048 -0.261 . . . . 2.27 110.642 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.9 tt -87.43 124.16 33.13 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.388 0.613 . . . . 0.79 109.578 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.508 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 90.3 mtt-85 -143.39 127.05 17.03 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.13 -0.941 . . . . 3.21 109.689 -175.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.01 110.73 4.6 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.344 -0.613 . . . . 2.46 109.344 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.8 m -157.8 115.47 3.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.266 -0.642 . . . . 1.58 109.266 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.2 m -89.84 105.35 17.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.766 0.317 . . . . 1.86 110.97 -177.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -91.62 118.59 68.43 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.818 -0.808 . . . . 1.45 108.818 173.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.99 121.36 9.75 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.098 2.532 . . . . 1.61 112.553 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.65 -23.36 24.37 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.722 -0.672 . . . . 1.74 112.369 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.539 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -122.63 -63.0 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.962 0.381 . . . . 1.41 111.082 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 127.76 -134.12 8.11 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.962 -0.637 . . . . 1.09 111.952 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.9 mt -89.18 159.48 17.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.398 -0.223 . . . . 2.31 110.398 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -157.68 164.96 33.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.702 -0.761 . . . . 0.59 111.944 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 33.8 m -101.25 117.18 46.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.766 0.793 . . . . 0.67 110.071 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.508 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 27.1 m95 -82.73 110.01 17.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.355 -0.839 . . . . 1.13 110.623 -171.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -62.22 115.2 3.94 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.882 -0.414 . . . . 0.54 109.882 176.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -81.8 -6.07 58.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.405 0.621 . . . . 1.68 109.849 178.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -129.61 160.75 32.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.033 -0.985 . . . . 3.5 108.688 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.578 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -92.79 158.48 15.86 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 120.87 0.367 . . . . 2.4 110.475 -178.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.594 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 55.0 mtm -131.89 153.02 50.66 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.167 -0.679 . . . . 1.22 109.167 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -105.64 137.57 43.28 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.353 0.408 . . . . 2.31 110.855 -176.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -38.25 115.18 0.42 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.679 1.237 . . . . 0.84 112.959 -173.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.67 6.96 14.07 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.379 -0.828 . . . . 1.04 111.034 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.493 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -73.6 165.68 24.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.196 0.522 . . . . 2.62 110.761 -178.275 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 3.9 tmm_? -145.68 134.7 22.64 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.923 -0.58 . . . . 3.62 110.959 -175.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.509 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 8.1 mt -98.05 135.01 40.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.942 -0.762 . . . . 0.53 108.942 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.79 167.29 38.48 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.423 -0.894 . . . . 1.02 112.21 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.43 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 6.2 Cg_exo -79.15 155.78 91.0 Favored 'Cis proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.307 -1.539 . . . . 2.1 112.0 -2.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.9 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.501 0.667 . . . . 2.0 109.846 176.919 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . . . . . . 0 N--CA 1.452 -0.276 0 CA-C-O 120.524 -0.042 . . . . 1.3 113.199 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 17.4 t -73.4 -15.39 61.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.023 0.44 . . . . 1.82 110.732 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.439 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 10.6 p-90 -72.77 -23.46 60.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.316 -0.402 . . . . 0.7 111.521 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.439 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 29.0 mt -86.09 -15.47 41.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.482 0.549 . . . . 0.66 112.482 -174.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -78.74 -4.65 50.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.271 -0.572 . . . . 1.48 110.381 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -77.84 -37.71 47.83 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.196 -0.457 . . . . 1.97 110.996 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.746 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -70.03 120.77 18.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.818 -0.438 . . . . 0.67 109.818 177.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -113.15 -168.68 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 4.34 112.033 -173.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.479 ' HA ' HG11 ' A' ' 208' ' ' VAL . 43.8 t -62.57 142.27 16.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 115.795 -0.639 . . . . 1.07 111.436 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.46 148.03 39.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.292 -0.867 . . . . 0.71 111.883 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 48.7 t -86.21 -8.94 57.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.373 -0.83 . . . . 1.88 110.122 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.5 t -143.98 145.22 32.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.971 -0.559 . . . . 1.63 111.208 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 78.1 m -83.2 -15.82 48.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.642 -0.708 . . . . 1.96 110.298 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -81.85 -25.73 34.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.617 0.722 . . . . 2.42 110.187 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -96.42 18.28 14.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.343 -0.844 . . . . 2.12 111.815 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -59.14 114.19 2.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.183 0.516 . . . . 1.35 111.547 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.868 ' H ' HD12 ' A' ' 183' ' ' LEU . 4.7 p-10 -152.01 29.74 0.58 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.007 -0.997 . . . . 1.68 109.202 170.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.868 HD12 ' H ' ' A' ' 182' ' ' ASN . 1.5 mp -112.03 118.95 36.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.93 -1.032 . . . . 0.81 109.13 -175.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 86.4 m -150.08 148.23 28.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.437 0.637 . . . . 0.51 112.589 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.437 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 28.0 tpp -97.45 145.64 25.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.255 -0.884 . . . . 1.35 111.411 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 41.7 t -129.93 131.47 45.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 1.73 110.267 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -123.05 105.78 10.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.588 -0.523 . . . . 1.93 109.588 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 24.2 pt -142.67 144.01 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.847 -0.615 . . . . 1.11 110.502 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.4 m 61.85 35.43 16.53 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.463 -0.335 . . . . 1.86 111.772 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 66.61 3.91 3.13 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.88 -0.6 . . . . 2.83 111.721 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.4 pt20 -120.61 163.74 17.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.083 0.468 . . . . 1.75 110.421 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.8 mm -107.08 136.11 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.872 -0.604 . . . . 1.01 111.196 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -138.14 156.44 47.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.029 -0.532 . . . . 3.94 110.917 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.556 ' CD2' ' HB3' ' A' ' 207' ' ' LEU . 2.4 m-30 -101.1 114.43 28.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.761 -0.654 . . . . 0.92 109.823 175.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -102.39 124.41 47.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.009 0.433 . . . . 1.11 110.178 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.53 HG22 HD11 ' A' ' 207' ' ' LEU . 0.9 OUTLIER -100.19 152.83 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.545 0.688 . . . . 0.7 110.38 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.575 HG13 ' HA ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -92.8 -41.04 12.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.813 -1.085 . . . . 0.62 112.471 -168.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.34 164.8 27.26 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.086 0.402 . . . . 1.38 112.086 -171.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.594 ' HA ' ' O ' ' A' ' 104' ' ' MET . 5.3 t70 -49.7 112.26 0.63 Allowed 'General case' 0 C--O 1.233 0.187 0 O-C-N 124.481 1.113 . . . . 2.23 110.671 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.512 HG13 ' HE3' ' A' ' 104' ' ' MET . 28.5 mm -83.13 129.2 37.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.104 -0.498 . . . . 0.88 110.868 -176.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 45.0 mt-10 -83.57 136.16 42.75 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.924 -0.58 . . . . 2.06 109.58 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 103' ' ' LYS . 31.3 Cg_exo -58.14 113.68 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.18 1.92 . . . . 0.51 111.71 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.17 -4.9 10.38 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.595 -0.812 . . . . 0.7 113.643 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.3 pt-20 -112.74 121.66 45.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.001 0.9 . . . . 1.27 111.037 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.539 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -110.6 93.79 4.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.553 -0.749 . . . . 2.92 111.658 177.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.681 ' C ' ' HG ' ' A' ' 183' ' ' LEU . 2.7 mm? -124.19 99.09 6.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.548 -0.461 . . . . 0.9 110.222 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.746 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -147.78 119.0 7.76 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.695 0.398 . . . . 0.53 110.074 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.593 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 7.4 p -154.12 157.8 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.285 -0.566 . . . . 0.91 111.473 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 16.4 t-80 -115.13 110.87 20.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.385 -0.968 . . . . 1.55 108.385 163.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 66.6 t . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.24 0.543 . . . . 2.56 110.051 -179.202 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 168' ' ' TRP . 66.5 mt . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 120.659 0.266 . . . . 2.45 110.693 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.25 115.88 3.55 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.184 1.922 . . . . 1.75 111.572 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.637 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -113.63 155.93 44.25 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.039 -0.528 . . . . 1.01 110.03 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.63 154.86 66.48 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.753 2.302 . . . . 0.73 111.862 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 -10.13 30.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.604 -0.725 . . . . 1.04 112.476 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 62.9 m-20 -104.71 7.75 34.86 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.927 -0.309 . . . . 1.66 111.598 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -132.54 136.44 46.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.649 -0.5 . . . . 1.0 109.649 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.437 ' OE2' ' HD2' ' A' ' 87' ' ' ARG . 35.9 tt0 -127.34 122.91 35.0 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.382 -0.527 . . . . 2.27 110.787 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tt -87.28 125.35 34.16 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.455 -0.943 . . . . 0.79 108.455 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.437 ' HD2' ' OE2' ' A' ' 85' ' ' GLU . 13.7 ptm180 -166.15 133.83 2.81 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.336 -0.847 . . . . 3.21 109.701 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.32 111.98 2.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.92 -0.582 . . . . 2.46 110.217 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -148.17 93.25 2.14 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.67 -0.863 . . . . 1.58 108.67 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.3 t -72.23 104.63 3.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.992 -0.549 . . . . 1.86 110.867 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.509 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -105.94 114.8 62.3 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.812 -0.631 . . . . 1.45 109.365 175.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.27 120.52 7.87 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.284 2.656 . . . . 1.61 112.765 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.23 -11.42 36.89 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.009 -0.615 . . . . 1.74 112.435 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.509 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -132.97 -71.1 0.53 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.916 -0.313 . . . . 1.41 111.476 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.83 -149.6 17.32 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.742 -0.742 . . . . 1.09 112.478 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.3 mt -104.5 122.71 46.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.568 0.21 . . . . 2.31 111.568 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -138.18 -153.85 6.36 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.818 -0.706 . . . . 0.59 112.159 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.52 HG21 ' CE3' ' A' ' 168' ' ' TRP . 35.6 m -112.17 112.27 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.934 0.873 . . . . 0.67 109.857 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -82.52 118.66 23.42 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.821 -0.627 . . . . 1.13 110.799 -171.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -66.15 117.97 9.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.426 -0.806 . . . . 0.54 110.374 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.9 -3.71 58.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.484 0.659 . . . . 1.68 110.079 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.412 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 24.6 ttm-85 -125.74 157.06 38.38 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.544 -0.91 . . . . 3.5 108.544 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.412 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -83.99 159.58 21.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.108 0.48 . . . . 2.4 110.145 177.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.625 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 44.6 mtm -128.32 153.53 46.91 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.02 -0.536 . . . . 1.22 109.912 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -120.45 139.06 53.41 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.8 -0.636 . . . . 2.31 109.925 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -39.22 122.69 1.29 Allowed 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.431 1.082 . . . . 0.84 113.395 -169.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.17 7.15 12.85 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.467 -0.788 . . . . 1.04 111.373 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.462 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -86.02 167.98 14.53 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.844 0.458 . . . . 2.62 111.019 -176.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.49 ' CZ ' ' HD3' ' A' ' 112' ' ' PRO . 3.7 ptt180 -142.77 164.15 30.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.065 -0.516 . . . . 3.62 110.514 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 109' ' ' ARG . 7.3 mt -118.48 139.25 51.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.542 -0.753 . . . . 0.53 109.055 170.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.7 -115.02 4.17 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.804 -0.712 . . . . 1.02 113.288 174.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.49 ' HD3' ' CZ ' ' A' ' 109' ' ' ARG . 70.4 Cg_endo -72.14 168.22 74.77 Favored 'Cis proline' 0 C--N 1.349 0.596 0 C-N-CA 123.858 -1.309 . . . . 2.1 112.94 4.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.507 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 52.7 t . . . . . 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.412 . . . . 2.0 110.528 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.445 -0.737 0 N-CA-C 112.776 -0.13 . . . . 1.3 112.776 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.404 ' HB2' HG23 ' A' ' 78' ' ' ILE . 3.4 m -61.47 -27.38 68.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.539 0.685 . . . . 1.82 110.035 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.52 ' CE3' HG21 ' A' ' 98' ' ' VAL . 16.4 p-90 -85.3 -19.33 31.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.245 -0.889 . . . . 0.7 111.084 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 40.6 mt -82.08 -14.95 55.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.059 -0.518 . . . . 0.66 111.864 -173.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -74.59 -8.65 57.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 1.48 110.01 175.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.557 ' O ' ' HD2' ' A' ' 173' ' ' ARG . 65.6 m-85 -85.98 -30.47 22.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.979 -0.555 . . . . 1.97 111.675 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.783 HG21 ' HB2' ' A' ' 207' ' ' LEU . 1.3 mm -51.3 138.01 8.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 O-C-N 123.393 0.433 . . . . 0.67 111.301 -173.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.557 ' HD2' ' O ' ' A' ' 171' ' ' TYR . 14.9 mmm180 -92.14 170.88 9.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.344 0.593 . . . . 4.34 111.874 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.478 HG22 HG11 ' A' ' 208' ' ' VAL . 61.6 t -89.64 160.76 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.26 -0.882 . . . . 1.07 108.669 173.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.538 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -46.67 125.0 6.61 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.323 0.389 . . . . 0.71 111.892 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 30.8 p -75.75 -14.11 60.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.057 -0.52 . . . . 1.88 110.989 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.4 m -148.39 164.19 34.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 1.63 109.86 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 57.4 m -74.91 -22.96 58.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.973 0.416 . . . . 1.96 111.062 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.13 5.32 45.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.213 0.53 . . . . 2.42 110.402 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -110.05 15.93 22.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.42 -0.809 . . . . 2.12 110.255 -174.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.87 114.34 7.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.449 . . . . 1.35 110.427 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.784 ' H ' HD12 ' A' ' 183' ' ' LEU . 18.7 t30 -157.43 36.74 0.28 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.001 0.905 . . . . 1.68 109.21 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.784 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.5 OUTLIER -122.9 124.57 43.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.043 -0.526 . . . . 0.81 111.169 -173.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.5 m -149.97 121.95 8.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.19 0.519 . . . . 0.51 110.735 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.432 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 48.1 ttm -97.96 133.02 43.01 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.202 -0.666 . . . . 1.35 109.202 172.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 25.0 t -112.83 132.19 55.38 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.289 -0.634 . . . . 1.73 109.289 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 24.7 tm0? -108.37 104.9 14.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.248 0.547 . . . . 1.93 109.712 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.578 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 25.3 pt -132.53 143.2 40.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.522 -0.763 . . . . 1.11 110.139 -176.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.8 m 54.1 35.93 23.49 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.324 0.39 . . . . 1.86 111.606 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 65.55 7.55 4.48 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.943 -0.571 . . . . 2.83 112.054 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 13.4 pt20 -113.79 155.26 25.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 1.75 110.529 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 113' ' ' CYS . 51.0 mm -87.81 112.75 23.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.858 -0.61 . . . . 1.01 110.425 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -110.53 135.6 50.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.889 -0.596 . . . . 3.94 110.274 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 9.9 m-85 -102.34 114.67 29.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.59 -0.277 . . . . 0.92 110.485 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.97 117.85 31.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.866 0.365 . . . . 1.11 110.048 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.462 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 2.2 t -89.6 152.85 3.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.533 0.682 . . . . 0.7 109.869 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.5 mm -90.34 -57.2 4.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.65 -1.159 . . . . 0.62 111.486 -166.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.582 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.7 OUTLIER -141.87 -178.83 5.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.634 -0.712 . . . . 1.38 111.368 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.625 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.9 m-20 -48.45 126.66 11.84 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 124.014 0.821 . . . . 2.23 112.703 -175.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.623 HD11 ' ND2' ' A' ' 182' ' ' ASN . 18.6 mm -96.66 138.01 22.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.445 -0.798 . . . . 0.88 110.714 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -86.17 133.29 41.12 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.941 -0.572 . . . . 2.06 109.51 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 52.4 Cg_exo -54.99 113.21 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.009 1.806 . . . . 0.51 111.615 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.93 -13.08 9.19 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.742 -0.742 . . . . 0.7 113.261 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -126.52 122.56 35.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.765 0.783 . . . . 1.27 111.733 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.533 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -111.29 115.79 29.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.807 -0.633 . . . . 2.92 111.254 175.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 205' ' ' GLU . 1.7 mm? -124.1 99.97 6.49 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.71 -0.478 . . . . 0.9 109.71 171.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.783 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.4 mm? -147.17 112.84 5.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.673 0.389 . . . . 0.53 110.156 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.646 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.4 p -154.92 160.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.816 -0.438 . . . . 0.91 109.816 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.432 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 53.7 t-80 -90.84 107.58 19.28 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.562 -1.273 . . . . 1.55 107.562 169.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.315 -0.905 0 CA-C-O 121.099 0.476 . . . . 2.56 110.098 178.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 110.458 -0.201 . . . . 2.45 110.458 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.64 124.57 10.37 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.702 2.268 . . . . 1.75 111.857 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.615 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -118.94 143.97 34.85 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.316 -0.402 . . . . 1.01 110.67 -178.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -54.62 147.53 48.62 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.414 2.743 . . . . 0.73 112.296 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.422 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -66.15 -12.84 58.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.92 -0.582 . . . . 1.04 112.104 -175.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.99 -24.12 59.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.19 0.519 . . . . 1.66 110.177 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 71.6 m-85 -123.72 177.39 5.73 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.074 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.545 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 28.2 tt0 -155.86 124.66 6.01 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.009 -0.276 . . . . 2.27 110.702 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.9 tt -84.0 125.01 31.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.474 -0.565 . . . . 0.79 109.474 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -147.79 138.9 23.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.196 -0.911 . . . . 3.21 109.538 -174.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.99 110.8 17.58 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.694 -0.484 . . . . 2.46 109.694 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m -150.0 106.61 3.52 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.749 -0.659 . . . . 1.58 109.309 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.6 m -75.91 104.17 6.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.061 0.458 . . . . 1.86 111.225 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.425 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -107.15 114.85 60.82 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.148 -0.686 . . . . 1.45 109.148 174.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 91' ' ' ILE . 37.5 Cg_exo -60.43 121.93 10.52 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.827 2.351 . . . . 1.61 112.653 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.33 -9.61 35.94 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.685 -0.769 . . . . 1.74 113.037 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -131.88 -70.6 0.57 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.892 0.346 . . . . 1.41 111.531 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 130.3 -161.51 23.17 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.816 -0.707 . . . . 1.09 112.047 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mt -94.68 116.78 29.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.091 -0.337 . . . . 2.31 110.091 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.464 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -119.04 -179.39 16.76 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.733 -0.746 . . . . 0.59 112.614 -176.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 19.6 m -100.78 112.7 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.698 0.761 . . . . 0.67 109.776 174.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -82.07 112.33 19.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.447 -0.797 . . . . 1.13 110.984 -169.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -66.5 114.64 5.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.54 109.703 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.554 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -95.73 2.18 53.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.427 0.632 . . . . 1.68 109.501 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -125.54 154.55 41.98 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.942 -1.027 . . . . 3.5 109.218 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.625 ' HD2' ' H ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -86.72 154.68 20.78 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.453 -0.573 . . . . 2.4 109.453 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.744 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 49.4 mtm -131.16 147.56 52.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.512 -0.313 . . . . 1.22 110.734 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -109.8 143.06 40.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.322 -0.622 . . . . 2.31 109.322 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.37 130.43 10.75 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 124.012 0.82 . . . . 0.84 112.458 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.61 7.54 13.5 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.156 -0.778 . . . . 1.04 111.156 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 0.8 OUTLIER -78.96 162.87 25.68 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 122.901 0.48 . . . . 2.62 111.589 -176.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 109' ' ' ARG . 2.8 tmm_? -146.93 128.26 14.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.856 -0.611 . . . . 3.62 110.881 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 3.2 mt -105.15 148.48 26.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.728 -0.841 . . . . 0.53 108.728 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 129.72 -151.2 19.22 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.532 -0.842 . . . . 1.02 112.181 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.557 ' HB3' ' CE2' ' A' ' 193' ' ' TYR . 86.4 Cg_endo -81.53 142.05 52.97 Favored 'Cis proline' 0 C--N 1.342 0.218 0 C-N-CA 123.823 -1.324 . . . . 2.1 112.67 0.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 121.19 0.519 . . . . 2.0 109.765 178.017 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 112.134 -0.386 . . . . 1.3 112.134 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 23.0 t -68.54 -24.79 64.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.325 0.583 . . . . 1.82 109.941 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -85.0 -18.79 33.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.794 -0.639 . . . . 0.7 109.857 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.538 ' O ' HG13 ' A' ' 172' ' ' ILE . 38.0 mt -84.1 -20.35 32.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.682 -0.69 . . . . 0.66 111.415 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.463 ' C ' ' HD3' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -76.2 -6.17 50.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.519 -0.472 . . . . 1.48 110.225 176.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.464 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 33.8 m-85 -75.83 -37.52 58.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.968 -0.56 . . . . 1.97 110.484 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.646 HD12 ' HB2' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -68.63 119.74 14.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.367 -0.605 . . . . 0.67 109.367 174.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -111.15 -172.29 2.0 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.539 -0.301 . . . . 4.34 110.847 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.412 HG22 HG11 ' A' ' 208' ' ' VAL . 20.6 t -68.19 149.04 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 1.07 110.771 -177.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.577 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -56.22 126.23 25.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.894 -0.594 . . . . 0.71 111.441 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 46.2 t -72.02 -17.46 62.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 1.88 110.838 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 m -126.33 150.42 48.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.313 -0.403 . . . . 1.63 109.975 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 10.7 p -78.57 -19.02 53.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.492 0.553 . . . . 1.96 112.492 -172.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -89.17 -4.09 58.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.468 0.651 . . . . 2.42 110.051 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.15 17.48 12.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.207 -0.906 . . . . 2.12 111.642 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -69.33 113.25 6.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.327 0.584 . . . . 1.35 110.952 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 1.033 ' H ' HD12 ' A' ' 183' ' ' LEU . 4.1 p-10 -155.25 35.14 0.38 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.178 -0.919 . . . . 1.68 109.582 171.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 1.033 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.5 OUTLIER -117.7 120.42 37.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.443 -0.799 . . . . 0.81 110.754 -171.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 92.7 m -148.53 139.8 23.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.099 0.476 . . . . 0.51 110.95 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 55.5 ttm -98.75 150.29 21.98 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.371 -0.603 . . . . 1.35 109.371 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 53.7 t -112.78 131.9 55.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.061 0.458 . . . . 1.73 109.97 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.557 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 20.7 tm0? -120.77 104.89 10.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.769 -0.651 . . . . 1.93 109.389 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 12.9 pt -140.71 132.63 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 1.11 110.123 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 51.1 m 58.51 29.88 18.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.118 0.485 . . . . 1.86 111.059 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.557 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 0.9 OUTLIER 63.97 11.5 6.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.145 -0.934 . . . . 2.83 112.753 176.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -112.08 140.03 47.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.539 -0.541 . . . . 1.75 109.539 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.1 mm -84.77 131.68 33.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.947 -0.57 . . . . 1.01 112.02 -172.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 112' ' ' PRO . 54.3 m-85 -128.37 165.11 21.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.045 -0.98 . . . . 3.94 109.709 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.557 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 3.9 m-85 -115.02 126.53 54.85 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.579 -0.526 . . . . 0.92 109.579 175.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -125.47 120.06 29.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.027 0.441 . . . . 1.11 110.604 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.503 HG22 HD11 ' A' ' 207' ' ' LEU . 1.5 t -85.82 152.9 3.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.126 -0.694 . . . . 0.7 109.126 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.538 HG13 ' HA ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -84.28 -48.54 16.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.891 -1.05 . . . . 0.62 111.039 -170.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.78 -178.08 6.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.635 -0.711 . . . . 1.38 111.193 -174.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.744 ' HA ' ' O ' ' A' ' 104' ' ' MET . 2.8 p-10 -43.23 124.49 3.34 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.454 1.096 . . . . 2.23 113.486 -176.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.482 HG13 ' HE3' ' A' ' 104' ' ' MET . 37.8 mm -100.98 133.11 45.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.947 -1.024 . . . . 0.88 110.122 175.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.676 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 46.5 mt-10 -90.12 128.74 48.46 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.402 -0.592 . . . . 2.06 109.402 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.76 116.75 2.03 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.952 2.435 . . . . 0.51 112.934 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 123.51 -16.11 8.0 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.953 -0.641 . . . . 0.7 113.653 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.676 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 13.9 pt-20 -111.7 122.86 48.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.827 0.814 . . . . 1.27 111.518 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -111.32 94.99 5.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.081 -0.509 . . . . 2.92 112.087 177.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.455 HD22 ' N ' ' A' ' 206' ' ' LEU . 1.2 mm? -122.77 100.17 6.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.874 -0.73 . . . . 0.9 109.859 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.646 ' HB2' HD12 ' A' ' 172' ' ' ILE . 0.6 OUTLIER -147.33 114.28 6.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.581 -0.281 . . . . 0.53 110.617 177.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.646 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.5 p -155.51 158.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.505 . . . . 0.91 109.635 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -85.81 110.41 19.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.245 -1.02 . . . . 1.55 108.245 166.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.32 -0.676 0 CA-C-O 121.264 0.554 . . . . 2.56 110.015 -177.669 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.795 -0.446 . . . . 2.45 109.795 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.78 116.39 3.41 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.349 2.033 . . . . 1.75 111.712 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.579 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -126.41 140.94 38.54 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.287 -0.415 . . . . 1.01 110.478 -178.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.45 138.38 83.71 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.509 2.14 . . . . 0.73 111.634 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.49 -4.12 13.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.145 0.497 . . . . 1.04 111.351 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.54 -23.01 61.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.785 -0.643 . . . . 1.66 109.457 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -128.43 177.31 7.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.295 -0.866 . . . . 1.0 108.872 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -145.54 131.43 19.14 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.18 -0.608 . . . . 2.27 110.906 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.4 tt -92.79 130.65 38.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.027 -0.533 . . . . 0.79 109.769 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -149.5 150.93 33.09 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.454 -0.794 . . . . 3.21 109.746 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -82.92 109.42 17.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.707 -0.849 . . . . 2.46 108.707 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.8 m -159.56 82.44 0.75 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.327 -0.62 . . . . 1.58 109.327 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.6 p -68.3 105.22 2.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.139 -0.482 . . . . 1.86 110.922 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.6 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -81.86 123.46 80.15 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.116 -0.698 . . . . 1.45 109.116 176.236 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -49.62 115.38 1.77 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.282 2.654 . . . . 1.61 113.297 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.09 -14.53 37.06 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.7 -0.762 . . . . 1.74 112.691 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.6 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -128.77 -55.77 1.21 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 1.41 111.477 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.92 -146.71 17.54 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.979 -0.629 . . . . 1.09 112.255 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 96' ' ' LEU . 1.3 pp -69.26 158.83 34.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.718 0.259 . . . . 2.31 110.914 177.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.71 172.15 43.56 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.796 -0.716 . . . . 0.59 111.995 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.1 m -108.24 120.45 59.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.678 0.751 . . . . 0.67 109.965 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -83.01 107.98 15.99 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.246 0.546 . . . . 1.13 110.859 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.42 115.56 7.99 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.551 -0.749 . . . . 0.54 110.16 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.537 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -86.57 -5.23 59.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.546 0.688 . . . . 1.68 109.359 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -128.88 159.17 36.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.008 -0.997 . . . . 3.5 109.176 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.432 ' H ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -85.37 137.09 33.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.244 0.545 . . . . 2.4 110.637 -177.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.634 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 25.3 mtm -94.97 116.62 28.93 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.74 -0.837 . . . . 1.22 108.74 172.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.69 173.62 12.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.403 0.621 . . . . 2.31 111.74 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.98 118.12 7.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.276 -0.874 . . . . 0.84 111.83 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.76 1.04 63.82 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.839 -0.696 . . . . 1.04 113.198 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.58 167.95 20.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.649 -0.5 . . . . 2.62 109.649 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.636 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 5.0 tmm_? -145.82 130.6 18.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.245 0.461 . . . . 3.62 112.245 -170.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.7 mt -88.18 139.91 30.02 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.84 -0.8 . . . . 0.53 108.84 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.04 173.3 40.72 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.801 -1.19 . . . . 1.02 113.05 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -80.97 152.27 81.0 Favored 'Cis proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.954 -1.686 . . . . 2.1 112.463 -2.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.442 ' HA ' ' HA2' ' A' ' 166' ' ' GLY . 42.7 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 121.037 0.446 . . . . 2.0 110.715 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 112.103 -0.399 . . . . 1.3 112.103 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 20.0 t -64.25 -26.94 68.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.028 0.442 . . . . 1.82 110.126 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.499 ' O ' ' HB2' ' A' ' 171' ' ' TYR . 44.3 p-90 -86.26 -21.16 27.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.7 111.201 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 15.5 mt -82.49 -14.93 54.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.785 0.291 . . . . 0.66 111.785 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -74.63 -4.35 36.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.152 0.501 . . . . 1.48 109.911 174.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' A' ' 168' ' ' TRP . 13.2 m-85 -76.3 -32.56 58.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.602 -0.726 . . . . 1.97 111.547 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.568 HG21 ' HB2' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -62.87 134.94 27.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.406 -0.518 . . . . 0.67 110.406 -175.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.495 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 13.3 mmm180 -110.2 160.1 16.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.084 0.469 . . . . 4.34 111.549 -177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.422 HG22 HG11 ' A' ' 208' ' ' VAL . 62.6 t -67.05 147.12 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.569 -0.741 . . . . 1.07 109.31 175.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.702 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -54.22 141.72 28.48 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.274 0.559 . . . . 0.71 112.117 -177.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 44.9 t -91.26 -2.8 57.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.247 -0.888 . . . . 1.88 110.34 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 180' ' ' ASP . 41.5 m -141.65 145.95 35.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.199 0.523 . . . . 1.63 110.548 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 59.8 m -72.19 -31.25 65.73 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.551 -0.749 . . . . 1.96 111.584 -173.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -84.05 2.4 39.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.151 0.5 . . . . 2.42 110.428 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 177' ' ' SER . 4.2 t70 -108.91 16.65 22.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.523 -0.762 . . . . 2.12 110.507 -173.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -63.89 114.19 3.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.037 0.446 . . . . 1.35 110.555 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.861 ' H ' HD12 ' A' ' 183' ' ' LEU . 10.5 t30 -148.6 32.27 0.79 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.045 -1.094 . . . . 1.68 108.045 175.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.861 HD12 ' H ' ' A' ' 182' ' ' ASN . 1.4 mp -117.15 122.16 43.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.334 -0.848 . . . . 0.81 110.746 -172.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 95.3 m -148.72 136.74 20.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.971 0.415 . . . . 0.51 110.306 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 49.7 ttm -106.07 141.92 36.63 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.54 -0.541 . . . . 1.35 109.54 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 53.4 t -111.93 131.61 55.27 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.268 -0.641 . . . . 1.73 109.268 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.1 103.86 9.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.146 -0.687 . . . . 1.93 109.146 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.529 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 22.4 pt -138.08 144.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.627 -0.715 . . . . 1.11 109.842 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.8 m 60.41 31.9 20.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.858 0.361 . . . . 1.86 111.392 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 60.11 24.09 13.36 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.785 -0.643 . . . . 2.83 112.026 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.4 pt20 -130.37 161.42 31.36 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.975 -0.38 . . . . 1.75 109.975 176.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.3 mm -103.94 131.45 52.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.21 0.529 . . . . 1.01 112.274 -174.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.636 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 30.1 m-85 -133.48 147.85 51.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.266 -0.879 . . . . 3.94 110.027 174.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 4.9 m-30 -101.57 114.44 28.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.739 -0.467 . . . . 0.92 109.739 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -99.22 121.81 41.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.392 . . . . 1.11 110.246 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 1.9 t -89.23 150.95 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 122.074 0.94 . . . . 0.7 110.173 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.413 HG13 ' HA ' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -95.6 -55.28 6.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 113.866 -1.515 . . . . 0.62 110.796 -165.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.39 175.22 10.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.758 -1.11 . . . . 1.38 109.733 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.634 ' HA ' ' O ' ' A' ' 104' ' ' MET . 9.2 p-10 -59.45 115.82 3.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.76 0.79 . . . . 2.23 112.2 -172.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.451 HD11 ' ND2' ' A' ' 182' ' ' ASN . 4.8 mm -69.33 140.13 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.857 -1.065 . . . . 0.88 110.867 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 37.2 mt-10 -84.04 118.19 70.64 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.21 -0.663 . . . . 2.06 109.21 171.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -45.58 121.17 3.78 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.943 2.428 . . . . 0.51 112.731 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.74 -11.17 9.56 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.91 -0.662 . . . . 0.7 112.506 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 10.9 pt-20 -133.92 124.65 26.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 1.27 110.965 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.504 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -109.45 107.66 17.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.82 0.343 . . . . 2.92 111.066 177.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.585 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.2 mm? -123.41 98.93 6.08 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.186 -0.606 . . . . 0.9 110.354 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.568 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.6 mm? -148.17 105.48 3.64 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.096 -0.705 . . . . 0.53 109.096 174.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.737 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 24.5 t -154.58 158.67 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.182 -1.044 . . . . 0.91 108.182 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -85.01 108.49 17.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.895 -1.15 . . . . 1.55 107.895 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--N 1.315 -0.926 0 CA-C-O 121.674 0.749 . . . . 2.56 110.68 -176.535 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 78.6 mt . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.581 0.229 . . . . 2.45 110.45 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.39 121.45 8.88 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.9 2.4 . . . . 1.75 112.522 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.577 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -120.83 152.96 56.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.901 -0.59 . . . . 1.01 109.934 178.386 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.85 150.58 85.74 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.391 2.061 . . . . 0.73 110.995 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.23 8.36 1.35 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.876 -0.602 . . . . 1.04 112.377 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -112.88 1.23 15.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.143 0.497 . . . . 1.66 111.243 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -137.38 136.11 37.58 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -123.12 130.02 52.21 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.077 -0.649 . . . . 2.27 111.127 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tt -83.7 130.55 34.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 0.79 109.505 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 97.0 mtt180 -143.71 126.85 16.53 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.507 -0.77 . . . . 3.21 109.468 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.76 111.78 17.52 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.479 -0.488 . . . . 2.46 109.891 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.0 p -162.69 97.47 0.96 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.657 -0.701 . . . . 1.58 109.463 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.5 m -68.21 104.08 1.73 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.966 0.412 . . . . 1.86 110.777 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -87.04 122.19 71.24 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.233 -0.654 . . . . 1.45 109.233 175.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.54 119.09 4.68 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.187 2.591 . . . . 1.61 112.821 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.01 -20.43 28.8 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 121.003 -0.618 . . . . 1.74 112.685 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.417 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -131.74 -72.45 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.032 0.416 . . . . 1.41 111.3 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.533 ' HA3' ' NH1' ' A' ' 173' ' ' ARG . . . 131.85 -130.58 5.99 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.932 -0.651 . . . . 1.09 112.557 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt -99.68 158.17 15.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.681 0.24 . . . . 2.31 110.485 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.24 -179.85 39.33 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.269 -0.732 . . . . 0.59 111.269 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.8 m -102.9 119.69 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.543 0.687 . . . . 0.67 109.504 174.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.482 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 49.4 m95 -83.83 114.62 21.76 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.562 -0.744 . . . . 1.13 111.023 -170.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.23 115.29 12.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.067 -0.716 . . . . 0.54 109.067 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.532 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -92.55 2.27 56.79 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.648 0.737 . . . . 1.68 109.641 -176.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -125.75 161.24 27.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.979 -1.01 . . . . 3.5 108.355 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 155.99 39.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.0 0.428 . . . . 2.4 111.169 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.668 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 34.8 mtm -120.15 149.31 42.44 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.393 -0.966 . . . . 1.22 108.393 171.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 47.1 mt-10 -119.39 173.88 6.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.523 0.678 . . . . 2.31 112.399 -172.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.12 115.58 6.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.884 -1.053 . . . . 0.84 111.976 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.32 1.88 57.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.685 -0.769 . . . . 1.04 113.522 171.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 6.8 pt-20 -86.07 166.27 15.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.483 0.641 . . . . 2.62 110.647 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.478 ' HG2' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -127.96 143.41 51.09 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.109 -0.496 . . . . 3.62 110.233 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.478 ' N ' ' HG2' ' A' ' 109' ' ' ARG . 7.5 mt -87.35 125.8 34.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.128 -1.064 . . . . 0.53 108.128 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -140.73 157.14 25.7 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 119.885 -1.15 . . . . 1.02 113.17 -172.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.92 154.33 96.94 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.585 -1.839 . . . . 2.1 112.175 -1.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.524 ' HA ' HD12 ' A' ' 169' ' ' LEU . 59.5 m . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.913 -0.585 . . . . 2.0 111.061 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.401 ' HA3' ' C ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 111.424 -0.671 . . . . 1.3 111.424 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 8.7 t -64.56 -17.66 64.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.267 0.556 . . . . 1.82 110.628 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.498 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 26.9 p-90 -74.31 -21.76 59.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.297 0.57 . . . . 0.7 110.274 177.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 40.6 mt -86.43 -20.22 28.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.738 -0.665 . . . . 0.66 112.1 -175.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -71.88 -5.04 31.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.623 -0.431 . . . . 1.48 110.577 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -79.9 -37.27 35.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.913 -0.585 . . . . 1.97 111.798 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.696 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -62.83 131.64 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.751 -0.38 . . . . 0.67 110.273 -178.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.533 ' NH1' ' HA3' ' A' ' 95' ' ' GLY . 99.2 mtt180 -115.07 -171.41 1.94 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.296 -0.411 . . . . 4.34 111.429 -174.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.509 HG22 HG11 ' A' ' 208' ' ' VAL . 4.4 t -76.47 141.0 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-N 116.298 -0.41 . . . . 1.07 110.229 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -61.07 138.44 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.821 -0.627 . . . . 0.71 111.944 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 37.6 t -72.85 -6.87 47.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.169 -0.923 . . . . 1.88 110.69 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.3 t -126.07 139.77 53.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 1.63 110.383 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 61.6 m -88.15 -18.81 27.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.052 -0.522 . . . . 1.96 110.59 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -83.97 -14.95 49.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.102 0.477 . . . . 2.42 110.522 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -110.04 17.57 20.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.828 -0.624 . . . . 2.12 111.185 -176.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.498 ' NE2' ' HB3' ' A' ' 175' ' ' ALA . 30.1 mm-40 -54.94 115.49 2.23 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.179 0.514 . . . . 1.35 110.86 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.722 ' H ' HD12 ' A' ' 183' ' ' LEU . 5.5 p-10 -144.05 32.36 1.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.667 0.746 . . . . 1.68 109.384 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.722 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.2 OUTLIER -116.0 124.51 50.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.038 -0.983 . . . . 0.81 110.606 -173.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 97.7 m -146.49 121.59 10.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.287 0.565 . . . . 0.51 111.387 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.596 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 39.0 ttm -113.24 129.49 56.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 1.35 109.431 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 35.2 t -115.86 165.05 13.52 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.407 -0.59 . . . . 1.73 109.407 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.435 HE22 ' HA ' ' A' ' 190' ' ' GLU . 25.3 tm0? -129.88 105.23 7.86 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.166 -0.679 . . . . 1.93 109.166 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.62 143.93 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.748 -0.66 . . . . 1.11 110.518 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.4 t 62.56 34.06 15.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.254 0.549 . . . . 1.86 110.312 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.435 ' HA ' HE22 ' A' ' 187' ' ' GLN . 17.3 mm-40 58.32 30.0 18.93 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.377 -0.829 . . . . 2.83 111.979 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -140.54 167.28 22.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.996 0.427 . . . . 1.75 110.212 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.3 mm -82.29 152.33 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.982 -0.748 . . . . 1.01 108.982 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -143.75 120.1 10.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.754 0.311 . . . . 3.94 110.542 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.545 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 15.0 m-85 -100.9 113.49 26.49 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.734 -0.469 . . . . 0.92 109.734 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -118.79 129.45 55.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.654 0.264 . . . . 1.11 110.31 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 1.2 t -95.3 150.99 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.951 0.882 . . . . 0.7 110.645 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -98.68 -45.47 12.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.176 -1.375 . . . . 0.62 112.004 -163.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 199' ' ' ASP . 0.1 OUTLIER -154.84 -177.66 6.67 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.155 -0.929 . . . . 1.38 109.886 -173.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.668 ' HA ' ' O ' ' A' ' 104' ' ' MET . 15.4 t70 -59.22 123.32 16.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.374 0.607 . . . . 2.23 111.515 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.413 HG13 ' HE3' ' A' ' 104' ' ' MET . 14.8 mm -106.94 136.58 41.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.805 -0.634 . . . . 0.88 110.323 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.54 122.6 80.89 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.714 -0.676 . . . . 2.06 110.331 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -51.46 119.97 6.26 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.51 2.14 . . . . 0.51 111.745 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.72 -8.5 9.35 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.456 -0.878 . . . . 0.7 112.374 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -132.5 123.24 26.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.295 0.569 . . . . 1.27 110.146 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.3 96.2 6.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.729 -0.668 . . . . 2.92 111.436 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.466 ' C ' HD22 ' A' ' 207' ' ' LEU . 0.8 OUTLIER -115.58 99.89 7.67 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.836 -0.745 . . . . 0.9 110.114 177.195 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.696 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.87 112.99 6.14 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.069 -0.715 . . . . 0.53 109.069 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.631 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 3.9 p -155.28 160.08 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 O-C-N 121.984 -0.447 . . . . 0.91 110.96 -176.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.596 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 54.9 t-80 -80.27 128.6 33.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.564 -0.902 . . . . 1.55 108.564 166.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 42.4 t . . . . . 0 C--N 1.325 -0.499 0 N-CA-C 109.386 -0.598 . . . . 2.56 109.386 174.183 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 74.0 mt . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 109.95 -0.389 . . . . 2.45 109.95 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.91 116.96 4.12 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.347 2.031 . . . . 1.75 111.442 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 168' ' ' TRP . 0.2 OUTLIER -131.59 147.28 65.41 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.399 -0.364 . . . . 1.01 110.365 -178.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 80' ' ' ILE . 2.8 Cg_exo -75.93 133.05 14.82 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.346 2.031 . . . . 0.73 110.761 171.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.03 -8.88 33.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.317 . . . . 1.04 111.6 -176.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -70.74 -19.7 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.049 -0.523 . . . . 1.66 110.606 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.53 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 19.0 m-85 -123.78 148.27 46.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.346 -0.612 . . . . 1.0 109.346 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.438 ' HB2' ' HE2' ' A' ' 101' ' ' LYS . 7.2 tp10 -109.9 117.38 33.67 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.786 -0.366 . . . . 2.27 110.495 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.443 ' HA ' HG12 ' A' ' 98' ' ' VAL . 8.3 tt -83.67 130.09 34.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.409 -0.589 . . . . 0.79 109.409 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -143.89 124.4 13.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.06 -0.518 . . . . 3.21 111.443 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -83.03 112.48 19.81 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.432 -0.581 . . . . 2.46 109.432 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 33.0 t -170.09 149.58 3.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.118 -0.697 . . . . 1.58 109.118 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.3 m -100.61 104.91 16.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.746 0.308 . . . . 1.86 110.871 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -97.56 123.77 50.99 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.229 -0.656 . . . . 1.45 109.229 175.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.16 121.1 9.36 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.023 2.482 . . . . 1.61 112.738 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.48 -15.66 35.16 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.724 -0.671 . . . . 1.74 112.07 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.502 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -132.99 -60.14 0.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.839 0.352 . . . . 1.41 111.7 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.561 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 121.74 -125.87 6.28 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.307 -0.717 . . . . 1.09 111.307 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 89' ' ' SER . 0.7 OUTLIER -89.0 160.67 17.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.803 -0.443 . . . . 2.31 109.803 173.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.2 169.49 41.27 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.19 -1.005 . . . . 0.59 112.779 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 86' ' ' LEU . 11.3 m -104.2 148.81 8.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.1 -0.704 . . . . 0.67 109.1 174.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -118.53 120.17 36.71 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.647 0.26 . . . . 1.13 110.753 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.517 ' H ' ' HG2' ' A' ' 205' ' ' GLU . . . -71.61 122.36 20.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.235 -0.283 . . . . 0.54 110.235 176.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.685 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -90.36 11.91 19.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.657 0.741 . . . . 1.68 110.141 -178.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.2 ttp85 -137.35 159.11 42.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.155 -0.929 . . . . 3.5 108.565 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.657 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -85.34 155.93 21.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.956 0.408 . . . . 2.4 110.744 -178.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 63.0 mtm -132.05 153.01 50.84 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.171 -0.677 . . . . 1.22 109.171 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -120.07 143.68 47.99 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.13 0.269 . . . . 2.31 110.842 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . . . -34.89 117.33 0.38 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.76 1.287 . . . . 0.84 113.544 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.44 7.89 11.77 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.688 -0.687 . . . . 1.04 111.76 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.507 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -80.39 161.71 24.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.114 0.483 . . . . 2.62 110.71 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.546 ' HG3' ' CE2' ' A' ' 193' ' ' TYR . 0.0 OUTLIER -141.17 145.45 35.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.139 -0.482 . . . . 3.62 110.513 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.53 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 6.3 mt -107.51 150.74 26.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.36 -0.607 . . . . 0.53 109.36 173.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.13 -143.24 17.14 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.318 -0.944 . . . . 1.02 113.319 173.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.23 165.94 47.59 Favored 'Cis proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.822 -1.324 . . . . 2.1 113.316 2.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 31.7 t . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 2.0 110.655 -177.082 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 N-CA-C 112.333 -0.307 . . . . 1.3 112.333 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.524 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 1.2 m -57.27 -29.9 64.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.668 0.387 . . . . 1.82 111.499 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.493 ' HB3' HG22 ' A' ' 80' ' ' ILE . 45.5 p-90 -85.59 -23.46 27.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.7 111.13 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 17.7 mt -86.4 -15.55 40.01 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.805 0.298 . . . . 0.66 111.805 -177.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -76.13 -1.71 27.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.806 -0.358 . . . . 1.48 110.413 177.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.426 ' CE2' HD11 ' A' ' 86' ' ' LEU . 37.9 m-85 -81.67 -37.13 27.92 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.112 -0.495 . . . . 1.97 112.058 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -65.07 140.99 18.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 120.151 -0.62 . . . . 0.67 110.913 -173.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 -123.7 -168.27 1.75 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.839 -0.619 . . . . 4.34 111.467 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.401 HG22 HG11 ' A' ' 208' ' ' VAL . 7.0 t -69.63 156.64 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.58 -0.737 . . . . 1.07 110.626 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.576 ' HA ' HD12 ' A' ' 206' ' ' LEU . . . -55.88 132.99 51.04 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.141 -0.481 . . . . 0.71 110.508 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.1 m -71.77 -20.87 61.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.604 -0.725 . . . . 1.88 111.033 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.403 ' HB2' ' OD1' ' A' ' 180' ' ' ASP . 24.7 m -130.63 157.11 43.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.466 -0.334 . . . . 1.63 111.181 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 3.3 p -59.01 -56.71 18.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.219 0.451 . . . . 1.96 112.219 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.76 -1.4 21.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 2.42 111.758 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.403 ' OD1' ' HB2' ' A' ' 177' ' ' SER . 4.5 m-20 -95.06 17.32 14.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.264 -0.426 . . . . 2.12 111.623 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 30.2 mm-40 -56.57 113.77 1.75 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.976 0.417 . . . . 1.35 109.889 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.554 ' OD1' ' HE2' ' A' ' 198' ' ' LYS . 17.8 t30 -159.25 43.82 0.24 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.121 -1.066 . . . . 1.68 108.121 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.599 ' HB3' ' O ' ' A' ' 206' ' ' LEU . 0.7 OUTLIER -142.42 128.86 20.11 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.003 -0.998 . . . . 0.81 111.578 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 29.8 m -150.38 120.81 7.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.088 -0.96 . . . . 0.51 110.184 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.585 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 44.9 ttm -109.19 118.44 36.72 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.654 -0.498 . . . . 1.35 109.654 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 36.7 t -113.86 166.42 11.59 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.169 -0.469 . . . . 1.73 109.774 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -124.09 134.39 53.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.829 0.347 . . . . 1.93 110.653 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 23.5 pt -148.05 140.94 18.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.722 -0.672 . . . . 1.11 109.946 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 190' ' ' GLU . 8.3 t 54.4 38.99 30.6 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.113 0.482 . . . . 1.86 110.62 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 190' ' ' GLU . 37.0 tt0 72.79 -1.47 3.0 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.186 -0.916 . . . . 2.83 112.163 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -117.8 154.2 32.18 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.443 -0.785 . . . . 1.75 111.367 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 192' ' ' ILE . 26.8 mm -81.66 129.12 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.348 -0.842 . . . . 1.01 111.157 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.546 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 72.8 t80 -114.97 131.19 56.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.763 -1.108 . . . . 3.94 109.737 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 3.9 m-85 -98.98 112.3 24.46 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.157 -0.683 . . . . 0.92 109.157 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.42 ' HD2' ' C ' ' A' ' 195' ' ' LYS . 5.0 tmmm? -112.1 120.07 40.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.7 -0.682 . . . . 1.11 109.454 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.56 HG22 HD11 ' A' ' 207' ' ' LEU . 1.8 t -94.33 150.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-O 121.591 0.71 . . . . 0.7 109.326 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.8 mm -87.71 -55.58 6.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.696 -1.138 . . . . 0.62 110.65 -166.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.554 ' HE2' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -144.71 -178.84 6.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.722 -0.672 . . . . 1.38 111.973 177.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.0 OUTLIER -47.25 128.71 12.15 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.767 1.025 . . . . 2.23 113.767 -171.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 38.7 mm -95.25 136.79 25.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.348 -0.842 . . . . 0.88 110.545 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 42.5 mt-10 -89.55 123.3 67.01 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.457 -0.572 . . . . 2.06 109.457 171.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' A' ' 103' ' ' LYS . 77.2 Cg_exo -47.22 123.18 7.36 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.258 2.639 . . . . 0.51 112.602 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.2 -18.77 8.32 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.914 -0.66 . . . . 0.7 112.84 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 11.0 pt-20 -132.55 121.25 22.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.523 0.661 . . . . 1.27 111.898 -178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.517 ' HG2' ' H ' ' A' ' 100' ' ' ALA . 13.2 mm-40 -110.32 118.02 35.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 2.92 109.982 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.599 ' O ' ' HB3' ' A' ' 183' ' ' LEU . 1.9 mm? -112.28 100.8 9.09 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.376 -0.972 . . . . 0.9 108.376 171.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.692 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.3 mm? -143.44 113.49 7.23 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.492 0.495 . . . . 0.53 109.891 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.549 HG12 HD12 ' A' ' 183' ' ' LEU . 1.4 p -152.21 159.53 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.837 0.351 . . . . 0.91 110.289 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.585 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 44.8 t-80 -98.52 111.22 23.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.689 -1.226 . . . . 1.55 107.689 171.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 109.241 -0.652 . . . . 2.56 109.241 175.32 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.5 mt . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.519 -0.178 . . . . 2.45 110.519 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.45 125.14 10.97 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.532 2.155 . . . . 1.75 112.218 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.694 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -111.9 159.03 35.03 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.142 -0.481 . . . . 1.01 110.973 -175.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -64.52 162.47 30.83 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.33 2.686 . . . . 0.73 112.648 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.19 -4.38 17.37 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.438 0.903 . . . . 1.04 113.438 -170.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 59.8 m-20 -111.64 1.78 16.95 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.529 -0.468 . . . . 1.66 111.839 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -128.2 140.67 51.78 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.456 ' HB2' ' HD2' ' A' ' 101' ' ' LYS . 37.0 tt0 -122.48 126.21 47.39 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.569 -0.452 . . . . 2.27 110.183 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.591 HD11 ' CE2' ' A' ' 171' ' ' TYR . 6.2 tt -83.98 127.2 33.71 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.85 -0.614 . . . . 0.79 109.533 -178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.42 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 45.4 mtp180 -152.86 128.44 10.05 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.231 -0.895 . . . . 3.21 109.792 -174.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.3 112.55 19.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.099 -0.704 . . . . 2.46 109.099 174.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -163.96 92.14 0.66 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.529 -0.915 . . . . 1.58 108.529 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 m -54.35 105.4 0.15 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.678 -0.692 . . . . 1.86 112.083 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -92.19 123.38 62.76 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.627 -0.715 . . . . 1.45 109.181 173.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -46.58 116.9 1.78 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.449 2.766 . . . . 1.61 113.366 -175.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.87 -27.18 13.54 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.005 -0.617 . . . . 1.74 112.491 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.05 -62.32 1.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.81 0.338 . . . . 1.41 111.133 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 115.09 -113.6 2.99 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.009 -0.615 . . . . 1.09 111.922 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.38 159.29 24.39 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 122.122 0.169 . . . . 2.31 110.683 176.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.04 -179.19 46.38 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.618 -0.801 . . . . 0.59 112.109 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.435 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 29.4 m -115.77 114.66 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.6 0.714 . . . . 0.67 109.88 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 28.2 m95 -83.22 120.14 25.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.513 -0.767 . . . . 1.13 110.98 -170.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -66.51 121.76 16.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.236 -0.438 . . . . 0.54 110.39 177.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.456 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 1.1 mppt? -90.73 -9.02 48.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.153 0.502 . . . . 1.68 110.286 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -135.47 157.44 46.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.308 -0.86 . . . . 3.5 108.681 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.6 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -79.27 159.83 27.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 120.913 0.387 . . . . 2.4 110.38 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.808 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 52.8 mtm -129.13 142.05 51.0 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.395 -0.594 . . . . 1.22 109.395 177.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.35 140.81 37.91 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.852 -0.425 . . . . 2.31 109.852 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.07 128.26 3.56 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 124.175 0.922 . . . . 0.84 112.488 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.85 7.8 11.38 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.55 -0.75 . . . . 1.04 111.681 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 0.6 OUTLIER -86.08 163.89 17.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.096 0.474 . . . . 2.62 111.297 -179.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -145.98 135.34 22.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.585 -0.524 . . . . 3.62 109.585 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 5.0 mt -101.47 143.37 31.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.848 -0.427 . . . . 0.53 109.848 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 124.77 -136.13 9.81 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.693 -0.765 . . . . 1.02 112.34 176.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.441 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 71.6 Cg_endo -75.22 149.54 93.62 Favored 'Cis proline' 0 C--N 1.343 0.267 0 C-N-CA 123.309 -1.538 . . . . 2.1 112.645 2.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.461 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 31.0 t . . . . . 0 N--CA 1.443 -0.783 0 N-CA-C 108.662 -0.866 . . . . 2.0 108.662 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 113' ' ' CYS . . . . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 112.768 -0.133 . . . . 1.3 112.768 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 17.3 m -79.3 -28.62 42.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.107 0.48 . . . . 1.82 110.447 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.518 ' CB ' HG22 ' A' ' 80' ' ' ILE . 40.5 p-90 -65.03 -17.46 64.46 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.693 -0.685 . . . . 0.7 111.33 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 65.3 mt -68.78 -14.18 62.86 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.229 -0.896 . . . . 0.66 112.002 -175.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.452 ' C ' ' HD3' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -69.69 -13.19 62.18 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.671 0.272 . . . . 1.48 111.189 178.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.591 ' CE2' HD11 ' A' ' 86' ' ' LEU . 46.1 m-85 -78.47 -37.83 42.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 1.97 111.924 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.579 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -70.51 125.68 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.638 -0.425 . . . . 0.67 110.141 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 173' ' ' ARG . 48.8 mtp85 -117.85 -161.76 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.282 -0.417 . . . . 4.34 111.657 -176.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.8 t -72.37 157.62 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.116 -0.493 . . . . 1.07 111.213 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.781 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -57.15 153.34 11.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.802 -0.635 . . . . 0.71 112.167 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 28.8 p -85.98 -10.72 54.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.333 -0.849 . . . . 1.88 110.678 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 34.0 m -153.63 170.87 19.79 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.193 -0.458 . . . . 1.63 110.82 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . 0.549 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 10.5 p -71.95 -43.09 65.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.154 0.502 . . . . 1.96 110.87 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -78.26 4.02 13.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.404 0.621 . . . . 2.42 110.439 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -101.94 16.46 25.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.371 -0.832 . . . . 2.12 110.468 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 31.5 mm-40 -67.53 113.89 5.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 1.35 111.015 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.785 ' H ' HD12 ' A' ' 183' ' ' LEU . 16.6 t30 -150.94 33.64 0.6 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.253 1.025 . . . . 1.68 108.354 173.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.785 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.2 OUTLIER -124.24 123.2 39.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.41 -0.813 . . . . 0.81 110.701 -171.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 96.0 m -150.8 127.4 10.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.111 0.482 . . . . 0.51 110.738 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.555 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 63.6 mtp -114.4 136.05 53.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.951 0.405 . . . . 1.35 110.218 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 1.4 p -113.51 137.56 51.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.654 -0.703 . . . . 1.73 110.775 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -109.08 104.01 13.12 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.796 -0.816 . . . . 1.93 108.796 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 27.5 pt -141.56 145.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 1.11 110.371 -176.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.2 m 65.13 26.4 12.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 1.86 110.897 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 62.76 19.47 11.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.407 -0.815 . . . . 2.83 111.28 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -131.7 168.03 18.46 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.481 -0.563 . . . . 1.75 109.481 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.44 ' HB ' ' HB3' ' A' ' 113' ' ' CYS . 48.3 mm -99.89 132.41 45.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.179 0.514 . . . . 1.01 111.903 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -125.02 137.4 54.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.995 -0.548 . . . . 3.94 110.747 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 7.3 m-85 -100.94 117.08 34.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.966 -0.561 . . . . 0.92 109.725 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -113.01 120.28 40.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.926 0.394 . . . . 1.11 110.405 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.43 HG22 HD11 ' A' ' 207' ' ' LEU . 2.0 t -88.01 152.74 3.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.321 -0.622 . . . . 0.7 109.321 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.55 -56.18 5.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.09 -0.959 . . . . 0.62 112.105 -166.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.632 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -135.02 175.79 9.25 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.953 -0.567 . . . . 1.38 111.379 -173.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.808 ' HA ' ' O ' ' A' ' 104' ' ' MET . 17.0 t70 -50.18 112.54 0.69 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.762 0.791 . . . . 2.23 112.061 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.69 HD11 ' ND2' ' A' ' 182' ' ' ASN . 8.9 mm -79.94 136.22 23.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.633 -1.167 . . . . 0.88 111.117 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.622 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 42.3 mt-10 -88.5 126.96 58.44 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 109.261 -0.644 . . . . 2.06 109.261 173.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.51 111.8 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 121.86 1.706 . . . . 0.51 111.019 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.04 -6.4 10.23 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.63 -0.795 . . . . 0.7 113.175 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 22.2 pt-20 -115.24 121.26 42.39 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.687 0.744 . . . . 1.27 110.636 174.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.456 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -111.72 95.38 5.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.045 -0.525 . . . . 2.92 111.549 174.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.49 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.8 mm? -122.35 99.72 6.57 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.121 -0.632 . . . . 0.9 109.569 174.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.579 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -146.47 113.37 6.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.973 0.509 . . . . 0.53 109.83 177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.659 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.1 p -154.87 160.4 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 110.098 -0.334 . . . . 0.91 110.098 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.555 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 59.3 t-80 -93.69 109.87 21.51 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.902 -1.147 . . . . 1.55 107.902 171.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 C--N 1.316 -0.868 0 N-CA-C 109.603 -0.517 . . . . 2.56 109.603 177.345 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 81.9 mt . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 110.445 -0.205 . . . . 2.45 110.445 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -72.12 116.56 4.76 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.322 2.014 . . . . 1.75 111.013 175.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.561 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -125.73 146.31 54.62 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.275 -0.42 . . . . 1.01 110.3 -177.127 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.03 124.45 16.3 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.27 1.98 . . . . 0.73 110.406 170.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.21 -8.37 12.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.415 0.524 . . . . 1.04 112.415 -173.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.61 -9.03 31.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.197 0.522 . . . . 1.66 111.542 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -134.52 156.75 48.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -121.46 116.15 24.18 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.135 -0.626 . . . . 2.27 111.246 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.406 HD11 ' CE2' ' A' ' 171' ' ' TYR . 8.3 tt -86.41 128.2 34.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.782 -0.451 . . . . 0.79 109.782 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -151.12 130.66 13.0 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.48 -0.782 . . . . 3.21 109.682 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -68.21 112.03 4.89 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.367 -0.605 . . . . 2.46 109.367 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.7 t -169.52 110.7 0.46 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.423 -0.584 . . . . 1.58 109.423 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 t -90.85 107.77 19.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.21 -0.45 . . . . 1.86 110.739 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.58 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -79.11 121.95 83.8 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.35 -0.611 . . . . 1.45 109.35 175.024 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.42 114.93 1.77 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.371 2.714 . . . . 1.61 112.988 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.09 -9.83 36.74 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.95 -0.643 . . . . 1.74 112.727 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.58 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -135.76 -60.26 0.74 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.971 0.385 . . . . 1.41 111.665 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.431 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 122.76 -146.09 16.5 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.647 -0.787 . . . . 1.09 112.716 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 mt -80.4 159.03 25.82 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.254 -0.276 . . . . 2.31 110.254 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.414 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -165.03 169.09 39.51 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.802 -0.713 . . . . 0.59 111.774 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 27.5 m -98.41 114.21 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.773 0.796 . . . . 0.67 109.262 172.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -81.76 101.76 10.34 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.234 -0.893 . . . . 1.13 110.663 -167.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.37 115.22 5.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.733 -0.667 . . . . 0.54 109.701 175.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.539 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -94.0 15.76 16.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.607 0.717 . . . . 1.68 109.515 -177.347 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -148.43 160.83 42.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.562 -1.199 . . . . 3.5 108.144 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.76 158.79 34.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.435 0.636 . . . . 2.4 111.453 -174.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 54.0 mtm -134.5 143.71 47.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.98 -1.119 . . . . 1.22 107.98 170.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 52.3 mt-10 -130.28 174.45 9.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.43 . . . . 2.31 112.157 -172.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.64 122.48 11.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.495 -0.775 . . . . 0.84 113.054 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.18 -25.53 11.28 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 1.04 113.927 169.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 10.1 pt-20 -73.98 160.92 30.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.375 0.607 . . . . 2.62 112.007 -174.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.71 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 0.7 OUTLIER -124.9 134.64 52.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.029 -0.987 . . . . 3.62 110.474 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mt -87.84 133.52 33.88 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.973 -0.751 . . . . 0.53 108.973 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.87 -132.87 5.43 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.487 -0.863 . . . . 1.02 112.433 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.06 134.4 17.97 Favored 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 123.947 -1.272 . . . . 2.1 112.881 1.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.486 -0.779 . . . . 2.0 111.642 -175.394 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 120.395 -0.114 . . . . 1.3 112.821 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.52 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 3.5 p -65.99 -24.74 66.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.138 0.494 . . . . 1.82 110.774 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -84.22 -17.68 39.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.019 -0.537 . . . . 0.7 110.544 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.7 -14.13 58.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.993 -0.549 . . . . 0.66 111.442 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 167' ' ' SER . 21.2 ptmt -64.66 -18.98 65.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.927 0.394 . . . . 1.48 110.5 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.414 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 53.6 m-85 -72.53 -37.57 68.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.92 -0.582 . . . . 1.97 111.621 -175.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -73.97 117.73 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.513 0.673 . . . . 0.67 110.855 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 -172.05 2.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.891 -1.05 . . . . 4.34 110.3 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.517 ' HA ' HD22 ' A' ' 183' ' ' LEU . 2.3 p -65.2 147.03 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.345 0.593 . . . . 1.07 111.781 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.593 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -59.15 149.45 28.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.611 -1.177 . . . . 0.71 112.599 -174.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 53.7 t -60.32 -44.43 95.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.117 -0.947 . . . . 1.88 110.828 175.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 87.1 p -137.75 164.64 28.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.72 -0.474 . . . . 1.63 109.72 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . 0.478 ' HA ' ' OE1' ' A' ' 181' ' ' GLN . 75.8 m -78.4 4.36 13.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 1.96 111.849 -176.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -89.06 -7.34 56.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.2 0.524 . . . . 2.42 109.647 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.529 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . 23.6 m-20 -109.04 15.59 23.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.566 -0.743 . . . . 2.12 110.813 -176.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.478 ' OE1' ' HA ' ' A' ' 178' ' ' CYS . 15.0 mm100 -66.52 115.7 6.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.572 0.701 . . . . 1.35 111.746 -172.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.748 ' H ' HD12 ' A' ' 183' ' ' LEU . 14.1 t30 -165.03 39.74 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.682 -1.229 . . . . 1.68 107.682 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.748 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.7 OUTLIER -122.05 119.87 32.67 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.522 -0.763 . . . . 0.81 111.301 -170.422 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.5 m -150.93 121.82 7.6 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.241 0.543 . . . . 0.51 111.884 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.575 ' HB3' ' HB2' ' A' ' 209' ' ' HIS . 10.8 ttm -111.51 129.3 56.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.273 -0.64 . . . . 1.35 109.273 172.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 49.9 t -115.31 155.79 26.66 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.733 0.301 . . . . 1.73 110.266 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -116.01 112.39 21.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.291 -0.633 . . . . 1.93 109.291 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.517 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 41.5 pt -138.54 143.17 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.46 -0.336 . . . . 1.11 110.675 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.9 t 55.86 37.86 29.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 1.86 111.639 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 60.47 28.43 18.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.824 -0.625 . . . . 2.83 111.712 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 12.9 pt20 -145.11 156.22 43.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.859 0.361 . . . . 1.75 110.49 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.6 mm -82.25 134.79 26.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.191 0.52 . . . . 1.01 111.264 -175.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -124.64 122.3 37.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.669 -0.696 . . . . 3.94 109.665 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.71 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 26.4 m-85 -99.37 113.69 26.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.095 -0.705 . . . . 0.92 109.095 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -111.25 127.1 55.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.351 -0.386 . . . . 1.11 110.375 -172.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.466 HG23 ' HG3' ' A' ' 108' ' ' GLU . 1.5 t -95.19 150.73 4.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.91 0.862 . . . . 0.7 110.248 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.6 mm -100.22 -53.67 7.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.841 -1.527 . . . . 0.62 111.618 -163.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.422 ' HE3' ' C ' ' A' ' 198' ' ' LYS . 0.0 OUTLIER -153.3 -178.89 7.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.065 -0.97 . . . . 1.38 110.799 -179.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 104' ' ' MET . 9.6 p-10 -52.85 110.96 0.58 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.992 0.808 . . . . 2.23 112.673 -172.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 200' ' ' ILE . 2.6 mm -80.89 134.47 27.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.693 -0.685 . . . . 0.88 110.349 171.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 12.5 mm-40 -81.67 120.56 78.16 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.548 -0.751 . . . . 2.06 109.559 173.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.51 115.43 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.145 2.564 . . . . 0.51 112.358 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.27 -11.49 9.18 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.71 -0.757 . . . . 0.7 113.076 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 13.0 pt-20 -123.46 125.59 45.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.78 0.79 . . . . 1.27 111.613 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -108.96 99.88 9.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.529 -1.214 . . . . 2.92 112.069 -175.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.552 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.1 mm? -122.55 100.38 6.9 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.492 -0.483 . . . . 0.9 110.473 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.53 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.0 mm? -145.61 113.67 6.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.816 0.446 . . . . 0.53 110.303 174.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.691 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.9 p -155.83 161.79 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 O-C-N 122.164 -0.335 . . . . 0.91 110.41 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.575 ' HB2' ' HB3' ' A' ' 185' ' ' MET . 33.0 t-80 -131.44 109.89 10.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.189 -0.671 . . . . 1.55 109.189 161.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 121.186 0.517 . . . . 2.56 109.746 174.519 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.492 0.186 . . . . 2.45 110.745 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.95 116.57 4.44 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.323 2.015 . . . . 1.75 111.867 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.545 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -118.43 134.81 23.42 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.199 -0.455 . . . . 1.01 109.933 178.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.52 146.9 50.54 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.584 2.189 . . . . 0.73 111.936 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.25 6.89 3.89 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.268 0.84 . . . . 1.04 113.268 -168.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -116.97 5.91 12.93 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.798 -0.564 . . . . 1.66 112.102 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.581 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 10.6 m-85 -130.47 138.35 50.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.66 -0.867 . . . . 1.0 108.66 176.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.481 ' HB2' ' HD2' ' A' ' 101' ' ' LYS . 1.2 tp10 -108.52 117.42 34.13 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.759 -0.376 . . . . 2.27 110.37 -174.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.439 ' HA ' HG12 ' A' ' 98' ' ' VAL . 6.6 tt -84.13 126.85 33.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.955 -0.758 . . . . 0.79 108.955 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.425 ' N ' HD23 ' A' ' 86' ' ' LEU . 78.5 mtp180 -149.52 119.02 6.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.622 -0.717 . . . . 3.21 110.74 -173.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -73.47 112.24 9.37 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.997 -0.742 . . . . 2.46 108.997 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.4 p -155.16 158.7 39.36 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.674 -0.694 . . . . 1.58 109.355 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.1 m -99.47 103.14 14.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.837 -0.431 . . . . 1.86 109.837 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.04 111.38 62.09 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.194 -0.457 . . . . 1.45 109.94 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -58.42 125.2 17.7 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.034 2.49 . . . . 1.61 112.92 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.76 -13.3 38.54 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.889 -0.672 . . . . 1.74 112.136 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -136.27 -54.83 0.75 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.125 0.488 . . . . 1.41 110.631 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.78 -94.65 0.5 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.319 -0.855 . . . . 1.09 111.213 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 171' ' ' TYR . 0.5 OUTLIER -108.99 160.52 15.95 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.805 -0.698 . . . . 2.31 109.626 172.196 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -170.39 165.63 38.89 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.079 -1.057 . . . . 0.59 112.997 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 15.9 m -106.7 147.17 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.825 -0.435 . . . . 0.67 109.825 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -109.2 117.21 33.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.533 -0.303 . . . . 1.13 110.617 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 202' ' ' PRO . . . -67.46 128.65 37.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.525 -0.307 . . . . 0.54 110.173 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.481 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -99.54 -9.07 23.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 1.68 111.249 -176.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 103' ' ' LYS . 20.9 tpt180 -125.85 150.3 47.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.208 0.528 . . . . 3.5 111.448 -176.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.471 ' N ' ' HG3' ' A' ' 102' ' ' ARG . 1.5 tptm -61.32 138.45 58.24 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.866 -1.061 . . . . 2.4 111.061 173.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.513 ' HE3' HG13 ' A' ' 200' ' ' ILE . 77.5 mtm -127.86 152.61 47.61 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.607 -0.886 . . . . 1.22 108.607 173.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.7 135.16 54.46 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 123.232 0.332 . . . . 2.31 110.563 -174.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.415 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . . . -37.79 112.7 0.23 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 124.872 1.357 . . . . 0.84 112.803 -174.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.95 7.26 11.75 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.581 -0.736 . . . . 1.04 111.341 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.464 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -75.37 165.91 24.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.907 0.384 . . . . 2.62 110.398 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.461 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 2.4 tmm_? -145.61 131.65 19.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.37 -0.377 . . . . 3.62 111.063 -176.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.581 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 4.8 mt -99.48 137.11 38.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.058 -0.719 . . . . 0.53 109.058 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.85 -168.21 31.15 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.314 -0.946 . . . . 1.02 112.438 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.45 146.11 86.0 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.736 -1.36 . . . . 2.1 112.395 1.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 2.0 110.691 -178.902 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.282 0 N-CA-C 112.913 -0.075 . . . . 1.3 112.913 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 5.7 m -66.22 -23.83 66.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.965 0.412 . . . . 1.82 110.352 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.449 ' O ' ' HB2' ' A' ' 171' ' ' TYR . 48.5 p-90 -86.0 -24.82 26.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.929 -0.578 . . . . 0.7 110.548 176.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 26.5 mt -76.89 -25.83 53.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.66 111.189 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.502 ' HE2' ' CE2' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -72.25 -1.57 15.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.049 0.452 . . . . 1.48 110.447 176.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.502 ' CE2' ' HE2' ' A' ' 170' ' ' LYS . 17.8 m-85 -82.2 -38.19 24.95 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.178 -0.464 . . . . 1.97 111.128 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -73.27 111.77 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.421 -0.511 . . . . 0.67 109.654 177.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.459 ' O ' ' HB ' ' A' ' 208' ' ' VAL . 3.3 mmp_? -114.22 -155.02 0.56 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.936 -0.574 . . . . 4.34 110.975 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 39.4 t -61.83 148.67 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 1.07 111.552 -173.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.408 ' HB2' ' CD1' ' A' ' 183' ' ' LEU . . . -50.84 121.91 6.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.026 -0.988 . . . . 0.71 112.405 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 2.4 p -73.82 -9.74 58.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.573 -0.739 . . . . 1.88 110.686 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.3 t -148.19 138.28 22.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.637 -0.71 . . . . 1.63 109.562 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . 0.632 ' HA ' ' OE1' ' A' ' 181' ' ' GLN . 8.5 p -86.22 -13.99 45.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.211 0.529 . . . . 1.96 111.027 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.67 -8.69 51.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.018 -0.537 . . . . 2.42 110.319 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -110.81 19.61 18.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.557 -0.747 . . . . 2.12 111.859 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.632 ' OE1' ' HA ' ' A' ' 178' ' ' CYS . 15.1 mm100 -52.89 116.07 2.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.508 0.671 . . . . 1.35 111.958 -173.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.767 ' ND2' HD11 ' A' ' 200' ' ' ILE . 28.7 t30 -152.94 37.05 0.49 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.097 -0.956 . . . . 1.68 108.787 177.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.725 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -117.85 121.08 39.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.545 -0.752 . . . . 0.81 111.027 -173.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 84.1 m -150.08 146.71 27.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.89 0.376 . . . . 0.51 110.938 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.485 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 51.7 tpp -109.88 145.85 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 1.35 110.093 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 8.4 m -132.05 140.05 48.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.198 0.523 . . . . 1.73 111.187 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.418 ' HG2' HD13 ' A' ' 192' ' ' ILE . 0.5 OUTLIER -116.44 104.47 11.48 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.953 -0.758 . . . . 1.93 108.953 177.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 21.7 pt -141.04 145.45 25.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.019 -0.537 . . . . 1.11 110.457 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.5 m 67.73 30.67 6.3 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.193 0.521 . . . . 1.86 110.916 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 62.13 22.24 12.99 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.089 -0.959 . . . . 2.83 111.926 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 193' ' ' TYR . 4.2 pt20 -141.05 167.28 22.56 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.16 -0.473 . . . . 1.75 109.8 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.418 HD13 ' HG2' ' A' ' 187' ' ' GLN . 43.5 mm -92.73 137.03 23.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.279 -0.418 . . . . 1.01 110.72 -175.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.461 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 27.8 m-85 -135.85 150.54 49.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.317 0.579 . . . . 3.94 111.508 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 6.6 m-85 -100.71 113.72 26.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.364 -0.835 . . . . 0.92 109.588 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.09 122.74 47.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.947 0.403 . . . . 1.11 110.195 -176.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.47 ' CG1' HD21 ' A' ' 182' ' ' ASN . 1.9 t -94.41 152.5 3.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.775 0.798 . . . . 0.7 109.96 -177.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.2 -54.5 7.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.606 -1.179 . . . . 0.62 111.395 -166.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.588 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -135.05 168.17 19.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.847 -0.615 . . . . 1.38 111.336 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 104' ' ' MET . 2.0 m-20 -46.36 125.87 7.3 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.143 0.902 . . . . 2.23 112.531 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.767 HD11 ' ND2' ' A' ' 182' ' ' ASN . 27.6 mm -94.4 134.95 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.72 -0.673 . . . . 0.88 111.319 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 50.6 mt-10 -105.35 125.79 32.58 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.481 -0.781 . . . . 2.06 109.518 174.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 87.8 Cg_exo -41.52 113.47 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.816 3.011 . . . . 0.51 113.551 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 120.43 6.37 9.72 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.815 -0.707 . . . . 0.7 113.054 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.7 pt-20 -118.26 123.8 46.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.193 0.497 . . . . 1.27 110.694 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.5 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -109.51 91.17 3.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.919 -0.582 . . . . 2.92 111.278 176.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.579 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 2.3 mm? -125.98 95.0 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.388 -0.525 . . . . 0.9 110.076 172.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.514 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.7 mm? -148.63 113.9 5.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.857 0.463 . . . . 0.53 109.883 172.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.656 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.7 p -156.65 159.41 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.676 0.671 . . . . 0.91 111.421 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 46.7 t-80 -106.56 111.98 24.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.313 -0.625 . . . . 1.55 109.313 164.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 C--N 1.321 -0.668 0 N-CA-C 109.869 -0.419 . . . . 2.56 109.869 173.964 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.7 mt . . . . . 0 N--CA 1.446 -0.65 0 N-CA-C 109.008 -0.738 . . . . 2.45 109.008 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.11 122.05 11.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.606 2.204 . . . . 1.75 112.323 -176.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.499 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.46 142.65 45.99 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.875 -0.602 . . . . 1.01 109.979 178.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.95 142.69 19.21 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.388 2.725 . . . . 0.73 112.686 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.67 -16.32 47.75 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.581 -0.736 . . . . 1.04 112.251 -175.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -68.43 -23.09 64.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.958 -0.565 . . . . 1.66 110.557 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -120.9 161.86 20.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.223 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.59 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 33.5 tt0 -139.15 130.53 26.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.814 -0.354 . . . . 2.27 110.922 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 171' ' ' TYR . 5.2 tt -85.68 127.74 34.58 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.351 0.596 . . . . 0.79 110.484 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -148.76 140.59 23.71 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.127 -0.942 . . . . 3.21 110.031 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -82.79 112.25 19.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.04 0.447 . . . . 2.46 109.88 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.5 m -156.23 94.99 1.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.982 -0.748 . . . . 1.58 108.982 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.9 t -62.05 105.85 0.64 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.128 0.489 . . . . 1.86 111.474 -174.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.452 HG21 ' HD3' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -99.56 117.25 64.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.018 -0.734 . . . . 1.45 109.018 172.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.77 121.71 9.7 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.152 2.568 . . . . 1.61 112.741 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.11 -15.39 36.55 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.804 -0.712 . . . . 1.74 112.338 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.446 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -133.91 -59.78 0.83 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.966 0.412 . . . . 1.41 111.299 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.73 -116.09 3.0 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.773 -0.727 . . . . 1.09 112.216 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.29 158.43 16.12 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 122.455 0.302 . . . . 2.31 110.766 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 171' ' ' TYR . . . -151.26 172.25 30.83 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.313 -0.946 . . . . 0.59 113.465 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 205' ' ' GLU . 14.3 m -117.64 111.19 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.399 0.619 . . . . 0.67 109.718 175.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -82.69 126.74 32.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.749 -0.66 . . . . 1.13 111.383 -170.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.31 114.74 9.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.394 -0.595 . . . . 0.54 109.394 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.59 ' CE ' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -94.58 0.46 55.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.002 -0.74 . . . . 1.68 109.002 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -124.66 157.53 35.33 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.675 -1.148 . . . . 3.5 108.831 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.613 ' HD2' ' H ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -90.28 155.1 19.23 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.671 -0.492 . . . . 2.4 109.671 -177.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.439 ' HE3' HG13 ' A' ' 200' ' ' ILE . 60.3 mtm -135.43 148.44 49.3 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.549 -0.908 . . . . 1.22 108.549 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.87 146.99 39.22 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.995 -0.282 . . . . 2.31 110.623 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.26 121.81 2.0 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 124.301 1.001 . . . . 0.84 113.024 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.59 7.49 11.99 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.367 -0.833 . . . . 1.04 111.318 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.599 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.9 OUTLIER -79.78 156.2 27.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.264 0.554 . . . . 2.62 110.799 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.525 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 7.3 tmm_? -145.49 135.89 24.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.685 -0.689 . . . . 3.62 110.355 -176.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 6.2 mt -101.1 151.38 21.89 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.82 -0.437 . . . . 0.53 109.82 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.14 -174.01 44.8 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.609 -0.597 . . . . 1.02 111.609 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -83.02 141.37 42.75 Favored 'Cis proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.982 -1.674 . . . . 2.1 112.44 -2.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 121.604 0.716 . . . . 2.0 109.513 175.648 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.37 0 N-CA-C 113.302 0.081 . . . . 1.3 113.302 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.4 t -71.39 -14.42 62.17 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.547 0.203 . . . . 1.82 111.547 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.416 ' HB2' HG22 ' A' ' 80' ' ' ILE . 48.5 p-90 -56.94 -23.46 45.59 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.027 0.441 . . . . 0.7 111.734 -176.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 32.1 mt -73.45 -12.83 60.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.241 0.46 . . . . 0.66 112.241 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.431 ' HD2' ' C ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -66.12 -14.37 61.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.012 0.434 . . . . 1.48 110.155 177.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.524 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 41.5 m-85 -72.61 -31.43 65.16 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 115.782 -0.644 . . . . 1.97 111.887 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.775 HG21 ' HB2' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -66.28 116.37 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.317 -0.553 . . . . 0.67 110.175 -177.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.452 ' HD3' HG21 ' A' ' 91' ' ' ILE . 18.0 ptt180 -75.83 155.79 35.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.573 -0.74 . . . . 4.34 111.83 -174.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.607 ' HB ' HG11 ' A' ' 208' ' ' VAL . 2.7 p -83.82 147.01 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.371 -0.831 . . . . 1.07 109.352 172.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -45.88 123.72 4.71 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 123.933 0.771 . . . . 0.71 112.391 -174.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 51.8 t -80.42 -9.43 59.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 1.88 109.504 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 13.0 t -126.27 138.43 53.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.166 -0.924 . . . . 1.63 109.21 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 61.3 m -77.48 -15.88 59.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.876 0.37 . . . . 1.96 111.093 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -89.68 0.62 56.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.016 0.436 . . . . 2.42 110.578 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.18 17.88 21.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.865 -0.607 . . . . 2.12 111.619 -172.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -59.16 113.5 2.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.126 0.489 . . . . 1.35 111.04 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.815 ' H ' HD12 ' A' ' 183' ' ' LEU . 62.4 t30 -146.64 29.28 1.03 Allowed 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.845 -0.798 . . . . 1.68 108.845 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.815 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.4 OUTLIER -118.76 121.59 40.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.687 -0.688 . . . . 0.81 111.113 -170.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.6 m -150.2 133.46 16.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.282 0.563 . . . . 0.51 111.518 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.4 ' HB3' ' CD2' ' A' ' 209' ' ' HIS . 46.6 ttm -100.14 135.09 42.11 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.146 -0.687 . . . . 1.35 109.146 174.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 15.2 m -117.84 131.69 56.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.181 0.515 . . . . 1.73 111.575 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.46 103.63 14.03 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.28 -1.007 . . . . 1.93 108.28 174.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 22.8 pt -138.4 144.18 30.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.734 -0.666 . . . . 1.11 109.839 -177.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 m 61.27 28.75 18.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.213 0.53 . . . . 1.86 110.318 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 56.2 34.86 24.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.121 -0.945 . . . . 2.83 111.789 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -142.06 157.64 44.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.626 -0.716 . . . . 1.75 109.619 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.6 mm -94.56 131.32 41.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.301 -0.409 . . . . 1.01 111.264 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.525 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 27.0 m-85 -131.98 157.47 43.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.935 -0.575 . . . . 3.94 111.148 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 3.3 m-85 -101.3 113.68 26.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.956 -0.757 . . . . 0.92 108.956 173.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -110.22 125.62 53.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.936 0.398 . . . . 1.11 110.012 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.599 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 1.9 t -96.57 151.44 4.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.747 0.784 . . . . 0.7 110.202 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 197' ' ' ILE . 0.9 OUTLIER -92.64 -53.8 8.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.543 -1.208 . . . . 0.62 110.591 -167.288 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.504 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -132.0 171.12 13.99 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.085 -0.961 . . . . 1.38 110.678 175.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -53.9 143.84 20.37 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.87 0.693 . . . . 2.23 112.87 -171.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.439 HG13 ' HE3' ' A' ' 104' ' ' MET . 31.4 mm -99.85 133.46 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.594 -0.73 . . . . 0.88 110.387 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -95.13 131.36 30.2 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 109.372 -0.603 . . . . 2.06 109.372 173.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -50.95 116.2 2.49 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.605 2.203 . . . . 0.51 112.042 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 123.26 -12.86 8.44 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.666 -0.778 . . . . 0.7 112.948 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.68 119.17 21.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.607 0.703 . . . . 1.27 111.032 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -113.05 96.72 6.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.283 -0.871 . . . . 2.92 111.484 177.177 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.474 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.1 mm? -114.14 99.07 7.35 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.52 -0.872 . . . . 0.9 110.524 177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.775 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.5 mm? -147.19 112.39 5.51 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.327 0.651 . . . . 0.53 109.502 174.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.695 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 2.6 p -156.64 161.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.392 -0.595 . . . . 0.91 109.392 -177.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.4 ' CD2' ' HB3' ' A' ' 185' ' ' MET . 23.1 t-80 -123.31 105.71 10.08 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.002 -0.74 . . . . 1.55 109.002 162.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 109.277 -0.638 . . . . 2.56 109.277 173.448 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 110.335 -0.246 . . . . 2.45 110.335 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.17 116.47 4.19 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.287 1.992 . . . . 1.75 111.695 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.531 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -122.03 151.56 58.48 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.051 -0.522 . . . . 1.01 110.292 -178.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 82.7 Cg_exo -48.31 134.37 25.41 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.195 2.596 . . . . 0.73 112.441 175.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.69 -20.94 66.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.51 -0.768 . . . . 1.04 112.225 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -68.62 -8.26 40.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.442 0.534 . . . . 1.66 112.442 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.438 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 7.4 m-85 -139.93 152.39 46.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' A' ' 87' ' ' ARG . 35.0 mt-10 -113.63 126.68 55.53 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.782 -0.367 . . . . 2.27 111.544 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.02 127.68 34.7 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.774 -0.824 . . . . 0.79 108.774 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' A' ' 85' ' ' GLU . 99.7 mtt180 -144.22 147.14 33.22 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.651 -0.704 . . . . 3.21 109.848 -174.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -82.3 112.3 19.16 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.862 -0.792 . . . . 2.46 108.862 172.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 23.3 t -164.9 140.78 5.62 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.366 -0.605 . . . . 1.58 109.366 -176.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 m -99.34 107.32 19.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.8 0.333 . . . . 1.86 110.692 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -105.9 120.46 48.99 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.427 -0.583 . . . . 1.45 109.427 175.245 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 91' ' ' ILE . 50.7 Cg_exo -56.02 123.31 13.53 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.031 2.487 . . . . 1.61 113.312 -176.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.75 -26.82 14.68 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.95 -0.643 . . . . 1.74 112.394 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.441 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -117.55 -57.96 2.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.212 0.53 . . . . 1.41 110.604 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.06 -120.13 4.13 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 111.199 -0.761 . . . . 1.09 111.199 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -87.17 127.81 35.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.387 -0.598 . . . . 2.31 109.387 173.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -129.2 157.47 21.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.295 -0.955 . . . . 0.59 113.053 -172.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 98' ' ' VAL . 35.6 m -97.52 114.61 35.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.597 0.713 . . . . 0.67 109.259 173.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -82.19 115.4 21.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.738 -0.665 . . . . 1.13 110.812 -170.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.57 114.78 12.2 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.331 -0.849 . . . . 0.54 109.981 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.424 ' CD ' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -95.09 8.58 42.54 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.975 0.893 . . . . 1.68 109.052 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 50.5 ttp85 -125.66 153.42 43.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.168 -1.378 . . . . 3.5 108.111 172.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.715 ' HB2' ' O ' ' A' ' 200' ' ' ILE . 0.0 OUTLIER -87.32 126.52 34.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.589 0.709 . . . . 2.4 109.475 -179.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.708 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 25.8 mtm -94.57 138.92 31.86 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.483 -0.562 . . . . 1.22 109.483 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 10.9 pt-20 -120.34 175.14 6.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.976 0.417 . . . . 2.31 111.945 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.57 125.65 17.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 0.84 112.955 -175.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.27 -14.74 62.12 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.91 -0.662 . . . . 1.04 114.274 168.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 6.7 pt-20 -78.3 158.62 28.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.79 0.795 . . . . 2.62 111.109 -176.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.664 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 8.5 ttm180 -119.59 143.86 47.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.471 -0.786 . . . . 3.62 110.654 -176.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.438 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 3.9 mt -101.34 146.99 26.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.247 -0.649 . . . . 0.53 109.247 172.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.83 -127.82 7.74 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.45 -0.881 . . . . 1.02 112.892 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.01 158.63 69.17 Favored 'Cis proline' 0 N--CA 1.477 0.55 0 C-N-CA 123.622 -1.408 . . . . 2.1 112.854 1.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.059 -0.519 . . . . 2.0 110.838 -177.01 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.575 0 N-CA-C 112.063 -0.415 . . . . 1.3 112.063 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 16.0 m -56.19 -41.35 75.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.383 0.273 . . . . 1.82 111.442 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.408 ' CZ2' ' HG2' ' A' ' 81' ' ' PRO . 27.4 p-90 -87.45 -22.04 25.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.846 0.355 . . . . 0.7 111.382 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.488 HD23 HD11 ' A' ' 172' ' ' ILE . 38.9 mt -85.61 -14.87 44.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.746 0.276 . . . . 0.66 111.746 -176.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.1 OUTLIER -75.29 -4.67 40.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 1.48 110.224 174.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.522 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 29.4 m-85 -77.43 -38.44 49.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.528 -0.76 . . . . 1.97 110.64 177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -81.45 117.48 27.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.145 0.497 . . . . 0.67 110.552 178.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 173' ' ' ARG . 43.1 mmt-85 -131.09 -161.8 1.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.627 -0.715 . . . . 4.34 110.825 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.47 ' HA ' HG11 ' A' ' 208' ' ' VAL . 6.2 t -62.49 139.65 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.286 0.565 . . . . 1.07 111.97 -168.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.563 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -71.7 164.82 25.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.154 -0.93 . . . . 0.71 111.276 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 47.4 t -92.45 -21.28 20.27 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.298 -0.864 . . . . 1.88 112.054 -169.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.3 m -143.16 -179.74 6.56 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.422 0.527 . . . . 1.63 112.422 -174.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 6.3 p -74.49 -53.03 10.28 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.117 0.414 . . . . 1.96 112.117 -175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.15 -12.9 61.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.817 0.817 . . . . 2.42 109.468 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.476 ' O ' ' HG ' ' A' ' 206' ' ' LEU . 28.5 t0 -80.54 -1.58 42.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.326 -1.307 . . . . 2.12 110.192 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.531 ' NE2' ' HB3' ' A' ' 175' ' ' ALA . 33.9 mm-40 -73.22 116.52 13.85 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.164 0.507 . . . . 1.35 111.572 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.543 ' H ' HD12 ' A' ' 183' ' ' LEU . 16.8 t30 -156.1 38.8 0.35 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.02 -1.104 . . . . 1.68 108.02 173.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.666 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.1 OUTLIER -124.55 124.76 42.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.442 -0.799 . . . . 0.81 111.233 -172.348 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 99.8 m -150.9 133.86 15.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.51 110.86 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.453 ' HB3' ' HB2' ' A' ' 209' ' ' HIS . 37.3 ttm -127.53 136.29 51.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.009 -0.541 . . . . 1.35 109.548 176.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 9.0 p -130.21 165.64 21.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.799 0.333 . . . . 1.73 110.41 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.79 104.98 11.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.189 -0.671 . . . . 1.93 109.189 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.519 HD11 ' CD2' ' A' ' 193' ' ' TYR . 43.9 pt -135.53 145.16 32.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 1.11 110.712 -175.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.8 m 62.06 28.76 17.39 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.36 0.413 . . . . 1.86 111.449 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 66.94 21.75 10.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.579 -0.737 . . . . 2.83 111.791 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -133.48 166.43 22.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.379 . . . . 1.75 110.421 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.6 mm -88.2 130.06 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.922 -0.581 . . . . 1.01 109.752 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.519 ' CD2' HD11 ' A' ' 188' ' ' ILE . 35.2 t80 -120.56 124.44 45.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 3.94 110.881 -173.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 7.4 m-85 -99.94 113.69 26.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.562 -0.903 . . . . 0.92 108.562 174.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -110.81 124.91 52.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.234 -0.284 . . . . 1.11 110.234 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 104' ' ' MET . 1.6 t -91.86 150.57 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.924 0.869 . . . . 0.7 110.53 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.66 -54.57 6.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 113.964 -1.471 . . . . 0.62 111.565 -163.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.508 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -146.21 169.77 18.1 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.849 -1.069 . . . . 1.38 109.576 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.708 ' HA ' ' O ' ' A' ' 104' ' ' MET . 4.0 m-20 -61.83 110.9 1.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.355 0.597 . . . . 2.23 111.973 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.715 ' O ' ' HB2' ' A' ' 103' ' ' LYS . 3.8 mm -69.05 148.0 11.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.032 -0.985 . . . . 0.88 110.545 175.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 52.6 mt-10 -89.0 117.57 68.39 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 108.646 -0.872 . . . . 2.06 108.646 170.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.12 117.79 2.43 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.87 2.38 . . . . 0.51 112.323 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.98 2.68 10.17 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.762 -0.732 . . . . 0.7 112.805 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 11.7 pt-20 -140.48 126.42 19.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.32 0.581 . . . . 1.27 110.505 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.44 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -108.7 105.27 14.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.657 -0.702 . . . . 2.92 111.839 -177.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.594 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.9 mm? -122.87 99.81 6.58 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.576 -0.45 . . . . 0.9 110.206 175.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.94 113.39 6.29 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.89 0.476 . . . . 0.53 109.763 175.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.666 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.6 p -155.93 160.87 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 122.07 -0.394 . . . . 0.91 110.58 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 185' ' ' MET . 43.5 t-80 -81.87 112.4 18.96 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.793 -1.558 . . . . 1.55 106.793 165.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.6 m . . . . . 0 C--N 1.315 -0.926 0 CA-C-O 122.064 0.935 . . . . 2.56 110.469 -178.737 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 88.7 mt . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 110.559 -0.163 . . . . 2.45 110.559 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.98 116.88 3.61 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.756 2.304 . . . . 1.75 112.067 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.634 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -118.3 147.05 40.87 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.042 -0.526 . . . . 1.01 109.781 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.52 133.97 61.19 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.15 1.9 . . . . 0.73 110.527 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.5 -16.5 15.65 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.569 0.543 . . . . 1.04 112.44 -174.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.9 -24.53 66.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.194 0.521 . . . . 1.66 110.309 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 59.7 m-85 -121.76 177.38 5.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.69 -0.687 . . . . 1.0 109.395 178.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.495 ' OE2' ' HD3' ' A' ' 87' ' ' ARG . 33.1 tt0 -154.93 131.72 10.73 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.723 -0.391 . . . . 2.27 110.732 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tt -84.5 131.14 34.68 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.726 -0.842 . . . . 0.79 108.726 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.495 ' HD3' ' OE2' ' A' ' 85' ' ' GLU . 14.4 mmm-85 -138.35 142.9 39.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.084 -0.507 . . . . 3.21 110.94 -173.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.72 110.21 12.37 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.364 -0.976 . . . . 2.46 108.364 171.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 p -168.99 94.58 0.32 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.874 -0.603 . . . . 1.58 110.01 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -81.64 104.68 12.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.203 -0.453 . . . . 1.86 111.016 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.503 HD12 ' SG ' ' A' ' 176' ' ' CYS . 0.0 OUTLIER -104.51 119.44 53.77 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.985 -0.552 . . . . 1.45 109.586 176.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -52.16 124.61 15.24 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.464 2.776 . . . . 1.61 113.12 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.7 -29.46 9.86 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.709 -0.678 . . . . 1.74 112.046 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.533 ' O ' ' HD2' ' A' ' 173' ' ' ARG . . . -118.4 -66.89 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.816 0.341 . . . . 1.41 111.242 177.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.94 -145.93 17.83 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.523 -0.631 . . . . 1.09 111.523 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mt -91.67 118.27 30.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.877 0.338 . . . . 2.31 110.254 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -129.6 -179.36 15.94 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.881 -0.676 . . . . 0.59 111.485 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.7 m -92.44 147.47 5.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.911 -0.774 . . . . 0.67 108.911 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -116.17 118.42 32.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.756 0.312 . . . . 1.13 110.544 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.45 ' H ' ' HG2' ' A' ' 205' ' ' GLU . . . -69.08 120.27 14.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.174 -0.466 . . . . 0.54 110.033 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.579 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -89.15 15.5 8.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.587 0.708 . . . . 1.68 110.063 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 32.7 ttp85 -141.66 158.49 43.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.092 -0.958 . . . . 3.5 108.423 176.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.622 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -82.61 158.98 22.82 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.953 0.406 . . . . 2.4 110.633 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.664 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 58.4 mtm -133.27 151.1 51.89 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.381 -0.6 . . . . 1.22 109.381 176.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -114.74 138.42 50.75 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 123.338 0.399 . . . . 2.31 110.745 -176.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . . . -37.24 122.05 0.86 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.783 1.302 . . . . 0.84 113.742 -171.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.66 7.16 12.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.928 -0.653 . . . . 1.04 112.141 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.473 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.6 OUTLIER -84.26 159.46 20.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.058 0.456 . . . . 2.62 110.744 -178.123 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.62 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 7.0 tmm_? -146.1 136.09 23.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 3.62 110.715 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.408 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 6.6 mt -93.22 142.25 27.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.555 -0.535 . . . . 0.53 109.555 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.17 171.59 44.43 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.675 -0.774 . . . . 1.02 111.904 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.2 137.94 46.25 Favored 'Cis proline' 0 C--N 1.345 0.382 0 C-N-CA 123.722 -1.366 . . . . 2.1 112.151 -0.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.786 ' SG ' ' HA ' ' A' ' 193' ' ' TYR . 13.3 m . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 2.0 111.429 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.448 0 N-CA-C 111.69 -0.564 . . . . 1.3 111.69 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.659 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 31.4 t -76.54 -20.24 57.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.16 0.505 . . . . 1.82 111.053 -175.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.416 ' CB ' HG22 ' A' ' 80' ' ' ILE . 42.4 p-90 -69.33 -18.65 63.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.066 0.46 . . . . 0.7 110.832 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 113' ' ' CYS . 33.3 mt -80.31 -17.91 50.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.001 -0.545 . . . . 0.66 112.269 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.659 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -82.66 -3.91 56.99 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.106 -0.638 . . . . 1.48 110.575 178.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.434 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 54.1 m-85 -77.88 -36.08 50.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 1.97 110.726 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.539 HD12 ' HB2' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -68.08 129.72 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.131 -0.692 . . . . 0.67 109.131 174.412 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.533 ' HD2' ' O ' ' A' ' 94' ' ' ALA . 45.7 mtt180 -129.7 -160.72 1.06 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.553 -0.294 . . . . 4.34 110.814 -174.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 16.1 t -62.96 148.95 10.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.355 0.409 . . . . 1.07 111.292 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.41 ' HA ' HD12 ' A' ' 206' ' ' LEU . . . -53.48 132.12 39.43 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.692 -0.685 . . . . 0.71 111.431 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.503 ' SG ' HD12 ' A' ' 91' ' ' ILE . 23.2 m -55.2 -25.01 30.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.949 -1.023 . . . . 1.88 112.237 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 92.8 p -149.29 -179.0 6.71 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.012 -0.366 . . . . 1.63 110.012 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 47.4 t -80.95 -23.69 38.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.902 0.382 . . . . 1.96 110.531 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -88.54 -10.27 49.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.699 0.285 . . . . 2.42 110.97 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -91.15 15.94 10.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.377 -0.374 . . . . 2.12 111.246 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 17.0 mm100 -63.33 114.04 3.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.129 0.49 . . . . 1.35 110.385 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.54 ' OD1' ' HE2' ' A' ' 198' ' ' LYS . 21.8 t30 -165.68 43.21 0.07 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.101 -1.074 . . . . 1.68 108.101 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.608 ' HB3' ' O ' ' A' ' 206' ' ' LEU . 0.8 OUTLIER -142.57 128.88 19.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.583 -0.735 . . . . 0.81 111.888 -175.426 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 29.3 m -151.34 141.51 22.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.803 -1.089 . . . . 0.51 110.335 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 54.0 tpp -90.11 139.77 30.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.947 -0.39 . . . . 1.35 109.947 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 52.8 t -113.67 132.11 55.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.173 0.511 . . . . 1.73 110.471 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -122.01 105.56 10.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.707 -0.849 . . . . 1.93 108.707 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.479 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 16.3 pt -139.64 142.99 31.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.987 -0.551 . . . . 1.11 110.689 -176.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.7 m 57.18 38.1 28.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.153 -0.476 . . . . 1.86 110.968 177.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 67.86 6.24 4.99 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.48 -0.782 . . . . 2.83 112.119 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.5 pt20 -124.94 161.13 27.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 1.75 110.842 -176.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.84 137.12 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.813 -0.63 . . . . 1.01 111.645 -176.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.786 ' HA ' ' SG ' ' A' ' 113' ' ' CYS . 25.4 m-85 -140.9 155.02 46.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.623 -0.717 . . . . 3.94 110.294 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 2.2 m-85 -100.15 113.2 25.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.735 -0.469 . . . . 0.92 109.735 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -102.78 123.51 46.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.076 0.465 . . . . 1.11 110.231 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.526 HG22 HD11 ' A' ' 207' ' ' LEU . 1.6 t -94.68 151.96 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.714 0.769 . . . . 0.7 109.632 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.8 mm -90.67 -56.4 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.361 -1.291 . . . . 0.62 111.201 -166.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.54 ' HE2' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -145.29 -178.16 5.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.373 -0.83 . . . . 1.38 111.891 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.664 ' HA ' ' O ' ' A' ' 104' ' ' MET . 18.6 t70 -46.07 132.44 9.53 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.689 0.996 . . . . 2.23 113.689 -172.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.492 HD11 ' ND2' ' A' ' 182' ' ' ASN . 26.4 mm -101.49 132.79 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.231 -0.895 . . . . 0.88 110.349 174.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 35.8 mt-10 -89.35 126.59 57.99 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.337 -0.616 . . . . 2.06 109.337 173.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.03 116.95 2.19 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.962 2.441 . . . . 0.51 112.86 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.05 -4.94 10.47 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.78 -0.724 . . . . 0.7 113.299 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 9.5 pt-20 -142.29 120.35 12.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.476 0.638 . . . . 1.27 112.022 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' A' ' 100' ' ' ALA . 17.7 mm-40 -111.96 125.35 53.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.73 -0.668 . . . . 2.92 110.225 171.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.608 ' O ' ' HB3' ' A' ' 183' ' ' LEU . 2.5 mm? -120.01 102.06 8.28 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.671 -0.862 . . . . 0.9 108.671 172.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.539 ' HB2' HD12 ' A' ' 172' ' ' ILE . 1.9 mm? -143.76 113.45 7.09 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.138 0.274 . . . . 0.53 110.925 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.541 HG12 HD12 ' A' ' 183' ' ' LEU . 1.9 p -153.61 159.8 3.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 O-C-N 122.105 -0.372 . . . . 0.91 111.259 176.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -94.47 111.88 23.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.659 -0.867 . . . . 1.55 108.659 167.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 210' ' ' VAL . 6.2 p . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 121.313 0.578 . . . . 2.56 111.589 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 83.5 mt . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.651 0.263 . . . . 2.45 110.987 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.88 121.12 8.53 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.838 2.358 . . . . 1.75 112.292 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.592 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -127.78 153.28 77.94 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.746 -0.661 . . . . 1.01 109.281 177.693 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.32 141.7 88.71 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.388 2.059 . . . . 0.73 111.746 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.516 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -65.68 -12.33 52.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.987 0.736 . . . . 1.04 112.987 -171.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -82.68 -19.71 37.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.037 0.384 . . . . 1.66 112.037 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.521 ' HE2' ' SD ' ' A' ' 104' ' ' MET . 5.1 m-85 -116.83 144.88 43.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -116.46 117.07 28.9 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.886 -0.326 . . . . 2.27 110.725 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.494 HD11 ' CE2' ' A' ' 171' ' ' TYR . 8.2 tt -86.09 124.3 32.36 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.962 -0.755 . . . . 0.79 108.962 176.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -140.37 128.4 22.13 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.791 -0.641 . . . . 3.21 110.692 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -81.83 112.95 19.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.899 -0.778 . . . . 2.46 108.899 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -166.9 162.73 15.99 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.881 -0.785 . . . . 1.58 108.881 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.0 t -99.83 105.55 17.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.905 0.383 . . . . 1.86 110.627 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -101.59 117.34 62.06 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.25 -0.648 . . . . 1.45 109.25 174.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -55.98 123.29 13.48 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.029 2.486 . . . . 1.61 113.116 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.412 ' HA3' ' SG ' ' A' ' 176' ' ' CYS . . . 105.65 -18.39 40.99 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.7 -0.762 . . . . 1.74 112.665 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.494 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -129.34 -55.91 1.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.215 0.531 . . . . 1.41 111.517 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.471 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 121.24 -103.35 0.88 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 111.267 -0.733 . . . . 1.09 111.267 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.4 160.78 14.24 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.95 -0.389 . . . . 2.31 109.95 172.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.96 171.79 44.66 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.512 -0.852 . . . . 0.59 112.464 177.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 86' ' ' LEU . 17.0 m -107.29 147.36 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.182 -0.673 . . . . 0.67 109.182 173.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -125.79 110.59 13.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.755 0.312 . . . . 1.13 111.07 -174.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.517 ' H ' ' HG3' ' A' ' 205' ' ' GLU . . . -59.83 125.77 24.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.85 -0.614 . . . . 0.54 111.115 177.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -93.18 -3.88 53.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.331 0.586 . . . . 1.68 110.203 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.5 ttp85 -133.16 155.3 49.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.934 -1.135 . . . . 3.5 107.934 171.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.658 ' C ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -84.16 158.56 21.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.277 0.56 . . . . 2.4 110.685 -175.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 54.9 mtm -117.36 154.33 31.49 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.784 . . . . 1.22 109.068 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -107.83 136.12 48.09 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.41 0.444 . . . . 2.31 110.376 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.422 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . . . -39.11 117.29 0.67 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.624 1.202 . . . . 0.84 112.991 -174.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.33 7.46 12.33 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.544 -0.753 . . . . 1.04 111.547 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.446 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -75.64 165.22 25.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.054 0.454 . . . . 2.62 110.742 -178.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.545 ' HD3' ' CD1' ' A' ' 193' ' ' TYR . 7.1 tmm_? -141.38 132.66 26.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.386 -0.37 . . . . 3.62 110.297 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.497 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 5.9 mt -100.75 138.49 37.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.616 -0.513 . . . . 0.53 109.616 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.49 173.75 46.43 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.976 -0.63 . . . . 1.02 111.696 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -83.9 146.86 53.15 Favored 'Cis proline' 0 C--O 1.236 0.4 0 C-N-CA 123.316 -1.535 . . . . 2.1 112.77 -0.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.1 t . . . . . 0 C--N 1.325 -0.468 0 CA-C-N 115.661 -0.7 . . . . 2.0 109.634 175.681 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.096 0 N-CA-C 113.665 0.226 . . . . 1.3 113.665 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.706 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 20.5 t -63.41 -16.05 59.41 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.809 0.444 . . . . 1.82 111.726 -174.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.503 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 25.5 p-90 -71.7 -23.58 61.67 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.019 -0.426 . . . . 0.7 110.293 178.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.503 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 29.2 mt -86.75 -17.65 33.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 0.66 112.283 -176.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.706 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -75.77 -10.73 59.68 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.382 -0.527 . . . . 1.48 110.248 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.494 ' CE2' HD11 ' A' ' 86' ' ' LEU . 52.1 m-85 -69.79 -36.98 76.16 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.824 -0.625 . . . . 1.97 111.06 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.693 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -69.83 127.01 31.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.482 -0.487 . . . . 0.67 109.729 177.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -115.07 179.15 4.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.022 -0.536 . . . . 4.34 110.401 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.627 ' HA ' HD22 ' A' ' 183' ' ' LEU . 1.7 p -71.4 142.37 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.458 . . . . 1.07 111.165 -177.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.28 142.47 21.05 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.16 -0.927 . . . . 0.71 112.572 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.412 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 47.5 t -82.87 -2.93 56.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.208 -0.906 . . . . 1.88 110.531 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 27.2 t -142.84 139.88 31.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.993 -0.549 . . . . 1.63 109.589 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 33.6 t -73.31 -13.99 61.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.309 0.576 . . . . 1.96 110.485 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -88.44 -4.42 58.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.346 0.593 . . . . 2.42 109.93 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -110.84 15.49 21.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.49 -0.777 . . . . 2.12 111.107 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 15.9 mm100 -60.11 115.67 3.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.528 -0.545 . . . . 1.35 109.528 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.6 ' OD1' ' HG3' ' A' ' 198' ' ' LYS . 19.2 t30 -153.63 32.97 0.45 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.165 0.983 . . . . 1.68 108.799 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.627 HD22 ' HA ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -122.52 129.51 52.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.368 -0.833 . . . . 0.81 110.315 -174.013 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.5 m -150.42 138.66 20.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.074 0.464 . . . . 0.51 110.933 177.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.485 ' HE2' ' HB2' ' A' ' 185' ' ' MET . 21.1 tpp -102.05 129.02 48.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.941 -0.572 . . . . 1.35 109.962 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 43.5 t -111.95 140.93 46.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.051 0.453 . . . . 1.73 110.585 -175.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.81 104.26 10.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.904 -0.589 . . . . 1.93 109.621 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.465 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 17.8 pt -142.73 145.33 23.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.679 -0.691 . . . . 1.11 110.229 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.4 m 63.15 27.61 15.72 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.114 0.483 . . . . 1.86 111.047 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 64.56 10.5 5.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.125 -0.943 . . . . 2.83 111.62 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.9 pt20 -120.6 167.95 11.88 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.974 -0.38 . . . . 1.75 109.974 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.2 mm -93.59 137.09 23.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.058 -0.519 . . . . 1.01 110.305 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.545 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 2.4 m-85 -138.52 151.4 47.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.221 0.534 . . . . 3.94 111.244 177.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.475 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 4.8 m-85 -99.54 113.6 26.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.568 -0.742 . . . . 0.92 109.627 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.28 118.83 37.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.992 -0.549 . . . . 1.11 110.176 -177.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.448 HG22 HD11 ' A' ' 207' ' ' LEU . 2.0 t -91.08 152.95 3.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.515 0.674 . . . . 0.7 110.057 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.405 HG13 ' HA ' ' A' ' 182' ' ' ASN . 1.2 mm -91.44 -58.07 3.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.64 -1.164 . . . . 0.62 111.301 -167.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.6 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -139.78 173.13 11.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.69 -0.686 . . . . 1.38 111.51 -176.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.592 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.1 m-20 -47.05 120.18 2.95 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.231 -0.895 . . . . 2.23 112.871 -176.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.485 HD11 ' ND2' ' A' ' 182' ' ' ASN . 21.0 mm -82.15 140.11 16.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.185 -0.916 . . . . 0.88 110.984 176.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 202' ' ' PRO . 44.6 mt-10 -86.97 130.71 47.31 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.534 -0.543 . . . . 2.06 109.534 171.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 201' ' ' GLU . 53.2 Cg_exo -55.11 117.53 4.13 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.493 2.128 . . . . 0.51 112.289 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.52 -11.11 9.71 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.798 -0.715 . . . . 0.7 112.576 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 200' ' ' ILE . 11.3 pt-20 -143.04 119.69 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 1.27 111.791 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.517 ' HG3' ' H ' ' A' ' 100' ' ' ALA . 40.6 mt-10 -111.7 127.21 55.7 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.196 -0.315 . . . . 2.92 110.518 169.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.487 ' C ' HD22 ' A' ' 207' ' ' LEU . 2.6 mm? -115.72 100.35 7.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.146 -0.686 . . . . 0.9 109.146 175.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.693 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.33 125.37 13.63 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.495 -0.928 . . . . 0.53 108.495 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.602 HG11 ' HB ' ' A' ' 174' ' ' VAL . 9.8 p -152.87 157.1 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.234 -0.586 . . . . 0.91 111.439 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -109.72 106.47 16.12 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.815 -0.809 . . . . 1.55 108.815 163.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 C--N 1.319 -0.736 0 N-CA-C 109.226 -0.657 . . . . 2.56 109.226 170.333 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.8 mt . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.688 -0.486 . . . . 2.45 109.688 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.97 135.06 33.86 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.603 2.202 . . . . 1.75 112.231 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.52 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.48 136.94 29.89 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.819 -0.628 . . . . 1.01 109.903 -178.732 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.55 151.58 7.2 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.358 2.706 . . . . 0.73 112.574 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.13 -6.44 3.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.671 0.989 . . . . 1.04 113.671 -169.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 52.1 m-20 -110.34 2.02 18.84 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.886 -0.509 . . . . 1.66 111.994 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -130.92 138.44 49.77 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.16 -0.681 . . . . 1.0 109.16 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.57 136.67 53.54 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.72 -0.392 . . . . 2.27 110.061 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.8 tt -85.37 126.44 33.76 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.454 0.645 . . . . 0.79 109.29 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.444 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 51.1 mtp180 -143.34 118.75 10.28 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.863 -1.062 . . . . 3.21 109.507 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -80.73 110.16 15.97 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.283 -0.636 . . . . 2.46 109.283 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.9 p -164.32 109.26 0.98 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.474 -0.785 . . . . 1.58 108.959 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.9 m -71.13 105.67 3.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.054 0.454 . . . . 1.86 110.953 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -92.99 117.99 67.71 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.049 -0.723 . . . . 1.45 109.049 173.082 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -51.93 121.27 8.44 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.016 2.477 . . . . 1.61 112.554 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.449 ' HA3' ' SG ' ' A' ' 176' ' ' CYS . . . 108.5 -16.34 34.61 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.015 -0.612 . . . . 1.74 112.45 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -135.21 -61.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.97 0.414 . . . . 1.41 111.244 178.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.483 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 121.09 -123.22 5.47 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 121.055 -0.593 . . . . 1.09 111.925 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mt -102.23 158.43 16.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.931 -0.396 . . . . 2.31 109.931 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -167.17 177.52 41.73 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.616 -0.802 . . . . 0.59 112.013 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.87 114.95 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.494 0.664 . . . . 0.67 109.689 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.444 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 51.3 m95 -82.76 127.55 33.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.583 -0.735 . . . . 1.13 111.405 -169.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -74.87 116.19 15.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.686 -0.688 . . . . 0.54 110.465 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.5 OUTLIER -90.45 1.0 57.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 1.68 110.096 -178.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 102' ' ' ARG . 17.4 ttp180 -140.46 156.18 46.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.552 -0.749 . . . . 3.5 109.13 175.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.541 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -80.4 159.0 25.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.112 0.482 . . . . 2.4 110.738 -178.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.689 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 55.3 mtm -129.46 152.11 49.36 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.064 -0.516 . . . . 1.22 110.026 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -121.5 139.81 53.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.117 -0.492 . . . . 2.31 110.273 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -39.19 125.04 1.57 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 124.708 1.255 . . . . 0.84 113.264 -170.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.26 7.03 12.87 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.319 -0.855 . . . . 1.04 111.094 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.62 162.18 18.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.116 0.484 . . . . 2.62 110.929 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.586 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 6.3 tmm_? -146.96 132.29 18.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.982 -0.554 . . . . 3.62 110.301 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 4.7 mt -95.26 130.78 41.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.027 -0.731 . . . . 0.53 109.027 173.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.13 166.6 38.28 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.308 -0.949 . . . . 1.02 112.426 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.469 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 94.5 Cg_endo -87.17 158.12 48.58 Favored 'Cis proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.917 -1.701 . . . . 2.1 112.553 -2.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.3 t . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 121.367 0.603 . . . . 2.0 109.557 174.579 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . . . . . . 0 N--CA 1.449 -0.444 0 N-CA-C 111.071 -0.812 . . . . 1.3 111.071 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.655 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 13.5 m -64.59 -15.04 60.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.362 -0.419 . . . . 1.82 111.47 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.59 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 17.5 p-90 -70.6 -25.99 63.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 0.7 111.197 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.59 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 18.2 mt -86.3 -15.15 41.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.643 0.609 . . . . 0.66 112.643 -173.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.655 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -77.8 -1.93 33.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.564 -0.454 . . . . 1.48 110.963 -179.296 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -84.38 -37.94 20.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.221 0.452 . . . . 1.97 112.221 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.747 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -65.07 128.64 28.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.975 0.417 . . . . 0.67 110.616 -176.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -119.67 -164.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 4.34 110.854 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.3 t -71.61 143.87 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.956 0.408 . . . . 1.07 110.523 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.532 ' HB3' ' NE2' ' A' ' 181' ' ' GLN . . . -65.59 143.49 57.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.759 -0.655 . . . . 0.71 111.111 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.449 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 42.0 t -63.52 -19.49 64.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.024 -0.989 . . . . 1.88 111.354 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 180' ' ' ASP . 17.8 t -125.62 138.78 53.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.218 0.532 . . . . 1.63 110.558 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . 0.554 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 8.6 p -77.49 -26.39 51.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.552 -0.749 . . . . 1.96 111.337 -176.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.47 -3.8 58.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.336 0.589 . . . . 2.42 110.224 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 177' ' ' SER . 1.2 m-20 -107.81 16.26 23.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.434 -0.803 . . . . 2.12 110.461 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.554 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 31.7 mm-40 -58.36 120.17 8.26 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.374 0.607 . . . . 1.35 110.961 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.584 ' ND2' HD11 ' A' ' 200' ' ' ILE . 13.5 t30 -142.86 35.54 1.4 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.394 -1.336 . . . . 1.68 107.394 175.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.678 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.2 OUTLIER -120.44 125.0 46.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.526 -1.215 . . . . 0.81 110.906 -173.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.5 m -150.5 133.08 15.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.923 0.392 . . . . 0.51 110.703 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 48.7 ttm -100.27 140.19 34.87 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.654 -0.498 . . . . 1.35 109.654 174.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 32.5 m -124.95 131.55 53.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.137 0.494 . . . . 1.73 111.138 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.74 104.96 14.79 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.656 -0.868 . . . . 1.93 108.656 176.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 22.3 pt -139.19 144.4 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.921 -0.582 . . . . 1.11 110.054 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.0 t 64.71 30.18 12.56 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.217 0.532 . . . . 1.86 110.235 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 58.48 34.11 23.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.387 -0.824 . . . . 2.83 111.355 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -145.3 154.44 42.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 1.75 110.711 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.99 128.45 45.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.167 -0.47 . . . . 1.01 111.749 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.586 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 40.9 m-85 -131.31 155.79 46.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.525 -0.761 . . . . 3.94 110.565 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.483 ' CE1' ' HB3' ' A' ' 169' ' ' LEU . 11.3 m-85 -103.5 114.52 28.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.96 -0.755 . . . . 0.92 108.96 173.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -100.1 118.83 37.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.175 -0.466 . . . . 1.11 109.887 -175.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.455 HG12 HD21 ' A' ' 182' ' ' ASN . 1.9 t -83.38 152.16 3.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.408 0.623 . . . . 0.7 109.649 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.1 mm -94.01 -55.15 6.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.912 -1.04 . . . . 0.62 111.202 -167.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.481 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -143.85 -179.71 6.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 1.38 111.963 -179.443 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.689 ' HA ' ' O ' ' A' ' 104' ' ' MET . 23.7 t70 -45.89 121.98 3.51 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.3 1.0 . . . . 2.23 113.009 -175.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.584 HD11 ' ND2' ' A' ' 182' ' ' ASN . 21.1 mm -92.23 130.77 40.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.999 -1.0 . . . . 0.88 111.38 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 11.8 mm-40 -76.93 121.59 85.01 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.38 -0.827 . . . . 2.06 108.933 171.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.88 114.1 1.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.001 1.801 . . . . 0.51 111.181 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.15 -0.53 10.65 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.57 -0.824 . . . . 0.7 113.428 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 10.2 pt-20 -133.45 123.38 25.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.492 0.646 . . . . 1.27 111.145 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.05 96.44 6.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.75 -0.659 . . . . 2.92 111.754 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.505 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.3 mm? -113.03 99.03 7.54 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.835 -0.746 . . . . 0.9 109.773 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.747 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -145.57 114.1 6.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.554 0.341 . . . . 0.53 110.452 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.678 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.8 p -155.83 160.48 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.137 -0.32 . . . . 0.91 110.137 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -93.22 110.2 21.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.006 -1.109 . . . . 1.55 108.006 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.317 -0.828 0 CA-C-O 121.257 0.551 . . . . 2.56 110.213 179.905 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.1 mt . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 110.496 -0.187 . . . . 2.45 110.496 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.33 120.41 7.55 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.607 2.205 . . . . 1.75 112.114 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.64 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -113.11 141.67 26.04 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.308 -0.405 . . . . 1.01 109.921 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.32 144.67 70.73 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.773 2.315 . . . . 0.73 112.14 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.662 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -62.82 -13.08 29.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.526 -0.761 . . . . 1.04 112.332 -173.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.95 -9.84 59.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.107 -0.497 . . . . 1.66 111.062 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.551 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 9.3 m-85 -138.13 149.97 46.4 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 -173.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.567 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 9.5 tp10 -125.27 133.84 52.51 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.428 -0.509 . . . . 2.27 111.316 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.88 122.79 33.26 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.214 -0.661 . . . . 0.79 109.214 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.445 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 39.8 mmt180 -147.28 124.58 11.55 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.913 -1.04 . . . . 3.21 109.452 -174.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.1 110.56 8.49 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.106 -0.702 . . . . 2.46 109.106 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.8 m -143.99 94.18 2.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.603 -0.726 . . . . 1.58 109.133 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -64.64 101.86 0.51 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.472 0.654 . . . . 1.86 111.357 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.581 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -108.91 117.03 54.77 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 108.501 -0.926 . . . . 1.45 108.501 172.211 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.86 123.48 13.61 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.907 2.404 . . . . 1.61 112.542 -173.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.51 -23.69 23.91 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.132 -0.556 . . . . 1.74 112.5 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -114.95 -68.33 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.95 -0.3 . . . . 1.41 111.513 -178.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.84 -158.09 15.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.665 -0.779 . . . . 1.09 112.339 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.466 ' C ' ' HD3' ' A' ' 173' ' ' ARG . 8.3 mt -101.17 122.55 43.82 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.684 0.242 . . . . 2.31 110.908 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -133.97 -159.35 8.9 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.711 -0.757 . . . . 0.59 112.388 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 98' ' ' VAL . 17.3 m -112.29 105.02 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 122.094 0.95 . . . . 0.67 109.812 177.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.445 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 6.4 m95 -83.3 123.28 29.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.173 -0.921 . . . . 1.13 110.194 -171.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.89 117.79 6.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.134 -0.485 . . . . 0.54 110.367 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.662 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -78.83 -0.15 29.45 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.063 0.459 . . . . 1.68 110.676 178.18 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 34.5 ttp180 -141.48 162.86 34.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.666 -0.864 . . . . 3.5 108.666 178.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.419 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -79.09 160.02 27.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.273 0.558 . . . . 2.4 111.182 178.316 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.567 ' HE3' HG13 ' A' ' 200' ' ' ILE . 44.9 mtm -130.77 153.04 49.47 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.063 -1.088 . . . . 1.22 108.063 172.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -126.66 146.97 49.99 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.091 0.244 . . . . 2.31 110.764 -177.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -36.34 121.13 0.69 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.716 1.26 . . . . 0.84 113.77 -168.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.2 6.83 13.18 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.268 -0.878 . . . . 1.04 111.349 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.491 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -85.03 157.01 20.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.05 0.453 . . . . 2.62 110.253 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.697 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 5.9 tmm_? -146.47 133.79 20.66 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.096 -0.502 . . . . 3.62 110.189 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.551 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 3.9 mt -96.92 135.68 38.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.429 -0.952 . . . . 0.53 108.429 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.67 169.63 38.25 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.878 -1.153 . . . . 1.02 112.732 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.599 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 74.0 Cg_endo -77.8 167.14 79.48 Favored 'Cis proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.977 -1.676 . . . . 2.1 112.297 -1.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.8 t . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 121.071 0.462 . . . . 2.0 110.539 177.924 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . . . . . . 0 N--CA 1.45 -0.392 0 N-CA-C 112.63 -0.188 . . . . 1.3 112.63 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.648 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 2.9 m -63.79 -14.86 56.37 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.669 0.388 . . . . 1.82 111.989 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' TRP . . . . . 0.498 ' HB2' HG22 ' A' ' 80' ' ' ILE . 19.7 p-90 -69.39 -21.42 63.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.988 0.366 . . . . 0.7 111.988 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 169' ' ' LEU . 18.3 mt -80.73 -14.56 58.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.942 0.719 . . . . 0.66 112.942 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.648 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -68.04 -10.44 53.75 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.286 -0.566 . . . . 1.48 110.205 176.334 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.565 ' O ' ' HD2' ' A' ' 173' ' ' ARG . 50.9 m-85 -78.89 -27.89 43.95 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.749 -0.66 . . . . 1.97 112.4 -175.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.647 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 1.6 mm -57.87 139.05 18.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 117.895 0.316 . . . . 0.67 111.289 -175.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.565 ' HD2' ' O ' ' A' ' 171' ' ' TYR . 18.2 mmm180 -95.24 147.67 23.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.103 0.478 . . . . 4.34 112.034 -174.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.434 HG22 HG11 ' A' ' 208' ' ' VAL . 81.6 t -66.56 148.61 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.374 -0.83 . . . . 1.07 108.773 168.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.738 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -57.32 122.94 13.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.026 0.441 . . . . 0.71 112.108 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.56 -28.7 68.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.573 -0.74 . . . . 1.88 109.967 175.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.0 p -126.73 139.51 53.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.879 -0.6 . . . . 1.63 110.614 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 54.0 t -76.97 -8.41 57.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.992 -0.549 . . . . 1.96 111.093 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.02 -3.87 58.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.204 0.526 . . . . 2.42 110.238 177.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -111.81 17.91 19.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.638 -0.71 . . . . 2.12 111.816 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.56 ' HA ' HE21 ' A' ' 181' ' ' GLN . 0.1 OUTLIER -55.43 114.84 1.99 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.289 0.566 . . . . 1.35 110.897 -176.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.862 ' H ' HD12 ' A' ' 183' ' ' LEU . 18.3 t30 -155.03 32.49 0.39 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 122.062 0.934 . . . . 1.68 108.7 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.862 HD12 ' H ' ' A' ' 182' ' ' ASN . 2.0 mp -115.36 120.36 39.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.381 -0.827 . . . . 0.81 110.975 -173.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 95.4 m -148.66 138.96 22.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.324 0.583 . . . . 0.51 111.366 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' MET . . . . . 0.466 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 65.5 mtp -120.71 135.51 55.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.93 -0.577 . . . . 1.35 109.758 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 44.2 t -114.52 141.9 47.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.93 0.395 . . . . 1.73 110.736 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLN . . . . . 0.416 ' HG2' HD13 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -106.71 103.93 13.49 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.026 -0.731 . . . . 1.93 109.026 177.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 11.6 pt -146.34 145.08 20.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.967 -0.56 . . . . 1.11 110.218 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.4 t 67.3 33.91 5.14 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.509 0.506 . . . . 1.86 110.242 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 66.33 8.38 5.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.419 -0.809 . . . . 2.83 111.701 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.35 167.72 19.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.062 0.458 . . . . 1.75 110.935 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.416 HD13 ' HG2' ' A' ' 187' ' ' GLN . 50.2 mm -98.35 128.45 49.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.674 -0.694 . . . . 1.01 110.469 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.697 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 2.2 m-85 -118.44 146.95 44.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.161 0.505 . . . . 3.94 110.708 175.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 3.2 m-85 -100.95 113.2 25.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.934 -0.765 . . . . 0.92 108.934 175.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -111.57 123.8 50.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.925 0.393 . . . . 1.11 110.184 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.494 ' CG1' HD21 ' A' ' 182' ' ' ASN . 2.1 t -93.67 152.3 3.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.777 0.799 . . . . 0.7 110.386 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.2 mm -92.98 -54.83 6.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.433 -1.258 . . . . 0.62 110.801 -166.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.49 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -138.78 -179.25 5.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.437 -0.801 . . . . 1.38 110.1 178.312 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 104' ' ' MET . 4.8 p-10 -56.09 135.8 52.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.68 0.752 . . . . 2.23 112.389 -173.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.567 HG13 ' HE3' ' A' ' 104' ' ' MET . 28.4 mm -96.48 138.11 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.238 -0.892 . . . . 0.88 110.817 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -83.34 127.51 68.29 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.949 -0.569 . . . . 2.06 109.534 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.2 115.57 2.26 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.835 2.357 . . . . 0.51 112.367 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.0 -12.94 9.17 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.471 -0.871 . . . . 0.7 113.543 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.76 123.0 34.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.563 0.681 . . . . 1.27 111.504 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.647 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -110.47 112.1 23.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.766 -0.652 . . . . 2.92 111.142 177.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.502 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 0.9 OUTLIER -122.51 98.96 6.16 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.317 -0.553 . . . . 0.9 109.606 173.551 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.621 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.7 mm? -147.74 106.55 3.83 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.722 -0.473 . . . . 0.53 109.722 175.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.753 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 19.5 t -154.91 157.45 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.014 -1.106 . . . . 0.91 108.014 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' HIS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 3.6 t-80 -89.23 109.86 20.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.731 -0.84 . . . . 1.55 108.731 173.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 C--N 1.32 -0.694 0 CA-C-O 121.624 0.726 . . . . 2.56 110.665 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.651 ' N ' ' HG1' ' A' ' 56' ' ' THR . . . . . . . . 0 N--CA 1.483 1.814 0 N-CA-C 111.79 -0.524 . . . . 33.26 111.79 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.423 ' OG ' ' HB3' ' A' ' 67' ' ' PRO . 19.5 m -71.92 132.37 44.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.045 0.45 . . . . 33.92 110.907 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.02 -22.95 9.54 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.965 -0.636 . . . . 32.35 111.907 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -145.72 141.02 16.32 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.287 -0.264 . . . . 31.65 110.287 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.12 95.45 0.14 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.657 2.238 . . . . 29.99 111.427 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.651 ' HG1' ' N ' ' A' ' 51' ' ' GLY . 21.2 m -71.74 -56.37 5.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.865 -0.607 . . . . 28.92 111.261 -174.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.1 t 56.2 59.98 3.42 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.057 0.456 . . . . 26.94 110.647 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -135.02 113.5 11.53 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.042 -0.527 . . . . 25.83 109.669 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 t70 64.74 -171.75 0.18 Allowed 'General case' 0 N--CA 1.466 0.349 0 O-C-N 123.98 0.8 . . . . 23.53 109.947 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -97.5 49.71 1.05 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.227 0.537 . . . . 21.64 110.545 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.8 m -83.69 114.27 52.63 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.253 -0.885 . . . . 19.42 110.548 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.01 125.62 13.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.662 2.241 . . . . 17.17 112.035 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -75.64 74.46 2.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.959 -0.564 . . . . 17.47 110.336 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -93.57 162.03 14.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.597 -0.728 . . . . 15.63 111.706 -175.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.54 12.28 78.4 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.739 -0.664 . . . . 12.04 113.216 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.2 t 58.14 75.15 0.56 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.826 0.346 . . . . 10.67 111.122 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.423 ' HB3' ' OG ' ' A' ' 52' ' ' SER . 2.8 Cg_exo -75.91 78.33 3.17 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.577 2.185 . . . . 9.69 111.422 177.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -114.84 143.71 44.67 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.234 -0.894 . . . . 7.7 110.626 -176.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -132.22 142.94 49.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.628 -0.508 . . . . 8.14 109.628 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.75 121.1 73.28 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.223 -0.444 . . . . 5.96 111.137 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.4 -160.95 0.14 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.784 2.323 . . . . 6.13 112.103 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.5 m -60.86 -42.07 91.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.815 0.34 . . . . 6.53 110.787 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -94.62 108.41 20.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.201 -0.666 . . . . 5.01 109.201 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.519 ' O ' HD12 ' A' ' 74' ' ' ILE . 1.9 pp -77.0 139.9 66.07 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.017 -0.538 . . . . 4.23 111.622 -178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.65 -4.88 16.17 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.049 2.499 . . . . 4.12 112.449 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' HB2' HD13 ' A' ' 74' ' ' ILE . 35.2 mt-10 -62.75 -57.73 9.93 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.504 -0.554 . . . . 3.82 109.504 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.6 t70 54.21 71.42 0.52 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.54 -1.209 . . . . 3.16 110.261 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.8 mt -68.69 128.27 92.97 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.13 -0.941 . . . . 2.45 110.172 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.448 ' O ' ' HA2' ' A' ' 164' ' ' GLY . 23.4 Cg_endo -63.17 127.53 20.44 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.384 2.056 . . . . 1.75 111.589 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.526 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.97 151.62 78.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.97 -0.559 . . . . 1.01 109.917 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.66 139.72 87.21 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.567 2.178 . . . . 0.73 111.241 174.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.661 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -67.73 -7.65 28.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.637 0.606 . . . . 1.04 112.637 -172.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.487 ' OD2' ' HD3' ' A' ' 102' ' ' ARG . 0.1 OUTLIER -80.01 -9.61 59.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.724 0.297 . . . . 1.66 111.492 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.524 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 8.4 m-85 -140.18 146.76 39.16 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 -173.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 99' ' ' TRP . 13.3 pt-20 -114.2 135.21 54.29 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.982 0.42 . . . . 2.27 110.946 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.2 tt -101.71 129.94 47.98 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.324 -0.991 . . . . 0.79 108.324 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -162.47 150.71 14.43 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.433 -0.803 . . . . 3.21 109.792 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -82.99 111.36 18.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.0 -0.741 . . . . 2.46 109.0 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.2 p -149.07 90.7 1.77 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.773 -0.649 . . . . 1.58 109.365 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 58.1 m -68.43 104.12 1.82 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.248 0.547 . . . . 1.86 110.805 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -94.89 118.95 66.63 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.649 -0.705 . . . . 1.45 109.199 174.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -52.44 121.22 8.65 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.251 2.634 . . . . 1.61 112.466 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.545 ' HA3' ' SG ' ' A' ' 176' ' ' CYS . . . 108.23 -16.02 35.68 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.843 -0.694 . . . . 1.74 112.36 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.436 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -135.89 -71.11 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.724 -0.28 . . . . 1.41 111.395 177.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.528 ' HA3' ' NH1' ' A' ' 173' ' ' ARG . . . 133.38 -127.91 4.85 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.877 -0.678 . . . . 1.09 111.954 -177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.0 mt -97.66 147.6 24.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.655 0.228 . . . . 2.31 110.5 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -158.21 171.4 35.12 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.585 -0.606 . . . . 0.59 111.585 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 27.7 m -99.31 111.58 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.497 0.665 . . . . 0.67 110.037 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.538 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 59.2 m95 -81.57 124.52 29.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.852 -0.613 . . . . 1.13 110.316 -172.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 202' ' ' PRO . . . -68.98 114.81 7.6 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.582 -0.525 . . . . 0.54 109.582 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.661 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -82.62 -9.48 59.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.37 0.605 . . . . 1.68 109.669 177.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.487 ' HD3' ' OD2' ' A' ' 83' ' ' ASP . 63.4 ttt180 -125.11 162.55 24.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.31 -0.859 . . . . 3.5 108.823 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.602 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -91.53 158.72 16.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.874 0.369 . . . . 2.4 110.952 -176.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.491 ' HE3' HG13 ' A' ' 200' ' ' ILE . 64.4 mtm -135.42 152.59 51.54 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.103 -0.703 . . . . 1.22 109.103 176.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -113.05 147.74 36.62 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.092 0.245 . . . . 2.31 110.516 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.81 123.97 2.91 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 124.474 1.109 . . . . 0.84 112.973 -170.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.75 7.7 13.01 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.451 -0.795 . . . . 1.04 111.183 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.508 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 1.0 OUTLIER -84.04 157.59 21.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.507 0.67 . . . . 2.62 110.923 -178.052 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.657 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 2.7 tmm_? -144.1 134.09 24.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.494 -0.776 . . . . 3.62 109.546 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.524 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 6.3 mt -87.76 137.36 32.41 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.875 -0.33 . . . . 0.53 110.119 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -171.38 170.99 43.76 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.917 -0.659 . . . . 1.02 111.481 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -88.62 148.38 27.1 Favored 'Cis proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.181 -1.591 . . . . 2.1 112.491 -2.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.514 ' HB2' HD12 ' A' ' 169' ' ' LEU . 28.9 t -100.57 -67.67 0.84 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.958 -0.756 . . . . 2.0 108.958 172.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.571 ' O ' ' HB2' ' A' ' 191' ' ' GLN . 16.7 m -139.31 140.9 36.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.842 -0.617 . . . . 2.03 109.66 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 115' ' ' VAL . 13.6 p -111.62 31.08 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 122.575 1.178 . . . . 3.95 109.095 176.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.437 HG22 ' HB ' ' A' ' 114' ' ' VAL . 12.2 m -75.96 120.09 80.13 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 114.479 -1.237 . . . . 5.21 111.289 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.589 ' HB2' ' OE1' ' A' ' 136' ' ' GLU . 48.7 Cg_endo -68.57 -165.56 0.13 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.126 2.551 . . . . 5.07 113.07 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.521 ' HD2' ' N ' ' A' ' 118' ' ' ARG . 5.1 mpt_? -63.62 -63.26 1.22 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.756 -0.656 . . . . 7.99 110.471 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.88 45.85 1.2 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.401 -0.818 . . . . 6.95 111.741 -175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -104.02 20.46 18.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.788 0.327 . . . . 6.09 111.575 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 63.2 83.79 0.16 Allowed 'General case' 0 CA--C 1.518 -0.25 0 CA-C-O 121.817 0.818 . . . . 5.56 111.682 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -94.11 150.63 20.16 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.133 -0.94 . . . . 7.42 109.517 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.482 ' CD ' ' H ' ' A' ' 123' ' ' GLU . 7.1 mp0 -57.36 -71.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.895 0.379 . . . . 9.01 110.376 -175.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.7 m -160.09 -60.52 0.06 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.378 -0.601 . . . . 8.88 109.378 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.48 ' HA ' ' CZ3' ' A' ' 128' ' ' TRP . 16.4 t0 -145.29 139.85 27.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.458 -0.792 . . . . 7.6 110.787 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -130.93 3.79 4.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.616 0.722 . . . . 7.23 109.441 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.415 ' O ' HG11 ' A' ' 220' ' ' VAL . . . 141.4 35.17 0.1 Allowed Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.507 -0.77 . . . . 4.59 112.502 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . 0.487 ' HE3' ' H ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -152.52 -87.16 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.416 0.627 . . . . 4.93 109.761 177.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.487 ' H ' ' HE3' ' A' ' 128' ' ' TRP . 7.3 pt-20 175.85 -47.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.401 -1.272 . . . . 7.65 108.398 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.418 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 22.8 pt20 -178.66 94.42 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.952 -1.022 . . . . 8.84 109.871 177.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.481 HG21 ' NE2' ' A' ' 187' ' ' GLN . 1.4 pp -70.31 -11.57 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 112.186 0.439 . . . . 6.05 112.186 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.17 57.74 4.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.273 1.035 . . . . 8.5 110.108 177.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.3 t -111.4 26.98 10.11 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.118 -1.401 . . . . 9.82 110.05 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -151.09 126.63 10.13 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.044 -0.98 . . . . 11.21 109.783 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.58 114.23 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.479 0.657 . . . . 10.84 110.822 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.589 ' OE1' ' HB2' ' A' ' 117' ' ' PRO . 40.4 tt0 -80.86 74.63 7.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.771 -0.649 . . . . 13.25 110.116 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.78 -35.64 37.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.693 -0.685 . . . . 13.89 110.217 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 24.9 m 51.38 80.4 0.3 Allowed Pre-proline 0 C--O 1.235 0.338 0 CA-C-N 116.081 -0.509 . . . . 14.05 111.745 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.85 127.27 24.5 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.776 2.318 . . . . 14.41 111.85 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -84.18 32.94 0.49 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.101 0.477 . . . . 14.44 111.125 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -114.22 -2.89 13.26 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.933 -0.576 . . . . 15.9 110.099 177.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -152.49 -68.71 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.845 -0.693 . . . . 15.6 112.021 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 9.6 p -79.51 93.08 5.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.06 0.457 . . . . 15.6 111.209 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.4 mt -125.04 -61.82 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.081 -0.509 . . . . 13.85 110.369 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 29.2 p 46.62 75.43 0.12 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.599 -0.728 . . . . 13.19 112.046 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -86.63 -15.74 38.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.549 0.69 . . . . 15.67 109.197 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 147' ' ' ILE . 2.4 pp -104.85 168.57 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.846 -1.07 . . . . 13.77 110.618 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 37.2 p -134.35 120.93 20.49 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.299 -0.41 . . . . 13.62 110.216 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.26 116.0 8.35 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.05 -0.352 . . . . 13.02 110.05 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -91.85 140.12 29.99 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.218 -0.446 . . . . 14.68 110.419 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -92.9 64.92 4.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.757 -0.656 . . . . 13.55 109.636 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -100.49 -149.08 23.13 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.729 -0.669 . . . . 15.8 113.218 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.9 m -93.21 28.32 2.22 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.251 0.463 . . . . 17.08 112.251 -171.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -86.52 -81.33 0.22 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.162 0.505 . . . . 18.43 110.247 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -145.69 47.38 1.27 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.515 -0.766 . . . . 18.53 109.308 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -132.97 83.61 2.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.696 -0.684 . . . . 14.32 111.179 -173.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 18.6 t -86.09 37.44 0.72 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.652 0.739 . . . . 14.51 109.53 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.2 t -123.61 130.38 74.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.597 -0.729 . . . . 13.06 109.385 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -96.94 82.05 3.18 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.227 0.537 . . . . 10.33 109.831 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 162' ' ' GLN . . . -148.2 158.56 44.15 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.716 -0.675 . . . . 9.88 109.918 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 55.86 33.13 20.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.563 0.697 . . . . 10.23 110.449 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 160' ' ' ALA . 29.8 mm-40 -118.32 -72.5 0.68 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.646 -0.706 . . . . 9.06 109.932 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -117.06 132.39 56.7 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.919 -0.582 . . . . 6.19 110.292 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 79' ' ' PRO . . . 151.1 91.7 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.782 -0.723 . . . . 3.97 111.862 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.35 -45.21 92.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.009 0.433 . . . . 2.63 110.561 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 113' ' ' CYS . . . 131.97 -31.76 3.0 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.739 -0.743 . . . . 1.3 112.947 176.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.676 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 23.1 t -65.56 -16.0 63.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.859 0.361 . . . . 1.82 111.349 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.558 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 24.4 p-90 -64.88 -23.82 67.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.846 0.355 . . . . 0.7 111.184 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.558 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 17.8 mt -86.3 -15.01 41.96 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.825 0.676 . . . . 0.66 112.825 -174.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.676 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -82.17 -2.01 50.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.013 -0.675 . . . . 1.48 110.785 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -79.2 -36.88 39.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.189 -0.459 . . . . 1.97 112.077 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.847 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -64.39 133.0 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.861 0.362 . . . . 0.67 111.03 -176.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.528 ' NH1' ' HA3' ' A' ' 95' ' ' GLY . 98.8 mtt180 -118.53 -172.92 2.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 4.34 111.222 -174.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -71.31 145.0 12.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.177 -0.465 . . . . 1.07 110.314 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.496 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -59.61 135.88 57.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.919 -0.582 . . . . 0.71 111.563 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.545 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 41.6 t -57.1 -34.56 68.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.609 -1.178 . . . . 1.88 111.629 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.7 p -126.7 144.15 51.02 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.072 0.463 . . . . 1.63 110.949 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 46.0 t -72.51 -9.71 58.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.789 -0.641 . . . . 1.96 110.808 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.68 -11.77 55.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.187 0.518 . . . . 2.42 110.059 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -110.21 16.64 21.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.628 -0.715 . . . . 2.12 111.347 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -60.95 115.14 3.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.947 0.403 . . . . 1.35 110.474 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.631 ' H ' HD12 ' A' ' 183' ' ' LEU . 18.0 t30 -154.82 38.17 0.42 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 122.084 0.945 . . . . 1.68 108.538 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.631 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.1 OUTLIER -123.18 129.93 52.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.13 -0.941 . . . . 0.81 110.711 -173.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 43.0 m -151.21 137.32 18.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.058 0.456 . . . . 0.51 111.467 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 51.2 tpp -88.18 134.91 33.66 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.952 -0.567 . . . . 1.35 110.65 176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 195' ' ' LYS . 39.9 t -113.15 131.93 55.66 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.939 -0.573 . . . . 1.73 110.387 176.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.519 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 25.2 tm0? -123.09 105.54 10.02 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.272 -0.64 . . . . 1.93 109.272 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.614 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 22.0 pt -136.84 142.58 37.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.191 -0.458 . . . . 1.11 110.426 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 15.9 m 57.48 27.07 13.45 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.403 0.439 . . . . 1.86 111.303 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.519 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 0.7 OUTLIER 64.5 14.56 9.0 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.7 -0.682 . . . . 2.83 112.475 -178.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 16.3 pt20 -117.75 159.66 22.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.551 -0.537 . . . . 1.75 109.551 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.9 mm -101.4 133.47 44.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.398 -0.364 . . . . 1.01 111.965 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.657 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 43.2 m-85 -141.42 150.62 42.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.702 -0.681 . . . . 3.94 110.499 176.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.464 ' CE1' ' HB3' ' A' ' 169' ' ' LEU . 13.4 m-85 -101.17 114.21 27.95 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.437 -0.579 . . . . 0.92 109.437 175.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.421 ' HD2' ' C ' ' A' ' 195' ' ' LYS . 5.2 tmmm? -98.78 127.05 44.59 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.4 -0.593 . . . . 1.11 109.4 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.508 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 2.0 t -93.01 151.26 3.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.627 0.727 . . . . 0.7 110.015 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 197' ' ' ILE . 1.2 mm -85.68 -58.13 3.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.708 -1.133 . . . . 0.62 110.274 -168.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.44 ' HE3' ' C ' ' A' ' 198' ' ' LYS . 0.0 OUTLIER -137.07 179.87 6.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.335 -0.848 . . . . 1.38 110.771 176.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -48.16 136.9 11.3 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 124.097 0.873 . . . . 2.23 113.223 -170.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.491 HG13 ' HE3' ' A' ' 104' ' ' MET . 33.1 mm -102.48 133.65 45.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.737 -0.665 . . . . 0.88 110.268 176.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 202' ' ' PRO . 49.1 mt-10 -98.68 138.87 20.78 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.611 -0.722 . . . . 2.06 109.607 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 49.7 Cg_exo -55.77 115.28 2.34 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.457 2.105 . . . . 0.51 111.962 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.72 7.44 8.06 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.497 -0.859 . . . . 0.7 113.498 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -144.62 122.27 11.83 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.643 0.722 . . . . 1.27 111.535 174.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -111.78 95.36 5.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.817 -0.629 . . . . 2.92 112.03 177.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.484 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.4 mm? -115.65 97.68 6.27 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.33 -0.948 . . . . 0.9 109.46 173.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.847 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 0.9 OUTLIER -146.96 115.07 6.57 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.53 109.806 176.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.612 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.9 p -153.64 158.42 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 121.729 -0.607 . . . . 0.91 111.191 -177.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -84.89 110.92 19.21 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.28 -1.008 . . . . 1.55 108.28 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 61.7 t -60.24 119.97 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.223 0.535 . . . . 2.56 110.226 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.485 ' HA ' ' HA3' ' A' ' 218' ' ' GLY . 0.3 OUTLIER -137.28 138.93 40.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.598 -0.728 . . . . 5.36 110.637 -175.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -133.34 30.17 3.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.615 0.721 . . . . 5.8 109.921 177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -168.82 -74.31 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 108.585 -1.806 . . . . 5.61 108.585 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.467 HG12 ' CD1' ' A' ' 215' ' ' TYR . 7.9 t -139.7 -66.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.459 0.647 . . . . 6.31 109.451 170.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.714 ' H ' ' HD2' ' A' ' 216' ' ' PRO . 70.8 m-85 -138.86 -56.77 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 115.213 -0.903 . . . . 8.83 112.814 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.714 ' HD2' ' H ' ' A' ' 215' ' ' TYR . 37.0 Cg_endo -64.16 -67.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.102 1.868 . . . . 7.78 113.97 -161.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -61.19 -9.19 4.42 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.238 0.459 . . . . 8.02 112.238 -172.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 211' ' ' LYS . . . -59.9 -44.06 97.47 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.926 -0.579 . . . . 8.64 113.085 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.2 t -145.63 -21.0 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.141 0.422 . . . . 9.72 112.141 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 216' ' ' PRO . 3.7 m -104.55 155.58 37.17 Favored Pre-proline 0 C--N 1.326 -0.446 0 C-N-CA 120.881 -0.328 . . . . 9.62 110.192 177.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -72.04 131.1 17.55 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.144 1.896 . . . . 11.65 111.486 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.3 -1.87 10.32 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.596 2.197 . . . . 13.11 112.214 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -125.76 49.86 0.9 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.425 -0.807 . . . . 14.03 111.288 176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 51.9 tp -64.85 134.18 53.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.562 0.22 . . . . 16.1 110.791 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 32.0 t70 68.33 13.56 9.04 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.689 -0.687 . . . . 17.7 111.108 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 C--O 1.25 1.093 0 CA-C-N 116.005 -0.543 . . . . 18.9 111.296 -179.619 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.153 -0.379 . . . . 33.26 112.153 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.7 t -113.13 68.76 0.68 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.376 0.608 . . . . 33.92 110.647 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.39 -47.99 3.89 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.598 -1.001 . . . . 32.35 110.598 174.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -88.97 121.72 69.47 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.541 -0.54 . . . . 31.65 109.541 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -59.62 109.64 0.61 Allowed 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.488 2.125 . . . . 29.99 112.091 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 3.3 p -95.42 11.33 33.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.015 0.436 . . . . 28.92 111.296 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.5 m -71.93 93.36 1.35 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.111 -0.495 . . . . 26.94 109.978 175.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 61.71 47.93 5.94 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.858 -0.61 . . . . 25.83 110.555 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.431 ' HB3' ' HA ' ' A' ' 56' ' ' THR . 7.1 p-10 -76.29 145.76 39.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.644 -0.707 . . . . 23.53 110.509 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.486 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 21.1 t80 -104.7 80.08 1.61 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.31 -0.626 . . . . 21.64 109.31 178.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 49.4 m -106.91 98.19 20.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.104 -0.498 . . . . 19.42 110.923 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 60' ' ' PHE . 3.5 Cg_exo -81.34 135.82 9.67 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.945 2.43 . . . . 17.17 111.825 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -82.55 -17.58 44.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.127 -0.488 . . . . 17.47 110.095 175.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -63.0 129.86 42.22 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.316 0.579 . . . . 15.63 110.561 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.34 -20.04 9.09 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.701 -0.761 . . . . 12.04 111.856 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.404 ' N ' ' HD3' ' A' ' 67' ' ' PRO . 9.2 t -133.89 64.4 66.67 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.914 0.388 . . . . 10.67 110.198 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 66' ' ' SER . 2.2 Cg_endo -84.17 79.12 2.7 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.648 2.232 . . . . 9.69 111.48 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -94.76 90.19 5.98 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.357 -0.838 . . . . 7.7 110.304 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -87.93 124.47 33.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.772 -0.649 . . . . 8.14 110.444 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -91.55 117.88 68.06 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 115.962 -0.563 . . . . 5.96 109.788 177.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 12.2 Cg_exo -70.69 -159.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.985 2.457 . . . . 6.13 112.303 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.0 m -53.71 -32.02 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 111.923 0.342 . . . . 6.53 111.923 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -101.22 114.69 28.9 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.595 -0.52 . . . . 5.01 109.595 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.531 HD13 ' H ' ' A' ' 77' ' ' ASP . 2.3 pp -83.54 138.92 41.09 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.135 0.493 . . . . 4.23 111.192 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.08 -4.22 14.16 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.91 2.407 . . . . 4.12 112.725 -176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -73.49 -67.59 0.57 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.073 -0.512 . . . . 3.82 109.663 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.531 ' H ' HD13 ' A' ' 74' ' ' ILE . 31.3 t70 49.92 75.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.131 -0.941 . . . . 3.16 110.914 177.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.549 HG23 ' HB3' ' A' ' 165' ' ' ALA . 41.5 mt -75.07 117.84 65.94 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.228 -0.896 . . . . 2.45 110.607 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.66 133.2 49.96 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.757 2.305 . . . . 1.75 112.798 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.581 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -125.68 146.6 55.51 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.59 -0.732 . . . . 1.01 109.891 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.64 147.9 76.92 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.683 2.255 . . . . 0.73 111.339 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.56 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -57.59 -23.58 51.61 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.462 0.912 . . . . 1.04 113.462 -170.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -89.83 8.35 32.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.596 0.591 . . . . 1.66 112.596 -173.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.457 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 23.8 m-85 -132.54 139.47 47.89 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.8 -0.815 . . . . 1.0 108.8 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.457 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 41.8 tt0 -114.36 119.56 37.35 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.839 -0.344 . . . . 2.27 111.103 -176.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 tt -84.19 131.67 34.74 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.291 -0.633 . . . . 0.79 109.291 177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -140.38 124.14 17.24 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.264 -0.426 . . . . 3.21 110.752 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -80.84 111.82 17.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.298 -0.631 . . . . 2.46 109.298 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -177.31 127.06 0.15 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.566 -0.901 . . . . 1.58 108.566 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.2 m -90.69 105.51 17.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.887 0.375 . . . . 1.86 111.132 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.538 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -85.44 123.62 72.66 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 108.766 -0.827 . . . . 1.45 108.766 174.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.5 119.13 5.69 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.337 2.691 . . . . 1.61 113.233 -172.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.7 -28.74 10.87 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.645 -0.707 . . . . 1.74 112.259 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -117.42 -58.45 2.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.898 0.38 . . . . 1.41 110.946 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 114.52 -138.68 15.03 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.894 -0.594 . . . . 1.09 111.722 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 96' ' ' LEU . 0.9 OUTLIER -73.32 159.74 32.91 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.503 -0.184 . . . . 2.31 110.503 175.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.57 178.17 46.46 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.576 -0.821 . . . . 0.59 112.269 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.65 148.33 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.239 -0.652 . . . . 0.67 109.239 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.2 m95 -119.14 120.21 36.44 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.074 -0.343 . . . . 1.13 110.074 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.508 ' H ' ' HG2' ' A' ' 205' ' ' GLU . . . -67.79 125.43 26.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.323 -0.399 . . . . 0.54 110.955 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.56 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -88.23 -1.04 57.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.881 0.372 . . . . 1.68 110.285 176.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 15.6 ttm-85 -125.7 152.62 45.03 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.392 -0.595 . . . . 3.5 109.392 174.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.54 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -76.7 159.62 30.04 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.358 -0.383 . . . . 2.4 110.728 176.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.672 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 47.3 mtm -134.25 152.11 51.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.51 -0.314 . . . . 1.22 110.262 176.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -130.66 144.52 51.49 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.691 0.62 . . . . 2.31 110.045 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -37.42 121.07 0.83 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 124.446 1.091 . . . . 0.84 113.467 -170.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.21 7.26 12.68 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.464 -0.789 . . . . 1.04 111.509 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.52 ' CD ' ' HB ' ' A' ' 196' ' ' VAL . 0.9 OUTLIER -83.68 164.42 19.66 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.96 0.41 . . . . 2.62 110.648 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.665 ' HG3' ' CE2' ' A' ' 193' ' ' TYR . 8.5 tmm_? -145.97 130.96 18.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.364 -0.38 . . . . 3.62 110.777 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.457 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 5.1 mt -96.45 138.24 34.33 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.304 -0.628 . . . . 0.53 109.304 175.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.453 ' HA3' ' C ' ' A' ' 112' ' ' PRO . . . 83.74 -117.39 4.43 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.651 -0.785 . . . . 1.02 112.608 177.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.453 ' C ' ' HA3' ' A' ' 111' ' ' GLY . 17.4 Cg_exo -66.73 167.35 56.63 Favored 'Cis proline' 0 C--N 1.347 0.498 0 CA-C-N 118.94 1.37 . . . . 2.1 113.716 5.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.436 ' O ' ' HA3' ' A' ' 166' ' ' GLY . 42.2 t -68.6 -39.85 80.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 2.0 110.139 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.582 ' HB ' ' H ' ' A' ' 192' ' ' ILE . 48.9 t -122.54 128.88 75.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.008 -0.738 . . . . 2.03 109.008 175.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.9 m -111.19 -174.73 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.078 -0.51 . . . . 3.95 110.154 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.479 ' HB ' ' HD3' ' A' ' 117' ' ' PRO . 16.2 t -57.4 -54.96 49.46 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 111.735 0.272 . . . . 5.21 111.735 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.479 ' HD3' ' HB ' ' A' ' 116' ' ' VAL . 55.2 Cg_endo -70.47 135.35 28.57 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 121.731 1.62 . . . . 5.07 112.254 176.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 67.3 178.99 0.23 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.773 -0.648 . . . . 7.99 111.378 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -159.95 146.99 16.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.266 -0.425 . . . . 6.95 110.56 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -81.19 73.43 8.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.395 0.617 . . . . 6.09 110.477 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.33 158.11 36.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.258 -0.883 . . . . 5.56 110.691 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -74.92 58.54 0.85 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.13 -0.941 . . . . 7.42 111.311 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -61.12 -45.71 93.56 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.375 -1.284 . . . . 9.01 109.978 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 9.3 m -143.59 -62.18 0.4 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.578 -0.737 . . . . 8.88 110.433 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -124.72 -176.35 3.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.008 0.432 . . . . 7.6 110.574 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -152.08 140.08 20.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.562 -0.745 . . . . 7.23 109.789 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.02 11.1 60.48 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.766 -0.731 . . . . 4.59 113.088 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . 0.48 ' CG ' ' N ' ' A' ' 129' ' ' GLU . 1.4 p90 -141.72 -78.55 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.059 0.43 . . . . 4.93 111.017 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.48 ' N ' ' CG ' ' A' ' 128' ' ' TRP . 3.4 pt-20 -167.91 -65.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.058 0.392 . . . . 7.65 112.058 -175.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.471 ' H ' ' HG3' ' A' ' 129' ' ' GLU . 29.2 pt20 -176.1 164.55 2.79 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 110.219 -0.289 . . . . 8.84 110.219 -169.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.49 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -122.21 4.42 5.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.357 0.599 . . . . 6.05 109.831 171.242 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.9 mp -95.53 155.37 16.77 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.419 -0.809 . . . . 8.5 109.316 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.7 t 41.67 43.34 2.36 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.234 0.959 . . . . 9.82 112.114 -177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -112.3 120.46 41.81 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.172 0.51 . . . . 11.21 110.665 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.8 p -85.11 133.12 30.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.454 -0.794 . . . . 10.84 111.368 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -64.06 131.58 47.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.82 -0.627 . . . . 13.25 110.299 176.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.1 p -88.17 -26.3 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.997 -0.547 . . . . 13.89 110.326 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.8 t -117.85 86.81 25.63 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.619 -0.512 . . . . 14.05 109.619 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.13 119.21 5.43 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.945 2.43 . . . . 14.41 112.428 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -82.33 83.47 7.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.992 -0.549 . . . . 14.44 110.644 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -99.59 -36.49 9.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.419 0.628 . . . . 15.9 110.02 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -146.34 166.94 28.05 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.787 -0.925 . . . . 15.6 110.787 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 24.7 t 58.51 40.96 23.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.697 0.76 . . . . 15.6 109.936 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.6 mt -83.74 -24.93 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.307 -0.86 . . . . 13.85 110.326 -176.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.6 t -70.03 115.22 8.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.421 0.629 . . . . 13.19 110.706 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -108.7 -62.33 1.48 Allowed 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 108.292 -1.003 . . . . 15.67 108.292 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.714 HG22 ' H ' ' A' ' 148' ' ' SER . 3.7 mt 61.95 177.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 114.333 -1.303 . . . . 13.77 110.427 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.714 ' H ' HG22 ' A' ' 147' ' ' ILE . 2.7 p -134.08 58.54 1.77 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.238 0.542 . . . . 13.62 111.072 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -138.03 151.42 47.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.803 -0.635 . . . . 13.02 110.945 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 60.77 60.64 1.85 Allowed 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 122.139 0.971 . . . . 14.68 111.524 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.6 pp -133.47 22.07 4.0 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.212 -1.358 . . . . 13.55 109.716 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 134.83 94.02 0.46 Allowed Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.73 -1.123 . . . . 15.8 110.919 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.6 p -66.19 -29.04 69.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.18 0.514 . . . . 17.08 110.546 -177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -111.71 -69.22 0.88 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.61 -0.723 . . . . 18.43 109.974 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.579 ' H ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -117.07 146.21 43.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.332 -0.849 . . . . 18.53 111.158 -174.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.19 151.7 23.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.021 -0.536 . . . . 14.32 110.431 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 10.2 p -108.97 -25.92 10.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.084 -0.507 . . . . 14.51 111.019 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.9 p -69.61 144.04 14.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.852 -0.425 . . . . 13.06 109.852 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 162' ' ' GLN . 43.5 t0 -85.76 137.92 32.46 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.45 -0.5 . . . . 10.33 110.724 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.441 ' HB1' ' HB2' ' A' ' 148' ' ' SER . . . -172.91 -59.13 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.214 -0.903 . . . . 9.88 109.727 -176.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -87.66 -28.63 21.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.673 -0.694 . . . . 10.23 110.896 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.405 ' HB2' ' OD1' ' A' ' 159' ' ' ASP . 47.4 mt-30 -68.1 -48.8 64.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.127 -0.694 . . . . 9.06 109.127 175.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 67.59 84.79 0.15 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.348 -0.842 . . . . 6.19 111.695 170.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -67.79 146.37 46.65 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 110.487 -1.045 . . . . 3.97 110.487 171.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.549 ' HB3' HG23 ' A' ' 78' ' ' ILE . . . -75.43 7.13 3.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.196 0.498 . . . . 2.63 111.949 -175.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 113' ' ' CYS . . . 80.54 -48.59 3.69 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.251 -0.431 . . . . 1.3 113.544 174.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.5 t -59.54 -23.31 62.74 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.6 0.36 . . . . 1.82 111.853 -176.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 41.4 p-90 -65.17 -17.48 64.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.007 0.432 . . . . 0.7 111.314 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 43.7 mt -80.16 -13.86 58.93 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.199 0.444 . . . . 0.66 112.199 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -70.55 -13.1 61.97 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 120.264 -0.574 . . . . 1.48 109.887 177.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -68.06 -36.81 80.49 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.707 -0.679 . . . . 1.97 111.406 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.655 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -69.36 124.77 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.325 -0.55 . . . . 0.67 109.942 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.493 ' HA ' ' NE ' ' A' ' 173' ' ' ARG . 3.9 mmp_? -112.29 -166.51 1.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.957 -0.565 . . . . 4.34 110.82 -176.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.0 t -73.55 151.9 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.332 . . . . 1.07 110.566 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -64.38 134.23 54.17 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.01 -0.541 . . . . 0.71 111.014 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 19.5 t -78.94 -12.46 60.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.381 -0.827 . . . . 1.88 110.245 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 180' ' ' ASP . 46.5 m -125.74 140.99 52.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.904 -0.589 . . . . 1.63 109.641 176.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 61.4 m -79.38 -19.39 50.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 1.96 111.2 -176.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -89.29 1.78 55.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.233 0.539 . . . . 2.42 110.099 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 177' ' ' SER . 27.6 t70 -110.78 15.81 21.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.545 -0.752 . . . . 2.12 110.412 -176.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 16.8 mm100 -60.91 116.79 4.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.85 -0.614 . . . . 1.35 110.632 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.611 ' ND2' HD11 ' A' ' 200' ' ' ILE . 23.7 t30 -153.9 33.18 0.44 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.076 0.941 . . . . 1.68 109.282 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -121.93 120.8 35.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.563 -0.744 . . . . 0.81 110.644 -172.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 30.3 m -142.92 121.91 12.81 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.265 0.555 . . . . 0.51 110.93 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.415 ' HB2' ' HE2' ' A' ' 185' ' ' MET . 52.2 tpp -92.19 127.74 37.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.639 -0.709 . . . . 1.35 109.981 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 38.6 t -126.11 162.43 25.36 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.402 -0.592 . . . . 1.73 109.402 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -134.43 147.06 50.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.757 0.313 . . . . 1.93 110.835 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.742 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 24.4 pt -137.42 133.48 46.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.53 -0.759 . . . . 1.11 109.479 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.7 t 55.33 28.87 12.01 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.954 0.407 . . . . 1.86 110.84 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 66.86 24.29 9.78 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.552 -0.749 . . . . 2.83 112.058 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.742 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 11.9 pt20 -118.53 155.01 31.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.09 -0.707 . . . . 1.75 109.09 172.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.582 ' H ' ' HB ' ' A' ' 114' ' ' VAL . 38.0 mm -81.65 126.06 39.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.108 0.48 . . . . 1.01 111.806 -170.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.665 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 63.0 t80 -121.92 127.64 50.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.401 -0.818 . . . . 3.94 110.401 -174.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 7.2 m-85 -99.9 113.48 26.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.046 0.45 . . . . 0.92 110.048 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -114.97 123.32 48.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.554 -0.748 . . . . 1.11 109.952 -177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.52 ' HB ' ' CD ' ' A' ' 108' ' ' GLU . 2.0 t -96.45 153.35 3.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.559 0.695 . . . . 0.7 109.754 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 2.1 mm -92.61 -58.05 3.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.575 -1.193 . . . . 0.62 111.931 -166.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.522 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.7 OUTLIER -141.03 -178.18 5.45 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.616 -0.72 . . . . 1.38 111.713 -173.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.672 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.5 m-20 -45.8 116.21 1.15 Allowed 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.986 0.804 . . . . 2.23 112.93 -177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.611 HD11 ' ND2' ' A' ' 182' ' ' ASN . 14.8 mm -88.28 135.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.563 -0.744 . . . . 0.88 109.535 170.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 46.4 mt-10 -99.94 130.43 26.35 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 109.236 -0.653 . . . . 2.06 109.236 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -47.33 117.71 2.45 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.067 2.512 . . . . 0.51 112.695 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.93 -9.99 9.63 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.872 -0.68 . . . . 0.7 112.982 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 19.9 pt-20 -138.52 121.48 16.66 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 117.569 0.685 . . . . 1.27 112.118 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.508 ' HG2' ' H ' ' A' ' 100' ' ' ALA . 7.7 mm-40 -111.2 125.0 53.33 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.061 -0.518 . . . . 2.92 110.201 170.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.538 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 2.4 mm? -122.28 99.29 6.34 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.327 -0.62 . . . . 0.9 109.327 174.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.655 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.3 mm? -145.62 115.59 7.38 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.497 -0.557 . . . . 0.53 109.497 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.495 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 6.3 p -153.21 157.89 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.509 -0.476 . . . . 0.91 111.169 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -98.6 111.4 23.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.84 -0.618 . . . . 1.55 109.828 173.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.45 HG23 HG13 ' A' ' 208' ' ' VAL . 52.6 t -122.04 94.92 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.329 -0.619 . . . . 2.56 109.329 171.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.459 ' HE3' ' HG2' ' A' ' 212' ' ' GLU . 26.3 ttpt -153.99 154.59 34.03 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.837 -0.801 . . . . 5.36 108.837 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.459 ' HG2' ' HE3' ' A' ' 211' ' ' LYS . 24.1 mm-40 36.25 89.45 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 O-C-N 124.804 1.315 . . . . 5.8 112.496 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.24 41.37 1.11 Allowed Glycine 0 C--O 1.227 -0.291 0 CA-C-N 116.234 -0.439 . . . . 5.61 113.006 -175.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 18.6 t -108.77 -65.79 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.136 0.493 . . . . 6.31 110.183 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.46 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 42.1 m-85 -61.88 -56.21 34.22 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.245 -0.889 . . . . 8.83 112.285 -175.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 17.9 Cg_endo -57.64 -44.15 44.08 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.193 1.929 . . . . 7.78 112.769 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.31 -33.45 63.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.01 0.433 . . . . 8.02 110.977 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 88.47 21.86 42.67 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.072 -0.585 . . . . 8.64 111.813 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 12.4 p -85.23 49.72 1.8 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.069 0.461 . . . . 9.72 111.464 -175.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 14.9 m -79.56 114.75 48.18 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.927 -0.578 . . . . 9.62 110.749 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.29 130.62 25.9 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.761 2.307 . . . . 11.65 112.223 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.83 55.58 5.3 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.95 2.433 . . . . 13.11 112.794 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -163.79 172.26 39.63 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.804 -0.712 . . . . 14.03 112.25 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 8.0 tt -144.75 129.53 18.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.547 -0.538 . . . . 16.1 109.547 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -112.3 -46.53 3.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.07 0.462 . . . . 17.7 110.649 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.288 -0.863 . . . . 18.9 110.232 -178.081 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 111.903 -0.479 . . . . 33.26 111.903 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.7 m -86.01 -39.16 17.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.838 0.351 . . . . 33.92 110.644 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.63 142.12 15.02 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.108 -0.568 . . . . 32.35 111.782 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -90.75 126.55 55.48 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.911 0.386 . . . . 31.65 110.975 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.84 117.9 5.22 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.421 2.081 . . . . 29.99 112.007 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -143.89 144.29 31.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.062 -0.517 . . . . 28.92 109.795 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 p -153.91 65.35 0.72 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.017 0.437 . . . . 26.94 110.984 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.6 136.96 56.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.013 -0.54 . . . . 25.83 110.423 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.34 88.44 6.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.999 0.428 . . . . 23.53 110.436 175.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -107.25 145.48 32.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.157 -0.474 . . . . 21.64 109.937 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 35.5 p 46.97 77.02 0.49 Allowed Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.38 0.672 . . . . 19.42 112.183 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.94 87.15 0.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.574 2.183 . . . . 17.17 111.267 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -96.42 44.65 1.06 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.956 -1.02 . . . . 17.47 110.945 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -78.29 97.93 5.74 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.851 -0.613 . . . . 15.63 110.094 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.33 74.79 1.43 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.884 -0.674 . . . . 12.04 112.016 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 48.8 m -147.98 137.76 12.38 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.891 -0.411 . . . . 10.67 109.891 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 66' ' ' SER . 25.6 Cg_exo -62.82 102.18 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.755 2.304 . . . . 9.69 111.909 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -96.15 120.37 36.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.124 -0.489 . . . . 7.7 110.94 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.488 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 42.4 tt0 -94.56 141.44 28.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.071 -0.513 . . . . 8.14 109.895 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.71 110.49 17.42 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.505 -0.316 . . . . 5.96 110.413 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 69' ' ' GLU . 32.1 Cg_exo -61.33 -74.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.865 2.377 . . . . 6.13 112.165 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 p -121.59 -32.92 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.167 -0.47 . . . . 6.53 110.631 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -98.27 124.79 43.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.157 -0.474 . . . . 5.01 110.323 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.438 HG13 ' H ' ' A' ' 74' ' ' ILE . 1.9 pp -77.48 152.31 81.01 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.201 -0.454 . . . . 4.23 111.675 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -90.96 26.42 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.052 2.501 . . . . 4.12 112.685 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' HB2' HD13 ' A' ' 74' ' ' ILE . 10.8 mm-40 -74.02 -61.91 1.69 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.888 -0.596 . . . . 3.82 110.054 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 62.96 67.91 0.66 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.536 -0.757 . . . . 3.16 110.56 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.0 mt -69.45 123.59 88.74 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.337 -0.847 . . . . 2.45 109.732 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.41 117.64 4.17 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.0 2.467 . . . . 1.75 112.983 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.504 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -128.41 146.03 58.18 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.823 -0.626 . . . . 1.01 109.584 176.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -53.19 147.71 34.27 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.823 2.349 . . . . 0.73 112.11 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.576 ' O ' ' HD2' ' A' ' 101' ' ' LYS . . . -70.56 -0.39 8.46 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.551 0.574 . . . . 1.04 112.551 -173.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -106.0 4.6 29.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.881 0.372 . . . . 1.66 111.167 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -136.1 138.5 42.14 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.502 ' HB2' ' HE2' ' A' ' 101' ' ' LYS . 5.8 tp10 -109.81 124.27 51.01 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.299 -0.56 . . . . 2.27 111.286 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.429 ' HB2' HG21 ' A' ' 80' ' ' ILE . 58.0 tp -87.91 128.3 35.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.158 -0.473 . . . . 0.79 110.078 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -147.87 118.87 7.66 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.635 -0.711 . . . . 3.21 109.796 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -74.14 112.62 10.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.989 0.424 . . . . 2.46 109.971 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.2 t -172.92 133.56 0.55 Allowed 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.338 -0.986 . . . . 1.58 108.338 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.4 t -87.36 106.04 17.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.929 0.395 . . . . 1.86 110.805 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -85.79 123.12 72.74 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.413 -0.588 . . . . 1.45 109.413 173.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -45.59 119.32 2.64 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.515 2.81 . . . . 1.61 113.346 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.32 -29.1 10.46 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.812 -0.631 . . . . 1.74 112.415 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 173' ' ' ARG . . . -124.28 -65.88 1.02 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.048 0.451 . . . . 1.41 111.671 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.604 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 123.5 -132.59 8.56 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.127 -0.789 . . . . 1.09 111.127 -175.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 1.2 pp -72.82 159.69 33.37 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.986 0.393 . . . . 2.31 110.746 175.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.91 174.73 47.09 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.844 -0.693 . . . . 0.59 111.958 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 19.4 m -106.64 130.8 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 121.266 0.555 . . . . 0.67 109.71 174.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.2 m95 -96.85 114.89 26.56 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.652 -0.704 . . . . 1.13 110.019 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 202' ' ' PRO . . . -64.34 114.26 4.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.235 -0.283 . . . . 0.54 110.235 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 82' ' ' ALA . 15.8 ptpt -83.71 -8.99 59.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.244 0.545 . . . . 1.68 110.665 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 27.2 ttp180 -125.66 155.75 40.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.547 -0.751 . . . . 3.5 109.772 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.432 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -81.88 155.45 25.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.95 -0.568 . . . . 2.4 109.779 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.584 ' HB3' ' OE2' ' A' ' 108' ' ' GLU . 59.6 mtm -136.13 153.31 51.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.684 -0.234 . . . . 1.22 110.507 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -117.34 140.37 49.66 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.129 -0.487 . . . . 2.31 109.716 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.62 131.39 3.92 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 124.421 1.076 . . . . 0.84 113.61 -169.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.25 7.67 11.03 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.528 -0.76 . . . . 1.04 112.368 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.584 ' OE2' ' HB3' ' A' ' 104' ' ' MET . 0.7 OUTLIER -85.74 167.9 14.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.293 0.568 . . . . 2.62 111.435 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -143.28 135.33 26.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.746 -0.661 . . . . 3.62 110.182 -177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 4.4 mt -104.6 132.91 50.3 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.598 -0.89 . . . . 0.53 108.598 171.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.82 166.48 39.67 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.188 -1.006 . . . . 1.02 112.724 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -83.18 142.03 43.75 Favored 'Cis proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.414 -1.494 . . . . 2.1 111.909 -2.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.614 ' SG ' HD13 ' A' ' 169' ' ' LEU . 56.9 m -88.32 -2.9 58.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.044 0.45 . . . . 2.0 110.765 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.493 HG13 ' H ' ' A' ' 192' ' ' ILE . 15.6 m -94.37 126.55 46.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.047 -0.524 . . . . 2.03 110.802 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 165' ' ' ALA . 45.7 t -74.0 140.27 17.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.702 -0.681 . . . . 3.95 109.359 176.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 32.6 m -43.95 113.35 1.54 Allowed Pre-proline 0 CA--C 1.536 0.435 0 O-C-N 124.012 0.82 . . . . 5.21 112.056 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 116' ' ' VAL . 23.4 Cg_exo -64.5 166.73 16.69 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.128 2.552 . . . . 5.07 113.407 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 74.17 148.7 0.1 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.009 -0.996 . . . . 7.99 110.788 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 71.32 -50.6 0.69 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.418 0.687 . . . . 6.95 112.328 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -69.19 -73.06 0.16 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 122.236 0.214 . . . . 6.09 111.383 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 55.87 94.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.691 0.619 . . . . 5.56 111.394 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -62.89 143.94 57.16 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.63 -0.714 . . . . 7.42 111.442 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 124' ' ' THR . 0.6 OUTLIER -141.42 -49.91 0.41 Allowed 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.209 -0.905 . . . . 9.01 108.717 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.41 ' N ' ' HG3' ' A' ' 123' ' ' GLU . 25.2 m -78.66 -58.57 3.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.672 -0.695 . . . . 8.88 110.304 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -91.59 124.55 35.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.35 -0.841 . . . . 7.6 111.169 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -125.14 -170.77 2.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.022 -0.535 . . . . 7.23 110.647 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 179.72 -39.52 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.013 -0.835 . . . . 4.59 111.013 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -126.45 -56.59 1.4 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.518 -0.549 . . . . 4.93 109.518 175.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.595 ' HG3' ' H ' ' A' ' 130' ' ' GLN . 6.7 pt-20 -179.64 -69.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.839 -0.619 . . . . 7.65 110.777 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.595 ' H ' ' HG3' ' A' ' 129' ' ' GLU . 6.1 tp-100 -174.29 161.26 3.43 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.107 -0.701 . . . . 8.84 109.107 -175.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.44 40.49 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.018 0.437 . . . . 6.05 111.512 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.95 57.34 4.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.026 0.917 . . . . 8.5 110.546 176.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.6 t -150.22 27.86 0.75 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.444 -1.253 . . . . 9.82 109.571 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -96.78 89.27 4.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.171 -0.922 . . . . 11.21 110.516 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.1 p -56.61 136.59 19.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.613 -0.721 . . . . 10.84 110.756 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.449 ' HA ' ' OE1' ' A' ' 136' ' ' GLU . 5.0 tp10 -80.23 82.89 6.19 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.988 -0.551 . . . . 13.25 110.038 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.72 -30.78 39.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.699 -0.682 . . . . 13.89 110.462 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.1 m -105.4 104.71 49.21 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.592 -0.521 . . . . 14.05 109.592 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -42.59 118.53 1.15 Allowed 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.427 2.752 . . . . 14.41 112.89 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.436 ' HB3' ' OE2' ' A' ' 136' ' ' GLU . 3.7 pt20 -80.09 47.17 0.87 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.629 0.728 . . . . 14.44 111.158 -174.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -111.02 74.34 0.86 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.609 -0.723 . . . . 15.9 110.602 -175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 144.65 -168.7 26.75 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.818 -0.706 . . . . 15.6 112.149 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 50.7 t -79.4 103.82 9.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.03 0.443 . . . . 15.6 110.178 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 61.6 mt -127.47 129.8 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.724 -0.843 . . . . 13.85 108.724 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.6 t -61.44 114.76 3.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.804 0.811 . . . . 13.19 111.126 -177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -126.46 -6.13 6.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.159 -0.928 . . . . 15.67 109.164 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.41 ' H ' HG13 ' A' ' 147' ' ' ILE . 2.8 pp -106.85 158.78 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 115.127 -0.942 . . . . 13.77 111.273 -174.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 48.5 t -123.39 139.79 53.67 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.271 -0.877 . . . . 13.62 108.642 173.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -94.22 145.46 24.7 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.039 0.447 . . . . 13.02 110.942 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -82.52 83.93 7.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.72 -0.673 . . . . 14.68 109.6 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.535 HD21 ' HA ' ' A' ' 160' ' ' ALA . 0.7 OUTLIER -89.88 49.04 1.66 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.585 -0.734 . . . . 13.55 111.941 -175.082 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -60.76 -24.79 62.79 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 121.216 -0.516 . . . . 15.8 112.686 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.5 m -148.33 25.66 0.98 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.104 0.478 . . . . 17.08 110.474 175.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 151' ' ' LEU . 18.9 mm-40 -95.41 -77.05 0.48 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.843 -0.617 . . . . 18.43 110.075 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.08 157.44 44.32 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.647 -0.871 . . . . 18.53 108.647 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -133.19 36.31 3.44 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.645 -0.422 . . . . 14.32 111.849 -175.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 85.0 m -135.89 -60.2 0.74 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.654 -0.248 . . . . 14.51 111.174 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 41.8 t -82.02 124.48 39.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.77 0.319 . . . . 13.06 111.627 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 48.47 67.91 0.77 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.15 -0.932 . . . . 10.33 112.403 176.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.535 ' HA ' HD21 ' A' ' 151' ' ' LEU . . . -86.68 162.73 17.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.037 -0.529 . . . . 9.88 110.493 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -104.87 46.77 0.9 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.305 0.574 . . . . 10.23 110.551 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -74.55 -21.64 59.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.804 -0.635 . . . . 9.06 110.766 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 68.81 -174.44 0.19 Allowed 'General case' 0 N--CA 1.462 0.158 0 O-C-N 124.233 0.958 . . . . 6.19 110.084 -174.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.54 ' O ' ' HD1' ' A' ' 168' ' ' TRP . . . 170.17 -80.91 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.162 -1.018 . . . . 3.97 112.334 179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 115' ' ' VAL . . . -50.6 119.06 3.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 2.63 111.242 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 82.65 -42.98 3.0 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.845 -0.616 . . . . 1.3 112.698 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.9 m -59.5 -39.49 83.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.001 0.371 . . . . 1.82 112.001 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.54 ' HD1' ' O ' ' A' ' 164' ' ' GLY . 29.9 p-90 -85.55 -22.66 28.01 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.42 -0.512 . . . . 0.7 111.157 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.614 HD13 ' SG ' ' A' ' 113' ' ' CYS . 28.7 mt -86.93 -15.0 40.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.389 0.514 . . . . 0.66 112.389 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.401 ' C ' ' HD3' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -75.33 -4.09 37.24 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.661 -0.415 . . . . 1.48 110.523 176.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -76.57 -37.62 56.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.085 -0.507 . . . . 1.97 111.586 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -67.34 129.36 31.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.539 -0.464 . . . . 0.67 110.057 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.427 ' HB3' ' H ' ' A' ' 174' ' ' VAL . 98.9 mtt180 -125.98 -163.38 1.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.933 -0.576 . . . . 4.34 111.835 -172.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.451 ' HA ' HG11 ' A' ' 208' ' ' VAL . 20.0 t -62.62 146.83 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.261 -0.881 . . . . 1.07 111.449 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.613 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -65.35 136.13 56.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.881 -0.6 . . . . 0.71 111.343 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.74 -19.3 64.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.35 -0.841 . . . . 1.88 111.143 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 63.6 m -146.03 147.56 31.77 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.227 -0.442 . . . . 1.63 110.027 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 10.6 p -76.89 -13.66 59.96 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.877 0.37 . . . . 1.96 111.427 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -73.56 -25.34 60.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.493 0.663 . . . . 2.42 110.101 172.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.451 ' O ' ' HG ' ' A' ' 206' ' ' LEU . 17.0 m-20 -92.61 17.27 10.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.428 -0.805 . . . . 2.12 111.606 -176.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 29.6 mm-40 -55.65 114.46 1.87 Allowed 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.36 0.6 . . . . 1.35 110.068 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.744 ' ND2' HD11 ' A' ' 200' ' ' ILE . 19.5 t30 -161.59 34.51 0.13 Allowed 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 122.597 1.189 . . . . 1.68 108.112 -178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.654 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -124.8 119.0 27.62 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.99 -1.005 . . . . 0.81 110.34 -172.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 61.3 m -150.62 129.37 12.38 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.06 0.457 . . . . 0.51 111.19 178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 49.4 ttm -91.04 137.29 32.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.174 -0.466 . . . . 1.35 110.11 176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 50.0 t -115.28 132.06 56.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.166 -0.47 . . . . 1.73 110.579 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 23.5 tm0? -108.87 105.21 14.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.278 -0.638 . . . . 1.93 109.278 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 13.3 pt -144.01 144.13 23.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.001 -0.545 . . . . 1.11 110.331 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.1 t 61.29 27.87 17.48 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.211 0.529 . . . . 1.86 110.371 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.416 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 6.0 mm-40 57.9 32.85 22.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.217 -0.901 . . . . 2.83 111.641 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -144.97 165.99 26.59 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.769 -0.65 . . . . 1.75 109.702 174.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.493 ' H ' HG13 ' A' ' 114' ' ' VAL . 48.7 mm -100.23 133.11 44.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.04 0.448 . . . . 1.01 111.668 -173.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -132.31 156.89 45.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.226 -0.897 . . . . 3.94 109.164 172.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 11.1 m-85 -100.31 119.3 38.2 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.43 -0.508 . . . . 0.92 109.776 173.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -98.17 118.01 33.84 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.462 -0.94 . . . . 1.11 108.462 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.533 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 1.8 t -89.32 151.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-O 121.493 0.663 . . . . 0.7 109.784 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.449 HG13 ' HA ' ' A' ' 182' ' ' ASN . 1.3 mm -97.0 -53.66 7.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 114.656 -1.156 . . . . 0.62 111.553 -163.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.551 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -135.76 174.27 10.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.484 -0.78 . . . . 1.38 111.491 -174.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' A' ' 104' ' ' MET . 3.0 m-20 -50.49 119.65 3.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.368 -0.833 . . . . 2.23 112.268 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.744 HD11 ' ND2' ' A' ' 182' ' ' ASN . 17.3 mm -86.99 135.81 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.985 -0.552 . . . . 0.88 110.627 177.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 20.1 mm-40 -101.65 134.64 20.09 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.656 -0.702 . . . . 2.06 109.481 174.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 73.5 Cg_exo -51.1 113.5 1.13 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.802 2.335 . . . . 0.51 112.953 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.31 -10.21 9.34 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.68 -0.771 . . . . 0.7 113.537 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.7 pt-20 -107.55 127.37 53.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.709 0.754 . . . . 1.27 111.541 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.564 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -109.4 93.59 4.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.471 -0.786 . . . . 2.92 111.616 177.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.616 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.6 mm? -124.56 95.82 4.67 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.57 -0.852 . . . . 0.9 110.885 175.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.532 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.8 mm? -148.07 111.7 5.03 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.263 -0.643 . . . . 0.53 109.263 170.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.654 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.7 p -157.05 160.8 2.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 117.892 0.314 . . . . 0.91 110.437 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -109.93 110.9 22.0 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.574 -0.528 . . . . 1.55 109.574 168.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 96.5 t -120.18 99.59 7.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 2.56 110.216 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -140.41 131.12 25.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.952 -0.567 . . . . 5.36 109.569 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -81.04 74.4 8.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.424 0.63 . . . . 5.8 110.475 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.405 ' HA2' HD13 ' A' ' 217' ' ' LEU . . . 151.31 63.08 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.533 -0.758 . . . . 5.61 111.882 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 21.3 t -98.05 -71.55 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.604 0.24 . . . . 6.31 110.524 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.513 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 88.4 t80 -73.65 -50.97 5.58 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.454 -0.339 . . . . 8.83 111.75 177.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 18.6 Cg_endo -59.67 -41.88 51.85 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.073 1.849 . . . . 7.78 112.517 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.434 ' O ' HG22 ' A' ' 220' ' ' VAL . 7.7 mp -101.75 -94.17 0.29 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.295 -0.411 . . . . 8.02 110.62 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 53.11 -115.29 4.43 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.379 -0.439 . . . . 8.64 112.442 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.5 32.36 2.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.947 0.403 . . . . 9.72 110.76 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 221' ' ' PRO . 27.7 m -73.66 138.47 77.2 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 116.161 -0.472 . . . . 9.62 110.766 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 20.8 Cg_exo -65.38 130.79 26.19 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.751 2.3 . . . . 11.65 112.3 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.47 58.9 6.5 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.948 2.432 . . . . 13.11 112.384 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -152.56 151.14 23.02 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 111.382 -0.687 . . . . 14.03 111.382 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 45.1 tp -141.03 126.21 18.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.331 -0.248 . . . . 16.1 110.331 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -119.69 -53.93 2.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.16 0.505 . . . . 17.7 110.363 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.597 -0.729 . . . . 18.9 109.716 -176.784 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 N-CA-C 111.673 -0.571 . . . . 33.26 111.673 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.5 t -71.44 -30.54 66.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.301 0.572 . . . . 33.92 110.03 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . -92.55 162.76 26.95 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.689 -0.767 . . . . 32.35 111.269 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -107.8 99.86 32.25 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 110.118 -0.327 . . . . 31.65 110.118 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 53' ' ' GLY . 23.5 Cg_exo -64.64 112.63 2.02 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.883 2.389 . . . . 29.99 112.245 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 p -91.57 141.49 28.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.988 -0.551 . . . . 28.92 110.442 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.407 ' HA ' ' OG1' ' A' ' 61' ' ' THR . 34.0 m 58.62 54.66 5.23 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.248 0.547 . . . . 26.94 110.298 -177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 58' ' ' GLU . 1.5 mp0 -53.39 101.25 0.04 OUTLIER 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.822 -1.081 . . . . 25.83 111.494 -176.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 52.11 47.29 25.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.826 -0.625 . . . . 23.53 111.146 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 40.3 t80 62.02 62.59 1.2 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.825 -0.625 . . . . 21.64 110.118 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.61 ' OG1' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -61.43 -52.14 72.42 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.933 -0.576 . . . . 19.42 112.048 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.61 ' HD3' ' OG1' ' A' ' 61' ' ' THR . 11.5 Cg_exo -71.23 103.42 1.39 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.903 1.736 . . . . 17.17 110.696 174.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -76.71 75.55 3.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.71 -0.677 . . . . 17.47 110.676 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -61.35 134.45 56.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.639 -0.71 . . . . 15.63 110.077 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.74 146.39 16.28 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.798 -0.715 . . . . 12.04 111.621 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.9 t -120.43 130.57 24.79 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 110.328 -0.249 . . . . 10.67 110.328 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.47 149.39 74.61 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.877 2.385 . . . . 9.69 112.402 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -68.23 129.03 38.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.906 -0.588 . . . . 7.7 110.396 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -103.19 145.6 29.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.07 0.462 . . . . 8.14 110.338 178.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.9 136.2 82.68 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.579 -0.737 . . . . 5.96 110.85 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.23 -159.42 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.964 2.442 . . . . 6.13 111.81 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.76 -36.75 50.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.718 0.294 . . . . 6.53 111.013 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -102.9 131.41 49.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.826 -0.435 . . . . 5.01 109.826 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.525 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.6 pp -78.57 141.07 60.14 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.051 -0.522 . . . . 4.23 111.904 -177.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -88.58 13.23 2.58 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 123.097 2.531 . . . . 4.12 113.067 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -85.32 -67.85 0.77 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.833 -0.432 . . . . 3.82 109.833 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.4 t70 57.25 67.14 1.02 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.93 0.871 . . . . 3.16 110.602 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 66.7 mt -105.91 108.65 62.05 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 114.88 -1.054 . . . . 2.45 109.459 178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.14 119.67 6.95 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.809 2.34 . . . . 1.75 112.256 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.545 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -126.86 144.03 48.73 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.913 -0.585 . . . . 1.01 109.723 178.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.87 144.76 87.18 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.579 2.186 . . . . 0.73 111.453 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.34 -12.27 8.77 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.798 0.666 . . . . 1.04 112.798 -173.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -80.96 -11.27 59.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.925 0.393 . . . . 1.66 110.911 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -133.92 165.1 25.8 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.911 -0.774 . . . . 1.0 108.911 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.444 ' HA ' HG13 ' A' ' 80' ' ' ILE . 10.1 pt-20 -155.84 147.01 22.46 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.914 0.388 . . . . 2.27 110.671 173.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.456 HD11 ' CZ ' ' A' ' 171' ' ' TYR . 7.0 tt -92.26 132.33 36.77 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.864 -0.607 . . . . 0.79 110.43 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.405 ' N ' HD23 ' A' ' 86' ' ' LEU . 76.1 mtt180 -144.27 138.88 28.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.403 -0.817 . . . . 3.21 109.841 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -82.04 112.91 19.55 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.348 -0.612 . . . . 2.46 109.348 174.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.3 p -169.03 90.11 0.22 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.678 -0.692 . . . . 1.58 109.749 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.1 p -69.95 105.43 2.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.243 0.544 . . . . 1.86 110.744 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.633 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -85.17 123.78 72.92 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.928 -0.767 . . . . 1.45 108.928 175.265 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.08 120.27 7.68 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.287 2.658 . . . . 1.61 112.735 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.6 -11.25 53.72 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.597 -0.811 . . . . 1.74 112.181 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.633 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -134.11 -63.07 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.711 -0.288 . . . . 1.41 111.609 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.03 -145.83 17.29 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.786 -0.721 . . . . 1.09 113.106 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 96' ' ' LEU . 0.6 OUTLIER -72.56 158.68 35.23 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.4 0.28 . . . . 2.31 110.83 177.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.09 175.97 43.33 Favored Glycine 0 C--O 1.237 0.308 0 C-N-CA 120.346 -0.931 . . . . 0.59 112.421 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 98' ' ' VAL . 35.3 m -111.22 114.27 46.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.634 0.73 . . . . 0.67 109.263 174.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -80.73 100.77 8.9 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.476 0.655 . . . . 1.13 110.996 -169.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.08 120.95 13.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.732 -1.122 . . . . 0.54 110.751 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.634 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -101.64 13.79 33.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.513 0.673 . . . . 1.68 109.447 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -125.83 155.94 40.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.961 -1.018 . . . . 3.5 109.16 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.483 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -83.3 116.27 22.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.211 0.529 . . . . 2.4 111.244 174.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.595 ' HE1' HG21 ' A' ' 200' ' ' ILE . 4.8 mpp? -86.92 130.96 34.24 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.573 -0.899 . . . . 1.22 108.573 172.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.65 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 8.4 pt-20 -116.32 174.45 6.05 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.902 0.382 . . . . 2.31 111.914 -173.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.93 126.46 18.3 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.645 -0.707 . . . . 0.84 112.899 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.58 -17.19 59.71 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.779 -0.646 . . . . 1.04 114.202 168.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 7.3 pt-20 -76.28 160.09 29.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.607 0.704 . . . . 2.62 111.799 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.794 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 6.6 ttt180 -116.42 142.09 47.31 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.418 -0.81 . . . . 3.62 110.667 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.7 mt -92.47 136.21 33.4 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.952 -0.758 . . . . 0.53 108.952 170.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 149.88 -147.79 18.41 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.374 -0.917 . . . . 1.02 112.649 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 75.4 Cg_endo -75.34 135.01 38.43 Favored 'Cis proline' 0 CA--C 1.532 0.376 0 C-N-CA 123.064 -1.64 . . . . 2.1 112.516 3.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.434 ' SG ' ' HA3' ' A' ' 166' ' ' GLY . 42.5 t -74.7 -67.46 0.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.466 -0.788 . . . . 2.0 109.789 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 191' ' ' GLN . 16.5 m -130.36 144.11 38.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.753 -0.658 . . . . 2.03 109.344 176.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.3 m -92.62 -161.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.076 -0.511 . . . . 3.95 110.325 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 26.4 m -39.96 129.84 1.57 Allowed Pre-proline 0 C--O 1.236 0.394 0 O-C-N 123.776 0.672 . . . . 5.21 111.936 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.22 92.47 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.411 2.741 . . . . 5.07 113.245 -173.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -122.84 -40.18 2.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.773 -0.649 . . . . 7.99 110.316 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -153.42 76.37 1.09 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.15 -0.477 . . . . 6.95 110.915 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.02 142.32 27.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.137 -0.483 . . . . 6.09 109.795 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -129.84 134.5 47.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.013 0.435 . . . . 5.56 111.526 -176.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -94.11 146.61 23.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.584 -0.735 . . . . 7.42 109.791 175.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -126.81 -82.99 0.62 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.234 -0.439 . . . . 9.01 110.031 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.8 m -126.46 -57.18 1.38 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.552 -0.536 . . . . 8.88 109.552 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.66 137.01 49.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.605 -0.725 . . . . 7.6 109.419 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -132.71 134.05 44.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.078 0.466 . . . . 7.23 111.283 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -98.7 9.11 62.08 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.677 -0.692 . . . . 4.59 111.817 177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . 0.437 ' HA ' ' HE3' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -158.82 -99.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.538 -0.331 . . . . 4.93 111.391 177.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -152.62 -53.2 0.11 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.004 0.43 . . . . 7.65 110.523 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -166.97 174.1 8.71 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.632 -0.507 . . . . 8.84 109.632 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.446 HD13 ' N ' ' A' ' 131' ' ' ILE . 0.1 OUTLIER -131.19 51.64 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.128 0.489 . . . . 6.05 111.32 -176.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.6 mp -87.66 58.25 4.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.95 0.881 . . . . 8.5 109.816 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.8 p -136.34 35.49 2.74 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.469 -1.242 . . . . 9.82 110.452 -175.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -59.4 127.63 33.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.799 -0.637 . . . . 11.21 110.209 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.31 134.63 21.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.524 -0.762 . . . . 10.84 111.293 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -125.9 -5.74 6.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.746 -0.661 . . . . 13.25 110.663 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.2 m -94.08 8.93 5.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.19 -0.459 . . . . 13.89 112.182 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.8 p -151.83 74.04 7.86 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 120.676 0.274 . . . . 14.05 110.975 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.76 72.82 3.71 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.79 2.326 . . . . 14.41 111.798 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -127.63 21.72 6.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.105 -0.952 . . . . 14.44 110.285 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -66.42 121.15 14.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 15.9 109.882 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 117.06 -17.42 12.79 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.795 -0.922 . . . . 15.6 110.795 -171.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 64.6 m -131.07 35.28 3.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.602 0.715 . . . . 15.6 110.168 176.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.9 mt -101.88 -52.13 8.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.309 -0.859 . . . . 13.85 109.281 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.9 p -83.31 39.54 0.66 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.564 -0.744 . . . . 13.19 110.51 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -83.43 -16.97 43.77 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.597 -0.729 . . . . 15.67 109.733 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 147' ' ' ILE . 1.9 pp -89.07 166.21 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.025 -0.989 . . . . 13.77 110.928 -178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.2 t -133.11 89.07 2.57 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.007 -0.542 . . . . 13.62 109.765 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -82.85 148.74 27.56 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.004 -0.544 . . . . 13.02 109.737 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -88.69 99.86 12.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.118 0.485 . . . . 14.68 110.489 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 76.3 mt -103.2 42.29 1.18 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.844 -0.616 . . . . 13.55 110.072 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -85.45 18.45 29.0 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.118 -0.563 . . . . 15.8 112.47 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.471 ' CB ' ' HA ' ' A' ' 158' ' ' VAL . 70.4 m 65.65 28.08 11.26 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.344 0.498 . . . . 17.08 112.344 175.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.37 -79.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 18.43 110.057 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -128.49 23.16 5.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.435 0.636 . . . . 18.53 110.638 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 157' ' ' CYS . 54.1 m-85 -115.43 29.28 8.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.305 -0.861 . . . . 14.32 109.83 176.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 156' ' ' PHE . 75.7 m 72.81 136.08 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 O-C-N 124.115 0.884 . . . . 14.51 111.399 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.471 ' HA ' ' CB ' ' A' ' 153' ' ' SER . 23.5 t -74.78 126.78 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.551 -0.75 . . . . 13.06 109.214 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 59.88 65.85 1.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.229 0.538 . . . . 10.33 109.651 -173.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.493 ' C ' HD22 ' A' ' 161' ' ' ASN . . . -72.7 -56.01 5.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.467 -0.788 . . . . 9.88 111.941 -175.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.493 HD22 ' C ' ' A' ' 160' ' ' ALA . 0.9 OUTLIER -118.53 52.39 1.04 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.966 0.412 . . . . 10.23 110.439 -177.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -112.64 -18.08 12.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.125 -0.489 . . . . 9.06 110.978 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -124.04 33.2 5.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.101 -0.499 . . . . 6.19 110.714 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -77.41 68.36 2.7 Favored Glycine 0 C--N 1.329 0.151 0 CA-C-N 115.711 -0.677 . . . . 3.97 112.355 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -160.49 -38.81 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.017 0.437 . . . . 2.63 110.893 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.434 ' HA3' ' SG ' ' A' ' 113' ' ' CYS . . . 101.26 20.34 13.99 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.845 -0.693 . . . . 1.3 111.706 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.3 m -54.13 -35.08 61.8 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.953 0.501 . . . . 1.82 112.226 -176.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 45.1 p-90 -84.44 -17.6 38.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.886 0.374 . . . . 0.7 111.299 -177.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 28.8 mt -86.11 -14.6 43.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.472 -0.331 . . . . 0.66 111.768 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -10.43 59.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.351 0.596 . . . . 1.48 109.541 175.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.456 ' CZ ' HD11 ' A' ' 86' ' ' LEU . 43.7 m-85 -79.52 -30.21 41.77 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.274 -0.875 . . . . 1.97 111.872 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.539 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 1.3 mm -56.03 129.64 17.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 120.858 0.361 . . . . 0.67 110.521 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -93.94 143.59 26.21 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.501 0.667 . . . . 4.34 111.819 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.53 ' HA ' ' CD2' ' A' ' 183' ' ' LEU . 10.1 p -77.77 153.76 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.209 -0.905 . . . . 1.07 109.174 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.485 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -48.04 111.59 0.46 Allowed 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.654 0.597 . . . . 0.71 112.176 -172.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 51.6 t -66.09 -33.63 76.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.277 -0.874 . . . . 1.88 109.771 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.467 ' HB3' ' OD1' ' A' ' 180' ' ' ASP . 11.9 t -131.08 152.28 50.54 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.907 -0.775 . . . . 1.63 108.907 176.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 61.8 m -71.92 -6.09 39.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.472 -0.331 . . . . 1.96 111.545 -175.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -89.89 1.38 56.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.77 0.319 . . . . 2.42 110.868 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 177' ' ' SER . 29.3 m-20 -110.14 15.27 22.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.378 -0.374 . . . . 2.12 111.093 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 15.0 mm100 -63.63 115.51 4.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.253 0.549 . . . . 1.35 111.946 -173.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.816 ' H ' HD12 ' A' ' 183' ' ' LEU . 22.7 t30 -161.39 31.58 0.13 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.093 0.949 . . . . 1.68 108.779 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.816 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.5 OUTLIER -119.28 122.52 42.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.722 -0.672 . . . . 0.81 111.184 -171.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 60.9 m -150.13 136.01 18.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.983 0.421 . . . . 0.51 110.421 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.471 ' HB3' ' HB2' ' A' ' 209' ' ' HIS . 49.9 ttm -125.62 135.49 52.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.208 -0.451 . . . . 1.35 109.852 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 18.6 t -115.11 152.51 32.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.221 -0.445 . . . . 1.73 109.836 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.73 104.86 11.78 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.011 -0.737 . . . . 1.93 109.011 178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 33.2 pt -135.49 144.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.978 -0.556 . . . . 1.11 110.541 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.8 m 57.46 30.11 18.11 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.459 0.474 . . . . 1.86 111.558 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 64.3 17.36 10.69 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.493 -0.776 . . . . 2.83 111.301 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.417 ' HB2' HG23 ' A' ' 114' ' ' VAL . 4.0 pt20 -124.93 167.2 15.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.289 -0.414 . . . . 1.75 110.189 177.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.6 mm -90.73 130.07 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.069 -0.514 . . . . 1.01 110.861 -176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -121.76 122.95 40.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.271 -0.422 . . . . 3.94 110.535 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.794 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 13.7 m-85 -99.79 113.96 26.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.915 -0.772 . . . . 0.92 108.915 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -110.45 124.14 51.21 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.9 -0.32 . . . . 1.11 110.217 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.417 HG21 ' HB3' ' A' ' 104' ' ' MET . 1.7 t -93.42 151.85 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 122.059 0.933 . . . . 0.7 110.688 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.57 -56.43 5.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 113.734 -1.576 . . . . 0.62 112.009 -164.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.445 ' HE3' ' HB2' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -140.9 162.78 34.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.975 -1.012 . . . . 1.38 110.117 -176.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.4 m-20 -58.27 111.67 1.29 Allowed 'General case' 0 C--N 1.33 -0.262 0 O-C-N 123.85 0.719 . . . . 2.23 112.189 -173.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.595 HG21 ' HE1' ' A' ' 104' ' ' MET . 6.1 mm -68.85 145.82 13.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.255 -0.884 . . . . 0.88 110.9 175.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 14.2 mt-10 -92.63 117.64 67.67 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.278 -0.873 . . . . 2.06 108.697 172.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -43.31 122.19 2.86 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.614 2.876 . . . . 0.51 113.688 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.91 -3.22 10.81 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.822 -0.704 . . . . 0.7 113.127 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 11.3 pt-20 -137.37 125.56 23.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.247 0.546 . . . . 1.27 111.031 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.539 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -109.57 108.05 18.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.017 -0.538 . . . . 2.92 111.507 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.561 ' O ' HD22 ' A' ' 207' ' ' LEU . 1.4 mm? -123.24 97.9 5.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.064 -0.655 . . . . 0.9 109.944 173.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.561 HD22 ' O ' ' A' ' 206' ' ' LEU . 1.1 mm? -149.1 102.12 3.21 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.985 -0.746 . . . . 0.53 108.985 173.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.793 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 6.8 t -157.28 158.25 3.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.1 -0.704 . . . . 0.91 109.1 -178.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 185' ' ' MET . 19.4 t-80 -136.25 110.57 8.45 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.453 -0.943 . . . . 1.55 108.453 162.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 3.1 p -88.16 100.75 10.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.632 0.73 . . . . 2.56 109.812 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 128' ' ' TRP . 67.5 mttm -84.02 121.18 27.05 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.515 -0.766 . . . . 5.36 110.448 -177.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.56 -58.37 1.91 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.419 -0.809 . . . . 5.8 110.133 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -81.57 40.42 2.6 Favored Glycine 0 C--N 1.31 -0.9 0 CA-C-N 115.322 -0.854 . . . . 5.61 111.889 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.518 ' O ' ' HA3' ' A' ' 218' ' ' GLY . 34.9 t -132.96 -70.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.258 0.551 . . . . 6.31 110.145 -178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.457 ' HB3' ' HD3' ' A' ' 216' ' ' PRO . 88.2 t80 -97.14 -58.56 0.17 Allowed Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 115.555 -0.748 . . . . 8.83 112.144 -176.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 215' ' ' TYR . 43.4 Cg_endo -69.51 -47.81 0.92 Allowed 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.56 1.507 . . . . 7.78 112.608 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 217' ' ' LEU . 6.6 mp -92.63 16.26 12.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.333 0.587 . . . . 8.02 109.815 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 214' ' ' VAL . . . -112.7 154.87 16.64 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 115.646 -0.706 . . . . 8.64 111.776 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.9 p -93.17 47.21 1.25 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.187 0.518 . . . . 9.72 110.692 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.433 ' O ' ' HD3' ' A' ' 222' ' ' PRO . 29.2 m -61.63 140.86 95.1 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.582 -0.735 . . . . 9.62 110.723 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 8.1 Cg_exo -71.79 110.48 2.91 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.854 2.369 . . . . 11.65 112.261 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 220' ' ' VAL . 91.1 Cg_endo -92.65 1.11 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.021 2.481 . . . . 13.11 112.123 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 139.55 -160.13 25.96 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.213 -0.903 . . . . 14.03 111.126 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 24.2 tp 68.83 120.69 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.503 0.668 . . . . 16.1 112.282 177.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -103.66 -44.33 5.12 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.803 -0.635 . . . . 17.7 109.866 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 . . . . . 0 C--O 1.249 1.067 0 CA-C-N 115.364 -0.835 . . . . 18.9 109.298 179.115 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.785 -0.526 . . . . 33.26 111.785 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 45.5 m -67.43 158.41 31.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.808 0.337 . . . . 33.92 111.004 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.67 76.52 1.29 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.706 -0.759 . . . . 32.35 111.545 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -98.22 108.84 49.39 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.716 0.294 . . . . 31.65 110.763 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.39 102.77 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.716 2.278 . . . . 29.99 111.7 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.9 m -76.0 87.67 2.94 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.908 -0.404 . . . . 28.92 109.908 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.2 t -78.21 77.09 4.71 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.286 0.565 . . . . 26.94 109.841 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.29 66.39 1.54 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.843 -0.799 . . . . 25.83 108.843 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -143.09 133.53 24.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.162 -0.926 . . . . 23.53 110.119 -176.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -96.9 152.43 18.71 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.381 -0.372 . . . . 21.64 110.828 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.2 p -98.18 108.27 46.04 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.265 -0.425 . . . . 19.42 110.356 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -70.04 96.45 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.668 2.245 . . . . 17.17 112.937 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -86.06 51.27 2.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.135 -0.938 . . . . 17.47 110.192 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -124.06 36.72 4.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.653 -0.703 . . . . 15.63 110.578 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.06 34.25 75.86 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.629 -0.796 . . . . 12.04 111.327 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.1 t -105.61 134.76 19.55 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 109.887 -0.412 . . . . 10.67 109.887 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.59 87.77 1.23 Allowed 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.643 2.229 . . . . 9.69 112.144 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -104.49 107.25 18.09 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.41 -0.814 . . . . 7.7 110.46 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -92.89 104.79 16.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.453 -0.34 . . . . 8.14 110.128 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.77 144.19 87.96 Favored Pre-proline 0 N--CA 1.448 -0.54 0 CA-C-N 116.211 -0.45 . . . . 5.96 109.9 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -40.52 -70.86 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.697 2.931 . . . . 6.13 113.94 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.1 p -110.76 -31.17 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.068 -0.515 . . . . 6.53 111.608 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -73.2 106.91 5.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.215 0.531 . . . . 5.01 111.293 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.51 ' O ' HD12 ' A' ' 74' ' ' ILE . 1.9 pp -79.6 141.96 56.9 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.72 -0.673 . . . . 4.23 110.981 174.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.86 4.65 6.29 Favored 'Trans proline' 0 CA--C 1.528 0.21 0 C-N-CA 122.953 2.435 . . . . 4.12 113.009 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.429 ' HB2' HD13 ' A' ' 74' ' ' ILE . 10.0 mm-40 -64.45 -61.25 2.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.201 -0.454 . . . . 3.82 110.02 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.1 t70 62.91 78.99 0.27 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.025 -0.989 . . . . 3.16 110.773 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.6 mt -85.5 125.55 69.2 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.289 -0.868 . . . . 2.45 110.196 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.01 115.94 3.87 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.177 1.918 . . . . 1.75 112.238 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -131.77 146.57 62.39 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.64 -0.504 . . . . 1.01 109.64 178.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.38 137.81 81.58 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.801 2.334 . . . . 0.73 111.667 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.426 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -65.26 -12.17 48.83 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.654 0.612 . . . . 1.04 112.654 -173.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -84.9 -7.52 59.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.805 0.336 . . . . 1.66 111.473 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.507 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 17.9 m-85 -120.14 161.76 20.48 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.23 -1.026 . . . . 1.0 108.23 170.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.405 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 5.9 tp10 -133.51 120.19 20.5 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.749 -0.78 . . . . 2.27 111.435 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HA ' HG12 ' A' ' 98' ' ' VAL . 7.2 tt -84.28 126.67 33.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.999 -0.741 . . . . 0.79 108.999 177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -148.61 149.26 31.22 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.842 -0.617 . . . . 3.21 110.726 -173.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.32 111.99 18.89 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.653 -0.869 . . . . 2.46 108.653 172.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.2 m -149.13 81.51 1.43 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.082 -0.508 . . . . 1.58 109.809 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.4 m -65.48 104.63 1.02 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.121 -0.49 . . . . 1.86 110.875 -178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.583 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -106.02 117.63 57.08 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.128 -0.487 . . . . 1.45 109.791 177.032 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 91' ' ' ILE . 52.5 Cg_exo -54.58 122.57 11.81 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.16 2.573 . . . . 1.61 112.678 -176.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.97 -16.46 36.19 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.711 -0.677 . . . . 1.74 111.958 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.583 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -131.63 -59.78 0.95 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.931 0.396 . . . . 1.41 111.277 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.9 -127.85 7.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.954 -0.641 . . . . 1.09 112.198 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.446 HD13 ' CD1' ' A' ' 171' ' ' TYR . 0.6 OUTLIER -89.53 159.79 17.05 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.677 -0.12 . . . . 2.31 110.677 176.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -161.96 172.51 38.13 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.586 -0.605 . . . . 0.59 111.586 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 86' ' ' LEU . 5.9 m -115.72 130.76 69.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.586 0.708 . . . . 0.67 109.79 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -98.11 109.17 21.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.255 -0.43 . . . . 1.13 110.498 -174.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -64.52 116.29 6.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.54 109.758 176.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.545 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -79.06 -2.8 42.15 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.453 0.644 . . . . 1.68 110.439 -177.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 41.1 ttp180 -127.41 155.78 43.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.257 -0.883 . . . . 3.5 108.823 175.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.64 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -82.8 156.59 23.59 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.829 -0.434 . . . . 2.4 109.829 176.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.625 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -127.18 152.32 47.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.323 -0.399 . . . . 1.22 110.476 177.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 10.4 pt-20 -105.48 173.67 6.21 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.394 0.616 . . . . 2.31 111.975 -170.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.93 127.29 30.69 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.247 -0.888 . . . . 0.84 112.656 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.23 0.77 67.46 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.101 -0.571 . . . . 1.04 113.544 170.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 1.6 pt-20 -87.14 168.41 13.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.439 0.619 . . . . 2.62 111.09 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 3.8 tmm_? -127.52 133.03 49.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.93 -0.577 . . . . 3.62 112.094 -173.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.507 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 7.7 mt -86.63 142.07 28.51 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.77 -0.826 . . . . 0.53 108.77 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.64 -128.05 7.63 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.4 -0.905 . . . . 1.02 112.618 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.461 ' O ' ' HA3' ' A' ' 166' ' ' GLY . 57.2 Cg_endo -68.35 145.6 76.59 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.829 -1.321 . . . . 2.1 112.761 2.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t -73.5 -26.46 60.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.618 -0.719 . . . . 2.0 110.962 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.488 ' HB ' ' H ' ' A' ' 192' ' ' ILE . 70.9 t -138.15 131.01 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.113 -0.494 . . . . 2.03 110.336 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.5 t -65.78 133.96 30.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.891 -0.595 . . . . 3.95 109.616 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.1 t -56.71 113.64 6.39 Favored Pre-proline 0 C--N 1.33 -0.268 0 O-C-N 123.503 0.502 . . . . 5.21 111.675 -175.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.47 145.57 59.24 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.732 2.288 . . . . 5.07 111.237 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.41 ' HB2' ' OD1' ' A' ' 134' ' ' ASP . 6.1 mpt_? -71.69 -34.96 70.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.086 -0.506 . . . . 7.99 111.143 -174.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -162.02 75.66 0.47 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.195 -0.457 . . . . 6.95 110.649 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -99.43 159.43 15.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.356 -0.384 . . . . 6.09 111.561 -177.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.84 95.46 2.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.69 -0.686 . . . . 5.56 110.021 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -53.71 131.42 39.25 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.841 0.829 . . . . 7.42 111.899 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -72.83 -66.94 0.6 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.455 -1.248 . . . . 9.01 110.68 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.4 m -83.71 -76.96 0.27 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.731 -0.668 . . . . 8.88 110.53 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.5 t70 179.74 -56.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.681 -0.859 . . . . 7.6 108.681 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -153.23 159.47 42.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.26 -1.336 . . . . 7.23 107.775 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.45 40.02 94.28 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.461 -0.876 . . . . 4.59 112.094 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . 0.539 ' HE3' ' N ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -89.13 -95.41 0.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.63 0.252 . . . . 4.93 111.334 -178.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.539 ' N ' ' HE3' ' A' ' 128' ' ' TRP . 12.0 pt-20 -161.9 -45.75 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.955 -0.758 . . . . 7.65 108.955 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 130' ' ' GLN . 6.4 tp60 176.34 131.79 0.05 OUTLIER 'General case' 0 CA--C 1.523 -0.074 0 CA-C-N 115.36 -0.836 . . . . 8.84 109.022 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.701 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -109.67 -1.84 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.622 -0.431 . . . . 6.05 110.955 176.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.6 mp -81.78 62.58 5.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.744 0.783 . . . . 8.5 110.134 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 19.4 p -128.05 30.24 5.27 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.649 -1.159 . . . . 9.82 110.484 -176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 118' ' ' ARG . 3.3 p30 -73.27 127.76 33.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.817 -0.629 . . . . 11.21 111.231 -177.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.8 p -68.35 138.15 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.356 -0.838 . . . . 10.84 110.677 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -71.18 119.1 14.83 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.44 -0.8 . . . . 13.25 111.179 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.2 p -79.12 -22.78 12.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.854 0.835 . . . . 13.89 108.857 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.8 m -144.99 94.61 5.32 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.892 -1.049 . . . . 14.05 108.887 173.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -35.21 124.1 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.811 3.674 . . . . 14.41 114.738 -173.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -104.66 -6.29 20.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.139 -0.937 . . . . 14.44 109.095 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -46.22 121.58 3.42 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.1 -0.955 . . . . 15.9 111.162 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 135.89 -41.04 1.47 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.18 -0.768 . . . . 15.6 111.18 -174.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 23.7 p -101.12 31.06 3.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.461 0.648 . . . . 15.6 110.938 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 61.4 mt -112.26 -65.82 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.516 -0.766 . . . . 13.85 109.595 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.2 p -88.14 43.18 1.11 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.543 0.687 . . . . 13.19 110.318 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -77.73 -13.04 60.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.215 -0.902 . . . . 15.67 110.097 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.7 pp -110.13 161.81 8.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.981 -1.008 . . . . 13.77 110.64 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.8 t -104.91 55.3 0.7 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.685 0.755 . . . . 13.62 110.459 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -93.4 59.18 2.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.592 -0.892 . . . . 13.02 108.592 172.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -88.39 80.95 7.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.516 -1.22 . . . . 14.68 110.578 -172.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -91.9 10.1 30.21 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.465 -0.789 . . . . 13.55 111.714 -178.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.501 ' HA2' ' CD1' ' A' ' 156' ' ' PHE . . . -97.58 12.79 64.58 Favored Glycine 0 C--N 1.317 -0.483 0 C-N-CA 120.78 -0.724 . . . . 15.8 112.771 -175.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.7 m -88.46 -39.09 14.49 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.901 0.381 . . . . 17.08 110.703 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -110.58 -78.79 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 18.43 111.372 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -137.95 133.84 34.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.895 0.379 . . . . 18.53 110.252 -177.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.501 ' CD1' ' HA2' ' A' ' 152' ' ' GLY . 38.8 p90 -151.06 167.6 27.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.144 0.497 . . . . 14.32 111.302 -176.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 34.5 m -133.47 122.32 23.49 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.621 -0.881 . . . . 14.51 108.621 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 32.9 t -69.85 129.37 34.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.274 -0.269 . . . . 13.06 110.274 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 60.55 54.05 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.563 0.697 . . . . 10.33 110.997 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -119.56 -60.96 1.67 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.146 -0.933 . . . . 9.88 109.995 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -81.44 -27.96 34.42 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.221 0.534 . . . . 10.23 109.655 176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -71.86 -21.4 61.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.402 -0.817 . . . . 9.06 109.616 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.459 ' C ' ' HB2' ' A' ' 167' ' ' SER . . . -90.53 61.45 4.92 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.439 -0.801 . . . . 6.19 110.269 176.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -126.67 -61.8 0.15 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.812 -0.709 . . . . 3.97 111.75 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.28 101.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.12 0.486 . . . . 2.63 110.716 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 112' ' ' PRO . . . 90.69 -37.55 3.36 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.756 -0.656 . . . . 1.3 112.354 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.459 ' HB2' ' C ' ' A' ' 163' ' ' ALA . 15.8 m -69.26 -14.54 63.01 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.885 0.328 . . . . 1.82 111.885 -177.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.423 ' O ' ' HD2' ' A' ' 171' ' ' TYR . 64.9 p-90 -56.46 -17.27 7.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.159 0.504 . . . . 0.7 111.307 176.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.502 HD13 ' CD1' ' A' ' 194' ' ' TYR . 24.8 mt -64.49 -12.79 47.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.309 -0.405 . . . . 0.66 111.876 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -11.84 26.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.76 0.314 . . . . 1.48 110.754 175.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.446 ' CD1' HD13 ' A' ' 96' ' ' LEU . 36.8 m-85 -77.95 -36.96 48.59 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.27 -0.423 . . . . 1.97 111.312 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.811 HG21 ' HB2' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -59.58 137.01 22.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 120.827 -0.349 . . . . 0.67 110.483 -174.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.484 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 41.7 mmt-85 -112.18 -177.52 3.19 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.851 0.686 . . . . 4.34 112.851 -175.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.464 HG22 HG21 ' A' ' 208' ' ' VAL . 41.5 t -76.56 158.87 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 114.954 -1.021 . . . . 1.07 110.488 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.533 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -55.52 113.73 1.56 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.241 -0.436 . . . . 0.71 111.816 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 28.1 t -72.05 -20.64 61.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 1.88 109.622 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.3 t -126.02 139.74 53.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.686 -0.688 . . . . 1.63 109.318 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 59.7 m -75.54 -33.41 60.68 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.107 0.78 . . . . 1.96 113.107 -168.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -88.33 -13.29 41.1 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.351 0.596 . . . . 2.42 110.58 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -82.57 19.29 1.31 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.529 -0.76 . . . . 2.12 112.033 -176.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.59 ' HA ' HE21 ' A' ' 181' ' ' GLN . 0.0 OUTLIER -53.42 113.85 1.3 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.022 0.439 . . . . 1.35 110.759 -176.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.691 ' H ' HD12 ' A' ' 183' ' ' LEU . 32.3 t30 -140.21 23.62 2.36 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 122.325 1.059 . . . . 1.68 108.94 174.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.691 HD12 ' H ' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -109.17 117.39 34.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.598 -0.728 . . . . 0.81 110.36 -172.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.1 m -149.1 135.07 18.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.056 0.455 . . . . 0.51 110.528 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.454 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 72.6 mtp -128.74 137.07 51.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.139 -0.482 . . . . 1.35 110.072 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 16.3 t -114.41 158.12 21.97 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.848 -0.614 . . . . 1.73 109.496 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.537 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 22.7 tm0? -122.88 105.19 9.79 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.134 -0.691 . . . . 1.93 109.134 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.632 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 34.9 pt -133.13 140.58 46.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.975 -0.557 . . . . 1.11 110.524 -175.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.1 m 53.78 26.24 5.84 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.394 0.434 . . . . 1.86 111.963 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.537 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 6.3 mm-40 63.4 25.41 14.56 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.595 -0.73 . . . . 2.83 112.049 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.1 pt20 -117.28 157.65 25.7 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.128 -0.693 . . . . 1.75 109.128 172.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.488 ' H ' ' HB ' ' A' ' 114' ' ' VAL . 49.5 mm -89.13 121.93 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.16 0.505 . . . . 1.01 110.564 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.63 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 45.5 t80 -114.57 121.27 42.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.365 -0.834 . . . . 3.94 110.377 -172.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.693 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 11.4 m-85 -99.65 112.81 25.0 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.374 -0.602 . . . . 0.92 109.374 177.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -116.0 122.93 46.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.844 0.354 . . . . 1.11 110.906 -173.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.574 HG11 ' SD ' ' A' ' 104' ' ' MET . 0.2 OUTLIER -90.46 149.84 3.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.438 0.637 . . . . 0.7 109.879 178.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 182' ' ' ASN . 1.3 mt -103.06 -30.11 2.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.165 -0.925 . . . . 0.62 112.009 -168.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 27.5 pttt -151.59 -179.91 7.82 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.137 -0.483 . . . . 1.38 111.736 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.625 ' HA ' ' O ' ' A' ' 104' ' ' MET . 17.2 t70 -82.65 131.24 35.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.32 -0.854 . . . . 2.23 110.508 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.614 HG13 ' ND2' ' A' ' 182' ' ' ASN . 43.9 mm -121.97 154.63 26.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.192 -0.458 . . . . 0.88 111.15 -173.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 48.9 mt-10 -78.62 120.97 82.95 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.851 -0.613 . . . . 2.06 109.85 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.3 123.7 12.56 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.025 2.483 . . . . 0.51 112.419 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.62 -1.67 10.23 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.636 -0.792 . . . . 0.7 113.097 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 10.5 pt-20 -136.27 123.95 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.147 0.499 . . . . 1.27 110.649 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.535 ' OE1' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -108.83 116.09 31.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.889 -0.596 . . . . 2.92 111.415 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.504 ' C ' HD22 ' A' ' 207' ' ' LEU . 4.7 mp -126.22 99.56 5.93 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.365 -0.534 . . . . 0.9 110.297 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.811 ' HB2' HG21 ' A' ' 172' ' ' ILE . 2.4 mm? -147.76 112.59 5.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.654 0.782 . . . . 0.53 109.58 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.664 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 7.8 p -155.99 158.01 3.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.621 -0.432 . . . . 0.91 111.199 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.454 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 27.9 t-80 -114.24 110.1 19.42 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.825 -0.806 . . . . 1.55 108.825 170.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 45.0 t -104.22 96.65 4.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.842 -0.429 . . . . 2.56 109.842 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -65.95 150.06 49.23 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.32 -0.4 . . . . 5.36 109.986 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -61.22 82.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 O-C-N 124.063 0.852 . . . . 5.8 112.49 -172.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.83 33.28 86.52 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 114.984 -1.007 . . . . 5.61 113.128 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 53.6 t -93.75 -83.06 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.949 -0.3 . . . . 6.31 110.899 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.563 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 71.5 m-85 -83.59 -50.12 0.68 Allowed Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 112.266 0.469 . . . . 8.83 112.266 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 18.2 Cg_endo -59.01 -44.6 33.82 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.062 1.841 . . . . 7.78 112.893 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.0 mp -92.16 -30.36 15.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.838 0.351 . . . . 8.02 111.357 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 74.48 24.95 71.55 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.174 -0.536 . . . . 8.64 112.878 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 8.6 p -97.02 55.0 1.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.057 0.456 . . . . 9.72 111.158 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 220' ' ' VAL . 22.4 m -120.45 107.76 38.54 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.892 -0.594 . . . . 9.62 111.374 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.03 116.59 4.77 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.4 2.067 . . . . 11.65 112.047 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.06 66.84 7.81 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.981 2.454 . . . . 13.11 112.422 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.26 46.49 5.83 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.628 -0.796 . . . . 14.03 111.622 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 32.9 tp -145.12 120.83 10.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.962 0.41 . . . . 16.1 110.242 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -136.83 -38.08 0.65 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.997 -0.547 . . . . 17.7 110.045 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.25 1.102 0 CA-C-N 115.627 -0.715 . . . . 18.9 110.491 -178.689 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.759 0 N-CA-C 111.658 -0.577 . . . . 33.26 111.658 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.3 p -94.87 -38.71 10.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.92 0.39 . . . . 33.92 110.541 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.66 141.02 15.35 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 121.023 -0.608 . . . . 32.35 112.066 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 52.49 67.86 3.59 Favored Pre-proline 0 C--O 1.233 0.231 0 C-N-CA 122.672 0.389 . . . . 31.65 110.91 -178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.61 -151.05 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.07 2.513 . . . . 29.99 112.406 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.0 m -60.98 -40.63 94.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.056 0.455 . . . . 28.92 111.255 -178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.7 m -126.09 104.34 8.2 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.149 -0.478 . . . . 26.94 110.411 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -127.65 152.38 47.75 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.804 -0.443 . . . . 25.83 109.804 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -160.9 175.09 12.91 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.078 -0.342 . . . . 23.53 110.078 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -144.51 49.08 1.33 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.957 0.884 . . . . 21.64 108.633 172.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.9 p -64.73 134.02 95.9 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.641 -1.163 . . . . 19.42 110.5 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -60.84 101.82 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.719 2.279 . . . . 17.17 112.664 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -88.66 -13.46 39.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.547 -0.751 . . . . 17.47 109.703 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.05 129.73 40.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.282 -0.872 . . . . 15.63 109.747 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 68' ' ' TYR . . . 89.33 -12.4 66.72 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.498 -0.858 . . . . 12.04 112.087 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.481 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 48.0 t -66.97 -53.29 26.87 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 110.071 -0.344 . . . . 10.67 110.071 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 66' ' ' SER . 96.3 Cg_endo -80.66 68.18 8.4 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.419 1.413 . . . . 9.69 110.036 167.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 65' ' ' GLY . 72.6 t80 -73.86 130.56 40.15 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.312 -1.313 . . . . 7.7 110.502 -173.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.15 84.19 1.02 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.224 0.535 . . . . 8.14 109.746 176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 73' ' ' TYR . . . -84.18 140.17 39.48 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.407 -0.815 . . . . 5.96 110.51 -178.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -46.63 -75.55 0.03 OUTLIER 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.399 2.732 . . . . 6.13 113.708 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.3 p -83.9 -31.91 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.294 -0.412 . . . . 6.53 111.568 -176.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.479 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 81.7 t80 -72.73 119.66 17.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.071 0.462 . . . . 5.01 110.66 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.493 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.2 pp -81.11 147.34 60.89 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.808 -0.633 . . . . 4.23 111.166 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -86.75 27.64 0.57 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.088 2.525 . . . . 4.12 112.975 -177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -96.84 -71.9 0.66 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.558 -0.534 . . . . 3.82 109.558 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.2 t70 49.36 70.63 0.46 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.154 -0.93 . . . . 3.16 111.444 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 67.7 mt -76.04 129.01 81.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.574 -0.739 . . . . 2.45 110.102 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.03 122.5 11.49 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.851 2.368 . . . . 1.75 112.722 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.537 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -127.38 149.3 69.5 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.843 -0.617 . . . . 1.01 109.758 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -60.74 143.14 99.35 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.635 2.223 . . . . 0.73 111.857 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.57 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -68.25 -5.19 17.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.34 0.496 . . . . 1.04 112.34 -173.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -87.56 -4.48 58.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.896 0.379 . . . . 1.66 110.928 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.509 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 11.7 m-85 -138.38 147.96 43.98 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 -176.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.45 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 12.2 tp10 -118.36 122.72 43.54 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 121.048 -0.261 . . . . 2.27 110.642 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.9 tt -87.43 124.16 33.13 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.388 0.613 . . . . 0.79 109.578 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 90.3 mtt-85 -143.39 127.05 17.03 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.13 -0.941 . . . . 3.21 109.689 -175.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -69.01 110.73 4.6 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.344 -0.613 . . . . 2.46 109.344 177.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.8 m -157.8 115.47 3.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.266 -0.642 . . . . 1.58 109.266 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.2 m -89.84 105.35 17.74 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.766 0.317 . . . . 1.86 110.97 -177.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -91.62 118.59 68.43 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.818 -0.808 . . . . 1.45 108.818 173.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.99 121.36 9.75 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.098 2.532 . . . . 1.61 112.553 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.65 -23.36 24.37 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.722 -0.672 . . . . 1.74 112.369 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.539 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -122.63 -63.0 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.962 0.381 . . . . 1.41 111.082 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.441 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 127.76 -134.12 8.11 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.962 -0.637 . . . . 1.09 111.952 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.9 mt -89.18 159.48 17.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.398 -0.223 . . . . 2.31 110.398 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -157.68 164.96 33.36 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.702 -0.761 . . . . 0.59 111.944 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 33.8 m -101.25 117.18 46.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.766 0.793 . . . . 0.67 110.071 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.508 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 27.1 m95 -82.73 110.01 17.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.355 -0.839 . . . . 1.13 110.623 -171.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -62.22 115.2 3.94 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.882 -0.414 . . . . 0.54 109.882 176.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -81.8 -6.07 58.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.405 0.621 . . . . 1.68 109.849 178.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -129.61 160.75 32.32 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.033 -0.985 . . . . 3.5 108.688 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.578 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -92.79 158.48 15.86 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 120.87 0.367 . . . . 2.4 110.475 -178.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.594 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 55.0 mtm -131.89 153.02 50.66 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.167 -0.679 . . . . 1.22 109.167 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -105.64 137.57 43.28 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.353 0.408 . . . . 2.31 110.855 -176.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -38.25 115.18 0.42 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 124.679 1.237 . . . . 0.84 112.959 -173.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.67 6.96 14.07 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.379 -0.828 . . . . 1.04 111.034 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.493 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -73.6 165.68 24.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.196 0.522 . . . . 2.62 110.761 -178.275 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 3.9 tmm_? -145.68 134.7 22.64 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.923 -0.58 . . . . 3.62 110.959 -175.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.509 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 8.1 mt -98.05 135.01 40.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.942 -0.762 . . . . 0.53 108.942 174.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.79 167.29 38.48 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.423 -0.894 . . . . 1.02 112.21 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.43 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 6.2 Cg_exo -79.15 155.78 91.0 Favored 'Cis proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.307 -1.539 . . . . 2.1 112.0 -2.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.9 t -110.43 4.47 20.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.501 0.667 . . . . 2.0 109.846 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.5 m -83.18 157.24 3.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.471 -0.786 . . . . 2.03 110.695 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.2 87.91 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.478 0.656 . . . . 3.95 110.72 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.468 ' HB ' ' HD3' ' A' ' 117' ' ' PRO . 20.9 t -60.59 -51.61 78.59 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.701 -0.681 . . . . 5.21 111.752 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.468 ' HD3' ' HB ' ' A' ' 116' ' ' VAL . 66.0 Cg_endo -73.52 75.18 3.05 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.837 1.691 . . . . 5.07 111.66 174.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.468 HH21 ' HG2' ' A' ' 136' ' ' GLU . 76.5 mtm-85 -66.06 -36.48 83.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.83 -0.623 . . . . 7.99 110.294 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 48.75 76.66 0.11 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 124.12 0.887 . . . . 6.95 111.438 175.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 67.0 104.38 0.04 OUTLIER 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.628 -0.714 . . . . 6.09 110.637 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -52.11 126.08 17.54 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.528 -0.76 . . . . 5.56 111.148 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.485 ' HG2' HD11 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -70.06 167.14 18.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.675 -0.693 . . . . 7.42 111.107 -177.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -50.4 -55.31 16.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.527 -0.76 . . . . 9.01 111.752 -175.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.2 m -128.93 -89.2 0.51 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.229 -0.286 . . . . 8.88 110.229 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 39.0 t0 -177.29 157.81 1.38 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.066 0.46 . . . . 7.6 110.561 176.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -123.81 -7.95 7.87 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.419 -0.809 . . . . 7.23 109.125 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -87.99 -68.63 1.29 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.208 -0.905 . . . . 4.59 112.876 -174.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . 0.621 ' CE3' ' HG2' ' A' ' 129' ' ' GLU . 6.5 p-90 -140.55 -35.27 0.5 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.386 0.884 . . . . 4.93 113.386 -171.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.621 ' HG2' ' CE3' ' A' ' 128' ' ' TRP . 9.3 pt-20 -177.3 -35.01 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.182 0.446 . . . . 7.65 111.342 174.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.461 ' CG ' ' HG ' ' A' ' 132' ' ' LEU . 28.0 tt0 -179.27 97.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.187 -0.671 . . . . 8.84 109.187 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.485 HD11 ' HG2' ' A' ' 122' ' ' LYS . 1.8 pp -76.51 -8.33 11.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.055 0.455 . . . . 6.05 111.315 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.461 ' HG ' ' CG ' ' A' ' 130' ' ' GLN . 0.3 OUTLIER -88.72 66.85 8.21 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.138 0.97 . . . . 8.5 109.812 176.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.0 t -113.23 23.4 13.33 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.506 -1.224 . . . . 9.82 109.465 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -155.84 125.7 6.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.063 -0.971 . . . . 11.21 110.139 -174.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.46 HG13 HG13 ' A' ' 137' ' ' VAL . 12.6 p -81.02 136.57 22.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.022 0.439 . . . . 10.84 110.302 176.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.468 ' HG2' HH21 ' A' ' 118' ' ' ARG . 4.2 mm-40 -77.14 85.7 3.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.025 0.441 . . . . 13.25 111.164 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.46 HG13 HG13 ' A' ' 135' ' ' VAL . 26.5 m -77.23 -23.01 14.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.869 -0.605 . . . . 13.89 109.393 173.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.7 m 53.58 89.08 0.11 Allowed Pre-proline 0 C--O 1.235 0.322 0 O-C-N 124.119 0.887 . . . . 14.05 111.581 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.35 77.9 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.136 2.557 . . . . 14.41 111.763 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -151.0 50.08 0.85 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.708 -0.678 . . . . 14.44 110.186 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -64.93 118.71 9.46 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.556 -0.747 . . . . 15.9 110.505 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.65 -61.34 4.5 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.853 -0.689 . . . . 15.6 111.836 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 3.9 p -88.44 87.68 7.37 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.036 0.446 . . . . 15.6 110.568 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 50.4 mm -65.66 -37.24 79.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.519 . . . . 13.85 110.382 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.2 t -123.42 113.31 18.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.481 0.658 . . . . 13.19 110.45 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -99.54 -11.02 21.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.514 0.673 . . . . 15.67 109.657 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.421 ' H ' HG13 ' A' ' 147' ' ' ILE . 2.8 pp -86.56 157.67 3.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.013 -0.994 . . . . 13.77 111.581 -174.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 15.9 m -132.24 70.91 1.46 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.038 -0.727 . . . . 13.62 109.038 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.55 156.28 46.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.873 -0.603 . . . . 13.02 111.313 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -136.94 135.97 38.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.379 -0.828 . . . . 14.68 109.267 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.15 38.93 0.9 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.328 0.585 . . . . 13.55 111.131 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -166.76 -139.56 2.69 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.738 -0.744 . . . . 15.8 112.01 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 46.7 m -145.46 -47.57 0.22 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.24 0.543 . . . . 17.08 109.903 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.54 -66.49 0.93 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.674 -0.693 . . . . 18.43 109.874 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -116.4 138.0 51.71 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.166 -0.925 . . . . 18.53 109.89 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -153.32 26.67 0.52 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.8 0.81 . . . . 14.32 110.491 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 6.4 p -90.17 -13.8 34.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.114 -0.948 . . . . 14.51 110.837 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 37.4 t -99.62 139.4 21.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.034 -0.53 . . . . 13.06 109.64 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.64 57.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.172 0.511 . . . . 10.33 110.986 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.94 -58.84 3.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.596 -0.729 . . . . 9.88 110.445 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -89.22 34.74 0.8 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.44 0.638 . . . . 10.23 110.567 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -138.99 -62.11 0.55 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.647 -0.706 . . . . 9.06 110.116 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 58.48 40.13 24.3 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.205 0.526 . . . . 6.19 111.551 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 66.0 -141.68 42.0 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.827 -0.624 . . . . 3.97 112.538 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -136.66 12.88 3.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.832 0.349 . . . . 2.63 110.583 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . -124.3 0.01 8.8 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.71 -0.757 . . . . 1.3 113.199 -177.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 17.4 t -73.4 -15.39 61.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.023 0.44 . . . . 1.82 110.732 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.439 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 10.6 p-90 -72.77 -23.46 60.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.316 -0.402 . . . . 0.7 111.521 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.439 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 29.0 mt -86.09 -15.47 41.08 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.482 0.549 . . . . 0.66 112.482 -174.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -78.74 -4.65 50.32 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.271 -0.572 . . . . 1.48 110.381 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -77.84 -37.71 47.83 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.196 -0.457 . . . . 1.97 110.996 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.746 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -70.03 120.77 18.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 109.818 -0.438 . . . . 0.67 109.818 177.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -113.15 -168.68 1.36 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 4.34 112.033 -173.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.479 ' HA ' HG11 ' A' ' 208' ' ' VAL . 43.8 t -62.57 142.27 16.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 115.795 -0.639 . . . . 1.07 111.436 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.46 148.03 39.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.292 -0.867 . . . . 0.71 111.883 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 48.7 t -86.21 -8.94 57.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.373 -0.83 . . . . 1.88 110.122 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.5 t -143.98 145.22 32.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.971 -0.559 . . . . 1.63 111.208 -177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 78.1 m -83.2 -15.82 48.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.642 -0.708 . . . . 1.96 110.298 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -81.85 -25.73 34.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.617 0.722 . . . . 2.42 110.187 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -96.42 18.28 14.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.343 -0.844 . . . . 2.12 111.815 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -59.14 114.19 2.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.183 0.516 . . . . 1.35 111.547 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.868 ' H ' HD12 ' A' ' 183' ' ' LEU . 4.7 p-10 -152.01 29.74 0.58 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.007 -0.997 . . . . 1.68 109.202 170.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.868 HD12 ' H ' ' A' ' 182' ' ' ASN . 1.5 mp -112.03 118.95 36.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.93 -1.032 . . . . 0.81 109.13 -175.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 86.4 m -150.08 148.23 28.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.437 0.637 . . . . 0.51 112.589 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.437 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 28.0 tpp -97.45 145.64 25.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.255 -0.884 . . . . 1.35 111.411 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 41.7 t -129.93 131.47 45.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 1.73 110.267 174.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -123.05 105.78 10.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.588 -0.523 . . . . 1.93 109.588 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 24.2 pt -142.67 144.01 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.847 -0.615 . . . . 1.11 110.502 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.4 m 61.85 35.43 16.53 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.463 -0.335 . . . . 1.86 111.772 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 66.61 3.91 3.13 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.88 -0.6 . . . . 2.83 111.721 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.4 pt20 -120.61 163.74 17.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.083 0.468 . . . . 1.75 110.421 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.8 mm -107.08 136.11 43.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.872 -0.604 . . . . 1.01 111.196 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -138.14 156.44 47.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.029 -0.532 . . . . 3.94 110.917 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.556 ' CD2' ' HB3' ' A' ' 207' ' ' LEU . 2.4 m-30 -101.1 114.43 28.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.761 -0.654 . . . . 0.92 109.823 175.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -102.39 124.41 47.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.009 0.433 . . . . 1.11 110.178 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.53 HG22 HD11 ' A' ' 207' ' ' LEU . 0.9 OUTLIER -100.19 152.83 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.545 0.688 . . . . 0.7 110.38 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.575 HG13 ' HA ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -92.8 -41.04 12.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.813 -1.085 . . . . 0.62 112.471 -168.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.34 164.8 27.26 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.086 0.402 . . . . 1.38 112.086 -171.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.594 ' HA ' ' O ' ' A' ' 104' ' ' MET . 5.3 t70 -49.7 112.26 0.63 Allowed 'General case' 0 C--O 1.233 0.187 0 O-C-N 124.481 1.113 . . . . 2.23 110.671 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.512 HG13 ' HE3' ' A' ' 104' ' ' MET . 28.5 mm -83.13 129.2 37.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.104 -0.498 . . . . 0.88 110.868 -176.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 45.0 mt-10 -83.57 136.16 42.75 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.924 -0.58 . . . . 2.06 109.58 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 103' ' ' LYS . 31.3 Cg_exo -58.14 113.68 1.64 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.18 1.92 . . . . 0.51 111.71 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.17 -4.9 10.38 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.595 -0.812 . . . . 0.7 113.643 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.3 pt-20 -112.74 121.66 45.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 118.001 0.9 . . . . 1.27 111.037 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.539 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -110.6 93.79 4.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.553 -0.749 . . . . 2.92 111.658 177.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.681 ' C ' ' HG ' ' A' ' 183' ' ' LEU . 2.7 mm? -124.19 99.09 6.06 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.548 -0.461 . . . . 0.9 110.222 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.746 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -147.78 119.0 7.76 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.695 0.398 . . . . 0.53 110.074 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.593 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 7.4 p -154.12 157.8 4.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.285 -0.566 . . . . 0.91 111.473 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 16.4 t-80 -115.13 110.87 20.16 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.385 -0.968 . . . . 1.55 108.385 163.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 66.6 t -75.44 99.12 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.24 0.543 . . . . 2.56 110.051 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 28.7 mtmm -79.33 121.24 24.87 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.517 -0.765 . . . . 5.36 110.709 -178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -98.74 3.69 47.64 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.427 -0.806 . . . . 5.8 111.696 -170.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -174.66 56.09 0.13 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.335 -0.936 . . . . 5.61 112.647 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.618 ' O ' ' HA3' ' A' ' 218' ' ' GLY . 39.3 t -124.7 -78.18 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.827 0.346 . . . . 6.31 110.292 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.566 ' H ' ' HD2' ' A' ' 216' ' ' PRO . 18.1 t80 -102.31 -57.41 0.1 Allowed Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.357 -0.383 . . . . 8.83 110.584 173.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.566 ' HD2' ' H ' ' A' ' 215' ' ' TYR . 35.2 Cg_endo -64.08 -46.82 7.44 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 121.574 1.516 . . . . 7.78 112.404 -172.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -108.68 16.82 22.55 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.532 -0.544 . . . . 8.02 109.532 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 214' ' ' VAL . . . -94.31 -141.5 11.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.585 -0.817 . . . . 8.64 113.292 -172.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.4 t -101.12 62.52 0.97 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.76 0.79 . . . . 9.72 110.414 -175.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.558 ' O ' ' HD3' ' A' ' 222' ' ' PRO . 33.0 m -117.07 153.05 49.56 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.384 -0.826 . . . . 9.62 110.164 176.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -94.73 98.04 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.274 2.649 . . . . 11.65 112.202 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 220' ' ' VAL . 93.8 Cg_endo -87.43 9.49 3.86 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.798 2.332 . . . . 13.11 112.642 -177.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -139.59 40.33 1.43 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.279 -0.729 . . . . 14.03 111.279 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.7 tt -88.54 127.95 35.55 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.978 0.418 . . . . 16.1 110.298 -176.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -123.94 -50.11 1.83 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.979 -0.555 . . . . 17.7 109.528 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.641 -0.695 . . . . 18.9 109.327 175.645 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.713 0 N-CA-C 111.713 -0.555 . . . . 33.26 111.713 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.0 p -75.78 121.52 22.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.721 0.296 . . . . 33.92 110.744 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.05 110.9 3.32 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.603 -0.808 . . . . 32.35 112.535 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -118.18 100.71 51.78 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 110.094 -0.335 . . . . 31.65 110.094 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.03 -8.31 17.65 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.4 2.067 . . . . 29.99 111.835 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.45 HG23 ' OD2' ' A' ' 59' ' ' ASP . 61.9 m -148.36 129.49 14.55 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.675 -0.693 . . . . 28.92 109.986 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.0 p -141.48 63.36 1.44 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.1 0.476 . . . . 26.94 110.951 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 60.57 73.9 0.47 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.281 -0.872 . . . . 25.83 110.823 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.45 ' OD2' HG23 ' A' ' 56' ' ' THR . 19.7 m-20 -65.83 129.67 40.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.663 -0.699 . . . . 23.53 110.865 -178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -99.11 123.3 43.31 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.409 -0.589 . . . . 21.64 109.409 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 5.7 p -94.31 113.42 60.79 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.739 0.304 . . . . 19.42 110.998 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.96 135.78 38.99 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.653 2.235 . . . . 17.17 112.359 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -78.81 160.58 27.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.482 -0.781 . . . . 17.47 111.183 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -123.49 45.07 2.53 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.081 -0.508 . . . . 15.63 109.801 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.09 67.46 0.48 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.847 -0.692 . . . . 12.04 112.572 -176.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.7 t -121.51 118.42 29.77 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.467 -0.568 . . . . 10.67 109.467 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -62.8 110.88 1.21 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.748 2.298 . . . . 9.69 112.222 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -115.81 102.6 9.86 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.585 -0.524 . . . . 7.7 109.585 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -70.02 145.46 51.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.978 -0.555 . . . . 8.14 110.162 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.04 115.61 30.28 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.067 -0.515 . . . . 5.96 110.853 -178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.63 -157.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.967 2.444 . . . . 6.13 112.835 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.06 -41.54 93.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 6.53 110.977 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -98.07 107.13 19.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.928 0.394 . . . . 5.01 110.123 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.431 ' H ' HG13 ' A' ' 74' ' ' ILE . 2.4 pp -86.19 139.88 34.46 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.696 -0.483 . . . . 4.23 109.696 173.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -76.93 21.97 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.924 2.416 . . . . 4.12 113.582 -173.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -99.38 -68.95 0.78 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.812 -0.44 . . . . 3.82 109.812 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.8 t70 59.68 89.54 0.06 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.395 -0.821 . . . . 3.16 110.561 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 168' ' ' TRP . 66.5 mt -80.12 122.64 83.22 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.594 -0.73 . . . . 2.45 110.693 -178.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.25 115.88 3.55 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.184 1.922 . . . . 1.75 111.572 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.637 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -113.63 155.93 44.25 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.039 -0.528 . . . . 1.01 110.03 -178.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.63 154.86 66.48 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.753 2.302 . . . . 0.73 111.862 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 -10.13 30.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.604 -0.725 . . . . 1.04 112.476 -173.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 62.9 m-20 -104.71 7.75 34.86 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.927 -0.309 . . . . 1.66 111.598 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -132.54 136.44 46.61 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.649 -0.5 . . . . 1.0 109.649 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.437 ' OE2' ' HD2' ' A' ' 87' ' ' ARG . 35.9 tt0 -127.34 122.91 35.0 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 120.382 -0.527 . . . . 2.27 110.787 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tt -87.28 125.35 34.16 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 108.455 -0.943 . . . . 0.79 108.455 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.437 ' HD2' ' OE2' ' A' ' 85' ' ' GLU . 13.7 ptm180 -166.15 133.83 2.81 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.336 -0.847 . . . . 3.21 109.701 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -64.32 111.98 2.87 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.92 -0.582 . . . . 2.46 110.217 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.1 t -148.17 93.25 2.14 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.67 -0.863 . . . . 1.58 108.67 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.3 t -72.23 104.63 3.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.992 -0.549 . . . . 1.86 110.867 -173.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.509 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -105.94 114.8 62.3 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.812 -0.631 . . . . 1.45 109.365 175.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.27 120.52 7.87 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.284 2.656 . . . . 1.61 112.765 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.23 -11.42 36.89 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 121.009 -0.615 . . . . 1.74 112.435 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.509 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -132.97 -71.1 0.53 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.916 -0.313 . . . . 1.41 111.476 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.83 -149.6 17.32 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.742 -0.742 . . . . 1.09 112.478 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.3 mt -104.5 122.71 46.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.568 0.21 . . . . 2.31 111.568 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -138.18 -153.85 6.36 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.818 -0.706 . . . . 0.59 112.159 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.52 HG21 ' CE3' ' A' ' 168' ' ' TRP . 35.6 m -112.17 112.27 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.934 0.873 . . . . 0.67 109.857 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 35.0 m95 -82.52 118.66 23.42 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.821 -0.627 . . . . 1.13 110.799 -171.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -66.15 117.97 9.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.426 -0.806 . . . . 0.54 110.374 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.9 -3.71 58.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.484 0.659 . . . . 1.68 110.079 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.412 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 24.6 ttm-85 -125.74 157.06 38.38 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.544 -0.91 . . . . 3.5 108.544 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.412 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -83.99 159.58 21.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.108 0.48 . . . . 2.4 110.145 177.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.625 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 44.6 mtm -128.32 153.53 46.91 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.02 -0.536 . . . . 1.22 109.912 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -120.45 139.06 53.41 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.8 -0.636 . . . . 2.31 109.925 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -39.22 122.69 1.29 Allowed 'General case' 0 N--CA 1.47 0.543 0 O-C-N 124.431 1.082 . . . . 0.84 113.395 -169.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.17 7.15 12.85 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.467 -0.788 . . . . 1.04 111.373 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.462 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -86.02 167.98 14.53 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 122.844 0.458 . . . . 2.62 111.019 -176.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.49 ' CZ ' ' HD3' ' A' ' 112' ' ' PRO . 3.7 ptt180 -142.77 164.15 30.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.065 -0.516 . . . . 3.62 110.514 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 109' ' ' ARG . 7.3 mt -118.48 139.25 51.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.542 -0.753 . . . . 0.53 109.055 170.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 86.7 -115.02 4.17 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.804 -0.712 . . . . 1.02 113.288 174.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.49 ' HD3' ' CZ ' ' A' ' 109' ' ' ARG . 70.4 Cg_endo -72.14 168.22 74.77 Favored 'Cis proline' 0 C--N 1.349 0.596 0 C-N-CA 123.858 -1.309 . . . . 2.1 112.94 4.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.507 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 52.7 t -66.76 -36.48 82.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.966 0.412 . . . . 2.0 110.528 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.454 ' HB ' ' H ' ' A' ' 192' ' ' ILE . 47.7 t -120.38 122.16 67.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.224 -0.658 . . . . 2.03 109.224 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.5 m -98.78 -163.07 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.268 -0.424 . . . . 3.95 110.546 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.4 m -57.1 140.28 78.2 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.431 -0.349 . . . . 5.21 110.716 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.06 100.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.267 2.645 . . . . 5.07 113.103 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -95.02 -34.48 12.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.965 -0.562 . . . . 7.99 109.8 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -159.34 160.07 34.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.151 -0.931 . . . . 6.95 109.866 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -77.78 80.24 4.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.955 0.407 . . . . 6.09 111.006 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.22 130.57 16.62 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.957 -0.565 . . . . 5.56 110.236 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -94.79 154.98 17.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.951 -0.568 . . . . 7.42 110.886 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -84.15 -71.4 0.51 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.959 -0.564 . . . . 9.01 110.598 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 125' ' ' ASP . 5.7 m -135.14 -94.51 0.27 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.053 -0.259 . . . . 8.88 110.875 176.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.433 ' H ' ' HB ' ' A' ' 124' ' ' THR . 8.9 t70 -171.92 -140.89 0.02 OUTLIER 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.385 -0.968 . . . . 7.6 108.385 -176.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 76.57 -43.83 0.46 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.014 0.926 . . . . 7.23 112.549 171.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -73.33 -34.77 57.29 Favored Glycine 0 C--N 1.31 -0.875 0 CA-C-N 115.53 -0.759 . . . . 4.59 113.109 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . 0.541 ' HE3' ' N ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -150.24 -103.24 0.07 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.036 0.384 . . . . 4.93 112.036 -179.118 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.541 ' N ' ' HE3' ' A' ' 128' ' ' TRP . 12.1 pt-20 -163.37 -37.23 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.309 -0.405 . . . . 7.65 110.034 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 178.36 141.74 0.1 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.941 -0.572 . . . . 8.84 109.768 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.571 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -118.63 -13.34 10.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.911 0.386 . . . . 6.05 110.343 173.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.9 mp -83.69 75.89 10.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.28 0.562 . . . . 8.5 110.132 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 44.2 p -128.72 59.58 1.54 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.299 -0.864 . . . . 9.82 109.131 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 67.17 70.7 0.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.293 -0.867 . . . . 11.21 109.645 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.4 t -71.14 111.0 4.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.296 -0.865 . . . . 10.84 110.624 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -68.42 142.01 55.52 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.795 -0.639 . . . . 13.25 109.475 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.5 t -43.73 -52.73 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 123.52 0.513 . . . . 13.89 111.381 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.3 m 55.21 83.35 0.23 Allowed Pre-proline 0 C--O 1.235 0.301 0 O-C-N 123.838 0.711 . . . . 14.05 110.689 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -47.03 121.71 5.44 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.282 2.655 . . . . 14.41 112.636 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.512 ' HB3' ' SG ' ' A' ' 143' ' ' CYS . 77.2 mt-30 -59.99 122.37 14.14 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.441 -0.799 . . . . 14.44 110.367 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -100.12 140.8 33.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.756 -0.656 . . . . 15.9 110.211 -178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.76 -59.94 3.59 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.671 -0.776 . . . . 15.6 112.122 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 140' ' ' GLN . 6.8 p -81.4 66.52 6.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.441 0.638 . . . . 15.6 111.154 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 49.7 mm -89.7 -57.07 4.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.721 -0.672 . . . . 13.85 110.05 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 26.9 m -78.08 92.64 4.41 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.828 -0.624 . . . . 13.19 110.4 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -116.2 -42.42 3.05 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.126 -0.488 . . . . 15.67 109.867 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.678 HG22 ' H ' ' A' ' 148' ' ' SER . 3.9 mt 59.08 -179.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.634 0.731 . . . . 13.77 111.106 173.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.678 ' H ' HG22 ' A' ' 147' ' ' ILE . 20.0 m -95.97 68.54 2.76 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.523 -0.547 . . . . 13.62 109.523 175.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -59.73 108.54 0.76 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.781 -0.645 . . . . 13.02 111.201 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -81.74 132.93 35.3 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.243 -0.651 . . . . 14.68 109.243 174.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.8 pp -111.03 23.72 13.79 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.359 0.599 . . . . 13.55 110.892 -176.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 154' ' ' GLU . . . 98.5 74.58 1.16 Allowed Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.623 -0.717 . . . . 15.8 111.48 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 21.9 t -76.66 37.19 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.471 0.653 . . . . 17.08 110.8 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' A' ' 152' ' ' GLY . 37.0 mt-10 -75.6 -60.81 2.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.485 -0.78 . . . . 18.43 108.914 175.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.432 ' H ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -134.55 20.12 3.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.781 -1.099 . . . . 18.53 110.026 177.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -128.14 87.64 2.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.643 -0.708 . . . . 14.32 110.794 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 37.3 t -120.55 36.75 4.47 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.551 -0.907 . . . . 14.51 108.551 176.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.7 136.75 56.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.143 -0.935 . . . . 13.06 110.475 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.488 ' OD1' ' HB2' ' A' ' 162' ' ' GLN . 34.6 t70 -75.42 99.5 4.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 10.33 110.675 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -126.65 -49.94 1.5 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.795 -0.639 . . . . 9.88 111.341 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -101.97 14.8 30.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.388 -0.369 . . . . 10.23 111.331 -175.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.488 ' HB2' ' OD1' ' A' ' 159' ' ' ASP . 54.2 mt-30 -109.75 -81.2 0.58 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.469 -0.332 . . . . 9.06 110.521 177.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.432 ' HB3' ' OD2' ' A' ' 159' ' ' ASP . . . -88.81 72.8 8.52 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.187 0.517 . . . . 6.19 110.833 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -75.46 85.14 0.84 Allowed Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.704 -0.68 . . . . 3.97 112.382 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -74.74 160.62 30.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.891 0.377 . . . . 2.63 110.562 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 113' ' ' CYS . . . -86.88 37.43 3.19 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.15 -0.548 . . . . 1.3 112.776 -176.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.404 ' HB2' HG23 ' A' ' 78' ' ' ILE . 3.4 m -61.47 -27.38 68.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.539 0.685 . . . . 1.82 110.035 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.52 ' CE3' HG21 ' A' ' 98' ' ' VAL . 16.4 p-90 -85.3 -19.33 31.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.245 -0.889 . . . . 0.7 111.084 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 40.6 mt -82.08 -14.95 55.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.059 -0.518 . . . . 0.66 111.864 -173.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -74.59 -8.65 57.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 1.48 110.01 175.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.557 ' O ' ' HD2' ' A' ' 173' ' ' ARG . 65.6 m-85 -85.98 -30.47 22.72 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.979 -0.555 . . . . 1.97 111.675 -178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.783 HG21 ' HB2' ' A' ' 207' ' ' LEU . 1.3 mm -51.3 138.01 8.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 O-C-N 123.393 0.433 . . . . 0.67 111.301 -173.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.557 ' HD2' ' O ' ' A' ' 171' ' ' TYR . 14.9 mmm180 -92.14 170.88 9.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.344 0.593 . . . . 4.34 111.874 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.478 HG22 HG11 ' A' ' 208' ' ' VAL . 61.6 t -89.64 160.76 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.26 -0.882 . . . . 1.07 108.669 173.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.538 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -46.67 125.0 6.61 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.323 0.389 . . . . 0.71 111.892 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 30.8 p -75.75 -14.11 60.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.057 -0.52 . . . . 1.88 110.989 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.4 m -148.39 164.19 34.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.108 -0.496 . . . . 1.63 109.86 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 57.4 m -74.91 -22.96 58.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.973 0.416 . . . . 1.96 111.062 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -89.13 5.32 45.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.213 0.53 . . . . 2.42 110.402 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -110.05 15.93 22.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.42 -0.809 . . . . 2.12 110.255 -174.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -68.87 114.34 7.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.449 . . . . 1.35 110.427 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.784 ' H ' HD12 ' A' ' 183' ' ' LEU . 18.7 t30 -157.43 36.74 0.28 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.001 0.905 . . . . 1.68 109.21 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.784 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.5 OUTLIER -122.9 124.57 43.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.043 -0.526 . . . . 0.81 111.169 -173.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.5 m -149.97 121.95 8.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.19 0.519 . . . . 0.51 110.735 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.432 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 48.1 ttm -97.96 133.02 43.01 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.202 -0.666 . . . . 1.35 109.202 172.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 25.0 t -112.83 132.19 55.38 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.289 -0.634 . . . . 1.73 109.289 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 24.7 tm0? -108.37 104.9 14.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.248 0.547 . . . . 1.93 109.712 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.578 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 25.3 pt -132.53 143.2 40.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.522 -0.763 . . . . 1.11 110.139 -176.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.8 m 54.1 35.93 23.49 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.324 0.39 . . . . 1.86 111.606 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 65.55 7.55 4.48 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.943 -0.571 . . . . 2.83 112.054 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.578 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 13.4 pt20 -113.79 155.26 25.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.978 0.418 . . . . 1.75 110.529 -178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.454 ' H ' ' HB ' ' A' ' 114' ' ' VAL . 51.0 mm -87.81 112.75 23.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.858 -0.61 . . . . 1.01 110.425 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -110.53 135.6 50.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.889 -0.596 . . . . 3.94 110.274 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 9.9 m-85 -102.34 114.67 29.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.59 -0.277 . . . . 0.92 110.485 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.97 117.85 31.28 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.866 0.365 . . . . 1.11 110.048 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.462 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 2.2 t -89.6 152.85 3.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.533 0.682 . . . . 0.7 109.869 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.5 mm -90.34 -57.2 4.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.65 -1.159 . . . . 0.62 111.486 -166.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.582 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.7 OUTLIER -141.87 -178.83 5.86 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.634 -0.712 . . . . 1.38 111.368 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.625 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.9 m-20 -48.45 126.66 11.84 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 124.014 0.821 . . . . 2.23 112.703 -175.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.623 HD11 ' ND2' ' A' ' 182' ' ' ASN . 18.6 mm -96.66 138.01 22.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.445 -0.798 . . . . 0.88 110.714 177.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -86.17 133.29 41.12 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.941 -0.572 . . . . 2.06 109.51 174.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 52.4 Cg_exo -54.99 113.21 1.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.009 1.806 . . . . 0.51 111.615 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.93 -13.08 9.19 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.742 -0.742 . . . . 0.7 113.261 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -126.52 122.56 35.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 117.765 0.783 . . . . 1.27 111.733 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.533 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -111.29 115.79 29.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.807 -0.633 . . . . 2.92 111.254 175.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 205' ' ' GLU . 1.7 mm? -124.1 99.97 6.49 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.71 -0.478 . . . . 0.9 109.71 171.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.783 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.4 mm? -147.17 112.84 5.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 122.673 0.389 . . . . 0.53 110.156 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.646 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.4 p -154.92 160.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.816 -0.438 . . . . 0.91 109.816 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.432 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 53.7 t-80 -90.84 107.58 19.28 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.562 -1.273 . . . . 1.55 107.562 169.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.7 m -73.89 126.0 33.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.099 0.476 . . . . 2.56 110.098 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -78.76 126.53 30.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.316 0.579 . . . . 5.36 110.581 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -115.54 14.84 16.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.407 -0.815 . . . . 5.8 110.267 -177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.402 ' HA2' HD23 ' A' ' 217' ' ' LEU . . . 70.16 27.39 72.97 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.514 -0.766 . . . . 5.61 112.624 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.499 ' HA ' ' OG1' ' A' ' 219' ' ' THR . 43.7 t -99.95 -71.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.946 0.403 . . . . 6.31 110.646 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.524 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 86.6 m-85 -60.52 -53.99 59.16 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.724 -0.671 . . . . 8.83 112.259 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 13.9 Cg_endo -54.5 -42.44 68.04 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.532 2.154 . . . . 7.78 112.98 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.402 HD23 ' HA2' ' A' ' 213' ' ' GLY . 3.8 mm? -85.33 -10.15 56.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.442 -0.345 . . . . 8.02 111.826 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 67.75 42.54 86.81 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 116.012 -0.54 . . . . 8.64 112.744 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 214' ' ' VAL . 24.4 p -81.63 -0.57 43.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.128 0.49 . . . . 9.72 111.414 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.441 ' HA ' ' HD3' ' A' ' 221' ' ' PRO . 20.4 m -80.77 139.85 50.61 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.991 -0.55 . . . . 9.62 110.436 177.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 15.6 Cg_exo -69.02 114.86 3.73 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.581 2.187 . . . . 11.65 111.756 177.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 221' ' ' PRO . 15.3 Cg_exo -67.71 96.38 0.43 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.844 2.363 . . . . 13.11 111.673 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 84.18 -118.23 4.65 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.726 -0.749 . . . . 14.03 111.623 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 37.2 tp -160.1 122.77 3.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.822 0.344 . . . . 16.1 110.636 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -128.18 -6.06 5.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.959 -0.564 . . . . 17.7 110.459 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.376 -0.821 . . . . 18.9 109.795 179.715 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 112.104 -0.398 . . . . 33.26 112.104 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.7 t -139.2 126.84 21.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.371 -0.603 . . . . 33.92 109.371 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.69 -47.88 3.03 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.407 -0.677 . . . . 32.35 111.407 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 60.23 85.76 0.17 Allowed Pre-proline 0 C--O 1.231 0.128 0 C-N-CA 123.045 0.538 . . . . 31.65 111.123 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -55.78 97.82 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.976 2.45 . . . . 29.99 112.394 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.6 m -113.65 136.6 52.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.642 -0.708 . . . . 28.92 110.199 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.0 m 64.91 61.65 0.77 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.401 0.619 . . . . 26.94 109.953 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -89.45 20.15 4.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.618 -0.719 . . . . 25.83 110.942 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -98.99 98.17 9.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.171 -0.468 . . . . 23.53 110.266 -177.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -104.53 137.94 41.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.93 -0.577 . . . . 21.64 110.443 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 19.3 m -96.07 115.3 65.48 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.96 -0.564 . . . . 19.42 110.518 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.9 92.9 0.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.393 2.062 . . . . 17.17 111.339 176.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -82.64 -37.38 25.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.249 -0.887 . . . . 17.47 110.352 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -90.58 165.18 13.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.686 -0.688 . . . . 15.63 110.346 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.15 -124.79 8.52 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.778 -0.725 . . . . 12.04 111.918 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.419 ' HA ' ' HD2' ' A' ' 67' ' ' PRO . 51.8 m -153.08 97.1 2.84 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 120.481 0.181 . . . . 10.67 110.598 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 66' ' ' SER . 30.1 Cg_endo -64.28 97.88 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.5 2.134 . . . . 9.69 111.64 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -86.9 130.99 34.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.849 -0.614 . . . . 7.7 110.866 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -132.06 147.39 52.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.794 -0.639 . . . . 8.14 109.547 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.74 112.05 26.27 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.366 -0.379 . . . . 5.96 110.485 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.07 -157.48 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.637 2.225 . . . . 6.13 112.234 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.6 m -60.58 -31.2 48.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.881 0.372 . . . . 6.53 110.984 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -112.63 120.33 41.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.35 -0.387 . . . . 5.01 110.066 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.463 ' O ' HD12 ' A' ' 74' ' ' ILE . 1.9 pp -77.01 149.56 80.08 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.361 -0.381 . . . . 4.23 110.225 175.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.32 12.54 1.53 Allowed 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.628 2.218 . . . . 4.12 114.333 -167.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -124.2 -83.49 0.65 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 121.139 -0.224 . . . . 3.82 110.978 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.5 t70 65.07 80.11 0.24 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.923 0.764 . . . . 3.16 110.176 -177.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.0 mt -72.97 124.39 90.66 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.356 -0.838 . . . . 2.45 110.458 -178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.64 124.57 10.37 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.702 2.268 . . . . 1.75 111.857 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.615 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -118.94 143.97 34.85 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.316 -0.402 . . . . 1.01 110.67 -178.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -54.62 147.53 48.62 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.414 2.743 . . . . 0.73 112.296 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.422 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -66.15 -12.84 58.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.92 -0.582 . . . . 1.04 112.104 -175.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.99 -24.12 59.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.19 0.519 . . . . 1.66 110.177 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 71.6 m-85 -123.72 177.39 5.73 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.074 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.545 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 28.2 tt0 -155.86 124.66 6.01 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 121.009 -0.276 . . . . 2.27 110.702 177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.9 tt -84.0 125.01 31.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.474 -0.565 . . . . 0.79 109.474 177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -147.79 138.9 23.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.196 -0.911 . . . . 3.21 109.538 -174.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.99 110.8 17.58 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.694 -0.484 . . . . 2.46 109.694 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.1 m -150.0 106.61 3.52 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.749 -0.659 . . . . 1.58 109.309 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.6 m -75.91 104.17 6.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.061 0.458 . . . . 1.86 111.225 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.425 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -107.15 114.85 60.82 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 109.148 -0.686 . . . . 1.45 109.148 174.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 91' ' ' ILE . 37.5 Cg_exo -60.43 121.93 10.52 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.827 2.351 . . . . 1.61 112.653 -177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.33 -9.61 35.94 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.685 -0.769 . . . . 1.74 113.037 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -131.88 -70.6 0.57 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.892 0.346 . . . . 1.41 111.531 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 130.3 -161.51 23.17 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.816 -0.707 . . . . 1.09 112.047 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mt -94.68 116.78 29.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.091 -0.337 . . . . 2.31 110.091 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.464 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -119.04 -179.39 16.76 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.733 -0.746 . . . . 0.59 112.614 -176.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 19.6 m -100.78 112.7 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.698 0.761 . . . . 0.67 109.776 174.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -82.07 112.33 19.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.447 -0.797 . . . . 1.13 110.984 -169.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' PHE . . . -66.5 114.64 5.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.54 109.703 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.554 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -95.73 2.18 53.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.427 0.632 . . . . 1.68 109.501 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -125.54 154.55 41.98 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.942 -1.027 . . . . 3.5 109.218 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.625 ' HD2' ' H ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -86.72 154.68 20.78 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.453 -0.573 . . . . 2.4 109.453 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.744 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 49.4 mtm -131.16 147.56 52.62 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.512 -0.313 . . . . 1.22 110.734 -177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -109.8 143.06 40.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.322 -0.622 . . . . 2.31 109.322 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.37 130.43 10.75 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 124.012 0.82 . . . . 0.84 112.458 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.61 7.54 13.5 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.156 -0.778 . . . . 1.04 111.156 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 0.8 OUTLIER -78.96 162.87 25.68 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 122.901 0.48 . . . . 2.62 111.589 -176.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 109' ' ' ARG . 2.8 tmm_? -146.93 128.26 14.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.856 -0.611 . . . . 3.62 110.881 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 3.2 mt -105.15 148.48 26.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.728 -0.841 . . . . 0.53 108.728 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 129.72 -151.2 19.22 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.532 -0.842 . . . . 1.02 112.181 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.557 ' HB3' ' CE2' ' A' ' 193' ' ' TYR . 86.4 Cg_endo -81.53 142.05 52.97 Favored 'Cis proline' 0 C--N 1.342 0.218 0 C-N-CA 123.823 -1.324 . . . . 2.1 112.67 0.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 14.2 m -72.48 -27.94 62.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.19 0.519 . . . . 2.0 109.765 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.5 t -121.44 116.64 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.342 -0.845 . . . . 2.03 109.131 175.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.421 HG23 ' HG2' ' A' ' 117' ' ' PRO . 1.4 m -91.25 -169.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.248 -0.433 . . . . 3.95 111.37 -177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.581 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 2.4 p -63.04 -38.1 39.1 Favored Pre-proline 0 CA--C 1.553 1.088 0 N-CA-C 114.491 1.293 . . . . 5.21 114.491 -173.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 116' ' ' VAL . 9.4 Cg_endo -53.22 140.53 61.41 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 121.687 1.592 . . . . 5.07 112.543 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -68.04 -28.55 67.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.308 -0.86 . . . . 7.99 111.792 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.12 74.41 0.22 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.928 -0.578 . . . . 6.95 110.683 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.8 -79.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.582 -0.736 . . . . 6.09 111.232 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 65.15 138.14 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.74 0.781 . . . . 5.56 111.575 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -66.8 138.8 57.62 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.41 -0.814 . . . . 7.42 110.256 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -69.15 -49.39 57.34 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.001 -0.74 . . . . 9.01 109.001 174.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 78.7 m -162.68 -58.79 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.197 -0.911 . . . . 8.88 108.722 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.88 177.59 6.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.182 -0.917 . . . . 7.6 111.055 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -132.4 156.61 46.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.359 -0.837 . . . . 7.23 109.465 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.739 ' HA3' ' SD ' ' A' ' 185' ' ' MET . . . -146.77 25.96 1.64 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.961 -1.114 . . . . 4.59 113.564 -177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 187' ' ' GLN . 0.0 OUTLIER -155.45 -111.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.533 0.568 . . . . 4.93 112.533 176.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -141.17 -57.94 0.5 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.927 0.343 . . . . 7.65 111.927 -171.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.601 ' HG2' ' H ' ' A' ' 132' ' ' LEU . 8.4 tt0 -172.05 142.46 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.502 0.191 . . . . 8.84 110.688 -172.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.575 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -127.11 13.81 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.324 0.583 . . . . 6.05 110.265 174.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.601 ' H ' ' HG2' ' A' ' 130' ' ' GLN . 9.5 mp -81.15 70.63 8.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.536 -0.756 . . . . 8.5 110.487 -177.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.1 p -101.78 41.7 1.19 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.317 -0.856 . . . . 9.82 110.524 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 60.67 67.19 0.85 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.649 -0.705 . . . . 11.21 110.166 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -58.5 130.94 22.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.931 -1.031 . . . . 10.84 111.287 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -85.9 148.26 25.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.735 -0.666 . . . . 13.25 110.326 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 138' ' ' SER . 27.5 m -96.1 9.77 5.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.457 -0.338 . . . . 13.89 110.452 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 137' ' ' VAL . 73.5 m 72.96 143.58 0.1 OUTLIER Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 114.934 -1.03 . . . . 14.05 111.276 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.41 87.75 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.532 2.155 . . . . 14.41 112.007 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -83.04 36.89 0.52 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.242 0.544 . . . . 14.44 110.077 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -85.46 -6.58 59.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.369 -0.832 . . . . 15.9 110.639 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -160.42 -179.21 35.05 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.865 -0.607 . . . . 15.6 111.69 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 38.4 t -72.56 130.77 41.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.986 0.422 . . . . 15.6 110.444 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.4 mt -101.24 62.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 122.172 0.987 . . . . 13.85 108.405 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.57 44.2 0.27 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.311 -1.313 . . . . 13.19 113.127 -172.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -101.79 -17.46 16.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.807 -0.812 . . . . 15.67 108.807 171.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.402 ' H ' HG13 ' A' ' 147' ' ' ILE . 2.3 pp -124.31 163.66 23.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.953 -1.021 . . . . 13.77 109.766 176.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.2 t -149.13 68.48 1.05 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.672 0.749 . . . . 13.62 109.766 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -131.28 75.72 1.67 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.401 -0.818 . . . . 13.02 110.162 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.41 97.74 7.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.066 -0.97 . . . . 14.68 110.234 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 56.7 mt -82.74 57.09 3.64 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.873 0.368 . . . . 13.55 110.734 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.54 31.98 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.627 -0.797 . . . . 15.8 112.666 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 31.9 m -114.92 -58.34 2.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.822 0.344 . . . . 17.08 110.532 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -101.75 -103.79 0.26 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.852 0.358 . . . . 18.43 111.427 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -119.37 23.13 11.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.273 0.559 . . . . 18.53 111.391 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -107.84 19.49 20.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.866 -0.607 . . . . 14.32 109.969 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 3.4 p -69.8 -29.54 66.86 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.387 -0.824 . . . . 14.51 110.503 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.0 t -70.74 125.16 28.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 109.311 -0.626 . . . . 13.06 109.311 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -81.4 82.11 7.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.476 0.655 . . . . 10.33 110.835 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -118.27 -23.73 7.18 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.539 -1.209 . . . . 9.88 109.068 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -71.54 -38.26 71.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.306 -1.315 . . . . 10.23 111.718 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.36 -41.31 7.89 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.897 -0.408 . . . . 9.06 109.897 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -66.67 101.11 0.75 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.854 -0.612 . . . . 6.19 110.866 176.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -166.74 -94.35 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.734 -0.946 . . . . 3.97 110.734 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 41.33 -92.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.667 0.988 . . . . 2.63 113.667 172.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -131.17 14.07 5.43 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.069 -0.586 . . . . 1.3 112.134 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 23.0 t -68.54 -24.79 64.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.325 0.583 . . . . 1.82 109.941 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 35.0 p-90 -85.0 -18.79 33.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.794 -0.639 . . . . 0.7 109.857 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.538 ' O ' HG13 ' A' ' 172' ' ' ILE . 38.0 mt -84.1 -20.35 32.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.682 -0.69 . . . . 0.66 111.415 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.463 ' C ' ' HD3' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -76.2 -6.17 50.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.519 -0.472 . . . . 1.48 110.225 176.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.464 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 33.8 m-85 -75.83 -37.52 58.96 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.968 -0.56 . . . . 1.97 110.484 177.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.646 HD12 ' HB2' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -68.63 119.74 14.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.367 -0.605 . . . . 0.67 109.367 174.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -111.15 -172.29 2.0 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.539 -0.301 . . . . 4.34 110.847 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.412 HG22 HG11 ' A' ' 208' ' ' VAL . 20.6 t -68.19 149.04 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 1.07 110.771 -177.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.577 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -56.22 126.23 25.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.894 -0.594 . . . . 0.71 111.441 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 46.2 t -72.02 -17.46 62.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.867 -0.606 . . . . 1.88 110.838 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 m -126.33 150.42 48.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.313 -0.403 . . . . 1.63 109.975 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 10.7 p -78.57 -19.02 53.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.492 0.553 . . . . 1.96 112.492 -172.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -89.17 -4.09 58.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.468 0.651 . . . . 2.42 110.051 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.15 17.48 12.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.207 -0.906 . . . . 2.12 111.642 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -69.33 113.25 6.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.327 0.584 . . . . 1.35 110.952 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 1.033 ' H ' HD12 ' A' ' 183' ' ' LEU . 4.1 p-10 -155.25 35.14 0.38 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.178 -0.919 . . . . 1.68 109.582 171.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 1.033 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.5 OUTLIER -117.7 120.42 37.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.443 -0.799 . . . . 0.81 110.754 -171.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 92.7 m -148.53 139.8 23.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.099 0.476 . . . . 0.51 110.95 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.739 ' SD ' ' HA3' ' A' ' 127' ' ' GLY . 55.5 ttm -98.75 150.29 21.98 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.371 -0.603 . . . . 1.35 109.371 174.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 53.7 t -112.78 131.9 55.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.061 0.458 . . . . 1.73 109.97 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.557 ' NE2' ' HA ' ' A' ' 190' ' ' GLU . 20.7 tm0? -120.77 104.89 10.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.769 -0.651 . . . . 1.93 109.389 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 12.9 pt -140.71 132.63 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 1.11 110.123 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 51.1 m 58.51 29.88 18.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.118 0.485 . . . . 1.86 111.059 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.557 ' HA ' ' NE2' ' A' ' 187' ' ' GLN . 0.9 OUTLIER 63.97 11.5 6.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.145 -0.934 . . . . 2.83 112.753 176.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -112.08 140.03 47.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.539 -0.541 . . . . 1.75 109.539 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.1 mm -84.77 131.68 33.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.947 -0.57 . . . . 1.01 112.02 -172.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 112' ' ' PRO . 54.3 m-85 -128.37 165.11 21.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.045 -0.98 . . . . 3.94 109.709 173.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.557 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 3.9 m-85 -115.02 126.53 54.85 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.579 -0.526 . . . . 0.92 109.579 175.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -125.47 120.06 29.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.027 0.441 . . . . 1.11 110.604 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.503 HG22 HD11 ' A' ' 207' ' ' LEU . 1.5 t -85.82 152.9 3.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.126 -0.694 . . . . 0.7 109.126 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.538 HG13 ' HA ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -84.28 -48.54 16.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 114.891 -1.05 . . . . 0.62 111.039 -170.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.78 -178.08 6.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.635 -0.711 . . . . 1.38 111.193 -174.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.744 ' HA ' ' O ' ' A' ' 104' ' ' MET . 2.8 p-10 -43.23 124.49 3.34 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 124.454 1.096 . . . . 2.23 113.486 -176.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.482 HG13 ' HE3' ' A' ' 104' ' ' MET . 37.8 mm -100.98 133.11 45.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.947 -1.024 . . . . 0.88 110.122 175.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.676 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 46.5 mt-10 -90.12 128.74 48.46 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.402 -0.592 . . . . 2.06 109.402 176.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.76 116.75 2.03 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.952 2.435 . . . . 0.51 112.934 -178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 123.51 -16.11 8.0 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.953 -0.641 . . . . 0.7 113.653 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.676 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 13.9 pt-20 -111.7 122.86 48.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.827 0.814 . . . . 1.27 111.518 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -111.32 94.99 5.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.081 -0.509 . . . . 2.92 112.087 177.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.455 HD22 ' N ' ' A' ' 206' ' ' LEU . 1.2 mm? -122.77 100.17 6.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 119.874 -0.73 . . . . 0.9 109.859 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.646 ' HB2' HD12 ' A' ' 172' ' ' ILE . 0.6 OUTLIER -147.33 114.28 6.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.581 -0.281 . . . . 0.53 110.617 177.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.646 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.5 p -155.51 158.59 3.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.505 . . . . 0.91 109.635 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -85.81 110.41 19.35 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.245 -1.02 . . . . 1.55 108.245 166.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 11.0 p -71.78 123.66 26.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.264 0.554 . . . . 2.56 110.015 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -144.02 131.86 21.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.0 -0.545 . . . . 5.36 110.801 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.456 ' O ' HD23 ' A' ' 217' ' ' LEU . 10.7 pt-20 -130.07 -2.95 4.54 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 5.8 110.366 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.55 ' HA2' ' HB2' ' A' ' 217' ' ' LEU . . . -163.59 60.82 0.26 Allowed Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.561 -0.828 . . . . 5.61 112.724 -179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 52.4 t -113.47 -75.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.846 0.355 . . . . 6.31 110.155 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.443 ' H ' ' HD2' ' A' ' 216' ' ' PRO . 52.3 t80 -87.48 -58.57 0.28 Allowed Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.119 -0.491 . . . . 8.83 110.971 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.443 ' HD2' ' H ' ' A' ' 215' ' ' TYR . 18.0 Cg_endo -57.87 -51.27 8.3 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 121.979 1.786 . . . . 7.78 112.628 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.55 ' HB2' ' HA2' ' A' ' 213' ' ' GLY . 2.4 mm? -102.7 41.96 1.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.396 0.617 . . . . 8.02 109.993 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -114.18 -165.56 15.48 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.398 -0.819 . . . . 8.64 111.741 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 2.9 p -89.41 54.05 2.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.322 0.582 . . . . 9.72 110.874 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 27.8 m -99.96 157.09 34.51 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.59 -0.732 . . . . 9.62 110.379 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -59.07 138.95 88.42 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.523 2.149 . . . . 11.65 112.27 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.93 99.39 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.734 2.289 . . . . 13.11 111.771 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 132.09 -119.92 2.64 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.882 -0.887 . . . . 14.03 110.882 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 40.1 tp -150.98 123.54 8.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.819 0.342 . . . . 16.1 110.184 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -88.01 -38.39 15.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.934 -0.575 . . . . 17.7 110.481 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.288 -0.863 . . . . 18.9 110.421 178.831 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 111.952 -0.459 . . . . 33.26 111.952 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.2 t -160.01 152.06 20.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.713 0.292 . . . . 33.92 110.476 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.22 -133.03 19.64 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.248 -0.501 . . . . 32.35 112.032 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -135.24 113.11 11.25 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.661 -0.496 . . . . 31.65 109.661 177.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.73 56.9 4.23 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.882 2.388 . . . . 29.99 112.723 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 p -67.31 -42.39 83.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.078 0.466 . . . . 28.92 110.462 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.9 t -99.6 67.47 1.5 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.095 -0.706 . . . . 26.94 109.095 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -94.36 82.01 4.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.942 -0.572 . . . . 25.83 110.323 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -96.08 112.52 24.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.472 -0.785 . . . . 23.53 110.097 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.567 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 66.5 m-85 -72.27 94.37 1.58 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.938 -0.393 . . . . 21.64 109.938 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.5 p -106.72 92.5 7.4 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.788 -0.642 . . . . 19.42 111.112 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.567 ' HD3' ' O ' ' A' ' 60' ' ' PHE . 7.7 Cg_exo -72.59 125.68 10.83 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.981 2.454 . . . . 17.17 111.922 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -86.16 49.05 1.71 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.276 0.56 . . . . 17.47 109.824 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -126.2 131.33 52.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.329 -0.851 . . . . 15.63 109.799 -176.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 67' ' ' PRO . . . -109.75 -114.69 3.65 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.671 -0.776 . . . . 12.04 111.669 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.3 m -110.25 91.62 11.86 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 109.608 -0.515 . . . . 10.67 109.608 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 65' ' ' GLY . 4.5 Cg_exo -73.5 98.69 1.06 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.906 2.404 . . . . 9.69 112.057 -176.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -83.45 89.23 7.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.093 -0.503 . . . . 7.7 109.747 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -113.64 152.01 30.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.017 -0.538 . . . . 8.14 110.438 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.439 ' HB2' ' HD3' ' A' ' 75' ' ' PRO . . . -83.11 122.41 77.6 Favored Pre-proline 0 C--N 1.319 -0.717 0 CA-C-N 115.739 -0.664 . . . . 5.96 111.239 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.97 -70.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.558 2.838 . . . . 6.13 113.064 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.1 p -124.33 -43.51 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.117 -0.492 . . . . 6.53 111.432 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -92.1 108.5 19.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.402 -0.363 . . . . 5.01 110.08 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.531 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.1 pp -80.0 134.61 56.09 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-O 121.22 0.533 . . . . 4.23 111.482 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.439 ' HD3' ' HB2' ' A' ' 70' ' ' ALA . 71.8 Cg_endo -77.27 0.5 9.68 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.953 2.435 . . . . 4.12 112.396 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.37 -59.5 2.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.092 -0.707 . . . . 3.82 109.092 175.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.447 ' H ' HD13 ' A' ' 74' ' ' ILE . 24.2 t70 65.44 100.34 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.736 -1.12 . . . . 3.16 111.756 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.0 118.01 67.22 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.331 -0.849 . . . . 2.45 109.795 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -61.78 116.39 3.41 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.349 2.033 . . . . 1.75 111.712 176.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.579 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -126.41 140.94 38.54 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.287 -0.415 . . . . 1.01 110.478 -178.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.45 138.38 83.71 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.509 2.14 . . . . 0.73 111.634 175.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.49 -4.12 13.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.145 0.497 . . . . 1.04 111.351 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.54 -23.01 61.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.785 -0.643 . . . . 1.66 109.457 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -128.43 177.31 7.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.295 -0.866 . . . . 1.0 108.872 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -145.54 131.43 19.14 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.18 -0.608 . . . . 2.27 110.906 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.4 tt -92.79 130.65 38.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.027 -0.533 . . . . 0.79 109.769 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -149.5 150.93 33.09 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.454 -0.794 . . . . 3.21 109.746 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -82.92 109.42 17.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.707 -0.849 . . . . 2.46 108.707 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.8 m -159.56 82.44 0.75 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.327 -0.62 . . . . 1.58 109.327 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.6 p -68.3 105.22 2.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.139 -0.482 . . . . 1.86 110.922 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.6 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -81.86 123.46 80.15 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 109.116 -0.698 . . . . 1.45 109.116 176.236 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -49.62 115.38 1.77 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.282 2.654 . . . . 1.61 113.297 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.09 -14.53 37.06 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.7 -0.762 . . . . 1.74 112.691 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.6 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -128.77 -55.77 1.21 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.936 0.398 . . . . 1.41 111.477 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 120.92 -146.71 17.54 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.979 -0.629 . . . . 1.09 112.255 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 96' ' ' LEU . 1.3 pp -69.26 158.83 34.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.718 0.259 . . . . 2.31 110.914 177.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.71 172.15 43.56 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.796 -0.716 . . . . 0.59 111.995 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.1 m -108.24 120.45 59.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.678 0.751 . . . . 0.67 109.965 176.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -83.01 107.98 15.99 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.246 0.546 . . . . 1.13 110.859 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.42 115.56 7.99 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.551 -0.749 . . . . 0.54 110.16 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.537 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -86.57 -5.23 59.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.546 0.688 . . . . 1.68 109.359 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -128.88 159.17 36.64 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.008 -0.997 . . . . 3.5 109.176 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.432 ' H ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -85.37 137.09 33.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.244 0.545 . . . . 2.4 110.637 -177.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.634 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 25.3 mtm -94.97 116.62 28.93 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.74 -0.837 . . . . 1.22 108.74 172.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.69 173.62 12.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.403 0.621 . . . . 2.31 111.74 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.98 118.12 7.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.276 -0.874 . . . . 0.84 111.83 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.76 1.04 63.82 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.839 -0.696 . . . . 1.04 113.198 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.58 167.95 20.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.649 -0.5 . . . . 2.62 109.649 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.636 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 5.0 tmm_? -145.82 130.6 18.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.245 0.461 . . . . 3.62 112.245 -170.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.7 mt -88.18 139.91 30.02 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.84 -0.8 . . . . 0.53 108.84 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.04 173.3 40.72 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 119.801 -1.19 . . . . 1.02 113.05 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -80.97 152.27 81.0 Favored 'Cis proline' 0 CA--C 1.528 0.209 0 C-N-CA 122.954 -1.686 . . . . 2.1 112.463 -2.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.442 ' HA ' ' HA2' ' A' ' 166' ' ' GLY . 42.7 t -96.57 -0.58 48.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.037 0.446 . . . . 2.0 110.715 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.8 m -120.18 133.46 66.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.231 -0.44 . . . . 2.03 111.074 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 116' ' ' VAL . 2.0 t -89.91 179.23 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.638 -0.875 . . . . 3.95 108.638 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.577 ' H ' HG12 ' A' ' 115' ' ' VAL . 21.6 t -51.99 -51.57 69.9 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 117.739 0.245 . . . . 5.21 111.616 177.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 116' ' ' VAL . 36.2 Cg_endo -66.0 89.96 0.25 Allowed 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.96 1.774 . . . . 5.07 111.479 171.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 -84.3 -39.63 18.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.001 -0.545 . . . . 7.99 110.081 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 49.87 47.51 23.03 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.671 0.607 . . . . 6.95 111.314 175.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -98.71 137.54 37.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.804 -0.634 . . . . 6.09 111.192 -175.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.09 89.21 0.92 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.808 -0.633 . . . . 5.56 110.284 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.545 ' HD3' ' O ' ' A' ' 124' ' ' THR . 7.3 ptpp? -95.84 157.22 15.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.261 -0.882 . . . . 7.42 110.882 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -98.16 -28.86 13.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.165 -0.679 . . . . 9.01 109.165 172.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.545 ' O ' ' HD3' ' A' ' 122' ' ' LYS . 87.1 m -154.02 -74.53 0.12 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.996 -1.002 . . . . 8.88 109.847 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -178.59 -74.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.76 -0.654 . . . . 7.6 109.807 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 63.42 17.99 10.71 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.629 0.728 . . . . 7.23 111.266 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 90.34 50.8 2.9 Favored Glycine 0 C--N 1.309 -0.947 0 CA-C-N 115.075 -0.966 . . . . 4.59 110.846 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . 0.511 ' CE2' HD11 ' A' ' 192' ' ' ILE . 28.8 t-105 71.97 131.88 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 123.266 1.508 . . . . 4.93 112.025 -178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.479 ' OE1' HD12 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -59.89 -25.61 65.24 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 111.993 -2.367 . . . . 7.65 112.365 177.421 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 128' ' ' TRP . 26.2 mt-30 64.49 35.61 9.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.277 -0.874 . . . . 8.84 112.848 173.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.615 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -64.57 -27.49 42.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.689 0.28 . . . . 6.05 111.385 178.48 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.92 80.75 2.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.253 0.549 . . . . 8.5 110.177 176.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.3 p -131.66 45.1 2.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.04 -0.527 . . . . 9.82 110.757 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.8 t70 68.36 105.55 0.05 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.255 -0.884 . . . . 11.21 111.324 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -53.75 131.71 16.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.261 -0.881 . . . . 10.84 111.38 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -87.95 -166.05 1.48 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.531 -0.759 . . . . 13.25 110.244 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.8 t -60.97 -39.34 81.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.104 0.478 . . . . 13.89 110.197 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.7 t -103.95 108.47 59.98 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.86 -0.609 . . . . 14.05 110.133 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.74 162.95 21.26 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.9 2.4 . . . . 14.41 112.121 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -104.26 35.38 2.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.492 0.663 . . . . 14.44 110.081 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -80.81 108.8 14.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.622 -0.717 . . . . 15.9 111.286 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -135.17 -92.59 0.4 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.514 -0.851 . . . . 15.6 111.932 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 3.6 p -89.13 45.31 1.28 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.338 0.59 . . . . 15.6 111.105 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.8 mt -87.66 -11.0 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.812 0.815 . . . . 13.85 109.626 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 14.8 t -147.79 147.2 29.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.666 -0.697 . . . . 13.19 109.989 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -113.99 -3.23 13.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.362 0.601 . . . . 15.67 109.672 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 39.0 pt -114.85 165.05 10.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.329 -0.851 . . . . 13.77 110.206 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 51.0 m -92.73 59.86 3.33 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.069 0.462 . . . . 13.62 110.174 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -68.44 146.27 53.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.566 -0.743 . . . . 13.02 109.826 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -128.36 121.44 29.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.976 0.417 . . . . 14.68 110.974 -176.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.02 31.63 1.07 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.012 -0.54 . . . . 13.55 110.936 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -113.38 43.57 1.68 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.93 -0.652 . . . . 15.8 111.937 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.6 t 66.21 15.37 10.06 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.086 0.554 . . . . 17.08 111.461 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -94.61 -92.74 0.19 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.847 0.356 . . . . 18.43 110.782 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -120.94 101.42 7.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.116 -0.493 . . . . 18.53 110.805 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -133.79 171.51 14.05 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.604 -0.725 . . . . 14.32 109.895 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 52.8 m -124.77 102.54 7.63 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.445 -0.343 . . . . 14.51 110.461 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.4 m 49.69 -172.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 124.29 0.994 . . . . 13.06 112.863 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -71.47 69.71 0.6 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.051 -0.977 . . . . 10.33 110.081 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -102.38 -83.13 0.47 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.228 -0.442 . . . . 9.88 111.014 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -90.27 39.49 0.97 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.094 0.473 . . . . 10.23 110.842 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -120.82 -80.89 0.63 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.913 -0.585 . . . . 9.06 110.156 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -163.86 170.62 16.56 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.932 -0.576 . . . . 6.19 109.975 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 155.48 -160.14 29.68 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.374 -0.917 . . . . 3.97 112.627 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -58.59 146.72 34.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.891 0.377 . . . . 2.63 111.203 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 113' ' ' CYS . . . 100.77 -41.42 2.15 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.587 -0.816 . . . . 1.3 112.103 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 20.0 t -64.25 -26.94 68.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.028 0.442 . . . . 1.82 110.126 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.499 ' O ' ' HB2' ' A' ' 171' ' ' TYR . 44.3 p-90 -86.26 -21.16 27.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 0.7 111.201 177.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 15.5 mt -82.49 -14.93 54.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.785 0.291 . . . . 0.66 111.785 -175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -74.63 -4.35 36.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.152 0.501 . . . . 1.48 109.911 174.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.499 ' HB2' ' O ' ' A' ' 168' ' ' TRP . 13.2 m-85 -76.3 -32.56 58.84 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.602 -0.726 . . . . 1.97 111.547 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.568 HG21 ' HB2' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -62.87 134.94 27.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.406 -0.518 . . . . 0.67 110.406 -175.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.495 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 13.3 mmm180 -110.2 160.1 16.8 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.084 0.469 . . . . 4.34 111.549 -177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.422 HG22 HG11 ' A' ' 208' ' ' VAL . 62.6 t -67.05 147.12 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.569 -0.741 . . . . 1.07 109.31 175.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.702 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -54.22 141.72 28.48 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.274 0.559 . . . . 0.71 112.117 -177.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 44.9 t -91.26 -2.8 57.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.247 -0.888 . . . . 1.88 110.34 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.518 ' HB2' ' HB2' ' A' ' 180' ' ' ASP . 41.5 m -141.65 145.95 35.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.199 0.523 . . . . 1.63 110.548 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 59.8 m -72.19 -31.25 65.73 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.551 -0.749 . . . . 1.96 111.584 -173.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -84.05 2.4 39.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.151 0.5 . . . . 2.42 110.428 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 177' ' ' SER . 4.2 t70 -108.91 16.65 22.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.523 -0.762 . . . . 2.12 110.507 -173.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -63.89 114.19 3.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.037 0.446 . . . . 1.35 110.555 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.861 ' H ' HD12 ' A' ' 183' ' ' LEU . 10.5 t30 -148.6 32.27 0.79 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.045 -1.094 . . . . 1.68 108.045 175.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.861 HD12 ' H ' ' A' ' 182' ' ' ASN . 1.4 mp -117.15 122.16 43.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.334 -0.848 . . . . 0.81 110.746 -172.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 95.3 m -148.72 136.74 20.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.971 0.415 . . . . 0.51 110.306 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 49.7 ttm -106.07 141.92 36.63 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.54 -0.541 . . . . 1.35 109.54 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 53.4 t -111.93 131.61 55.27 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.268 -0.641 . . . . 1.73 109.268 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.1 103.86 9.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.146 -0.687 . . . . 1.93 109.146 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.529 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 22.4 pt -138.08 144.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.627 -0.715 . . . . 1.11 109.842 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.8 m 60.41 31.9 20.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.858 0.361 . . . . 1.86 111.392 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 60.11 24.09 13.36 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.785 -0.643 . . . . 2.83 112.026 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.4 pt20 -130.37 161.42 31.36 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.975 -0.38 . . . . 1.75 109.975 176.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.511 HD11 ' CE2' ' A' ' 128' ' ' TRP . 49.3 mm -103.94 131.45 52.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-O 121.21 0.529 . . . . 1.01 112.274 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.636 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 30.1 m-85 -133.48 147.85 51.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.266 -0.879 . . . . 3.94 110.027 174.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 4.9 m-30 -101.57 114.44 28.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.739 -0.467 . . . . 0.92 109.739 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -99.22 121.81 41.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.922 0.392 . . . . 1.11 110.246 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 1.9 t -89.23 150.95 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 122.074 0.94 . . . . 0.7 110.173 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.413 HG13 ' HA ' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -95.6 -55.28 6.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 113.866 -1.515 . . . . 0.62 110.796 -165.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.39 175.22 10.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.758 -1.11 . . . . 1.38 109.733 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.634 ' HA ' ' O ' ' A' ' 104' ' ' MET . 9.2 p-10 -59.45 115.82 3.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.76 0.79 . . . . 2.23 112.2 -172.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.451 HD11 ' ND2' ' A' ' 182' ' ' ASN . 4.8 mm -69.33 140.13 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.857 -1.065 . . . . 0.88 110.867 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 37.2 mt-10 -84.04 118.19 70.64 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.21 -0.663 . . . . 2.06 109.21 171.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -45.58 121.17 3.78 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.943 2.428 . . . . 0.51 112.731 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.74 -11.17 9.56 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.91 -0.662 . . . . 0.7 112.506 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 10.9 pt-20 -133.92 124.65 26.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.954 0.407 . . . . 1.27 110.965 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.504 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -109.45 107.66 17.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.82 0.343 . . . . 2.92 111.066 177.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.585 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.2 mm? -123.41 98.93 6.08 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.186 -0.606 . . . . 0.9 110.354 177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.568 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.6 mm? -148.17 105.48 3.64 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.096 -0.705 . . . . 0.53 109.096 174.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.737 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 24.5 t -154.58 158.67 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.182 -1.044 . . . . 0.91 108.182 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -85.01 108.49 17.63 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.895 -1.15 . . . . 1.55 107.895 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 15.3 m -85.06 94.55 3.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.674 0.749 . . . . 2.56 110.68 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -93.19 125.64 37.89 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.424 -0.807 . . . . 5.36 111.05 -175.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -132.98 26.25 4.27 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.042 -0.981 . . . . 5.8 109.4 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.643 ' HA3' HD13 ' A' ' 217' ' ' LEU . . . 105.29 97.43 2.49 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.17 -0.923 . . . . 5.61 111.34 -174.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 28.2 t -98.01 -62.39 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.177 0.513 . . . . 6.31 110.276 -177.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.498 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 59.5 t80 -59.31 -52.0 77.51 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.003 -0.999 . . . . 8.83 111.766 178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 19.3 Cg_endo -61.63 -42.99 29.09 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.275 1.983 . . . . 7.78 112.946 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.643 HD13 ' HA3' ' A' ' 213' ' ' GLY . 7.6 mp -89.64 28.76 1.25 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.071 0.462 . . . . 8.02 110.917 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -149.38 170.21 29.64 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.961 -0.856 . . . . 8.64 110.961 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 1.1 m -104.56 17.07 24.82 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.179 0.514 . . . . 9.72 110.447 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.484 ' HA ' ' HD3' ' A' ' 221' ' ' PRO . 6.6 m -61.63 125.81 85.44 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.713 -0.676 . . . . 9.62 111.266 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 10.6 Cg_exo -71.37 155.27 60.42 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.69 2.26 . . . . 11.65 111.975 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.11 48.41 2.02 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.081 2.521 . . . . 13.11 111.689 176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 122.21 -99.85 0.68 Allowed Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 110.715 -0.954 . . . . 14.03 110.715 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 33.9 tp -151.04 122.42 7.85 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.646 -0.501 . . . . 16.1 109.646 176.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -112.16 -66.38 1.09 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.368 -0.378 . . . . 17.7 110.756 -176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 . . . . . 0 C--O 1.249 1.064 0 O-C-N 123.71 0.632 . . . . 18.9 111.274 -179.55 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 111.945 -0.462 . . . . 33.26 111.945 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.5 m -135.41 46.9 2.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.199 0.523 . . . . 33.92 110.551 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.78 8.03 17.08 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.575 -0.821 . . . . 32.35 112.274 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -102.15 139.71 20.52 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 110.325 -0.25 . . . . 31.65 110.325 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.42 98.47 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.427 2.085 . . . . 29.99 111.497 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 p -64.91 113.42 3.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.284 0.564 . . . . 28.92 110.967 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.3 m -153.12 44.11 0.63 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.59 -0.732 . . . . 26.94 109.286 179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -87.2 67.0 9.51 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.355 -0.839 . . . . 25.83 111.129 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -106.46 140.12 39.85 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.01 -0.541 . . . . 23.53 109.653 176.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -62.92 109.25 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.0 0.429 . . . . 21.64 110.381 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.7 m -108.97 117.99 52.49 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.864 -0.607 . . . . 19.42 110.821 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.85 144.74 97.06 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.604 2.203 . . . . 17.17 111.402 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 62.9 mttp -86.21 40.43 0.87 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.161 0.505 . . . . 17.47 111.889 -175.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -96.77 116.72 29.63 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.435 -0.58 . . . . 15.63 109.435 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.47 -4.75 84.1 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.798 -0.715 . . . . 12.04 111.89 -176.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 63' ' ' LYS . 14.9 m -65.42 -46.11 69.78 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 112.436 0.532 . . . . 10.67 112.436 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' A' ' 66' ' ' SER . 52.5 Cg_exo -57.26 98.92 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 121.975 1.783 . . . . 9.69 112.12 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -98.75 125.97 44.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.595 -0.73 . . . . 7.7 111.47 -175.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -95.96 135.95 37.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.714 -0.675 . . . . 8.14 109.432 174.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.69 112.92 46.05 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.46 -0.337 . . . . 5.96 110.689 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -62.14 -76.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.269 2.646 . . . . 6.13 112.564 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.3 p -120.96 -32.31 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.939 0.399 . . . . 6.53 110.801 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -105.69 119.86 40.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.055 -0.521 . . . . 5.01 109.763 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.55 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.3 pp -79.06 138.37 56.79 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.978 0.418 . . . . 4.23 110.994 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -77.12 -2.34 12.56 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.752 2.302 . . . . 4.12 113.003 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -72.82 -62.72 1.35 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.688 -0.486 . . . . 3.82 109.688 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.406 ' H ' HD13 ' A' ' 74' ' ' ILE . 16.1 t70 57.2 83.34 0.11 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.766 -1.106 . . . . 3.16 111.02 176.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 78.6 mt -68.43 132.94 91.17 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.446 -0.797 . . . . 2.45 110.45 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.39 121.45 8.88 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.9 2.4 . . . . 1.75 112.522 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.577 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -120.83 152.96 56.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.901 -0.59 . . . . 1.01 109.934 178.386 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.85 150.58 85.74 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.391 2.061 . . . . 0.73 110.995 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.23 8.36 1.35 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.876 -0.602 . . . . 1.04 112.377 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -112.88 1.23 15.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.143 0.497 . . . . 1.66 111.243 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -137.38 136.11 37.58 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.396 -0.964 . . . . 1.0 108.396 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -123.12 130.02 52.21 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.077 -0.649 . . . . 2.27 111.127 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 tt -83.7 130.55 34.96 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.505 -0.554 . . . . 0.79 109.505 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 97.0 mtt180 -143.71 126.85 16.53 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.507 -0.77 . . . . 3.21 109.468 -176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -80.76 111.78 17.52 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.479 -0.488 . . . . 2.46 109.891 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 55.0 p -162.69 97.47 0.96 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.657 -0.701 . . . . 1.58 109.463 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.5 m -68.21 104.08 1.73 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.966 0.412 . . . . 1.86 110.777 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -87.04 122.19 71.24 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.233 -0.654 . . . . 1.45 109.233 175.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.54 119.09 4.68 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.187 2.591 . . . . 1.61 112.821 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 109.01 -20.43 28.8 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 121.003 -0.618 . . . . 1.74 112.685 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.417 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -131.74 -72.45 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 117.032 0.416 . . . . 1.41 111.3 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.533 ' HA3' ' NH1' ' A' ' 173' ' ' ARG . . . 131.85 -130.58 5.99 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.932 -0.651 . . . . 1.09 112.557 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.4 mt -99.68 158.17 15.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.681 0.24 . . . . 2.31 110.485 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.24 -179.85 39.33 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.269 -0.732 . . . . 0.59 111.269 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.8 m -102.9 119.69 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.543 0.687 . . . . 0.67 109.504 174.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.482 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 49.4 m95 -83.83 114.62 21.76 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.562 -0.744 . . . . 1.13 111.023 -170.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.23 115.29 12.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.067 -0.716 . . . . 0.54 109.067 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.532 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -92.55 2.27 56.79 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.648 0.737 . . . . 1.68 109.641 -176.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -125.75 161.24 27.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.979 -1.01 . . . . 3.5 108.355 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 155.99 39.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.0 0.428 . . . . 2.4 111.169 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.668 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 34.8 mtm -120.15 149.31 42.44 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.393 -0.966 . . . . 1.22 108.393 171.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 47.1 mt-10 -119.39 173.88 6.7 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.523 0.678 . . . . 2.31 112.399 -172.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -67.12 115.58 6.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.884 -1.053 . . . . 0.84 111.976 -177.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.32 1.88 57.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.685 -0.769 . . . . 1.04 113.522 171.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 6.8 pt-20 -86.07 166.27 15.97 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.483 0.641 . . . . 2.62 110.647 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.478 ' HG2' ' N ' ' A' ' 110' ' ' LEU . 0.0 OUTLIER -127.96 143.41 51.09 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 116.109 -0.496 . . . . 3.62 110.233 -179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.478 ' N ' ' HG2' ' A' ' 109' ' ' ARG . 7.5 mt -87.35 125.8 34.46 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.128 -1.064 . . . . 0.53 108.128 172.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -140.73 157.14 25.7 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 119.885 -1.15 . . . . 1.02 113.17 -172.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.92 154.33 96.94 Favored 'Cis proline' 0 C--O 1.231 0.171 0 C-N-CA 122.585 -1.839 . . . . 2.1 112.175 -1.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.524 ' HA ' HD12 ' A' ' 169' ' ' LEU . 59.5 m -92.31 -21.47 20.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.913 -0.585 . . . . 2.0 111.061 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.6 m -140.05 176.37 5.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.991 -0.55 . . . . 2.03 110.056 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 165' ' ' ALA . 29.9 m -65.01 -178.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.513 0.673 . . . . 3.95 111.354 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.0 m -73.52 156.79 88.51 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.707 -0.678 . . . . 5.21 110.15 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.72 167.83 4.85 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.503 2.135 . . . . 5.07 112.138 176.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 70.52 -171.7 0.17 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.878 -0.601 . . . . 7.99 109.725 -173.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 58.2 -161.28 0.24 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.783 0.325 . . . . 6.95 111.211 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.28 92.6 1.43 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.092 -0.504 . . . . 6.09 110.383 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.65 116.98 9.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.377 -0.374 . . . . 5.56 111.006 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -88.28 143.18 27.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.044 -0.525 . . . . 7.42 110.655 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -64.77 -39.3 93.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.747 -0.66 . . . . 9.01 109.798 177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.4 m -149.06 -102.02 0.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.625 -0.716 . . . . 8.88 109.497 171.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -159.5 25.18 0.19 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.99 0.424 . . . . 7.6 110.116 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -141.45 155.9 45.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.956 -0.566 . . . . 7.23 111.194 -172.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 119.61 -38.76 2.69 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.901 -0.879 . . . . 4.59 110.901 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.72 -111.91 0.06 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.987 -0.607 . . . . 4.93 111.034 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 130' ' ' GLN . 6.2 pt-20 -149.42 -60.39 0.21 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.522 0.201 . . . . 7.65 110.959 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.441 ' H ' ' HG3' ' A' ' 129' ' ' GLU . 78.9 mt-30 -150.65 141.78 23.11 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 110.223 -0.288 . . . . 8.84 110.223 -176.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 pp -124.26 19.93 4.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.858 0.361 . . . . 6.05 111.917 175.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -90.41 50.82 1.9 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 122.484 1.135 . . . . 8.5 109.509 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.2 t -94.67 25.29 4.09 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.721 -1.581 . . . . 9.82 111.03 -172.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -73.58 132.66 43.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.611 -0.885 . . . . 11.21 108.611 172.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 40.2 t -74.21 85.58 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.526 0.679 . . . . 10.84 110.57 -174.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -103.9 1.57 31.5 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.34 -0.846 . . . . 13.25 109.922 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.5 m -80.84 -7.18 10.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.654 -0.703 . . . . 13.89 111.076 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 44.0 m -85.59 144.26 39.79 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.079 -0.51 . . . . 14.05 110.065 177.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.26 107.6 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.859 2.372 . . . . 14.41 112.261 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 138' ' ' SER . 12.3 mm100 -102.62 38.26 1.75 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.992 -0.549 . . . . 14.44 109.614 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -78.09 -36.47 48.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.492 -0.776 . . . . 15.9 110.841 -173.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -94.19 169.64 29.47 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.762 -0.733 . . . . 15.6 112.171 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 5.4 p -77.69 57.61 1.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.252 0.549 . . . . 15.6 111.142 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 53.7 mt -82.21 -46.54 19.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.742 -0.663 . . . . 13.85 109.841 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.4 p -82.95 134.67 35.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.639 -0.71 . . . . 13.19 111.34 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 -3.41 23.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.209 0.528 . . . . 15.67 109.882 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.488 ' O ' HD12 ' A' ' 147' ' ' ILE . 2.2 pp -80.68 142.23 14.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.457 -0.792 . . . . 13.77 111.458 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.0 p -173.04 48.18 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.301 -0.863 . . . . 13.62 108.81 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -74.59 106.23 6.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.992 -1.003 . . . . 13.02 110.813 -170.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -72.36 127.15 31.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.903 -0.589 . . . . 14.68 111.015 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.5 pp -130.06 31.95 4.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.791 -0.641 . . . . 13.55 109.49 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 132.05 96.57 0.67 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.14 -0.936 . . . . 15.8 111.179 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 24.8 m -65.79 -35.23 80.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.83 0.347 . . . . 17.08 111.246 -176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -106.19 -72.09 0.73 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.391 0.615 . . . . 18.43 110.743 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -129.77 142.11 50.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.245 -0.888 . . . . 18.53 111.171 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -148.37 126.18 11.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.951 -0.568 . . . . 14.32 110.472 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 84.8 m -83.96 61.04 6.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.843 0.354 . . . . 14.51 110.505 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 42.6 t 62.91 108.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.248 -0.887 . . . . 13.06 111.05 -174.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.594 ' OD2' ' HB2' ' A' ' 162' ' ' GLN . 5.2 t70 60.57 169.49 0.09 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.08 -0.964 . . . . 10.33 111.07 -172.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -177.32 -43.54 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.824 -0.625 . . . . 9.88 110.438 -178.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -114.87 19.34 15.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.988 -0.551 . . . . 10.23 111.453 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.594 ' HB2' ' OD2' ' A' ' 159' ' ' ASP . 21.7 mt-30 -127.59 -48.87 1.4 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.036 -0.266 . . . . 9.06 110.702 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 62.01 53.24 3.07 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.365 0.603 . . . . 6.19 110.602 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 115' ' ' VAL . . . -146.12 87.73 0.16 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.381 -0.827 . . . . 3.97 111.557 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 115' ' ' VAL . . . -143.65 170.22 16.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.62 0.248 . . . . 2.63 110.84 -176.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.401 ' HA3' ' C ' ' A' ' 113' ' ' CYS . . . -115.95 14.02 16.86 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.424 -0.671 . . . . 1.3 111.424 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 8.7 t -64.56 -17.66 64.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.267 0.556 . . . . 1.82 110.628 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.498 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 26.9 p-90 -74.31 -21.76 59.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.297 0.57 . . . . 0.7 110.274 177.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 40.6 mt -86.43 -20.22 28.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.738 -0.665 . . . . 0.66 112.1 -175.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -71.88 -5.04 31.62 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.623 -0.431 . . . . 1.48 110.577 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -79.9 -37.27 35.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.913 -0.585 . . . . 1.97 111.798 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.696 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -62.83 131.64 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 120.751 -0.38 . . . . 0.67 110.273 -178.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.533 ' NH1' ' HA3' ' A' ' 95' ' ' GLY . 99.2 mtt180 -115.07 -171.41 1.94 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.296 -0.411 . . . . 4.34 111.429 -174.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.509 HG22 HG11 ' A' ' 208' ' ' VAL . 4.4 t -76.47 141.0 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-N 116.298 -0.41 . . . . 1.07 110.229 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -61.07 138.44 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.821 -0.627 . . . . 0.71 111.944 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 37.6 t -72.85 -6.87 47.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.169 -0.923 . . . . 1.88 110.69 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.3 t -126.07 139.77 53.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 1.63 110.383 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 61.6 m -88.15 -18.81 27.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.052 -0.522 . . . . 1.96 110.59 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -83.97 -14.95 49.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.102 0.477 . . . . 2.42 110.522 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -110.04 17.57 20.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.828 -0.624 . . . . 2.12 111.185 -176.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.498 ' NE2' ' HB3' ' A' ' 175' ' ' ALA . 30.1 mm-40 -54.94 115.49 2.23 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.179 0.514 . . . . 1.35 110.86 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.722 ' H ' HD12 ' A' ' 183' ' ' LEU . 5.5 p-10 -144.05 32.36 1.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.667 0.746 . . . . 1.68 109.384 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.722 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.2 OUTLIER -116.0 124.51 50.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.038 -0.983 . . . . 0.81 110.606 -173.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 97.7 m -146.49 121.59 10.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.287 0.565 . . . . 0.51 111.387 174.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.596 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 39.0 ttm -113.24 129.49 56.51 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 1.35 109.431 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 35.2 t -115.86 165.05 13.52 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.407 -0.59 . . . . 1.73 109.407 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.435 HE22 ' HA ' ' A' ' 190' ' ' GLU . 25.3 tm0? -129.88 105.23 7.86 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.166 -0.679 . . . . 1.93 109.166 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 18.1 pt -136.62 143.93 34.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.748 -0.66 . . . . 1.11 110.518 -175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.4 t 62.56 34.06 15.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.254 0.549 . . . . 1.86 110.312 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.435 ' HA ' HE22 ' A' ' 187' ' ' GLN . 17.3 mm-40 58.32 30.0 18.93 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.377 -0.829 . . . . 2.83 111.979 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -140.54 167.28 22.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.996 0.427 . . . . 1.75 110.212 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.3 mm -82.29 152.33 4.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.982 -0.748 . . . . 1.01 108.982 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -143.75 120.1 10.92 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.754 0.311 . . . . 3.94 110.542 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.545 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 15.0 m-85 -100.9 113.49 26.49 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.734 -0.469 . . . . 0.92 109.734 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.0 tmmm? -118.79 129.45 55.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.654 0.264 . . . . 1.11 110.31 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 1.2 t -95.3 150.99 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.951 0.882 . . . . 0.7 110.645 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -98.68 -45.47 12.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 114.176 -1.375 . . . . 0.62 112.004 -163.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 199' ' ' ASP . 0.1 OUTLIER -154.84 -177.66 6.67 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.155 -0.929 . . . . 1.38 109.886 -173.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.668 ' HA ' ' O ' ' A' ' 104' ' ' MET . 15.4 t70 -59.22 123.32 16.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.374 0.607 . . . . 2.23 111.515 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.413 HG13 ' HE3' ' A' ' 104' ' ' MET . 14.8 mm -106.94 136.58 41.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.805 -0.634 . . . . 0.88 110.323 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.54 122.6 80.89 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.714 -0.676 . . . . 2.06 110.331 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -51.46 119.97 6.26 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.51 2.14 . . . . 0.51 111.745 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.72 -8.5 9.35 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.456 -0.878 . . . . 0.7 112.374 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -132.5 123.24 26.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.295 0.569 . . . . 1.27 110.146 172.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.3 96.2 6.14 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.729 -0.668 . . . . 2.92 111.436 -178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.466 ' C ' HD22 ' A' ' 207' ' ' LEU . 0.8 OUTLIER -115.58 99.89 7.67 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.836 -0.745 . . . . 0.9 110.114 177.195 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.696 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.87 112.99 6.14 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.069 -0.715 . . . . 0.53 109.069 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.631 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 3.9 p -155.28 160.08 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 O-C-N 121.984 -0.447 . . . . 0.91 110.96 -176.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.596 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 54.9 t-80 -80.27 128.6 33.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.564 -0.902 . . . . 1.55 108.564 166.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.48 94.58 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.386 -0.598 . . . . 2.56 109.386 174.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 209' ' ' HIS . 49.8 mtpt -86.78 126.67 34.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.615 -0.721 . . . . 5.36 111.017 -173.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 216' ' ' PRO . 12.3 pt-20 -154.1 -147.69 0.22 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.469 -0.787 . . . . 5.8 108.9 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -81.63 42.66 2.82 Favored Glycine 0 C--N 1.32 -0.324 0 C-N-CA 121.098 -0.573 . . . . 5.61 113.401 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 29.9 t -109.35 -80.74 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.946 0.403 . . . . 6.31 110.698 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.512 ' H ' ' HD2' ' A' ' 216' ' ' PRO . 64.0 m-85 -94.95 -50.03 0.25 Allowed Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 113.022 0.749 . . . . 8.83 113.022 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.512 ' HD2' ' H ' ' A' ' 215' ' ' TYR . 17.8 Cg_endo -60.79 -44.87 23.23 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.741 1.627 . . . . 7.78 112.709 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.8 mp -86.72 -25.26 24.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.218 0.532 . . . . 8.02 110.707 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 69.81 17.11 72.96 Favored Glycine 0 C--N 1.33 0.247 0 CA-C-N 115.582 -0.735 . . . . 8.64 112.891 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 4.9 p -88.1 48.8 1.69 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.241 0.543 . . . . 9.72 111.542 -176.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 221' ' ' PRO . 3.9 m -85.63 116.49 65.85 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.8 -0.636 . . . . 9.62 111.251 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 2.3 Cg_endo -80.34 129.35 7.56 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.637 2.225 . . . . 11.65 111.509 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.52 95.41 0.39 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.637 2.225 . . . . 13.11 112.267 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 88.92 165.24 41.09 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.788 -0.642 . . . . 14.03 112.215 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 50.0 tp -115.38 123.98 50.06 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.734 -0.469 . . . . 16.1 109.734 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.62 -22.61 14.42 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.984 0.421 . . . . 17.7 110.983 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.321 -0.847 . . . . 18.9 109.759 177.111 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.771 0 N-CA-C 111.737 -0.545 . . . . 33.26 111.737 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.1 p -65.4 110.33 2.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.11 0.481 . . . . 33.92 111.342 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.73 -41.84 0.69 Allowed Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.302 -0.719 . . . . 32.35 111.302 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -120.15 108.38 38.37 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 109.785 -0.45 . . . . 31.65 109.785 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.76 125.92 16.39 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.498 2.132 . . . . 29.99 111.717 -176.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.7 p 46.81 68.72 0.58 Allowed 'General case' 0 C--O 1.233 0.227 0 O-C-N 123.759 0.662 . . . . 28.92 111.465 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.4 m -62.66 141.93 58.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.907 -0.588 . . . . 26.94 109.969 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -103.01 18.81 20.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.217 0.532 . . . . 25.83 110.498 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -90.65 51.6 2.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.756 -0.656 . . . . 23.53 110.662 -177.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -70.9 109.5 5.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 21.64 110.736 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.4 p -113.06 108.74 52.85 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.551 -0.75 . . . . 19.42 110.371 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.24 117.43 4.28 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.576 2.184 . . . . 17.17 112.235 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -114.31 55.55 0.74 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.585 -0.734 . . . . 17.47 109.061 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -108.48 103.91 13.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.361 -0.836 . . . . 15.63 110.913 -172.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.21 64.61 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.528 -0.844 . . . . 12.04 112.517 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.7 m -128.0 86.38 58.27 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.722 0.296 . . . . 10.67 110.78 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -86.48 156.07 9.25 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.865 2.377 . . . . 9.69 112.671 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.444 ' CE1' ' HG2' ' A' ' 75' ' ' PRO . 71.7 t80 -76.2 85.44 3.03 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.737 -0.665 . . . . 7.7 109.644 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.494 ' O ' ' HD3' ' A' ' 71' ' ' PRO . 8.9 tp10 -81.72 121.17 26.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.25 -0.432 . . . . 8.14 110.088 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.4 93.45 13.67 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 116.132 -0.485 . . . . 5.96 110.808 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 69' ' ' GLU . 28.6 Cg_endo -91.53 -156.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.983 2.455 . . . . 6.13 111.74 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.21 -31.8 46.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.08 0.466 . . . . 6.53 110.793 178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -111.03 107.01 16.27 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.528 -0.545 . . . . 5.01 109.528 176.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.413 HD12 ' CG ' ' A' ' 76' ' ' GLU . 27.9 pt -80.11 154.43 74.92 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.202 -0.453 . . . . 4.23 111.232 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.444 ' HG2' ' CE1' ' A' ' 68' ' ' TYR . 87.1 Cg_endo -87.8 14.67 2.31 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.972 2.448 . . . . 4.12 113.163 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.413 ' CG ' HD12 ' A' ' 74' ' ' ILE . 24.5 mm-40 -68.82 -58.86 3.59 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.283 -0.636 . . . . 3.82 109.283 173.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 66.21 84.73 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.597 -1.183 . . . . 3.16 111.503 175.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 74.0 mt -86.71 120.04 71.6 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.152 -0.931 . . . . 2.45 109.95 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.91 116.96 4.12 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.347 2.031 . . . . 1.75 111.442 175.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 168' ' ' TRP . 0.2 OUTLIER -131.59 147.28 65.41 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.399 -0.364 . . . . 1.01 110.365 -178.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 80' ' ' ILE . 2.8 Cg_exo -75.93 133.05 14.82 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.346 2.031 . . . . 0.73 110.761 171.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.03 -8.88 33.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.765 0.317 . . . . 1.04 111.6 -176.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -70.74 -19.7 62.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.049 -0.523 . . . . 1.66 110.606 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.53 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 19.0 m-85 -123.78 148.27 46.82 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.346 -0.612 . . . . 1.0 109.346 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.438 ' HB2' ' HE2' ' A' ' 101' ' ' LYS . 7.2 tp10 -109.9 117.38 33.67 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.786 -0.366 . . . . 2.27 110.495 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.443 ' HA ' HG12 ' A' ' 98' ' ' VAL . 8.3 tt -83.67 130.09 34.96 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.409 -0.589 . . . . 0.79 109.409 178.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -143.89 124.4 13.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.06 -0.518 . . . . 3.21 111.443 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -83.03 112.48 19.81 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.432 -0.581 . . . . 2.46 109.432 171.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 33.0 t -170.09 149.58 3.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.118 -0.697 . . . . 1.58 109.118 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 31.3 m -100.61 104.91 16.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.746 0.308 . . . . 1.86 110.871 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -97.56 123.77 50.99 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.229 -0.656 . . . . 1.45 109.229 175.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.16 121.1 9.36 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.023 2.482 . . . . 1.61 112.738 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.48 -15.66 35.16 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.724 -0.671 . . . . 1.74 112.07 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.502 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -132.99 -60.14 0.87 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.839 0.352 . . . . 1.41 111.7 179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.561 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 121.74 -125.87 6.28 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.307 -0.717 . . . . 1.09 111.307 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 89' ' ' SER . 0.7 OUTLIER -89.0 160.67 17.0 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.803 -0.443 . . . . 2.31 109.803 173.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -178.2 169.49 41.27 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.19 -1.005 . . . . 0.59 112.779 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 86' ' ' LEU . 11.3 m -104.2 148.81 8.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.1 -0.704 . . . . 0.67 109.1 174.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -118.53 120.17 36.71 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.647 0.26 . . . . 1.13 110.753 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.517 ' H ' ' HG2' ' A' ' 205' ' ' GLU . . . -71.61 122.36 20.39 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.235 -0.283 . . . . 0.54 110.235 176.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.685 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -90.36 11.91 19.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.657 0.741 . . . . 1.68 110.141 -178.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 35.2 ttp85 -137.35 159.11 42.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.155 -0.929 . . . . 3.5 108.565 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.657 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -85.34 155.93 21.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.956 0.408 . . . . 2.4 110.744 -178.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 63.0 mtm -132.05 153.01 50.84 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.171 -0.677 . . . . 1.22 109.171 176.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -120.07 143.68 47.99 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.13 0.269 . . . . 2.31 110.842 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . . . -34.89 117.33 0.38 Allowed 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.76 1.287 . . . . 0.84 113.544 -172.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.44 7.89 11.77 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.688 -0.687 . . . . 1.04 111.76 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.507 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -80.39 161.71 24.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.114 0.483 . . . . 2.62 110.71 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.546 ' HG3' ' CE2' ' A' ' 193' ' ' TYR . 0.0 OUTLIER -141.17 145.45 35.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.139 -0.482 . . . . 3.62 110.513 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.53 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 6.3 mt -107.51 150.74 26.46 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.36 -0.607 . . . . 0.53 109.36 173.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 111.13 -143.24 17.14 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.318 -0.944 . . . . 1.02 113.319 173.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.23 165.94 47.59 Favored 'Cis proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.822 -1.324 . . . . 2.1 113.316 2.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 31.7 t -87.51 -57.96 2.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 2.0 110.655 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.7 m -115.48 132.29 65.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.905 0.383 . . . . 2.03 110.35 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.4 t -117.29 35.99 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.899 0.857 . . . . 3.95 109.285 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.9 p -89.63 116.91 67.55 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.1 -0.955 . . . . 5.21 110.783 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 118' ' ' ARG . 60.7 Cg_endo -88.15 104.5 0.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.733 2.289 . . . . 5.07 112.1 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.622 ' NE ' ' HA ' ' A' ' 118' ' ' ARG . 1.4 mmp_? 73.76 144.93 0.08 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.727 -0.669 . . . . 7.99 111.42 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 54.49 62.81 2.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.226 -0.897 . . . . 6.95 110.349 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.75 114.52 2.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.687 -0.688 . . . . 6.09 111.527 -178.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -135.46 122.56 21.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.761 -0.654 . . . . 5.56 110.304 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -76.51 167.27 22.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.887 -0.597 . . . . 7.42 110.278 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.68 -74.4 0.07 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.94 0.4 . . . . 9.01 110.338 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 42.8 m -159.15 -56.36 0.06 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.38 -0.6 . . . . 8.88 109.38 175.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -73.46 160.13 32.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.54 -0.755 . . . . 7.6 110.569 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -141.32 139.76 33.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.012 0.434 . . . . 7.23 110.631 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -89.15 -9.21 67.76 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.96 -0.638 . . . . 4.59 111.865 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 209' ' ' HIS . 0.8 OUTLIER -130.76 -78.41 0.53 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 110.553 -0.166 . . . . 4.93 110.553 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.641 ' OE1' ' HD2' ' A' ' 216' ' ' PRO . 1.8 pt-20 -168.42 -72.94 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.624 0.231 . . . . 7.65 111.624 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.431 ' HG3' ' HG ' ' A' ' 132' ' ' LEU . 6.4 tp-100 -171.76 160.68 5.72 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.247 -0.279 . . . . 8.84 110.247 -174.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.443 ' CG2' HD11 ' A' ' 192' ' ' ILE . 0.2 OUTLIER -126.66 47.75 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 6.05 111.503 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.431 ' HG ' ' HG3' ' A' ' 130' ' ' GLN . 0.9 OUTLIER -81.14 53.45 2.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 122.327 1.06 . . . . 8.5 111.065 179.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 25.3 p -95.31 27.32 3.35 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.143 -1.389 . . . . 9.82 109.282 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.403 ' CG ' HH22 ' A' ' 118' ' ' ARG . 27.5 t70 -133.56 98.51 4.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.609 -1.178 . . . . 11.21 109.992 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 49.7 t -77.48 109.81 12.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.953 -0.567 . . . . 10.84 109.97 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -76.12 78.62 2.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.308 0.575 . . . . 13.25 110.282 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 p -128.71 4.42 2.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.529 0.681 . . . . 13.89 110.294 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.0 m -127.67 97.58 30.13 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.074 -0.512 . . . . 14.05 111.111 -175.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.87 77.69 3.98 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.657 2.238 . . . . 14.41 111.683 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.24 30.66 2.42 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.713 -0.676 . . . . 14.44 110.983 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -95.39 171.62 8.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.83 -0.623 . . . . 15.9 110.546 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.77 -80.04 0.2 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.939 -0.573 . . . . 15.6 111.669 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 7.0 p -111.66 46.13 1.15 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.124 0.488 . . . . 15.6 110.78 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 61.5 mt -76.37 -38.13 32.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.112 0.482 . . . . 13.85 110.272 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.7 t -82.11 55.92 2.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.2 1.0 . . . . 13.19 110.332 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -90.8 -16.25 28.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.413 -0.812 . . . . 15.67 110.229 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.426 ' H ' HG13 ' A' ' 147' ' ' ILE . 2.1 pp -96.85 155.24 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.562 -0.744 . . . . 13.77 110.661 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.4 m -136.09 152.72 51.15 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.687 0.279 . . . . 13.62 110.838 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -93.38 85.1 4.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.233 -0.439 . . . . 13.02 110.374 177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.68 79.49 9.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.0 -0.546 . . . . 14.68 110.501 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.3 54.05 2.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.6 0.714 . . . . 13.55 110.741 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.85 137.28 2.96 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.32 -0.854 . . . . 15.8 111.035 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.3 m -76.26 -16.83 59.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.202 0.525 . . . . 17.08 110.805 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -113.35 -66.08 1.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.402 0.62 . . . . 18.43 109.787 175.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.03 170.88 15.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.19 -0.914 . . . . 18.53 109.128 177.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -132.48 27.89 4.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.272 0.558 . . . . 14.32 110.925 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 50.4 t -75.8 90.02 2.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.355 -0.839 . . . . 14.51 110.33 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.1 p -161.91 135.94 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.788 -0.642 . . . . 13.06 109.994 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -75.76 63.88 1.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.457 0.646 . . . . 10.33 110.84 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -116.41 -69.29 0.86 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.136 -0.938 . . . . 9.88 109.562 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -93.23 -13.92 27.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.311 0.576 . . . . 10.23 109.783 174.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -84.47 -18.93 34.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.481 -0.781 . . . . 9.06 110.398 178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.48 35.18 0.22 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.78 -0.645 . . . . 6.19 111.148 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -87.14 55.78 4.57 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.831 -0.622 . . . . 3.97 111.567 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -69.35 -30.78 68.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.964 0.411 . . . . 2.63 110.835 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 84.85 -34.62 3.16 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.005 -0.617 . . . . 1.3 112.333 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.524 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 1.2 m -57.27 -29.9 64.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.668 0.387 . . . . 1.82 111.499 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.493 ' HB3' HG22 ' A' ' 80' ' ' ILE . 45.5 p-90 -85.59 -23.46 27.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.7 111.13 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 17.7 mt -86.4 -15.55 40.01 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.805 0.298 . . . . 0.66 111.805 -177.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -76.13 -1.71 27.44 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.806 -0.358 . . . . 1.48 110.413 177.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.426 ' CE2' HD11 ' A' ' 86' ' ' LEU . 37.9 m-85 -81.67 -37.13 27.92 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.112 -0.495 . . . . 1.97 112.058 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -65.07 140.99 18.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 120.151 -0.62 . . . . 0.67 110.913 -173.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 -123.7 -168.27 1.75 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.839 -0.619 . . . . 4.34 111.467 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.401 HG22 HG11 ' A' ' 208' ' ' VAL . 7.0 t -69.63 156.64 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.58 -0.737 . . . . 1.07 110.626 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.576 ' HA ' HD12 ' A' ' 206' ' ' LEU . . . -55.88 132.99 51.04 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.141 -0.481 . . . . 0.71 110.508 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 21.1 m -71.77 -20.87 61.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.604 -0.725 . . . . 1.88 111.033 -174.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.403 ' HB2' ' OD1' ' A' ' 180' ' ' ASP . 24.7 m -130.63 157.11 43.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.466 -0.334 . . . . 1.63 111.181 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 3.3 p -59.01 -56.71 18.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.219 0.451 . . . . 1.96 112.219 -177.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -74.76 -1.4 21.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.097 -0.501 . . . . 2.42 111.758 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.403 ' OD1' ' HB2' ' A' ' 177' ' ' SER . 4.5 m-20 -95.06 17.32 14.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.264 -0.426 . . . . 2.12 111.623 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 30.2 mm-40 -56.57 113.77 1.75 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.976 0.417 . . . . 1.35 109.889 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.554 ' OD1' ' HE2' ' A' ' 198' ' ' LYS . 17.8 t30 -159.25 43.82 0.24 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 108.121 -1.066 . . . . 1.68 108.121 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.599 ' HB3' ' O ' ' A' ' 206' ' ' LEU . 0.7 OUTLIER -142.42 128.86 20.11 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.003 -0.998 . . . . 0.81 111.578 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 29.8 m -150.38 120.81 7.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.088 -0.96 . . . . 0.51 110.184 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.585 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 44.9 ttm -109.19 118.44 36.72 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.654 -0.498 . . . . 1.35 109.654 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 36.7 t -113.86 166.42 11.59 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.169 -0.469 . . . . 1.73 109.774 -176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -124.09 134.39 53.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.829 0.347 . . . . 1.93 110.653 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 23.5 pt -148.05 140.94 18.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.722 -0.672 . . . . 1.11 109.946 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 190' ' ' GLU . 8.3 t 54.4 38.99 30.6 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.113 0.482 . . . . 1.86 110.62 176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 190' ' ' GLU . 37.0 tt0 72.79 -1.47 3.0 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.186 -0.916 . . . . 2.83 112.163 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -117.8 154.2 32.18 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.443 -0.785 . . . . 1.75 111.367 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.443 HD11 ' CG2' ' A' ' 131' ' ' ILE . 26.8 mm -81.66 129.12 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.348 -0.842 . . . . 1.01 111.157 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.546 ' CE2' ' HG3' ' A' ' 109' ' ' ARG . 72.8 t80 -114.97 131.19 56.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.763 -1.108 . . . . 3.94 109.737 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 3.9 m-85 -98.98 112.3 24.46 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.157 -0.683 . . . . 0.92 109.157 179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.42 ' HD2' ' C ' ' A' ' 195' ' ' LYS . 5.0 tmmm? -112.1 120.07 40.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.7 -0.682 . . . . 1.11 109.454 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.56 HG22 HD11 ' A' ' 207' ' ' LEU . 1.8 t -94.33 150.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 CA-C-O 121.591 0.71 . . . . 0.7 109.326 176.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.8 mm -87.71 -55.58 6.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 114.696 -1.138 . . . . 0.62 110.65 -166.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.554 ' HE2' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -144.71 -178.84 6.21 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.722 -0.672 . . . . 1.38 111.973 177.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.0 OUTLIER -47.25 128.71 12.15 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.767 1.025 . . . . 2.23 113.767 -171.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 38.7 mm -95.25 136.79 25.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.348 -0.842 . . . . 0.88 110.545 176.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 42.5 mt-10 -89.55 123.3 67.01 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.457 -0.572 . . . . 2.06 109.457 171.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' A' ' 103' ' ' LYS . 77.2 Cg_exo -47.22 123.18 7.36 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.258 2.639 . . . . 0.51 112.602 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.2 -18.77 8.32 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.914 -0.66 . . . . 0.7 112.84 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 11.0 pt-20 -132.55 121.25 22.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.523 0.661 . . . . 1.27 111.898 -178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.517 ' HG2' ' H ' ' A' ' 100' ' ' ALA . 13.2 mm-40 -110.32 118.02 35.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 2.92 109.982 172.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.599 ' O ' ' HB3' ' A' ' 183' ' ' LEU . 1.9 mm? -112.28 100.8 9.09 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.376 -0.972 . . . . 0.9 108.376 171.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.692 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.3 mm? -143.44 113.49 7.23 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.492 0.495 . . . . 0.53 109.891 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.549 HG12 HD12 ' A' ' 183' ' ' LEU . 1.4 p -152.21 159.53 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.837 0.351 . . . . 0.91 110.289 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.585 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 44.8 t-80 -98.52 111.22 23.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.689 -1.226 . . . . 1.55 107.689 171.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.5 m -66.91 110.36 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 109.241 -0.652 . . . . 2.56 109.241 175.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -51.05 124.59 11.75 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.565 -0.743 . . . . 5.36 111.279 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -111.37 -1.87 15.82 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.179 -0.918 . . . . 5.8 110.611 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' A' ' 217' ' ' LEU . . . 101.22 67.05 0.8 Allowed Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.381 -0.827 . . . . 5.61 112.599 176.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 44.1 t -109.88 -62.09 2.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.59 0.71 . . . . 6.31 109.398 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.447 ' HB3' ' HD3' ' A' ' 216' ' ' PRO . 90.9 t80 -92.38 -63.07 0.18 Allowed Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.339 -0.846 . . . . 8.83 112.239 -179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.641 ' HD2' ' OE1' ' A' ' 129' ' ' GLU . 32.1 Cg_endo -63.56 -50.42 3.38 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.033 1.822 . . . . 7.78 113.355 -173.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.478 ' HB2' ' HA2' ' A' ' 213' ' ' GLY . 7.7 mp -73.64 -42.53 61.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 8.02 110.978 -177.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 107.41 -134.41 12.18 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.97 -0.634 . . . . 8.64 111.689 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 41.2 p 51.68 44.46 29.19 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.385 0.674 . . . . 9.72 111.191 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 27.2 m -67.7 153.25 95.38 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.675 -0.693 . . . . 9.62 111.616 -173.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.462 ' HB2' ' HD3' ' A' ' 222' ' ' PRO . 53.5 Cg_exo -50.5 -51.65 10.6 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.422 2.081 . . . . 11.65 113.404 177.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.462 ' HD3' ' HB2' ' A' ' 221' ' ' PRO . 90.0 Cg_endo -77.72 27.27 0.47 Allowed 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 121.771 1.647 . . . . 13.11 112.57 176.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -101.57 153.44 18.85 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.501 -0.639 . . . . 14.03 111.501 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 40.6 tp -150.57 127.57 11.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.666 0.27 . . . . 16.1 110.829 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.08 6.77 4.6 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.832 -0.433 . . . . 17.7 109.832 174.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 . . . . . 0 C--O 1.252 1.203 0 CA-C-N 115.554 -0.748 . . . . 18.9 110.416 -177.213 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 112.27 -0.332 . . . . 33.26 112.27 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 p -132.21 36.37 3.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.278 0.561 . . . . 33.92 110.169 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.16 62.79 4.21 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.622 -0.717 . . . . 32.35 112.413 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.438 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 88.9 m-85 -102.36 133.41 20.58 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 109.817 -0.438 . . . . 31.65 109.817 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 54' ' ' PHE . 21.2 Cg_exo -65.36 83.28 0.21 Allowed 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.741 2.294 . . . . 29.99 111.679 176.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.2 p -73.31 -18.23 61.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.149 -0.478 . . . . 28.92 111.283 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.6 p -77.55 57.03 1.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.798 -0.637 . . . . 26.94 110.98 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -82.58 79.65 8.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.039 -0.528 . . . . 25.83 110.705 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.82 134.36 53.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.959 0.409 . . . . 23.53 110.402 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -117.13 98.43 6.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.899 -0.591 . . . . 21.64 110.012 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.6 m -83.91 117.4 68.57 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.126 -0.488 . . . . 19.42 109.875 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.62 120.53 8.1 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.092 1.862 . . . . 17.17 110.978 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -81.25 66.19 6.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.499 0.666 . . . . 17.47 111.123 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -77.05 109.51 10.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.079 -0.964 . . . . 15.63 109.551 174.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.14 154.13 33.67 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 121.03 -0.605 . . . . 12.04 111.921 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.4 t -71.36 113.84 22.85 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 110.034 -0.358 . . . . 10.67 110.034 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -84.7 142.75 9.3 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.7 2.266 . . . . 9.69 112.344 -176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -83.49 129.16 34.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.637 -0.505 . . . . 7.7 109.637 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -96.08 136.43 36.55 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.849 -0.614 . . . . 8.14 110.219 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.503 ' HB1' ' O ' ' A' ' 73' ' ' TYR . . . -63.36 118.55 44.84 Favored Pre-proline 0 N--CA 1.448 -0.534 0 CA-C-N 116.175 -0.466 . . . . 5.96 110.116 176.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 22.7 Cg_exo -65.43 -81.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.899 2.399 . . . . 6.13 112.725 -178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.411 ' H ' ' HB2' ' A' ' 71' ' ' PRO . 10.2 p -107.79 -39.87 4.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.281 -0.418 . . . . 6.53 110.476 178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.503 ' O ' ' HB1' ' A' ' 70' ' ' ALA . 33.2 p90 -87.75 119.13 27.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.068 -0.515 . . . . 5.01 109.966 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.468 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.4 pp -87.25 151.25 51.0 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 116.273 -0.422 . . . . 4.23 110.945 177.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -87.27 19.24 1.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.856 2.371 . . . . 4.12 112.963 -175.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' HB2' HD13 ' A' ' 74' ' ' ILE . 33.8 mt-10 -89.58 -68.61 0.77 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.656 -0.498 . . . . 3.82 109.656 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.9 t70 53.88 78.29 0.16 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.73 0.643 . . . . 3.16 111.244 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 59.5 mt -107.64 133.53 20.38 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.106 -0.497 . . . . 2.45 110.519 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.45 125.14 10.97 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.532 2.155 . . . . 1.75 112.218 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.694 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -111.9 159.03 35.03 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.142 -0.481 . . . . 1.01 110.973 -175.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -64.52 162.47 30.83 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.33 2.686 . . . . 0.73 112.648 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.19 -4.38 17.37 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.438 0.903 . . . . 1.04 113.438 -170.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 59.8 m-20 -111.64 1.78 16.95 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.529 -0.468 . . . . 1.66 111.839 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -128.2 140.67 51.78 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.456 ' HB2' ' HD2' ' A' ' 101' ' ' LYS . 37.0 tt0 -122.48 126.21 47.39 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.569 -0.452 . . . . 2.27 110.183 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.591 HD11 ' CE2' ' A' ' 171' ' ' TYR . 6.2 tt -83.98 127.2 33.71 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.85 -0.614 . . . . 0.79 109.533 -178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.42 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 45.4 mtp180 -152.86 128.44 10.05 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.231 -0.895 . . . . 3.21 109.792 -174.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.3 112.55 19.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 109.099 -0.704 . . . . 2.46 109.099 174.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -163.96 92.14 0.66 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.529 -0.915 . . . . 1.58 108.529 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 m -54.35 105.4 0.15 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.678 -0.692 . . . . 1.86 112.083 -172.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -92.19 123.38 62.76 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.627 -0.715 . . . . 1.45 109.181 173.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -46.58 116.9 1.78 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.449 2.766 . . . . 1.61 113.366 -175.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.87 -27.18 13.54 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.005 -0.617 . . . . 1.74 112.491 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.05 -62.32 1.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.81 0.338 . . . . 1.41 111.133 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 115.09 -113.6 2.99 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.009 -0.615 . . . . 1.09 111.922 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.38 159.29 24.39 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 122.122 0.169 . . . . 2.31 110.683 176.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.04 -179.19 46.38 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.618 -0.801 . . . . 0.59 112.109 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.435 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 29.4 m -115.77 114.66 46.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.6 0.714 . . . . 0.67 109.88 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 28.2 m95 -83.22 120.14 25.44 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.513 -0.767 . . . . 1.13 110.98 -170.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -66.51 121.76 16.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.236 -0.438 . . . . 0.54 110.39 177.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.456 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 1.1 mppt? -90.73 -9.02 48.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.153 0.502 . . . . 1.68 110.286 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -135.47 157.44 46.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.308 -0.86 . . . . 3.5 108.681 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.6 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.1 OUTLIER -79.27 159.83 27.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 120.913 0.387 . . . . 2.4 110.38 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.808 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 52.8 mtm -129.13 142.05 51.0 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.395 -0.594 . . . . 1.22 109.395 177.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.35 140.81 37.91 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.852 -0.425 . . . . 2.31 109.852 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.07 128.26 3.56 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 124.175 0.922 . . . . 0.84 112.488 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.85 7.8 11.38 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.55 -0.75 . . . . 1.04 111.681 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 108' ' ' GLU . 0.6 OUTLIER -86.08 163.89 17.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.096 0.474 . . . . 2.62 111.297 -179.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -145.98 135.34 22.97 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.585 -0.524 . . . . 3.62 109.585 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 5.0 mt -101.47 143.37 31.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.848 -0.427 . . . . 0.53 109.848 178.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 124.77 -136.13 9.81 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.693 -0.765 . . . . 1.02 112.34 176.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.441 ' HA ' ' HA3' ' A' ' 111' ' ' GLY . 71.6 Cg_endo -75.22 149.54 93.62 Favored 'Cis proline' 0 C--N 1.343 0.267 0 C-N-CA 123.309 -1.538 . . . . 2.1 112.645 2.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.461 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . 31.0 t -95.67 151.39 19.39 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.662 -0.866 . . . . 2.0 108.662 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 53.4 t 59.47 84.97 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.776 -0.824 . . . . 2.03 108.776 -168.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 163' ' ' ALA . 28.3 m -71.54 -166.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.12 -0.945 . . . . 3.95 111.88 -174.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 2.1 p -47.33 115.24 3.47 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 116.029 -0.532 . . . . 5.21 111.28 -178.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 116' ' ' VAL . 27.7 Cg_exo -62.45 88.63 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.145 2.563 . . . . 5.07 112.877 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -100.51 -32.06 10.97 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.044 -0.724 . . . . 7.99 109.044 172.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -151.6 -53.51 0.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.895 -1.048 . . . . 6.95 109.56 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 49.53 55.99 8.52 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.804 0.69 . . . . 6.09 111.984 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -124.01 89.66 3.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.49 -0.777 . . . . 5.56 110.835 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -90.99 172.58 8.48 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.172 -0.922 . . . . 7.42 110.289 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -60.07 -70.84 0.15 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.279 -0.419 . . . . 9.01 110.812 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 47.1 m -149.16 -69.3 0.21 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.597 -0.52 . . . . 8.88 109.597 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.2 t70 65.06 163.53 0.15 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.644 0.735 . . . . 7.6 111.647 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -113.84 121.6 44.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.968 -0.56 . . . . 7.23 110.676 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -175.41 -48.88 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.377 -0.689 . . . . 4.59 111.377 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . 0.539 ' CD1' HD11 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -136.95 -109.56 0.19 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.517 -0.341 . . . . 4.93 111.117 176.102 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' A' ' 130' ' ' GLN . 10.7 pt-20 -165.0 -43.03 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.002 0.429 . . . . 7.65 109.937 176.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.402 ' N ' ' HG3' ' A' ' 129' ' ' GLU . 48.4 mt-30 -144.55 150.73 38.0 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.125 -0.489 . . . . 8.84 110.28 -177.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.43 -20.06 6.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.953 0.406 . . . . 6.05 110.772 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.76 65.5 9.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.865 0.84 . . . . 8.5 111.37 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 56.1 p -93.04 37.34 1.03 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.118 -0.946 . . . . 9.82 110.22 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.4 t70 58.66 66.92 0.99 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.379 -0.828 . . . . 11.21 109.755 -175.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.01 108.14 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.365 -0.834 . . . . 10.84 111.418 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -143.37 78.78 1.61 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.593 -0.731 . . . . 13.25 109.74 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.8 p -86.83 -16.55 9.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.813 0.816 . . . . 13.89 108.865 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 27.3 t -173.53 136.56 0.7 Allowed Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 114.499 -1.228 . . . . 14.05 108.211 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.9 78.07 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.518 2.145 . . . . 14.41 112.013 177.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -92.08 54.02 2.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.72 -0.673 . . . . 14.44 110.718 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.22 83.43 3.69 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.752 -0.658 . . . . 15.9 110.511 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 138.93 -42.74 1.23 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.956 -0.64 . . . . 15.6 111.812 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 34.3 t -135.24 83.84 2.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.993 0.425 . . . . 15.6 110.624 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.57 -35.74 75.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.232 0.539 . . . . 13.85 109.75 176.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -156.93 132.23 9.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.652 -0.704 . . . . 13.19 110.219 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -94.46 -13.2 26.42 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.529 0.681 . . . . 15.67 109.599 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.9 pt -109.79 168.07 4.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.13 -0.941 . . . . 13.77 110.366 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 33.3 t -129.31 120.5 25.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.037 0.446 . . . . 13.62 110.579 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -78.33 86.54 4.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.055 -0.72 . . . . 13.02 109.055 172.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -139.24 140.93 37.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.539 -0.755 . . . . 14.68 109.975 -174.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 pp -109.73 14.69 23.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.286 0.565 . . . . 13.55 111.539 -176.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 140.58 143.45 4.32 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.738 -0.744 . . . . 15.8 112.224 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.0 m -84.52 -1.1 55.29 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.889 0.376 . . . . 17.08 111.121 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -94.07 -82.7 0.35 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.201 -0.454 . . . . 18.43 111.705 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -115.77 168.07 10.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.821 -0.627 . . . . 18.53 111.4 -172.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 62.1 35.65 15.67 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.442 -0.799 . . . . 14.32 111.225 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 42.4 t -83.65 -24.95 31.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.126 0.488 . . . . 14.51 110.674 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 55.4 t -125.96 129.86 72.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.046 -0.524 . . . . 13.06 110.025 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.46 70.67 0.56 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 123.674 0.609 . . . . 10.33 111.309 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -148.6 -96.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.113 -0.494 . . . . 9.88 110.996 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -122.53 -32.25 3.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.709 0.29 . . . . 10.23 111.611 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.554 ' HG2' ' N ' ' A' ' 163' ' ' ALA . 1.0 OUTLIER -79.89 -45.43 18.63 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 122.02 0.914 . . . . 9.06 108.952 -179.062 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.554 ' N ' ' HG2' ' A' ' 162' ' ' GLN . . . -122.47 142.31 50.7 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.705 -1.588 . . . . 6.19 110.219 175.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.74 11.15 74.7 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.576 -0.821 . . . . 3.97 112.174 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -75.78 -8.07 55.96 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.893 0.331 . . . . 2.63 111.893 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 113' ' ' CYS . . . -140.21 19.45 2.86 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.31 -0.948 . . . . 1.3 112.768 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 17.3 m -79.3 -28.62 42.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.107 0.48 . . . . 1.82 110.447 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.518 ' CB ' HG22 ' A' ' 80' ' ' ILE . 40.5 p-90 -65.03 -17.46 64.46 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.693 -0.685 . . . . 0.7 111.33 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 65.3 mt -68.78 -14.18 62.86 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.229 -0.896 . . . . 0.66 112.002 -175.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.452 ' C ' ' HD3' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -69.69 -13.19 62.18 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.671 0.272 . . . . 1.48 111.189 178.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.591 ' CE2' HD11 ' A' ' 86' ' ' LEU . 46.1 m-85 -78.47 -37.83 42.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 1.97 111.924 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.579 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -70.51 125.68 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.638 -0.425 . . . . 0.67 110.141 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 173' ' ' ARG . 48.8 mtp85 -117.85 -161.76 0.84 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.282 -0.417 . . . . 4.34 111.657 -176.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.8 t -72.37 157.62 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.116 -0.493 . . . . 1.07 111.213 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.781 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -57.15 153.34 11.93 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.802 -0.635 . . . . 0.71 112.167 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 28.8 p -85.98 -10.72 54.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.333 -0.849 . . . . 1.88 110.678 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 34.0 m -153.63 170.87 19.79 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.193 -0.458 . . . . 1.63 110.82 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . 0.549 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 10.5 p -71.95 -43.09 65.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.154 0.502 . . . . 1.96 110.87 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -78.26 4.02 13.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.404 0.621 . . . . 2.42 110.439 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -101.94 16.46 25.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.371 -0.832 . . . . 2.12 110.468 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 31.5 mm-40 -67.53 113.89 5.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 1.35 111.015 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.785 ' H ' HD12 ' A' ' 183' ' ' LEU . 16.6 t30 -150.94 33.64 0.6 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.253 1.025 . . . . 1.68 108.354 173.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.785 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.2 OUTLIER -124.24 123.2 39.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.41 -0.813 . . . . 0.81 110.701 -171.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 96.0 m -150.8 127.4 10.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.111 0.482 . . . . 0.51 110.738 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.555 ' SD ' ' HB2' ' A' ' 209' ' ' HIS . 63.6 mtp -114.4 136.05 53.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.951 0.405 . . . . 1.35 110.218 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 1.4 p -113.51 137.56 51.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.654 -0.703 . . . . 1.73 110.775 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -109.08 104.01 13.12 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.796 -0.816 . . . . 1.93 108.796 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 27.5 pt -141.56 145.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.957 -0.565 . . . . 1.11 110.371 -176.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 29.2 m 65.13 26.4 12.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 1.86 110.897 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 62.76 19.47 11.46 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.407 -0.815 . . . . 2.83 111.28 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -131.7 168.03 18.46 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.481 -0.563 . . . . 1.75 109.481 177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.539 HD11 ' CD1' ' A' ' 128' ' ' TRP . 48.3 mm -99.89 132.41 45.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.179 0.514 . . . . 1.01 111.903 -175.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -125.02 137.4 54.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.995 -0.548 . . . . 3.94 110.747 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 169' ' ' LEU . 7.3 m-85 -100.94 117.08 34.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.966 -0.561 . . . . 0.92 109.725 178.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.2 tmmm? -113.01 120.28 40.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.926 0.394 . . . . 1.11 110.405 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.43 HG22 HD11 ' A' ' 207' ' ' LEU . 2.0 t -88.01 152.74 3.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.321 -0.622 . . . . 0.7 109.321 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.55 -56.18 5.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 115.09 -0.959 . . . . 0.62 112.105 -166.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.632 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -135.02 175.79 9.25 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.953 -0.567 . . . . 1.38 111.379 -173.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.808 ' HA ' ' O ' ' A' ' 104' ' ' MET . 17.0 t70 -50.18 112.54 0.69 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.762 0.791 . . . . 2.23 112.061 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.69 HD11 ' ND2' ' A' ' 182' ' ' ASN . 8.9 mm -79.94 136.22 23.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.633 -1.167 . . . . 0.88 111.117 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.622 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 42.3 mt-10 -88.5 126.96 58.44 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 109.261 -0.644 . . . . 2.06 109.261 173.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.51 111.8 0.78 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 121.86 1.706 . . . . 0.51 111.019 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.04 -6.4 10.23 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.63 -0.795 . . . . 0.7 113.175 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 22.2 pt-20 -115.24 121.26 42.39 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.687 0.744 . . . . 1.27 110.636 174.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.456 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -111.72 95.38 5.46 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.045 -0.525 . . . . 2.92 111.549 174.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.49 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.8 mm? -122.35 99.72 6.57 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.121 -0.632 . . . . 0.9 109.569 174.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.579 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -146.47 113.37 6.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.973 0.509 . . . . 0.53 109.83 177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.659 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.1 p -154.87 160.4 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 110.098 -0.334 . . . . 0.91 110.098 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.555 ' HB2' ' SD ' ' A' ' 185' ' ' MET . 59.3 t-80 -93.69 109.87 21.51 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.902 -1.147 . . . . 1.55 107.902 171.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 28.5 m -73.75 128.99 36.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.603 -0.517 . . . . 2.56 109.603 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -123.9 164.32 19.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.094 -0.503 . . . . 5.36 111.437 -169.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -91.23 14.44 14.35 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.336 -0.847 . . . . 5.8 109.927 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.418 ' HA3' HD13 ' A' ' 217' ' ' LEU . . . 92.42 78.9 1.41 Allowed Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.74 -0.664 . . . . 5.61 111.917 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.83 -73.08 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.935 0.398 . . . . 6.31 110.819 -175.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.472 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 99.6 m-85 -72.45 -52.75 6.48 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.754 -0.657 . . . . 8.83 111.913 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 34.9 Cg_endo -65.42 -56.97 0.29 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.108 1.872 . . . . 7.78 113.489 -176.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.418 HD13 ' HA3' ' A' ' 213' ' ' GLY . 7.8 mp -75.33 -71.12 0.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.528 0.204 . . . . 8.02 110.869 -175.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 219' ' ' THR . . . 157.02 159.35 9.43 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.483 -0.865 . . . . 8.64 112.689 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 218' ' ' GLY . 14.6 t 175.67 -23.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 122.791 0.436 . . . . 9.72 109.851 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 35.4 m -88.56 150.82 47.14 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.952 -0.567 . . . . 9.62 110.098 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.4 111.38 0.85 Allowed 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.891 2.394 . . . . 11.65 112.336 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -80.65 47.55 2.6 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.003 2.469 . . . . 13.11 112.451 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -119.57 154.29 16.51 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.703 -0.68 . . . . 14.03 111.56 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.3 tp -69.0 125.83 27.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.924 0.392 . . . . 16.1 110.434 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.74 -49.51 0.89 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.192 -0.458 . . . . 17.7 110.725 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 119.002 -0.523 . . . . 18.9 110.685 -179.719 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 111.845 -0.502 . . . . 33.26 111.845 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.5 m -74.55 104.17 5.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.184 0.516 . . . . 33.92 110.964 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.32 -150.62 22.37 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.066 -0.814 . . . . 32.35 111.066 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -122.97 77.02 50.38 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.941 0.371 . . . . 31.65 110.824 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.22 120.97 7.37 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.664 2.242 . . . . 29.99 111.425 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.5 m -61.3 113.66 2.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.042 0.449 . . . . 28.92 110.524 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.5 m -100.18 61.64 1.08 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.153 -0.476 . . . . 26.94 110.223 -175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 60.46 28.89 18.56 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.277 -0.874 . . . . 25.83 111.044 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -113.55 137.96 50.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.027 -0.533 . . . . 23.53 110.613 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -102.59 139.2 38.5 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.885 -0.598 . . . . 21.64 110.175 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 9.9 t -106.57 127.0 29.0 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.398 -0.365 . . . . 19.42 110.032 176.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 36.7 Cg_exo -61.02 138.27 77.37 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.785 2.323 . . . . 17.17 112.516 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -72.2 -16.86 61.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.615 -0.721 . . . . 17.47 110.235 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.83 106.54 1.91 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.582 -0.735 . . . . 15.63 110.104 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.92 12.43 74.35 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.765 -0.731 . . . . 12.04 111.963 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.8 t -84.99 113.6 50.94 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.981 -0.377 . . . . 10.67 109.981 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.25 100.02 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.828 2.352 . . . . 9.69 111.999 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -147.5 117.56 7.26 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.765 -0.652 . . . . 7.7 109.63 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -100.64 153.79 19.13 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.839 -0.619 . . . . 8.14 110.07 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.51 110.08 10.47 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.961 -0.563 . . . . 5.96 111.563 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.34 -164.67 0.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.963 2.442 . . . . 6.13 111.326 177.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 p -62.84 -34.34 65.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.929 0.395 . . . . 6.53 110.146 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -116.61 113.31 22.53 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.731 -0.47 . . . . 5.01 109.731 174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.487 ' CD1' ' H ' ' A' ' 77' ' ' ASP . 2.4 pp -88.46 137.58 30.54 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.245 -0.434 . . . . 4.23 110.497 176.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -85.88 10.74 3.56 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.932 2.421 . . . . 4.12 112.586 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -82.7 -64.65 1.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.812 -0.631 . . . . 3.82 110.858 -177.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.487 ' H ' ' CD1' ' A' ' 74' ' ' ILE . 1.7 m-20 68.46 95.3 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.578 -0.737 . . . . 3.16 110.963 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 81.9 mt -69.26 124.45 90.46 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.429 -0.805 . . . . 2.45 110.445 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -72.12 116.56 4.76 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.322 2.014 . . . . 1.75 111.013 175.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.561 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -125.73 146.31 54.62 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.275 -0.42 . . . . 1.01 110.3 -177.127 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.03 124.45 16.3 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.27 1.98 . . . . 0.73 110.406 170.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.21 -8.37 12.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.415 0.524 . . . . 1.04 112.415 -173.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.61 -9.03 31.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.197 0.522 . . . . 1.66 111.542 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -134.52 156.75 48.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -121.46 116.15 24.18 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.135 -0.626 . . . . 2.27 111.246 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.406 HD11 ' CE2' ' A' ' 171' ' ' TYR . 8.3 tt -86.41 128.2 34.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.782 -0.451 . . . . 0.79 109.782 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -151.12 130.66 13.0 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.48 -0.782 . . . . 3.21 109.682 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -68.21 112.03 4.89 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.367 -0.605 . . . . 2.46 109.367 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.7 t -169.52 110.7 0.46 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.423 -0.584 . . . . 1.58 109.423 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 t -90.85 107.77 19.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.21 -0.45 . . . . 1.86 110.739 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.58 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -79.11 121.95 83.8 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.35 -0.611 . . . . 1.45 109.35 175.024 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -51.42 114.93 1.77 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.371 2.714 . . . . 1.61 112.988 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.09 -9.83 36.74 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.95 -0.643 . . . . 1.74 112.727 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.58 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -135.76 -60.26 0.74 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.971 0.385 . . . . 1.41 111.665 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.431 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 122.76 -146.09 16.5 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.647 -0.787 . . . . 1.09 112.716 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 mt -80.4 159.03 25.82 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.254 -0.276 . . . . 2.31 110.254 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.414 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -165.03 169.09 39.51 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.802 -0.713 . . . . 0.59 111.774 178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 27.5 m -98.41 114.21 35.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.773 0.796 . . . . 0.67 109.262 172.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -81.76 101.76 10.34 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.234 -0.893 . . . . 1.13 110.663 -167.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.37 115.22 5.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.733 -0.667 . . . . 0.54 109.701 175.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.539 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -94.0 15.76 16.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.607 0.717 . . . . 1.68 109.515 -177.347 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -148.43 160.83 42.65 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.562 -1.199 . . . . 3.5 108.144 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.76 158.79 34.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.435 0.636 . . . . 2.4 111.453 -174.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 54.0 mtm -134.5 143.71 47.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.98 -1.119 . . . . 1.22 107.98 170.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 52.3 mt-10 -130.28 174.45 9.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.004 0.43 . . . . 2.31 112.157 -172.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.64 122.48 11.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.495 -0.775 . . . . 0.84 113.054 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.18 -25.53 11.28 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 1.04 113.927 169.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 10.1 pt-20 -73.98 160.92 30.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.375 0.607 . . . . 2.62 112.007 -174.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.71 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 0.7 OUTLIER -124.9 134.64 52.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.029 -0.987 . . . . 3.62 110.474 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 mt -87.84 133.52 33.88 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.973 -0.751 . . . . 0.53 108.973 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 141.87 -132.87 5.43 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.487 -0.863 . . . . 1.02 112.433 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.06 134.4 17.97 Favored 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 123.947 -1.272 . . . . 2.1 112.881 1.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.401 ' O ' ' HB ' ' A' ' 114' ' ' VAL . 53.4 t -70.06 -28.23 65.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.486 -0.779 . . . . 2.0 111.642 -175.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 113' ' ' CYS . 8.0 p 178.72 151.31 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 109.862 -0.421 . . . . 2.03 109.862 -177.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.3 -159.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.926 -0.768 . . . . 3.95 108.926 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.3 p -54.99 117.28 13.59 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-O 120.965 0.412 . . . . 5.21 110.195 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.523 ' HB2' ' O ' ' A' ' 121' ' ' ALA . 81.9 Cg_endo -77.3 62.92 7.72 Favored 'Trans proline' 0 C--O 1.237 0.439 0 C-N-CA 122.978 2.452 . . . . 5.07 113.132 -174.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 69.19 -58.59 0.5 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.895 0.878 . . . . 7.99 111.103 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.71 -66.5 0.23 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.672 -0.694 . . . . 6.95 109.268 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -163.16 56.37 0.19 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.682 -0.69 . . . . 6.09 109.96 175.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 117' ' ' PRO . . . -145.55 121.1 10.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.106 -0.952 . . . . 5.56 110.245 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -57.63 140.76 50.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.702 -0.681 . . . . 7.42 111.52 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -115.36 -33.34 5.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.297 0.57 . . . . 9.01 110.989 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 36.1 m -155.7 -40.98 0.08 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 122.067 0.937 . . . . 8.88 109.21 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -51.62 158.62 0.9 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.219 -1.81 . . . . 7.6 111.931 176.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -167.04 149.37 6.17 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.24 -0.891 . . . . 7.23 109.427 175.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.483 ' HA3' ' HE3' ' A' ' 211' ' ' LYS . . . 106.78 59.28 0.59 Allowed Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.226 -0.988 . . . . 4.59 113.487 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . 0.465 ' CD1' HD11 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -138.91 -162.63 1.34 Allowed 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.515 -1.291 . . . . 4.93 107.515 176.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 130' ' ' GLN . 10.0 pt-20 -83.15 -46.82 12.29 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.131 -0.692 . . . . 7.65 109.131 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 129' ' ' GLU . 47.4 tt0 165.63 103.91 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.092 0 O-C-N 124.29 0.994 . . . . 8.84 109.44 176.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.404 HD12 HD12 ' A' ' 132' ' ' LEU . 1.9 pp -92.17 3.81 7.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.405 -0.518 . . . . 6.05 110.51 175.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.404 HD12 HD12 ' A' ' 131' ' ' ILE . 5.8 mp -80.62 69.97 7.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.839 -0.619 . . . . 8.5 109.722 177.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.1 p -120.17 29.21 7.62 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.338 -0.847 . . . . 9.82 110.253 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -64.34 110.4 2.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.321 -0.854 . . . . 11.21 110.415 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 56.5 t -74.41 137.27 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.856 -0.611 . . . . 10.84 109.888 178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.94 71.59 1.56 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.8 0.81 . . . . 13.25 110.584 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.7 p -93.35 -20.73 6.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.303 -0.862 . . . . 13.89 109.534 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.6 m -124.04 95.13 44.5 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.598 -0.728 . . . . 14.05 110.365 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.02 89.25 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.857 2.372 . . . . 14.41 111.554 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -101.69 -16.04 16.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.993 -0.548 . . . . 14.44 111.636 -175.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -57.58 130.5 46.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.223 0.535 . . . . 15.9 111.342 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.77 -11.47 49.66 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.741 -0.742 . . . . 15.6 111.57 -175.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 13.4 p -159.24 40.25 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.249 0.547 . . . . 15.6 110.294 178.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 63.6 mt -78.8 116.44 22.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.725 -0.671 . . . . 13.85 109.98 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.2 t -84.28 124.36 31.15 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.491 -0.559 . . . . 13.19 109.491 178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -122.06 -7.84 8.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.846 -0.616 . . . . 15.67 111.497 -172.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.3 pp -104.72 134.25 46.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.217 0.532 . . . . 13.77 111.052 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.6 t 174.41 53.56 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.81 -1.086 . . . . 13.62 108.574 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -128.01 44.48 2.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.399 -0.819 . . . . 13.02 112.141 -170.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -86.25 80.6 8.69 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.487 0.661 . . . . 14.68 109.457 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.474 ' HB2' ' CG ' ' A' ' 156' ' ' PHE . 2.7 pp -113.2 25.6 11.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.678 -0.692 . . . . 13.55 111.035 -177.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -117.72 66.04 0.35 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.694 -0.685 . . . . 15.8 111.993 178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.3 t -145.78 -77.29 0.19 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.1 -0.333 . . . . 17.08 110.1 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -107.77 -76.45 0.61 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.038 0.446 . . . . 18.43 111.012 -176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -152.42 153.18 33.06 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.808 -0.633 . . . . 18.53 110.215 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.474 ' CG ' ' HB2' ' A' ' 151' ' ' LEU . 39.2 p90 -144.03 149.94 37.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.039 0.447 . . . . 14.32 111.099 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 43.0 t -138.5 34.77 2.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.576 0.703 . . . . 14.51 109.13 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.4 p -132.06 134.69 59.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.525 -0.761 . . . . 13.06 110.961 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.401 ' HA ' HE21 ' A' ' 162' ' ' GLN . 27.3 t0 -93.28 90.09 6.66 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.272 -0.422 . . . . 10.33 109.881 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -100.59 -45.63 5.46 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.09 -0.504 . . . . 9.88 110.594 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -126.66 25.64 6.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.215 -0.448 . . . . 10.23 111.712 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' A' ' 159' ' ' ASP . 50.2 mt-30 -97.3 -49.77 4.81 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 121.151 -0.22 . . . . 9.06 110.758 -178.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 57.66 57.85 4.04 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.548 0.689 . . . . 6.19 110.814 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -105.04 -116.49 4.22 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.478 -0.783 . . . . 3.97 111.696 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 59.86 -79.7 0.02 OUTLIER 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.45 0.7 . . . . 2.63 112.778 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -134.33 18.47 4.17 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.714 -0.755 . . . . 1.3 112.821 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.52 ' O ' ' HG2' ' A' ' 170' ' ' LYS . 3.5 p -65.99 -24.74 66.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.138 0.494 . . . . 1.82 110.774 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -84.22 -17.68 39.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.019 -0.537 . . . . 0.7 110.544 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.7 -14.13 58.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.993 -0.549 . . . . 0.66 111.442 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 167' ' ' SER . 21.2 ptmt -64.66 -18.98 65.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.927 0.394 . . . . 1.48 110.5 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.414 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 53.6 m-85 -72.53 -37.57 68.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.92 -0.582 . . . . 1.97 111.621 -175.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -73.97 117.73 18.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.513 0.673 . . . . 0.67 110.855 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.73 -172.05 2.48 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.891 -1.05 . . . . 4.34 110.3 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.517 ' HA ' HD22 ' A' ' 183' ' ' LEU . 2.3 p -65.2 147.03 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.345 0.593 . . . . 1.07 111.781 -176.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.593 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -59.15 149.45 28.08 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.611 -1.177 . . . . 0.71 112.599 -174.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 53.7 t -60.32 -44.43 95.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.117 -0.947 . . . . 1.88 110.828 175.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 87.1 p -137.75 164.64 28.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.72 -0.474 . . . . 1.63 109.72 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . 0.478 ' HA ' ' OE1' ' A' ' 181' ' ' GLN . 75.8 m -78.4 4.36 13.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.279 -0.419 . . . . 1.96 111.849 -176.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -89.06 -7.34 56.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.2 0.524 . . . . 2.42 109.647 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.529 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . 23.6 m-20 -109.04 15.59 23.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.566 -0.743 . . . . 2.12 110.813 -176.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.478 ' OE1' ' HA ' ' A' ' 178' ' ' CYS . 15.0 mm100 -66.52 115.7 6.68 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.572 0.701 . . . . 1.35 111.746 -172.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.748 ' H ' HD12 ' A' ' 183' ' ' LEU . 14.1 t30 -165.03 39.74 0.07 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.682 -1.229 . . . . 1.68 107.682 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.748 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.7 OUTLIER -122.05 119.87 32.67 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.522 -0.763 . . . . 0.81 111.301 -170.422 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.5 m -150.93 121.82 7.6 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.241 0.543 . . . . 0.51 111.884 174.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.575 ' HB3' ' HB2' ' A' ' 209' ' ' HIS . 10.8 ttm -111.51 129.3 56.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.273 -0.64 . . . . 1.35 109.273 172.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 49.9 t -115.31 155.79 26.66 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.733 0.301 . . . . 1.73 110.266 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.44 ' HG3' ' HB3' ' A' ' 128' ' ' TRP . 25.4 tm0? -116.01 112.39 21.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.291 -0.633 . . . . 1.93 109.291 178.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.517 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 41.5 pt -138.54 143.17 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.46 -0.336 . . . . 1.11 110.675 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.9 t 55.86 37.86 29.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.067 -0.515 . . . . 1.86 111.639 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 60.47 28.43 18.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.824 -0.625 . . . . 2.83 111.712 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 12.9 pt20 -145.11 156.22 43.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.859 0.361 . . . . 1.75 110.49 178.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.465 HD11 ' CD1' ' A' ' 128' ' ' TRP . 47.6 mm -82.25 134.79 26.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 121.191 0.52 . . . . 1.01 111.264 -175.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -124.64 122.3 37.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.669 -0.696 . . . . 3.94 109.665 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.71 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 26.4 m-85 -99.37 113.69 26.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.095 -0.705 . . . . 0.92 109.095 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -111.25 127.1 55.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.351 -0.386 . . . . 1.11 110.375 -172.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.466 HG23 ' HG3' ' A' ' 108' ' ' GLU . 1.5 t -95.19 150.73 4.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.91 0.862 . . . . 0.7 110.248 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.6 mm -100.22 -53.67 7.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 113.841 -1.527 . . . . 0.62 111.618 -163.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.422 ' HE3' ' C ' ' A' ' 198' ' ' LYS . 0.0 OUTLIER -153.3 -178.89 7.26 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.065 -0.97 . . . . 1.38 110.799 -179.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 104' ' ' MET . 9.6 p-10 -52.85 110.96 0.58 Allowed 'General case' 0 N--CA 1.465 0.287 0 O-C-N 123.992 0.808 . . . . 2.23 112.673 -172.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 200' ' ' ILE . 2.6 mm -80.89 134.47 27.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.693 -0.685 . . . . 0.88 110.349 171.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 12.5 mm-40 -81.67 120.56 78.16 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.548 -0.751 . . . . 2.06 109.559 173.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -46.51 115.43 1.19 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.145 2.564 . . . . 0.51 112.358 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.27 -11.49 9.18 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.71 -0.757 . . . . 0.7 113.076 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 13.0 pt-20 -123.46 125.59 45.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.78 0.79 . . . . 1.27 111.613 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -108.96 99.88 9.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.529 -1.214 . . . . 2.92 112.069 -175.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.552 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.1 mm? -122.55 100.38 6.9 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.492 -0.483 . . . . 0.9 110.473 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.53 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.0 mm? -145.61 113.67 6.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.816 0.446 . . . . 0.53 110.303 174.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.691 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.9 p -155.83 161.79 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 O-C-N 122.164 -0.335 . . . . 0.91 110.41 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.575 ' HB2' ' HB3' ' A' ' 185' ' ' MET . 33.0 t-80 -131.44 109.89 10.63 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.189 -0.671 . . . . 1.55 109.189 161.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 86.1 t -68.93 121.79 18.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.186 0.517 . . . . 2.56 109.746 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.483 ' HE3' ' HA3' ' A' ' 127' ' ' GLY . 53.9 mttm -112.0 164.35 13.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.618 -0.719 . . . . 5.36 110.083 -174.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -77.75 50.88 0.88 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.283 -0.417 . . . . 5.8 112.122 -173.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.553 ' HA2' HD13 ' A' ' 217' ' ' LEU . . . 52.16 49.44 50.02 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.882 -0.599 . . . . 5.61 113.674 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.1 -74.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.044 0.449 . . . . 6.31 110.018 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.582 ' H ' ' HD2' ' A' ' 216' ' ' PRO . 66.7 m-85 -94.82 -46.81 0.27 Allowed Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.928 -0.578 . . . . 8.83 112.367 175.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.582 ' HD2' ' H ' ' A' ' 215' ' ' TYR . 14.8 Cg_endo -56.54 -46.26 31.34 Favored 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 121.901 1.734 . . . . 7.78 112.805 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.553 HD13 ' HA2' ' A' ' 213' ' ' GLY . 7.2 mp -94.46 -57.27 2.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.943 0.402 . . . . 8.02 110.425 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 94.27 47.55 2.8 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.623 -0.799 . . . . 8.64 112.001 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 23.1 p -105.04 4.18 31.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.02 0.438 . . . . 9.72 110.984 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 19.8 m -85.47 150.34 53.91 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.155 -0.475 . . . . 9.62 111.135 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.459 ' HB2' ' HD3' ' A' ' 222' ' ' PRO . 50.7 Cg_exo -50.95 -51.82 10.39 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.714 2.276 . . . . 11.65 113.687 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 221' ' ' PRO . 92.7 Cg_endo -81.1 26.86 0.59 Allowed 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 121.643 1.562 . . . . 13.11 112.212 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -111.99 73.0 0.21 Allowed Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.905 -0.589 . . . . 14.03 111.632 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.4 tt -59.27 127.2 30.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.922 0.392 . . . . 16.1 110.355 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -115.89 9.0 14.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.077 0.465 . . . . 17.7 110.705 -177.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.873 -0.584 . . . . 18.9 110.63 -177.036 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.953 -0.459 . . . . 33.26 111.953 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.9 m 63.83 23.81 13.53 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.174 0.512 . . . . 33.92 111.211 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.14 137.73 4.35 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.006 -0.616 . . . . 32.35 111.699 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.469 ' CD2' ' HD2' ' A' ' 55' ' ' PRO . 64.0 t80 -167.34 141.08 2.97 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 108.978 -0.749 . . . . 31.65 108.978 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.469 ' HD2' ' CD2' ' A' ' 54' ' ' PHE . 30.3 Cg_endo -64.74 70.1 0.24 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.78 2.32 . . . . 29.99 112.438 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 m -101.13 30.04 4.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.732 0.777 . . . . 28.92 109.307 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 p -87.16 110.59 20.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.206 -0.907 . . . . 26.94 111.275 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.16 84.39 1.94 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.246 0.546 . . . . 25.83 109.65 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -127.22 126.55 42.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.588 -0.733 . . . . 23.53 109.671 174.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.7 t80 54.86 78.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.381 -0.827 . . . . 21.64 111.407 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.4 137.72 97.21 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.067 -0.515 . . . . 19.42 110.299 174.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.8 99.73 0.15 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.557 2.171 . . . . 17.17 111.482 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -80.87 -31.1 35.46 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.265 -0.879 . . . . 17.47 110.697 -176.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -122.59 147.1 46.8 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.866 -0.607 . . . . 15.63 110.37 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.23 66.74 3.14 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.067 -0.587 . . . . 12.04 111.707 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 p -55.99 120.21 32.13 Favored Pre-proline 0 C--N 1.328 -0.362 0 C-N-CA 122.885 0.474 . . . . 10.67 111.645 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -68.12 96.35 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.842 2.362 . . . . 9.69 112.132 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -101.39 118.91 37.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.613 -0.721 . . . . 7.7 109.954 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -81.13 96.37 7.17 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.1 0.476 . . . . 8.14 110.601 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.91 140.06 95.95 Favored Pre-proline 0 N--CA 1.447 -0.589 0 CA-C-N 115.483 -0.781 . . . . 5.96 110.419 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.68 -158.59 0.07 OUTLIER 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.809 2.339 . . . . 6.13 112.312 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.43 -38.55 70.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.27 -0.423 . . . . 6.53 111.028 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -87.77 121.05 29.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.362 -0.381 . . . . 5.01 109.99 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.511 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.0 pp -77.23 140.83 65.93 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.058 -0.519 . . . . 4.23 111.929 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.6 1.51 9.2 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.266 2.644 . . . . 4.12 112.453 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.32 -53.08 62.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.696 -0.683 . . . . 3.82 109.758 176.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 28.2 t70 74.16 94.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.54 -1.209 . . . . 3.16 110.551 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 69.3 mt -80.87 123.46 82.25 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.238 -0.892 . . . . 2.45 110.745 -174.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.95 116.57 4.44 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.323 2.015 . . . . 1.75 111.867 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.545 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -118.43 134.81 23.42 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.199 -0.455 . . . . 1.01 109.933 178.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.52 146.9 50.54 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.584 2.189 . . . . 0.73 111.936 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.25 6.89 3.89 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.268 0.84 . . . . 1.04 113.268 -168.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -116.97 5.91 12.93 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 121.798 -0.564 . . . . 1.66 112.102 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.581 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 10.6 m-85 -130.47 138.35 50.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.66 -0.867 . . . . 1.0 108.66 176.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.481 ' HB2' ' HD2' ' A' ' 101' ' ' LYS . 1.2 tp10 -108.52 117.42 34.13 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.759 -0.376 . . . . 2.27 110.37 -174.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.439 ' HA ' HG12 ' A' ' 98' ' ' VAL . 6.6 tt -84.13 126.85 33.5 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.955 -0.758 . . . . 0.79 108.955 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.425 ' N ' HD23 ' A' ' 86' ' ' LEU . 78.5 mtp180 -149.52 119.02 6.91 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.622 -0.717 . . . . 3.21 110.74 -173.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -73.47 112.24 9.37 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.997 -0.742 . . . . 2.46 108.997 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.4 p -155.16 158.7 39.36 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.674 -0.694 . . . . 1.58 109.355 -174.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.1 m -99.47 103.14 14.88 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.837 -0.431 . . . . 1.86 109.837 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -108.04 111.38 62.09 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 116.194 -0.457 . . . . 1.45 109.94 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -58.42 125.2 17.7 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.034 2.49 . . . . 1.61 112.92 -177.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.76 -13.3 38.54 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.889 -0.672 . . . . 1.74 112.136 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -136.27 -54.83 0.75 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.125 0.488 . . . . 1.41 110.631 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.78 -94.65 0.5 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 115.319 -0.855 . . . . 1.09 111.213 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.495 HD13 ' HA ' ' A' ' 171' ' ' TYR . 0.5 OUTLIER -108.99 160.52 15.95 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.805 -0.698 . . . . 2.31 109.626 172.196 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -170.39 165.63 38.89 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.079 -1.057 . . . . 0.59 112.997 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 205' ' ' GLU . 15.9 m -106.7 147.17 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.825 -0.435 . . . . 0.67 109.825 174.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -109.2 117.21 33.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.533 -0.303 . . . . 1.13 110.617 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 202' ' ' PRO . . . -67.46 128.65 37.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.525 -0.307 . . . . 0.54 110.173 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.481 ' HD2' ' HB2' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -99.54 -9.07 23.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 1.68 111.249 -176.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 103' ' ' LYS . 20.9 tpt180 -125.85 150.3 47.97 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.208 0.528 . . . . 3.5 111.448 -176.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.471 ' N ' ' HG3' ' A' ' 102' ' ' ARG . 1.5 tptm -61.32 138.45 58.24 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.866 -1.061 . . . . 2.4 111.061 173.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.513 ' HE3' HG13 ' A' ' 200' ' ' ILE . 77.5 mtm -127.86 152.61 47.61 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.607 -0.886 . . . . 1.22 108.607 173.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -114.7 135.16 54.46 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 123.232 0.332 . . . . 2.31 110.563 -174.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.415 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . . . -37.79 112.7 0.23 Allowed 'General case' 0 N--CA 1.464 0.248 0 O-C-N 124.872 1.357 . . . . 0.84 112.803 -174.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.95 7.26 11.75 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.581 -0.736 . . . . 1.04 111.341 -177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.464 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -75.37 165.91 24.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.907 0.384 . . . . 2.62 110.398 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.461 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 2.4 tmm_? -145.61 131.65 19.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.37 -0.377 . . . . 3.62 111.063 -176.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.581 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 4.8 mt -99.48 137.11 38.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.058 -0.719 . . . . 0.53 109.058 176.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.85 -168.21 31.15 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.314 -0.946 . . . . 1.02 112.438 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.45 146.11 86.0 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.736 -1.36 . . . . 2.1 112.395 1.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 t -76.49 -18.14 58.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 2.0 110.691 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.4 p -171.79 132.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 116.213 -0.449 . . . . 2.03 110.527 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.87 72.44 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.645 -0.872 . . . . 3.95 108.645 175.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.9 p -105.25 110.0 63.88 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.688 -0.687 . . . . 5.21 111.604 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -87.14 52.29 2.48 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.822 2.348 . . . . 5.07 111.32 174.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -142.8 -76.41 0.26 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.07 -0.968 . . . . 7.99 109.977 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -176.97 161.16 1.9 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.175 -0.92 . . . . 6.95 108.938 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -97.2 119.7 36.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.887 -0.412 . . . . 6.09 109.887 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -113.48 128.51 56.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.924 0.392 . . . . 5.56 110.985 -177.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.459 ' HD3' ' HG2' ' A' ' 130' ' ' GLN . 24.5 pttm -67.41 136.24 54.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.625 -0.716 . . . . 7.42 111.608 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -84.75 -57.46 3.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.967 -1.015 . . . . 9.01 110.902 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 17.3 m -145.15 -64.03 0.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.85 0.315 . . . . 8.88 111.85 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -99.35 -170.67 1.94 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.269 0.557 . . . . 7.6 112.125 -170.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.467 ' HB3' ' HG3' ' A' ' 130' ' ' GLN . 36.3 p90 -146.13 145.48 30.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.052 -0.976 . . . . 7.23 110.121 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.415 ' HA2' ' HD3' ' A' ' 211' ' ' LYS . . . -139.82 -76.26 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.7 -0.762 . . . . 4.59 112.065 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . 0.648 ' CD1' ' HG2' ' A' ' 129' ' ' GLU . 16.5 p90 -77.38 -36.99 53.0 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.305 -0.998 . . . . 4.93 108.305 176.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.648 ' HG2' ' CD1' ' A' ' 128' ' ' TRP . 13.7 pt-20 -160.11 -159.08 0.68 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.845 -1.525 . . . . 7.65 107.03 170.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.467 ' HG3' ' HB3' ' A' ' 126' ' ' PHE . 31.8 tt0 -120.83 53.04 1.14 Allowed 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.409 -0.516 . . . . 8.84 111.408 -167.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.499 HG13 ' HG3' ' A' ' 129' ' ' GLU . 1.9 pp -139.78 40.67 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.204 0.526 . . . . 6.05 111.073 175.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.459 ' HG ' ' CH2' ' A' ' 128' ' ' TRP . 10.0 mp -59.41 100.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.547 -0.751 . . . . 8.5 110.504 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.6 t -106.26 47.55 0.87 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.529 0.681 . . . . 9.82 110.897 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -73.92 83.64 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.735 -0.666 . . . . 11.21 110.033 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.8 p -46.96 112.21 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.642 0.734 . . . . 10.84 111.836 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -106.37 -74.8 0.65 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.451 -0.795 . . . . 13.25 110.525 -176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.3 p -94.45 -26.44 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.171 -0.468 . . . . 13.89 110.178 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.7 t 57.6 80.11 0.3 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.095 -0.502 . . . . 14.05 111.313 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -86.18 163.14 10.0 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.408 2.072 . . . . 14.41 111.832 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 61.1 33.81 19.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.987 -0.551 . . . . 14.44 111.342 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.49 -178.97 4.06 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.703 -0.48 . . . . 15.9 109.703 176.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.97 -45.45 3.2 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.656 -0.783 . . . . 15.6 111.592 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 6.0 p -95.52 32.06 1.88 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.454 0.645 . . . . 15.6 110.509 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.7 mt -108.92 -44.21 6.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.32 -0.854 . . . . 13.85 109.319 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.9 p -77.71 54.05 1.18 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.395 -0.82 . . . . 13.19 111.08 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -85.93 -19.14 30.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.988 0.899 . . . . 15.67 108.752 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 147' ' ' ILE . 19.3 pt -97.08 168.05 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.02 -1.445 . . . . 13.77 109.337 175.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 28.8 m -117.72 114.13 22.87 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.817 0.341 . . . . 13.62 110.332 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -81.3 85.22 6.44 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.239 -0.437 . . . . 13.02 110.306 178.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -65.78 121.56 15.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.925 -0.58 . . . . 14.68 109.997 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 52.7 mt -109.16 35.04 3.41 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.209 -0.451 . . . . 13.55 110.521 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 173.96 -89.84 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.255 -0.974 . . . . 15.8 112.675 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.8 t -168.43 -36.97 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.226 0.536 . . . . 17.08 109.985 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -107.06 -83.02 0.54 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.775 -0.648 . . . . 18.43 110.232 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -135.87 -178.33 5.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.544 -0.753 . . . . 18.53 109.925 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -145.68 120.56 9.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.109 0.481 . . . . 14.32 110.985 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 63.3 m -100.33 46.7 0.95 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.338 0.59 . . . . 14.51 109.737 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.87 147.33 13.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.783 -0.644 . . . . 13.06 110.366 -176.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -92.79 139.99 29.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.008 -0.542 . . . . 10.33 110.24 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -124.17 -76.96 0.59 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.81 0.338 . . . . 9.88 110.863 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -80.75 -8.44 59.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.995 0.426 . . . . 10.23 110.931 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -77.08 -20.36 55.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.792 -0.64 . . . . 9.06 110.609 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.74 90.47 4.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.012 -0.54 . . . . 6.19 111.09 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.65 -105.66 0.19 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.098 -0.801 . . . . 3.97 111.098 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.418 ' C ' ' H ' ' A' ' 167' ' ' SER . . . 47.95 79.89 0.06 Allowed 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.184 0.593 . . . . 2.63 112.221 177.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -75.03 26.88 1.16 Allowed Glycine 0 CA--C 1.519 0.282 0 CA-C-N 116.015 -0.539 . . . . 1.3 112.913 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 5.7 m -66.22 -23.83 66.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.965 0.412 . . . . 1.82 110.352 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.449 ' O ' ' HB2' ' A' ' 171' ' ' TYR . 48.5 p-90 -86.0 -24.82 26.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.929 -0.578 . . . . 0.7 110.548 176.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 26.5 mt -76.89 -25.83 53.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.66 111.189 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.502 ' HE2' ' CE2' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -72.25 -1.57 15.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.049 0.452 . . . . 1.48 110.447 176.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.502 ' CE2' ' HE2' ' A' ' 170' ' ' LYS . 17.8 m-85 -82.2 -38.19 24.95 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.178 -0.464 . . . . 1.97 111.128 176.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.514 HG21 ' HB2' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -73.27 111.77 8.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.421 -0.511 . . . . 0.67 109.654 177.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.459 ' O ' ' HB ' ' A' ' 208' ' ' VAL . 3.3 mmp_? -114.22 -155.02 0.56 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.936 -0.574 . . . . 4.34 110.975 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 39.4 t -61.83 148.67 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.031 -0.531 . . . . 1.07 111.552 -173.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.408 ' HB2' ' CD1' ' A' ' 183' ' ' LEU . . . -50.84 121.91 6.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.026 -0.988 . . . . 0.71 112.405 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 2.4 p -73.82 -9.74 58.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.573 -0.739 . . . . 1.88 110.686 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 28.3 t -148.19 138.28 22.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.637 -0.71 . . . . 1.63 109.562 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . 0.632 ' HA ' ' OE1' ' A' ' 181' ' ' GLN . 8.5 p -86.22 -13.99 45.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.211 0.529 . . . . 1.96 111.027 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.67 -8.69 51.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.018 -0.537 . . . . 2.42 110.319 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -110.81 19.61 18.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.557 -0.747 . . . . 2.12 111.859 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.632 ' OE1' ' HA ' ' A' ' 178' ' ' CYS . 15.1 mm100 -52.89 116.07 2.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.508 0.671 . . . . 1.35 111.958 -173.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.767 ' ND2' HD11 ' A' ' 200' ' ' ILE . 28.7 t30 -152.94 37.05 0.49 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.097 -0.956 . . . . 1.68 108.787 177.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.725 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -117.85 121.08 39.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.545 -0.752 . . . . 0.81 111.027 -173.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 84.1 m -150.08 146.71 27.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.89 0.376 . . . . 0.51 110.938 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.485 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 51.7 tpp -109.88 145.85 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 1.35 110.093 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 8.4 m -132.05 140.05 48.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.198 0.523 . . . . 1.73 111.187 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.418 ' HG2' HD13 ' A' ' 192' ' ' ILE . 0.5 OUTLIER -116.44 104.47 11.48 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.953 -0.758 . . . . 1.93 108.953 177.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 21.7 pt -141.04 145.45 25.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.019 -0.537 . . . . 1.11 110.457 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 23.5 m 67.73 30.67 6.3 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.193 0.521 . . . . 1.86 110.916 178.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 62.13 22.24 12.99 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.089 -0.959 . . . . 2.83 111.926 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.422 ' HG3' ' CE1' ' A' ' 193' ' ' TYR . 4.2 pt20 -141.05 167.28 22.56 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.16 -0.473 . . . . 1.75 109.8 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.418 HD13 ' HG2' ' A' ' 187' ' ' GLN . 43.5 mm -92.73 137.03 23.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.279 -0.418 . . . . 1.01 110.72 -175.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.461 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 27.8 m-85 -135.85 150.54 49.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.317 0.579 . . . . 3.94 111.508 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 6.6 m-85 -100.71 113.72 26.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.364 -0.835 . . . . 0.92 109.588 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -107.09 122.74 47.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.947 0.403 . . . . 1.11 110.195 -176.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.47 ' CG1' HD21 ' A' ' 182' ' ' ASN . 1.9 t -94.41 152.5 3.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.775 0.798 . . . . 0.7 109.96 -177.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.2 -54.5 7.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.606 -1.179 . . . . 0.62 111.395 -166.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.588 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -135.05 168.17 19.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.847 -0.615 . . . . 1.38 111.336 -177.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.454 ' HA ' ' O ' ' A' ' 104' ' ' MET . 2.0 m-20 -46.36 125.87 7.3 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.143 0.902 . . . . 2.23 112.531 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.767 HD11 ' ND2' ' A' ' 182' ' ' ASN . 27.6 mm -94.4 134.95 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.72 -0.673 . . . . 0.88 111.319 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 50.6 mt-10 -105.35 125.79 32.58 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.481 -0.781 . . . . 2.06 109.518 174.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 100' ' ' ALA . 87.8 Cg_exo -41.52 113.47 0.27 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.816 3.011 . . . . 0.51 113.551 -177.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 120.43 6.37 9.72 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.815 -0.707 . . . . 0.7 113.054 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 12.7 pt-20 -118.26 123.8 46.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.193 0.497 . . . . 1.27 110.694 176.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.5 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -109.51 91.17 3.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.919 -0.582 . . . . 2.92 111.278 176.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.579 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 2.3 mm? -125.98 95.0 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.388 -0.525 . . . . 0.9 110.076 172.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.514 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.7 mm? -148.63 113.9 5.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.857 0.463 . . . . 0.53 109.883 172.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.656 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 5.7 p -156.65 159.41 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 118.676 0.671 . . . . 0.91 111.421 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 46.7 t-80 -106.56 111.98 24.77 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.313 -0.625 . . . . 1.55 109.313 164.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 16.9 m -98.12 136.76 27.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.869 -0.419 . . . . 2.56 109.869 173.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.415 ' HD3' ' HA2' ' A' ' 127' ' ' GLY . 27.0 pttt -98.39 113.99 26.17 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.422 0.629 . . . . 5.36 110.488 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -105.2 12.77 31.55 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.551 -0.749 . . . . 5.8 111.401 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -171.75 51.71 0.18 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.201 -0.999 . . . . 5.61 112.539 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 31.3 t -132.43 -75.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.019 0.437 . . . . 6.31 110.268 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.509 ' H ' ' HD2' ' A' ' 216' ' ' PRO . 86.1 t80 -98.98 -56.5 0.17 Allowed Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.14 -0.482 . . . . 8.83 111.687 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.509 ' HD2' ' H ' ' A' ' 215' ' ' TYR . 33.0 Cg_endo -65.73 -43.74 9.34 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.529 1.486 . . . . 7.78 112.185 -176.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 5.6 mp -107.71 77.16 1.11 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.326 0.584 . . . . 8.02 109.559 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -169.71 173.67 43.93 Favored Glycine 0 C--N 1.312 -0.779 0 CA-C-N 115.301 -0.863 . . . . 8.64 111.742 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 16.8 p -95.89 57.74 1.85 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.46 0.647 . . . . 9.72 110.252 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 29.3 m -85.12 146.37 45.2 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.378 -0.828 . . . . 9.62 111.149 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.448 ' HB2' ' HD3' ' A' ' 222' ' ' PRO . 85.8 Cg_exo -43.85 -50.59 7.16 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.253 2.635 . . . . 11.65 114.52 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' A' ' 221' ' ' PRO . 6.6 Cg_exo -74.79 9.17 2.04 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.152 1.901 . . . . 13.11 113.098 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -74.81 -35.46 50.56 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.918 -0.873 . . . . 14.03 110.918 175.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 49.3 tp -153.99 124.86 7.23 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.733 -0.469 . . . . 16.1 109.733 175.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -137.98 16.32 2.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.109 0.481 . . . . 17.7 110.459 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.679 -0.676 . . . . 18.9 110.467 179.794 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.223 -0.351 . . . . 33.26 112.223 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 26.7 t -83.38 165.22 19.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.694 0.283 . . . . 33.92 110.243 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.59 81.82 1.39 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.917 -0.659 . . . . 32.35 111.95 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 55.37 76.37 0.51 Allowed Pre-proline 0 N--CA 1.464 0.269 0 C-N-CA 122.485 0.314 . . . . 31.65 110.915 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.78 143.53 80.36 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.925 2.416 . . . . 29.99 112.854 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.2 m -113.11 134.13 54.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.092 -0.504 . . . . 28.92 110.269 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 m -82.89 136.45 34.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.094 0.473 . . . . 26.94 110.755 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -93.59 20.18 7.69 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.821 -0.627 . . . . 25.83 109.826 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -84.1 62.0 6.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.443 -0.799 . . . . 23.53 111.638 -172.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -115.48 44.13 1.92 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.32 -0.622 . . . . 21.64 109.32 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.6 p -123.11 93.33 48.31 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.243 -0.889 . . . . 19.42 110.925 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.2 107.82 0.87 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.69 2.26 . . . . 17.17 112.49 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -95.36 5.45 51.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.738 -0.665 . . . . 17.47 110.248 177.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -105.7 24.74 11.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.806 -0.634 . . . . 15.63 110.975 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.27 -177.78 18.71 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.749 . . . . 12.04 112.093 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.6 p -121.31 88.94 46.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 120.922 0.391 . . . . 10.67 111.296 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.97 135.03 12.16 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.69 2.26 . . . . 9.69 112.214 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -87.28 149.88 24.26 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.799 -0.445 . . . . 7.7 109.799 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -76.86 98.71 4.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.017 0.437 . . . . 8.14 111.03 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.07 128.6 64.54 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.751 -0.659 . . . . 5.96 109.905 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.57 -168.48 0.36 Allowed 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.642 2.228 . . . . 6.13 112.742 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.06 -38.34 73.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.285 -0.416 . . . . 6.53 110.732 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -90.43 109.88 20.99 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.725 -0.472 . . . . 5.01 109.725 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.1 pp -78.12 141.57 62.83 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-O 121.026 0.441 . . . . 4.23 110.564 176.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.43 -5.27 13.6 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.18 2.587 . . . . 4.12 113.821 -172.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -79.1 -65.79 0.95 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.914 0.387 . . . . 3.82 110.123 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.455 ' H ' ' CD1' ' A' ' 74' ' ' ILE . 37.1 t70 54.23 71.3 0.53 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.126 -0.943 . . . . 3.16 110.326 -177.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.7 mt -89.82 120.0 69.41 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.304 -0.862 . . . . 2.45 109.008 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.658 ' O ' ' HA2' ' A' ' 164' ' ' GLY . 18.2 Cg_endo -58.11 122.05 11.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.606 2.204 . . . . 1.75 112.323 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.499 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.46 142.65 45.99 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.875 -0.602 . . . . 1.01 109.979 178.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.95 142.69 19.21 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.388 2.725 . . . . 0.73 112.686 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.67 -16.32 47.75 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.581 -0.736 . . . . 1.04 112.251 -175.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -68.43 -23.09 64.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.958 -0.565 . . . . 1.66 110.557 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -120.9 161.86 20.83 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.223 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.59 ' HB2' ' CE ' ' A' ' 101' ' ' LYS . 33.5 tt0 -139.15 130.53 26.97 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 120.814 -0.354 . . . . 2.27 110.922 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 171' ' ' TYR . 5.2 tt -85.68 127.74 34.58 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.351 0.596 . . . . 0.79 110.484 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -148.76 140.59 23.71 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.127 -0.942 . . . . 3.21 110.031 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -82.79 112.25 19.45 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.04 0.447 . . . . 2.46 109.88 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.5 m -156.23 94.99 1.56 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.982 -0.748 . . . . 1.58 108.982 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.9 t -62.05 105.85 0.64 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.128 0.489 . . . . 1.86 111.474 -174.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.452 HG21 ' HD3' ' A' ' 173' ' ' ARG . 0.0 OUTLIER -99.56 117.25 64.07 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.018 -0.734 . . . . 1.45 109.018 172.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.77 121.71 9.7 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.152 2.568 . . . . 1.61 112.741 -176.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.11 -15.39 36.55 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.804 -0.712 . . . . 1.74 112.338 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.446 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -133.91 -59.78 0.83 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.966 0.412 . . . . 1.41 111.299 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 121.73 -116.09 3.0 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.773 -0.727 . . . . 1.09 112.216 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.29 158.43 16.12 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 122.455 0.302 . . . . 2.31 110.766 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 171' ' ' TYR . . . -151.26 172.25 30.83 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.313 -0.946 . . . . 0.59 113.465 -177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 205' ' ' GLU . 14.3 m -117.64 111.19 33.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.399 0.619 . . . . 0.67 109.718 175.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 63.2 m95 -82.69 126.74 32.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.749 -0.66 . . . . 1.13 111.383 -170.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.31 114.74 9.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.394 -0.595 . . . . 0.54 109.394 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.59 ' CE ' ' HB2' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -94.58 0.46 55.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.002 -0.74 . . . . 1.68 109.002 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -124.66 157.53 35.33 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.675 -1.148 . . . . 3.5 108.831 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.613 ' HD2' ' H ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -90.28 155.1 19.23 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.671 -0.492 . . . . 2.4 109.671 -177.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.439 ' HE3' HG13 ' A' ' 200' ' ' ILE . 60.3 mtm -135.43 148.44 49.3 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.549 -0.908 . . . . 1.22 108.549 175.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.87 146.99 39.22 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.995 -0.282 . . . . 2.31 110.623 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -42.26 121.81 2.0 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 124.301 1.001 . . . . 0.84 113.024 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.59 7.49 11.99 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.367 -0.833 . . . . 1.04 111.318 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.599 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.9 OUTLIER -79.78 156.2 27.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.264 0.554 . . . . 2.62 110.799 -179.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.525 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 7.3 tmm_? -145.49 135.89 24.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.685 -0.689 . . . . 3.62 110.355 -176.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 6.2 mt -101.1 151.38 21.89 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.82 -0.437 . . . . 0.53 109.82 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.14 -174.01 44.8 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.609 -0.597 . . . . 1.02 111.609 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -83.02 141.37 42.75 Favored 'Cis proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.982 -1.674 . . . . 2.1 112.44 -2.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -88.43 -8.37 55.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.604 0.716 . . . . 2.0 109.513 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.2 m -121.34 132.05 71.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.367 -0.833 . . . . 2.03 109.489 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.5 m -133.52 -164.77 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.338 -0.392 . . . . 3.95 110.772 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.469 HG23 ' HG2' ' A' ' 118' ' ' ARG . 21.4 m -52.45 152.69 6.05 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.753 -0.658 . . . . 5.21 111.974 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 116' ' ' VAL . 6.0 Cg_exo -78.36 59.82 7.25 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.91 2.407 . . . . 5.07 112.507 -178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.469 ' HG2' HG23 ' A' ' 116' ' ' VAL . 16.0 ptt-85 -169.23 165.71 10.86 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.82 -0.807 . . . . 7.99 108.82 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 53.4 -147.06 0.5 Allowed 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.45 0.469 . . . . 6.95 111.042 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 64.49 -83.41 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.182 0.593 . . . . 6.09 111.961 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 56.32 93.44 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 123.162 0.585 . . . . 5.56 111.188 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -59.19 130.82 48.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.54 -0.755 . . . . 7.42 111.447 -176.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -95.44 -56.85 2.57 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.397 -1.274 . . . . 9.01 110.372 -175.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 m -101.47 -83.83 0.45 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.177 -0.465 . . . . 8.88 109.784 176.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.5 t70 60.2 -170.61 0.14 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.127 -0.488 . . . . 7.6 111.654 172.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -90.61 -30.55 17.12 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 122.105 0.955 . . . . 7.23 109.213 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.92 33.42 26.95 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 113.918 -1.492 . . . . 4.59 113.292 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . 0.443 ' HZ2' HG23 ' A' ' 131' ' ' ILE . 2.1 p90 -60.12 -46.34 89.96 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.358 -0.608 . . . . 4.93 109.358 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 173.88 -171.03 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.347 -1.353 . . . . 7.65 107.347 176.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -121.47 108.36 13.55 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.129 0.49 . . . . 8.84 110.678 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.613 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -59.38 -20.63 18.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.357 -0.838 . . . . 6.05 111.378 176.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 132' ' ' LEU . 0.3 OUTLIER -81.16 68.26 7.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.812 0.815 . . . . 8.5 109.599 174.023 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.8 t -122.15 28.33 7.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.672 -1.149 . . . . 9.82 109.274 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -141.73 89.43 2.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.827 -1.078 . . . . 11.21 109.461 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.57 141.83 15.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.021 -0.536 . . . . 10.84 110.592 -177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -73.64 93.55 2.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.002 -0.544 . . . . 13.25 110.628 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.4 -39.92 82.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.558 -0.746 . . . . 13.89 109.62 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t 48.32 74.99 0.71 Allowed Pre-proline 0 C--O 1.236 0.365 0 CA-C-N 115.578 -0.737 . . . . 14.05 110.781 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -70.99 85.91 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.925 2.417 . . . . 14.41 111.553 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -85.61 59.24 5.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.753 -0.658 . . . . 14.44 111.408 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -70.96 -38.52 72.81 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.204 -0.665 . . . . 15.9 109.204 174.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -109.0 -172.59 21.07 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.724 -0.95 . . . . 15.6 110.724 172.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 58.7 m -83.4 60.39 5.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.182 0.515 . . . . 15.6 110.839 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 10.5 mt -87.42 54.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.638 0.732 . . . . 13.85 110.317 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.4 t -121.92 12.4 10.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.709 0.766 . . . . 13.19 109.801 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -83.76 -10.38 58.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.274 -0.876 . . . . 15.67 109.813 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.41 HG13 ' H ' ' A' ' 147' ' ' ILE . 1.9 pp -81.91 172.98 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.88 -1.055 . . . . 13.77 111.6 -177.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 50.5 m -144.47 64.12 1.31 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.185 -0.461 . . . . 13.62 110.252 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 69.11 143.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.447 -0.797 . . . . 13.02 111.868 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -88.64 68.01 8.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.64 0.733 . . . . 14.68 109.83 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.59 105.32 4.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.757 -1.11 . . . . 13.55 109.809 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 118.74 74.35 0.45 Allowed Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.607 -0.997 . . . . 15.8 110.607 -174.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.0 t -151.65 -60.56 0.17 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.684 0.278 . . . . 17.08 110.713 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -123.65 -83.03 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 18.43 111.614 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.0 23.62 6.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.022 0.439 . . . . 18.53 110.853 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -143.15 112.57 6.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.919 -0.582 . . . . 14.32 110.753 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 42.0 t -151.53 -70.17 0.17 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.11 -0.495 . . . . 14.51 110.755 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -96.78 120.9 46.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.837 0.351 . . . . 13.06 110.919 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 49.94 48.26 22.08 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.134 -0.939 . . . . 10.33 111.561 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -69.76 -39.71 76.52 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.0 -1.0 . . . . 9.88 111.076 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -111.15 16.47 21.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.846 -0.615 . . . . 10.23 109.744 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -121.73 -39.73 2.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.991 -0.55 . . . . 9.06 112.239 -171.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.4 21.0 3.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.363 0.601 . . . . 6.19 111.247 -178.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.658 ' HA2' ' O ' ' A' ' 79' ' ' PRO . . . 136.63 166.37 10.82 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.359 -0.837 . . . . 3.97 112.173 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -117.36 23.08 12.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.415 0.626 . . . . 2.63 110.334 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 77.85 -59.49 3.84 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.6 -0.727 . . . . 1.3 113.302 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 7.4 t -71.39 -14.42 62.17 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.547 0.203 . . . . 1.82 111.547 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.416 ' HB2' HG22 ' A' ' 80' ' ' ILE . 48.5 p-90 -56.94 -23.46 45.59 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.027 0.441 . . . . 0.7 111.734 -176.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 194' ' ' TYR . 32.1 mt -73.45 -12.83 60.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.241 0.46 . . . . 0.66 112.241 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.431 ' HD2' ' C ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -66.12 -14.37 61.69 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.012 0.434 . . . . 1.48 110.155 177.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.524 ' O ' ' HA2' ' A' ' 97' ' ' GLY . 41.5 m-85 -72.61 -31.43 65.16 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 115.782 -0.644 . . . . 1.97 111.887 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.775 HG21 ' HB2' ' A' ' 207' ' ' LEU . 0.5 OUTLIER -66.28 116.37 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.317 -0.553 . . . . 0.67 110.175 -177.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.452 ' HD3' HG21 ' A' ' 91' ' ' ILE . 18.0 ptt180 -75.83 155.79 35.04 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.573 -0.74 . . . . 4.34 111.83 -174.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.607 ' HB ' HG11 ' A' ' 208' ' ' VAL . 2.7 p -83.82 147.01 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.371 -0.831 . . . . 1.07 109.352 172.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -45.88 123.72 4.71 Favored 'General case' 0 CA--C 1.521 -0.164 0 O-C-N 123.933 0.771 . . . . 0.71 112.391 -174.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 51.8 t -80.42 -9.43 59.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 1.88 109.504 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 13.0 t -126.27 138.43 53.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.166 -0.924 . . . . 1.63 109.21 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 61.3 m -77.48 -15.88 59.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.876 0.37 . . . . 1.96 111.093 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -89.68 0.62 56.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.016 0.436 . . . . 2.42 110.578 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.18 17.88 21.13 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.865 -0.607 . . . . 2.12 111.619 -172.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -59.16 113.5 2.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.126 0.489 . . . . 1.35 111.04 -177.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.815 ' H ' HD12 ' A' ' 183' ' ' LEU . 62.4 t30 -146.64 29.28 1.03 Allowed 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 108.845 -0.798 . . . . 1.68 108.845 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.815 HD12 ' H ' ' A' ' 182' ' ' ASN . 0.4 OUTLIER -118.76 121.59 40.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.687 -0.688 . . . . 0.81 111.113 -170.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 66.6 m -150.2 133.46 16.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.282 0.563 . . . . 0.51 111.518 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.4 ' HB3' ' CD2' ' A' ' 209' ' ' HIS . 46.6 ttm -100.14 135.09 42.11 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.146 -0.687 . . . . 1.35 109.146 174.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 15.2 m -117.84 131.69 56.53 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.181 0.515 . . . . 1.73 111.575 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.46 103.63 14.03 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.28 -1.007 . . . . 1.93 108.28 174.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 22.8 pt -138.4 144.18 30.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.734 -0.666 . . . . 1.11 109.839 -177.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 m 61.27 28.75 18.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.213 0.53 . . . . 1.86 110.318 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 56.2 34.86 24.72 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.121 -0.945 . . . . 2.83 111.789 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -142.06 157.64 44.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.626 -0.716 . . . . 1.75 109.619 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.6 mm -94.56 131.32 41.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.301 -0.409 . . . . 1.01 111.264 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.525 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 27.0 m-85 -131.98 157.47 43.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.935 -0.575 . . . . 3.94 111.148 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 3.3 m-85 -101.3 113.68 26.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.956 -0.757 . . . . 0.92 108.956 173.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? -110.22 125.62 53.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.936 0.398 . . . . 1.11 110.012 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.599 ' CG2' ' HG2' ' A' ' 108' ' ' GLU . 1.9 t -96.57 151.44 4.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.747 0.784 . . . . 0.7 110.202 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 197' ' ' ILE . 0.9 OUTLIER -92.64 -53.8 8.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.543 -1.208 . . . . 0.62 110.591 -167.288 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.504 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -132.0 171.12 13.99 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.085 -0.961 . . . . 1.38 110.678 175.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -53.9 143.84 20.37 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.87 0.693 . . . . 2.23 112.87 -171.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.439 HG13 ' HE3' ' A' ' 104' ' ' MET . 31.4 mm -99.85 133.46 42.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.594 -0.73 . . . . 0.88 110.387 178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -95.13 131.36 30.2 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 109.372 -0.603 . . . . 2.06 109.372 173.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -50.95 116.2 2.49 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.605 2.203 . . . . 0.51 112.042 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 123.26 -12.86 8.44 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.666 -0.778 . . . . 0.7 112.948 -176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.68 119.17 21.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.607 0.703 . . . . 1.27 111.032 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -113.05 96.72 6.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.283 -0.871 . . . . 2.92 111.484 177.177 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.474 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.1 mm? -114.14 99.07 7.35 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.52 -0.872 . . . . 0.9 110.524 177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.775 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.5 mm? -147.19 112.39 5.51 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.327 0.651 . . . . 0.53 109.502 174.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.695 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 2.6 p -156.64 161.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 109.392 -0.595 . . . . 0.91 109.392 -177.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.4 ' CD2' ' HB3' ' A' ' 185' ' ' MET . 23.1 t-80 -123.31 105.71 10.08 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.002 -0.74 . . . . 1.55 109.002 162.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 53.5 t -132.82 95.22 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.277 -0.638 . . . . 2.56 109.277 173.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -123.11 139.44 54.06 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.986 -0.552 . . . . 5.36 109.66 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -96.87 2.21 51.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.778 0.323 . . . . 5.8 111.074 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -132.8 33.98 2.54 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.44 -0.886 . . . . 5.61 113.035 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 65.3 t -128.54 -77.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.788 0.327 . . . . 6.31 111.014 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.541 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 56.3 t80 -65.19 -53.76 38.02 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 112.387 0.514 . . . . 8.83 112.387 -176.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 11.4 Cg_endo -52.21 -37.85 70.71 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.921 2.414 . . . . 7.78 112.731 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 mp -77.81 20.24 0.36 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.611 -0.722 . . . . 8.02 112.242 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 93.78 20.98 29.77 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.873 -0.68 . . . . 8.64 112.644 176.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 9.1 m 60.92 67.82 0.79 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.549 0.69 . . . . 9.72 110.006 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.85 154.18 72.98 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.255 -0.884 . . . . 9.62 110.374 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' A' ' 222' ' ' PRO . 28.5 Cg_endo -64.06 141.95 78.93 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.404 2.07 . . . . 11.65 111.616 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 221' ' ' PRO . 11.7 Cg_exo -71.52 42.31 0.47 Allowed 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 123.185 2.59 . . . . 13.11 112.974 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -143.91 18.71 2.17 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.939 -0.865 . . . . 14.03 110.939 176.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 42.5 tp -94.07 129.65 40.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.631 -0.285 . . . . 16.1 110.395 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -103.24 -16.2 15.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.96 0.409 . . . . 17.7 110.848 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.592 -0.718 . . . . 18.9 110.259 179.503 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 112.003 -0.439 . . . . 33.26 112.003 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.6 m -73.22 -21.8 60.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.835 0.35 . . . . 33.92 110.925 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.88 49.77 3.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.044 -0.598 . . . . 32.35 112.291 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.431 ' HB3' ' HD3' ' A' ' 55' ' ' PRO . 83.8 t80 -69.73 -44.96 24.57 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 111.731 0.271 . . . . 31.65 111.731 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 54' ' ' PHE . 21.6 Cg_exo -65.76 -15.37 48.87 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.012 1.808 . . . . 29.99 111.783 176.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 m -74.87 78.2 2.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.504 0.669 . . . . 28.92 110.246 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.6 t -135.77 96.28 3.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.242 -0.89 . . . . 26.94 109.208 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -86.17 28.14 0.85 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.288 0.566 . . . . 25.83 110.741 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -87.76 59.57 5.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.922 -0.581 . . . . 23.53 110.6 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -91.17 58.57 3.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.979 -0.555 . . . . 21.64 109.681 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.467 ' HB ' ' CG ' ' A' ' 64' ' ' GLU . 11.7 p -118.7 83.48 22.35 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.762 -0.653 . . . . 19.42 110.879 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.94 118.74 5.83 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 123.075 2.517 . . . . 17.17 112.832 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt 50.17 67.27 0.94 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.483 -0.781 . . . . 17.47 112.825 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.467 ' CG ' ' HB ' ' A' ' 61' ' ' THR . 71.7 mm-40 -69.42 118.15 11.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.174 -0.466 . . . . 15.63 109.749 173.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.03 -28.83 6.46 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.01 -0.836 . . . . 12.04 111.01 -174.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 42.7 m -88.99 124.61 64.72 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 109.773 -0.455 . . . . 10.67 109.773 176.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 66' ' ' SER . 23.1 Cg_exo -64.37 102.14 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.59 2.193 . . . . 9.69 112.042 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -92.52 126.86 37.78 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.996 -0.547 . . . . 7.7 110.1 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.6 120.82 15.22 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.348 -0.387 . . . . 8.14 110.167 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.47 118.7 39.82 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.234 -0.439 . . . . 5.96 111.249 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -84.91 -157.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.098 2.532 . . . . 6.13 112.411 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.1 p -58.45 -40.55 78.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.095 -0.502 . . . . 6.53 110.496 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -81.86 110.78 17.47 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.033 0.444 . . . . 5.01 110.11 174.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.477 ' O ' HD12 ' A' ' 74' ' ' ILE . 1.8 pp -77.85 142.89 65.77 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.988 -0.551 . . . . 4.23 110.847 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.73 39.56 0.77 Allowed 'Trans proline' 0 CA--C 1.53 0.283 0 C-N-CA 122.755 2.304 . . . . 4.12 113.167 -176.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.4 ' CG ' HD13 ' A' ' 74' ' ' ILE . 8.6 mm-40 -83.6 -68.85 0.68 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.318 -0.401 . . . . 3.82 110.668 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.5 t70 52.67 69.99 0.63 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.631 -0.713 . . . . 3.16 110.191 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 61.0 mt -80.36 120.76 80.4 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.475 -0.784 . . . . 2.45 110.335 -175.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.17 116.47 4.19 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.287 1.992 . . . . 1.75 111.695 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.531 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -122.03 151.56 58.48 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.051 -0.522 . . . . 1.01 110.292 -178.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.408 ' HG2' ' CZ2' ' A' ' 168' ' ' TRP . 82.7 Cg_exo -48.31 134.37 25.41 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.195 2.596 . . . . 0.73 112.441 175.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.69 -20.94 66.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.51 -0.768 . . . . 1.04 112.225 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -68.62 -8.26 40.43 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.442 0.534 . . . . 1.66 112.442 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.438 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 7.4 m-85 -139.93 152.39 46.33 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' A' ' 87' ' ' ARG . 35.0 mt-10 -113.63 126.68 55.53 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.782 -0.367 . . . . 2.27 111.544 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 tt -86.02 127.68 34.7 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.774 -0.824 . . . . 0.79 108.774 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' A' ' 85' ' ' GLU . 99.7 mtt180 -144.22 147.14 33.22 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.651 -0.704 . . . . 3.21 109.848 -174.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -82.3 112.3 19.16 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.862 -0.792 . . . . 2.46 108.862 172.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 23.3 t -164.9 140.78 5.62 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.366 -0.605 . . . . 1.58 109.366 -176.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 m -99.34 107.32 19.56 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.8 0.333 . . . . 1.86 110.692 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -105.9 120.46 48.99 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.427 -0.583 . . . . 1.45 109.427 175.245 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 91' ' ' ILE . 50.7 Cg_exo -56.02 123.31 13.53 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.031 2.487 . . . . 1.61 113.312 -176.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.75 -26.82 14.68 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.95 -0.643 . . . . 1.74 112.394 178.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.441 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -117.55 -57.96 2.08 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.212 0.53 . . . . 1.41 110.604 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 123.06 -120.13 4.13 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 111.199 -0.761 . . . . 1.09 111.199 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER -87.17 127.81 35.14 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.387 -0.598 . . . . 2.31 109.387 173.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -129.2 157.47 21.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.295 -0.955 . . . . 0.59 113.053 -172.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 98' ' ' VAL . 35.6 m -97.52 114.61 35.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.597 0.713 . . . . 0.67 109.259 173.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -82.19 115.4 21.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.738 -0.665 . . . . 1.13 110.812 -170.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.57 114.78 12.2 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.331 -0.849 . . . . 0.54 109.981 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.424 ' CD ' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -95.09 8.58 42.54 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.975 0.893 . . . . 1.68 109.052 179.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 50.5 ttp85 -125.66 153.42 43.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.168 -1.378 . . . . 3.5 108.111 172.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.715 ' HB2' ' O ' ' A' ' 200' ' ' ILE . 0.0 OUTLIER -87.32 126.52 34.9 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.589 0.709 . . . . 2.4 109.475 -179.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.708 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 25.8 mtm -94.57 138.92 31.86 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.483 -0.562 . . . . 1.22 109.483 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 10.9 pt-20 -120.34 175.14 6.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.976 0.417 . . . . 2.31 111.945 -175.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.57 125.65 17.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 0.84 112.955 -175.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.27 -14.74 62.12 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.91 -0.662 . . . . 1.04 114.274 168.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 105' ' ' GLU . 6.7 pt-20 -78.3 158.62 28.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.79 0.795 . . . . 2.62 111.109 -176.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.664 ' HA ' ' O ' ' A' ' 194' ' ' TYR . 8.5 ttm180 -119.59 143.86 47.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.471 -0.786 . . . . 3.62 110.654 -176.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.438 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 3.9 mt -101.34 146.99 26.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.247 -0.649 . . . . 0.53 109.247 172.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 115.83 -127.82 7.74 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.45 -0.881 . . . . 1.02 112.892 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.01 158.63 69.17 Favored 'Cis proline' 0 N--CA 1.477 0.55 0 C-N-CA 123.622 -1.408 . . . . 2.1 112.854 1.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t -81.78 -19.57 41.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.059 -0.519 . . . . 2.0 110.838 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 31.1 m -142.66 152.78 17.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.018 -0.537 . . . . 2.03 109.91 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.8 p -134.53 29.56 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 122.376 1.084 . . . . 3.95 109.575 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.0 p -103.32 110.11 63.07 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 114.864 -1.062 . . . . 5.21 111.06 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -81.3 80.84 2.84 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.715 2.276 . . . . 5.07 112.816 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -124.77 -82.96 0.64 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.1 -0.5 . . . . 7.99 110.882 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -172.07 -43.18 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.337 0.589 . . . . 6.95 110.192 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -131.18 153.55 49.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.594 -0.73 . . . . 6.09 109.713 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -141.26 90.38 2.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.396 0.617 . . . . 5.56 110.19 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 124' ' ' THR . 19.8 ptmt -112.04 153.38 26.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.238 -0.892 . . . . 7.42 111.491 -177.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.448 ' HB2' ' H ' ' A' ' 124' ' ' THR . 6.6 mt-10 -85.53 -76.64 0.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.816 -0.809 . . . . 9.01 108.816 175.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.497 ' O ' ' HE2' ' A' ' 122' ' ' LYS . 32.5 m -113.7 -72.18 0.72 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.309 -0.859 . . . . 8.88 109.138 174.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -179.1 -53.94 0.01 OUTLIER 'General case' 0 C--N 1.338 0.069 0 CA-C-O 121.214 0.531 . . . . 7.6 111.218 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.443 ' HA ' HG11 ' A' ' 214' ' ' VAL . 67.9 m-85 -84.82 10.65 10.95 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.213 0.82 . . . . 7.23 113.213 -170.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -65.99 -28.14 73.42 Favored Glycine 0 C--N 1.314 -0.65 0 CA-C-N 116.187 -0.461 . . . . 4.59 113.256 -177.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . 0.512 ' HB2' ' CG ' ' A' ' 209' ' ' HIS . 0.3 OUTLIER -150.03 -51.51 0.14 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.188 0.518 . . . . 4.93 110.36 -179.441 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -175.37 -179.25 1.26 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.363 -0.835 . . . . 7.65 108.949 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -106.38 90.3 3.31 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.076 -0.712 . . . . 8.84 109.076 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.427 HD12 ' CZ2' ' A' ' 128' ' ' TRP . 0.2 OUTLIER -67.74 130.48 33.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.78 -0.645 . . . . 6.05 110.552 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.95 55.05 0.88 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.169 0.985 . . . . 8.5 110.234 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.9 t -119.98 21.84 11.71 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.2 -1.364 . . . . 9.82 109.511 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.12 61.31 6.42 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.653 -1.158 . . . . 11.21 110.221 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.64 121.63 18.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.11 -0.95 . . . . 10.84 111.053 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -89.99 78.67 6.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.275 0.56 . . . . 13.25 110.018 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.89 -24.0 19.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.744 0.783 . . . . 13.89 109.356 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 38.3 t -131.73 116.83 16.11 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-N 115.093 -0.958 . . . . 14.05 108.828 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -43.58 109.3 0.14 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.401 2.734 . . . . 14.41 112.074 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -119.18 6.42 11.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.872 -0.604 . . . . 14.44 111.602 -172.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -76.58 115.07 15.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.974 0.416 . . . . 15.9 110.286 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 145.61 -150.12 22.31 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.411 -0.676 . . . . 15.6 111.411 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 46.2 t -85.83 93.54 8.93 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.997 0.427 . . . . 15.6 110.532 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 65.7 mt -73.02 -39.36 57.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.084 -0.71 . . . . 13.85 109.084 174.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.8 t -157.78 138.78 13.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.364 -0.834 . . . . 13.19 109.818 175.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -116.52 -10.33 11.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.292 0.568 . . . . 15.67 110.0 177.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 28.3 pt -86.5 165.37 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.553 -0.749 . . . . 13.77 110.385 178.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 13.5 p -134.21 119.36 18.69 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.153 -0.476 . . . . 13.62 110.191 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -77.32 132.04 38.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.053 -0.522 . . . . 13.02 110.453 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -123.17 125.15 44.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.159 -0.473 . . . . 14.68 110.169 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.42 35.41 0.71 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.042 -0.526 . . . . 13.55 110.715 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.58 ' HA2' ' O ' ' A' ' 156' ' ' PHE . . . -147.21 69.71 0.36 Allowed Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.778 -0.929 . . . . 15.8 110.778 176.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.5 p -145.49 -65.29 0.32 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.668 0.27 . . . . 17.08 111.64 -175.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -78.32 -83.29 0.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.416 -0.356 . . . . 18.43 111.423 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.413 ' HD2' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -127.54 -0.43 6.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.916 0.389 . . . . 18.53 111.045 -178.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.58 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 95.0 m-85 -98.76 147.66 24.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.321 -0.399 . . . . 14.32 110.055 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 15.2 t -149.88 32.0 0.7 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.426 0.631 . . . . 14.51 109.822 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 66.7 t -130.95 138.98 52.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.655 -0.702 . . . . 13.06 109.77 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -79.88 53.97 1.77 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.073 0.463 . . . . 10.33 110.719 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -68.01 -57.51 6.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.687 -0.688 . . . . 9.88 111.14 -176.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -86.85 -2.48 58.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.148 -0.478 . . . . 10.23 110.781 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.418 ' C ' ' H ' ' A' ' 164' ' ' GLY . 22.5 mt-30 -97.83 -15.68 20.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.12 -0.491 . . . . 9.06 110.646 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -78.13 33.02 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.908 -0.587 . . . . 6.19 110.861 174.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 162' ' ' GLN . . . -88.68 58.45 4.08 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.308 -0.717 . . . . 3.97 111.308 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -118.48 147.45 43.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.884 0.373 . . . . 2.63 110.62 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -88.33 1.06 84.07 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.905 -0.664 . . . . 1.3 112.063 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 16.0 m -56.19 -41.35 75.42 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.383 0.273 . . . . 1.82 111.442 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.408 ' CZ2' ' HG2' ' A' ' 81' ' ' PRO . 27.4 p-90 -87.45 -22.04 25.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.846 0.355 . . . . 0.7 111.382 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.488 HD23 HD11 ' A' ' 172' ' ' ILE . 38.9 mt -85.61 -14.87 44.33 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.746 0.276 . . . . 0.66 111.746 -176.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.1 OUTLIER -75.29 -4.67 40.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 1.48 110.224 174.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.522 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 29.4 m-85 -77.43 -38.44 49.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.528 -0.76 . . . . 1.97 110.64 177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -81.45 117.48 27.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.145 0.497 . . . . 0.67 110.552 178.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 173' ' ' ARG . 43.1 mmt-85 -131.09 -161.8 1.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.627 -0.715 . . . . 4.34 110.825 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.47 ' HA ' HG11 ' A' ' 208' ' ' VAL . 6.2 t -62.49 139.65 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.286 0.565 . . . . 1.07 111.97 -168.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.563 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -71.7 164.82 25.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.154 -0.93 . . . . 0.71 111.276 -178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 47.4 t -92.45 -21.28 20.27 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.298 -0.864 . . . . 1.88 112.054 -169.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 12.3 m -143.16 -179.74 6.56 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.422 0.527 . . . . 1.63 112.422 -174.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 6.3 p -74.49 -53.03 10.28 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.117 0.414 . . . . 1.96 112.117 -175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.15 -12.9 61.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.817 0.817 . . . . 2.42 109.468 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.476 ' O ' ' HG ' ' A' ' 206' ' ' LEU . 28.5 t0 -80.54 -1.58 42.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.326 -1.307 . . . . 2.12 110.192 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.531 ' NE2' ' HB3' ' A' ' 175' ' ' ALA . 33.9 mm-40 -73.22 116.52 13.85 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.164 0.507 . . . . 1.35 111.572 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.543 ' H ' HD12 ' A' ' 183' ' ' LEU . 16.8 t30 -156.1 38.8 0.35 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.02 -1.104 . . . . 1.68 108.02 173.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.666 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.1 OUTLIER -124.55 124.76 42.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.442 -0.799 . . . . 0.81 111.233 -172.348 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 99.8 m -150.9 133.86 15.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.208 -0.451 . . . . 0.51 110.86 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.453 ' HB3' ' HB2' ' A' ' 209' ' ' HIS . 37.3 ttm -127.53 136.29 51.52 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.009 -0.541 . . . . 1.35 109.548 176.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 9.0 p -130.21 165.64 21.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.799 0.333 . . . . 1.73 110.41 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.79 104.98 11.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.189 -0.671 . . . . 1.93 109.189 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.519 HD11 ' CD2' ' A' ' 193' ' ' TYR . 43.9 pt -135.53 145.16 32.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 1.11 110.712 -175.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.8 m 62.06 28.76 17.39 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.36 0.413 . . . . 1.86 111.449 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 66.94 21.75 10.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.579 -0.737 . . . . 2.83 111.791 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -133.48 166.43 22.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.379 . . . . 1.75 110.421 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.6 mm -88.2 130.06 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.922 -0.581 . . . . 1.01 109.752 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.519 ' CD2' HD11 ' A' ' 188' ' ' ILE . 35.2 t80 -120.56 124.44 45.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.351 -0.386 . . . . 3.94 110.881 -173.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 7.4 m-85 -99.94 113.69 26.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.562 -0.903 . . . . 0.92 108.562 174.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -110.81 124.91 52.94 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.234 -0.284 . . . . 1.11 110.234 -174.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 104' ' ' MET . 1.6 t -91.86 150.57 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.924 0.869 . . . . 0.7 110.53 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.66 -54.57 6.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 113.964 -1.471 . . . . 0.62 111.565 -163.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.508 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -146.21 169.77 18.1 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.849 -1.069 . . . . 1.38 109.576 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.708 ' HA ' ' O ' ' A' ' 104' ' ' MET . 4.0 m-20 -61.83 110.9 1.67 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.355 0.597 . . . . 2.23 111.973 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.715 ' O ' ' HB2' ' A' ' 103' ' ' LYS . 3.8 mm -69.05 148.0 11.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.032 -0.985 . . . . 0.88 110.545 175.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 52.6 mt-10 -89.0 117.57 68.39 Favored Pre-proline 0 C--N 1.318 -0.79 0 N-CA-C 108.646 -0.872 . . . . 2.06 108.646 170.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.12 117.79 2.43 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.87 2.38 . . . . 0.51 112.323 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.98 2.68 10.17 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.762 -0.732 . . . . 0.7 112.805 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 11.7 pt-20 -140.48 126.42 19.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.32 0.581 . . . . 1.27 110.505 173.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.44 ' O ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -108.7 105.27 14.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.657 -0.702 . . . . 2.92 111.839 -177.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.594 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.9 mm? -122.87 99.81 6.58 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.576 -0.45 . . . . 0.9 110.206 175.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.94 113.39 6.29 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.89 0.476 . . . . 0.53 109.763 175.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.666 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.6 p -155.93 160.87 2.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 122.07 -0.394 . . . . 0.91 110.58 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.512 ' CG ' ' HB2' ' A' ' 128' ' ' TRP . 43.5 t-80 -81.87 112.4 18.96 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.793 -1.558 . . . . 1.55 106.793 165.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 9.6 m -73.67 94.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 122.064 0.935 . . . . 2.56 110.469 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -87.67 142.64 27.68 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.742 -1.117 . . . . 5.36 110.289 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -136.72 15.49 3.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.887 0.375 . . . . 5.8 110.941 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 154.13 89.99 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.106 -1.045 . . . . 5.61 112.854 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . 0.443 HG11 ' HA ' ' A' ' 126' ' ' PHE . 14.5 t -94.29 -71.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.786 0.326 . . . . 6.31 110.367 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.469 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 72.1 t80 -76.83 -56.56 1.32 Allowed Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 116.299 -0.409 . . . . 8.83 111.576 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 19.3 Cg_endo -59.81 -42.03 49.37 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.168 1.912 . . . . 7.78 112.744 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.4 mp -94.45 17.27 13.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.101 -0.5 . . . . 8.02 110.898 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -101.74 166.56 18.18 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.855 -0.688 . . . . 8.64 111.626 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.2 p -84.14 49.32 1.62 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.186 0.517 . . . . 9.72 110.725 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 27.0 m -95.57 133.53 25.58 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.909 -0.587 . . . . 9.62 111.288 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -84.41 119.98 2.42 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.427 2.085 . . . . 11.65 111.813 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -68.59 -13.05 36.38 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.33 2.02 . . . . 13.11 111.966 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -121.0 57.63 0.59 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.346 -1.102 . . . . 14.03 110.346 174.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 10.0 tt -62.02 119.79 9.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.301 0.572 . . . . 16.1 111.474 -172.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -129.61 -21.58 3.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.278 -0.874 . . . . 17.7 110.242 177.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.437 -0.792 . . . . 18.9 110.443 -177.235 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 112.004 -0.438 . . . . 33.26 112.004 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.4 m -82.25 -22.85 35.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.936 0.398 . . . . 33.92 110.548 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -140.39 -147.59 5.01 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.95 -0.643 . . . . 32.35 111.908 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.42 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 68.2 m-85 -74.63 141.42 76.06 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.311 0.1 . . . . 31.65 110.806 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 54' ' ' PHE . 3.1 Cg_exo -74.77 68.04 5.62 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.93 2.42 . . . . 29.99 112.392 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.6 p -81.05 61.25 4.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.308 -0.406 . . . . 28.92 111.013 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.0 m 60.79 62.44 1.48 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.579 0.704 . . . . 26.94 109.83 -174.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' A' ' 55' ' ' PRO . 11.8 mm-40 -90.34 11.88 20.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.365 -0.834 . . . . 25.83 110.856 -174.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -75.02 114.0 13.0 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.442 -0.799 . . . . 23.53 110.466 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -120.21 136.03 54.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.29 -0.414 . . . . 21.64 109.935 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.2 m -74.44 116.9 57.53 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.359 -0.382 . . . . 19.42 110.872 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.03 112.19 1.08 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.195 2.597 . . . . 17.17 112.532 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -126.43 40.93 3.63 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.593 -0.731 . . . . 17.47 109.342 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -82.96 149.17 27.18 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.314 -0.857 . . . . 15.63 110.337 -177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.9 -130.06 1.53 Allowed Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.804 -0.712 . . . . 12.04 112.112 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.1 m 57.28 72.43 0.93 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.013 0.435 . . . . 10.67 111.115 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -73.82 139.04 27.07 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.965 2.443 . . . . 9.69 111.823 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -85.62 93.2 8.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.052 0.453 . . . . 7.7 110.475 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -96.28 129.77 43.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.913 -0.585 . . . . 8.14 109.944 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.67 128.08 75.8 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.139 -0.482 . . . . 5.96 111.08 -176.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -45.4 -74.82 0.04 OUTLIER 'Trans proline' 0 C--O 1.236 0.421 0 C-N-CA 123.784 2.989 . . . . 6.13 114.453 -175.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.9 p -115.22 -48.88 4.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.151 -0.477 . . . . 6.53 111.761 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -85.17 140.81 30.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.712 0.292 . . . . 5.01 110.242 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.535 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.2 pp -76.38 139.22 67.74 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.222 0.534 . . . . 4.23 111.625 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -84.68 8.7 4.48 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.849 2.366 . . . . 4.12 112.533 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.47 -61.21 2.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.874 -0.603 . . . . 3.82 109.713 177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.4 t70 56.16 76.59 0.28 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.038 -0.983 . . . . 3.16 110.668 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 88.7 mt -73.65 133.17 80.06 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.178 -0.919 . . . . 2.45 110.559 -177.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.98 116.88 3.61 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.756 2.304 . . . . 1.75 112.067 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.634 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -118.3 147.05 40.87 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.042 -0.526 . . . . 1.01 109.781 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.52 133.97 61.19 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.15 1.9 . . . . 0.73 110.527 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.5 -16.5 15.65 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.569 0.543 . . . . 1.04 112.44 -174.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -66.9 -24.53 66.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.194 0.521 . . . . 1.66 110.309 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.408 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 59.7 m-85 -121.76 177.38 5.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.69 -0.687 . . . . 1.0 109.395 178.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.495 ' OE2' ' HD3' ' A' ' 87' ' ' ARG . 33.1 tt0 -154.93 131.72 10.73 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.723 -0.391 . . . . 2.27 110.732 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tt -84.5 131.14 34.68 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.726 -0.842 . . . . 0.79 108.726 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.495 ' HD3' ' OE2' ' A' ' 85' ' ' GLU . 14.4 mmm-85 -138.35 142.9 39.68 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.084 -0.507 . . . . 3.21 110.94 -173.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.72 110.21 12.37 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.364 -0.976 . . . . 2.46 108.364 171.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.2 p -168.99 94.58 0.32 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.874 -0.603 . . . . 1.58 110.01 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.1 p -81.64 104.68 12.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.203 -0.453 . . . . 1.86 111.016 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.503 HD12 ' SG ' ' A' ' 176' ' ' CYS . 0.0 OUTLIER -104.51 119.44 53.77 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.985 -0.552 . . . . 1.45 109.586 176.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -52.16 124.61 15.24 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.464 2.776 . . . . 1.61 113.12 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.7 -29.46 9.86 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.709 -0.678 . . . . 1.74 112.046 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.533 ' O ' ' HD2' ' A' ' 173' ' ' ARG . . . -118.4 -66.89 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.816 0.341 . . . . 1.41 111.242 177.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.94 -145.93 17.83 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.523 -0.631 . . . . 1.09 111.523 -177.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mt -91.67 118.27 30.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.877 0.338 . . . . 2.31 110.254 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -129.6 -179.36 15.94 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.881 -0.676 . . . . 0.59 111.485 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 30.7 m -92.44 147.47 5.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.911 -0.774 . . . . 0.67 108.911 174.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -116.17 118.42 32.77 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.756 0.312 . . . . 1.13 110.544 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.45 ' H ' ' HG2' ' A' ' 205' ' ' GLU . . . -69.08 120.27 14.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.174 -0.466 . . . . 0.54 110.033 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.579 ' H ' ' HD2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -89.15 15.5 8.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.587 0.708 . . . . 1.68 110.063 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 32.7 ttp85 -141.66 158.49 43.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.092 -0.958 . . . . 3.5 108.423 176.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.622 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -82.61 158.98 22.82 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.953 0.406 . . . . 2.4 110.633 178.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.664 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 58.4 mtm -133.27 151.1 51.89 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.381 -0.6 . . . . 1.22 109.381 176.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -114.74 138.42 50.75 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 123.338 0.399 . . . . 2.31 110.745 -176.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.508 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . . . -37.24 122.05 0.86 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.783 1.302 . . . . 0.84 113.742 -171.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.66 7.16 12.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.928 -0.653 . . . . 1.04 112.141 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.473 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.6 OUTLIER -84.26 159.46 20.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.058 0.456 . . . . 2.62 110.744 -178.123 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.62 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 7.0 tmm_? -146.1 136.09 23.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 3.62 110.715 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.408 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 6.6 mt -93.22 142.25 27.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.555 -0.535 . . . . 0.53 109.555 178.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -177.17 171.59 44.43 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.675 -0.774 . . . . 1.02 111.904 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.2 137.94 46.25 Favored 'Cis proline' 0 C--N 1.345 0.382 0 C-N-CA 123.722 -1.366 . . . . 2.1 112.151 -0.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.786 ' SG ' ' HA ' ' A' ' 193' ' ' TYR . 13.3 m -87.18 -32.3 19.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 2.0 111.429 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 p -123.96 98.78 5.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.434 0.635 . . . . 2.03 110.166 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.465 HG21 ' HB3' ' A' ' 165' ' ' ALA . 32.9 m -106.37 25.16 2.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.473 0.654 . . . . 3.95 111.147 -177.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.55 128.1 70.77 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.379 -0.828 . . . . 5.21 110.145 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.56 161.99 42.79 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.807 2.338 . . . . 5.07 112.488 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 66.57 -81.71 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.702 0.626 . . . . 7.99 110.887 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -178.65 -38.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.779 -0.646 . . . . 6.95 109.365 -177.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 62.56 84.98 0.13 Allowed 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.963 0.79 . . . . 6.09 112.115 175.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.407 ' CB ' ' HA ' ' A' ' 132' ' ' LEU . . . -76.94 83.34 3.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.614 -0.721 . . . . 5.56 109.967 174.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.479 ' HE3' ' HB3' ' A' ' 125' ' ' ASP . 55.9 pttt -74.49 176.83 6.46 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.797 -1.092 . . . . 7.42 111.432 -177.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.585 ' CD ' ' H ' ' A' ' 123' ' ' GLU . 5.1 mp0 -46.15 -71.71 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.585 -1.189 . . . . 9.01 111.781 -174.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.6 p -146.79 -100.24 0.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.461 -0.336 . . . . 8.88 110.916 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.479 ' HB3' ' HE3' ' A' ' 122' ' ' LYS . 36.2 t70 63.08 116.86 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.9 0.857 . . . . 7.6 111.705 -177.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -86.9 157.67 19.47 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.495 -0.775 . . . . 7.23 110.585 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 147.12 -47.26 0.69 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.66 -0.781 . . . . 4.59 111.662 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -158.87 -40.19 0.06 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.844 -0.428 . . . . 4.93 109.844 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.543 ' O ' HD13 ' A' ' 131' ' ' ILE . 16.0 mt-10 67.93 -77.33 0.05 OUTLIER 'General case' 0 C--O 1.223 -0.325 0 O-C-N 124.303 1.002 . . . . 7.65 110.944 173.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 41.42 -88.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.012 1.115 . . . . 8.84 114.012 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.543 HD13 ' O ' ' A' ' 129' ' ' GLU . 0.2 OUTLIER -58.81 -24.94 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 113.283 0.846 . . . . 6.05 113.283 -169.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' A' ' 129' ' ' GLU . 0.4 OUTLIER -82.25 60.96 5.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.901 0.858 . . . . 8.5 111.772 -179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.445 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 24.6 p -144.7 42.16 1.34 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.259 -1.337 . . . . 9.82 108.794 173.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 133' ' ' THR . 31.8 t70 73.92 105.39 0.07 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.984 -1.007 . . . . 11.21 109.548 -168.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 63.7 t -70.23 94.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 10.84 111.156 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -119.55 -6.3 10.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.506 -0.77 . . . . 13.25 109.386 175.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.25 -3.96 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.324 -0.853 . . . . 13.89 111.47 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.1 m -153.11 75.19 6.72 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.427 -0.351 . . . . 14.05 110.947 -178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.4 106.19 1.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.973 2.449 . . . . 14.41 111.515 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 61.25 73.52 0.48 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.087 -0.506 . . . . 14.44 110.598 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -11.99 58.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.107 -0.497 . . . . 15.9 111.876 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 164.25 -38.02 0.3 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.742 -0.742 . . . . 15.6 112.181 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 25.1 p -100.95 144.16 30.22 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.023 -0.362 . . . . 15.6 110.023 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 27.8 mm -108.71 50.89 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 122.061 0.934 . . . . 13.85 109.101 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.63 95.24 3.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.789 -1.096 . . . . 13.19 110.312 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -105.55 -20.63 13.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.829 -0.623 . . . . 15.67 110.301 -175.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.9 pt -128.7 168.12 22.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.448 -0.796 . . . . 13.77 110.837 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.5 p -123.28 113.19 18.56 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.923 -0.58 . . . . 13.62 110.872 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -88.29 148.86 24.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.905 -0.589 . . . . 13.02 109.753 175.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -91.07 124.56 35.39 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.912 0.387 . . . . 14.68 110.759 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 pp -99.98 14.34 30.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.19 0.519 . . . . 13.55 111.042 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 126.61 106.83 1.48 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.321 -0.854 . . . . 15.8 111.6 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 18.0 m -80.15 -29.04 38.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.766 0.317 . . . . 17.08 110.803 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -95.08 -68.04 0.82 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.032 0.444 . . . . 18.43 110.046 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -124.66 149.19 47.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.762 -0.654 . . . . 18.53 110.02 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.18 142.41 15.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.18 -0.463 . . . . 14.32 110.44 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 60.0 m -130.31 7.1 4.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.219 -0.446 . . . . 14.51 110.34 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.14 135.46 44.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.108 -0.497 . . . . 13.06 110.772 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -97.35 125.98 42.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.005 -0.543 . . . . 10.33 111.138 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -120.23 -53.07 2.15 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.623 -0.717 . . . . 9.88 109.756 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -136.48 42.18 2.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.892 -0.595 . . . . 10.23 110.41 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -94.7 -15.77 23.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.082 0.468 . . . . 9.06 110.438 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 66.33 39.43 4.06 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.84 -1.073 . . . . 6.19 110.819 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -59.62 -31.13 70.22 Favored Glycine 0 C--N 1.33 0.247 0 CA-C-N 115.558 -0.746 . . . . 3.97 113.417 -176.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.465 ' HB3' HG21 ' A' ' 115' ' ' VAL . . . -64.97 -14.88 61.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.928 0.344 . . . . 2.63 111.928 -177.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -125.42 4.59 8.19 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.784 -0.722 . . . . 1.3 111.69 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.659 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 31.4 t -76.54 -20.24 57.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.16 0.505 . . . . 1.82 111.053 -175.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.416 ' CB ' HG22 ' A' ' 80' ' ' ILE . 42.4 p-90 -69.33 -18.65 63.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.066 0.46 . . . . 0.7 110.832 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 113' ' ' CYS . 33.3 mt -80.31 -17.91 50.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.001 -0.545 . . . . 0.66 112.269 -175.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.659 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -82.66 -3.91 56.99 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.106 -0.638 . . . . 1.48 110.575 178.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.434 ' HB3' ' HA2' ' A' ' 97' ' ' GLY . 54.1 m-85 -77.88 -36.08 50.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 1.97 110.726 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.539 HD12 ' HB2' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -68.08 129.72 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.131 -0.692 . . . . 0.67 109.131 174.412 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.533 ' HD2' ' O ' ' A' ' 94' ' ' ALA . 45.7 mtt180 -129.7 -160.72 1.06 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.553 -0.294 . . . . 4.34 110.814 -174.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 16.1 t -62.96 148.95 10.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.355 0.409 . . . . 1.07 111.292 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.41 ' HA ' HD12 ' A' ' 206' ' ' LEU . . . -53.48 132.12 39.43 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.692 -0.685 . . . . 0.71 111.431 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.503 ' SG ' HD12 ' A' ' 91' ' ' ILE . 23.2 m -55.2 -25.01 30.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.949 -1.023 . . . . 1.88 112.237 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 92.8 p -149.29 -179.0 6.71 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.012 -0.366 . . . . 1.63 110.012 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 47.4 t -80.95 -23.69 38.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.902 0.382 . . . . 1.96 110.531 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -88.54 -10.27 49.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.699 0.285 . . . . 2.42 110.97 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -91.15 15.94 10.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.377 -0.374 . . . . 2.12 111.246 177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 17.0 mm100 -63.33 114.04 3.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.129 0.49 . . . . 1.35 110.385 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.54 ' OD1' ' HE2' ' A' ' 198' ' ' LYS . 21.8 t30 -165.68 43.21 0.07 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.101 -1.074 . . . . 1.68 108.101 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.608 ' HB3' ' O ' ' A' ' 206' ' ' LEU . 0.8 OUTLIER -142.57 128.88 19.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.583 -0.735 . . . . 0.81 111.888 -175.426 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 29.3 m -151.34 141.51 22.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 114.803 -1.089 . . . . 0.51 110.335 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 54.0 tpp -90.11 139.77 30.31 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.947 -0.39 . . . . 1.35 109.947 177.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 52.8 t -113.67 132.11 55.9 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.173 0.511 . . . . 1.73 110.471 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -122.01 105.56 10.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.707 -0.849 . . . . 1.93 108.707 177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.479 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 16.3 pt -139.64 142.99 31.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.987 -0.551 . . . . 1.11 110.689 -176.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 33.7 m 57.18 38.1 28.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.153 -0.476 . . . . 1.86 110.968 177.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 67.86 6.24 4.99 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.48 -0.782 . . . . 2.83 112.119 176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.5 pt20 -124.94 161.13 27.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 1.75 110.842 -176.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.84 137.12 25.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.813 -0.63 . . . . 1.01 111.645 -176.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.786 ' HA ' ' SG ' ' A' ' 113' ' ' CYS . 25.4 m-85 -140.9 155.02 46.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.623 -0.717 . . . . 3.94 110.294 174.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 109' ' ' ARG . 2.2 m-85 -100.15 113.2 25.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.735 -0.469 . . . . 0.92 109.735 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.6 tmmm? -102.78 123.51 46.58 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.076 0.465 . . . . 1.11 110.231 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.526 HG22 HD11 ' A' ' 207' ' ' LEU . 1.6 t -94.68 151.96 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 CA-C-O 121.714 0.769 . . . . 0.7 109.632 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.8 mm -90.67 -56.4 5.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.361 -1.291 . . . . 0.62 111.201 -166.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.54 ' HE2' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -145.29 -178.16 5.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.373 -0.83 . . . . 1.38 111.891 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.664 ' HA ' ' O ' ' A' ' 104' ' ' MET . 18.6 t70 -46.07 132.44 9.53 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.689 0.996 . . . . 2.23 113.689 -172.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.492 HD11 ' ND2' ' A' ' 182' ' ' ASN . 26.4 mm -101.49 132.79 46.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.231 -0.895 . . . . 0.88 110.349 174.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 35.8 mt-10 -89.35 126.59 57.99 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.337 -0.616 . . . . 2.06 109.337 173.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.03 116.95 2.19 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.962 2.441 . . . . 0.51 112.86 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.05 -4.94 10.47 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.78 -0.724 . . . . 0.7 113.299 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 9.5 pt-20 -142.29 120.35 12.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.476 0.638 . . . . 1.27 112.022 178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' A' ' 100' ' ' ALA . 17.7 mm-40 -111.96 125.35 53.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.73 -0.668 . . . . 2.92 110.225 171.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.608 ' O ' ' HB3' ' A' ' 183' ' ' LEU . 2.5 mm? -120.01 102.06 8.28 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.671 -0.862 . . . . 0.9 108.671 172.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.539 ' HB2' HD12 ' A' ' 172' ' ' ILE . 1.9 mm? -143.76 113.45 7.09 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.138 0.274 . . . . 0.53 110.925 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.541 HG12 HD12 ' A' ' 183' ' ' LEU . 1.9 p -153.61 159.8 3.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 O-C-N 122.105 -0.372 . . . . 0.91 111.259 176.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -94.47 111.88 23.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.659 -0.867 . . . . 1.55 108.659 167.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 210' ' ' VAL . 6.2 p -137.88 94.72 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.313 0.578 . . . . 2.56 111.589 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 66.5 129.8 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.024 -0.989 . . . . 5.36 112.843 175.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -141.2 173.95 11.0 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.311 -0.996 . . . . 5.8 108.311 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.561 ' HA2' HD23 ' A' ' 217' ' ' LEU . . . -89.37 45.71 3.15 Favored Glycine 0 C--N 1.304 -1.222 0 CA-C-N 115.376 -0.829 . . . . 5.61 112.263 -175.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 39.1 t -98.34 -72.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.916 0.389 . . . . 6.31 110.773 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.472 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 77.2 t80 -76.92 -53.79 1.72 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.326 -0.397 . . . . 8.83 111.593 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 19.8 Cg_endo -61.11 -45.67 18.51 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.987 1.791 . . . . 7.78 112.692 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.561 HD23 ' HA2' ' A' ' 213' ' ' GLY . 4.2 mm? -86.97 -66.58 0.89 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.514 -0.312 . . . . 8.02 110.881 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 138.7 -135.93 7.71 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.327 -0.94 . . . . 8.64 112.219 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 74.8 p 54.02 35.97 23.4 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.665 0.786 . . . . 9.72 110.73 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.505 ' O ' ' HD3' ' A' ' 222' ' ' PRO . 29.9 m -69.64 142.22 91.23 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 115.419 -0.81 . . . . 9.62 110.781 -175.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 2.3 Cg_endo -81.04 106.19 1.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.71 2.273 . . . . 11.65 111.725 177.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 220' ' ' VAL . 89.5 Cg_endo -84.81 70.1 5.66 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.734 2.29 . . . . 13.11 111.982 -177.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 86.67 -32.46 3.95 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.849 -0.614 . . . . 14.03 112.003 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 36.8 tp -124.7 127.67 47.63 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.058 -0.349 . . . . 16.1 110.058 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -121.08 2.46 10.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.234 0.54 . . . . 17.7 110.158 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.464 -0.779 . . . . 18.9 110.238 178.945 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 111.769 -0.532 . . . . 33.26 111.769 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.5 m -114.89 29.99 7.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.012 0.434 . . . . 33.92 111.171 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.96 -56.39 3.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.81 -0.709 . . . . 32.35 112.14 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -130.33 139.86 36.92 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 110.037 -0.357 . . . . 31.65 110.037 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.74 -12.59 31.27 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.959 2.439 . . . . 29.99 112.723 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 p -80.71 122.44 27.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.077 -0.511 . . . . 28.92 110.745 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.8 p -80.31 59.43 3.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.409 0.623 . . . . 26.94 111.9 -176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -90.63 56.66 3.36 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.012 -0.736 . . . . 25.83 109.012 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.79 57.63 0.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.579 -0.737 . . . . 23.53 110.61 -177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -74.59 102.37 4.53 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.358 -0.608 . . . . 21.64 109.358 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.8 t -137.95 137.3 21.02 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.603 -0.726 . . . . 19.42 109.931 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.84 79.27 0.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.44 2.094 . . . . 17.17 112.413 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -106.02 -28.32 10.61 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.365 -1.288 . . . . 17.47 109.667 177.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -91.73 3.99 53.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.588 -0.733 . . . . 15.63 109.963 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -140.24 123.17 2.35 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.119 -0.946 . . . . 12.04 111.38 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -120.49 102.16 45.53 Favored Pre-proline 0 C--N 1.319 -0.731 0 N-CA-C 110.343 -0.243 . . . . 10.67 110.343 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.94 135.11 36.68 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.197 1.931 . . . . 9.69 111.231 178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -68.94 121.27 16.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.208 -0.451 . . . . 7.7 110.715 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -111.1 125.62 53.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.718 -0.674 . . . . 8.14 110.479 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -87.19 170.63 11.58 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.859 -0.61 . . . . 5.96 110.079 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.66 -154.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.379 2.053 . . . . 6.13 112.458 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.0 p -55.95 -41.98 69.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.098 -0.501 . . . . 6.53 111.17 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -97.46 112.62 24.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.897 0.38 . . . . 5.01 110.531 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.535 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.1 pp -78.49 141.97 61.69 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.916 -0.584 . . . . 4.23 110.52 174.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.44 26.03 0.65 Allowed 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.779 2.319 . . . . 4.12 112.832 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -101.35 -72.22 0.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.265 -0.425 . . . . 3.82 111.124 -176.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.9 t70 63.7 94.44 0.05 Allowed 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.946 0.779 . . . . 3.16 109.712 -172.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 83.5 mt -67.83 123.33 86.76 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.556 -0.747 . . . . 2.45 110.987 -175.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.88 121.12 8.53 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.838 2.358 . . . . 1.75 112.292 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.592 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -127.78 153.28 77.94 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.746 -0.661 . . . . 1.01 109.281 177.693 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.32 141.7 88.71 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.388 2.059 . . . . 0.73 111.746 176.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.516 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -65.68 -12.33 52.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.987 0.736 . . . . 1.04 112.987 -171.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -82.68 -19.71 37.59 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.037 0.384 . . . . 1.66 112.037 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.521 ' HE2' ' SD ' ' A' ' 104' ' ' MET . 5.1 m-85 -116.83 144.88 43.97 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.838 -0.43 . . . . 1.0 109.838 -176.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -116.46 117.07 28.9 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.886 -0.326 . . . . 2.27 110.725 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.494 HD11 ' CE2' ' A' ' 171' ' ' TYR . 8.2 tt -86.09 124.3 32.36 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.962 -0.755 . . . . 0.79 108.962 176.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -140.37 128.4 22.13 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.791 -0.641 . . . . 3.21 110.692 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -81.83 112.95 19.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.899 -0.778 . . . . 2.46 108.899 173.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -166.9 162.73 15.99 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.881 -0.785 . . . . 1.58 108.881 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.0 t -99.83 105.55 17.32 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.905 0.383 . . . . 1.86 110.627 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -101.59 117.34 62.06 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.25 -0.648 . . . . 1.45 109.25 174.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -55.98 123.29 13.48 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.029 2.486 . . . . 1.61 113.116 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.412 ' HA3' ' SG ' ' A' ' 176' ' ' CYS . . . 105.65 -18.39 40.99 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.7 -0.762 . . . . 1.74 112.665 178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.494 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -129.34 -55.91 1.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.215 0.531 . . . . 1.41 111.517 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.471 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 121.24 -103.35 0.88 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 111.267 -0.733 . . . . 1.09 111.267 -176.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.4 160.78 14.24 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.95 -0.389 . . . . 2.31 109.95 172.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -172.96 171.79 44.66 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.512 -0.852 . . . . 0.59 112.464 177.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 86' ' ' LEU . 17.0 m -107.29 147.36 12.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.182 -0.673 . . . . 0.67 109.182 173.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -125.79 110.59 13.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.755 0.312 . . . . 1.13 111.07 -174.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.517 ' H ' ' HG3' ' A' ' 205' ' ' GLU . . . -59.83 125.77 24.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.85 -0.614 . . . . 0.54 111.115 177.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -93.18 -3.88 53.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.331 0.586 . . . . 1.68 110.203 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.5 ttp85 -133.16 155.3 49.55 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.934 -1.135 . . . . 3.5 107.934 171.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.658 ' C ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -84.16 158.56 21.3 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.277 0.56 . . . . 2.4 110.685 -175.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 54.9 mtm -117.36 154.33 31.49 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.476 -0.784 . . . . 1.22 109.068 177.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -107.83 136.12 48.09 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.41 0.444 . . . . 2.31 110.376 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.422 ' HB2' ' HA ' ' A' ' 198' ' ' LYS . . . -39.11 117.29 0.67 Allowed 'General case' 0 N--CA 1.467 0.391 0 O-C-N 124.624 1.202 . . . . 0.84 112.991 -174.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.33 7.46 12.33 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.544 -0.753 . . . . 1.04 111.547 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.446 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -75.64 165.22 25.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.054 0.454 . . . . 2.62 110.742 -178.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.545 ' HD3' ' CD1' ' A' ' 193' ' ' TYR . 7.1 tmm_? -141.38 132.66 26.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.386 -0.37 . . . . 3.62 110.297 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.497 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 5.9 mt -100.75 138.49 37.74 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.616 -0.513 . . . . 0.53 109.616 176.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.49 173.75 46.43 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.976 -0.63 . . . . 1.02 111.696 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -83.9 146.86 53.15 Favored 'Cis proline' 0 C--O 1.236 0.4 0 C-N-CA 123.316 -1.535 . . . . 2.1 112.77 -0.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 53.1 t -94.16 -39.46 10.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.661 -0.7 . . . . 2.0 109.634 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.3 p -171.11 132.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.619 -0.719 . . . . 2.03 109.922 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.9 t -65.34 150.53 10.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.051 -0.722 . . . . 3.95 109.051 176.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.2 t -44.54 114.09 1.89 Allowed Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 123.663 0.602 . . . . 5.21 111.003 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 120' ' ' ALA . 77.6 Cg_exo -50.68 97.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.778 2.986 . . . . 5.07 113.524 -175.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -137.02 -65.69 0.54 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.15 -0.932 . . . . 7.99 109.274 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.23 -39.6 39.9 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.312 0.577 . . . . 6.95 109.724 174.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 117' ' ' PRO . . . -125.5 143.65 50.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.336 -0.847 . . . . 6.09 109.619 176.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.68 107.65 3.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.772 0.32 . . . . 5.56 111.033 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -68.66 112.35 5.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.565 0.697 . . . . 7.42 111.156 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -117.91 -41.06 2.93 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.015 -0.993 . . . . 9.01 109.639 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 28.9 m -60.17 -52.82 63.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.458 -0.792 . . . . 8.88 109.949 173.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.85 126.93 31.95 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.35 -0.841 . . . . 7.6 109.192 173.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -69.43 143.07 53.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.055 0.455 . . . . 7.23 111.615 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -153.37 -69.57 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.033 -0.827 . . . . 4.59 111.033 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.51 -118.18 0.29 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 110.04 -0.355 . . . . 4.93 110.04 172.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.532 ' HG3' ' N ' ' A' ' 130' ' ' GLN . 7.7 pt-20 -142.75 -54.09 0.41 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.58 0.229 . . . . 7.65 110.771 178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.532 ' N ' ' HG3' ' A' ' 129' ' ' GLU . 45.2 mt-30 -151.07 153.31 34.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.545 -0.298 . . . . 8.84 110.531 -173.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.406 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -124.3 -16.65 4.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.917 0.389 . . . . 6.05 110.249 168.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.36 58.14 4.89 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.86 0.838 . . . . 8.5 111.198 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.2 t -178.96 28.51 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 114.337 -1.301 . . . . 9.82 109.298 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -68.18 115.12 7.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.19 -0.914 . . . . 11.21 110.701 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.86 131.26 26.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.578 -0.737 . . . . 10.84 110.914 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -81.38 97.88 7.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.152 0.501 . . . . 13.25 110.373 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.77 -23.79 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.798 -0.637 . . . . 13.89 110.01 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.1 t -107.26 126.29 30.42 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.674 -0.694 . . . . 14.05 110.062 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.28 80.79 2.14 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.532 2.155 . . . . 14.41 111.632 177.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -95.87 100.86 12.51 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.673 -0.694 . . . . 14.44 111.077 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -127.66 173.51 9.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.3 -0.863 . . . . 15.9 110.325 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.63 -97.36 0.4 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.08 -0.581 . . . . 15.6 112.389 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 7.4 p -80.79 69.22 7.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.405 0.621 . . . . 15.6 110.626 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 39.8 mt -89.04 102.9 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.836 -0.62 . . . . 13.85 110.178 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 t -118.66 142.82 47.29 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.011 0.434 . . . . 13.19 110.485 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -121.79 -4.18 9.18 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.28 0.562 . . . . 15.67 109.971 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.45 ' H ' HG13 ' A' ' 147' ' ' ILE . 2.7 pp -107.49 168.56 3.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.731 -0.668 . . . . 13.77 111.266 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 49.7 m -154.0 57.43 0.72 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.706 -0.849 . . . . 13.62 108.706 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -87.28 46.24 1.36 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.181 -0.918 . . . . 13.02 110.958 -170.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -159.67 142.47 13.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.337 -0.847 . . . . 14.68 109.387 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.407 HD23 ' NE2' ' A' ' 162' ' ' GLN . 4.6 pp -130.27 159.29 37.35 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 120.958 0.409 . . . . 13.55 110.083 -177.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 154' ' ' GLU . . . -89.44 100.31 2.65 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.543 -0.753 . . . . 15.8 111.253 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 38.7 m -68.11 14.11 0.07 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.556 0.576 . . . . 17.08 112.556 -175.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 152' ' ' GLY . 36.1 mt-10 -63.35 -61.92 2.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.732 0.777 . . . . 18.43 109.746 174.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.549 ' H ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -117.42 -0.75 11.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.877 -1.056 . . . . 18.53 110.814 -179.24 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -100.39 87.63 3.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.172 0.511 . . . . 14.32 111.054 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 53.8 t -82.96 -46.61 12.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.773 -0.825 . . . . 14.51 108.773 172.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 67.1 t -101.34 128.34 53.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.534 -0.757 . . . . 13.06 109.788 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' A' ' 162' ' ' GLN . 23.9 t70 -88.31 117.03 26.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.348 0.594 . . . . 10.33 111.543 -177.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -108.26 -28.56 9.38 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.195 -0.911 . . . . 9.88 109.611 172.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -52.73 -57.57 9.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.353 -1.294 . . . . 10.23 111.442 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.449 ' HB2' ' OD1' ' A' ' 159' ' ' ASP . 35.5 mt-30 -85.55 -55.26 4.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.827 -0.624 . . . . 9.06 110.012 -177.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.0 71.46 6.71 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.666 -0.697 . . . . 6.19 110.705 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -66.21 109.42 2.89 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.859 -0.686 . . . . 3.97 111.714 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.88 -58.04 10.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.574 0.226 . . . . 2.63 110.779 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 74.97 -57.06 2.69 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 116.079 -0.51 . . . . 1.3 113.665 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.706 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 20.5 t -63.41 -16.05 59.41 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.809 0.444 . . . . 1.82 111.726 -174.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.503 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 25.5 p-90 -71.7 -23.58 61.67 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 122.019 -0.426 . . . . 0.7 110.293 178.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.503 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 29.2 mt -86.75 -17.65 33.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.027 -0.533 . . . . 0.66 112.283 -176.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.706 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -75.77 -10.73 59.68 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.382 -0.527 . . . . 1.48 110.248 179.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.494 ' CE2' HD11 ' A' ' 86' ' ' LEU . 52.1 m-85 -69.79 -36.98 76.16 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 115.824 -0.625 . . . . 1.97 111.06 179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.693 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -69.83 127.01 31.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.482 -0.487 . . . . 0.67 109.729 177.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -115.07 179.15 4.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.022 -0.536 . . . . 4.34 110.401 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.627 ' HA ' HD22 ' A' ' 183' ' ' LEU . 1.7 p -71.4 142.37 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.063 0.458 . . . . 1.07 111.165 -177.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.28 142.47 21.05 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.16 -0.927 . . . . 0.71 112.572 -173.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.412 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 47.5 t -82.87 -2.93 56.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.208 -0.906 . . . . 1.88 110.531 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 27.2 t -142.84 139.88 31.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.993 -0.549 . . . . 1.63 109.589 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 33.6 t -73.31 -13.99 61.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.309 0.576 . . . . 1.96 110.485 -178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -88.44 -4.42 58.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.346 0.593 . . . . 2.42 109.93 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -110.84 15.49 21.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.49 -0.777 . . . . 2.12 111.107 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 15.9 mm100 -60.11 115.67 3.64 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.528 -0.545 . . . . 1.35 109.528 178.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.6 ' OD1' ' HG3' ' A' ' 198' ' ' LYS . 19.2 t30 -153.63 32.97 0.45 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.165 0.983 . . . . 1.68 108.799 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.627 HD22 ' HA ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -122.52 129.51 52.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.368 -0.833 . . . . 0.81 110.315 -174.013 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.5 m -150.42 138.66 20.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.074 0.464 . . . . 0.51 110.933 177.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.485 ' HE2' ' HB2' ' A' ' 185' ' ' MET . 21.1 tpp -102.05 129.02 48.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.941 -0.572 . . . . 1.35 109.962 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 43.5 t -111.95 140.93 46.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.051 0.453 . . . . 1.73 110.585 -175.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.81 104.26 10.4 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.904 -0.589 . . . . 1.93 109.621 -178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.465 ' O ' ' HG2' ' A' ' 191' ' ' GLN . 17.8 pt -142.73 145.33 23.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.679 -0.691 . . . . 1.11 110.229 -177.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 22.4 m 63.15 27.61 15.72 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.114 0.483 . . . . 1.86 111.047 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 64.56 10.5 5.91 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.125 -0.943 . . . . 2.83 111.62 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 188' ' ' ILE . 4.9 pt20 -120.6 167.95 11.88 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.974 -0.38 . . . . 1.75 109.974 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.2 mm -93.59 137.09 23.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.058 -0.519 . . . . 1.01 110.305 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.545 ' CD1' ' HD3' ' A' ' 109' ' ' ARG . 2.4 m-85 -138.52 151.4 47.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.221 0.534 . . . . 3.94 111.244 177.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.475 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 4.8 m-85 -99.54 113.6 26.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.568 -0.742 . . . . 0.92 109.627 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.28 118.83 37.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.992 -0.549 . . . . 1.11 110.176 -177.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.448 HG22 HD11 ' A' ' 207' ' ' LEU . 2.0 t -91.08 152.95 3.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.515 0.674 . . . . 0.7 110.057 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.405 HG13 ' HA ' ' A' ' 182' ' ' ASN . 1.2 mm -91.44 -58.07 3.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.64 -1.164 . . . . 0.62 111.301 -167.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.6 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.9 OUTLIER -139.78 173.13 11.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.69 -0.686 . . . . 1.38 111.51 -176.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.592 ' HA ' ' O ' ' A' ' 104' ' ' MET . 1.1 m-20 -47.05 120.18 2.95 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.231 -0.895 . . . . 2.23 112.871 -176.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.485 HD11 ' ND2' ' A' ' 182' ' ' ASN . 21.0 mm -82.15 140.11 16.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.185 -0.916 . . . . 0.88 110.984 176.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 202' ' ' PRO . 44.6 mt-10 -86.97 130.71 47.31 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 109.534 -0.543 . . . . 2.06 109.534 171.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 201' ' ' GLU . 53.2 Cg_exo -55.11 117.53 4.13 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.493 2.128 . . . . 0.51 112.289 -179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 121.52 -11.11 9.71 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.798 -0.715 . . . . 0.7 112.576 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 200' ' ' ILE . 11.3 pt-20 -143.04 119.69 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.883 0.373 . . . . 1.27 111.791 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.517 ' HG3' ' H ' ' A' ' 100' ' ' ALA . 40.6 mt-10 -111.7 127.21 55.7 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 122.196 -0.315 . . . . 2.92 110.518 169.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.487 ' C ' HD22 ' A' ' 207' ' ' LEU . 2.6 mm? -115.72 100.35 7.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.146 -0.686 . . . . 0.9 109.146 175.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.693 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 2.1 mm? -145.33 125.37 13.63 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.495 -0.928 . . . . 0.53 108.495 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.602 HG11 ' HB ' ' A' ' 174' ' ' VAL . 9.8 p -152.87 157.1 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 120.234 -0.586 . . . . 0.91 111.439 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -109.72 106.47 16.12 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.815 -0.809 . . . . 1.55 108.815 163.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 19.4 m -107.4 143.07 18.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.226 -0.657 . . . . 2.56 109.226 170.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -111.42 127.35 55.65 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.434 0.635 . . . . 5.36 111.282 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -130.88 47.13 2.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.226 -0.897 . . . . 5.8 109.722 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 71.08 49.53 27.02 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.578 -0.737 . . . . 5.61 112.401 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.0 -83.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 O-C-N 122.765 -0.256 . . . . 6.31 111.133 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.405 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 69.2 m-85 -68.71 -61.37 3.72 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 112.761 0.652 . . . . 8.83 112.761 -175.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 19.7 Cg_endo -56.44 -41.05 80.31 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.348 2.032 . . . . 7.78 113.228 -172.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.46 -8.12 54.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.764 -0.653 . . . . 8.02 111.67 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 63.66 27.13 70.53 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 121.326 -0.464 . . . . 8.64 112.874 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 10.1 t -110.24 41.62 1.71 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.547 0.689 . . . . 9.72 110.436 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 21.5 m -75.42 126.91 87.09 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.794 -0.639 . . . . 9.62 110.08 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.78 116.95 4.91 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.357 2.038 . . . . 11.65 111.933 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.41 53.87 4.47 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.686 2.257 . . . . 13.11 112.318 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 155.58 -160.11 29.69 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.332 -0.707 . . . . 14.03 111.332 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 54.4 tp -140.47 124.12 17.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.941 0.37 . . . . 16.1 110.451 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -123.9 -52.47 1.78 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.1 -0.5 . . . . 17.7 110.674 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.674 -0.679 . . . . 18.9 110.056 -176.517 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 112.259 -0.337 . . . . 33.26 112.259 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.4 m 64.37 38.1 7.97 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.859 0.464 . . . . 33.92 111.054 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.82 55.66 5.02 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 121.012 -0.613 . . . . 32.35 112.243 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -116.42 121.54 33.21 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 110.274 -0.269 . . . . 31.65 110.274 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.19 122.93 12.14 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.824 2.35 . . . . 29.99 112.444 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 t -138.26 95.52 3.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.199 0.523 . . . . 28.92 110.066 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m -63.01 109.1 1.37 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.894 -0.593 . . . . 26.94 109.846 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 63.03 -160.74 0.3 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.447 -0.797 . . . . 25.83 109.932 -175.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t70 69.26 27.21 5.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.804 0.811 . . . . 23.53 110.146 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -84.52 69.68 10.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.494 0.664 . . . . 21.64 110.117 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 7.4 p -87.62 117.29 68.33 Favored Pre-proline 0 N--CA 1.448 -0.569 0 CA-C-N 115.652 -0.704 . . . . 19.42 110.021 175.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 61' ' ' THR . 34.9 Cg_exo -58.94 103.72 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.968 2.446 . . . . 17.17 112.747 -176.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -92.28 -11.29 35.62 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.625 -0.716 . . . . 17.47 109.746 177.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.27 148.08 32.58 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.501 -0.772 . . . . 15.63 110.215 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.9 110.97 2.94 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.821 -0.627 . . . . 12.04 112.03 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.2 m -98.4 113.34 64.02 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 109.882 -0.414 . . . . 10.67 109.882 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -61.53 100.39 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.863 2.375 . . . . 9.69 112.296 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -105.28 107.85 19.05 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.263 -0.426 . . . . 7.7 110.143 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -72.37 142.8 48.75 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.963 -0.562 . . . . 8.14 109.771 178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.51 116.07 63.45 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 116.151 -0.477 . . . . 5.96 110.678 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.53 -151.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.649 2.232 . . . . 6.13 111.369 174.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.08 -34.87 71.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.167 0.508 . . . . 6.53 109.787 175.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -88.46 107.73 19.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.031 -0.531 . . . . 5.01 109.592 172.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.532 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.3 pp -79.72 137.84 54.5 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 120.943 0.401 . . . . 4.23 110.705 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.84 4.07 6.79 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.75 2.3 . . . . 4.12 113.02 -176.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -79.79 -66.27 0.9 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.226 -0.443 . . . . 3.82 109.857 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.419 ' H ' ' CD1' ' A' ' 74' ' ' ILE . 21.4 t70 62.04 98.26 0.03 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-N 114.914 -1.039 . . . . 3.16 111.777 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 70.8 mt -84.73 111.45 35.19 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.735 -0.666 . . . . 2.45 109.688 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.97 135.06 33.86 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.603 2.202 . . . . 1.75 112.231 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.52 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -129.48 136.94 29.89 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.819 -0.628 . . . . 1.01 109.903 -178.732 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.55 151.58 7.2 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.358 2.706 . . . . 0.73 112.574 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.13 -6.44 3.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.671 0.989 . . . . 1.04 113.671 -169.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 100' ' ' ALA . 52.1 m-20 -110.34 2.02 18.84 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.886 -0.509 . . . . 1.66 111.994 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -130.92 138.44 49.77 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.16 -0.681 . . . . 1.0 109.16 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.57 136.67 53.54 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.72 -0.392 . . . . 2.27 110.061 177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.8 tt -85.37 126.44 33.76 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.454 0.645 . . . . 0.79 109.29 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.444 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 51.1 mtp180 -143.34 118.75 10.28 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.863 -1.062 . . . . 3.21 109.507 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -80.73 110.16 15.97 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.283 -0.636 . . . . 2.46 109.283 178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.9 p -164.32 109.26 0.98 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.474 -0.785 . . . . 1.58 108.959 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.9 m -71.13 105.67 3.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.054 0.454 . . . . 1.86 110.953 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -92.99 117.99 67.71 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.049 -0.723 . . . . 1.45 109.049 173.082 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -51.93 121.27 8.44 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.016 2.477 . . . . 1.61 112.554 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.449 ' HA3' ' SG ' ' A' ' 176' ' ' CYS . . . 108.5 -16.34 34.61 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.015 -0.612 . . . . 1.74 112.45 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -135.21 -61.72 0.73 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.97 0.414 . . . . 1.41 111.244 178.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.483 ' O ' HG22 ' A' ' 91' ' ' ILE . . . 121.09 -123.22 5.47 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 121.055 -0.593 . . . . 1.09 111.925 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.1 mt -102.23 158.43 16.19 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.931 -0.396 . . . . 2.31 109.931 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -167.17 177.52 41.73 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.616 -0.802 . . . . 0.59 112.013 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.87 114.95 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.494 0.664 . . . . 0.67 109.689 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.444 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 51.3 m95 -82.76 127.55 33.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.583 -0.735 . . . . 1.13 111.405 -169.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 83' ' ' ASP . . . -74.87 116.19 15.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.686 -0.688 . . . . 0.54 110.465 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.5 OUTLIER -90.45 1.0 57.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.236 0.541 . . . . 1.68 110.096 -178.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 102' ' ' ARG . 17.4 ttp180 -140.46 156.18 46.44 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.552 -0.749 . . . . 3.5 109.13 175.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.541 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -80.4 159.0 25.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.112 0.482 . . . . 2.4 110.738 -178.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.689 ' O ' ' HA ' ' A' ' 199' ' ' ASP . 55.3 mtm -129.46 152.11 49.36 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.064 -0.516 . . . . 1.22 110.026 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -121.5 139.81 53.01 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.117 -0.492 . . . . 2.31 110.273 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -39.19 125.04 1.57 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 124.708 1.255 . . . . 0.84 113.264 -170.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.26 7.03 12.87 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.319 -0.855 . . . . 1.04 111.094 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.62 162.18 18.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.116 0.484 . . . . 2.62 110.929 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.586 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 6.3 tmm_? -146.96 132.29 18.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.982 -0.554 . . . . 3.62 110.301 -178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 194' ' ' TYR . 4.7 mt -95.26 130.78 41.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.027 -0.731 . . . . 0.53 109.027 173.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -175.13 166.6 38.28 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.308 -0.949 . . . . 1.02 112.426 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.469 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 94.5 Cg_endo -87.17 158.12 48.58 Favored 'Cis proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.917 -1.701 . . . . 2.1 112.553 -2.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.3 t -102.74 -52.46 3.07 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.367 0.603 . . . . 2.0 109.557 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -158.11 133.76 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.581 -0.736 . . . . 2.03 109.435 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 119' ' ' ALA . 34.0 m -133.64 163.45 37.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.911 -0.586 . . . . 3.95 109.867 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.493 ' HB ' ' HD3' ' A' ' 117' ' ' PRO . 17.8 t -65.21 -54.71 30.87 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 112.178 0.436 . . . . 5.21 112.178 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.493 ' HD3' ' HB ' ' A' ' 116' ' ' VAL . 71.6 Cg_endo -73.77 135.95 22.4 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.828 1.686 . . . . 5.07 112.956 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 71.01 -52.31 0.68 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.14 0.793 . . . . 7.99 113.14 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 115' ' ' VAL . . . -72.74 161.34 30.87 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.222 -0.288 . . . . 6.95 110.222 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.514 ' HB1' ' HE2' ' A' ' 122' ' ' LYS . . . -114.75 102.25 9.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.892 0.377 . . . . 6.09 110.799 -177.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.21 97.3 7.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.988 -0.551 . . . . 5.56 110.891 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.514 ' HE2' ' HB1' ' A' ' 120' ' ' ALA . 74.5 mmtt -93.79 135.77 34.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.513 -0.767 . . . . 7.42 110.674 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -77.02 -25.23 52.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.744 -0.662 . . . . 9.01 109.546 174.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 11.6 m -47.25 -51.91 17.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.847 -1.07 . . . . 8.88 111.07 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -85.53 79.73 9.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.861 -0.609 . . . . 7.6 110.501 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -90.06 104.06 16.67 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.888 0.852 . . . . 7.23 110.895 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -138.86 5.75 3.11 Favored Glycine 0 C--N 1.316 -0.565 0 CA-C-N 114.805 -1.089 . . . . 4.59 111.529 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . 0.496 ' HE3' ' N ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -114.1 -113.7 0.34 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.276 -0.462 . . . . 4.93 110.923 -177.225 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.496 ' N ' ' HE3' ' A' ' 128' ' ' TRP . 5.9 pt-20 -142.26 -49.15 0.36 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 110.276 -0.268 . . . . 7.65 110.276 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -175.57 125.23 0.23 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.54 -0.3 . . . . 8.84 110.216 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 pp -119.33 18.17 6.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.824 0.345 . . . . 6.05 111.345 175.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.2 mp -74.65 88.57 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.967 -0.561 . . . . 8.5 110.071 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 5.2 t -170.39 82.0 0.1 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.057 0.932 . . . . 9.82 110.209 -174.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.25 67.52 7.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.624 -0.716 . . . . 11.21 110.19 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.452 HG12 HG21 ' A' ' 116' ' ' VAL . 15.0 p -60.89 136.08 24.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.515 -0.766 . . . . 10.84 110.883 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -65.59 118.14 9.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.783 -0.644 . . . . 13.25 110.624 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.5 p -79.37 -10.73 12.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.021 -0.536 . . . . 13.89 110.419 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.0 m 58.84 77.69 0.39 Allowed Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 115.174 -0.921 . . . . 14.05 111.227 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.62 130.13 25.58 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.759 2.306 . . . . 14.41 111.783 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -84.96 65.32 9.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.247 0.546 . . . . 14.44 110.846 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -100.2 148.08 25.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.86 -0.609 . . . . 15.9 110.177 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 111.47 52.39 0.55 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.719 -0.753 . . . . 15.6 112.016 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 64.3 m 61.56 43.74 9.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.344 0.592 . . . . 15.6 110.743 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 57.2 mt -127.48 83.76 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.586 -0.734 . . . . 13.85 109.869 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 17.9 p -126.76 88.0 2.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.97 0.414 . . . . 13.19 111.099 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -104.32 -13.14 16.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.965 -0.561 . . . . 15.67 110.247 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.459 ' H ' HG13 ' A' ' 147' ' ' ILE . 2.4 pp -72.46 155.84 7.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.61 -0.723 . . . . 13.77 111.374 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.5 p -164.24 54.3 0.15 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.26 0.552 . . . . 13.62 110.787 -177.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.63 139.19 44.95 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.777 -0.647 . . . . 13.02 109.981 178.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -160.83 131.21 5.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.426 -0.352 . . . . 14.68 110.551 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 66.5 mt -72.72 93.56 1.66 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.964 -0.562 . . . . 13.55 110.13 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 136.79 35.38 0.2 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.657 -0.701 . . . . 15.8 112.037 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.1 p -117.0 -63.58 1.43 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.106 0.479 . . . . 17.08 109.923 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -99.31 -71.67 0.69 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.509 0.671 . . . . 18.43 109.368 175.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.41 160.7 29.76 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.075 -0.966 . . . . 18.53 108.667 174.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -149.86 143.11 25.1 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.79 -0.448 . . . . 14.32 109.79 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 48.5 t -160.91 -39.48 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.038 0.446 . . . . 14.51 110.403 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.2 t -87.03 127.11 40.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.985 -0.552 . . . . 13.06 110.391 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.477 ' OD1' ' HB2' ' A' ' 162' ' ' GLN . 18.1 t70 -65.18 106.67 1.36 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.914 -0.585 . . . . 10.33 110.191 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -107.62 -76.99 0.6 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.061 0.457 . . . . 9.88 111.348 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -91.73 -1.34 57.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.97 -0.559 . . . . 10.23 111.981 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.477 ' HB2' ' OD1' ' A' ' 159' ' ' ASP . 15.9 mm100 -79.1 -25.47 43.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.973 0.416 . . . . 9.06 110.752 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 63.17 32.98 14.75 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.245 -0.889 . . . . 6.19 111.996 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -92.9 -29.56 10.43 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.332 -0.707 . . . . 3.97 111.332 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -76.8 77.7 3.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.265 0.555 . . . . 2.63 109.979 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . -158.21 -40.26 0.02 OUTLIER Glycine 0 C--N 1.316 -0.571 0 CA-C-N 114.933 -1.03 . . . . 1.3 111.071 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.655 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 13.5 m -64.59 -15.04 60.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.362 -0.419 . . . . 1.82 111.47 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.59 ' CE2' ' HG ' ' A' ' 169' ' ' LEU . 17.5 p-90 -70.6 -25.99 63.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.785 0.326 . . . . 0.7 111.197 -178.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.59 ' HG ' ' CE2' ' A' ' 168' ' ' TRP . 18.2 mt -86.3 -15.15 41.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.643 0.609 . . . . 0.66 112.643 -173.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.655 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -77.8 -1.93 33.9 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.564 -0.454 . . . . 1.48 110.963 -179.296 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -84.38 -37.94 20.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.221 0.452 . . . . 1.97 112.221 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.747 ' HB ' ' O ' ' A' ' 207' ' ' LEU . 0.0 OUTLIER -65.07 128.64 28.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.975 0.417 . . . . 0.67 110.616 -176.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -119.67 -164.73 1.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 4.34 110.854 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.3 t -71.61 143.87 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.956 0.408 . . . . 1.07 110.523 -176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.532 ' HB3' ' NE2' ' A' ' 181' ' ' GLN . . . -65.59 143.49 57.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.759 -0.655 . . . . 0.71 111.111 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.449 ' SG ' ' HA3' ' A' ' 93' ' ' GLY . 42.0 t -63.52 -19.49 64.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.024 -0.989 . . . . 1.88 111.354 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 180' ' ' ASP . 17.8 t -125.62 138.78 53.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.218 0.532 . . . . 1.63 110.558 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . 0.554 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 8.6 p -77.49 -26.39 51.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.552 -0.749 . . . . 1.96 111.337 -176.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.47 -3.8 58.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.336 0.589 . . . . 2.42 110.224 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 177' ' ' SER . 1.2 m-20 -107.81 16.26 23.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.434 -0.803 . . . . 2.12 110.461 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.554 ' HG2' ' O ' ' A' ' 178' ' ' CYS . 31.7 mm-40 -58.36 120.17 8.26 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.374 0.607 . . . . 1.35 110.961 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.584 ' ND2' HD11 ' A' ' 200' ' ' ILE . 13.5 t30 -142.86 35.54 1.4 Allowed 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.394 -1.336 . . . . 1.68 107.394 175.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.678 ' HB3' ' H ' ' A' ' 208' ' ' VAL . 0.2 OUTLIER -120.44 125.0 46.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.526 -1.215 . . . . 0.81 110.906 -173.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 98.5 m -150.5 133.08 15.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.923 0.392 . . . . 0.51 110.703 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . . . . . . . . . 48.7 ttm -100.27 140.19 34.87 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.654 -0.498 . . . . 1.35 109.654 174.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 32.5 m -124.95 131.55 53.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.137 0.494 . . . . 1.73 111.138 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.74 104.96 14.79 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.656 -0.868 . . . . 1.93 108.656 176.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 22.3 pt -139.19 144.4 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.921 -0.582 . . . . 1.11 110.054 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.0 t 64.71 30.18 12.56 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.217 0.532 . . . . 1.86 110.235 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 58.48 34.11 23.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.387 -0.824 . . . . 2.83 111.355 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -145.3 154.44 42.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 1.75 110.711 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.99 128.45 45.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.167 -0.47 . . . . 1.01 111.749 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.586 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 40.9 m-85 -131.31 155.79 46.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.525 -0.761 . . . . 3.94 110.565 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.483 ' CE1' ' HB3' ' A' ' 169' ' ' LEU . 11.3 m-85 -103.5 114.52 28.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.96 -0.755 . . . . 0.92 108.96 173.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -100.1 118.83 37.28 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.175 -0.466 . . . . 1.11 109.887 -175.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.455 HG12 HD21 ' A' ' 182' ' ' ASN . 1.9 t -83.38 152.16 3.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.408 0.623 . . . . 0.7 109.649 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.1 mm -94.01 -55.15 6.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 114.912 -1.04 . . . . 0.62 111.202 -167.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.481 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -143.85 -179.71 6.64 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.148 -0.478 . . . . 1.38 111.963 -179.443 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.689 ' HA ' ' O ' ' A' ' 104' ' ' MET . 23.7 t70 -45.89 121.98 3.51 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 124.3 1.0 . . . . 2.23 113.009 -175.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.584 HD11 ' ND2' ' A' ' 182' ' ' ASN . 21.1 mm -92.23 130.77 40.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.999 -1.0 . . . . 0.88 111.38 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 11.8 mm-40 -76.93 121.59 85.01 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.38 -0.827 . . . . 2.06 108.933 171.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.88 114.1 1.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.001 1.801 . . . . 0.51 111.181 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.15 -0.53 10.65 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.57 -0.824 . . . . 0.7 113.428 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 201' ' ' GLU . 10.2 pt-20 -133.45 123.38 25.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 117.492 0.646 . . . . 1.27 111.145 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.05 96.44 6.23 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.75 -0.659 . . . . 2.92 111.754 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.505 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 1.3 mm? -113.03 99.03 7.54 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.835 -0.746 . . . . 0.9 109.773 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.747 ' O ' ' HB ' ' A' ' 172' ' ' ILE . 1.5 mm? -145.57 114.1 6.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.554 0.341 . . . . 0.53 110.452 177.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.678 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 4.8 p -155.83 160.48 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 110.137 -0.32 . . . . 0.91 110.137 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -93.22 110.2 21.71 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.006 -1.109 . . . . 1.55 108.006 169.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 14.8 m -72.48 117.31 15.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.257 0.551 . . . . 2.56 110.213 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -74.21 129.8 38.51 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.676 0.75 . . . . 5.36 112.708 -170.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 0.0 OUTLIER -111.95 -14.28 13.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.514 -1.221 . . . . 5.8 109.405 174.144 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 94.44 79.35 1.45 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 114.656 -1.156 . . . . 5.61 112.668 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 45.6 t -111.95 -78.57 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.773 0.32 . . . . 6.31 110.931 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.562 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 75.9 t80 -66.32 -52.63 36.23 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 111.85 0.315 . . . . 8.83 111.85 -177.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 12.5 Cg_endo -54.08 -39.68 84.66 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.613 2.209 . . . . 7.78 112.867 -179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 mp -84.55 -4.86 59.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.251 -0.431 . . . . 8.02 111.913 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . 61.97 46.9 93.13 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.941 -0.572 . . . . 8.64 112.918 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.9 p -83.54 -36.12 24.27 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.911 0.386 . . . . 9.72 111.211 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 221' ' ' PRO . 24.3 m -67.25 138.84 94.58 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.021 -0.536 . . . . 9.62 111.085 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 220' ' ' VAL . 5.1 Cg_exo -79.26 120.24 4.45 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.688 2.259 . . . . 11.65 111.97 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.69 50.68 3.51 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.879 2.386 . . . . 13.11 111.96 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -179.9 153.12 11.59 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.064 -0.814 . . . . 14.03 111.064 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 48.1 tp -120.12 125.69 48.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.138 0.494 . . . . 16.1 110.881 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -139.93 17.19 2.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.47 -0.787 . . . . 17.7 109.371 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 C--O 1.249 1.032 0 CA-C-N 115.098 -0.955 . . . . 18.9 110.068 -177.041 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 112.529 -0.228 . . . . 33.26 112.529 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.0 m -91.05 22.83 3.5 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.836 0.35 . . . . 33.92 111.547 -176.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.03 -156.89 53.41 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.891 -0.671 . . . . 32.35 112.138 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -148.69 95.48 3.96 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.926 -0.398 . . . . 31.65 109.926 177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.9 107.41 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.859 2.373 . . . . 29.99 111.599 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.5 m -106.98 81.62 1.58 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.238 0.542 . . . . 28.92 110.231 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.6 t -92.56 151.04 20.36 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.963 -0.562 . . . . 26.94 110.141 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -152.19 145.26 24.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.245 -0.434 . . . . 25.83 109.995 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -85.04 109.33 18.13 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.085 -0.709 . . . . 23.53 109.085 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -79.28 65.06 4.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.029 -0.532 . . . . 21.64 110.925 -175.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.9 p -59.22 127.81 84.59 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.555 -0.748 . . . . 19.42 110.878 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.42 95.54 0.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.811 2.341 . . . . 17.17 112.283 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -113.26 87.6 2.64 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.299 -0.864 . . . . 17.47 109.747 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -108.94 155.47 20.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.307 -0.406 . . . . 15.63 110.116 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.78 -156.97 24.14 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.802 -0.713 . . . . 12.04 111.812 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.3 p -112.17 98.15 41.66 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 110.224 -0.287 . . . . 10.67 110.224 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.19 106.98 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.673 2.248 . . . . 9.69 112.344 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -119.97 139.27 52.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.084 -0.507 . . . . 7.7 109.874 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -128.51 145.49 51.1 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.864 0.364 . . . . 8.14 110.368 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.87 124.18 55.33 Favored Pre-proline 0 N--CA 1.447 -0.601 0 CA-C-N 115.825 -0.625 . . . . 5.96 110.021 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.78 -165.55 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.596 2.198 . . . . 6.13 112.089 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.2 m -60.01 -37.77 73.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.734 0.302 . . . . 6.53 111.262 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -105.45 127.7 53.14 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.884 -0.413 . . . . 5.01 109.884 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.562 ' O ' HD12 ' A' ' 74' ' ' ILE . 2.2 pp -77.77 141.11 63.81 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.138 -0.483 . . . . 4.23 111.573 -178.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.3 28.25 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.887 2.391 . . . . 4.12 112.515 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -92.55 -68.69 0.78 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.332 -0.394 . . . . 3.82 111.032 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.95 68.52 0.57 Allowed 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.716 0.635 . . . . 3.16 110.183 -175.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 71.1 mt -76.68 119.1 75.98 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.481 -0.781 . . . . 2.45 110.496 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.33 120.41 7.55 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.607 2.205 . . . . 1.75 112.114 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.64 ' H ' HD13 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -113.11 141.67 26.04 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.308 -0.405 . . . . 1.01 109.921 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.32 144.67 70.73 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.773 2.315 . . . . 0.73 112.14 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.662 ' O ' ' HD3' ' A' ' 101' ' ' LYS . . . -62.82 -13.08 29.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.526 -0.761 . . . . 1.04 112.332 -173.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.95 -9.84 59.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.107 -0.497 . . . . 1.66 111.062 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.551 ' CZ ' HD22 ' A' ' 110' ' ' LEU . 9.3 m-85 -138.13 149.97 46.4 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 -173.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.567 ' HB2' ' HE3' ' A' ' 101' ' ' LYS . 9.5 tp10 -125.27 133.84 52.51 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.428 -0.509 . . . . 2.27 111.316 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.88 122.79 33.26 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.214 -0.661 . . . . 0.79 109.214 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.445 ' HB2' ' CD1' ' A' ' 99' ' ' TRP . 39.8 mmt180 -147.28 124.58 11.55 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.913 -1.04 . . . . 3.21 109.452 -174.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.1 110.56 8.49 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.106 -0.702 . . . . 2.46 109.106 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.8 m -143.99 94.18 2.55 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.603 -0.726 . . . . 1.58 109.133 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -64.64 101.86 0.51 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.472 0.654 . . . . 1.86 111.357 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.581 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -108.91 117.03 54.77 Favored Pre-proline 0 N--CA 1.446 -0.672 0 N-CA-C 108.501 -0.926 . . . . 1.45 108.501 172.211 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.86 123.48 13.61 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.907 2.404 . . . . 1.61 112.542 -173.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.51 -23.69 23.91 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.132 -0.556 . . . . 1.74 112.5 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB3' HG23 ' A' ' 91' ' ' ILE . . . -114.95 -68.33 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.95 -0.3 . . . . 1.41 111.513 -178.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 119.84 -158.09 15.36 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.665 -0.779 . . . . 1.09 112.339 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.466 ' C ' ' HD3' ' A' ' 173' ' ' ARG . 8.3 mt -101.17 122.55 43.82 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.684 0.242 . . . . 2.31 110.908 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 171' ' ' TYR . . . -133.97 -159.35 8.9 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.711 -0.757 . . . . 0.59 112.388 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 98' ' ' VAL . 17.3 m -112.29 105.02 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 122.094 0.95 . . . . 0.67 109.812 177.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.445 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 6.4 m95 -83.3 123.28 29.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.173 -0.921 . . . . 1.13 110.194 -171.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.89 117.79 6.37 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.134 -0.485 . . . . 0.54 110.367 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.662 ' HD3' ' O ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -78.83 -0.15 29.45 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.063 0.459 . . . . 1.68 110.676 178.18 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' A' ' 103' ' ' LYS . 34.5 ttp180 -141.48 162.86 34.44 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.666 -0.864 . . . . 3.5 108.666 178.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.419 ' N ' ' HG2' ' A' ' 102' ' ' ARG . 0.0 OUTLIER -79.09 160.02 27.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.273 0.558 . . . . 2.4 111.182 178.316 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.567 ' HE3' HG13 ' A' ' 200' ' ' ILE . 44.9 mtm -130.77 153.04 49.47 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.063 -1.088 . . . . 1.22 108.063 172.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -126.66 146.97 49.99 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.091 0.244 . . . . 2.31 110.764 -177.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -36.34 121.13 0.69 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.716 1.26 . . . . 0.84 113.77 -168.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.2 6.83 13.18 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.268 -0.878 . . . . 1.04 111.349 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.491 ' HG2' ' CG2' ' A' ' 196' ' ' VAL . 0.8 OUTLIER -85.03 157.01 20.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.05 0.453 . . . . 2.62 110.253 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.697 ' HD3' ' CD2' ' A' ' 193' ' ' TYR . 5.9 tmm_? -146.47 133.79 20.66 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.096 -0.502 . . . . 3.62 110.189 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.551 HD22 ' CZ ' ' A' ' 84' ' ' PHE . 3.9 mt -96.92 135.68 38.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.429 -0.952 . . . . 0.53 108.429 175.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.67 169.63 38.25 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.878 -1.153 . . . . 1.02 112.732 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.599 ' O ' ' HA2' ' A' ' 166' ' ' GLY . 74.0 Cg_endo -77.8 167.14 79.48 Favored 'Cis proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.977 -1.676 . . . . 2.1 112.297 -1.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.8 t -109.52 -1.6 18.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.071 0.462 . . . . 2.0 110.539 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.38 149.37 20.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.01 0.433 . . . . 2.03 111.236 -176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.5 p -140.57 97.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.395 -0.82 . . . . 3.95 109.397 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.522 ' CG1' ' HD3' ' A' ' 117' ' ' PRO . 3.2 p -75.29 -34.11 1.56 Allowed Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 113.265 0.839 . . . . 5.21 113.265 -176.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.522 ' HD3' ' CG1' ' A' ' 116' ' ' VAL . 15.7 Cg_exo -69.46 101.61 0.89 Allowed 'Trans proline' 0 C--N 1.363 1.306 0 CA-C-N 120.891 1.354 . . . . 5.07 111.662 176.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.8 mtp-105 70.08 153.63 0.12 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.918 0.761 . . . . 7.99 111.124 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 63.65 -91.06 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.998 -0.546 . . . . 6.95 111.272 -178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 53.39 59.97 4.03 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.253 0.549 . . . . 6.09 111.662 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -123.99 122.0 36.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.782 -0.645 . . . . 5.56 111.356 -177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.406 ' HD2' ' HB3' ' A' ' 126' ' ' PHE . 23.8 pttm -75.91 144.19 41.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.689 -0.687 . . . . 7.42 109.971 176.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -133.63 -39.86 0.89 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.811 0.3 . . . . 9.01 111.811 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 41.0 m -83.36 -69.0 0.66 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.749 0.309 . . . . 8.88 111.162 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.92 172.67 13.32 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.601 -0.518 . . . . 7.6 109.601 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.406 ' HB3' ' HD2' ' A' ' 122' ' ' LYS . 23.7 p90 -133.96 126.56 30.56 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.381 0.61 . . . . 7.23 111.012 -177.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -94.08 -13.64 53.95 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.635 -0.793 . . . . 4.59 111.421 176.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TRP . . . . . 0.427 ' CZ2' HG23 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -138.76 -101.43 0.17 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.495 -0.353 . . . . 4.93 111.392 179.154 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -146.92 -59.95 0.29 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.495 -0.321 . . . . 7.65 110.74 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -166.47 159.94 14.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.047 -0.353 . . . . 8.84 110.047 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.591 ' H ' HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -113.12 -5.39 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.606 -0.27 . . . . 6.05 111.522 178.681 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.77 51.92 1.61 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 122.25 1.024 . . . . 8.5 111.179 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 12.8 t -122.86 17.33 10.18 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.073 -1.421 . . . . 9.82 109.034 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.443 ' HB3' HG21 ' A' ' 116' ' ' VAL . 31.1 t70 -122.41 126.04 47.14 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.324 -1.307 . . . . 11.21 108.984 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.8 t -75.7 115.56 17.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.041 -0.527 . . . . 10.84 111.267 -173.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.21 150.15 47.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.516 -0.766 . . . . 13.25 109.769 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.3 m -92.02 43.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.394 0.616 . . . . 13.89 110.877 -177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 66.7 m -124.94 72.8 64.11 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.643 -0.708 . . . . 14.05 110.706 176.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.42 122.95 9.43 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.724 2.283 . . . . 14.41 111.465 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 60.96 81.17 0.19 Allowed 'General case' 0 C--O 1.232 0.145 0 O-C-N 123.669 0.606 . . . . 14.44 111.077 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -57.84 124.57 19.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.315 -0.402 . . . . 15.9 110.387 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.24 84.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.439 -0.665 . . . . 15.6 111.439 -176.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 49.6 t 59.37 73.35 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.445 0.64 . . . . 15.6 110.594 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 73.2 mt -106.1 -44.29 7.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.608 -0.724 . . . . 13.85 110.069 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 38.6 p 48.95 69.89 0.53 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.766 -0.652 . . . . 13.19 111.916 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -95.3 -13.13 25.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.691 -0.686 . . . . 15.67 110.154 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.456 ' H ' HG13 ' A' ' 147' ' ' ILE . 2.1 pp -86.61 166.58 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.576 -0.738 . . . . 13.77 111.566 -177.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.5 t -164.59 134.5 3.88 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.195 -1.039 . . . . 13.62 108.195 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 66.57 75.62 0.32 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.854 0.721 . . . . 13.02 110.99 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -76.33 149.03 37.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.531 -0.759 . . . . 14.68 109.944 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.534 ' HB3' ' O ' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -90.79 87.27 6.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.626 0.727 . . . . 13.55 112.181 -174.405 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -112.86 64.45 0.27 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.012 -0.835 . . . . 15.8 111.012 171.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.9 t 69.38 21.15 7.05 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.219 0.608 . . . . 17.08 110.559 -177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -98.52 -77.34 0.51 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.862 -0.608 . . . . 18.43 110.619 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 151' ' ' LEU . 15.9 ptpt -143.65 153.52 42.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.214 -0.903 . . . . 18.53 109.94 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -110.86 79.27 1.19 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.174 0.511 . . . . 14.32 110.19 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 47.2 t -69.34 122.42 18.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.688 -0.687 . . . . 14.51 110.766 -178.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.31 147.11 7.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.82 -0.627 . . . . 13.06 110.336 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 55.05 52.51 11.68 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.412 0.625 . . . . 10.33 110.453 -176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.14 -65.57 0.07 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.987 -1.006 . . . . 9.88 110.463 -176.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -129.98 23.18 5.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.52 . . . . 10.23 111.623 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -86.85 -40.07 15.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.86 0.362 . . . . 9.06 110.98 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.26 136.32 51.76 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.097 -0.501 . . . . 6.19 110.628 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 140.23 -40.23 1.41 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.775 -0.726 . . . . 3.97 111.668 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -80.97 66.8 6.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.247 0.546 . . . . 2.63 110.698 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.599 ' HA2' ' O ' ' A' ' 112' ' ' PRO . . . -130.9 -33.11 0.48 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.339 -0.846 . . . . 1.3 112.63 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.648 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 2.9 m -63.79 -14.86 56.37 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 122.669 0.388 . . . . 1.82 111.989 -177.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' TRP . . . . . 0.498 ' HB2' HG22 ' A' ' 80' ' ' ILE . 19.7 p-90 -69.39 -21.42 63.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.988 0.366 . . . . 0.7 111.988 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 169' ' ' LEU . 18.3 mt -80.73 -14.56 58.0 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.942 0.719 . . . . 0.66 112.942 -173.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.648 ' HG3' ' O ' ' A' ' 167' ' ' SER . 0.0 OUTLIER -68.04 -10.44 53.75 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.286 -0.566 . . . . 1.48 110.205 176.334 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.565 ' O ' ' HD2' ' A' ' 173' ' ' ARG . 50.9 m-85 -78.89 -27.89 43.95 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.749 -0.66 . . . . 1.97 112.4 -175.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.647 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 1.6 mm -57.87 139.05 18.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 117.895 0.316 . . . . 0.67 111.289 -175.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.565 ' HD2' ' O ' ' A' ' 171' ' ' TYR . 18.2 mmm180 -95.24 147.67 23.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.103 0.478 . . . . 4.34 112.034 -174.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.434 HG22 HG11 ' A' ' 208' ' ' VAL . 81.6 t -66.56 148.61 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 115.374 -0.83 . . . . 1.07 108.773 168.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.738 ' HB2' HD11 ' A' ' 183' ' ' LEU . . . -57.32 122.94 13.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.026 0.441 . . . . 0.71 112.108 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 52.9 t -66.56 -28.7 68.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.573 -0.74 . . . . 1.88 109.967 175.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.0 p -126.73 139.51 53.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.879 -0.6 . . . . 1.63 110.614 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' CYS . . . . . . . . . . . . . 54.0 t -76.97 -8.41 57.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.992 -0.549 . . . . 1.96 111.093 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.02 -3.87 58.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.204 0.526 . . . . 2.42 110.238 177.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -111.81 17.91 19.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.638 -0.71 . . . . 2.12 111.816 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.56 ' HA ' HE21 ' A' ' 181' ' ' GLN . 0.1 OUTLIER -55.43 114.84 1.99 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.289 0.566 . . . . 1.35 110.897 -176.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.862 ' H ' HD12 ' A' ' 183' ' ' LEU . 18.3 t30 -155.03 32.49 0.39 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 122.062 0.934 . . . . 1.68 108.7 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.862 HD12 ' H ' ' A' ' 182' ' ' ASN . 2.0 mp -115.36 120.36 39.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.381 -0.827 . . . . 0.81 110.975 -173.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 95.4 m -148.66 138.96 22.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.324 0.583 . . . . 0.51 111.366 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' MET . . . . . 0.466 ' HB2' ' HB2' ' A' ' 209' ' ' HIS . 65.5 mtp -120.71 135.51 55.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.93 -0.577 . . . . 1.35 109.758 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' CYS . . . . . . . . . . . . . 44.2 t -114.52 141.9 47.11 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.93 0.395 . . . . 1.73 110.736 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLN . . . . . 0.416 ' HG2' HD13 ' A' ' 192' ' ' ILE . 0.0 OUTLIER -106.71 103.93 13.49 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.026 -0.731 . . . . 1.93 109.026 177.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 11.6 pt -146.34 145.08 20.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.967 -0.56 . . . . 1.11 110.218 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.4 t 67.3 33.91 5.14 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.509 0.506 . . . . 1.86 110.242 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 66.33 8.38 5.62 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.419 -0.809 . . . . 2.83 111.701 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -132.35 167.72 19.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.062 0.458 . . . . 1.75 110.935 -175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.416 HD13 ' HG2' ' A' ' 187' ' ' GLN . 50.2 mm -98.35 128.45 49.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.674 -0.694 . . . . 1.01 110.469 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.697 ' CD2' ' HD3' ' A' ' 109' ' ' ARG . 2.2 m-85 -118.44 146.95 44.08 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.161 0.505 . . . . 3.94 110.708 175.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.466 ' HB2' ' HB2' ' A' ' 110' ' ' LEU . 3.2 m-85 -100.95 113.2 25.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.934 -0.765 . . . . 0.92 108.934 175.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -111.57 123.8 50.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.925 0.393 . . . . 1.11 110.184 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.494 ' CG1' HD21 ' A' ' 182' ' ' ASN . 2.1 t -93.67 152.3 3.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.777 0.799 . . . . 0.7 110.386 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.2 mm -92.98 -54.83 6.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.433 -1.258 . . . . 0.62 110.801 -166.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.49 ' HG3' ' OD1' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -138.78 -179.25 5.72 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.437 -0.801 . . . . 1.38 110.1 178.312 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 104' ' ' MET . 4.8 p-10 -56.09 135.8 52.72 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.68 0.752 . . . . 2.23 112.389 -173.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.567 HG13 ' HE3' ' A' ' 104' ' ' MET . 28.4 mm -96.48 138.11 22.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.238 -0.892 . . . . 0.88 110.817 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -83.34 127.51 68.29 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.949 -0.569 . . . . 2.06 109.534 172.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.2 115.57 2.26 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.835 2.357 . . . . 0.51 112.367 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 122.0 -12.94 9.17 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.471 -0.871 . . . . 0.7 113.543 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.76 123.0 34.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.563 0.681 . . . . 1.27 111.504 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.647 ' OE2' ' HA ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -110.47 112.1 23.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.766 -0.652 . . . . 2.92 111.142 177.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.502 ' HB3' ' HG ' ' A' ' 183' ' ' LEU . 0.9 OUTLIER -122.51 98.96 6.16 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.317 -0.553 . . . . 0.9 109.606 173.551 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.621 ' HB2' HG21 ' A' ' 172' ' ' ILE . 1.7 mm? -147.74 106.55 3.83 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.722 -0.473 . . . . 0.53 109.722 175.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.753 ' H ' ' HB3' ' A' ' 183' ' ' LEU . 19.5 t -154.91 157.45 4.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.014 -1.106 . . . . 0.91 108.014 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 185' ' ' MET . 3.6 t-80 -89.23 109.86 20.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.731 -0.84 . . . . 1.55 108.731 173.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 4.2 m -124.8 93.89 2.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.624 0.726 . . . . 2.56 110.665 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -142.01 139.69 32.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.369 -0.832 . . . . 5.36 109.893 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -89.75 1.13 56.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.214 -0.448 . . . . 5.8 111.184 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.443 ' CA ' ' HB2' ' A' ' 217' ' ' LEU . . . -139.09 65.89 0.53 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.616 -0.802 . . . . 5.61 112.647 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 41.3 t -103.49 -72.23 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.831 0.348 . . . . 6.31 110.611 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' TYR . . . . . 0.44 ' N ' ' HD2' ' A' ' 216' ' ' PRO . 66.8 t80 -82.33 -57.17 0.49 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.218 -0.446 . . . . 8.83 111.214 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 215' ' ' TYR . 18.9 Cg_endo -60.43 -43.1 35.89 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.252 1.968 . . . . 7.78 112.828 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.443 ' HB2' ' CA ' ' A' ' 213' ' ' GLY . 7.2 mp -99.73 25.82 6.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.95 0.405 . . . . 8.02 110.782 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -104.9 169.73 17.11 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.781 -0.724 . . . . 8.64 112.077 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 17.3 p -85.28 -2.31 57.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.982 0.42 . . . . 9.72 110.852 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . 0.425 ' O ' ' HD3' ' A' ' 222' ' ' PRO . 23.5 m -63.31 129.21 93.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.774 -0.648 . . . . 9.62 110.218 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.07 112.17 3.03 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.48 2.12 . . . . 11.65 112.941 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 220' ' ' VAL . 92.2 Cg_endo -85.28 3.38 7.32 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.715 2.277 . . . . 13.11 111.438 176.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 224' ' ' LEU . . . 166.23 169.57 30.01 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.195 -1.162 . . . . 14.03 110.195 -177.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.436 ' HB3' ' O ' ' A' ' 223' ' ' GLY . 59.1 tp 70.79 136.9 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.335 0.588 . . . . 16.1 111.366 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -140.6 -51.89 0.47 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.823 -0.626 . . . . 17.7 110.314 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 C--O 1.249 1.064 0 CA-C-N 116.044 -0.525 . . . . 18.9 110.564 179.79 . . . . . . . . 0 0 . 1 stop_ save_